PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Rutledge, RG; Stewart, D; Overton, C; Klimaszewska, K				Rutledge, R. G.; Stewart, D.; Overton, C.; Klimaszewska, K.			Gene expression analysis of primordial shoot explants collected from mature white spruce (Picea glauca) trees that differ in their responsiveness to somatic embryogenesis induction	PLOS ONE			English	Article							ASCORBATE PEROXIDASE; NORWAY SPRUCE; GENOME; PROPAGATION; ANNOTATION; BLAST2GO; CULTURES; PCR	Within a plantation of clonal somatic embryo-derived white spruce trees that belonged to four genotypes, one genotype (G6) has consistently responded for the last 16 years, to the induction of somatic embryogenesis within primordial shoot explants. Analysis of fourteen individuals within this genotype subsequently revealed a group of clonal trees that were non-responsive. This in turn provided a unique opportunity to conduct differential gene expression analysis in the absence of genotype-specific factors. Absolute qPCR was first used to expand the analysis of several genes previously identified via microarray analysis to be differentially expressed during SE induction, along with the inclusion of two nonresponsive genotypes. While this demonstrated a high level of repeatability within, and between, responsive and nonresponsive genotypes, it did not support our previous contention that an adaptive stress response plays a role in SE induction responsiveness, at least with respect to the candidate genes we analyzed. RNAseq analysis was then used to compare responsive and nonresponsive G6 primordial shoots during the somatic embryogenesis induction treatment. Although not analyzed in this study, this included samples of callus and embryonal masses previously generated from G6 explants. In addition to revealing a large number of differentially expressed genes, de novo assembly of unmapped reads was used to generate over 25,000 contigs that potentially represent previously unidentified transcripts. This included a MADS-domain gene that was found to be the most highly differentially expressed gene within responsive shoot explants during the first seven days of the induction treatment.	[Rutledge, R. G.; Stewart, D.; Overton, C.; Klimaszewska, K.] Nat Resources Canada, Laurentian Forestry Ctr, Canadian Forest Serv, 1055 PEPS, Stn St Foy, PQ, Canada	Natural Resources Canada; Canadian Forest Service	Klimaszewska, K (corresponding author), Nat Resources Canada, Laurentian Forestry Ctr, Canadian Forest Serv, 1055 PEPS, Stn St Foy, PQ, Canada.	Krystyna.Klimaszewska@canada.ca			Natural Resources Canada, Canadian Forest Service	Natural Resources Canada, Canadian Forest Service(Natural Resources CanadaCanadian Forest Service)	This work was financially supported by Natural Resources Canada, Canadian Forest Service. The funders had no role in study design,	Adams G., 2016, VEGETATIVE PROPAGATI, P323; Birol I, 2013, BIOINFORMATICS, V29, P1492, DOI 10.1093/bioinformatics/btt178; Bonga JM, 2010, PLANT CELL TISS ORG, V100, P241, DOI 10.1007/s11240-009-9647-2; Chalupa V., 1985, Communicationes Instituti Forestalis Cechosloveniae, V14, P57; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Devonshire AS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-118; Elhiti M, 2013, IN VITRO CELL DEV-PL, V49, P631, DOI 10.1007/s11627-013-9547-3; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Garcia-Mendiguren O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128679; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gramzow L, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-214; HAKMAN I, 1985, PLANT SCI, V38, P53, DOI 10.1016/0168-9452(85)90079-2; Harvengt L, 2001, PLANTA, V213, P828, DOI 10.1007/s004250100628; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ishikawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P1143, DOI 10.1271/bbb.80062; Klimaszewska K., 2016, VEGETATIVE PROPAGATI, P195; Klimaszewska K, 2011, PLANTA, V233, P635, DOI 10.1007/s00425-010-1325-4; Koussevitzky S, 2008, J BIOL CHEM, V283, P34197, DOI 10.1074/jbc.M806337200; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Panchuk II, 2002, PLANT PHYSIOL, V129, P838, DOI 10.1104/pp.001362; Park SY, 2010, TREE PHYSIOL, V30, P1469, DOI 10.1093/treephys/tpq081; Park Y., 2016, VEGETATIVE PROPAGATI, P302; Rigault P, 2011, PLANT PHYSIOL, V157, P14, DOI 10.1104/pp.111.179663; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Rutledge RG, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-116; Rutledge RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017636; Rutledge RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009731; Rutledge RG, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-96; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; Sutton B, 2002, ANN FOR SCI, V59, P657, DOI 10.1051/forest:2002052; Trontin JF, 2016, VEGETATIVE PROPAGATI, P211; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47; Vermeulen J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp721; Yakovlev IA, 2008, PLANTA, V228, P459, DOI 10.1007/s00425-008-0750-0	36	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185015	10.1371/journal.pone.0185015	http://dx.doi.org/10.1371/journal.pone.0185015			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968421	Green Published, Green Submitted, gold			2022-12-27	WOS:000412029600011
J	Floegel, M; Kell, CA				Floegel, Mareike; Kell, Christian Alexander			Functional hemispheric asymmetries during the planning and manual control of virtual avatar movements	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; AGE-RELATED-CHANGES; PREMOTOR CORTEX; MOTOR CONTROL; GRIP FORCE; CEREBRAL ASYMMETRIES; REACHING MOVEMENTS; MENTAL ROTATION; TIME-ESTIMATION; NEURAL SYSTEMS	Both hemispheres contribute to motor control beyond the innervation of the contralateral alpha motoneurons. The left hemisphere has been associated with higher-order aspects of motor control like sequencing and temporal processing, the right hemisphere with the transformation of visual information to guide movements in space. In the visuomotor context, empirical evidence regarding the latter has been limited though the right hemisphere's specialization for visuospatial processing is well-documented in perceptual tasks. This study operationalized temporal and spatial processing demands during visuomotor processing and investigated hemispheric asymmetries in neural activation during the unimanual control of a visual cursor by grip force. Functional asymmetries were investigated separately for visuomotor planning and online control during functional magnetic resonance imaging in 19 young, healthy, right-handed participants. The expected cursor movement was coded with different visual trajectories. During planning when spatial processing demands predominated, activity was right-lateralized in a hand-independent manner in the inferior temporal lobe, occipito-parietal border, and ventral premotor cortex. When temporal processing demands overweighed spatial demands, BOLD responses during planning were left-lateralized in the temporo-parietal junction. During online control of the cursor, right lateralization was not observed. Instead, left lateralization occurred in the intraparietal sulcus. Our results identify movement phase and spatiotemporal demands as important determinants of dynamic hemispheric asymmetries during visuomotor processing. We suggest that, within a bilateral visuomotor network, the right hemisphere exhibits a processing preference for planning global spatial movement features whereas the left hemisphere preferentially times local features of visual movement trajectories and adjusts movement online.	[Kell, Christian Alexander] Goethe Univ, Cognit Neurosci Grp, Brain Imaging Ctr, Frankfurt, Germany; Goethe Univ, Dept Neurol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Kell, CA (corresponding author), Goethe Univ, Cognit Neurosci Grp, Brain Imaging Ctr, Frankfurt, Germany.	c.kell@em.uni-frankfurt.de			LOEWE grant of the State of Hesse; Deutsche Forschungsgemeinschaft [KE 1514/2-1]	LOEWE grant of the State of Hesse; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by a LOEWE grant of the State of Hesse to CK (NEFF). CK and MF were supported by the Deutsche Forschungsgemeinschaft (KE 1514/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; Begliomini C, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00167; Begliomini C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003388; Binder E, 2014, NEUROPSYCHOLOGIA, V54, P18, DOI 10.1016/j.neuropsychologia.2013.11.018; Callaert DV, 2011, HUM BRAIN MAPP, V32, P1311, DOI 10.1002/hbm.21110; Chen R, 1997, ANN NEUROL, V41, P247, DOI 10.1002/ana.410410216; Cohen Jacob, 1975, APPL MULTIPLE REGRES; Corballis MC, 1996, NEUROPSYCHOLOGY, V10, P42, DOI 10.1037/0894-4105.10.1.42; Corballis MC, 1997, BRAIN LANG, V57, P100, DOI 10.1006/brln.1997.1835; Corballis MC, 1997, PSYCHOL REV, V104, P714, DOI 10.1037/0033-295X.104.4.714; Corballis PM, 2003, BRAIN COGNITION, V53, P171, DOI 10.1016/S0278-2626(03)00103-9; Coull JT, 1998, J NEUROSCI, V18, P7426; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Cramer SC, 2002, HUM BRAIN MAPP, V16, P197, DOI 10.1002/hbm.10040; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; Davis B, 2009, J NEUROSCI, V29, P3182, DOI 10.1523/JNEUROSCI.5793-08.2009; Della-Maggiore V, 2004, J NEUROSCI, V24, P9971, DOI 10.1523/JNEUROSCI.2833-04.2004; Deruelle C, 1997, Laterality, V2, P233, DOI 10.1080/135765097397468; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ellermann JM, 1998, J MAGN RESON, V131, P272, DOI 10.1006/jmre.1998.1379; Erdeniz B, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00116; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; FISK JD, 1988, EXP BRAIN RES, V72, P425; Frak V, 2006, THESCIENTIFICWORLDJO, V6, P1805, DOI 10.1100/tsw.2006.291; Frey SH, 2008, PHILOS T R SOC B, V363, P1951, DOI 10.1098/rstb.2008.0008; Frey SH, 2005, COGNITIVE BRAIN RES, V23, P397, DOI 10.1016/j.cogbrainres.2004.11.010; Friston K, 2011, NEURON, V72, P488, DOI 10.1016/j.neuron.2011.10.018; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; GAZZANIG.MS, 1965, BRAIN, V88, P221, DOI 10.1093/brain/88.2.221; Glover S, 2005, J COGNITIVE NEUROSCI, V17, P124, DOI 10.1162/0898929052880066; Gonzalez CLR, 2007, EXP BRAIN RES, V182, P275, DOI 10.1007/s00221-007-1090-1; GOODALE MA, 1990, VISION ACTION CONTRO, P14; Grosskopf A, 2006, EXP BRAIN RES, V168, P230, DOI 10.1007/s00221-005-0083-1; Haaland KY, 2004, J COGNITIVE NEUROSCI, V16, P621, DOI 10.1162/089892904323057344; Hammond GR, 2005, NEUROREPORT, V16, P559, DOI 10.1097/00001756-200504250-00008; Hopkins WD, 1997, NEUROPSYCHOLOGIA, V35, P343, DOI 10.1016/S0028-3932(96)00089-9; Ivry RB, 1997, 2 SIDES PERCEPTION; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Keisker B, 2009, HUM BRAIN MAPP, V30, P2453, DOI 10.1002/hbm.20676; Kell CA, 2016, SPEECH MOTOR CONTROL, P25; KIMURA D, 1974, BRAIN, V97, P337, DOI 10.1093/brain/97.1.337; King M, 2014, NEUROIMAGE, V102, P923, DOI 10.1016/j.neuroimage.2014.05.064; Kuhtz-Buschbeck JP, 2008, NEUROIMAGE, V40, P1469, DOI 10.1016/j.neuroimage.2008.01.037; LANCASTER BP, 1999, ANN M SW ED RES ASS; Ludlow L, 2014, J STAT ED, V22, P1, DOI DOI 10.1080/10691898.2014.11889703; Martin K, 2011, NEUROIMAGE, V57, P502, DOI 10.1016/j.neuroimage.2011.04.036; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; Milivojevic B, 2009, J COGNITIVE NEUROSCI, V21, P945, DOI 10.1162/jocn.2009.21085; Morillon B, 2009, J NEUROSCI, V29, P14803, DOI 10.1523/JNEUROSCI.3222-09.2009; Mumford JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126255; Neely KA, 2013, HUM BRAIN MAPP, V34, P698, DOI 10.1002/hbm.21467; Ng VWK, 2000, HUM BRAIN MAPP, V10, P80, DOI 10.1002/(SICI)1097-0193(200006)10:2<80::AID-HBM40>3.0.CO;2-2; Nicholls MER, 2002, INT J PSYCHOPHYSIOL, V44, P37, DOI 10.1016/S0167-8760(01)00190-8; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Penny W., 2003, RANDOM EFFECTS ANAL; Pohl PS, 2000, NEUROREHAB NEURAL RE, V14, P33, DOI 10.1177/154596830001400104; Poline JB, 2006, CONTRASTS CLASSICAL; PRABLANC C, 1979, BIOL CYBERN, V35, P183, DOI 10.1007/BF00337063; Rice NJ, 2007, BRAIN RES, V1175, P76, DOI 10.1016/j.brainres.2007.08.009; Riemann BL, 2002, J ATHL TRAINING, V37, P80; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rotella MF, 2015, J NEUROPHYSIOL, V113, P1873, DOI 10.1152/jn.00255.2014; Schubotz RI, 2002, NEUROIMAGE, V16, P920, DOI 10.1006/nimg.2002.1183; Schubotz RI, 2002, NEUROIMAGE, V15, P787, DOI 10.1006/nimg.2001.1043; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Stephan KE, 2007, NEUROPSYCHOLOGIA, V45, P209, DOI 10.1016/j.neuropsychologia.2006.07.002; Sterr A, 2009, NEUROSCI LETT, V457, P61, DOI 10.1016/j.neulet.2009.04.013; Sulzer JS, 2011, IEEE ENG MED BIO, P2342, DOI 10.1109/IEMBS.2011.6090655; Talelli P, 2008, NEUROIMAGE, V40, P1772, DOI 10.1016/j.neuroimage.2008.01.039; Tretriluxana J, 2009, NEUROREHAB NEURAL RE, V23, P679, DOI 10.1177/1545968309332733; Vaillancourt DE, 2006, J NEUROPHYSIOL, V95, P922, DOI 10.1152/jn.00718.2005; Vaillancourt DE, 2003, J NEUROPHYSIOL, V90, P3330, DOI 10.1152/jn.00394.2003; van Duinen H, 2008, HUM BRAIN MAPP, V29, P281, DOI 10.1002/hbm.20388; Ward NS, 2008, NEUROBIOL AGING, V29, P1434, DOI 10.1016/j.neurobiolaging.2007.04.017; Ward NS, 2003, BRAIN, V126, P873, DOI 10.1093/brain/awg071; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026; Woolley DG, 2010, NEUROIMAGE, V50, P1566, DOI 10.1016/j.neuroimage.2010.01.012	80	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185152	10.1371/journal.pone.0185152	http://dx.doi.org/10.1371/journal.pone.0185152			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957344	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200030
J	Kashani, K; Thongprayoon, C; Cheungpasitporn, W; Iacovella, GM; Akhoundi, A; Albright, RC				Kashani, Kianoush; Thongprayoon, Charat; Cheungpasitporn, Wisit; Iacovella, Gina M.; Akhoundi, Abbasali; Albright, Robert C., Jr.			Association between mortality and replacement solution bicarbonate concentration in continuous renal replacement therapy: A propensity-matched cohort study	PLOS ONE			English	Article							CONTINUOUS VENOVENOUS HEMOFILTRATION; CRITICALLY-ILL PATIENTS; SODIUM-BICARBONATE; LACTIC-ACIDOSIS; HYPERCARBIC ACIDOSIS; INTERMITTENT; SCORE; CONTRACTILITY; HEMODYNAMICS; DIALYSIS	Background Given the known deleterious effects seen with bicarbonate supplementation for acidemia, we hypothesized that utilizing high bicarbonate concentration replacement solution in continuous venovenous hemofiltration (CVVH) would be independently associated with higher mortality. Methods In a propensity score-matched historical cohort study conducted at a single tertiary care center from December 9, 2006, through December 31, 2009, a total of 287consecutive adult critically ill patients with Stage III acute kidney injury (AKI) requiring CVVH were enrolled. We excluded patients on maintenance dialysis, those who received other modalities of continuous renal replacement therapies, and patients that received a mixed of 22 and 32 mEq/L bicarbonate solution pre-and post-filter. The primary outcome was in-hospital and 90-day mortality rates. Results Among enrollees, 68 were used 32 mEq/L bicarbonate solution, and 219 received 22mEq/L bicarbonate solution for CVVH. Patients on 32 mEq/L bicarbonate solution were more often non-surgical, had lower pH and bicarbonate level but had higher blood potassium and phosphorus levels in comparison with those on 22 mEq/L bicarbonate solution. After adjustment for the baseline characteristics, the use of 32 bicarbonate solution was significantly associated with increased in-hospital (HR = 1.94; 95% CI 1.02-3.79) and 90-day mortality (HR = 1.50; 95% CI 1.03-2.14). There was a significant increase in the hospital (p =.03) and 90- day (p =.04) mortality between the 22 vs. 32 mEq/L bicarbonate solution groups following propensity matching. Conclusion Our data showed there is a strong association between using high bicarbonate solution and mortality independent of severity of illness and comorbid conditions. These findings need to be evaluated further in prospective studies.	[Kashani, Kianoush; Thongprayoon, Charat; Cheungpasitporn, Wisit; Akhoundi, Abbasali; Albright, Robert C., Jr.] Mayo Clin, Dept Internal Med, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Kashani, Kianoush; Iacovella, Gina M.] Mayo Clin, Div Pulm & Crit Care, Dept Internal Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Kashani, K (corresponding author), Mayo Clin, Dept Internal Med, Div Nephrol & Hypertens, Rochester, MN 55905 USA.; Kashani, K (corresponding author), Mayo Clin, Div Pulm & Crit Care, Dept Internal Med, Rochester, MN 55905 USA.	Kashani.kianoush@mayo.edu	Thongprayoon, Charat/J-4184-2019; Cheungpasitporn, Wisit/H-8194-2019	Thongprayoon, Charat/0000-0002-8313-3604; Cheungpasitporn, Wisit/0000-0001-9954-9711; Kashani, Kianoush/0000-0003-2184-3683				Adrogue HJ, 1998, NEW ENGL J MED, V338, P26, DOI 10.1056/NEJM199801013380106; Akhoundi A, 2015, BLOOD PURIFICAT, V39, P333, DOI 10.1159/000380903; [Anonymous], 2012, Kidney Int Suppl (2011), V2, P89; ARIEFF AI, 1983, CLIN SCI, V64, P573, DOI 10.1042/cs0640573; Augustine JJ, 2004, AM J KIDNEY DIS, V44, P1000, DOI 10.1053/j.ajkd.2004.08.022; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; Bagshaw SM, 2008, CRIT CARE MED, V36, P610, DOI 10.1097/01.CCM.0B013E3181611F552; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; BERENYI KJ, 1975, CIRCULATION, V52, P319, DOI 10.1161/01.CIR.52.2.319; BERSIN RM, 1989, AM J MED, V87, P7, DOI 10.1016/S0002-9343(89)80476-0; COOPER DJ, 1990, ANN INTERN MED, V112, P492, DOI 10.7326/0003-4819-112-7-492; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; GEDEBORG R, 1989, RESUSCITATION, V18, P49, DOI 10.1016/0300-9572(89)90112-3; GROGONO AW, 1986, INT ANESTHESIOL CLIN, V24, P11, DOI 10.1097/00004311-198602410-00003; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; HUSEBY JS, 1981, CHEST, V79, P552, DOI 10.1378/chest.79.5.552; Jaber S, 2008, ANESTHESIOLOGY, V108, P651, DOI 10.1097/ALN.0b013e31816725a6; Karvellas CJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10061; Kellum JA, 2008, CRIT CARE MED, V36, pS141, DOI 10.1097/CCM.0b013e318168c4a4; Kraut JA, 2010, NAT REV NEPHROL, V6, P274, DOI 10.1038/nrneph.2010.33; MALDONADO FA, 1993, ANESTHESIOLOGY, V78, P343, DOI 10.1097/00000542-199302000-00019; MATHIEU D, 1991, CRIT CARE MED, V19, P1352, DOI 10.1097/00003246-199111000-00008; MCELROY WT, 1958, AM J PHYSIOL, V195, P412, DOI 10.1152/ajplegacy.1958.195.2.412; Mehta RL, 2001, KIDNEY INT, V60, P1154, DOI 10.1046/j.1523-1755.2001.0600031154.x; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Payen D, 2009, CRIT CARE MED, V37, P803, DOI 10.1097/CCM.0b013e3181962316; Richardson DE, 2003, FREE RADICAL BIO MED, V35, P1538, DOI 10.1016/j.freeradbiomed.2003.08.019; Rocktaschel J, 2003, INT J ARTIF ORGANS, V26, P19, DOI 10.1177/039139880302600104; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sekhon JS, 2011, J STAT SOFTW, V42, P1; TANG W, 1991, CRIT CARE MED, V19, P218, DOI 10.1097/00003246-199102000-00018; Uehlinger DE, 2005, NEPHROL DIAL TRANSPL, V20, P1630, DOI 10.1093/ndt/gfh880; Vinsonneau C, 2006, LANCET, V368, P379, DOI 10.1016/S0140-6736(06)69111-3; Vukmir RB, 1996, AM J EMERG MED, V14, P192, DOI 10.1016/S0735-6757(96)90133-3; Wald R, 2012, CRIT CARE, V16, DOI 10.1186/cc11835; WU DJ, 1990, JPN HEART J, V31, P109; [No title captured]; [No title captured]	41	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185064	10.1371/journal.pone.0185064	http://dx.doi.org/10.1371/journal.pone.0185064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957333	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200027
J	Loutfy, M; de Pokomandy, A; Kennedy, VL; Carter, A; O'Brien, N; Proulx-Boucher, K; Ding, E; Lewis, J; Nicholson, V; Beaver, K; Greene, S; Tharao, W; Benoit, A; Dubuc, D; Thomas-Pavanel, J; Sereda, P; Jabbari, S; Shurgold, JH; Colley, G; Hogg, RS; Kaida, A				Loutfy, Mona; de Pokomandy, Alexandra; Kennedy, V. Logan; Carter, Allison; O'Brien, Nadia; Proulx-Boucher, Karene; Ding, Erin; Lewis, Johanna; Nicholson, Valerie; Beaver, Kerrigan; Greene, Saara; Tharao, Wangari; Benoit, Anita; Dubuc, Daniele; Thomas-Pavanel, Jamie; Sereda, Paul; Jabbari, Shahab; Shurgold, Jayson H.; Colley, Guillaume; Hogg, Robert S.; Kaida, Angela		CHIWOS Res Team	Cohort profile: The Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS)	PLOS ONE			English	Article							COMMUNITY-BASED RESEARCH; GENDER-DIFFERENCES; INTERSECTIONALITY; REFLECTIONS; QUALITY	Globally, women are at increased vulnerability to HIV due to biological, social, structural, and political reasons. Women living with HIV also experience unique issues related to their medical and social healthcare, which makes a clinical care model specific to their needs worthy of exploration. Furthermore, there is a dearth of research specific to women living with HIV. Research for this population has often been narrowly focused on pregnancy-related issues without considering their complex structural inequalities, social roles, and healthcare and biological needs. For these reasons, we have come together, as researchers, clinicians and community members in Canada, to develop the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS) to investigate the concept of women-centred HIV care (WCHC) and its impact on the overall, HIV, women's, mental, sexual, and reproductive health outcomes of women living with HIV. Here, we present the CHIWOS cohort profile, which describes the cohort and presents preliminary findings related to perceived WCHC. CHIWOS is a prospective, observational cohort study of women living with HIV in British Columbia (BC), Ontario, and Quebec. Two additional Canadian provinces, Saskatchewan and Manitoba, will join the cohort in 2018. Using community-based research principles, CHIWOS engages women living with HIV throughout the entire research process meeting the requirements of the 'Greater Involvement of People living with HIV/AIDS'. Study data are collected through an interviewer-administered questionnaire that uses a web-based platform. From August 2013 to May 2015, a total of 1422 women living with HIV in BC, Ontario, and Quebec were enrolled and completed the baseline visit.Follow-up interviews are being conducted at 18-month intervals. Of the 1422 participants at baseline, 356 were from BC (25%), 713 from Ontario (50%), 353 from Quebec (25%). The median age of the participants at baseline was 43 years (range, 16-74). 22% identified as Indigenous, 30% as African, Caribbean or Black, 41% as Caucasian/White, and 7% as other ethnicities. Overall, 83% of women were taking antiretroviral therapy at the time of the baseline interview and of them, 87% reported an undetectable viral load. Of the 1326 women who received HIV medical care in the previous year and responded to corresponding questions, 57% (95% CI: 54%-60%) perceived that the care they received from their primary HIV doctor had been women-centred. There were provincial and age differences among women who indicated that they received WCHC versus not; women from BC or Ontario were more likely to report WCHC compared to participants in Quebec. They were also more likely to be younger. CHIWOS will be an important tool to develop care models specific for women living with HIV. Moreover, CHIWOS is collecting extensive information on socio-demographics, social determinants of health, psychological factors, and sexual and reproductive health and offers an important platform to answer many relevant research questions for and with women living with HIV. Information on the cohort can be found on the study website(http://www.chiwos.ca).	[Loutfy, Mona; Kennedy, V. Logan; Lewis, Johanna; Beaver, Kerrigan; Benoit, Anita; Thomas-Pavanel, Jamie] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Loutfy, Mona; Thomas-Pavanel, Jamie] Univ Toronto, Fac Med, Toronto, ON, Canada; [Loutfy, Mona; Benoit, Anita] Univ Toronto, Dalla Sch Publ Hlth, Toronto, ON, Canada; [de Pokomandy, Alexandra; O'Brien, Nadia] McGill Univ, Dept Family Med, Montreal, PQ, Canada; [de Pokomandy, Alexandra; Proulx-Boucher, Karene; Dubuc, Daniele] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Carter, Allison; Nicholson, Valerie; Shurgold, Jayson H.; Hogg, Robert S.; Kaida, Angela] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Carter, Allison; Ding, Erin; Sereda, Paul; Jabbari, Shahab; Colley, Guillaume; Hogg, Robert S.] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Lewis, Johanna] York Univ, Dept Environm Sci, Toronto, ON, Canada; [Greene, Saara] McMaster Univ, Sch Social Work, Hamilton, ON, Canada; [Tharao, Wangari] Womens Hlth Womens Hands Community Hlth Ctr, Toronto, ON, Canada; [Shurgold, Jayson H.] Contag Consulting Grp, Vancouver, BC, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; McGill University; McGill University; Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; York University - Canada; McMaster University	Loutfy, M (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada.; Loutfy, M (corresponding author), Univ Toronto, Fac Med, Toronto, ON, Canada.; Loutfy, M (corresponding author), Univ Toronto, Dalla Sch Publ Hlth, Toronto, ON, Canada.	mona.loutfy@wchospital.ca		Carter, Allison/0000-0003-2151-2622; Sereda, Paul/0000-0002-6411-8089	Canadian Institutes of Health Research (CIHR) Operating Grant [MOP -111041]; CIHR Canadian HIV Trials Network [CTN 262]; Ontario HIV Treatment Network; Academic Health Science Centres (AHSC) Alternative Funding Plans (AFP) Innovation Fund; CHIWOS Indigenous Advisory Board; CHIWOS African, Caribbean and Black Advisory Board; provincial Community Advisory Boards	Canadian Institutes of Health Research (CIHR) Operating Grant(Canadian Institutes of Health Research (CIHR)); CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network; Academic Health Science Centres (AHSC) Alternative Funding Plans (AFP) Innovation Fund; CHIWOS Indigenous Advisory Board; CHIWOS African, Caribbean and Black Advisory Board; provincial Community Advisory Boards	This work was funded by a Canadian Institutes of Health Research (CIHR) Operating Grant (grant# MOP -111041), the CIHR Canadian HIV Trials Network (CTN 262), the Ontario HIV Treatment Network, and the Academic Health Science Centres (AHSC) Alternative Funding Plans (AFP) Innovation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS) Research Team would like to especially thank all of the women living with HIV who participate in the research and entrust CHIWOS with their experiences of HIV treatment, care, and support. We also thank the entire national team of Co-Investigators, Collaborators, and Peer Research Associates. We would like to acknowledge the three provincial Community Advisory Boards, and the national CHIWOS Indigenous Advisory Board, CHIWOS African, Caribbean and Black Advisory Board, and our partnering organizations for supporting the study. We also acknowledge the BC Centre for Excellence in HIV/AIDS for in kind data management and analytic support.	Abelsohn K, 2015, PROG COMM HLTH PARTN, V9, P561, DOI 10.1353/cpr.2015.0079; [Anonymous], 2013, GLOB AIDS RESP PROGR; BC Centre for Disease Control, 2011, DAT REQ FEM TEST NEW; Bowleg L, 2008, SEX ROLES, V59, P312, DOI 10.1007/s11199-008-9400-z; Bredstrom A, 2006, EUR J WOMENS STUD, V13, P229, DOI 10.1177/1350506806065754; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Carter A, 2017, BMC RES NOTES; Carter A, 2015, HEALTH CARE WOMEN IN, V36, P936, DOI 10.1080/07399332.2014.954703; Carter A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092334; CHIWOS, 2014, CHIWOS PAP QUEST; CHIWOS, 2013, CAN HIV WOM SEX REPR; Cornell M, 2012, PLOS ONE; DeReus L, 2005, MULTICULTURAL CRITIC; Druyts E, 2013, AIDS, V27, P417, DOI 10.1097/QAD.0b013e328359b89b; Dworkin SL, 2007, AM J PUBLIC HEALTH, V97, P13, DOI 10.2105/AJPH.2005.074591; Gray K, 2012, CONDUCTING RES HARD; Hankivsky O, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-5; Hirschhorn LR, 2006, WOMEN HEALTH ISS, V16, P104, DOI 10.1016/j.whi.2006.02.004; Institut national de sante A publique Que A bec, 2012, SURV INF TRANSM SEX; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Loutfy M, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0190-7; Mills EJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-52; Monforte AD, 2010, AIDS, V24, P1091, DOI 10.1097/QAD.0b013e3283390db3; Mrus JM, 2005, QUAL LIFE RES, V14, P479, DOI 10.1007/s11136-004-4693-z; OBrien N, 6 INT WORKSH HIV WOM; Oguntibeju OO, 2012, HIV AIDS-RES PALLIAT, V4, P117, DOI 10.2147/HIV.S32321; Ontario HIV Treatment Network, 2014, ONT HIV TREATM NETW; Ontario HIV Treatment Network, 2013, INT HIV OTH HLTH REL; Palmer AK, 2011, INT J EPIDEMIOL, V40, P25, DOI 10.1093/ije/dyp393; Patterson S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0969-x; Public Health Agency of Canada, 2015, SUMM EST HIV INC PRE; Raikhel E., 2009, EPISTEMOLOGICAL FRAM; Remis RS, 2013, REPORT HIV AIDS ONTA; UNAIDS, 2011, GREAT INV PEOPL LIV; Walmsley SL, 2010, HIV POSITIVE WOMEN C, P197; Wingood GM, 2003, J URBAN HEALTH, V80, P67; World Health Organization, 2017, CONS GUID SEX REPR H	37	50	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184708	10.1371/journal.pone.0184708	http://dx.doi.org/10.1371/journal.pone.0184708			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957412	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200017
J	Sashourpour, M; Zahri, S; Radjabian, T; Ruf, V; Pan-Montojo, F; Morshedi, D				Sashourpour, Mandyeh; Zahri, Saber; Radjabian, Tayebeh; Ruf, Viktoria; Pan-Montojo, Francisco; Morshedi, Dina			A study on the modulation of alpha-synuclein fibrillation by Scutellaria pinnatifida extracts and its neuroprotective properties	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; APOPTOSIS INDUCTION; ALZHEIMERS-DISEASE; OLIGOMER FORMATION; PARKINSON-DISEASE; GROWTH-INHIBITION; ANTIOXIDANT; FLAVONOIDS; BAICALEIN	Aggregation of alpha-synuclein (alpha-SN) is a key pathogenic event in Parkinson's disease (PD) leading to dopaminergic degeneration. The identification of natural compounds inhibiting alpha-SN aggregation may have a major role in treating PD. Different Scutellaria species are known as valuable medicinal plants, primarily due to their high flavonoid levels. Scutellaria pinnatifida (S. pinnatifida) is endemic to Iran; however, the knowledge of its pharmaceutical properties is limited. Here we report that S. pinnatifida extracts have an anti-fibrillation effect on alpha-SN aggregation and neuroprotective properties on PC12 and primary dopaminergic neurons. Treatment during alpha-SN fibril formation with S. pinnatifida extracts showed that the extractions performed with dichloromethane (DCMEx) and n-butanol (BuOHEx) strongly inhibited alpha-SN fibrillation. TLC-based analysis revealed that S. pinnatifida contains a great amount of flavonoids with high antioxidant properties as shown using a radical scavenging assay. Further analysis using HPLC and Mass spectroscopy on the DCMEx revealed the presence of baicalein in this extract. We then selected the more efficient extracts based on cell viability and ROS scavenging on PC12 cells and tested their neuroprotective properties on primary dopaminergic neurons. Our results showed the extracts strongly protected against alpha-SN oligomers. Surprisingly, they also neutralized the severe toxicity of paraquat. Therefore, S. pinnatifida may be a potential valuable medicinal herb for further studies related to the treatment of PD.	[Sashourpour, Mandyeh; Zahri, Saber] Mohaghegh Ardabili Univ, Dept Biol, Fac Sci, Ardebil, Iran; [Sashourpour, Mandyeh; Morshedi, Dina] NIGEB, Dept Ind & Environm Biotechnol, Tehran, Iran; [Radjabian, Tayebeh] Shahed Univ, Fac Basic Sci, Dept Biol, Tehran, Iran; [Ruf, Viktoria] Ludwig Maximilians Univ Munchen, Ctr Neuropathol & Prion Res, Munich, Germany; [Pan-Montojo, Francisco] LMU, Univ Hosp, Dept Neurol, Munich, Germany; [Pan-Montojo, Francisco] Munich Cluster Syst Neurol SyNergy, Munich, Germany	University of Mohaghegh Ardabili; Shahed University; University of Munich; University of Munich; University of Munich	Zahri, S (corresponding author), Mohaghegh Ardabili Univ, Dept Biol, Fac Sci, Ardebil, Iran.; Morshedi, D (corresponding author), NIGEB, Dept Ind & Environm Biotechnol, Tehran, Iran.; Pan-Montojo, F (corresponding author), LMU, Univ Hosp, Dept Neurol, Munich, Germany.; Pan-Montojo, F (corresponding author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.	Zahri@uma.ac.ir; francisco.pan-montoio@med.uni-muenchen.de; morsheci@nigeb.ac.ir	Zahri, Saber/AAD-3707-2022; Radjabian, Tayebeh/W-1658-2019	Radjabian, Tayebeh/0000-0001-8280-9409; Morshedi, Dina/0000-0002-0751-8772	Iranian Ministry of Science and Technology; Deutsche Forschungsgesellschaft (DFG) through Munich Excellence Cluster for Systems Neurology; Ministry of Science, Research and Technology of Iran	Iranian Ministry of Science and Technology; Deutsche Forschungsgesellschaft (DFG) through Munich Excellence Cluster for Systems Neurology(German Research Foundation (DFG)); Ministry of Science, Research and Technology of Iran	This project was funded by the Iranian Ministry of Science and Technology (Grant given to SZ) and the Deutsche Forschungsgesellschaft (DFG) through the Munich Excellence Cluster for Systems Neurology (Grant given to F.P-M). MS received a travel grant from the Ministry of Science, Research and Technology of Iran to perform an internship in Munich.; This project was funded by the Iranian Ministry of Science and Technology (Grant given to SZ) and the Deutsche Forschungsgesellschaft (DFG) through the Munich Excellence Cluster for Systems Neurology (Grant given to F.P-M). MS received a travel grant from the Ministry of Science, Research and Technology of Iran to perform an internship in Munich. The authors would like to acknowledge Mr. Farhang Aliakbari for helping in the protein expression and purification and Mr. Esmaeil Eskandary for helping to find the IUCN protection list.	Alves G, 2005, NEUROLOGY, V65, P1436, DOI 10.1212/01.wnl.0000183359.50822.f2; Bader B, 2011, BIOCHEM BIOPH RES CO, V411, P190, DOI 10.1016/j.bbrc.2011.06.135; Bhattacharjee N, 2016, NEUROCHEM INT, V101, P48, DOI 10.1016/j.neuint.2016.10.001; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bodles AM, 2001, J NEUROCHEM, V78, P384, DOI 10.1046/j.1471-4159.2001.00408.x; Boozari M, 2015, ENVIRON TOXICOL PHAR, V39, P307, DOI 10.1016/j.etap.2014.12.002; BORS W, 1990, RADICAL CHEM FLAVONO, P165; Bueler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006; Chen YC, 2000, BIOCHEM PHARMACOL, V59, P1445, DOI 10.1016/S0006-2952(00)00255-0; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Feng J, 2010, J PHARMACEUT BIOMED, V53, P591, DOI 10.1016/j.jpba.2010.04.002; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Ghahreman A., 1999, BIODIVERSITY PLANT S; Gilgun-Sherki Y, 2001, NEUROPHARMACOLOGY, V40, P959, DOI 10.1016/S0028-3908(01)00019-3; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hong DP, 2008, J MOL BIOL, V383, P214, DOI 10.1016/j.jmb.2008.08.039; Hu Q, 2016, BBA-MOL BASIS DIS, V1862, P1883, DOI 10.1016/j.bbadis.2016.07.008; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Huang KC, 2010, PHARM CHINESE HERBS; Huang WH, 2006, BIOSCI BIOTECH BIOCH, V70, P2371, DOI 10.1271/bbb.50698; Jameson D. M., 2014, INTRO FLUORESCENCE; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim DH, 2006, MECH AGEING DEV, V127, P719, DOI 10.1016/j.mad.2006.05.002; Kim DO, 2003, FOOD CHEM, V81, P321, DOI 10.1016/S0308-8146(02)00423-5; Krenna L, 2003, FLAVONOIDS ACHILLEA; LAMAISON JL, 1990, PHARM ACTA HELV, V65, P315; Lamer-Zarawska E, 2010, ADV CLIN EXP MED, V19, P419; Lee HH, 2003, BRAIN RES, V986, P103, DOI 10.1016/S0006-8993(03)03197-4; Levites Y, 2001, J NEUROCHEM, V78, P1073, DOI 10.1046/j.1471-4159.2001.00490.x; Lindstrom V, 2017, MOL CELL NEUROSCI, V82, P143, DOI 10.1016/j.mcn.2017.04.009; Lu JH, 2011, CHEMBIOCHEM, V12, P615, DOI 10.1002/cbic.201000604; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; Meng X, 2010, EFFECTS VARIOUS FLAV; Meng XY, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/650794; Meng XY, 2009, BIOCHEMISTRY-US, V48, P8206, DOI 10.1021/bi900506b; Mohammadi A AJ, 2012, NATURAL PRODUCTS M S, V4, P102; Motaez M, 2015, AVICENNA J PHYTOMEDI, V5, P553; Mousavi SNM, 2015, IRAN J PHARM RES, V14, P215; Murphy DD, 2000, J NEUROSCI, V20, P5214; Mustafa RA, 2010, J FOOD SCI, V75, pC28, DOI 10.1111/j.1750-3841.2009.01401.x; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Niranjan R, 2014, MOL NEUROBIOL, V49, P28, DOI 10.1007/s12035-013-8483-x; Paillusson S., 2017, ACTA NEUROPATHOL; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Piao HZ, 2004, ARCH PHARM RES, V27, P930, DOI 10.1007/BF02975846; Poblocka-Olech L, 2016, ACTA PHARMACEUT, V66, P543, DOI 10.1515/acph-2016-0038; Roberts HL, 2015, BIOMOLECULES, V5, P282, DOI 10.3390/biom5020282; Sauvage Severine, 2010, Oriental Pharmacy and Experimental Medicine, V10, P304; Sereikaite J, 2006, ACTA BIOCHIM POL, V53, P87; Shieh DE, 2000, ANTICANCER RES, V20, P2861; Smallwood I, 2012, HDB ORG SOLVENT PROP; Souri E., 2010, IJPR, V3, P55, DOI [DOI 10.22037/IJPR.2010.298, 10.22037/IJPR.2010.298]; Suk K, 2005, NEUROSIGNALS, V14, P23, DOI 10.1159/000085383; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Taebnia N, 2016, LANGMUIR, V32, P13394, DOI 10.1021/acs.langmuir.6b02935; Tai MC, 2005, CNS DRUG REV, V11, P141; Toyoda Y, 2014, BIOL OPEN; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Uversky VN, 2015, CURR PROTEIN PEPT SC, V16, P682, DOI 10.2174/138920371608150828114357; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108	63	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184483	10.1371/journal.pone.0184483	http://dx.doi.org/10.1371/journal.pone.0184483			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957336	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200014
J	Zhao, X; Li, P; An, K; Jia, XH; Cheng, YT; Jia, TJ				Zhao, Xia; Li, Ping; An, Kang; Jia, Xiaohui; Cheng, Yongting; Jia, Tianjun			Chlamydia pneumoniae inclusion membrane protein Cpn0147 interacts with host protein CREB3	PLOS ONE			English	Article							TRANSCRIPTION; STRESS; LUMAN	Chlamydiae are Gram-negative obligate intracellular bacteria that cause diseases with significant medical and economic impacts. Like other chlamydial species, Chlamydia pneumoniae possesses a unique developmental cycle, the infectious elementary body gains access to the susceptible host cell, where it transforms into the replicative reticulate body. The cytoplasmic vacuole where Chlamydia pneumoniae replicates is called an inclusion, which is extensively modified by the insertion of chlamydial effectors known as inclusion membrane proteins (Incs). The C. pneumoniae-specific inclusion membrane protein (Inc) Cpn0147 contains domains that are predicted to be exposed to the host cytoplasm. To map host cell binding partners of Cpn0147, a yeast two-hybrid system was used to screen Cpn0147 against a HeLa cell cDNA library, which led to the finding that Cpn0147 interacted with the host cell protein cyclic adenosine monophosphate (cAMP)-responsive element (CRE)-binding protein (CREB3). The interaction was validated by co-immunoprecipitation of Cpn0147 with CREB3 from HeLa cells ectopically expressing both. Furthermore, Cpn0147 and CREB3 were co-localised in HeLa cells under confocal fluorescence microscopy. The above observations suggest that CREB3 may directly bind to the cytoplasmic domain of Cpn0147 to mediate the interactions of chlamydial inclusions with host cell endoplasmic reticulum.	[Zhao, Xia; Li, Ping; An, Kang; Jia, Xiaohui; Cheng, Yongting; Jia, Tianjun] Hebei North Univ, Lab Med Coll, Zhang Jiakou, Hebei, Peoples R China	Hebei North University	Jia, TJ (corresponding author), Hebei North Univ, Lab Med Coll, Zhang Jiakou, Hebei, Peoples R China.	tjjia1968@163.com			Hebei Natural Science Foundation [C2014405041]	Hebei Natural Science Foundation(Natural Science Foundation of Hebei Province)	This study was supported by the Hebei Natural Science Foundation (http://www.hensf.gov.cn/), grant no. C2014405041 to TJ. The funder had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grant of Hebei Natural Science Foundation (grant numbers: C2014405041).	Agaisse H, 2014, INFECT IMMUN, V82, P2037, DOI 10.1128/IAI.01530-14; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; Blot G, 2006, J MOL BIOL, V364, P1034, DOI 10.1016/j.jmb.2006.09.080; Cortes C, 2007, INFECT IMMUN, V75, P5586, DOI 10.1128/IAI.01020-07; Delevoye C, 2004, J BIOL CHEM, V279, P46896, DOI 10.1074/jbc.M407227200; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Dumoux M, 2012, TRAFFIC, V13, P1612, DOI 10.1111/tra.12002; Flores R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127909; Grieshaber S, 2002, CELL MICROBIOL, V4, P273, DOI 10.1046/j.1462-5822.2002.00191.x; Hackstadt T, 1997, TRENDS MICROBIOL, V5, P288, DOI 10.1016/S0966-842X(97)01061-5; Liang GQ, 2006, MOL CELL BIOL, V26, P7999, DOI 10.1128/MCB.01046-06; Lu R, 2000, J VIROL, V74, P934, DOI 10.1128/JVI.74.2.934-943.2000; Luo JH, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-38; Mirabelli C, 2016, J GEN VIROL, V97, P2194, DOI 10.1099/jgv.0.000544; Reiling JH, 2013, NAT CELL BIOL, V15, P1473, DOI 10.1038/ncb2865; Shima K, 2015, CELL MICROBIOL, V17, P923, DOI 10.1111/cmi.12416; Tatu U, 1997, J CELL BIOL, V136, P555, DOI 10.1083/jcb.136.3.555	17	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185593	10.1371/journal.pone.0185593	http://dx.doi.org/10.1371/journal.pone.0185593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957394	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200090
J	Adach, W; Olas, B				Adach, Weronika; Olas, Beata			The role of CORM-2 as a modulator of oxidative stress and hemostatic parameters of human plasma in vitro	PLOS ONE			English	Article							MONOXIDE-RELEASING MOLECULES; CARBON-MONOXIDE; PLATELET MEMBRANES; DISULFIDE GROUPS; CO; COAGULATION; EXPRESSION; SULFHYDRYL; DISEASE	Purpose The main aim of the experiment is to examine the effect of CORM-2, a donor of carbon monoxide (CO), on oxidative stress in human plasma in vitro. In addition, it examines the effects of CORM-2 on the hemostatic parameters of plasma: the activated partial thromboplastin time (APTT), thrombin time (TT) and prothrombin time (PT). Methods Human plasma was incubated for 5 -60 min with different concentrations of CORM-2: 0.1-100 mu M. Following this, various hemostatic factors and biomarkers of oxidative stress were studied. Lipid peroxidation was measured as thiobarbituric acid reactive substance (TBARS) concentration, and the oxidation of amino acid residues in proteins was measured by determining the amounts of carbonyl and thiol groups. Results Two oxidative stress inducers: hydrogen peroxide (H2O2) and the donor of hydroxyl radical (H2O2/Fe) were used. Decrease in protein carbonylation, thiol group oxidation and lipid peroxidation were detected at tested concentrations of CORM-2. Conclusion Our results indicate that CORM-2 may have antioxidant properties in human plasma treated with H2O2 or H2O2/Fe. In addition, our results indicate the anti-coagulant activities of CORM-2 in vitro.	[Adach, Weronika; Olas, Beata] Univ Lodz, Fac Biol & Environm Protect, Dept Gen Biochem, Lodz, Poland	University of Lodz	Olas, B (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Gen Biochem, Lodz, Poland.	beata.olas@biol.uni.lodz.pl		Olas, Beata/0000-0002-7048-2952				ANDO Y, 1973, BIOCHIM BIOPHYS ACTA, V311, P26, DOI 10.1016/0005-2736(73)90251-4; ANDO Y, 1973, BIOCHIM BIOPHYS ACTA, V311, P38, DOI 10.1016/0005-2736(73)90252-6; Babu D, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00031; Bartosz B., 2008, WARSZAWA1, V7, P99; Durante W, 2006, J CELL MOL MED, V10, P672, DOI 10.1111/j.1582-4934.2006.tb00427.x; Foresti R, 2008, INTENS CARE MED, V34, P649, DOI 10.1007/s00134-008-1011-1; Fredenburgh LE, 2015, EUR HEART J, V36, P1512, DOI 10.1093/eurheartj/ehv114; Kshirsagar AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078930; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Liu D, 2016, SYSTEMS ENGINEERING: DESIGN PRINCIPLES AND MODELS, P1; Liu Dadong, 2015, Zhonghua Shao Shang Za Zhi, V31, P354; LUZZATTO E, 1995, FREE RADICAL RES, V23, P453, DOI 10.3109/10715769509065266; Malinowska J, 2012, FOOD CHEM TOXICOL, V50, P4023, DOI 10.1016/j.fct.2012.07.065; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Motterlini R, 2017, AM J PHYSIOL-CELL PH, V312, pC302, DOI 10.1152/ajpcell.00360.2016; Nielsen VG, 2015, CURR NEUROVASC RES, V12, P31, DOI 10.2174/1567202612666150102150042; Nielsen VG, 2014, BLOOD COAGUL FIBRIN, V25, P801, DOI 10.1097/MBC.0000000000000146; Nielsen VG, 2014, BLOOD COAGUL FIBRIN, V25, P695, DOI 10.1097/MBC.0000000000000128; Nielsen VG, 2014, THROMB RES, V133, P315, DOI 10.1016/j.thromres.2013.12.004; Nielsen VG, 2012, BLOOD COAGUL FIBRIN, V23, P104, DOI 10.1097/MBC.0b013e32834ea012; Nielsen VG, 2009, CARBON MONOXIDE RELE; Olas B, 2014, CHEM-BIOL INTERACT, V222, P37, DOI 10.1016/j.cbi.2014.08.005; Sandstrom BE, 1997, FREE RADIC BIOL MED; Srisook K, 2006, BIOCHEM PHARMACOL, V71, P307, DOI 10.1016/j.bcp.2005.10.042; Sun BW, 2008, INT J BIOL SCI, V4, P176; Truss NJ, 2011, PHARMACOL THERAPEUT, V132, P196, DOI 10.1016/j.pharmthera.2011.07.001; Tsai MH, 2017, REDOX BIOL, V12, P377, DOI 10.1016/j.redox.2017.02.019; Vreman H.J., 2000, CARBON MONOXIDE TOXI, P19; WACHOWICZ B, 1984, CELL BIOCHEM FUNCT, V2, P167, DOI 10.1002/cbf.290020310; WHITAKER JR, 1980, ANAL BIOCHEM, V109, P156, DOI 10.1016/0003-2697(80)90024-X	30	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0184787	10.1371/journal.pone.0184787	http://dx.doi.org/10.1371/journal.pone.0184787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950024	Green Published, gold, Green Submitted			2022-12-27	WOS:000411671000015
J	DeMasi, O; Kording, K; Recht, B				DeMasi, Orianna; Kording, Konrad; Recht, Benjamin			Meaningless comparisons lead to false optimism in medical machine learning	PLOS ONE			English	Article							MENTAL-HEALTH; RECOGNITION; SELECTION; BEHAVIOR	A new trend in medicine is the use of algorithms to analyze big datasets, e.g. using everything your phone measures about you for diagnostics or monitoring. However, these algorithms are commonly compared against weak baselines, which may contribute to excessive optimism. To assess how well an algorithm works, scientists typically ask how well its output correlates with medically assigned scores. Here we perform a meta-analysis to quantify how the literature evaluates their algorithms for monitoring mental wellbeing. We find that the bulk of the literature (similar to 77%) uses meaningless comparisons that ignore patient baseline state. For example, having an algorithm that uses phone data to diagnose mood disorders would be useful. However, it is possible to explain over 80% of the variance of some mood measures in the population by simply guessing that each patient has their own average mood D the patient-specific baseline. Thus, an algorithm that just predicts that our mood is like it usually is can explain the majority of variance, but is, obviously, entirely useless. Comparing to the wrong (population) baseline has a massive effect on the perceived quality of algorithms and produces baseless optimism in the field. To solve this problem we propose "user lift" that reduces these systematic errors in the evaluation of personalized medical monitoring.	[DeMasi, Orianna; Recht, Benjamin] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Kording, Konrad] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Kording, Konrad] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	University of California System; University of California Berkeley; University of Pennsylvania; University of Pennsylvania	DeMasi, O (corresponding author), Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.	odemasi@eecs.berkeley.edu	Kording, Konrad/A-1233-2007	Kording, Konrad/0000-0001-8408-4499				Aharony N, 2011, PERVASIVE MOB COMPUT, V7, P643, DOI 10.1016/j.pmcj.2011.09.004; Asselbergs J, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5505; Ben-Zeev D, 2015, PSYCHIATR REHABIL J, V38, P218, DOI 10.1037/prj0000130; Bogomolov A, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P477, DOI 10.1145/2647868.2654933; Bogomolov A, 2014, INT CONF PERVAS COMP, P345, DOI 10.1109/PerComW.2014.6815230; BOYKO EJ, 1994, MED DECIS MAKING, V14, P175, DOI 10.1177/0272989X9401400210; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Calvo RA, 2016, P 2016 CHI C EXTENDE, P3438, DOI [10.1145/2851581.2856463, DOI 10.1145/2851581.2856463]; Canzian L, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING (UBICOMP 2015), P1293, DOI 10.1145/2750858.2805845; Carroll EA, 2013, INT CONF AFFECT, P252, DOI 10.1109/ACII.2013.48; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Darcy AM, 2016, JAMA-J AM MED ASSOC, V315, P551, DOI 10.1001/jama.2015.18421; De Choudhury M, 2014, P 17 ACM C COMP SUPP, P626, DOI DOI 10.1145/2531602.2531675; De Choudhury M, 2016, 34TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, CHI 2016, P2098, DOI 10.1145/2858036.2858207; Deng Y, 2012, 2012 IEEE 13TH INTERNATIONAL CONFERENCE ON INFORMATION REUSE AND INTEGRATION (IRI), P584, DOI 10.1109/IRI.2012.6303062; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Hernandez J, 2011, LECT NOTES COMPUT SC, V6974, P125, DOI 10.1007/978-3-642-24600-5_16; Jaques  N., 2015, P NIPS WORKSH MULT M; Jaques N, 2015, INT CONF AFFECT, P222, DOI 10.1109/ACII.2015.7344575; KEMPTHOR.O, 1969, BIOMETRIKA, V56, P231; Kessler R. C., 2016, MOL PSYCHIAT; Likamwa R., 2013, P 11 ANN INT C MOB S, P389, DOI [DOI 10.1145/2462456.2464449, 10.1145/2462456.2464449]; Lu H., 2012, P 2012 ACM C UB COMP; Marzano L, 2015, LANCET PSYCHIAT, V2, P942, DOI 10.1016/S2215-0366(15)00268-0; Moturu ST, 2011, IEEE ENG MED BIO, P5267, DOI 10.1109/IEMBS.2011.6091303; Murphy GE, 1984, AM J PSYCHOTHERAPY; Olff M, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.27882; Pantelopoulos A, 2010, IEEE T SYST MAN CY C, V40, P1, DOI 10.1109/TSMCC.2009.2032660; Powers D. M, 2011, ARXIV201016061; Saeb S., 2016, VOODOO MACHINE LEARN; Saeb S, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4273; Sandulescu V, 2015, LECT NOTES COMPUT SC, V9107, P526, DOI 10.1007/978-3-319-18914-7_55; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smucker MD, 2007, P 16 ACM C INF KNOWL, V2007, P623; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tran T, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P1410; Valenza G, 2014, IEEE J BIOMED HEALTH, V18, P1625, DOI 10.1109/JBHI.2013.2290382; Valenza G, 2013, ARTIF INTELL MED, V57, P49, DOI 10.1016/j.artmed.2012.12.001; Wang R, 2014, UBICOMP'14: PROCEEDINGS OF THE 2014 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P3, DOI 10.1145/2632048.2632054; Weiss G. M., 2004, SIGKDD EXPLORATIONS, V6, P7, DOI DOI 10.1145/1007730.1007734; Witten IH, 2011, MOR KAUF D, P1; Wu M, 2015, IEEE ENG MED BIO, P1625, DOI 10.1109/EMBC.2015.7318686; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	46	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0184604	10.1371/journal.pone.0184604	http://dx.doi.org/10.1371/journal.pone.0184604			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949964	gold, Green Published, Green Submitted			2022-12-27	WOS:000411671000012
J	Siska, EK; Weisman, I; Romano, J; Ivics, Z; Izsvak, Z; Barkai, U; Petrakis, S; Koliakos, G				Siska, Evangelia K.; Weisman, Itamar; Romano, Jacob; Ivics, Zoltan; Izsvak, Zsuzsanna; Barkai, Uriel; Petrakis, Spyros; Koliakos, George			Generation of an immortalized mesenchymal stem cell line producing a secreted biosensor protein for glucose monitoring	PLOS ONE			English	Article							GLUCOSE/GALACTOSE-BINDING PROTEIN; PROLIFERATION IN-VITRO; STROMAL CELLS; HLA-G; EXPRESSION; VIVO; DIFFERENTIATION; SENSOR; PLURIPOTENT; DYNAMICS	Diabetes is a chronic disease characterized by high levels of blood glucose. Diabetic patients should normalize these levels in order to avoid short and long term clinical complications. Presently, blood glucose monitoring is dependent on frequent finger pricking and enzyme based systems that analyze the drawn blood. Continuous blood glucose monitors are already on market but suffer from technical problems, inaccuracy and short operation time. A novel approach for continuous glucose monitoring is the development of implantable cell- based biosensors that emit light signals corresponding to glucose concentrations. Such devices use genetically modified cells expressing chimeric genes with glucose binding properties. MSCs are good candidates as carrier cells, as they can be genetically engineered and expanded into large numbers. They also possess immunomodulatory properties that, by reducing local inflammation, may assist long operation time. Here, we generated a novel immortalized human MSC line co-expressing hTERT and a secreted glucose biosensor transgene using the Sleeping Beauty transposon technology. Genetically modified hMSCs retained their mesenchymal characteristics. Stable transgene expression was validated biochemically. Increased activity of hTERT was accompanied by elevated and constant level of stem cell pluripotency markers and subsequently, by MSC immortalization. Furthermore, these cells efficiently suppressed PBMC proliferation in MLR transwell assays, indicating that they possess immunomodulatory properties. Finally, biosensor protein produced by MSCs was used to quantify glucose in cell-free assays. Our results indicate that our immortalized MSCs are suitable for measuring glucose concentrations in a physiological range. Thus, they are appropriate for incorporation into a cell-based, immune-privileged, glucose-monitoring medical device.	[Siska, Evangelia K.; Koliakos, George] Aristotle Univ Thessaloniki, Fac Life Sci, Sch Med, Thessaloniki, Greece; [Siska, Evangelia K.; Petrakis, Spyros; Koliakos, George] Biohellenika SA Biotechnol Co, Thessaloniki, Greece; [Weisman, Itamar; Romano, Jacob; Barkai, Uriel] GluSense Ltd, Rabin Sci Parkm, Rehovot, Israel; [Ivics, Zoltan] Paul Ehrlich Inst, Langen, Germany; [Izsvak, Zsuzsanna] Helmholtz Assoc, Max Delbruck Ctr Mol Med, Berlin, Germany; [Siska, Evangelia K.] Biomerieux SA, Parc Technol Delta Sud, Verniolle, France; [Petrakis, Spyros] Ctr Res & Technol Hellas CERTH, Inst Appl Biosci INAB, Thessaloniki, Greece	Aristotle University of Thessaloniki; Paul Ehrlich Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Centre for Research & Technology Hellas	Petrakis, S (corresponding author), Biohellenika SA Biotechnol Co, Thessaloniki, Greece.; Petrakis, S (corresponding author), Ctr Res & Technol Hellas CERTH, Inst Appl Biosci INAB, Thessaloniki, Greece.	spetrak@certh.gr	Petrakis, Spyros/AAA-6778-2021; Barkai, Uriel/I-6316-2019; Koliakos, George/AAC-8888-2021	Petrakis, Spyros/0000-0001-9094-3480; Siska, Evangelia/0000-0001-5861-9891	General Secretariat for Research and Technology, Greece [ISR_2789]; Israel Innovation Authority [OCS_51574]	General Secretariat for Research and Technology, Greece(Greek Ministry of Development-GSRT); Israel Innovation Authority	This work was generously supported by the General Secretariat for Research and Technology, Greece, project ISR_2789 to Biohellenika SA and Israel Innovation Authority, project OCS_51574 to Glusense Ltd, under the framework of the Bilateral R&D Cooperation between Greece and Israel 2013-2015. The funders provided support in the form of salaries for authors [EKS, IW, JR, UB, SP] and research materials but had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of all authors are articulated in the author contributions section	Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180; Amiss TJ, 2007, PROTEIN SCI, V16, P2350, DOI 10.1110/ps.073119507; Anderson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076979; [Anonymous], GLOB REP DIAB 2016; Aslan H, 2006, STEM CELLS, V24, P1728, DOI 10.1634/stemcells.2005-0546; Barash S, 2002, BIOCHEM BIOPH RES CO, V294, P835, DOI 10.1016/S0006-291X(02)00566-1; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Belay E, 2010, STEM CELLS, V28, P1760, DOI 10.1002/stem.501; Bronstone Amy, 2016, J Diabetes Sci Technol, V10, P905, DOI 10.1177/1932296816633233; Buntru A, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00074; Campbell-Thompson M, 2016, DIABETES, V65, P719, DOI 10.2337/db15-0779; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Castle Jessica R, 2016, J Diabetes Sci Technol, V10, P1169, DOI 10.1177/1932296816631569; DelaRosa O, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00182; Deuschle K, 2005, PROTEIN SCI, V14, P2304, DOI 10.1110/ps.051508105; DeVries JH, 2016, ACCURACY LONGEVITY I; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dutt-Ballerstadt Ralph, 2013, J Diabetes Sci Technol, V7, P35; Dutt-Ballerstadt Ralph, 2012, J Diabetes Sci Technol, V6, P362; Dutt-Ballerstadt R, 2008, DIABETES TECHNOL THE, V10, P453, DOI 10.1089/dia.2008.0033; Fehr M, 2003, J BIOL CHEM, V278, P19127, DOI 10.1074/jbc.M301333200; Isa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010900; Jin S, 2011, BIOSENS BIOELECTRON, V26, P3427, DOI 10.1016/j.bios.2011.01.017; Kapetanou M, 2017, FREE RADICAL BIO MED, V103, P226, DOI 10.1016/j.freeradbiomed.2016.12.035; Khan F, 2010, ANAL BIOCHEM, V399, P39, DOI 10.1016/j.ab.2009.11.035; Klinger RY, 2006, P NATL ACAD SCI USA, V103, P2500, DOI 10.1073/pnas.0508184103; La Rocca G, 2013, CURR STEM CELL RES T, V8, P100, DOI 10.2174/1574888X11308010012; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Liu QJ, 2007, BIOSENS BIOELECTRON, V22, P810, DOI 10.1016/j.bios.2006.03.006; Magnuson AM, 2015, P NATL ACAD SCI USA, V112, P1511, DOI 10.1073/pnas.1423769112; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Mizutani T, 2010, CLIN CANCER RES, V16, P3964, DOI 10.1158/1078-0432.CCR-10-0548; Mortellaro M, 2014, BIOSENS BIOELECTRON, V61, P227, DOI 10.1016/j.bios.2014.05.022; Petrakis S, 2012, BIOTECHNOL J, V7, P891, DOI 10.1002/biot.201100471; Richter M, 2016, BLOOD, V128, P2206, DOI 10.1182/blood-2016-04-711580; Ristich V, 2005, EUR J IMMUNOL, V35, P1133, DOI 10.1002/eji.200425741; Selmani Z, 2009, TRANSPLANTATION, V87, pS62, DOI 10.1097/TP.0b013e3181a2a4b3; Soleymaninejadian E, 2012, AM J REPROD IMMUNOL, V67, P1, DOI 10.1111/j.1600-0897.2011.01069.x; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Veetil JV, 2010, BIOSENS BIOELECTRON, V26, P1650, DOI 10.1016/j.bios.2010.08.052; Vigersky Robert A, 2015, J Diabetes Sci Technol, V9, P320; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wang JC, 2016, NAT PROTOC, V11, P327, DOI 10.1038/nprot.2016.016; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; World Health Organization, TOP 10 CAUS DEATH 20; Wu YC, 2001, BIOSENS BIOELECTRON, V16, P277, DOI 10.1016/S0956-5663(01)00138-5; ZUKIN RS, 1977, BIOCHEMISTRY-US, V16, P381, DOI 10.1021/bi00622a007	51	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185498	10.1371/journal.pone.0185498	http://dx.doi.org/10.1371/journal.pone.0185498			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949988	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000411671000059
J	Tarjus, A; Maase, M; Jeggle, P; Martinez-Martinez, E; Fassot, C; Loufrani, L; Henrion, D; Hansen, PBL; Kusche-Vihrog, K; Jaisser, F				Tarjus, Antoine; Maase, Martina; Jeggle, Pia; Martinez-Martinez, Ernesto; Fassot, Celine; Loufrani, Laurent; Henrion, Daniel; Hansen, Pernille B. L.; Kusche-Vihrog, Kristina; Jaisser, Frederic			The endothelial aENaC contributes to vascular endothelial function in vivo	PLOS ONE			English	Article							EPITHELIAL SODIUM-CHANNEL; BLOOD-PRESSURE; NA+ CHANNELS; MICE LACKING; ENAC; CELLS; FLOW; ALDOSTERONE; ADAPTATION; EXPRESSION	The Epithelial Sodium Channel (ENaC) is a key player in renal sodium homeostasis. The expression of alpha beta gamma ENaC subunits has also been described in the endothelium and vascular smooth muscle, suggesting a role in vascular function. We recently demonstrated that endothelial ENaC is involved in aldosterone-modulated endothelial stiffness. Here we explore the functional role of the endothelial aENaC subunit in vascular function in vivo. Compared to littermates, mice with conditional aENaC subunit gene inactivation in the endothelium only (endo-aENaC Knock Out mice) had no difference in their physiological parameters such as systolic blood pressure or heart rate. Acute and long-term renal Na+ handlings were not affected, indicating that endothelial aENaC subunit is not involved in renal sodium balance. Pharmacological inhibition of ENaC with benzamil blunted acetylcholine-induced nitric oxide production in mesenteric arteries from wild type mice but not in endo-aENaC(KO) mice, suggesting a critical role of endothelial ENaC in agonist-induced nitric oxide production. In endo-aENaC(KO) mice, compensatory mechanisms occurred and steady state vascular function was not altered except for flow-mediated dilation. Our data suggest that endothelial aENaC contributes to vascular endothelial function in vivo.	[Tarjus, Antoine; Martinez-Martinez, Ernesto; Jaisser, Frederic] INSERM, U1138, Ctr Rech Cordeliers, Paris, France; [Tarjus, Antoine; Martinez-Martinez, Ernesto; Jaisser, Frederic] Univ Paris 06, Paris, France; [Maase, Martina; Jeggle, Pia; Kusche-Vihrog, Kristina] Univ Munster, Inst Physiol 2, Munster, Germany; [Fassot, Celine; Loufrani, Laurent; Henrion, Daniel] Univ Angers, CNRS, INSERM 1083, UMR 6214, Angers, France; [Hansen, Pernille B. L.] Univ Southern Denmark, Cardiovasc & Renal Res, Odense, Denmark; [Hansen, Pernille B. L.] AstraZeneca, Gothenburg, Sweden; [Jaisser, Frederic] INSERM, Clin Invest Ctr 1433, Vandoeuvre Les Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; University of Munster; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; University of Southern Denmark; AstraZeneca; Institut National de la Sante et de la Recherche Medicale (Inserm)	Tarjus, A (corresponding author), INSERM, U1138, Ctr Rech Cordeliers, Paris, France.; Tarjus, A (corresponding author), Univ Paris 06, Paris, France.	antoine.tarjus@gmail.com	Jaisser, Frederic/P-4287-2017; Martinez-Martinez, Ernesto/M-1376-2017; Henrion, Daniel/J-8141-2015; Henrion, Daniel/N-7023-2015; Fassot, Celine/K-1494-2015; Henrion, Daniel/AAK-1995-2021	Jaisser, Frederic/0000-0001-9051-1901; Martinez-Martinez, Ernesto/0000-0002-3011-2041; Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Hansen, Pernille B. Laerkegaard/0000-0003-0661-1665; Tarjus, Antoine/0000-0002-9867-4585				Ben-Shahar Y, 2011, ADV GENET, V76, P1, DOI 10.1016/B978-0-12-386481-9.00001-8; Buchanan CF, 2014, CELL ADHES MIGR, V8, P517, DOI 10.4161/19336918.2014.970001; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Golestaneh N, 2001, BIOCHEM BIOPH RES CO, V280, P1300, DOI 10.1006/bbrc.2001.4275; Guo DQ, 2016, J CELL SCI, V129, P290, DOI 10.1242/jcs.168831; Heinz WF, 1999, TRENDS BIOTECHNOL, V17, P143, DOI 10.1016/S0167-7799(99)01304-9; Henrion D, 1997, J CLIN INVEST, V100, P2909, DOI 10.1172/JCI119840; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Jeggle P, 2013, HYPERTENSION, V61, P1053, DOI 10.1161/HYPERTENSIONAHA.111.199455; Jernigan NL, 2005, AM J PHYSIOL-RENAL, V289, pF891, DOI 10.1152/ajprenal.00019.2005; Kasas S, 2008, PFLUG ARCH EUR J PHY, V456, P13, DOI 10.1007/s00424-008-0448-y; Korte S, 2014, FASEB J, V28, P4015, DOI 10.1096/fj.14-250282; Kosari F, 1998, J BIOL CHEM, V273, P13469, DOI 10.1074/jbc.273.22.13469; Kusche-Vihrog K, 2008, PFLUG ARCH EUR J PHY, V455, P849, DOI 10.1007/s00424-007-0341-0; Kusche-Vihrog K, 2011, HYPERTENSION, V57, P231, DOI 10.1161/HYPERTENSIONAHA.110.163444; Liu HB, 2015, BRIT J PHARMACOL, V172, P5634, DOI 10.1111/bph.13185; Loufrani L, 2002, CIRC RES, V91, P1183, DOI 10.1161/01.RES.0000047505.11002.81; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Perez FR, 2009, HYPERTENSION, V53, P1000, DOI 10.1161/HYPERTENSIONAHA.108.128520; Pradervand S, 1999, J AM SOC NEPHROL, V10, P2527; Prince LS, 1998, BIOCHEM J, V336, P705, DOI 10.1042/bj3360705; Rossier BC, 2014, CURR OPIN PHARMACOL, V15, P33, DOI 10.1016/j.coph.2013.11.010; Rossier BC, 2013, FEBS LETT, V587, P1929, DOI 10.1016/j.febslet.2013.05.013; Rubera I, 2003, J CLIN INVEST, V112, P554, DOI 10.1172/JCI200316956; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Svenningsen P, 2014, PFLUG ARCH EUR J PHY, V466, P2205, DOI 10.1007/s00424-014-1492-4; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Wang S, 2009, MICROCIRCULATION, V16, P276, DOI 10.1080/10739680802653150	29	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185319	10.1371/journal.pone.0185319	http://dx.doi.org/10.1371/journal.pone.0185319			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950003	Green Published, gold, Green Submitted			2022-12-27	WOS:000411671000037
J	Brisse, HJ; Blanc, T; Schleiermacher, G; Mosseri, V; Philippe-Chomette, P; Janoueix-Lerosey, I; Pierron, G; Lapouble, E; Peuchmaur, M; Freneaux, P; Galmiche, L; Algret, N; Peycelon, M; Michon, J; Delattre, O; Sarnacki, S				Brisse, Herve J.; Blanc, Thomas; Schleiermacher, Gudrun; Mosseri, Veronique; Philippe-Chomette, Pascale; Janoueix-Lerosey, Isabelle; Pierron, Gaelle; Lapouble, Eve; Peuchmaur, Michel; Freneaux, Paul; Galmiche, Louise; Algret, Nathalie; Peycelon, Matthieu; Michon, Jean; Delattre, Olivier; Sarnacki, Sabine			Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival	PLOS ONE			English	Article							SEGMENTAL CHROMOSOMAL ALTERATIONS; CHILDRENS-CANCER-GROUP; DEFINED RISK-FACTORS; THORACIC NEUROBLASTOMA; PELVIC NEUROBLASTOMA; PEDIATRIC-ONCOLOGY; PATHOLOGY CLASSIFICATION; MYCN AMPLIFICATION; ARRAY-CGH; MORBIDITY	Purpose This study investigated relationships between neuroblastomas (NBs) imaging phenotypes, tumor genomic profile and patient outcome. Patients and methods This IRB-approved retrospective observational study included 133 NB patients (73 M, 60 F; median age 15 months, range 0-151) treated in a single institution between 1998 and 2012. A consensus review of imaging (CT-scan, MRI) categorized tumors according to both the primarily involved compartment (i.e., neck, chest, abdomen or pelvis) and the sympathetic anatomical structure the tumors rose from (i.e., cervical, paravertebral or periarterial chains, or adrenal gland). Tumor shape, volume and image-defined surgical risk factors (IDRFs) at diagnosis were recorded. Genomic profiles were assessed using array-based comparative genomic hybridization and divided into three groups: "numerical-only chromosome alterations" (NCA), "segmental chromosome alterations" (SCA) and "MYCN amplification" (MNA). Statistical analyses included Kruskal-Wallis, Chi(2) and Fisher's exact tests and the Kaplan-Meier method with log-rank tests and Cox model for univariate and multivariate survival analyses. Results A significant association between the sympathetic structure origin of tumors and genomic profiles was demonstrated. NBs arising from cervical sympathetic chains were all NCA. Paravertebral NBs were NCA or SCA in 75% and 25%, respectively and none were MNA. Periarterial NBs were NCA, SCA or MNA in 33%, 56% and 11%, respectively. Adrenal NBs were NCA, SCA or MNA in 16%, 36% and 48%, respectively. Among MNA NBs, 92% originated from the adrenal gland. The sympathetic anatomical classification was significantly better correlated to overall survival than the compartmental classification (P < .0003). The tumor volume of MNA NBs was significantly higher than NCA or SCA NBs (P < .0001). Patients with initial volume less than 160 mL had significantly better overall survival (P < .009). A "single mass: pattern was significantly more frequent in NCA NBs (P = .0003). The number of IDRFs was significantly higher in MNA NBs (P < .0001). Conclusion Imaging phenotypes of neuroblastomas, including tumor origin along the sympathetic system, correlate with tumor genomic profile and patient outcome.	[Brisse, Herve J.] Inst Curie, Imaging Dept, Paris, France; [Brisse, Herve J.; Schleiermacher, Gudrun; Mosseri, Veronique; Janoueix-Lerosey, Isabelle; Pierron, Gaelle; Freneaux, Paul; Michon, Jean; Delattre, Olivier] Paris Sci & Lettres Res Univ, Paris, France; [Blanc, Thomas; Peycelon, Matthieu; Sarnacki, Sabine] Necker Enfants Malad Univ Hosp, AP HP, Dept Pediat Surg, Paris, France; [Blanc, Thomas; Galmiche, Louise; Peycelon, Matthieu; Sarnacki, Sabine] Paris Descartes Sorbonne Paris Cite Univ, Paris, France; [Schleiermacher, Gudrun; Lapouble, Eve; Michon, Jean] Inst Curie, Dept Pediat Oncol, Paris, France; [Schleiermacher, Gudrun; Pierron, Gaelle; Delattre, Olivier] Inst Curie, Unite Genet Somat, Paris, France; [Mosseri, Veronique; Algret, Nathalie] Inst Curie, Dept Biostat, Paris, France; [Philippe-Chomette, Pascale] Robert Debre Univ Hosp, AP HP, Dept Pediat Surg & Urol, Paris, France; [Philippe-Chomette, Pascale; Peuchmaur, Michel] Paris Diderot Sorbonne Paris Cite Univ, Paris, France; [Janoueix-Lerosey, Isabelle; Delattre, Olivier] Inst Curie, INSERM, Equipe Labellisee Ligue Contre Canc, U830, Paris, France; [Peuchmaur, Michel] Robert Debre Univ Hosp, AP HP, Dept Pathol, Paris, France; [Freneaux, Paul] Inst Curie, Dept Biopathol, Paris, France; [Galmiche, Louise] Necker Enfants Malad Univ Hosp, AP HP, Dept Pathol, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Brisse, HJ (corresponding author), Inst Curie, Imaging Dept, Paris, France.; Brisse, HJ (corresponding author), Paris Sci & Lettres Res Univ, Paris, France.	herve.brisse@curie.fr	Schleiermacher, Gudrun/AAN-4711-2021; Janoueix-Lerosey, Isabelle/G-1758-2018; Peycelon, Matthieu/Q-8139-2017; Sarnacki, Sabine/I-2692-2017	Schleiermacher, Gudrun/0000-0002-0133-5879; Janoueix-Lerosey, Isabelle/0000-0003-0434-3003; Peycelon, Matthieu/0000-0003-3617-4849; delattre, olivier/0000-0002-8730-2276; Sarnacki, Sabine/0000-0003-4304-5578; BRISSE, Herve J./0000-0003-2794-5875	Site de Recherche Integre sur le Cancer, Institut National du Cancer, Direction Generale de l'Offre de Soins [4654]; Direction Generale de l'Offre de Soins [PHRC AOM 02014, PHRC IC2007-09]; Institut National de la Sante et de la Recherche Medicale; Ligue Nationale contre le Cancer (Equipe labellisee); <<Carte d'ldentite des Tumeurs>> program (Ligue Nationale Contre le Cancer); CEST of Institut Curie; Annenberg foundation; APAESIC (Association des Parents et des Amis des Enfants Soignes a l'Institut Curie); Association Hubert Gouin Enfance et Cancer; Les Bagouz a Manon; Enfants et Sante; Les Amis de Claire	Site de Recherche Integre sur le Cancer, Institut National du Cancer, Direction Generale de l'Offre de Soins; Direction Generale de l'Offre de Soins; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Nationale contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); <<Carte d'ldentite des Tumeurs>> program (Ligue Nationale Contre le Cancer); CEST of Institut Curie; Annenberg foundation; APAESIC (Association des Parents et des Amis des Enfants Soignes a l'Institut Curie); Association Hubert Gouin Enfance et Cancer; Les Bagouz a Manon; Enfants et Sante; Les Amis de Claire	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by the following grants: Grant-4654 (Site de Recherche Integre sur le Cancer, Institut National du Cancer, Direction Generale de l'Offre de Soins); http://www.e-cancer.fr/, http://social-saute.gouv.fr/ministere/organisation/directions/article/dgos-direction-generale-de-l-offre-de-soins; PHRC AOM 02014 and PHRC IC2007-09 (Direction Generale de l'Offre de Soins); http://social-sante.gouv.fr/ministere/organisation/directions/article/dgos-direction-generale-de-l-offre-de-soins; Institut National de la Sante et de la Recherche Medicale, http://www.inserm.fr/; Ligue Nationale contre le Cancer (Equipe labellisee), https://wwv.ligue-cancer.net/; << Carte d'ldentite des Tumeurs >> program (Ligue Nationale Contre le Cancer), https://www.ligue-cancer.net/; CEST of Institut Curie, https://curie.fr/. The authors also thank the following associations for their continuous support: The Annenberg foundation, https://www.annenberg.org/ The APAESIC (Association des Parents et des Amis des Enfants Soignes a l'Institut Curie), http://www.apaesic.org/; The << Association Hubert Gouin Enfance et Cancer >>, http://www.enfance-et-cancer.org/; << Les Bagouz a Manon >>, http://www.lesbagouzamanon.org/; << Enfants et Sante >>, http://www.enfants-cancers-sante.fr/; << Les Amis de Claire >>, https://curie.fr/page/assocation-les-amis-de-claire.	ABRAMSON SJ, 1993, PEDIATR RADIOL, V23, P253, DOI 10.1007/BF02010908; ADAMS GA, 1993, J PEDIATR SURG, V28, P372, DOI 10.1016/0022-3468(93)90234-C; Ambros PF, 2009, BRIT J CANCER, V100, P1471, DOI 10.1038/sj.bjc.6605014; Bleeker G, 2015, EUR J NUCL MED MOL I, V42, P222, DOI 10.1007/s00259-014-2909-1; Brisse HJ, 2011, RADIOLOGY, V261, P243, DOI 10.1148/radiol.11101352; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; COLDMAN AJ, 1980, CANCER, V46, P1896, DOI 10.1002/1097-0142(19801015)46:8<1896::AID-CNCR2820460833>3.0.CO;2-Y; Cotterill SJ, 2000, EUR J CANCER, V36, P901, DOI 10.1016/S0959-8049(00)00058-7; Cruccetti A, 2000, J PEDIATR SURG, V35, P724, DOI 10.1053/jpsu.2000.6076; De Bernardi B, 2008, J CLIN ONCOL, V26, P1710, DOI 10.1200/JCO.2006.08.8799; Gahr N, 2011, EUR J RADIOL, V79, P443, DOI 10.1016/j.ejrad.2010.04.005; HAASE GM, 1995, ANN SURG ONCOL, V2, P516, DOI 10.1007/BF02307085; Haberle B, 2002, EUR J PEDIATR SURG, V12, P145, DOI 10.1055/s-2002-32721; Horiuchi A, 2004, PEDIATR SURG INT, V20, P714, DOI 10.1007/s00383-003-1049-7; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; La Rosa P, 2006, BIOINFORMATICS, V22, P2066, DOI 10.1093/bioinformatics/btl359; Leclair MD, 2004, J CLIN ONCOL, V22, P1689, DOI 10.1200/JCO.2004.04.069; Monclair T, 2015, PEDIATR BLOOD CANCER, V62, P1536, DOI 10.1002/pbc.25460; Monclair T, 2009, J CLIN ONCOL, V27, P298, DOI 10.1200/JCO.2008.16.6876; MORRIS JA, 1995, J PEDIATR SURG, V30, P296, DOI 10.1016/0022-3468(95)90577-4; Moukheiber AK, 2001, INT J PEDIATR OTORHI, V60, P155, DOI 10.1016/S0165-5876(01)00499-2; Peuchmaur M, 2003, CANCER, V98, P2274, DOI 10.1002/cncr.11773; Qureshi SS, 2014, PEDIATR SURG INT, V30, P267, DOI 10.1007/s00383-013-3431-4; Schleiermacher G, 2007, BRIT J CANCER, V97, P238, DOI 10.1038/sj.bjc.6603820; Schleiermacher G, 2012, BRIT J CANCER, V107, P1418, DOI 10.1038/bjc.2012.375; Schleiermacher G, 2011, BRIT J CANCER, V105, P1940, DOI 10.1038/bjc.2011.472; Schleiermacher G, 2010, J CLIN ONCOL, V28, P3122, DOI 10.1200/JCO.2009.26.7955; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shimada H, 1999, CANCER, V86, P349, DOI 10.1002/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.3.CO;2-P; Shimada H, 2001, CANCER, V92, P2451, DOI 10.1002/1097-0142(20011101)92:9<2451::AID-CNCR1595>3.0.CO;2-S; Simon T, 2008, PEDIATR BLOOD CANCER, V50, P965, DOI 10.1002/pbc.21343; Suita S, 2000, EUR J PEDIATR SURG, V10, P353, DOI 10.1055/s-2008-1072390; Sung KW, 2009, J KOREAN MED SCI, V24, P461, DOI 10.3346/jkms.2009.24.3.461; TURKEL SB, 1974, AM J PATHOL, V76, P225; Vo KT, 2014, J CLIN ONCOL, V32, P3169, DOI 10.1200/JCO.2014.56.1621; Yoo SY, 2013, CANCER-AM CANCER SOC, V119, P656, DOI 10.1002/cncr.27775	38	24	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185190	10.1371/journal.pone.0185190	http://dx.doi.org/10.1371/journal.pone.0185190			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945781	gold, Green Published, Green Submitted			2022-12-27	WOS:000411645100028
J	Solomon-Zemler, R; Sarfstein, R; Werner, H				Solomon-Zemler, Ravid; Sarfstein, Rive; Werner, Haim			Nuclear insulin-like growth factor-1 receptor (IGF1R) displays proliferative and regulatory activities in non-malignant cells	PLOS ONE			English	Article							EXPRESSION; IGF-1R; ANTIBODY; PATHWAY	The insulin-like growth factor-1 receptor (IGF1R) mediates the biological actions of IGF1 and IGF2. The IGF1R is involved in both physiological and pathological activities and is usually overexpressed in most types of cancer. In addition to its classical mechanism of action, recent evidence has shown a nuclear presence of IGF1R, associated with novel genomic/transcriptional types of activities. The present study was aimed at evaluating the hypothesis that nuclear IGF1R localization is not restricted to cancer cells and might constitute a novel physiologically relevant regulatory mechanism. Our data shows that nuclear translocation takes place in a wide array of cells, including normal diploid fibroblasts. In addition, we provide evidence for a synergistic effect of a nuclear translocation blocker along with selective IGF1R inhibitors in terms of decreasing cell proliferation. Given the important role of the IGF1R in mitogenesis, the present results may be of translational relevance in cancer research. In conclusion, results are consistent with the concept that nuclear IGF1R fulfills important physiological and pathological roles.	[Solomon-Zemler, Ravid; Sarfstein, Rive; Werner, Haim] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, Tel Aviv, Israel; [Werner, Haim] Tel Aviv Univ, Yoran Inst Human Genome Res, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Werner, H (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, Tel Aviv, Israel.; Werner, H (corresponding author), Tel Aviv Univ, Yoran Inst Human Genome Res, Tel Aviv, Israel.	hwerner@post.tau.ac.il			European Foundation	European Foundation(European Science Foundation (ESF))	This study was supported by a grant from the European Foundation for the study of Diabetes. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was performed in partial fulfillment of the requirements for a Ph.D. degree by Ravid Solomon-Zemler at the Sackler Faculty of Medicine, Tel Aviv University. This work was supported by a grant from the European Foundation for the Study of Diabetes to H.W. The authors wish to thank Drs. Joy L. Ware, Derek LeRoith and Eli Sprecher for providing cell lines.	Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; Asmane I, 2012, EUR J CANCER, V48, P3027, DOI 10.1016/j.ejca.2012.05.009; BASERGA R, 1995, CANCER RES, V55, P249; Baserga R, 1999, EXP CELL RES, V253, P1, DOI 10.1006/excr.1999.4667; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Deng H, 2011, BIOCHEM BIOPH RES CO, V404, P667, DOI 10.1016/j.bbrc.2010.12.038; Dupont J, 2001, HORM RES, V55, P22, DOI 10.1159/000063469; Foulstone E, 2005, J PATHOL, V205, P145, DOI 10.1002/path.1712; Iams WT, 2015, CLIN CANCER RES, V21, P4270, DOI 10.1158/1078-0432.CCR-14-2518; KALEKO M, 1990, MOL CELL BIOL, V10, P464, DOI 10.1128/MCB.10.2.464; Lin YC, 2015, CHEM-BIOL INTERACT, V231, P119, DOI 10.1016/j.cbi.2015.01.016; Lin YB, 2017, J CELL PHYSIOL, V232, P2722, DOI 10.1002/jcp.25818; Maloney EK, 2003, CANCER RES, V63, P5073; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; Ouban A, 2003, HUM PATHOL, V34, P803, DOI 10.1016/S0046-8177(03)00291-0; Packham S, 2015, ONCOGENE, V34, P2227, DOI 10.1038/onc.2014.165; Sachdev D, 2007, MOL CANCER THER, V6, P1, DOI 10.1158/1535-7163.MCT-06-0080; Sarfstein R, 2012, J BIOL CHEM, V287, P2766, DOI 10.1074/jbc.M111.281782; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; Wang Z, 2015, IEEE ST CONF RES DEV, P1, DOI 10.1109/SCORED.2015.7449302; Warsito D, 2012, EMBO REP, V13, P244, DOI 10.1038/embor.2011.251	22	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185164	10.1371/journal.pone.0185164	http://dx.doi.org/10.1371/journal.pone.0185164			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945762	gold, Green Published, Green Submitted			2022-12-27	WOS:000411645100026
J	Fabiani, M; Ferrante, G; Minardi, V; Giambi, C; Riccardo, F; Declich, S; Masocco, M				Fabiani, Massimo; Ferrante, Gianluigi; Minardi, Valentina; Giambi, Cristina; Riccardo, Flavia; Declich, Silvia; Masocco, Maria			Comparison of rubella immunization rates in immigrant and Italian women of childbearing age: Results from the Italian behavioral surveillance system PASSI (2011-2015)	PLOS ONE			English	Article							VACCINATION COVERAGE; PREGNANT-WOMEN; VIRUS-ANTIBODIES; SELF-REPORT; HEALTH; POPULATION; SEROPREVALENCE; SUSCEPTIBILITY; PREVALENCE; CATALONIA	Background International migration rapidly increased in the last decade, raising a renewed attention to its impact on public health. We evaluated differences in rubella immunization rate (RIR) between immigrant and Italian women of childbearing age and tried to identify the driving factors causing them. Methods We analyzed data from the Italian behavioral surveillance system PASSI collected in 2011-2015 in a nationally representative sample of residents in Italy. The analysis was performed using log-binomial models to compare RIR between 41,094 Italian women and 3140 regular immigrant women of childbearing age (18-49 years), stratifying the latter by area of origin and length-of-stay in Italy (recent: <= 5-years; mid-term: 6-10-years; long-term: > 10-years). Results Immigrant women showed a RIR of 36.0% compared to 60.2% among Italian women (RIR-ratio = 0.60, 95% confidence interval (CI): 0.57-0.63). Adjusting for demographic characteristics (i.e., sex, age and area of residence), socio-economic factors (i.e., education, occupation, family composition and economic status) and an indicator of the presence of at least one health-risk behavior (i.e., physical inactivity, current cigarette smoking, excessive alcohol consumption and excess weight) did not significantly change this difference (RIR-ratio = 0.56, 95% CI: 0.53-0.59). Recent immigrants (RIR-ratio = 0.47, 95% CI: 0.42-0.53) and immigrants from high migratory pressure countries (HMPC) in sub-Saharan Africa (RIR-ratio = 0.41, 95% CI: 0.31-0.56) and Asia (RIR-ratio = 0.42, 95% CI: 0.33-0.53) showed the greatest differences in RIR compared with Italian women. Conclusions Differences in RIR between immigrant and Italian women were not explained by different demographic, socioeconomic and health-risk behaviors characteristics. As entitlement to free-of-charge immunization in Italy is universal, regardless of migration status, other informal barriers (e.g., cultural and barriers to information access) might explain lower RIRs in immigrant women, especially recent immigrants and those from HMPC in sub-Saharan Africa and Asia. Further investigations are needed to identify obstacles and appropriate promotion and access-enabling strategies for rubella immunization.	[Fabiani, Massimo; Ferrante, Gianluigi; Minardi, Valentina; Giambi, Cristina; Riccardo, Flavia; Declich, Silvia; Masocco, Maria] Italian Natl Inst Hlth ISS, Natl Ctr Epidemiol Surveillance & Hlth Promot CNE, Rome, Italy; [Riccardo, Flavia] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden	Istituto Superiore di Sanita (ISS); European Centre for Disease Prevention & Control	Fabiani, M (corresponding author), Italian Natl Inst Hlth ISS, Natl Ctr Epidemiol Surveillance & Hlth Promot CNE, Rome, Italy.	massimo.fabiani@iss.it	Ferrante, Gianluigi/AAG-3608-2021; Riccardo, Flavia/GRJ-5156-2022; Ferrante, Gianluigi/K-3274-2018	Riccardo, Flavia/0000-0002-1582-6329; Ferrante, Gianluigi/0000-0003-0182-4506; minardi, valentina/0000-0002-3512-3778; Fabiani, Massimo/0000-0002-5893-7117; Masocco, Maria/0000-0003-2930-3542; Declich, Silvia/0000-0002-5916-3889	National Centre for Disease Prevention and Control of the Italian Ministry of Health [4M30/2014-CCM]	National Centre for Disease Prevention and Control of the Italian Ministry of Health	This work was funded by the National Centre for Disease Prevention and Control of the Italian Ministry of Health (grant no. 4M30/2014-CCM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association for Public Opinion Research (AAPOR), 2008, STAND DEF FIN DISP C; [Anonymous], 2012, GLOB VACC ACT PLAN 2; Baldissera S, 2011, PREV CHRONIC DIS, V8; Barsanti S, 2013, 042013 I MAN SCUOL S; Borras E, 2007, VACCINE, V25, P3240, DOI 10.1016/j.vaccine.2007.01.026; Byrne L, 2012, VACCINE, V30, P161, DOI 10.1016/j.vaccine.2011.11.045; Calimeri S, 2012, INT J GYNECOL OBSTET, V116, P211, DOI 10.1016/j.ijgo.2011.10.029; Centro Studi e Ricerche IDOS, 2015, DOSSIER STAT IMMIGRA; Chiaradia G, 2011, ITAL J PUBLIC HLTH, V8, P268; De Paschale M, 2012, INFECT DIS REP, V4, P59, DOI 10.4081/idr.2012.e17; Dustmann C, 2011, 2211 CREAM U COLL LO; Duszak RS, 2009, OPTOMETRY, V80, P36, DOI 10.1016/j.optm.2008.03.006; European Foundation for the Improvement of Living and Working Conditions, 2007, EMPL WORK COND MIGR; Eurostat, 2016, MIGR MIGR POP STAT; Fabiani M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166517; Flores G, 2005, MED CARE RES REV, V62, P255, DOI 10.1177/1077558705275416; Garcia-Comas L, 2015, J INFECT PUBLIC HEAL, V8, P432, DOI 10.1016/j.jiph.2015.01.012; Giambi C, 2015, EURO SURVEILL, V20; Gigantesco A, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150154; Grimaldi-Bensouda L, 2013, PHARMACOEPIDEM DR S, V22, P278, DOI 10.1002/pds.3401; Italian Ministry of Health, 2011, PLAN NAZ EL MORB ROS; Italian National Institute of Statistics (ISTAT), 2015, DEM FIG; Jimenez-Garcia R, 2014, VACCINE, V32, P4386, DOI 10.1016/j.vaccine.2014.06.074; Kentikelenis A, 2015, EUR J PUBLIC HEALTH, V25, P937, DOI 10.1093/eurpub/ckv151; Kogan I, 2011, INT MIGR, V49, P91, DOI 10.1111/j.1468-2435.2010.00609.x; Lo Giudice D, 2014, TRAVEL MED INFECT DI, V12, P253, DOI 10.1016/j.tmaid.2014.01.003; Mladovsky P, 2012, CLIN MED, V12, P248, DOI 10.7861/clinmedicine.12-3-248; Nicodemo C., 2009, 0909 U AUT BARC DEP; Norredam M, 2014, TROP MED INT HEALTH, V19, P958, DOI 10.1111/tmi.12340; Ogundele M, 2016, J PUBLIC HEALTH-UK, V38, P243, DOI 10.1093/pubmed/fdv033; Pallasch G, 2005, GESUNDHEITSWESEN, V67, P33, DOI 10.1055/s-2004-813912; Poethko-Muller C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042867; Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8; Riccardo F, 2015, INT J ENV RES PUB HE, V12, P11640, DOI 10.3390/ijerph120911640; Riccardo F, 2012, HEALTH POLICY, V105, P17, DOI 10.1016/j.healthpol.2012.02.004; Sbarchi Papavero G., 2015, RICHIEDENTI ASILO PR; UNDP, 2007, HUMAN DEV REPORT 200; United Nations, 2016, INT MIGR REP 2015 HI; Vandermeulen C, 2008, EUR J PEDIATR, V167, P1161, DOI 10.1007/s00431-007-0652-3; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Vilajeliu A, 2015, VACCINE, V33, P1767, DOI 10.1016/j.vaccine.2015.02.043; World Health Organization, 2010, HLTH MIGR WAY FORW R; Wormann T., 2011, Migration and health in the European Union, P121	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0178122	10.1371/journal.pone.0178122	http://dx.doi.org/10.1371/journal.pone.0178122			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968403	Green Published, gold, Green Submitted			2022-12-27	WOS:000412029600002
J	Mei, LL; Wang, WJ; Qiu, YT; Xie, XF; Bai, J; Shi, ZZ				Mei, Li-Li; Wang, Wen-Jun; Qiu, Yun-Tan; Xie, Xiu-Feng; Bai, Jie; Shi, Zhi-Zhou			miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma	PLOS ONE			English	Article							BREAST-CANCER; MESENCHYMAL TRANSITION; DOWN-REGULATION; PROGNOSIS; INVASION; MICRORNA; METASTASIS; EXPRESSION; RESISTANCE; MIGRATION	MicroRNAs (miRNAs) play important roles in the progression of human cancer including esophageal squamous cell carcinoma (ESCC). Although previous reports showed that miR-125b-5p was down-regulated in ESCC, the roles and mechanisms of loss of function of miR-125b-5p in ESCC were still unknown. Using microRNA microarray and GEO datasets, we found and confirmed that miR-125b-5p was down-regulated in ESCC tissues. In-vitro assays showed that ectopic miR-125b-5p expression repressed cell proliferation, migration and invasion, and induced cell senescence. We also found that miR-125b-5p reduced the expressions of cell cycle regulatory genes including CCNA2, CCND1 and CCNE1, and regulated the markers of epithelial to mesenchymal transition (EMT) including E-cadherin, N-cadherin and EMT associated transcription factor Slug, and also decreased the MMPs including MMP2, MMP7 and MMP13. Furthermore, the candidate target gene HMGA2 was negatively regulated by miR-125b-5p both in mRNA and protein levels. Importantly, knockdown of HMGA2 partially phenocopied the effects of miR-125b-5p overexpression on cell cycle regulators and EMT markers. In conclusion, our results suggested that overexpression of miR-125b-5p inhibited cell proliferation, migration and invasion partially by down-regulating HMGA2 in ESCC.	[Mei, Li-Li; Wang, Wen-Jun; Qiu, Yun-Tan; Xie, Xiu-Feng; Bai, Jie; Shi, Zhi-Zhou] Kunming Univ Sci & Technol, Med Sch, Kunming, Yunnan, Peoples R China; [Shi, Zhi-Zhou] CAMS, Canc Hosp, State Key Lab Mol Oncol, Beijing, Peoples R China	Kunming University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College	Bai, J; Shi, ZZ (corresponding author), Kunming Univ Sci & Technol, Med Sch, Kunming, Yunnan, Peoples R China.; Shi, ZZ (corresponding author), CAMS, Canc Hosp, State Key Lab Mol Oncol, Beijing, Peoples R China.	jiebai662001@126.com; zhizhoushi@kmust.edu.cn		Qiu, Yuntan/0000-0001-5653-7956; Mei, LiLi/0000-0003-2100-736X	National Natural Science Foundation of China [81460425, 81760526]; Open Project Program of State Key Laboratory of Molecular Oncology [SKL-KF-2017-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Project Program of State Key Laboratory of Molecular Oncology	The National Natural Science Foundation of China (No.81460425 and No. 81760526) and the Open Project Program of State Key Laboratory of Molecular Oncology (SKL-KF-2017-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bu QG, 2017, BIOMED PHARMACOTHER, V88, P443, DOI 10.1016/j.biopha.2016.11.090; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cisneros-Soberanis F, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2475-z; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Deakin NE, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00070; Dong JQ, 2017, CLIN CANCER RES, V23, P3461, DOI 10.1158/1078-0432.CCR-16-2180; Fassan M, 2013, HUM PATHOL, V44, P1804, DOI 10.1016/j.humpath.2013.01.023; Foda HD, 2001, DRUG DISCOV TODAY, V6, P478, DOI 10.1016/S1359-6446(01)01752-4; Fujino Y, 2017, CANCER SCI, V108, P390, DOI 10.1111/cas.13152; Gu J, 2013, CURR PHARM DESIGN, V19, P1292; Hong LQ, 2016, ONCOTARGETS THER, V9, P2639, DOI 10.2147/OTT.S102713; Hsieh YS, 2017, J CELL BIOCH; Jin Liyan, 2016, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V32, P1238; Liu BQ, 2017, HUM PATHOL, V64, P44, DOI 10.1016/j.humpath.2017.03.016; Liu Q, 2012, MOL BIOL REP, V39, P1239, DOI 10.1007/s11033-011-0854-7; Luo YW, 2017, ONCOL LETT, V13, P867, DOI 10.3892/ol.2016.5482; Mittal R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091885; Nakanishi H, 2014, ONCOGENE, V33, P702, DOI 10.1038/onc.2013.13; Palumbo A, 2016, ONCOTARGET, V7, P25872, DOI 10.18632/oncotarget.8288; Palumbo A, 2016, CELL CYCLE, V15, P2410, DOI 10.1080/15384101.2016.1215388; Pei GS, 2017, ONCOTARGET, V8, P13898, DOI 10.18632/oncotarget.14687; Shi Z, 2016, J BIOSCIENCES, V41, P229, DOI 10.1007/s12038-016-9603-3; Sun JY, 2017, AM J CANCER RES, V7, P260; Sun M, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0445-8; Wei RN, 2016, J CANCER RES THER, V12, P1291, DOI 10.4103/0973-1482.180616; Wu SQ, 2015, J ELECTR COMPUT ENG, V2015, DOI 10.1155/2015/835357; Yang D, 2017, SCI REP-UK, V7, DOI 10.1038/srep43109; Yang LL, 2017, ONCOTARGET, V8, P59867, DOI 10.18632/oncotarget.16729; Yu XF, 2017, SCI REP-UK, V7, DOI 10.1038/srep42226; Yuan TZ, 2017, MOL MED REP, V15, P2223, DOI 10.3892/mmr.2017.6233; Zang B, 2015, INT J CLIN EXP PATHO, V8, P13687; Zhang MY, 2016, MINERVA CHIR, V71, P239; Zhang X, 2017, ONCOTARGET; Zuberi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153902	35	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185636	10.1371/journal.pone.0185636	http://dx.doi.org/10.1371/journal.pone.0185636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968424	gold, Green Published, Green Submitted			2022-12-27	WOS:000412029600033
J	Shao, XX; Sheng, XC; Wu, M; Wu, H; Ning, X				Shao, Xuexin; Sheng, Xuancai; Wu, Ming; Wu, Hao; Ning, Xiao			Methane production potential and emission at different water levels in the restored reed wetland of Hangzhou Bay	PLOS ONE			English	Article							NATURAL WETLANDS; DIURNAL-VARIATIONS; TABLE; CHINA; METHANOGENESIS; EXCHANGE; PEATLAND; IMPACT; MARSH; RATES	Changes in the hydrological conditions of coastal wetlands may potentially affect the role of wetlands in the methane (CH4) cycle. In this study, the CH4 production potential and emissions from restored coastal reed wetlands at different water levels were examined in eastern China at a field scale in two phenological seasons. Results showed that the total CH4 flux from reeds at various water levels were positive, indicating that they were "sources" of CH4. During the peak growing season, CH4 flux from reeds was greater than that during the spring thaw. CH4 flux from reeds in inundated conditions was greater than that in non-inundated conditions. The CH4 production potential during the peak growing season was far greater than that during the spring thaw. However, the effect of water level on wetland CH4 production potential differed among seasons. The correlations among CH4 production potential, soil properties and CH4 flux change at different water level. These results demonstrate that water level was related to CH4 production and CH4 flux. The growing season also plays a role in CH4 fluxes. Controlling the hydrological environment in restored wetlands has important implications for the maintenance of their function as carbon sinks.	[Shao, Xuexin; Wu, Ming; Wu, Hao; Ning, Xiao] Chinese Acad Forestry, Res Inst Subtrop Forestry, Wetland Ecosyst Res Stn Hangzhou Bay, Hangzhou, Zhejiang, Peoples R China; [Sheng, Xuancai] State Forestry Adm, East China Forest Inventory & Planning Inst, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Wu, M (corresponding author), Chinese Acad Forestry, Res Inst Subtrop Forestry, Wetland Ecosyst Res Stn Hangzhou Bay, Hangzhou, Zhejiang, Peoples R China.	hangzhoubay@126.com			Special Fund for Forest Scientific Research in the Public Welfare [201404210]; Fundamental Research Funds for the Central Non-profit Research Institution [CAFYBB2014MA002]; Fund for Cooperation of Zhejiang Province; Chinese Academy of Forestry [2015SY01]	Special Fund for Forest Scientific Research in the Public Welfare; Fundamental Research Funds for the Central Non-profit Research Institution; Fund for Cooperation of Zhejiang Province; Chinese Academy of Forestry	This study was supported by the Special Fund for Forest Scientific Research in the Public Welfare (201404210), the Fundamental Research Funds for the Central Non-profit Research Institution (CAFYBB2014MA002) and the Fund for Cooperation of Zhejiang Province and Chinese Academy of Forestry (2015SY01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery GB, 2003, BIOGEOCHEMISTRY, V62, P19, DOI 10.1023/A:1021128400602; Berglund O, 2011, SOIL BIOL BIOCHEM, V43, P923, DOI 10.1016/j.soilbio.2011.01.002; Brix H, 2001, AQUAT BOT, V69, P313, DOI 10.1016/S0304-3770(01)00145-0; Buckley DH, 2008, ENVIRON MICROBIOL, V10, P967, DOI 10.1111/j.1462-2920.2007.01517.x; Chang YiLu, 1999, Mangroves and Salt Marshes, V3, P41; Chasar LS, 2000, ANN BOT-LONDON, V86, P655, DOI 10.1006/anbo.2000.1172; Chen H, 2013, GLOBAL CHANGE BIOL, V19, P19, DOI 10.1111/gcb.12034; Dasselaar PV, 1999, SOIL BIOL BIOCHEM, V31, P877; Ding WX, 2007, PEDOSPHERE, V17, P475, DOI 10.1016/S1002-0160(07)60057-5; Ding WX, 2010, ATMOS ENVIRON, V44, P3894, DOI 10.1016/j.atmosenv.2010.07.025; Ding WX, 2004, ATMOS ENVIRON, V38, P751, DOI 10.1016/j.atmosenv.2003.10.016; Duan XN, 2005, ATMOS ENVIRON, V39, P4479, DOI 10.1016/j.atmosenv.2005.03.045; Faubert P, 2010, ATMOS ENVIRON, V44, P4432, DOI 10.1016/j.atmosenv.2010.07.039; [冯利华 FENG Lihua], 2006, [海洋科学, Marine Sciences], V30, P88; Grunfeld S, 1999, AQUAT BOT, V64, P63, DOI 10.1016/S0304-3770(99)00010-8; Herbst M, 2011, AGR FOREST METEOROL, V151, P841, DOI 10.1016/j.agrformet.2011.02.002; Hu QF, 2009, WATER SCI ENG, V2, P1, DOI 10.3882/j.issn.1674-2370.2009.01.001; Huang Pu-yi, 2011, Yingyong Shengtai Xuebao, V22, P1219; Joabsson A, 1999, TRENDS ECOL EVOL, V14, P385, DOI 10.1016/S0169-5347(99)01649-3; Joosten H, 2002, WISE USE MIRES PEATL; Juutinen S, 2003, BIOL FERT SOILS, V38, P10, DOI 10.1007/s00374-003-0618-1; Kettunen A, 1999, SOIL BIOL BIOCHEM, V31, P1741, DOI 10.1016/S0038-0717(99)00093-0; Knorr KH, 2008, SOIL BIOL BIOCHEM, V40, P1781, DOI 10.1016/j.soilbio.2008.03.019; Kohl JG, 2000, AQUAT BOT, V54, P199; Liu DY, 2014, APPL MICROBIOL BIOT, V98, P4711, DOI 10.1007/s00253-014-5571-4; [刘小燕 Liu Xiaoyan], 2006, [生态环境, Ecology and Environment], V15, P265; Lu L. K, 1999, SOIL AGRO CHEM ANALY; Luo G, 2013, BIOGEOSCI DISCUSS, V10, P927, DOI DOI 10.5194/bgd-10-927-2013; Ma ZJ, 2014, SCIENCE, V346, P912, DOI 10.1126/science.1257258; Macdonald JA, 1998, ATMOS ENVIRON, V32, P3219, DOI 10.1016/S1352-2310(97)00464-0; Purvaja R, 2004, GLOBAL CHANGE BIOL, V10, P1825, DOI 10.1111/j.1365-2486.2004.00834.x; 王明星, 1993, Advances in Atmospheric Sciences, V10, P307; Shang QY, 2011, GLOBAL CHANGE BIOL, V17, P2196, DOI 10.1111/j.1365-2486.2010.02374.x; Shao X, ENV PROGR SUSTAINABL; Shao XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142677; Singh S.N., 2000, CHEMOSPHERE GLOB CHA, V2, DOI [10.1016/S1465- 9972(99)00046-X, DOI 10.1016/S1465-9972(99)00046-X]; Sun L, 2013, ATMOS ENVIRON, V81, P356, DOI 10.1016/j.atmosenv.2013.09.033; Tiiva P, 2009, ATMOS ENVIRON, V43, P5469, DOI 10.1016/j.atmosenv.2009.07.026; Tong C, 2013, ESTUAR COAST, V36, P633, DOI 10.1007/s12237-013-9596-1; Villa Jorge A., 2014, Ecohydrology & Hydrobiology, V14, P253, DOI 10.1016/j.ecohyd.2014.07.005; [万忠梅 Wan Zhongmei], 2013, [生态环境学报, Ecology and Environmental Sciences], V22, P465; WANG ZP, 1993, SOIL SCI SOC AM J, V57, P382, DOI 10.2136/sssaj1993.03615995005700020016x; Whalen SC, 2005, ENVIRON ENG SCI, V22, P73, DOI 10.1089/ees.2005.22.73; Yang JS, 2013, SOIL BIOL BIOCHEM, V61, P52, DOI 10.1016/j.soilbio.2013.02.009; Yuan JJ, 2014, APPL MICROBIOL BIOT, V98, P1817, DOI 10.1007/s00253-013-5104-6	45	11	13	8	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185709	10.1371/journal.pone.0185709	http://dx.doi.org/10.1371/journal.pone.0185709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968419	Green Published, gold, Green Submitted			2022-12-27	WOS:000412029600037
J	McClellan, SA; Jerome, A; Suvas, S; Hazlett, LD				McClellan, Sharon A.; Jerome, Andrew; Suvas, Susmit; Hazlett, Linda D.			NLRC4 regulates caspase-1 and IL-1beta production in a CD11b(low) Ly6G(low) population of cells required for resistance to Pseudomonas aeruginosa keratitis	PLOS ONE			English	Article							CORNEAL INFECTION; SUPPRESSOR-CELLS; OCULAR INFECTION; GAMMA PRODUCTION; DENDRITIC CELLS; RISK-FACTORS; SOUTH-INDIA; MICE; INFLAMMASOMES; ACTIVATION	Psbetaeudomonas (P.) aeruginosa infection of the cornea in BALB/c mice does not result in perforation and the mice have been classified as resistant. However, regulation of this response via inflammasome activation remained untested. Therefore, BALB/c mice were infected with P. aeruginosa ATCC strain 19660 and NLRP3 and NLRC4 protein tested by ELISA. Since NLRC4 vs NLRP3 protein levels were significantly higher in the corneas of BALB/c at 1 and 5 days postinfection we used silencing to knockdown NLRC4. Silencing NLRC4 vs scrambled siRNA treatment exacerbated disease in BALB/c mice, reduced myeloperoxidase levels and elevated bacterial plate counts at 5 days postinfection. It also increased pro IL-1beta, but reduced total protein for IL-1beta and IL-18 at 5 days postinfection. Flow cytometry to identify cells affected by silencing, showed reduced caspase-1 levels in a CD11b(low) Ly6G(low) population of cells, (but not PMN or macrophages) from the infected cornea of siNLRC4 treated mice that produced less mature IL-1beta. These data provide evidence that the NLRC4 inflammasome contributes to resistance through regulation of caspase-1, IL-1beta and IL-18 in a CD11b(low) Ly6G(low) population of cells.	[McClellan, Sharon A.; Jerome, Andrew; Suvas, Susmit; Hazlett, Linda D.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Suvas, Susmit; Hazlett, Linda D.] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI 48202 USA	Wayne State University; Wayne State University	Hazlett, LD (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.; Hazlett, LD (corresponding author), Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI 48202 USA.	lhaziett@med.wayne.edu		Jerome, Andrew/0000-0002-6748-8114	National Eye Institute, National Institutes of Health [R01EY016058, R01EY022417, P30EY004068]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY022417] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants R01EY016058 (LDH), R01EY022417 (SS) and P30EY004068 (LDH) from the National Eye Institute, National Institutes of Health and by a Research to Prevent Blindness unrestricted grant to the Department of Ophthalmology/Kresge Eye Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauernfeind F, 2011, CELL MOL LIFE SCI, V68, P765, DOI 10.1007/s00018-010-0567-4; Bharathi MJ, 2007, OPHTHAL EPIDEMIOL, V14, P61, DOI 10.1080/09286580601001347; Bharathi MJ, 2009, INDIAN J MED RES, V130, P749; Brissette-Storkus CS, 2002, INVEST OPHTH VIS SCI, V43, P2264; Carvalho FA, 2012, MUCOSAL IMMUNOL, V5, P288, DOI 10.1038/mi.2012.8; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Chen KWW, 2013, CURR OPIN MICROBIOL, V16, P311, DOI 10.1016/j.mib.2013.02.004; Cohen TS, 2013, J CLIN INVEST, V123, P1630, DOI 10.1172/JCI66142; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Gorham JD, 1996, P NATL ACAD SCI USA, V93, P12467, DOI 10.1073/pnas.93.22.12467; Hamrah P, 2003, INVEST OPHTH VIS SCI, V44, P581, DOI 10.1167/iovs.02-0838; Hazlett LD, 2004, PROG RETIN EYE RES, V23, P1, DOI 10.1016/j.preteyeres.2003.10.002; Hazlett LD, 2000, INVEST OPHTH VIS SCI, V41, P805; HAZLETT LD, 1987, INVEST OPHTH VIS SCI, V28, P1978; Huang X, 2005, INVEST OPHTH VIS SCI, V46, P4209, DOI 10.1167/iovs.05-0185; Huang X, 2003, INVEST OPHTH VIS SCI, V44, P3409, DOI 10.1167/iovs.03-0162; Huang X, 2002, J IMMUNOL, V168, P5756, DOI 10.4049/jimmunol.168.11.5756; Karmakar M, 2012, J IMMUNOL, V189, P4231, DOI 10.4049/jimmunol.1201447; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Kwon B, 1997, J IMMUNOL, V159, P6283; Lighvani S, 2005, EUR J IMMUNOL, V35, P1567, DOI 10.1002/eji.200425902; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Rudner XL, 2000, J IMMUNOL, V164, P6576, DOI 10.4049/jimmunol.164.12.6576; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Singh PK, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.34; Singh PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119541; Tolle L, 2015, J INNATE IMMUN, V7, P177, DOI 10.1159/000367790; West TE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003178; WILHELMUS K R, 1987, CLAO Journal, V13, P211; WILLIAMS RN, 1982, CURR EYE RES, V2, P465, DOI 10.3109/02713688208996350; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895	36	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185718	10.1371/journal.pone.0185718	http://dx.doi.org/10.1371/journal.pone.0185718			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961278	Green Published, Green Submitted, gold			2022-12-27	WOS:000412027700035
J	Ahn, C; Hwang, Y; Park, SK				Ahn, Choonghyun; Hwang, Yunji; Park, Sue K.			Predictors of all-cause mortality among 514,866 participants from the Korean National Health Screening Cohort	PLOS ONE			English	Article							POPULATION; RISK; METAANALYSIS	Background There is not enough evidence regarding how information obtained from general health check-ups can predict individual mortality based on long-term follow-ups and large sample sizes. This study evaluated the applicability of various health information and measurements, consisting of self-reported data, anthropometric measurements and laboratory test results, in predicting individual mortality. Methods The National Health Screening Cohort included 514,866 participants (aged 40-79 years) who were randomly selected from the overall database of the national health screening program in 2002-2003. Death was determined from causes of death statistics provided by Statistics Korea. We assessed variables that were collected at baseline and repeatedly measured for two consecutive years using traditional and time-variant Cox proportional hazards models in addition to random forest and boosting algorithms to identify predictors of 10-year all-cause mortality. Participants' age at enrollment, lifestyle factors, anthropometric measurements and laboratory test results were included in the prediction models. We used c-statistics to assess the discriminatory ability of the models, their external validity and the ratio of expected to observed numbers to evaluate model calibration. Eligibility of Medicaid and household income levels were used as inequality indexes. Results After the follow-up by 2013, 38,031 deaths were identified. The risk score based on the selected health information and measurements achieved a higher discriminatory ability for mortality prediction (c-statistics = 0.832, 0.841, 0.893, and 0.712 for Cox model, time-variant Cox model, random forest and boosting, respectively) than that of the previous studies. The results were externally validated using the community-based cohort data (c-statistics = 0.814). Conclusions Individuals' health information and measurements based on health screening can provide early indicators of their 10-year death risk, which can be useful for health monitoring and related policy decisions.	[Ahn, Choonghyun; Hwang, Yunji; Park, Sue K.] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Ahn, Choonghyun; Hwang, Yunji; Park, Sue K.] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Ahn, Choonghyun; Hwang, Yunji; Park, Sue K.] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Park, SK (corresponding author), Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.; Park, SK (corresponding author), Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea.; Park, SK (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.	suepark@snu.ac.kr		Hwang, Yunji/0000-0001-8598-275X	grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHI DI) - Ministry of Health & Welfare, Republic of Korea [H116C1127]	grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHI DI) - Ministry of Health & Welfare, Republic of Korea	This work was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHI DI; http://www.khidi.or.kr), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: H116C1127).; This work was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI16C1127).	American Diabetes Association, 2016, DIABETES CARE, V39, pS13, DOI [10.2337/dc16-S005, DOI 10.2337/DC16-S005, DOI 10.2337/DC16-ER09]; [Anonymous], 2009, BRIT MED J, P244; [Anonymous], NAT HLTH INS SYST KO; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2156; Barr ELM, 2009, DIABETOLOGIA, V52, P415, DOI 10.1007/s00125-008-1246-y; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cho B, 2011, J KOREAN MED ASS TEA, V54; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Ganna A, 2015, LANCET, V386, P533, DOI 10.1016/S0140-6736(15)60175-1; Gentile S, 2013, J NUTR HEALTH AGING, V17, P290, DOI 10.1007/s12603-012-0398-0; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gupte Amit, 2014, INT J COMPUTER SCI I, V5, P6261; Hyattsville M., NATL HLTH NUTR EXAMI; Ikeda N, 2015, INT J EPIDEMIOLOGY; Jensen-Urstad M, 2014, SCAND J PUBLIC HEALT, V42, P780, DOI 10.1177/1403494814550177; Krogsboll LT, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009009.pub2; Kuulasmaa K, 2012, ARCH PUBLIC HEALTH, V70, DOI 10.1186/0778-7367-70-20; Lahart IM, 2015, ACTA ONCOL, V54, P635, DOI 10.3109/0284186X.2014.998275; Lee H, 2015, PREV MED, V70, P19, DOI 10.1016/j.ypmed.2014.11.007; Lin CC, 2011, PUBLIC HEALTH, V125, P187, DOI 10.1016/j.puhe.2010.12.004; Martinsson A, 2014, EUR J EPIDEMIOL, V29, P489, DOI 10.1007/s10654-014-9929-9; McGee DL, 1999, AM J EPIDEMIOL, V149, P41; NHIS, 2014, NAT HLTH SCR STAT YB; Park C, 2013, DIABETES CARE, V36, P1988, DOI 10.2337/dc12-1577; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Ravnskov U, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010401; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; [SERVICES USDO-HAH Blood Institute National Heart L Health NIo], 2004, 7 REP JOINT NAT COMM; Si S, 2014, BRIT J GEN PRACT, V64, pE47, DOI 10.3399/bjgp14X676456; Tolonen H, 2008, B222008 HELS NAT PUB; Tu Z, 2005, 10 IEEE INT C COMP V, V1; Tuikkala P, 2010, SCAND J PRIM HEALTH, V28, P121, DOI 10.3109/02813432.2010.487371; van Buuren S, 2011, J STAT SOFTW, V45, P1; WHO, 2004, LANCET, V363, P902; Yoo Keun Young, 2002, Asian Pac J Cancer Prev, V3, P85	36	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185458	10.1371/journal.pone.0185458	http://dx.doi.org/10.1371/journal.pone.0185458			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957371	Green Submitted, Green Published, gold			2022-12-27	WOS:000411985200062
J	Quides, KW; Stomackin, GM; Lee, HH; Chang, JH; Sachs, JL				Quides, Kenjiro W.; Stomackin, Glenna M.; Lee, Hsu-Han; Chang, Jeff H.; Sachs, Joel L.			Lotus japonicus alters in planta fitness of Mesorhizobium loti dependent on symbiotic nitrogen fixation	PLOS ONE			English	Article							LEGUMINOSARUM BV TRIFOLII; PARTNER CHOICE; INEFFECTIVE NODULATION; MUTUALISM STABILITY; RHIZOBIUM-TRIFOLII; HOST SANCTIONS; MUTANT; DIVERSITY; INFECTION; GENOTYPE	Rhizobial bacteria are known for their capacity to fix nitrogen for legume hosts. However ineffective rhizobial genotypes exist and can trigger the formation of nodules but fix little if any nitrogen for hosts. Legumes must employ mechanisms to minimize exploitation by the ineffective rhizobial genotypes to limit fitness costs and stabilize the symbiosis. Here we address two key questions about these host mechanisms. What stages of the interaction are controlled by the host, and can hosts detect subtle differences in nitrogen fixation? We provide the first explicit evidence for adaptive host control in the interaction between Lotus japonicus and Mesorhizobium loti. In both single inoculation and co-inoculation experiments, less effective rhizobial strains exhibited reduced in planta fitness relative to the wildtype M. loti. We uncovered evidence of host control during nodule formation and during post-infection proliferation of symbionts within nodules. We found a linear relationship between rhizobial fitness and symbiotic effectiveness. Our results suggest that L. japonicus can adaptively modulate the fitness of symbionts as a continuous response to symbiotic nitrogen fixation.	[Quides, Kenjiro W.; Stomackin, Glenna M.; Lee, Hsu-Han; Sachs, Joel L.] Univ Calif Riverside, Dept Evolut Ecol & Organismal Biol, Riverside, CA 92521 USA; [Chang, Jeff H.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Sachs, Joel L.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Sachs, Joel L.] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; Oregon State University; University of California System; University of California Riverside; University of California System; University of California Riverside	Sachs, JL (corresponding author), Univ Calif Riverside, Dept Evolut Ecol & Organismal Biol, Riverside, CA 92521 USA.; Sachs, JL (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.; Sachs, JL (corresponding author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	joels@ucr.edu	Sachs, Joel/AAB-9348-2019	Sachs, Joel/0000-0002-0221-9247	University of California, Riverside Department of Biology; National Science Foundation, Division of Environmental Biology [1150278]; U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) [2014-51181-22384]; Division Of Environmental Biology [1150278] Funding Source: National Science Foundation	University of California, Riverside Department of Biology; National Science Foundation, Division of Environmental Biology(National Science Foundation (NSF)); U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	KWQ was supported by a grant through the University of California, Riverside Department of Biology (http://www.biology.ucr.edu1). JLS was supported by the National Science Foundation, Division of Environmental Biology #1150278 (https://www.nsf.goy/by/index.jsp?div=DEB). JHC is supported in part by the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) grant 2014-51181-22384 (https://nifa.usda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARGER N, 1981, SOIL BIOL BIOCHEM, V13, P481, DOI 10.1016/0038-0717(81)90038-9; AMARGER N, 1981, SOIL BIOL BIOCHEM, V13, P475, DOI 10.1016/0038-0717(81)90037-7; BEATTIE GA, 1989, APPL ENVIRON MICROB, V55, P2755, DOI 10.1128/AEM.55.11.2755-2761.1989; Berrabah F, 2015, J EXP BOT, V66, P1977, DOI 10.1093/jxb/eru545; Bromfield ESP, 2010, MICROBIOL-SGM, V156, P505, DOI 10.1099/mic.0.034058-0; Burdon JJ, 1999, J APPL ECOL, V36, P398, DOI 10.1046/j.1365-2664.1999.00409.x; CHAMPION RA, 1992, CROP SCI, V32, P457, DOI 10.2135/cropsci1992.0011183X003200020034x; Checcucci A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00835; Chen LS, 2002, BIOL FERT SOILS, V35, P448, DOI 10.1007/s00374-002-0493-1; Chungopast S, 2014, J PLANT PHYSIOL, V171, P104, DOI 10.1016/j.jplph.2013.10.015; Collins MT, 2002, AUST J SOIL RES, V40, P1319, DOI 10.1071/SR01052; Cooper JE, 2007, J APPL MICROBIOL, V103, P1355, DOI 10.1111/j.1365-2672.2007.03366.x; Crespo-Rivas JC, 2016, ENVIRON MICROBIOL, V18, P2392, DOI 10.1111/1462-2920.13101; DEBOER MH, 1995, PROTOPLASMA, V185, P58, DOI 10.1007/BF01272754; Denison RF, 2000, AM NAT, V156, P567, DOI 10.1086/316994; Denton MD, 2000, AUST J EXP AGR, V40, P25, DOI 10.1071/EA99035; Devine TE, 1996, PLANT SOIL, V186, P173, DOI 10.1007/BF00035072; DEVINE TE, 1990, THEOR APPL GENET, V80, P33, DOI 10.1007/BF00224012; DJORDJEVIC SP, 1988, J BACTERIOL, V170, P1848, DOI 10.1128/jb.170.4.1848-1857.1988; Ehinger M, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-8; Fening JO, 2002, APPL SOIL ECOL, V21, P23, DOI 10.1016/S0929-1393(02)00042-2; Friesen ML, 2013, NEW PHYTOL, V198, P7, DOI 10.1111/nph.12173; Friesen ML, 2012, NEW PHYTOL, V194, P1096, DOI 10.1111/j.1469-8137.2012.04099.x; Gano-Cohen KA, 2016, APPL ENVIRON MICROB, V82, P5259, DOI 10.1128/AEM.01116-16; GAUR YD, 1980, NEW ZEAL J AGR RES, V23, P529; GIBSON AH, 1975, SOIL BIOL BIOCHEM, V7, P95, DOI 10.1016/0038-0717(75)90005-X; Gubry-Rangin C, 2010, P ROY SOC B-BIOL SCI, V277, P1947, DOI 10.1098/rspb.2009.2072; HAHN M, 1986, FEMS MICROBIOL LETT, V33, P143; HANDBERG K, 1992, PLANT J, V2, P487, DOI 10.1111/j.1365-313X.1992.00487.x; Heath KD, 2009, EVOLUTION, V63, P652, DOI 10.1111/j.1558-5646.2008.00582.x; Ivanova KA, 2015, PROTOPLASMA, V252, P1505, DOI 10.1007/s00709-015-0780-y; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Kawaguchi M, 2002, MOL PLANT MICROBE IN, V15, P17, DOI 10.1094/MPMI.2002.15.1.17; Kiers ET, 2006, EVOL ECOL RES, V8, P1077; Kiers ET, 2013, NEW PHYTOL, V198, P4, DOI 10.1111/nph.12015; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; KOSCH K, 1994, Z NATURFORSCH C, V49, P727; KUYKENDALL LD, 1976, APPL ENVIRON MICROB, V32, P511, DOI 10.1128/AEM.32.4.511-519.1976; Limpens E, 2015, ANN REV PHYTOPATHOL; Ling J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070138; Lotocka B, 2000, ACTA BIOL CRACOV BOT, V42, P87; Marco DE, 2009, J THEOR BIOL, V259, P423, DOI 10.1016/j.jtbi.2009.03.033; Moawad H, 1998, PLANT SOIL, V204, P95, DOI 10.1023/A:1004335112402; NOEL KD, 1986, J BACTERIOL, V168, P1392, DOI 10.1128/jb.168.3.1392-1401.1986; Oono R, 2011, P ROY SOC B-BIOL SCI, V278, P2698, DOI 10.1098/rspb.2010.2193; Oono R, 2010, NEW PHYTOL, V187, P508, DOI 10.1111/j.1469-8137.2010.03261.x; PARNISKE M, 1990, BOT ACTA, V103, P143, DOI 10.1111/j.1438-8677.1990.tb00140.x; PARNISKE M, 1994, MOL PLANT MICROBE IN, V7, P631, DOI 10.1094/MPMI-7-0631; Porter SS, 2014, ECOL LETT, V17, P1121, DOI 10.1111/ele.12318; Puppo A, 2005, NEW PHYTOL, V165, P683, DOI 10.1111/j.1469-8137.2004.01285.x; Quigley PE, 1997, AUST J EXP AGR, V37, P623, DOI 10.1071/EA96089; Rangin C, 2008, APPL ENVIRON MICROB, V74, P5653, DOI 10.1128/AEM.01107-08; Ratcliff WC, 2009, ISME J, V3, P870, DOI 10.1038/ismej.2009.38; Regus JU, 2015, J EVOLUTION BIOL, V28, P447, DOI 10.1111/jeb.12579; Regus JU, 2017, AM J BOT, V104, P1299, DOI 10.3732/ajb.1700165; Regus JU, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2587; Roth V., 2006, DOUBLING TIME COMPUT; Sachs JL, 2010, J EVOLUTION BIOL, V23, P1919, DOI 10.1111/j.1420-9101.2010.02056.x; Sachs JL, 2010, J EVOLUTION BIOL, V23, P1075, DOI 10.1111/j.1420-9101.2010.01980.x; Sachs JL, 2009, APPL ENVIRON MICROB, V75, P4727, DOI 10.1128/AEM.00667-09; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Shimoda Y, 2008, DNA RES, V15, P297, DOI 10.1093/dnares/dsn017; Simms EL, 2006, P ROY SOC B-BIOL SCI, V273, P77, DOI 10.1098/rspb.2005.3292; Simms EL, 2002, INTEGR COMP BIOL, V42, P369, DOI 10.1093/icb/42.2.369; SINGLETON PW, 1983, CROP SCI, V23, P69, DOI 10.2135/cropsci1983.0011183X002300010019x; Somasegaran P., 1994, HDB RHIZOBIA, DOI [10.1007/978-1-4613-8375-8, DOI 10.1007/978-1-4613-8375-8]; SPRENT JI, 1987, PHILOS T R SOC B, V317, P111, DOI 10.1098/rstb.1987.0051; Trainer MA, 2006, APPL MICROBIOL BIOT, V71, P377, DOI 10.1007/s00253-006-0354-1; VASSE J, 1993, PLANT J, V4, P555, DOI 10.1046/j.1365-313X.1993.04030555.x; West SA, 2002, J EVOLUTION BIOL, V15, P830, DOI 10.1046/j.1420-9101.2002.00441.x; West SA, 2002, P ROY SOC B-BIOL SCI, V269, P685, DOI 10.1098/rspb.2001.1878; Westhoek A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01634-2; Yasuda M, 2016, PLANT CELL PHYSIOL, V57, P1791, DOI 10.1093/pcp/pcw104; Zgadzaj R, 2016, P NATL ACAD SCI USA	74	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185568	10.1371/journal.pone.0185568	http://dx.doi.org/10.1371/journal.pone.0185568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957401	Green Published, gold			2022-12-27	WOS:000411985200087
J	Stabeno, PJ; Duffy-Anderson, JT; Eisner, LB; Farley, EV; Heintz, RA; Mordy, CW				Stabeno, P. J.; Duffy-Anderson, J. T.; Eisner, L. B.; Farley, E. V.; Heintz, R. A.; Mordy, C. W.			Return of warm conditions in the southeastern Bering Sea: Physics to fluorescence	PLOS ONE			English	Article							CLIMATE; SHELF; TRANSPORT; ECOSYSTEM; IMPACTS	From 2007 to 2013, the southeastern Bering Sea was dominated by extensive sea ice and below-average ocean temperatures. In 2014 there was a shift to reduced sea ice on the southern shelf and above-average ocean temperatures. These conditions continued in 2015 and 2016. During these three years, the spring bloom at mooring site M4 (57.9 degrees N, 168.9 degrees W) occurred primarily in May, which is typical of years without sea ice. At mooring site M2 (56.9 degrees N, 164.1 degrees W) the spring bloom occurred earlier especially in 2016. Higher chlorophyll fluorescence was observed at M4 than at M2. In addition, these three warm years continued the pattern near St. Matthew Island of high concentrations (>1 mu M) of nitrite occurring during summer in warm years. Historically, the dominant parameters controlling sea-ice extent are winds and air temperature, with the persistence of frigid, northerly winds in winter and spring resulting in extensive ice. After mid-March 2014 and 2016 there were no cold northerly or northeasterly winds. Cold northerly winds persisted into mid-April in 2015, but did not result in extensive sea ice south of 58 degrees N. The apparent mechanism that helped limit ice on the southeastern shelf was the strong advection of warm water from the Gulf of Alaska through Unimak Pass. This pattern has been uncommon, occurring in only one other year (2003) in a 37-year record of estimated transport through Unimak Pass. During years with no sea ice on the southern shelf (e.g. 2001-2005, 2014-2016), the depth-averaged temperature there was correlated to the previous summers ocean temperature.	[Stabeno, P. J.; Mordy, C. W.] NOAA, Pacific Marine Environm Lab, 7600 Sand Point Way Ne, Seattle, WA 98115 USA; [Duffy-Anderson, J. T.; Eisner, L. B.] NOAA, Alaska Fisheries Sci Ctr, Seattle, WA USA; [Farley, E. V.; Heintz, R. A.] NOAA, Alaska Fisheries Sci Ctr, Juneau, AK USA; [Mordy, C. W.] Univ Washington, Joint Inst Study Atmosphere & Ocean, Seattle, WA 98195 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle	Stabeno, PJ (corresponding author), NOAA, Pacific Marine Environm Lab, 7600 Sand Point Way Ne, Seattle, WA 98115 USA.	Phyllis.Stabeno@noaa.gov	Mordy, Calvin/J-6808-2017; Farley, E/HHM-4227-2022		National Oceanic and Atmospheric Administration; University of Washington JISAO	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Washington JISAO	The National Oceanic and Atmospheric Administration and the University of Washington JISAO provided support for this project.	[Anonymous], 2016, ECOSYSTEM CONSIDERAT; Bond N, 2015, ECOSYSTEM CONSIDERAT, P90; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; COACHMAN LK, 1986, CONT SHELF RES, V5, P23, DOI 10.1016/0278-4343(86)90011-7; Duffy-Anderson JT, PLOS ONE, V12; Eisner L, 2016, DEEP SEA RES 2; Eisner LB, 2015, SPATIAL TEMPORAL CHA, P181; Eisner LB, 2014, DEEP-SEA RES PT II, V109, P157, DOI 10.1016/j.dsr2.2014.03.004; Gordon LI, 1993, 911 WHPO WOCE HYDR G; Heintz RA, 2013, DEEP-SEA RES PT II, V94, P150, DOI 10.1016/j.dsr2.2013.04.006; Hunt GL, 2011, ICES J MAR SCI, V68, P1230, DOI 10.1093/icesjms/fsr036; Knap AH, 1996, 19 JFOGS; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Mordy CW, 2010, MAR CHEM, V121, P157, DOI 10.1016/j.marchem.2010.04.004; Napp JM, 2001, FISH OCEANOGR, V10, P61, DOI 10.1046/j.1365-2419.2001.00155.x; PEASE CH, 1980, MON WEATHER REV, V108, P2015, DOI 10.1175/1520-0493(1980)108<2015:EBSIP>2.0.CO;2; Siddon EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084526; Sigler MF, 2014, DEEP-SEA RES PT II, V109, P71, DOI 10.1016/j.dsr2.2013.12.007; Solomon S., 2007, CONTRIBUTION WORKING, P996; Stabeno PJ, 2007, DEEP-SEA RES PT II, V54, P2599, DOI 10.1016/j.dsr2.2007.08.023; Stabeno PJ, 2016, DEEP-SEA RES PT II, V134, P13, DOI 10.1016/j.dsr2.2016.05.010; Stabeno P, 2010, PROG OCEANOGR, V85, P180, DOI 10.1016/j.pocean.2010.02.010; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P31, DOI 10.1016/j.dsr2.2012.02.020; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P14, DOI 10.1016/j.dsr2.2012.02.019; Stabeno PJ, 2002, DEEP-SEA RES PT II, V49, P5919, DOI 10.1016/S0967-0645(02)00326-0; VanPelt T, 2015, BERING SEA PROJECT U	26	57	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185464	10.1371/journal.pone.0185464	http://dx.doi.org/10.1371/journal.pone.0185464			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957386	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200064
J	Stein, K; Pearson, RM; Stein, A; Fazel, M				Stein, Kate; Pearson, Rebecca. M.; Stein, Alan; Fazel, Mina			The predictive value of childhood recurrent abdominal pain for adult emotional disorders, and the influence of negative cognitive style. Findings from a cohort study	PLOS ONE			English	Article							FUNCTIONAL SOMATIC SYMPTOMS; DIFFICULTIES QUESTIONNAIRE; COMMUNITY SAMPLE; POPULATION; DEPRESSION; CHILDREN; ANXIETY; EPIDEMIOLOGY; INFORMATION; COMPLAINTS	Background Recurrent abdominal pain (RAP) in childhood is common, with no explanatory pathology identified in the majority of cases. Previous studies have consistently demonstrated an association between childhood RAP and later emotional distress disorders. The aim of this study was to replicate this finding through the analysis of a large dataset, and explore how a negative style of thinking could potentially influence this relationship. Methods The Avon Longitudinal Study of Parents and Children (ALSPAC) is a population cohort of children born in the Avon area of the UK, between 1991-1992. Data on childhood RAP was collected via maternal reports at 3, 4, 7 and 9 years. Mood, anxiety and cognitive style were measured at age 18. We controlled for various confounding factors, including maternal anxiety and the child's pre-existing psychopathology. Logistic regression models were used to examine associations, and moderation effects of cognitive style were analysed using likelihood ratios. Results Experiencing RAP at any one time-point is associated with an increased odds of depression and/or anxiety disorder at 18 (OR = 1.41, 95% CI 1.09-1.83). We found a dose-response relationship and each additional marker of RAP was associated with a 26% (CI: 7% to 47%) increase in risk of having a mood and/or anxiety disorder. Individuals who attribute adversity to global, stable or personal factors were at amplified risk. Conclusions Childhood RAP predicts depression and anxiety disorders at 18 and should be targeted for early intervention. Individuals with a negative cognitive style may be particularly vulnerable, suggesting that cognitive interpretations of physical symptoms could play an important role in long-term health outcomes.	[Stein, Kate; Stein, Alan; Fazel, Mina] Univ Oxford, Dept Psychiat, Oxford, England; [Pearson, Rebecca. M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Oxford; University of Bristol	Stein, K (corresponding author), Univ Oxford, Dept Psychiat, Oxford, England.	kate.stein@psych.ox.ac.uk		Pearson, Rebecca/0000-0001-8527-3400; STEIN, KATE/0000-0001-8788-984X; Fazel, Mina/0000-0001-9342-2365; Stein, Alan/0000-0001-8207-2822	NIHR; Wellcome Trust [092731]; Oxford University Clinical Academic Graduate Scheme (OUCAGS); Medical Research Council [G9815508, MC_PC_15018] Funding Source: researchfish; National Institute for Health Research [ACF-2014-13-013] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Oxford University Clinical Academic Graduate Scheme (OUCAGS); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Dr Kate Stein is an NIHR funded Academic Clinical Fellow and Dr Mina Fazel is an NIHR funded post-doctoral research fellow. The UK Medical Research Council and the Wellcome Trust (Grant ref: 092731) and the University of Bristol provide core support for ALSPAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. The UK Medical Research Council and the Wellcome Trust (Grant ref: 092731) and the University of Bristol provide core support for ALSPAC. Ethical approval for this study was obtained from the ALSPAC Law and Ethics Committee.; This publication is the work of the authors and Kate Stein and Mina Fazel will serve as guarantors for the contents of this paper. Dr Kate Stein is an NIHR funded Academic Clinical Fellow and Dr Mina Fazel is an NIHR funded post-doctoral research fellow. We are also grateful to Oxford University Clinical Academic Graduate Scheme (OUCAGS) for their support.	ALLOY LB, 1988, BRIT J CLIN PSYCHOL, V27, P5, DOI 10.1111/j.2044-8260.1988.tb00749.x; APLEY J, 1958, ARCH DIS CHILD, V33, P165, DOI 10.1136/adc.33.168.165; Barrett PM, 1996, J ABNORM CHILD PSYCH, V24, P187, DOI 10.1007/BF01441484; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Campo JV, 2012, J CHILD PSYCHOL PSYC, V53, P575, DOI 10.1111/j.1469-7610.2012.02535.x; Chitkara DK, 2005, AM J GASTROENTEROL, V100, P1868, DOI 10.1111/j.1572-0241.2005.41893.x; Clark DM, 1997, J CONSULT CLIN PSYCH, V65, P203, DOI 10.1037/0022-006X.65.2.203; Creswell C, 2011, BEHAV COGN PSYCHOTH, V39, P191, DOI 10.1017/S1352465810000494; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Goubert L, 2008, J PAIN, V9, P272, DOI 10.1016/j.jpain.2007.11.006; Goubert L, 2006, PAIN, V123, P254, DOI 10.1016/j.pain.2006.02.035; Hewitt CE, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13360; Hotopf M, 1998, BRIT MED J, V316, P1196, DOI 10.1136/bmj.316.7139.1196; Hyde JS, 2008, PSYCHOL REV, V115, P291, DOI 10.1037/0033-295X.115.2.291; Janssens KAM, 2010, J CHILD PSYCHOL PSYC, V51, P304, DOI 10.1111/j.1469-7610.2009.02174.x; Kolk AM, 2003, SOC SCI MED, V57, P2343, DOI 10.1016/S0277-9536(02)00451-3; Langer SL, 2009, CHILD HEALTH CARE, V38, P169, DOI 10.1080/02739610903038750; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Mars B, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5954; Pearson RM, 2015, J AFFECT DISORDERS, V171, P60, DOI 10.1016/j.jad.2014.08.057; Pearson RM, 2013, JAMA PSYCHIAT, V70, P1312, DOI 10.1001/jamapsychiatry.2013.2163; Ramchandani PG, 2005, PEDIATRICS, V116, P46, DOI 10.1542/peds.2004-1854; Saps M, 2009, J PEDIATR-US, V154, P322, DOI 10.1016/j.jpeds.2008.09.047; Scharff L, 1997, CLIN PSYCHOL REV, V17, P145, DOI 10.1016/S0272-7358(96)00001-3; Schoth DE, 2016, HEALTH PSYCHOL, V35, P944, DOI 10.1037/hea0000342; Shanahan L, 2015, PSYCHOL MED, V45, P1721, DOI 10.1017/S0033291714002840; SRINATH S, 1993, J AM ACAD CHILD PSY, V32, P822, DOI 10.1097/00004583-199307000-00017; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Williams N, 1999, BRIT MED J, V318, P1455, DOI 10.1136/bmj.318.7196.1455	31	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185643	10.1371/journal.pone.0185643	http://dx.doi.org/10.1371/journal.pone.0185643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957435	Green Published, gold			2022-12-27	WOS:000411985200100
J	Twa, DDW; Skinnider, MA; Squair, JW; Lukac, CD				Twa, David D. W.; Skinnider, Michael A.; Squair, Jordan W.; Lukac, Christine D.		Canadian MDPHD Program Invest Grp	Cross-sectional-derived determinants of satisfaction with physician-scientist training among Canadian MD/PhD graduates	PLOS ONE			English	Article							CLINICIAN-SCIENTIST; PROGRAM; ATTRITION	Although MD/PhD programs require considerable commitment on behalf of students and learning institutions, they serve as an integral means of training future physician-scientists; individuals who engage in translational medicine. As attrition from these programs has long-standing effects on the community of translational medicine and comes at substantial cost to MD/PhD programs, we aimed to identify determinants that were associated with satisfaction among MD/PhD graduates, a feature that might inform on limiting program attrition. Anonymized data from a national survey of 139 Canadian MD/PhD alumni was analyzed. Factor analysis was conducted to evaluate the reliability of three questions that measured satisfaction and logistic regression was used to assess the association of outcomes with 17 independent determinants. Eighty-one percent of graduates were satisfied with MD/PhD training. Factor analysis confirmed the reliability of the questions measuring satisfaction. Determinants of self-reported satisfaction with physician-scientist training included co-authorship of more than six manuscripts during MD/PhD training. Additionally, protected research time at the place of current appointment was strongly associated with agreement that MD/PhD training had helped career progression. Demographic variables were not associated with any satisfaction indicator. Taken together, the majority of Canadian MD/PhD graduates are satisfied with their physician-scientist training. Project collaboration leading to co-authorships and protected research time were strongly associated with training satisfaction among graduates. If the value of collaboration can be realized among current and future physician-scientist trainees who are dissatisfied with their training, this might ultimately reduce program attrition.	[Twa, David D. W.; Skinnider, Michael A.; Squair, Jordan W.] Univ British Columbia, Fac Med, MD PhD Training Program, Vancouver, BC, Canada; [Twa, David D. W.] BCCA, Ctr Lymphoid Canc, Vancouver, BC, Canada; [Skinnider, Michael A.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC, Canada; [Squair, Jordan W.] Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada; [Lukac, Christine D.] BCCDC, Vancouver, BC, Canada; [Lukac, Christine D.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Twa, DDW (corresponding author), Univ British Columbia, Fac Med, MD PhD Training Program, Vancouver, BC, Canada.; Twa, DDW (corresponding author), BCCA, Ctr Lymphoid Canc, Vancouver, BC, Canada.; Lukac, CD (corresponding author), BCCDC, Vancouver, BC, Canada.; Lukac, CD (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.	dtwa@bccrc.ca; christine.lukac@bccdc.ca		Skinnider, Michael/0000-0002-2168-1621; Squair, Jordan/0000-0003-0551-859X	Vancouver Coastal Health-CIHR-UBC MD/PhD Studentship Awards; CIHR Vanier Scholarship; Killam Scholarship; UBC Four Year Fellowship; Elizabeth C Watters Fellowship; CI HR Frederick Banting and Charles Best Canada Graduate Scholarship; Killam Doctoral Scholarship; UBC Innovation fund	Vancouver Coastal Health-CIHR-UBC MD/PhD Studentship Awards; CIHR Vanier Scholarship(Canadian Institutes of Health Research (CIHR)); Killam Scholarship; UBC Four Year Fellowship; Elizabeth C Watters Fellowship; CI HR Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Killam Doctoral Scholarship; UBC Innovation fund	D.D.W.T., J.W.S., and M.A.S. are supported by Vancouver Coastal Health-CIHR-UBC MD/PhD Studentship Awards. D.D.W.T. is supported by a CIHR Vanier Scholarship, a Killam Scholarship, a UBC Four Year Fellowship, and an Elizabeth C Watters Fellowship. J.W.S. is supported by a CI HR Frederick Banting and Charles Best Canada Graduate Scholarship, a Killam Doctoral Scholarship, and a UBC Four Year Fellowship. M.A. S. is supported by a CI HR Frederick Banting and Charles Best Canada Graduate Scholarship and UBC Four Year Fellowship. This work is collectively supported by the UBC Innovation fund-2016.; DDWT, JWS, and MAS are supported by Vancouver Coastal Health-CIHR-UBC MD/PhD Studentship Awards. DDWT is supported by a CIHR Vanier Scholarship, a Killam Scholarship, a UBC Four Year Fellowship, and an Elizabeth C Watters Fellowship. JWS is supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship, a Killam Doctoral Scholarship, and a UBC Four Year Fellowship. MAS is supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship and UBC Four Year Fellowship. This work is collectively supported by the UBC Innovation fund-2016.	Alamri Y, 2016, CLIN MED, V16, P215, DOI 10.7861/clinmedicine.16-3-215; Andriole DA, 2008, JAMA-J AM MED ASSOC, V300, P1165, DOI 10.1001/jama.300.10.1165; Andriole DA, 2016, MED EDUC ONLINE, V21, DOI 10.3402/meo.v21.30941; Bosse D, 2011, CLIN INVEST MED, V34, pE324; Brass LF, 2010, ACAD MED, V85, P692, DOI 10.1097/ACM.0b013e3181d3ca17; Dickler HB, 2007, JAMA-J AM MED ASSOC, V297, P2496, DOI 10.1001/jama.297.22.2496; Htun NMM, 2016, NAGOYA J MED SCI, V78, P27; Jeffe DB, 2014, ACAD MED, V89, P84, DOI 10.1097/ACM.0000000000000071; Jones AA, 2016, CLIN INVEST MED, V39, pE132; Keeton K, 2007, OBSTET GYNECOL, V109, P949, DOI 10.1097/01.AOG.0000258299.45979.37; Lander B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013168; Lewinson RT, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad4355; Lewinson RT, 2015, NAT MED, V21, P1111, DOI 10.1038/nm1015-1111; Milewicz DM, 2015, J CLIN INVEST, V125, P3742, DOI 10.1172/JCI84170; Rosenblum ND, 2016, ACAD MED, V91, P1612, DOI 10.1097/ACM.0000000000001252; Simpson KH, 1996, MED EDUC, V30, P172, DOI 10.1111/j.1365-2923.1996.tb00739.x; Skinnider Michael A, 2017, CMAJ Open, V5, pE308, DOI 10.9778/cmajo.20160152; Twa DDW, 2015, J CLIN INVEST, V125, P4317, DOI 10.1172/JCI85194; Zhou T., 2016, J SCI IND METROL, V1, P1, DOI [10.21767/2472-1948.100007, DOI 10.21767/2472-1948.100007]; Zink BJ, 2007, TEACH LEARN MED, V19, P55, DOI 10.1207/s15328015tlm1901_10	20	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185218	10.1371/journal.pone.0185218	http://dx.doi.org/10.1371/journal.pone.0185218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957354	Green Submitted, Green Published, gold			2022-12-27	WOS:000411985200034
J	Canela, C; Buadze, A; Dube, A; Eich, D; Liebrenz, M				Canela, Carlos; Buadze, Anna; Dube, Anish; Eich, Dominique; Liebrenz, Michael			Skills and compensation strategies in adult ADHD - A qualitative study	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; AGE-DEPENDENT DECLINE; SUBSTANCE USE; YOUNG-ADULTS; METAANALYSIS; COMORBIDITY; PREVALENCE; INTERVIEWS; SYMPTOMS	Objective The primary objectives of this study were to investigate how adult patients with ADHD coped with their symptoms prior to diagnosis and treatment, what skills and compensation strategies they had developed and what their self-perceptions of these strategies were. Methods We used a qualitative approach to analyze interviews with 32 outpatients of a specialty care unit at a university hospital. Results Patients reported frequent use of diverse compensatory strategies with varying degrees of effectiveness. These were classified into five categories (organizational, motoric, attentional, social, psychopharmacological). In certain circumstances, ADHD symptoms were even perceived as useful. Conclusion Before diagnosis and treatment, patients with ADHD may develop a variety of skills to cope with their symptoms. Several of these skills are perceived as helpful. Knowledge of self-generated coping strategies may help better understand patients and their histories and thus facilitate patient cooperation. Moreover, knowing ways in which such patients cope with their symptoms may help elucidate reasons for late or under-diagnosing of the disorder.	[Canela, Carlos; Liebrenz, Michael] Univ Bern, Inst Forens Med, Dept Forens Psychiat, Bern, Switzerland; [Buadze, Anna; Eich, Dominique] Psychiat Univ Hosp Zurich, Div ADHD Res, Zurich, Switzerland; [Dube, Anish] Santa Barbara Child & Family Serv, Santa Barbara, CA USA	University of Bern; University of Zurich	Canela, C (corresponding author), Univ Bern, Inst Forens Med, Dept Forens Psychiat, Bern, Switzerland.	canelacarlos@hin.ch		Buadze, Ana/0000-0002-8683-6807; Liebrenz, Michael/0000-0001-8040-2744				Able SL, 2007, PSYCHOL MED, V37, P97, DOI 10.1017/S0033291706008713; Asherson P, 2012, J ATTEN DISORD, V16, p20S, DOI 10.1177/1087054711435360; BARKLEY RA, 1991, J AM ACAD CHILD PSY, V30, P752, DOI 10.1097/00004583-199109000-00009; Barkley RA, 2006, J AM ACAD CHILD PSY, V45, P192, DOI 10.1097/01.chi.0000189134.97436.e2; Barkley RA, 2002, J INT NEUROPSYCH SOC, V8, P655, DOI 10.1017/S1355617702801345; Bekker EM, 2005, PSYCHOL MED, V35, P807, DOI 10.1017/S0033291704003459; BIEDERMAN J, 1995, AM J PSYCHIAT, V152, P1652; Biederman J, 2008, J CLIN PSYCHIAT; Boonstra AM, 2005, PSYCHOL MED, V35, P1097, DOI 10.1017/S003329170500499X; Bramham J, 2008, J ATTENTION DISORDER; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Das Banerjee T, 2007, ACTA PAEDIATR, V96, P1269, DOI 10.1111/j.1651-2227.2007.00430.x; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Eakin L, 2004, J Atten Disord, V8, P1, DOI 10.1177/108705470400800101; Excellence NIfC, 2009, BRIT PSYCH SOC ROYAL; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Faraone SV, 2000, BIOL PSYCHIAT, V48, P9, DOI 10.1016/S0006-3223(00)00889-1; Faraone SV, 2004, J CLIN PSYCHOPHARM, V24, P24, DOI 10.1097/01.jcp.0000108984.11879.95; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Fayyad J, 2007, BRIT J PSYCHIAT, V190, P402, DOI 10.1192/bjp.bp.106.034389; Fischer M, 2007, ACCIDENT ANAL PREV, V39, P94, DOI 10.1016/j.aap.2006.06.008; Frei A, 2010, NERVENARZT, V81, P860, DOI 10.1007/s00115-009-2922-y; Friedman SR, 2003, NEUROPSYCHOLOGY, V17, P50, DOI 10.1037/0894-4105.17.1.50; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; Gapin JI, 2011, PREV MED, V52, pS70, DOI 10.1016/j.ypmed.2011.01.022; Gill P, 2008, BRIT DENT J, V204, P291, DOI 10.1038/bdj.2008.192; Halmoy A, 2009, J ATTEN DISORD, V13, P175, DOI 10.1177/1087054708329777; Harpin V, 2016, J ATTEN DISORD, V20, P295, DOI 10.1177/1087054713486516; Harpin VA, 2005, ARCH DIS CHILD, V90, pI2, DOI 10.1136/adc.2004.059006; Hill JC, 1996, AM J PSYCHIAT, V153, P1143; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kooij JJS, 2013, ADULT ADHD DIAGNOSIT; Kooij SJJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-67; Kuntsi J, 2005, BIOL PSYCHIAT, V57, P647, DOI 10.1016/j.biopsych.2004.12.032; Larsson JO, 2004, J AM ACAD CHILD PSY, V43, P1267, DOI 10.1097/01.chi.0000135622.05219.bf; Levin ED, 1996, PSYCHOPHARMACOLOGY, V123, P55, DOI 10.1007/BF02246281; Liebrenz M, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-141; Mayring Philipp, 2001, FORUM QUALITATIVE SO; McGough JJ, 2005, AM J PSYCHIAT, V162, P1621, DOI 10.1176/appi.ajp.162.9.1621; Meszaros A, 2009, INT J NEUROPSYCHOPH, V12, P1137, DOI 10.1017/S1461145709990198; Nehlin C, 2015, J ATTEN DISORD, V19, P343, DOI 10.1177/1087054714554618; Ohlmeier MD, 2008, ALCOHOL ALCOHOLISM, V43, P300, DOI 10.1093/alcalc/agn014; Organization WH, 1992, ICD 10 CLASS MENT BE; Ramsay JR, 2010, J COGN PSYCHOTHER, V24, P37, DOI 10.1891/0889-8391.24.1.37; Ramsay JR, 2014, COGNITIVE BEHAV THER; Robin A.L., 2002, ADHD REPORT, V10, P9, DOI DOI 10.1521/ADHD.10.3.9.20553; Rosler M, 2010, WORLD J BIOL PSYCHIA, V11, P684, DOI 10.3109/15622975.2010.483249; Safren SA, 2005, BEHAV RES THER, V43, P831, DOI 10.1016/j.brat.2004.07.001; Secnik K, 2005, PHARMACOECONOMICS, V23, P93, DOI 10.2165/00019053-200523010-00008; Seidman LJ, 2004, PSYCHIAT CLIN N AM, V27, P323, DOI 10.1016/j.psc.2004.01.002; Seidman LJ, 2005, BIOL PSYCHIAT, V57, P1263, DOI 10.1016/j.biopsych.2004.11.019; Shaw-Zirt Barbara, 2005, J Atten Disord, V8, P109; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Solanto MV, 2014, EFFICACY META COGNIT; Spencer T, 1998, J CLIN PSYCHIAT, V59, P59; Stevens SE, 2008, J ABNORM CHILD PSYCH, V36, P385, DOI 10.1007/s10802-007-9185-5; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wender PH, 2001, ANN NY ACAD SCI, V931, P1; Young S, 2005, PERS INDIV DIFFER, V38, P809, DOI 10.1016/j.paid.2004.06.005; Young S, 2010, J CHILD PSYCHOL PSYC, V51, P116, DOI 10.1111/j.1469-7610.2009.02191.x	60	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184964	10.1371/journal.pone.0184964	http://dx.doi.org/10.1371/journal.pone.0184964			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4WR	28953946	Green Published, gold, Green Submitted			2022-12-27	WOS:000411980300028
J	Nakazatol, Y; Kurane, R; Hirose, S; Watanabe, A; Shimoyama, H				Nakazatol, Yuichi; Kurane, Riichi; Hirose, Satoru; Watanabe, Akihisa; Shimoyama, Hiromi			Aging and death-associated changes in serum albumin variability over the course of chronic hemodialysis treatment	PLOS ONE			English	Article							BLOOD-PRESSURE VARIABILITY; CHRONIC KIDNEY-DISEASE; INTRAINDIVIDUAL VARIATION; HEMOGLOBIN VARIABILITY; DIALYSIS PATIENTS; NUTRITIONAL PARAMETERS; BIOLOGICAL VARIATION; ALL-CAUSE; FRAILTY; MORTALITY	Background Several epidemiological studies have demonstrated associations between variability in a number of biological parameters and adverse outcomes. As the variability may reflect impaired homeostatic regulation, we assessed albumin variability over time in chronic hemodialysis (HD) patients. Methods Data from 1346 subjects who received chronic HD treatment from May 2001 to February 2015 were analyzed according to three phases of HD treatment: post-HD initiation, during maintenance HD treatment, and before death. The serum albumin values were grouped according to the time interval from HD initiation or death, and the yearly trends for both the albumin levels and the intra-individual albumin variability (quantified by the residual coefficient of variation: Alb-rCV) were examined. The HD initiation and death-associated changes were also analyzed using generalized additive mixed models. Furthermore, the long-term trend throughout the maintenance treatment period was evaluated separately using linear regression models. Results Albumin levels and variability showed distinctive changes during each of the 3 periods. After HD initiation, albumin variability decreased and reached a nadir within a year. During the subsequent maintenance treatment period (interquartile range = 5.2-11.0 years), the log Alb-rCV showed a significant upward trend (mean slope: 0.011 +/- 0.035/year), and its overall mean was -1.49 +/- 0.08 (equivalent to an Alb-rCV of 3.22%). During the 1-2 years before death, this upward trend clearly accelerated, and the mean log Alb-rCV in the last year of life was -1.36 +/- 0.17. The albumin levels and variability were negatively correlated with each other and exhibited exactly opposite movements throughout the course of chronic HD treatment. Different from the albumin levels, albumin variability was not dependent on chronological age but was independently associated with an individual's aging and death process. Conclusion The observed upward trend in albumin variability seems to be consistent with a presumed aging-related decline in homeostatic capacity.	[Nakazatol, Yuichi] Hakuyukai Med Corp, Yuai Nisshin Clin, Div Nephrol, Saitama, Saitama, Japan; [Kurane, Riichi; Shimoyama, Hiromi] Hakuyukai Med Corp, Yuai Clin, Div Nephrol, Saitama, Saitama, Japan; [Hirose, Satoru] Hakuyukai Med Corp, Yuai Mihashi Clin, Div Nephrol, Saitama, Saitama, Japan; [Watanabe, Akihisa] Hakuyukai Med Corp, Yuai Nakagawa Clin, Div Nephrol, Saitama, Saitama, Japan		Nakazatol, Y (corresponding author), Hakuyukai Med Corp, Yuai Nisshin Clin, Div Nephrol, Saitama, Saitama, Japan.	nkzt@hakuyukai.jp	Barretti, Pasqual/K-4156-2012	Barretti, Pasqual/0000-0003-4979-4836; Nakazato, Yuichi/0000-0001-7541-3799				Arbeev KG, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00003; Boudville NC, 2009, CLIN J AM SOC NEPHRO, V4, P1176, DOI 10.2215/CJN.04920908; Broers NJH, 2015, NEPHROL DIAL TRANSPL, V30, P676, DOI 10.1093/ndt/gfu367; Cohen AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122541; Corte Z, 2015, ANN CLIN BIOCHEM, V52, P53, DOI 10.1177/0004563214545116; Dalrymple LS, 2013, CLIN J AM SOC NEPHRO, V8, P2091, DOI 10.2215/CJN.02870313; Dalrymple LS, 2013, J RENAL NUTR, V23, P91, DOI 10.1053/j.jrn.2012.03.001; Danielski M, 2003, AM J KIDNEY DIS, V42, P286, DOI 10.1016/S0272-6386(03)00653-X; den Hoedt CH, 2014, CLIN J AM SOC NEPHRO, V9, P318, DOI 10.2215/CJN.04470413; Fedarko NS, 2011, CLIN GERIATR MED, V27, P27, DOI 10.1016/j.cger.2010.08.006; Ferrucci L, 2008, MECH AGEING DEV, V129, P677, DOI 10.1016/j.mad.2008.09.007; Flythe JE, 2013, AM J KIDNEY DIS, V61, P966, DOI 10.1053/j.ajkd.2012.12.023; FRASER CG, 1989, CLIN CHEM, V35, P783; Fried LP, 2009, J GERONTOL A-BIOL, V64, P1049, DOI 10.1093/gerona/glp076; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Friedman AN, 2010, J AM SOC NEPHROL, V21, P223, DOI 10.1681/ASN.2009020213; Gama-Axelsson T, 2012, CLIN J AM SOC NEPHRO, V7, P1446, DOI 10.2215/CJN.10251011; Goldwasser P, 1999, KIDNEY INT, V56, P2260, DOI 10.1046/j.1523-1755.1999.00768.x; Gorostidi M, 2015, J HYPERTENS, V33, pE40, DOI 10.1097/01.hjh.0000467455.93515.1e; HOLZEL WGE, 1987, CLIN CHEM, V33, P1133; HOLZEL WGE, 1987, CLIN CHEM, V33, P670; HOLZEL WGE, 1987, CLIN CHEM, V33, P57; Isaia G, 2009, AGING CLIN EXP RES, V21, P453, DOI 10.1007/BF03327448; Kainz A, 2010, NEPHROL DIAL TRANSPL, V25, P3701, DOI 10.1093/ndt/gfq287; Kalantar-Zadeh K, 2005, NEPHROL DIAL TRANSPL, V20, P1880, DOI 10.1093/ndt/gfh941; Kalyani RR, 2012, J GERONTOL A-BIOL, V67, P1300, DOI 10.1093/gerona/glr141; Kotanko P, 2009, BLOOD PURIFICAT, V27, P38, DOI 10.1159/000167007; Leavey SF, 2000, KIDNEY INT, V58, P2119; Li Q, 2015, AGING CELL, V14, P1103, DOI 10.1111/acel.12402; Lloyd D, 2001, ScientificWorldJournal, V1, P133; Ma WY, 2012, J DIABETES COMPLICAT, V26, P296, DOI 10.1016/j.jdiacomp.2012.03.028; Mendez CE, 2013, DIABETES CARE, V36, P4091, DOI 10.2337/dc12-2430; Michelis R, 2010, BIOCHEM BIOPH RES CO, V401, P137, DOI 10.1016/j.bbrc.2010.09.027; MORGAN DB, 1983, ANN CLIN BIOCHEM, V20, P257, DOI 10.1177/000456328302000501; Nakazato Y, 2015, CLIN EXP NEPHROL, V19, P1165, DOI 10.1007/s10157-015-1108-0; Ram N., 2015, HDB INTRAINDIVIDUAL, P16; Ramsay DS, 2014, PSYCHOL REV, V121, P225, DOI 10.1037/a0035942; Ricos C, 2007, ANN CLIN BIOCHEM, V44, P343, DOI 10.1258/000456307780945633; Ricos C, 2009, BIOCHEM MEDICA, V19, P250; Rocco MV, 2004, KIDNEY INT, V65, P2321, DOI 10.1111/j.1523-1755.2004.00647.x; Selvarajah V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086514; Usvyat LA, 2013, KIDNEY INT, V84, P149, DOI 10.1038/ki.2013.73; Varadhan R, 2008, MECH AGEING DEV, V129, P666, DOI 10.1016/j.mad.2008.09.013; Varadhan R, 2009, J GERONTOL A-BIOL, V64, P682, DOI 10.1093/gerona/glp013; Webb AJS, 2014, STROKE, V45, P2967, DOI 10.1161/STROKEAHA.114.005982; Whittle J, 2016, CLIN J AM SOC NEPHRO, V11, P471, DOI 10.2215/CJN.04660415; Wilhelm-Leen ER, 2009, AM J MED, V122, P664, DOI 10.1016/j.amjmed.2009.01.026; Wood S, 2016, PACKAGE GAMM4; Yang W, 2007, J AM SOC NEPHROL, V18, P3164, DOI 10.1681/ASN.2007010058	49	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185216	10.1371/journal.pone.0185216	http://dx.doi.org/10.1371/journal.pone.0185216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4WR	28953942	gold, Green Submitted, Green Published			2022-12-27	WOS:000411980300044
J	Abera, H; Mengistu, D; Bedaso, A				Abera, Hiwot; Mengistu, Daniel; Bedaso, Asres			Effectiveness of planned teaching intervention on knowledge and practice of breast self-examination among first year midwifery students	PLOS ONE			English	Article								Introduction The prevalence of cancer is growing rapidly in all parts of the word and Ethiopia is no exception. Secondary prevention, as simple as monthly breast self-examination, is the best option to tackle the rising of this epidemic. Health awareness programs on screening and early detection are the corner stones to reduce the morbidity and mortality resulting from breast cancer. Objective The aim of the study is to assess the effectiveness of planned teaching program on knowledge and practice of breast self-examination among first year female midwifery students in Hawassa health Sciences College. Methods and materials A pre-experimental one group pre-posttest design was used among 61 students who were selected by systematic random sampling technique. Data was collected using structured questionnaire and adapted and approved checklist. Data was entered using Epi-Info and analyzed using SPSS version 20. Pre-and post-intervention results were calculated using paired t-test. Results The mean age of the study participants was 20.13(+/- 2.27) and 77% of the study participants were single. Before the intervention 14(23%) of respondents had information and practiced breast self-examination, only 8(13.1%) performed breast self -examination on a regular monthly basis. The number and percentage of the knowledgeable respondents pre-post intervention is 23(37.7%) and 35(57.4%), respectively. The mean knowledge difference for the pre-post intervention is 0.18 +/- 0.695 (P < 0.05). The respondents' pre-post interventions score of satisfactory practical competency were 10(16.4%) and 43(70.5%), respectively as well. The mean net gain for the pre-post breast self-examination intervention is 0.51 +/- 0.62 (P < 0.001). Both the knowledge and practical competency scores showed highly significant increment after the intervention, showing that the research hypothesis was accepted. Conclusion and recommendations Planned teaching intervention on knowledge and Breast self-examination of students has resulted in an increment of both knowledge and the practice of breast self-examination. Teaching breast self-examination with demonstration to all at risk groups as a secondary prevention for breast cancer and large scale studies on heterogeneous groups is important.	[Abera, Hiwot; Bedaso, Asres] Hawassa Univ, Coll Med & Hlth Sci, Sch Nursing & Midwifery, Hawassa, Ethiopia; [Mengistu, Daniel] Addis Ababa Univ, Coll Med & Hlth Sci, Dept Nursing & Midwifery, Addis Ababa, Ethiopia	Hawassa University; Addis Ababa University	Abera, H (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Nursing & Midwifery, Hawassa, Ethiopia.	hiwotab_2005@yahoo.com	Tilahune, Asres Bedaso/AAP-9118-2020; Tilahune, Asres Bedaso/AAP-9464-2020	Tilahune, Asres Bedaso/0000-0001-7859-0264; Bekele, Daniel Mengistu/0000-0003-3570-1117; Abera, Hiwot/0000-0002-3049-7236				Discigil G, 2007, MARMARA MED J, V20, P29; Gwarzo UMD, 2009, ANN AFR MED, V8, P55, DOI 10.4103/1596-3519.55766; Haji-Mahmoodi Mehregan, 2002, Breast J, V8, P222, DOI 10.1046/j.1524-4741.2002.08406.x; Heidari Z., 2008, Acta Medica Iranica, V46, P321; Hislop TG, 1997, CMAJ, V157, P1205; HOWE HL, 1981, AM J PUBLIC HEALTH, V71, P251, DOI 10.2105/AJPH.71.3.251; JACOB TC, 1989, J NATL MED ASSOC, V81, P769; Kayode F, 2005, EUROPEAN J SCI RES, V10, P42; Marc E., 2004, US HARRISONS PRINCIP; MCMASTER V, 1985, J ROY COLL GEN PRACT, V35, P578; Memis S, 2009, ONCOL NURS FORUM, V36, P37, DOI 10.1188/09.ONF.E39-E46; Obaikol R., 2010, East and Central African Journal of Surgery, V15, P22; Odusanya O., 2000, BREAST J, V17, P171; Parkin DM, 2003, CANC AFRICA EPIDEMIO; Rao R. S. P, 2005, INDIAN J MED SCI, V59, P396; Saladin A. G., 2009, RES J SOC SCI, V4, P61; Samira H, 2006, SUDANESE J PUBLIC HL, V1, P36; Seif YN, 2000, J EGYPTIAN NATL CANC, V12, P105; Semiglazov V. F, 1987, BREAST SELFEXAMINATI, P391; Shallwani K, 2010, ASIAN PAC J CANCER P, V11, P145	20	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0184636	10.1371/journal.pone.0184636	http://dx.doi.org/10.1371/journal.pone.0184636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI1DL	28949972	Green Published, gold, Green Submitted			2022-12-27	WOS:000411671000013
J	Hu, ML; Pu, HM; Gao, JQ; Long, WH; Chen, F; Zhang, W; Zhou, XY; Peng, Q; Chen, S; Zhang, JF				Hu, Maolong; Pu, Huiming; Gao, Jianqin; Long, Weihua; Chen, Feng; Zhang, Wei; Zhou, Xiaoyin; Peng, Qi; Chen, Song; Zhang, Jiefu			Comparative analysis of miRNAs of two rapeseed genotypes in response to acetohydroxyacid synthase-inhibiting herbicides by high-throughput sequencing	PLOS ONE			English	Article							BRASSICA-NAPUS; CONFERS RESISTANCE; MICRORNAS; GENE; IDENTIFICATION; EXPRESSION; MUTATION; RNA; DATABASE; REVEALS	Acetohydroxyacid synthase (AHAS), also called acetolactate synthase, is a key enzyme involved in the first step of the biosynthesis of the branched-chain amino acids valine, isoleucine and leucine. Acetohydroxyacid synthase-inhibiting herbicides (AHAS herbicides) are five chemical families of herbicides that inhibit AHAS enzymes, including imidazolinones (IMI), sulfonylureas (SU), pyrimidinylthiobenzoates, triazolinones and triazolopyrimidines. Five AHAS genes have been identified in rapeseed, but little information is available regarding the role of miRNAs in response to AHAS herbicides. In this study, an AHAS herbicides tolerant genotype and a sensitive genotype were used for miRNA comparative analysis. A total of 20 small RNA libraries were obtained of these two genotypes at three time points (0h, 24 h and 48 h) after spraying SU and IMI herbicides with two replicates. We identified 940 conserved miRNAs and 1515 novel candidate miRNAs in Brassica napus using high-throughput sequencing methods combined with computing analysis. A total of 3284 genes were predicted to be targets of these miRNAs, and their functions were shown using GO, KOG and KEGG annotations. The differentiation expression results of miRNAs showed almost twice as many differentiated miRNAs were found in tolerant genotype M342 (309 miRNAs) after SU herbicide application than in sensitive genotype N131 (164 miRNAs). In additiond 177 and 296 miRNAs defined as differentiated in sensitive genotype and tolerant genotype in response to SU herbicides. The miR398 family was observed to be associated with AHAS herbicide tolerance because their expression increased in the tolerant genotype but decreased in the sensitive genotype. Moreover, 50 novel miRNAs from 39 precursors were predicted. There were 8 conserved miRNAs, 4 novel miRNAs and 3 target genes were validated by quantitative real-time PCR experiment. This study not only provides novel insights into the miRNA content of AHAS herbicides tolerant rapeseed in response to AHAS herbicides, but also demonstrates that miRNAs may be involved in AHAS herbicides tolerance.	[Hu, Maolong; Pu, Huiming; Gao, Jianqin; Long, Weihua; Chen, Feng; Zhang, Wei; Zhou, Xiaoyin; Peng, Qi; Chen, Song; Zhang, Jiefu] Jiangsu Acad Agr Sci, Minist Agr, Key Lab Cotton & Rapeseed Nanjing,Inst Ind Crops, Nanjing Sub Ctr,Natl Ctr Oil Crops Improvement, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Pu, HM (corresponding author), Jiangsu Acad Agr Sci, Minist Agr, Key Lab Cotton & Rapeseed Nanjing,Inst Ind Crops, Nanjing Sub Ctr,Natl Ctr Oil Crops Improvement, Nanjing, Jiangsu, Peoples R China.	puhuiming@126.com	Peng, Qi/ABD-4752-2021					Aryal R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-682; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Burgess AL, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0580-8; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Gupta S, 2017, FUNCT INTEGR GENOMIC, V17, P335, DOI 10.1007/s10142-016-0538-4; HATTORI J, 1995, MOL GEN GENET, V246, P419, DOI 10.1007/BF00290445; Jain P, 2014, GENOME, V57, P593, DOI 10.1139/gen-2014-0145; Katiyar A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00506; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lee H, 2011, P NATL ACAD SCI USA, V108, P8909, DOI 10.1073/pnas.1105612108; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Liu CN, 2005, NUCLEIC ACIDS RES, V33, pD112, DOI 10.1093/nar/gki041; Manabe Y, 2007, PLANT CELL PHYSIOL, V48, P1340, DOI 10.1093/pcp/pcm105; Miyagawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081326; Oldach KH, 2008, ANN BOT-LONDON, V101, P997, DOI 10.1093/aob/mcn028; OUELLET T, 1992, PLANT J, V2, P321; Peever TL, 1995, WEED TECHNOL, V9, P840, DOI 10.1017/S0890037X00024313; RUTLEDGE RG, 1991, MOL GEN GENET, V229, P31, DOI 10.1007/BF00264210; Sarmah AK, 1998, AUST J AGR RES, V49, P775, DOI 10.1071/A97131; Schnell J, 2012, TRANSGENIC RES, V21, P1255, DOI 10.1007/s11248-012-9597-z; Schulte JH, 2010, NUCLEIC ACIDS RES, V38, P5919, DOI 10.1093/nar/gkq342; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Tan SY, 2005, PEST MANAG SCI, V61, P246, DOI 10.1002/ps.993; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang L, 2007, FEBS LETT, V581, P3848, DOI 10.1016/j.febslet.2007.07.010; Wang Z, 2015, GENE, V571, P178, DOI 10.1016/j.gene.2015.06.047; Whaley CM, 2007, WEED SCI, V55, P83, DOI 10.1614/WS-06-082.1; Wu P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00429; Xie FL, 2007, FEBS LETT, V581, P1464, DOI 10.1016/j.febslet.2007.02.074; Yi X, 2015, NUCLEIC ACIDS RES, V43, pD982, DOI 10.1093/nar/gku1162; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666; Zhu C, 2011, PHYSIOL PLANTARUM, V143, P1, DOI 10.1111/j.1399-3054.2011.01477.x; Zhu XJ, 2012, PLANT CELL ENVIRON, V35, P2014, DOI 10.1111/j.1365-3040.2012.02533.x	40	1	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0184917	10.1371/journal.pone.0184917	http://dx.doi.org/10.1371/journal.pone.0184917			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950015	Green Published, gold, Green Submitted			2022-12-27	WOS:000411671000019
J	Lin, XC; Chen, ZY; Jin, L; Gao, WY; Qu, B; Zuo, YJ; Liu, RJ; Yu, MB				Lin, Xianchai; Chen, Ziyan; Jin, Ling; Gao, Wuyou; Qu, Bo; Zuo, Yajing; Liu, Rongjiao; Yu, Minbin			Rasch analysis of the hospital anxiety and depression scale among Chinese cataract patients	PLOS ONE			English	Article							OLDER-ADULTS; MENTAL-HEALTH; EYE; SURGERY; POPULATION; PREVALENCE; SYMPTOMS; VISION; IMPAIRMENT; DISORDERS	Purpose To analyze the validity of the Hospital Anxiety and Depression Scale (HADS) among Chinese cataract population. Methods A total of 275 participants with unilateral or bilateral cataract were recruited to complete the Chinese version of HADS. The patients' demographic and ophthalmic characteristics were documented. Rasch analysis was conducted to examine the model fit statistics, the thresholds ordering of the polytomous items, targeting, person separation index and reliability, local dependency, unidimentionality, differential item functioning (DIF) and construct validity of the HADS individual and summary measures. Results Rasch analysis was performed on anxiety and depression subscales as well as HADS-Total score respectively. The items of original HADS-Anxiety, HADS-Depression and HADSTotal demonstrated evidence of misfit of the Rasch model. Removing items A7 for anxiety subscale and rescoring items D14 for depression subscale significantly improved Rasch model fit. A 12-item higher order total scale with further removal of D12 was found to fit the Rasch model. The modified items had ordered response thresholds. No uniform DIF was detected, whereas notable non-uniform DIF in high-ability group was found. The revised cut-off points were given for the modified anxiety and depression subscales. Conclusion The modified version of HADS with HADS-A and HADS-D as subscale and HADS-T as a higher-order measure is a reliable and valid instrument that may be useful for assessing anxiety and depression states in Chinese cataract population.	[Lin, Xianchai; Chen, Ziyan; Jin, Ling; Gao, Wuyou; Qu, Bo; Zuo, Yajing; Liu, Rongjiao; Yu, Minbin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Yu, MB (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.	yuminbin@mail.sysu.edu.cn						Ayaki M, 2015, NEUROPSYCH DIS TREAT, V11, P889, DOI 10.2147/NDT.S81515; Bond T, 2012, APPL RASCH MODEL FUN, P41; Duan XR, 2013, GRAEF ARCH CLIN EXP, V251, P203, DOI 10.1007/s00417-012-2012-x; Eramudugolla R, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00056; Evans JR, 2007, OPHTHALMOLOGY, V114, P283, DOI 10.1016/j.ophtha.2006.10.006; Fenwick EK, 2017, BRIT J OPHTHALMOL, V101, P686, DOI 10.1136/bjophthalmol-2016-308701; Fisher JWP., 2007, RASCH MEAS T, V21; Fraser ML, 2013, PSYCHOGERIATRICS, V13, P237, DOI 10.1111/psyg.12028; Freeman EE, 2009, CAN J OPHTHALMOL, V44, P171, DOI 10.3129/i09-001; Gibbons CJ, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-82; Gough K, 2009, J PAIN SYMPTOM MANAG, V37, P797, DOI 10.1016/j.jpainsymman.2008.04.012; Hong LY, 2016, CURR EYE RES, V41, P590, DOI 10.3109/02713683.2015.1056804; Hu JY, 2017, INT J OPHTHALMOL-CHI, V10, P140, DOI 10.18240/ijo.2017.01.23; Khadka J, 2011, INVEST OPHTH VIS SCI, V52, P6971, DOI 10.1167/iovs.11-7423; LAM CLK, 1995, FAM PRACT, V12, P149, DOI 10.1093/fampra/12.2.149; Lambert SD, 2013, PSYCHOL ASSESSMENT, V25, P379, DOI 10.1037/a0031154; Leung C M, 1993, Int J Psychosom, V40, P29; Linacre JM, 1994, RASCH MEASURE T, V7, P28; McGwin G, 2003, OPHTHAL EPIDEMIOL, V10, P303, DOI 10.1076/opep.10.5.303.17323; Meuleners LB, 2013, ACTA OPHTHALMOL, V91, pe445, DOI 10.1111/aos.12124; Palagyi A, 2016, CLIN EXP OPHTHALMOL, V44, P789, DOI 10.1111/ceo.12800; Pesudovs K, 2007, OPTOMETRY VISION SCI, V84, P663, DOI 10.1097/OPX.0b013e318141fe75; Pop-Jordanova Nada, 2014, Pril (Makedon Akad Nauk Umet Odd Med Nauki), V35, P53; Rasch G., 1960, PROBABILISTIC MODELS; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Tang WK, 2007, PSYCHIAT RES, V150, P97, DOI 10.1016/j.psychres.2006.01.015; Tennant A., 2006, RASCH MEAS T, V20, P1048; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; van der Aa HPA, 2015, INVEST OPHTH VIS SCI, V56, P849, DOI 10.1167/iovs.14-15848; WAINER H, 1987, J EDUC MEAS, V24, P185, DOI 10.1111/j.1745-3984.1987.tb00274.x; Wang C, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3930-z; Wang HF, 2016, OPTOMETRY VISION SCI, V93, P1479, DOI 10.1097/OPX.0000000000000960; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023; Zheng YJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46453; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185287	10.1371/journal.pone.0185287	http://dx.doi.org/10.1371/journal.pone.0185287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI1DL	28949992	Green Published, gold, Green Submitted			2022-12-27	WOS:000411671000034
J	Forbes, AE; Schutzer-Weissmann, J; Menassa, DA; Wilson, MH				Forbes, Anna E.; Schutzer-Weissmann, John; Menassa, David A.; Wilson, Mark H.			Head injury patterns in helmeted and non-helmeted cyclists admitted to a London Major Trauma Centre with serious head injury	PLOS ONE			English	Article							BICYCLE SAFETY HELMETS; BRAIN-INJURY	Background Cycle use across London and the UK has increased considerably over the last 10 years. With this there has been an increased interest in cycle safety and injury prevention. Head injuries are an important cause of mortality and morbidity in cyclists. This study aimed to ascertain the frequency of different head injury types in cyclists and whether wearing a bicycle helmet affords protection against specific types of head injury. Methods A retrospective observational study of all cyclists older than 16 years admitted to a London Major Trauma Centre between 1st January 2011 and 31st December 2015 was completed. A cohort of patients who had serious head injury was identified (n = 129). Of these, data on helmet use was available for 97. Comparison was made between type of injury frequency in helmeted and non-helmeted cyclists within this group of patients who suffered serious head injury. Results Helmet use was shown to be protective against intracranial injury in general (OR 0.2, CI 0.07-0.55, p = 0.002). A protective effect against subdural haematoma was demonstrated (OR 0.14, CI 0.03-0.72, p = 0.02). Wearing a helmet was also protective against skull fractures (OR 0.12, CI 0.04-0.39, p<0.0001) but not any other specific extracranial injuries. This suggests that bicycle helmets are protective against those injuries caused by direct impact to the head. Further research is required to clarify their role against injuries caused by shearing forces. Conclusions In a largely urban environment, the use of cycle helmets appears to be protective for certain types of serious intra and extracranial head injuries. This may help to inform future helmet design.	[Forbes, Anna E.; Schutzer-Weissmann, John] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Crit Care, Adult Intens Care Unit, London, England; [Menassa, David A.] Univ Oxford, Div Clin Neurol, Nuffield Dept Clin Neurosci, Oxford, England; [Wilson, Mark H.] St Marys Hosp, Imperial Coll Healthcare Trust, Imperial Neurotrauma Ctr, Biomed Res Ctr, London, England; [Forbes, Anna E.] Royal London Hosp, Barts & London Sch Anaesthesia, Barts Hlth NHS Trust, London, England; [Schutzer-Weissmann, John] Royal Natl Orthopaed Hosp NHS Trust, Dept Anaesthesia & Pain Management, Stanmore, Middx, England	Imperial College London; University of Oxford; Imperial College London; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust	Forbes, AE (corresponding author), Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Crit Care, Adult Intens Care Unit, London, England.; Forbes, AE (corresponding author), Royal London Hosp, Barts & London Sch Anaesthesia, Barts Hlth NHS Trust, London, England.	anna.forbes@bartshealth.nhs.uk	Menassa, David/L-8726-2019	Wilson, Mark/0000-0002-2346-4911; Menassa, David/0000-0002-5984-8407				Amoros E., 2011, INJ PREV; [Anonymous], 2016, COLL CAS LOND ROADS, P1; Bambach MR, 2013, ACCIDENT ANAL PREV, V53, P78, DOI 10.1016/j.aap.2013.01.005; Dagher JH, 2016, CAN J NEUROL SCI, V43, P56, DOI 10.1017/cjn.2015.281; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; Forbes A, 2015, J TRAUMA RESUC EM S2, V23, pA12; Lustenberger T, 2010, J TRAUMA, V69, P1120, DOI 10.1097/TA.0b013e3181d0f68b; MAIMARIS C, 1994, BRIT MED J, V308, P1537, DOI 10.1136/bmj.308.6943.1537; Manson J, 2013, EMERG MED J, V30, P32, DOI 10.1136/emermed-2011-200966; MCDERMOTT FT, 1993, J TRAUMA, V34, P834, DOI 10.1097/00005373-199306000-00015; Melo N, 2014, TRAUMA, V16, P183, DOI 10.1177/1460408614530953; Olivier J., 2016, INT J EPIDEMIOL; Olivier J, 2014, J AUSTRALAS COLL ROA, V25, P10; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; Thompson DC, 1999, COCHRANE DATABASE SY, V4; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Transparency International, 2015, CAN VEH US STUD 2014, P1; Transport for London, 2017, 9 TRANSP LOND, P1	19	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185367	10.1371/journal.pone.0185367	http://dx.doi.org/10.1371/journal.pone.0185367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945822	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000411645100052
J	Li, FK; Gong, AJ; Qiu, LN; Zhang, WW; Li, JR; Liu, Y; Liu, YN; Yuan, HT				Li, FuKai; Gong, AiJun; Qiu, LiNa; Zhang, WeiWei; Li, JingRui; Liu, Yu; Liu, YuNing; Yuan, HuiTing			Simultaneous determination of trace rare-earth elements in simulated water samples using ICP-OES with TODGA extraction/backextraction	PLOS ONE			English	Article							PLASMA-MASS SPECTROMETRY; SOLID-PHASE EXTRACTION; RAY-FLUORESCENCE SPECTROMETRY; ATOMIC EMISSION-SPECTROMETRY; NEUTRON-ACTIVATION ANALYSIS; ONLINE PRECONCENTRATION; ENVIRONMENTAL-SAMPLES; MS; RESIN; DIGLYCOLAMIDE	The determination of trace rare-earth elements (REEs) can be used for the assessment of environmental pollution, and is of great significance to the study of toxicity and toxicology in animals and plants. N, N, N', N'-tetraoctyl diglycolamide (TODGA) is an environmental friendly extractant that is highly selective to REEs. In this study, an analytical method was developed for the simultaneous determination of 16 trace REEs in simulated water samples by inductively coupled plasma optical emission spectroscopy (ICP-OES). With this method, TODGA was used as the extractant to perform the liquid-liquid extraction (LLE) sample pretreatment procedure. All 16 REEs were extracted from a 3 M nitric acid medium into an organic phase by a 0.025 M TODGA petroleum ether solution. A 0.03 M ethylenediaminetetraacetic acid disodium salt (EDTA) solution was used for back-extraction to strip the REEs from the organic phase into the aqueous phase. The aqueous phase was concentrated using a vacuum rotary evaporator and the concentration of the 16 REEs was detected by ICP-OES. Under the optimum experimental conditions, the limits of detection (3 sigma, n = 7) for the REEs ranged from 0.0405 ng mL(-1) (Nd) to 0.5038 ng mL(-1) (Ho). The relative standard deviations (c = 100 ng mL(-1), n = 7) were from 0.5% (Eu) to 4.0% (Tm) with a linear range of 4-1000 ng mL(-1) (R-2 > 0.999). The recoveries of 16 REEs ranged from 95% to 106%. The LLE-ICP-OES method established in this study has the advantages of simple operation, low detection limits, fast analysis speed and the ability to simultaneously determine 16 REEs, thereby acting as a viable alternative for the simultaneous detection of trace amounts of REEs in water samples.	[Li, FuKai; Gong, AiJun; Qiu, LiNa; Zhang, WeiWei; Li, JingRui; Liu, Yu; Liu, YuNing; Yuan, HuiTing] Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Beijing, Peoples R China	University of Science & Technology Beijing	Gong, AJ (corresponding author), Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Beijing, Peoples R China.	gongaijun5661@ustb.edu.cn		Li, Fukai/0000-0001-7143-4680	Beijing Natural Science Foundation [8172033]; Fundamental Research Funds for the Central Universities of China [FRF-BR-15-015A]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was financially supported by Beijing Natural Science Foundation Program (No. 8172033 to AG), and Fundamental Research Funds for the Central Universities of China (No. FRF-BR-15-015A to AG).	Aniwashi J, 2011, GENET MOL RES, V10, P1075, DOI 10.4238/vol10-2gmr1070; Ansari SA, 2012, CHEM REV, V112, P1751, DOI 10.1021/cr200002f; de Carvalho GGA, 2016, TALANTA, V161, P707, DOI 10.1016/j.talanta.2016.09.027; Berijani S, 2015, J IRAN CHEM SOC, V12, P737, DOI 10.1007/s13738-014-0532-5; Cai DJ, 2011, J VERBRAUCH LEBENSM, V6, P349, DOI 10.1007/s00003-010-0650-7; Connelly NG, 2007, CHEM INT NEWSMAGAZIN, V27, P25; De Vito IE, 1999, TALANTA, V49, P929, DOI 10.1016/S0039-9140(99)00089-2; De Vito IE, 2001, J ANAL ATOM SPECTROM, V16, P275, DOI 10.1039/b008165p; Donard A, 2015, J ANAL ATOM SPECTROM, V30, P2420, DOI 10.1039/c5ja00309a; DULSKI P, 1994, FRESEN J ANAL CHEM, V350, P194, DOI 10.1007/BF00322470; El-Taher A, 2007, APPL RADIAT ISOTOPES, V65, P458, DOI 10.1016/j.apradiso.2006.07.014; Guo XQ, 2014, RSC ADV, V4, P19960, DOI 10.1039/c4ra01576b; Hassanien MM, 2016, MICROCHEM J, V127, P125, DOI 10.1016/j.microc.2016.02.014; Husain M, 2008, DESALINATION, V229, P294, DOI 10.1016/j.desal.2007.10.016; Jia Q, 2008, MICROCHEM J, V89, P82, DOI 10.1016/j.microc.2007.12.005; KARADAS C, 2014, WATER AIR SOIL POLLT, V225; Kumar K, 2014, J RADIOANAL NUCL CH, V301, P667, DOI 10.1007/s10967-014-3221-z; Labrecque C, 2014, ANAL METHODS-UK, V6, P9291, DOI [10.1039/c4ay01911c, 10.1039/C4AY01911C]; Li Y, 2012, J AGR FOOD CHEM, V60, P3033, DOI 10.1021/jf2049646; Li YT, 2016, MICROCHEM J, V126, P194, DOI 10.1016/j.microc.2015.12.006; Li YJ, 2010, J HAZARD MATER, V174, P534, DOI 10.1016/j.jhazmat.2009.09.084; Liang T, 2014, ENVIRON MONIT ASSESS, V186, P1499, DOI 10.1007/s10661-013-3469-8; Pyrzynska K, 2016, TALANTA, V154, P15, DOI 10.1016/j.talanta.2016.03.022; Sereshti H, 2012, ANAL LETT, V45, P1426, DOI 10.1080/00032719.2012.675490; Sitko R, 2005, J ANAL ATOM SPECTROM, V20, P741, DOI 10.1039/b502994e; Su SW, 2014, TALANTA, V119, P458, DOI 10.1016/j.talanta.2013.11.027; Tajabadi F, 2013, MICROCHIM ACTA, V180, P65, DOI 10.1007/s00604-012-0913-3; Wen HR, 1998, PARIS METAL IONS BIO, P199; Yousefi SR, 2014, ANAL METHODS-UK, V6, P3694, DOI 10.1039/c4ay00176a; Zereen F, 2013, MICROCHEM J, V110, P178, DOI 10.1016/j.microc.2013.03.012; Zhang YA, 2015, RSC ADV, V5, P5996, DOI 10.1039/c4ra13333a; Zhao XW, 2010, J RARE EARTH, V28, P79, DOI 10.1016/S1002-0721(10)60342-0; Zhu YB, 2010, J ANAL ATOM SPECTROM, V25, P364, DOI 10.1039/b921214k	33	7	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185302	10.1371/journal.pone.0185302	http://dx.doi.org/10.1371/journal.pone.0185302			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945788	Green Submitted, Green Published, gold			2022-12-27	WOS:000411645100042
J	Ying, N; Ju, CJ; Sun, XW; Li, LT; Chang, HB; Song, GP; Li, ZY; Wan, JY; Dai, EY				Ying, Na; Ju, Chuanjing; Sun, Xiuwei; Li, Letian; Chang, Hongbiao; Song, Guangping; Li, Zhongyi; Wan, Jiayu; Dai, Enyong			Lateral flow nucleic acid biosensor for sensitive detection of microRNAs based on the dual amplification strategy of duplex-specific nuclease and hybridization chain reaction	PLOS ONE			English	Article							DNA DETECTION; QUANTIFICATION	MicroRNAs (miRNAs) constitute novel biomarkers for various diseases. Accurate and quantitative analysis of miRNA expression is critical for biomedical research and clinical theranostics. In this study, a method was developed for sensitive and specific detection of miRNAs via dual signal amplification based on duplex specific nuclease (DSN) and hybridization chain reaction (HCR). A reporter probe (RP), comprising recognition sequence (3' end modified with biotin) for a target miRNA of miR-21 and capture sequence (5' end modified with Fam) for HCR product, was designed and synthesized. HCR was initiated by partial sequence of initiator probe (IP), the other part of which can hybridize with capture sequence of RP, and was assembled by hairpin probes modified with biotin (H1-bio and H2-bio). A miR-21 triggered cyclical DSN cleavage of RP, which was immobilized to a streptavidin (SA) coated magnetic bead (MB). The released Fam labeled capture sequence then hybridized with the HCR product to generate a detectable dsDNA. This polymer was then dropped on lateral flow strip and positive result was observed. The proposed method allowed quantitative sequence-specific detection of miR-21 (with a detection limit of 2.1 fM, S/N = 3) in a dynamic range from 100 fM to 100 pM, with an excellent ability to discriminate differences in miRNAs. The method showed acceptable testing recoveries for the determination of miRNAs in serum.	[Ying, Na; Ju, Chuanjing; Sun, Xiuwei; Li, Letian; Chang, Hongbiao; Song, Guangping; Li, Zhongyi; Wan, Jiayu] Acad Mil Med Sci, Inst Mil Vet, Changchun, Jilin, Peoples R China; [Ying, Na] China Acad Fishery Sci, East China Sea Fisheries Res Inst, Shanghai, Peoples R China; [Ju, Chuanjing] Gen Hosp FAW, Changchun, Jilin, Peoples R China; [Ju, Chuanjing] Jilin Univ, Hosp 4, Changchun, Jilin, Peoples R China; [Sun, Xiuwei] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China; [Chang, Hongbiao] Changchun Univ Sci & Technol, Sch Life Sci & Technol, Changchun, Jilin, Peoples R China; [Song, Guangping] Heilongjiang Bayi Agr Univ, Daqing, Peoples R China; [Dai, Enyong] Jilin Univ, China Japan Union Hosp, Dept Oncol & Hematol, Changchun, Jilin, Peoples R China	Academy of Military Medical Sciences - China; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS; Jilin University; Jilin Agricultural University; Changchun University of Science & Technology; Heilongjiang Bayi Agricultural University; Jilin University	Wan, JY (corresponding author), Acad Mil Med Sci, Inst Mil Vet, Changchun, Jilin, Peoples R China.; Dai, EY (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Oncol & Hematol, Changchun, Jilin, Peoples R China.	wanjiayu@hotmail.com; daiey@jlu.edu.cn			Basic Work of Science and Technology Special of China [2013FY113600]; National Key Technologies R&D Program of China [2013BAD12B04]; Science and technology development plans of Jilin Province [20150101105JC]; National Key Research and Development Program of China [2016YFD0501000]	Basic Work of Science and Technology Special of China; National Key Technologies R&D Program of China(National Key Technology R&D Program); Science and technology development plans of Jilin Province; National Key Research and Development Program of China	This study was funded by The Basic Work of Science and Technology Special of China (NO.2013FY113600), National Key Technologies R&D Program of China (No.2013BAD12B04), Science and technology development plans of Jilin Province (20150101105JC) and The National Key Research and Development Program of China (No.2016YFD0501000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Campuzano S, 2014, ANAL BIOANAL CHEM, V406, P27, DOI 10.1007/s00216-013-7459-z; Chen AY, 2016, ANAL CHEM, V88, P3203, DOI 10.1021/acs.analchem.5b04578; Chun HYY, 2011, NUCL ACIDS RES, V39; Cissell KA, 2008, ANAL CHEM, V80, P2319, DOI 10.1021/ac702577a; Degliangeli F, 2014, J AM CHEM SOC, V136, P2264, DOI 10.1021/ja412152x; Deng SL, 2014, J FOOD PROTECT, V77, P1998, DOI 10.4315/0362-028X.JFP-14-086; Ding XJ, 2015, ANAL CHIM ACTA, V874, P59, DOI 10.1016/j.aca.2015.03.021; Driskell JD, 2008, BIOSENS BIOELECTRON, V24, P917, DOI 10.1016/j.bios.2008.07.060; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Hao N, 2015, CHEM COMMUN, V51, P13504, DOI 10.1039/c5cc05350a; He YC, 2014, CHEM COMMUN, V50, P6236, DOI 10.1039/c4cc00705k; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Jamali AA, 2014, TRAC-TREND ANAL CHEM, V55, P24, DOI 10.1016/j.trac.2013.10.008; Labib M, 2015, ANAL CHEM, V87, P1395, DOI 10.1021/ac504331c; Li CX, 2015, ANAL CHEM, V87, P4283, DOI 10.1021/ac5047032; Li JJ, 2016, BIOSENS BIOELECTRON, V85, P764, DOI 10.1016/j.bios.2016.05.088; Li JB, 2014, CHEM SOC REV, V43, P506, DOI 10.1039/c3cs60312a; Li RD, 2016, BIOSENS BIOELECTRON, V77, P995, DOI 10.1016/j.bios.2015.10.082; Lin XY, 2013, CHEM COMMUN, V49, P7243, DOI 10.1039/c3cc43224f; Liu P, 2013, ANAL CHEM, V85, P7689, DOI 10.1021/ac4001157; Lv WF, 2016, BIOSENS BIOELECTRON, V83, P250, DOI 10.1016/j.bios.2016.04.053; Ma CP, 2014, ANAL BIOCHEM, V457, P19, DOI 10.1016/j.ab.2014.04.022; Miller DFB, 2013, METHODS, V63, P126, DOI 10.1016/j.ymeth.2013.03.023; Pierce RMDaNA, 2004, PNAS, V101, P4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shagin DA, 2002, GENOME RES, V12, P1935, DOI 10.1101/gr.547002; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Wang LC, 2014, ADV INTEL SYS RES, V109, P9, DOI 10.1371/journal.pone.0085683; Wang Q, 2016, BIOSENS BIOELECTRON, V80, P366, DOI 10.1016/j.bios.2016.02.005; Wu H, 2016, BIOSENS BIOELECTRON, V81, P303, DOI 10.1016/j.bios.2016.03.013; Xu FF, 2016, ANAL CHEM, V88, P754, DOI 10.1021/acs.analchem.5b03056; Yin BC, 2012, J AM CHEM SOC, V134, P5064, DOI 10.1021/ja300721s; Yin R, 2016, FOOD CONTROL, V60, P146, DOI 10.1016/j.foodcont.2015.07.030; Zhang XY, 2014, ACS NANO, V8, P3444, DOI 10.1021/nn406339n	35	15	15	11	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185091	10.1371/journal.pone.0185091	http://dx.doi.org/10.1371/journal.pone.0185091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945768	Green Published, gold, Green Submitted			2022-12-27	WOS:000411645100022
J	Svard, D; Nilsson, M; Lampinen, B; Latt, J; Sundgren, PC; Stomurd, E; Minthon, L; Hansson, O; van Westen, D				Svard, Daniel; Nilsson, Markus; Lampinen, Bjorn; Latt, Jimmy; Sundgren, Pia C.; Stomurd, Erik; Minthon, Lennart; Hansson, Oskar; van Westen, Danielle			The effect of white matter hyperintensities on statistical analysis of diffusion tensor imaging in cognitively healthy elderly and prodromal Alzheimer's disease	PLOS ONE			English	Article							SMALL VESSEL DISEASE; TRACT; LESIONS; MICROSTRUCTURE; ABNORMALITIES; TRACTOGRAPHY; IMPAIRMENT; INTEGRITY; EXCLUDE; PEOPLE	Diffusion tensor imaging (DTI) has been used to study microstructural white matter alterations in a variety of conditions including normal aging and Alzheimer's disease (AD). White matter hyperintensities (WMH) are common in cognitively healthy elderly as well as in AD and exhibit elevated mean diffusivity (MD) and reduced fractional anisotropy (FA). However, the effect of WMH on statistical analysis of DTI estimates has not been thoroughly studied. In the present study we address this in two ways. First, we investigate the effect of WMH on MD and FA in the dorsal and ventral cingulum, the superior longitudinal fasciculus, and the corticospinal tract, by comparing two matched groups of cognitively healthy elderly (n = 21 + 21) with unequal WMH load. Second, we assess the effects of adjusting for WMH load when comparing MD and FA in prodromal AD subjects (n = 83) to cognitively healthy elderly (n = 132) in the abovementioned white matter tracts. Results showed the WMH in cognitively healthy elderly to have a generally large effect on DTI estimates (Cohen's d = 0.63 to 1.27 for significant differences in MD and -1.06 to -0.69 for FA). These effect sizes were comparable to those of various neurological and psychiatric diseases (Cohen's d = 0.57 to 2.20 for differences in MD and -1.76 to -0.61 for FA). Adjusting for WMH when comparing DTI estimates in prodromal AD subjects to cognitively healthy elderly improved the explanatory power as well as the outcome of the analysis, indicating that some of the differences in MD and FA were largely driven by unequal WMH load between the groups rather than alterations in normal-appearing white matter (NAWM). Thus, our findings suggest that if the purpose of a study is to compare alterations in NAWM between two groups using DTI it may be necessary to adjust the statistical analysis for WMH.	[Svard, Daniel; Sundgren, Pia C.; van Westen, Danielle] Lund Univ, Diagnost Radiol, Lund, Sweden; [Svard, Daniel; Latt, Jimmy; Sundgren, Pia C.; van Westen, Danielle] Skane Univ Hosp, Med Imaging & Physiol, Lund, Sweden; [Nilsson, Markus] Lund Univ, Bioimaging Ctr, Lund, Sweden; [Lampinen, Bjorn] Lund Univ, Med Radiat Phys, Lund, Sweden; [Stomurd, Erik; Minthon, Lennart; Hansson, Oskar] Lund Univ, Clin Memory Res, Malmoo, Sweden; [Hansson, Oskar] Skane Univ Hosp, Memory Clin, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Lund University; Lund University; Skane University Hospital	Svard, D (corresponding author), Lund Univ, Diagnost Radiol, Lund, Sweden.; Svard, D (corresponding author), Skane Univ Hosp, Med Imaging & Physiol, Lund, Sweden.	daniel.svard@med.lu.se	Hansson, Oskar/A-7134-2013; Nilsson, Markus/C-6920-2012	Hansson, Oskar/0000-0001-8467-7286; van Westen, Danielle/0000-0001-8649-9874; Sundgren, Pia/0000-0001-9237-1236; Nilsson, Markus/0000-0002-3140-8223	European Research Council; Swedish Research Council; Strategic Research Area MultiPark (Multidisciplinary Research in Parkinson's disease) at Lund University; Crafoord Foundation; Swedish Brain Foundation; Skke University Hospital Foundation; Swedish Alzheimer Association; Stiftelsen for gamla tjnarinnor; Swedish Federal Government under the ALF Agreement	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Strategic Research Area MultiPark (Multidisciplinary Research in Parkinson's disease) at Lund University; Crafoord Foundation; Swedish Brain Foundation; Skke University Hospital Foundation; Swedish Alzheimer Association; Stiftelsen for gamla tjnarinnor; Swedish Federal Government under the ALF Agreement	The study was supported by the European Research Council, the Swedish Research Council, the Strategic Research Area MultiPark (Multidisciplinary Research in Parkinson's disease) at Lund University, the Crafoord Foundation, the Swedish Brain Foundation, the Skke University Hospital Foundation, the Swedish Alzheimer Association, Stiftelsen for gamla tjnarinnor, and the Swedish Federal Government under the ALF Agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; BRETELER MMB, 1994, NEUROLOGY, V44, P1246, DOI 10.1212/WNL.44.7.1246; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; de Groot M, 2015, ALZHEIMERS DEMENT, V11, P321, DOI 10.1016/j.jalz.2014.06.011; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gattellaro G, 2009, AM J NEURORADIOL, V30, P1222, DOI 10.3174/ajnr.A1556; Gouw AA, 2011, J NEUROL NEUROSUR PS, V82, P126, DOI 10.1136/jnnp.2009.204685; Gustavsson AM, 2015, CEREBROVASC DIS EXTR, V5, P41, DOI 10.1159/000377710; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Iverson GL, 2011, BRAIN INJURY, V25, P1325, DOI 10.3109/02699052.2011.608409; Janelidze S, 2016, ANN CLIN TRANSL NEUR, V3, P154, DOI 10.1002/acn3.274; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jones DK, 1999, STROKE, V30, P393, DOI 10.1161/01.STR.30.2.393; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kodl CT, 2008, DIABETES, V57, P3083, DOI 10.2337/db08-0724; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Lange RT, 2014, J NEUROTRAUM, V31, P198, DOI 10.1089/neu.2013.2866; Launer Lenore J, 2004, Top Magn Reson Imaging, V15, P365, DOI 10.1097/01.rmr.0000168216.98338.8d; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Leritz EC, 2014, HUM BRAIN MAPP, V35, P1085, DOI 10.1002/hbm.22236; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Maillard P, 2014, STROKE, V45, P1721, DOI 10.1161/STROKEAHA.113.004084; Maillard P, 2012, LANCET NEUROL, V11, P1039, DOI 10.1016/S1474-4422(12)70241-7; Maillard P, 2011, STROKE, V42, P1917, DOI 10.1161/STROKEAHA.110.609768; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Mori S., 2005, MRI ATLAS HUMAN WHIT; Nilsson M, PLOS ONE, V10; Nilsson M, 2013, MAGN RESON MATER PHY, V26, P345, DOI 10.1007/s10334-013-0371-x; Nucifora PGP, 2012, ACAD RADIOL, V19, P622, DOI 10.1016/j.acra.2012.01.002; Pelletier A, 2016, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00255; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Potter GM, 2010, STROKE, V41, P267, DOI 10.1161/STROKEAHA.109.566307; Remy F, 2015, NEUROIMAGE-CLIN, V7, P482, DOI 10.1016/j.nicl.2015.01.014; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Santillo AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066932; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Schmidt R, 2011, ACTA NEUROPATHOL, V122, P171, DOI 10.1007/s00401-011-0851-x; Sexton CE, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.019; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Stenset V, 2011, NEUROBIOL AGING, V32, P581, DOI 10.1016/j.neurobiolaging.2009.04.014; Surova Y, 2015, NEURORADIOLOGY, V57, P1079, DOI 10.1007/s00234-015-1563-z; Svard D, 2014, P INT SOC MAG RESON, V22, P1839; Szczepankiewicz F, 2013, NEUROIMAGE, V76, P145, DOI 10.1016/j.neuroimage.2013.02.078; Vernooij MW, 2008, NEUROIMAGE, V43, P470, DOI 10.1016/j.neuroimage.2008.07.052; Wang F, 2004, AM J PSYCHIAT, V161, P573, DOI 10.1176/appi.ajp.161.3.573; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; YLIKOSKI A, 1995, STROKE, V26, P1171, DOI 10.1161/01.STR.26.7.1171; Yoshita M, 2006, NEUROLOGY, V67, P2192, DOI 10.1212/01.wnl.0000249119.95747.1f; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhuang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058887	58	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185239	10.1371/journal.pone.0185239	http://dx.doi.org/10.1371/journal.pone.0185239			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934374	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900132
J	Wasfy, JH; Stewart, C; Bhambhani, V				Wasfy, Jason H.; Stewart, Charles, III; Bhambhani, Vijeta			County community health associations of net voting shift in the 2016 US presidential election	PLOS ONE			English	Article							POLITICAL-IDEOLOGY; UNITED-STATES; TURNOUT; MORTALITY; BEHAVIOR	Importance In the U.S. presidential election of 2016, substantial shift in voting patterns occurred relative to previous elections. Although this shift has been associated with both education and race, the extent to which this shift was related to public health status is unclear. Objective To determine the extent to which county community health was associated with changes in voting between the presidential elections of 2016 and 2012. Design Ecological study with principal component analysis (PCA) using principal axis method to extract the components, then generalized linear regression. Setting General community. Participants All counties in the United States. Exposures Physically unhealthy days, mentally unhealthy days, percent food insecure, teen birth rate, primary care physician visit rate, age-adjusted mortality rate, violent crime rate, average health care costs, percent diabetic, and percent overweight or obese. Main outcome The percentage of Donald Trump votes in 2016 minus percentage of Mitt Romney votes in 2012 ("net voting shift"). Results Complete public health data was available for 3,009 counties which were included in the analysis. The mean net voting shift was 5.4% (+/- 5.8%). Of these 3,009 counties, 2,641 (87.8%) had positive net voting shift (shifted towards Trump) and 368 counties (12.2%) had negative net voting shift (shifted away from Trump). The first principal component ("unhealthy score") accounted for 68% of the total variance in the data. The unhealthy score included all health variables except primary care physician rate, violent crime rate, and health care costs. The mean unhealthy score for counties was 0.39 (SD 0.16). Higher normalized unhealthy score was associated with positive net voting shift (22.1% shift per unit unhealthy, p < 0.0001). This association was stronger in states that switched Electoral College votes from 2012 to 2016 than in other states (5.9% per unit unhealthy, p < 0.0001). Conclusions and relevance Substantial association exists between a shift toward voting for Donald Trump in 2016 relative to Mitt Romney in 2012 and measures of poor public health. Although these results do not demonstrate causality, these results suggest a possible role for health status in political choices.	[Wasfy, Jason H.; Bhambhani, Vijeta] Harvard Med Sch, Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02115 USA; [Stewart, Charles, III] MIT, Dept Polit Sci, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Wasfy, JH (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02115 USA.	jwasfy@mgh.harvard.edu		Wasfy, Jason/0000-0002-0871-5970	NCATS NIH HHS [KL2 TR001100] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Aitchison J, 1954, ECONOMETRICA, V22, P104; American Health Care Act, 2017, AM HLTH CAR ACT; [Anonymous], 2014, TOTAL MED REIMBURSEM; Bernstein S, 2016, AM J PUBLIC HEALTH, V106, P1879, DOI 10.2105/AJPH.2016.303381; Blendon RJ, 2016, NEW ENGL J MED, V375, DOI 10.1056/NEJMsr1606159; Bor J., 2017, AM J PUBLIC HEALTH, pe1; Buchanan L., 2016, NY TIMES; Clinton H, 2016, NEW ENGL J MED, V375, DOI 10.1056/NEJMsb1612292; Denny K, 2009, AM J POLIT SCI, V53, P17, DOI 10.1111/j.1540-5907.2008.00355.x; Denny KJ, 2007, EUR J PUBLIC HEALTH, V17, P400, DOI 10.1093/eurpub/ckm002; Dorling D, 2001, BRIT MED J, V322, P1336, DOI 10.1136/bmj.322.7298.1336; Enten H., EVEN WEALTHY ED PRED; Gelman A, 2010, RED STATE, BLUE STATE, RICH STATE, POOR STATE: WHY AMERICANS VOTE THE WAY THEY DO, EXPANDED EDITION, P1; Johnson A., 2017, GEORG J PUBLIC POLIC, P3; Leip Dave, ATLAS US PRESIDENTIA; Mattila M, 2013, ELECT STUD, V32, P886, DOI 10.1016/j.electstud.2013.07.010; Ojeda C, 2015, SOC SCI QUART, V96, P1226, DOI 10.1111/ssqu.12173; Pabayo R, 2015, J EPIDEMIOL COMMUN H, V69, P423, DOI 10.1136/jech-2014-204803; Pacheco J., 2014, POLICY CONSEQUENCES; Pacheco J, 2015, POLIT RES QUART, V68, P104, DOI 10.1177/1065912914563548; Shin ME, 2013, PREV MED, V57, P721, DOI 10.1016/j.ypmed.2013.07.026; Soderlund Peter, 2015, Politics Life Sci, V34, P28, DOI 10.1017/pls.2015.3; Subramanian SV, 2010, J EPIDEMIOL COMMUN H, V64, P838, DOI 10.1136/jech.2009.097915	23	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185051	10.1371/journal.pone.0185051	http://dx.doi.org/10.1371/journal.pone.0185051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968415	Green Published, Green Submitted, gold			2022-12-27	WOS:000412029600013
J	Aveni, E; Bauer, B; Ramelet, AS; Decosterd, I; Ballabeni, P; Bonvin, E; Rodondi, PY				Aveni, Eleonore; Bauer, Brent; Ramelet, Anne-Sylvie; Decosterd, Isabelle; Ballabeni, Pierluigi; Bonvin, Eric; Rodondi, Pierre-Yves			Healthcare professionals' sources of knowledge of complementary medicine in an academic center	PLOS ONE			English	Article							THEORY-PRACTICE GAP; ALTERNATIVE MEDICINE; INTERPROFESSIONAL EDUCATION; PHYSICIANS ATTITUDES; THERAPIES; NURSES; COMMUNICATION; PAIN	Background Complementary medicine ( CM) is utilized in a growing number of academic centers despite the debate concerning its value, risks and benefits. Healthcare professionals often feel uncomfortable discussing CM with patients, and little is known about their sources of knowledge in the field of CM. Objective To assess healthcare professionals' sources of knowledge and attitude toward CM in an academic hospital. Design and participants The cross-sectional web-based survey took place from October to December 2013. A total of 4,925 healthcare professionals working at Lausanne University Hospital, Switzerland, were invited to answer the questionnaire. Main measures Factors influencing healthcare professionals' opinion toward CM, knowledge and communication about CM. Key results The questionnaire was answered by 1,247 healthcare professionals. The three key factors influencing professionals' opinion toward CM were personal experience, clinical experience and evidence demonstrating the physiological mechanism of CM. Personal experience was more associated with nurses' and midwives' opinion compared to physicians' (80.8% vs 57.1%, OR = 3.08, [95% CI: 2.35-4.05], P<0.001 and 85.3% vs 57.1%, OR = 3.83, [95% CI: 1.95-7.53], P<0.001, respectively) as well as with professionals trained in CM compared tonon-trained professionals (86.0% vs 73.2%, OR = 2.60, [95% CI: 1.92-3.53], P<0.001). Physicians relied more on randomized controlled clinical trials compared to nurses (81.3% vs 62.9%, OR = 0.43, [95% CI: 0.33-0.57], P<0.001). A majority of the respondents (82.5%) agreed that they lacked knowledge about CM and 65.0% noted that it was the patient who initially started the discussion about CM. Conclusions Different professionals used different strategies to forge opinions regarding CM: physicians relied more on scientific evidence, while nurses and midwives were more influenced by personal experience. Regardless of preferred information source, most respondents did not feel prepared to address patient questions regarding CM. Enhancing interprofessional education opportunities is an important strategy to help providers become empowered to discuss CM with patients. This in turn will help patients making informed decisions in their healthcare.	[Aveni, Eleonore; Ballabeni, Pierluigi; Rodondi, Pierre-Yves] Lausanne Univ Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [Bauer, Brent] Mayo Clin, Div Gen Internal Med, Rochester, MN USA; [Ramelet, Anne-Sylvie] Lausanne Univ, IUFRS, Inst Higher Educ & Res Healthcare, Lausanne, Switzerland; [Decosterd, Isabelle] Lausanne Univ Hosp, Dept Anesthesiol, Pain Ctr, Lausanne, Switzerland; [Bonvin, Eric] Lausanne Univ Hosp, Dept Psychiat, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Mayo Clinic; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Aveni, E (corresponding author), Lausanne Univ Hosp, Inst Social & Prevent Med, Lausanne, Switzerland.	eleonore.aveni@chuv.ch	Ramelet, Anne-Sylvie/G-8451-2013; Rodondi, Pierre-Yves/AAU-3708-2020	Ramelet, Anne-Sylvie/0000-0001-8809-2920; Ballabeni, Pierluigi/0000-0002-1572-7179; Rodondi, Pierre-Yves/0000-0003-2007-2995; Bonvin, Eric/0000-0001-7995-2490	Lebherz-Cornelius Celsius Foundation	Lebherz-Cornelius Celsius Foundation	This study was supported by a grant from the Lebherz-Cornelius Celsius Foundation. The authors who received the funding: PYR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association of American Medical Colleges (AAMS), 1998, LEARN OBJ MED STUD E; Aveni E, 2016, EXPLORE-NY, V12, P341, DOI 10.1016/j.explore.2016.06.001; Blue AV, 2010, J INTERPROF CARE, V24, P204, DOI 10.3109/13561820903442887; Brock D, 2013, POSTGRAD MED J, V89, P642, DOI [10.1136/postgradmedj-2012-000952rep, 10.1136/bmjqs-2012-000952]; Brooke Joanne, 2015, Nurse Educ Today, V35, pe6, DOI 10.1016/j.nedt.2015.02.026; Chen L, 2010, PAIN MED, V11, P530, DOI 10.1111/j.1526-4637.2010.00815.x; Chen XW, 2011, CURR MED CHEM, V18, P4836, DOI 10.2174/092986711797535317; Clarke TC, 2015, NATL HLTH STAT REPOR, P1; Condon C, 2016, PHYSIOTHERAPY, V102, P10, DOI 10.1016/j.physio.2015.06.003; Coulter ID, 2008, HOSP BASED INTEGRATI; Coulter ID, 2004, MAINSTREAMING COMPLE, P103; Cowen VS, 2015, AM J PREV MED, V49, pS257, DOI 10.1016/j.amepre.2015.07.035; Dawes Martin, 2005, BMC Med Educ, V5, P1; Estabrooks CA, 2005, QUAL HEALTH RES, V15, P460, DOI 10.1177/1049732304273702; Forsman H, 2012, INT J NURS STUD, V49, P1155, DOI 10.1016/j.ijnurstu.2012.04.002; Geisler C, 2015, J AM ASSOC NURSE PRA, V27, P380, DOI 10.1002/2327-6924.12190; Hall Amanda, 2004, Health Info Libr J, V21, P102, DOI 10.1111/j.1471-1842.2004.00506.x; Hall H, 2017, INT J NURS STUD, V69, P47, DOI 10.1016/j.ijnurstu.2017.01.008; Hatlevik IK, 2012, J ADV NURS, V68, P868; Hollenberg DB, 2011, J COMPLEMENT INTEGR; HUMPHREYS BL, 1994, B MED LIBR ASSOC, V82, P18; Institute of Medicine (US), 2005, COMM US COMPL ALT ME; Interprofessional Education Collaborative Expert Panel, 2011, COR COMP INT COLL PR; Jong MC, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-4; Jung B, 2016, EXPLORE; Kadar GE, 2015, J INTERPROF CARE, V29, P377, DOI 10.3109/13561820.2014.967337; Klein SD, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0141985, 10.1371/journal.pone.0144676]; Labriola D, 1999, ONCOLOGY-NY, V13, P1003; Lin V, 2015, HEALTH EXPECT, V18, P2651, DOI 10.1111/hex.12239; Nematollahi R, 2012, INT NURS REV, V59, P194, DOI 10.1111/j.1466-7657.2011.00949.x; Ott M, 2015, TRACE ELEM ELECTROLY, V32, P74; Patterson C, 2008, INTEGR MED INSIGHTS, V3; Reeves S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002213.pub3; Robinson A, 2004, COMPLEMENT THER MED, V12, P90, DOI 10.1016/j.ctim.2004.09.006; Scully NJ, 2011, COLLEGIAN, V18, P93, DOI 10.1016/j.colegn.2010.04.002; Silverman J, 2012, SKILLS COMMUNICATING; Straus SE, 2009, CAN MED ASSOC J, V181, P165, DOI 10.1503/cmaj.081229; SUDMAN S, 1985, EVALUATION REV, V9, P349, DOI 10.1177/0193841X8500900306; Templeman K, 2011, COMPLEMENT THER MED, V19, P84, DOI 10.1016/j.ctim.2011.02.003; Thompson Carl, 2004, Evid Based Nurs, V7, P68; Trimborn A, 2013, ANN ONCOL, V24, P2641, DOI 10.1093/annonc/mdt299; VanGeest JB, 2007, EVAL HEALTH PROF, V30, P303, DOI 10.1177/0163278707307899; Vaucher C, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0120-5; Verloo H, 2017, J EVAL CLIN PRACT, V23, P139, DOI 10.1111/jep.12653; Wahner-Roedler DL, 2006, EVID-BASED COMPL ALT, V3, P495, DOI 10.1093/ecam/nel036; Wahner-Roedler DL, 2014, COMPLEMENT THER CLIN, V20, P54, DOI 10.1016/j.ctcp.2013.09.003; Widmer M, 2006, FORSCH KOMP KLAS NAT, V13, P356, DOI 10.1159/000097254; Winslow LC, 2002, ARCH INTERN MED, V162, P1176; World Health Organization, TRADITIONAL MED; Youngblut J M, 2001, AACN Clin Issues, V12, P468, DOI 10.1097/00044067-200111000-00003	50	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184979	10.1371/journal.pone.0184979	http://dx.doi.org/10.1371/journal.pone.0184979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MG	28961256	gold, Green Published, Green Submitted			2022-12-27	WOS:000412027700013
J	Akkus, B; Postmes, T; Stroebe, K				Akkus, Birol; Postmes, Tom; Stroebe, Katherine			Community Collectivism: A social dynamic approach to conceptualizing culture	PLOS ONE			English	Article							OF-FIT INDEXES; MEASUREMENT INVARIANCE; INDIVIDUALISM-COLLECTIVISM; DESCRIPTIVE NORMS; VALUES; SELF; SCALE; PSYCHOLOGY; AUTONOMY; REFLECT	Culture shapes individuals, but the measurement of cultural differences has proven a challenge. Traditional measures of cultural values focus on individual perceptions. We suggest that values are established and maintained within social communities of proximate others, such as the family and its social environment. Within such communities, values serve to maintain collective harmony whilst preserving individual agency. From a social-dynamic analysis of communities, we infer that community values of loyalty regulate individual commitment, values of honor regulate norm compliance, and values of group hierarchy maintain a division of labor. In addition, communities may regulate the ways in which individuals have independent agency. A new scale to measure these values was validated in four studies (N = 398, 112, 465 and 111) among Dutch (religious and non-religious), Turkish-Dutch, Surinamese and Turkish groups. Values and practices were measured at the level of the individual ('What do you value?') and at the level of the perceived community ('What does your community value?'). Results show that, unlike individual-level measures of individualism/ collectivism, this scale has excellent reliability, differentiates between cultural groups, and has predictive validity for future (voting) behavior. This approach provides a new way of conceptualizing culture, a new measure of collectivism and new insights into the role of proximate others in shaping culture.	[Akkus, Birol; Postmes, Tom; Stroebe, Katherine] Univ Groningen, Fac Behav & Social Sci, Groningen, Netherlands; [Akkus, Birol] Saxion Univ Appl Sci, Acad Social Work, Enschede, Netherlands	University of Groningen; Saxion University of Applied Sciences	Akkus, B (corresponding author), Univ Groningen, Fac Behav & Social Sci, Groningen, Netherlands.; Akkus, B (corresponding author), Saxion Univ Appl Sci, Acad Social Work, Enschede, Netherlands.	birol.akkus@gmail.com	Postmes, Tom/A-9004-2010	Postmes, Tom/0000-0002-8029-7398	Netherlands Organisation for Scientific Research (NWO) [023.001.164]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by the Netherlands Organisation for Scientific Research (NWO) under project number: 023.001.164. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Netherlands Organisation for Scientific Research (NWO) under project number: 023.001.164.	Arends-Toth J, 2004, INT J INTERCULT REL, V28, P19, DOI 10.1016/j.ijintrel.2003.09.001; Arends-Toth J, 2009, INT J PSYCHOL, V44, P161, DOI 10.1080/00207590701545676; Becker M, 2012, J PERS SOC PSYCHOL, V102, P833, DOI 10.1037/a0026853; Bettencourt BA, 2001, J PERS SOC PSYCHOL, V81, P1131, DOI 10.1037/0022-3514.81.6.1131; BOWLBY J, 1982, AM J ORTHOPSYCHIAT, V52, P664, DOI 10.1111/j.1939-0025.1982.tb01456.x; Buckholtz JW, 2012, NAT NEUROSCI, V15, P655, DOI 10.1038/nn.3087; Caporael LR, 2000, PSYCHOL INQ, V11, P23; Chen FF, 2008, J RES PERS, V42, P259, DOI 10.1016/j.jrp.2007.05.006; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Chiu CY, 2010, PERSPECT PSYCHOL SCI, V5, P482, DOI 10.1177/1745691610375562; Cv Eck, 2010, PURIFIED BLOOD HONOU; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Fischer R, 2012, SWISS J PSYCHOL; Fischer R, 2006, PERS SOC PSYCHOL B, V32, P1419, DOI 10.1177/0146167206291425; Fischer R, 2011, J CROSS CULT PSYCHOL, V42, P1127, DOI 10.1177/0022022110381429; Fischer R, 2009, INT J CROSS CULT MAN, V9, P25, DOI 10.1177/1470595808101154; Fischer R, 2009, J CROSS CULT PSYCHOL, V40, P187, DOI 10.1177/0022022109332738; Gelfand MJ, 2011, SCIENCE, V332, P1100, DOI 10.1126/science.1197754; Georgas J, 2006, FAMILIES ACROSS CULTURES: A 30-NATION PSYCHOLOGICAL STUDY, P1, DOI 10.2277/ 0521529875; GIORGI L, 1990, EUR J SOC PSYCHOL, V20, P499; Hitlin S, 2004, ANNU REV SOCIOL, V30, P359, DOI 10.1146/annurev.soc.30.012703.110640; Holzinger KJ, 1937, PSYCHOMETRIKA, V2, P41, DOI 10.1007/BF02287965; Ijzerman H, 2011, EUR J SOC PSYCHOL, V41, P456, DOI 10.1002/ejsp.806; Inglehart R, 2000, AM SOCIOL REV, V65, P19, DOI 10.2307/2657288; Jahoda G, 2012, CULT PSYCHOL, V18, P289, DOI 10.1177/1354067X12446229; Kagitcibasi C, 2005, J CROSS CULT PSYCHOL, V36, P403, DOI 10.1177/0022022105275959; Kagitcibasi C., 1996, FAMILY HUMAN DEV CUL; Kagitcibasi C, 2013, J RES ADOLESCENCE, V23, P223, DOI 10.1111/jora.12041; Kagitcibasi C, 1996, EUR PSYCHOL, V1, P180, DOI 10.1027/1016-9040.1.3.180; Kessler T, 2008, GROUP DYN-THEOR RES, V12, P73, DOI 10.1037/1089-2699.12.1.73; Koudenburg N, 2013, SOC PSYCHOL QUART, V76, P224, DOI 10.1177/0190272513496794; Lavaan RY, 2012, R PACKAGE STRUCTURAL; Leung AKY, 2011, J PERS SOC PSYCHOL, V100, P507, DOI 10.1037/a0022151; Lickel B, 2000, J PERS SOC PSYCHOL, V78, P223, DOI 10.1037/0022-3514.78.2.223; Markus HR, 2010, PERSPECT PSYCHOL SCI, V5, P420, DOI 10.1177/1745691610375557; McFadyen RG, 1998, HUM RELAT, V51, P179, DOI 10.1023/A:1016914319477; Minkov M, 2012, CROSS-CULT RES, V46, P133, DOI 10.1177/1069397111427262; Mucchi-Faina A., 2010, PSYCHOL STUD, V55, P365, DOI [10.1007/s12646-010-0042-1., DOI 10.1007/S12646-010-0042-1]; Owe E, 2013, J CROSS CULT PSYCHOL, V44, P24, DOI 10.1177/0022022111430255; Oyserman D, 2002, RETHINKING INDIVIDUA; Oyserman D, 2008, PSYCHOL BULL, V134, P311, DOI 10.1037/0033-2909.134.2.311; PELTO PJ, 1968, TRANS-ACT-SOC SCI MO, V5, P37; Phalet K, 2001, J COMP FAM STUD, V32, P489, DOI 10.3138/jcfs.32.4.489; Postmes T, 2015, J CROSS CULT PSYCHOL, V46, P1336, DOI 10.1177/0022022115610818; Reise SP, 2000, PSYCHOL ASSESSMENT, V12, P287, DOI 10.1037//1040-3590.12.3.287; Reise SP, 2012, MULTIVAR BEHAV RES, V47, P667, DOI 10.1080/00273171.2012.715555; Robert C, 2006, PERS PSYCHOL, V59, P65, DOI 10.1111/j.1744-6570.2006.00804.x; Russell DW, 2002, PERS SOC PSYCHOL B, V28, P1629, DOI 10.1177/014616702237645; Schmitt DP, 2005, J PERS SOC PSYCHOL, V89, P623, DOI 10.1037/0022-3514.89.4.623; SCHWARTZ SH, 1994, J SOC ISSUES, V50, P19, DOI 10.1111/j.1540-4560.1994.tb01196.x; Schwartz SH, 2012, J PERS SOC PSYCHOL, V103, P663, DOI 10.1037/a0029393; Semin GR, 2002, COGNITION EMOTION, V16, P11, DOI 10.1080/02699930143000112; Shariff A., 2009, CAN J COUNS, V43, P35; Shteynberg G, 2009, J CROSS CULT PSYCHOL, V40, P46, DOI 10.1177/0022022108326196; Singelis T.M., 1995, CROSS-CULT RES, V29, P240, DOI [10.1177/106939719502900302, DOI 10.1177/106939719502900302]; Sivadas E, 2008, J BUS RES, V61, P201, DOI 10.1016/j.jbusres.2007.06.016; Smith T. N., 2011, MARRIAGE FAMILY THER, P255; Smits IAM, 2011, J PERS SOC PSYCHOL, V100, P1124, DOI 10.1037/a0022874; Tadmor CT, 2006, J CROSS CULT PSYCHOL, V37, P173, DOI 10.1177/0022022105284495; Tamis-LeMonda CS, 2008, SOC DEV, V17, P183, DOI 10.1111/j.1467-9507.2007.00419.x; Terracciano A, 2005, SCIENCE, V310, P96, DOI 10.1126/science.1117199; Tetlock P.E., 1996, REVISING VALUE PLURA; TRIANDIS HC, 1989, PSYCHOL REV, V96, P506, DOI 10.1037/0033-295X.96.3.506; Triandis HC, 1998, J PERS SOC PSYCHOL, V74, P118, DOI 10.1037/0022-3514.74.1.118; TRIANDIS HC, 1988, J PERS SOC PSYCHOL, V54, P323, DOI 10.1037/0022-3514.54.2.323; Turner Jonathan H., 2012, ADV GROUP PROCESSES, V29, P1, DOI DOI 10.1108/S0882-6145(2012)0000029004; Van de Vijver F., 1997, HDB CROSS CULTURAL P, V2nd ed., P257; van Oudenhoven JP, 2001, INT J INTERCULT REL, V25, P89; Vignoles VL, 2000, PERS SOC PSYCHOL REV, V4, P337, DOI 10.1207/S15327957PSPR0404_4; Vignoles VL, 2000, IDENTITY CULTURE DIS; Wan C, 2007, J CROSS CULT PSYCHOL, V38, P213, DOI 10.1177/0022022106297300; Wan C, 2010, SOC COGNITION, V28, P422, DOI 10.1521/soco.2010.28.3.422; Wichmann SS, 2011, J HUMANIST COUNS, V50, P16, DOI 10.1002/j.2161-1939.2011.tb00103.x; Yamagishi T, 2010, EVOLUTION, CULTURE, AND THE HUMAN MIND, P185; Yaman A, 2010, J CHILD FAM STUD, V19, P617, DOI 10.1007/s10826-009-9346-y; Yuki M., 2013, CULTURE GROUP PROCES; Zou X, 2009, J PERS SOC PSYCHOL, V97, P579, DOI 10.1037/a0016399	78	16	16	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185725	10.1371/journal.pone.0185725	http://dx.doi.org/10.1371/journal.pone.0185725			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957447	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200110
J	Kang'''', N; Cauraugh, JH				Kang, Nyeonju; Cauraugh, James H.			Does non-invasive brain stimulation reduce essential tremor? A systematic review and meta-analysis	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST STIMULATION; MOTOR CORTEX; PERIPHERAL STIMULATION; REPEATED SESSIONS; RTMS; EXCITABILITY; CONNECTIVITY; IMPROVEMENT; PREVALENCE	Essential tremor (ET) is the most common age-related disease leading to abnormal tremulous behaviors in the upper and lower extremities. Non-invasive brain stimulation (NIBS) may be an effective ET therapy by modulating the oscillating network of the brain. The current systematic review and meta-analysis examined the effects of NIBS interventions on tremor symptoms in ET patients. Our comprehensive search identified eight studies that used 1 Hz of rTMS, cTBS, or ctDCS protocols. Twenty total comparisons from the eight qualified studies were statistically synthesized, and the meta-analytic findings revealed that NIBS techniques reduced tremulous behaviors in individuals with ET. Moreover, the four moderator variable analyses demonstrated that the positive therapeutic effects of NIBS appeared across the following subgroups: (a) tremor assessment (clinical test vs. quantitative tremor assessment), (b) stimulation site (cerebellum vs. motor cortex), (c) session number (single session vs. multiple sessions), and (d) sustained positive treatment effect (posttest vs. retention test). This comprehensive systematic review and meta-analysis provided evidence that support positive treatment effects of NIBS techniques on ET motor therapy.	[Kang, Nyeonju] Univ Florida, Lab Rehabil Neurosci, Dept Appl Physiol & Kinesiol, Gainesville, FL USA; [Kang, Nyeonju; Cauraugh, James H.] Univ Florida, Motor Behav Lab, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA; [Kang, Nyeonju] Incheon Natl Univ, Div Sport Sci, Incheon, South Korea	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Incheon National University	Cauraugh, JH (corresponding author), Univ Florida, Motor Behav Lab, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA.	cauraugh@ufl.edu	Kang, Nyeonju/AAX-1879-2021	KANG, NYEONJU/0000-0003-4440-4413	University of Florida Open Access Publishing Fund	University of Florida Open Access Publishing Fund	Publication of this article was funded in part by the University of Florida Open Access Publishing Fund.	Avanzino L, 2009, EUR J NEUROSCI, V30, P1971, DOI 10.1111/j.1460-9568.2009.06984.x; Badran BW, 2016, BRAIN STIMUL, V9, P945, DOI 10.1016/j.brs.2016.08.003; BAIN PG, 1994, BRAIN, V117, P805, DOI 10.1093/brain/117.4.805; Baumer T, 2003, NEUROIMAGE, V20, P550, DOI 10.1016/S1053-8119(03)00310-0; Blobaum P, 2006, J MED LIBR ASSOC, V94, P477; Boggio PS, 2007, RESTOR NEUROL NEUROS, V25, P123; Bologna M, 2015, CEREBELLUM, V14, P133, DOI 10.1007/s12311-014-0621-0; Borenstein M, 2009, INTRO META ANAL; Borenstein M, 2013, PREV SCI, V14, P134, DOI 10.1007/s11121-013-0377-7; Borich M, 2009, RESTOR NEUROL NEUROS, V27, P55, DOI 10.3233/RNN-2009-0461; Chalah MA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00440; Chen R, 2012, CLIN NEUROPHYSIOL, V123, P850, DOI 10.1016/j.clinph.2011.09.015; Chuang WL, 2014, MOVEMENT DISORD, V29, P501, DOI 10.1002/mds.25809; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V565, P945, DOI 10.1113/jphysiol.2005.087288; Dupuis MJM, 2010, MOVEMENT DISORD, V25, P2884, DOI 10.1002/mds.23328; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Elble RJ, 2009, CURR NEUROL NEUROSCI, V9, P273, DOI 10.1007/s11910-009-0041-6; Ferrucci Roberta, 2016, Cerebellum Ataxias, V3, P16, DOI 10.1186/s40673-016-0054-2; Gironell A, 2002, ARCH NEUROL-CHICAGO, V59, P413, DOI 10.1001/archneur.59.3.413; Gironell A, 2015, TREMOR OTHER HYPERK, V5, DOI 10.7916/D8DV1HQC; Grimaldi G, 2008, TREATMENT PATHOGENES; Hellriegel H, 2012, CLIN NEUROPHYSIOL, V123, P1010, DOI 10.1016/j.clinph.2011.08.033; Helmich RC, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0378-8; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Khedr EM, 2005, J NEUROL NEUROSUR PS, V76, P833, DOI 10.1136/jnnp.2004.055806; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Lindenberg R, 2012, NEUROREHAB NEURAL RE, V26, P479, DOI 10.1177/1545968311427568; Louis ED, 2000, ARCH NEUROL-CHICAGO, V57, P1194, DOI 10.1001/archneur.57.8.1194; Louis ED, 2001, MOVEMENT DISORD, V16, P914, DOI 10.1002/mds.1184; Louis Elan D, 2011, Front Neurol, V2, P91, DOI 10.3389/fneur.2011.00091; Louis ED, 2010, MOVEMENT DISORD, V25, P534, DOI 10.1002/mds.22838; Louis ED, 2009, NEUROEPIDEMIOLOGY, V32, P208, DOI 10.1159/000195691; Lu R., 2017, BRAIN STIMUL, V10, P513, DOI [10.1016/j.brs.2017.01.499, DOI 10.1016/J.BRS.2017.01.499]; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Nettekoven C, 2014, J NEUROSCI, V34, P6849, DOI 10.1523/JNEUROSCI.4993-13.2014; Ni Z, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0045-x; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Obeso I, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00486; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Pinto AD, 2003, NEUROLOGY, V60, P1985, DOI 10.1212/01.WNL.0000065890.75790.29; Popa T, 2013, BRAIN STIMUL, V6, P175, DOI 10.1016/j.brs.2012.04.009; Raethjen J, 2012, CLIN NEUROPHYSIOL, V123, P61, DOI 10.1016/j.clinph.2011.09.024; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Sandvik U, 2012, NEUROSURGERY, V70, P840, DOI 10.1227/NEU.0b013e318236a809; Shih LC, 2017, TREMOR OTHER HYPERK, V7, DOI 10.7916/D8G44W01; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Vanneste S, 2013, BRAIN STIMUL, V6, P155, DOI 10.1016/j.brs.2012.03.019; Yilmaz NH, 2016, NEUROLOGIST, V21, P28, DOI 10.1097/NRL.0000000000000070; Zhang K, 2010, J NEUROSURG, V112, P1271, DOI 10.3171/2009.10.JNS09371	51	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185462	10.1371/journal.pone.0185462	http://dx.doi.org/10.1371/journal.pone.0185462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957367	Green Submitted, Green Published, gold			2022-12-27	WOS:000411985200063
J	Kennedy, AE; Kandalam, S; Olivares-Navarrete, R; Dickinson, AJG				Kennedy, Allyson E.; Kandalam, Suraj; Olivares-Navarrete, Rene; Dickinson, Amanda J. G.			E-cigarette aerosol exposure can cause craniofacial defects in Xenopus laevis embryos and mammalian neural crest cells	PLOS ONE			English	Article							PROPYLENE-GLYCOL; OROFACIAL DEVELOPMENT; MATERNAL SMOKING; CLEFT-LIP; NICOTINE; BUTTER; MODEL; MALFORMATIONS; METABOLISM; DIACETYL	Since electronic cigarette (ECIG) introduction to American markets in 2007, vaping has surged in popularity. Many, including women of reproductive age, also believe that ECIG use is safer than traditional tobacco cigarettes and is not hazardous when pregnant. However, there are few studies investigating the effects of ECIG exposure on the developing embryo and nothing is known about potential effects on craniofacial development. Therefore, we have tested the effects of several aerosolized e-cigarette liquids (e-cigAM) in an in vivo craniofacial model, Xenopus laevis, as well as a mammalian neural crest cell line. Results demonstrate that e-cigAM exposure during embryonic development induces a variety of defects, including median facial clefts and midface hypoplasia in two of e-cigAMs tested e-cigAMs. Detailed quantitative analyses of the facial morphology revealed that nicotine is not the main factor in inducing craniofacial defects, but can exacerbate the effects of the other e-liquid components. Additionally, while two different e-cigAMs can have very similar consequences on facial appearances, there are subtle differences that could be due to the differences in e-cigAM components. Further assessment of embryos exposed to these particular e-cigAMs revealed cranial cartilage and muscle defects and a reduction in the blood supply to the face. Finally, the expression of markers for vascular and cartilage differentiation was reduced in a mammalian neural crest cell line corroborating the in vivo effects. Our work is the first to show that ECIG use could pose a potential hazard to the developing embryo and cause craniofacial birth defects. This emphasizes the need for more testing and regulation of this new popular product.	[Kennedy, Allyson E.; Dickinson, Amanda J. G.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; [Kandalam, Suraj; Olivares-Navarrete, Rene] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Dickinson, AJG (corresponding author), Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA.	ajdickinson@vou.edu		Dickinson, Amanda/0000-0002-1427-9140	NIDCR [5R56DE026024-02]; NIH National Institute of Dental and Craniofacial Research [5R56DE026024-02]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R56DE026024] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by NIDCR 5R56DE026024-02 to Olivares-Navarrete and Dickinson co-PIs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by a Grant awarded by the NIH National Institute of Dental and Craniofacial Research (Grant number: 5R56DE026024-02) to Rene Olivares-Navarrete and Amanda Dickinson. The authors would also like to acknowledge Chesapeake Tschaenn and Deborah Howton for specimen collection and frog husbandry (Dickinson lab). Finally we would like to especially thank Alison Breland and Tom Eissenberg for their insight into the human use of ECIGs and the needs for testing these products in embryos.	Adams DS, 2016, J PHYSIOL-LONDON, V594, P3245, DOI 10.1113/JP271930; Ashford K, 2016, NURS RES, V65, P408, DOI 10.1097/NNR.0000000000000176; Bahl V, 2012, REPROD TOXICOL, V34, P529, DOI 10.1016/j.reprotox.2012.08.001; Bailey RL, 2015, AM J IND MED, V58, P1235, DOI 10.1002/ajim.22533; Martelli DRB, 2015, BRAZ J OTORHINOLAR, V81, P514, DOI 10.1016/j.bjorl.2015.07.011; Bnait KS, 1995, EXP TOXICOL PATHOL, V47, P453, DOI 10.1016/S0940-2993(11)80327-1; Brass DM, 2017, AM J RESP CELL MOL B; Breland A, 2017, ANN NY ACAD SCI, V1394, P5, DOI 10.1111/nyas.12977; Breland AB, 2014, J ADDICT MED, V8, P223, DOI 10.1097/ADM.0000000000000049; Bruin JE, 2010, TOXICOL SCI, V116, P364, DOI 10.1093/toxsci/kfq103; Burstyn I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-18; Cavalcanti ZD, 2012, J BRAS PNEUMOL, V38, P395, DOI 10.1590/S1806-37132012000300016; Conlon F, 2011, BENZIDINE PEROXIDASE; Curwin BD, 2015, J EXPO SCI ENV EPID, V25, P324, DOI 10.1038/jes.2014.52; DARLINGTON RB, 1973, REV EDUC RES, V43, P433, DOI 10.3102/00346543043004433; Deniz E, 2017, SCI REP-UK, V7, DOI 10.1038/srep42506; Devotta A, 2016, DEV BIOL, V415, P371, DOI 10.1016/j.ydbio.2016.02.010; Dickinson AJG, 2016, SEMIN CELL DEV BIOL, V51, P53, DOI 10.1016/j.semcdb.2016.03.005; Dickinson AJG, 2016, SEMIN CELL DEV BIOL, V51, P54, DOI 10.1016/j.semcdb.2016.01.016; Dubey A, 2017, CURR PATHOBIOL REP, V5, P79, DOI 10.1007/s40139-017-0128-8; FDA, 2017, VAP E CIG OTH EL NIC; Fowles JR, 2013, CRIT REV TOXICOL, V43, P363, DOI 10.3109/10408444.2013.792328; Gouignard N, 2016, DIS MODEL MECH, V9, P607, DOI 10.1242/dmm.024661; Griffin JN, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005018; Gunnerbeck A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084715; Hanken J, 2005, J ANAT, V207, P437, DOI 10.1111/j.1469-7580.2005.00481.x; HEMMATIBRIVANLOU A, 1995, DEV GENET, V17, P78, DOI 10.1002/dvg.1020170109; Holden VK, 2016, CURR OPIN PULM MED, V22, P158, DOI 10.1097/MCP.0000000000000250; Honein MA, 2014, BIRTH DEFECTS RES A, V100, P822, DOI 10.1002/bdra.23274; Huerta TR, 2017, AM J PREV MED, V52, P339, DOI 10.1016/j.amepre.2016.10.017; Jensen RP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42549; JOSCHKO MA, 1991, NEUROTOXICOL TERATOL, V13, P307, DOI 10.1016/0892-0362(91)90076-9; Kang P, 2003, Orthod Craniofac Res, V6, P129, DOI 10.1034/j.1600-0544.2003.02236.x; Kennedy AE, 2014, JOVE-J VIS EXP, DOI 10.3791/52062; Kennedy AE, 2014, ANAT REC, V297, P834, DOI 10.1002/ar.22864; Kienhuis AS, 2015, TOB INDUC DIS, V13, DOI 10.1186/s12971-015-0038-7; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kreiss K, 2002, NEW ENGL J MED, V347, P330, DOI 10.1056/NEJMoa020300; Lauterstein DE, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040417; Levine AJ, 2003, DEV BIOL, V254, P50, DOI 10.1016/S0012-1606(02)00029-5; Mark KS, 2015, J ADDICT MED, V9, P266, DOI 10.1097/ADM.0000000000000128; Massarsky A, 2017, ZEBRAFISH, V14, P216, DOI 10.1089/zeb.2016.1400; MCCARTHY M, 2014, BMJ-BRIT MED J, V349, DOI DOI 10.1136/BMJ.G5154; McMillen RC, 2015, NICOTINE TOB RES, V17, P1195, DOI 10.1093/ntr/ntu213; Oncken C, 2017, NICOTINE TOB RES, V19, P585, DOI 10.1093/ntr/ntw225; Palpant NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126259; Pankow JF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173055; Peace MR, 2016, J ANAL TOXICOL, V40, P403, DOI 10.1093/jat/bkw037; Pu J, 2017, PERSPECT PUBLIC HEAL; Rigler MW, 2010, INT J OCCUP ENV HEAL, V16, P291; Rinon A, 2007, DEVELOPMENT, V134, P3065, DOI 10.1242/dev.002501; Rom O, 2015, ANN NY ACAD SCI, V1340, P65, DOI 10.1111/nyas.12609; Rowell TR, 2017, AM J PHYSIOL-LUNG C, V313, pL52, DOI 10.1152/ajplung.00392.2016; Schmidt J, 2013, J ANAT, V222, P134, DOI 10.1111/j.1469-7580.2012.01541.x; [Services DoHaH Administration FaD], 2016, RESTR SAL DISTR TOB; Shen X, 2004, INT J PHARMACEUT, V275, P249, DOI 10.1016/j.ijpharm.2004.02.005; Shi M, 2007, AM J HUM GENET, V80, P76, DOI 10.1086/510518; Singh T, 2016, TOBACCO USE AMONOG M; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Spindle TR, 2015, NICOTINE TOB RES, V17, P142, DOI 10.1093/ntr/ntu186; Tahir R, 2014, MECH DEVELOP, V133, P91, DOI 10.1016/j.mod.2014.05.004; TAYLOR DJ, 1985, BIOCHEM J, V225, P315, DOI 10.1042/bj2250315; Tierney PA, 2016, TOB CONTROL, V25, pE10, DOI 10.1136/tobaccocontrol-2014-052175; van Rooij IALM, 2001, EPIDEMIOLOGY, V12, P502, DOI 10.1097/00001648-200109000-00007; Wagner NJ, 2017, MATERN CHILD HLTH J, V21, P1655, DOI 10.1007/s10995-016-2257-9; Wahl SE, 2015, DEV BIOL, V405, P108, DOI 10.1016/j.ydbio.2015.07.001; Warkman AS, 2007, SEMIN CELL DEV BIOL, V18, P46, DOI 10.1016/j.semcdb.2006.11.010; Werley MS, 2011, TOXICOLOGY, V287, P76, DOI 10.1016/j.tox.2011.05.015; Wheeler GN, 2012, GENESIS, V50, P207, DOI 10.1002/dvg.22009; Wickstrom R, 2007, CURR NEUROPHARMACOL, V5, P213, DOI 10.2174/157015907781695955; Wyszynski DF, 1997, CLEFT PALATE-CRAN J, V34, P206, DOI 10.1597/1545-1569(1997)034<0206:MCSAOC>2.3.CO;2; Xu YQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147184; Yildirim M, 2012, J DENT RES, V91, P556, DOI 10.1177/0022034512444928; Yingst JM, 2017, NICOTINE TOB RES; Zaccone EJ, 2015, TOXICOL APPL PHARM, V289, P542, DOI 10.1016/j.taap.2015.10.004; Zhao ZY, 2005, BIRTH DEFECTS RES B, V74, P383, DOI 10.1002/bdrb.20052; Zhu SH, 2014, TOB CONTROL, V23, P3, DOI 10.1136/tobaccocontrol-2014-051670; Ziermann JM, 2014, J EXP ZOOL PART B, V322, P586, DOI 10.1002/jez.b.22566	78	29	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185729	10.1371/journal.pone.0185729	http://dx.doi.org/10.1371/journal.pone.0185729			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957438	Green Submitted, Green Published, gold			2022-12-27	WOS:000411985200111
J	Magalhaes, FB; Neto, ALC; Nascimento, MB; Santos, WJT; Medeiros, ZM; Neto, ASL; Costa, DL; Costa, CHN; dos Santos, WLC; de Carvalho, LCP; Oliveira, GGS; Neto, OPD				Magalhaes, Franklin B.; Castro Neto, Artur L.; Nascimento, Marilia B.; Santos, Wagner J. T.; Medeiros, Zulma M.; Lima Neto, Adelino S.; Costa, Dorcas L.; Costa, Carlos H. N.; dos Santos, Washington L. C.; Pontes de Carvalho, Lain C.; Oliveira, Geraldo G. S.; de Melo Neto, Osvaldo P.			Evaluation of a new set of recombinant antigens for the serological diagnosis of human and canine visceral leishmaniasis	PLOS ONE			English	Article							IMMUNE-RESPONSE; TRYPANOSOMA-BRUCEI; EAST-AFRICA; INFANTUM; BRAZIL; PROTEINS; ANTIBODY; K-39; IDENTIFICATION; SERODIAGNOSIS	Current strategies for the control of zoonotic visceral leishmaniasis (VL) rely on its efficient diagnosis in both human and canine hosts. The most promising and cost effective approach is based on serologic assays with recombinant proteins. However, no single antigen has been found so far which can be effectively used to detect the disease in both dogs and humans. In previous works, we identified Leishmania infantum antigens with potential for the serodiagnosis of VL. Here, we aimed to expand the panel of the available antigens for VL diagnosis through another screening of a genomic expression library. Seven different protein-coding gene fragments were identified, five of which encoding proteins which have not been previously studied in Leishmania and rich in repetitive motifs. Poly-histidine tagged polypeptides were generated from six genes and evaluated for their potential for diagnosis of VL by ELISA (Enzyme Linked ImmunoSorbent Assay) with sera from infected humans and dogs. None of those was valid for the detection of human VL (26-52% sensitivity) although their performance was increased in the canine sera (48-91% sensitivity), with one polypeptide useful for the diagnosis of canine leishmaniasis. Next, we assayed a mixture of three antigens, found to be best for human or canine VL, among 13 identified through different screenings. This "Mix" resulted in similar levels of sensitivity for both human (84%) and canine (88%) sera. With improvements, this validates the use of multiple proteins, including antigens identified here, as components of a single system for the diagnosis of both forms of leishmaniasis.	[Magalhaes, Franklin B.] Assoc Caruaruense Ensino Super & Tecn, Caruaru, PE, Brazil; [Castro Neto, Artur L.; Nascimento, Marilia B.; Santos, Wagner J. T.; Medeiros, Zulma M.; de Melo Neto, Osvaldo P.] Fundacao Oswaldo Cruz Fiocruz Pernambuco, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil; [Lima Neto, Adelino S.; Costa, Dorcas L.; Costa, Carlos H. N.] Inst Doencas Trop Natan Portella IDTNP, Teresina, Piaui, Brazil; [dos Santos, Washington L. C.; Pontes de Carvalho, Lain C.; Oliveira, Geraldo G. S.] Fundacao Oswaldo Cruz Fiocruz Bahia, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Neto, OPD (corresponding author), Fundacao Oswaldo Cruz Fiocruz Pernambuco, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.	opmn@cpqam.fiocruz.br	de Sá Oliveira, Geraldo Gileno/AAO-4099-2021; dos Santos, Wagner José Tenório/AAQ-6888-2021; dos-Santos, Washington LC/AAO-4649-2021; dos Santos, Wagner José Tenório/AAE-3702-2022; de Castro Neto, Artur Leonel/L-2193-2015; de Melo Neto, Osvaldo P/B-1366-2015; Medeiros, Zulma/J-5407-2015	de Sá Oliveira, Geraldo Gileno/0000-0001-6065-6480; dos-Santos, Washington LC/0000-0002-5075-1254; dos Santos, Wagner José Tenório/0000-0001-7605-4687; de Castro Neto, Artur Leonel/0000-0002-1356-6703; de Melo Neto, Osvaldo P/0000-0001-5402-7346; Medeiros, Zulma/0000-0002-4434-955X	CNPq; Brazilian Ministry of Health (Grant MCTI/CNPq/MS-SCTIE) [404259/2012]; CNPq [554797]; Brazilian Ministry of Science and Technology (Program RENORBIO); FACEPE; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Health (Grant MCTI/CNPq/MS-SCTIE); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Science and Technology (Program RENORBIO); FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work in Dr. de Melo Neto's laboratory was more recently funded with grants provided by the Brazilian funding agency CNPq and the Brazilian Ministry of Health (Grant MCTI/CNPq/MS-SCTIE No.: 404259/2012). The work in Dr. C. H. N. Costa's lab was funded by CNPq (Grant 554797). Fellowships and studentships for the graduate students (FBM, ALCM, MBN, WJTS and ASLN) were provided by CNPq, FACEPE or CAPES. The work carried out at Fiocruz-BA was funded by the Brazilian Ministry of Science and Technology (Program RENORBIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abass E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116408; Boarino A, 2005, CLIN DIAGN LAB IMMUN, V12, P647, DOI 10.1128/CDLI.12.5.647-653.2005; Boelaert M, 2008, T ROY SOC TROP MED H, V102, P32, DOI 10.1016/j.trstmh.2007.09.003; BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775; Campos RM, 2008, MOL BIOCHEM PARASIT, V160, P157, DOI 10.1016/j.molbiopara.2008.04.013; Camussone C, 2009, CLIN VACCINE IMMUNOL, V16, P899, DOI 10.1128/CVI.00005-09; Castro JG, 2014, REV INST MED TROP SP, V56, P225, DOI 10.1590/S0036-46652014000300008; Creek DJ, 2008, ANTIMICROB AGENTS CH, V52, P1291, DOI 10.1128/AAC.01033-07; DeGrasse JA, 2009, MOL CELL PROTEOMICS, V8, P2119, DOI 10.1074/mcp.M900038-MCP200; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; Faria AR, 2015, PLOS NEGLECT TROP D, V9, P13; Fonseca AM, 2014, ACTA TROP, V137, P25, DOI 10.1016/j.actatropica.2014.04.028; Gomes YM, 2008, VET J, V175, P45, DOI 10.1016/j.tvjl.2006.10.019; Goto Y, 2008, INFECT IMMUN, V76, P3967, DOI 10.1128/IAI.00604-08; Goto Y, 2007, INFECT IMMUN, V75, P846, DOI 10.1128/IAI.01205-06; Goto Y, 2010, INFECT IMMUN, V78, P2138, DOI 10.1128/IAI.01102-09; Goto Y, 2009, VET PARASITOL, V160, P215, DOI 10.1016/j.vetpar.2008.10.097; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Harhay MO, 2011, AM J TROP MED HYG, V84, P543, DOI 10.4269/ajtmh.2011.10-0321; Houghton RL, 1998, J INFECT DIS, V177, P1339, DOI 10.1086/515289; Elmahallawy EK, 2014, J INFECT DEV COUNTR, V8, P961, DOI 10.3855/jidc.4310; LEE MGS, 1994, J BIOL CHEM, V269, P8408; Maia C, 2008, VET PARASITOL, V158, P274, DOI 10.1016/j.vetpar.2008.07.028; Maia Z, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001484; Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024; Martins-Melo FR, 2014, T ROY SOC TROP MED H, V108, P338, DOI 10.1093/trstmh/tru050; Mettler M, 2005, J CLIN MICROBIOL, V43, P5515, DOI 10.1128/JCM.43.11.5515-5519.2005; Fraga DBM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-136; Noli C, 2014, VET J, V202, P425, DOI 10.1016/j.tvjl.2014.09.002; Oliveira GGS, 2011, AM J TROP MED HYG, V85, P1025, DOI 10.4269/ajtmh.2011.11-0102; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Peixoto HM, 2015, TROP MED INT HEALTH, V20, P334, DOI 10.1111/tmi.12429; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; Quinnell RJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001992; RINDISBACHER L, 1993, MOL BIOCHEM PARASIT, V58, P83, DOI 10.1016/0166-6851(93)90093-D; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Roque Andre Luiz R., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P251, DOI 10.1016/j.ijppaw.2014.08.004; Rosati S, 2003, CLIN DIAGN LAB IMMUN, V10, P1153, DOI 10.1128/CDLI.10.6.1153-1156.2003; Shakya Nishi, 2011, J Parasit Dis, V35, P104; Singh Om Prakash, 2015, J Parasitol Res, V2015, P239469, DOI 10.1155/2015/239469; Singh S, 1995, J PARASITOL, V81, P1000, DOI 10.2307/3284056; Singh S, 2002, CLIN DIAGN LAB IMMUN, V9, P568, DOI 10.1128/CDLI.9.3.568-572.2002; Srivastava P, 2011, T ROY SOC TROP MED H, V105, P1, DOI 10.1016/j.trstmh.2010.09.006; Srividya G, 2012, PARASITOL RES, V110, P1065, DOI 10.1007/s00436-011-2680-1; Teixeira MCA, 2007, BIOLOGICALS, V35, P51, DOI 10.1016/j.biologicals.2006.01.005; Valiente-Gabioud AA, 2011, EXP PARASITOL, V127, P672, DOI 10.1016/j.exppara.2010.11.011; Vos Q, 2000, IMMUNOL REV, V176, P154; Webb JR, 1996, J IMMUNOL, V157, P5034; Zinoviev A, 2011, NUCLEIC ACIDS RES, V39, P8404, DOI 10.1093/nar/gkr555	49	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184867	10.1371/journal.pone.0184867	http://dx.doi.org/10.1371/journal.pone.0184867			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957332	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200019
J	Tavares, AM; Fronteira, I; Couto, I; Machado, D; Viveiros, M; Abecasis, AB; Dias, S				Tavares, Ana Maria; Fronteira, Ines; Couto, Isabel; Machado, Diana; Viveiros, Miguel; Abecasis, Ana B.; Dias, Sonia			HIV and tuberculosis co-infection among migrants in Europe: A systematic review on the prevalence, incidence and mortality	PLOS ONE			English	Article							INFECTIOUS-DISEASES; ANTIRETROVIRAL THERAPY; RISK-FACTORS; IMMIGRANTS; EPIDEMIOLOGY; IMPACT; AREA; POPULATIONS; MIGRATION; COHORT	Background International human migration has been rapidly growing. Migrants coming from low and middle income countries continue to be considerably vulnerable and at higher risk for infectious diseases, namely HIV (Human Immunodeficiency Virus) and tuberculosis (TB). In Europe, the number of patients with HIV-TB co-infection has been increasing and migration could be one of the potential driving forces. Objective This systematic review aims to improve the understanding on the burden of HIV-TB co-infection among migrants in Europe and to assess whether these populations are particularly vulnerable to this co-infection compared to nationals. Design MEDLINE (R), Web of Science (R) and Scopus (R) databases were searched from March to April 2016 using combinations of keywords. Titles and abstracts were screened and studies meeting the inclusion criteria proceeded for full-text revision. These articles were then selected for data extraction on the prevalence, incidence and mortality. Results The majority of HIV-TB prevalence data reported in the analysed studies, including extrapulmonary/disseminated TB forms, was higher among migrant vs. nationals, some of the studies even showing increasing trends over time. Additionally, while HIV-TB incidence rates have decreased among migrants and nationals, migrants are still at a higher risk for this coinfection. Migrants with HIV-TB co-infection were also more prone to unsuccessful treatment outcomes, death and drug resistant TB. However, contradicting results also showed lower mortality compared to nationals. Conclusions Overall, a disproportionate vulnerability of migrants to acquire the HIV-TBco-infection was observed across studies. Such vulnerability has been associated to low socioeconomic status, poor living conditions and limited access to healthcare. Adequate social support, early detection, appropriate treatment, and adequate access to healthcare are key improvements to tackle HIV-TBco-infection among these populations.	[Tavares, Ana Maria; Fronteira, Ines; Couto, Isabel; Machado, Diana; Viveiros, Miguel; Abecasis, Ana B.; Dias, Sonia] Univ Nova Lisboa, GHTM, IHMT, Lisbon, Portugal	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Tavares, AM; Dias, S (corresponding author), Univ Nova Lisboa, GHTM, IHMT, Lisbon, Portugal.	ana.tavares@ihmt.unl.pt; SEDias@ihmt.unl.pt	Dias, Sónia/I-7876-2012; Abecasis, Ana/B-6295-2009; Abecasis, Ana/ABF-6657-2020; Couto, Isabel/I-2640-2012; Viveiros, Miguel/A-7326-2008; Machado, Diana/L-7027-2013; Dias, Sónia/AAD-3788-2019; Fronteira, Inês/I-2380-2012	Dias, Sónia/0000-0001-5085-0685; Abecasis, Ana/0000-0002-3903-5265; Abecasis, Ana/0000-0002-3903-5265; Couto, Isabel/0000-0003-3536-2733; Viveiros, Miguel/0000-0001-9676-6251; Machado, Diana/0000-0003-2375-2726; Dias, Sónia/0000-0001-5085-0685; Fronteira, Inês/0000-0003-1406-4585; Tavares, Ana Maria/0000-0002-4393-8387	Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e a Tecnologia - FCT); Global Health and Tropical Medicine Research Center (GHTM) [UID/Multi/04413/2013, PTDC/DTP-EPI/7066/2014]; GHTM, through the project Characterization of Drug-Resistant TB and HIV; Associated Socio-Behavioural Factors Among Migrants in Lisbon, Portugal; FCT [PD/BD/105916/2014, SFRH/BPD/100688/2014]; Investigador FCT programme	Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e a Tecnologia - FCT)(Portuguese Foundation for Science and Technology); Global Health and Tropical Medicine Research Center (GHTM); GHTM, through the project Characterization of Drug-Resistant TB and HIV; Associated Socio-Behavioural Factors Among Migrants in Lisbon, Portugal; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Investigador FCT programme(Portuguese Foundation for Science and Technology)	This study was funded by the Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e a Tecnologia - FCT, www.FCT.pt), through funds to the Global Health and Tropical Medicine Research Center (GHTM - UID/Multi/04413/2013) and through the project MigrantHIV: Genomics, socio-behavioral and clinical data to prevent HIV transmission in migrants: an innovative approach (PTDC/DTP-EPI/7066/2014). This study was supported by funds of the GHTM, through the project Characterization of Drug-Resistant TB and HIV, and Associated Socio-Behavioural Factors Among Migrants in Lisbon, Portugal. AMT and DM were supported by FCT: grants PD/BD/105916/2014 and SFRH/BPD/100688/2014, respectively. ABA was funded by the Investigador FCT programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abgrall S, 2010, B EPIDEMIOL HEBD, V30, P320; Abgrall S, 2010, AIDS, V24, P763, DOI 10.1097/QAD.0b013e3283366747; [Anonymous], 2016, SYST REV MET AN DAT; [Anonymous], 2016, INT MIGR REP 2015; [Anonymous], 2016, SYST REV PROC DAT GR; [Anonymous], 2016, MEDL FACT SHEET; Barratt H, 2009, ELECT BIBLIO DATABAS; Baussano I, 2006, EPIDEMIOL INFECT, V134, P1353, DOI 10.1017/S0950268806006261; Belay M, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.27949; Brindicci G, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9362708; Camoni L, 2013, EUR J PUBLIC HEALTH, V23, P658, DOI 10.1093/eurpub/cks122; Diz S, 2007, INT J TUBERC LUNG D, V11, P769; Domnich A, 2012, EPIDEMIOL BIOSTAT PU, V9, DOI 10.2427/7532; Ospina JE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-158; Ennemoser K, 2015, EUR J INFLAMM, V13, P209, DOI 10.1177/1721727X15618972; European Centre for Disease Prevention and Control (ECDC), 2014, TECHN REP ASS BURD K; Ezsol S, 2009, ENFERM EMERG, V11, P7; Flahaux M.-L., 2016, COMP MIGR STUD, V4, P1, DOI [10.1186/s40878-015-0015-6, DOI 10.1186/S40878-015-0015-6]; Gebremariam MK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-651; Giehl C, 2011, OPEN INFECT DIS J, P21; Girardi E, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/931325; Hacker K, 2015, RISK MANAG HEALTHC P, V8, P175, DOI 10.2147/RMHP.S70173; Hargreaves S, 2016, CLIN MICROBIOL INFEC; International Organization for Migration, 2012, MIGRATION TUBERCULOS; Karo B, 2016, AIDS, V49, P1089; Karo B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-148; Kesselring AM, 2010, ANTIVIR THER, V15, P871, DOI 10.3851/IMP1638; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lewandowski Clare M., 2015, EFFECTS BRIEF MINDFU, V1, P1689, DOI [10.1017/CB09781107415324.004, DOI 10.1017/CB09781107415324.004]; List of countries in Europe, 2016, LIST COUNTRIES EUROP; Llenas-garcia J, 2016, ENFERM INFEC MICR CL, V30, P441; Loos J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174677; Caro-Murillo AM, 2009, ENFERM INFEC MICR CL, V27, P380, DOI 10.1016/j.eimc.2008.10.007; Martin V, 2011, J EPIDEMIOL, V21, P108, DOI 10.2188/jea.JE20100072; Meyssonnier V, 2012, J INFECTION, V64, P589, DOI 10.1016/j.jinf.2012.01.013; Montales MT, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00281; Ortega MEV, 2007, MED CLIN-BARCELONA, V128, P2006; Palmisano L, 2011, BRIEF HIST ANTIRETRO, P44; Pareek M, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0595-5; Parikh R, 2008, INDIAN J OPHTHALMOL, V56, P45, DOI 10.4103/0301-4738.37595; Paulino J, 2016, INT J TUBERC LUNG D, V20, P357, DOI 10.5588/ijtld.15.0430; Pimpin L, 2011, EUR RESPIR J, V38, P1382, DOI 10.1183/09031936.00198410; Podlekareva DN, 2014, EUR RESPIR J, V43, P166, DOI 10.1183/09031936.00138712; Rajamanoharan S, 2004, INT J STD AIDS, V15, P509, DOI 10.1258/0956462041558140; Ramos JM, 2004, ENFERM INFEC MICR CL, V22, P315, DOI 10.1157/13063041; Riccardo F, 2015, INT J ENV RES PUB HE, V12, P11640, DOI 10.3390/ijerph120911640; Rice B, 2013, AIDS, V27, P1151, DOI 10.1097/QAD.0b013e32835e2cb1; Rifes G, 2000, REV PORT PNEUMOL, V9, P195; Rodriguez-Valin E, 2015, REV ESP SALUD PUBLIC, V89, P459, DOI 10.4321/S1135-57272015000500004; Scotto G, 2009, NEW MICROBIOL, V32, P39; Staehelin C, 2003, AIDS, V17, P2237, DOI 10.1097/00002030-200310170-00012; Supervia A, 2015, ARCH BRONCONEUMOL, V51, P2015; van der Werf MJ, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.12.30174; Velasco M, 2008, HIV MED, V9, P227, DOI 10.1111/j.1468-1293.2008.00550.x; [WHO Regional Office for Europe European Centre for Disease Prevention and Control], 2015, TUB SURV MON EUR 201; [WHO Regional Office for Europe European Centre for Disease Prevention and Control], 2017, TUB SURV MON EUR 201; World Health Organization, 2013, MAN TUB HIV COINF CL; World Health Organization (WHO) Regional office for Europe, 2016, MIGR HLTH KEY ISS MI	58	32	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185526	10.1371/journal.pone.0185526	http://dx.doi.org/10.1371/journal.pone.0185526			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957400	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200076
J	Tonussi, RL; Silva, RMD; Magalhaes, AFB; Espigolan, R; Peripolli, E; Olivieri, BF; Feitosal, FLB; Lemos, MVA; Berton, MP; Chiaia, HLJ; Pereira, ASC; Lobo, RB; Bezerra, LAF; Magnabosco, CU; Lourenco, DAL; Aguilar, I; Baldi, F				Tonussi, Rafael Lara; de Oliveira Silva, Rafael Medeiros; Braga Magalhaes, Ana Fabricia; Espigolan, Rafael; Peripolli, Elisa; Olivieri, Bianca Ferreira; Braga Feitosal, Fabieli Loise; Antunes Lemos, Marcos Vinicfus; Berton, Mariana Piatto; Justino Chiaia, Hermenegildo Lucas; Cravo Pereira, Angelica Simone; Lobo, Raysildo Barbosa; Framartino Bezerra, Luiz Antonio; Magnabosco, Claudio de Ulhoa; Lourenco, Daniela Andressa Lino; Aguilar, Ignacio; Baldi, Fernando			Application of single step genomic BLUP under different uncertain paternity scenarios using simulated data	PLOS ONE			English	Article							UNKNOWN-PARENT GROUPS; FULL PEDIGREE; US HOLSTEINS; FINAL SCORE; GENETIC EVALUATION; SIRE EVALUATION; INFORMATION; TRAITS; CATTLE; MODEL	The objective of this study was to investigate the application of BLUP and single step genomic BLUP (ssGBLUP) models in different scenarios of paternity uncertainty with different strategies of scaling the G matrix to match the A(22) matrix, using simulated data for beef cattle. Genotypes, pedigree, and phenotypes for age at first calving (AFC) and weight at 550 days (W550) were simulated using heritabilities based on real data (0.12 for AFC and 0.34 for W550). Paternity uncertainty scenarios using 0, 25, 50, 75, and 100% of multiple sires (MS) were studied. The simulated genome had a total length of 2,333 cM, containing 735,293 biallelic markers and 7,000 QTLs randomly distributed over the 29 BTA. It was assumed that QTLs explained 100% of the genetic variance. For QTL, the amount of alleles per loci randomly ranged from two to four. The BLUP model that considers phenotypic and pedigree data, and the ssGBLUP model that combines phenotypic, pedigree and genomic information were used for genetic evaluations. Four ways of scaling the mean of the genomic matrix (G) to match to the mean of the pedigree relationship matrix among genotyped animals (A(22)) were tested. Accuracy, bias, and inflation were investigated for five groups of animals: ALL = all animals; BULL = only bulls; GEN = genotyped animals; FEM = females; and YOUNG = young males. With the BLUP model, the accuracies of genetic evaluations decreased for both traits as the proportion of unknown sires in the population increased. The EBV accuracy reduction was higher for GEN and YOUNG groups. By analyzing the scenarios for YOUNG (from 0 to 100% of MS), the decrease was 87.8 and 86% for AFC and W550, respectively. When applying the ssGBLUP model, the accuracies of genetic evaluation also decreased as the MS in the pedigree for both traits increased. However, the accuracy reduction was less than those observed for BLUP model. Using the same comparison (scenario 0 to 100% of MS), the accuracies reductions were 38 and 44.6% for AFC and W550, respectively. There were no differences between the strategies for scaling the G matrix for ALL, BULL, and FEM groups under the different scenarios with missing pedigree. These results pointed out that the uninformative part of the A(22) matrix and genotyped animals with paternity uncertainty did not influence the scaling of G matrix. On the basis of the results, it is important to have a G matrix in the same scale of the A(22) matrix, especially for the evaluation of young animals in situations with missing pedigree information. In these situations, the ssGBLUP model is an appropriate alternative to obtain a more reliable and less biased estimate of breeding values, especially for young animals with few or no phenotypic records. For accurate and unbiased genomic predictions with ssGBLUP, it is necessary to assure that the G matrix is compatible with the A(22) matrix, even in situations with paternity uncertainty.	[Tonussi, Rafael Lara; de Oliveira Silva, Rafael Medeiros; Braga Magalhaes, Ana Fabricia; Espigolan, Rafael; Peripolli, Elisa; Olivieri, Bianca Ferreira; Braga Feitosal, Fabieli Loise; Antunes Lemos, Marcos Vinicfus; Berton, Mariana Piatto; Justino Chiaia, Hermenegildo Lucas; Baldi, Fernando] Sch Agr & Veterinarian Sci, Dept Anim Sci, Sao Paulo, Brazil; [Cravo Pereira, Angelica Simone] Fac Anim Sci & Food Engn, Dept Nutr & Anim Prod, Pirassununga, Brazil; [Lobo, Raysildo Barbosa] Natl Assoc Breeders & Researchers ANCP, Ribeirao Preto, Brazil; [Framartino Bezerra, Luiz Antonio] Med Sch Ribeirao Preto, Dept Genet, Ribeirao Preto, Brazil; [Magnabosco, Claudio de Ulhoa] Brazilian Agr Res Corp EMBRAPA, Brasilia, DF, Brazil; [Lourenco, Daniela Andressa Lino] Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA; [Aguilar, Ignacio] Natl Inst Agr Res, Dept Anim Breeding, Las Brujas, Uruguay	Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University System of Georgia; University of Georgia; Instituto Nacional de Investigacion Agropecuaria Uruguay (INIA)	Baldi, F (corresponding author), Sch Agr & Veterinarian Sci, Dept Anim Sci, Sao Paulo, Brazil.	fernandobaldiuy@gmail.com	Baldi, Fernando/E-5492-2012; Aguilar, Ignacio/C-2528-2012; Feitosa, Fabieli L. B./D-4996-2014; Magnabosco, Cláudio Ulhoa/ABC-4494-2021; Magalhães, Ana Fabrícia Braga/GLQ-5906-2022	Baldi, Fernando/0000-0003-4094-2011; Feitosa, Fabieli L. B./0000-0003-4218-0348; Magnabosco, Cláudio Ulhoa/0000-0002-7274-0134; Piatto Berton, Mariana/0000-0001-7129-1990; Aguilar, Ignacio/0000-0002-1038-4752; Peripolli, Elisa/0000-0002-0962-6603; Magalhaes, Ana/0000-0003-2063-6957; Lourenco, Daniela/0000-0003-3140-1002	Sao Paulo Research Foundation (FAPESP) [2013/25910-0, 2011/21241-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by the Sao Paulo Research Foundation (FAPESP), 2013/25910-0, Mr Rafael Lara Tonussi, and Sao Paulo Research Foundation (FAPESP), 2011/21241-0, PhD Fernando Baldi.	Aguilar I, 2011, J ANIM BREED GENET, V128, P422, DOI 10.1111/j.1439-0388.2010.00912.x; Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Aguilar I., 2014, P 10 WORLD C GENETIC; Berry DP, 2016, ANIM FRONT, V6, P32, DOI 10.2527/af.2016-0005; Brito FV, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-80; Cardoso FF, 2003, GENET SEL EVOL, V35, P469, DOI [10.1051/gse:2003035, 10.1186/1297-9686-35-6-469]; Chen CY, 2011, J ANIM SCI, V89, P2673, DOI 10.2527/jas.2010-3555; Chen CY, 2011, J ANIM SCI, V89, P23, DOI 10.2527/jas.2010-3071; Christensen OF, 2012, ANIMAL, V6, P1565, DOI 10.1017/S1751731112000742; Espigolan R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-305; Forni S, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-1; Garrick J. D., 2011, GENET SEL EVOL, V47, P1; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; HENDERSO.CR, 1974, J DAIRY SCI, V57, P963, DOI 10.3168/jds.S0022-0302(74)84993-3; KENNEDY BW, 1981, J DAIRY SCI, V64, P689, DOI 10.3168/jds.S0022-0302(81)82631-8; Koury W, 2010, REV BRAS ZOOTECN, V39, P1015, DOI 10.1590/S1516-35982010000500011; Laureano MMM, 2011, ARQ BRAS MED VET ZOO, V63, P143, DOI 10.1590/S0102-09352011000100022; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Lourenco DAL, 2014, J DAIRY SCI, V97, P3930, DOI 10.3168/jds.2013-7769; Lourenco DAL, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0137-1; Masuda Y, 2016, J DAIRY SCI, V99, P1968, DOI 10.3168/jds.2015-10540; Misztal I, 2013, J ANIM BREED GENET, V130, P252, DOI 10.1111/jbg.12025; Misztal I, 2009, J DAIRY SCI, V92, P4648, DOI 10.3168/jds.2009-2064; Misztal I., 2002, P 7 WORLD C GEN APPL, P19; Misztal I, 2013, POULTRY SCI, V92, P2530, DOI 10.3382/ps.2012-02739; Nietlisbach P, 2016, HEREDITY, V116, P1, DOI 10.1038/hdy.2015.59; Olson KM, 2011, J DAIRY SCI, V94, P2613, DOI 10.3168/jds.2010-3877; Sargolzaei M, 2009, BIOINFORMATICS, V25, P680, DOI 10.1093/bioinformatics/btp045; Snelling WM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r165; Tsuruta S, 2014, J DAIRY SCI, V97, P5814, DOI 10.3168/jds.2013-7821; Tsuruta S, 2013, J DAIRY SCI, V96, P3332, DOI 10.3168/jds.2012-6272; Tsuruta S, 2011, J DAIRY SCI, V94, P4198, DOI 10.3168/jds.2011-4256; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vitezica ZG, 2011, GENET RES, V93, P357, DOI 10.1017/S001667231100022X; WESTELL RA, 1988, J DAIRY SCI, V71, P1310, DOI 10.3168/jds.S0022-0302(88)79688-5; Wiggans GR, 2011, J DAIRY SCI, V94, P3202, DOI 10.3168/jds.2010-3866; Wilkinson S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-45; Yokoo MJ, 2012, ARQ BRAS MED VET ZOO, V64, P91, DOI 10.1590/S0102-09352012000100014	38	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0181752	10.1371/journal.pone.0181752	http://dx.doi.org/10.1371/journal.pone.0181752			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957330	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200003
J	Khoshnood, B; Dacklin, I; Grabbe, C				Khoshnood, Behzad; Dacklin, Ingrid; Grabbe, Caroline			A proteomics approach to identify targets of the ubiquitin-like molecule Urm1 in Drosophila melanogaster	PLOS ONE			English	Article							PROTEIN CONJUGATION; OXIDATIVE STRESS; SULFUR TRANSFER; MODIFIER URM1; REDUCTASE; REGULATOR; SYSTEM; YEAST; HOMEOSTASIS; URMYLATION	By covalently conjugating to target proteins, ubiquitin-like modifiers (UBLs) act as important regulators of target protein localization and activity, thereby playing a critical role in the orchestration of cellular biology. The most ancient and one of the least studied UBLs is Urm1, a dual-function protein that in parallel to performing similar functions as its prokaryotic ancestors in tRNA modification, also has adopted the capacity to conjugate to cellular proteins analogous to ubiquitin and other UBL modifiers. In order to increase the understanding of Urm1 and its role in multicellular organisms, we have used affinity purification followed by mass spectrometry to identify putative targets of Urm1 conjugation (urmylation) at three developmental stages of the Drosophila melanogaster lifecycle. Altogether we have recovered 79 Urm1-interacting proteins in Drosophila, which include the already established Urm1 binding partners Prx5 and Uba4, together with 77 candidate urmylation targets that are completely novel in the fly. Among these, the majority was exclusively identified during either embryogenesis, larval stages or in adult flies. We further present biochemical evidence that four of these proteins are covalently conjugated by Urm1, whereas the fifth verified Urm1-binding protein appears to interact with Urm1 via non-covalent means. Besides recapitulating the previously established roles of Urm1 in tRNA modification and during oxidative stress, functional clustering of the newly identified Urm1-associated proteins further positions Urm1 in protein networks that control other types of cellular stress, such as immunological threats and DNA damage. In addition, the functional characteristics of several of the candidate targets strongly match the phenotypes displayed by Urm1(n123) null animals, including embryonic lethality, reduced fertility and shortened lifespan. In conclusion, this identification of candidate targets of urmylation significantly increases the knowledge of Urm1 and presents an excellent starting point for unravelling the role of Urm1 in the context of a complex living organism.	[Khoshnood, Behzad; Dacklin, Ingrid; Grabbe, Caroline] Umea Univ, Dept Mol Biol, Umea, Sweden	Umea University	Grabbe, C (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	caroline.grabbe@umu.se		Grabbe, Caroline/0000-0002-1758-2217	Swedish Research Council [621-2012-4749]; Swedish Foundation for Strategic Research [ICA08-0035]; Insamlingsstiftelsen for medicinsk forskning vid Umea universitet [Dnr 223-2808-12]; Swedish Foundation for Strategic research (SSF) [ICA08-0035]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Insamlingsstiftelsen for medicinsk forskning vid Umea universitet; Swedish Foundation for Strategic research (SSF)(Swedish Foundation for Strategic Research); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Swedish Research Council, 621-2012-4749, (URL: https://www.vr.se/inenglish.4 12fff4451215cbd83e4800015152.html) to CG; the Swedish Foundation for Strategic Research, ICA08-0035, (URL: http://stratresearch.se/en/) to CG; and Insamlingsstiftelsen for medicinsk forskning vid Umea universitet, Dnr 223-2808-12, (URL:http://stittelse.umu.se/medforsk/) to CG.r We would like to thank several people that made this work possible. First of all those who shared their reagents with us, including Prof. R. Lehmann (Jafracl antibodies) and Prof. T. Preat (pCasper:Crammer-GFP transgenic flies). Secondly, we are highly grateful for the professional help and guidance obtained by the SciLifeLab facility for mass-spectrometry based proteomics in Stockholm/Uppsala, Sweden. We would further like to acknowledge the importance of the Bloomington Drosophila Stock Center (NIH P400D018537) and F1yORF (Zurich ORFeome project) [31] for providing fly stocks. This work was supported by the Swedish Foundation for Strategic research (SSF) (ICA08-0035), The Swedish Research Council (621-2012-4749) and Insamlingsstiftelsen for medicinsk forskning vid Umea universitet (Dnr 223-2808-12).	Ahn HM, 2012, DEV COMP IMMUNOL, V38, P466, DOI 10.1016/j.dci.2012.07.002; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Anjum RS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9163; Barak O, 2003, EMBO J, V22, P6089, DOI 10.1093/emboj/cdg582; Bischof J, 2013, DEVELOPMENT, V140, P2434, DOI 10.1242/dev.088757; Burroughs AM, 2012, FRONT BIOSCI-LANDMRK, V17, P1433, DOI 10.2741/3996; Burroughs AM, 2008, PROTEINS; Campanale JP, 2017, J CELL SCI, V130, P1201, DOI 10.1242/jcs.188599; Cappadocia L, 2018, CHEM REV, V118, P889, DOI 10.1021/acs.chemrev.6b00737; Chiang HS, 2011, FREE RADICAL BIO MED, V51, P688, DOI 10.1016/j.freeradbiomed.2011.05.015; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; DeGennaro M, 2011, DEV CELL, V20, P233, DOI 10.1016/j.devcel.2010.12.007; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.e03-02-0079; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; Humbard MA, 2010, NATURE, V463, P54, DOI 10.1038/nature08659; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Judes A, 2016, MICROB CELL, V3, P423, DOI 10.15698/mic2016.11.539; Judes A, 2015, FEBS LETT, V589, P904, DOI 10.1016/j.febslet.2015.02.024; Kean MJ, 2012, METHODS, V57, P400, DOI 10.1016/j.ymeth.2012.06.002; Khoshnood B, 2016, CELL MOL LIFE SCI, V73, P1939, DOI 10.1007/s00018-015-2121-x; Kongton K, 2014, DEV COMP IMMUNOL, V44, P389, DOI 10.1016/j.dci.2014.01.007; Kwon SY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005969; Laxman S, 2013, CELL, V154, P416, DOI 10.1016/j.cell.2013.06.043; Lee KS, 2009, J BIOL CHEM, V284, P29454, DOI 10.1074/jbc.M109.028027; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Li ZG, 2017, ARCH VIROL, V162, P603, DOI 10.1007/s00705-016-3130-2; Liu X, 2013, CYTOKINE GROWTH F R, V24, P559, DOI 10.1016/j.cytogfr.2013.07.002; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Maupin-Furlow JA, 2014, ANNU REV MICROBIOL, V68, P155, DOI 10.1146/annurev-micro-091313-103447; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Minniti AN, 2009, AGING CELL, V8, P690, DOI 10.1111/j.1474-9726.2009.00521.x; Miranda HV, 2011, P NATL ACAD SCI USA, V108, P4417, DOI 10.1073/pnas.1018151108; Mohan M, 2011, MOL CELL BIOL, V31, P4310, DOI 10.1128/MCB.06092-11; Nakai Y, 2008, J BIOL CHEM, V283, P27469, DOI 10.1074/jbc.M804043200; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Orr WC, 2003, J BIOL CHEM, V278, P26418, DOI 10.1074/jbc.M303095200; Petroski MD, 2011, P NATL ACAD SCI USA, V108, P1749, DOI 10.1073/pnas.1019043108; R Core Team, 2021, R LANGUAGE ENV STAT; Radyuk SN, 2009, BIOCHEM J, V419, P437, DOI 10.1042/BJ20082003; Ranjan N, 2011, J MOL BIOL, V405, P1040, DOI 10.1016/j.jmb.2010.11.040; Rodriguez-Jato S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027479; Roesijadi G, 2007, BIOCHEM BIOPH RES CO, V354, P511, DOI 10.1016/j.bbrc.2007.01.005; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Schlieker CD, 2008, P NATL ACAD SCI USA, V105, P18255, DOI 10.1073/pnas.0808756105; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Schwertman P, 2016, NAT REV MOL CELL BIO, V17, P379, DOI 10.1038/nrm.2016.58; Shigi N, 2012, J BIOL CHEM, V287, P17568, DOI 10.1074/jbc.M112.359844; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Van der Veen AG, 2011, P NATL ACAD SCI USA, V108, P1763, DOI 10.1073/pnas.1014402108; Wang CY, 2001, NAT STRUCT BIOL, V8, P47; Warnes G, 2016, R PACKAGE VERSION 3; Wei HC, 2003, CURR BIOL, V13, P1882, DOI 10.1016/j.cub.2003.09.056; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8	63	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185611	10.1371/journal.pone.0185611	http://dx.doi.org/10.1371/journal.pone.0185611			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953965	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300077
J	Rosas-Umbert, M; Mothe, B; Noguera-Julian, M; Bellido, R; Puertas, MC; Carrillo, J; Rodriguez, C; Perez-Alvarez, N; Cobarsi, P; Gomez, CE; Esteban, M; Jimenez, JL; Garcia, F; Blanco, J; Martinez-Picado, J; Paredes, R; Brander, C				Rosas-Umbert, Miriam; Mothe, Beatriz; Noguera-Julian, Marc; Bellido, Rocio; Puertas, Maria C.; Carrillo, Jorge; Rodriguez, C.; Perez-Alvarez, Nuria; Cobarsi, Patricia; Gomez, Carmen E.; Esteban, Mariano; Luis Jimenez, Jose; Garcia, Felipe; Blanco, Julia; Martinez-Picado, Javier; Paredes, Roger; Brander, Christian			Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B	PLOS ONE			English	Article							HIV-1 VACCINE; THERAPEUTIC IMMUNIZATION; ANTIRETROVIRAL THERAPY; VIRAL RESERVOIR; T-CELLS; EFFICACY; STIMULATION; REMISSION; SELECTION; STEP	The most relevant endpoint in therapeutic HIV vaccination is the assessment of time to viral rebound or duration of sustained control of low-level viremia upon cART treatment cessation. Structured treatment interruptions (STI) are however not without risk to the patient and reliable predictors of viral rebound/control after therapeutic HIV-1 vaccination are urgently needed to ensure patient safety and guide therapeutic vaccine development. Here, we integrated immunological and virological parameters together with viral rebound dynamics after STI in a phase I therapeutic vaccine trial of a polyvalent MVA-B vaccine candidate to define predictors of viral control. Clinical parameters, proviral DNA, host HLA genetics and measures of humoral and cellular immunity were evaluated. A sieve effect analysis was conducted comparing pre-treatment viral sequences to breakthrough viruses after STI. Our results show that a reduced proviral HIV-1 DNA at study entry was independently associated with two virological parameters, delayed HIV-1 RNA rebound (p = 0.029) and lower peak viremia after treatment cessation (p = 0.019). Reduced peak viremia was also positively correlated with a decreased number of HLA class I allele associated polymorphisms in Gag sequences in the rebounding virus population (p = 0.012). Our findings suggest that proviral DNA levels and the number of HLA-associated Gag polymorphisms may have an impact on the clinical outcome of STI. Incorporation of these parameters in future therapeutic vaccine trials may guide refined immunogen design and help conduct safer STI approaches.	[Rosas-Umbert, Miriam; Mothe, Beatriz; Noguera-Julian, Marc; Bellido, Rocio; Puertas, Maria C.; Carrillo, Jorge; Rodriguez, C.; Blanco, Julia; Martinez-Picado, Javier; Paredes, Roger; Brander, Christian] Hosp Germans Trias i Pujol, IrsiCaixa AIDS Res Inst HIVACAT, Badalona, Spain; [Rosas-Umbert, Miriam; Martinez-Picado, Javier; Paredes, Roger] Univ Autonoma Barcelona, Barcelona, Spain; [Mothe, Beatriz; Perez-Alvarez, Nuria; Cobarsi, Patricia; Paredes, Roger] Hosp Germans Trias i Pujol, Lluita SIDA Fdn, Badalona, Spain; [Mothe, Beatriz; Noguera-Julian, Marc; Blanco, Julia; Paredes, Roger; Brander, Christian] Univ VIC & Cent Catalonia, Vic, Spain; [Perez-Alvarez, Nuria] Univ Politecn Cataluna, Barcelona, Spain; [Gomez, Carmen E.; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Luis Jimenez, Jose] Hosp Gregorio Maranon, Madrid, Spain; [Garcia, Felipe] Univ Barcelona, IDIBAPS, Hosp Clin, HIVACAT, Barcelona, Spain; [Blanco, Julia] IGTP, Hlth Sci Res Inst Germans Trias i Pujol, Badalona, Spain; [Martinez-Picado, Javier; Brander, Christian] ICREA, Barcelona, Spain	Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Universitat Politecnica de Catalunya; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); General University Gregorio Maranon Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); ICREA	Brander, C (corresponding author), Hosp Germans Trias i Pujol, IrsiCaixa AIDS Res Inst HIVACAT, Badalona, Spain.; Brander, C (corresponding author), Univ VIC & Cent Catalonia, Vic, Spain.; Brander, C (corresponding author), ICREA, Barcelona, Spain.	cbrander@irsicaixa.es	Gomez, Carmen Elena/K-1940-2014; Jiménez, José Luis/AAK-6193-2020; Martinez-Picado, Javier/G-5507-2012; Perez-Alvarez, Nuria/O-9244-2014; Esteban, Mariano/ABG-5375-2020; Carrillo, Jorge/AAL-9481-2021; , Felipe/F-4242-2014; Noguera-Julian, Marc/F-8651-2016; Blanco, Julià/A-5347-2008; Puertas, Maria/G-3251-2016	Gomez, Carmen Elena/0000-0002-5414-7935; Jiménez, José Luis/0000-0001-6187-6223; Martinez-Picado, Javier/0000-0002-4916-2129; Perez-Alvarez, Nuria/0000-0001-6582-1553; Esteban, Mariano/0000-0003-0846-2827; Carrillo, Jorge/0000-0003-0221-5948; , Felipe/0000-0001-7658-5832; Noguera-Julian, Marc/0000-0002-6194-1395; Blanco, Julià/0000-0002-2225-0217; Puertas, Maria/0000-0002-6750-2318; Mothe, Beatriz/0000-0001-9975-407X; Rosas-Umbert, Miriam/0000-0002-2850-6586	amfAR, The Foundation for AIDS Research (US) [108532-53-RGRL, EC10-153, TRA-094]; RIS [Red Tematica Cooperativa de Grupos de Investigacion en Sida del Fondo de Investigacion Sanitaria (FIS)]; HIVACAT (Catalan Programme for the Development of HIV-1 Vaccines; Ministerio de Economia y Competitividad del Gobierno de Espana [MTM2015-64465-C2-1-R]; Departament d'Economia i Coneixement de la Generalitat de Catalunya [SGR 464]	amfAR, The Foundation for AIDS Research (US); RIS [Red Tematica Cooperativa de Grupos de Investigacion en Sida del Fondo de Investigacion Sanitaria (FIS)](Instituto de Salud Carlos III); HIVACAT (Catalan Programme for the Development of HIV-1 Vaccines; Ministerio de Economia y Competitividad del Gobierno de Espana(Spanish Government); Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya)	This study was partially supported by grants: amfAR, The Foundation for AIDS Research (US) grant number 108532-53-RGRL, EC10-153, TRA-094, RIS [Red Tematica Cooperativa de Grupos de Investigacion en Sida del Fondo de Investigacion Sanitaria (FIS)], HIVACAT (Catalan Programme for the Development of HIV-1 Vaccines, by grant MTM2015-64465-C2-1-R from the Ministerio de Economia y Competitividad del Gobierno de Espana and by 2014 SGR 464 from the Departament d'Economia i Coneixement de la Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2015, AIDS RES HUM RETROV, V31, P36, DOI [10.1089/aid.2014.0236, 10.1089/AID.2014.0236]; Autran B, 2008, AIDS, V22, P1313, DOI 10.1097/QAD.0b013e3282fdce94; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Blanco J, 2004, J LEUKOCYTE BIOL, V76, P804, DOI 10.1189/jlb.0204100; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borducchi EN, 2016, NATURE, V540, P284, DOI 10.1038/nature20583; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Carlson JM, 2012, J VIROL, V86, P13202, DOI 10.1128/JVI.01998-12; Crawford KW, 2012, LANCET INFECT DIS, V12, P550, DOI 10.1016/S1473-3099(12)70134-2; Daucher M, 2008, J VIROL, V82, P4102, DOI 10.1128/JVI.02212-07; de Goede AL, 2013, AIDS, V27, P2679, DOI 10.1097/01.aids.0000433813.67662.92; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Dommaraju K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111334; Edlefsen PT, 2013, CURR OPIN HIV AIDS, V8, P432, DOI 10.1097/COH.0b013e328362db2b; El-Sadr WM, 2006, NEW ENGL J MED, P35522; Gomez CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141456; FISCHER W, 2010, PLOS ONE, V5; Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Henrich TJ, 2014, ANN INTERN MED, V161, P319, DOI 10.7326/M14-1027; Holmes CB, 2010, JAMA-J AM MED ASSOC, V304, P313, DOI 10.1001/jama.2010.993; Hurst J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9495; Jacobson JM, 2006, J INFECT DIS, V194, P623, DOI 10.1086/506364; Janes H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043396; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li JZ, 2016, AIDS, V30, P343, DOI 10.1097/QAD.0000000000000953; Li JZ, 2014, AIDS, V28, P2649, DOI 10.1097/QAD.0000000000000478; Li JZ, 2011, J INFECT DIS, V203, P976, DOI 10.1093/infdis/jiq143; Li JZ, AIDS, V28, P343; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Llano A, 2009, HIV MOL IMMUNOL, V2009, P3, DOI DOI 10.1016/J.M0LIMM.2008.12.019; LLANO A, 2012, RETROVIROLOGY S2, V9, DOI DOI 10.1186/1742-4690-9-S2-P63; Luzuriaga K, 2015, NEW ENGL J MED, V372, P786, DOI 10.1056/NEJMc1413931; Martin E, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0064-1; Martinez-Bonet M, 2015, CLIN INFECT DIS, V61, P1169, DOI 10.1093/cid/civ456; Mothe B, 2015, J ANTIMICROB CHEMOTH, P1; Papagno L, 2011, AIDS, V25, P27, DOI 10.1097/QAD.0b013e328340fe55; Piketty C, 2010, INFECT AGENTS CANCER, V5, P1, DOI [10.1186/1750-9378-5-S1-A59, DOI 10.1186/1750-9378-5-S1-A59]; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Rallon N, 2016, AIDS, V30, P553, DOI 10.1097/QAD.0000000000000966; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Sanchez-Palomino S, 2011, VACCINE, V29, P5250, DOI 10.1016/j.vaccine.2011.05.016; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Syed F, 2009, NAT METHODS, V6, pI; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thompson M, 2016, DNA MVA VACCINATION, P1, DOI [10.1371/journal.pone.0163164, DOI 10.1371/JOURNAL.PONE.0163164]; Topfer A, 2013, J COMPUT BIOL, V20, P113, DOI 10.1089/cmb.2012.0232; Treasure GC, 2016, JAIDS-J ACQ IMM DEF, V72, P310, DOI 10.1097/QAI.0000000000000964; Williams JP, 2014, ELIFE, V3, DOI 10.7554/eLife.03821	53	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184929	10.1371/journal.pone.0184929	http://dx.doi.org/10.1371/journal.pone.0184929			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953921	Green Published, gold			2022-12-27	WOS:000411980300026
J	Welsh, EA; Stewart, PA; Kuenzi, BM; Eschrich, JA				Welsh, Eric A.; Stewart, Paul A.; Kuenzi, Brent M.; Eschrich, James A.			Escape Excel: A tool for preventing gene symbol and accession conversion errors	PLOS ONE			English	Article							NAME ERRORS	Background Microsoft Excel automatically converts certain gene symbols, database accessions, and other alphanumeric text into dates, scientific notation, and other numerical representations. These conversions lead to subsequent, irreversible, corruption of the imported text. A recent survey of popular genomic literature estimates that one-fifth of all papers with supplementary gene lists suffer from this issue. Results Here, we present an open-source tool, Escape Excel, which prevents these erroneous conversions by generating an escaped text file that can be safely imported into Excel. Escape Excel is implemented in a variety of formats (http://www.github.com/pstew/escape_excel), including a command line based Perl script, a Windows-only Excel Add-In, an OS X drag-and-drop application, a simple web-server, and as a Galaxy web environment interface. Test server implementations are accessible as a Galaxy interface (http://apostl.moffitt.org) and simple non-Galaxy web server (http://apostl.moffitt.org:8000/). Conclusions Escape Excel detects and escapes a wide variety of problematic text strings so that they are not erroneously converted into other representations upon importation into Excel. Examples of problematic strings include date-like strings, time-like strings, leading zeroes in front of numbers, and long numeric and alphanumeric identifiers that should not be automatically converted into scientific notation. It is hoped that greater awareness of these potential data corruption issues, together with diligent escaping of text files prior to importation into Excel, will help to reduce the amount of Excel-corrupted data in scientific analyses and publications.	[Welsh, Eric A.; Eschrich, James A.] H Lee Moffitt Canc Ctr & Res Inst, Canc Informat, Tampa, FL 33612 USA; [Stewart, Paul A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL USA; [Kuenzi, Brent M.] H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL USA; [Kuenzi, Brent M.] Univ S Florida, Canc Biol, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Welsh, EA (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Canc Informat, Tampa, FL 33612 USA.	Eric.Welsh@moffitt.org		Kuenzi, Brent/0000-0002-6771-0432	National Cancer Institute Cancer Center Support Grant (CCSG) [P30-CA076292-18]; National Cancer Institute [F99/K00, F99 CA212456]	National Cancer Institute Cancer Center Support Grant (CCSG); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part (EAW) by National Cancer Institute (https://grants.nih.gov/) Cancer Center Support Grant (CCSG) for NCI-designated Cancer Centers, award number P30-CA076292-18, and in part (BMK) by National Cancer Institute F99/K00 Predoctoral to Postdoctoral Transition Award, award number F99 CA212456. Views and opinions of, endorsements by, the author(s) do not reflect those of the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Microsoft, 2015, TEXT NUMB CONV UN NU; Zeeberg BR, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-80; Ziemann M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1044-7	4	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185207	10.1371/journal.pone.0185207	http://dx.doi.org/10.1371/journal.pone.0185207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953918	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300043
J	Cho, GJ; Shim, JY; Ouh, YT; Kim, LY; Lee, TS; Ahn, KH; Hong, SC; Oh, MJ; Kim, HJ; Lee, PR				Cho, Geum Joon; Shim, Jae-Yoon; Ouh, Yung-Taek; Kim, Log Young; Lee, Tae Seon; Ahn, Ki Hoon; Hong, Soon-Cheol; Oh, Min-Jeong; Kim, Hai-Joong; Lee, Pil Ryang			Previous uterine artery embolization increases the rate of repeat embolization in a subsequent pregnancy	PLOS ONE			English	Article							POSTPARTUM HEMORRHAGE; OBSTETRIC HEMORRHAGE; FERTILITY; MANAGEMENT; MORTALITY; OUTCOMES; MENSES	This study aimed to determine the rate of repeat uterine artery embolization (UAE) in women with a previous UAE. Study data were collected from the Korea National Health Insurance Claims Database of the Health Insurance Review and Assessment Service for 2009 - 2013. We enrolled women who had a first delivery in 2009 and a second delivery between 2010 and 2013. Among 226,408 women who had a first delivery in 2009, 296 underwent UAE. A total of 127,506 women had a second delivery between 2010 and 2013. Of 296 women who underwent UAE after the first delivery, 94 had a second delivery between 2010 and 2013. Women with a previous UAE had a higher rate of UAE at the second delivery than women without a previous UAE. Multivariate adjusted analysis showed that a UAE at the first delivery increased the rate of UAE at the second delivery (odds ratio 25.56, 95% confidence interval 9.86 - 66.23). Women with a previous UAE should be appropriately counseled and monitored for the need for a repeat UAE.	[Cho, Geum Joon; Ouh, Yung-Taek; Ahn, Ki Hoon; Hong, Soon-Cheol; Oh, Min-Jeong; Kim, Hai-Joong] Korea Univ, Coll Med, Dept Obstet & Gynecol, Guro Hosp, Seoul, South Korea; [Shim, Jae-Yoon; Lee, Pil Ryang] Univ Ulsan, Asan Med Ctr, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Kim, Log Young; Lee, Tae Seon] Hlth Insurance Review & Assessment Serv Korea, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); University of Ulsan; Asan Medical Center	Oh, MJ (corresponding author), Korea Univ, Coll Med, Dept Obstet & Gynecol, Guro Hosp, Seoul, South Korea.; Shim, JY (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea.	jyshim@amc.seoul.kr; mjohmd@korea.ac.kr	Rhim, Sonny H./W-9532-2019	Ouh, Yung-Taek/0000-0001-5887-4497				Berg CJ, 2010, OBSTET GYNECOL, V116, P1302, DOI 10.1097/AOG.0b013e3181fdfb11; Buzaglo N, 2015, J MATERN-FETAL NEO M, V28, P932, DOI 10.3109/14767058.2014.937698; Descargues G, 2004, HUM REPROD, V19, P339, DOI 10.1093/humrep/deh082; Eller AG, 2011, OBSTET GYNECOL, V117, P331, DOI 10.1097/AOG.0b013e3182051db2; Ford JB, 2007, MED J AUSTRALIA, V187, P391, DOI 10.5694/j.1326-5377.2007.tb01308.x; Fullerton G, 2013, BJOG-INT J OBSTET GY, V120, P621, DOI 10.1111/1471-0528.12120; HALL MH, 1985, BRIT J OBSTET GYNAEC, V92, P732, DOI 10.1111/j.1471-0528.1985.tb01456.x; Hunter LA, 2010, J PERINAT NEONAT NUR, V24, P207, DOI 10.1097/JPN.0b013e3181e8c994; Kang HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-646; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kim JA, 2017, J KOREAN MED SCI, V32, P718, DOI 10.3346/jkms.2017.32.5.718; Kim JY, 2005, STRATEGIES ENHANCE U; King JF, 2004, MED J AUSTRALIA, V181, P413, DOI 10.5694/j.1326-5377.2004.tb06361.x; Oberg AS, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.872; Park BJ., 2002, STRATEGIES IMPROVE V, P118; Pelage JP, 1998, RADIOLOGY, V208, P359, DOI 10.1148/radiology.208.2.9680559; Salomon LJ, 2003, HUM REPROD, V18, P849, DOI 10.1093/humrep/deg168; Sentilhes L, 2010, BJOG-INT J OBSTET GY, V117, P84, DOI 10.1111/j.1471-0528.2009.02381.x; Sentilhes L, 2011, ACTA OBSTET GYN SCAN, V90, P615, DOI 10.1111/j.1600-0412.2011.01119.x; Shim JY, 2006, ACTA OBSTET GYN SCAN, V85, P815, DOI 10.1080/00016340500438652; Shim Jae-Yoon, 2013, Obstet Gynecol Sci, V56, P194, DOI 10.5468/ogs.2013.56.3.194; Sidhu HK, 2010, ACTA OBSTET GYN SCAN, V89, P1096, DOI 10.3109/00016349.2010.481015; StancatoPasik A, 1997, RADIOLOGY, V204, P791, DOI 10.1148/radiology.204.3.9280261; Wright JD, 2010, OBSTET GYNECOL, V115, P1194, DOI 10.1097/AOG.0b013e3181df94e8	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185467	10.1371/journal.pone.0185467	http://dx.doi.org/10.1371/journal.pone.0185467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950018	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000055
J	Hayoz, S; Tiwari, PB; Piszczek, G; Uren, A; Brelidze, TI				Hayoz, Sebastien; Tiwari, Purushottam B.; Piszczek, Grzegorz; Uren, Aykut; Brelidze, Tinatin I.			Investigating cyclic nucleotide and cyclic dinucleotide binding to HCN channels by surface plasmon resonance	PLOS ONE			English	Article							ACTIVATED PACEMAKER CHANNELS; CURRENT I-H; STRUCTURAL BASIS; GATED CHANNELS; SINOATRIAL NODE; CATION CHANNELS; HUMAN PROTEINS; ION-CHANNEL; DI-GMP; CAMP	Hyperpolarization-activated cyclic nucleotide-modulated (HCN) channels control cardiac and neuronal rhythmicity. HCN channels contain cyclic nucleotide-binding domain (CNBD) in their C-terminal region linked to the pore-forming transmembrane segment with a Clinker. The C-linker couples the conformational changes caused by the direct binding of cyclic nucleotides to the HCN pore opening. Recently, cyclic dinucleotides were shown to antagonize the effect of cyclic nucleotides in HCN4 but not in HCN2 channels. Based on the structural analysis and mutational studies it has been proposed that cyclic dinucleotides affect HCN4 channels by binding to the C-linker pocket (CLP). Here, we first show that surface plasmon resonance (SPR) can be used to accurately measure cyclic nucleotide binding affinity to the C-linker/CNBD of HCN2 and HCN4 channels. We then used SPR to investigate cyclic dinucleotide binding in HCN channels. To our surprise, we detected no binding of cyclic dinucleotides to the isolated monomeric C-linker/CNBDs of HCN4 channels with SPR. The binding of cyclic dinucleotides was further examined with isothermal calorimetry (ITC), which indicated no binding of cyclic dinucleotides to both monomeric and tetrameric C-linker/CNBDs of HCN4 channels. Taken together, our results suggest that interaction of the C-linker/CNBD with other parts of the channel is necessary for cyclic-dinucleotide binding in HCN4 channels.	[Hayoz, Sebastien; Brelidze, Tinatin I.] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA; [Tiwari, Purushottam B.; Uren, Aykut] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Piszczek, Grzegorz] NHLBI, Biophys Core, NIH, Bldg 10, Bethesda, MD 20892 USA	Georgetown University; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Brelidze, TI (corresponding author), Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA.	tib5@georgetown.edu	Piszczek, Grzegorz/GYU-2029-2022	Brelidze, Tinatin/0000-0003-3046-8184	Georgetown University and Toulmin Pilot Award from Georgetown University; National Cancer Institute [P30CA51008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL000338] Funding Source: NIH RePORTER	Georgetown University and Toulmin Pilot Award from Georgetown University; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by startup funds provided by Georgetown University and Toulmin Pilot Award from Georgetown University (T.I.B.). The authors thank the Biacore Molecular Interaction Shared Resource at the Lombardi Comprehensive Cancer Center (Georgetown University), which is supported by a grant P30CA51008 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto M, 2014, J BIOL CHEM, V289, P22205, DOI 10.1074/jbc.M114.572164; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bankston JR, 2012, P NATL ACAD SCI USA, V109, P7899, DOI 10.1073/pnas.1201997109; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Campbell CT, 2007, BIOMATERIALS, V28, P2380, DOI 10.1016/j.biomaterials.2007.01.047; Carlson AE, 2013, J GEN PHYSIOL, V141, P347, DOI 10.1085/jgp.201210900; Chow SS, 2012, J BIOL CHEM, V287, P600, DOI 10.1074/jbc.M111.269563; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; DeBerg HA, 2016, J BIOL CHEM, V291, P371, DOI 10.1074/jbc.M115.696450; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Fivash M, 1998, CURR OPIN BIOTECH, V9, P97, DOI 10.1016/S0958-1669(98)80091-8; Goldschen-Ohm MP, 2016, ELIFE, V5, DOI 10.7554/eLife.20797; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; Nguyen HH, 2015, SENSORS-BASEL, V15, P10481, DOI 10.3390/s150510481; Ingram SL, 1996, J PHYSIOL-LONDON, V492, P97, DOI 10.1113/jphysiol.1996.sp021292; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Jorgensen TJ, 2009, J MOL RECOGNIT, V22, P446, DOI 10.1002/jmr.962; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Komagiri Y, 2007, BIOMED RES-TOKYO, V28, P177, DOI 10.2220/biomedres.28.177; Kwan DCH, 2012, J GEN PHYSIOL, V140, P279, DOI 10.1085/jgp.201210838; Lee CH, 2017, CELL, V168, P111, DOI 10.1016/j.cell.2016.12.023; Liao Z, 2012, J GEN PHYSIOL, V140, P557, DOI 10.1085/jgp.201210858; Liao ZD, 2010, J GEN PHYSIOL, V136, P247, DOI 10.1085/jgp.201010488; Lolicato M, 2014, NAT CHEM BIOL, V10, P457, DOI [10.1038/NCHEMBIO.1521, 10.1038/nchembio.1521]; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Malmqvist M, 1999, BIOCHEM SOC T, V27, P335, DOI 10.1042/bst0270335; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Moller S, 2014, ACS CHEM BIOL, V9, P1128, DOI 10.1021/cb400904s; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Ng LCT, 2016, STRUCTURE, V24, P1629, DOI 10.1016/j.str.2016.06.024; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; Puljung MC, 2014, P NATL ACAD SCI USA, V111, P9816, DOI 10.1073/pnas.1405371111; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Saponaro A, 2014, P NATL ACAD SCI USA, V111, P14577, DOI 10.1073/pnas.1410389111; Shi WM, 1999, CIRC RES, V85, pE1; Taraska JW, 2009, P NATL ACAD SCI USA, V106, P16227, DOI 10.1073/pnas.0905207106; Vargas G, 2002, J MEMBRANE BIOL, V188, P115, DOI 10.1007/s00232-001-0178-y; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Wu SJ, 2011, BIOPHYS J, V100, P1226, DOI 10.1016/j.bpj.2011.01.034; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhao HY, 2015, METHODS, V76, P137, DOI 10.1016/j.ymeth.2014.11.012; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	57	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185359	10.1371/journal.pone.0185359	http://dx.doi.org/10.1371/journal.pone.0185359			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950029	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000042
J	Karandrea, S; Yin, HQ; Liang, XM; Slitt, AL; Heart, EA				Karandrea, Shpetim; Yin, Huquan; Liang, Xiaomei; Slitt, Angela L.; Heart, Emma A.			Thymoquinone ameliorates diabetic phenotype in Diet-Induced Obesity mice via activation of SIRT-1-dependent pathways	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; PANCREATIC BETA-CELLS; INSULIN-RESISTANCE; NIGELLA-SATIVA; TOXICOLOGICAL PROPERTIES; SIRT1; DYSLIPIDEMIA; AMPK; BIOAVAILABILITY; INFLAMMATION	Thymoquinone, a natural occurring quinone and the main bioactive component of plant Nigella sativa, undergoes intracellular redox cycling and re-oxidizes NADH to NAD(+). TQ administration (20 mg/kg/bw/day) to the Diet-Induced Obesity (DIO) mice reduced their diabetic phenotype by decreasing fasting blood glucose and fasting insulin levels, and improved glucose tolerance and insulin sensitivity as evaluated by oral glucose and insulin tolerance tests (OGTT and ITT). Furthermore, TQ decreased serum cholesterol levels and liver triglycerides, increased protein expression of phosphorylated Akt, decreased serum levels of inflammatory markers resistin and MCP-1, and decreased NADH/NAD(+) ratio. These changes were paralleled by an increase in phosphorylated SIRT-1 and AMPKa in liver and phosphorylated SIRT-1 in skeletal muscle. TQ also increased insulin sensitivity in insulin-resistant HepG2 cells via a SIRT-1-dependent mechanism. These findings are consistent with the TQ-dependent re-oxidation of NADH to NAD(+), which stimulates glucose and fatty acid oxidation and activation of SIRT-1-dependent pathways. Taken together, these results demonstrate that TQ ameliorates the diabetic phenotype in the DIO mouse model of type 2 diabetes.	[Karandrea, Shpetim; Yin, Huquan; Liang, Xiaomei; Heart, Emma A.] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Slitt, Angela L.] Univ Rhode Isl, Dept Pharmaceut Sci, Kingston, RI 02881 USA	State University System of Florida; University of South Florida; University of Rhode Island	Heart, EA (corresponding author), Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	eheart@health.usf.edu			National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK-098747]; American Diabetes Association [7-12- BS-073]; Graduate Student Success Fellowship (University of South Florida)	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); Graduate Student Success Fellowship (University of South Florida)	The work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK-098747 and American Diabetes Association Grant No. 7-12- BS-073 (E. A. Heart). Shpetim Karandrea was supported by the Graduate Student Success Fellowship (University of South Florida).	Al-Ali Amein, 2008, J Ayub Med Coll Abbottabad, V20, P25; Ali BH, 2003, PHYTOTHER RES, V17, P299, DOI 10.1002/ptr.1309; Alkharfy KM, 2015, EUR J DRUG METAB PH, V40, P319, DOI 10.1007/s13318-014-0207-8; [Anonymous], 2016, P EUR WIR EW MAY, DOI DOI 10.1109/WCNC.2016.7564893; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Bergman RN, 2005, HORM RES, V64, P8, DOI 10.1159/000089312; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Coughlan KA, 2014, DIABET METAB SYND OB, V7, P241, DOI 10.2147/DMSO.S43731; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Dula SB, 2010, CELL CALCIUM, V48, P133, DOI 10.1016/j.ceca.2010.07.007; Elmowafy M, 2016, AAPS PHARMSCITECH, V17, P663, DOI 10.1208/s12249-015-0391-0; Fararh KM, 2005, RES VET SCI, V79, P219, DOI 10.1016/j.rvsc.2005.01.001; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Gaikwad A, 2001, J BIOL CHEM, V276, P22559, DOI 10.1074/jbc.M101053200; Gray JP, 2016, TOXICOL LETT, V262, P1, DOI 10.1016/j.toxlet.2016.08.021; Gray JP, 2016, AM J PHYSIOL-ENDOC M, V310, pE394, DOI 10.1152/ajpendo.00250.2015; Heart E, 2012, TOXICOL APPL PHARM, V258, P216, DOI 10.1016/j.taap.2011.11.002; Ido Y, 2007, ANTIOXID REDOX SIGN, V9, P931, DOI 10.1089/ars.2007.1630; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Khader M, 2009, FOOD CHEM TOXICOL, V47, P129, DOI 10.1016/j.fct.2008.10.019; Kitada M, 2013, DIABETES METAB J, V37, P315, DOI 10.4093/dmj.2013.37.5.315; Krauss RM, 2004, MED CLIN N AM, V88, P897, DOI 10.1016/j.mcna.2004.04.004; Le PM, 2004, J ETHNOPHARMACOL, V94, P251, DOI 10.1016/j.jep.2004.04.030; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Luo XT, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/512618; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Neter J, 1992, APPL LINEAR STAT MOD; Nomura S, 2000, CLIN EXP IMMUNOL, V121, P437, DOI 10.1046/j.1365-2249.2000.01324.x; Pari L, 2009, LIFE SCI, V85, P830, DOI 10.1016/j.lfs.2009.10.021; Petro AE, 2004, METABOLISM, V53, P454, DOI 10.1016/j.metabol.2003.11.018; Piemonti L, 2009, DIABETES CARE, V32, P2105, DOI 10.2337/dc09-0763; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Rchid H, 2004, FUND CLIN PHARMACOL, V18, P525, DOI 10.1111/j.1472-8206.2004.00275.x; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; S R, 2013, RHEUMATOL CURR RES, V3, P115, DOI DOI 10.4172/2161-1149.1000115; Sankaranarayanan C, 2011, CHEM-BIOL INTERACT, V190, P148, DOI 10.1016/j.cbi.2011.02.029; Santilli F, 2016, THROMB HAEMOSTASIS, V116, P1089, DOI 10.1160/TH16-06-0471; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Srinivasan K, 2007, INDIAN J MED RES, V125, P451; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y; Tateya S, 2010, ENDOCRINOLOGY, V151, P971, DOI 10.1210/en.2009-0926; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Wu JZ, 2016, DIABET METAB SYND OB, V9, P145, DOI 10.2147/DMSO.S106087; Yan LJ, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/137919; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zhang J, 2007, J BIOL CHEM, V282, P34356, DOI 10.1074/jbc.M706644200; Zhu D, 2017, RSC ADV, V7, P1363, DOI 10.1039/c6ra25901d; Zhu D, 2015, J AGR FOOD CHEM, V63, P10903, DOI 10.1021/acs.jafc.5b04533; Zietz B, 2005, DIABETES OBES METAB, V7, P570, DOI 10.1111/j.1463-1326.2004.00436.x	54	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185374	10.1371/journal.pone.0185374	http://dx.doi.org/10.1371/journal.pone.0185374			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950020	Green Published, gold, Green Submitted			2022-12-27	WOS:000411671000043
J	Park, JY; Kim, SG; Kim, J; Han, SJ; Oh, S; Choi, JM; Lim, JH; Chung, H; Jung, HC				Park, Jae Yong; Kim, Sang Gyun; Kim, Jung; Han, Seung Jun; Oh, Sooyeon; Choi, Ji Min; Lim, Joo Hyun; Chung, Hyunsoo; Jung, Hyun Chae			Risk factors for early metachronous tumor development after endoscopic resection for early gastric cancer	PLOS ONE			English	Article							HELICOBACTER-PYLORI ERADICATION; SUBMUCOSAL DISSECTION; CLINICAL-OUTCOMES; NEOPLASMS; SURGERY	Background Metachronous gastric tumor (MGT) is one of major concerns after endoscopic submucosal dissection (ESD) for early gastric cancer (EGC). Optimal follow-up strategy has not been yet well-established. The aim of this study was to identify the different clinical features of the patients according to the time interval to development of MGT. Methods Among 1,780 consecutive patients with EGC who underwent ESD between 2005 and 2014, 115 patients with MGT were retrospectively reviewed. MGT was defined as secondary gastric cancer or dysplasia detected > 1 year after initial ESD. Clinicopathological factors associated with early development of MGT were evaluated. Results The median interval to development of MGT was 37 months. In univariate analysis, the median interval to MGT was shorter if EGC lesion was non-elevated type (39.4 vs 57.0 months, p = 0.011), or synchronous primary lesion was absent (39.8 vs 51.4 months, p = 0.050). In multivariate Cox's proportional hazards analysis, the hazard ratios for early occurrence of MGT were 1.966 (95% CI: 1.141 -3.386, p = 0.015) and 1.911 (95% CI: 1.163 - 3.141, p = 0.011), respectively. There was no significant difference in overall survival after diagnosis of MGT between the early occurrence group and the late occurrence group. Conclusions Non-elevated gross type and absence of synchronous gastric tumor were independent risk factors for early development of MGT. Meticulous endoscopic inspection is especially important for the detection of MGT during the early follow-up period in patients with these initial tumor characteristics.	[Park, Jae Yong] Chung Ang Univ Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Sang Gyun; Kim, Jung; Han, Seung Jun; Oh, Sooyeon; Chung, Hyunsoo; Jung, Hyun Chae] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Sang Gyun; Kim, Jung; Han, Seung Jun; Oh, Sooyeon; Chung, Hyunsoo; Jung, Hyun Chae] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Choi, Ji Min; Lim, Joo Hyun] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Healthcare Res Inst, Dept Internal Med, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, SG (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Kim, SG (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.	harley1333@hanmail.net	Chung, Hyunsoo/AAD-3634-2020	Chung, Hyunsoo/0000-0001-5159-357X; Kim, Sang Gyun/0000-0003-1799-9028	Promising-Pioneering Researcher Program through Seoul National University	Promising-Pioneering Researcher Program through Seoul National University	This work was supported by Promising-Pioneering Researcher Program through Seoul National University in 2015 to JYP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2011, BRIT J SURG, V98, P255, DOI 10.1002/bjs.7310; BEDIKIAN AY, 1984, J CLIN ONCOL, V2, P305, DOI 10.1200/JCO.1984.2.4.305; Boda T, 2014, GASTROENT RES PRACT, V2014; Choi IJ, 2014, CLIN ENDOSC, V47, P497, DOI 10.5946/ce.2014.47.6.497; Choi Il Ju, 2009, Korean J Gastroenterol, V54, P67; Choi J, 2015, SURG ENDOSC, V29, P1223, DOI 10.1007/s00464-014-3800-7; Choi MK, 2013, SURG ENDOSC, V27, P4250, DOI 10.1007/s00464-013-3030-4; Chung IK, 2009, GASTROINTEST ENDOSC, V69, P1228, DOI 10.1016/j.gie.2008.09.027; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Folli S, 2001, JPN J CLIN ONCOL, V31, P495, DOI 10.1093/jjco/hye107; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Gotoda Takuji, 2000, Gastric Cancer, V3, P219, DOI 10.1007/PL00011720; Han JS, 2011, SCAND J GASTROENTERO, V46, P1099, DOI 10.3109/00365521.2011.591427; Hosokawa O, 2002, ENDOSCOPY, V34, P469, DOI 10.1055/s-2002-32007; Jung DH, 2013, SURG ENDOSC, V27, P3690, DOI 10.1007/s00464-013-2947-y; Kang HY, 2010, SURG ENDOSC, V24, P509, DOI 10.1007/s00464-009-0614-0; Kim SG, 2017, GUT LIVER, V11, P87, DOI 10.5009/gnl15549; Kim YG, 2014, J GASTRIC CANCER, V14, P129, DOI 10.5230/jgc.2014.14.2.129; Kwon YH, 2014, ALIMENT PHARM THER, V39, P609, DOI 10.1111/apt.12633; Lee JH, 2016, SURG ENDOSC, V30, P430, DOI 10.1007/s00464-015-4215-9; Lee YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164339; Lim JH, 2015, GASTRIC CANCER, V18, P817, DOI 10.1007/s10120-014-0438-z; Nakajima Takeshi, 2006, Gastric Cancer, V9, P93, DOI 10.1007/s10120-006-0372-9; Pyo JH, 2016, AM J GASTROENTEROL, V111, P240, DOI 10.1038/ajg.2015.427; Sano T, 2011, GASTRIC CANCER, V14, P97, DOI 10.1007/s10120-011-0040-6; Sasaki S, 2011, ONCOL LETT, V2, P217, DOI 10.3892/ol.2010.231; Seo JH, 2010, DIGESTION, V81, P35, DOI 10.1159/000235921; TATSUTA M, 1979, CANCER, V43, P317, DOI 10.1002/1097-0142(197901)43:1<317::AID-CNCR2820430146>3.0.CO;2-F; Watari J, 2012, INT J CANCER, V130, P2349, DOI 10.1002/ijc.26275; Yoon H, 2016, GUT LIVER, V10, P228, DOI 10.5009/gnl14472; Yoon H, 2013, SURG ENDOSC, V27, P1561, DOI 10.1007/s00464-012-2627-3; Yoon SB, 2016, GASTROINTEST ENDOSC, V83, P1176, DOI 10.1016/j.gie.2015.10.024	33	9	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185501	10.1371/journal.pone.0185501	http://dx.doi.org/10.1371/journal.pone.0185501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950014	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000060
J	Vaccher, SJ; Grulich, AE; Haire, BG; Conway, DP; Poynten, IM; Ooi, C; Foster, R; Templeton, DJ; Zablotska, IB				Vaccher, Stefanie J.; Grulich, Andrew E.; Haire, Bridget G.; Conway, Damian P.; Poynten, Isobel M.; Ooi, Catriona; Foster, Rosalind; Templeton, David J.; Zablotska, Iryna B.		PRELUDE Study Team	Validation of participant eligibility for preexposure prophylaxis: Baseline data from the PRELUDE demonstration project	PLOS ONE			English	Article							AUSTRALIAN HOMOSEXUAL-MEN; HIV-INFECTION; RISK; PREVENTION; TRIAL; SEX	Background In Australia, pre-exposure prophylaxis (PrEP) is targeted to individuals at high risk for HIV infection. We describe the HIV risk profile and characteristics of PRELUDE participants, and evaluate the population validity of the sample in representing high-risk gay and bisexual men (GBM) eligible for PrEP. Methods PRELUDE is an on-going, open-label, single-arm observational study. Participants were identified in clinics and screened for eligibility using a paper-based risk assessment tool which followed the New South Wales (NSW) PrEP guidelines. Selection was validated using an independent online behavioural survey, completed by study participants upon enrolment. Demographic information was analysed using descriptive statistics, and kappa tests were used to determine agreement between reporting of high-risk practices in the risk assessment and behavioural survey. Results During 2014 +/- 15, 471 individuals were targeted for enrolment; 341 were assessed for PrEP eligibility and 313 were enrolled. Of these, 303 (97%) identified as GBM. Overall, 85% of GBM met at least one high-risk criterion; 68% reported receptive intercourse with an HIVpositive or unknown status casual male partner, and 37% reported methamphetamine use in the three months preceding enrolment. The remaining 15% were enrolled based on medium-risk behaviours, or at the clinicians' discretion. We found an 82% total agreement between self-reported high-risk behaviour and clinicians' categorisation of GBM as being at high risk for HIV based on PrEP eligibility criteria. Conclusions Behavioural eligibility criteria used by clinicians successfully identified individuals at high risk for HIV infection. This targeted approach ensures that the greatest public health and HIV prevention benefits can be derived in a setting without universal access to PrEP.	[Vaccher, Stefanie J.; Grulich, Andrew E.; Haire, Bridget G.; Conway, Damian P.; Poynten, Isobel M.; Foster, Rosalind; Templeton, David J.; Zablotska, Iryna B.] UNSW Sydney, Kirby Inst, Kensington, NSW, Australia; [Conway, Damian P.] Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [Ooi, Catriona] Western Sydney Sexual Hlth Ctr, Parramatta, NSW, Australia; [Foster, Rosalind] Northern Sydney Sexual Hlth, Clin 16, St Leonards, NSW, Australia; [Templeton, David J.] Univ Sydney, Sydney Local Hlth Dist & Cent Clin Sch, RPA Sexual Hlth, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute; University of Sydney	Vaccher, SJ; Zablotska, IB (corresponding author), UNSW Sydney, Kirby Inst, Kensington, NSW, Australia.	svaccher@kirby.unsw.edu.au; Izablotska@kirby.unsw.edu.au	Ooi, Catriona/AAO-2238-2020; Vaccher, Stefanie/J-8808-2019; Conway, Damian Patrick/F-2789-2012; Haire, Bridget Gabrielle/H-8292-2019	Vaccher, Stefanie/0000-0001-5170-4110; Conway, Damian Patrick/0000-0003-3316-2199; Haire, Bridget Gabrielle/0000-0002-0657-9610; Templeton, David/0000-0003-2157-9587	New South Wales (NSW) Ministry of Health	New South Wales (NSW) Ministry of Health	The study is funded by the New South Wales (NSW) Ministry of Health (http://www.health.nsw.gov.au/Pages/default.aspx). Gilead Sciences Inc (http://www.gilead.com/) is providing an in-kind supply of the study medication, Truvada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHM, 2015, AUSTR COMM US PUBL H; Baeten J, 2016, INTEGRATED DELIVERY; Bekker LG, 2016, S AFR J HIV MED, V17, DOI 10.4102/sajhivmed.v17i1.455; Caceres CF, 2015, J INT AIDS SOC, V18, P5, DOI [10.7448/IAS.18.4.19949, 10.7448/IAS.18.4.20527]; Carnegie NB, 2015, JAIDS-J ACQ IMM DEF, V69, P119, DOI 10.1097/QAI.0000000000000555; Chan PA, 2015, AIDS PATIENT CARE ST, V29, P597, DOI 10.1089/apc.2015.0113; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cremin I, 2015, AIDS, V29, P733, DOI 10.1097/QAD.0000000000000591; Dolling DI, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1286-4; EACS. EACS guidelines, 2015, EACS GUID; FDA, 2012, FDA APPR 1 DRUG RED; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grulich AE, 2015, HIV TRANSMISSION MAL; Haire B., 2015, HIV AIDS AUCKL, P241; Hull P, 2016, GAY COMM PER SURV SY; Jin FY, 2010, JAIDS-J ACQ IMM DEF, V53, P144, DOI 10.1097/QAI.0b013e3181b48f33; Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liu AY, 2015, JAMA INTERN MED, V176, P79; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Pharmaceutical Benefits Advisory Committee, 2016, PBAC OUTC 1 TIM DEC; Poynten IM, 2010, HIV MED, V11, P635, DOI 10.1111/j.1468-1293.2010.00833.x; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Spinner CD, 2016, INFECTION, V44, P151, DOI 10.1007/s15010-015-0850-2; Templeton DJ, 2009, AIDS, V23, P2347, DOI 10.1097/QAD.0b013e32833202b8; The Kirby Institute, 2016, HIV VIR HEP SEX TRAN; Therapeutic Goods Administration, TRUVADA TEN DIS FUM; US Public Health Service, 2015, PREEXP PROPH PREV HI; Vaccher S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012179; Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778; Wilton J, 2015, HIV AIDS-RES PALLIAT, V7, P125, DOI 10.2147/HIV.S50025; World Health Organization, 2015, GUID WHEN START ANT; Zablotska I., NSW PRESP GUID CLIN; Zablotska I, 2016, AUSTR EPIC NSW EVID; Zablotska IB, 2016, SEX HLTH	38	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185398	10.1371/journal.pone.0185398	http://dx.doi.org/10.1371/journal.pone.0185398			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950022	gold, Green Submitted, Green Published			2022-12-27	WOS:000411671000048
J	Wang, T; Zhu, XH; Dai, F; Li, CF; Huang, DK; Fang, ZH; Zhang, Q; Lu, YX				Wang, Ting; Zhu, Xiaohuan; Dai, Fang; Li, Chaofei; Huang, Dake; Fang, Zhaohui; Zhang, Qiu; Lu, Yunxia			Effects of a standard high-fat diet with or without multiple deficiencies on bone parameters in ovariectomized mature rat	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; INSULIN-RESISTANCE; MINERAL DENSITY; BODY-WEIGHT; OSTEOPOROSIS; MICE; MASS; TURNOVER; OBESITY; MODEL	The aim of this study was to determine the effects of a standard high fat diet (D12451) with or without vitamin D3, phosphorus, and calcium (i.e., high-fat diet [HFD] or high-fat deficient diet [HFDD]) on the bone parameters of ovariectomized female rats. Six-month-old of female Sprauge Dawley (SD) rats were randomly divided into six study groups: sham operation with standard chow diet (SSCD), sham operation with a HFD (SHFD), sham operation with a HFDD (SHFDD), ovariectomized (OVX), OVX with a HFD (OVX-HFD), and OVX with a HFDD (OVX-HFDD). A bilateral ovariectomy was administered to the OVX, OVX-HFD, and OVX-HFDD rats, while the SSCD, SHFD, and SHFDD rats were only given a laparotomy. Multiple analyses concerning the glucose and insulin tolerance, structure, bone strength, bone matrix, and mineralization of the rats were conducted in order to produce a detailed characterization of the effects of a HFD and a HFDD on postmenopausal osteoporotic rats. Seven months of HFD and HFDD feeding resulted in obesity and insulin resistance in female SD rats. A standard HFD increased the bone calcium content and bone strength of OVX rats. Conversely, the serum N-mid osteocalcin (N-MID-OT) and tartrateresistant acid phosphatase (TRAP) levels in the OVX-HFDD group were increased, accompanied by a clear decrease in the bone mineral density (BMD), bone mineral content (BMC), bone calcium and bone strength, as well as reduced osteocalcin expression. A HFDD weakened the activity of the osteoblasts while aggravating bone loss and decreasing bone strength in ovariectomized rats, which may be due to the calcium, phosphorus and vitamin D3 deficiencies in the diet.	[Wang, Ting; Zhu, Xiaohuan; Dai, Fang; Zhang, Qiu] Anhui Med Univ, Affiliated Hosp 1, Dept Endocrinol, Hefei, Anhui, Peoples R China; [Li, Chaofei; Lu, Yunxia] Anhui Med Univ, Coll Basic Med, Dept Biochem & Mol Biol, Hefei, Anhui, Peoples R China; [Huang, Dake; Lu, Yunxia] Anhui Med Univ, Coll Basic Med, Comprehens Lab, Hefei, Anhui, Peoples R China; [Fang, Zhaohui] Anhui Univ Tradit Chinese Med, Affilliated Hosp 1, Dept Endocrinol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui University of Chinese Medicine	Zhang, Q (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Endocrinol, Hefei, Anhui, Peoples R China.; Lu, YX (corresponding author), Anhui Med Univ, Coll Basic Med, Dept Biochem & Mol Biol, Hefei, Anhui, Peoples R China.; Lu, YX (corresponding author), Anhui Med Univ, Coll Basic Med, Comprehens Lab, Hefei, Anhui, Peoples R China.	aynfmkqz87@163.com; wwwdluyx@sina.com	Lu, Yunxia/AAU-6408-2021	Lu, Yunxia/0000-0002-8739-7789				Andreollo NA, 2012, ABCD-ARQ BRAS CIR DI, V25, P49, DOI 10.1590/S0102-67202012000100011; Baek K, 2014, J CELL PHYSIOL, V229, P640, DOI 10.1002/jcp.24487; Beranger GE, 2014, ENDOCRINOLOGY, V155, P1340, DOI 10.1210/en.2013-1688; Bruyere O, 2007, CURR MED RES OPIN, V23, P1939, DOI 10.1185/030079907X219562; Chen X, 2018, CONNECT TISSUE RES, V59, P99, DOI 10.1080/03008207.2017.1290085; Choudhary D, 2017, BIOMED PHARMACOTHER, V92, P757, DOI 10.1016/j.biopha.2017.05.120; El Wakf AM, 2014, CYTOTECHNOLOGY, V66, P335, DOI 10.1007/s10616-013-9580-4; Fisher JE, 2012, BONE, V50, P1332, DOI 10.1016/j.bone.2012.03.004; Garcia-Gavilan JF, 2017, CLIN NUTR; Gautam J, 2014, BRIT J NUTR, V111, P1811, DOI 10.1017/S0007114514000051; Gilsanz V, 2009, J CLIN ENDOCR METAB, V94, P3387, DOI 10.1210/jc.2008-2422; Gordon RR, 2008, MAMM GENOME, V19, P163, DOI 10.1007/s00335-008-9095-z; Govindarajan P, 2014, AM J PATHOL, V184, P765, DOI 10.1016/j.ajpath.2013.11.011; Halade GV, 2010, J NUTR BIOCHEM, V21, P1162, DOI 10.1016/j.jnutbio.2009.10.002; Iida Tadayuki, 2012, Hiroshima Journal of Medical Sciences, V61, P23; Iwaniec UT, 2009, BONE, V44, P404, DOI 10.1016/j.bone.2008.10.058; Kaivosoia SM, 2008, METABOLISM, V57, P1052, DOI 10.1016/j.metabol.2008.03.007; Kurrat A, 2015, MOL NUTR FOOD RES, V59, P2407, DOI 10.1002/mnfr.201500240; Lee Y. H. D., 2007, SMJ Singapore Medical Journal, V48, P1117; Lin TH, 2016, ACTA BIOMATER, V41, P273, DOI 10.1016/j.actbio.2016.05.038; Lu YX, 2013, LIFE SCI, V92, P1165, DOI 10.1016/j.lfs.2013.05.002; Lv S, 2010, EXP THER MED, V1, P603, DOI 10.3892/etm_00000095; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; Melhus G, 2010, CALCIFIED TISSUE INT, V87, P77, DOI 10.1007/s00223-010-9371-2; Nieves JW, 2005, AM J CLIN NUTR, V81, p1232S; Ok HM, 2015, CALCIFIED TISSUE INT, V97, P624, DOI 10.1007/s00223-015-0057-7; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Russell AL, 2017, HORM METAB RES, V49, P457, DOI 10.1055/s-0043-108250; Sahni S, 2015, CURR OSTEOPOROS REP, V13, P245, DOI 10.1007/s11914-015-0272-1; Shanbhogue VV, 2016, J CLIN ENDOCR METAB, V101, P3114, DOI 10.1210/jc.2016-1726; Simpson ER, 2005, ENDOCR REV, V26, P322, DOI 10.1210/er.2004-0020; Sugimoto M, 2013, BONE, V52, P181, DOI 10.1016/j.bone.2012.09.031; Tonks KT, 2017, J CLIN ENDOCR METAB, V102, P1112, DOI 10.1210/jc.2016-3282; Watt J, 2015, TOXICOLOGY, V331, P66, DOI 10.1016/j.tox.2015.03.006; Wu J, 2017, ACTA PHARM SIN  0817; Zaidi M, 2012, ENDOCRINOLOGY, V153, P2070, DOI 10.1210/en.2012-1022; Zhang YY, 2015, INT J CLIN EXP MED, V8, P16352	37	5	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0184983	10.1371/journal.pone.0184983	http://dx.doi.org/10.1371/journal.pone.0184983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950016	Green Published, gold, Green Submitted			2022-12-27	WOS:000411671000020
J	Chen, JN; Huang, M; Cao, FB; Pardha-Saradhi, P; Zou, YB				Chen, Jiana; Huang, Min; Cao, Fangbo; Pardha-Saradhi, P.; Zou, Yingbin			Urea application promotes amino acid metabolism and membrane lipid peroxidation in Azolla	PLOS ONE			English	Article							OXIDATIVE STRESS; ENZYMES; NITROGEN; WATER; ASSIMILATION; TOLERANCE; SALINITY; LEAVES; PLANTS	A pot experiment was conducted to evaluate the effect of urea on nitrogen metabolism and membrane lipid peroxidation in Azolla pinnata. Compared to controls, the application of urea to A. pinnata resulted in a 44% decrease in nitrogenase activity, no significant change in glutamine synthetase activity, 660% higher glutamic-pyruvic transaminase, 39% increase in free amino acid levels, 22% increase in malondialdehyde levels, 21% increase in Na (+)/ K (+)- levels, 16% increase in Ca (2+)/ Mg (2+)- ATPase levels, and 11% decrease in superoxide dismutase activity. In terms of H2O2 detoxifying enzymes, peroxidase activity did not change and catalase activity increased by 64% in urea-treated A. pinnata. These findings suggest that urea application promotes amino acid metabolism and membrane lipid peroxidation in A. pinnata.	[Chen, Jiana; Huang, Min; Cao, Fangbo; Zou, Yingbin] Hunan Agr Univ, Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha, Hunan, Peoples R China; [Pardha-Saradhi, P.] Univ Delhi, Dept Environm Studies, Delhi, India	Hunan Agricultural University; University of Delhi	Huang, M (corresponding author), Hunan Agr Univ, Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha, Hunan, Peoples R China.	jxhuangmin@163.com		Huang, Min/0000-0002-6944-8538	Earmarked Fund for China Agriculture Research System [CARS-01]	Earmarked Fund for China Agriculture Research System	This work was supported by the Earmarked Fund for China Agriculture Research System (CARS-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H., 1974, METHODS ENZYMATIC AN, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]; Arora A, 2003, BIOMASS BIOENERG, V24, P175, DOI 10.1016/S0961-9534(02)00133-2; ASHRAF M, 1995, J AGRON CROP SCI, V174, P351, DOI 10.1111/j.1439-037X.1995.tb01122.x; CABAUD P, 1956, AM J CLIN PATHOL, V26, P1101, DOI 10.1093/ajcp/26.9_ts.1101; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Chien HF, 2000, PLANT GROWTH REGUL, V36, P1; Cisse M, 2003, PLANT SOIL, V250, P105, DOI 10.1023/A:1022830423154; Crawford RMM, 1996, J EXP BOT, V47, P145, DOI 10.1093/jxb/47.2.145; Fahnenstich H, 2008, PLANT SIGNAL BEHAV, V3, P1122, DOI 10.4161/psb.3.12.7040; FOUGERE F, 1991, PLANT PHYSIOL, V96, P1228, DOI 10.1104/pp.96.4.1228; Ge TiDa, 2006, Agricultural Sciences in China, V5, P291, DOI 10.1016/S1671-2927(06)60052-7; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Hafsi C, 2011, ACTA PHYSIOL PLANT, V33, P193, DOI 10.1007/s11738-010-0537-3; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; HUBER W, 1973, OECOLOGIA, V13, P271, DOI 10.1007/BF00360516; Ishikawa T, 2010, PLANT CELL PHYSIOL, V51, P9, DOI 10.1093/pcp/pcp162; KOCH B, 1966, PLANT PHYSIOL, V41, P1748, DOI 10.1104/pp.41.10.1748; Kuiper P. J. C., 1984, Salinity tolerance in plants - strategies for crop improvement, P77; LEA PJ, 1992, PR PHYT SOC, V33, P153; LILJENBERG CS, 1992, PROG LIPID RES, V31, P335, DOI 10.1016/0163-7827(92)90012-8; Lumpkin T. A., 1987, Azolla utilization. Proceedings of the Workshop on Azolla Use, Fuzhou, Fujian, China, 13 March-5 April 1985., P89; Miflin BJ, 2002, J EXP BOT, V53, P979, DOI 10.1093/jexbot/53.370.979; OHNISHI T, 1975, ANAL BIOCHEM, V69, P261, DOI 10.1016/0003-2697(75)90585-0; Pratelli R, 2007, PLANT SIGNAL BEHAV, V2, P182, DOI 10.4161/psb.2.3.3972; Qin JQ, 2013, FIELD CROP RES, V148, P15, DOI 10.1016/j.fcr.2013.04.004; Raja W., 2012, INTERNAT J RES BIOL, V2, P68; ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2; Sadeghi R., 2013, Caspian Journal of Environmental Sciences, V11, P65; Surjus A, 1996, J EXP BOT, V47, P17, DOI 10.1093/jxb/47.1.17; Tewari RK, 2007, J INTEGR PLANT BIOL, V49, P313, DOI 10.1111/j.1744-7909.2007.00358.x; Turner G. L., 1980, Methods for evaluating biological nitrogen fixation., P111; Vlek PLG, 1995, FERT RES, V42, P165, DOI 10.1007/BF00750511; Wagner GM, 1997, BOT REV, V63, P1, DOI 10.1007/BF02857915; Xiao W, 2008, BIOL TRACE ELEM RES, V126, P269, DOI 10.1007/s12011-008-8196-6; Xu JT, 2011, DESALINATION, V280, P58, DOI 10.1016/j.desal.2011.06.050; Xue TL, 2000, AGR FOOD SCI FINLAND, V9, P177, DOI 10.23986/afsci.5659; Yan B, 1996, PLANT SOIL, V179, P261, DOI 10.1007/BF00009336; Yin XL, 2016, WATER AIR SOIL POLL, V227, DOI 10.1007/s11270-016-2763-9; Yoon YE, 2017, FOOD CHEM, V215, P185, DOI 10.1016/j.foodchem.2016.07.167; Zhang J, 2010, AFR J BIOTECHNOL, V9, P2521	40	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							0185230	10.1371/journal.pone.0185230	http://dx.doi.org/10.1371/journal.pone.0185230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945775	Green Published, gold, Green Submitted			2022-12-27	WOS:000411645100033
J	Gentile, LB; Nagamine, MK; Biondi, LR; Sanches, DS; Toyota, F; Giovani, TM; de Jesus, IP; da Fonseca, IIM; Queiroz-Hazarbassanov, N; Diaz, BL; Gomes, CDMS; Daglil, MLZ				Gentile, Luciana B.; Nagamine, Marcia K.; Biondi, Luiz R.; Sanches, Daniel S.; Toyota, Fabio; Giovani, Tatiane M.; de Jesus, Isis P.; da Fonseca, Ivone I. M.; Queiroz-Hazarbassanov, Nicolle; Diaz, Bruno L.; Massoco Salles Gomes, Cristina de O.; Daglil, Maria Lucia Z.			Establishment of primary mixed cell cultures from spontaneous canine mammary tumors: Characterization of classic and new cancer-associated molecules	PLOS ONE			English	Article							ESTROGEN-RELATED-RECEPTOR; MATERNAL STILBESTROL THERAPY; ORPHAN NUCLEAR RECEPTORS; BREAST-CANCER; ERR-GAMMA; EXPRESSION; GROWTH; GENE; MODELS; ALPHA	There are many factors which make canine cancer like cancer in humans. The occurrence of spontaneous mammary tumors in pet dogs, tumor genetics, molecular targets and exposure to the same environmental risk factors are among these factors. Therefore, the study of canine cancer can provide useful information to the oncology field. This study aimed to establish and characterize a panel of primary mixed cell cultures obtained from spontaneous canine mammary tumors. Eight established cell cultures obtained from one normal mammary gland, one complex adenoma, one mixed adenoma, two complex carcinomas and two mixed carcinomas were analyzed. The gene expression levels of classic molecular cancer players such as fibroblast growth factor receptor (FGFR) 2, breast cancer (BRCA) 1, BRCA2 and estrogen receptor (ESR) 1 were evaluated. For the first time, three orphan nuclear receptors, estrogen-related receptors (ERRs) alpha,beta and gamma were studied in canine mammary cancer. The highest expression level of ERR alpha was observed in complex carcinoma-derived cell culture, while the highest levels of ERR beta and gamma were observed in cells derived from a mixed carcinoma. Meanwhile, complex carcinomas presented the highest levels of expression of ESR1, BRCA1 and FGFR2 among all samples. BRCA2 was found exclusively in complex adenoma. The transcription factor GATA3 had its highest levels in mixed carcinoma samples and its lowest levels in complex adenoma. Proliferation assays were also performed to evaluate the mixed cell cultures response to ER ligands, genistein and DES, both in normoxia and hypoxic conditions. Our results demonstrate that morphological and functional studies of primary mixed cell cultures derived from spontaneous canine mammary tumors are possible and provide valuable tool for the study of various stages of mammary cancer development.	[Gentile, Luciana B.; Nagamine, Marcia K.; Biondi, Luiz R.; Sanches, Daniel S.; de Jesus, Isis P.; da Fonseca, Ivone I. M.; Daglil, Maria Lucia Z.] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Pathol, Lab Expt & Comparat Oncol, Sao Paulo, Brazil; [Toyota, Fabio] Vet Hosp Caes & Gatos, Sao Paulo, Brazil; [Giovani, Tatiane M.] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Pathol, Sao Paulo, Brazil; [Queiroz-Hazarbassanov, Nicolle; Massoco Salles Gomes, Cristina de O.] Univ Sao Paulo, Sch Vet Med & Anim Sci, Appl Pharmacol & Toxicol Lab, Sao Paulo, Brazil; [Diaz, Bruno L.] Fed Univ Rio de Janeiro UFRJ, Lab Inflammat, Carlos Chagas Filho Biophys Inst IBCCF, Rio De Janeiro, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro	Gentile, LB; Daglil, MLZ (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Pathol, Lab Expt & Comparat Oncol, Sao Paulo, Brazil.	lubuffoni@biof.ufrj.br; mlzdagli@usp.br	Biondi, Luiz Roberto/AAG-1110-2022; Biondi, Luiz Roberto/AFK-2807-2022; Diaz, Bruno L./A-5673-2009; Queiroz-Hazarbassanov, Nicolle/Q-6901-2019	Biondi, Luiz Roberto/0000-0002-2677-8182; Biondi, Luiz Roberto/0000-0002-2677-8182; Diaz, Bruno L./0000-0001-8393-3823; Queiroz-Hazarbassanov, Nicolle/0000-0002-5692-0565	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/02400-0, 2011/014177-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Luciana Boffoni Gentile was the recipient of a postdoctoral fellowship from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), process number 2011/02400-0. This study was sponsored by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), process number 2011/014177-4.	Ariazi EA, 2002, CANCER RES, V62, P6510; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Carvalho MI, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4917387; Cassali G. D., 2011, Brazilian Journal of Veterinary Pathology, V4, P153; Cerliani JP, 2012, BREAST CANCER RES TR, V133, P997, DOI 10.1007/s10549-011-1883-6; Chen F, 1999, GENE, V228, P101, DOI 10.1016/S0378-1119(98)00619-2; Chen S, 2001, J BIOL CHEM, V276, P28465, DOI 10.1074/jbc.M102638200; Cheung CP, 2005, J CLIN ENDOCR METAB, V90, P1830, DOI 10.1210/jc.2004-1421; Connor EE, 2005, J ENDOCRINOL, V185, P593, DOI 10.1677/joe.1.06139; Eudy JD, 1998, GENOMICS, V50, P382, DOI 10.1006/geno.1998.5345; Fang SH, 2009, J SURG RES, V157, P290, DOI 10.1016/j.jss.2008.07.015; Fang Y, 2016, INT J ONCOL, V48, P1016, DOI 10.3892/ijo.2016.3327; Fletcher MNC, 2013, NATURE COMMUNICATION, V4, P1; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Haga S, 2001, ONCOL REP, V8, P1215; He Fu-jin, 2002, Zhongguo Zhongyao Zazhi, V27, P936; Heard DJ, 2000, MOL ENDOCRINOL, V14, P382, DOI 10.1210/me.14.3.382; Herbst AL, 1999, AM J OBSTET GYNECOL, V181, P1574, DOI 10.1016/S0002-9378(99)70411-4; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; Hershey AE, 2005, VET PATHOL, V42, P805, DOI 10.1354/vp.42-6-805; Hoffman MM, 2007, MOL BIOL EVOL, V24, P522, DOI 10.1093/molbev/msl179; Hong H, 1999, J BIOL CHEM, V274, P22618, DOI 10.1074/jbc.274.32.22618; Hovey RC, 1999, J MAMMARY GLAND BIOL, V4, P53, DOI 10.1023/A:1018704603426; Hsu WL, 2010, VET J, V184, P351, DOI 10.1016/j.tvjl.2009.03.022; Ijichi N, 2011, J STEROID BIOCHEM, V123, P1, DOI 10.1016/j.jsbmb.2010.09.002; Jenkins S, 2012, J STEROID BIOCHEM, V129, P191, DOI 10.1016/j.jsbmb.2011.06.003; Knapp DW, 1997, MOL MED TODAY, V3, P8, DOI 10.1016/S1357-4310(96)20031-0; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; London CA, 1996, J COMP PATHOL, V115, P399, DOI 10.1016/S0021-9975(96)80074-0; Madhavan S, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0150-9; NANDI S, 1995, P NATL ACAD SCI USA, V92, P3650, DOI 10.1073/pnas.92.9.3650; Nieto A, 2003, J COMP PATHOL, V128, P260, DOI 10.1053/jcpa.2002.0631; Ozaki K, 2002, VET PATHOL, V39, P557, DOI 10.1354/vp.39-5-557; Porrello A, 2006, J EXP CLIN CANC RES, V25, P97; Pryer NK, 2003, CLIN CANCER RES, V9, P5729; Ribeiro-Silva Alfredo, 2005, J. Bras. Patol. Med. Lab., V41, P197, DOI 10.1590/S1676-24442005000300010; Riggins RB, 2008, CANCER RES, V68, P8908, DOI 10.1158/0008-5472.CAN-08-2669; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Schwertfeger KL, 2006, J MAMMARY GLAND BIOL, V11, P229, DOI 10.1007/s10911-006-9028-y; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Sengupta D, 2014, BRIT J CANCER, V110, P2144, DOI 10.1038/bjc.2014.53; Setoguchi A, 2001, AM J VET RES, V62, P433, DOI 10.2460/ajvr.2001.62.433; Slattery ML, 2013, BREAST CANCER RES TR, V140, P587, DOI 10.1007/s10549-013-2644-5; Sun PM, 2005, J MOL MED, V83, P457, DOI 10.1007/s00109-005-0639-3; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Tenhagen M, 2012, ENDOCR-RELAT CANCER, V19, pR115, DOI 10.1530/ERC-12-0060; Tiraby C, 2011, CANCER RES, V71, P2518, DOI 10.1158/0008-5472.CAN-10-1315; Troisi R, 2007, INT J CANCER, V121, P356, DOI 10.1002/ijc.22631; Uifalean A, 2016, MOLECULES, V21, DOI 10.3390/molecules21010013; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Walia V, 2010, STEM CELLS DEV, V19, P1175, DOI 10.1089/scd.2009.0430; Yang C, 1998, CANCER RES, V58, P5695; Yu S, 2008, ONCOGENE, V27, P3313, DOI 10.1038/sj.onc.1210986; Zhang ZP, 2001, MOL CELL ENDOCRINOL, V172, P223, DOI 10.1016/S0303-7207(00)00372-5; Zhang ZP, 2000, J BIOL CHEM, V275, P20837, DOI 10.1074/jbc.M001880200	60	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0184228	10.1371/journal.pone.0184228	http://dx.doi.org/10.1371/journal.pone.0184228			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945747	gold, Green Published			2022-12-27	WOS:000411645100006
J	Gilmore, S				Gilmore, Stephen			Melanoma screening: Informing public health policy with quantitative modelling	PLOS ONE			English	Article							SKIN-CANCER; GENERAL-PRACTITIONERS; CUTANEOUS MELANOMA; EXCISION RATES; MARKOV-MODEL; LUNG-CANCER; DIAGNOSIS; NUMBER; POPULATION; LESIONS	Australia and New Zealand share the highest incidence rates of melanoma worldwide. Despite the substantial increase in public and physician awareness of melanoma in Australia over the last 30 years-as a result of the introduction of publicly funded mass media campaigns that began in the early 1980s-mortality has steadily increased during this period. This increased mortality has led investigators to question the relative merits of primary versus secondary prevention; that is, sensible sun exposure practices versus early detection. Increased melanoma vigilance on the part of the public and among physicians has resulted in large increases in public health expenditure, primarily from screening costs and increased rates of office surgery. Has this attempt at secondary prevention been effective? Unfortunately epidemiologic studies addressing the causal relationship between the level of secondary prevention and mortality are prohibitively difficult to implement-it is currently unknown whether increased melanoma surveillance reduces mortality, and if so, whether such an approach is cost-effective. Here I address the issue of secondary prevention of melanoma with respect to incidence and mortality (and cost per life saved) by developing a Markov model of melanoma epidemiology based on Australian incidence and mortality data. The advantages of developing a methodology that can determine constraint-based surveillance outcomes are twofold: first, it can address the issue of effectiveness; and second, it can quantify the trade-off between cost and utilisation of medical resources on one hand, and reduced morbidity and lives saved on the other. With respect to melanoma, implementing the model facilitates the quantitative determination of the relative effectiveness and trade-offs associated with different levels of secondary and tertiary prevention, both retrospectively and prospectively. For example, I show that the surveillance enhancement that began in 1982 has resulted in greater diagnostic incidence and reduced mortality, but the reduced mortality carried a significant cost per life saved. I implement the model out to 2028 and demonstrate that the enhanced secondary prevention that began in 1982 becomes increasingly cost-effective over the period 2013-2028. On the other hand, I show that reductions in mortality achieved by significantly enhancing secondary prevention beyond 2013 levels are comparable with those achieved by only modest improvements in late-stage disease survival. Given the ballooning costs of increased melanoma surveillance, I suggest the process of public health policy decision-making-particularly with respect to the publicfunding of melanoma screening and discretionary mole removal-would be better served by incorporating the results of quantitative modelling.	[Gilmore, Stephen] Skin & Canc Fdn, Melbourne, Vic, Australia; [Gilmore, Stephen] Univ Queensland, Diamantina Inst, Dermatol Res Ctr, Brisbane, Qld, Australia	SKIN & CANCER FOUNDATION AUSTRALIA; University of Queensland	Gilmore, S (corresponding author), Skin & Canc Fdn, Melbourne, Vic, Australia.; Gilmore, S (corresponding author), Univ Queensland, Diamantina Inst, Dermatol Res Ctr, Brisbane, Qld, Australia.	s.gilmore1@uq.edu.au			Skin and Cancer Foundation, Victoria, Australia	Skin and Cancer Foundation, Victoria, Australia	The Skin and Cancer Foundation, Victoria, Australia, provided funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnlide I, 2014, ACTA DERM-VENEREOL, V94, P683, DOI 10.2340/00015555-1831; Alexandrescu Doru Traian, 2009, Dermatol Online J, V15, P1; Baade PD, 2008, ARCH DERMATOL, V144, P1468, DOI 10.1001/archderm.144.11.1468; Basu S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001540; Brady MS, 2000, CANCER-AM CANCER SOC, V89, P342, DOI 10.1002/1097-0142(20000715)89:2<342::AID-CNCR19>3.0.CO;2-P; Buchanan L., 2013, DERMATOLOGY ONLINE J, V19, P1; Chadeau-Hyam M, 2014, EPIDEMIOLOGY, V25, P28, DOI 10.1097/EDE.0000000000000032; Chouaid C, 2004, BRIT J CANCER, V90, P397, DOI 10.1038/sj.bjc.6601547; Czarnecki D, 2014, ACTA DERM-VENEREOL, V94, P539, DOI 10.2340/00015555-1877; Del Mar CB, 1997, AUST NZ J PUBL HEAL, V21, P751; Dos Santos Silva I, 1999, ANCER EPIDEMIOLGOGY; English DR, 2004, MED J AUSTRALIA, V180, P16, DOI 10.5694/j.1326-5377.2004.tb05766.x; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Gelfand JM, 2011, NEJM J WATCH; Gilmore S, 2010, EXP DERMATOL, V19, P830, DOI 10.1111/j.1600-0625.2010.01112.x; Grob JJ, 2002, ARCH DERMATOL, V138, P1251, DOI 10.1001/archderm.138.9.1251; Guy GP, 2012, AM J PREV MED, V43, P537, DOI 10.1016/j.amepre.2012.07.031; Hansen C, 2009, J AM ACAD DERMATOL, V61, P599, DOI 10.1016/j.jaad.2009.04.021; Moynihan R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001655; Richard MA, 2000, INT J CANCER, V89, P271, DOI 10.1002/1097-0215(20000520)89:3<271::AID-IJC10>3.0.CO;2-7; Richard MA, 2000, INT J CANCER, V89, P280, DOI 10.1002/1097-0215(20000520)89:3<280::AID-IJC11>3.0.CO;2-2; Richard MA, 1999, ARCH DERMATOL, V135, P269, DOI 10.1001/archderm.135.3.269; Rolfe H, 2012, AUSTRALAS J DERMATOL, V53, P240, DOI [10.1111/j.1440-0960.2012.00935.x, 10.1111/j.1440-0960.2012.00933.x]; Sandru A, 2014, J Med Life, V7, P572; Shih STF, 2009, PREV MED, V49, P449, DOI 10.1016/j.ypmed.2009.09.008; Sidhu S, 2012, CLIN EXP DERMATOL, V37, P6, DOI 10.1111/j.1365-2230.2011.04148.x; Tsao HS, 1998, J AM ACAD DERMATOL, V38, P669, DOI 10.1016/S0190-9622(98)70195-1; Wartman D, 2008, CANCER EPIDEM BIOMAR, V17, P469, DOI 10.1158/1055-9965.EPI-07-0301; Weinstock MA, 2016, BR J DERMATOL; Welch HG, 2005, BRIT MED J, V331, P481, DOI 10.1136/bmj.38516.649537.E0; Wernli KJ, 2016, SCREENING SKIN CANC; Whiteman D, ENQUIRY SKIN CANC AU; Whiteman DC, 2016, J INVEST DERMATOL, V136, P1161, DOI 10.1016/j.jid.2016.01.035; Wolff T, 2009, ANN INTERN MED, V150, P194, DOI 10.7326/0003-4819-150-3-200902030-00009	34	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0182349	10.1371/journal.pone.0182349	http://dx.doi.org/10.1371/journal.pone.0182349			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945758	gold, Green Published, Green Submitted			2022-12-27	WOS:000411645100003
J	Kusi, KA; Manu, EA; Gwira, TM; Kyei-Baafour, E; Dickson, EK; Amponsah, JA; Remarque, EJ; Faber, BW; Kocken, CHM; Dodoo, D; Gyan, BA; Awandare, GA; Atuguba, F; Oduro, AR; Koram, KA				Kusi, Kwadwo A.; Manu, Emmanuel A.; Gwira, Theresa Manful; Kyei-Baafour, Eric; Dickson, Emmanuel K.; Amponsah, Jones A.; Remarque, Edmond J.; Faber, Bart W.; Kocken, Clemens H. M.; Dodoo, Daniel; Gyan, Ben A.; Awandare, Gordon A.; Atuguba, Frank; Oduro, Abraham R.; Koram, Kwadwo A.			Variations in the quality of malaria-specific antibodies with transmission intensity in a seasonal malaria transmission area of Northern Ghana	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM APICAL-MEMBRANE-ANTIGEN-1; ERYTHROCYTE-BINDING ANTIGEN-175; HETEROLOGOUS STRAINS; SEROLOGICAL MARKERS; MEROZOITE ANTIGENS; ACQUIRED-IMMUNITY; CLINICAL-DISEASE; PROTECTION; RESPONSES; POLYMORPHISM	Introduction Plasmodium falciparum induced antibodies are key components of anti-malarial immunity in malaria endemic areas, but their antigen targets can be polymorphic. Induction of a high proportion of strain-specific antibodies will limit the recognition of a broad diversity of parasite strains by these responses. There are indications that circulating parasite diversity varies with malaria transmission intensity, and this may affect the specificity of elicited anti-malarial antibodies. This study therefore assessed the effect of varying malaria transmission patterns on the specificity of elicited antibody responses and to identify possible antibody correlates of naturally acquired immunity to malaria in children in an area of Ghana with seasonal malaria transmission. Methods This retrospective study utilized plasma samples collected longitudinally at six time points from children aged one to five years. Multiplex assays were used to measure antibody levels against four P. falciparum AMA 1 variants (from the 3D7, FVO, HB3 and CAMP parasite strains) and the 3D7 variant of the EBA 175 region II antigen and the levels compared between symptomatic and asymptomatic children. The relative proportions of cross-reactive and strain-specific antibodies against the four AMA 1 variants per sampling time point were assessed by Bland-Altman plots. The levels of antibodies against allelic AMA1 variants, measured by singleplex and multiplex luminex assays, were also compared. Results The data show that increased transmission intensity is associated with higher levels of cross-reactive antibody responses, most likely a result of a greater proportion of multiple parasite clone infections during the high transmission period. Anti-AMA1 antibodies were however associated with a history of infection rather than protection in this age group. Conclusion The data contribute to understanding the underlying mechanism of the acquisition of strain-transcending antibody immunity following repeated exposure to diverse parasite strains.	[Kusi, Kwadwo A.; Kyei-Baafour, Eric; Dickson, Emmanuel K.; Amponsah, Jones A.; Dodoo, Daniel; Gyan, Ben A.] Univ Ghana, Noguchi Mem Inst Med Res, Dept Immunol, Coll Hlth Sci, Legon, Ghana; [Kusi, Kwadwo A.; Manu, Emmanuel A.; Gwira, Theresa Manful; Awandare, Gordon A.] Univ Ghana, Dept Biochem Cell & Mol Biol, Coll Basic & Appl Sci, Legon, Ghana; [Kusi, Kwadwo A.; Manu, Emmanuel A.; Gwira, Theresa Manful; Awandare, Gordon A.; Koram, Kwadwo A.] Univ Ghana, Coll Basic & Appl Sci, West African Ctr Cell Biol Infect Pathogens, Legon, Ghana; [Remarque, Edmond J.; Faber, Bart W.; Kocken, Clemens H. M.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Atuguba, Frank; Oduro, Abraham R.] Ghana Hlth Serv, Navrongo Hlth Res Ctr, Navrongo, Ghana; [Koram, Kwadwo A.] Univ Ghana, Noguchi Mem Inst Med Res, Dept Epidemiol, Coll Hlth Sci, Legon, Ghana; [Remarque, Edmond J.] Biomed Primate Res Ctr, Dept Virol, Rijswijk, Netherlands	University of Ghana; University of Ghana; University of Ghana; Ghana Health Service; Navrongo Health Research Center; University of Ghana	Kusi, KA (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Dept Immunol, Coll Hlth Sci, Legon, Ghana.; Kusi, KA (corresponding author), Univ Ghana, Dept Biochem Cell & Mol Biol, Coll Basic & Appl Sci, Legon, Ghana.; Kusi, KA (corresponding author), Univ Ghana, Coll Basic & Appl Sci, West African Ctr Cell Biol Infect Pathogens, Legon, Ghana.	akusi@noguchi.ug.edu.gh	Eric, Kyei-Baafour/X-7280-2019; Remarque, Ed/AAE-8643-2020; Awandare, Gordon/J-1392-2019; Kusi, Kwadwo Asamoah/J-5941-2019	Eric, Kyei-Baafour/0000-0001-6423-1885; Awandare, Gordon/0000-0002-8793-3641; Kusi, Kwadwo Asamoah/0000-0001-5483-9985; ODURO, ABRAHAM/0000-0002-4191-7419; Kocken, Clemens/0000-0002-4784-1734; Faber, Bart/0000-0001-6808-1204	Division of Microbiology and Immunology Diseases, NIAID, NIH [HHSN266200400016C]; World Bank African Centres of Excellence [ACE02-WACCBIP]	Division of Microbiology and Immunology Diseases, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); World Bank African Centres of Excellence	The original study that collected the samples was funded by the Division of Microbiology and Immunology Diseases, NIAID, NIH (Contract number HHSN266200400016C), awarded to FA and KA Koram. EAM was supported by a Master's fellowship from a World Bank African Centres of Excellence grant (ACE02-WACCBIP) awarded to GAA. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyeman-Budu A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-22; Aubouy A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-12; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Chattopadhyay R, 2003, INFECT IMMUN, V71, P597, DOI 10.1128/IAI.71.2.597-604.2003; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; Cortes A, 2005, INFECT IMMUN, V73, P422, DOI 10.1128/IAI.73.1.422-430.2005; Daou M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0567-9; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; Dent AE, 2015, J INFECT DIS, V212, P1429, DOI 10.1093/infdis/jiv224; Dodoo D, 2001, INFECT IMMUN, V69, P3713, DOI 10.1128/IAI.69.6.3713-3718.2001; Dodoo D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-108; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Dutta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003840; Echeverry DF, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-2; Faber BW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164053; Faber BW, 2008, VACCINE, V26, P6143, DOI 10.1016/j.vaccine.2008.08.055; Farnert A, 1999, J INFECT DIS, V179, P989, DOI 10.1086/314652; FORSYTH KP, 1989, AM J TROP MED HYG, V40, P344, DOI 10.4269/ajtmh.1989.40.344; Fouda GG, 2006, CLIN VACCINE IMMUNOL, V13, P1307, DOI 10.1128/CVI.00183-06; Gray JC, 2007, CLIN CHEM, V53, P1244, DOI 10.1373/clinchem.2006.081695; Greenhouse B, 2011, J INFECT DIS, V204, P19, DOI 10.1093/infdis/jir223; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Iriemenam NC, 2009, VACCINE, V27, P62, DOI 10.1016/j.vaccine.2008.10.025; JEFFERY GM, 1966, B WORLD HEALTH ORGAN, V35, P873; John CC, 2005, AM J TROP MED HYG, V73, P222, DOI 10.4269/ajtmh.2005.73.222; Jones TR, 2000, AM J TROP MED HYG, V62, P675, DOI 10.4269/ajtmh.2000.62.675; Kangoye DT, 2016, VACCINE, V34, P160, DOI 10.1016/j.vaccine.2015.10.058; Kasasa S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-63; Kerkhof K, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1576-z; Kidima W, 2015, J Parasitol Res, V2015, P721201, DOI 10.1155/2015/721201; Kusi KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167175; Kusi KA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-32; Kusi KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015391; Kusi KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-40; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Linkov Faina, 2007, Expert Opin Med Diagn, V1, P129, DOI 10.1517/17530059.1.1.129; MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315; McCarra MB, 2011, PEDIATR INFECT DIS J, V30, P1037, DOI 10.1097/INF.0b013e31822d1451; McGregor IA, 1964, AM J TROP MED HYG S9, V13, P9; McQueen PG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000149; Miura K, 2007, INFECT IMMUN, V75, P5827, DOI 10.1128/IAI.00593-07; Oduro AR, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-96; Ohas EA, 2004, INFECT IMMUN, V72, P735, DOI 10.1128/IAI.72.2.735-741.2004; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Owusu-Agyei S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-103; Priest JW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004699; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Salem MSOA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-26; Sarr JB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-212; THOMAS AW, 1990, MOL BIOCHEM PARASIT, V42, P285, DOI 10.1016/0166-6851(90)90172-I; Toure FS, 2006, CLIN MED RES, V4, P175, DOI [10.3121/cmr.4.3.175, 10.3121/cmr.4.1.1]; Trieu A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007948; WHO, 2016, WORLD MAL REP 2016	59	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185303	10.1371/journal.pone.0185303	http://dx.doi.org/10.1371/journal.pone.0185303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945794	gold, Green Submitted, Green Published			2022-12-27	WOS:000411645100043
J	Lee, YS; Ku, KM; Becker, TM; Juvik, JA				Lee, Young-Sang; Ku, Kang-Mo; Becker, Talon M.; Juvik, John A.			Chemopreventive glucosinolate accumulation in various broccoli and collard tissues: Microfluidic-based targeted transcriptomics for by-product valorization	PLOS ONE			English	Article							QUINONE REDUCTASE-ACTIVITY; OLERACEA VAR. ITALICA; HAIRY ROOT CULTURES; BRASSICA-OLERACEA; DEGRADATION-PRODUCTS; VERTICILLIUM WILT; BIOSYNTHESIS; ARABIDOPSIS; ISOTHIOCYANATES; INDUCTION	Floret, leaf, and root tissues were harvested from broccoli and collard cultivars and extracted to determine their glucosinolate and hydrolysis product profiles using high performance liquid chromatography and gas chromotography. Quinone reductase inducing bioactivity, an estimate of anti-cancer chemopreventive potential, of the extracts was measured using a hepa1c1c7 murine cell line. Extracts from root tissues were significantly different from other tissues and contained high levels of gluconasturtiin and glucoerucin. Targeted gene expression analysis on glucosinolate biosynthesis revealed that broccoli root tissue has elevated gene expression of AOP2 and low expression of FMOGS-OX homologs, essentially the opposite of what was observed in broccoli florets, which accumulated high levels of glucoraphanin. Broccoli floret tissue has significantly higher nitrile formation (%) and epithionitrile specifier protein gene expression than other tissues. This study provides basic information of the glucosinolate metabolome and transcriptome for various tissues of Brassica oleracea that maybe utilized as potential byproducts for the nutraceutical market.	[Lee, Young-Sang] Soonchunhyang Univ, Dept Med Biotechnol, Asan, South Korea; [Ku, Kang-Mo] West Virginia Univ, Div Plant & Soil Sci, Morgantown, WV 26506 USA; [Becker, Talon M.; Juvik, John A.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	Soonchunhyang University; West Virginia University; University of Illinois System; University of Illinois Urbana-Champaign	Juvik, JA (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	juvik@illinois.edu		Ku, Kang Mo/0000-0002-8588-1163	Soonchunhyang University; West Virginia Agricultural and Forestry Experiment Station [WVA00698, 3327]	Soonchunhyang University; West Virginia Agricultural and Forestry Experiment Station	Young-San Lee was funded by Soonchunhyang University. Kang-Mo Ku was funded by the West Virginia Agricultural and Forestry Experiment Station (WVA00698: Scientific Article No. 3327). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2011, SUSTAINABLE AGRICULTURE, VOL 2, P623, DOI 10.1007/978-94-007-0394-0_28; Augustine R, 2015, SCI REP-UK, V5, DOI 10.1038/srep18005; Barth C, 2006, PLANT J, V46, P549, DOI 10.1111/j.1365-313X.2006.02716.x; Becker Talon M, 2016, Diseases, V4, DOI 10.3390/diseases4020022; Bhandari SR, 2015, MOLECULES, V20, P15827, DOI 10.3390/molecules200915827; BIALY Z, 1990, PLANT SOIL, V129, P277, DOI 10.1007/BF00032423; Bones AM, 1996, PHYSIOL PLANTARUM, V97, P194, DOI [10.1034/j.1399-3054.1996.970128.x, 10.1111/j.1399-3054.1996.tb00497.x]; Burow M, 2008, PHYTOCHEMISTRY, V69, P663, DOI 10.1016/j.phytochem.2007.08.027; Buskov S, 2002, J AGR FOOD CHEM, V50, P690, DOI 10.1021/jf010470s; Chen SX, 2001, PLANT PHYSIOL, V127, P194, DOI 10.1104/pp.127.1.194; Clarke DB, 2010, ANAL METHODS-UK, V2, P310, DOI 10.1039/b9ay00280d; de Saint Laumer JY, 2010, ANAL CHEM, V82, P6457, DOI 10.1021/ac1006574; Dominguez-Perles R, 2010, J FOOD SCI, V75, pC383, DOI 10.1111/j.1750-3841.2010.01606.x; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Giamoustaris A, 1996, THEOR APPL GENET, V93, P1006, DOI 10.1007/BF00224105; Hanschen FS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132931; Ikeda K, 2015, J GEN PLANT PATHOL, V81, P77, DOI 10.1007/s10327-014-0559-6; Kang YH, 2004, METHOD ENZYMOL, V382, P380; Kassahun K, 1997, CHEM RES TOXICOL, V10, P1228, DOI 10.1021/tx970080t; Kastell A, 2015, PLANT MOL BIOL REP, V33, P598, DOI 10.1007/s11105-014-0781-6; Kim HH, 2013, ASIAN J CHEM, V25, P6099, DOI 10.14233/ajchem.2013.14266; Kim SJ, 2013, NAT PROD COMMUN, V8, P217; Ku KM, 2013, J AGR FOOD CHEM, V61, P9623, DOI 10.1021/jf4027734; Ku KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077127; Ku KM, 2015, J AGR FOOD CHEM, V63, P2947, DOI 10.1021/jf505591z; Ku KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103407; Li J, 2008, PLANT PHYSIOL, V148, P1721, DOI 10.1104/pp.108.125757; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Luang-In V, 2014, MOL NUTR FOOD RES, V58, P875, DOI 10.1002/mnfr.201300377; Matusheski NV, 2006, J AGR FOOD CHEM, V54, P2069, DOI 10.1021/jf0525277; Rose P, 2000, CARCINOGENESIS, V21, P1983, DOI 10.1093/carcin/21.11.1983; Smith LB, 2000, MOL BREEDING, V6, P603, DOI 10.1023/A:1011370525688; Sotelo T, 2015, APPL ENVIRON MICROB, V81, P432, DOI 10.1128/AEM.03142-14; Subbarao KV, 1999, PLANT DIS, V83, P124, DOI 10.1094/PDIS.1999.83.2.124; Talalay P, 1995, TOXICOL LETT, V82-3, P173, DOI 10.1016/0378-4274(95)03553-2; Traka MH, 2013, NEW PHYTOL, V198, P1085, DOI 10.1111/nph.12232; Viturro E, 2014, MICROCHIM ACTA, V181, P1725, DOI 10.1007/s00604-014-1205-x; Wilson EA, 2012, J SEP SCI, V35, P2026, DOI 10.1002/jssc.201200071; Wold S., 1994, CHEMOMETRIC METHODS; Yuan HN, 2009, IND ENG CHEM RES, V48, P5070, DOI 10.1021/ie8015329; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602	42	15	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185112	10.1371/journal.pone.0185112	http://dx.doi.org/10.1371/journal.pone.0185112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945821	Green Published, gold, Green Submitted			2022-12-27	WOS:000411645100024
J	Mukaihara, K; Tanabe, Y; Kubota, D; Akaike, K; Hayashi, T; Mogushi, K; Hosoya, M; Sato, S; Kobayashi, E; Okubo, T; Kim, Y; Kohsaka, S; Saito, T; Kaneko, K; Suehara, Y				Mukaihara, Kenta; Tanabe, Yu; Kubota, Daisuke; Akaike, Keisuke; Hayashi, Takuo; Mogushi, Kaoru; Hosoya, Masaki; Sato, Shingo; Kobayashi, Eisuke; Okubo, Taketo; Kim, Youngji; Kohsaka, Shinji; Saito, Tsuyoshi; Kaneko, Kazuo; Suehara, Yoshiyuki			Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma	PLOS ONE			English	Article							MUSCULOSKELETAL ONCOLOGY GROUP; TYROSINE KINASE INHIBITOR; TIVANTINIB ARQ 197; TRANSCRIPTION FACTOR; TISSUE SARCOMA; SELECTIVE INHIBITOR; CYTOTOXIC ACTIVITY; MET INHIBITION; CANCER; ANGIOGENESIS	Background Alveolar soft part sarcoma (ASPS) is an extremely rare metastatic soft tissue tumor with a poor prognosis for which no effective systemic therapies have yet been established. Therefore, the development of novel effective treatment approaches is required. Tyrosine kinases (TKs) are being increasingly used as therapeutic targets in a variety of cancers. The purpose of this study was to identify novel therapeutic target TKs and to clarify the efficacy of TK inhibitors (TKIs) in the treatment of ASPS. Experimental design To identify novel therapeutic target TKs in ASPS, we evaluated the antitumor effects and kinase activity of three TKIs (pazopanib, dasatinib, and cabozantinib) against ASPS cells using an in vitro assay. Based on these results, we then investigated the phosphorylation activities of the identified targets using western blotting, in addition to examining antitumor activity through in vivo assays of several TKIs to determine both the efficacy of these substances and accurate targets. Results In cell proliferation and invasion assays using pazopanib, cabozantinib, and dasatinib, all three TKIs inhibited the cell growth in ASPS cells. Statistical analyses of the cell proliferation and invasion assays revealed that dasatinib had a significant inhibitory effect in cell proliferation assays, and cabozantinib exhibited marked inhibitory effects on cellular functions in both assays. Through western blotting, we also confirmed that cabozantinib inhibited c-MET phosphorylation and dasatinib inhibited SRC phosphorylation in dose-dependent fashion. Mice that received cabozantinib and dasatinib had significantly smaller tumor volumes than control animals, demonstrating the in vivo antitumor activity of, these substances. Conclusions Our findings suggest that cabozantinib and dasatinib may be more effective than pazopanib against ASPS cells. These in vitro and in vivo data suggest that c-MET may be a potential therapeutic target in ASPS, and cabozantinib may be a particularly useful therapeutic option for patients with ASPS, including those with pazopanib-resistant ASPS.	[Mukaihara, Kenta; Tanabe, Yu; Kubota, Daisuke; Akaike, Keisuke; Okubo, Taketo; Kim, Youngji; Kaneko, Kazuo; Suehara, Yoshiyuki] Juntendo Univ, Dept Orthoped Surg, Sch Med, Tokyo, Japan; [Hayashi, Takuo; Saito, Tsuyoshi] Juntendo Univ, Dept Human Pathol, Sch Med, Tokyo, Japan; [Mogushi, Kaoru; Hosoya, Masaki] Juntendo Univ, Ctr Genom & Regenerat Med, Sch Med, Tokyo, Japan; [Sato, Shingo] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Grad Sch, Tokyo, Japan; [Sato, Shingo] Fac Med, Tokyo, Japan; [Kobayashi, Eisuke] Natl Canc Ctr, Div Musculoskeletal Oncol, Tokyo, Japan; [Kohsaka, Shinji] Univ Tokyo, Grad Sch Med, Dept Med Genom, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Tokyo Medical & Dental University (TMDU); National Cancer Center - Japan; University of Tokyo	Suehara, Y (corresponding author), Juntendo Univ, Dept Orthoped Surg, Sch Med, Tokyo, Japan.	ysuehara@juntendo.ac.jp		HAYASHI, TAKUO/0000-0002-8544-9370; Hosoya, Masaki/0000-0003-1841-2743; Mogushi, Kaoru/0000-0002-2618-8684	Japan Agency for Medical Research and Development [15H04964, 16K15670, 15KK0353, 16H07186]; Grants-in-Aid for Scientific Research [17K10987] Funding Source: KAKEN	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Number #15H04964, #16K15670, and #15KK0353 to Y.S. # 16H07186 to K.M.) and Leading Advanced Projects for Medical Innovation (LEAP) from the Japan Agency for Medical Research and Development to Y.S.; This study was supported by the Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Number #15H04964, #16K15670, and #15KK0353 to Y.S. # 16H07186 to K.M.) and Leading Advanced Projects for Medical Innovation (LEAP) from the Japan Agency for Medical Research and Development to Y.S.	Araujo JC, 2013, LANCET ONCOL, V14, P1307, DOI 10.1016/S1470-2045(13)70479-0; Azizi AA, 2006, LANCET ONCOL, V7, P521, DOI 10.1016/S1470-2045(06)70729-X; Basilico C, 2013, CLIN CANCER RES, V19, P2381, DOI 10.1158/1078-0432.CCR-12-3459; Casanova M, 2000, ANN ONCOL, V11, P1445, DOI 10.1023/A:1026579623136; Christensen JG, 2003, CANCER RES, V63, P7345; Covell DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048023; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Funakoshi Y, 2017, J PEDIAT HEMATOL ONC; Gao CF, 2005, CELL RES, V15, P49, DOI 10.1038/sj.cr.7290264; Goldberg JM, 2014, J CLIN ONCOL, V32, pE114, DOI 10.1200/JCO.2013.48.7462; Grullich C, 2014, RECENT RESULTS CANC, V201, P207, DOI 10.1007/978-3-642-54490-3_12; HINDI N, 2015, J CLIN ONCOL S, V33; Hoshino M, 2009, CANCER GENET CYTOGEN, V190, P75, DOI 10.1016/j.cancergencyto.2008.11.014; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Jun HJ, 2010, MED ONCOL, V27, P459, DOI 10.1007/s12032-009-9234-8; Katayama R, 2013, CANCER RES, V73, P3087, DOI 10.1158/0008-5472.CAN-12-3256; Kenney S, 2011, J PEDIAT HEMATOL ONC, V33, P360, DOI 10.1097/MPH.0b013e3182002f9f; Kim Y, 2016, ONCOTARGET, V7, P70832, DOI 10.18632/oncotarget.12225; Kobos R, 2013, J PATHOL, V229, P743, DOI 10.1002/path.4158; Kummar S, 2013, J CLIN ONCOL, V31, P2296, DOI 10.1200/JCO.2012.47.4288; Ladanyi M, 2001, ONCOGENE, V20, P48, DOI 10.1038/sj.onc.1204074; Laird AD, 2003, EXPERT OPIN INV DRUG, V12, P51, DOI 10.1517/eoid.12.1.51.21253; Lazar AJ, 2009, HISTOPATHOLOGY, V55, P750, DOI 10.1111/j.1365-2559.2009.03436.x; Lazar AJF, 2007, CLIN CANCER RES, V13, P7314, DOI 10.1158/1078-0432.CCR-07-0174; Li T, 2016, INVEST NEW DRUG, V34, P701, DOI 10.1007/s10637-016-0390-3; LIEBERMAN PH, 1989, CANCER-AM CANCER SOC, V63, P1, DOI 10.1002/1097-0142(19890101)63:1<1::AID-CNCR2820630102>3.0.CO;2-E; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Maslikowski BM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-41; Munshi N, 2010, MOL CANCER THER, V9, P1544, DOI 10.1158/1535-7163.MCT-09-1173; Nakamura T, 2016, CANCER-AM CANCER SOC, V122, P1408, DOI 10.1002/cncr.29961; Nakayama R, 2016, ONCOTARGET, V7, P16581, DOI 10.18632/oncotarget.7667; Ogose A, 2003, ONCOLOGY-BASEL, V65, P7, DOI 10.1159/000071199; OGURA K, 2012, SARCOMA, DOI DOI 10.1155/2012/907179; Pennacchioli E, 2010, ANN SURG ONCOL, V17, P3229, DOI 10.1245/s10434-010-1186-x; Portera CA, 2001, CANCER, V91, P585, DOI 10.1002/1097-0142(20010201)91:3<585::AID-CNCR1038>3.0.CO;2-0; Ranieri G, 2014, CRIT REV ONCOL HEMAT, V89, P322, DOI 10.1016/j.critrevonc.2013.08.012; Read WL, 2016, CASE REP ONCOL, V9, P639, DOI 10.1159/000450545; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Stacchiotti S, 2011, ANN ONCOL, V22, P1682, DOI 10.1093/annonc/mdq644; Stacchiotti S, 2009, CLIN CANCER RES, V15, P1096, DOI 10.1158/1078-0432.CCR-08-2050; Stockwin LH, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-22; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tsuda M, 2007, CANCER RES, V67, P919, DOI 10.1158/0008-5472.CAN-06-2855; Wagner AJ, 2012, CANCER-AM CANCER SOC, V118, P5894, DOI 10.1002/cncr.27582; Yakes FM, 2011, MOL CANCER THER, V10, P2298, DOI 10.1158/1535-7163.MCT-11-0264; You WK, 2011, CANCER RES, V71, P4758, DOI 10.1158/0008-5472.CAN-10-2527	47	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185321	10.1371/journal.pone.0185321	http://dx.doi.org/10.1371/journal.pone.0185321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945796	gold, Green Submitted, Green Published			2022-12-27	WOS:000411645100045
J	Doosti-lrani, A; Mansournia, MA; Rahimi-Foroushani, A; Haddad, P; Holakouie-Naieni, K				Doosti-lrani, Amin; Mansournia, Mohammad Ali; Rahimi-Foroushani, Abbas; Haddad, Peiman; Holakouie-Naieni, Kourosh			Complications of stent placement in patients with esophageal cancer: A systematic review and network meta-analysis	PLOS ONE			English	Review							EXPANDABLE METAL STENTS; CONVENTIONAL STENTS; ANTIREFLUX STENT; GASTRIC CARDIA; ENDOLUMINAL BRACHYTHERAPY; DISTAL ESOPHAGEAL; RANDOMIZED-TRIAL; ULTRAFLEX STENT; CLINICAL-TRIAL; PALLIATION	Background Palliative treatments and stents are necessary for relieving dysphagia in patients with esophageal cancer. The aim of this study was to simultaneously compare available treatments in terms of complications. Methods Web of Science, Medline, Scopus, Cochrane Library and Embase were searched. Statistical heterogeneity was assessed using the Chi(2) test and was quantified by I-2. The results of this study were summarized in terms of Risk Ratio (RR). The random effects model was used to report the results. The rank probability for each treatment was calculated using the p-score. Results Out of 17855 references, 24 RCTs reported complications including treatment related death (TRD), bleeding, stent migration, aspiration, severe pain and fistula formation. In the ranking of treatments, thermal ablative therapy (p-score = 0.82), covered Evolution (R) stent (p-score = 0.70), brachytherapy (p-score = 0.72) and antireflux stent (p-score = 0.74) were better treatments in the network of TRD. Thermal ablative therapy (p-score = 0.86), the conventional stent (p-score = 0.62), covered Evolution (R) stent (p-score = 0.96) and brachytherapy (p-score = 0.82) were better treatments in the network of bleeding complications. Covered Evolution (R) (p-score = 0.78), uncovered (p-score = 0.88) and irradiation stents (p-score = 0.65) were better treatments in network of stent migration complications. In the network of severe pain, Conventional self-expandable nitinol alloy covered stent (p-score = 0.73), polyflex (p-score = 0.79), latex prosthesis (p-score = 0.96) and brachytherapy (p-score = 0.65) were better treatments. Conclusion According to our results, thermal ablative therapy, covered Evolution (R) stents, brachytherapy, and antireflux stents are associated with a lower risk of TRD. Moreover, thermal ablative therapy, conventional, covered Evolution (R) and brachytherapy had lower risks of bleeding. Overall, fewer complications were associated with covered Evolution (R) stent and brachytherapy.	[Doosti-lrani, Amin] Hamadan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Hamadan, Iran; [Doosti-lrani, Amin; Mansournia, Mohammad Ali; Rahimi-Foroushani, Abbas; Holakouie-Naieni, Kourosh] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Haddad, Peiman] Univ Tehran Med Sci, Canc Inst, Radiat Oncol Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences	Holakouie-Naieni, K (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran.	holakoik@gmail.com		Holakouie-Naieni, Kourosh/0000-0003-3256-9966	Tehran University of Medical Sciences (TUMS); TUMS	Tehran University of Medical Sciences (TUMS)(Tehran University of Medical Sciences); TUMS	This study supported by Tehran University of Medical Sciences (TUMS). We would like to thank Vic-Chancellor of Research and Technology of TUMS for financial support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study supported by Tehran University of Medical Sciences (TUMS). We would like to thank Vic-Chancellor of Research and Technology of TUMS for financial support of this study.	Amdal CD, 2013, RADIOTHER ONCOL, V107, P428, DOI 10.1016/j.radonc.2013.04.008; Bergquist H, 2005, DIS ESOPHAGUS, V18, P131, DOI 10.1111/j.1442-2050.2005.00467.x; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Conio M, 2007, AM J GASTROENTEROL, V102, P2667, DOI 10.1111/j.1572-0241.2007.01565.x; Dallal HJ, 2001, GASTROINTEST ENDOSC, V54, P549, DOI 10.1067/mge.2001.118947; DePalma GD, 1996, GASTROINTEST ENDOSC, V43, P478; Doosti-Irani Amin, 2016, Asian Pac J Cancer Prev, V17, P867; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fuccio L, 2017, RADIOTHER ONCOL, V122, P332, DOI 10.1016/j.radonc.2016.12.034; Fuccio L, 2016, DIGEST LIVER DIS, V48, P1233, DOI 10.1016/j.dld.2016.07.003; Greenland S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1981; Guo JH, 2008, RADIOLOGY, V247, P574, DOI 10.1148/radiol.2472070999; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Homs MYV, 2004, GASTROINTEST ENDOSC, V60, P695, DOI 10.1016/S0016-5107(04)02047-4; Homs MYV, 2004, LANCET, V364, P1497, DOI 10.1016/S0140-6736(04)17272-3; Irani S, 2010, TECH GASTROINTEST EN, V12, P178, DOI 10.1016/j.tgie.2011.01.001; Javed Amit, 2012, J Gastrointest Cancer, V43, P63, DOI 10.1007/s12029-010-9206-4; KNYRIM K, 1993, NEW ENGL J MED, V329, P1302, DOI 10.1056/NEJM199310283291803; Laasch HU, 2002, RADIOLOGY, V225, P359, DOI 10.1148/radiol.2252011763; Lettmaier S, 2014, J CONTEMP BRACHYTHER, V6, P236, DOI 10.5114/jcb.2014.43780; Mills EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016237; O'Donnell CA, 2002, BRIT J SURG, V89, P985, DOI 10.1046/j.1365-2168.2002.02152.x; Power C, 2007, DIS ESOPHAGUS, V20, P466, DOI 10.1111/j.1442-2050.2007.00696.x; Rucker G, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0060-8; Sabharwal T, 2003, GUT, V52, P922, DOI 10.1136/gut.52.7.922; Sabharwal T, 2008, J GASTROEN HEPATOL, V23, P723, DOI 10.1111/j.1440-1746.2008.05396.x; Sgourakis G, 2010, DIGEST DIS SCI, V55, P3018, DOI 10.1007/s10620-010-1250-1; Shenfine J, 2009, AM J GASTROENTEROL, V104, P1674, DOI 10.1038/ajg.2009.155; Siersema PD, 1998, GASTROINTEST ENDOSC, V47, P113, DOI 10.1016/S0016-5107(98)70342-6; Siersema PD, 2001, GASTROINTEST ENDOSC, V54, P145, DOI 10.1016/S0016-5107(01)70098-3; Sreedharan A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005048.pub2; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Trinquart L, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-150; Tytgat GNJ, 2004, DIS ESOPHAGUS, V17, P10, DOI 10.1111/j.1442-2050.2004.00371.x; Vakil N, 2001, AM J GASTROENTEROL, V96, P1791, DOI 10.1016/S0002-9270(01)02486-8; van Heel NCM, 2012, GASTROINTEST ENDOSC, V76, P52, DOI 10.1016/j.gie.2012.02.050; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222; Verschuur EML, 2008, AM J GASTROENTEROL, V103, P304, DOI 10.1111/j.1572-0241.2007.01542.x; Wenger U, 2006, SURG ENDOSC, V20, P1675, DOI 10.1007/s00464-006-0088-2; Wenger U, 2005, EUR J GASTROEN HEPAT, V17, P1369, DOI 10.1097/00042737-200512000-00017; White RE, 2015, J CLIN GASTROENTEROL, V49, P660, DOI 10.1097/MCG.0000000000000333; Zhu HD, 2014, LANCET ONCOL, V15, P612, DOI 10.1016/S1470-2045(14)70131-7	44	16	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0184784	10.1371/journal.pone.0184784	http://dx.doi.org/10.1371/journal.pone.0184784			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968416	Green Published, Green Submitted, gold			2022-12-27	WOS:000412029600009
J	Brand, EC; Crook, JE; Thomas, CS; Siersema, PD; Rex, DK; Wallace, MB				Brand, Eelco C.; Crook, Julia E.; Thomas, Colleen S.; Siersema, Peter D.; Rex, Douglas K.; Wallace, Michael B.			Development and validation of a prediction model for adenoma detection during screening and surveillance colonoscopy with comparison to actual adenoma detection rates	PLOS ONE			English	Article							ADVANCED COLORECTAL NEOPLASIA; RISK STRATIFICATION; QUALITY INDICATORS; CANCER INCIDENCE; SCORING SYSTEM; INDIVIDUALS; PERFORMANCE; IMPUTATION; DERIVATION; TOOL	Objective The adenoma detection rate (ADR) varies widely between physicians, possibly due to patient population differences, hampering direct ADR comparison. We developed and validated a prediction model for adenoma detection in an effort to determine if physicians ADRs should be adjusted for patient-related factors. Materials and methods Screening and surveillance colonoscopy data from the cross-sectional multicenter cluster-randomized Endoscopic Quality Improvement Program-3 (EQUIP-3) study (NCT02325635) was used. The dataset was split into two cohorts based on center. A prediction model for detection of >= 1 adenoma was developed using multivariable logistic regression and subsequently internally (bootstrap resampling) and geographically validated. We compared predicted to observed ADRs. Results The derivation (5 centers, 35 physicians, overall-ADR: 36%) and validation (4 centers, 31 physicians, overall-ADR: 40%) cohort included respectively 9934 and 10034 patients (both cohorts: 48% male, median age 60 years). Independent predictors for detection of >= 1 adenoma were: age (optimism-corrected odds ratio (OR): 1.02; 95%-confidence interval (CI): 1.02-1.03), male sex (OR: 1.73; 95%-CI: 1.60-1.88), body mass index (OR: 1.02; 95%-CI: 1.01-1.03), American Society of Anesthesiology physical status class (OR class II vs. I: 1.29; 95%-CI: 1.17-1.43, OR class >= III vs. I: 1.57; 95%-CI: 1.32-1.86), surveillance versus screening (OR: 1.39; 95%-CI: 1.27-1.53), and Hispanic or Latino ethnicity (OR: 1.13; 95%-CI: 1.00-1.27). The models discriminative ability was modest (C-statistic in the derivation: 0.63 and validation cohort: 0.60). The observed ADR was considerably lower than predicted for 12/66 (18.2%) physicians and 2/9 (22.2%) centers, and considerably higher than predicted for 18/66 (27.3%) physicians and 4/9 (44.4%) centers. Conclusion The substantial variation in ADRs could only partially be explained by patient-related factors. These data suggest that ADR variation could likely also be due to other factors, e.g. physician or technical issues.	[Brand, Eelco C.; Wallace, Michael B.] Mayo Clin, Dept Gastroenterol & Hepatol, Jacksonville, FL 32224 USA; [Brand, Eelco C.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Crook, Julia E.; Thomas, Colleen S.] Mayo Clin, Div Biomed Stat & Informat, Jacksonville, FL 32224 USA; [Siersema, Peter D.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands; [Rex, Douglas K.] Indiana Univ, Med Ctr, Dept Gastroenterol & Hepatol, Indianapolis, IN USA	Mayo Clinic; Utrecht University; Utrecht University Medical Center; Mayo Clinic; Radboud University Nijmegen; Indiana University System; Indiana University-Purdue University Indianapolis	Wallace, MB (corresponding author), Mayo Clin, Dept Gastroenterol & Hepatol, Jacksonville, FL 32224 USA.	Wallace.Michael@mayo.edu	Siersema, Peter/V-1636-2019; Wallace, Michael/GZL-9731-2022	Wallace, Michael/0000-0002-6446-5785	Dutch Digestive Foundation (Maag Lever Darm Stichting) [16-03S]	Dutch Digestive Foundation (Maag Lever Darm Stichting)	Eelco C. Brand received an unrestricted scientific internship (16-03S) abroad grant from The Dutch Digestive Foundation (Maag Lever Darm Stichting). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein BA, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-97; Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; ASA Phyiscal Status Classification System, 2014, ASA PHYISCAL STATUS; Betes M, 2003, AM J GASTROENTEROL, V98, P2648, DOI 10.1016/j.amjgastroenterol.2203.09.041; Bouwmeester W, 2013, AM J EPIDEMIOL, V177, P1209, DOI 10.1093/aje/kws396; Brand Eelco C, 2017, Curr Treat Options Gastroenterol, V15, P184, DOI 10.1007/s11938-017-0126-2; Brenner H, 2015, GASTROENTEROLOGY, V149, P356, DOI 10.1053/j.gastro.2015.04.012; Bretthauer M, 2016, JAMA INTERN MED, V176, P894, DOI 10.1001/jamainternmed.2016.0960; Cai QC, 2012, AM J EPIDEMIOL, V175, P584, DOI 10.1093/aje/kwr337; Coe SG, 2013, AM J GASTROENTEROL, V108, P219, DOI 10.1038/ajg.2012.417; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Corley DA, 2014, NEW ENGL J MED, V370, P1298, DOI 10.1056/NEJMoa1309086; Diamond SJ, 2011, GASTROINTEST ENDOSC, V74, P135, DOI 10.1016/j.gie.2011.03.1178; GIQuIC, 2016, CLIN DAT REG; Imperiale TF, 2015, ANN INTERN MED, V163, P339, DOI 10.7326/M14-1720; Jensen CD, 2015, CLIN GASTROENTEROL H, V13, P739, DOI 10.1016/j.cgh.2014.10.020; Kaminski MF, 2017, ENDOSCOPY, V49, P378, DOI 10.1055/s-0043-103411; Kaminski MF, 2016, GUT, V65, P616, DOI 10.1136/gutjnl-2014-307503; Kaminski MF, 2014, GUT, V63, P1112, DOI 10.1136/gutjnl-2013-304965; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Kim DH, 2015, J CLIN GASTROENTEROL, V49, P41, DOI 10.1097/MCG.0000000000000102; Lin OS, 2006, GASTROENTEROLOGY, V131, P1011, DOI 10.1053/j.gastro.2006.08.015; Marcondes FO, 2015, GASTROINTEST ENDOSC, V82, P668, DOI 10.1016/j.gie.2014.12.056; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Ng SC, 2016, GASTROENTEROLOGY, V150, P608, DOI 10.1053/j.gastro.2015.11.003; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Omata F, 2011, EUR J GASTROEN HEPAT, V23, P1036, DOI 10.1097/MEG.0b013e32834a2882; Peters U, 2003, LANCET, V361, P1491, DOI 10.1016/S0140-6736(03)13173-X; R Core Team, 2015, R A LANG ENV STAT CO; Rex DK, 2015, AM J GASTROENTEROL, V110, P72, DOI 10.1038/ajg.2014.385; Robertson DJ, 2014, GUT, V63, P949, DOI 10.1136/gutjnl-2012-303796; Schroy PC, 2015, AM J GASTROENTEROL, V110, P1062, DOI 10.1038/ajg.2015.146; Shaukat A, 2015, CANCER EPIDEM BIOMAR, V24, P913, DOI 10.1158/1055-9965.EPI-14-1321; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Steyerberg EW, 2009, CLIN PREDICTION MODE, P361; Tao S, 2014, CLIN GASTROENTEROL H, V12, P478, DOI 10.1016/j.cgh.2013.08.042; van Buuren S, 2011, J STAT SOFTW, V45, P1; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Wallace MB, 2017, GASTROINTEST ENDOSC, V85; Wong MCS, 2016, AM J GASTROENTEROL, V111, P1621, DOI 10.1038/ajg.2016.52; Wong MCS, 2014, GUT, V63, P1130, DOI 10.1136/gutjnl-2013-305639; Yeoh KG, 2011, GUT, V60, P1236, DOI 10.1136/gut.2010.221168; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	43	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185560	10.1371/journal.pone.0185560	http://dx.doi.org/10.1371/journal.pone.0185560			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957445	Green Published, gold			2022-12-27	WOS:000411985200086
J	Brauswetter, D; Gurbi, B; Varga, A; Varkondi, E; Schwab, R; Banhegyi, G; Fabian, O; Keri, G; Valyi-Nagy, I; Petak, I				Brauswetter, Diana; Gurbi, Bianka; Varga, Attila; Varkondi, Edit; Schwab, Richard; Banhegyi, Gabor; Fabian, Orsolya; Keri, Gyorgy; Valyi-Nagy, Istvan; Petak, Istvan			Molecular subtype specific efficacy of MEK inhibitors in pancreatic cancers	PLOS ONE			English	Article							LUNG-CANCER; KRAS; ADENOCARCINOMA; COMBINATION; TRAMETINIB; EXPRESSION; LANDSCAPE; FEEDBACK; GROWTH; MODEL	Pancreatic cancer is an increasing cause of cancer related death worldwide. KRAS is the dominant oncogene in this cancer type and molecular rationale would indicate, that inhibitors of the downstream target MEK could be appropriate targeted agents, but clinical trials have failed so far to achieve statistically significant benefit in unselected patients. We aimed to identify predictive molecular biomarkers that can help to define subgroups where MEK inhibitors might be beneficial alone or in combination. Next-generation sequencing data of 50 genes in three pancreatic cancer cell lines (MiaPaCa2, BxPC3 and Panc1) were analyzed and compared to the molecular profile of 138 clinical pancreatic cancer samples to identify the molecular subtypes of pancreatic cancer these cell lines represent. Luminescent cell viability assay was used to determine the sensitivity of cell lines to kinase inhibitors. Western blot was used to analyze the pathway activity of the examined cell lines. According to our cell viability and pathway activity data on these model cell lines only cells harboring the rare G12C KRAS mutation and low EGFR expression are sensitive to single MEK inhibitor (trametinib) treatment. The common G12D KRAS mutation leads to elevated baseline Akt activity, thus treatment with single MEK inhibitors fails. However, combination of MEK and Akt inhibitors are synergistic in this case. In case of wild-type KRAS and high EGFR expression MEK inhibitor induced Akt phosphorylation leads to trametinib resistance which necessitates for MEK and EGFR or Akt inhibitor combination treatment. In all we provide strong preclinical rational and possible molecular mechanism to revisit MEK inhibitor therapy in pancreatic cancer in both monotherapy and combination, based on molecular profile analysis of pancreatic cancer samples and cell lines. According to our most remarkable finding, a small subgroup of patients with G12C KRAS mutation may still benefit from MEK inhibitor monotherapy.	[Brauswetter, Diana; Gurbi, Bianka; Varga, Attila; Banhegyi, Gabor; Keri, Gyorgy; Petak, Istvan] MTA SE Pathobiochem Res Grp, Budapest, Hungary; [Varkondi, Edit; Schwab, Richard; Fabian, Orsolya; Petak, Istvan] Oncompass Med Ltd, Budapest, Hungary; [Banhegyi, Gabor] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary; [Valyi-Nagy, Istvan] St Istvan & St Laszlo Hosp, Budapest, Hungary	Semmelweis University; Semmelweis University	Brauswetter, D (corresponding author), MTA SE Pathobiochem Res Grp, Budapest, Hungary.	brauswetter.diana@med.semmelweis-univ.hu	Petak, Istvan/X-3656-2019; Gurbi, Bianka/F-4220-2017; Schwab, Richard/AAX-9262-2020	Gurbi, Bianka/0000-0002-5635-6255; Valyi-Nagy, Istvan/0000-0003-3581-113X	(National Oncogenomical and Precision Oncotherapy Program) by NFKI Fund of National Research, Development and Innovation Office [NVKP_16-1-2016-0005]	(National Oncogenomical and Precision Oncotherapy Program) by NFKI Fund of National Research, Development and Innovation Office	This study was supported by the grant NVKP_16-1-2016-0005 (National Oncogenomical and Precision Oncotherapy Program) by NFKI Fund of National Research, Development and Innovation Office.	Bedard PL, 2015, CLIN CANCER RES, V21, P730, DOI 10.1158/1078-0432.CCR-14-1814; Bloomston M, 2006, DIGEST SURG, V23, P74, DOI 10.1159/000093497; Bodoky G, 2012, INVEST NEW DRUG, V30, P1216, DOI 10.1007/s10637-011-9687-4; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Collisson EA, 2012, CANCER DISCOV, V2, P685, DOI 10.1158/2159-8290.CD-11-0347; Dumble M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100880; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Glubb DM, 2011, CLIN CANCER RES, V17, P5257, DOI 10.1158/1078-0432.CCR-11-0379; Heestand GM, 2015, ONCOTARGET, V6, P4553, DOI 10.18632/oncotarget.2972; Ihle NT, 2012, JNCI-J NATL CANCER I, V104, P228, DOI 10.1093/jnci/djr523; Infante JR, 2014, EUR J CANCER, V50, P2072, DOI 10.1016/j.ejca.2014.04.024; Janne PA, 2015, BRIT J CANCER, V113, P199, DOI 10.1038/bjc.2015.215; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Makohon-Moore A, 2016, NAT REV CANCER, V16, P553, DOI 10.1038/nrc.2016.66; Manchado E, 2016, NATURE, V534, P647, DOI 10.1038/nature18600; Mirzoeva OK, 2013, MOL CANCER THER, V12, P2213, DOI 10.1158/1535-7163.MCT-13-0104; Modest DP, 2013, J CANCER RES CLIN, V139, P953, DOI 10.1007/s00432-013-1401-9; Mullendore ME, 2009, CLIN CANCER RES, V15, P2291, DOI 10.1158/1078-0432.CCR-08-2004; Nadal E, 2015, J THORAC ONCOL, V10, pE9, DOI 10.1097/JTO.0000000000000438; Pettazzoni P, 2015, CANCER RES, V75, P1091, DOI 10.1158/0008-5472.CAN-14-1854; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Silva IP, 2016, CLIN CANCER RES, V22, P2377, DOI 10.1158/1078-0432.CCR-15-1811; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Walters DM, 2013, NEOPLASIA, V15, P143, DOI 10.1593/neo.121712; Wolfgang CL, 2013, CA-CANCER J CLIN, V63, P318, DOI 10.3322/caac.21190; Zhang NN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153546; Zhou L, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0745-9	30	15	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185687	10.1371/journal.pone.0185687	http://dx.doi.org/10.1371/journal.pone.0185687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957417	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000411985200106
J	Hossein, F; Ghosh, P; Khan, MAA; Duthie, MS; Vallur, AC; Picone, A; Howard, RF; Reed, SG; Mondai, D				Hossein, Faria; Ghosh, Prakash; Khan, Md. Anik Ashfaq; Duthie, Malcolm S.; Vallur, Aarthy C.; Picone, Alessandro; Howard, Randall F.; Reed, Steven G.; Mondai, Dinesh			Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment	PLOS ONE			English	Article							AZAR DERMAL LEISHMANIASIS; POLYMERASE-CHAIN-REACTION; PERIPHERAL-BLOOD; CLINICAL MANAGEMENT; INFANTUM DNA; ENDEMIC AREA; ASSAY; QUANTIFICATION; SAMPLES; TOOLS	Sustained elimination of Visceral Leishmaniasis (VL) requires the reduction and control of parasite reservoirs to minimize the transmission of Leishmania donovani infection. A simple, reproducible and definitive diagnostic procedure is therefore indispensable for the early and accurate detection of parasites in VL, Relapsed VL (RVL) and Post Kala-azar Dermal Leishmaniasis (PKDL) patients, all of whom are potential reservoirs of Leishmania parasites. To overcome the limitations of current diagnostic approaches, a novel quantitative real-time polymerase chain reaction (qPCR) method based on Taqman chemistry was devised for the detection and quantification of L. donovani in blood and skin. The diagnostic efficacy was evaluated using archived peripheral blood buffy coat DNA from 40 VL, 40 PKDL, 10 RVL, 20 cured VL, and 40 cured PKDL along with 10 tuberculosis (TB) cases and 80 healthy endemic controls. Results were compared to those obtained using a Leishmania-specific nested PCR (Ln-PCR). The real time PCR assay was 100% (95% CI, 91.19-100%) sensitive in detecting parasite genomes in VL and RVL samples and 85.0% (95% CI, 70.16-94.29%) sensitive for PKDL samples. In contrast, the sensitivity of Ln-PCR was 77.5% (95% CI, 61.55-89.16%) for VL samples, 100% (95% CI, 69.15-100%) for RVL samples, and 52.5% (95% CI, 36.13-68.49%) for PKDL samples. There was significant discordance between the two methods with the overall sensitivity of the qPCR assay being considerably higher than Ln-PCR. None of the assay detected L. donovani DNA in buffy coats from cured VL cases, and reduced infectious burdens were demonstrated in cured PKDL cases who remained positive in 7.5% (3/40) and 2.5% (1/40) cases by real-time PCR and Ln-PCR, respectively. Both assays were 100% (95% CI, 95.98-100) specific with no positive signals in either endemic healthy control or TB samples. The real time PCR assay we developed offers a molecular tool for accurate detection of circulating L. donovani parasites in VL, PKDL and RVL patients, as well as being capable of assessing response to treatment. As such, this real time PCR assay represents an important contribution in efforts to eliminate VL.	[Hossein, Faria; Ghosh, Prakash; Khan, Md. Anik Ashfaq; Mondai, Dinesh] Int Ctr Diarrhoea Dis Res, Nutr & Clin Sci Div, Lab Emerging Infect & Parasitol, Dhaka, Bangladesh; [Duthie, Malcolm S.; Picone, Alessandro; Howard, Randall F.; Reed, Steven G.] Infect Dis Res Inst, Seattle, WA USA; [Vallur, Aarthy C.] InBios Int Inc, Seattle, WA USA	International Centre for Diarrhoeal Disease Research (ICDDR)	Mondai, D (corresponding author), Int Ctr Diarrhoea Dis Res, Nutr & Clin Sci Div, Lab Emerging Infect & Parasitol, Dhaka, Bangladesh.	din63d@icddrb.org	Khan, Md Anik Ashfaq/ABA-7789-2021; Ghosh, Prakash/ABS-4307-2022	Khan, Md Anik Ashfaq/0000-0003-2963-7649; Ghosh, Prakash/0000-0002-4300-8761; Duthie, Malcolm/0000-0002-8515-5516	Bill and Melinda Gates Foundation [OPP49932, OPP1084251]; NIAID of the National Institutes of Health [R01A1025038]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIAID of the National Institutes of Health	This research was supported with funding from the Bill and Melinda Gates Foundation, under grants OPP49932 and OPP1084251 and by Grant No. R01A1025038 from NIAID of the National Institutes of Health to Dr. Steven G Reed. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Bill and Melinda Gates Foundation or the National Institutes of Health. The funder provided support in the form of salaries for authors [DM, PG, FH, MAAK,], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section". One of the authors is working in InBios International Inc who voluntarily worked in developing the manuscript. Therefore, InBios International Inc has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeijon C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002161; Adams ER, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/150746; Antinori S, 2007, CLIN INFECT DIS, V44, P1602, DOI 10.1086/518167; Antinori S, 2009, AM J TROP MED HYG, V81, P46, DOI 10.4269/ajtmh.2009.81.46; Bossolasco S, 2003, J CLIN MICROBIOL, V41, P5080, DOI 10.1128/JCM.41.11.5080-5084.2003; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Cruz I, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS185, DOI 10.1016/S0035-9203(02)90074-X; Cruz I, 2006, J CLIN MICROBIOL, V44, P2343, DOI 10.1128/JCM.02297-05; Freitas-Junior LH, 2012, INT J PARASITOL-DRUG, V2, P11, DOI 10.1016/j.ijpddr.2012.01.003; Ghasemian Mehrdad, 2016, J Parasit Dis, V40, P81, DOI 10.1007/s12639-014-0452-4; Ghosh P, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1667-2; Hasnain MG, 2016, AM J TROP MED HYG, V94, P99, DOI 10.4269/ajtmh.15-0136; Islam S, 2013, AM J TROP MED HYG, V89, P345, DOI 10.4269/ajtmh.12-0711; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Lima Junior M. S. da C., 2013, Asian Pacific Journal of Tropical Disease, V3, P10; Marking U, 2014, PLOS NEGLECT TROP D, V8, P6; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Mary C, 2006, AM J TROP MED HYG, V75, P858, DOI 10.4269/ajtmh.2006.75.858; Matlashewski G, 2011, LANCET INFECT DIS, V11, P322, DOI 10.1016/S1473-3099(10)70320-0; Mondal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000355; Mukhopadhyay D, 2014, TRENDS PARASITOL, V30, P65, DOI 10.1016/j.pt.2013.12.004; Nasreen SA, 2012, JPN J INFECT DIS, V65, P315, DOI 10.7883/yoken.65.315; Pereira MR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/639310; Pita-Pereira D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-15; Ruiter CM, 2014, J CLIN MICROBIOL, V52; Salam MA, 2010, ACTA TROP, V113, P52, DOI 10.1016/j.actatropica.2009.09.005; Salotra P, 2006, INDIAN J MED RES, V123, P295; Sharma Umakant, 2008, Journal of Vector Borne Diseases, V45, P255; Sreenivas G, 2004, J CLIN MICROBIOL, V42, P1777, DOI 10.1128/JCM.42.4.1777-1778.2004; Srivastava P, 2011, T ROY SOC TROP MED H, V105, P1, DOI 10.1016/j.trstmh.2010.09.006; Srividya G, 2012, PARASITOL RES, V110, P1065, DOI 10.1007/s00436-011-2680-1; Sudarshan M, 2015, J CLIN MICROBIOL, V53, P3905, DOI 10.1128/JCM.01465-15; Sudarshan M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003366; Sudarshan M, 2011, J ANTIMICROB CHEMOTH, V66, P1751, DOI 10.1093/jac/dkr185; Tiwary P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061370; Topno RK, 2010, AM J TROP MED HYG, V83, P502, DOI 10.4269/ajtmh.2010.09-0345; Tsokana CN, 2014, LEISHMANIASIS - TRENDS IN EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT, P161, DOI 10.5772/57448; Vallur AC, 2014, CLIN MICROBIOL INFEC, V20, pO374, DOI 10.1111/1469-0691.12421; Verma N, 2013, J CLIN MICROBIOL, V51, P4217, DOI 10.1128/JCM.01482-13; Verma S, 2010, PLOS ONE, V5; Verma S, 2013, TROP MED INT HEALTH, V18, P268, DOI 10.1111/tmi.12047; Weirather JL, 2011, J CLIN MICROBIOL, V49, P3892, DOI 10.1128/JCM.r00764-11; World Health Organization, 2015, KAL AZ EL PROGR; Wortmann G, 2005, AM J TROP MED HYG, V73, P999, DOI 10.4269/ajtmh.2005.73.999; Zijlstra EE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1721-0	45	46	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185606	10.1371/journal.pone.0185606	http://dx.doi.org/10.1371/journal.pone.0185606			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957391	gold, Green Published, Green Submitted			2022-12-27	WOS:000411985200093
J	Ryan, TP; Morrison, RD; Sutherland, JJ; Milne, SB; Ryan, KA; Daniels, JS; Misra-Hebert, A; Hicks, JK; Vogan, E; Teng, K; Daly, TM				Ryan, Timothy P.; Morrison, Ryan D.; Sutherland, Jeffrey J.; Milne, Stephen B.; Ryan, Kendall A.; Daniels, J. Scott; Misra-Hebert, Anita; Hicks, J. Kevin; Vogan, Eric; Teng, Kathryn; Daly, Thomas M.			Medication adherence, medical record accuracy, and medication exposure in real-world patients using comprehensive medication monitoring	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; UNITED-STATES; HEALTH-CARE; MS ASSAY; DRUG; THERAPY; ANTIDEPRESSANTS; RECONCILIATION; ESCITALOPRAM; TRANSITIONS	Background Poor adherence to medication regimens and medical record inconsistencies result in incomplete knowledge of medication therapy in polypharmacy patients. By quantitatively identifying medications in the blood of patients and reconciling detected medications with the medical record, we have defined the severity of this knowledge gap and created a path toward optimizing medication therapy. Methods and findings We validated a liquid chromatography-tandem mass spectrometry assay to detect and/or quantify 38 medications across a broad range of chronic diseases to obtain a comprehensive survey of patient adherence, medical record accuracy, and exposure variability in two patient populations. In a retrospectively tested 821-patient cohort representing U.S. adults, we found that 46% of medications assessed were detected in patients as prescribed in the medical record. Of the remaining medications, 23% were detected, but not listed in the medical record while 30% were prescribed to patients, but not detected in blood. To determine how often each detected medication fell within literature-derived reference ranges when taken as prescribed, we prospectively enrolled a cohort of 151 treatment-regimen adherent patients. In this cohort, we found that 53% of medications that were taken as prescribed, as determined using patient self-reporting, were not within the blood reference range. Of the medications not in range, 83% were below and 17% above the lower and upper range limits, respectively. Only 32% of out-of-range medications could be attributed to short oral half-lives, leaving extensive exposure variability to result from patient behavior, undefined drug interactions, genetics, and other characteristics that can affect medication exposure. Conclusions This is the first study to assess compliance, medical record accuracy, and exposure as determinants of real-world treatment and response. Variation in medication detection and exposure is greater than previously demonstrated, illustrating the scope of current therapy issues and opening avenues that warrant further investigation to optimize medication therapy.	[Ryan, Timothy P.; Morrison, Ryan D.; Sutherland, Jeffrey J.; Milne, Stephen B.; Ryan, Kendall A.; Daniels, J. Scott] Sano Informed Prescribing, Sano Labs, Franklin, TN USA; [Misra-Hebert, Anita] Cleveland Clin, Dept Internal Med, Cleveland, OH 44106 USA; [Hicks, J. Kevin; Teng, Kathryn] Cleveland Clin, Med Dept, Cleveland, OH 44106 USA; [Vogan, Eric] Cleveland Clin, Reporting & Analyt, Cleveland, OH 44106 USA; [Daly, Thomas M.] Cleveland Clin, Robert J Tomsich Pathol & Lab Med Inst, Cleveland, OH 44106 USA; [Hicks, J. Kevin] H Lee Moffitt Canc Ctr & Res Inst, Div Populat Sci, Tampa, FL USA; [Teng, Kathryn] Metro Hlth, Internal & Community Med, Cleveland, OH USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; H Lee Moffitt Cancer Center & Research Institute; MetroHealth System	Ryan, TP (corresponding author), Sano Informed Prescribing, Sano Labs, Franklin, TN USA.	tim@thinksano.com		Misra-Hebert, Anita/0000-0003-3079-7025	Sano Informed Prescribing	Sano Informed Prescribing	Sano Informed Prescribing provided support in the form of salaries for TPR, RDM, JJS, SBM, KAR, and JSD. Study design and sample collection was performed by the investigator site (AMH, JKH, EV, TMD), and blinded sample analysis was performed as indicated in Methods by RDM, SBM, and KAR. All authors agreed to publish results and analysis, with joint manuscript organization and composition taking place after study completion.	Aitken M, 2015, GLOBAL USE MEDICINES; Aitken MV., 2013, AVOIDABLE COSTS US H; Albert NM, 2008, CRIT CARE NURSE, V28, P54; Baer D. M., 2015, CUTOFF TOXICITY LEVE; Bruckart J., 2013, MEDI ADHERENCE AM NA, P1; Brummel A, 2014, J MANAG CARE SPEC PH, V20, P1152, DOI 10.18553/jmcp.2014.20.12.1152; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Bunting BA, 2008, J AM PHARM ASSOC, V48, P23, DOI 10.1331/JAPhA.2008.07140; Bunting BA, 2011, AM HEALTH DRUG BENEF, V4, P343; Cao Z, 2015, J ANAL TOXICOL, V39, P335, DOI 10.1093/jat/bkv024; Choudhry N. K., 2017, JAMA INT MED; Costedoat-Chalumeau N, 2013, BEST PRACT RES CL RH, V27, P329, DOI 10.1016/j.berh.2013.07.001; Crettol S, 2014, CLIN PHARMACOL THER, V95, P254, DOI 10.1038/clpt.2013.221; Cumbler E, 2010, J HOSP MED, V5, P83, DOI 10.1002/jhm.566; Cutler DM, 2010, NEW ENGL J MED, V362, P1553, DOI 10.1056/NEJMp1002305; Czobor P, 2011, MOL INTERV, V11, P107, DOI 10.1124/mi.11.2.8; DeGorter MK, 2013, CIRC-CARDIOVASC GENE, V6, P400, DOI 10.1161/CIRCGENETICS.113.000099; Dias E, 2013, J CHROMATOGR B, V937, P44, DOI 10.1016/j.jchromb.2013.08.010; Dieleman JL, 2016, JAMA-J AM MED ASSOC, V316, P2627, DOI 10.1001/jama.2016.16885; Gjestad C, 2015, THER DRUG MONIT, V37, P90, DOI 10.1097/FTD.0000000000000101; Gleason KM, 2010, J GEN INTERN MED, V25, P441, DOI 10.1007/s11606-010-1256-6; Grundmann M, 2015, BIOMED PAP, V159, P35, DOI 10.5507/bp.2013.020; Hammett-Stabler C. A, 2015, CRITICAL VALUES THER; Hefner G, 2013, INT REV PSYCHIATR, V25, P494, DOI 10.3109/09540261.2013.836475; Hiemke C, 2011, PHARMACOPSYCHIATRY, V44, P195, DOI 10.1055/s-0031-1286287; Horn SD, 2007, MED CARE, V45, pS50, DOI 10.1097/MLR.0b013e318070c07b; Jin YY, 2010, J CLIN PHARMACOL, V50, P62, DOI 10.1177/0091270009337946; Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V316, P858, DOI 10.1001/jama.2016.11237; Kessler C, 2016, JAMA-J AM MED ASSOC, V316, P2092, DOI 10.1001/jama.2016.16392; Kootstra-Ros JE, 2006, J CLIN PHARMACOL, V46, P1320, DOI 10.1177/0091270006293754; Kymes SM, 2016, AM J MANAG CARE, V22, pE295; Mekonnen AB, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010003; Mixon AS, 2015, GERONTOLOGY, V61, P32, DOI 10.1159/000363765; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; PAN HY, 1990, CLIN PHARMACOL THER, V48, P201, DOI 10.1038/clpt.1990.136; Phansalkar S, 2015, AM J HEALTH-SYST PH, V72, P212, DOI 10.2146/ajhp140082; Poggenborg RP, 2006, BASIC CLIN PHARMACOL, V99, P209, DOI 10.1111/j.1742-7843.2006.pto_318.x; Roblek T, 2015, EUR J CLIN PHARMACOL, V71, P131, DOI 10.1007/s00228-014-1786-7; Schoretsanitis G, 2016, EUR J CLIN PHARMACOL, V72, P1091, DOI 10.1007/s00228-016-2085-2; Schulz M, 1997, PHARMAZIE, V52, P895; Schulz M, 2012, CRIT CARE, V16, DOI 10.1186/cc11441; Sutherland JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118991; Traylor AH, 2010, J GEN INTERN MED, V25, P1172, DOI 10.1007/s11606-010-1424-8; Viswanathan M, 2012, ANN INTERN MED, V157, P785, DOI 10.7326/0003-4819-157-11-201212040-00538	44	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185471	10.1371/journal.pone.0185471	http://dx.doi.org/10.1371/journal.pone.0185471			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957369	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200067
J	Schweitzer, MD; Salamo, O; Campos, M; Schraufnagel, DE; Sadikot, R; Mirsaeidi, M				Schweitzer, Michael D.; Salamo, Oriana; Campos, Michael; Schraufnagel, Dean E.; Sadikot, Ruxana; Mirsaeidi, Mehdi			Body habitus in patients with and without bronchiectasis and non-tuberculous mycobacteria	PLOS ONE			English	Article							AVIUM COMPLEX; CYSTIC-FIBROSIS; INDICUS-PRANII; DISEASE; INFECTIONS; DIAGNOSIS; CT	Background Female gender, tall stature, presence of bronchiectasis are associated with pulmonary non-tuberculous mycobacterial (NTM) infections. The biologic relationship between the body habitus and NTM infection is not well defined and the body habitus profile of the patients with NTM and concurrent bronchiectasis is completely unknown. Methods We conducted a case control study at the Miami VA Healthcare System and the University of Illinois Medical Center on patients with pulmonary NTM infections between 2010 and 2015. We compared pulmonary NTM subjects with and without bronchiectasis. NTM infection was confirmed by using the American Thoracic Society/Infectious Disease Society of America criteria. Standard radiological criteria were used to define bronchiectasis in chest CT-scan. Results Two hundred twenty subjects with pulmonary NTM were enrolled in the study. Sixty six subjects (30%) had bronchiectasis on CT scan of the chest. Subjects in the bronchiectasis group included more women (p = 0.002) and were significantly older (p = 0.005). Those patients who had bronchiectasis tended to have a significantly lower weight (less than 50kg) and height <= 155 cm (p < 0.0001 and p = 0.018, respectively). Kaplan-Meier analysis confirmed that subjects who had bronchiectasis were shorter and weighed less, after adjusting for gender. Conclusions This study defines a new sub-phenotype of NTM subjects with bronchiectasis who tend to be short with lower body weight. Further studies are needed to better understand and define the body habitus profiles of this new sub-phenotype and their clinical implications.	[Schweitzer, Michael D.; Salamo, Oriana; Campos, Michael; Mirsaeidi, Mehdi] Miami VA Med Ctr, Dept Med, Sect Pulm, Miami, FL 33125 USA; [Campos, Michael; Mirsaeidi, Mehdi] Univ Miami, Dept Med, Div Pulm & Crit Care, Miami, FL 33146 USA; [Schraufnagel, Dean E.] Univ Illinois, Dept Med, Div Pulm & Crit Care, Chicago, IL USA; [Sadikot, Ruxana] Univ Emory, Dept Med, Div Pulm & Crit Care, Atlanta, GA USA	University of Miami; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mirsaeidi, M (corresponding author), Miami VA Med Ctr, Dept Med, Sect Pulm, Miami, FL 33125 USA.; Mirsaeidi, M (corresponding author), Univ Miami, Dept Med, Div Pulm & Crit Care, Miami, FL 33146 USA.	msm249@med.miami.edu	Campos, Michael/X-2025-2019	Campos, Michael/0000-0001-5485-9062; Schraufnagel, Dean/0000-0003-0063-7223; Mirsaeidi, Mehdi/0000-0001-5298-8442				Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; Bonaiti G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/197950; Chan ED, 2010, GENDER MED, V7, P5, DOI 10.1016/j.genm.2010.01.005; COLE PJ, 1986, EUR J RESPIR DIS, V69, P6; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Han XY, 2005, J CLIN MICROBIOL, V43, P4407, DOI 10.1128/JCM.43.9.4407-4412.2005; HARTMAN TE, 1994, RADIOGRAPHICS, V14, P991, DOI 10.1148/radiographics.14.5.7991828; Johnson MM, 2014, J THORAC DIS, V6, P210, DOI 10.3978/j.issn.2072-1439.2013.12.24; Kamada M, 2001, AM J OBSTET GYNECOL, V184, P309, DOI 10.1067/mob.2001.109940; Kim RD, 2008, AM J RESP CRIT CARE, V178, P1066, DOI 10.1164/rccm.200805-686OC; King Paul T, 2009, Int J Chron Obstruct Pulmon Dis, V4, P411; Koh WJ, 2005, RADIOLOGY, V235, P282, DOI 10.1148/radiol.2351040371; Diaz LVL, 2017, INT J CHRONIC OBSTR, V12, P2257, DOI 10.2147/COPD.S143424; Medrek SK, 2017, COPD, V14, P484, DOI 10.1080/15412555.2017.1336209; Mirsaeidi M, 2017, CHEST, V151, P947, DOI 10.1016/j.chest.2017.02.013; Mirsaeidi M, 2015, INT J MYCOBACT, V4, P92, DOI 10.1016/j.ijmyco.2015.05.002; Mirsaeidi M, 2014, EUR J INTERN MED, V25, P356, DOI 10.1016/j.ejim.2014.03.008; Mirsaeidi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091879; Mirsaeidi M, 2013, INT J INFECT DIS, V17, pE1000, DOI 10.1016/j.ijid.2013.03.018; Morrissey BM, 2007, CLIN CHEST MED, V28, P289, DOI 10.1016/j.ccm.2007.02.014; Okumura M, 2008, INTERNAL MED, V47, P1465, DOI 10.2169/internalmedicine.47.1114; Pappalettera M, 2009, CLIN RESPIR J, V3, P126, DOI 10.1111/j.1752-699X.2009.00131.x; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Rahman SA, 2014, MBIO, V5, DOI 10.1128/mBio.02020-14; REICH JM, 1992, CHEST, V101, P1605, DOI 10.1378/chest.101.6.1605; Saini V, 2012, NUCLEIC ACIDS RES, V40, P10832, DOI 10.1093/nar/gks793; Shoemark A, 2007, RESP MED, V101, P1163, DOI 10.1016/j.rmed.2006.11.008; Singh Y, 2014, INT J MED MICROBIOL, V304, P742, DOI 10.1016/j.ijmm.2014.05.006; Strausbaugh SD, 2007, CLIN CHEST MED, V28, P279, DOI 10.1016/j.ccm.2007.02.011; Van De Poel E, 2008, B WORLD HEALTH ORGAN, V86, P282, DOI 10.2471/BLT.07.044800; Velayati AA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/254285; Winthrop KL, 2011, PHARMACOEPIDEM DR S, V20, P229, DOI 10.1002/pds.2049	32	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185095	10.1371/journal.pone.0185095	http://dx.doi.org/10.1371/journal.pone.0185095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957340	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200029
J	Smith, CEL; Alexandraki, A; Cordery, SF; Parmar, R; Bonthron, DT; Valleley, EMA				Smith, Claire E. L.; Alexandraki, Alexia; Cordery, Sarah F.; Parmar, Rekha; Bonthron, David T.; Valleley, Elizabeth M. A.			A tissue-specific promoter derived from a SINE retrotransposon drives biallelic expression of PLAGL1 in human lymphocytes	PLOS ONE			English	Review							T-CELLS; GENE; ZAC/PLAGL1	The imprinted gene PLAGL1 is an important regulator of apoptosis and cell cycle arrest. Loss of its expression has been implicated in tumorigenesis in a range of different cancers, and overexpression during fetal development causes transient neonatal diabetes mellitus (TNDM). PLAGL1 lies within an imprinted region of chromosome 6q24, and monoallelic expression from the major, differentially methylated promoter (P1) occurs in most human tissues. However, in peripheral blood leukocytes, the active promoter (P2) is non-imprinted and drives biallelic transcription. We report here a novel PLAGL1 promoter (P5) derived from the insertion of a primate-specific, MIR3 SINE retrotransposon. P5 is highly utilized in lymphocytes, particularly in T cells, and like P2, directs biallelic transcription. Our results show that it is important to consider P5 in relation to PLAGL1 function in T cells when investigating the dysregulation of this gene.	[Smith, Claire E. L.; Alexandraki, Alexia; Cordery, Sarah F.; Parmar, Rekha; Bonthron, David T.; Valleley, Elizabeth M. A.] Univ Leeds, St Jamess Univ Hosp, Sch Med, Leeds, W Yorkshire, England; [Cordery, Sarah F.] Univ Bath, Dept Pharm & Pharmacol, Bath, Avon, England	Saint James's University Hospital; University of Leeds; University of Bath	Valleley, EMA (corresponding author), Univ Leeds, St Jamess Univ Hosp, Sch Med, Leeds, W Yorkshire, England.	E.M.A.Valleley@leeds.ac.uk		Smith, Claire/0000-0001-8320-5105	Yorkshire Cancer Research Pump-Priming awards; Pilot grant award from Breast Cancer Campaign; Yorkshire Cancer Research project grant [L330]; University of Leeds 110 Anniversary Postgraduate Research Scholarship; Medical Research Council [MR/M009084/1] Funding Source: researchfish; MRC [MR/M009084/1] Funding Source: UKRI	Yorkshire Cancer Research Pump-Priming awards; Pilot grant award from Breast Cancer Campaign; Yorkshire Cancer Research project grant; University of Leeds 110 Anniversary Postgraduate Research Scholarship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CELS, SFC and RP were supported by two Yorkshire Cancer Research Pump-Priming awards and a Pilot grant award from Breast Cancer Campaign. Funding is also acknowledged from a Yorkshire Cancer Research project grant (L330) to EMAV and DTB. AA is supported by a University of Leeds 110 Anniversary Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2007, J CELL PHYSIOL, V210, P16, DOI 10.1002/jcp.20835; Berg JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026410; Bilanges B, 2001, ONCOGENE, V20, P1246, DOI 10.1038/sj.onc.1204237; Carr IM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm330; Cheong CY, 2015, GENOME RES, V25, P611, DOI 10.1101/gr.183301.114; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Estecio MRH, 2012, MOL CANCER RES, V10, P1332, DOI 10.1158/1541-7786.MCR-12-0351; Frost JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013556; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Hide T, 2009, CANCER RES, V69, P7953, DOI 10.1158/0008-5472.CAN-09-2006; Hubley R., 2013, REPEATMASKER OPEN 40; Iglesias-Platas I, 2013, NUCLEIC ACIDS RES, V41, P2171, DOI 10.1093/nar/gks1355; Jjingo D, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-14; Kamiya M, 2000, HUM MOL GENET, V9, P453, DOI 10.1093/hmg/9.3.453; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Lin L, 2009, HUM MOL GENET, V18, P2204, DOI 10.1093/hmg/ddp152; Macaulay EC, 2011, MAMM GENOME, V22, P722, DOI 10.1007/s00335-011-9355-1; Miyagawa Y, 2009, IMMUNOLOGY, V128, P405, DOI 10.1111/j.1365-2567.2009.03122.x; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; SMIT AFA, 1995, NUCLEIC ACIDS RES, V23, P98, DOI 10.1093/nar/23.1.98; Valleley EM, 2007, HUM MOL GENET, V16, P972, DOI 10.1093/hmg/ddm041; Valleley EMA, 2010, GENE CHROMOSOME CANC, V49, P480, DOI 10.1002/gcc.20758; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Vega-Benedetti AF, 2017, J APPL GENET, V58, P71, DOI 10.1007/s13353-016-0355-4; Wang J, 2015, P NATL ACAD SCI USA, V112, pE4428, DOI 10.1073/pnas.1507253112	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185678	10.1371/journal.pone.0185678	http://dx.doi.org/10.1371/journal.pone.0185678			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957425	Green Published, gold			2022-12-27	WOS:000411985200105
J	Pessoa, R; Sanabani, SS				Pessoa, Rodrigo; Sanabani, Sabri S.			High prevalence of HIV-1 transmitted drug-resistance mutations from proviral DNA massively parallel sequencing data of therapy-naive chronically infected Brazilian blood donors	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RIO-DE-JANEIRO; REVERSE-TRANSCRIPTASE; GENOTYPIC RESISTANCE; ANTIRETROVIRAL THERAPY; INDIVIDUALS; FREQUENCY; VARIANTS; DIVERSITY; INTEGRASE	Background An improved understanding of the prevalence of low-abundance transmitted drug-resistance mutations (TDRM) in therapy-naive HIV-1-infected patients may help determine which patients are the best candidates for therapy. In this study, we aimed to obtain a comprehensive picture of the evolving HIV-1 TDRM across the massive parallel sequences (MPS) of the viral entire proviral genome in a well-characterized Brazilian blood donor naive to antiretroviral drugs. Materials and methods The MPS data from 128 samples used in the analysis were sourced from Brazilian blood donors and were previously classified by less-sensitive (LS) or "detuned" enzyme immunoassay as non-recent or longstanding HIV-1 infections. The Stanford HIV Resistance Database (HIVDBv 6.2) and IAS-USA mutation lists were used to interpret the pattern of drug resistance. The minority variants with TDRM were identified using a threshold of >= 1.0% and <= 20% of the reads sequenced. The rate of TDRM in the MPS data of the proviral genome were compared with the corresponding published consensus sequences of their plasma viruses. Results No TDRM were detected in the integrase or envelope regions. The overall prevalence of TDRM in the protease (PR) and reverse transcriptase (RT) regions of the HIV-1 pol gene was 44.5% (57/128), including any mutations to the nucleoside analogue reverse transcriptase inhibitors (NRTI) and non-nucleoside analogue reverse transcriptase inhibitors (NNRTI). Of the 57 subjects, 43 (75.4%) harbored a minority variant containing at least one clinically relevant TDRM. Among the 43 subjects, 33 (76.7%) had detectable minority resistant variants to NRTIs, 6 (13.9%) to NNRTIs, and 16 (37.2%) to PR inhibitors. The comparison of viral sequences in both sources, plasma and cells, would have detected 48 DNA provirus disclosed TDRM by MPS previously missed by plasma bulk analysis. Conclusion Our findings revealed a high prevalence of TDRM found in this group, as the use of MPS drastically increased the detection of these mutations. Sequencing proviral DNA provided additional information about TDRM, which may impact treatment decisions. The overall results emphasize the importance of continuous monitoring.	[Pessoa, Rodrigo; Sanabani, Sabri S.] Univ Sao Paulo, Trop Med Inst Sao Paulo, Dept Dermatol, Lab Dermatol & Immunodeficiencies, Sao Paulo, Brazil; [Sanabani, Sabri S.] Univ Sao Paulo, Sch Med, Hosp Clin, Dept Pathol,Clin Lab, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Sanabani, SS (corresponding author), Univ Sao Paulo, Trop Med Inst Sao Paulo, Dept Dermatol, Lab Dermatol & Immunodeficiencies, Sao Paulo, Brazil.; Sanabani, SS (corresponding author), Univ Sao Paulo, Sch Med, Hosp Clin, Dept Pathol,Clin Lab, Sao Paulo, Brazil.	sabyem_63@yahoo.com	Sanabani, Sabri Saeed/F-5600-2012; Pessôa, Rodrigo/B-7206-2018	Sanabani, Sabri Saeed/0000-0002-8876-8262; 	Fundagao de Amparo a Pesquisa do Estado de Sao Paulo [2014/26983-3, 2014/24596-2]	Fundagao de Amparo a Pesquisa do Estado de Sao Paulo	This work was supported by grants 2014/26983-3, and 2014/24596-2 from the Fundagao de Amparo a Pesquisa do Estado de Sao Paulo. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants 2014/26983-3, and 2014/24596-2 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo.	Afonso JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042996; [Anonymous], 2006, HLTH CAN HIV 1 STRAI; Avila-Rios S, 2015, AIDS RES HUM RETROV, V31, P401, DOI 10.1089/aid.2014.0057; Avila-Rios S, 2011, REV PANAM SALUD PUBL, V30, P641, DOI 10.1590/S1020-49892011001200024; Avila-Rios S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027812; Banks Lauren, 2012, J AIDS Clin Res, V3, P141; Bansode V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-52; Barreto CC, 2006, JAIDS-J ACQ IMM DEF, V41, P338; Baxter JD, 2015, HIV MED, V16, P77, DOI 10.1111/hiv.12236; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bimber BN, 2010, J VIROL, V84, P12087, DOI 10.1128/JVI.01378-10; Boltz VF, 2011, P NATL ACAD SCI USA, V108, P9202, DOI 10.1073/pnas.1105688108; Bon I, 2007, J CLIN VIROL, V38, P313, DOI 10.1016/j.jcv.2006.12.018; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P1047, DOI 10.1093/jac/dkm082; Brindeiro R, 1999, ANTIMICROB AGENTS CH, V43, P1674, DOI 10.1128/AAC.43.7.1674; Buchacz K, 2015, J ANTIMICROB CHEMOTH, V70, P2337, DOI 10.1093/jac/dkv120; Chabria SB, 2014, ANNU REV GENOM HUM G, V15, P295, DOI 10.1146/annurev-genom-091212-153406; Charpentier C, 2010, AIDS, V24, P867, DOI 10.1097/QAD.0b013e3283367796; DiazGranados CA, 2010, INT J INFECT DIS, V14, pE298, DOI 10.1016/j.ijid.2009.05.006; Dudley DM, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0122-8; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Fisher R, 2012, J VIROL, V86, P6231, DOI 10.1128/JVI.06541-11; Frentz D, 2012, AIDS REV, V14, P17; Gibson RM, 2014, ANTIMICROB AGENTS CH, V58, P2167, DOI 10.1128/AAC.02710-13; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Holguin A, 2013, CLIN MICROBIOL INFEC, V19, pE523, DOI 10.1111/1469-0691.12264; Jakobsen MR, 2010, CLIN INFECT DIS, V50, P566, DOI 10.1086/650001; Kabamba-Mukadi B, 2010, HIV MED, V11, P483, DOI 10.1111/j.1468-1293.2009.00814.x; Kasang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023091; Kearney M, 2009, J VIROL, V83, P2715, DOI 10.1128/JVI.01960-08; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Luciani F, 2012, TRENDS BIOTECHNOL, V30, P443, DOI 10.1016/j.tibtech.2012.05.005; Melikian GL, 2014, J ANTIMICROB CHEMOTH, V69, P12, DOI 10.1093/jac/dkt316; Metzner KJ, 2011, J CLIN VIROL, V50, P156, DOI 10.1016/j.jcv.2010.10.001; Metzner KJ, 2003, J INFECT DIS, V188, P1433, DOI 10.1086/379215; Murillo W, 2010, J CLIN VIROL, V49, P239, DOI 10.1016/j.jcv.2010.03.013; Noe A, 2005, J ANTIMICROB CHEMOTH, V55, P410, DOI 10.1093/jac/dki038; Novak RM, 2005, CLIN INFECT DIS, V40, P468, DOI 10.1086/427212; Paredes R, 2010, ANTIVIR RES, V85, P245, DOI 10.1016/j.antiviral.2009.09.015; Pessoa R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152499; Pessoa R, 2015, TRANSFUSION, V55, P980, DOI 10.1111/trf.12936; Pessoa R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112674; Pillay D, 2004, ANTIVIR THER, V9, P695; Pilotto JH, 2013, AIDS RES HUM RETROV, V29, P681, DOI [10.1089/aid.2011.0333, 10.1089/AID.2011.0333]; Pires IL, 2004, J CLIN MICROBIOL, V42, P426, DOI 10.1128/JCM.42.1.426-430.2004; Rowley CF, 2016, J ANTIMICROB CHEMOTH, V71, P1361, DOI 10.1093/jac/dkv500; Schuurman R, 1999, J CLIN MICROBIOL, V37, P2291, DOI 10.1128/JCM.37.7.2291-2296.1999; Shafer RW, 2008, AIDS REV, V10, P67; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Soares MA, 2003, AIDS, V17, P11, DOI 10.1097/00002030-200301030-00004; Ssemwanga D, 2015, AIDS REV, V17, P3; Truong HHM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025281; Van Laethem K, 1999, J ACQ IMMUN DEF SYND, V22, P107; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Xu HT, 2010, ANTIMICROB AGENTS CH, V54, P2401, DOI 10.1128/AAC.01795-09; Yanik EL, 2012, JAIDS-J ACQ IMM DEF, V61, P258, DOI 10.1097/QAI.0b013e3182618f05	62	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185559	10.1371/journal.pone.0185559	http://dx.doi.org/10.1371/journal.pone.0185559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953964	Green Submitted, Green Published, gold			2022-12-27	WOS:000411980300076
J	Winther, TL; Torp, SH				Winther, Theo L.; Torp, Sverre H.			The anti-apoptotic protein survivin can improve the prognostication of meningioma patients	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MALIGNANT MENINGIOMAS; ATYPICAL MENINGIOMA; COLORECTAL-CANCER; NUCLEAR SURVIVIN; LABELING INDEX; GENETIC MODEL; EXPRESSION; PROLIFERATION; RECURRENCE	Background The 2016 WHO histopathological grading includes a substantial within-variation in recurrence risk, and is thus insufficient to predict prognosis after initial surgery of patients suffering from meningiomas. The aim of this study was to compare the prognostic value of the histopathological grading and the conventional biomarker MIB-1 with expression of the antiapoptotic protein survivin to see if this biomarker could complement recurrence prediction. Methods Using immunohistochemistry, the expression of MIB-1 and survivin were determined as labeling indices (LIs) in tissue micro arrays from 160 human meningiomas. The accuracy of prognostication was assessed with receiver operator characteristics analyses and standard survival analyses. Results The expression of survivin was significantly associated with both histopathological grade (P = 0.022) and recurrence status (P = 0.035). A survivin LI of 1% was identified as the optimal cutoff value to predict recurrence (P = 0.003), and was proven as more reliable than the histopathological grading (P = 0.497) and MIB-1 expression (P = 0.091). This result was further strengthened in multivariate analyses where survivin expression was revealed as an independent predictor of recurrence-free survival, while the histopathological grading and MIB-1 expression did not reach significance (P >= 0.156). Conclusions These findings suggest that incorporation of survivin in the clinical practice might be useful as complement for the histopathological grading and should further be evaluated in independent prospective studies.	[Winther, Theo L.; Torp, Sverre H.] Univ Sci & Technol, Dept Lab Med, Childrens & Womens Hlth, Trondheim, Norway; [Torp, Sverre H.] St Olays Hosp, Dept Pathol & Med Genet, Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Winther, TL (corresponding author), Univ Sci & Technol, Dept Lab Med, Childrens & Womens Hlth, Trondheim, Norway.	theolw@stud.ntnu.no	Torp, Sverre Helge/AAN-4229-2020	Torp, Sverre Helge/0000-0001-8345-6852	Norwegian University of Science and Technology	Norwegian University of Science and Technology	This study was founded by the Norwegian University of Science and Technology, and 50 000 kr was recieved by TLW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Website: http://www.ntnu.no/.	Abry E, 2010, PATHOL RES PRACT, V206, P810, DOI 10.1016/j.prp.2010.09.002; Adida C, 1998, AM J PATHOL, V152, P43; Akat K, 2003, ACTA NEUROPATHOL, V106, P337, DOI 10.1007/s00401-003-0736-8; Al-Khalaf HH, 2008, BRAIN RES, V1188, P25, DOI 10.1016/j.brainres.2007.10.074; Alahmadi H, 2011, SEMIN DIAGN PATHOL, V28, P314, DOI 10.1053/j.semdp.2011.01.002; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Backer-Grondahl T, 2012, INT J CLIN EXP PATHO, V5, P231; Bayram S, 2011, CANCER EPIDEMIOL, V35, P555, DOI 10.1016/j.canep.2011.01.004; Boidot R, 2008, GENE CHROMOSOME CANC, V47, P299, DOI 10.1002/gcc.20533; Borges BD, 2011, CLIN EXP MED, V11, P189, DOI 10.1007/s10238-010-0122-5; Bruna J, 2007, NEUROPATHOLOGY, V27, P114, DOI 10.1111/j.1440-1789.2007.00750.x; Das A, 2003, CANCER LETT, V193, P217, DOI 10.1016/S0304-3835(02)00741-3; Fontaine B, 1991, ANN NY ACAD SCI, V615, P338; Gazouli M, 2009, INT J COLORECTAL DIS, V24, P145, DOI 10.1007/s00384-008-0601-2; Ho DMT, 2002, CANCER, V94, P1538, DOI 10.1002/cncr.10351; Jaiswal PK, 2015, INDIAN J MED RES, V141, P389, DOI 10.4103/0971-5916.159250; Jaiswal PK, 2012, MOL BIOL REP, V39, P5615, DOI 10.1007/s11033-011-1366-1; Joachim T, 2001, INT J CANCER, V94, P218, DOI 10.1002/ijc.1467; Kami K, 2004, SURGERY, V136, P443, DOI 10.1016/j.surg.2004.05.023; Kaur G, 2014, NEURO-ONCOLOGY, V16, P628, DOI 10.1093/neuonc/nou025; Kawasaki H, 1998, CANCER RES, V58, P5071; Kayaselcuk F, 2004, J NEURO-ONCOL, V67, P209, DOI 10.1023/B:NEON.0000021823.05163.2c; Lee SH, 2015, J KOREAN MED SCI, V30, P1157, DOI 10.3346/jkms.2015.30.8.1157; Leone PE, 1999, ONCOGENE, V18, P2231, DOI 10.1038/sj.onc.1202531; Lin H, 2012, MED ONCOL, V29, P1272, DOI 10.1007/s12032-011-9835-x; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Lu B, 2004, BRIT J CANCER, V91, P537, DOI 10.1038/sj.bjc.6602027; Lusis EA, 2005, J NEURO-ONCOL, V73, P219, DOI 10.1007/s11060-004-5233-y; MENON AG, 1990, CANCER SURV, V9, P689; Olar A, 2015, BRAIN PATHOL, V25, P266, DOI 10.1111/bpa.12174; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Perry A, 1997, AM J SURG PATHOL, V21, P1455, DOI 10.1097/00000478-199712000-00008; Perry A, 2016, WHO CLASSIFICATION T, P231; Preusser M, 2005, AM J CLIN PATHOL, V124, P543, DOI 10.1309/PP25GAAFKV82DTG; Ridley L, 2008, NEURO-ONCOLOGY, V10, P675, DOI 10.1215/15228517-2008-036; Riemenschneider MJ, 2006, LANCET NEUROL, V5, P1045, DOI 10.1016/S1474-4422(06)70625-1; Roser F, 2004, J CLIN PATHOL, V57, P1033, DOI 10.1136/jcp.2004.018333; Shariat SF, 2004, CANCER, V100, P751, DOI 10.1002/cncr.20039; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Shinohara ET, 2005, CANCER-AM CANCER SOC, V103, P1685, DOI 10.1002/cncr.20951; SIMON M, 1995, CANCER RES, V55, P4696; Tamm I, 1998, CANCER RES, V58, P5315; Theodoropoulos GE, 2010, PANCREAS, V39, P976, DOI 10.1097/MPA.0b013e3181d705d4; Torp SH, 2001, CLIN NEUROPATHOL, V20, P190; Vranic A., 2013, ISRN NEUROSCI, V2013; Weber RG, 1997, P NATL ACAD SCI USA, V94, P14719, DOI 10.1073/pnas.94.26.14719; Winther TL, 2016, AM J CLIN PATHOL, V146, P510, DOI [10.1093/AJCP/AQW141, 10.1093/ajcp/aqw141]; Zhen HN, 2005, CANCER-AM CANCER SOC, V104, P2775, DOI 10.1002/cncr.21490	48	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185217	10.1371/journal.pone.0185217	http://dx.doi.org/10.1371/journal.pone.0185217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953948	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300045
J	Mitura, A; Niemczuk, K; Zareba, K; Zajac, M; Laroucau, K; Szymanska-Czerwinska, M				Mitura, Agata; Niemczuk, Krzysztof; Zareba, Kinga; Zajac, Magdalena; Laroucau, Karine; Szymanska-Czerwinska, Monika			Free-living and captive turtles and tortoises as carriers of new Chlamydia spp.	PLOS ONE			English	Article							MOLECULAR EVIDENCE; CHLAMYDOPHILA-PNEUMONIAE; FAMILY CHLAMYDIACEAE; CROCODILES; INFECTION; REPTILES; IDENTIFICATION; MYCOBACTERIA; PROPOSAL; ALIEN	A variety of Chlamydia species belonging to the Chlamydiaceae family have been reported in reptilian hosts but scarce data about their occurrence in turtles and tortoises are available. In this study, research was conducted to acquire information on invasive alien species (IAS) of turtles and indigenous turtles and tortoises, living both free and in captivity, as possible reservoirs of Chlamydiaceae. Analysis of specimens (pharyngeal and cloacal swabs and tissues) from 204 turtles and tortoises revealed an overall Chlamydiaceae prevalence of 18.3% and 28.6% among free-living and captive animals respectively, with variable levels of shedding. Further testing conducted with a species-specific real-time PCR and microarray test was unsuccessful. Subsequently sequencing was applied to genotype the Chlamydiaceae-positive samples. Almost the full lengths of the 16S rRNA and ompA genes as well as the 16S-23S intergenic spacer (IGS) and 23S rRNA domain I were obtained for 14, 20 and 8 specimens respectively. Phylogenetic analysis of 16S rRNA amplicons revealed two distinct branches. Group 1 (10 specimens), specific to freshwater turtles and reported here for the first time, was most closely related to Chlamydia (C.) pneumoniae strains and the newly described Candidatus C. sanzinia. Group 2 (four specimens), detected in Testudo spp. samples, showed highest homology to C. pecorum strains but formed a separate sub-branch. Finally, molecular analysis conducted on positive samples together with their geographical distribution in places distant from each other strongly suggest that Group 1 specimens correspond to a new species in the Chlamydiaceae family. In-depth studies of Chlamydia spp. from turtles and tortoises are needed to further characterise these atypical strains and address arising questions about their pathogenicity and zoonotic potential.	[Mitura, Agata; Niemczuk, Krzysztof; Zareba, Kinga; Szymanska-Czerwinska, Monika] Natl Inst Vet Res, Dept Cattle & Sheep Dis, Pulawy, Poland; [Zajac, Magdalena] Natl Inst Vet Res, Dept Microbiol, Pulawy, Poland; [Laroucau, Karine] Univ Paris Est, Anim Hlth Lab, Bacterial Zoonoses Unit, Anses, Maisons Alfort, France	National Veterinary Institute - National Research Institute; National Veterinary Institute - National Research Institute; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Mitura, A (corresponding author), Natl Inst Vet Res, Dept Cattle & Sheep Dis, Pulawy, Poland.	agata.mitura@piwet.pulawy.pl	Mitura, Agata/ABC-9809-2020; Niemczuk, Krzysztof/AAV-7798-2021; Zaręba-Marchewka, Kinga/AAX-3839-2020; Zajac, Magdalena/Q-1909-2019; Szymańska-Czerwińska, Monika/ABI-7174-2020; Laroucau, Karine/GSO-1980-2022	Niemczuk, Krzysztof/0000-0003-1611-9770; Zaręba-Marchewka, Kinga/0000-0003-0657-4171; Zajac, Magdalena/0000-0002-8155-7614; Szymańska-Czerwińska, Monika/0000-0001-8974-0870; Laroucau, Karine/0000-0001-7605-8602	Polish National Science Centre project "Invasive turtle species as a source and vector of animal and human pathogens" [2013/11/B/NZ7/01690]	Polish National Science Centre project "Invasive turtle species as a source and vector of animal and human pathogens"	This work was supported by the Polish National Science Centre project Invasive turtle species as a source and vector of animal and human pathogens (Grant No. 2013/11/B/NZ7/01690) to AM.	Bellard C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0623; Bodetti TJ, 2002, SYST APPL MICROBIOL, V25, P146, DOI 10.1078/0723-2020-00086; Bouricha M, 2014, INT J INFECT DIS, V21, P17, DOI 10.1016/j.ijid.2013.11.020; Cadi A, 2004, AQUAT CONSERV, V14, P237, DOI 10.1002/aqc.607; DENAMUR E, 1991, J GEN MICROBIOL, V137, P2525, DOI 10.1099/00221287-137-11-2525; Di Ianni F, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0405-x; Early R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12485; Ebani VV, 2012, RES VET SCI, V93, P1136, DOI 10.1016/j.rvsc.2012.05.006; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Frutos MC, 2014, REV ARGENT MICROBIOL, V46, P45, DOI 10.1016/S0325-7541(14)70047-1; Golawska O, 2017, POSTEP MIKROBIOL, V56, P163; Harkinezhad T, 2009, VET MICROBIOL, V135, P68, DOI 10.1016/j.vetmic.2008.09.046; Harris JR, 2010, CLIN INFECT DIS, V50, P554, DOI 10.1086/649932; Hotzel H, 2005, VET RES COMMUN, V29, P71, DOI 10.1007/s11259-005-0838-y; Huchzermeyer FW, 2008, J S AFR VET ASSOC, V79, P99; Huchzermeyer FW, 2002, REV SCI TECH OIE, V21, P265, DOI 10.20506/rst.21.2.1334; HUCHZERMEYER FW, 1994, J S AFR VET ASSOC, V65, P20; Jacobson E, 2002, J VET DIAGN INVEST, V14, P487, DOI 10.1177/104063870201400607; JACOBSON ER, 1990, J WILDLIFE DIS, V26, P572, DOI 10.7589/0090-3558-26.4.572; Jodelko A, 2017, PLOS ONE, V12; Kabeya H, 2015, MICROBIOL IMMUNOL, V59, P507, DOI 10.1111/1348-0421.12287; Kohhepp SJ, 2005, J CLIN MICROBIOL, V43, P3030, DOI 10.1128/JCM.43.6.3030.2005; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Nagano N, 2006, JPN J INFECT DIS, V59, P132; Oi M, 2012, RES VET SCI, V93, P826, DOI 10.1016/j.rvsc.2011.10.001; Pantchev A, 2010, COMP IMMUNOL MICROB, V33, P473, DOI 10.1016/j.cimid.2009.08.002; Pees M, 2010, EUROSURVEILLANCE, V18; Pudjiatmoko, 1997, INT J SYST BACTERIOL, V47, P425; Rivera S, 2009, J VET DIAGN INVEST, V21, P415, DOI 10.1177/104063870902100402; Robertson T, 2010, VET MICROBIOL, V145, P373, DOI 10.1016/j.vetmic.2010.04.007; Sachse K, 2014, SYST APPL MICROBIOL, V37, P79, DOI 10.1016/j.syapm.2013.12.004; Sariya L, 2015, JPN J VET RES, V63, P5; Soldati G, 2004, VET PATHOL, V41, P388, DOI 10.1354/vp.41-4-388; Szymanska-Czerwinska M, 2013, B VET I PULAWY, V57, P25, DOI 10.2478/bvip-2013-0005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor-Brown A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3055-x; Taylor-Brown A, 2015, VET MICROBIOL, V178, P88, DOI 10.1016/j.vetmic.2015.04.021; Taylor-Brown A, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftu009; Thomas V, 2006, ENVIRON MICROBIOL, V8, P2125, DOI 10.1111/j.1462-2920.2006.01094.x; Thompson PE, 1944, J INFECT DIS, V74, P68, DOI 10.1093/infdis/74.1.68; Wasyl D, 2013, VET MICROBIOL; Zimmerman LM, 2010, J EXP BIOL, V213, P661, DOI 10.1242/jeb.038315; Zimmerman LM, 2013, J EXP BIOL, V216, P633, DOI 10.1242/jeb.078832	44	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185407	10.1371/journal.pone.0185407	http://dx.doi.org/10.1371/journal.pone.0185407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950002	Green Submitted, Green Published, gold			2022-12-27	WOS:000411671000050
J	Warmerdam, M; Stolwijk, F; Boogert, A; Sharma, M; Tetteroo, L; Lucke, J; Mooijaart, S; Ansems, A; Cuevas, LE; Rijpsma, D; de Groot, B				Warmerdam, Mats; Stolwijk, Frank; Boogert, Anjelica; Sharma, Meera; Tetteroo, Lisa; Lucke, Jacinta; Mooijaart, Simon; Ansems, Annemieke; Cuevas, Laura Esteve; Rijpsma, Douwe; de Groot, Bas			Initial disease severity and quality of care of emergency department sepsis patients who are older or younger than 70 years of age	PLOS ONE			English	Article							SEPTIC SHOCK; ANTIMICROBIAL THERAPY; IMPROVEMENT PROGRAM; SURVIVING SEPSIS; PERFORMANCE; CAMPAIGN; ILLNESS; IMPACT	Objective Due to atypical symptom presentation older patients are more prone to delayed sepsis recognition. We investigated whether initial disease severity before emergency department (ED) treatment (including treatable acute organ dysfunction), quality of ED sepsis care and the impact on mortality was different between patients older and younger than 70 years. If differences exist, improvements are needed for ED management of older patients at risk for sepsis. Methods In this observational multicenter study, ED patients who were hospitalized with a suspected infection were stratified by age < 70 and >= 70 years. The presence of treatable and potentially reversible acute organ dysfunction was measured by the RO components of the Predisposition, Infection, Response and Organ dysfunction (PIRO) score, reflecting acute sepsis-related organ dysfunction developed before ED presentation. Quality of care, as assessed by the full compliance with nine quality performance measures and the standardized mortality ratio (SMR: observed/expected in-hospital mortality), was compared between older and younger patients. Results The RO-components of the PIRO score were 8 (interquartile range; 4-9) in the 833 older patients, twice as high as the 4 (2-8; P < 0.001) in the 1537 younger patients. However, full compliance with all nine quality performance measures was achieved in 34.2 (31.0-37.4)% of the older patients, not higher than the 33.0 (30.7-35.4)% in younger patients (P = 0.640). In-hospital mortality was 9.2% (95%-CI, 7.3-11.2) in patients >= 70, twice as high as the 4.6% (3.6-5.6) in patients < 70 years, resulting in an SMR (in study period) of similar to 0.7 in both groups (P > 0.05). Conclusion Older sepsis patients are sicker at ED presentation but are not treated more expediently or reliably despite their extra acuity The presence of twice as much treatable acute organ dysfunction before ED treatment suggests that acute organ dysfunction is recognized relatively late by general practitioners or patients in the out of hospital setting.	[Warmerdam, Mats; Stolwijk, Frank; Boogert, Anjelica; Sharma, Meera; Tetteroo, Lisa; Lucke, Jacinta; de Groot, Bas] Leiden Univ, Med Ctr, Emergency Dept, Leiden, Zuid Holland, Netherlands; [Mooijaart, Simon] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Zuid Holland, Netherlands; [Mooijaart, Simon] Inst Evidence Based Med Old Age IEMO, Leiden, Netherlands; [Ansems, Annemieke; Cuevas, Laura Esteve] Albert Schweitzer Ziekenhuis, Emergency Dept, Dordrecht, Zuid Holland, Netherlands; [Rijpsma, Douwe] Rijnstate Ziekenhuis, Emergency Dept, Arnhem, Gelderland, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Rijnstate Hospital	Warmerdam, M (corresponding author), Leiden Univ, Med Ctr, Emergency Dept, Leiden, Zuid Holland, Netherlands.	m.i.warmerdam.2@umail.leidenuniv.nl	Mooijaart, Simon P./A-5306-2008	Mooijaart, Simon P./0000-0003-3106-3568				Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Aslaner MA, 2017, AM J EMERG MED, V35, P71, DOI 10.1016/j.ajem.2016.10.004; Bowling A, 1996, BRIT MED J, V312, P670; Brinkman S, 2012, CRIT CARE MED, V40, P373, DOI 10.1097/CCM.0b013e318232d7b0; Capp R, 2011, J EMERG MED, V41, P573, DOI 10.1016/j.jemermed.2010.10.024; Chalfin DB, 2007, CRIT CARE MED, V35, P1477, DOI 10.1097/01.CCM.0000266585.74905.5A; Churpek MM, 2015, CRIT CARE MED, V43, P816, DOI 10.1097/CCM.0000000000000818; Cooke MW, 1999, J ACCID EMERG MED, V16, P179; De Groot B, 2017, EMERG MED J, V34, P578, DOI 10.1136/emermed-2015-205645; de Groot B, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0936-3; de Groot B, 2014, EMERG MED J, V31, P882, DOI 10.1136/emermed-2013-202865; de Groot B, 2014, EMERG MED J, V31, P292, DOI 10.1136/emermed-2012-202165; de Groot B, 2012, EUR J EMERG MED, V19, P316, DOI 10.1097/MEJ.0b013e32834d6efb; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; Girard TD, 2005, CLIN INFECT DIS, V40, P719, DOI 10.1086/427876; Hamel MB, 2000, J AM GERIATR SOC, V48, pS176, DOI 10.1111/j.1532-5415.2000.tb03129.x; Heidt JW, 2009, ANN EMERG MED, V54, pS81, DOI 10.1016/j.annemergmed.2009.06.289; Henning DJ, 2017, CRIT CARE MED; Howell MD, 2011, CRIT CARE MED, V39, P322, DOI 10.1097/CCM.0b013e3182037a8e; Hustey FM, 2002, ANN EMERG MED, V39, P248, DOI 10.1067/mem.2002.122057; Kakebeeke D, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-4; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Pouw ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059160; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stelfox HT, 2015, J CRIT CARE, V30, P1025, DOI 10.1016/j.jcrc.2015.05.018; Wester AL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-346	31	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185214	10.1371/journal.pone.0185214	http://dx.doi.org/10.1371/journal.pone.0185214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945774	Green Published, Green Submitted, gold			2022-12-27	WOS:000411645100030
J	Kirchner, TW; Niehaus, M; Debener, T; Schenk, MK; Herde, M				Kirchner, Thomas W.; Niehaus, Markus; Debener, Thomas; Schenk, Manfred K.; Herde, Marco			Efficient generation of mutations mediated by CRISPR/Cas9 in the hairy root transformation system of Brassica carinata	PLOS ONE			English	Article							AGROBACTERIUM-RHIZOGENES; RNA INTERFERENCE; GENE; PLANTS; NUCLEASES; CELLS; ARABIDOPSIS; MECHANISMS; EXPRESSION; SEQUENCE	A protocol for the induction of site-directed deletions and insertions in the genome of Brassica carinata with CRISPR is described. The construct containing the Cas9 nuclease and the guide RNA (gRNA) was delivered by the hairy root transformation technique, and a successful transformation was monitored by GFP fluorescence. PAGE analysis of an amplified region, presumably containing the deletions and insertions, demonstrated up to seven different indels in one transgenic root and in all analyzed roots a wildtype allele of the modified gene was not detectable. Interestingly, many of these mutations consisted of relatively large indels with up to 112 bp. The exact size of the deletions was determined to allow an estimation whether the targeted gene was not functional due to a considerable deletion or a frame shift within the open reading frame. This allowed a direct phenotypic assessment of the previously characterized roots and, in fact, deletions in FASCICLIN-LIKE ARABINOGALACTAN PROTEIN 1 (BcFLA1) -a gene with an expression pattern consistent with a role in root hair architecture-resulted in shorter root hairs compared to control roots ectopically expressing an allele of the gene that cannot be targeted by the gRNA in parallel to the CRISPR construct. As an additional line of evidence, we monitored BcFLA1 expression with qPCR and detected a significant reduction of the transcript in roots with an active CRISPR construct compared to the control, although residual amounts of the transcript were detected, possibly due to inefficient nonsense-mediated mRNA decay. Additionally, the presence of deletions and insertions were verified by Sanger sequencing of the respective amplicons. In summary we demonstrate the successful application of CRISPR/Cas9 in hairy roots of B. carinata, the proof of its effectiveness and its effect on the root hair phenotype. This study paves the way for experimental strategies involving the phenotypic assessment of gene lesions by CRISPR which do not require germline transmission.	[Kirchner, Thomas W.; Niehaus, Markus; Schenk, Manfred K.; Herde, Marco] Leibniz Univ Hannover, Inst Plant Nutr, Hannover, Germany; [Debener, Thomas] Leibniz Univ Hannover, Inst Plant Genet, Hannover, Germany	Leibniz University Hannover; Leibniz University Hannover	Herde, M (corresponding author), Leibniz Univ Hannover, Inst Plant Nutr, Hannover, Germany.	mherde@pflern.un-hannover.de	Debener, Thomas/AAJ-9056-2020; Herde, Marco/L-1541-2018	Herde, Marco/0000-0003-2804-0613; Kirchner, Thomas Wolfgang/0000-0002-0232-8021; Debener, Thomas/0000-0002-2012-2246	German Research Foundation (DFG) [GRK1798]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded by the German Research Foundation (DFG, http://www.dfg.de) as part of the Research Training Group (GRK1798) "Signaling at the Plant-Soil Interface".	Barrangou R, 2015, NUCLEIC ACIDS RES, V43, P3407, DOI 10.1093/nar/gkv226; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dadami E, 2013, FEBS LETT, V587, P706, DOI 10.1016/j.febslet.2013.01.045; Ding YD, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00703; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Harper BK, 1999, NAT BIOTECHNOL, V17, P1125, DOI 10.1038/15114; Iaffaldano B, 2016, IND CROP PROD, V89, P356, DOI 10.1016/j.indcrop.2016.05.029; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kahl G, 2012, J PLANT BIOCHEM BIOT, V21, pS119, DOI 10.1007/s13562-012-0129-y; Knoll A, 2014, CHROMOSOME RES, V22, P191, DOI 10.1007/s10577-014-9415-y; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Michno JM, 2015, GM CROPS FOOD, V6, P243, DOI 10.1080/21645698.2015.1106063; Ron M, 2014, PLANT PHYSIOL, V166, P455, DOI 10.1104/pp.114.239392; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shan G, 2010, INT J BIOCHEM CELL B, V42, P1243, DOI 10.1016/j.biocel.2009.04.023; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veena V, 2007, IN VITRO CELL DEV-PL, V43, P383, DOI 10.1007/s11627-007-9096-8; Vieweg MF, 2004, MOL PLANT MICROBE IN, V17, P62, DOI 10.1094/MPMI.2004.17.1.62; Wang K, 2015, J BIOTECHNOL, V214, P128, DOI 10.1016/j.jbiotec.2015.09.029; WANG LX, 2016, FRONT PLANT SCI, V7; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Zhang DD, 2016, J GENET GENOMICS, V43, P251, DOI 10.1016/j.jgg.2016.03.001; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	38	28	30	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185429	10.1371/journal.pone.0185429	http://dx.doi.org/10.1371/journal.pone.0185429			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28937992	Green Published, Green Submitted, gold			2022-12-27	WOS:000411524700032
J	Melo, HA; Rossoni, DF; Teodoro, U				Melo, Helen Aline; Rossoni, Diogo Francisco; Teodoro, Ueslei			Spatial distribution of cutaneous leishmaniasis in the state of Parana, Brazil	PLOS ONE			English	Article							SOUTHERN BRAZIL; MUNICIPALITY; PSYCHODIDAE; WHITMANI; DIPTERA; VECTOR	The geographic distribution of cutaneous leishmaniasis (CL) makes it a disease of major clinical importance in Brazil, where it is endemic in the state of Parana A. The objective of this study was to analyze the spatial distribution of CL in Parana A between 2001 and 2015, based on data from the Sistema de Informacao de Agravos de Notificacao (Information System for Notifiable Diseases) regarding autochthonous CL cases. Spatial autocorrelation was performed using Moran's Global Index and the Local Indicator of Spatial Association (LISA). The construction of maps was based on categories of association (high-high, low-low, highlow, and low-high). A total of 4,557 autochthonous cases of CL were registered in the state of Parana A, with an annual average of 303.8 (+/- 135.2) and a detection coefficient of 2.91. No correlation was found between global indices and their respective significance in 2001 (I = -0.456, p = 0.676), but evidence of spatial autocorrelation was found in other years (p< 0.05). In the construction and analysis of the cluster maps, areas with a high-high positive association were found in the Ivai-Pirapo, Tibagi, Cinzas-Laranjinha, and Ribeira areas. The state of Parana A should keep a constant surveillance over CL due to the prominent presence of socioeconomic and environmental factors such as the favorable circumstances for the vectors present in peri-urban and agriculture areas.	[Melo, Helen Aline; Teodoro, Ueslei] Univ Estadual Maringa, Postgrad Program Hlth Sci, Maringa, PR, Brazil; [Rossoni, Diogo Francisco] Univ Estadual Maringa, Dept Stat, Maringa, PR, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	Melo, HA (corresponding author), Univ Estadual Maringa, Postgrad Program Hlth Sci, Maringa, PR, Brazil.	helen_alinemelo@hotmail.com						Anselin L, 2013, SPATIAL ECONOMETRICS; Bivand R, 2015, J STAT SOFTW, V63, P1; Bivand R, 2013, GEOGR ANAL, V45, P150, DOI 10.1111/gean.12008; CAMARA G, 2002, ANAL ESPACIAL DADOS, P1; da Silva AM, 2008, NEOTROP ENTOMOL, V37, P209, DOI 10.1590/S1519-566X2008000200017; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Eisen RJ, 2008, J MED ENTOMOL, V45, P181, DOI 10.1603/0022-2585(2008)45[181:SMOHRO]2.0.CO;2; Fonseca ED, 2014, J VECTOR DIS, V51, P271; Instituto Agronomico do Parana, 2002, CARTAS CLIMATICAS PA; INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA, 2010, CENS DEM 2010; Instituto Brasileiro de Geografia e Estatistica, 2016, EST POP; Lima Airton Pereira, 2002, An. Bras. Dermatol., V77, P681, DOI 10.1590/S0365-05962002000600005; Lonardoni Maria Valdrinez Campana, 2006, Cad. Saúde Pública, V22, P2713, DOI 10.1590/S0102-311X2006001200020; Lovelock J, 2010, GAIA ALERTA FINAL; Luz E, 2000, ANN TROP MED PARASIT, V94, P623, DOI 10.1080/00034983.2000.11813585; Magalhaes GB, 2012, HYGIEA, V8, P63; Massunari GK, 2009, CAD SAUDE PUBLICA, V25, P97, DOI 10.1590/S0102-311X2009000100010; Medronho Roberto de Andrade, 2003, Rev. bras. epidemiol., V6, P328; Membrive NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047050; Ministerio da Saude (BR), 2016, GUIA VIG SAUD; Mollalo A, 2015, ZOONOSES PUBLIC HLTH, V62, P18, DOI 10.1111/zph.12109; Monteiro WM, 2008, CAD SAUDE PUBLICA, V24, P1291, DOI 10.1590/S0102-311X2008000600010; Monteiro WM, 2009, CAD SAUDE PUBLICA, V25, P1082; Neitzke-Abreu HC, 2014, REV INST MED TROP SP, V56, P391, DOI 10.1590/S0036-46652014000500004; Oliveira DM, 2011, VECTOR-BORNE ZOONOT, V11, P137, DOI 10.1089/vbz.2009.0218; R Development Core Team, 2014, R LANG ENV STAT; Reinhold-Castro KR, 2013, J VECTOR ECOL, V38, P63, DOI 10.1111/j.1948-7134.2013.12009.x; Reinhold-Castro KR, 2008, REV SOC BRAS MED TRO, V41, P269, DOI 10.1590/S0037-86822008000300009; Teodoro U., 2001, Revista de Patologia Tropical, V30, P209; Teodoro U., 1998, REV SOC BRASILEIRA M, V31, P517; Voltarelli EM, 2009, J VENOM ANIM TOXINS, V15, P732, DOI 10.1590/S1678-91992009000400011; Zanzarini Paulo Donizeti, 2005, Cad. Saúde Pública, V21, P1957, DOI 10.1590/S0102-311X2005000600047	32	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185401	10.1371/journal.pone.0185401	http://dx.doi.org/10.1371/journal.pone.0185401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938013	Green Published, Green Submitted, gold			2022-12-27	WOS:000411524700031
J	Yassin, AK; Gong, JS; Kelly, P; Lu, GW; Guardabassi, L; Wei, LJ; Han, XG; Qiu, HX; Price, S; Cheng, DR; Wang, CM				Yassin, Afrah Kamal; Gong, Jiansen; Kelly, Patrick; Lu, Guangwu; Guardabassi, Luca; Wei, Lanjing; Han, Xiangan; Qiu, Haixiang; Price, Stuart; Cheng, Darong; Wang, Chengming			Antimicrobial resistance in clinical Escherichia coli isolates from poultry and livestock, China	PLOS ONE			English	Article							FOOD ANIMALS; CHICKENS; INTEGRONS; SAMPLES; SWINE	Poultry and livestock are the most important reservoirs for pathogenic Escherichia coli and use of antimicrobials in animal farming is considered the most important factor promoting the emergence, selection and dissemination of antimicrobial-resistant microorganisms. The aim of our study was to investigate antimicrobial resistance in E. coli isolated from food animals in Jiangsu, China. The disc diffusion method was used to determine susceptibility to 18 antimicrobial agents in 862 clinical isolates collected from chickens, ducks, pigs, and cows between 2004 and 2012. Overall, 94% of the isolates showed resistance to at least one drug with 83% being resistance to at least three different classes of antimicrobials. The isolates from the different species were most commonly resistant to tetracycline, nalidixic acid, sulfamethoxazole, trimethoprim/sulfamethoxazole and ampicillin, and showed increasing resistance to amikacin, aztreonam, ceftazidime, cefotaxime, chloramphenicol, ciprofloxacin. They were least resistant to amoxicillin/clavulanic acid (3.4%) and ertapenem (0.2%). MDR was most common in isolates from ducks (44/44, 100%), followed by chickens (568/644, 88.2%), pigs (93/113, 82.3%) and cows (13/61, 21.3%). Our finding that clinical E. coli isolates from poultry and livestock are commonly resistant to multiple antibiotics should alert public health and veterinary authorities to limit and rationalize antimicrobial use in China.	[Yassin, Afrah Kamal; Lu, Guangwu; Qiu, Haixiang; Cheng, Darong; Wang, Chengming] Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Yassin, Afrah Kamal] Univ Khartoum, Fac Publ & Environm Hlth, Dept Food Hyg & Safety, Khartoum, Sudan; [Gong, Jiansen] Chinese Acad Agr Sci, Poultry Inst, Yangzhou, Jiangsu, Peoples R China; [Kelly, Patrick; Guardabassi, Luca] Ross Univ, Dept Biomed Sci, Sch Vet Med, Basseterre, St Kitts & Nevi; [Wei, Lanjing] Kansas State Univ, Dept Diagnost Med, Manhattan, KS 66506 USA; [Han, Xiangan] Chinese Acad Agr Sci Shanghai, Shanghai Vet Res Inst, Shanghai, Peoples R China; [Price, Stuart; Wang, Chengming] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA	Yangzhou University; University of Khartoum; Chinese Academy of Agricultural Sciences; Kansas State University; Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Auburn University System; Auburn University	Cheng, DR; Wang, CM (corresponding author), Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.; Wang, CM (corresponding author), Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA.	jsyzcdr@aliyun.com; wangche@auburn.edu		Guardabassi, Luca/0000-0002-2389-5084; Han, Xiangan/0000-0001-5625-637X	National Key R AMP; D Program of China [2016YFD0500804]	National Key R AMP; D Program of China	This project is funded by the National Key R & D Program of China (2016YFD0500804). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2004, J VET MED B, V51, P380, DOI 10.1111/j.1439-0450.2004.00775.x; Aarestrup FM, 2008, EXPERT REV ANTI-INFE, V6, P733, DOI 10.1586/14787210.6.5.733; Akhtardanesh B, 2016, VET RES FORUM, V7, P301; Atnafie B, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0938-1; Boyen F, 2010, VET MICROBIOL, V144, P359, DOI 10.1016/j.vetmic.2010.01.010; Chambers Lindsey, 2015, PLoS One, V10, pe0133764, DOI 10.1371/journal.pone.0133764; Chen X, 2014, VET J, V202, P112, DOI 10.1016/j.tvjl.2014.06.016; CLSI, 2013, VET01A4 CLSI; Dai L, 2008, FEMS MICROBIOL LETT, V286, P178, DOI 10.1111/j.1574-6968.2008.01272.x; Fish DN, 2006, CRIT CARE CLIN, V22, P291, DOI 10.1016/j.ccc.2006.02.006; Gong JS, 2013, AVIAN PATHOL, V42, P290, DOI 10.1080/03079457.2013.788129; Hvistendahl M, 2012, SCIENCE, V336, P795, DOI 10.1126/science.336.6083.795; Lanz R, 2003, VET MICROBIOL, V91, P73, DOI 10.1016/S0378-1135(02)00263-8; Lei T, 2010, VET MICROBIOL, V146, P85, DOI 10.1016/j.vetmic.2010.04.025; Li D, 2010, J MICROBIOL METH, V82, P71, DOI 10.1016/j.mimet.2010.04.008; Liu JH, 2007, INT J ANTIMICROB AG, V29, P576, DOI 10.1016/j.ijantimicag.2006.12.015; Lu LM, 2010, ACTA TROP, V113, P20, DOI 10.1016/j.actatropica.2009.08.028; Olowe OA, 2008, AFR J MICROBIOL RES, V2, P8; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Tenover FC, 2006, AM J INFECT CONTROL, V34, pS3, DOI 10.1016/j.ajic.2006.05.219; Wang GQ, 2008, VET MICROBIOL, V127, P73, DOI 10.1016/j.vetmic.2007.08.003; Wang N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156889; White DG, 2000, J CLIN MICROBIOL, V38, P4593, DOI 10.1128/JCM.38.12.4593-4598.2000; Yang HC, 2004, J CLIN MICROBIOL, V42, P3483, DOI 10.1128/JCM.42.8.3483-3489.2004; Zhang P, 2017, VET MICROBIOL, V203, P49, DOI 10.1016/j.vetmic.2017.02.008; Zhang QQ, 2015, ENVIRON SCI TECHNOL, V49, P6772, DOI 10.1021/acs.est.5b00729	26	58	61	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185326	10.1371/journal.pone.0185326	http://dx.doi.org/10.1371/journal.pone.0185326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934348	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900147
J	Kim, EY; Park, KH; Choi, SJ; Chung, WJ				Kim, Eun Young; Park, Kwi Hwa; Choi, Seung Joon; Chung, Wook-Jin			Educational value of pocket-sized ultrasound devices to improve understanding of ultrasound examination principles and sonographic anatomy for medical student	PLOS ONE			English	Article							POINT; SKILLS	Purpose Medical students must understand the principles of ultrasonography (US), because US examinations are an important component of patient care in clinical practice. Pocket-sized ultrasound devices have the benefits of accessibility and ease of use. The primary objective of the present study was to evaluate the educational value of these devices in terms of improving medical student interest and understanding of US and sonographic anatomy. Methods We added a US training program comprised of a self-study learning module and a hands-on training session to a two-week block curriculum of medical imaging for first year medical students (n = 40). Multiple pocket-sized US devices were used on a small-group basis during a single afternoon. Students were asked to complete a questionnaire before and after the US training session; these two questionnaires contained 6 and 10 questions, respectively, which were rated by students using a five-point Likert scale. In addition, understanding of sonographic anatomy was tested before and after the training program. Results Forty students completed the two questionnaires and the anatomy-related tests. Students found the program educationally valuable (4.37 +/- 0.54 of 5) and reported that US practice was useful for improving their understanding of the principles of US examinations (4.23 +/- 0.66 of 5) and sonographic anatomy (4.40 +/- 0.55 of 5). Overall confidence at performing US examinations and understanding of sonographic anatomy were significantly increased after US training (increased overall confidence score, 1.87 +/- 0.91 and improvement in sonographic anatomy score, 6.55 +/- 1.55, p values < 0.001). Conclusion US training using pocket-sized ultrasound devices was found to be educationally valuable for medical students in terms of improving understanding of US principles and familiarizing students with sonographic anatomy.	[Kim, Eun Young; Choi, Seung Joon] Gachon Univ, Gil Med Ctr, Dept Radiol, Incheon, South Korea; [Park, Kwi Hwa] Gachon Univ, Coll Med, Dept Med Educ, Incheon, South Korea; [Chung, Wook-Jin] Gachon Univ, Gil Med Ctr, Heart Ctr, Div Cardiol, Incheon, South Korea	Gachon University; Gachon University; Gachon University	Park, KH (corresponding author), Gachon Univ, Coll Med, Dept Med Educ, Incheon, South Korea.	ghpark@gachon.ac.kr	Chung, Wook-Jin/AAJ-5613-2021	Chung, Wook-Jin/0000-0002-9767-7098; PARK, KWI HWA/0000-0002-0008-2400	Ministry of Science, ICT, and Future Planning (MSIP) through the Next-generation Medical Device Development Program for Newly Created Market of the National Research Foundation (NRF) - Korean government [2015M3D5A1066043]; Gachon University Gil Medical Center [FRD2015-02]	Ministry of Science, ICT, and Future Planning (MSIP) through the Next-generation Medical Device Development Program for Newly Created Market of the National Research Foundation (NRF) - Korean government; Gachon University Gil Medical Center	This research was supported by Ministry of Science, ICT, and Future Planning (MSIP; grant no. 2015M3D5A1066043 through the Next-generation Medical Device Development Program for Newly Created Market of the National Research Foundation (NRF) funded by the Korean government; and was partially supported by the Gachon University Gil Medical Center (grant no. FRD2015-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen GN, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-156; Bahner DP, 2013, CRIT ULTRASOUND J, V5, DOI 10.1186/2036-7902-5-6; Sanchez GGD, 2014, REV CLIN ESP, V214, P131, DOI 10.1016/j.rce.2013.09.006; Green DE, 2013, RADIOGRAPHICS, V33, P533, DOI 10.1148/rg.332135003; Hoppmann RA, 2011, CRIT ULTRASOUND J, V3, P1, DOI 10.1007/s13089-011-0052-9; Lee M, 2014, J ULTRAS MED, V33, P1225, DOI 10.7863/ultra.33.7.1225; Mjolstad OC, 2012, EUR J INTERN MED, V23, P185, DOI 10.1016/j.ejim.2011.10.009; Moore CL, 2011, NEW ENGL J MED, V364, P749, DOI 10.1056/NEJMra0909487; Mouratev G, 2013, TEACH LEARN MED, V25, P84, DOI 10.1080/10401334.2012.741535; Skubas NJ, 2015, ANESTHESIOLOGY, V123, P499, DOI 10.1097/ALN.0000000000000777; Webb EM, 2014, ACAD RADIOL, V21, P893, DOI 10.1016/j.acra.2014.03.001	11	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185031	10.1371/journal.pone.0185031	http://dx.doi.org/10.1371/journal.pone.0185031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961257	gold, Green Published, Green Submitted			2022-12-27	WOS:000412027700014
J	Calle-Bustos, AM; Juan, MC; Garcia-Garcia, I; Abad, F				Calle-Bustos, Andres-Marcelo; Juan, M. -Carmen; Garcia-Garcia, Inmaculada; Abad, Francisco			An augmented reality game to support therapeutic education for children with diabetes	PLOS ONE			English	Article							USABILITY; SYSTEM	Therapeutic education in diabetes helps patients take responsibility for self-control of their disease, and providing technological support systems facilitates this education. In this paper, we present an augmented reality game to support therapeutic education for patients with diabetes. Our game helps children (aged 5-14 years) to learn carbohydrate (carb) content of different foods. The game shows virtual foods on a real dish. The number of carb choices corresponding to the visualized food is also shown (1 carb choice = 10 grams of carbs). A study to determine the effectiveness of the game in terms of learning and perceived satisfaction and usability was carried out. A total of seventy children with diabetes participated in the study. From the results, we observed that the initial knowledge about carb choices of the children who participated in the study was low (a mean of 2 on a scale from 0 to 9). This indicates that therapeutic education for patients with diabetes is needed. When the results for the pre-knowledge questionnaire and the post-knowledge questionnaire were compared, it was shown that the children learned about carb choices by playing our game. We used two post-knowledge questionnaires (one post-knowledge questionnaire that contained the same foods as the pre-knowledge questionnaire and a second post-knowledge questionnaire that contained foods that were different from the ones on the pre-knowledge questionnaire). There were no statistically significant differences between these two different post-knowledge questionnaires. Moreover, the knowledge acquired was independent of gender and age. We also evaluated usability and perceived satisfaction. The children were satisfied with the game and considered that the game offers a high degree of usability. This game could be a valuable therapeutic education tool for patients with diabetes.	[Calle-Bustos, Andres-Marcelo; Juan, M. -Carmen; Abad, Francisco] Univ Politecn Valencia, Inst Univ Automat & Informat Ind, Valencia, Spain; [Garcia-Garcia, Inmaculada] Univ Politecn Valencia, Dept Sistemas Informat & Comp, Valencia, Spain	Universitat Politecnica de Valencia; Universitat Politecnica de Valencia	Juan, MC (corresponding author), Univ Politecn Valencia, Inst Univ Automat & Informat Ind, Valencia, Spain.	mcarmen@dsic.upv.es	Juan, M.-Carmen/I-3585-2015; Abad, Francisco/ABA-6229-2020	Juan, M.-Carmen/0000-0002-8764-1470; 	Conselleria d'Educacio, Investigacio, Cultura i Esport	Conselleria d'Educacio, Investigacio, Cultura i Esport	This publication was partially supported by the Conselleria d'Educacio, Investigacio, Cultura i Esport through the grant for consolidable research groups in favour of the Computer Graphics and Multimedia group of the ai2 (IP. Prof. M. -Carmen Juan) (2017-2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcayir M, 2017, EDUC RES REV-NETH, V20, P1, DOI 10.1016/j.edurev.2016.11.002; Aoki N, 2005, DIABETES CARE, V28, P760, DOI 10.2337/diacare.28.3.760; Aoki N, 2004, ST HEAL T, V107, P855; Azuma RT, 1997, PRESENCE-VIRTUAL AUG, V6, P355, DOI 10.1162/pres.1997.6.4.355; Bacca J, 2014, EDUC TECHNOL SOC, V17, P133; Blake MB, 2009, COMPUT EDUC, V53, P966, DOI 10.1016/j.compedu.2009.05.014; Boulos MNK, 2015, JMIR SERIOUS GAMES, V3, DOI 10.2196/games.3930; Brown SJ, 1997, MED INFORM, V22, P77, DOI 10.3109/14639239709089835; Cefalu WT, 2014, DIABETES CARE, V37, P3137, DOI 10.2337/dc14-2329; Chiang THC, 2014, EDUC TECHNOL SOC, V17, P352; Chu HC, 2010, COMPUT EDUC, V55, P1618, DOI 10.1016/j.compedu.2010.07.004; Clark DB, 2011, COMPUT EDUC, V57, P2178, DOI 10.1016/j.compedu.2011.05.007; Dall TM, 2014, DIABETES CARE, V37, P3172, DOI 10.2337/dc14-1036; Dall TM, 2010, HEALTH AFFAIR, V29, DOI 10.1377/hlthaff.2009.0155; DeShazo J, 2010, DIABETES TECHNOL THE, V12, P815, DOI 10.1089/dia.2010.0030; Deterding S., 2011, P 15 INT ACAD MINDTR, P9; Domhardt Michael, 2015, J Diabetes Sci Technol, V9, P516, DOI 10.1177/1932296815578880; Egenfeldt-Nielsen S, 2013, EDUTAINMENT EXPLORIN; Elliott JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057400; Ferrer-Garcia JC, 2012, AV DIABETOL, V28, P38, DOI 10.1016/j.avdiab.2012.03.003; Furio D, 2015, J COMPUT ASSIST LEAR, V31, P189, DOI 10.1111/jcal.12071; Furio D, 2013, COMPUT EDUC, V64, P24, DOI 10.1016/j.compedu.2012.12.015; Furio D, 2013, COMPUT EDUC, V64, P1, DOI 10.1016/j.compedu.2012.12.001; Glover I., 2013, 2013 PRESENTED EDMED, P1999; Henkemans OAB, 2013, PATIENT EDUC COUNS, V92, P174, DOI 10.1016/j.pec.2013.04.012; Highfield K., 2013, MATH ED YESTERDAY TO, P378; Hung JL, 2012, J COMPUT HIGH EDUC, V24, P1, DOI 10.1007/s12528-011-9044-9; Hwang GJ, 2014, INT J MOBILE LEARNIN, V8, p[83, 12], DOI DOI 10.1504/IJML0.2014.062346; Jones A, 1999, INTERACT COMPUT, V11, P499, DOI 10.1016/S0953-5438(98)00064-2; Juan MC, 2017, IEEE INT CONF ADV LE, P466, DOI 10.1109/ICALT.2017.27; Juan MC, 2016, DIGIT EDUC REV, P234; Juan MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113751; Juan MC, 2005, IEEE COMPUT GRAPH, V25, P31, DOI 10.1109/MCG.2005.143; Klingensmith GJ, 2013, PEDIATR DIABETES, V14, P350, DOI 10.1111/j.1399-5448.2011.00791.x; Lange K, 2014, PEDIATR DIABETES, V15, P77, DOI 10.1111/pedi.12187; Lieberman Debra A, 2012, J Diabetes Sci Technol, V6, P802; Liu PHE, 2013, BRIT J EDUC TECHNOL, V44, pE1, DOI 10.1111/j.1467-8535.2012.01302.x; Marti-Parreno J, 2016, J COMPUT ASSIST LEAR, V32, P663, DOI 10.1111/jcal.12161; Mayes JT, 1999, INTERACT COMPUT, V11, P485, DOI 10.1016/S0953-5438(98)00065-4; Nordisk Novo, 2013, DIABETES VOICE, V58, P4; Schafer I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095035; Shen RM, 2008, BRIT J EDUC TECHNOL, V39, P1073, DOI 10.1111/j.1467-8535.2007.00778.x; Squires D, 1999, INTERACT COMPUT, V11, P467, DOI 10.1016/S0953-5438(98)00063-0; Sun PC, 2008, COMPUT EDUC, V50, P1183, DOI 10.1016/j.compedu.2006.11.007; UNESCO, 2012, INT STAND CLASS ED I; Ward N.D., 2013, J GEOSCIENCE ED, V61, P378; Yoldi C, 2011, AV DIABETOL, V27, P100; Zydney JM, 2016, COMPUT EDUC, V94, P1, DOI 10.1016/j.compedu.2015.11.001	48	27	28	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184645	10.1371/journal.pone.0184645	http://dx.doi.org/10.1371/journal.pone.0184645			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957355	gold, Green Published, Green Submitted			2022-12-27	WOS:000411985200016
J	Clawson, GA; Matters, GL; Xin, P; McGovern, C; Wafula, E; dePamphilis, C; Meckley, M; Wong, J; Stewart, L; D'Jamoos, C; Altmann, N; Kawasawa, YI; Du, Z; Honaas, L; Abraham, T				Clawson, Gary A.; Matters, Gail L.; Xin, Ping; McGovern, Christopher; Wafula, Eric; dePamphilis, Claude; Meckley, Morgan; Wong, Joyce; Stewart, Luke; D'Jamoos, Christopher; Altmann, Naomi; Kawasawa, Yuka Imamura; Du, Zhen; Honaas, Loren; Abraham, Thomas			"Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma	PLOS ONE			English	Article							MIGRATION-INHIBITORY FACTOR; LONG NONCODING RNA; EPITHELIAL-MESENCHYMAL TRANSITION; PROTEIN-TYROSINE-PHOSPHATASE; CYCLASE-ASSOCIATED PROTEIN-1; BREAST-CANCER PATIENTS; FATTY-ACID SYNTHASE; POOR-PROGNOSIS; LUNG-CANCER; MALIGNANT PHENOTYPE	Here we describe isolation and characterization of macrophage-tumor cell fusions (MTFs) from the blood of pancreatic ductal adenocarcinoma (PDAC) patients. The MTFs were generally aneuploidy, and immunophenotypic characterizations showed that the MTFs express markers characteristic of PDAC and stem cells, as well as M2-polarized macrophages. Single cell RNASeq analyses showed that the MTFs express many transcripts implicated in cancer progression, LINE1 retrotransposons, and very high levels of several long non-coding transcripts involved in metastasis (such as MALAT1). When cultured MTFs were transplanted orthotopically into mouse pancreas, they grew as obvious well-differentiated islands of cells, but they also disseminated widely throughout multiple tissues in "stealth" fashion. They were found distributed throughout multiple organs at 4, 8, or 12 weeks after transplantation (including liver, spleen, lung), occurring as single cells or small groups of cells, without formation of obvious tumors or any apparent progression over the 4 to 12 week period. We suggest that MTFs form continually during PDAC development, and that they disseminate early in cancer progression, forming "niches" at distant sites for subsequent colonization by metastasis-initiating cells.	[Clawson, Gary A.; Xin, Ping; Meckley, Morgan; Du, Zhen] Penn State Univ, Hershey Med Ctr, Gittlen Canc Res Labs, Hershey, PA 17033 USA; [Clawson, Gary A.; Xin, Ping; Meckley, Morgan; Du, Zhen] Penn State Univ, Hershey Med Ctr, Dept Pathol, Hershey, PA 17033 USA; [Matters, Gail L.; McGovern, Christopher] PSU, HMC, Dept Biochem & Mol Biol, Hershey, PA USA; [Wafula, Eric; dePamphilis, Claude; Honaas, Loren] Penn State Univ, Eberly Coll, Dept Biol, University Pk, PA 16802 USA; [Wong, Joyce] PSU, HMC, Dept Surg, Hershey, PA USA; [Stewart, Luke; D'Jamoos, Christopher] Fluidigm Corp, Applicat Support, San Francisco, CA USA; [Altmann, Naomi] PSU, Eberly Coll, Dept Stat, University Pk, PA USA; [Kawasawa, Yuka Imamura] PSU, HMC, Inst Personalized Med, Dept Pharmacol & Biochem & Mol Biol, Hershey, PA USA; [Abraham, Thomas] PSU, HMC, Dept Neural & Behav Sci, Hershey, PA USA; [Abraham, Thomas] PSU, HMC, Microscopy Imaging Facil, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Clawson, GA (corresponding author), Penn State Univ, Hershey Med Ctr, Gittlen Canc Res Labs, Hershey, PA 17033 USA.; Clawson, GA (corresponding author), Penn State Univ, Hershey Med Ctr, Dept Pathol, Hershey, PA 17033 USA.	gac4@psu.edu	Honaas, Loren/GWC-8659-2022; Abraham, Thomas/AAJ-7950-2020; Abraham, Thomas/J-7080-2014	Honaas, Loren/0000-0001-9187-8254; Abraham, Thomas/0000-0003-0750-8774; Matters, Gail/0000-0001-8613-8649	NIH [UL1TR000125, 1S10OD010756-01A1, 1S10OD018124-01A1]; Pennsylvania State Hershey Clinical and Translational Science Institute; National Center for Advancing Translational Science [TL1R000125]; Fluidigm; Gittlen Cancer Research Laboratories; NATIONAL CANCER INSTITUTE [R01CA167535] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000127, UL1TR002014] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania State Hershey Clinical and Translational Science Institute; National Center for Advancing Translational Science; Fluidigm; Gittlen Cancer Research Laboratories; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the NIH (UL1TR000125, 1S10OD010756-01A1 and 1S10OD018124-01A1), the Pennsylvania State Hershey Clinical and Translational Science Institute, the National Center for Advancing Translational Science (TL1R000125), and gift funds from the Gittlen Cancer Research Laboratories. Funding was also provided by Fluidigm. This funder provided support in the form of salaries for authors (LSand CD'J) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ali-Rahmani F, 2016, CANCER RES, V76, P1560, DOI 10.1158/0008-5472.CAN-15-2401; Anania MC, 2013, J CLIN ENDOCR METAB, V98, pE1591, DOI 10.1210/jc.2013-1652; Ankeny JS, 2016, BRIT J CANCER, V114, P1367, DOI 10.1038/bjc.2016.121; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Bacher R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0927-y; Baenke F, 2013, DIS MODEL MECH, V6, P1353, DOI 10.1242/dmm.011338; Bai J, 2015, ONCOTARGET, V6, P25295, DOI 10.18632/oncotarget.4716; Bankovic J, 2010, LUNG CANCER, V67, P151, DOI 10.1016/j.lungcan.2009.04.010; Barkley LR, 2009, CELL CYCLE, V8, P1577, DOI 10.4161/cc.8.10.8535; Baskin R, 2015, SCI REP-UK, V5, DOI 10.1038/srep17367; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bickeboller M, 2015, ONCOGENE, V34, P1150, DOI 10.1038/onc.2014.40; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonde AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-35; Borin TF, 2016, J PINEAL RES, V60, P3, DOI 10.1111/jpi.12270; Brown KE, 2013, CELL CYCLE, V12, P3253, DOI 10.4161/cc.26223; Cano CE, 2012, EMBO MOL MED, V4, P964, DOI 10.1002/emmm.201201255; Capello M, 2016, ONCOTARGET, V7, P5598, DOI 10.18632/oncotarget.6798; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chekhun S. V., 2014, Experimental Oncology, V36, P179; Chen CH, 2015, ONCOTARGET, V6, P15194, DOI 10.18632/oncotarget.3827; Chen CH, 2014, AM J RESP CRIT CARE, V190, P1127, DOI 10.1164/rccm.201408-1505OC; Chen H, 2015, INT J CLIN EXP PATHO, V8, P5798; Chen HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052864; Chen MB, 2011, MOL BIOL REP, V38, P4687, DOI 10.1007/s11033-010-0603-3; Chen XP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/241983; Chen YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18815; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Cheng JC, 2013, J CLIN INVEST, V123, P4344, DOI 10.1172/JCI64791; Cheng TC, 2015, ONCOTARGET, V6, P21283, DOI 10.18632/oncotarget.4238; Cheng Z, 2014, GENET MOL RES, V13, P5514, DOI 10.4238/2014.July.25.5; Cheong JY, 2016, GENE, V584, P47, DOI 10.1016/j.gene.2016.03.006; Chong YK, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv326; Clawson GA, 2015, REV CELL BIOL MOL ME; Clawson GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134320; Clawson GA, 2013, SCIENCE, V342, P699, DOI 10.1126/science.1244270; Clawson GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041052; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cordani M, 2017, BBA-REV CANCER, V1867, P19, DOI 10.1016/j.bbcan.2016.11.003; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Cristofanilli M, 2004, NEW ENGL J MED, V351, P2453; Cui YZ, 2009, CANCER INVEST, V27, P747, DOI 10.1080/07357900802672746; Damaghi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9752; Datar I, 2015, ONCOTARGET, V6, P39050, DOI 10.18632/oncotarget.5176; Davies JQ, 2011, ONCOL REP, V25, P619, DOI 10.3892/or.2010.1117; de Andrade BAB, 2011, ORAL DIS, V17, P808, DOI 10.1111/j.1601-0825.2011.01841.x; De Smaele E, 2011, NEOPLASIA, V13, P374, DOI 10.1593/neo.101630; Denz A, 2010, J SURG RES, V160, P29, DOI 10.1016/j.jss.2009.03.048; Diao Y, 2015, INT J CLIN EXP PATHO, V8, P6967; Ding JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041942; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Dittmar T, 2013, CURR MOL MED, V13; Du P, 2013, INT J ONCOL, V42, P1249, DOI 10.3892/ijo.2013.1802; Duelli D, 2003, CANCER CELL, V3, P445, DOI 10.1016/S1535-6108(03)00114-4; ESKELINEN M, 1992, SCAND J GASTROENTERO, V27, P39, DOI 10.3109/00365529209011164; ESKELINEN M, 1991, PANCREAS, V6, P90, DOI 10.1097/00006676-199101000-00012; Eun YG, 2013, AM J SURG, V205, P631, DOI 10.1016/j.amjsurg.2012.05.035; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Friedlander TW, 2014, INT J CANCER, V134, P2284, DOI 10.1002/ijc.28561; Friedlander TW, 2013, PHARMACOL THERAPEUT, P0163; Fu XJ, 2015, MOL MED REP, V12, P127, DOI 10.3892/mmr.2015.3359; Funamizu N, 2013, INT J CANC; Galdiero MR, 2013, J CELL PHYSIOL, V228, P1404, DOI 10.1002/jcp.24260; Gao Q, 2014, GASTROENTEROLOGY, V146, P1397, DOI 10.1053/j.gastro.2014.01.062; Gao X, 2015, J INT TRANSL MED, V3, P1; Gawlik-Rzemieniewska N, 2016, CANCER BIOL THER, V17, P1, DOI 10.1080/15384047.2015.1121348; Gemoll T, 2015, ONCOTARGET, V6, P43869, DOI 10.18632/oncotarget.6103; Gemoll T, 2015, ONCOTARGET, V6, P16517, DOI 10.18632/oncotarget.4140; Glaser J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/379847; Goldenberg DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107927; Gong ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110483; Gornes J, 2009, J HISTOCHEM CYTOCHEM, V57, P79, DOI 10.1369/jhc.2008.952283; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gremme G, 2013, IEEE ACM T COMPUT BI, V10, P645, DOI 10.1109/TCBB.2013.68; Grover PK, 2014, ANN ONCOL; Gu LN, 2014, TUMOR BIOL, V35, P7831, DOI 10.1007/s13277-014-2035-5; Guan JJ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.546; Guo DW, 2016, INT J CANCER, V139, P2056, DOI 10.1002/ijc.30278; Guo S, 2015, INT J CLIN EXP PATHO, V8, P5395; Guo XT, 2012, ANAT REC, V295, P2114, DOI 10.1002/ar.22571; Gustschner T, 2013, CANCER RES, V73, P1180; Harouaka R, 2014, PHARMACOL THERAPEUT, V141, P209, DOI 10.1016/j.pharmthera.2013.10.004; He CB, 2016, APMIS, V124, P169, DOI 10.1111/apm.12480; Hou YC, 2014, CANCER-AM CANCER SOC, V120, P2766, DOI 10.1002/cncr.28774; Hua MH, 2015, INT J MOL MED, V35, P941, DOI 10.3892/ijmm.2015.2089; Huang CF, 2016, PATHOL ONCOL RES, V22, P109, DOI 10.1007/s12253-015-9981-0; Huang J, 2009, MOL CELL, V35, P384, DOI 10.1016/j.molcel.2009.06.011; Huisman A, 2007, PROSTATE, V67, P248, DOI 10.1002/pros.20507; Huo YM, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0202-1; Ichikawa H, 2013, J PROTEOME RES, V12, P3780, DOI 10.1021/pr400439m; IKUTA S, 1994, J GASTROENTEROL, V29, P727, DOI 10.1007/BF02349278; Ilicic T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0888-1; Irandoust M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052143; Jeong SM, 2016, BIOCHEM BIOPH RES CO, V471, P373, DOI 10.1016/j.bbrc.2016.02.023; Jezequel P, 2012, INT J CANCER, V131, P426, DOI 10.1002/ijc.26397; Ji LL, 2014, J MOL HISTOL, V45, P573, DOI 10.1007/s10735-014-9582-3; Jiang JH, 2006, J BIOL CHEM, V281, P9482, DOI 10.1074/jbc.M504489200; Jiao F, 2014, ONCOL REP, V32, P2485, DOI 10.3892/or.2014.3518; Kamphues C, 2013, PANCREAS, V42, P807, DOI 10.1097/MPA.0b013e3182773eb6; Kanno H, 2013, NEURO-ONCOLOGY, V15, P853, DOI 10.1093/neuonc/not028; Karamitopoulou E, 2013, EUR J CANCER, V49, P1032, DOI 10.1016/j.ejca.2012.10.022; Karamitopoulou E, 2013, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00209; Karlsson E, 2015, BREAST CANCER RES TR, V153, P31, DOI 10.1007/s10549-015-3516-y; Ke Q, 2012, CANCER BIOTHER RADIO, V27, P678, DOI 10.1089/cbr.2012.1191; Kikuchi A, 2013, INT J CANCER, V132, P2295, DOI 10.1002/ijc.27911; Kindrat I, 2016, ONCOTARGET, V7, P1276, DOI 10.18632/oncotarget.6004; Kindt N, 2012, ANTICANCER RES, V32, P4499; Kohsaka S, 2014, NEURO-ONCOLOGY, V16, P960, DOI 10.1093/neuonc/not315; Kolde R., 2013, PHEATMAP PRETTY HEAT; Koong AC, 2000, CANCER RES, V60, P883; Kosaka Y, 2007, INT J ONCOL, V31, P333; Krieg A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130192; Kulemann B, 2015, PANCREAS, V44, P547, DOI 10.1097/MPA.0000000000000324; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Kyriakis JM, 2009, J BIOL CHEM, V284, P10993, DOI 10.1074/jbc.R800085200; Lan CY, 2013, TECHNOL CANCER RES T, V12, P259, DOI 10.7785/tcrt.2012.500312; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lazebnik Y, 2014, CELL CYCLE, V13, P2323, DOI 10.4161/cc.29704; Lazova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066731; Leber B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000915; Lee SM, 2011, MOL CELLS, V32, P343, DOI 10.1007/s10059-011-0073-z; Lee YK, 2015, HEPATOLOGY, V62, P1174, DOI 10.1002/hep.27976; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li R, 2015, EUR REV MED PHARMACO, V19, P4533; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WS, 2014, GENE, V547, P346, DOI 10.1016/j.gene.2014.06.042; Li YM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.347; Li YS, 2015, CELL PHYSIOL BIOCHEM, V37, P2375, DOI 10.1159/000438591; Li YL, 2015, ONCOTARGET, V6, P27641, DOI 10.18632/oncotarget.4737; Lin CH, 2007, FEBS J, V274, P2946, DOI 10.1111/j.1742-4658.2007.05828.x; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Liu JH, 2014, ASIAN PAC J CANCER P, V15, P2971, DOI 10.7314/APJCP.2014.15.7.2971; Liu JH, 2017, FRONT BIOSCI-LANDMRK, V22, P66, DOI 10.2741/4472; Liu K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.51; Liu YH, 2014, PATHOL RES PRACT, V210, P169, DOI 10.1016/j.prp.2013.11.011; Lo MC, 2013, CANC LETT; Long J, 2012, INT J ONCOL, V41, P1662, DOI 10.3892/ijo.2012.1613; Lyu XJ, 2015, ONCOTARGET, V6, P6656, DOI 10.18632/oncotarget.3169; Lyu XJ, 2015, CELL BIOCHEM BIOPHYS, V71, P279, DOI 10.1007/s12013-014-0196-x; Ma X, 2014, TUMOUR BIOL; Ma YL, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0799-3; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Makkonen H, 2008, ONCOGENE, V27, P4865, DOI 10.1038/onc.2008.125; Mansfeld J, 2011, NAT CELL BIOL, V13, P1234, DOI 10.1038/ncb2347; Markiewicz Aleksandra, 2013, Cancers (Basel), V5, P1485, DOI 10.3390/cancers5041485; Marques E, 2016, ONCOGENE, V35, P1386, DOI 10.1038/onc.2015.196; Martinez-Iglesias OA, 2016, P NATL ACAD SCI USA, V113, pE328, DOI 10.1073/pnas.1520469113; Matsumura Y, 2012, CANCER SCI, V103, P1342, DOI 10.1111/j.1349-7006.2012.02275.x; Meyer-Siegler KL, 2007, GENES IMMUN, V8, P646, DOI 10.1038/sj.gene.6364427; Mijaljica D, 2013, J CELL SCI, V126, P4325, DOI 10.1242/jcs.133090; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Morandi F, 2015, ONCOTARGET, V6, P25602, DOI 10.18632/oncotarget.4693; Mossad NA, 2014, TUMOR BIOL, V35, P11559, DOI 10.1007/s13277-014-2467-y; Namiki T, 2011, ONCOTARGET, V2, P695; Namiki T, 2011, P NATL ACAD SCI USA, V108, P6597, DOI 10.1073/pnas.1007694108; Natraian R, 2014, J PATHOL, V232, P5553; Nesmiyanov PP, 2016, IMMUNOBIOLOGY, V221, P6, DOI 10.1016/j.imbio.2015.08.008; Ni P, 2015, INT J CLIN EXP PATHO, V8, P15940; Nikkuni O, 2015, PATHOL ONCOL RES, V21, P1175, DOI 10.1007/s12253-015-9954-3; Noh HS, 2016, ONCOTARGET, V7, P4632, DOI 10.18632/oncotarget.6728; Ocak S, 2014, J THORAC ONCOL, V9, P324, DOI 10.1097/JTO.0000000000000090; Pandey V, 2012, INT J CANCER, V130, P497, DOI 10.1002/ijc.26048; Park SL, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju061; Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901; Patani Neill, 2008, Cancer Genomics & Proteomics, V5, P333; Pathania AS, 2015, MOL CANCER, V14, DOI 10.1186/1476-4598-14-6; Pawelek JM, 2008, ADV CANCER RES, V101, P397, DOI 10.1016/S0065-230X(08)00410-7; Pedersen Irene Munk, 2016, Mob Genet Elements, V6, pe1175537, DOI 10.1080/2159256X.2016.1175537; Peng C, 2016, ONCOGENE, V35, P1170, DOI 10.1038/onc.2015.175; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Picco G, 2010, GLYCOBIOLOGY, V20, P1241, DOI 10.1093/glycob/cwq085; Ping FM, 2015, INT J CLIN EXP PATHO, V8, P10164; Pizarro JG, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00014; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Poret N, 2015, CANCER RES, V75, P3902, DOI 10.1158/0008-5472.CAN-15-0893; Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223; Principe M, 2015, ONCOTARGET, V6, P11098, DOI 10.18632/oncotarget.3572; Quidville V, 2013, CANCER RES, V73, P2247, DOI 10.1158/0008-5472.CAN-12-2501; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rangasamy D, 2015, CURR MOL MED, V15, P588, DOI 10.2174/1566524015666150831130827; Realini N, 2016, J BIOL CHEM, V291, P2422, DOI 10.1074/jbc.M115.666909; Rello-Varona S, 2012, CELL CYCLE, V11, P170, DOI 10.4161/cc.11.1.18564; Ren DY, 2016, ONCOL LETT, V11, P1621, DOI 10.3892/ol.2016.4138; Renhua G, 2016, J THORAC ONCOL, V11, pS129, DOI 10.1016/S1556-0864(16)30275-1; Rhim AD, 2014, GASTROENTEROLOGY, V146, P647, DOI 10.1053/j.gastro.2013.12.007; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Riese DJ, 2014, SEMIN CELL DEV BIOL, V28, P49, DOI 10.1016/j.semcdb.2014.03.005; Roh JL, 2016, EUR J CANCER, V52, P163, DOI 10.1016/j.ejca.2015.10.056; Rohrbach TD, 2015, INT J ONCOL, V46, P1079, DOI 10.3892/ijo.2014.2799; Ruan J, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0503-9; Rutkowski MJ, 2011, J NEURO-ONCOL, V105, P165, DOI 10.1007/s11060-011-0576-7; Salmi M, 2013, CIRC RES, V112, P1577, DOI 10.1161/CIRCRESAHA.111.300476; Sato T, 2007, J BIOL CHEM, V282, P27702, DOI 10.1074/jbc.M611862200; Scharl M, 2012, ANN NY ACAD SCI, V1257, P93, DOI 10.1111/j.1749-6632.2012.06578.x; Schouppe E, 2013, CANC RES; Schulz R, 2014, CURR OPIN ONCOL, V26, P108, DOI 10.1097/CCO.0000000000000036; Schulz R, 2012, J EXP MED, V209, P275, DOI 10.1084/jem.20111117; Seguin F, 2012, BRIT J CANCER, V107, P077; Sevenich L, 2014, NAT CELL BIOL, V16, P876, DOI 10.1038/ncb3011; Shabo I, 2008, INT J CANCER, V123, P780, DOI 10.1002/ijc.23527; Shabo I, 2011, ADV EXP MED BIOL, V714, P141, DOI 10.1007/978-94-007-0782-5_7; Shabo I, 2009, INT J CANCER, V125, P1826, DOI 10.1002/ijc.24506; Sharma MC, 2016, CANCER LETT, V373, P27, DOI 10.1016/j.canlet.2016.01.013; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Shimada K, 2014, BREAST CANCER-TOKYO, V21, P715, DOI 10.1007/s12282-013-0447-5; Shindo-Okada N, 2003, BIOCHEM BIOPH RES CO, V312, P889, DOI 10.1016/j.bbrc.2003.10.200; Shrivastava S, 2016, MOL CANCER THER, V15, P471, DOI 10.1158/1535-7163.MCT-15-0581; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Solimini NL, 2013, P NATL ACAD SCI USA, V110, pE407, DOI 10.1073/pnas.1221385110; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Sun YL, 2015, WORLD J GASTROENTERO, V21, P10840, DOI 10.3748/wjg.v21.i38.10840; Sun ZL, 2007, BBA-PROTEINS PROTEOM, V1774, P764, DOI 10.1016/j.bbapap.2007.04.001; Swierczynski J, 2014, WORLD J GASTROENTERO, V20, P2279, DOI 10.3748/wjg.v20.i9.2279; Takahashi K, 2006, INT J ONCOL, V28, P321; Tan C, 2016, MOL CARCINOGEN, V55, P397, DOI 10.1002/mc.22290; Tang XQ, 2013, CANCER LETT, V332, P3, DOI 10.1016/j.canlet.2013.01.024; Thai P, 2013, AM J RESP CELL MOL, V49, P204, DOI 10.1165/rcmb.2013-0159RC; Theocharides APA, 2012, J EXP MED, V209, P1883, DOI 10.1084/jem.20120502; Torres C, 2015, PANCREAS, V44, P302, DOI 10.1097/MPA.0000000000000250; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsavaris N, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-264; van Dijk M, 2015, HUM MOL GENET, V24, P5475, DOI 10.1093/hmg/ddv274; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Videira PA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-357; Vizeacoumar FJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.54; Wang D, 2014, ONCOL REP, V31, P1199, DOI 10.3892/or.2013.2946; Wang HY, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-226; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang Q, 2015, J PATHOL, V236, P278, DOI 10.1002/path.4518; Wang SJ, 2015, ONCOTARGET, V6, P243, DOI 10.18632/oncotarget.2801; Wang T, 2015, ONCOTARGET, V6, P30975, DOI 10.18632/oncotarget.5199; Wang W, 2014, CANCER RES, V74, P497, DOI 10.1158/0008-5472.CAN-13-1224; Wang W, 2013, HISTOPATHOLOGY, V62, P931, DOI 10.1111/his.12101; WANG XF, 2016, SCI REP UK, V6; Wang Y, 2015, ONCOL REP, V34, P2106, DOI 10.3892/or.2015.4157; Wei Y, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/164635; Wermke M, 2015, BLOOD, V125, P3760, DOI 10.1182/blood-2014-07-590646; Whitworth H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038950; Williams KA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004809; Wilson JM, 2005, GASTROENTEROLOGY, V129, P1485, DOI 10.1053/j.gastro.2005.07.061; Winner M, 2007, CANCER RES, V67, P186, DOI 10.1158/0008-5472.CAN-06-3292; Woo T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142642; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Wu TF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149361; Wu YC, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0455-5; Xie SS, 2015, ONCOL REP, V33, P363, DOI 10.3892/or.2014.3577; Xue H, 2016, ONCOTARGET, V7, P4785, DOI 10.18632/oncotarget.6735; Xynos Ioannis D, 2013, ISRN Gastroenterol, V2013, P490578, DOI 10.1155/2013/490578; Yaddanapudi K, 2013, J IMMUNOL, V190, P2984, DOI 10.4049/jimmunol.1201650; Yamaguchi H, 2008, MOL CARCINOGEN, V47, P739, DOI 10.1002/mc.20423; Yang LX, 2015, PATHOL RES PRACT, V211, P731, DOI 10.1016/j.prp.2015.04.014; Yang WE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152165; Yang Y, 2015, LEUKEMIA, V29, P715, DOI 10.1038/leu.2014.255; Yang Y, 2013, EMBO REP, V14, P741, DOI 10.1038/embor.2013.80; Yoshikawa K, 2012, CANCER SCI, V103, P2012, DOI 10.1111/j.1349-7006.2012.02411.x; Yu XF, 2014, EXP MOL PATHOL, V96, P188, DOI 10.1016/j.yexmp.2014.02.002; Yu XB, 2016, GENE, V576, P339, DOI 10.1016/j.gene.2015.10.072; Zavareh RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043721; Zecchin KG, 2011, LAB INVEST, V91, P232, DOI 10.1038/labinvest.2010.157; Zeng Wen-Li, 2015, Asian Pac J Cancer Prev, V16, P513; Zhang HJ, 2015, TUMOR BIOL, V36, P9373, DOI 10.1007/s13277-015-3678-6; Zhang JJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-211; Zhang L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-60; Zhang LX, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005109; Zhang M, 2014, INT J CLIN EXP PATHO, V7, P487; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060781, 10.1371/journal.pone.0053931, 10.1371/journal.pone.0061922]; Zhang XJ, 2014, J SURG RES, V192, P487, DOI 10.1016/j.jss.2014.05.066; Zhao MY, 2015, ONCOTARGET, V6, P15610, DOI 10.18632/oncotarget.3639; Zheng DW, 2016, MOL CARCINOGEN, V55, P300, DOI 10.1002/mc.22279; Zheng ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep26093; Zhou D, 2015, WORLD J GASTROENTERO, V21, P1814, DOI 10.3748/wjg.v21.i6.1814; Zhou H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.186; 2003, DRUGS RES DEV, V4, P198	274	34	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184451	10.1371/journal.pone.0184451	http://dx.doi.org/10.1371/journal.pone.0184451			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957348	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200013
J	Elffers, TW; de Mutsert, R; Lamb, HJ; de Roos, A; van Dijk, KW; Rosendaal, FR; Jukema, JW; Trompet, S				Elffers, Theodora W.; de Mutsert, Renee; Lamb, Hildo J.; de Roos, Albert; van Dijk, Ko Willems; Rosendaal, Frits R.; Jukema, J. Wouter; Trompet, Stella			Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in obese women	PLOS ONE			English	Article							ADIPOSE-TISSUE; METABOLICALLY HEALTHY; WAIST CIRCUMFERENCE; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; GENDER-DIFFERENCES; ABDOMINAL FAT; MEN; ACCUMULATION; DISEASE	Background Body fat distribution is, next to overall obesity, an important risk factor for cardiometabolic outcomes in the general population. In particular, visceral adipose tissue ( VAT) is strongly associated with cardiometabolic risk factors. Since it is unclear whether body fat distribution is also important in men and women with obesity we investigated the associations between measures of body fat distribution and cardiometabolic risk factors in men and women with obesity. Methods In this cross-sectional analysis of obese men and women ( BMI >= 30 kg/m(2)) included in the Netherlands Epidemiology of Obesity Study, waist: hip ratio(WHR), waist circumference, and MRI-based abdominal subcutaneous adipose tissue (aSAT) and VAT were determined. Associations between measures of body fat distribution and presence of >= 1 risk factor, such as hypertension or hypertriglyceridemia, were examined using logistic regression analyses; stratified by sex and adjusted for age, ethnicity, education, tobacco smoking, alcohol consumption, physical activity and depending on the association additionally for total body fat or VAT. Results We included 2,983 obese individuals (57% women) with a mean age of 56 and standard deviation (SD) of 6 and mean BMI of 34.0 kg/m(2) (4.0), after exclusion of individuals with missing values of cardiometabolic risk factors (n = 33). 241 individuals were obese without other cardiometabolic risk factors. In obese women, all measures of body fat distribution except aSAT (OR per SD: 0.76, 95% CI: 0.53, 1.10) were associated with having >= 1 cardiometabolic risk factor, of which VAT most strongly associated (5.77; 3.02, 11.01). In obese men, associations of body fat distribution and the presence of cardiometabolic risk factors were attenuated. (e.g. VAT: 1.42; 0.84, 2.41). Conclusions In obese women, but less so in men, measures of body fat distribution, of which VAT most strongly, are associated with cardiometabolic risk factors.	[Elffers, Theodora W.; de Mutsert, Renee; Rosendaal, Frits R.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Elffers, Theodora W.; Jukema, J. Wouter; Trompet, Stella] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Lamb, Hildo J.; de Roos, Albert] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Med, Div Endocrinol, Leiden, Netherlands; [Trompet, Stella] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Elffers, TW (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands.; Elffers, TW (corresponding author), Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands.	t.w.elffers@lumc.nl	Jukema, J. Wouter/ABD-6503-2021; Lamb, Hildo/ABE-1171-2021; Rosendaal, Frits/Q-3842-2017; van Dijk, Ko Willems/A-1798-2008; van Dijk, Ko Willems/AAT-4681-2021; Elffers, Theodora/V-3065-2017	Jukema, J. Wouter/0000-0002-3246-8359; Lamb, Hildo/0000-0002-6969-2418; Rosendaal, Frits/0000-0003-2558-7496; van Dijk, Ko Willems/0000-0002-2172-7394; van Dijk, Ko Willems/0000-0002-2172-7394; Elffers, Theodora/0000-0002-6304-0507	Leiden University Medical Centre; Leiden University, Research Profile Area 'Vascular and Regenerative Medicine'	Leiden University Medical Centre; Leiden University, Research Profile Area 'Vascular and Regenerative Medicine'	The NEO study is supported by the participating Departments, the Division and the Board of Directors of the Leiden University Medical Centre, and by the Leiden University, Research Profile Area 'Vascular and Regenerative Medicine'.	Blaak E, 2001, CURR OPIN CLIN NUTR, V4, P499, DOI 10.1097/00075197-200111000-00006; Bluher M, 2012, CURR OPIN ENDOCRINOL, V19, P341, DOI 10.1097/MED.0b013e328357f0a3; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Boonchaya-Anant P, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0441-1; Chandra A, 2014, J AM COLL CARDIOL, V64, P997, DOI 10.1016/j.jacc.2014.05.057; de Mutsert R, 2013, EUR J EPIDEMIOL, V28, P513, DOI 10.1007/s10654-013-9801-3; Demerath EW, 2007, AM J CLIN NUTR, V85, P362, DOI 10.1093/ajcn/85.2.362; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flint DJ, 2006, J ENDOCRINOL, V191, P101, DOI 10.1677/joe.1.06939; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Kanaya AM, 2004, DIABETES CARE, V27, P1375, DOI 10.2337/diacare.27.6.1375; Karastergiou K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-13; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Karelis AD, 2011, NAT REV ENDOCRINOL, V7, P699, DOI 10.1038/nrendo.2011.181; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Lemieux I, 2001, ARTERIOSCL THROM VAS, V21, P961, DOI 10.1161/01.ATV.21.6.961; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Marini MA, 2007, DIABETES CARE, V30, P2145, DOI 10.2337/dc07-0419; MAURIEGE P, 1987, EUR J CLIN INVEST, V17, P156, DOI 10.1111/j.1365-2362.1987.tb02395.x; Meinhardt UJ, 2006, CLIN ENDOCRINOL, V65, P413, DOI 10.1111/j.1365-2265.2006.02676.x; Miyazawa-Hoshimoto S, 2003, DIABETOLOGIA, V46, P1483, DOI 10.1007/s00125-003-1221-6; Neeland IJ, 2012, JAMA-J AM MED ASSOC, V308, P1150, DOI 10.1001/2012.jama.11132; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Primeau V, 2011, INT J OBESITY, V35, P971, DOI 10.1038/ijo.2010.216; REBUFFESCRIVE M, 1989, METABOLISM, V38, P453, DOI 10.1016/0026-0495(89)90198-4; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; Stefan N, 2013, LANCET DIABETES ENDO, V1, P152, DOI 10.1016/S2213-8587(13)70062-7; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Tanaka S, 2004, INT J OBESITY, V28, P320, DOI 10.1038/sj.ijo.0802545; TONG Y, 1989, MOL CELL ENDOCRINOL, V67, P11, DOI 10.1016/0303-7207(89)90225-6; Toth MJ, 2000, INT J OBESITY, V24, P226, DOI 10.1038/sj.ijo.0801118; Trayhurn P, 2013, PHYSIOL REV, V93, P1, DOI 10.1152/physrev.00017.2012; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Verkleij-Hagoort AC, 2007, EUR J CLIN NUTR, V61, P610, DOI 10.1038/sj.ejcn.1602581; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; Yatagai T, 2003, METABOLISM, V52, P1274, DOI 10.1016/S0026-0495(03)00195-1	41	79	84	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185403	10.1371/journal.pone.0185403	http://dx.doi.org/10.1371/journal.pone.0185403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957363	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200053
J	Guo, YY; We, HY; Li, X; Li, Q; Zhao, XY; Duan, XQ; An, YR; Lv, W; An, HL				Guo, Yuyu; We, Hongyu; Li, Xiang; Li, Qi; Zhao, Xinyan; Duan, Xueqing; An, Yanrong; Lv, Wei; An, Hailong			Identification and expression of GRAS family genes in maize (Zea mays L.)	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; GIBBERELLIN SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTOR; MOLECULAR ANALYSIS; SCARECROW GENE; ARABIDOPSIS; PROTEINS; PHYTOCHROME; REGULATOR; RICE	GRAS transcriptional factors have diverse functions in plant growth and development, and are named after the first three transcription factors, namely, GAI (GIBBERELLIC ACID INSENSITIVE), RGA (REPRESSOR OF GAI) and SCR (SCARECROW) identified in this family. Knowledge of the GRAS gene family in maize remains was largely unknown, and their characterization is necessary to understand their importance in the maize life cycle. This study identified 86 GRAS genes in maize, and further characterized with phylogenetics, gene structural analysis, genomic loci, and expression patterns. The 86 GRAS genes were divided into 8 groups (SCL3, HAM, LS, SCR, DELLA, SHR, PAT1 and LISCL) by phylogenetic analysis. Most of the maize GRAS genes contain one exon (80.23%) and closely related members in the phylogenetic tree had similar structure and motif composition. Different motifs especially in the N-terminus might be the sources of their functional divergence. Segmental-and tandem-duplication occurred in this family leading to expansion of maize GRAS genes and the expression patterns of the duplicated genes in the heat map according to the published microarray data were very similar. Quantitative RT-PCR (qRT-PCR) results demonstrated that the expression level of genes in different tissues were different, suggesting their differential roles in plant growth and development. The data set expands our knowledge to understanding the function of GRAS genes in maize, an important crop plant in the world.	[Guo, Yuyu; We, Hongyu; Li, Xiang; Li, Qi; Zhao, Xinyan; Duan, Xueqing; An, Yanrong; Lv, Wei; An, Hailong] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Lv, W; An, HL (corresponding author), Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	lvwei_star@163.com; hlan@sdau.edu.cn	Li, Qi/AHD-9922-2022	Li, Qi/0000-0002-7736-764X; An, Hailong/0000-0002-5169-0246	Ministry of Agriculture of China [2016ZX08009002]; foundation of the Ministry of Education Key Laboratory of Cell Activities and Stress Adaptations [lzujbky-2016-bt05]; National Natural Science Foundation of China [31301080]; Funds of Shandong "Double Tops" Program	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); foundation of the Ministry of Education Key Laboratory of Cell Activities and Stress Adaptations; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funds of Shandong "Double Tops" Program	This work was supported by the Ministry of Agriculture of China (grant number 2016ZX08009002), the foundation of the Ministry of Education Key Laboratory of Cell Activities and Stress Adaptations (grant number lzujbky-2016-bt05), the National Natural Science Foundation of China (grant number 31301080) and Funds of Shandong "Double Tops" Program.	Abarca D, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0354-8; Andersen JR, 2005, THEOR APPL GENET, V111, P206, DOI 10.1007/s00122-005-1996-6; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bolle C, 2000, GENE DEV, V14, P1269; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chandler PM, 2002, PLANT PHYSIOL, V129, P181, DOI 10.1104/pp.010917; Claeys H, 2014, TRENDS PLANT SCI, V19, P231, DOI 10.1016/j.tplants.2013.10.001; Curaba J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-6; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Dill A, 2001, GENETICS, V159, P777; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fuxreiter M, 2011, TRENDS BIOCHEM SCI, V36, P415, DOI 10.1016/j.tibs.2011.04.006; Gallagher KL, 2009, PLANT J, V57, P785, DOI 10.1111/j.1365-313X.2008.03735.x; Greb T, 2003, GENE DEV, V17, P1175, DOI 10.1101/gad.260703; Gubler F, 2002, PLANT PHYSIOL, V129, P191, DOI 10.1104/pp.010918; GUILTINAN MJ, 1994, PLANT MOL BIOL, V26, P1041, DOI 10.1007/BF00040687; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Heo JO, 2011, P NATL ACAD SCI USA, V108, P2166, DOI 10.1073/pnas.1012215108; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Huang W, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0590-6; Ikeda A, 2002, PLANT CELL PHYSIOL, V43, P974, DOI 10.1093/pcp/pcf115; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawit SJ, 2010, PLANT CELL PHYSIOL, V51, P1854, DOI 10.1093/pcp/pcq153; Lee H, 2008, PLANT MOL BIOL, V67, P659, DOI 10.1007/s11103-008-9345-1; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Lim J, 2000, PLANT CELL, V12, P1307, DOI 10.1105/tpc.12.8.1307; Liu XY, 2014, PLANT MOL BIOL REP, V32, P1129, DOI 10.1007/s11105-014-0721-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lu JX, 2015, MOL GENET GENOMICS, V290, P303, DOI 10.1007/s00438-014-0918-1; Ma ZX, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004519; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; PATTHY L, 1987, FEBS LETT, V214, P1, DOI 10.1016/0014-5793(87)80002-9; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Revell LJ, 2014, METHODS ECOL EVOL, V5, P976, DOI 10.1111/2041-210X.12233; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schulze S, 2010, PLANT J, V64, P668, DOI 10.1111/j.1365-313X.2010.04359.x; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Shimada MK, 2017, MOL PHYLOGENET EVOL, V109, P409, DOI 10.1016/j.ympev.2017.02.012; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Slewinski TL, 2012, PLANT CELL PHYSIOL, V53, P2030, DOI 10.1093/pcp/pcs147; Song LL, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2393-x; Song XM, 2014, GENOMICS, V103, P135, DOI 10.1016/j.ygeno.2013.12.004; Stuurman J, 2002, GENE DEV, V16, P2213, DOI 10.1101/gad.230702; Sun XL, 2012, BIOCHEM J, V442, P1, DOI 10.1042/BJ20111766; Sun XL, 2011, PLANT MOL BIOL, V77, P205, DOI 10.1007/s11103-011-9803-z; Sun X, 2016, FUNCT INTEGR GENOMIC, V16, P347, DOI 10.1007/s10142-016-0479-y; Sutoh K, 2003, PLANT J, V34, P635, DOI 10.1046/j.1365-313X.2003.01753.x; Tamagnone L, 1998, PLANT CELL, V10, P135, DOI 10.1105/tpc.10.2.135; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tian CG, 2004, PLANT MOL BIOL, V54, P519, DOI 10.1023/B:PLAN.0000038256.89809.57; Torres-Galea P, 2006, MOL GENET GENOMICS, V276, P13, DOI 10.1007/s00438-006-0123-y; Torres-Galea P, 2013, PLANT PHYSIOL, V161, P291, DOI 10.1104/pp.112.206607; Wang L, 2010, MOL PLANT, V3, P794, DOI 10.1093/mp/ssq042; Wang Y, 2016, PEERJ, V4, DOI 10.7717/peerj.2388; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xu W, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071004; Zhang L, 2016, CHIN J NAT MEDICINES, V14, P161, DOI 10.1016/S1875-5364(16)30013-9	68	46	50	8	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185418	10.1371/journal.pone.0185418	http://dx.doi.org/10.1371/journal.pone.0185418			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957440	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200054
J	Liew, JWY; Loh, KS; Ahmad, A; Lim, KL; Daud, WRW				Liew, Joy Wei Yi; Loh, Kee Shyuan; Ahmad, Azizan; Lim, Kean Long; Daud, Wan Ramli Wan			Synthesis and characterization of modified kappa-carrageenan for enhanced proton conductivity as polymer electrolyte membrane	PLOS ONE			English	Article							METHYLENE PHOSPHONIC CHITOSAN; CELLULOSE DERIVATIVES; COMPLEXES; HYDROGELS; BLEND; CELL	Polymer electrolyte membranes based on the natural polymer kappa-carrageenan were modified and characterized for application in electrochemical devices. In general, pure kappa-carrageenan membranes show a low ionic conductivity. New membranes were developed by chemically modifying kappa-carrageenan via phosphorylation to produce O-methylene phosphonic kappa-carrageenan (OMPC), which showed enhanced membrane conductivity. The membranes were prepared by a solution casting method. The chemical structure of OMPC samples were characterized using Fourier transform infrared spectroscopy (FTIR), H-1 nuclear magnetic resonance (H-1 NMR) spectroscopy and P-31 nuclear magnetic resonance (P-31 NMR) spectroscopy. The conductivity properties of the membranes were investigated by electrochemical impedance spectroscopy (EIS). The characterization demonstrated that the membranes had been successfully produced. The ionic conductivity of kappa-carrageenan and OMPC were 2.79 x 10(-6) S cm(-1) and 1.54 x 10(-5) S cm(-1), respectively. The hydrated membranes showed a two orders of magnitude higher ionic conductivity than the dried membranes.	[Liew, Joy Wei Yi; Loh, Kee Shyuan; Lim, Kean Long; Daud, Wan Ramli Wan] Univ Kebangsaan Malaysia, Fuel Cell Inst, Bangi, Selangor, Malaysia; [Ahmad, Azizan] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Chem Sci & Food Technol, Bangi, Selangor, Malaysia; [Daud, Wan Ramli Wan] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Chem & Proc Engn, Bangi, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Loh, KS (corresponding author), Univ Kebangsaan Malaysia, Fuel Cell Inst, Bangi, Selangor, Malaysia.	ksloh@ukm.edu.my	Daud, Wan Ramli Wan/GQA-6740-2022; Daud, Wan Ramli/B-3635-2013; Loh, Kee Shyuan/B-3648-2016; liew, joy/GXG-6715-2022; Loh, Kee Shyuan/N-6132-2019; Lim, Kean Long/A-1809-2009	Daud, Wan Ramli Wan/0000-0002-1023-456X; Daud, Wan Ramli/0000-0002-1023-456X; Loh, Kee Shyuan/0000-0002-2555-7521; Loh, Kee Shyuan/0000-0002-2555-7521; Lim, Kean Long/0000-0002-7227-5391	Ministry of Education Malaysia [LRGS/2013/UKM-UKM/TP/01]; Universiti Kebangsaan Malaysia (UKM) [GUP-2016-038]	Ministry of Education Malaysia; Universiti Kebangsaan Malaysia (UKM)	This research work is jointly financially supported by the Ministry of Education Malaysia through the Long-term Research Grant Scheme (LRGS/2013/UKM-UKM/TP/01) and the Universiti Kebangsaan Malaysia (UKM) through the University Research Grants (GUP-2016-038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad LV, 2011, RADIAT PHYS CHEM, V80, P977, DOI 10.1016/j.radphyschem.2011.04.006; Abad L.V., 2013, WORLD ACAD SCI ENG T, V77, P422; Al Sagheer FA, 2009, CARBOHYD POLYM, V77, P410, DOI 10.1016/j.carbpol.2009.01.032; Aliste AJ, 2000, RADIAT PHYS CHEM, V57, P305, DOI 10.1016/S0969-806X(99)00471-5; Alves VD, 2010, CARBOHYD POLYM, V79, P269, DOI 10.1016/j.carbpol.2009.08.002; Binsu VV, 2006, REACT FUNCT POLYM, V66, P1619, DOI 10.1016/j.reactfunctpolym.2006.06.003; Campo VL, 2009, CARBOHYD POLYM, V77, P167, DOI 10.1016/j.carbpol.2009.01.020; Choi JH, 2005, LWT-FOOD SCI TECHNOL, V38, P417, DOI 10.1016/j.lwt.2004.07.004; Datta P, 2012, CARBOHYD POLYM, V87, P1354, DOI 10.1016/j.carbpol.2011.09.023; Sanchez-Garcia MD, 2010, J AGR FOOD CHEM, V58, P12847, DOI 10.1021/jf102764e; Freile-Pelegrin Y, 2011, J AQUAT FOOD PROD T, V20, P73, DOI 10.1080/10498850.2010.541590; Fujishima M, 2008, ELECTROCHEM COMMUN, V10, P1482, DOI 10.1016/j.elecom.2008.07.040; Goktepe F, 2008, J NON-CRYST SOLIDS, V354, P3637, DOI 10.1016/j.jnoncrysol.2008.03.023; Heras A, 2001, CARBOHYD POLYM, V44, P1, DOI 10.1016/S0144-8617(00)00195-8; Idris NH, 2005, IONICS, V11, P375, DOI 10.1007/BF02430249; Jeeju PP, 2012, MATER CHEM PHYS, V134, P803, DOI 10.1016/j.matchemphys.2012.03.072; Jumaah FN, 2015, IONICS, V21, P1311, DOI 10.1007/s11581-014-1306-x; Kadir MFZ, 2011, SPECTROCHIM ACTA A, V78, P1068, DOI 10.1016/j.saa.2010.12.051; Ko YG, 2010, SOLID STATE IONICS, V181, P1178, DOI 10.1016/j.ssi.2010.06.036; Lebouc F, 2005, POLYMER, V46, P319, DOI 10.1016/j.polymer.2004.11.017; Ma SF, 2012, INT J GREEN ENERGY, V9, P13, DOI 10.1080/15435075.2011.617018; Mobarak NN, 2013, ELECTROCHIM ACTA, V92, P161, DOI 10.1016/j.electacta.2012.12.126; Mobarak NN, 2012, SOLID STATE IONICS, V224, P51, DOI 10.1016/j.ssi.2012.07.010; Murata K, 2000, ELECTROCHIM ACTA, V45, P1501, DOI 10.1016/S0013-4686(99)00365-5; Cabello SDP, 2014, J POWER SOURCES, V265, P345, DOI 10.1016/j.jpowsour.2014.04.093; Ramesh S, 2012, CARBOHYD POLYM, V87, P701, DOI 10.1016/j.carbpol.2011.08.047; Ramos VM, 2003, CARBOHYD POLYM, V52, P39, DOI 10.1016/S0144-8617(02)00264-3; Rudhziah S, 2015, ELECTROCHIM ACTA, V175, P162, DOI 10.1016/j.electacta.2015.02.153; Rudhziah S, 2015, IND CROP PROD, V72, P133, DOI 10.1016/j.indcrop.2014.12.051; Santo VE, 2009, BIOMACROMOLECULES, V10, P1392, DOI 10.1021/bm8014973; Saxena A, 2006, J COLLOID INTERF SCI, V303, P484, DOI 10.1016/j.jcis.2006.07.061; Smitha B, 2005, EUR POLYM J, V41, P1859, DOI 10.1016/j.eurpolymj.2005.02.018; Tranquilan-Aranilla C, 2012, CARBOHYD POLYM, V87, P1810, DOI 10.1016/j.carbpol.2011.10.009; van Herk T, 2005, ADV SYNTH CATAL, V347, P1155, DOI 10.1002/adsc.200505072; Volod'ko AV, 2014, CARBOHYD POLYM, V101, P1087, DOI 10.1016/j.carbpol.2013.10.049; Wan Y, 2003, MACROMOL CHEM PHYSIC, V204, P850, DOI 10.1002/macp.200390056; Yahya M.Z.A., 2006, J APPL SCI, V6, P3150; Yu GL, 2002, CARBOHYD RES, V337, P433, DOI 10.1016/S0008-6215(02)00009-5; Zhao D, 2012, J APPL POLYM SCI, V125, pE299, DOI 10.1002/app.36834; Zhu DW, 2010, J MATER SCI-MATER M, V21, P223, DOI 10.1007/s10856-009-3849-3	40	39	39	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185313	10.1371/journal.pone.0185313	http://dx.doi.org/10.1371/journal.pone.0185313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957374	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200044
J	Lapbenjakul, S; Thapana, W; Twilprawat, P; Muangmai, N; Kanchanaketu, T; Temsiripong, Y; Unajak, S; Peyachoknagul, S; Srikulnath, K				Lapbenjakul, Sorravis; Thapana, Watcharaporn; Twilprawat, Panupon; Muangmai, Narongrit; Kanchanaketu, Thiti; Temsiripong, Yosapong; Unajak, Sasimanas; Peyachoknagul, Surin; Srikulnath, Kornsorn			High genetic diversity and demographic history of captive Siamese and Saltwater crocodiles suggest the first step toward the establishment of a breeding and reintroduction program in Thailand	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; CROCODYLUS-MORELETII; CONSERVATION UNITS; STATISTICAL TESTS; DNA; HYBRIDIZATION; SOFTWARE; POROSUS; TRANSLOCATIONS; IDENTIFICATION	The Siamese crocodile (Crocodylus siamensis) and Saltwater crocodile (C. porosus) are two of the most endangered animals in Thailand. Their numbers have been reduced severely by hunting and habitat fragmentation. A reintroduction plan involving captive-bred populations that are used commercially is important and necessary as a conservation strategy to aid in the recovery of wild populations. Here, the genetic diversity and population structure of 69 individual crocodiles, mostly members of captive populations, were analyzed using both mitochondrial D-loop DNA and microsatellite markers. The overall haplotype diversity was 0.924-0.971 and the mean expected heterozygosity across 22 microsatellite loci was 0.578-0.701 for the two species. This agreed with the star-like shaped topology of the haplotype network, which suggests a high level of genetic diversity. The mean ratio of the number of alleles to the allelic range (M ratio) for the populations of both species was considerably lower than the threshold of 0.68, which was interpreted as indicative of a historical genetic bottleneck. Microsatellite markers provided evidence of introgression for three individual crocodiles, which suggest that hybridization might have occurred between C. siamensis and C. porosus. D-loop sequence analysis detected bi-directional hybridization between male and female individuals of the parent species. Therefore, identification of genetically non-hybrid and hybrid individuals is important for long-term conservation management. Relatedness values were low within the captive populations, which supported their genetic integrity and the viability of a breeding and reintroduction management plan. This work constitutes the first step in establishing an appropriate source population from a scientifically managed perspective for an in situ/ex situ conservation program and reintroduction of crocodile individuals to the wild in Thailand.	[Lapbenjakul, Sorravis; Thapana, Watcharaporn; Twilprawat, Panupon; Peyachoknagul, Surin; Srikulnath, Kornsorn] Kasetsart Univ, Dept Genet, Lab Anim Cytogenet & Comparat Genom ACCG, Fac Sci, Bangkok, Thailand; [Lapbenjakul, Sorravis; Thapana, Watcharaporn; Muangmai, Narongrit; Srikulnath, Kornsorn] Kasetsart Univ, Anim Breeding & Genet Consortium, ABG KU, Bangkok, Thailand; [Thapana, Watcharaporn; Peyachoknagul, Surin; Srikulnath, Kornsorn] Kasetsart Univ, Natl Res Univ, Ctr Adv Studies Trop Nat Resources, CASTNAR, Bangkok, Thailand; [Muangmai, Narongrit] Kasetsart Univ, Dept Fishery Biol, Fac Fisheries, Bangkok, Thailand; [Kanchanaketu, Thiti] Kasetsart Univ, Fac Liberal Arts & Sci, Dept Sci, Div Genet, Kamphaeng Saen Campus, Kamphaeng Saen, Nakhon Pathom, Thailand; [Temsiripong, Yosapong] Sriracha Moda Co Ltd, R&D Ctr, Sriracha, Chonburi, Thailand; [Unajak, Sasimanas] Kasetsart Univ, Dept Biochem, Fac Sci, Bangkok, Thailand; [Peyachoknagul, Surin] Naresuan Univ, Fac Sci, Dept Biol, Muang Phitsanulok, Phitsanulok, Thailand; [Srikulnath, Kornsorn] Ctr Excellence Agr Biotechnol AG BIO PERDO CHE, Bangkok, Thailand	Kasetsart University; Kasetsart University; Kasetsart University; Kasetsart University; Kasetsart University; Kasetsart University; Naresuan University	Srikulnath, K (corresponding author), Kasetsart Univ, Dept Genet, Lab Anim Cytogenet & Comparat Genom ACCG, Fac Sci, Bangkok, Thailand.; Srikulnath, K (corresponding author), Kasetsart Univ, Anim Breeding & Genet Consortium, ABG KU, Bangkok, Thailand.; Srikulnath, K (corresponding author), Kasetsart Univ, Natl Res Univ, Ctr Adv Studies Trop Nat Resources, CASTNAR, Bangkok, Thailand.; Srikulnath, K (corresponding author), Ctr Excellence Agr Biotechnol AG BIO PERDO CHE, Bangkok, Thailand.	kornsorn.s@ku.ac.th	Muangmai, Narongrit/W-4073-2019; Unajak, Sasimanas/AAM-4340-2021; Srikulnath, Kornsorn/GLU-1326-2022	Muangmai, Narongrit/0000-0001-7954-7348; Srikulnath, Kornsorn/0000-0002-5985-7258; Unajak, Sasimanas/0000-0002-3242-3978	Kasetsart University Research and Development Institute (KURDI) [80.60]; Graduate School, Kasetsart University [10/2557, PM4/2558]; Special Track Staff (STS) [STS1/2558]; Science Research Fund (ScRF) from the Faculty of Science, Kasetsart University [ScRF-S19-2558]; Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University (CASTNAR, NRU-KU, Thailand) [10/2559]; National Research Council of Thailand (NRCT); Graduate School, Kasetsart University; Science Achievement Scholarship of Thailand (SAST) from the Office of the Higher Education Commission, Thailand [5717400381]; Center of Excellence on Agricultural Biotechnology, Science and Technology Postgraduate Education and Research Development Office, Office of Higher Education Commission, Ministry of Education (AG-BIO/PERDO-CHE)	Kasetsart University Research and Development Institute (KURDI); Graduate School, Kasetsart University; Special Track Staff (STS); Science Research Fund (ScRF) from the Faculty of Science, Kasetsart University; Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University (CASTNAR, NRU-KU, Thailand); National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Graduate School, Kasetsart University; Science Achievement Scholarship of Thailand (SAST) from the Office of the Higher Education Commission, Thailand; Center of Excellence on Agricultural Biotechnology, Science and Technology Postgraduate Education and Research Development Office, Office of Higher Education Commission, Ministry of Education (AG-BIO/PERDO-CHE)	This study was financially supported by grants from Kasetsart University Research and Development Institute (KURDI; grant no. 80.60), Kasetsart University 72 year anniversary graduate scholarship (no. 10/2557) from the Graduate School, Kasetsart University, Professor Motivation (PM; no. PM4/2558), Special Track Staff (STS; no. STS1/2558), and the Science Research Fund (ScRF; no. ScRF-S19-2558) from the Faculty of Science, Kasetsart University, the Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University (CASTNAR, NRU-KU, Thailand; no. 10/2559), the graduate scholarship provided by the National Research Council of Thailand (NRCT) as of fiscal year 2017, the Graduate School, Kasetsart University, and the Science Achievement Scholarship of Thailand (SAST; no. 5717400381) from the Office of the Higher Education Commission, Thailand. This research is also partially supported by the Center of Excellence on Agricultural Biotechnology, Science and Technology Postgraduate Education and Research Development Office, Office of Higher Education Commission, Ministry of Education (AG-BIO/PERDO-CHE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Yosapong Temsiripong is employed by Sriracha Moda Co., Ltd. Sriracha Moda Co., Ltd provided support in the form of salary for author YT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.; We thank the crocodile farm members of the Crocodile Co-operatives of Thailand (COCOT), Department of Fisheries, Ministry of Agriculture and Cooperatives (Thailand), and Faculty of Veterinary Science, Mahidol University (Thailand) for advice on sample preparation. We are also grateful to Siwapech Sillapaprayoon (Kasetsart University, Thailand) for helpful discussions. This research is partially supported from graduate scholarship provided by the National Research Council of Thailand (NRCT) as of fiscal year 2017, the Graduate School, Kasetsart University and the Center of Excellence on Agricultural Biotechnology, Science and Technology Postgraduate Education and Research Development Office, Office of Higher Education Commission, Ministry of Education (AG-BIO/PERDO-CHE).	Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Barrow D, 2016, SPO 8 3 BIOPSY POLE; Benavides E, 2012, ZOO BIOL, V31, P107, DOI 10.1002/zoo.20397; Benbouza Halima, 2006, Biotechnologie Agronomie Societe et Environnement, V10, P77; Chavananikul V, 1998, RES REPORT KARYOTYPE; Clement M., 2002, P 16 INT PARALLEL DI, P7; COHEN M M, 1970, Cytogenetics (Basel), V9, P81, DOI 10.1159/000130080; Cornuet JM, 1996, GENETICS, V144, P2001; Crocodile Specialist Group, 1996, IUCN RED LIST THREAT; Department of International Trade Promotion Ministry of Commerce, 2017, STATISTICS; Dinets V, 2013, COPEIA, P517, DOI 10.1643/CE-12-125; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fitzsimmons NN, 2002, J EXP ZOOL, V294, P373, DOI 10.1002/jez.10201; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Funk SM, 2006, CONSERV GENET, V7, P651, DOI 10.1007/s10592-005-9068-7; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Hampl V, 2001, INT J SYST EVOL MICR, V51, P731, DOI 10.1099/00207713-51-3-731; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Jelden DC, 2005, CROCODILE CONSERVATI; Lacy RC, 1995, ZOO BIOL, V14, P565, DOI 10.1002/zoo.1430140609; Li Yan, 2007, Journal of Genetics and Genomics, V34, P119, DOI 10.1016/S1673-8527(07)60013-7; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin G, 2015, BEHAV MODIFICATION W; Meganathan PR, 2010, MOL PHYLOGENET EVOL, V57, P393, DOI 10.1016/j.ympev.2010.06.011; Meraner A, 2014, ECOL EVOL, V4, P1313, DOI 10.1002/ece3.931; Milan-Garcia Y, 2015, HEREDITY, V114, P272, DOI 10.1038/hdy.2014.96; Miles LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-339; Miles LG, 2009, CONSERV GENET, V10, P963, DOI 10.1007/s10592-008-9600-7; Milian-Garcia Y, 2011, J EXP ZOOL PART A, V315A, P358, DOI 10.1002/jez.683; Moritz C, 1999, HEREDITAS, V130, P217, DOI 10.1111/j.1601-5223.1999.00217.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nwafili Sylvanus A., 2016, Archives of Polish Fisheries, V24, P85; Park S.D.E., 2001, THESIS; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Platt Steven G., 2002, Natural History Bulletin of the Siam Society, V50, P7; Pritchard JK, 2000, GENETICS, V155, P945; Ramirez O, 2006, CONSERV GENET, V7, P861, DOI 10.1007/s10592-006-9123-z; Ratanakorn P, 1994, CROCODILES PROCEEDIN, P35; Ray DA, 2004, CONSERV GENET, V5, P449, DOI 10.1023/B:COGE.0000041024.96928.fe; Ray DA, 2002, J EXP ZOOL, V294, P334, DOI 10.1002/jez.10198; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Cedeno-Vazquez JR, 2008, J EXP ZOOL PART A, V309A, P661, DOI 10.1002/jez.473; Ross F.D., 1983, P305; Ross J. P., 1998, CROCODILES STATUS SU; Russello MA, 2007, CONSERV GENET, V8, P777, DOI 10.1007/s10592-006-9225-7; Simpson BK, 2010, CROCODILES STATUS SU, P120; Srikulnath Kornsorn, 2015, Genomics & Informatics, V13, P102, DOI 10.5808/GI.2015.13.4.102; Srikulnath K, 2012, MOL BIOL REP, V39, P4709, DOI 10.1007/s11033-011-1263-7; Starr A, 2010, NEWSLETTER IUCN SSC, V28, P5; Storfer A, 1999, BIOL CONSERV, V87, P173, DOI 10.1016/S0006-3207(98)00066-4; Supikamolseni A, 2015, GENET MOL RES, V14, P13981, DOI 10.4238/2015.October.29.18; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Temsiripong Y., 2001, CSG NEWSLETTER, V20, P10; Temsiripong Yosapong, 2007, Re-introduction News, V26, P55; Thang NQ, 1994, CROCODILES, P141; Thorbjarnarson J., 1992, CROCODILES ACTION PL; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Weaver JP, 2008, J EXP ZOOL PART A, V309A, P649, DOI 10.1002/jez.471; Witzenberger KA, 2011, BIODIVERS CONSERV, V20, P1843, DOI 10.1007/s10531-011-0074-4; Wongsongsarn C., 2010, ANN SURVEY REPORT SI; Youngprapakorn P., 1990, SAMUTPRAKAN CROCODIL, P3	70	17	17	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184526	10.1371/journal.pone.0184526	http://dx.doi.org/10.1371/journal.pone.0184526			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953895	Green Submitted, gold, Green Published			2022-12-27	WOS:000411980300014
J	Trevisan, B; Primon, JF; Marques, FPL				Trevisan, Bruna; Primon, Juliana F.; Marques, Fernando P. L.			Systematics and diversification of Anindobothrium Marques, Brooks & Lasso, 2001 (Eucestoda: Rhinebothriidea)	PLOS ONE			English	Article							MULTIPLE-SEQUENCE ALIGNMENT; FRESH-WATER STINGRAYS; ACANTHOBOTHRIUM CESTODA TETRAPHYLLIDEA; BOCAS-DEL-TORO; N. SP CESTODA; PHYLOGENETIC-RELATIONSHIPS; CRYPTIC DIVERSITY; CYCLOPHYLLIDEA HYMENOLEPIDIDAE; MOLECULAR DIFFERENTIATION; HISTORICAL BIOGEOGRAPHY	Tapeworms of the genus Anindobothrium Marques, Brooks & Lasso, 2001 are found in both marine and Neotropical freshwater stingrays of the family Potamotrygonidae. The patterns of host association within the genus support the most recent hypothesis about the history of diversification of potamotrygonids, which suggests that the ancestor of freshwater lineages of the Potamotrygonidae colonized South American river systems through marine incursion events. Despite the relevance of the genus Anindobothrium to understand the history of colonization and diversification of potamotrygonids, no additional efforts were done to better investigate the phylogenetic relationship of this taxon with other lineages of cestodes since its erection. This study is a result of recent collecting efforts to sample members of the genus in marine and freshwater potamotrygonids that enabled the most extensive documentation of the fauna of Anindobothrium parasitizing species of Styracura de Carvalho, Loboda & da Silva, Potamotrygon schroederi Ferna A ndez-Ye A pez, P. orbignyi (Castelnau) and P. yepezi Castex & Castello from six different countries, representing the eastern Pacific Ocean, Caribbean Sea, and river basins in South America (Rio Negro, Orinoco, and Maracaibo). The newly collected material provided additional specimens for morphological studies and molecular samples for subsequent phylogenetic analyses that allowed us to address the phylogenetic position of Anindobothrium and provide molecular and morphological evidence to recognize two additional species for the genus. The taxonomic actions that followed our analyses included the proposition of a new family, Anindobothriidae fam. n., to accommodate the genus Anindobothriumin the order Rhinebothriidea Healy, Caira, Jensen, Webster & Littlewood, 2009 and the description of two new species-one from the eastern Pacific Ocean, A. carrioni sp. n., and the other from the Caribbean Sea, A. inexpectatum sp. n. In addition, we also present a redescription of the type species of the genus, A. anacolum (Brooks, 1977) Marques, Brooks & Lasso, 2001, and of A. lisae Marques, Brooks & Lasso, 2001. Finally, we discuss the paleogeographical events mostly linked with the diversification of the genus and the protocols adopted to uncover cryptic diversity in Anindobothrium.	[Trevisan, Bruna] Univ Sao Paulo, Curso Posgrad, Inst Biociencias, Sao Paulo, SP, Brazil; [Trevisan, Bruna; Primon, Juliana F.; Marques, Fernando P. L.] Univ Sao Paulo, Dept Zool, Inst Biociencias, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Trevisan, B (corresponding author), Univ Sao Paulo, Curso Posgrad, Inst Biociencias, Sao Paulo, SP, Brazil.; Trevisan, B (corresponding author), Univ Sao Paulo, Dept Zool, Inst Biociencias, Sao Paulo, SP, Brazil.	bruna.trevisan@usp.br	Marques, Fernando/J-3629-2012	Marques, Fernando/0000-0002-4281-8711; Trevisan, Bruna/0000-0002-7872-985X	NSF PBI grant [DEB 0818696, DEB 0818823]; State University of New York College at Oneonta Research Foundation; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2014/10220-0]	NSF PBI grant(National Science Foundation (NSF)); State University of New York College at Oneonta Research Foundation; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported in part with funds from NSF PB&I grants DEB 0818696 and DEB 0818823; grants from the State University of New York College at Oneonta Research Foundation; and by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) grant #2014/10220-0.r We would like to thank Dr. Janine N. Caira (University of Connecticut, Storrs, CT, U.S.A.) for providing material from her personal collection and for conducting SEM sections at UCONN. We thank Dr. Janine Caira, Dr. Kirsten Jensen (University of Kansas, Lawrence, KS, U.S.A.), M.Sc. Veronica M. Bueno (University of Connecticut, Storrs, CT, U.S.A.) and Dr. Joana Cielocha (University of Kansas, Lawrence, KS, U.S.A.) for their help during the collecting trip to Belize; and to Dr. Bjoern C. Schaeffner (Universidade de Sao Paulo, Sao Paulo, SP, Brazil) and Dr. Florian B. Reyda (State University of New York College of Oneonta, Oneonta, New York, U.S.A.) for their help during the field trip to Panama. We appreciated the help and hospitality of Otto Castillo and Luis Sanchez (UNELLEZ, Guanare) during the collecting trips inVenezuela. We are indebted to Dr. Angel Javier Vega and M.Sc. Leysi del Carmem from Centro Regional Universitario de Veraguas-Universidad de Panama (Santiago de Veraguas, Veraguas, Panama) for facilitating our field trip in Panama and for the assistance during the field trip on that country. We thank Dr. Anna J. Phillips from the National Museum of Natural History (Smithsonian Institution, Washington, D.C., U.S.A.) and Dr. Gabor Racz from the Harold W. Manter Laboratory (University of Nebraska, Lincoln, Nebraska, U.S.A.) for the loan of the type material of Anindobothrium anacolum, and also Dr. Marcelo Knoff from the Colecao Helmintologica do Instituto Oswaldo Cruz (Rio de Janeiro, RJ, Brazil) for allowing us to examine the type material of A. lisae. We also would like to thank B.Sc. Beatriz V. Freire for her help in gathering the molecular data. Finally, we appreciated comments and criticisms provided by Dr. Bjoern C. Schaeffner, Florian Reyda, Kirsten Jensen and Veronica M. Bueno on earlier versions of this manuscript. This work was supported in part with funds from NSF PB&I grants DEB 0818696 and DEB 0818823; grants from the State University of New York College at Oneonta Research Foundation; and by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) grant # 2014/10220-0. Any opinions, findings, conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.	Agrawal N, 2008, BIOSCI TRENDS, V2, P128; Aschliman NC, 2011, BATOID TREE LIFE REC; Bernot JP, 2015, J PARASITOL, V101, P167, DOI 10.1645/14-571.1; Beveridge I, 2014, INT J PARASITOL, V44, P859, DOI 10.1016/j.ijpara.2014.06.001; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Binkiene R, 2015, PARASITOL RES, V114, P209, DOI 10.1007/s00436-014-4180-6; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; BROOKS DR, 1977, P HELM SOC WASH, V44, P51; Caira JN, 2014, INT J PARASITOL, V44, P55, DOI 10.1016/j.ijpara.2013.10.004; Caira JN, 2011, PARASITOLOGY, V138, P1675, DOI 10.1017/S0031182011000643; Caira JN, 2001, INT J PARASITOL, V31, P960, DOI 10.1016/S0020-7519(01)00206-5; Caira JN, 2016, GLOBAL CESTODE DATAB; Carus JV, 1863, HDB ZOOLOGIE, P422, DOI DOI 10.5962/BHL.TITLE.1399; Carvalho MD, 2016, ZOOTAXA, V4175, P201; Chervy L, 2009, FOLIA PARASIT, V56, P199, DOI 10.14411/fp.2009.025; Chilton NB, 2007, PARASITOL RES, V100, P1187, DOI 10.1007/s00436-006-0388-4; Clopton RE, 2004, COMP PARASITOL, V71, P130, DOI 10.1654/4151; Clouse RM, 2014, ZOOTAXA, V3814, P177, DOI 10.11646/zootaxa.3814.2.2; Coates AG, 2005, CARIBB J SCI, V41, P374; Coates AG, 2003, GEOL SOC AM BULL, V115, P271, DOI 10.1130/0016-7606(2003)115<0271:ENHOTC>2.0.CO;2; Cook LG, 2010, INVERTEBR SYST, V24, P322, DOI 10.1071/IS10011; Cutmore SC, 2011, FOLIA PARASIT, V58, P187, DOI 10.14411/fp.2011.019; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Carvalho MR, 2016, ZOOTAXA, V4167, P1, DOI 10.11646/zootaxa.4167.1.1; De Carvalho MR, 2004, B AM MUS NAT HIST, P1; de Chambrier A, 2009, J PARASITOL, V95, P160, DOI 10.1645/GE-1594.1; Melo FTD, 2011, MEM I OSWALDO CRUZ, V106, P670, DOI 10.1590/S0074-02762011000600005; Ekman S., 1953, P417; Esselstyn JA, 2007, BIOL J LINN SOC, V90, P761, DOI 10.1111/j.1095-8312.2007.00776.x; Euzet L., 1953, 14 INT C ZOOL 1956 P, P347; Euzet L., 1863, KEYS CESTODE PARASIT, P149; Euzet L, 1980, MEMOIRE SOC ZOOLO 40, V3, P239; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Fontaneto D, 2009, MOL PHYLOGENET EVOL, V53, P182, DOI 10.1016/j.ympev.2009.04.011; Fontenelle JP, 2017, ZOOTAXA, V4310, P1, DOI 10.11646/zootaxa.4310.1.1; Fouquet A, 2007, MOL PHYLOGENET EVOL, V43, P567, DOI 10.1016/j.ympev.2006.12.006; Fyler CA, 2010, INVERTEBR SYST, V24, P419, DOI 10.1071/IS10034; Fyler CA, 2011, COMP PARASITOL, V78, P4, DOI 10.1654/4454.1; Fyler CA, 2009, FOLIA PARASIT, V56, P107, DOI 10.14411/fp.2009.016; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff P, 2008, CLADISTICS, V24, P91; Goodman M., 1982, Acta Zoologica Fennica, P19; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Grant T, 2008, MOL PHYLOGENET EVOL, V49, P405, DOI 10.1016/j.ympev.2008.04.023; Grant T, 2008, CLADISTICS, V24, P1051, DOI 10.1111/j.1096-0031.2008.00231.x; Greiman SE, 2013, J PARASITOL, V99, P1045, DOI 10.1645/13-302.1; Greiman SE, 2012, PARASITOL INT, V61, P343, DOI 10.1016/j.parint.2012.01.003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hanzelova V, 2005, PARASITOL INT, V54, P207, DOI 10.1016/j.parint.2005.05.001; Haukisalmi V, 2014, ZOOTAXA, V3873, P371, DOI 10.11646/zootaxa.3873.4.3; Haukisalmi V, 2010, ZOOL SCR, V39, P631, DOI 10.1111/j.1463-6409.2010.00444.x; Healy CJ, 2009, INT J PARASITOL, V39, P497, DOI 10.1016/j.ijpara.2008.09.002; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Jaiswara R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075930; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Jia WZ, 2012, ACTA TROP, V123, P154, DOI 10.1016/j.actatropica.2012.04.006; Jorger KM, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-59; Jordan DS, 1908, AM NAT, V42, P73, DOI 10.1086/278905; Karanovic T, 2016, SYST BIOL, V65, P304, DOI 10.1093/sysbio/syv088; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Kuchta R, 2006, J PARASITOL, V92, P126, DOI 10.1645/GE-3511.1; Kuchta R, 2008, J PARASITOL, V94, P500, DOI 10.1645/GE-1425.1; Kuchta R, 2012, ZOOTAXA, P1; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lajus D, 2015, ECOL EVOL, V5, P2374, DOI 10.1002/ece3.1521; Lavikainen A, 2016, INT J PARASITOL, V46, P361, DOI 10.1016/j.ijpara.2016.01.009; Lee MSY, 2003, SYST BIOL, V52, P15, DOI 10.1080/10635150390132650; Leigh EG, 2014, BIOL REV, V89, P148, DOI 10.1111/brv.12048; Leliaert F, 2014, EUR J PHYCOL, V49, P179, DOI 10.1080/09670262.2014.904524; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Lovejoy NR, 2006, J S AM EARTH SCI, V21, P5, DOI 10.1016/j.jsames.2005.07.009; Lovejoy NR, 1998, NATURE, V396, P421, DOI 10.1038/24757; Lovejoy NR, 1996, ZOOL J LINN SOC-LOND, V117, P207, DOI 10.1006/zjls.1996.0038; Machado DJ, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0642-9; Makarikov AA, 2015, PARASITOL RES, V114, P2107, DOI 10.1007/s00436-015-4399-x; Makarikov AA, 2013, ZOOTAXA, V3608, P401, DOI 10.11646/zootaxa.3608.6.1; Marques FPL, 2016, J PARASITOL, V102, P249, DOI 10.1645/15-894; Marques FPL, 2001, J PARASITOL, V87, P666, DOI 10.1645/0022-3395(2001)087[0666:ANGETI]2.0.CO;2; Marques FPL, 2000, THESIS; Marques JF, 2007, PARASITOLOGY, V134, P1057, DOI 10.1017/S0031182007002491; Mayer F, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-4; Meireles CM, 1999, GENET MOL BIOL, V22, P337, DOI 10.1590/S1415-47571999000300009; Morard R, 2016, SYST BIOL, V65, P925, DOI 10.1093/sysbio/syw031; Morard R, 2013, PALAEOGEOGR PALAEOCL, V391, P13, DOI 10.1016/j.palaeo.2013.05.011; Nakao M, 2013, INT J PARASITOL, V43, P427, DOI 10.1016/j.ijpara.2012.11.014; Naylor GJP, 2012, CRC MAR BIOL SER, P31; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; O'Dea A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600883; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Page RDM, 1998, TRENDS ECOL EVOL, V13, P356, DOI 10.1016/S0169-5347(98)01438-4; Pante E, 2015, MOL ECOL, V24, P525, DOI 10.1111/mec.13048; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Parsons S, 2000, J EXP BIOL, V203, P2641; de Leon GPP, 2018, J HELMINTHOL, V92, P197, DOI [10.1017/S0022149X17000189, 10.1017/s0022149x17000189]; de Leon GPP, 2010, J PARASITOL, V96, P453, DOI 10.1645/GE-2260.1; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Phillips AJ, 2014, FOLIA PARASIT, V61, P441, DOI 10.14411/fp.2014.058; Pleijel F, 2008, MOL PHYLOGENET EVOL, V48, P369, DOI 10.1016/j.ympev.2008.03.024; R Core Team, 2021, R LANGUAGE ENV STAT; Randhawa HS, 2008, SYST PARASITOL, V70, P41, DOI 10.1007/s11230-007-9122-6; RAO CR, 1948, J ROY STAT SOC B, V10, P159; Renner SS, 2016, SYST BIOL, V65, P1085, DOI 10.1093/sysbio/syw032; Reyda FB, 2008, J PARASITOL, V94, P684, DOI 10.1645/GE-1230.1; Reyda FB, 2016, FOLIA PARASIT, V63, DOI 10.14411/fp.2016.038; Reyda FB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022604; Robertson DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102918; Ruhnke TR, 2013, SYST PARASITOL, V85, P37, DOI 10.1007/s11230-013-9411-1; Ruhnke TR, 2015, ZOOTAXA, V3904, P51, DOI 10.11646/zootaxa.3904.1.3; Ruhnke Timothy R., 2011, Bulletin of the University of Nebraska State Museum, V25, P1; Ruhnke TR, 2009, PLANETARY BIODIVERSI, P327; Schaeffner BC, 2011, SYST PARASITOL, V80, P1, DOI 10.1007/s11230-011-9309-8; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scholz T, 2014, PARASITOL INT, V63, P841, DOI 10.1016/j.parint.2014.07.015; Swofford D., 1990, PAUP PHYLOGENETIC AN; TEMPLETON AR, 1992, GENETICS, V132, P619; Tkach VV, 2013, ZOOTAXA, V3691, P389, DOI 10.11646/zootaxa.3691.3.7; Trevisan B, 2017, ZOOTAXA, V4300, P421, DOI 10.11646/zootaxa.4300.3.5; Trontelj P, 2009, SYST BIODIVERS, V7, P1, DOI 10.1017/S1477200008002909; Varon A, 2010, CLADISTICS, V26, P72, DOI 10.1111/j.1096-0031.2009.00282.x; Vermes Braun M., 1894, KLASSEN ORDNUNGEN TH, P927; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wheeler W, 1996, CLADISTICS, V12, P1, DOI 10.1111/j.1096-0031.1996.tb00189.x; Wheeler WC, 2003, CLADISTICS, V19, P261, DOI 10.1016/S0748-3007(03)00049-5; Wheeler WC, 2003, CLADISTICS, V19, P254, DOI 10.1016/S0748-3007(03)00047-1; Wheeler WC, 2006, DYNAMIC HOMOLOGY PHY; Zwickl D. J, 2006, GENETIC ALGORITHM AP	134	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184632	10.1371/journal.pone.0184632	http://dx.doi.org/10.1371/journal.pone.0184632			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953933	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300017
J	Adjei, NK; Brand, T; Zeeb, H				Adjei, Nicholas Kofi; Brand, Tilman; Zeeb, Hajo			Gender inequality in self-reported health among the elderly in contemporary welfare countries: A cross-country analysis of time use activities, socioeconomic positions and family characteristics	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; RATED HEALTH; OLDER-ADULTS; CARDIOVASCULAR-DISEASE; PERCEIVED HEALTH; MULTIPLE ROLES; SLEEP DURATION; STATE REGIMES; SOCIAL ROLES; FOLLOW-UP	Background Paradoxically, despite their longer life expectancy, women report poorer health than men. Time devoted to differing social roles could be an explanation for the observed gender differences in health among the elderly. The objective of this study was to explain gender differences in self-reported health among the elderly by taking time use activities, socioeconomic positions, family characteristics and cross-national differences into account. Methods Data from the Multinational Time Use Study (MTUS) on 13,223 men and 18,192 women from Germany, Italy, Spain, UK and the US were analyzed. Multiple binary logistic regression models were used to examine the association between social factors and health for men and women separately. We further identified the relative contribution of different factors to total gender inequality in health using the Blinder-Oaxaca decomposition method. Results Whereas time allocated to paid work, housework and active leisure activities were positively associated with health, time devoted to passive leisure and personal activities were negatively associated with health among both men and women, but the magnitude of the association varied by gender and country. We found significant gender differences in health in Germany, Italy and Spain, but not in the other countries. The decomposition showed that differences in the time allocated to active leisure and level of educational attainment accounted for the largest health gap. Conclusions Our study represents a first step in understanding cross-national differences in the association between health status and time devoted to role-related activities among elderly men and women. The results, therefore, demonstrate the need of using an integrated framework of social factors in analyzing and explaining the gender and cross-national differences in the health of the elderly population.	[Adjei, Nicholas Kofi; Brand, Tilman; Zeeb, Hajo] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Adjei, Nicholas Kofi; Zeeb, Hajo] Univ Bremen, Hlth Sci Bremen, Bremen, Germany	Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen	Adjei, NK (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany.; Adjei, NK (corresponding author), Univ Bremen, Hlth Sci Bremen, Bremen, Germany.	adjei@uni-bremen.de	Adjei, Nicholas Kofi/AAA-9315-2020; Zeeb, Hajo/I-2701-2019	Zeeb, Hajo/0000-0001-7509-242X; Brand, Tilman/0000-0001-5140-7511				ADELMANN PK, 1994, RES AGING, V16, P142, DOI 10.1177/0164027594162002; ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Aguiar M., 2006, MEASURING TRENDS LEI; Anxo D., 2007, TIME ALLOCATION WORK; ARBER S, 1993, SOC SCI MED, V36, P33, DOI 10.1016/0277-9536(93)90303-L; ASSARI S, 2015, INT J PREVENTIVE MED, V6; Assari S, 2016, SAGE OPEN MED, V4, DOI 10.1177/2050312116666975; Austad Steven N, 2006, Gend Med, V3, P79, DOI 10.1016/S1550-8579(06)80198-1; Bambra C, 2009, J EPIDEMIOL COMMUN H, V63, P38, DOI 10.1136/jech.2007.070292; Barreto SM, 2004, REV PANAM SALUD PUBL, V16, P110, DOI 10.1590/S1020-49892004000800006; Bianchi SM., 2006, CHANGING RHYTHMS AM; Bianchi SM, 2012, SOC FORCES, V91, P55, DOI 10.1093/sf/sos120; BIRD CE, 1991, J HEALTH SOC BEHAV, V32, P114, DOI 10.2307/2137147; Bird CE, 1999, J HEALTH SOC BEHAV, V40, P32, DOI 10.2307/2676377; Boerma T, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3352-y; Bonke J, 2005, SOC INDIC RES, V70, P349, DOI 10.1007/s11205-004-1547-6; Borrell C, 2004, SOC SCI MED, V58, P1869, DOI 10.1016/S0277-9536(03)00408-8; Bratberg E, 2002, EUR SOCIOL REV, V18, P233, DOI 10.1093/esr/18.2.233; Burda M, 2013, J POPUL ECON, V26, P239, DOI 10.1007/s00148-012-0408-x; Chien MY, 2015, GERONTOLOGY, V61, P399, DOI 10.1159/000371847; Coltrane S, 2000, J MARRIAGE FAM, V62, P1208, DOI 10.1111/j.1741-3737.2000.01208.x; Dahl E, 1997, SOC SCI MED, V44, P871, DOI 10.1016/S0277-9536(96)00189-X; Dalstra JAA, 2006, SOC SCI MED, V62, P2046, DOI 10.1016/j.socscimed.2005.09.001; Daly M, 2000, BRIT J SOCIOL, V51, P281, DOI 10.1111/j.1468-4446.2000.00281.x; Eikemo TA, 2008, SOC SCI MED, V66, P2281, DOI 10.1016/j.socscimed.2008.01.022; Eskes T, 2007, EUR J OBSTET GYN R B, V133, P126, DOI 10.1016/j.ejogrb.2007.01.006; Eurofound, 2012, INC WORK RET EU; Fisher K., 2012, MULTINATIONAL TIME U; Friedberg L, 2007, WOMEN, V55, P64; Gardner B, 2014, INT J BEHAV NUTR PHY, V11; Gauthier AH, 2003, RES AGING, V25, P247, DOI 10.1177/0164027503025003003; Gershuny J, 2003, SOC POLIT, V10, P205, DOI 10.1093/sp/jxg012; Glaser K, 2005, HEALTH SOC CARE COMM, V13, P470, DOI 10.1111/j.1365-2524.2005.00574.x; Glass TA, 1999, BRIT MED J, V319, P478, DOI 10.1136/bmj.319.7208.478; Gorman BK, 2006, J HEALTH SOC BEHAV, V47, P95, DOI 10.1177/002214650604700201; GOVE WR, 1978, SOC SCI MED-MED ANTH, V12, P187, DOI 10.1016/0160-7987(78)90032-7; Grundy E, 2001, J EPIDEMIOL COMMUN H, V55, P895, DOI 10.1136/jech.55.12.895; Hammerman-Rozenberg R, 2005, AGING CLIN EXP RES, V17, P508, DOI 10.1007/BF03327419; Hook JL, 2010, AM J SOCIOL, V115, P1480, DOI 10.1086/651384; Hosseinpoor AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034799; HOUSE JS, 1994, J HEALTH SOC BEHAV, V35, P213, DOI 10.2307/2137277; Huisman M, 2003, SOC SCI MED, V57, P861, DOI 10.1016/S0277-9536(02)00454-9; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Gimenez-Nadal JI, 2016, IZA J EUR LABOR STUD, V5, DOI 10.1186/s40174-016-0055-4; Gimenez-Nadal JI, 2015, ECON MODEL, V46, P188, DOI 10.1016/j.econmod.2014.12.034; Gimenez-Nadal JI, 2013, APPL ECON LETT, V20, P1435, DOI 10.1080/13504851.2013.818205; Gimenez-Nadal JI, 2012, EUR ECON REV, V56, P1338, DOI 10.1016/j.euroecorev.2012.02.011; Ikehara S, 2009, SLEEP, V32, P295, DOI 10.1093/sleep/32.3.295; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Jiang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082715; Jurges H, 2007, HEALTH ECON, V16, P163, DOI 10.1002/hec.1134; Kan MY, 2011, SOCIOLOGY, V45, P234, DOI 10.1177/0038038510394014; Kan MY, 2008, SOCIOL METHODOL, V38, P101, DOI 10.1111/j.1467-9531.2008.00197.x; Kim J, 2014, INT J QUALITATIVE ST, V9; Kowal P, 2010, GLOBAL HLTH ACTION, V3; Lankarani MM, 2017, WOMENS HLTH B; Lawlor DA, 2002, J EPIDEMIOL COMMUN H, V56, P473, DOI 10.1136/jech.56.6.473; Leinonen R, 1998, SOC SCI MED, V46, P591, DOI 10.1016/S0277-9536(97)00205-0; Lucas M, 2011, AM J EPIDEMIOL, V174, P1017, DOI 10.1093/aje/kwr218; Luoh MC, 2002, J HEALTH SOC BEHAV, V43, P490, DOI 10.2307/3090239; Malmberg J, 2005, PREV MED, V41, P141, DOI 10.1016/j.ypmed.2004.09.036; Malmusi D, 2012, EUR J PUBLIC HEALTH, V22, P781, DOI 10.1093/eurpub/ckr184; Manor O, 2000, INT J EPIDEMIOL, V29, P149, DOI 10.1093/ije/29.1.149; Marks NF, 1994, SOCIOECONOMIC STATUS; McDonough P, 2001, SOC SCI MED, V52, P547, DOI 10.1016/S0277-9536(00)00159-3; MCLEOD JD, 1990, J HEALTH SOC BEHAV, V31, P162, DOI 10.2307/2137170; McMunn A, 2009, AGE AGEING, V38, P181, DOI 10.1093/ageing/afn236; NATHANSON CA, 1980, SOC SCI MED-MED SOC, V14, P463, DOI 10.1016/S0271-7123(80)80050-2; Nguyen GT, 2008, GERONTOLOGIST, V48, P300, DOI 10.1093/geront/48.3.300; Oksuzyan A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131691; PARNES HS, 1994, J GERONTOL, V49, pS117; Podor M, 2012, HEALTH ECON, V21, P514, DOI 10.1002/hec.1725; POTTS R, 1994, J BROADCAST ELECTRON, V38, P79; Prus SG, 2003, CAN J PUBLIC HEALTH, V94, P306, DOI 10.1007/BF03403611; Regan JC, 2013, BEST PRACT RES CL EN, V27, P467, DOI 10.1016/j.beem.2013.05.016; Rieker PP, 2005, J GERONTOL B-PSYCHOL, V60, P40; Rueda S, 2008, J EPIDEMIOL COMMUN H, V62, P492, DOI 10.1136/jech.2006.059279; Rueda S, 2009, AGEING SOC, V29, P625, DOI 10.1017/S0144686X08008349; Sachs-Ericsson N, 2000, SEX ROLES, V43, P605, DOI 10.1023/A:1007148407005; Sayer LC, 2016, TRENDS WOMENS MENS T, P43; Schnittker J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084933; Short SE, 2013, AM J PUBLIC HEALTH, V103, P93, DOI 10.2105/AJPH.2013.301229; Singh L, 2013, SAGE OPEN, V3, DOI 10.1177/2158244013487914; Smith JP, 1997, DEMOGRAPHY, V34, P159, DOI 10.2307/2061665; StataCorp, 2015, SOCIAL SCI MED; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Thorslund M, 1994, J Aging Health, V6, P51, DOI 10.1177/089826439400600104; Tubeuf S, 2011, EUR J HEALTH ECON, V12, P61, DOI 10.1007/s10198-010-0229-3; United Nations, 2013, WORLD POP AG 2013 ST; WALTERS V, 1993, SOC SCI MED, V36, P393, DOI 10.1016/0277-9536(93)90401-O; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105; Wilkinson RG, 2003, SOCIAL DETERMINANTS; Williams JAS, 2009, SOC SCI MED, V69, P1072, DOI 10.1016/j.socscimed.2009.07.012; Wu CY, 2015, PREV MED, V72, P23, DOI 10.1016/j.ypmed.2014.12.023; Yun MS, 2004, ECON LETT, V82, P275, DOI 10.1016/j.econlet.2003.09.008; Zhang H, 2015, ECON HUM BIOL, V18, P13, DOI 10.1016/j.ehb.2015.03.001; Zimmer Z, 1996, J Cross Cult Gerontol, V11, P167, DOI 10.1007/BF00114859	97	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0184676	10.1371/journal.pone.0184676	http://dx.doi.org/10.1371/journal.pone.0184676			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI1DL	28949984	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000014
J	Boyer, PH; Boulanger, N; Nebbak, A; Collin, E; Jaulhac, B; Almeras, L				Boyer, Pierre H.; Boulanger, Nathalie; Nebbak, Amira; Collin, Elodie; Jaulhac, Benoit; Almeras, Lionel			Assessment of MALDI-TOF MS biotyping for Borrelia burgdorferi sl detection in Ixodes ricinus	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; LYME BORRELIOSIS; SPECIES DETERMINATION; DEVELOPMENTAL-STAGES; TICK VECTORS; SENSU-LATO; IDENTIFICATION; DISEASE; EXPRESSION	Matrix Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDITOF MS) has been demonstrated to be useful for tick identification at the species level. More recently, this tool has been successfully applied for the detection of bacterial pathogens directly in tick vectors. The present work has assessed the detection of Borrelia burgdorferi sensu lato in Ixodes ricinus tick vector by MALDI-TOF MS. To this aim, experimental infection model of I. ricinus ticks by B. afzelii was carried out and specimens collected in the field were also included in the study. Borrelia infectious status of I. ricinus ticks was molecularly controlled using half-idiosome to classify specimens. Among the 39 ticks engorged on infected mice, 14 were confirmed to be infected by B. afzelii. For field collection, 14.8% (n = 12/81) I. ricinus ticks were validated molecularly as infected by B. burgdorferi sl. To determine the body part allowing the detection of MS protein profile changes between noninfected and B. afzelii infected specimens, ticks were dissected in three compartments (i.e. 4 legs, capitulum and half-idiosome) prior to MS analysis. Highly reproducible MS spectra were obtained for I. ricinus ticks according to the compartment tested and their infectious status. However, no MS profile change was found when paired body part comparison between non-infected and B. afzelii infected specimens was made. Statistical analyses did not succeed to discover, per body part, specific MS peaks distinguishing Borrelia-infected from non-infected ticks whatever their origins, laboratory reared or field collected. Despite the unsuccessful of MALDI-TOF MS to classify tick specimens according to their B. afzelii infectious status, this proteomic tool remains a promising method for rapid, economic and accurate identification of tick species. Moreover, the singularity of MS spectra between legs and half-idiosome of I. ricinus could be used to reinforce this proteomic identification by submission of both these compartments to MS.	[Boyer, Pierre H.; Boulanger, Nathalie; Collin, Elodie; Jaulhac, Benoit] Univ Strasbourg, Federat Med Translat Strasbourg, VBP EA 7290, Early Bacterial Virulence Lyme Borreliosis Grp, Strasbourg, France; [Boulanger, Nathalie; Jaulhac, Benoit] Hop Univ Strasbourg, French Natl Reference Ctr Borrelia, Strasbourg, France; [Nebbak, Amira; Almeras, Lionel] Aix Marseille Univ, URMITE, Inst Hosp Univ Mediterrane Infect, UM63,CNRS 7278,IRD 198,Inserm 1095, 19-21 Blvd Jean Moulin, Marseille, France; [Nebbak, Amira] USTHB, Fac Sci Biol, Lab Biodiversite & Environm Interact Genomes, Algiers, Algeria; [Almeras, Lionel] Inst Rech Biomed Armees, Unite Parasitol & Entomol, Dept Malad Infect, Marseille, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); University Science & Technology Houari Boumediene; UDICE-French Research Universities; Aix-Marseille Universite	Boulanger, N (corresponding author), Univ Strasbourg, Federat Med Translat Strasbourg, VBP EA 7290, Early Bacterial Virulence Lyme Borreliosis Grp, Strasbourg, France.; Boulanger, N (corresponding author), Hop Univ Strasbourg, French Natl Reference Ctr Borrelia, Strasbourg, France.	nboulanger@unistra.fr	BOYER, Pierre/AAL-6569-2020; NEBBAK, Amira/AAU-9609-2021; Alméras, Lionel/ABD-9797-2021; Boulanger, Nathalie/ABF-1353-2020	NEBBAK, Amira/0000-0002-1060-0152; 				BEATI L, 1994, AM J TROP MED HYG, V51, P138, DOI 10.4269/ajtmh.1994.51.138; Boyer PH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2212-7; Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x; Cutler SJ, 2016, MOL CELL PROBE, P22; Diarra AZ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005762; Dieme C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0544-0; Dunham-Ems SM, 2009, J CLIN INVEST, V119, P3652, DOI 10.1172/JCI39401; Duron O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004892; Ferquel E, 2006, APPL ENVIRON MICROB, V72, P3074, DOI 10.1128/AEM.72.4.3074-3078.2006; Fotso AF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002984; GUY EC, 1991, J CLIN PATHOL, V44, P610, DOI 10.1136/jcp.44.7.610; Hidri N, 2012, CLIN MICROBIOL INFEC, V18, pE531, DOI 10.1111/1469-0691.12016; Jacquet M, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2187-4; Kahl Olaf, 2002, P29, DOI 10.1079/9780851996325.0029; Karger A, 2012, TICKS TICK-BORNE DIS, V3, P78, DOI 10.1016/j.ttbdis.2011.11.002; Kern A, 2011, VECTOR-BORNE ZOONOT, V11, P1343, DOI 10.1089/vbz.2010.0197; Kumsa B, 2016, PARASITOL RES, V115, P4199, DOI 10.1007/s00436-016-5197-9; Lafri I, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004351; MBOW ML, 1994, IMMUNOLOGY, V82, P596; Nebbak A, 2017, MED VET ENTOMOL; Nebbak A, 2016, PROTEOMICS, V16, P3148, DOI 10.1002/pmic.201600287; Perez-Eid C., 2007, LAVOISIER; Piesman J, 2001, J CLIN MICROBIOL, V39, P4145, DOI 10.1128/JCM.39.11.4145-4148.2001; Rijpkema S, 1996, EXP APPL ACAROL, V20, P23; Rudenko N, 2007, INSECT MOL BIOL, V16, P501, DOI 10.1111/j.1365-2583.2007.00745.x; Rudenko N, 2005, J MED ENTOMOL, V42, P36, DOI 10.1603/0022-2585(2005)042[0036:DEOIRT]2.0.CO;2; Schnell G, 2015, MOL CELL PROTEOMICS, V14, P1254, DOI 10.1074/mcp.M114.046540; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Tonetti N, 2015, TICKS TICK-BORNE DIS, V6, P334, DOI 10.1016/j.ttbdis.2015.02.007; Uhlmann KR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-392; Van Treuren W, 2015, APPL ENVIRON MICROB, V81, P6200, DOI 10.1128/AEM.01562-15; Yssouf A, 2016, FUTURE MICROBIOL, V11, P549, DOI 10.2217/fmb.16.5; Yssouf A, 2015, TICKS TICK-BORNE DIS, V6, P579, DOI 10.1016/j.ttbdis.2015.04.013; Yssouf A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003473; Yssouf A, 2014, PARASITOL RES, V113, P2375, DOI 10.1007/s00436-014-3876-y; Yssouf A, 2013, J CLIN MICROBIOL, V51, P522, DOI 10.1128/JCM.02665-12	37	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185430	10.1371/journal.pone.0185430	http://dx.doi.org/10.1371/journal.pone.0185430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950023	Green Published, gold, Green Submitted			2022-12-27	WOS:000411671000052
J	Larson, EC; Novis, CL; Martins, LJ; Macedo, AB; Kimball, KE; Bosque, A; Planelles, V; Barrows, LR				Larson, Erica C.; Novis, Camille L.; Martins, Laura J.; Macedo, Amanda B.; Kimball, Kadyn E.; Bosque, Alberto; Planelles, Vicente; Barrows, Louis R.			Mycobacterium tuberculosis reactivates latent HIV-1 in T cells in vitro	PLOS ONE			English	Article							LONG TERMINAL REPEAT; TRANSCRIPTIONAL ACTIVATION; REPLICATION; INFECTION; RECOGNITION; MACROPHAGES; EXPRESSION; RESERVOIR; INDUCTION; PROTEIN	Following proviral integration into the host cell genome and establishment of a latent state, the human immunodeficiency virus type 1 (HIV-1) can reenter a productive life cycle in response to various stimuli. HIV-1 reactivation occurs when transcription factors, such as nuclear factor-.B (NF-.B), nuclear factor of activated T cells (NFAT), and activator protein -1 (AP-1), bind cognate sites within the long terminal repeat (LTR) region of the HIV-1 provirus to promote transcription. Interestingly, pattern recognition receptors (PRRs) that recognize pathogen-associated molecular patterns (PAMPs) can reactivate latent HIV-1 through activation of the transcription factor NF-.B. Some PRRs are expressed on central memory CD4 + T cells (TCM), which in HIV-1 patients constitute the main reservoir of latent HIV-1. Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), interacts with PRRs through membrane components. However, the ability of Mtb to reactivate latent HIV1 has not been extensively studied. Here we show that phosphatidylinositol mannoside 6 (PIM6), a component of the Mtb membrane, in addition to whole bacteria in co-culture, can reactivate HIV-1 in a primary TCM cell model of latency. Using a JLAT model of HIV-1 latency, we found this interaction to be mediated through Toll-like receptor-2 (TLR-2). Thus, we describe a mechanism by which Mtb can exacerbate HIV-1 infection. We hypothesize that chronic Mtb infection can drive HIV-1 reactivation. The phenomenon described here could explain, in part, the poor prognosis that characterizes HIV-1/Mtb co-infection.	[Larson, Erica C.; Barrows, Louis R.] Univ Utah, Dept Pharmacol & Toxicol, 112 Skaggs Hall, Salt Lake City, UT 84112 USA; [Novis, Camille L.; Martins, Laura J.; Macedo, Amanda B.; Kimball, Kadyn E.; Bosque, Alberto; Planelles, Vicente] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Macedo, Amanda B.; Bosque, Alberto] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; George Washington University	Barrows, LR (corresponding author), Univ Utah, Dept Pharmacol & Toxicol, 112 Skaggs Hall, Salt Lake City, UT 84112 USA.	lbarrows@pharm.utah.edu	Bosque, Alberto/H-7267-2019	Bosque, Alberto/0000-0002-8800-2160; Martins, Laura/0000-0001-8535-5350	National Institute of Allergy and Infectious Diseases of the NIH [R21AI124823, R01 AI124722]; University of Utah Flow Cytometry Facility in addition to the National Cancer Institute [5P30CA042014-24]; American Foundation for Pharmaceutical Education Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124722] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Utah Flow Cytometry Facility in addition to the National Cancer Institute; American Foundation for Pharmaceutical Education Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the NIH under award number R21AI124823 to L.R.B. and V.P. and R01 AI124722 to A.B. This work was supported by the University of Utah Flow Cytometry Facility in addition to the National Cancer Institute through Award Number 5P30CA042014-24. Support for E.C.L. was provided by the American Foundation for Pharmaceutical Education Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafica A, 2003, J IMMUNOL, V171, P1123, DOI 10.4049/jimmunol.171.3.1123; Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; Beatty WL, 2000, INFECT IMMUN, V68, P6997, DOI 10.1128/IAI.68.12.6997-7002.2000; Bernier R, 1998, J GEN VIROL, V79, P1353, DOI 10.1099/0022-1317-79-6-1353; Bhat KH, 2012, J BIOL CHEM, V287, P16930, DOI 10.1074/jbc.M111.327825; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bosque A, 2011, METHODS, V53, P54, DOI 10.1016/j.ymeth.2010.10.002; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004; Chapman NM, 2013, CELL SIGNAL, V25, P639, DOI 10.1016/j.cellsig.2012.11.026; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Diedrich CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009611; Donovan RM, 1996, J INFECT DIS, V174, P401, DOI 10.1093/infdis/174.2.401; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; GAYNOR R, 1992, AIDS, V6, P347, DOI 10.1097/00002030-199204000-00001; Goletti D, 2004, J INFECT DIS, V189, P624, DOI 10.1086/381554; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; Hernandez JC, 2012, AIDS RES HUM RETROV, V28, P1313, DOI 10.1089/aid.2011.0297; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Kalsdorf B, 2009, AM J RESP CRIT CARE, V180, P1262, DOI 10.1164/rccm.200907-1011OC; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; LAHM HW, 1985, J CHROMATOGR, V326, P357, DOI 10.1016/S0021-9673(01)87461-6; Lancioni CL, 2011, INFECT IMMUN, V79, P663, DOI 10.1128/IAI.00806-10; Larson EC, 2016, AIDS RES HUM RETROV, V32, P1171, DOI 10.1089/aid.2016.0067; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; LEDERMAN MM, 1994, J ACQ IMMUN DEF SYND, V7, P727; Li Q, 2012, J LEUKOCYTE BIOL, V91, P311, DOI 10.1189/jlb.0711364; Martins LJ, 2016, AIDS RES HUM RETROV, V32, P187, DOI 10.1089/aid.2015.0106; Matthews K, 2012, EUR J IMMUNOL, V42, P147, DOI 10.1002/eji.201141927; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mortaz E, 2015, J CLIN IMMUNOL, V35, P1, DOI 10.1007/s10875-014-0103-7; Mwandumba HC, 2004, J IMMUNOL, V172, P4592, DOI 10.4049/jimmunol.172.7.4592; Novis CL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-119; Nusbaum RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21522; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Ranjbar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006116; Reuter MA, 2010, J VIROL, V84, P8549, DOI 10.1128/JVI.02303-09; Rodriguez ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080938; Rong LB, 2009, J THEOR BIOL, V260, P308, DOI 10.1016/j.jtbi.2009.06.011; Scanga CA, 2007, J INFECT DIS, V195, P246, DOI 10.1086/510244; Scheller C, 2004, J BIOL CHEM, V279, P21897, DOI 10.1074/jbc.M311609200; Schlaepfer E, 2011, J IMMUNOL, V186, P4314, DOI 10.4049/jimmunol.1003174; SHATTOCK RJ, 1994, J GEN VIROL, V75, P849, DOI 10.1099/0022-1317-75-4-849; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Thayil SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041093; Thibault S, 2009, VIROLOGY, V389, P20, DOI 10.1016/j.virol.2009.04.019; Toossi T, 2001, J ACQ IMMUN DEF SYND, V28, P1, DOI 10.1097/00042560-200109010-00001; Toossi Z, 1999, CLIN EXP IMMUNOL, V117, P324; Verrier JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020553; WHALEN C, 1995, AM J RESP CRIT CARE, V151, P129, DOI 10.1164/ajrccm.151.1.7812542; WHO, 2015, HIV ASS TUB; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; ZHANG YH, 1995, J CLIN INVEST, V95, P2324, DOI 10.1172/JCI117924	59	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185162	10.1371/journal.pone.0185162	http://dx.doi.org/10.1371/journal.pone.0185162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949981	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000027
J	Moon, S; Oh, CM; Choi, MK; Park, YK; Chun, S; Choi, M; Yu, JM; Yoo, HJ				Moon, Shinje; Oh, Chang-Myung; Choi, Moon-Ki; Park, Yoo-Kyung; Chun, Sukyung; Choi, Minkyung; Yu, Jae Myung; Yoo, Hyung Joon			The influence of physical activity on risk of cardiovascular disease in people who are obese but metabolically healthy	PLOS ONE			English	Article							HEART-FAILURE; FAT; BROWN; AGE	The metabolic outcomes of metabolically healthy obesity (MHO) remain controversial. The aim of the present study was to determine the effect of physical activity on the cardiovascular disease (CVD) outcomes of MHO. The study included participants who were followed for 10 years and recruited from the Korean Genome and Epidemiology Study (KoGES), a population-based cohort study. Participants with previously recorded CVDs or cancer, or who had received steroids or anticoagulants at baseline were excluded. A total of 8144 participants (3,942 men and 4,202 women) fulfilled inclusion criteria. In a multivariate Cox regression model adjusted for age and sex, MHO participants were not at elevated risk of CVD compared with their metabolically healthy non-obese (MHNO) counterparts (HR, 1.28; 95% CI, 0.96-1.71), although both the non-obese (HR, 1.50; 95% CI, 1.19-1.90) and obese (HR, 1.85; 95% CI, 1.48-2.30) participants with metabolic abnormalities were at elevated risk. However, in the subgroup analysis by physical activity, physically inactive MHO participants had a significantly higher HR for CVD events compared to active MHNO participants (HR, 1.54; 95% CI, 1.03-2.30), while active MHO participants were not at elevated risk (HR, 1.15; 95% CI, 0.70-1.89). Physically inactive MHO participants had significantly increased risk of CVD compared to physically active MHNO participants whereas physically active MHO participants did not.	[Moon, Shinje; Choi, Moon-Ki; Park, Yoo-Kyung; Yu, Jae Myung; Yoo, Hyung Joon] Hallym Univ, Div Endocrinol & Metab, Coll Med, Chunchon, South Korea; [Oh, Chang-Myung; Chun, Sukyung; Choi, Minkyung] CHA Univ, Div Endocrinol & Metab, CHA Bundang Med Ctr, Sch Med, Pangyo, Seongnam, South Korea	Hallym University; Pochon Cha University	Yu, JM; Yoo, HJ (corresponding author), Hallym Univ, Div Endocrinol & Metab, Coll Med, Chunchon, South Korea.	jaemyungyu@hallym.or.kr; hjoonyoo@gmail.com	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Chun, sukyung/0000-0001-8331-8521	Korean Diabetes Association, Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016S-1, 2016R1A6A3A04010466]	Korean Diabetes Association, Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the grant (C.M.O., 2016S-1) from the Korean Diabetes Association, Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1A6A3A04010466 to C.M.O). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Bener A, 2013, J OBES, V2013, DOI 10.1155/2013/269038; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Choi SH, 2011, DIABETES CARE, V34, P944, DOI 10.2337/dc10-0644; Cronin CG, 2012, RADIOLOGY, V263, P836, DOI 10.1148/radiol.12100683; Dinas PC, 2015, CLIN ENDOCRINOL, V82, P147, DOI 10.1111/cen.12620; Donohoe CL, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-12; Gastaldelli A, 2002, J CLIN ENDOCR METAB, V87, P5098, DOI 10.1210/jc.2002-020696; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hinnouho GM, 2013, DIABETES CARE, V36, P2294, DOI 10.2337/dc12-1654; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Karelis AD, 2011, NAT REV ENDOCRINOL, V7, P699, DOI 10.1038/nrendo.2011.181; Korean Society for the Study of Obesity (KSSO), 2016, 2016 OB FACT SHEET; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Lin WY, 2002, INT J OBESITY, V26, P1232, DOI 10.1038/sj.ijo.0802040; Morkedal B, 2014, J AM COLL CARDIOL, V63, P1071, DOI 10.1016/j.jacc.2013.11.035; Ogorodnikova AD, 2012, OBESITY, V20, P651, DOI 10.1038/oby.2011.243; Ortega FB, 2013, EUR HEART J, V34, P390, DOI 10.1093/eurheartj/ehs174; Rahman M, 2010, OBSTET GYNECOL, V115, P982, DOI 10.1097/AOG.0b013e3181da9423; Rey-Lopez JP, 2014, OBES REV, V15, P781, DOI 10.1111/obr.12198; Seo MH, 2014, ENDOCRINOL METAB, V29, P427, DOI 10.3803/EnM.2014.29.4.427; Shimizu I, 2015, DIABETES, V64, P3984, DOI 10.2337/dbi15-0013; Shiroma EJ, 2010, CIRCULATION, V122, P743, DOI 10.1161/CIRCULATIONAHA.109.914721; Solomon CG, 1997, AM J CLIN NUTR, V66, P1044, DOI 10.1093/ajcn/66.4.1044S; Strasser B, 2013, ANN NY ACAD SCI, V1281, P141, DOI 10.1111/j.1749-6632.2012.06785.x; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Vatten LJ, 2014, J AM COLL CARDIOL, V63, P8; Velho S, 2010, EUR J CLIN NUTR, V64, P1043, DOI 10.1038/ejcn.2010.114; Voulgari C, 2011, J AM COLL CARDIOL, V58, P1343, DOI 10.1016/j.jacc.2011.04.047; Way KL, 2016, DIABETES METAB J, V40, P253, DOI 10.4093/dmj.2016.40.4.253; Wells JCK, 2006, ARCH DIS CHILD, V91, P612, DOI 10.1136/adc.2005.085522; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2012, WORLD HLTH STAT 2012; Yoo HK, 2013, KOREAN J FAM MED, V34, P19, DOI 10.4082/kjfm.2013.34.1.19; Zanovec Michael, 2009, Int J Exerc Sci, V2, P175	38	15	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185127	10.1371/journal.pone.0185127	http://dx.doi.org/10.1371/journal.pone.0185127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949994	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000025
J	Poblaciones, MJ; Damon, P; Rengel, Z				Poblaciones, Maria J.; Damon, Paul; Rengel, Zed			Foliar zinc biofortification effects in Lolium rigidum and Trifolium subterraneum grown in cadmium-contaminated soil	PLOS ONE			English	Article							TOXICITY; PLANTS; WHEAT; ACCUMULATION; HUMANS; FIELD; GRAIN; IRON; BIOAVAILABILITY; FERTILIZATION	Zinc (Zn) is an important micronutrient that can alleviate cadmium (Cd) toxicity to plants and limit Cd entry into the food chain. However, little is known about the Zn-Cd interactions in pasture plants. We characterized the effects of foliar Zn application and Cd uptake by ryegrass (Lolium rigidum L.) and clover (Trifolium subterraneum L.) grown on Cd-contaminated soils; all combinations of foliar Zn applications (0, 0.25 and 0.5% (w/v) ZnSO4 center dot 7H(2)O) and soil Cd concentrations (0, 2.5 and 5 mg Cd kg(-1)) were tested. For both plant species, soil concentrations of DTPA-extractable Cd and Zn increased with an increase in the Cd and Zn treatments, respectively. Compared with L. rigidum, T. subterraneum accumulated, respectively, 3.3-and 4.1-fold more Cd in the 2.5-Cd and 5-Cd treatments and about 1.3-, 2.3-and 2.8-fold more Zn in the No-Zn, 0.25-Zn and 0.5-Zn treatments. Also, DTPA-Zn concentration was higher in soil after T. subterraneum than L. rigidum growth regardless of Zn applications. Foliar application of 0.25% (w/v) Zn significantly decreased the total Cd concentration in shoots of both species grown in the Cd-contaminated soil and ameliorated the adverse effects of Cd exposure on root growth, particularly in T. subterraneum.	[Poblaciones, Maria J.] Univ Extremadura, Dept Agron & Forest Environm Engn, Badajoz, Spain; [Poblaciones, Maria J.; Damon, Paul; Rengel, Zed] Univ Western Australia, Sch Agr & Environm, Perth, WA, Australia	Universidad de Extremadura; University of Western Australia	Poblaciones, MJ (corresponding author), Univ Extremadura, Dept Agron & Forest Environm Engn, Badajoz, Spain.; Poblaciones, MJ (corresponding author), Univ Western Australia, Sch Agr & Environm, Perth, WA, Australia.	majops@unex.es	Poblaciones, Maria J./K-5106-2014; Poblaciones, Maria J/AAA-6673-2019	Poblaciones, Maria J./0000-0002-1559-2382; Poblaciones, Maria J/0000-0002-1559-2382; D, Paul/0000-0001-5620-1571	Ministry of Education, Culture and Sport of Spain (Program: Jose Castillejo) [CAS14/00146]	Ministry of Education, Culture and Sport of Spain (Program: Jose Castillejo)	Financial support was provided by the Ministry of Education, Culture and Sport of Spain (Program: Jose Castillejo, CAS14/00146) for Dr. Poblacioness stay in the School of Earth and Environment at the University of Western Australia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiloglu A., 2002, ARCH AGRON SOIL SCI, V48, P553; Akay A, 2007, BANGLADESH J BOTANY, V36, P13; Alloway BJ, 2009, ENVIRON GEOCHEM HLTH, V31, P537, DOI 10.1007/s10653-009-9255-4; Alloway B. J., 2008, ZINC SOILS CROP NUTR, DOI DOI 10.1016/S0065-2113(06)94003-6; [Anonymous], 2008, BIOL TRACE ELEM RES, V124, P110; Arienzo M, 2004, SCI TOTAL ENVIRON, V319, P13, DOI 10.1016/S0048-9697(03)00435-2; BAKER AJM, 1994, RESOUR CONSERV RECY, V11, P41, DOI 10.1016/0921-3449(94)90077-9; Bidar G, 2009, ENVIRON SCI POLLUT R, V16, P42, DOI 10.1007/s11356-008-0021-4; Bolan NS, 2013, ADV AGRON, V119, P183, DOI 10.1016/B978-0-12-407247-3.00004-4; BRENNAN RF, 1992, FERT RES, V31, P215, DOI 10.1007/BF01063295; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Cakmak I, 2010, J AGR FOOD CHEM, V58, P9092, DOI 10.1021/jf101197h; Cherif J, 2011, J ENVIRON SCI, V23, P837, DOI 10.1016/S1001-0742(10)60415-9; Choppala G, 2014, CRIT REV PLANT SCI, V33, P374, DOI 10.1080/07352689.2014.903747; Ekmekci Y, 2008, J PLANT PHYSIOL, V165, P600, DOI 10.1016/j.jplph.2007.01.017; Fahad S, 2015, CLEAN-SOIL AIR WATER, V43, P1433, DOI 10.1002/clen.201400376; Fernandez V, 2009, CRIT REV PLANT SCI, V28, P36, DOI 10.1080/07352680902743069; Graham RD, 2012, ADV AGRON, V115, P1, DOI 10.1016/B978-0-12-394276-0.00001-9; Grant C.A, 2011, PEDOLOGIST, V54, P143, DOI [10.18920/pedologist.54.3_143, DOI 10.18920/PEDOLOGIST.54.3_143]; Han YL, 2007, ECOTOXICOLOGY, V16, P557, DOI 10.1007/s10646-007-0162-0; Haslett BS, 2001, ANN BOT-LONDON, V87, P379, DOI 10.1006/anbo.2000.1349; HAUG W, 1983, J SCI FOOD AGR, V34, P1423, DOI 10.1002/jsfa.2740341217; HAWF LR, 1967, PLANT SOIL, V27, P249, DOI 10.1007/BF01373393; Koleli N, 2004, ENVIRON POLLUT, V131, P453, DOI 10.1016/j.envpol.2004.02.012; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Luo HJ, 2011, ECOTOXICOLOGY, V20, P770, DOI 10.1007/s10646-011-0628-y; Manoj Kumari, 2011, Journal of Phytology, V3, P43; Marchiol L, 1996, J ENVIRON QUAL, V25, P562, DOI 10.2134/jeq1996.00472425002500030022x; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Matovic V, 2011, ARH HIG RADA TOKSIKO, V62, P65, DOI 10.2478/10004-1254-62-2011-2075; MORRIS ER, 1989, BIOL TRACE ELEM RES, V19, P107, DOI 10.1007/BF02925452; National Research Council NRC, 2001, REF INT VIT A VIT K, P37; Nursita Ayulungit Intan, 2005, Australasian Journal of Ecotoxicology, V11, P73; OTT EA, 1966, J ANIM SCI, V25, P419, DOI 10.2527/jas1966.252419x; PERKINS DJ, 1961, BIOCHEM J, V80, P668, DOI 10.1042/bj0800668; Poblaciones MJ, 2016, FOOD CHEM, V212, P427, DOI 10.1016/j.foodchem.2016.05.189; Saifullah, 2016, ENVIRON SCI POLLUT R, V23, P16432, DOI 10.1007/s11356-016-6822-y; Saifullah, 2014, ENVIRON EARTH SCI, V71, P1663, DOI 10.1007/s12665-013-2570-1; Sarwar N, 2015, ECOTOX ENVIRON SAFE, V122, P528, DOI 10.1016/j.ecoenv.2015.09.011; Sarwar N, 2010, J SCI FOOD AGR, V90, P925, DOI 10.1002/jsfa.3916; Shute T, 2006, SCI TOTAL ENVIRON, V371, P63, DOI 10.1016/j.scitotenv.2006.07.034; SIMS JT, 1991, SOIL SCI SOC AM BOOK, V4, P427, DOI DOI 10.2136/SSSAB00KSER4.2ED.C12; Stravinskiene V, 2014, POL J ENVIRON STUD, V23, P1355; Taspinar MS, 2011, TOXICOL IND HEALTH, V27, P73, DOI 10.1177/0748233710381888; Weiss W. P, 2000, CURSO NUTR GANADO LE, P1; Zhang YQ, 2010, J AGR FOOD CHEM, V58, P12268, DOI 10.1021/jf103039k	46	3	4	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185395	10.1371/journal.pone.0185395	http://dx.doi.org/10.1371/journal.pone.0185395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950025	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000047
J	Xiong, L; Chen, XC; Liu, N; Wang, Z; Miao, BL; Gan, WD; Li, DM; Guo, HQ				Xiong, Lei; Chen, Xiancheng; Liu, Ning; Wang, Zhen; Miao, Baolei; Gan, Weidong; Li, Dongmei; Guo, Hongqian			PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue	PLOS ONE			English	Article							TFE3 GENE FUSIONS; TRANSCRIPTION FACTOR E3; IN-SITU-HYBRIDIZATION; BREAK-APART FISH; CATHEPSIN-K; TRANSLOCATION CARCINOMAS; EXPRESSION; NEOPLASMS; PRCC; ADULTS	PRCC-TFE3 renal cell carcinoma (RCC) is one of the most common types of Xp11.2 translocation renal cell carcinoma (tRCC), of which the diagnosis mainly relies on reverse transcription-polymerase chain reaction (RT-PCR) or chromosomal analysis in fresh frozen samples. Herein, we developed a new dual-fusion fluorescence in situ hybridization (FISH) probe to succinctly identify PRCC-TFE3 RCC in paraffin-embedded tissue. We immunohistochemically analyzed TFE3 and cathepsin K expression in 23 cases of Xp11.2 tRCC which had been confirmed by break-apart TFE3 FISH probe. Next, the dual-fusion FISH assay was performed on these selected cases. Twenty typical cases of clear renal cell carcinoma and 20 cases of papillary renal cell carcinoma were collected as control groups. Seven cases were finally confirmed as PRCC-TFE3 RCC by FISH detection, emerging dual-fusion signals, of which 2 cases were identified as PRCC-TFE3 RCC by RT-PCR previously. All remaining cases were negative for the PRCC-TFE3 rearrangement by FISH. The TFE3 immunohistochemistry was positive in 22/23 cases and the cathepsin K was positive in 16/23 cases. All 7 PRCC-TFE3 RCCs showed positive cathepsin K immunoreactivity. Our results reveal that PRCC-TFE3 dual-fusion FISH probe is an efficient and concise technique for diagnosing PRCC-TFE3 RCC in paraffin-embedded tissue.	[Xiong, Lei; Liu, Ning; Wang, Zhen; Miao, Baolei; Gan, Weidong; Guo, Hongqian] Nanjing Univ, Inst Urol, Med Sch, Dept Urol,Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; [Chen, Xiancheng] Nanjing Univ, Nanjing Drum Tower Hosp, Dept Crit Care Med, Med Sch, Nanjing, Jiangsu, Peoples R China; [Li, Dongmei] Nanjing Univ, Med Sch, Immunol & Reprod Biol Lab, Nanjing, Jiangsu, Peoples R China; [Li, Dongmei] Nanjing Univ, Med Sch, State Key Lab Analyt Chem Life Sci, Nanjing, Jiangsu, Peoples R China; [Li, Dongmei] Nanjing Univ, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University	Gan, WD (corresponding author), Nanjing Univ, Inst Urol, Med Sch, Dept Urol,Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China.; Li, DM (corresponding author), Nanjing Univ, Med Sch, Immunol & Reprod Biol Lab, Nanjing, Jiangsu, Peoples R China.; Li, DM (corresponding author), Nanjing Univ, Med Sch, State Key Lab Analyt Chem Life Sci, Nanjing, Jiangsu, Peoples R China.; Li, DM (corresponding author), Nanjing Univ, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China.	gwd@nju.edu.cn; lidm@nju.edu.cn	冬梅, 李/AHI-8180-2022	冬梅, 李/0000-0003-3819-355X; Liu, Ning/0000-0002-7283-7294				Argani P, 2002, AM J SURG PATHOL, V26, P1553, DOI 10.1097/00000478-200212000-00003; Argani P, 2003, PATHOLOGY, V35, P492, DOI 10.1080/00313020310001619901; Argani P, 2003, AM J SURG PATHOL, V27, P750, DOI 10.1097/00000478-200306000-00005; Argani P, 2001, AM J PATHOL, V159, P179, DOI 10.1016/S0002-9440(10)61684-7; Argani P, 2016, WHO CLASSIFICATION T, P33; Argani P, 2007, AM J SURG PATHOL, V31, P1149, DOI 10.1097/PAS.0b013e318031ffff; Argani P, 2017, AM J SURG PATHOL, V41, P655, DOI 10.1097/PAS.0000000000000835; Argani P, 2016, AM J SURG PATHOL, V40, P723, DOI 10.1097/PAS.0000000000000631; Argani P, 2015, SEMIN DIAGN PATHOL, V32, P103, DOI 10.1053/j.semdp.2015.02.003; Argani P, 2010, AM J SURG PATHOL, V34, P1395, DOI 10.1097/PAS.0b013e3181f17ac0; ARTANDI SE, 1995, NUCLEIC ACIDS RES, V23, P3865, DOI 10.1093/nar/23.19.3865; Camparo P, 2008, AM J SURG PATHOL, V32, P656, DOI 10.1097/PAS.0b013e3181609914; Chen XC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000873; Clark J, 1997, ONCOGENE, V15, P2233, DOI 10.1038/sj.onc.1201394; DEJONG B, 1986, CANCER GENET CYTOGEN, V21, P165, DOI 10.1016/0165-4608(86)90042-7; Dijkhuizen T, 1998, CANCER GENET CYTOGEN, V104, P74; Ellis CL, 2014, MODERN PATHOL, V27, P875, DOI 10.1038/modpathol.2013.208; Gaillot-Durand L, 2013, PATHOL RES PRACT, V209, P83, DOI 10.1016/j.prp.2012.10.013; Green WM, 2013, AM J SURG PATHOL, V37, P1150, DOI 10.1097/PAS.0b013e31828a69ae; Heimann P, 2001, CANCER RES, V61, P4130; Hirobe M, 2016, INT J UROL, V23, P140, DOI 10.1111/iju.13007; Klatte T, 2012, AM J CLIN PATHOL, V137, P761, DOI 10.1309/AJCPQ6LLFMC4OXGC; Komai Y, 2009, CLIN CANCER RES, V15, P1170, DOI 10.1158/1078-0432.CCR-08-1183; Macher-Goeppinger S, 2012, MODERN PATHOL, V25, P308, DOI 10.1038/modpathol.2011.169; Malouf GG, 2014, CLIN CANCER RES, V20, P4129, DOI 10.1158/1078-0432.CCR-13-3036; Martignoni G, 2009, MODERN PATHOL, V22, P1016, DOI 10.1038/modpathol.2009.58; Martignoni G, 2011, MODERN PATHOL, V24, P1313, DOI 10.1038/modpathol.2011.93; MELONI AM, 1993, CANCER GENET CYTOGEN, V65, P1, DOI 10.1016/0165-4608(93)90050-V; Motyckova G, 2001, P NATL ACAD SCI USA, V98, P5798, DOI 10.1073/pnas.091479298; Rao Q, 2013, AM J SURG PATHOL, V37, P804, DOI 10.1097/PAS.0b013e31827e17cb; Rao Q, 2012, AM J SURG PATHOL, V36, P1327, DOI 10.1097/PAS.0b013e31825aafb5; Rao Q, 2011, INT J SURG PATHOL, V19, P170, DOI 10.1177/1066896909354337; Ross H, 2010, PATHOLOGY, V42, P369, DOI 10.3109/00313021003767348; SHIPLEY JM, 1995, CYTOGENET CELL GENET, V71, P280, DOI 10.1159/000134127; Sidhar SK, 1996, HUM MOL GENET, V5, P1333, DOI 10.1093/hmg/5.9.1333; Skalsky YM, 2001, ONCOGENE, V20, P178, DOI 10.1038/sj.onc.1204056; Weterman MAJ, 1996, P NATL ACAD SCI USA, V93, P15294, DOI 10.1073/pnas.93.26.15294; Weterman MAJ, 1996, CYTOGENET CELL GENET, V75, P2, DOI 10.1159/000134444; Weterman MAJ, 2000, ONCOGENE, V19, P69, DOI 10.1038/sj.onc.1203255; Weterman MAJ, 2001, P NATL ACAD SCI USA, V98, P13808, DOI 10.1073/pnas.241304198; Zhong MH, 2012, AM J SURG PATHOL, V36, P654, DOI 10.1097/PAS.0b013e31824f24a6	41	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185337	10.1371/journal.pone.0185337	http://dx.doi.org/10.1371/journal.pone.0185337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949976	gold, Green Published, Green Submitted			2022-12-27	WOS:000411671000039
J	Zhai, SY; Song, GX; Qin, YC; Ye, XY; Lee, J				Zhai, Shiyan; Song, Genxin; Qin, Yaochen; Ye, Xinyue; Lee, Jay			Modeling the impacts of climate change and technical progress on the wheat yield in inland China: An autoregressive distributed lag approach	PLOS ONE			English	Article							WINTER-WHEAT; FERTILIZER MANAGEMENT; CROP YIELD; DIFFERENT IRRIGATION; REGRESSION-MODELS; USE EFFICIENCY; SILAGE MAIZE; GRAIN-YIELD; GROWTH; AGRICULTURE	This study aims to evaluate the impacts of climate change and technical progress on the wheat yield per unit area from 1970 to 2014 in Henan, the largest agricultural province in China, using an autoregressive distributed lag approach. The bounded F-test for cointegration among the model variables yielded evidence of a long-run relationship among climate change, technical progress, and the wheat yield per unit area. In the long run, agricultural machinery and fertilizer use both had significantly positive impacts on the per unit area wheat yield. A 1% increase in the aggregate quantity of fertilizer use increased the wheat yield by 0.19%. Additionally, a 1% increase in machine use increased the wheat yield by 0.21%. In contrast, precipitation during the wheat growth period (from emergence to maturity, consisting of the period from last October to June) led to a decrease in the wheat yield per unit area. In the short run, the coefficient of the aggregate quantity of fertilizer used was negative. Land size had a significantly positive impact on the per unit area wheat yield in the short run. There was no significant short-run or long-run impact of temperature on the wheat yield per unit area in Henan Province. The results of our analysis suggest that climate change had a weak impact on the wheat yield, while technical progress played an important role in increasing the wheat yield per unit area. The results of this study have implications for national and local agriculture policies under climate change. To design well-targeted agriculture adaptation policies for the future and to reduce the adverse effects of climate change on the wheat yield, climate change and technical progress factors should be considered simultaneously. In addition, adaptive measures associated with technical progress should be given more attention.	[Zhai, Shiyan; Qin, Yaochen] Henan Univ, Henan Collaborat Innovat Ctr Yellow River Civiliz, Coll Environm & Planning, Lab Geospatial Technol Middle & Lower Yellow Rive, Kaifeng, Peoples R China; [Zhai, Shiyan; Song, Genxin] East China Normal Univ, Minist Educ, Key Lab Geog Informat Sci, Shanghai, Peoples R China; [Ye, Xinyue; Lee, Jay] Kent State Univ, Dept Geog, Kent, OH 44242 USA	Henan University; East China Normal University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Zhai, SY (corresponding author), Henan Univ, Henan Collaborat Innovat Ctr Yellow River Civiliz, Coll Environm & Planning, Lab Geospatial Technol Middle & Lower Yellow Rive, Kaifeng, Peoples R China.; Zhai, SY (corresponding author), East China Normal Univ, Minist Educ, Key Lab Geog Informat Sci, Shanghai, Peoples R China.	zsycenu@hotmail.com	Ye, Xinyue/A-7677-2011	Ye, Xinyue/0000-0001-8838-9476	National Natural Science Foundation of China [41301149]; China Postdoctoral Science Foundation of the fifty-seventh batch of funds [2015M570626]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation of the fifty-seventh batch of funds(China Postdoctoral Science Foundation)	This work was supported by: 1.National Natural Science Foundation of China (Grant NO. 41301149), https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list; 2.China Postdoctoral Science Foundation of the fifty-seventh batch of funds (Grant NO. 2015M570626), http://rsc.henu.edu.cn/info/1072/1287.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acaravci A, 2010, ENERGY, V35, P5412, DOI 10.1016/j.energy.2010.07.009; Administration C.M., 2012, CHIN GROUND CLIM DAT; [Anonymous], 2012, THESIS; Arshed N., 2016, INT J EC FINANCIAL R, V2, P183; Asumadu-Sarkodie S, 2016, ENVIRON SCI POLLUT R, V23, P10968, DOI 10.1007/s11356-016-6252-x; Ben-Ari T, 2016, AGR FOREST METEOROL, V220, P130, DOI 10.1016/j.agrformet.2016.01.009; BROWN RL, 1975, J ROY STAT SOC B MET, V37, P149; Chami DE, 2015, AGR SYST, V140, P19, DOI DOI 10.1016/J.AGSY.2015.08.008; Chuan LM, 2013, FIELD CROP RES, V140, P1, DOI 10.1016/j.fcr.2012.09.020; Conradt T, 2016, AGR FOREST METEOROL, V216, P68, DOI 10.1016/j.agrformet.2015.10.003; Duan RD, 2011, THESIS; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; FAO, FAO STAT DAT; Fuinhas JA, 2012, ENERG ECON, V34, P511, DOI 10.1016/j.eneco.2011.10.003; Ghosh S, 2010, ENERG POLICY, V38, P3008, DOI 10.1016/j.enpol.2010.01.040; Gomann H, 2015, PROCEDIA ENVIRON SCI, V29, P119, DOI 10.1016/j.proenv.2015.07.197; Gornott C, 2016, AGR FOREST METEOROL, V217, P89, DOI 10.1016/j.agrformet.2015.10.005; [郭建平 Guo Jianping], 2015, [应用气象学报, Journal of Applied Meteorolgical Science], V26, P1; Guo ZJ, 2015, FIELD CROP RES, V180, P100, DOI 10.1016/j.fcr.2015.05.015; Guo ZJ, 2014, FIELD CROP RES, V166, P102, DOI 10.1016/j.fcr.2014.06.004; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Hartmann TE, 2015, FIELD CROP RES, V174, P30, DOI 10.1016/j.fcr.2015.01.006; Henan statistical Bureau, 2014, HEN STAT YB 2014; [黄维 Huang Wei], 2010, [地理科学进展, Progress in Geography], V29, P677; Jalota SK, 2014, AGR SYST, V131, P77, DOI 10.1016/j.agsy.2014.07.009; Janjua PZ, 2014, NJAS-WAGEN J LIFE SC, V68, P13, DOI 10.1016/j.njas.2013.11.002; Kaur H, 2012, INDIAN J AGR SCI, V82, P213; Leadley PW, 1992, PLANT ECOL, p[104, 3]; Li KeNan, 2012, Acta Agronomica Sinica, V38, P1483; Li SA, 2010, AGR FOREST METEOROL, V150, P1412, DOI 10.1016/j.agrformet.2010.07.003; [李彤霄 LI Tong-xiao], 2009, [中国农业气象, Chinese Journal of Agrometeorology], V30, P143; Li ZH, 2015, EUR J AGRON, V71, P53, DOI 10.1016/j.eja.2015.08.006; Licker R, 2013, AGR FOREST METEOROL, V176, P25, DOI 10.1016/j.agrformet.2013.02.010; Liu J, 2007, IRRIGATION SCI, V26, P21, DOI 10.1007/s00271-007-0069-9; Liu RJ, 2015, AGR SYST, V132, P167, DOI 10.1016/j.agsy.2014.10.002; Liu YN, 2015, J INTEGR AGR, V14, P1184, DOI 10.1016/S2095-3119(14)60867-4; Lobell DB, 2012, NAT CLIM CHANGE, V2, P186, DOI [10.1038/nclimate1356, 10.1038/NCLIMATE1356]; Lobell DB, 2010, AGR FOREST METEOROL, V150, P1443, DOI 10.1016/j.agrformet.2010.07.008; Lobell DB, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034007; Martin MMS, 2015, AGR FOREST METEOROL, V202, P51, DOI 10.1016/j.agrformet.2014.11.003; Meng QF, 2016, PEDOSPHERE, V26, P137, DOI 10.1016/S1002-0160(15)60030-3; Meza FJ, 2009, CLIMATIC CHANGE, V94, P143, DOI [10.1007/s10584-009-9544-z, 10.1007/s10584-009-9544-Z]; Mishra A, 2013, SCI TOTAL ENVIRON, V468, pS132, DOI 10.1016/j.scitotenv.2013.05.080; Montesino-San Martin M, 2014, AGR FOREST METEOROL, V187, P1, DOI 10.1016/j.agrformet.2013.11.009; Nkoro E., 2016, J STAT ECONOMETRIC M, V5, P63; Ozdogan M, 2011, AGR ECOSYST ENVIRON, V141, P1, DOI 10.1016/j.agee.2011.02.001; Ozturk I, 2013, ENERG ECON, V36, P262, DOI 10.1016/j.eneco.2012.08.025; Pesaran M.H., 1999, ECONOMET SOC MONOGR, P371, DOI DOI 10.1017/CCOL521633230.011; Pesaran MH, 2001, J APPL ECONOMET, V16, P289, DOI 10.1002/jae.616; Potgieter A, 2013, CLIMATIC CHANGE, V117, P163, DOI 10.1007/s10584-012-0543-0; Reilly J, 2003, CLIMATIC CHANGE, V57, P43, DOI 10.1023/A:1022103315424; Saadi S, 2015, AGR WATER MANAGE, V147, P103, DOI 10.1016/j.agwat.2014.05.008; Siddiqui R, 2012, PAKISTAN DEV REV, P261, DOI DOI 10.30541/v51i4IIpp.261-276; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tao FL, 2006, AGR FOREST METEOROL, V138, P82, DOI 10.1016/j.agrformet.2006.03.014; Tao FL, 2013, AGR FOREST METEOROL, V170, P146, DOI 10.1016/j.agrformet.2011.10.003; Tao FL, 2014, AGR FOREST METEOROL, V189, P91, DOI 10.1016/j.agrformet.2014.01.013; Tao FL, 2012, EUR J AGRON, V43, P201, DOI 10.1016/j.eja.2012.07.005; Tao FL, 2008, CLIM RES, V38, P83, DOI 10.3354/cr00771; Tian WM, 2000, J PROD ANAL, V13, P159, DOI 10.1023/A:1007805015716; Tong CL, 2003, AGR ECOSYST ENVIRON, V95, P523, DOI 10.1016/S0167-8809(02)00182-2; Wang CY, 2014, FIELD CROP RES, V165, P138, DOI 10.1016/j.fcr.2014.04.011; Wang J., 2011, THESIS; Wang XX, 2013, AGR WATER MANAGE, V129, P95, DOI 10.1016/j.agwat.2013.07.010; Webb LB, 2008, CLIM RES, V36, P99, DOI 10.3354/cr00740; Wilcox J, 2014, FIELD CROP RES, V156, P180, DOI 10.1016/j.fcr.2013.11.008; Xiong W, 2014, AGR ECOSYST ENVIRON, V196, P125, DOI 10.1016/j.agee.2014.06.014; Yang W.-D., 2007, THESIS; You LZ, 2009, AGR FOREST METEOROL, V149, P1009, DOI 10.1016/j.agrformet.2008.12.004; Zhang TY, 2013, INT J CLIMATOL, V33, P699, DOI 10.1002/joc.3463; Zhang XB, 2016, GEODERMA, V265, P176, DOI 10.1016/j.geoderma.2015.11.027; Zhao Jun-fang, 2010, Yingyong Shengtai Xuebao, V21, P2922	72	36	36	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							0184474	10.1371/journal.pone.0184474	http://dx.doi.org/10.1371/journal.pone.0184474			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI1DL	28950027	Green Submitted, gold, Green Published			2022-12-27	WOS:000411671000010
J	Torres, R; Samudio, R; Carrera, JP; Young, J; Marquez, R; Hurtado, L; Weaver, S; Chaves, LF; Tesh, R; Caceres, L				Torres, Rolando; Samudio, Rafael; Carrera, Jean-Paul; Young, Josue; Marquez, Ricardo; Hurtado, Lisbeth; Weaver, Scott; Fernando Chaves, Luis; Tesh, Robert; Caceres, Lorenzo			Enzootic mosquito vector species at equine encephalitis transmission foci in the Republica de Panama	PLOS ONE			English	Article							ARTHROPOD-BORNE VIRUSES; AMAZON BASIN REGION; LOWER CAURA RIVER; SAO-PAULO STATE; CULEX MELANOCONION; CUTANEOUS LEISHMANIASIS; AEDES-SCAPULARIS; VENEZUELAN ENCEPHALITIS; ENCEPHALOMYELITIS VIRUS; ALMIRANTE PANAMA	The identification of mosquito vector species present at arboviral enzootic transmission foci is important to understand transmission eco-epidemiology and to propose and implement prevention and control strategies that reduce vector-borne equine encephalitis transmission. The goal of this study was to identify mosquito species potentially involved in the transmission of enzootic equine encephalitis, in relation to their abundance and diversity at three endemic regions in the Republica de Panama A. We sampled adult mosquitoes during the dry and rainy season of Panama A. We employed CDC light traps with octanol, EV traps with CO2 and Trinidad 17 traps baited with live hamsters. Traps were deployed in the peridomicile and extradomicile of houses from 18: 00 to 6: 00 h. We estimated the abundance and diversity of sampled species. We collected a total of 4868 mosquitoes, belonging to 45 species and 11 genera, over 216 sampling nights. Culex Melanoconion) pedroi, a major Venezuelan equine encephalitis vector was relatively rare (< 2.0% of all sampled mosquitoes). We also found Cx. Mel) adamesi, Cx. Mel) crybda, Cx. Mel) ocossa, Cx. Mel) spissipes, Cx. Mel) taeniopus, Cx. Mel) vomerifer, Aedes scapularis, Ae. angustivittatus, Coquillettidia venezuelensis, Cx. nigripalpus, Cx. declarator, Mansonia titillans, M. pseudotitillans and Psorophora ferox all species known to be vectorially competent for the transmission of arboviruses. Abundance and diversity of mosquitoes in the sampled locations was high, when compared with similar surveys in temperate areas. Information from previous reports about vectorial competence /capacity of the sampled mosquito species suggest that sampled locations have all the elements to support enzootic outbreaks of Venezuelan and Eastern equine encephalitides.	[Torres, Rolando; Young, Josue; Marquez, Ricardo; Caceres, Lorenzo] Inst Commemorat Gorgas Estudios Salud, Dept Entomol Med, Ciudad De Panama, Panama; [Samudio, Rafael] Mastozool Soc Panama, Ciudad De Panama, Panama; [Carrera, Jean-Paul] Inst Commemorat Gorgas Estudios Salud, Dept Genom & Prote, Ciudad De Panama, Panama; [Hurtado, Lisbeth] Inst Commemorat Gorgas Estudios Salud, Dept Anal Epidemiol & Bioestadist, Ciudad De Panama, Panama; [Weaver, Scott; Tesh, Robert] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Weaver, Scott; Tesh, Robert] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Fernando Chaves, Luis] Univ Nacl, PIET, Escuela Med Vet, Heredia, Costa Rica; [Fernando Chaves, Luis] Univ Costa Rica, CIET, San Pedro, De Montes Oca, Costa Rica	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Universidad Nacional Costa Rica; Universidad Costa Rica	Caceres, L (corresponding author), Inst Commemorat Gorgas Estudios Salud, Dept Entomol Med, Ciudad De Panama, Panama.	lcaceres@gorgas.gob.pa	Chaves, Luis Fernando/F-3448-2010	Chaves, Luis Fernando/0000-0002-5301-2764; Hurtado, Lisbeth/0000-0003-4722-0417; Marquez, Ricardo/0000-0002-5169-3551; Caceres Carrera, Lorenzo/0000-0002-2025-6893; Carrera, Jean-Paul/0000-0002-1459-2858	Ministry of Economy and Finance of Panama	Ministry of Economy and Finance of Panama	The study was funded by the Ministry of Economy and Finance of Panama to LC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adames A, 1979, REV MED PANAMA, V4, P246; Adames A J, 1993, Rev Med Panama, V18, P106; Aguilar PV, 2011, FUTURE VIROL, V6, P721, DOI 10.2217/FVL.11.50; AITKEN THG, 1960, SCIENCE, V131, P986, DOI 10.1126/science.131.3405.986; Alba Salas Rosa, 2001, American Journal of Tropical Medicine and Hygiene, V64, P84; Arechiga-Ceballos N, 2015, REV SCI TECH OIE, V34, P491, DOI 10.20506/rst.34.2.2374; Atasheva S, 2015, J VIROL, V89, P71, DOI 10.1128/JVI.02252-14; Atasheva S, 2013, J VIROL, V87, P2023, DOI 10.1128/JVI.02881-12; Autoridad Nacional Del Ambiente, 2010, ATL AMB REP PAN; Barrera R, 2002, AM J TROP MED HYG, V67, P324, DOI 10.4269/ajtmh.2002.67.324; Brault AC, 2002, J VIROL, V76, P1718, DOI 10.1128/JVI.76.4.1718-1730.2002; Calzada JE, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0987-6; Calzada JE, 2015, PARASITOLOGY, V142, P1202, DOI 10.1017/S0031182015000475; Calzada JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053289; Carrera JP, 2015, AM J TROP MED HYG, V93, P1014, DOI 10.4269/ajtmh.15-0117; Carrera JP, 2013, NEW ENGL J MED, V369, P732, DOI 10.1056/NEJMoa1212628; CAUSEY OR, 1961, AM J TROP MED HYG, V10, P227, DOI 10.4269/ajtmh.1961.10.227; Chaves L.F., 2017, INVERTEBRATES GLOBAL, P126, DOI [10.1002/9781119070894.ch8, DOI 10.1002/9781119070894.CH8]; Chaves LF, 2004, ACTA TROP, V92, P219, DOI 10.1016/j.actatropica.2004.08.001; Chaves LF, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00088.1; Chaves LF, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-3; Chaves LF, 2016, INT J BIOMETEOROL, V60, P1727, DOI 10.1007/s00484-016-1162-7; Chaves LF, 2016, ACTA TROP, V153, P7, DOI 10.1016/j.actatropica.2015.10.001; COIMBRA TLM, 1993, INTERVIROLOGY, V36, P144, DOI 10.1159/000150333; Colwell RK, 2014, ECOGRAPHY, V37, P609, DOI 10.1111/ecog.00814; CUPP EW, 1979, AM J TROP MED HYG, V28, P1060, DOI 10.4269/ajtmh.1979.28.1060; Day JF, 1999, J MED ENTOMOL, V36, P176, DOI 10.1093/jmedent/36.2.176; Deardorff ER, 2010, AM J TROP MED HYG, V82, P1047, DOI 10.4269/ajtmh.2010.09-0556; Dickerman R. W., 1986, VENEZUELAN EQUINE EN; Dutary B E, 1984, Rev Med Panama, V9, P200; Eastwood G, 2016, AM J TROP MED HYG, V94, P786, DOI 10.4269/ajtmh.15-0445; Edman J.D., 1988, Miscellaneous Publications of the Entomological Society of America, P43; Chaves LF, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-164; Ferro C, 2003, EMERG INFECT DIS, V9, P49; Ferro C, 2008, BIOMEDICA, V28, P234, DOI 10.7705/biomedica.v28i2.94; Forattini O.P., 2002, CULICIDOLOGIA MED ID; FORATTINI OP, 1989, REV SAUDE PUBL, V23, P9, DOI 10.1590/S0034-89101989000100003; FORATTINI OP, 1995, REV SAUDE PUBL, V29, P199, DOI 10.1590/S0034-89101995000300007; FORATTINI OP, 1988, REV SAUDE PUBL, V22, P84, DOI 10.1590/S0034-89101988000200003; GALINDO P, 1966, AM J TROP MED HYG, V15, P385, DOI 10.4269/ajtmh.1966.15.385; GALINDO P, 1956, AM J TROP MED HYG, V5, P1022, DOI 10.4269/ajtmh.1956.5.1022; GALINDO P, 1971, SCIENCE, V172, P594, DOI 10.1126/science.172.3983.594; Galindo P., 1972, Venezuelan encephalitis-proceedings of the workshop-symposium on Venezuelan encephalitis virus., P249; GALINDO P, 1951, AM J TROP MED, V31, P98; Galindo P, 1983, Rev Med Panama, V8, P89; Galindo P, 1978, REV MED PANAMA, V3, P1; Gonzalez Kadir, 2015, Tropical Medicine and Health, V43, P75, DOI 10.2149/tmh.2014-30; GRAYSON MA, 1968, AM J EPIDEMIOL, V88, P80, DOI 10.1093/oxfordjournals.aje.a120870; Groot H., 1996, Biomedica, V16, P331; GROOT H, 1959, AM J TROP MED HYG, V8, P175, DOI 10.4269/ajtmh.1959.8.175; Guimaraes AE, 2000, REV SAUDE PUBL, V34, P243, DOI 10.1590/S0034-89102000000300006; Herve JP, 1986, ASPECTOS ECOLOGICOS, P409; Hidrometeorologia Dd, 2014, EST SIT FIS, P38; Hoshi T, 2014, J AM MOSQUITO CONTR, V30, P260, DOI 10.2987/14-6432R.1; JOHNSON KM, 1968, AM J TROP MED HYG, V17, P432, DOI 10.4269/ajtmh.1968.17.432; Kesler RA, 1937, VET B, V31, P19; Kopp A, 2013, MBIO, V4, DOI 10.1128/mBio.00322-13; Krebs CJ, 1998, ECOLOGICAL METHODOLO, V2; Lane J., 1953, NEOTROPICAL CULICIDA, V2; Loaiza JR, 2008, J MED ENTOMOL, V45, P841, DOI 10.1603/0022-2585(2008)45[841:SCADOA]2.0.CO;2; LOPES J, 1995, REV SAUDE PUBL, V29, P183, DOI 10.1590/S0034-89101995000300005; Mendez W, 2001, J MED ENTOMOL, V38, P813, DOI 10.1603/0022-2585-38.6.813; Molaei G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004347; Navia-Gine WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081788; O'Guinn ML, 2004, AM J TROP MED HYG, V70, P164, DOI 10.4269/ajtmh.2004.70.164; Obaldia N., 1991, Notas Veterinarias, V1, P4; Parra-Henao G, 2012, BIOMEDICA, V32, P252, DOI 10.1590/S0120-41572012000300013; Petrov A, 2014, ZH MIKROBIOLOGII EPI, P103; Powers AM, 1997, J VIROL, V71, P6697, DOI 10.1128/JVI.71.9.6697-6705.1997; Quiroz E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000472; Reisen WK, 2014, INFECT GENET EVOL, V28, P573, DOI 10.1016/j.meegid.2013.11.025; Rubio-Palis Y, 2013, MEM I OSWALDO CRUZ, V108, P220, DOI 10.1590/0074-0276108022013015; Rubio-Palis Y, 2010, B MALARIOL SALUD AMB, V50, P95; Sallum MAM, 1996, J AM MOSQUITO CONTR, V12, P517; SANMARTIN C, 1973, B OFIC SANIT PANAM, V74, P108; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; Smith DR, 2008, VIROLOGY, V372, P176, DOI 10.1016/j.virol.2007.10.011; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; SRIHONGSE SUNTHORN, 1967, MOSQUITO NEWS, V27, P74; SUDIA WD, 1971, MOSQ NEWS, V31, P350; Taira Katsuya, 2012, Medical Entomology and Zoology, V63, P289, DOI 10.7601/mez.63.289; Turell MJ, 2005, J MED ENTOMOL, V42, P891, DOI 10.1603/0022-2585(2005)042[0891:IOVFMD]2.0.CO;2; Turell MJ, 2000, J MED ENTOMOL, V37, P835, DOI 10.1603/0022-2585-37.6.835; VASCONCELOS PFD, 1991, REV INST MED TROP SP, V33, P465, DOI 10.1590/S0036-46651991000600007; Velasquez G, 2013, EVIDENCE PRESENCE W; Vittor AY, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004554; Wang EY, 1999, J VIROL, V73, P4266, DOI 10.1128/JVI.73.5.4266-4271.1999; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008	91	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185491	10.1371/journal.pone.0185491	http://dx.doi.org/10.1371/journal.pone.0185491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH9IR	28937995	Green Submitted, gold, Green Published			2022-12-27	WOS:000411524700036
J	Cedeno, RJ; Nakauka-Ddamba, A; Yousefi, M; Sterling, S; Leu, NA; Li, N; Pehrson, JR; Lengner, CJ				Cedeno, Ryan James; Nakauka-Ddamba, Angela; Yousefi, Maryam; Sterling, Stephanie; Leu, Nicolae Adrian; Li, Ning; Pehrson, John R.; Lengner, Christopher Joachim			The histone variant macroH2A confers functional robustness to the intestinal stem cell compartment	PLOS ONE			English	Article							INACTIVE X-CHROMOSOME; EPIGENETIC REGULATOR; TUMOR-SUPPRESSOR; CORE HISTONE; CANCER; EXPRESSION; CHROMATIN; GENE; TRANSCRIPTION; LGR5	A stem cell's epigenome directs cell fate during development, homeostasis, and regeneration. Epigenetic dysregulation can lead to inappropriate cell fate decisions, aberrant cell function, and even cancer. The histone variant macroH2A has been shown to influence gene expression, guide cell fate, and safeguard against genotoxic stress. Interestingly, mice lacking functional macroH2A histones (hereafter referred to as macroH2A DKO) are viable and fertile; yet suffer from increased perinatal death and reduced weight and size compared to wildtype (WT). Here, we ask whether the ostensible reduced vigor of macroH2A DKO mice extends to intestinal stem cell (ISC) function during homeostasis, regeneration, and oncogenesis. Lgr5-eGFP-IRES-CreERT2 or Hopx-CreERT2::Rosa26-LSL-tdTomato ISC reporter mice or the C57BL/6J-Apc(min)/J murine intestinal adenoma model were bred into a macroH2A DKO or strain-matched WT background and assessed for ISC functionality, regeneration and tumorigenesis. High-dose (12Gy) whole-body gamma-irradiation was used as an injury model. We show that macroH2A is dispensable for intestinal homeostasis and macroH2A DKO mice have similar numbers of active crypt-base columnar ISCs (CBCs). MacroH2A DKO intestine exhibits impaired regeneration following injury, despite having significantly more putative reserve ISCs. DKO reserve ISCs disproportionately undergo apoptosis compared to WT after DNA damage infliction. Interestingly, a macroH2A DKO background does not significantly increase tumorigenesis in the Apc(min) model of intestinal adenoma. We conclude that macroH2A influences reserve ISC number and function during homeostasis and regeneration. These data suggest macroH2A enhances reserve ISC survival after DNA damage and thus confers functional robustness to the intestinal epithelium.	[Cedeno, Ryan James; Nakauka-Ddamba, Angela; Yousefi, Maryam; Sterling, Stephanie; Leu, Nicolae Adrian; Li, Ning; Pehrson, John R.; Lengner, Christopher Joachim] Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA; [Cedeno, Ryan James; Yousefi, Maryam] Univ Penn, Perelman Sch Med, Cell & Mol Biol Grad Program, Philadelphia, PA 19104 USA; [Sterling, Stephanie; Leu, Nicolae Adrian; Lengner, Christopher Joachim] Univ Penn, Sch Vet Med, Ctr Anim Transgenesis, Philadelphia, PA 19104 USA; [Lengner, Christopher Joachim] Univ Penn, Ctr Mol Studies Digest & Liver Dis, Philadelphia, PA 19104 USA; [Lengner, Christopher Joachim] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Lengner, CJ (corresponding author), Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA.; Lengner, CJ (corresponding author), Univ Penn, Sch Vet Med, Ctr Anim Transgenesis, Philadelphia, PA 19104 USA.; Lengner, CJ (corresponding author), Univ Penn, Ctr Mol Studies Digest & Liver Dis, Philadelphia, PA 19104 USA.; Lengner, CJ (corresponding author), Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA.	lengner@vet.upenn.edu			National Cancer Institute [R01CA168654]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK106309]; NATIONAL CANCER INSTITUTE [R01CA168654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Cancer Institute under project number R01CA168654, as well as a grant from the National Institute of Diabetes and Digestive and Kidney Diseases under project number R01DK106309. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelov D, 2003, MOL CELL, V11, P1033, DOI 10.1016/S1097-2765(03)00100-X; Asfaha S, 2015, CELL STEM CELL, V16, P627, DOI 10.1016/j.stem.2015.04.013; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barzily-Rokni M, 2011, NUCLEIC ACIDS RES, V39, P1326, DOI 10.1093/nar/gkq994; Buschbeck M, 2009, NAT STRUCT MOL BIOL, V16, P1074, DOI 10.1038/nsmb.1665; Cantarino N, 2013, CANCER LETT, V336, P247, DOI 10.1016/j.canlet.2013.03.022; Chadwick BP, 2002, J CELL BIOL, V157, P1113, DOI 10.1083/jcb.200112074; Chadwick BP, 2001, HUM MOL GENET, V10, P1101, DOI 10.1093/hmg/10.10.1101; Chang CC, 2005, DEV BIOL, V278, P367, DOI 10.1016/j.ydbio.2004.11.032; Chang EY, 2008, BIOCHEMISTRY-US, V47, P13726, DOI 10.1021/bi8016944; Changolkar LN, 2007, MOL CELL BIOL, V27, P2758, DOI 10.1128/MCB.02334-06; Changolkar LN, 2006, MOL CELL BIOL, V26, P4410, DOI 10.1128/MCB.02258-05; Chen HS, 2014, NAT STRUCT MOL BIOL, V21, P981, DOI 10.1038/nsmb.2903; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Costanzi C, 2000, DEVELOPMENT, V127, P2283; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Costanzi C, 2001, J BIOL CHEM, V276, P21776, DOI 10.1074/jbc.M010919200; Creppe C, 2012, MOL CELL BIOL, V32, P1442, DOI 10.1128/MCB.06323-11; Douet J, 2017, J CELL SCI; Doyen CM, 2006, MOL CELL BIOL, V26, P1156, DOI 10.1128/MCB.26.3.1156-1164.2006; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Gaspar-Maia A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2582; Grigoryev SA, 2004, J CELL SCI, V117, P6153, DOI 10.1242/cs.01537; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Khurana S, 2014, CELL REP, V8, P1049, DOI 10.1016/j.celrep.2014.07.024; Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Lavigne MD, 2015, CELL REP, V11, P1090, DOI 10.1016/j.celrep.2015.04.022; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Li N, 2016, GASTROENTEROLOGY, V151, P298, DOI 10.1053/j.gastro.2016.04.049; Li N, 2014, STEM CELL REP, V3, P876, DOI 10.1016/j.stemcr.2014.09.011; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Mermoud JE, 1999, J CELL BIOL, V147, P1399, DOI 10.1083/jcb.147.7.1399; Mermoud JE, 2001, EXP CELL RES, V268, P245, DOI 10.1006/excr.2001.5277; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Novikov L, 2011, MOL CELL BIOL, V31, P4244, DOI 10.1128/MCB.05244-11; Ouararhni K, 2006, GENE DEV, V20, P3324, DOI 10.1101/gad.396106; Pasque V, 2012, J CELL SCI, V125, P6094, DOI 10.1242/jcs.113019; Pasque V, 2011, EMBO J, V30, P2373, DOI 10.1038/emboj.2011.144; Pehrson JR, 2014, MOL CELL BIOL, V34, P4523, DOI 10.1128/MCB.00794-14; PEHRSON JR, 1992, SCIENCE, V257, P1398; Pehrson JR, 1997, J CELL BIOCHEM, V65, P107, DOI 10.1002/(SICI)1097-4644(199704)65:1<107::AID-JCB11>3.0.CO;2-H; Pehrson JR, 1998, NUCLEIC ACIDS RES, V26, P2837, DOI 10.1093/nar/26.12.2837; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; Sporn JC, 2012, AM J PATHOL, V180, P2516, DOI 10.1016/j.ajpath.2012.02.027; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tao S, 2015, EMBO J, V34, P624, DOI 10.15252/embj.201490700; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Xu C, 2012, FEBS LETT, V586, P3920, DOI 10.1016/j.febslet.2012.09.030; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yanai H, 2017, SCI REP-UK, V7, DOI 10.1038/srep41838; Yildirim O, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004515; Yousefi M, 2016, J CELL BIOL, V215, P401, DOI 10.1083/jcb.201604119; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	64	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185196	10.1371/journal.pone.0185196	http://dx.doi.org/10.1371/journal.pone.0185196			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934364	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900118
J	Robinson, DP; Jaidah, MY; Bach, SS; Rohner, CA; Jabado, RW; Ormond, R; Pierce, SJ				Robinson, David P.; Jaidah, Mohammed Y.; Bach, Steffen S.; Rohner, Christoph A.; Jabado, Rima W.; Ormond, Rupert; Pierce, Simon J.			Some like it hot: Repeat migration and residency of whale sharks within an extreme natural environment	PLOS ONE			English	Article							RHINCODON-TYPUS; DIVING BEHAVIOR; NINGALOO REEF; INDIAN-OCEAN; GULF; AGGREGATION; TELEMETRY; MOVEMENT; PATTERNS; SEA	The Arabian Gulf is the warmest sea in the world and is host to a globally significant population of the whale shark Rhincodon typus. To investigate regional whale shark behaviour and movements, 59 satellite-linked tags were deployed on whale sharks in the Al Shaheen area off Qatar from 2011-14. Four different models of tag were used throughout the study, each model able to collect differing data or quantities of data. Retention varied from one to 227 days. While all tagged sharks crossed international maritime boundaries, they typically stayed within the Arabian Gulf. Only nine sharks dispersed through the narrow Strait of Hormuz into the Gulf of Oman. Most sharks stayed close to known or suspected feeding aggregation sites over summer months, but dispersed throughout the Arabian Gulf in winter. Sharks rarely ventured into shallow areas (< 40 m depth). A single, presumably pregnant female shark was the sole animal to disperse a long distance, crossing five international maritime boundaries in 37 days before the tag detached at a distance of approximately 2644 km from the tagging site, close to the Yemeni-Somali border. No clear space-use differentiation was evident between years, for sharks of different sizes, or between sexes. Whale sharks spent the most time (similar to n 66%) in temperatures of 24-30 degrees C and in shallow waters < 100 m depth (similar to 60%). Sharks spent relatively more time in cooler (X-2 = 121.692; p< 0.05) and deeper (X-2 = 46.402; p< 0.05) water at night. Sharks rarely made dives deeper than 100 m, reflecting the bathymetric constraints of the Gulf environment. Kernel density analysis demonstrated that the tagging site at Al Shaheen was the regional hotspot for these sharks, and revealed a probable secondary aggregation site for whale sharks in nearby Saudi Arabian waters. Analysis of visual re-sightings data of tagged sharks revealed that 58% of tagged individuals were re-sighted back in Al Shaheen over the course of this study, with 40% recorded back at Al Shaheen in the year following their initial identification. Two sharks were confirmed to return to Al Shaheen in each of the five years of study.	[Robinson, David P.; Ormond, Rupert] Heriot Watt Univ, Edinburgh, Midlothian, Scotland; [Jaidah, Mohammed Y.] Qatar Minist Environm, Doha, Qatar; [Bach, Steffen S.] North Oil Co, Doha, Qatar; [Rohner, Christoph A.; Pierce, Simon J.] Marine Megafauna Fdn, Truckee, CA USA; [Jabado, Rima W.] Gulf Elasmo Project, Dubai, U Arab Emirates; [Ormond, Rupert] Marine Conservat Int, Edinburgh, Midlothian, Scotland	Heriot Watt University	Robinson, DP (corresponding author), Heriot Watt Univ, Edinburgh, Midlothian, Scotland.	sharkwatcharabia@gmail.com	Pierce, Simon J./A-7621-2010	Pierce, Simon J./0000-0002-9375-5175; Robinson, David/0000-0003-2572-9271; Rohner, Christoph/0000-0001-8760-8972; Jabado, Rima/0000-0001-6239-6723	MORTC; North Oil Company (NOC); Save Our Seas Foundation; Shark Foundation; Aqua-Firma; Waterlust	MORTC; North Oil Company (NOC); Save Our Seas Foundation; Shark Foundation; Aqua-Firma; Waterlust	Logistics for this project were provided by the Qatar Ministry of Municipality and Environment (QMMOE) and, Maersk Oil Research and Technology Centre (MORTC). SB acted as an independent researcher throughout this study with financial support in the form of a salary from the MORTC. The journal publication fees for this manuscript were provided by the North Oil Company (NOC). The MORTC or NOC did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of SBs salary and research materials. DPRs work on this manuscript was supported by two small grants from the Save Our Seas Foundation. Many thanks to the Save Our Seas Foundation, Al Ghurair Foods and the Emirates Diving Association, Emirates Natural History Group and, Le Meridien Al Aqah Beach Resort for providing financial support for individual satellite tags. Christoph Rohner and Simon Pierces contribution to this project were supported by private trusts, the Shark Foundation, Aqua-Firma, and Waterlust	Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Berumen ML, 2014, PLOS ONE, V9; Brunnschweiler JM, 2009, J FISH BIOL, V74, P706, DOI 10.1111/j.1095-8649.2008.02155.x; Cagua EF, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0092; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Gleiss AC, 2011, FUNCT ECOL, V25, P595, DOI 10.1111/j.1365-2435.2010.01801.x; Gleiss AC, 2009, FISH RES, V97, P11, DOI 10.1016/j.fishres.2008.12.012; Graham RT, 2006, J ROY SOC INTERFACE, V3, P109, DOI 10.1098/rsif.2005.0082; Hanfee F, 2001, GENTLE GIANTS SEA IN; Hearn A.R., 2013, ANIM BIOTELEMETRY, V1, P1, DOI [10.1186/2050-3385-1-11, DOI 10.1186/2050-3385-1-11]; Hearn AR, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2991-y; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Hoffmayer Eric R., 2007, Gulf and Caribbean Research, V19, P69; Hueter RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071883; Jabado R., 2012, MARINE ECOSYSTEMS UN; MacLeod C., 2013, INTRO USING GIS MARI; Marcus L, 2016, MAR ECOL PROG SER, V554, P115, DOI 10.3354/meps11807; Marrero D, 2014, PLOS ONE, V9; Meekan MG, 2006, MAR ECOL PROG SER, V319, P275, DOI 10.3354/meps319275; Motta PJ, 2010, ZOOLOGY, V113, P199, DOI 10.1016/j.zool.2009.12.001; Norman B, 2016, RHINCODON TYPUS IUCN; Norman B., 2007, EC IMPORTANCE CONSER; Ramirez-Macias D, 2012, J FISH BIOL, V80, P1401, DOI 10.1111/j.1095-8649.2012.03258.x; Ramirez-Macias Deni, 2012, Endangered Species Research, V18, P115, DOI 10.3354/esr00437; Robinson DP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158593; Robinson DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058255; Rohner C, 2013, MARINE ECOLOGY PROGR, V493, P1; Rohner C, 2014, PEER J, V22; Rohner CA, 2015, J PLANKTON RES, V37, P352, DOI 10.1093/plankt/fbv010; Rowat D, 2008, ENVIRON BIOL FISH, V82, P215, DOI 10.1007/s10641-007-9280-z; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Rowat D, 2012, J FISH BIOL, V80, P1019, DOI 10.1111/j.1095-8649.2012.03252.x; Schmidt Jennifer V., 2010, Endangered Species Research, V12, P117, DOI 10.3354/esr00300; Sheppard C, 2010, MAR POLLUT BULL, V60, P13, DOI 10.1016/j.marpolbul.2009.10.017; Speed CW, 2008, J FISH BIOL, V72, P1488, DOI 10.1111/j.1095-8649.2008.01810.x; Thums M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0477; Tyminski JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142156; Wilson SG, 2001, ENVIRON BIOL FISH, V61, P1, DOI 10.1023/A:1011069914753	38	26	27	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185360	10.1371/journal.pone.0185360	http://dx.doi.org/10.1371/journal.pone.0185360			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934371	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900150
J	Jin, FL; Yao, EJ; Zhang, YS; Liu, SS				Jin, Fanglei; Yao, Enjian; Zhang, Yongsheng; Liu, Shasha			Metro passengers' route choice model and its application considering perceived transfer threshold	PLOS ONE			English	Article							BEHAVIOR	With the rapid development of the Metro network in China, the greatly increased route alternatives make passengers' route choice behavior and passenger flow assignment more complicated, which presents challenges to the operation management. In this paper, a path sized logit model is adopted to analyze passengers' route choice preferences considering such parameters as in-vehicle time, number of transfers, and transfer time. Moreover, the "perceived transfer threshold" is defined and included in the utility function to reflect the penalty difference caused by transfer time on passengers' perceived utility under various numbers of transfers. Next, based on the revealed preference data collected in the Guangzhou Metro, the proposed model is calibrated. The appropriate perceived transfer threshold value and the route choice preferences are analyzed. Finally, the model is applied to a personalized route planning case to demonstrate the engineering practicability of route choice behavior analysis. The results show that the introduction of the perceived transfer threshold is helpful to improve the model's explanatory abilities. In addition, personalized route planning based on route choice preferences can meet passengers' diversified travel demands.	[Jin, Fanglei; Yao, Enjian; Zhang, Yongsheng] Beijing Jiaotong Univ, MOE Key Lab Urban Transportat Complex Syst Theory, Beijing, Peoples R China; [Jin, Fanglei] Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China; [Liu, Shasha] Beijing Jiaotong Univ, State Key Lab Rail Traff Control & Safety, Beijing, Peoples R China	Beijing Jiaotong University; Beijing Jiaotong University; Beijing Jiaotong University	Yao, EJ (corresponding author), Beijing Jiaotong Univ, MOE Key Lab Urban Transportat Complex Syst Theory, Beijing, Peoples R China.	enjyao@bjtu.edu.cn	Liu, Shasha/AAU-5605-2021	Liu, Shasha/0000-0002-2005-540X; Jin, Fanglei/0000-0003-3342-2472	Beijing Natural Science Foundation [8171003]; Fundamental Research Funds for the Central Universities [2017YJS101]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is supported by the Beijing Natural Science Foundation (8171003) to EY, and the Fundamental Research Funds for the Central Universities (No. 2017YJS101) to FJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Akiva M., 1999, HDB TRANSPORTATION S, P5, DOI DOI 10.1007/978-1-4615-5203-1_2; Bovy PHL, 2005, TRANSPORTATION, V32, P341, DOI 10.1007/s11116-004-7963-2; Broach J, 2012, TRANSPORT RES A-POL, V46, P1730, DOI 10.1016/j.tra.2012.07.005; Choi WK, 2007, LECT NOTES ARTIF INT, V4694, P645; Ding C, 2014, TRANSPORT RES D-TR E, V32, P230, DOI 10.1016/j.trd.2014.08.001; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Eluru N, 2012, PUBLIC TRANSPORT, V4, P129, DOI 10.1007/s12469-012-0056-2; Evans JR, 1992, OPTIMIZATION ALGORIT; Hawas YE, 2004, J TRANSP ENG, V130, P159, DOI 10.1061/(ASCE)0733-947X(2004)130:2(159); Hochmair H., 2000, Spatial Cognition and Computation, V2, P283, DOI 10.1023/A:1015566423907; Hochmair H, 2009, CARTOGR J, V46, P242, DOI 10.1179/000870409X12472347560623; Hood J, 2011, TRANSP LETT, V3, P63, DOI 10.3328/TL.2011.03.01.63-75; Hoogendoorn-Lanser S, 2007, TRANSPORT RES REC, P74, DOI 10.3141/2003-10; Koppelman FS, 2000, TRANSPORT RES B-METH, V34, P75, DOI 10.1016/S0191-2615(99)00012-0; Letchner J., 1999, P NAT C ART INT, V21; Letchner J, 1999, P NAT C ART INT, V21; Leurent F, ANN M TRANSP RES BOA; [刘莎莎 Liu Shasha], 2014, [交通运输系统工程与信息, Journal of Transporation Systems Engineering & Information Technology], V14, P100; Ma XL, 2017, J TRANSP GEOGR, V58, P135, DOI 10.1016/j.jtrangeo.2016.12.001; Nadi S, 2011, INT J APPL EARTH OBS, V13, P322, DOI 10.1016/j.jag.2011.01.003; Neter J, 1990, APPL LINEAR STAT MOD; Park K, 2007, IET INTELL TRANSP SY, V1, P159, DOI 10.1049/iet-its:20060074; Pillat J, 2011, TRANSPORT RES REC, P18, DOI 10.3141/2231-03; Prashker JN, 2004, TRANSPORT REV, V24, P437, DOI 10.1080/0144164042000181707; Prato CG, 2009, J CHOICE MODEL, V2, P65; Pursula M., 1999, TRANSPORT RES RECORD, V1669, P30, DOI [10.3141/1669-04, DOI 10.3141/1669-04]; Raveau S, 2014, TRANSPORT RES A-POL, V66, P185, DOI 10.1016/j.tra.2014.05.010; Raveau S, 2011, TRANSPORT RES A-POL, V45, P138, DOI 10.1016/j.tra.2010.12.004; [四兵锋 SI Bingfeng], 2007, [铁道学报, Journal of the China Railway Society], V29, P12; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Sun Y, 2015, J TRANSP ENG, V142, P1; Sun YS, 2012, TRANSPORT RES REC, P58, DOI 10.3141/2275-07; Tirachini A, 2013, TRANSPORT RES A-POL, V53, P36, DOI 10.1016/j.tra.2013.06.005; Train K., 2001, COMP HIERARCHICAL BA, P1; Whynes DK, 1996, FAM PRACT, V13, P174, DOI 10.1093/fampra/13.2.174; Zhang Y, 2013, ADV MECH ENG, V2013, P1, DOI [DOI 10.4225/08/58B5BAAD4FCC2, DOI 10.3864/J.ISSN.0578-1752.2013.10.014]	36	5	5	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185349	10.1371/journal.pone.0185349	http://dx.doi.org/10.1371/journal.pone.0185349			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957376	Green Submitted, Green Published, gold			2022-12-27	WOS:000411985200048
J	Zhu, XM; Sun, WF				Zhu, Xu-Ming; Sun, Wei-Feng			Association between matrix metalloproteinases polymorphisms and ovarian cancer risk: A meta-analysis and systematic review	PLOS ONE			English	Article							PROMOTER POLYMORPHISM; GENE PROMOTER; FUNCTIONAL POLYMORPHISMS; REGIONS; MMP-12	Background Published data on the relationship between matrix metalloproteinases (MMPs) polymorphisms and ovarian cancer risk have implicated inconclusive results. To evaluate the role of MMPs polymorphisms in ovarian cancer risk, a meta- analysis and systematic review were performed. Methods MMPs polymorphisms which could be quantitatively synthesized were involved in metaanalysis. Five comparison models (homozygote model, heterozygote model, dominant model, recessive model, additive model) were carried out, a subgroup analysis was performed to clarify heterogeneity source. The remaining polymorphisms which could not be quantitatively synthesized were involved in systematic review. Results 10 articles with 20 studies were included in this paper. Among those studies, 8 studies involving MMP1 rs1799750 and MMP3 rs34093618 could be meta- analyzed and 12 studies involving 12 polymorphisms could not. Meta- analysis showed that no associations were found between MMP1 rs1799750 (homozygote model: OR = 0.93, 95% CI = 0.70-1.23, POR = 0.60; heterozygote model: OR = 1.09, 95% CI = 0.78-1.54, POR = 0.61; dominant model: OR = 1.02, 95% CI = 0.83-1.25, POR = 0.84; recessive model: OR = 0.95, 95% CI = 0.75-1.21, POR = 0.67; additive model: OR = 1.00, 95% CI = 0.85-1.17, POR = 0.99), MMP3 rs34093618 (homozygote model: OR = 1.25, 95% CI = 0.70-2.24, POR = 0.46; heterozygote model: OR = 1.08, 95% CI = 0.51-2.31, POR = 0.84; dominant model: OR = 0.97, 95% CI = 0.68-1.38, POR = 0.85; recessive model: OR = 1.12, 95% CI = 0.69-1.80, POR = 0.65; additive model: OR = 1.01, 95% CI = 0.79-1.31, POR = 0.91) and ovarian cancer. Furthermore, similar results were detected in subgroup analysis. The systematic review on 12 polymorphisms suggested that MMP2 C-735T, MMP7 A-181G, MMP8 rs11225395, MMP9 rs6094237, MMP12 rs2276109, MMP20 rs2292730, MMP20 rs12278250, MMP20 rs9787933 might have a potential effect on ovarian cancer risk. Conclusions In summary, polymorphisms of MMPs might not be associated with ovarian cancer risk. However, it is necessary to conduct more larger-scale, multicenter, and high-quality studies in the future.	[Zhu, Xu-Ming; Sun, Wei-Feng] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Med Lab, Wuxi, Jiangsu, Peoples R China	Jiangnan University; Nanjing Medical University	Zhu, XM (corresponding author), Nanjing Med Univ, Wuxi Peoples Hosp, Dept Med Lab, Wuxi, Jiangsu, Peoples R China.	zxm18@sohu.com						Al-Alem L, 2015, REPRODUCTION, V150, pR55, DOI 10.1530/REP-14-0546; Arechavaleta-Velasco F, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0132-3; Biondi ML, 2000, CLIN CHEM, V46, P2023; Chen SS, 2015, INT J CLIN EXP MED, V8, P10845; Chung CC, 2011, HUM GENET, V130, P59, DOI 10.1007/s00439-011-1030-9; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Geng PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136269; Hu XX, 2012, ARCH GYNECOL OBSTET, V286, P1537, DOI 10.1007/s00404-012-2456-6; Jia Jing-hui, 2010, Zhonghua Yixue Yichuanxue Zazhi, V27, P209, DOI 10.3760/cma.j.issn.1003-9406.2010.02.020; Ju W, 2007, J OBSTET GYNAECOL RE, V33, P155, DOI 10.1111/j.1447-0756.2007.00511.x; Kaku Tsunehisa, 2003, Medical Electron Microscopy, V36, P9, DOI 10.1007/s007950300002; Kanamori Y, 1999, CANCER RES, V59, P4225; Li Xiu-Lan, 2008, Yi Chuan, V30, P455, DOI 10.3724/SP.J.1005.2008.00455; Li Y, 2006, GYNECOL ONCOL, V101, P92, DOI 10.1016/j.ygyno.2005.09.058; Li Y, 2009, INT J GYNECOL CANCER, V19, P129, DOI 10.1111/IGC.0b013e31819a1d8e; Li Yan, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P472; Liu LL, 2015, INT J CLIN EXP MED, V8, P11896; MANTEL N, 1959, J NATL CANCER I, V22, P719; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Ozols RF, 2005, INT J GYNECOL CANCER, V15, P3, DOI 10.1111/j.1525-1438.2005.15351.x; Rasool M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167149; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Six L, 2006, GYNECOL ONCOL, V100, P506, DOI 10.1016/j.ygyno.2005.08.049; Smolarz Beata, 2003, Pol J Pathol, V54, P233; Szyllol K, 2002, J EXP CLIN CANC RES, V21, P357; Thakkinstian A, 2011, AM J EPIDEMIOL, V173, P1365, DOI 10.1093/aje/kwr025; Wang L., 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1111/JIPB.12335; Wang Y, 2015, BIOMED RES INT, V2015, P6, DOI DOI 10.1128/MBI0.01280-15; Wenham RM, 2003, J SOC GYNECOL INVEST, V10, P381, DOI 10.1016/S1071-5576(03)00141-2; Wu RL, 1999, BIOMETRICS, V55, P355	31	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185456	10.1371/journal.pone.0185456	http://dx.doi.org/10.1371/journal.pone.0185456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957437	gold, Green Submitted, Green Published			2022-12-27	WOS:000411985200060
J	Hagey, TJ; Harte, S; Vickers, M; Harmon, LJ; Schwarzkopf, L				Hagey, Travis J.; Harte, Scott; Vickers, Mathew; Harmon, Luke J.; Schwarzkopf, Lin			There's more than one way to climb a tree: Limb length and microhabitat use in lizards with toe pads	PLOS ONE			English	Article							GEKKOTAN ADHESIVE SYSTEM; PERCH DIAMETER; ANOLIS LIZARDS; TRADE-OFFS; LOCOMOTOR PERFORMANCE; HABITAT USE; MORPHOLOGICAL-DIFFERENTIATION; HINDLIMB KINEMATICS; FRICTIONAL ADHESION; SPRINT PERFORMANCE	Ecomorphology links microhabitat and morphology. By comparing ecomorphological associations across clades, we can investigate the extent to which evolution can produce similar solutions in response to similar challenges. While Anolis lizards represent a well-studied example of repeated convergent evolution, very few studies have investigated the ecomorphology of geckos. Similar to anoles, gekkonid lizards have independently evolved adhesive toe pads and many species are scansorial. We quantified gecko and anole limb length and microhabitat use, finding that geckos tend to have shorter limbs than anoles. Combining these measurements with microhabitat observations of geckos in Queensland, Australia, we observed geckos using similar microhabitats as reported for anoles, but geckos with relatively longer limbs were using narrower perches, differing from patterns observed in anoles and other lizards. We also observed arboreal geckos with relatively shorter proximal limb segments as compared to rock-dwelling and terrestrial geckos, similar to patterns observed for other lizards. We conclude that although both geckos and anoles have adhesive pads and use similar microhabitats, their locomotor systems likely complement their adhesive pads in unique ways and result in different ecomorphological patterns, reinforcing the idea that species with convergent morphologies still have idiosyncratic characteristics due to their own separate evolutionary histories.	[Hagey, Travis J.] Michigan State Univ, BEACON Ctr Evolut Act, E Lansing, MI 48824 USA; [Harte, Scott; Vickers, Mathew; Schwarzkopf, Lin] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia; [Vickers, Mathew] Commonwealth Sci & Ind Res Org, Ctr Trop Biol & Climate Change, Townsville, Qld, Australia; [Harmon, Luke J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	Michigan State University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Idaho; University of Idaho	Hagey, TJ (corresponding author), Michigan State Univ, BEACON Ctr Evolut Act, E Lansing, MI 48824 USA.	hageyt@egr.msu.edu	Hagey, Travis J/H-5140-2019; Schwarzkopf, Lin/C-1242-2012	Schwarzkopf, Lin/0000-0002-1009-670X; Harmon, Luke/0000-0002-4985-5750; Hagey, Travis/0000-0002-3960-6814	National Geographic Society; Waitt Institute [W216-12]; BEACON Center for the Study of Evolution in Action [302, 429]; BEACON Center for the Study of Evolution in Action via the University of Idaho's Institute for Bioinformatics and Evolutionary Studies (IBEST) [302, 429]	National Geographic Society(National Geographic Society); Waitt Institute; BEACON Center for the Study of Evolution in Action; BEACON Center for the Study of Evolution in Action via the University of Idaho's Institute for Bioinformatics and Evolutionary Studies (IBEST)	We received funding from the National Geographic Society and the Waitt Institute (#W216-12) for TLH to travel to Australia and conduct field observations. The BEACON Center for the Study of Evolution in Action (Request #302, #429) provided financial support to TJH.; We received helpful comments from multiple anonymous reviewers. We received funding from the National Geographic Society and the Waitt Institute (#W216-12) and the BEACON Center for the Study of Evolution in Action (Request #302, #429) via the University of Idaho's Institute for Bioinformatics and Evolutionary Studies (IBEST). We constructed custom field equipment with the assistance of the Autumn lab, Mitch Day, the McGowan lab, and the UI Facilities and Mechanical Engineering Departments. While in Australia, we received assistance from the Schwarzkopf lab and the James Cook University Biology department staff and motor pool, the Australian Wildlife Conservancy, and lastly the Queensland landowners who allowed us access to their properties. None of the authors declare any conflicts of interest. Data have been made available in the Supporting information (S1 and S2 Tables).	Aerts P, 2000, NETH J ZOOL, V50, P261, DOI 10.1163/156854200505865; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Autumn K, 2006, J EXP BIOL, V209, P3558, DOI 10.1242/jeb.02469; Autumn K, 2006, J EXP BIOL, V209, P3569, DOI 10.1242/jeb.02486; Autumn K, 2002, Q REV BIOL, V77, P383, DOI 10.1086/344413; BAUER A M, 1990, Memoirs of the Queensland Museum, V29, P299; Bauer A.M., 1996, African Journal of Herpetology, V45, P8, DOI 10.1080/21564574.1996.9649959; BAUWENS D, 1995, EVOLUTION, V49, P848, DOI 10.1111/j.1558-5646.1995.tb02321.x; Birn-Jeffery AV, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0144-2; Brown D, 2012, ZOOTAXA, P1; Calsbeek R, 2007, EVOLUTION, V61, P2493, DOI 10.1111/j.1558-5646.2007.00206.x; Carillo de Espinoza N., 1990, Amphibia-Reptilia, V11, P1, DOI 10.1163/156853890X00267; Clemente CJ, 2009, J ZOOL, V278, P270, DOI 10.1111/j.1469-7998.2009.00559.x; Clemente CJ, 2013, J EXP BIOL, V216, P3854, DOI 10.1242/jeb.089060; Cole NC, 2005, BIOL CONSERV, V125, P467, DOI 10.1016/j.biocon.2005.04.017; Collins CE, 2015, FUNCT ECOL, V29, P66, DOI 10.1111/1365-2435.12312; Conroy CJ, 2009, J AM ASSOC LAB ANIM, V48, P28; Crandell KE, 2014, ZOOLOGY, V117, P363, DOI 10.1016/j.zool.2014.05.001; Elstrott J, 2004, BIOL J LINN SOC, V83, P389, DOI 10.1111/j.1095-8312.2004.00402.x; Fischer MS, 2010, ZOOLOGY, V113, P67, DOI 10.1016/j.zool.2009.07.001; Foster KL, 2012, J EXP BIOL, V215, P2288, DOI 10.1242/jeb.069856; Gamble C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039429, 10.1371/journal.pone.0035982]; Gardner AS, 1984, EVOLUTIONARY ECOLOGY; Goodman BA, 2007, EVOL ECOL RES, V9, P527; Goodman BA, 2009, EVOLUTION, V63, P1279, DOI 10.1111/j.1558-5646.2009.00621.x; Goodman BA, 2008, ECOLOGY, V89, P3462, DOI 10.1890/07-2093.1; GOULD SJ, 1971, AM NAT, V105, P113, DOI 10.1086/282710; Grandcolas P, 2009, MEM MUS NAT HIST NAT, V198, P13; Hagey TJ, 2013, MECH DIVERSITY ECOLO; Hagey TJ, 2016, J EXP BIOL, V219, P1603, DOI 10.1242/jeb.129940; Hagey TJ, 2014, ZOOMORPHOLOGY, V133, P111, DOI 10.1007/s00435-013-0207-2; Hansen WR, 2005, P NATL ACAD SCI USA, V102, P385, DOI 10.1073/pnas.0408304102; Harmon LJ, 2007, OIKOS, V116, P1863, DOI 10.1111/j.0030-1299.2007.15958.x; Higham TE, 2004, J EXP BIOL, V207, P233, DOI 10.1242/jeb.00763; Higham TE, 2010, BIOL J LINN SOC, V101, P860, DOI 10.1111/j.1095-8312.2010.01539.x; Huber G, 2007, ACTA BIOMATER, V3, P607, DOI 10.1016/j.actbio.2007.01.007; Irschick DJ, 1998, EVOLUTION, V52, P219, DOI 10.1111/j.1558-5646.1998.tb05155.x; Irschick DJ, 1997, ECOLOGY, V78, P2191, DOI 10.2307/2265955; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1111/j.1095-8312.1996.tb01451.x; Johnson MK, 2005, CAN J ZOOL, V83, P1511, DOI 10.1139/Z05-112; Jones ZM, 2012, J EXP BIOL, V215, P2096, DOI 10.1242/jeb.067413; Jusufi A, 2008, P NATL ACAD SCI USA, V105, P4215, DOI 10.1073/pnas.0711944105; Kohlsdorf T, 2001, J MORPHOL, V248, P151, DOI 10.1002/jmor.1026; Krause C, 2013, J EXP BIOL, V216, P1448, DOI 10.1242/jeb.082586; Lamb T, 2010, P R SOC B, V273, P855; LOSOS JB, 1990, ECOL MONOGR, V60, P369, DOI 10.2307/1943062; LOSOS JB, 1989, J EXP BIOL, V145, P23; Losos JB, 1996, ANIM BEHAV, V51, P593, DOI 10.1006/anbe.1996.0063; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; LOSOS JB, 1990, EVOLUTION, V44, P1189, DOI 10.1111/j.1558-5646.1990.tb05225.x; LOSOS JB, 1994, ANNU REV ECOL SYST, V25, P467, DOI 10.1146/annurev.es.25.110194.002343; LOSOS JB, 1994, SYST BIOL, V43, P117, DOI 10.2307/2413584; LOSOS JB, 1993, FUNCT ECOL, V7, P281, DOI 10.2307/2390206; Macrini TE, 1998, BIOL J LINN SOC, V63, P579, DOI 10.1006/bijl.1997.0203; Macrini TE, 2003, J HERPETOL, V37, P52, DOI 10.1670/0022-1511(2003)037[0052:EDITCB]2.0.CO;2; Mattingly WB, 2004, ECOLOGY, V85, P1111, DOI 10.1890/03-0293; Melville J, 2006, P ROY SOC B-BIOL SCI, V273, P557, DOI 10.1098/rspb.2005.3328; MILES DB, 1994, LIZARD ECOLOGY, P207; Oliver PM, 2016, ZOOTAXA, V4088, P151, DOI 10.11646/zootaxa.4088.2.1; Oliver PM, 2012, MOL PHYLOGENET EVOL, V63, P255, DOI 10.1016/j.ympev.2011.12.013; Ord TJ, 2014, OECOLOGIA, V175, P651, DOI 10.1007/s00442-014-2921-y; Orme C.D.L., 2011, CAPER COMP ANAL PHYL; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Persson BNJ, 2007, J ADHES SCI TECHNOL, V21, P1145, DOI 10.1163/156856107782328335; Pesika NS, 2009, J ADHESION, V85, P512, DOI 10.1080/00218460902996390; PETERSON JA, 1984, J ZOOL, V202, P1; PIANKA ER, 1978, COPEIA, P691; Pugno NM, 2008, BIOSYSTEMS, V94, P218, DOI 10.1016/j.biosystems.2008.06.009; Pyron RA, 2014, ECOL LETT, V17, P13, DOI 10.1111/ele.12168; Revell LJ, 2007, EVOLUTION, V61, P2898, DOI 10.1111/j.1558-5646.2007.00225.x; RStudio Team, 2015, RSTUDIO INT DEV ENV; RUIBAL R, 1965, J MORPHOL, V117, P271, DOI 10.1002/jmor.1051170302; Russell AP, 2007, CAN J ZOOL, V85, P1228, DOI 10.1139/Z07-103; Russell AP, 2015, J MORPHOL, V276, P1311, DOI 10.1002/jmor.20420; Russell AP, 2014, ACTA ZOOL-STOCKHOLM, V95, P299, DOI 10.1111/azo.12028; Russell AP, 2009, P R SOC B, V276, P3705, DOI 10.1098/rspb.2009.0946; Russell AP, 2002, INTEGR COMP BIOL, V42, P1154, DOI 10.1093/icb/42.6.1154; Russell AP, 2001, COMP BIOCHEM PHYS A, V131, P89, DOI 10.1016/S1095-6433(01)00469-X; RUSSELL AP, 1979, COPEIA, P1, DOI 10.2307/1443723; Sadlier R. A., 2005, Memoirs of the Queensland Museum, V51, P573; Schulte JA, 2004, J EVOLUTION BIOL, V17, P408, DOI 10.1046/j.1420-9101.2003.00659.x; SINERVO B, 1991, ECOLOGY, V72, P1225, DOI 10.2307/1941096; Sistrom M, 2012, J EVOLUTION BIOL, V25, P647, DOI 10.1111/j.1420-9101.2012.02460.x; Spezzano LC, 2004, J EXP BIOL, V207, P2115, DOI 10.1242/jeb.00995; Thompson GG, 2005, AMPHIBIA-REPTILIA, V26, P65, DOI 10.1163/1568538053693323; Thompson GG, 2008, AUST J ZOOL, V56, P351, DOI 10.1071/ZO08030; Vanhooydonck B, 2005, BIOL J LINN SOC, V85, P385, DOI 10.1111/j.1095-8312.2005.00495.x; Vanhooydonck B, 2001, J EVOLUTION BIOL, V14, P46, DOI 10.1046/j.1420-9101.2001.00260.x; Vitt LJ, 1997, P NATL ACAD SCI USA, V94, P3828, DOI 10.1073/pnas.94.8.3828; Wainwright P.C., 1994, ECOLOGICAL MORPHOLOG; Wang ZY, 2011, CHINESE SCI BULL, V56, P573, DOI 10.1007/s11434-010-4082-7; Wang ZY, 2010, SCI CHINA TECHNOL SC, V53, P1688, DOI 10.1007/s11431-010-3188-0; Yamaguchi T, 2009, J PHYS CHEM B, V113, P3622, DOI 10.1021/jp8067415; Zaaf A, 2001, ZOOMORPHOLOGY, V121, P45, DOI 10.1007/s004350100044; Zaaf A, 1999, ZOOMORPHOLOGY, V119, P9, DOI 10.1007/s004350050077; Zani PA, 2000, J EVOLUTION BIOL, V13, P316, DOI 10.1046/j.1420-9101.2000.00166.x; Zhuang MNV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153520	98	11	12	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184641	10.1371/journal.pone.0184641	http://dx.doi.org/10.1371/journal.pone.0184641			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953920	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000411980300019
J	Shin, HW; Ju, BJ; Jang, YK; You, HS; Kang, H; Park, JY				Shin, Hye Won; Ju, Bum Jun; Jang, Yoo Kyung; You, Hae Seun; Kang, Hyun; Park, Ji Yong			Effect of tramadol as an adjuvant to local anesthetics for brachial plexus block: A systematic review and meta-analysis	PLOS ONE			English	Article							NERVE BLOCK; POSTOPERATIVE ANALGESIA; PERIPHERAL-NERVE; MOTOR BLOCKADE; PAIN; LEVOBUPIVACAINE; ROPIVACAINE; 0.5-PERCENT; DEXAMETHASONE; MEPIVACAINE	Background Tramadol, a 4-phenyl-piperidine analog of codeine, has a unique action in that it has a central opioidergic, noradrenergic, serotonergic analgesic, and peripheral local anesthetic (LA) effect. Many studies have reported contradictory findings regarding the peripheral analgesic effect of tramadol as an adjuvant to LA in brachial plexus block (BPB). This meta-analysis aimed to evaluate the effects of tramadol as an adjunct to LA in BPB during shoulder or upper extremity surgery. Methods We searched the PubMed, EMBASE, Cochrane, KoreaMed databases, and Google Scholar for eligible randomized controlled trials (RCTs) that compared BPB with LA alone and BPB with LA and tramadol. Primary outcomes were the effects of tramadol as an adjuvant on duration of sensory block, motor block, and analgesia. Secondary outcomes were the effects of tramadol as an adjuvant on time to onset of sensory block and motor block and on adverse effects. We performed the meta-analysis using Review Manager 5.3 software. Results We identified 16 RCTs with 751 patients. BPB with tramadol prolonged the duration of sensory block (mean difference [MD], -61.5 min; 95% CI, -95.5 to -27.6; P = 0.0004), motor block (MD, -65.6 min; 95% CI, -101.5 to -29.7; P = 0.0003), and analgesia (MD, -125.5 min; 95% CI, -175.8 to -75.3; P < 0.0001) compared with BPB without tramadol. Tramadol also shortened the time to onset of sensory block (MD, 2.1 min; 95% CI, 1.1 to 3.1; P < 0.0001) and motor block (MD, 1.2 min; 95% CI, 0.2 to 2.1; P = 0.010). In subgroup analysis, the duration of sensory block, motor block, and analgesia was prolonged for BPB with tramadol 100 mg (P < 0.05) but not for BPB with tramadol 50 mg. The quality of evidence was high for duration of analgesia according to the GRADE system. Adverse effects were comparable between the studies. Conclusions In upper extremity surgery performed under BPB, use of tramadol 100 mg as an adjuvant to LA appears to prolong the duration of sensory block, motor block, and analgesia, and shorten the time to onset of sensory and motor blocks without altering adverse effects.	[Shin, Hye Won; Ju, Bum Jun; Jang, Yoo Kyung; You, Hae Seun; Park, Ji Yong] Korea Univ, Dept Anesthesiol & Pain Med, Coll Med, Anam Hosp, Seoul, South Korea; [Kang, Hyun] Chung Ang Univ Hosp, Dept Anesthesiol & Pain Med, Coll Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Chung Ang University; Chung Ang University Hospital	Shin, HW (corresponding author), Korea Univ, Dept Anesthesiol & Pain Med, Coll Med, Anam Hosp, Seoul, South Korea.	drhwshin@naver.com	Kang, Hyun/AAE-7872-2020	Kang, Hyun/0000-0003-2844-5880; Jang, Yookyung/0000-0002-3491-1430				Abdallah FW, 2013, BRIT J ANAESTH, V110, P915, DOI 10.1093/bja/aet066; Alemanno F, 2012, MINERVA ANESTESIOL, V78, P291; Altunkaya H, 2003, BRIT J ANAESTH, V90, P320, DOI 10.1093/bja/aeg079; Antonucci S, 2001, Minerva Anestesiol, V67, P23; Arcioni R, 2002, ANESTH ANALG, V94, P1553, DOI 10.1097/00000539-200206000-00033; Broch O, 2005, ANASTH INTENSIV NOTF, V40, P526, DOI 10.1055/s-2005-870205; Budd K, 1999, BRIT J ANAESTH, V82, P493, DOI 10.1093/bja/82.4.493; Chattopadhyay S, 2007, J ANAESTHESIOL CLIN, V23, P187; Choi S, 2014, BRIT J ANAESTH, V112, P427, DOI 10.1093/bja/aet417; Dikmen B, 2009, TURK J MED SCI, V39, P733, DOI 10.3906/sag-0903-8; Fanelli G, 2001, ACTA ANAESTH SCAND, V45, P590, DOI 10.1034/j.1399-6576.2001.045005590.x; Geze S, 2012, EUR J GEN MED, V9, P118, DOI [DOI 10.29333/EJGM/82475, 10.29333/ejgm/82475]; Gormley WP, 1996, BRIT J ANAESTH, V76, P802, DOI 10.1093/bja/76.6.802; Grond S, 2004, CLIN PHARMACOKINET, V43, P879, DOI 10.2165/00003088-200443130-00004; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Kaabachi O, 2009, ANESTH ANALG, V108, P367, DOI 10.1213/ane.0b013e31818e0c6b; Kapral S, 1999, ANESTH ANALG, V88, P853, DOI 10.1097/00000539-199904000-00032; KAYSER V, 1992, EUR J PHARMACOL, V224, P83, DOI 10.1016/0014-2999(92)94822-D; Kesimci E, 2007, ACTA ANAESTH SCAND, V51, P736, DOI 10.1111/j.1399-6576.2007.01308.x; Khosa AH, 2015, PAK J MED HEALTH SCI, V9, P1120; Kirksey MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137312; Knezevic NN, 2015, PAIN PHYSICIAN, V18, P1; Madhusudhana R, 2011, INT J BIOL MED RES, V2, P1061; Mannion S, 2005, BRIT J ANAESTH, V94, P352, DOI 10.1093/bja/aei057; Mert T, 2003, PHARMACOLOGY, V69, P68, DOI 10.1159/000072358; Mukherjee K, 2014, J RES PHARM PRACT, V3, P123, DOI 10.4103/2279-042X.145387; Nagpal Vishal, 2015, J Anaesthesiol Clin Pharmacol, V31, P191, DOI 10.4103/0970-9185.155147; Omar AM, 2011, EGYPT J ANAESTH, V27, P101, DOI 10.1016/j.egja.2011.04.002; Park CH, 2013, KOREAN J PAIN, V26, P265, DOI 10.3344/kjp.2013.26.3.265; Popping DM, 2009, ANESTHESIOLOGY, V111, P406, DOI 10.1097/ALN.0b013e3181aae897; Robaux S, 2004, ANESTH ANALG, V98, P1172, DOI 10.1213/01.ANE.0000108966.84797.72; Saryazdi Hamid, 2015, Adv Biomed Res, V4, P232, DOI 10.4103/2277-9175.167901; Scott LJ, 2000, DRUGS, V60, P139, DOI 10.2165/00003495-200060010-00008; Senel AC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/686287; Sousa AM, 2012, BRAZ J MED BIOL RES, V45, P147, DOI 10.1590/S0100-879X2011007500164; Trabelsi W, 2013, ANALG RESUSC CURR RE, V2, P2; Yalcin P, 2005, PHARMACOL BIOCHEM BE, V80, P69, DOI 10.1016/j.pbb.2004.10.020; Yurtlu BS, 2012, TURK J MED SCI, V42, P55, DOI 10.3906/sag-1010-1250	38	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184649	10.1371/journal.pone.0184649	http://dx.doi.org/10.1371/journal.pone.0184649			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953949	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300020
J	Wagensveld, IM; Blokker, BM; Wielopolski, PA; Renken, NS; Krestin, GP; Hunink, MG; Oosterhuis, JW; Weustink, AC				Wagensveld, Ivo M.; Blokker, Britt M.; Wielopolski, Piotr A.; Renken, Nomdo S.; Krestin, Gabriel P.; Hunink, Myriam G.; Oosterhuis, J. Wolter; Weustink, Annick C.			Total-body CT and MR features of postmortem change in in-hospital deaths	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY FINDINGS; QUANTITATIVE-ANALYSIS; VIRTUAL AUTOPSY; MYOCARDIAL-INFARCTION; INTRAHEPATIC GAS; SUDDEN-DEATH; RIGOR-MORTIS; VIRTOPSY; TRAUMA; FEASIBILITY	Objectives To evaluate the frequency of total-body CT and MR features of postmortem change in in-hospital deaths. Materials and methods In this prospective blinded cross-sectional study, in-hospital deceased adult patients underwent total-body postmortem CT and MR followed by image-guided biopsies. The presence of PMCT and PMMR features related to postmortem change was scored retrospectively and correlated with postmortem time interval, post-resuscitation status and intensive care unit (ICU) admittance. Results Intravascular air, pleural effusion, periportal edema, and distended intestines occurred more frequently in patients who were resuscitated compared to those who were not. Postmortem clotting was seen less often in resuscitated patients (p = 0.002). Distended intestines and loss of grey-white matter differentiation in the brain showed a significant correlation with postmortem time interval ( p = 0.001, p<0.001). Hyperdense cerebral vessels, intravenous clotting, subcutaneous edema, fluid in the abdomen and internal livores of the liver were seen more in ICU patients. Longer postmortem time interval led to a significant increase in decomposition related changes ( p = 0.026). Conclusions There is a wide variety of imaging features of postmortem change in in-hospital deaths. These imaging features vary among clinical conditions, increase with longer postmortem time interval and must be distinguished from pathologic changes.	[Wagensveld, Ivo M.; Blokker, Britt M.; Wielopolski, Piotr A.; Krestin, Gabriel P.; Hunink, Myriam G.; Weustink, Annick C.] Erasmus Univ, Med Ctr, Dept Radiol & Nucl Med, Rotterdam, Zuid Holland, Netherlands; [Wagensveld, Ivo M.; Blokker, Britt M.; Oosterhuis, J. Wolter; Weustink, Annick C.] Erasmus Univ, Dept Pathol, Med Ctr, Rotterdam, Zuid Holland, Netherlands; [Renken, Nomdo S.] Reinier de Graaf Gasthuis, Dept Radiol, Delft, Zuid Holland, Netherlands; [Hunink, Myriam G.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Reinier de Graaf Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Wagensveld, IM (corresponding author), Erasmus Univ, Med Ctr, Dept Radiol & Nucl Med, Rotterdam, Zuid Holland, Netherlands.; Wagensveld, IM (corresponding author), Erasmus Univ, Dept Pathol, Med Ctr, Rotterdam, Zuid Holland, Netherlands.	i.wagensveld@erasmusmc.nl			Erasmus MC health care efficiency [2010-10112]; Stichting Coolsingel (NL) [255]; Erasmus MC vriendenfonds [104117]	Erasmus MC health care efficiency; Stichting Coolsingel (NL); Erasmus MC vriendenfonds	The following funders supported this work: Erasmus MC health care efficiency, 2010-10112; Stichting Coolsingel (NL), 255; Erasmus MC vriendenfonds, 104117. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampanozi G, 2015, LEGAL MED-TOKYO, V17, P493, DOI 10.1016/j.legalmed.2015.10.008; Arthurs OJ, 2015, INT J LEGAL MED, V129, P1113, DOI 10.1007/s00414-015-1189-z; Arthurs OJ, 2015, PEDIATR RADIOL, V45, P527, DOI 10.1007/s00247-014-3166-y; Blokker BM, 2015, EUR RADIOL; Bruguier C, 2013, INT J LEGAL MED, V127, P639, DOI 10.1007/s00414-013-0840-9; Burke M, 2015, AM J FOREN MED PATH, V36, P224, DOI 10.1097/PAF.0000000000000180; Burke M, 2012, FORENSIC SCI MED PAT, V8, P367, DOI 10.1007/s12024-012-9347-9; Burton JL, 2007, LANCET, V369, P1471, DOI 10.1016/S0140-6736(07)60376-6; Charlier P, 2012, EUR J RADIOL, V81, P639, DOI 10.1016/j.ejrad.2011.01.054; Christe A, 2010, LEGAL MED, V12, P215, DOI 10.1016/j.legalmed.2010.05.005; Crooijmans HJA, 2014, J MAGN RESON IMAGING, V40, P915, DOI 10.1002/jmri.24460; Dirnhofer R, 2006, RADIOGRAPHICS, V26, P1305, DOI 10.1148/rg.265065001; Eggen MD, 2012, MAGN RESON MED, V67, P1703, DOI 10.1002/mrm.23194; Egger C, 2012, INT J LEGAL MED, V126, P559, DOI 10.1007/s00414-012-0686-6; Egger C, 2012, INT J LEGAL MED, V126, P3, DOI 10.1007/s00414-010-0542-5; Eriksson A, 2016, EUR J RADIOL; Fischer F, 2012, FORENSIC SCI INT, V214, P118, DOI 10.1016/j.forsciint.2011.07.033; Flach Patricia M, 2014, AJR Am J Roentgenol, V202, pW325, DOI 10.2214/AJR.12.10283; Gaensbacher S, 2012, EUR J EPIDEMIOL, V27, P577, DOI 10.1007/s10654-012-9709-3; Gebhart FTF, 2012, FORENSIC SCI INT, V222, P162, DOI 10.1016/j.forsciint.2012.05.020; Germerott T, 2010, LEGAL MED-TOKYO, V12, P276, DOI 10.1016/j.legalmed.2010.07.001; Hyodoh H, 2012, JPN J RADIOL, V30, P840, DOI 10.1007/s11604-012-0134-z; Jackowski C, 2006, INVEST RADIOL, V41, P572, DOI 10.1097/01.rli.0000221323.38443.8d; Jackowski C, 2006, INT J LEGAL MED, V120, P233, DOI 10.1007/s00414-005-0023-4; Jackowski C, 2005, FORENSIC SCI INT, V149, P11, DOI 10.1016/j.forsciint.2004.05.019; Jackowski C, 2007, J TRAUMA, V62, P979, DOI 10.1097/01.ta.0000198733.22654.de; Jackowski C, 2006, EUR HEART J, V27, P2459, DOI 10.1093/eurheartj/ehl255; Jackowski C, 2013, J AM COLL CARDIOL, V62, P617, DOI 10.1016/j.jacc.2013.01.089; Jackowski C, 2013, EUR RADIOL, V23, P1266, DOI 10.1007/s00330-012-2728-3; Jackowski C, 2012, FORENSIC SCI INT, V214, pE16, DOI 10.1016/j.forsciint.2011.07.010; Kanazawa A, 2014, LEGAL MED-TOKYO, V16, P297, DOI 10.1016/j.legalmed.2014.05.004; Klein WM, 2015, PEDIATR RADIOL, V45, P517, DOI 10.1007/s00247-014-3258-8; Kobayashi M, 1996, FORENSIC SCI INT, V82, P243, DOI 10.1016/S0379-0738(96)02005-1; Kobayashi T, 2010, JPN J RADIOL, V28, P8, DOI 10.1007/s11604-009-0373-9; KROMPECHER T, 1981, FORENSIC SCI INT, V17, P19, DOI 10.1016/0379-0738(81)90184-5; Levy AD, 2007, RADIOLOGY, V243, P862, DOI 10.1148/radiol.2433061009; Levy AD, 2010, AM J FOREN MED PATH, V31, P12, DOI 10.1097/PAF.0b013e3181c65e1a; Michiue T, 2012, FORENSIC SCI INT, V220, P232, DOI 10.1016/j.forsciint.2012.03.007; O'Donnell C, 2008, CLIN RADIOL, V63, P1189, DOI 10.1016/j.crad.2008.05.008; Okuda T, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-86; Roberts ISD, 2012, LANCET, V379, P136, DOI 10.1016/S0140-6736(11)61483-9; Roberts ISD, 2003, HISTOPATHOLOGY, V42, P424, DOI 10.1046/j.1365-2559.2003.01614.x; Ross SG, 2012, RADIOLOGY, V264, P250, DOI 10.1148/radiol.12092415; Ruder TD, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130567; Scheurer E, 2011, AM J NEURORADIOL, V32, P1518, DOI 10.3174/ajnr.A2508; Scholing M, 2009, EUR RADIOL, V19, P2333, DOI 10.1007/s00330-009-1440-4; Schwendener N, 2013, FORENSIC SCI INT, V225, P67, DOI 10.1016/j.forsciint.2012.09.002; Shiotani S, 2004, FORENSIC SCI INT, V139, P39, DOI 10.1016/j.forsciint.2003.09.016; Shiotani S, 2011, LEGAL MED-TOKYO, V13, P151, DOI 10.1016/j.legalmed.2010.12.008; Shiotani Seiji, 2003, Radiat Med, V21, P29; Shiotani S, 2010, JPN J RADIOL, V28, P1, DOI 10.1007/s11604-009-0372-x; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; Smith AB, 2012, AM J NEURORADIOL, V33, P1387, DOI 10.3174/ajnr.A2966; Takahashi N, 2013, FORENSIC SCI INT, V225, P27, DOI 10.1016/j.forsciint.2012.04.037; Takahashi N, 2010, AM J ROENTGENOL, V195, pW388, DOI 10.2214/AJR.10.4442; Takahashi N, 2010, JPN J RADIOL, V28, P349, DOI 10.1007/s11604-010-0430-4; Thali Michael J., 2007, Legal Medicine, V9, P100, DOI 10.1016/j.legalmed.2006.11.011; Thali MJ, 2005, J FORENSIC SCI, V50, P428; Thali MJ, 2003, FORENSIC SCI INT, V134, P109, DOI 10.1016/S0379-0738(03)00137-3; Turnbull A, 2015, LANCET, V386, P2141, DOI 10.1016/S0140-6736(15)01049-1; Weustink AC, 2009, RADIOLOGY, V250, P897, DOI 10.1148/radiol.2503080421; Yamazaki K., 2003, LEGAL MED-TOKYO, V5, P338; Zech WD, 2015, EUR RADIOL, V25, P2381, DOI 10.1007/s00330-015-3588-4	63	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185115	10.1371/journal.pone.0185115	http://dx.doi.org/10.1371/journal.pone.0185115			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953923	Green Submitted, Green Published, gold			2022-12-27	WOS:000411980300035
J	Chen, L; Yang, WJ; Guo, YJ; Chen, W; Zheng, P; Zeng, JS; Tong, WS				Chen, Lei; Yang, Wenjin; Guo, Yijun; Chen, Wei; Zheng, Ping; Zeng, Jinsong; Tong, Wusong			Exosomal lncRNA GAS5 regulates the apoptosis of macrophages and vascular endothelial cells in atherosclerosis	PLOS ONE			English	Article							LONG NONCODING RNAS; ANTIINFLAMMATORY THERAPIES; ROLES	Atherosclerosis is universally recognized as a chronic lipid-induced inflammation of the vessel wall. Oxidized low density lipoprotein (oxLDL)drives the onset of atherogenesis involving macrophages and endothelial cells (ECs).Our earlier work showed that expression of long noncoding RNA-growth arrest-specific 5 (lncRNA GAS5) was significantly increased in the plaque of atherosclerosis collected from patients and animal models. In this study, we found that knockdown of lncRNA GAS5 reduced the apoptosis of THP-1 cells treated with oxLDL. On the contrary, overexpression of lncRNA GAS5 significantly elevated the apoptosis of THP-1 cells after oxLDL stimulation. The expressions of apoptotic factors including Caspases were changed with lncRNA GAS5 levels. Moreover, lncRNA GAS5 was found in THP-1 derived-exosomes after oxLDL stimulation. Exosomes derived from lncRNA GAS5-overexpressing THP-1 cells enhanced the apoptosis of vascular endothelial cells after taking up these exosomes. However, exosomes shed by lncRNA GAS5 knocked-down THP-1 cells inhibited the apoptosis of endothelial cells. These findings reveal the function of lncRNA GAS5 in atherogenesis which regulates the apoptosis of macrophages and endothelial cells via exosomes and suggest that suppressing the lncRNA GAS5 might be an effective way for the therapy of atherosclerosis.	[Chen, Lei; Yang, Wenjin; Guo, Yijun; Chen, Wei; Zheng, Ping; Zeng, Jinsong; Tong, Wusong] Peoples Hosp Pudong New Area, Dept Neurosurg, Shanghai, Peoples R China		Tong, WS (corresponding author), Peoples Hosp Pudong New Area, Dept Neurosurg, Shanghai, Peoples R China.	tongws0599@163.com			Shanghai Pudong New Area health system excellent young medical talents training plan [PWRq2016-29]; Pudong New Area Science and Technology Development Fund [PKJ2015-Y29]	Shanghai Pudong New Area health system excellent young medical talents training plan; Pudong New Area Science and Technology Development Fund	This research was funded by Shanghai Pudong New Area health system excellent young medical talents training plan (No. PWRq2016-29) and Pudong New Area Science and Technology Development Fund (PKJ2015-Y29) to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahadi A, 2016, GENOM DATA, V9, P7, DOI 10.1016/j.gdata.2016.05.010; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Arase M, 2014, CANCER SCI, V105, P974, DOI 10.1111/cas.12454; Aryal B, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0407-3; Ayari H, 2013, ANN BIOL CLIN-PARIS, V71, P381, DOI 10.1684/abc.2013.0868; Back M, 2015, NAT REV CARDIOL, V12, P199, DOI 10.1038/nrcardio.2015.5; Bianchessi V, 2015, J MOL CELL CARDIOL, V81, P62, DOI 10.1016/j.yjmcc.2015.01.012; Cardilo-Reis L, 2012, EMBO MOL MED, V4, P1072, DOI 10.1002/emmm.201201374; Chen L, 2016, GENE, V592, P43, DOI 10.1016/j.gene.2016.07.023; Chen X, 2013, BIOINFORMATICS, V29, P2617, DOI 10.1093/bioinformatics/btt426; De Jong OG, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00608; Gezer U, 2014, CELL BIOL INT, V38, P1076, DOI 10.1002/cbin.10301; Khan R, 2015, ATHEROSCLEROSIS, V240, P497, DOI 10.1016/j.atherosclerosis.2015.04.783; Krell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098561; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120550; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; Ma HD, 2012, SCI WORLD J, DOI 10.1100/2012/541786; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; MEHTA A, 1995, ARTERIOSCL THROM VAS, V15, P2076, DOI 10.1161/01.ATV.15.11.2076; Novak J, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/275867; Rafieian-Kopaei M, 2014, INT J PREVENTIVE MED, V5, P927; Saha P, 2009, CURR OPIN PHARMACOL, V9, P109, DOI 10.1016/j.coph.2008.12.017; Sun XH, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0372-2; Toba H, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-013-0386-9; Williams GT, 2011, BIOCHEM SOC T, V39, P482, DOI 10.1042/BST0390482; Zhou T, 2016, ATHEROSCLEROSIS, V248, P51, DOI 10.1016/j.atherosclerosis.2016.02.025	27	176	188	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185406	10.1371/journal.pone.0185406	http://dx.doi.org/10.1371/journal.pone.0185406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945793	Green Published, gold, Green Submitted			2022-12-27	WOS:000411645100058
J	Plummer, R; Dzyundzyak, A; Baird, J; Bodin, O; Armitage, D; Schultz, L				Plummer, Ryan; Dzyundzyak, Angela; Baird, Julia; Bodin, Orjan; Armitage, Derek; Schultz, Lisen			How do environmental governance processes shape evaluation of outcomes by stakeholders? A causal pathways approach	PLOS ONE			English	Article							NATURAL-RESOURCE MANAGEMENT; ADAPTIVE COMANAGEMENT; ECOSYSTEM SERVICES; COLLABORATIVE GOVERNANCE; PARTICIPATION; FRAMEWORK; RESILIENCE; PRINCIPLES; SYSTEMS; WORLD	Multi-stakeholder environmental management and governance processes are essential to realize social and ecological outcomes. Participation, collaboration, and learning are emphasized in these processes; to gain insights into how they influence stakeholders' evaluations of outcomes in relation to management and governance interventions we use a path analysis approach to examine their relationships in individuals in four UNESCO Biosphere Reserves. We confirm a model showing that participation in more activities leads to greater ratings of process, and in turn, better evaluations of outcomes. We show the effects of participation in activities on evaluation of outcomes appear to be driven by learning more than collaboration. Original insights are offered as to how the evaluations of outcomes by stakeholders are shaped by their participation in activities and their experiences in management and governance processes. Understanding stakeholder perceptions about the processes in which they are involved and their evaluation of outcomes is imperative, and influences current and future levels of engagement. As such, the evaluation of outcomes themselves are an important tangible product from initiatives. Our research contributes to a future research agenda aimed at better understanding these pathways and their implications for engagement in stewardship and ultimately social and ecological outcomes, and to developing recommendations for practitioners engaged in environmental management and governance.	[Plummer, Ryan; Dzyundzyak, Angela; Baird, Julia] Brock Univ, Environm Sustainabil Res Ctr, St Catharines, ON, Canada; [Plummer, Ryan; Bodin, Orjan; Schultz, Lisen] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Armitage, Derek] Univ Waterloo, Sch Environm Resources & Sustainabil, Waterloo, ON, Canada	Brock University; Stockholm University; University of Waterloo	Baird, J (corresponding author), Brock Univ, Environm Sustainabil Res Ctr, St Catharines, ON, Canada.	jbaird@brocku.ca	Armitage, Derek/ABE-6315-2020; Bodin, Örjan/A-5098-2010	Bodin, Örjan/0000-0002-8218-1153; Schultz, Lisen/0000-0003-4763-8872; Armitage, Derek/0000-0002-8921-1693	Vetenskapsradet, the Swedish Research Council [2012-5498]; Mistra	Vetenskapsradet, the Swedish Research Council(Swedish Research Council); Mistra	This work was supported by Vetenskapsradet, the Swedish Research Council (grant 2012-5498; http://www.vr.se/) (RP, DA, OB,LS). Further support for researchers at the Stockholm Resilience Centre (OB, LS) comes from a core grant from Mistra.	[Anonymous], 2003, PROMISE PERFORMANCE; [Anonymous], 2005, SOCIAL LEARNING ENV; Ansell C, 2008, J PUBL ADM RES THEOR, V18, P543, DOI 10.1093/jopart/mum032; Armitage D, ENV POLICY IN PRESS; Armitage D, 2008, GLOBAL ENVIRON CHANG, V18, P86, DOI 10.1016/j.gloenvcha.2007.07.002; Armitage DR, 2009, FRONT ECOL ENVIRON, V7, P95, DOI 10.1890/070089; Baird J, 2014, GLOBAL ENVIRON CHANG, V27, P51, DOI 10.1016/j.gloenvcha.2014.04.019; Beierle TC, 2002, RISK ANAL, V22, P739, DOI 10.1111/0272-4332.00065; Bennett NJ, 2016, CONSERV BIOL, V30, P582, DOI 10.1111/cobi.12681; Berkhout F, 2003, NEGOTIATING ENVIRONMENTAL CHANGE, P1; Biddle JC, 2014, J ENVIRON MANAGE, V145, P268, DOI 10.1016/j.jenvman.2014.06.029; Biggs R, 2012, ANNU REV ENV RESOUR, V37, P421, DOI 10.1146/annurev-environ-051211-123836; Birnbaum S, 2015, POLICY SCI, V48, P443, DOI 10.1007/s11077-015-9230-0; Brody SD, 2003, J PLAN EDUC RES, V22, P407, DOI 10.1177/0739456X03022004007; Butler JRA, 2015, J ENVIRON MANAGE, V160, P212, DOI 10.1016/j.jenvman.2015.06.019; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Cebrian-Piqueras MA, 2017, ECOSYST SERV, V23, P108, DOI 10.1016/j.ecoser.2016.11.009; Cundill G, 2012, J ENVIRON MANAGE, V113, P7, DOI 10.1016/j.jenvman.2012.08.021; Dietz T, 2013, P NATL ACAD SCI USA, V110, P14081, DOI 10.1073/pnas.1212740110; Folke C, 2005, ANNU REV ENV RESOUR, V30, P441, DOI 10.1146/annurev.energy.30.050504.144511; Folke C, 2002, AMBIO, V31, P437, DOI 10.1639/0044-7447(2002)031[0437:RASDBA]2.0.CO;2; Fritsch O, 2012, REFLEXIVE GOVERNANCE; Garmestani, 2015, ADAPTIVE MANAGEMENT, P147, DOI [10.1007/978-94-017-9682-8_9, DOI 10.1007/978-94-017-9682-8_9]; Gohler D, 2014, TROP FOREST, V9, P333, DOI 10.1007/978-3-642-41404-6_12; Grese R, 2000, RESTORING NATURE PER; Guerry AD, 2015, P NATL ACAD SCI USA, V112, P7348, DOI 10.1073/pnas.1503751112; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Holling C.S., 1978, ADAPTIVE ENV ASSESSM; Hurlbert M, 2015, ENVIRON SCI POLICY, V50, P100, DOI 10.1016/j.envsci.2015.01.011; Innes JE, 1999, J AM PLANN ASSOC, V65, P412, DOI 10.1080/01944369908976071; Kline R., 2016, PRINCIPLES PRACTICE; Koontz TM, 2005, POLICY STUD J, V33, P459, DOI 10.1111/j.1541-0072.2005.00125.x; Koontz TM, 2006, PUBLIC ADMIN REV, V66, P111, DOI 10.1111/j.1540-6210.2006.00671.x; Leach WD, 2005, SWIMMING UPSTREAM CO, P233; Lebel L, 2006, ECOL SOC, V11; Lockwood M, 2010, SOC NATUR RESOUR, V23, P986, DOI 10.1080/08941920802178214; Lubell M, 2004, J POLICY ANAL MANAG, V23, P549, DOI 10.1002/pam.20026; Lubell M, 2015, CURR OPIN ENV SUST, V12, P41, DOI 10.1016/j.cosust.2014.08.011; Lubell M, 2013, POLICY STUD J, V41, P537, DOI 10.1111/psj.12028; Luyet V, 2012, J ENVIRON MANAGE, V111, P213, DOI 10.1016/j.jenvman.2012.06.026; Mandarano LA, 2008, J PLAN EDUC RES, V27, P456, DOI 10.1177/0739456X08315888; McAllister RRJ, 2015, CURR OPIN ENV SUST, V12, P86, DOI 10.1016/j.cosust.2015.01.001; Muro M, 2008, J ENVIRON PLANN MAN, V51, P325, DOI 10.1080/09640560801977190; Muthen LK, 2013, MPLUS USERS GUIDE; Newig J., 2009, Environmental Policy and Governance, V19, P197, DOI 10.1002/eet.509; Plummer R, 2014, BEIJER DISCUSSION PA, V245; Plummer R, 2007, ECOL ECON, V61, P62, DOI 10.1016/j.ecolecon.2006.09.025; Plummer R, 2012, ECOL SOC, V17, DOI 10.5751/ES-04952-170311; Plummer R, 2009, ECOL SOC, V14; Prell C, 2010, ECOL SOC, V15; Pretty J, 2003, SCIENCE, V302, P1912, DOI 10.1126/science.1090847; Reed MS, 2008, BIOL CONSERV, V141, P2417, DOI 10.1016/j.biocon.2008.07.014; Rodela R, 2012, ECOL ECON, V77, P16, DOI 10.1016/j.ecolecon.2012.02.032; Ryan R.L., 2001, J ENVIRON PLANN MAN, V44, P629, DOI [10.1080/09640560120079948, DOI 10.1080/09640560120079948]; Rydin Y., 2000, LOCAL ENVIRON, V5, P153, DOI DOI 10.1080/13549830050009328; Sabatier P.A., 2005, SWIMMING UPSTREAM CO, P3; Sandstrom A, 2014, ENVIRON POLICY GOV, V24, P60, DOI 10.1002/eet.1633; Schultz L, 2015, P NATL ACAD SCI USA, V112, P7369, DOI 10.1073/pnas.1406493112; Schultz L, 2011, WORLD DEV, V39, P662, DOI 10.1016/j.worlddev.2010.09.014; Scott T, 2015, J POLICY ANAL MANAG, V34, P537, DOI 10.1002/pam.21836; Selin SW, 2000, SOC NATUR RESOUR, V13, P735, DOI 10.1080/089419200750035593; Steffen W, 2011, AMBIO, V40, P739, DOI 10.1007/s13280-011-0185-x; Stoll-Kleemann S, 2010, ENVIRON CONSERV, V37, P227, DOI 10.1017/S037689291000038X; UNESCO, 1996, UNESCO 1996 BIOSPH R; WALTERS CJ, 1990, ECOLOGY, V71, P2060, DOI 10.2307/1938620; Webler T, 2001, ENVIRON MANAGE, V27, P435; Wondolleck J. M., 2000, MAKING COLLABORATION	67	22	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185375	10.1371/journal.pone.0185375	http://dx.doi.org/10.1371/journal.pone.0185375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI0UK	28945792	Green Published, gold, Green Submitted			2022-12-27	WOS:000411645100053
J	Purvis, LAB; Clarke, WT; Biasiolli, L; Valkovic, L; Robson, MD; Rodgers, CT				Purvis, Lucian A. B.; Clarke, William T.; Biasiolli, Luca; Valkovic, Ladislav; Robson, Matthew D.; Rodgers, Christopher T.			OXSA: An open-source magnetic resonance spectroscopy analysis toolbox in MATLAB	PLOS ONE			English	Article							PRIOR-KNOWLEDGE; 7 T; QUANTITATION; SPECTRA; TIME; QUANTIFICATION; LCMODEL; AMARES; BOUNDS	In vivo magnetic resonance spectroscopy provides insight into metabolism in the human body. New acquisition protocols are often proposed to improve the quality or efficiency of data collection. Processing pipelines must also be developed to use these data optimally. Current fitting software is either targeted at general spectroscopy fitting, or for specific protocols. We therefore introduce the MATLAB-based OXford Spectroscopy Analysis (OXSA) toolbox to allow researchers to rapidly develop their own customised processing pipelines. The toolbox aims to simplify development by: being easy to install and use; seamlessly importing Siemens Digital Imaging and Communications in Medicine (DICOM) standard data; allowing visualisation of spectroscopy data; offering a robust fitting routine; flexibly specifying prior knowledge when fitting; and allowing batch processing of spectra. This article demonstrates how each of these criteria have been fulfilled, and gives technical details about the implementation in MATLAB. The code is freely available to download from https://github.com/oxsatoolbox/oxsa.	[Purvis, Lucian A. B.; Clarke, William T.; Biasiolli, Luca; Valkovic, Ladislav; Robson, Matthew D.; Rodgers, Christopher T.] Univ Oxford, John Radcliffe Hosp, Oxford Ctr Clin Magnet Resonance Res OCMR, Oxford, England; [Valkovic, Ladislav] Slovak Acad Sci, Inst Measurement Sci, Dept Imaging Methods, Bratislava, Slovakia	University of Oxford; Slovak Academy of Sciences; Institute of Measurement Science, SAS	Purvis, LAB (corresponding author), Univ Oxford, John Radcliffe Hosp, Oxford Ctr Clin Magnet Resonance Res OCMR, Oxford, England.	lucian.purvis@cardiov.ox.ac.uk	Rodgers, Christopher T./AAD-3344-2019; Valkovič, Ladislav/J-5731-2019	Rodgers, Christopher T./0000-0003-1275-1197; Valkovič, Ladislav/0000-0003-2567-3642; Biasiolli, Luca/0000-0002-0452-8756	Sir Henry Dale Fellowship from the Wellcome Trust; Royal Society [098436/Z/12/Z]; Medical Research Council (UK); Medical Research Council [1515231] Funding Source: researchfish	Sir Henry Dale Fellowship from the Wellcome Trust; Royal Society(Royal Society of London); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by a Sir Henry Dale Fellowship from the Wellcome Trust and the Royal Society (Grant Number 098436/Z/12/Z) to CTR. LP has a DPhil studentship from the Medical Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funded by a Sir Henry Dale Fellowship from the Wellcome Trust and the Royal Society (Grant Number 098436/Z/12/Z). LP has a DPhil studentship from the Medical Research Council (UK).	CADY EB, 1991, J MAGN RESON, V91, P637, DOI 10.1016/0022-2364(91)90393-8; Cavassila S, 2001, NMR BIOMED, V14, P278, DOI 10.1002/nbm.701; Chmelik M, 2014, NMR BIOMED, V27, P478, DOI 10.1002/nbm.3084; Clarke WT, 2017, MAGN RESON MED, V78, P20, DOI 10.1002/mrm.26357; Clarke WT, 2016, MAGN RESON MED, V76, P1047, DOI 10.1002/mrm.26005; Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023; De Graaf RA, 2007, IN VIVO NMR SPECTROS; Kanowski M, 2004, MAGNET RESON MED, V51, P904, DOI 10.1002/mrm.20063; Lanz B, 2013, MAGN RESON MED, V69, P1512, DOI 10.1002/mrm.24406; Poullet JB, 2008, J MAGN RESON, V195, P134, DOI 10.1016/j.jmr.2008.09.005; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Purvis LAB, 2017, MAGNETIC RESONANCE M; Rodgers CT, 2014, MAGN RESON MED, V72, P304, DOI 10.1002/mrm.24922; Schar M, 2010, MAGN RESON MED, V63, P1493, DOI 10.1002/mrm.22347; Schulte RF, 2006, NMR BIOMED, V19, P255, DOI 10.1002/nbm.1026; Stefan D, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/10/104035; Stoll VM, 2016, RADIOLOGY, V281, P409, DOI 10.1148/radiol.2016152629; Valkovic L, 2016, NMR BIOMED, V29, P1825, DOI 10.1002/nbm.3662; Valkovic L, 2014, MAGN RESON MED, V72, P1509, DOI 10.1002/mrm.25058; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wilson M, 2011, MAGN RESON MED, V65, P1, DOI 10.1002/mrm.22579; Zeilinger G, 2006, DCM4CHE OPEN SOURCE	22	49	49	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185356	10.1371/journal.pone.0185356	http://dx.doi.org/10.1371/journal.pone.0185356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938003	gold, Green Published			2022-12-27	WOS:000411524700027
J	Altschul, D; Jensen, G; Terrace, H				Altschul, Drew; Jensen, Greg; Terrace, Herbert			Perceptual category learning of photographic and painterly stimuli in rhesus macaques (Macaca mulatta) and humans	PLOS ONE			English	Article							GORILLA-GORILLA-GORILLA; VISUAL RECOGNITION; EXECUTIVE CONTROL; NATURAL CONCEPTS; TOP-DOWN; CATEGORIZATION; MONKEYS; PIGEONS; RESEMBLANCE; IMAGES	Humans are highly adept at categorizing visual stimuli, but studies of human categorization are typically validated by verbal reports. This makes it difficult to perform comparative studies of categorization using non-human animals. Interpretation of comparative studies is further complicated by the possibility that animal performance may merely reflect reinforcement learning, whereby discrete features act as discriminative cues for categorization. To assess and compare how humans and monkeys classified visual stimuli, we trained 7 rhesus macaques and 41 human volunteers to respond, in a specific order, to four simultaneously presented stimuli at a time, each belonging to a different perceptual category. These exemplars were drawn at random from large banks of images, such that the stimuli presented changed on every trial. Subjects nevertheless identified and ordered these changing stimuli correctly. Three monkeys learned to order naturalistic photographs; four others, close-up sections of paintings with distinctive styles. Humans learned to order both types of stimuli. All subjects classified stimuli at levels substantially greater than that predicted by chance or by feature-driven learning alone, even when stimuli changed on every trial. However, humans more closely resembled monkeys when classifying the more abstract painting stimuli than the photographic stimuli. This points to a common classification strategy in both species, one that humans can rely on in the absence of linguistic labels for categories.	[Altschul, Drew] Univ Edinburgh, Dept Psychol, 7 George Sq, Edinburgh, Midlothian, Scotland; [Altschul, Drew] Scottish Primate Res Grp, Edinburgh, Midlothian, Scotland; [Altschul, Drew] Ctr Cognit Ageing & Cognit Epidemiol, 7 George Sq, Edinburgh, Midlothian, Scotland; [Jensen, Greg; Terrace, Herbert] Columbia Univ, Dept Psychol, New York, NY 10027 USA	University of Edinburgh; Columbia University	Altschul, D (corresponding author), Univ Edinburgh, Dept Psychol, 7 George Sq, Edinburgh, Midlothian, Scotland.; Altschul, D (corresponding author), Scottish Primate Res Grp, Edinburgh, Midlothian, Scotland.; Altschul, D (corresponding author), Ctr Cognit Ageing & Cognit Epidemiol, 7 George Sq, Edinburgh, Midlothian, Scotland.; Terrace, H (corresponding author), Columbia Univ, Dept Psychol, New York, NY 10027 USA.	dmaltschul@gmail.com; terrace@columbia.edu		Jensen, Greg/0000-0001-5050-4360	US National Institute of Health [5R01MH081153-04]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081153] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by US National Institute of Health, grant 5R01MH081153-04 awarded to HST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avdagic E, 2014, ANIM COGN, V17, P619, DOI 10.1007/s10071-013-0693-0; BHATT RS, 1988, J EXP PSYCHOL ANIM B, V14, P219, DOI 10.1037/0097-7403.14.3.219; Brosnan SF, 2013, EVOLUTIONARY PSYCHOL; Cadieu CF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003963; Carpenter B., 2015, ARXIV PREPRINT ARXIV; Chater N., 1994, MIND LANG, V9, P209, DOI [10.1111/j.1468-0017.1994.tb00224.x, DOI 10.1111/J.1468-0017.1994.TB00224.X]; Close J, 2010, MAKING HUMAN CONCEPT, P29; Couchman JJ, 2010, J EXP PSYCHOL ANIM B, V36, P172, DOI 10.1037/a0016748; Fabre-Thorpe M, 1998, NEUROREPORT, V9, P303, DOI 10.1097/00001756-199801260-00023; Fagot J, 2009, ANIM COGN, V12, P369, DOI 10.1007/s10071-008-0196-6; Fize D, 2011, P NATL ACAD SCI USA, V108, P7635, DOI 10.1073/pnas.1016213108; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; Goldstone RL, 2003, HDB PSYCHOL, V4, P597, DOI DOI 10.1002/0471264385.WEI0422; Grill-Spector K, 2005, PSYCHOL SCI, V16, P152, DOI 10.1111/j.0956-7976.2005.00796.x; Hampton JA, 2010, CONCEPTS HUMAN ADULT, V14; Heitz RP, 2012, NEURON, V76, P616, DOI 10.1016/j.neuron.2012.08.030; HERRNSTEIN RJ, 1976, J EXP PSYCHOL ANIM B, V2, P285, DOI 10.1037/0097-7403.2.4.285; HERRNSTEIN RJ, 1990, COGNITION, V37, P133, DOI 10.1016/0010-0277(90)90021-B; Huber L, 2000, PICTURE PERCEPTION A, P219; Ikkatai Y, 2011, ANIM COGN, V14, P227, DOI 10.1007/s10071-010-0356-3; Jensen G, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00168; Jensen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070285; Jitsumori M, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P269; JITSUMORI M, 1991, PRIMATES, V32, P473, DOI 10.1007/BF02381938; Katz JS, 2007, COMP COGN BEHAV REV, V2, P79, DOI 10.3819/ccbr.2008.20005; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; LEA SEG, 1984, ANIMAL COGNITION, P263; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Lu Y, 2015, ARXIV150908379; Marsh HL, 2008, ANIM COGN, V11, P569, DOI 10.1007/s10071-008-0148-1; Matsukawa A, 2004, BEHAV PROCESS, V65, P25, DOI 10.1016/S0376-6357(03)00147-5; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; Miller EK, 2003, CURR OPIN NEUROBIOL, V13, P198, DOI 10.1016/S0959-4388(03)00037-0; Murphy G., 2004, BIG BOOK CONCEPTS; O'Hara S., 2011, ARXIV11013354; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Pezaris JS, 2007, P NATL ACAD SCI USA, V104, P7670, DOI 10.1073/pnas.0608563104; Reddy L, 2010, NEUROIMAGE, V50, P818, DOI 10.1016/j.neuroimage.2009.11.084; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; ROBERTS WA, 1988, J EXP PSYCHOL ANIM B, V14, P247, DOI 10.1037/0097-7403.14.3.247; ROBERTS WA, 1996, ADV PSYCHOL, P35; SCHRIER AM, 1984, J EXP PSYCHOL ANIM B, V10, P564, DOI 10.1037/0097-7403.10.4.564; SCHRIER AM, 1987, J EXP PSYCHOL ANIM B, V13, P136; Sigala N., 2009, OPEN NEUROSCIENCE J, V3; Smith JD, 2013, COGNITION, V129, P598, DOI 10.1016/j.cognition.2013.08.001; Sovrano VA, 2015, ANIM COGN, V18, P533, DOI 10.1007/s10071-014-0821-5; Srihasam K, 2014, NAT NEUROSCI, V17, P1776, DOI 10.1038/nn.3855; Stoet G, 2003, NEUROPSYCHOLOGIA, V41, P1357, DOI 10.1016/S0028-3932(03)00048-4; Tanner N, J NEUROSCIE IN PRESS; Terrace HS, 2005, TRENDS COGN SCI, V9, P202, DOI 10.1016/j.tics.2005.02.003; TERRACE HS, 1984, QUANTITATIVE ANAL BE, P115; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; Vonk J, 2002, J EXP ANAL BEHAV, V78, P315, DOI 10.1901/jeab.2002.78-315; Vonk J, 2013, PEERJ, V1, DOI 10.7717/peerj.158; Wasserman EA, 2015, COGNITION, V136, P99, DOI 10.1016/j.cognition.2014.11.020; Watanabe S, 2001, Anim Cogn, V4, P147, DOI 10.1007/s100710100112; Watanabe S., 2013, PLOS ONE, V8; Wolfe JM, 2003, J EXP PSYCHOL HUMAN, V29, P483, DOI 10.1037/0096-1523.29.2.483; Wright AA, 2010, LEARN MOTIV, V41, P273, DOI 10.1016/j.lmot.2010.08.004; Zentall TR, 2008, COMP COGN BEHAV REV, V3, P13, DOI 10.3819/ccbr.2008.30002	62	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185576	10.1371/journal.pone.0185576	http://dx.doi.org/10.1371/journal.pone.0185576			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MG	28961270	gold, Green Published, Green Submitted			2022-12-27	WOS:000412027700024
J	Cordioli, RL; Costa, ELV; Azevedo, LCP; Gomes, S; Amato, MBP; Park, M				Cordioli, Ricardo Luiz; Vieira Costa, Eduardo Leite; Pontes Azevedo, Luciano Cesar; Gomes, Susimeire; Passos Amato, Marcelo Britto; Park, Marcelo			Physiologic effects of alveolar recruitment and inspiratory pauses during moderately-high-frequency ventilation delivered by a conventional ventilator in a severe lung injury model	PLOS ONE			English	Article							END-EXPIRATORY PRESSURE; CO2 ELIMINATION; OSCILLATORY VENTILATION; MECHANICAL VENTILATION; POSITIVE-PRESSURE; TIDAL VOLUME; MORTALITY; PULMONARY; ADULTS	Background and aims To investigate whether performing alveolar recruitment or adding inspiratory pauses could promote physiologic benefits (VT) during moderately-high-frequency positive pressure ventilation (MHFPPV) delivered by a conventional ventilator in a porcine model of severe acute respiratory distress syndrome (ARDS). Methods Prospective experimental laboratory study with eight pigs. Induction of acute lung injury with sequential pulmonary lavages and injurious ventilation was initially performed. Then, animals were ventilated on a conventional mechanical ventilator with a respiratory rate (RR) = 60 breaths/minute and PEEP titrated according to ARDS Network table. The first two steps consisted of a randomized order of inspiratory pauses of 10 and 30% of inspiratory time. In final step, we removed the inspiratory pause and titrated PEEP, after lung recruitment, with the aid of electrical impedance tomography. At each step, PaCO2 was allowed to stabilize between 57-63 mmHg for 30 minutes. Results The step with RR of 60 after lung recruitment had the highest PEEP when compared with all other steps (17 [16,19] vs 14 [10, 17]cmH(2)O), but had lower driving pressures (13 [13,11] vs 16 [14, 17]cmH(2)O), higher P/F ratios (212 [191,243] vs 141 [105, 184] mmHg), lower shunt (23 [20, 23] vs 32 [27, 49]%), lower dead space ventilation (10 [0, 15] vs 30 [20, 37]%), and a more homogeneous alveolar ventilation distribution. There were no detrimental effects in terms of lung mechanics, hemodynamics, or gas exchange. Neither the addition of inspiratory pauses or the alveolar recruitment maneuver followed by decremental PEEP titration resulted in further reductions in VT. Conclusions During MHFPPV set with RR of 60 bpm delivered by a conventional ventilator in severe ARDS swine model, neither the inspiratory pauses or PEEP titration after recruitment maneuver allowed reduction of VT significantly, however the last strategy decreased driving pressures and improved both shunt and dead space.	[Cordioli, Ricardo Luiz; Vieira Costa, Eduardo Leite; Pontes Azevedo, Luciano Cesar; Park, Marcelo] Hosp Sino Libanes, Res & Educ Inst, Sao Paulo, Brazil; [Cordioli, Ricardo Luiz; Vieira Costa, Eduardo Leite; Gomes, Susimeire; Passos Amato, Marcelo Britto] Univ Sao Paulo, Heart Inst Incor, Pulm Div, Cardiopulm Dept, Sao Paulo, Brazil; [Cordioli, Ricardo Luiz] Hosp Israelite Albert Einstein, Intens Care Unit, Sao Paulo, Brazil; [Cordioli, Ricardo Luiz] Hosp Alemao Oswaldo Cruz, Intens Care Unit, Sao Paulo, Brazil; [Pontes Azevedo, Luciano Cesar; Park, Marcelo] Univ Sao Paulo, Emergency Med Discipline, Sao Paulo, Brazil	Hospital Sirio Libanes; Universidade de Sao Paulo; Hospital Israelita Albert Einstein; Universidade de Sao Paulo	Cordioli, RL (corresponding author), Hosp Sino Libanes, Res & Educ Inst, Sao Paulo, Brazil.; Cordioli, RL (corresponding author), Univ Sao Paulo, Heart Inst Incor, Pulm Div, Cardiopulm Dept, Sao Paulo, Brazil.; Cordioli, RL (corresponding author), Hosp Israelite Albert Einstein, Intens Care Unit, Sao Paulo, Brazil.; Cordioli, RL (corresponding author), Hosp Alemao Oswaldo Cruz, Intens Care Unit, Sao Paulo, Brazil.	rlcordioli@gmail.com	Costa, Eduardo/K-5841-2012; amato, Marcelo Britto Passo/L-5001-2016; Azevedo, Luciano CP/H-2652-2012	Costa, Eduardo/0000-0002-6941-3626; amato, Marcelo Britto Passo/0000-0003-3525-8282; Azevedo, Luciano CP/0000-0001-6759-3910	Research and Education Institute, Hospital Sirio-Libanes, Sao Paulo Brazil; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Sao Paulo, Brazil	Research and Education Institute, Hospital Sirio-Libanes, Sao Paulo Brazil; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors are grateful to the Research and Education Institute, Hospital Sirio-Libanes, Sao Paulo Brazil and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Sao Paulo, Brazil for the Grant offered to the study development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; [Anonymous], 1980, ANESTH ANALG, V59, P585; Astrom E, 2008, INTENS CARE MED, V34, P377, DOI 10.1007/s00134-007-0840-7; BARZILAY E, 1987, CRIT CARE MED, V15, P118, DOI 10.1097/00003246-198702000-00007; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Cordioli RL, 2014, INTENS CARE MED EXP, V2, DOI 10.1186/2197-425X-2-13; Devaquet J, 2008, J APPL PHYSIOL, V105, P1944, DOI 10.1152/japplphysiol.90682.2008; Fan E, 2008, AM J RESP CRIT CARE, V178, P1156, DOI 10.1164/rccm.200802-335OC; Ferguson ND, 2013, NEW ENGL J MED, V368, P795, DOI 10.1056/NEJMoa1215554; Gates KL, 2013, AM J RESP CELL MOL, V49, P821, DOI 10.1165/rcmb.2012-0487OC; Guervilly C, 2012, CRIT CARE MED, V40, P1539, DOI 10.1097/CCM.0b013e3182451b4a; Hager DN, 2007, CRIT CARE MED, V35, P1522, DOI 10.1097/01.CCM.0000266586.04676.55; Laffey JG, 2000, AM J RESP CRIT CARE, V162, P2287, DOI 10.1164/ajrccm.162.6.2003066; Marini JJ, 2014, RESP CARE, V59, P1808, DOI 10.4187/respcare.03687; Mercat A, 2001, CRIT CARE MED, V29, P40, DOI 10.1097/00003246-200101000-00011; Mireles-Cabodevila E, 2014, RESP CARE, V59, P1619, DOI 10.4187/respcare.03105; Phoenix SI, 2009, ANESTHESIOLOGY, V110, P1098, DOI 10.1097/ALN.0b013e31819fae06; Ranieri VM, 2000, JAMA-J AM MED ASSOC, V284, P43, DOI 10.1001/jama.284.1.43; Retamal J, 2013, CRIT CARE, V17, DOI 10.1186/cc12487; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; SLUTSKY AS, 1988, AM REV RESPIR DIS, V138, P175, DOI 10.1164/ajrccm/138.1.175; Tusman G, 2010, ANESTH ANALG, V111, P968, DOI 10.1213/ANE.0b013e3181f0c2da; Wang Wenfei, 2015, Intensive Care Med Exp, V3, P33, DOI 10.1186/s40635-015-0068-8; WEBB HH, 1974, AM REV RESPIR DIS, V110, P556; Young D, 2013, NEW ENGL J MED, V368, P806, DOI 10.1056/NEJMoa1215716	26	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185769	10.1371/journal.pone.0185769	http://dx.doi.org/10.1371/journal.pone.0185769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961282	Green Published, Green Submitted, gold			2022-12-27	WOS:000412027700036
J	Tang, L; Wang, MM; Liu, DH; Gong, MT; Ying, QL; Ye, SD				Tang, Ling; Wang, Manman; Liu, Dahai; Gong, Mengting; Ying, Qi-Long; Ye, Shoudong			Sp5 induces the expression of Nanog to maintain mouse embryonic stem cell self-renewal	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; PATHWAYS CONVERGE; WNT/BETA-CATENIN; GENE-EXPRESSION; RAT BLASTOCYSTS; ES CELLS; PLURIPOTENCY; DIFFERENTIATION; TARGET; STAT3	Activation of signal transducer and activator of transcription 3 (STAT3) by leukemia inhibitory factor (LIF) maintains mouse embryonic stem cell (mESC) self-renewal. Our previous study showed that trans-acting transcription factor 5 (Sp5), an LIF/STAT3 downstream target, supports mESC self-renewal. However, the mechanism by which Sp5 exerts these effects remains elusive. Here, we found that Nanog is a direct target of Sp5 and mediates the self-renewal-promoting effect of Sp5 in mESCs. Overexpression of Sp5 induced Nanog expression, while knockdown or knockout of Sp5 decreased the Nanog level. Moreover, chromatin immunoprecipitation (ChIP) assays showed that Sp5 directly bound to the Nanog promoter. Functional studies revealed that knockdown of Nanog eliminated the mESC self-renewal-promoting ability of Sp5. Finally, we demonstrated that the self-renewal-promoting function of Sp5 was largely dependent on its zinc finger domains. Taken together, our study provides unrecognized functions of Sp5 in mESCs and will expand our current understanding of the regulation of mESC pluripotency.	[Tang, Ling; Wang, Manman; Liu, Dahai; Gong, Mengting; Ye, Shoudong] Anhui Univ, Sch Life Sci, Ctr Stem Cell & Translat Med, Hefei, Anhui, Peoples R China; [Ying, Qi-Long] Univ Southern Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Stem Cell Biol & Regenerat Med, Keck Sch Med, Los Angeles, CA USA	Anhui University; University of Southern California	Ye, SD (corresponding author), Anhui Univ, Sch Life Sci, Ctr Stem Cell & Translat Med, Hefei, Anhui, Peoples R China.	shdye@126.com			Natural Science Foundation of China and Anhui Province [31501191, 31671535, 1508085SQC204]; Anhui University [J01006068, J01006045]	Natural Science Foundation of China and Anhui Province; Anhui University(Anhui University)	This work was supported by the Natural Science Foundation of China and Anhui Province [31501191, 31671535, 1508085SQC204] and the Scientific Research Startup Fund of Anhui University [J01006068, J01006045]. We aim to find out the molecular mechanism of embryonic self-renewal under these funding supports. Shoudong Ye, the corresponding author, is the leader of these fundings.	Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Aksoy I, 2007, STEM CELLS, V25, P2996, DOI 10.1634/stemcells.2007-0066; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Casanova EA, 2011, STEM CELLS, V29, P474, DOI 10.1002/stem.588; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen XL, 2012, INT J PHARMACEUT, V426, P248, DOI 10.1016/j.ijpharm.2012.01.043; ELBARADI T, 1991, MECH DEVELOP, V35, P155, DOI 10.1016/0925-4773(91)90015-X; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Harrison SM, 2000, DEV BIOL, V227, P358, DOI 10.1006/dbio.2000.9878; Hu Q, 2013, ONCOGENE, V32, P3933, DOI 10.1038/onc.2012.414; Ilias M, 2012, PLANTA MED, V78, P1690, DOI 10.1055/s-0032-1315213; Jeon H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150715; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kooistra SM, 2010, STEM CELLS, V28, P1703, DOI 10.1002/stem.497; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Newcomer LN, 2012, AM J MANAG CARE, V18; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Qiu DB, 2015, STEM CELL REP, V5, P314, DOI 10.1016/j.stemcr.2015.07.014; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Tai CI, 2013, J CELL SCI, V126, P1093, DOI 10.1242/jcs.118273; Treichel D, 2001, MECH DEVELOP, V101, P175, DOI 10.1016/S0925-4773(00)00544-X; Waaler J, 2011, CANCER RES, V71, P197, DOI 10.1158/0008-5472.CAN-10-1282; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; WIMMER EA, 1993, NATURE, V366, P690, DOI 10.1038/366690a0; Ye SD, 2016, J CELL SCI, V129, P269, DOI 10.1242/jcs.177675; Ye SD, 2013, EMBO J, V32, P2548, DOI 10.1038/emboj.2013.175; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958	43	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185714	10.1371/journal.pone.0185714	http://dx.doi.org/10.1371/journal.pone.0185714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961274	Green Published, gold, Green Submitted			2022-12-27	WOS:000412027700034
J	Yao, BZ; Yan, QQ; Zhang, MJ; Yang, YN				Yao, Baozhen; Yan, Qianqian; Zhang, Mengjie; Yang, Yunong			Improved artificial bee colony algorithm for vehicle routing problem with time windows	PLOS ONE			English	Article							SCHEDULING PROBLEMS; OPTIMIZATION; NETWORK; SOLVE	This paper investigates a well-known complex combinatorial problem known as the vehicle routing problem with time windows (VRPTW). Unlike the standard vehicle routing problem, each customer in the VRPTW is served within a given time constraint. This paper solves the VRPTW using an improved artificial bee colony (IABC) algorithm. The performance of this algorithm is improved by a local optimization based on a crossover operation and a scanning strategy. Finally, the effectiveness of the IABC is evaluated on some well-known benchmarks. The results demonstrate the power of IABC algorithm in solving the VRPTW.	[Yao, Baozhen; Yan, Qianqian; Zhang, Mengjie] Dalian Univ Technol, Automot Engn Coll, Dalian, Peoples R China; [Yang, Yunong] Dalian Maritime Univ, Transportat Management Coll, Dalian, Peoples R China	Dalian University of Technology; Dalian Maritime University	Yao, BZ (corresponding author), Dalian Univ Technol, Automot Engn Coll, Dalian, Peoples R China.	yaobaozhen@sohu.com	yao, Baozhen/I-9650-2014		National Natural Science Foundation of China [51578112];  [DUT16YQ104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This research was supported in National Natural Science Foundation of China 51578112 to BY and the fundamental research funds for the central universities (DUT16YQ104) to BY.	AlMuhaideb S, 2014, APPL INTELL, V41, P282, DOI 10.1007/s10489-014-0519-z; Backer BD, 2000, J HEURISTICS, V6, P501, DOI 10.1023/A:1009621410177; Chen BY, 2013, NETW SPAT ECON, V13, P123, DOI 10.1007/s11067-012-9175-1; Chen GY, 2015, APPL INTELL, V42, P276, DOI 10.1007/s10489-014-0593-2; Cuevas E, 2012, APPL INTELL, V37, P321, DOI 10.1007/s10489-011-0330-z; DANTZIG GB, 1959, MANAGE SCI, V6, P80, DOI 10.1287/mnsc.6.1.80; DESROCHERS M, 1992, OPER RES, V40, P342, DOI 10.1287/opre.40.2.342; Du WB, 2016, TRANSPORT RES E-LOG, V89, P108, DOI 10.1016/j.tre.2016.03.009; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; Du WB, 2017, CHINESE J AERONAUT, V30, P330, DOI 10.1016/j.cja.2016.12.001; Gambardella L. M., 1999, NEW IDEAS OPTIMIZATI, P63; Ghoseiri K, 2010, APPL SOFT COMPUT, V10, P1096, DOI 10.1016/j.asoc.2010.04.001; Guimarans D, 2011, ANN MATH ARTIF INTEL, V62, P299, DOI 10.1007/s10472-011-9261-y; Huo Y, 2015, APPL INTELL, V42, P661, DOI 10.1007/s10489-014-0617-y; Jih W., 2004, B COLL ENG NATL TAIW, V90, P89; Karaboga D, 2008, APPL SOFT COMPUT, V8, P687, DOI 10.1016/j.asoc.2007.05.007; Karaboga D., 2005, IDEA BASED HONEY BEE, DOI 10.1.1.714.4934; Karaboga D, 2007, LECT NOTES COMPUT SC, V4529, P789, DOI 10.1007/978-3-540-72950-1_77; Karaboga N, 2013, APPL INTELL, P1; Koudil M, 2007, APPL MATH COMPUT, V186, P1710, DOI 10.1016/j.amc.2006.08.166; Kumar N, 2012, INT J LATEST RES SCI, V1, P144; Laporte G, 2009, TRANSPORT SCI, V43, P408, DOI 10.1287/trsc.1090.0301; Lau HC, 2001, DIVERSIFICATION NEIG; LENSTRA JK, 1981, NETWORKS, V11, P221, DOI 10.1002/net.3230110211; Liu H, 2015, APPL INTELL, V43, P162, DOI 10.1007/s10489-014-0640-z; Misevicius A., 2005, Information Technology and Control, V34, P109; Ombuki B, 2006, APPL INTELL, V24, P17, DOI 10.1007/s10489-006-6926-z; Ozbakir L, 2010, APPL MATH COMPUT, V215, P3782, DOI 10.1016/j.amc.2009.11.018; Ozfirat PM, 2010, APPL ARTIF INTELL, V24, P277, DOI 10.1080/08839511003715196; Peng ZX, 2016, TRANSPORT RES E-LOG, V95, P76, DOI 10.1016/j.tre.2016.08.007; Potvin J.-Y., 1996, INFORMS Journal of Computing, V8, P158, DOI 10.1287/ijoc.8.2.158; Rochat Y., 1995, Journal of Heuristics, V1, P147, DOI 10.1007/BF02430370; Szeto WY, 2011, EUR J OPER RES, V215, P126, DOI 10.1016/j.ejor.2011.06.006; Taillard E, 1997, TRANSPORT SCI, V31, P170, DOI 10.1287/trsc.31.2.170; Tan KC, 2006, COMPUT OPTIM APPL, V34, P115, DOI 10.1007/s10589-005-3070-3; Tavares J, 2003, P 2003 ACM S APPL CO, P753, DOI [10.1145/952532.952679, DOI 10.1145/952532.952679]; Thangiah S. R., 1994, UKCIMSOR944; Vaira G, 2013, BALT J MOD COMPUT, V1, P161; Wainwright RL, 1993, MULTIPLE VEHICLE ROU, P452; Wen-Chyuan Chiang, 1997, INFORMS Journal on Computing, V9, P417, DOI 10.1287/ijoc.9.4.417; Yao BZ, 2017, COMPUT-AIDED CIV INF, V32, P154, DOI 10.1111/mice.12221; Yao BZ, 2014, TRANSPORT RES C-EMER, V43, P233, DOI 10.1016/j.trc.2013.12.005; Yao BZ, 2013, SIMUL-T SOC MOD SIM, V89, P762, DOI 10.1177/0037549713481503; Yu B, 2016, J TRANSP ENG, V142, DOI 10.1061/(ASCE)TE.1943-5436.0000816; Yu B, 2015, TRANSPORT RES C-EMER, V55, P310, DOI 10.1016/j.trc.2015.02.014; Yu B, 2013, J TRANSP GEOGR, V33, P62, DOI 10.1016/j.jtrangeo.2013.09.008; Zhang JL, 2016, EUR J OPER RES, V249, P144, DOI 10.1016/j.ejor.2015.08.050; Zhang JL, 2013, NETW SPAT ECON, V13, P471, DOI 10.1007/s11067-013-9190-x; Zhang P, 2014, APPL INTELL, V40, P427, DOI 10.1007/s10489-013-0471-3	50	12	12	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0181275	10.1371/journal.pone.0181275	http://dx.doi.org/10.1371/journal.pone.0181275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961252	gold, Green Submitted, Green Published			2022-12-27	WOS:000412027700001
J	Fujii, T; Reuben, JM; Huo, L; Fernandez, JRE; Gong, Y; Krupa, R; Suraneni, MV; Graf', RP; Lee, J; Greene, S; Rodriguez, A; Dugan, L; Louw, J; Lim, B; Barcenas, CH; Marx, AN; Tripathy, D; Wang, YP; Landers, M; Dittamore, R; Ueno, NT				Fujii, Takeo; Reuben, James M.; Huo, Lei; Fernandez, Jose Rodrigo Espinosa; Gong, Yun; Krupa, Rachel; Suraneni, Mahipal V.; Graf', Ryon P.; Lee, Jerry; Greene, Stephanie; Rodriguez, Angel; Dugan, Lyndsey; Louw, Jessica; Lim, Bora; Barcenas, Carlos H.; Marx, Angela N.; Tripathy, Debu; Wang, Yipeng; Landers, Mark; Dittamore, Ryan; Ueno, Naoto T.			Androgen receptor expression on circulating tumor cells in metastatic breast cancer	PLOS ONE			English	Article							RESISTANT PROSTATE-CANCER; PIK3CA MUTATIONAL STATUS; SURVIVAL; PROGRESSION; CHEMOTHERAPY; SUBTYPES; GROWTH; TRIAL	Purpose Androgen receptor (AR) is frequently detected in breast cancers, and AR-targeted therapies are showing activity in AR-positive (AR+) breast cancer. However, the role of AR in breast cancers is still not fully elucidated and the biology of AR in breast cancer remains incompletely understood. Circulating tumor cells (CTCs) can serve as prognostic and diagnostic tools, prompting us to measure AR protein expression and conduct genomic analyses on CTCs in patients with metastatic breast cancer. Methods Blood samples from patients with metastatic breast cancer were deposited on glass slides, subjected to nuclear staining with DAPI, and reacted with fluorescent-labeled antibodies to detect CD45, cytokeratin (CK), and biomarkers of interest (AR, estrogen receptor [ER], and HER2) on all nucleated cells. The stained slides were scanned and enumerated by non-enrichment- based non-biased approach independent of cell surface epithelial cell adhesion molecule (EpCAM) using the Epic Sciences CTC platform. Data were analyzed using established digital pathology algorithms. Results Of 68 patients, 51 (75%) had at least 1 CTC, and 49 of these 51 (96%) had hormone-receptor- positive (HR+)/HER2-negative primary tumors. AR was expressed in CK+ CTCs in 10 patients. Of these 10 patients, 3 also had ER expression in CK+ CTCs. Single cell genomic analysis of 78 CTCs from 1 of these 3 patients identified three distinct copy number patterns. AR+ cells had a lower frequency of chromosomal changes than ER+ and HER2+ cells. Conclusions CTC enumeration and analysis using no enrichment or selection provides a non-biased approach to detect AR expression and chromosomal aberrations in CTCs in patients with metastatic breast cancer. The heterogeneity of intrapatient AR expression in CTCs leads to the new hypothesis that patients with AR+ CTCs have heterogeneous disease with multiple drivers. Further studies are warranted to investigate the clinical applicability of AR+ CTCs and their heterogeneity.	[Fujii, Takeo; Fernandez, Jose Rodrigo Espinosa; Lim, Bora; Barcenas, Carlos H.; Marx, Angela N.; Tripathy, Debu; Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Huo, Lei; Gong, Yun] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Krupa, Rachel; Suraneni, Mahipal V.; Graf', Ryon P.; Lee, Jerry; Greene, Stephanie; Rodriguez, Angel; Dugan, Lyndsey; Louw, Jessica; Wang, Yipeng; Landers, Mark; Dittamore, Ryan] Epic Sci, Dept Translat Res, La Jolla, CA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ueno, NT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA.	nueno@mdanderson.org	Fujii, Takeo/GYJ-8304-2022; Fujii, Takeo/AAX-4717-2021; , 0000-0002-4182-6058/F-9978-2014	, 0000-0002-4182-6058/0000-0002-4182-6058; Espinosa Fernandez, Jose Rodrigo/0000-0002-0005-5672; Graf, Ryon/0000-0002-8065-4148	Morgan Welch Inflammatory Breast Cancer Research Program; State of Texas Rare and Aggressive Breast Cancer Research Program; MD Anderson Cancer Center's Cancer Center Support Grant from the National Cancer Institute [CA016672]; Epic Sciences	Morgan Welch Inflammatory Breast Cancer Research Program; State of Texas Rare and Aggressive Breast Cancer Research Program; MD Anderson Cancer Center's Cancer Center Support Grant from the National Cancer Institute; Epic Sciences	This study was funded by the Morgan Welch Inflammatory Breast Cancer Research Program; a grant from the State of Texas Rare and Aggressive Breast Cancer Research Program; MD Anderson Cancer Center's Cancer Center Support Grant from the National Cancer Institute, CA016672, which supports the Biostatistics Shared Resource; and Epic Sciences. The Morgan Welch Inflammatory Breast Cancer Research Program and the National Cancer Institute had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Epic Sciences provided support in the form of salaries for authors RK, MVS, RPG, JLee, SG, AR, LD, JLouw, YW, ML, and RD but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Epic Sciences employees contributed to study design (RD), data collection and analysis (RK, MVS, RPG, JLee, SG, AR, LD, JLouw, YW, ML, and RD), decision to publish (RD), and preparation of the manuscript (RK, MVS, RPG, JLee, SG, AR, LD, JLouw, YW, ML, and RD).	Abreu-Martin MT, 1999, MOL CELL BIOL, V19, P5143; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Anantharaman A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2758-3; Budd GT, 2006, CLIN CANCER RES, V12, P6403, DOI 10.1158/1078-0432.CCR-05-1769; Chang C, 2014, ONCOGENE, V33, P3225, DOI 10.1038/onc.2013.274; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Collins LC, 2011, MODERN PATHOL, V24, P924, DOI 10.1038/modpathol.2011.54; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; De Amicis F, 2010, BREAST CANCER RES TR, V121, P1, DOI 10.1007/s10549-009-0436-8; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Elebro K, 2015, CLIN CANCER RES, V21, P3640, DOI 10.1158/1078-0432.CCR-14-2564; Fehm T, 2010, BREAST CANCER RES TR, V124, P403, DOI 10.1007/s10549-010-1163-x; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Giuliano M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2907; Graf RP, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-1740; Greene SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165089; Gucalp A, 2013, CLIN CANCER RES, V19, P5505, DOI 10.1158/1078-0432.CCR-12-3327; Guiu S, 2015, FUTURE ONCOL, V11, P2283, DOI 10.2217/fon.15.102; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Hilborn E, 2016, BRIT J CANCER, V114, P248, DOI 10.1038/bjc.2015.464; Hu R, 2011, CLIN CANCER RES, V17, P1867, DOI 10.1158/1078-0432.CCR-10-2021; Keilty D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081740; Kono M, 2017, JAMA ONCOLOGY; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lianidou ES, 2013, BRIT J CANCER, V108, P2426, DOI 10.1038/bjc.2013.265; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Lu D, 2015, AM ASS CANC RES AACR; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Markou A, 2014, CLIN CANCER RES, V20, P5823, DOI 10.1158/1078-0432.CCR-14-0149; Marrinucci D, 2010, J ONCOL, V2010, P1, DOI DOI 10.1016/S1470-2045(07)70140-7; Marrinucci D, 2007, HUM PATHOL, V38, P514, DOI 10.1016/j.humpath.2006.08.027; Marrinucci D, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016003; Masuda H, 2013, CLIN CANCER RES, V19, P5533, DOI 10.1158/1078-0432.CCR-13-0799; McDaniel AS, 2016, BJU INT; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P190, DOI 10.1038/nrclinonc.2009.23; Parker JS, 2015 ASCO ANN M CHIC; Pestrin M, 2015, MOL ONCOL, V9, P749, DOI 10.1016/j.molonc.2014.12.001; Peters AA, 2009, CANCER RES, V69, P6131, DOI 10.1158/0008-5472.CAN-09-0452; Plaks V, 2013, SCIENCE, V341, P1186, DOI 10.1126/science.1235226; Punnoose EA, 2015, BRIT J CANCER, V113, P1225, DOI 10.1038/bjc.2015.332; Reyes EE, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0313-z; Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125; Scher H. I., 2016, ASCO 2016 GEN CANC S; Scher HI, 2016, JAMA ONCOL, V2, P1441, DOI 10.1001/jamaoncol.2016.1828; Smerage JB, 2014, J CLIN ONCOL, V32, P3483, DOI 10.1200/JCO.2014.56.2561; Takagi K, 2010, ENDOCR-RELAT CANCER, V17, P415, DOI 10.1677/ERC-09-0257; Traina T, 2015 ASCO ANN M CHIC; Traish AM, 2009, BRIT J CANCER, V101, P1949, DOI 10.1038/sj.bjc.6605376; Tsang JYS, 2014, ANN SURG ONCOL, V21, P2218, DOI 10.1245/s10434-014-3629-2; Turner-Ivey B, 2014, NEOPLASIA, V16, P644, DOI 10.1016/j.neo.2014.07.007; Vera-Badillo FE, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt319; Werner Shannon L, 2015, J Circ Biomark, V4, P3, DOI 10.5772/60725; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984	54	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185231	10.1371/journal.pone.0185231	http://dx.doi.org/10.1371/journal.pone.0185231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957377	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200036
J	Shrestha, S; Kamel, F; Umbach, DM; Freeman, LEB; Koutros, S; Alavanja, M; Sandler, DP; Chen, HL				Shrestha, Srishti; Kamel, Freya; Umbach, David M.; Freeman, Laura E. Beane; Koutros, Stella; Alavanja, Michael; Sandler, Dale P.; Chen, Honglei			Nonmotor symptoms and Parkinson disease in United States farmers and spouses	PLOS ONE			English	Article							GENDER-DIFFERENCES; SEX-DIFFERENCES; RISK; PREVALENCE; MOTOR; DEPRESSION; IMPAIRMENT; DISORDERS; ANXIETY; ONSET	Objectives Few studies have evaluated the presence of multiple nonmotor symptoms (NMS) in relation to Parkinson disease (PD). Therefore, we examined cross-sectional associations between individual and multiple NMS and PD in the Agricultural Health Study. Methods 20,473 male farmers and 16,259 female spouses provided information on six NMS (reduced sense of smell, dream-enacting behavior, daytime sleepiness, infrequent bowel movement, depression, and anxiety) in the cohort's 2013-2015 follow-up survey. 191 men and 68 women reported physician-diagnosed PD. We estimated odds ratios (ORs) and 95% confidence intervals (CIs) using multivariable logistic regression models separately by sex. Results NMS were each associated with PD, with the strongest association for reduced sense of smell in men and dream-enacting behavior in women. The number of NMS showed a strong dose-response relationship with PD, particularly in men. ORs were 5.5 (95% CI 3.4-8.8) for one, 17 (95% CI 10.4-28.0) for two, and 53.4 (95% CI 33.2-86.1) for three or more NMS in men; the corresponding ORs were 4.6 (95% CI 2.3-9.5), 6.7 (95% CI 2.9-15.6), and 23.6 (95% CI 10.7-52.4) in women (PNMS-interaction-with-sex = 0.07). Conclusions The number of NMS was associated with PD in a dose-response manner and the association appeared stronger in men than in women. These findings should be further investigated in population-based prospective studies.	[Shrestha, Srishti; Kamel, Freya; Sandler, Dale P.; Chen, Honglei] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [Umbach, David M.] NIEHS, Biostat & Computat Biol Branch, POB 12233, Res Triangle Pk, NC 27709 USA; [Freeman, Laura E. Beane; Koutros, Stella; Alavanja, Michael] NCI, Occupat & Environm Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Chen, Honglei] Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Michigan State University; Michigan State University College of Human Medicine	Chen, HL (corresponding author), NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA.; Chen, HL (corresponding author), Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.	hchen@epi.msu.edu	Freeman, Laura E. Beane/C-4468-2015; Shrestha, Srishti/ABF-6248-2021; Koutros, Stella/W-5788-2019	Freeman, Laura E. Beane/0000-0003-1294-4124; Koutros, Stella/0000-0001-5294-5485; Chen, Honglei/0000-0003-3446-7779	Intramural NIH HHS [Z01 ES049030, Z01 ES049028, Z01 CP010119, Z01 ES101986] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIACP010119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049030] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adams-Carr KL, 2016, J NEUROL NEUROSUR PS, V87, P710, DOI 10.1136/jnnp-2015-311680; Adler CH, 2016, MOVEMENT DISORD, V31, P1114, DOI 10.1002/mds.26605; Alavanja MCR, 1996, ENVIRON HEALTH PERSP, V104, P362, DOI 10.2307/3432672; Berg D, 2015, MOVEMENT DISORD, V30, P1600, DOI 10.1002/mds.26431; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Chen HL, 2003, ARCH NEUROL-CHICAGO, V60, P1059, DOI 10.1001/archneur.60.8.1059; Chen HL, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/2047-9158-4-1; Chen HL, 2014, MOVEMENT DISORD, V29, P1316, DOI 10.1002/mds.25950; Claassen DO, 2010, NEUROLOGY, V75, P494, DOI 10.1212/WNL.0b013e3181ec7fac; Duncan GW, 2014, MOVEMENT DISORD, V29, P195, DOI 10.1002/mds.25664; Fang F, 2010, MOVEMENT DISORD, V25, P1157, DOI 10.1002/mds.23092; Gaenslen A, 2011, MOVEMENT DISORD, V26, P653, DOI 10.1002/mds.23499; Gao JJ, 2011, AM J EPIDEMIOL, V173, P1032, DOI 10.1093/aje/kwq478; Gao X, 2011, AM J EPIDEMIOL, V174, P546, DOI 10.1093/aje/kwr119; Gillies GE, 2014, FRONT NEUROENDOCRIN, V35, P370, DOI 10.1016/j.yfrne.2014.02.002; Guo XY, 2013, PARKINSONISM RELAT D, V19, P961, DOI 10.1016/j.parkreldis.2013.06.009; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; Huang XM, 2015, MOVEMENT DISORD, V30, P552, DOI 10.1002/mds.26152; Khoo TK, 2013, NEUROLOGY, V80, P276, DOI 10.1212/WNL.0b013e31827deb74; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Liu R, 2015, NEUROLOGY, V84, P2107, DOI 10.1212/WNL.0000000000001609; Martinez-Martin P, 2012, J NEUROL, V259, P1639, DOI 10.1007/s00415-011-6392-3; Mollenhauer B, 2013, NEUROLOGY, V81, P1226, DOI 10.1212/WNL.0b013e3182a6cbd5; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Nalls MA, 2015, LANCET NEUROL, V14, P1002, DOI 10.1016/S1474-4422(15)00178-7; Picillo M, 2016, PARKINSONISM RELAT D, V27, P89, DOI 10.1016/j.parkreldis.2016.04.001; Picillo M, 2014, PARKINSONISM RELAT D, V20, P850, DOI 10.1016/j.parkreldis.2014.04.023; Picillo M, 2013, J NEUROL, V260, P2849, DOI [10.1007/s00415-013-7085-x, 10.1007/s00415-013-6851-0]; Pont-Sunyer C, 2015, MOVEMENT DISORD, V30, P229, DOI 10.1002/mds.26077; Postuma RB, 2015, NEUROLOGY, V84, P1104, DOI 10.1212/WNL.0000000000001364; Postuma Ronald B, 2012, Mov Disord, V27, P913, DOI 10.1002/mds.25037; Postuma RB, 2012, MOVEMENT DISORD, V27, P617, DOI 10.1002/mds.24996; Ross GW, 2008, ANN NEUROL, V63, P167, DOI 10.1002/ana.21291; Ross G Webster, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS199, DOI 10.1016/S1353-8020(11)70062-1; Solla P, 2012, J NEUROL SCI, V323, P33, DOI 10.1016/j.jns.2012.07.026; Song Y, 2014, NEUROL SCI, V35, P1991, DOI 10.1007/s10072-014-1879-1; Szewczyk-Krolikowski K, 2014, PARKINSONISM RELAT D, V20, P99, DOI 10.1016/j.parkreldis.2013.09.025; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Weisskopf MG, 2003, MOVEMENT DISORD, V18, P646, DOI 10.1002/mds.10425	41	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185510	10.1371/journal.pone.0185510	http://dx.doi.org/10.1371/journal.pone.0185510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953962	gold, Green Published, Green Submitted			2022-12-27	WOS:000411980300072
J	Al-Janabi, H; Manca, A; Coast, J				Al-Janabi, Hareth; Manca, Andrea; Coast, Joanna			Predicting carer health effects for use in economic evaluation	PLOS ONE			English	Article							QUALITY-OF-LIFE; INFORMAL CARE; COST-EFFECTIVENESS; CHILDREN; SPILLOVER; DISEASE; ILLNESS; BURDEN; FAMILY; IMPACT	Background Illnesses and interventions can affect the health status of family carers in addition to patients. However economic evaluation studies rarely incorporate data on health status of carers. Objectives We investigated whether changes in carer health status could be 'predicted' from the health data of those they provide care to (patients), as a means of incorporating carer outcomes in economic evaluation. Methods We used a case study of the family impact of meningitis, with 497 carer-patient dyads surveyed at two points. We used regression models to analyse changes in carers' health status, to derive predictive algorithms based on variables relating to the patient. We evaluated the predictive accuracy of different models using standard model fit criteria. Results It was feasible to estimate models to predict changes in carers' health status. However, the predictions generated in an external testing sample were poorly correlated with the observed changes in individual carers' health status. When aggregated, predictions provided some indication of the observed health changes for groups of carers. Conclusions At present, a 'one-size-fits-all' predictive model of carer outcomes does not appear possible and further research aimed to identify predictors of carer's health status from (readily available) patient data is recommended. In the meanwhile, it may be better to encourage the 'targeted collection of carer data in primary research to enable carer outcomes to be better reflected in economic evaluation.	[Al-Janabi, Hareth] Univ Birmingham, Inst Appl Hlth Res, Hlth Econ Unit, Birmingham, W Midlands, England; [Manca, Andrea] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Manca, Andrea] Luxembourg Inst Hlth, Dept Populat Hlth, Luxembourg, Luxembourg; [Coast, Joanna] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Coast, Joanna] Univ Hosp Bristol NHS Fdn Trust, NIHR CLAHRC West, Bristol, Avon, England	University of Birmingham; University of York - UK; Luxembourg Institute of Health; University of Bristol; University of Bristol	Al-Janabi, H (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Hlth Econ Unit, Birmingham, W Midlands, England.	h.aljanabi@bham.ac.uk		Coast, Joanna/0000-0002-3537-5166; Al-Janabi, Hareth/0000-0002-3691-8310	MRC [G1002334] Funding Source: UKRI; Medical Research Council [G1002334] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Acaster S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-346; Al-Janabi H, 2016, HEALTH ECON, V25, P1529, DOI 10.1002/hec.3259; Al-Janabi H, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1651; Al-Janabi H, 2016, MED DECIS MAKING, V36, P176, DOI 10.1177/0272989X15605094; Al-Janabi H, 2011, PHARMACOECONOMICS, V29, P1015, DOI 10.2165/11593940-000000000-00000; Al-Janabi H, 2011, MED DECIS MAKING, V31, P458, DOI 10.1177/0272989X10381280; Al-Janabi H, 2010, INT J NURS STUD, V47, P984, DOI 10.1016/j.ijnurstu.2009.12.015; Alava MH, 2015, STATA J, V15, P737, DOI 10.1177/1536867X1501500307; Argimon JM, 2004, FAM PRACT, V21, P454, DOI 10.1093/fampra/cmh418; Basu A, 2012, MED DECIS MAKING, V32, P56, DOI 10.1177/0272989X11416988; Basu A, 2010, MED DECIS MAKING, V30, P355, DOI 10.1177/0272989X09349959; Bilcke J, 2009, MED DECIS MAKING, V29, P33, DOI 10.1177/0272989X08324955; Bobinac A, 2011, MED DECIS MAKING, V31, P292, DOI 10.1177/0272989X10374212; Bobinac A, 2010, J HEALTH ECON, V29, P549, DOI 10.1016/j.jhealeco.2010.05.003; Brouwer WBF, 2006, QUAL LIFE RES, V15, P1005, DOI 10.1007/s11136-005-5994-6; Brouwer WBF, 2005, HEALTH POLICY, V74, P85, DOI 10.1016/j.healthpol.2004.12.008; Brouwer WBF, 2003, HEALTH ECON, V12, P629, DOI 10.1002/hec.764; Brouwer WBF, 1999, INT J TECHNOL ASSESS, V15, P147, DOI 10.1017/S0266462399152346; Busschbach JJV, 1998, PHARMACOECONOMICS, V13, P21, DOI 10.2165/00019053-199813010-00003; Christensen H, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5725; Claxton K, 2010, 54 U YORK CTR HLTH E, P54; CLIPP EC, 1993, GERONTOLOGIST, V33, P534, DOI 10.1093/geront/33.4.534; Coast J, 2004, BRIT MED J, V329, P1233, DOI 10.1136/bmj.329.7476.1233; Coast J, 2008, SOC SCI MED, V67, P874, DOI 10.1016/j.socscimed.2008.05.015; Cohen CA, 2002, INT J GERIATR PSYCH, V17, P184, DOI 10.1002/gps.561; Cohen J.E., 1988, STAT POWER ANAL BEHA; Defenderfer EK, 2017, QUAL LIFE RES, V26, P1405, DOI 10.1007/s11136-016-1491-3; Devlin NJ, 2010, HEALTH ECON, V19, P886, DOI 10.1002/hec.1608; Dixon S, 2006, PHARMACOECONOMICS, V24, P43, DOI 10.2165/00019053-200624010-00004; Dujardin C, 2011, SOC SCI MED, V73, P1123, DOI 10.1016/j.socscimed.2011.07.016; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Fuchs VR, 2004, J HEALTH ECON, V23, P653, DOI 10.1016/j.jhealeco.2004.04.004; Gage H, 2006, CLIN REHABIL, V20, P232, DOI 10.1191/0269215506cr936oa; Goodrich K, 2012, VALUE HEALTH, V15, P975, DOI 10.1016/j.jval.2012.05.009; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hoefman RJ, 2013, PHARMACOECONOMICS, V31, P1105, DOI 10.1007/s40273-013-0104-z; Hughes SL, 1999, GERONTOLOGIST, V39, P534, DOI 10.1093/geront/39.5.534; JCVI, 2014, JCVI POS STAT US BEX; Jones C, 2014, QUALITATIVE EXPLORAT; JONES DA, 1992, AGE AGEING, V21, P421, DOI 10.1093/ageing/21.6.421; Kleijnen S, 2012, VALUE HEALTH, V15, P954, DOI 10.1016/j.jval.2012.04.010; Krol M, 2015, PHARMACOECONOMICS, V33, P123, DOI 10.1007/s40273-014-0218-y; Lavelle TA, 2014, APPL HEALTH ECON HEA, V12, P117, DOI 10.1007/s40258-014-0079-8; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; Netten A, 1990, APPROACH COSTING INF, P637; Neumann PJ, 1999, MED CARE, V37, P27, DOI 10.1097/00005650-199901000-00005; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Posnett J, 1996, HEALTH ECON, V5, P13, DOI 10.1002/(SICI)1099-1050(199601)5:1<13::AID-HEC182>3.0.CO;2-J; Prosser LA, 2015, MED DECIS MAKING, V35, P81, DOI 10.1177/0272989X14541328; Ratcliffe J, 2013, HEALTH SOC CARE COMM, V21, P35, DOI 10.1111/j.1365-2524.2012.01085.x; Rowen D, 2016, EUR J HEALTH ECON, V17, P733, DOI 10.1007/s10198-015-0718-5; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; SMITH K, 1994, HEALTH ECON, V3, P137, DOI 10.1002/hec.4730030303; Sogaard R, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004105; Tilford JM, 2005, QUAL LIFE RES, V14, P1087, DOI 10.1007/s11136-004-3305-2; Tooth L, 2008, QUAL LIFE RES, V17, P267, DOI 10.1007/s11136-007-9300-7; van den Berg B, 2005, HEALTH ECON, V14, P169, DOI 10.1002/hec.893; van den Berg B, 2014, J HEALTH ECON, V35, P123, DOI 10.1016/j.jhealeco.2014.01.008; van Exel NJA, 2004, CLIN REHABIL, V18, P203, DOI 10.1191/0269215504cr723oa; van Hout B, 2012, VALUE HEALTH, V15, P708, DOI 10.1016/j.jval.2012.02.008; Viner RM, 2012, LANCET NEUROL, V11, P774, DOI 10.1016/S1474-4422(12)70180-1; Wiseman V, 1997, HEALTH POLICY, V39, P43, DOI 10.1016/S0168-8510(96)00848-2; Wittenberg E, 2013, PHARMACOECONOMICS, V31, P489, DOI 10.1007/s40273-013-0040-y; Wittenberg E, 2013, MED DECIS MAKING, V33, P235, DOI 10.1177/0272989X12464434; Yamazaki S, 2005, QUAL LIFE RES, V14, P1079, DOI 10.1007/s11136-004-3288-z	66	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0184886	10.1371/journal.pone.0184886	http://dx.doi.org/10.1371/journal.pone.0184886			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI1DL	28949969	Green Published, Green Accepted, gold			2022-12-27	WOS:000411671000018
J	Kral, R; Osima, M; Borgen, TT; Vestgaard, R; Richardsen, E; Bjornerem, A				Kral, Rita; Osima, Marit; Borgen, Tove T.; Vestgaard, Roald; Richardsen, Elin; Bjornerem, Ashild			Increased cortical porosity and reduced cortical thickness of the proximal femur are associated with nonvertebral fracture independent of Fracture Risk Assessment Tool and Garvan estimates in postmenopausal women	PLOS ONE			English	Article							INDIVIDUALIZING 5-YEAR; BONE; PROBABILITY; AREA; FRAX; MEN	The Fracture Risk Assessment Tool (FRAX) and Garvan Calculator have improved the individual prediction of fracture risk. However, additional bone measurements that might enhance the predictive ability of these tools are the subject of research. There is increasing interest in cortical parameters, especially cortical porosity. Neither FRAX nor Garvan include measurements of cortical architecture, important for bone strength, and providing independent information beyond the conventional approaches. We tested the hypothesis that cortical parameters are associated with fracture risk, independent of FRAX and Garvan estimates. This nested case-control study included 211 postmenopausal women aged 54-94 years with nonvertebral fractures, and 232 controls from the Tromso Study in Norway. We assessed FRAX and Garvan 10-year risk estimates for fragility fracture, and quantified femoral subtrochanteric cortical porosity, thickness, and area from computed tomography images using StrAx1.0 software. Per standard deviation higher cortical porosity, thinner cortices, and smaller cortical area, the odds ratio (95% confidence interval) for fracture was 1.71 (1.38-2.11), 1.79 (1.44-2.23), and 1.52 (1.19-1.95), respectively. Cortical porosity and thickness, but not area, remained associated with fracture when adjusted for FRAX and Garvan estimates. Adding cortical porosity and thickness to FRAX or Garvan resulted in greater area under the receiver operating characteristic curves. When using cortical porosity (>80th percentile) or cortical thickness (<20th percentile) combined with FRAX (threshold >20%), 45.5% and 42.7% of fracture cases were identified, respectively. Using the same cutoffs for cortical porosity or thickness combined with Garvan (threshold >25%), 51.2% and 48.3% were identified, respectively. Specificity for all combinations ranged from 81.0-83.6%. Measurement of cortical porosity or thickness identified 20.4% and 17.5% additional fracture cases that, were unidentified using FRAX alone, and 16.6% and 13.7% fracture cases unidentified using Garvan alone. In conclusion, cortical parameters may help to improve identification of women at risk for fracture.and 48.3% were identified, respectively. Specificity for all combinations ranged from 81.0-83.6%. Measurement of cortical porosity or thickness identified 20.4% and 17.5% additional fracture cases that, were unidentified using FRAX alone, and 16.6% and 13.7% fracture cases unidentified using Garvan alone. In conclusion, cortical parameters may help to improve identification of women at risk for fracture.	[Kral, Rita; Bjornerem, Ashild] Univ Hosp North Norway, Dept Obstet & Gynaecol, Tromso, Norway; [Kral, Rita; Bjornerem, Ashild] UiT Arctic Univ Norway, Dept Clin Med, Tromso, Norway; [Osima, Marit] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway; [Osima, Marit] Univ Hosp North Norway, Dept Orthopaed Surg, Tromso, Norway; [Borgen, Tove T.] Hosp Drammen, Vestre Viken Hosp Trust, Dept Rheumatol, Drammen, Norway; [Vestgaard, Roald] Univ Hosp North Norway, Div Internal Med, Tromso, Norway; [Richardsen, Elin] UiT Arctic Univ Norway, Dept Med Biol, Tromso, Norway; [Richardsen, Elin] Univ Hosp North Norway, Dept Pathol, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Bjornerem, A (corresponding author), Univ Hosp North Norway, Dept Obstet & Gynaecol, Tromso, Norway.; Bjornerem, A (corresponding author), UiT Arctic Univ Norway, Dept Clin Med, Tromso, Norway.	ashild.bjornerem@uit.no			North Norwegian Health Authorities [5645, 9167, 9168, 10295, 12156]	North Norwegian Health Authorities	The North Norwegian Health Authorities funded the study (ID 5645, 9167, ID 9168, ID 10295, ID 12156) but they had no role in design and conduct of the study; in the collection, analyses, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Ahmed LA, 2015, OSTEOPOROSIS INT, V26, P2137, DOI 10.1007/s00198-015-3118-x; Ahmed LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107695; Bala Y, 2014, J BONE MINER RES, V29, P1356, DOI 10.1002/jbmr.2167; Bell KL, 1999, BONE, V24, P57, DOI 10.1016/S8756-3282(98)00143-4; Bjornerem A, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.77; Bolland MJ, 2011, J BONE MINER RES, V26, P420, DOI 10.1002/jbmr.215; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Hernlund E., 2013, ARCH OSTEOPOROS, V8; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2013, OSTEOPOROSIS INT, V24, P23, DOI 10.1007/s00198-012-2074-y; Leslie WD, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0145-0; McCloskey EV, 2016, CURR OPIN RHEUMATOL, V28, P433, DOI 10.1097/BOR.0000000000000304; McCloskey EV, 2015, CALCIFIED TISSUE INT, V96, P500, DOI 10.1007/s00223-015-9980-x; Nguyen ND, 2008, OSTEOPOROSIS INT, V19, P1431, DOI 10.1007/s00198-008-0588-0; Ohlsson C, 2017, J CLIN ENDOCR METAB, V102, P516, DOI 10.1210/jc.2016-3177; Peeters G, 2009, BEST PRACT RES CL RH, V23, P797, DOI 10.1016/j.berh.2009.09.004; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Sandhu SK, 2010, OSTEOPOROSIS INT, V21, P863, DOI 10.1007/s00198-009-1026-7; Shigdel R., 2016, THESIS; Shigdel R, 2016, J BONE MINER RES, V31, P758, DOI 10.1002/jbmr.2751; Shigdel R, 2015, BONE, V81, P1, DOI 10.1016/j.bone.2015.06.016; Siris ES, 2004, ARCH INTERN MED, V164, P1108, DOI 10.1001/archinte.164.10.1108; Sundh D, 2016, J INTERN MED, V280, P496, DOI 10.1111/joim.12514; Sundh D, 2015, J BONE MINER RES, V30, P1692, DOI 10.1002/jbmr.2509; van Geel TACM, 2014, MATURITAS, V77, P174, DOI 10.1016/j.maturitas.2013.10.021; van Geel TACM, 2011, ANN RHEUM DIS, V70, P92, DOI 10.1136/ard.2010.131813; Zebaze R, 2013, BONE, V54, P8, DOI 10.1016/j.bone.2013.01.007; Zebaze R, 2016, J BONE MINER RES, V31, P1827, DOI 10.1002/jbmr.2855; Zebaze R, 2015, J BONE MINER RES, V30, P24, DOI 10.1002/jbmr.2419; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	32	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185363	10.1371/journal.pone.0185363	http://dx.doi.org/10.1371/journal.pone.0185363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945789	Green Published, gold			2022-12-27	WOS:000411645100051
J	Bragazzi, NL; Alicino, C; Trucchi, C; Paganino, C; Barberis, I; Martini, M; Sticchi, L; Trinka, E; Brigo, F; Ansaldi, F; Icardi, G; Orsi, A				Bragazzi, Nicola Luigi; Alicino, Cristiano; Trucchi, Cecilia; Paganino, Chiara; Barberis, Ilaria; Martini, Mariano; Sticchi, Laura; Trinka, Eugen; Brigo, Francesco; Ansaldi, Filippo; Icardi, Giancarlo; Orsi, Andrea			Global reaction to the recent outbreaks of Zika virus: Insights from a Big Data analysis	PLOS ONE			English	Article							DIGITAL DISEASE DETECTION; EBOLA OUTBREAK; UNITED-STATES; WEB; BEHAVIOR; TWITTER; TRENDS	Objective The recent spreading of Zika virus represents an emerging global health threat. As such, it is attracting public interest worldwide, generating a great amount of related Internet searches and social media interactions. The aim of this research was to understand Zika-related digital behavior throughout the epidemic spreading and to assess its consistence with real-world epidemiological data, using a behavioral informatics and analytics approach. Methods In this study, the global web-interest and reaction to the recently occurred outbreaks of the Zika Virus were analyzed in terms of tweets and Google Trends (GT), Google News, You-Tube, and Wikipedia search queries. These data streams were mined from 1 st January 2004 to 31 st October 2016, with a focus on the period November 2015-October 2016. This analysis was complemented with the use of epidemiological data. Spearman's correlation was performed to correlate all Zika-related data. Moreover, a multivariate regression was performed using Zika-related search queries as a dependent variable, and epidemiological data, number of inhabitants in 2015 and Human Development Index as predictor variables. Results Overall 3,864,395 tweets, 284,903 accesses to Wikipedia pages dedicated to the Zika virus were analyzed during the study period. All web-data sources showed that the main spike of researches and interactions occurred in February 2016 with a second peak in August 2016. All novel data streams-related activities increased markedly during the epidemic period with respect to pre-epidemic period when no web activity was detected. Correlations between data from all these web platforms resulted very high and statistically significant. The countries in which web searches were particularly concentrated are mainly from Central and South Americas. The majority of queries concerned the symptoms of the Zika virus, its vector of transmission, and its possible effect to babies, including microcephaly. No statistically significant correlation was found between novel data streams and global real-world epidemiological data. At country level, a correlation between the digital interest towards the Zika virus and Zika incidence rate or microcephaly cases has been detected. Conclusions An increasing public interest and reaction to the current Zika virus outbreak was documented by all web-data sources and a similar pattern of web reactions has been detected. The public opinion seems to be particularly worried by the alert of teratogenicity of the Zika virus. Stakeholders and health authorities could usefully exploited these internet tools for collecting the concerns of public opinion and reply to them, disseminating key information.	[Bragazzi, Nicola Luigi; Alicino, Cristiano; Trucchi, Cecilia; Paganino, Chiara; Barberis, Ilaria; Martini, Mariano; Sticchi, Laura; Ansaldi, Filippo; Icardi, Giancarlo; Orsi, Andrea] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Sticchi, Laura; Icardi, Giancarlo; Orsi, Andrea] IRCCS, Osped Policlin San Martino, Teaching Hosp, Hyg Unit, Genoa, Italy; [Trinka, Eugen] Paracelsus Med Univ, Ctr Cognit Neurosci, Dept Neurol, Christian Doppler Klin, Salzburg, Austria; [Trinka, Eugen] UMIT Univ Hlth Sci Med Informat & Technol, Dept Publ Hlth Technol Assessment, Hall iT, Innsbruck, Austria; [Brigo, Francesco] Franz Tappeiner Hosp, Dept Neurol, Merano, Italy; [Brigo, Francesco] Univ Verona, Dept Neurol Biomed & Movement Sci, Verona, Italy	University of Genoa; Paracelsus Private Medical University; UMIT - Private University for Health Sciences, Medical Informatics & Technology GmbH; Ospedale Franz Tappeiner; University of Verona	Alicino, C (corresponding author), Univ Genoa, Dept Hlth Sci, Genoa, Italy.	cristiano.alicino@unige.it	Orsi, Andrea/AAC-7431-2022; Bragazzi, Nicola Luigi/G-1672-2011; PAN, ZEQIANG/X-6341-2018; Martini, Mariano/GXF-0253-2022; Brigo, Francesco/H-6513-2013	Orsi, Andrea/0000-0002-2433-9610; Bragazzi, Nicola Luigi/0000-0001-8409-868X; Martini, Mariano/0000-0001-5703-0858; Trinka, Eugen/0000-0002-5950-2692; Brigo, Francesco/0000-0003-0928-1577				Alicino C, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0090-9; Althouse BM, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0054-0; [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00014-3; Ayers John W, 2016, JMIR Public Health Surveill, V2, pe16, DOI 10.2196/publichealth.5304; Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505; Brown C, 2016, CAN MED ASSOC J, V188, pE34, DOI 10.1503/cmaj.109-5212; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1; Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253; Hossain L, 2016, EPIDEMIOL INFECT, V144, P2136, DOI 10.1017/S095026881600039X; Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367; Khattab A., 2016, 2016 IEEE Sensors Applications Symposium (SAS), P1, DOI 10.1109/SAS.2016.7479827; Lazard AJ, 2015, AM J INFECT CONTROL, V43, P1109, DOI 10.1016/j.ajic.2015.05.025; Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814; Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Segev E, 2016, PUBLIC UNDERST SCI; Sharma M, 2016, AM J INFECT CONTROL; Smallwood C., 2015, COMPLETE GUIDE USING; Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415; Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179; Valero N, 2015, INVEST CLIN, V56, P241; Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376; Wojda TR, 2015, J GLOB INFECT DIS, V7, P127, DOI 10.4103/0974-777X.170495; Wong R, 2017, J PUBLIC HEALTH MAN, V23, pE16, DOI 10.1097/PHH.0000000000000342; World Health Organization, 2016, ZIK VIR MICR GUILL B	33	37	38	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185263	10.1371/journal.pone.0185263	http://dx.doi.org/10.1371/journal.pone.0185263			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934352	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900134
J	Zheng, XY; Soroush, F; Long, J; Hall, ET; Adishesha, PK; Bhattacharya, S; Kiani, MF; Bhalla, V				Zheng, Xiaoyi; Soroush, Fariborz; Long, Jin; Hall, Evan T.; Adishesha, Puneeth K.; Bhattacharya, Sanchita; Kiani, Mohammad F.; Bhalla, Vivek			Murine glomerular transcriptome links endothelial cell-specific molecule-1 deficiency with susceptibility to diabetic nephropathy	PLOS ONE			English	Article							KIDNEY-DISEASE; CARDIOVASCULAR EVENTS; NATURAL-HISTORY; RENAL INJURY; INFLAMMATION; EXPRESSION; ABNORMALITIES; AMELIORATION; CYTOKINES; SURVIVAL	Diabetic nephropathy (DN) is the leading cause of kidney disease; however, there are no early biomarkers and no cure. Thus, there is a large unmet need to predict which individuals will develop nephropathy and to understand the molecular mechanisms that govern this susceptibility. We compared the glomerular transcriptome from mice with distinct susceptibilities to DN at four weeks after induction of diabetes, but before histologic injury, and identified differential regulation of genes that modulate inflammation. From these genes, we identified endothelial cell specific molecule-1 (Esm-1), as a glomerular-enriched determinant of resistance to DN. Glomerular Esm-1 mRNA and protein were lower in DN-susceptible, DBA/2, compared to DN-resistant, C57BL/6, mice. We demonstrated higher Esm-1 secretion from primary glomerular cultures of diabetic mice, and high glucose was sufficient to increase Esm-1 mRNA and protein secretion in both strains of mice. However, induction was significantly attenuated in DN-susceptible mice. Urine Esm-1 was also significantly higher only in DN-resistant mice. Moreover, using intravital microscopy and a biomimetic microfluidic assay, we showed that Esm-1 inhibited rolling and transmigration in a dose-dependent manner. For the first time we have uncovered glomerular-derived Esm-1 as a potential non-invasive biomarker of DN. Esm-1 inversely correlates with disease susceptibility and inhibits leukocyte infiltration, a critical factor in protecting the kidney from DN.	[Zheng, Xiaoyi; Long, Jin; Hall, Evan T.; Adishesha, Puneeth K.; Bhalla, Vivek] Stanford Univ, Dept Med, Div Nephrol, Sch Med, Stanford, CA 94305 USA; [Soroush, Fariborz; Kiani, Mohammad F.] Temple Univ, Dept Mech Engn, Coll Engn, Philadelphia, PA 19122 USA; [Bhattacharya, Sanchita] Univ Calif San Francisco, Inst Computat Hlth Sci, San Francisco, CA 94143 USA	Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of California System; University of California San Francisco	Bhalla, V (corresponding author), Stanford Univ, Dept Med, Div Nephrol, Sch Med, Stanford, CA 94305 USA.	vbhalla@stanford.edu	Soroush, Fariborz/O-1778-2019; Soroush, Fariborz/K-7873-2019	Soroush, Fariborz/0000-0003-2742-1684; Bhalla, Vivek/0000-0002-5420-9657; Hall, Evan/0000-0002-0305-7745	Larry L. Hillblom Foundation Postdoctoral Fellowship [2014-D-021-FEL]; National Institutes of Health Grant [1R01GM114359]; Shriners Hospitals for Children [86400]; National Institutes of Health, National Institute of Diabetes and Digestive Kidney Diseases - Pilot and Feasbility Grant; Diabetic Complications Consortium [3U24DK076169-08S4]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114359] Funding Source: NIH RePORTER	Larry L. Hillblom Foundation Postdoctoral Fellowship; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; National Institutes of Health, National Institute of Diabetes and Digestive Kidney Diseases - Pilot and Feasbility Grant; Diabetic Complications Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported Larry L. Hillblom Foundation Postdoctoral Fellowship (2014-D-021-FEL) to Xiaoyi Zheng; National Institutes of Health Grant (1R01GM114359) to Mohammad F. Kiani; The Shriners Hospitals for Children (86400); National Institutes of Health, National Institute of Diabetes and Digestive Kidney Diseases - Pilot and Feasbility Grant sponsored by the Diabetic Complications Consortium (3U24DK076169-08S4) to Vivek Bhalla; Holmgren Family Foundation Philanthropic gift for diabetes research in the Division of Nephrology, Department of Medicine, Stanford University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad AS, 2015, KIDNEY INT, V88, P722, DOI 10.1038/ki.2015.162; Bechard D, 2000, J VASC RES, V37, P417, DOI 10.1159/000025758; Bechard D, 2001, J IMMUNOL, V167, P3099, DOI 10.4049/jimmunol.167.6.3099; Brunskill EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012034; Chow FY, 2007, DIABETOLOGIA, V50, P471, DOI 10.1007/s00125-006-0497-8; Chow FY, 2005, J AM SOC NEPHROL, V16, P1711, DOI 10.1681/ASN.2004070612; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Cong R, 2006, BIOCHEM BIOPH RES CO, V346, P535, DOI 10.1016/j.bbrc.2006.05.153; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Guo M, 2005, J ANAT, V207, P813, DOI 10.1111/j.1469-7580.2005.00492.x; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Gurley SB, 2011, AM J PHYSIOL-RENAL, V298, pF788; Hodgin JB, 2013, DIABETES, V62, P299, DOI 10.2337/db11-1667; Huang JQ, 2009, ENDOCRINOLOGY, V150, P5557, DOI 10.1210/en.2009-0442; Huang WJ, 2015, CLIN ENDOCRINOL, V82, P229, DOI 10.1111/cen.12576; Janssen U, 1998, J AM SOC NEPHROL, V9, P1805; Ju W, 2016, PEDIAT NEPHROLOGY; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kim JH, 2004, KIDNEY INT, V66, P1826, DOI 10.1111/j.1523-1755.2004.00956.x; Kiyici S, 2006, ARCH MED RES, V37, P998, DOI 10.1016/j.arcmed.2006.06.002; Kosugi T, 2007, LAB INVEST, V87, P903, DOI 10.1038/labinvest.3700599; Kothary N, 2011, J AM ACAD DERMATOL, V65, P546, DOI 10.1016/j.jaad.2010.05.033; Kramer HJ, 2003, JAMA-J AM MED ASSOC, V289, P3273, DOI 10.1001/jama.289.24.3273; KROLEWSKI AS, 1985, AM J MED, V78, P785, DOI 10.1016/0002-9343(85)90284-0; Lamberti G, 2015, MICROVASC RES, V99, P19, DOI 10.1016/j.mvr.2015.02.004; Lamberti G, 2014, ANAL CHEM, V86, P8344, DOI 10.1021/ac5018716; Lassalle P, 1996, J BIOL CHEM, V271, P20458, DOI 10.1074/jbc.271.34.20458; Maezawa Y, 2015, J DIABETES INVEST, V6, P3, DOI 10.1111/jdi.12255; Mikkelsen ME, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.07.077; Moon JY, 2012, AM J NEPHROL, V35, P164, DOI 10.1159/000334928; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Nguyen D, 2006, NEPHROLOGY, V11, P226, DOI 10.1111/j.1440-1797.2006.00576.x; Okada S, 2003, DIABETES, V52, P2586, DOI 10.2337/diabetes.52.10.2586; OSTERBY R, 1992, DIABETOLOGIA, V35, P803, DOI 10.1007/BF00399925; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423; Qi ZH, 2005, DIABETES, V54, P2628, DOI 10.2337/diabetes.54.9.2628; Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506; Rodrigues KF, 2015, DIABETES-METAB RES, V31, P479, DOI 10.1002/dmrr.2639; Rossing P, 1996, BRIT MED J, V313, P779; Sanders JSF, 2011, SEMIN RESP CRIT CARE, V32, P328, DOI 10.1055/s-0031-1279829; Sharma K, 2003, AM J PHYSIOL-RENAL, V284, pF1138, DOI 10.1152/ajprenal.00315.2002; Soroush F, 2016, J LEUKOC BIOL; Sun Y, 2009, AM J NEPHROL, V29, P558, DOI 10.1159/000191469; Velez MG, 2012, NEPHROLOGY THERAPEUT, pS2; Verzola D, 2014, KIDNEY INT, V86, P1229, DOI 10.1038/ki.2014.116; Wang Y, 2012, J IMMUNOL, V188, P222, DOI 10.4049/jimmunol.1002958; Whiteside C, 2009, EXP DIABETES RES, DOI 10.1155/2009/910783; Wu XY, 2007, AM J PHYSIOL-RENAL, V293, pF1262, DOI 10.1152/ajprenal.00445.2006; Yilmaz MI, 2014, KIDNEY INT, V86, P1213, DOI 10.1038/ki.2014.227; You HN, 2013, AM J PHYSIOL-RENAL, V305, pF1719, DOI 10.1152/ajprenal.00141.2013; Zhang HY, 2008, AM J PHYSIOL-RENAL, V295, pF1071, DOI 10.1152/ajprenal.90208.2008; Ziyadeh FN, 2008, CURR DIABETES REV, V4, P39, DOI 10.2174/157339908783502370	57	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185250	10.1371/journal.pone.0185250	http://dx.doi.org/10.1371/journal.pone.0185250			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934365	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900133
J	Buffinton, CM; Benjamin, AK; Firment, AN; Moon, AM				Buffinton, Christine Miller; Benjamin, Alyssa K.; Firment, Ashley N.; Moon, Anne M.			Myocardial wall stiffening in a mouse model of persistent truncus arteriosus	PLOS ONE			English	Article							LEFT-HEART HYPOPLASIA; CHICK-EMBRYO; OUTFLOW TRACT; PIPETTE ASPIRATION; MECHANICAL-PROPERTIES; BLOOD-FLOW; TISSUE; MORPHOGENESIS; EXPRESSION; STRESS	Background Genetic and epigenetic programs regulate dramatic structural changes during cardiac morphogenesis. Concurrent biomechanical forces within the heart created by blood flow and pressure in turn drive downstream cellular, molecular and genetic responses. Thus, a genetic-morphogenetic-biomechanical feedback loop is continually operating to regulate heart development. During the evolution of a congenital heart defect, concomitant abnormalities in blood flow, hemodynamics, and patterns of mechanical loading would be predicted to change the output of this feedback loop, impacting not only the ultimate morphology of the defect, but potentially altering tissue-level biomechanical properties of structures that appear structurally normal. Aim The goal of this study was to determine if abnormal hemodynamics present during outflow tract formation and remodeling in a genetically engineered mouse model of persistent truncus arteriosus (PTA) causes tissue-level biomechanical abnormalities. Methods The passive stiffness of surface locations on the left ventricle (LV), right ventricle (RV), and outflow tract (OFT) was measured with a pipette aspiration technique in Fgf8; Isl1Cre conditional mutant embryonic mouse hearts and controls. Control and mutant experimental results were compared by a strain energy metric based on the measured relationship between pressure and aspirated height, and also used as target behavior for finite element models of the ventricles. Model geometry was determined from 3D reconstructions of whole-mount, confocal-imaged hearts. The stress-strain relationship of the model was adjusted to achieve an optimal match between model and experimental behavior. Results and conclusion Although the OFT is the most severely affected structure in Fgf8; Isl1Cre hearts, its passive stiffness was the same as in control hearts. In contrast, both the LV and RV showed markedly increased passive stiffness, doubling in LVs and quadrupling in RVs of mutant hearts. These differences are not attributable to differences in ventricular volume, wall thickness, or trabecular density. Excellent agreement was obtained between the model and experimental results. Overall our findings show that hearts developing PTA have early changes in ventricular tissue biomechanics relevant to cardiac function and ongoing development.	[Buffinton, Christine Miller] Bucknell Univ, Dept Mech Engn, Lewisburg, PA 17837 USA; [Benjamin, Alyssa K.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA; [Firment, Ashley N.; Moon, Anne M.] Geisinger Med Ctr, Weis Ctr Res, Dept Mol & Funct Genom, Danville, PA 17822 USA	Bucknell University; Bucknell University; Geisinger Medical Center	Buffinton, CM (corresponding author), Bucknell Univ, Dept Mech Engn, Lewisburg, PA 17837 USA.	christine.buffinton@bucknell.edu		Buffinton, Christine/0000-0001-7369-3651; moon, anne/0000-0002-9090-1093	BucknellGeisinger Research Initiation	BucknellGeisinger Research Initiation	This work was supported by a BucknellGeisinger Research Initiation Grant to CMB and AMM (website: httplAwfw.bucknell.edu/BGR I). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 1997, ANN BIOMED ENG, V25, P581, DOI 10.1007/BF02684197; Azaripour A, 2016, PROG HISTOCHEM CYTO, V51, P9, DOI 10.1016/j.proghi.2016.04.001; Bharadwaj KN, 2012, ANN BIOMED ENG, V40, P2212, DOI 10.1007/s10439-012-0574-8; Boudou T, 2006, J BIOMECH, V39, P1677, DOI 10.1016/j.jbiomech.2005.04.026; Buffinton CM, 2013, BIOMECH MODEL MECHAN, V12, P1037, DOI 10.1007/s10237-012-0461-0; Buffinton CM, 2015, J MECH BEHAV BIOMED, V51, P367, DOI 10.1016/j.jmbbm.2015.07.022; Buskohl P. R., 2011, J BIOMECH; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; CLARK EB, 1989, AM J PHYSIOL, V257, pH55, DOI 10.1152/ajpheart.1989.257.1.H55; CLARK EB, 1984, AM J CARDIOL, V53, P324, DOI 10.1016/0002-9149(84)90447-8; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Groenendijk BCW, 2007, PHYSIOLOGY, V22, P380, DOI 10.1152/physiol.00023.2007; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hirschy A, 2006, DEV BIOL, V289, P430, DOI 10.1016/j.ydbio.2005.10.046; Hogers B, 1999, CARDIOVASC RES, V41, P87, DOI 10.1016/S0008-6363(98)00218-1; Hogers B, 1997, CIRC RES, V80, P473, DOI 10.1161/01.RES.80.4.473; Hu N, 2009, ANAT REC, V292, P652, DOI 10.1002/ar.20885; Jacot JG, 2010, J BIOMECH, V43, P93, DOI 10.1016/j.jbiomech.2009.09.014; Jahrling N, 2009, ORGANOGENESIS, V5, P227, DOI 10.4161/org.5.4.10403; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kolesova H, 2016, HISTOCHEM CELL BIOL, V146, P141, DOI 10.1007/s00418-016-1441-8; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Li P, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2153851; Lindsey SE, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00318; Lucitti JL, 2005, J EXP BIOL, V208, P1877, DOI 10.1242/jeb.01574; Macatee TL, 2003, DEVELOPMENT, V130, P6361, DOI 10.1242/dev.00850; Majkut S, 2013, CURR BIOL, V23, P2434, DOI 10.1016/j.cub.2013.10.057; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Mavroudis C, 2015, WORLD J PEDIATR CONG, V6, P226, DOI 10.1177/2150135115572375; Mekkaoui C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072795; Midgettand M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00287; Miller CE, 2005, MICROSC MICROANAL, V11, P216, DOI 10.1017/S1431927605050464; Miller CE, 2003, AM J PHYSIOL-HEART C, V285, pH1849, DOI 10.1152/ajpheart.00384.2002; Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409; Ohashi T, 2005, J BIOMECH, V38, P2248, DOI 10.1016/j.jbiomech.2004.09.019; Park EJ, 2008, DEVELOPMENT, V135, P3599, DOI 10.1242/dev.025437; Park EJ, 2006, DEVELOPMENT, V133, P2419, DOI 10.1242/dev.02367; Schroder EA, 2002, CIRC RES, V91, P353, DOI 10.1161/01.RES.0000030179.78135.FA; Sedmera D, 1999, ANAT RECORD, V254, P238, DOI 10.1002/(SICI)1097-0185(19990201)254:2<238::AID-AR10>3.0.CO;2-V; Sedmera D, 1997, ANAT RECORD, V248, P421; Sedmera D, 2002, ANAT REC, V267, P137, DOI 10.1002/ar.10098; Sissman N J, 1970, Am J Cardiol, V25, P141, DOI 10.1016/0002-9149(70)90575-8; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tobita K, 2000, AM J PHYSIOL-HEART C, V279, pH959, DOI 10.1152/ajpheart.2000.279.3.H959; Tobita K, 2002, AM J PHYSIOL-HEART C, V282, pH2386, DOI 10.1152/ajpheart.00879.2001; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Wang YJ, 2009, ANN BIOMED ENG, V37, P1069, DOI 10.1007/s10439-009-9682-5; Wyczalkowski MA, 2012, BIRTH DEFECTS RES C, V96, P132, DOI 10.1002/bdrc.21013; Yalcin HC, 2011, DEV DYNAM, V240, P23, DOI 10.1002/dvdy.22512; Yancy CW, 2006, J AM COLL CARDIOL, V47, P76, DOI 10.1016/j.jacc.2005.09.022; Zhao RG, 2011, ACTA BIOMATER, V7, P1220, DOI 10.1016/j.actbio.2010.11.004; Zile MR, 2015, CIRCULATION, V131, P1247, DOI 10.1161/CIRCULATIONAHA.114.013215	56	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184678	10.1371/journal.pone.0184678	http://dx.doi.org/10.1371/journal.pone.0184678			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961240	Green Submitted, Green Published, gold			2022-12-27	WOS:000412027700009
J	Bongers, A				Bongers, Aneli			Learning and forgetting in the jet fighter aircraft industry	PLOS ONE			English	Article							PROGRESS FUNCTIONS; MARKET; CURVE; PRODUCTIVITY; SPILLOVERS	A recent strategy carried out by the aircraft industry to reduce the total cost of the new generation fighters has consisted in the development of a single airframe with different technical and operational specifications. This strategy has been designed to reduce costs in the Research, Design and Development phase with the ultimate objective of reducing the final unit price per aircraft. This is the case of the F-35 Lightning II, where three versions, with significant differences among them, are produced simultaneously based on a single airframe. Whereas this strategy seems to be useful to cut down pre-production sunk costs, their effects on production costs remain to be studied. This paper shows that this strategy can imply larger costs in the production phase by reducing learning acquisition and hence, the total effect on the final unit price of the aircraft is indeterminate. Learning curves are estimated based on the flyaway cost for the latest three fighter aircraft models: The A/F-18E/F Super Hornet, the F-22A Raptor, and the F-35A Lightning II. We find that learning rates for the F-35A are significantly lower (an estimated learning rate of around 9%) than for the other two models (around 14%).	[Bongers, Aneli] Univ Malaga, Dept Econ & Econ Hist, Malaga, Spain	Universidad de Malaga	Bongers, A (corresponding author), Univ Malaga, Dept Econ & Econ Hist, Malaga, Spain.	ahongers@uma.es	Bongers, Aneli Anelí/F-7902-2016	Bongers, Aneli/0000-0002-4063-2585	Junta de Andalucia, Agencia de Innovacion y Desarrollo de Andalucia, Research Grant [SEJ-122]; Ministerio de Educacion y Ciencia, Secretaria de Estado de Innovacion [ECO2016-76818-C3-2-P]	Junta de Andalucia, Agencia de Innovacion y Desarrollo de Andalucia, Research Grant(Junta de Andalucia); Ministerio de Educacion y Ciencia, Secretaria de Estado de Innovacion(German Research Foundation (DFG))	This work was supported by Junta de Andalucia, Agencia de Innovacion y Desarrollo de Andalucia, Research Grant SEJ-122 and Project financed by Ministerio de Educacion y Ciencia, Secretaria de Estado de Innovacion, ECO2016-76818-C3-2-P.; I thank J. Gardeazabal, L. Puch, J. Rodriguez, G. F-de-Cordoba, B. Molinari, Jose L. Torres and two anonymous reviewers for their very useful comments on a previous version of this paper. I acknowledge financial support from Junta de Andalucia, Agencia de Innovacion y Desarrollo de Andalucia, Research Grant SEJ-122, and Research Project financed by Ministerio de Educacion y Ciencia, Secreteria de Estado de Innovacion, ECO2016-76818-C3-2-P.	ALCHIAN A, 1963, ECONOMETRICA, V31, P679, DOI 10.2307/1909166; Alchian A., 1959, COSTS AND OUTPUTS; ARGOTE L, 1990, MANAGE SCI, V36, P140, DOI 10.1287/mnsc.36.2.140; ARROW KJ, 1962, REV ECON STUD, V29, P155, DOI 10.2307/2295952; Asher H., 1956, COST QUANTITY RELATI; Benkard CL, 2000, AM ECON REV, V90, P1034, DOI 10.1257/aer.90.4.1034; Benkard CL, 2004, REV ECON STUD, V71, P581, DOI 10.1111/j.1467-937X.2004.00297.x; Besanko D, 2010, ECONOMETRICA, V78, P453, DOI 10.3982/ECTA6994; Bongers A, 2014, RES POLICY, V43, P1570, DOI 10.1016/j.respol.2014.03.009; Boston Consulting Group, 1968, PERSP EXP, V1st; CABRAL LMB, 1994, ECONOMETRICA, V62, P1115, DOI 10.2307/2951509; Crawford J.R., 1944, LEARNING CURVE SHIP; Darr ED, 1995, MANAGE SCI, V41, P1750, DOI 10.1287/mnsc.41.11.1750; DASGUPTA P, 1988, OXFORD ECON PAP, V40, P246, DOI 10.1093/oxfordjournals.oep.a041850; David G, 2011, AM ECON J-MICROECON, V3, P100, DOI 10.1257/mic.3.3.100; DUTTON JM, 1984, BUS HIST REV, V58, P204, DOI 10.2307/3115048; FRISCHTAK CR, 1994, RES POLICY, V23, P601, DOI 10.1016/0048-7333(94)01009-9; FUDENBERG D, 1983, BELL J ECON, V14, P522, DOI 10.2307/3003653; Gertler J., 2013, CRS REP C; GRUBER H, 1992, APPL ECON, V24, P885, DOI 10.1080/00036849200000056; Gruber H, 1996, RES POLICY, V25, P723, DOI 10.1016/0048-7333(95)00858-6; HARTLEY K, 1969, ECON J, V79, P861, DOI 10.2307/2229796; HARTLEY K, 1965, J IND ECON, V13, P122, DOI 10.2307/2097667; Hirsch WZ, 1952, REV ECON STAT, V34, P143, DOI 10.2307/1928465; HIRSCHMANN WB, 1964, HARVARD BUS REV, V42, P125; HIRSHLEIFER J, 1962, J BUS, V35, P235, DOI 10.1086/294508; IRWIN DA, 1994, J POLIT ECON, V102, P1200, DOI 10.1086/261968; JOSKOW PL, 1979, REV ECON STAT, V61, P161, DOI 10.2307/1924583; JOSKOW PL, 1985, RAND J ECON, V16, P1, DOI 10.2307/2555585; Kelly P., 1993, PRICE MEASUREMENTS T; Kleiner M, 2012, IND LABOR RELAT REV, V65; Knaack Marcelle Size, 1978, ENCY US AIR FORCE AI, V1; Lane FC, 1951, SHIPS FOR VICTORY; LEE WY, 1975, J ECON THEORY, V11, P35, DOI 10.1016/0022-0531(75)90037-X; LEVHARL D, 1966, REV ECON STUD, V33, P31, DOI 10.2307/2296638; Levitt SD, 2013, J POLIT ECON, V121, P643, DOI 10.1086/671137; Loerch AG., 2001, ENCY OPERATIONS RES; Mishina K, 1999, NBER CONF R, P145; OI WY, 1967, ECON J, V77, P579, DOI 10.2307/2228992; PRESTON LE, 1964, AM ECON REV, V54, P100; RAPPING L, 1965, REV ECON STAT, V47, P81, DOI 10.2307/1924126; REINHARDT UE, 1973, J FINANC, V28, P821, DOI 10.2307/2978336; ROSEN S, 1972, Q J ECON, V83, P366; Searle AD, 1945, MON LABOR REV, V61, P1132; Shafer SM, 2001, MANAGE SCI, V47, P1639, DOI 10.1287/mnsc.47.12.1639.10236; SHESHINSKI E, 1967, REV ECON STAT, V49, P568, DOI 10.2307/1928342; Smunt TL, 1999, INT J PROD RES, V37, P3901, DOI 10.1080/002075499189826; SPENCE AM, 1981, BELL J ECON, V12, P49, DOI 10.2307/3003508; STOKEY NL, 1988, J POLIT ECON, V96, P701, DOI 10.1086/261559; STURMEY SG, 1964, ECON J, V74, P954, DOI 10.2307/2228853; Thompson P, 2001, J POLIT ECON, V109, P103, DOI 10.1086/318605; Thompson P, 2007, MANAGE SCI, V53, P908, DOI 10.1287/mnsc.1060.0678; Thornton RA, 2001, AM ECON REV, V91, P1350, DOI 10.1257/aer.91.5.1350; WOMER NK, 1979, MANAGE SCI, V25, P312, DOI 10.1287/mnsc.25.4.312; Womer NK, 1983, J BUS ECON STAT, V1, P265, DOI DOI 10.1080/07350015.1983.10509350; Wright T.P., 1936, J AERONAUT SCI, V3, P122, DOI [10.2514/8.155, DOI 10.2514/8.155]; Yelle JE., 1979, DECISION SCI, V10, P302; YOUNG A, 1991, Q J ECON, V106, P369, DOI 10.2307/2937942; ZIMMERMAN MB, 1982, BELL J ECON, V13, P297, DOI 10.2307/3003455	59	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185364	10.1371/journal.pone.0185364	http://dx.doi.org/10.1371/journal.pone.0185364			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957359	Green Submitted, gold, Green Published			2022-12-27	WOS:000411985200051
J	Nemeth, L				Nemeth, Laszlo			Life expectancy versus lifespan inequality: A smudge or a clear relationship?	PLOS ONE			English	Article							POPULATIONS; AGE; COUNTRIES	Interest in inequality, including lifespan inequality, is growing. Several studies, using various measures of variation in the length of life, reveal that as life expectancy increases, lifespan inequality tends to decrease, albeit with considerable variation across populations and over time. The aim of this article is to understand why the strength of the relationship between life expectancy and lifespan inequality varies across publications. Results differ in large part because they are based on different data sources. In addition, some measures show more smudginess than others. All the analyses presented here support the basic finding of a strong relationship between life expectancy and lifespan inequality.	[Nemeth, Laszlo] Max Planck Inst Demog Res, Lab Survival & Longev, Rostock, Germany	Max Planck Society	Nemeth, L (corresponding author), Max Planck Inst Demog Res, Lab Survival & Longev, Rostock, Germany.	nemeth@demogr.mpg.de						Baudisch A, 2011, METHODS ECOL EVOL, V2, P375, DOI 10.1111/j.2041-210X.2010.00087.x; Colchero F, 2016, P NATL ACAD SCI USA, V113, pE7681, DOI 10.1073/pnas.1612191113; Department of Health Statistics and information Systems WHO G, 2014, WHO METH LIF EXP HLT; Edwards RD, 2005, POPUL DEV REV, V31, P645, DOI 10.1111/j.1728-4457.2005.00092.x; Engelman M, 2010, POPUL DEV REV, V36, P511, DOI 10.1111/j.1728-4457.2010.00344.x; Gillespie DOS, 2014, DEMOGRAPHY, V51, P1003, DOI 10.1007/s13524-014-0287-8; Keyfitz N., 1977, APPL MATH DEMOGRAPHY; Missov TI, 2016, PALGR COMMUN, V2, DOI 10.1057/palcomms.2015.49; Noymer A., 2014, PAA ANN M 2014 BOST, p[1, 1]; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Population Division Department of Economic and Social Affairs United Nations, 2015, NOT EXT MOD LIF TABL; Shkolnikov V, 2007, METHODOLOGY NOTE HUM; Shkolnikov V.M., 2003, DEMOGR RES, V8, P305, DOI [DOI 10.4054/DEMRES.2003.8.11, 10.4054/DemRes.2003.8.11]; Shkolnikov VM, 2011, DEMOGRAPHY, V48, P211, DOI 10.1007/s13524-011-0015-6; Smits J, 2009, SOC SCI MED, V68, P1114, DOI 10.1016/j.socscimed.2008.12.034; van Raalte AA, 2014, DEMOGRAPHY, V51, P73, DOI 10.1007/s13524-013-0253-x; van Raalte AA, 2011, INT J EPIDEMIOL, V40, P1703, DOI 10.1093/ije/dyr146; Vaupel JW, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000128; VAUPEL JW, 1986, POP STUD-J DEMOG, V40, P147, DOI 10.1080/0032472031000141896; Wilmoth JR, 1999, DEMOGRAPHY, V36, P475, DOI 10.2307/2648085; Wilmoth JR, 2007, METHODS PROTOCOL HUM; World Health Organization, 2015, WHO GLOB HLTH OBS DA; WPP, 2015, 2015 REV WORLD POP P; Wrycza TF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119163	24	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185702	10.1371/journal.pone.0185702	http://dx.doi.org/10.1371/journal.pone.0185702			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957421	gold, Green Published, Green Submitted			2022-12-27	WOS:000411985200108
J	Ogata, T; Ito, K; Shindo, T; Hatanaka, K; Eguchi, K; Kurosawa, R; Kagaya, Y; Monma, Y; Ichijo, S; Taki, H; Kanai, H; Shimokawa, H				Ogata, Tsuyoshi; Ito, Kenta; Shindo, Tomohiko; Hatanaka, Kazuaki; Eguchi, Kumiko; Kurosawa, Ryo; Kagaya, Yuta; Monma, Yuto; Ichijo, Sadamitsu; Taki, Hirofumi; Kanai, Hiroshi; Shimokawa, Hiroaki			Low-intensity pulsed ultrasound enhances angiogenesis and ameliorates contractile dysfunction of pressure-overloaded heart in mice	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; RHO-KINASE; IN-VIVO; FAILURE; EPIDEMIOLOGY; PROMOTES; CONTRIBUTES; TRANSITION; BLOCKADE; FIBROSIS	Introduction Chronic left ventricular (LV) pressure overload causes relative ischemia with resultant LV dysfunction. We have recently demonstrated that low-intensity pulsed ultrasound (LIPUS) improves myocardial ischemia in a pig model of chronic myocardial ischemia through enhanced myocardial angiogenesis. In the present study, we thus examined whether LIPUS also ameliorates contractile dysfunction in LV pressure-overloaded hearts. Methods and results Chronic LV pressure overload was induced with transverse aortic constriction (TAC) in mice. LIPUS was applied to the whole heart three times in the first week after TAC and was repeated once a week for 7 weeks thereafter (n = 22). Animals in the control groups received the sham treatment without LIPUS (n = 23). At 8 weeks after TAC, LV fractional shortening was depressed in the TAC-Control group, which was significantly ameliorated in the TAC-LIPUS group (30.4 +/- 0.5 vs. 36.2 +/- 3.8%, P < 0.05). Capillary density was higher and perivascular fibrosis was less in the LV in the TAC-LIPUS group than in the TAC-Control group. Myocardial relative ischemia evaluated with hypoxyprobe was noted in the TAC-Control group, which was significantly attenuated in the TAC-LIPUS group. In the TAC-LIPUS group, as compared with the control group, mRNA expressions of BNP and collagen III were significantly lower (both P < 0.05) and protein expressions of VEGF and eNOS were significantly up-regulated associated with Akt activation (all P < 0.05). No adverse effect related to the LIPUS therapy was noted. Conclusions These results indicate that the LIPUS therapy ameliorates contractile dysfunction in chronically pressure-overloaded hearts through enhanced myocardial angiogenesis and attenuated perivascular fibrosis. Thus, the LIPUS therapy may be a promising, non-invasive treatment for cardiac dysfunction due to chronic pressure overload.	[Ogata, Tsuyoshi; Ito, Kenta; Shindo, Tomohiko; Hatanaka, Kazuaki; Eguchi, Kumiko; Kurosawa, Ryo; Kagaya, Yuta; Monma, Yuto; Ichijo, Sadamitsu; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi, Japan; [Taki, Hirofumi; Kanai, Hiroshi] Tohoku Univ, Grad Sch Engn, Dept Elect Engn, Sendai, Miyagi, Japan; [Taki, Hirofumi; Kanai, Hiroshi] Tohoku Univ, Grad Sch Biomed Engn, Div Biomed Measurements & Diagnost, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University	Ito, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi, Japan.	ito-kenta@cardio.med.tohoku.ac.jp	Kanai, Hiroshi/T-4996-2019; Ito, Kenta/AAX-4906-2020	Kanai, Hiroshi/0000-0002-6567-1687; Ito, Kenta/0000-0002-9725-399X; Shimokawa, Hiroaki/0000-0001-7534-4826	Japanese Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan; Japanese Ministry of Health, Labor, and Welfare, Tokyo, Japan	Japanese Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor, and Welfare, Tokyo, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan, and the Japanese Ministry of Health, Labor, and Welfare, Tokyo, Japan.	Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Asimakopoulos G, 1997, CIRCULATION, V96, P3403; Barzelai S, 2006, ULTRASOUND MED BIOL, V32, P139, DOI 10.1016/j.ultrasmedbio.2005.08.010; Carnell DM, 2006, INT J RADIAT ONCOL, V65, P91, DOI 10.1016/j.ijrobp.2005.11.044; Chaanine AH, 2011, EUR J HEART FAIL, V13, P825, DOI 10.1093/eurjhf/hfr080; Chintalgattu V, 2010, J CLIN INVEST, V120, P472, DOI 10.1172/JCI39434; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; Dorn GW, 2007, CELL METAB, V5, P326, DOI 10.1016/j.cmet.2007.04.003; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Friehs I, 2006, CIRCULATION, V114, pI290, DOI 10.1161/CIRCULATIONAHA.105.001289; Godecke A, 2001, J PHYSIOL-LONDON, V532, P195, DOI 10.1111/j.1469-7793.2001.0195g.x; Hanawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104863; Harada K, 1996, AM J PHYSIOL-HEART C, V270, pH1791, DOI 10.1152/ajpheart.1996.270.5.H1791; Higashikuni Y, 2012, ARTERIOSCL THROM VAS, V32, P654, DOI 10.1161/ATVBAHA.111.240341; Ikeda S, 2014, ARTERIOSCL THROM VAS, V34, P1260, DOI 10.1161/ATVBAHA.114.303320; Izumiya Y, 2006, HYPERTENSION, V47, P887, DOI 10.1161/01.HYP.0000215207.54689.31; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Lin WY, 2011, WORLD J UROL, V29, P165, DOI 10.1007/s00345-008-0369-6; Miura K, 2013, CIRC J, V77, P2226, DOI 10.1253/circj.CJ-13-0847; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nazer B, 2015, CIRC J, V79, P2043, DOI 10.1253/circj.CJ-15-0366; Oka T, 2014, CIRC RES, V114, P565, DOI 10.1161/CIRCRESAHA.114.300507; PEARLMAN JD, 1995, NAT MED, V1, P1085, DOI 10.1038/nm1095-1085; Raleigh JA, 2001, INT J RADIAT ONCOL, V49, P569, DOI 10.1016/S0360-3016(00)01505-4; Ramli R, 2009, INT J ORAL MAX IMPL, V24, P591; Roger VL, 2013, CIRC RES, V113, P646, DOI 10.1161/CIRCRESAHA.113.300268; Ruetten H, 2005, CARDIOVASC RES, V66, P444, DOI 10.1016/j.cardiores.2005.01.021; Sakata Y, 2013, CIRC J, V77, P2209, DOI 10.1253/circj.CJ-13-0971; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Santana LD, 2013, ULTRASONICS, V53, P870, DOI 10.1016/j.ultras.2012.12.009; Sato M, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0798-8; Scherrer-Crosbie M, 2001, CIRCULATION, V104, P1286, DOI 10.1161/hc3601.094298; Shimokawa H, 2015, EUR J HEART FAIL, V17, P884, DOI 10.1002/ejhf.319; Shindo T, 2016, ARTERIOSCL THROM VAS, V36, P1220, DOI 10.1161/ATVBAHA.115.306477; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiojima I, 2012, AM J PATHOL, V181, P1969, DOI 10.1016/j.ajpath.2012.08.020; Shiroto T, 2009, J AM COLL CARDIOL, V54, P2321, DOI 10.1016/j.jacc.2009.07.045; Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F; Simons M, 2003, NAT REV DRUG DISCOV, V2, P863, DOI 10.1038/nrd1226; Suzuki K, 2016, ARTERIOSCL THROM VAS, V36, P636, DOI 10.1161/ATVBAHA.115.306686; ter Haar G, 2007, PROG BIOPHYS MOL BIO, V93, P111, DOI 10.1016/j.pbiomolbio.2006.07.005; Tomita H, 1998, HYPERTENSION, V32, P273, DOI 10.1161/01.HYP.32.2.273	42	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185555	10.1371/journal.pone.0185555	http://dx.doi.org/10.1371/journal.pone.0185555			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957396	Green Submitted, Green Published, gold			2022-12-27	WOS:000411985200084
J	Romero, AN; Herlin, M; Finnila, M; Korkalainen, M; Hakansson, H; Viluksela, M; Sholts, SB				Romero, Ashly N.; Herlin, Maria; Finnila, Mikko; Korkalainen, Merja; Hakansson, Helen; Viluksela, Matti; Sholts, Sabrina B.			Skeletal and dental effects on rats following in utero/lactational exposure to the non-dioxin-like polychlorinated biphenyl PCB 180	PLOS ONE			English	Article							2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; TOOTH DEVELOPMENT; RECEPTOR CAR; HALF-LIVES; BONE; INDUCTION; UTERO; TEETH; EXPRESSION; BIOMARKER	Polychlorinated biphenyls (PCBs) are a large class of persistent organic pollutants that are potentially harmful to human and wildlife health. Although a small number of dioxin-like (DL) PCBs are well characterized, the majority of PCBs have non-dioxin-like (NDL) modes of action and biological effects that are less understood. We conducted a dose-response study of the skeletal and dental effects of in utero/lactational exposure to 2,2', 3,4,4', 5,5'-hepta-chlorobiphenyl (PCB 180), a NDL PCB congener that is abundantly present in the environment and foods, including mother's milk. In a sample of 35-and 84-day-old male and female offspring from pregnant rats exposed to different doses of PCB 180 (0, 10, 30, 100, 300, and 1000 mg/kg bw), we measured the three-dimensional (3D) coordinates of 27 landmarks on the craniofacial skeleton with a Microscribe G2X system, the buccolingual width of all molars with digital sliding calipers, and a variety of tibial parameters with peripheral quantitative computed tomography (pQCT) and a biomechanical testing apparatus. The landmark coordinates were analyzed for variation in size, shape, and fluctuating asymmetry (FA) using MorphoJ software, showing no effects on cranial size, on FA in females only (i.e., decreased asymmetry), and on shape in both sexes (i.e., decreased facial length and shift in the palatal suture). In the maxillary teeth, females in the highest dose group showed a significant decrease of 0.1 mm (p = 0.033) of the second molar only, whereas males in most dose groups showed average increases of 0.1 mm (p = 0.006-0.044) in all three molars. In the mandibular teeth, the only significant response to PCB 180 exposure was the average increase of 0.1 mm (p = 0.001-0.025) in the third molars of males only. Males also shower greater sensitivity in postcranial effects of increased tibial length and decreased cortical bone mass density, although only females showed significant effects on tibial bone area and thickness. These results demonstrate marked sex differences in effects of PCB 180, which can be attributed to differences in their underlying biological mechanisms of toxicity. Furthermore, although tooth and bone development are targets of both DL and NDL compounds, this study shows that there are marked differences in their mechanisms and effects.	[Romero, Ashly N.] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA; [Herlin, Maria; Hakansson, Helen] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Finnila, Mikko] Univ Oulu, Res Grp Med Imaging Phys & Technol, Oulu, Finland; [Finnila, Mikko] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Korkalainen, Merja; Viluksela, Matti] Natl Inst Hlth & Welf, Chem & Hlth Unit, Kuopio, Finland; [Viluksela, Matti] Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland; [Sholts, Sabrina B.] Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Washington, DC 20560 USA	University of Arkansas System; University of Arkansas Fayetteville; Karolinska Institutet; University of Oulu; University of Eastern Finland; Finland National Institute for Health & Welfare; University of Eastern Finland; Smithsonian Institution; Smithsonian National Museum of Natural History	Sholts, SB (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Washington, DC 20560 USA.	sholtss@si.edu	Romero, Ashly Noel/GPX-2819-2022; Finnila, Mikko/X-6492-2019; Romero, Ashly/AGZ-0957-2022	Sholts, Sabrina/0000-0003-4168-0578; Finnila, Mikko/0000-0002-3348-5759; Romero, Ashly/0000-0002-9571-2099; Hakansson, Helen/0000-0002-7524-8209	European Commission (ATHON (Assessing the toxicity and hazards of NDL-PCBs present in food)) [FOOD-CT-2005-022923]; National Science Foundation (REU Site) [EAR 1062692]	European Commission (ATHON (Assessing the toxicity and hazards of NDL-PCBs present in food)); National Science Foundation (REU Site)(National Science Foundation (NSF))	This study was funded by the European Commission (ATHON (Assessing the toxicity and hazards of NDL-PCBs present in food), FOOD-CT-2005-022923) to Matti Viluksela, and by the National Science Foundation (REU Site, EAR 1062692) to Ashly N. Romero. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AK, 1996, MOL PHARMACOL, V49, P523; Alaluusua S, 1999, LANCET, V353, P206, DOI 10.1016/S0140-6736(05)77214-7; Alaluusua S, 2004, ENVIRON HEALTH PERSP, V112, P1313, DOI 10.1289/ehp.6920; Allen DE, 2001, ECOTOXICOLOGY, V10, P167, DOI 10.1023/A:1016693911300; Assessment ME, 2005, ECOSYSTEMS HUMAN WEL; Carpenter David O., 2006, Reviews on Environmental Health, V21, P1; Carreira SC, 2011, PLACENTA, V32, P283, DOI 10.1016/j.placenta.2010.12.024; EFSA, 2005, EFSA J, V263, P1, DOI DOI 10.2903/J.EFSA.2005.284; Faroon O., 2000, TOXICOLOGICAL PROFIL; Fiedler H, 2002, PERSISTENT ORGANIC P; FRITZ H, 1970, TERATOLOGY, V3, P331, DOI 10.1002/tera.1420030409; Gahrs M, 2013, TOXICOL APPL PHARM, V272, P77, DOI 10.1016/j.taap.2013.05.034; Galliford T M, 2005, Minerva Endocrinol, V30, P237; Hamers T, 2011, TOXICOL SCI, V121, P88, DOI 10.1093/toxsci/kfr043; Hansen LG, 2012, ORTHO SIDE PCBS OCCU; HEBEL R, 1986, ANATOMY EMBRIOLOGY L; Jamsa T, 1998, BONE, V23, P155, DOI 10.1016/S8756-3282(98)00076-3; Jamsa T, 1999, J BONE MINER RES, V14, P1708, DOI 10.1359/jbmr.1999.14.10.1708; Jan J, 2000, CARIES RES, V34, P469, DOI 10.1159/000016625; JECFA, 2016, WHO FOOD ADD SER; Jepson PD, 2016, SCI REP-UK, V6, DOI 10.1038/srep18573; Kattainen H, 2001, TOXICOL APPL PHARM, V174, P216, DOI 10.1006/taap.2001.9216; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Leppaniemi A, 2001, CARIES RES, V35, P36; Lind PM, 2000, TOXICOLOGY, V151, P11, DOI 10.1016/S0300-483X(00)00262-6; Miettinen HM, 2006, TOXICOL SCI, V91, P568, DOI 10.1093/toxsci/kfj158; Miettinen HM, 2002, TOXICOL APPL PHARM, V184, P57, DOI 10.1006/taap.2002.9490; Miettinen HM, 2005, TOXICOL SCI, V85, P1003, DOI 10.1093/toxsci/kfi136; Mourier B, 2014, SCI TOTAL ENVIRON, V476, P568, DOI 10.1016/j.scitotenv.2014.01.026; Murtomaa M, 2007, CHEMOSPHERE, V68, P951, DOI 10.1016/j.chemosphere.2007.01.030; Oberg M, 2002, TOXICOL SCI, V70, P171, DOI 10.1093/toxsci/70.2.171; Ritter R, 2011, ENVIRON HEALTH PERSP, V119, P225, DOI 10.1289/ehp.1002211; Roos A, 2010, ECOTOX ENVIRON SAFE, V73, P1063, DOI 10.1016/j.ecoenv.2010.02.008; Roos R, 2011, TOXICOLOGY, V284, P42, DOI 10.1016/j.tox.2011.03.013; Sakai H, 2006, TOXICOL SCI, V94, P57, DOI 10.1093/toxsci/kfl088; Schecter A, 2010, ENVIRON HEALTH PERSP, V118, P796, DOI 10.1289/ehp.0901347; Shellis P, 1981, DENT ANATOMY EMBRYOL, P432; Sholts SB, 2015, TOXICOL REP, V2, P472, DOI 10.1016/j.toxrep.2014.12.007; Sholts SB, 2015, TOXICOLOGY, V337, P30, DOI 10.1016/j.tox.2015.08.010; Slob W, 2002, TOXICOL SCI, V66, P298, DOI 10.1093/toxsci/66.2.298; Squadrone S, 2015, FOOD CHEM, V175, P10, DOI 10.1016/j.foodchem.2014.11.107; Van den Berg M, 1998, ENVIRON HEALTH PERSP, V106, P775, DOI 10.1289/ehp.98106775; Viluksela M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104639; Wang SL, 2003, ENVIRON RES, V93, P131, DOI 10.1016/S0013-9351(03)00040-9; Warmlander SKTS, 2011, ENVIRON HEALTH PERSP, V119, P1203, DOI 10.1289/ehp.1103478; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Wimmerova S, 2011, CHEMOSPHERE, V82, P687, DOI 10.1016/j.chemosphere.2010.10.099; Yasuda I, 2005, REPROD TOXICOL, V20, P21, DOI 10.1016/j.reprotox.2004.12.016; Yoshinari K, 2001, MOL PHARMACOL, V59, P278, DOI 10.1124/mol.59.2.278; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007	51	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185241	10.1371/journal.pone.0185241	http://dx.doi.org/10.1371/journal.pone.0185241			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957439	Green Published, gold			2022-12-27	WOS:000411985200037
J	Wang, WP; Li, P; Li, W; Jiang, JZ; Cui, YY; Li, SR; Wang, ZX				Wang, Wenping; Li, Pei; Li, Wei; Jiang, Junzi; Cui, Yanyan; Li, Shirong; Wang, Zhenxiang			Osteopontin activates mesenchymal stem cells to repair skin wound	PLOS ONE			English	Article							BONE-MARROW; NEUTROPHIL INFILTRATION; STROMAL CELLS; IN-VITRO; DIFFERENTIATION; CD44; MIGRATION; CANCER; VIVO; INFLAMMATION	Mesenchymal stem cells (MSCs) are promising candidates for skin wound repair due to their capabilities of accumulating at wounds and differentiating into multiple types of skin cells. However, the underlying mechanisms responsible for these processes remain unclear. In this study, we found that osteopontin (OPN) stimulated the migration of MSCs in vitro, and observed the recruitment of endogenous MSCs to a skin wound and their differentiation into keratinocytes and endothelial cells. In OPN knock-out mice, the recruitment of MSCs to the skin wound was significantly inhibited, and wound closure was hampered after an intradermal injection of exogenous MSCs compared to wild-type mice. Consistent with these observations, the expressions of adhesion molecule CD44 and its receptor E-selectin were significantly decreased in the lesions of OPN knock-out mice compared with wild-type mice suggesting that OPN may regulate the migration of MSCs through its interactions with CD44 during skin wound recovery. In summary, our data demonstrated that OPN played a critical role in activating the migration of MSCs to injured sites and their differentiation into specific skin cell types during skin wound healing.	[Wang, Wenping; Jiang, Junzi; Li, Shirong; Wang, Zhenxiang] Third Mil Med Univ, Southwest Hosp, Dept Plast & Aesthet Surg, Chongqing, Peoples R China; [Li, Pei] 89 Hosp Peoples Liberat Army, Dept Orthoped, Weifang, Shandong, Peoples R China; [Li, Wei] Bengbu Med Coll, Affiliated Hosp 1, Dept Plast & Burn Surg, Bengbu, Peoples R China; [Cui, Yanyan] Chongqing Med Univ, Dept Genet & Cell Biol, Chongqing, Peoples R China	Army Medical University; Bengbu Medical College; Chongqing Medical University	Li, SR; Wang, ZX (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Plast & Aesthet Surg, Chongqing, Peoples R China.	xinanzhengxing@126.com; wangzx0921@126.com			National Natural Science Foundation of China [81071563, 81272102]; Chongqing Application Development Grant [CSTC2014yykfA110015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Application Development Grant	The study is supported by the National Natural Science Foundation of China (No.81071563 and 81272102) and the Chongqing Application Development Grant(NO.CSTC2014yykfA110015) to ZW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Al-Shami R, 2005, J CELL BIOCHEM, V94, P1218, DOI 10.1002/jcb.20379; Anjos-Afonso F, 2004, J CELL SCI, V117, P5655, DOI 10.1242/jcs.01488; Apte UM, 2005, TOXICOL APPL PHARM, V207, P25, DOI 10.1016/j.taap.2004.12.018; Banerjee A, 2006, J PATHOL, V208, P473, DOI 10.1002/path.1917; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Chinh Chung Doan, 2014, Iranian Biomedical Journal, V18, P67, DOI 10.6091/ibj.12612.2013; de la Fuente R, 2010, CANCER RES, V70, P6682, DOI 10.1158/0008-5472.CAN-10-2451; Denhardt DT, 2003, CLIN EXP METASTAS, V20, P77, DOI 10.1023/A:1022550721404; Denhardt DT, 2001, BIOCHEM BIOPH RES CO, V288, P448, DOI 10.1006/bbrc.2001.5780; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; El-Tanani MK, 2006, CYTOKINE GROWTH F R, V17, P463, DOI 10.1016/j.cytogfr.2006.09.010; Gebler A, 2012, TRENDS MOL MED, V18, P128, DOI 10.1016/j.molmed.2011.10.004; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kang SK, 2004, J CELL SCI, V117, P4289, DOI 10.1242/jcs.01264; Katayama Y, 2005, J EXP MED, V201, P1183, DOI 10.1084/jem.20042014; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Khan SA, 2005, CLIN EXP METASTAS, V22, P663, DOI 10.1007/s10585-006-9007-0; Liaw L, 1998, J CLIN INVEST, V101, P1468; Mahdavishahri N, 2012, IRAN J BASIC MED SCI, V15, P1185; Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018; Mazzini L, 2006, NEUROL RES, V28, P523, DOI 10.1179/016164106X116791; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; Moviglia GA, 2006, CYTOTHERAPY, V8, P202, DOI 10.1080/14653240600736048; Nuschke A, 2014, ORGANOGENESIS, V10, P29, DOI 10.4161/org.27405; Paquet-Fifield S, 2009, J CLIN INVEST, V119, P2795, DOI 10.1172/JCI38535; Ramaiah SK, 2008, TOXICOL SCI, V103, P4, DOI 10.1093/toxsci/kfm246; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Rittling SR, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001839; ROWE PSN, 1994, HUM GENET, V94, P457; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Sgodda M, 2007, EXP CELL RES, V313, P2875, DOI 10.1016/j.yexcr.2007.05.020; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Standal T, 2004, EXP ONCOL, V26, P179; Steck E, 2005, STEM CELLS, V23, P403, DOI 10.1634/stemcells.2004-0107; Tropel P, 2006, STEM CELLS, V24, P2868, DOI 10.1634/stemcells.2005-0636; Wang QH, 2016, MOL MED REP, V14, P5551, DOI 10.3892/mmr.2016.5953; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509	40	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185346	10.1371/journal.pone.0185346	http://dx.doi.org/10.1371/journal.pone.0185346			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957406	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200047
J	Ziegler, TE; Sosa, ME; Colman, RJ				Ziegler, Toni E.; Sosa, Megan E.; Colman, Ricki J.			Fathering style influences health outcome in common marmoset (Callithrix jacchus) offspring	PLOS ONE			English	Article							INFANT; CARE; GROWTH; RESPONSIVENESS; TESTOSTERONE; EXPERIENCE; CHILDHOOD; PRIMATES; SUCCESS; MONKEYS	In the cooperative breeding common marmoset monkey, Callithrix jacchus, fathers share the care responsibility and energetic load with their mate from the time their infants are born. However, not all fathers show the same level of participation in direct infant care. Here we present the first results demonstrating that fathering style can improve both survival and growth trajectory of a male's offspring during the first 30 weeks of life and that these infant outcomes are consistent within a father throughout successive births. Twenty-four marmoset fathers were tested for their responsiveness to an infant distress call when their infants were approximately two weeks old. These fathers were categorized as either responsive (RS) or nonresponsive (NRS) based on their response to the calls. Survival past 1 month was then determined and bi-monthly weights of current infants through 30 weeks of age were taken. Infant survival to the first month was significantly higher with RS fathers than with NRS fathers during this critical time period. Infants from RS fathers also had a higher growth trajectory with significant differences in body weight in the 28th and 30th week after birth. Only the RS fathers showed a significant increase in serum testosterone in response to infant cries suggesting a physiological role of testosterone in the motivation to search for the infant. Furthermore, all offspring born to RS fathers from subsequent births also showed a significantly higher survival rate and higher growth trajectory than for offspring of NRS fathers. These results suggest that fathering style is a consistent trait and responsive fathers improve infant survival rate and growth during the first 30 weeks. Such fathering style traits may be passed on to the male offspring due to environmental or genetic factors.	[Ziegler, Toni E.; Sosa, Megan E.; Colman, Ricki J.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Colman, Ricki J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ziegler, TE (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.	ziegler@primate.wisc.edu		Ziegler, Toni/0000-0003-2598-730X; Colman, Ricki/0000-0001-9706-0525	NIH [HD057684, MH070423]; Wisconsin National Primate Research Center [P51OD011106, R21]; Institute for Clinical and Translational Research at the University of Wisconsin-Madison [UL1TR000427]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin National Primate Research Center; Institute for Clinical and Translational Research at the University of Wisconsin-Madison	Funding for these data were provided by the following grants: NIH: HD057684 and MH070423 to TEZ as research R21 grants, P51OD011106 to the Wisconsin National Primate Research Center in part for Institutional support, salary support in part and infrastructure, and UL1TR000427 to the Institute for Clinical and Translational Research at the University of Wisconsin-Madison for partial salary support for TEZ.	Albuquerque ACSR, 2001, INT J PRIMATOL, V22, P631, DOI 10.1023/A:1010741702831; Alonzo SH, 2010, TRENDS ECOL EVOL, V25, P99, DOI 10.1016/j.tree.2009.07.012; Boyce WT, 2006, J AM ACAD CHILD PSY, V45, P1510, DOI 10.1097/01.chi.0000237706.50884.8b; Brown GR, 2005, AM J PRIMATOL, V65, P301, DOI 10.1002/ajp.20117; Burkart JM, 2009, EVOL ANTHROPOL, V18, P175, DOI 10.1002/evan.20222; Burkart JM, 2015, NEUROSCI RES, V93, P8, DOI 10.1016/j.neures.2014.09.003; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Fernandez-Duque E, 2009, ANNU REV ANTHROPOL, V38, P115, DOI 10.1146/annurev-anthro-091908-164334; Finkenwirth C, 2016, HORM BEHAV, V80, P10, DOI 10.1016/j.yhbeh.2016.01.008; Fleming AS, 2002, HORM BEHAV, V42, P399, DOI 10.1006/hbeh.2002.1840; Garfield CF, 2006, PEDIATRICS, V117, pE637, DOI 10.1542/peds.2005-1612; Gustafsson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2713; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Hrdy SB, 2016, HORM BEHAV, V77, P272, DOI 10.1016/j.yhbeh.2015.10.016; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; INGRAM J C, 1975, Laboratory Animals (London), V9, P249, DOI 10.1258/002367775780957205; Jaquish CE, 1997, AM J PRIMATOL, V42, P269, DOI 10.1002/(SICI)1098-2345(1997)42:4<269::AID-AJP2>3.0.CO;2-V; Johnson EO, 1996, PEDIATR RES, V39, P999, DOI 10.1203/00006450-199606000-00012; Kramer KL, 2010, ANNU REV ANTHROPOL, V39, P417, DOI 10.1146/annurev.anthro.012809.105054; LEVYSHIFF R, 1990, PEDIATRICS, V86, P289; Lukas D, 2016, P ROY SOC LOND B BIO, V279, P4065; Mascaro JS, 2014, SOC COGN AFFECT NEUR, V9, P1704, DOI 10.1093/scan/nst166; Soltis J, 2004, BEHAV BRAIN SCI, V27, P443, DOI 10.1017/S0140525X0400010X; Stafford M, 2016, J POSIT PSYCHOL, V11, P326, DOI 10.1080/17439760.2015.1081971; Tardif S, 1998, LAB ANIM SCI, V48, P264; TARDIF SD, 1984, AM J PRIMATOL, V6, P377, DOI 10.1002/ajp.1350060408; TARDIF SD, 1993, BIOL REPROD, V48, P1113, DOI 10.1095/biolreprod48.5.1113; van Anders SM, 2012, HORM BEHAV, V61, P31, DOI 10.1016/j.yhbeh.2011.09.012; West HER, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11854; Williams E, 1999, AM J ORTHOPSYCHIAT, V69, P328, DOI 10.1037/h0080407; WOODROFFE R, 1994, TRENDS ECOL EVOL, V9, P294, DOI 10.1016/0169-5347(94)90033-7; Yogman M., 1995, J AM ACAD CHILD ADOL, V34, P66, DOI DOI 10.1097/00004583-; Zahed SR, 2008, AM J PRIMATOL, V70, P84, DOI 10.1002/ajp.20460; Ziegler TE, 2005, HORM BEHAV, V47, P56, DOI 10.1016/j.yhbeh.2004.08.009; Ziegler TE, 1986, CURRENT PERSPECTIVES; Ziegler TE, 2016, HORM BEHAV, V78, P13, DOI 10.1016/j.yhbeh.2015.10.004; Ziegler TE, 2009, HORM BEHAV, V56, P436, DOI 10.1016/j.yhbeh.2009.07.012	37	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185695	10.1371/journal.pone.0185695	http://dx.doi.org/10.1371/journal.pone.0185695			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957433	gold, Green Published, Green Submitted			2022-12-27	WOS:000411985200107
J	Dai, DL; Wen, FQ; Zhou, SM; Su, Z; Liu, GS; Wang, MB; Zhou, JL; He, FS				Dai, Dongling; Wen, Feiqiu; Zhou, Shaoming; Su, Zhe; Liu, Guosheng; Wang, Mingbang; Zhou, Jianli; He, Fusheng			Association of MTTP gene variants with pediatric NAFLD: A candidate-gene-based analysis of single nucleotide variations in obese children	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; TRIGLYCERIDE TRANSFER PROTEIN; NOREPINEPHRINE TRANSPORTER; INSULIN SENSITIVITY; METABOLIC SYNDROME; RISK-FACTORS; DISEASE; POLYMORPHISMS; SUSCEPTIBILITY; ADOLESCENTS	Objective We used targeted next-generation sequencing to investigate whether genetic variants of lipid metabolism-related genes are associated with increased susceptibility to nonalcoholic fatty liver disease ( NAFLD) in obese children. Methods A cohort of 100 obese children aged 6 to 18 years were divided into NAFLD and nonNAFLD groups and subjected to hepatic ultrasound, anthropometric, and biochemical analyses. We evaluated the association of genetic variants with NAFLD susceptibility by investigating the single nucleotide polymorphisms in each of 36 lipid-metabolism-related genes. The panel genes were assembled for target region sequencing. Correlations between single nucleotide variations, biochemical markers, and clinical phenotypes were analyzed. Results 97 variants in the 36 target genes per child were uncovered. Twenty-six variants in 16 genes were more prevalent in NAFLD subjects than in in-house controls. The mutation rate of MTTP rs2306986 and SLC6A2 rs3743788 was significantly higher in NAFLD subjects than in non-NAFLD subjects ( OR: 3.879; P = 0.004; OR: 6.667, P = 0.005). Logistic regression analysis indicated the MTTP variant rs2306986 was an independent risk factor for NAFLD ( OR: 23.468, P = 0.044). Conclusions The results of this study, examining a cohort of obese children, suggest that the genetic variation at MTTP rs2306986 was associated with higher susceptibility to NAFLD. This may contribute to the altered lipid metabolism by disruption of assembly and secretion of lipoprotein, leading to reducing fat export from the involved hepatocytes.	[Dai, Dongling; Wen, Feiqiu; Zhou, Shaoming; Su, Zhe] Shenzhen Childrens Hosp, Shenzhen, Peoples R China; [Dai, Dongling; Liu, Guosheng; Zhou, Jianli] Jinan Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Wang, Mingbang] Fudan Univ, Key Lab Birth Defects, Childrens Hosp, Shanghai, Peoples R China; [Wang, Mingbang; He, Fusheng] Shenzhen Following Precis Med Res Inst, Shenzhen, Peoples R China	Jinan University; Fudan University	Wen, FQ; Zhou, SM (corresponding author), Shenzhen Childrens Hosp, Shenzhen, Peoples R China.	fwen621@126.com; zhousm15d@aliyun.com	Wang, Mingbang/F-4457-2018	Wang, Mingbang/0000-0002-5989-5377	Shenzhen Innovation and Technology Committee [JCYJ20150403100317080]	Shenzhen Innovation and Technology Committee	This study was funded by Shenzhen Innovation and Technology Committee (Grant number JCYJ20150403100317080).	Abdelmalek MF, 2006, CLIN GASTROENTEROL H, V4, P1162, DOI 10.1016/j.cgh.2006.06.001; Achmad E, 2015, ABDOM IMAGING, V40, P3084, DOI 10.1007/s00261-015-0506-9; Angulo P, 2007, ALIMENT PHARM THER, V25, P883, DOI 10.1111/j.1365-2036.2007.03246.x; Bedogni G, 2016, CHILD OBES, V12, P426, DOI 10.1089/chi.2016.0141; Bernard S, 2000, DIABETOLOGIA, V43, P995, DOI 10.1007/s001250051481; Bonisch H, 2006, HANDB EXP PHARM, V175, P485; Bradbury Michael W, 2004, Clin Liver Dis, V8, P639, DOI 10.1016/j.cld.2004.04.005; Brouwers MCGJ, 2009, GASTROENTEROLOGY, V137, P1536, DOI 10.1053/j.gastro.2009.03.065; Chalasani N, 2010, GASTROENTEROLOGY, V139, P1567, DOI 10.1053/j.gastro.2010.07.057; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Daly AK, 2011, EXPERT REV GASTROENT, V5, P253, DOI [10.1586/egh.11.18, 10.1586/EGH.11.18]; Day CP, 2011, CLIN MED, V11, P176, DOI 10.7861/clinmedicine.11-2-176; Day CP, 2010, DIGEST DIS, V28, P255, DOI 10.1159/000282098; Di Filippo M, 2012, J LIPID RES, V53, P548, DOI 10.1194/jlr.M020024; Duarte MASM, 2011, J PEDIAT-BRAZIL, V87, P150, DOI [10.2223/JPED.2065, 10.1590/S0021-75572011000200011]; Eberle D, 2004, DIABETES, V53, P2153, DOI 10.2337/diabetes.53.8.2153; Ebstein RP, 2000, EUR J PHARMACOL, V410, P205, DOI 10.1016/S0014-2999(00)00852-9; El-Koofy NM, 2011, SAUDI J GASTROENTERO, V17, P265, DOI 10.4103/1319-3767.82582; Fan JG, 2013, J GASTROEN HEPATOL, V28, P11, DOI 10.1111/jgh.12036; Friedel S, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-17; de Armas MGG, 2015, MED CLIN-BARCELONA, V144, P55, DOI 10.1016/j.medcli.2014.02.018; Hsiao PJ, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0242-6; Hsiao PJ, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-54; Klannemark M, 1998, DIABETOLOGIA, V41, P1516, DOI 10.1007/s001250051099; Kodhelaj K, 2014, MINERVA PEDIATR, V66, P23; Li L, 2014, GENET MOL RES, V13, P10150, DOI 10.4238/2014.December.4.9; Li Rong-shan, 2005, Zhonghua Yi Xue Za Zhi, V85, P2492; Lin YC, 2011, ANN HEPATOL, V10, P125, DOI 10.1016/S1665-2681(19)31560-1; Lin YC, 2010, PEDIATR NEONATOL, V51, P149, DOI 10.1016/S1875-9572(10)60028-9; Loomba R, 2008, GASTROENTEROLOGY, V134, P953, DOI 10.1053/j.gastro.2008.01.037; Lu JF, 2014, HUM IMMUNOL, V75, P1062, DOI 10.1016/j.humimm.2014.09.004; Macavei B, 2016, EUR REV MED PHARMACO, V20, P5081; Min Wen-jiao, 2009, Zhonghua Yixue Yichuanxue Zazhi, V26, P388, DOI 10.3760/cma.j.issn.1003-9406.2009.04.006; Min WJ, 2009, PSYCHOPHARMACOLOGY, V205, P409, DOI 10.1007/s00213-009-1550-3; Moreno-Navarrete JM, 2009, OBESITY, V17, P1755, DOI 10.1038/oby.2009.65; Musso G, 2010, J NUTR BIOCHEM, V21, P834, DOI 10.1016/j.jnutbio.2009.06.007; Namikawa C, 2004, J HEPATOL, V40, P781, DOI 10.1016/j.jhep.2004.01.028; Pacifico L, 2011, WORLD J GASTROENTERO, V17, P3082, DOI 10.3748/wjg.v17.i26.3082; Passaro A, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-112; Peng XE, 2014, LIVER INT, V34, P118, DOI 10.1111/liv.12220; Pereira IVA, 2011, EXPERT REV GASTROENT, V5, P245, DOI [10.1586/EGH.11.22, 10.1586/egh.11.22]; Phillips CM, 2010, J LIPID RES, V51, P3500, DOI 10.1194/jlr.M008474; Phillips JL, 2015, ACTA NEUROPSYCHIATR, V27, P353, DOI 10.1017/neu.2015.25; Pozzato C, 2010, J PEDIATR GASTR NUTR, V51, P331, DOI 10.1097/MPG.0b013e3181d70468; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; RAIZADA MK, 1988, NEUROCHEM RES, V13, P297, DOI 10.1007/BF00972477; Riancho JA, 2011, MOL GENET METAB, V104, P670, DOI 10.1016/j.ymgme.2011.08.013; Sanders RH, 2015, EUR J PEDIATR, V174, P715, DOI 10.1007/s00431-015-2551-3; Schwimmer JB, 2009, GASTROENTEROLOGY, V136, P1585, DOI 10.1053/j.gastro.2009.01.050; Shang XR, 2015, J PEDIATR GASTR NUTR, V60, P669, DOI 10.1097/MPG.0000000000000662; Sharma M, 2013, MOL BIOL REP, V40, P6261, DOI 10.1007/s11033-013-2738-5; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Siqueira ERF, 2012, BRAZ J MED BIOL RES, V45, P72, DOI 10.1590/S0100-879X2011007500160; Stan S, 2005, J LIPID RES, V46, P320, DOI 10.1194/jlr.M400346-JLR200; Tomeno W, 2015, J GASTROEN HEPATOL, V30, P1009, DOI 10.1111/jgh.12897; Valenti L, 2010, HEPATOLOGY, V52, P1274, DOI 10.1002/hep.23823; Wang YF, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000778; Watt KD, 2013, AM J TRANSPLANT, V13, P2450, DOI 10.1111/ajt.12355; Youssef NA, 2013, LIVER INT, V33, P1062, DOI 10.1111/liv.12165; Yu GI, 2011, INFLAMM RES, V60, P1099, DOI 10.1007/s00011-011-0372-z; Zegers D, 2016, CLIN RES HEPATOL GAS, V40, P333, DOI 10.1016/j.clinre.2015.09.001	61	9	10	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185396	10.1371/journal.pone.0185396	http://dx.doi.org/10.1371/journal.pone.0185396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953935	Green Submitted, Green Published, gold			2022-12-27	WOS:000411980300061
J	Elliott, SM; Brigham, ME; Lee, KE; Banda, JA; Choy, SJ; Gefell, DJ; Minarik, TA; Moore, JN; Jorgenson, ZG				Elliott, Sarah M.; Brigham, Mark E.; Lee, Kathy E.; Banda, Jo A.; Choy, Steven J.; Gefell, Daniel J.; Minarik, Thomas A.; Moore, Jeremy N.; Jorgenson, Zachary G.			Contaminants of emerging concern in tributaries to the Laurentian Great Lakes: I. Patterns of occurrence	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; WASTE-WATER CONTAMINANTS; 2-BUTOXYETHYL PHOSPHATE TBOEP; ORGANIC CONTAMINANTS; FLAME RETARDANTS; PHARMACEUTICALS; SEDIMENTS; FISH; MUSSELS; RECONNAISSANCE	Human activities introduce a variety of chemicals to the Laurentian Great Lakes including pesticides, pharmaceuticals, flame retardants, plasticizers, and solvents (collectively referred to as contaminants of emerging concern or CECs) potentially threatening the vitality of these valuable ecosystems. We conducted a basin-wide study to identify the presence of CECs and other chemicals of interest in 12 U.S. tributaries to the Laurentian Great Lakes during 2013 and 2014. A total of 292 surface-water and 80 sediment samples were collected and analyzed for approximately 200 chemicals. A total of 32 and 28 chemicals were detected in at least 30% of water and sediment samples, respectively. Concentrations ranged from 0.0284 (indole) to 72.2 (cholesterol) mu g/L in water and 1.75 (diphenhydramine) to 20,800 mu g/kg (fluoranthene) in sediment. Cluster analyses revealed chemicals that frequently co-occurred such as pharmaceuticals and flame retardants at sites receiving similar inputs such as wastewater treatment plant effluent. Comparison of environmental concentrations to water and sediment-quality benchmarks revealed that polycyclic aromatic hydrocarbon concentrations often exceeded benchmarks in both water and sediment. Additionally, bis(2-ethylhexyl) phthalate and dichlorvos concentrations exceeded water-quality benchmarks in several rivers. Results from this study can be used to understand organism exposure, prioritize river basins for future management efforts, and guide detailed assessments of factors influencing transport and fate of CECs in the Great Lakes Basin.	[Elliott, Sarah M.; Brigham, Mark E.] US Geol Survey, Mounds View, MN 55112 USA; [Lee, Kathy E.] US Geol Survey, Grand Rapids, MI USA; [Banda, Jo A.] US Fish & Wildlife Serv, Columbus, OH USA; [Choy, Steven J.] US Fish & Wildlife Serv, Madison, WI USA; [Gefell, Daniel J.] US Fish & Wildlife Serv, Cortland, NY USA; [Minarik, Thomas A.] Metropolitan Water Reclamat Dist Greater Chicago, Cicero, IL USA; [Moore, Jeremy N.] US Fish & Wildlife Serv, Chubbuck, ID USA; [Jorgenson, Zachary G.] St Cloud State Univ, Dept Biol, St Cloud, MN 56301 USA; [Jorgenson, Zachary G.] US Fish & Wildlife Serv, Bloomington, MN USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; Minnesota State Colleges & Universities; Saint Cloud State University; United States Department of the Interior; US Fish & Wildlife Service	Elliott, SM (corresponding author), US Geol Survey, Mounds View, MN 55112 USA.	selliott@usgs.gov		Elliott, Sarah/0000-0002-1414-3024; Brigham, Mark/0000-0001-7412-6800	U.S. Fish and Wildlife Service; Great Lakes Restoration Initiative through the U.S. Fish and Wildlife Service's CEC Team	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Great Lakes Restoration Initiative through the U.S. Fish and Wildlife Service's CEC Team	MEB and KEL (U.S. Geological Survey) received funding from the U.S. Fish and Wildlife Service for this project. Funding was provided from the Great Lakes Restoration Initiative through the U.S. Fish and Wildlife Service's CEC Team. In-kind support from the Metropolitan Water Reclamation District of Greater Chicago is acknowledged.	[Anonymous], [No title captured]; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Baldwin AK, 2016, SCI TOTAL ENVIRON, V554, P42, DOI 10.1016/j.scitotenv.2016.02.137; Barber LB, 2015, SCI TOTAL ENVIRON, V517, P195, DOI 10.1016/j.scitotenv.2015.02.035; Barber LB, 2013, ENVIRON SCI TECHNOL, V47, P2177, DOI 10.1021/es303720g; Blair BD, 2013, CHEMOSPHERE, V93, P2116, DOI 10.1016/j.chemosphere.2013.07.057; Booij K, 2002, CHEMOSPHERE, V46, P683, DOI 10.1016/S0045-6535(01)00232-6; BURKHARDT MR, 2006, DETERMINATION WASTEW; Childress C.J., 1999, NEW REPORTING PROCED; Ciocan CM, 2010, ENVIRON POLLUT, V158, P2977, DOI 10.1016/j.envpol.2010.05.025; Clement RE, 2012, ANAL BIOANAL CHEM, V404, P2639, DOI 10.1007/s00216-012-6300-4; Coquery M, 2009, ENVIRON POLLUT, V157, P1721; Crago J, 2016, GEN COMP ENDOCR, V232, P185, DOI 10.1016/j.ygcen.2015.12.030; Dodder NG, 2014, MAR POLLUT BULL, V81, P340, DOI 10.1016/j.marpolbul.2013.06.041; Elliott S.M., 2016, CHEM EMERGING CONCER; Elliott SM, 2015, CHEM EMERGING CONCER; Fischer J.M., 2015, US GEOLOGICAL SURVEY, V905, P42, DOI DOI 10.3133/DS905; Focazio MJ, 2008, SCI TOTAL ENVIRON, V402, P201, DOI 10.1016/j.scitotenv.2008.02.021; Foreman W. T., 2012, DETERMINATION STEROI; Furlong E.T., 2014, BOOK, V5, DOI DOI 10.3133/TM5B10; Gauthier PT, 2014, AQUAT TOXICOL, V154, P253, DOI 10.1016/j.aquatox.2014.05.026; Giraudo M, 2015, CHEMOSPHERE, V132, P159, DOI 10.1016/j.chemosphere.2015.03.028; Glassmeyer ST, 2005, ENVIRON SCI TECHNOL, V39, P5157, DOI 10.1021/es048120k; Great Lakes Commission, 2015, ANN REP GREAT LAK RE; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Kinney CA, 2006, ENVIRON TOXICOL CHEM, V25, P317, DOI 10.1897/05-187R.1; Kinney CA, 2006, ENVIRON SCI TECHNOL, V40, P7207, DOI 10.1021/es0603406; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Lee K.E., 2015, US GEOLOGICAL SURVEY, V910, P14; Lee K.E., 2012, US GEOLOGICAL SURVEY, V723, P26; Lee KE, 2009, US GEOLOGICAL SURVEY; Li A, 2006, ENVIRON SCI TECHNOL, V40, P7528, DOI 10.1021/es0609506; Loos R, 2013, WATER RES, V47, P6475, DOI 10.1016/j.watres.2013.08.024; Loos R, 2009, ENVIRON POLLUT, V157, P561, DOI 10.1016/j.envpol.2008.09.020; Ma ZY, 2016, CHEMOSPHERE, V144, P1920, DOI 10.1016/j.chemosphere.2015.10.049; Mcgee MR, 2009, AQUAT TOXICOL, V91, P355, DOI 10.1016/j.aquatox.2008.12.002; Moreirinha C, 2011, ARCH ENVIRON CON TOX, V61, P211, DOI 10.1007/s00244-010-9610-6; Niemuth NJ, 2015, CHEMOSPHERE, V135, P38, DOI 10.1016/j.chemosphere.2015.03.060; Nilsen E, 2014, J AM WATER RESOUR AS, V50, P291, DOI 10.1111/jawr.12161; O'Toole S, 2006, J GREAT LAKES RES, V32, P361, DOI 10.3394/0380-1330(2006)32[361:SMIFFU]2.0.CO;2; Pal A, 2010, SCI TOTAL ENVIRON, V408, P6062, DOI 10.1016/j.scitotenv.2010.09.026; Palace VP, 2006, ENVIRON TOXICOL CHEM, V25, P1114, DOI 10.1897/04-557R1.1; Paulos P, 2010, AQUAT TOXICOL, V99, P256, DOI 10.1016/j.aquatox.2010.05.001; Reiner JL, 2011, POLYCYCLIC MUSKS WAT, P335; Route WT, 2014, ENVIRON SCI TECHNOL, V48, P12516, DOI 10.1021/es501859a; Route WT, 2014, ENVIRON SCI TECHNOL, V48, P6653, DOI 10.1021/es501055d; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Schultz MM, 2013, ENVIRON INT, V61, P138, DOI 10.1016/j.envint.2013.08.006; Servos MR, 2005, SCI TOTAL ENVIRON, V336, P155, DOI 10.1016/j.scitotenv.2004.05.025; Shappell NW, 2010, AQUAT TOXICOL, V100, P1, DOI 10.1016/j.aquatox.2010.07.005; Song WL, 2005, ENVIRON SCI TECHNOL, V39, P3474, DOI 10.1021/es048291p; Song WL, 2004, ENVIRON SCI TECHNOL, V38, P3286, DOI 10.1021/es035297q; Song WL, 2005, ENVIRON SCI TECHNOL, V39, P5600, DOI 10.1021/es050631z; Stahl LL, 2014, SCI TOTAL ENVIRON, V499, P185, DOI 10.1016/j.scitotenv.2014.07.126; Thomas LM, 2017, PLOS ONE; U. S. Environmental Protection Agency, 2017, CHEM DASHB; Venier M, 2010, CHEMOSPHERE, V80, P1234, DOI 10.1016/j.chemosphere.2010.05.043; Warnes M.G.R., 2016, PACKAGE GPLOTS VARIO; WIDNR, 2003, CONS BAS SED QUAL GU; Writer JH, 2010, SCI TOTAL ENVIRON, V409, P100, DOI 10.1016/j.scitotenv.2010.07.018; Yang RQ, 2012, ENVIRON SCI TECHNOL, V46, P3119, DOI 10.1021/es204141p; Zaugg SD, 2006, DETERMINATION WASTEW	62	65	65	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0182868	10.1371/journal.pone.0182868	http://dx.doi.org/10.1371/journal.pone.0182868			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953889	Green Submitted, gold, Green Published			2022-12-27	WOS:000411980300005
J	Rabell, M; Meisinger, C; Peters, A; Holle, R; Laxy, M				Rabell, Matthias; Meisinger, Christa; Peters, Annette; Holle, Rolf; Laxy, Michael			The longitudinal association between change in physical activity, weight, and health-related quality of life: Results from the population-based KORA S4/F4/FF4 cohort study	PLOS ONE			English	Article							BODY-MASS INDEX; DOETINCHEM COHORT; ADULT-POPULATION; GERMANY; OBESITY; COSTS; TIME	Introduction Longitudinal evidence on the association between physical activity (PA) or weight and health-related quality of life (HRQL) is sparse and studies describe inconclusive results. The aim of this study was to examine longitudinal associations between change in PA and HRQL as between change in weight and HRQL respectively. Methods Analyses are based on data from the KORA S4 cohort study (1999-2001; n = 4,261, mean age 49.0 +/- 13.3 years) and the two follow-up examinations (F4: 2006-2008; FF4: 2013-2014). Information on PA was collected in standardized interviews. Weight was measured objectively. Mental and physical components of HRQL were assessed via the SF-12 questionnaire. First, change in HRQL was regressed on change in PA and weight. Second, hierarchical linear models were fitted, which allowed estimation of between-subject and within-subject effects. Analyses were adjusted for the covariates sex, baseline diseases, and education. Results A change to a physically more active lifestyle is positively associated with physical and mental HRQL. Although weight gain is associated with impairments in physical HRQL, the data show an inverse relationship between weight gain and mental HRQL. The results were consistent for both the change score analyses and the hierarchical linear models. Discussion Our findings stress the importance of interventions on PA/weight. Nonetheless, more research is needed to reveal the causal relationship between PA/weight and HRQL.	[Rabell, Matthias] Tech Univ Munich, Dept Sport & Hlth Sci, Munich, Germany; [Rabell, Matthias] Ludwig Maximilians Univ Munchen, Inst Med Informat Proc Biometr & Epidemiol IBE, Munich, Germany; [Rabell, Matthias; Holle, Rolf; Laxy, Michael] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Meisinger, Christa; Peters, Annette] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany	Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Rabell, M (corresponding author), Tech Univ Munich, Dept Sport & Hlth Sci, Munich, Germany.; Rabell, M (corresponding author), Ludwig Maximilians Univ Munchen, Inst Med Informat Proc Biometr & Epidemiol IBE, Munich, Germany.; Rabell, M (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany.	matthias.rabel@tum.de	Holle, Rolf/D-9333-2013; Meisinger, Christine/B-5358-2014; Peters, Annette/A-6117-2011	Holle, Rolf/0000-0001-5395-2695; Peters, Annette/0000-0001-6645-0985	German Federal Ministry of Education and Research; State of Bavaria; Helmholtz Zentrum Munchen-German Research Center for Environmental Health; Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of the LMU innovative	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Helmholtz Zentrum Munchen-German Research Center for Environmental Health(Helmholtz Association); Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of the LMU innovative	The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen-German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of the LMU innovative.	Balboa-Castillo T, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-47; Bize R, 2007, PREV MED, V45, P401, DOI 10.1016/j.ypmed.2007.07.017; Blacklock Rachel E, 2007, J Phys Act Health, V4, P138; Bullinger M., 2000, BUNDESGESUNDHEITSBLA, V43, P190, DOI DOI 10.1007/S001030050034; Cameron AJ, 2012, INT J OBESITY, V36, P295, DOI 10.1038/ijo.2011.103; Capehorn MS, 2016, CURRENT OBESITY REPO, P1; Doring N, 2015, PREV MED, V75, P12, DOI 10.1016/j.ypmed.2015.03.007; Ellert U, 2013, BUNDESGESUNDHEITSBLA, V56, P643, DOI 10.1007/s00103-013-1700-y; Elmer PJ, 2004, INT J OBESITY, V28, P1365, DOI 10.1038/sj.ijo.0802774; Hedeker D, 2004, QUANTITATIVE METHODO; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Hopman WM, 2007, QUAL LIFE RES, V16, P1595, DOI 10.1007/s11136-007-9273-6; Hunger M, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-53; Laxy M, 2014, INT J PUBLIC HEALTH, V59, P279, DOI 10.1007/s00038-013-0506-x; Leon-Munoz LM, 2005, INT J OBESITY, V29, P1385, DOI 10.1038/sj.ijo.0803049; May AM, 2010, AM J CLIN NUTR, V92, P491, DOI 10.3945/ajcn.2010.29404; Milder IEJ, 2014, J EPIDEMIOL COMMUN H, V68, P471, DOI 10.1136/jech-2013-203127; Pucci GCMF, 2012, REV SAUDE PUBL, V46, P166, DOI 10.1590/S0034-89102012000100021; Muller-Nordhorn J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093071; Organization WH, 2009, GLOB HLTH RISKS MORT; Pratt M, 2000, PHYSICIAN SPORTSMED, V28, P63, DOI 10.3810/psm.2000.10.1237; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Smolkowski K., 2015, GAIN SCORE ANAL 2013; Soltoft F, 2009, QUAL LIFE RES, V18, P1293, DOI 10.1007/s11136-009-9541-8; STENDER M, 1991, SOZ PRAVENTIV MED, V36, P176, DOI 10.1007/BF01352697; Tessier S, 2007, PREV MED, V44, P202, DOI 10.1016/j.ypmed.2006.11.012; Verkleij SPJ, 2013, EUR J PUBLIC HEALTH, V23, P285, DOI 10.1093/eurpub/cks058; Wang R, 2012, EUR J PUBLIC HEALTH, V22, P497, DOI 10.1093/eurpub/ckr080; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Warkentin LM, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0175-5; Wendel-Vos GCW, 2004, QUAL LIFE RES, V13, P667, DOI 10.1023/B:QURE.0000021313.51397.33; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Yates N, 2016, OBESITY FACTS, V9, P397, DOI 10.1159/000452248	33	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185205	10.1371/journal.pone.0185205	http://dx.doi.org/10.1371/journal.pone.0185205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4WR	28953956	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300042
J	Bertoli, S; Leone, A; Krakauer, NY; Bedogni, G; Vanzulli, A; Redaelli, VI; De Amicis, R; Vignati, L; Krakauer, JC; Battezzati, A				Bertoli, Simona; Leone, Alessandro; Krakauer, Nir Y.; Bedogni, Giorgio; Vanzulli, Angelo; Redaelli, Valentino Ippocrates; De Amicis, Ramona; Vignati, Laila; Krakauer, Jesse C.; Battezzati, Alberto			Association of Body Shape Index (ABSI) with cardio-metabolic risk factors: A cross-sectional study of 6081 Caucasian adults	PLOS ONE			English	Article							FAT-FREE MASS; ANTHROPOMETRIC MEASURES; WAIST CIRCUMFERENCE; OBESITY	A Body Shape Index (ABSI) was specifically developed as a transformation of waist circumference (WC), statistically independent of BMI to better evaluate the relative contribution of WC to central obesity and clinical outcomes. Previous studies have found ABSI is associated with total mortality and cardiovascular events. However, no study has specifically evaluated the joint contribution of ABSI and BMI to cardio-metabolic outcomes (high triglycerides, low HDL, high fasting glucose and high blood pressure). With this aim, we performed a retrospective study on 6081 Caucasian adults. Subjects underwent a medical interview, anthropometric measurements, blood sampling, measurement of blood pressure, and measurement of visceral abdominal fat thickness (VAT) by ultrasound. Generalized linear models (GLM) were used to evaluate the sex and age adjusted association of ABSI with binary and continuous cardio-metabolic risk factors. Four pre-specified GLM were evaluated for each outcome: M1 = ABSI, BMI and ABSI*BMI interaction, M2 = ABSI and BMI, M3 = ABSI alone and M4 = BMI alone. Bayesian Information Criterion (BIC) was calculated and used to identify the best predictive model. ABSI and BMI contributed independently to all outcomes. Compared to BMI alone, the joint use of BMI and ABSI yielded significantly improved associations for having high triglycerides (BIC = 5261 vs. 5286), low HDL (BIC = 5371 vs. 5381), high fasting glucose (BIC = 6328 vs. 6337) but not high blood pressure (BIC = 6580 vs. 6580). The joint use of BMI and ABSI was also more strongly associated with VAT than BMI alone (BIC = 22930 vs. 23479). In conclusion, ABSI is a useful index for evaluating the independent contribution of WC, in addition to that of BMI, as a surrogate for central obesity on cardio-metabolic risk.	[Bertoli, Simona; Leone, Alessandro; Bedogni, Giorgio; Redaelli, Valentino Ippocrates; De Amicis, Ramona; Vignati, Laila; Battezzati, Alberto] Univ Milan, Dept Food Environm & Nutr Sci DeFENS, ICANS, Milan, Italy; [Krakauer, Nir Y.] CUNY City Coll, Dept Civil Engn, New York, NY USA; [Vanzulli, Angelo] Osped Niguarda Ca Granda, Niguarda Canc Ctr, Milan, Italy; [Vanzulli, Angelo] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy; [Krakauer, Jesse C.] Metro Detroit Diabet & Endocrinol, Southfield, MI USA	University of Milan; City University of New York (CUNY) System; City College of New York (CUNY); IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Milan	Bertoli, S (corresponding author), Univ Milan, Dept Food Environm & Nutr Sci DeFENS, ICANS, Milan, Italy.	simona.bertoli@unimi.it	Vanzulli, Angelo/X-4175-2019; Battezzati, Alberto/J-1717-2012; Bedogni, Giorgio/K-1911-2018; DE AMICIS, RAMONA/AFY-2040-2022; Leone, Alessandro/F-4769-2015; Bertoli, Simona/K-2805-2018; Krakauer, Jesse/AAV-2692-2021; DE AMICIS, RAMONA/S-5585-2019	Vanzulli, Angelo/0000-0002-2452-3370; Bedogni, Giorgio/0000-0002-1495-9306; DE AMICIS, RAMONA/0000-0003-0403-5465; Leone, Alessandro/0000-0001-8063-8490; BERTOLI, SIMONA/0000-0001-5867-8074	ICANS	ICANS	This study was supported by ICANS internal grants. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2013, SCIENCE, V341, P856, DOI 10.1126/science.1241244; ARMELLINI F, 1993, INT J OBESITY, V17, P209; ARMELLINI F, 1990, J CLIN ULTRASOUND, V18, P563, DOI 10.1002/jcu.1870180707; Bedogni G, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-98; Bertoli S, 2016, NUTR J, V15, DOI 10.1186/s12937-015-0120-2; Bertoli S, 2015, CLIN NUTR, V34, P1266, DOI 10.1016/j.clnu.2015.10.003; Biolo G, 2015, CLIN NUTR, V34, P323, DOI 10.1016/j.clnu.2014.03.015; Boniface D., 2013, EUR J PUBLIC HLTH S1, V23; Bouchi R, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2015-000188; Bozorgmanesh M, 2016, EUR J NUTR, V55, P147, DOI 10.1007/s00394-015-0833-1; Cheung Yin Bun, 2014, PLoS One, V9, pe85421, DOI 10.1371/journal.pone.0085421; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Dhana K, 2016, MATURITAS, V88, P96, DOI 10.1016/j.maturitas.2016.03.018; Dhana K, 2016, J EPIDEMIOL COMMUN H, V70, P90, DOI 10.1136/jech-2014-205257; Dhana K, 2015, HEART, V101, P377, DOI 10.1136/heartjnl-2014-306704; Duncan MJ, 2013, ANN HUM BIOL, V40, P163, DOI 10.3109/03014460.2012.752861; Haghighatdoost F, 2014, NUTRITION, V30, P636, DOI 10.1016/j.nut.2013.10.021; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; He S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050573; Krakauer JC, 2016, CASE REP MED, V2016, DOI 10.1155/2016/1526175; Krakauer N. Y., 2014, Journal of Obesity & Weight Loss Therapy, V4, P216; Krakauer NY, 2016, J OBES, V2016, DOI 10.1155/2016/8094275; Krakauer NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088793; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Leone A, 2016, BRIT J NUTR, V116, P1984, DOI 10.1017/S0007114516004141; Lohmann TG, 1988, ANTHROPOMETRIC STAND; Long J.S., 2006, REGRESSION MODELS CA; Maessen Martijn F H, 2014, PLoS One, V9, pe107212, DOI 10.1371/journal.pone.0107212; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; NHLBI Obesity Education Initiative Expert Panel on the Identification Evaluation and Treatment of Obesity in Adults (US), 1998, CLIN GUID ID EV TREA; Park SH, 2014, CLIN NUTR, V33, P668, DOI 10.1016/j.clnu.2013.08.008; Roth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015923; Rothney MP, 2013, OBESITY, V21, P1798, DOI 10.1002/oby.20223; Siervo M, 2016, EUR J NUTR, V55, P1755, DOI 10.1007/s00394-015-0993-z; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Soldati L, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-34; Song X, 2015, NUTR METAB CARDIOVAS, V25, P295, DOI 10.1016/j.numecd.2014.09.004; Spadafranca A, 2015, CLIN NUTR, V34, P674, DOI 10.1016/j.clnu.2014.07.014	39	54	57	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185013	10.1371/journal.pone.0185013	http://dx.doi.org/10.1371/journal.pone.0185013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945809	Green Published, Green Submitted, gold			2022-12-27	WOS:000411645100015
J	Euskirchen, P; Radke, J; Schmidt, MS; Heuling, ES; Kadikowski, E; Maricos, M; Knab, F; Grittner, U; Zerbe, N; Czabanka, M; Dieterich, C; Miletic, H; Mork, S; Koch, A; Endres, M; Harms, C				Euskirchen, Philipp; Radke, Josefine; Schmidt, Marc Soeren; Heuling, Eva Schulze; Kadikowski, Eric; Maricos, Meron; Knab, Felix; Grittner, Ulrike; Zerbe, Norman; Czabanka, Marcus; Dieterich, Christoph; Miletic, Hrvoje; Mork, Sverre; Koch, Arend; Endres, Matthias; Harms, Christoph			Cellular heterogeneity contributes to subtype-specific expression of ZEB1 in human glioblastoma	PLOS ONE			English	Article							IMAGE-ANALYSIS; RNA-SEQ; GLIOMAS; INVASION; DIFFERENTIATION; PHENOTYPES; REVEALS; GROWTH; TUMORS; LINES	The transcription factor ZEB1 has gained attention in tumor biology of epithelial cancers because of its function in epithelial-mesenchymal transition, DNA repair, stem cell biology and tumor-induced immunosuppression, but its role in gliomas with respect to invasion and prognostic value is controversial. We characterized ZEB1 expression at single cell level in 266 primary brain tumors and present a comprehensive dataset of high grade gliomas with Ki67, p53, IDH1, and EGFR immunohistochemistry, as well as EGFR FISH. ZEB1 protein expression in glioma stem cell lines was compared to their parental tumors with respect to gene expression subtypes based on RNA-seq transcriptomic profiles. ZEB1 is widely expressed in glial tumors, but in a highly variable fraction of cells. In glioblastoma, ZEB1 labeling index is higher in tumors with EGFR amplification or IDH1 mutation. Co-labeling studies showed that tumor cells and reactive astroglia, but not immune cells contribute to the ZEB1 positive population. In contrast, glioma cell lines constitutively express ZEB1 irrespective of gene expression subtype. In conclusion, our data indicate that immune infiltration likely contributes to differential labelling of ZEB1 and confounds interpretation of bulk ZEB1 expression data.	[Euskirchen, Philipp; Endres, Matthias] Charite, Dept Neurol, Berlin, Germany; [Euskirchen, Philipp; Schmidt, Marc Soeren; Heuling, Eva Schulze; Kadikowski, Eric; Maricos, Meron; Knab, Felix; Endres, Matthias; Harms, Christoph] Charite, Dept Expt Neurol, Berlin, Germany; [Euskirchen, Philipp; Radke, Josefine; Koch, Arend; Harms, Christoph] BIH, Berlin, Germany; [Radke, Josefine; Koch, Arend] Charite, Dept Neuropathol, Berlin, Germany; [Radke, Josefine; Koch, Arend] German Canc Consortium DKTK, Partner Site Charite Berlin, Berlin, Germany; [Grittner, Ulrike; Endres, Matthias; Harms, Christoph] Charite, Ctr Stroke Res Berlin, Berlin, Germany; [Grittner, Ulrike] Charite, Dept Biostat & Clin Epidemiol, Berlin, Germany; [Zerbe, Norman] Charite, Dept Pathol, Berlin, Germany; [Czabanka, Marcus] Charite, Dept Neurosurg, Berlin, Germany; [Dieterich, Christoph] Max Planck Inst Biol Ageing, Computat RNA Biol & Ageing Grp, Cologne, Germany; [Miletic, Hrvoje] Univ Bergen, Dept Biomed, Bergen, Norway; [Miletic, Hrvoje; Mork, Sverre] Haukeland Hosp, Dept Pathol, Bergen, Norway; [Endres, Matthias] Deutsch Zentrum Herz Kreislauf Forsch DZHK, Standort Berlin, Berlin, Germany; [Endres, Matthias] DZNE, Standort Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; University of Bergen; University of Bergen; Haukeland University Hospital; German Centre for Cardiovascular Research; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Euskirchen, P (corresponding author), Charite, Dept Neurol, Berlin, Germany.; Euskirchen, P (corresponding author), Charite, Dept Expt Neurol, Berlin, Germany.; Euskirchen, P (corresponding author), BIH, Berlin, Germany.	philipp.euskirchen@charite.de	Grittner, Ulrike/I-2026-2019; Dieterich, Christoph/ABF-8459-2021; Radke, Josefine/GQH-8274-2022; Euskirchen, Philipp/AFL-2848-2022; Harms, Christoph/HIK-2989-2022; Mörk, Sverre Jarl/AAW-1330-2020; Harms, Christoph/AAD-7895-2021	Grittner, Ulrike/0000-0003-2595-0224; Radke, Josefine/0000-0001-9860-2007; Euskirchen, Philipp/0000-0002-9138-805X; Harms, Christoph/0000-0002-2063-2860; Zerbe, Norman/0000-0002-0314-3037; Knab, Felix/0000-0002-7240-5926; Endres, Matthias/0000-0001-6520-3720	Berliner Krebsgesellschaft [EUFF-2012-36]; Einstein Foundation Berlin [EZK-2012-157]; Charite-Universitatsmedizin Berlin; Berlin Institute of Health	Berliner Krebsgesellschaft; Einstein Foundation Berlin; Charite-Universitatsmedizin Berlin; Berlin Institute of Health	This work was supported by Berliner Krebsgesellschaft (EUFF-2012-36, to PE and CH) and the Einstein Foundation Berlin (EZK-2012-157, to PE). JR and PE are participants of the BIH-Charite Clinician Scientist Program funded by the Charite-Universitatsmedizin Berlin and the Berlin Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Janet Lips, Petra Matylewski and Randi Koll for excellent technical support, as well as Peter Hufnagl for access to slide scanners. JR and PE are participants of the BIH-Charite Clinician Scientist Program funded by the Charite Universitatsmedizin Berlin and the Berlin Institute of Health.	Amankulor NM, 2017, GENE DEV, V31, P774, DOI 10.1101/gad.294991.116; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bates D., 2014, ARXIV14065823STAT; Berghoff AS, 2017, NEUROONCOLOGY; Bowman RL, 2017, NEURO-ONCOLOGY, V19, P139, DOI 10.1093/neuonc/now247; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; CHEN L, 2014, IEEE IJCNN, P1, DOI DOI 10.1038/NC0MMS6241; Engler JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043339; Euskirchen P, 2011, EXP CELL RES, V317, P2864, DOI 10.1016/j.yexcr.2011.09.002; Gabrusiewicz K, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85841; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Heuling ES, 2017, MOL CANC RES; Joseph JV, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.395; Joseph JV, 2015, CANCER LETT, V359, P107, DOI 10.1016/j.canlet.2015.01.010; Kahlert U, 2012, CANC LETT; Kahlert U, 2014, BRAIN PATHOL; Klein R, 2001, ACTA NEUROPATHOL, V101, P245; Kohanbash G, 2017, J CLIN INVEST, V127, P1425, DOI 10.1172/JCI90644; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Louis DN, 2016, ACTA NEUROPATHOL, V1-18; MORANTZ RA, 1979, J NEUROSURG, V50, P305, DOI 10.3171/jns.1979.50.3.0305; Nesvick CL, 2016, J NEUROONCOL; Nordfors K, 2015, J CLIN PATHOL, V68, P905, DOI 10.1136/jclinpath-2015-202868; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; ROSSI ML, 1987, ACTA NEUROPATHOL, V74, P269, DOI 10.1007/BF00688191; Siebzehnrubl FA, 2013, EMBO MOL MED, V5, P1196, DOI 10.1002/emmm.201302827; Singh DK, 2017, CELL REP, V18, P961, DOI 10.1016/j.celrep.2016.12.064; Singh SK, 2016, CELL REP; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Talasila KM, 2013, ACTA NEUROPATHOL, V125, P683, DOI 10.1007/s00401-013-1101-1; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Zerbe N, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S16; Zhang L, 2016, ONCOGENE; Zhang P, 2014, NAT CELL BIOL, V16, P864, DOI 10.1038/ncb3013	48	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185376	10.1371/journal.pone.0185376	http://dx.doi.org/10.1371/journal.pone.0185376			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945795	gold, Green Published, Green Submitted			2022-12-27	WOS:000411645100054
J	Hu, XL; Zhao, S; Shi, F; Huang, J; Shan, XH				Hu, Xinlei; Zhao, Shuo; Shi, Feng; Huang, Jie; Shan, Xinghua			Circuity analyses of HSR network and highspeed train paths in China	PLOS ONE			English	Article								Circuity, defined as the ratio of the shortest network distance to the Euclidean distance between one origin-destination (O-D) pair, can be adopted as a helpful evaluation method of indirect degrees of train paths. In this paper, the maximum circuity of the paths of operated trains is set to be the threshold value of the circuity of high-speed train paths. For the shortest paths of any node pairs, if their circuity is not higher than the threshold value, the paths can be regarded as the reasonable paths. With the consideration of a certain relative or absolute error, we cluster the reasonable paths on the basis of their inclusion relationship and the center path of each class represents a passenger transit corridor. We take the highspeed rail (HSR) network in China at the end of 2014 as an example, and obtain 51 passenger transit corridors, which are alternative sets of train paths. Furthermore, we analyze the circuity distribution of paths of all node pairs in the network. We find that the high circuity of train paths can be decreased with the construction of a high-speed railway line, which indicates that the structure of the HSR network in China tends to be more complete and the HSR network can make the Chinese railway network more efficient.	[Hu, Xinlei; Zhao, Shuo; Shi, Feng] Cent South Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China; [Huang, Jie] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Reg Sustainable Dev Modeling, Beijing, Peoples R China; [Shan, Xinghua] China Acad Railway Sci, Inst Comp Technol, Beijing, Peoples R China	Central South University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Shi, F (corresponding author), Cent South Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China.	shifeng@csu.edu.cn			National Natural Science Foundation of China [U1334207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. U1334207).	Ballou RH, 2002, TRANSPORT RES A-POL, V36, P843, DOI 10.1016/S0965-8564(01)00044-1; Barthelemy M, 2011, PHYS REP, V499, P1; China Railways Corporation, CHIN RAILW YB 2014; Corbusier Le, 1929, CITY TOMORROW ITS PL; CSBTS and Ministry of Construction of China, 1995, URB ROAD TRAFF PLANN; Dhakar NS, 2014, TRANSPORT RES REC, P65, DOI 10.3141/2413-07; Du WB, 2016, TRANSPORT RES E-LOG, V89, P108, DOI 10.1016/j.tre.2016.03.009; Giacomin DJ, 2014, ENVIRON PLANN B, V42, P1040; Huang J, 2015, J TRANSP GEOGR, V48, P145, DOI 10.1016/j.jtrangeo.2015.09.004; [康维韬 KANG Weitao], 2008, [中国铁道科学, China Railway Science], V29, P93; Lee YJ., 2012, J TRANSPORTATION RES, V47, P149; Lee YJ, 2015, J PUBLIC TRANSPORT, V18, P89, DOI 10.5038/2375-0901.18.2.7; Levinson D, 2009, REG SCI URBAN ECON, V39, P732, DOI 10.1016/j.regsciurbeco.2009.07.003; Li Y, 2015, INT C LOG ENG MAN IC; [吕晓艳 Lu Xiaoyan], 2007, [中国铁道科学, China Railway Science], V28, P122; Meilus A, 2014, INTEG COMMUN NAVIG; Newell G., 1980, TRAFFIC FLOW TRANSPO; Popken DA, 2006, TRANSPORT RES E-LOG, V42, P431, DOI 10.1016/j.tre.2005.05.002; Russon MG, 1989, REV REG STUD, V19, P50; Sen P, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.036106; The National Development and Reform Commission, 2008, MID TO LONG TERM RAI; Transport Bureau of China Railways Corporation, 2014, NAT RAILW PASS TRAIN; WARSHALL S, 1962, J ACM, V9, P11, DOI 10.1145/321105.321107; Zhang J, 2010, PHYSICA A, V389, P3922, DOI 10.1016/j.physa.2010.05.042	24	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0176005	10.1371/journal.pone.0176005	http://dx.doi.org/10.1371/journal.pone.0176005			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945757	Green Submitted, Green Published, gold			2022-12-27	WOS:000411645100001
J	Hernandez, C; Mella, C; Navarro, G; Olivera-Nappa, A; Araya, J				Hernandez, Cecilia; Mella, Carlos; Navarro, Gonzalo; Olivera-Nappa, Alvaro; Araya, Jaime			Protein complex prediction via dense subgraphs and false positive analysis	PLOS ONE			English	Article							INTERACTION NETWORKS; SACCHAROMYCES-CEREVISIAE; BIOLOGICAL NETWORKS; IDENTIFICATION; DATABASE; YEAST; INTERACTOME; CLIQUES	Many proteins work together with others in groups called complexes in order to achieve a specific function. Discovering protein complexes is important for understanding biological processes and predict protein functions in living organisms. Large-scale and throughput techniques have made possible to compile protein-protein interaction networks (PPI networks), which have been used in several computational approaches for detecting protein complexes. Those predictions might guide future biologic experimental research. Some approaches are topology-based, where highly connected proteins are predicted to be complexes; some propose different clustering algorithms using partitioning, overlaps among clusters for networks modeled with unweighted or weighted graphs; and others use density of clusters and information based on protein functionality. However, some schemes still require much processing time or the quality of their results can be improved. Furthermore, most of the results obtained with computational tools are not accompanied by an analysis of false positives. We propose an effective and efficient mining algorithm for discovering highly connected subgraphs, which is our base for defining protein complexes. Our representation is based on transforming the PPI network into a directed acyclic graph that reduces the number of represented edges and the search space for discovering subgraphs. Our approach considers weighted and unweighted PPI networks. We compare our best alternative using PPI networks from Saccharomyces cerevisiae (yeast) and Homo sapiens (human) with state-of-the-art approaches in terms of clustering, biological metrics and execution times, as well as three gold standards for yeast and two for human. Furthermore, we analyze false positive predicted complexes searching the PDBe (Protein Data Bank in Europe) database in order to identify matching protein complexes that have been purified and structurally characterized. Our analysis shows that more than 50 yeast protein complexes and more than 300 human protein complexes found to be false positives according to our prediction method, i. e., not described in the gold standard complex databases, in fact contain protein complexes that have been characterized structurally and documented in PDBe. We also found that some of these protein complexes have recently been classified as part of a Periodic Table of Protein Complexes.	[Hernandez, Cecilia; Mella, Carlos; Araya, Jaime] Univ Concepcion, Comp Sci, Concepcion, Chile; [Hernandez, Cecilia; Navarro, Gonzalo] Univ Chile, Ctr Biotechnol & Bioengn CeBiB, Dept Comp Sci, Santiago, Chile; [Olivera-Nappa, Alvaro] Univ Chile, Ctr Biotechnol & Bioengn CeBiB, Dept Chem Engn & Biotechnol, Santiago, Chile	Universidad de Concepcion; Universidad de Chile; Universidad de Chile	Hernandez, C (corresponding author), Univ Concepcion, Comp Sci, Concepcion, Chile.; Hernandez, C (corresponding author), Univ Chile, Ctr Biotechnol & Bioengn CeBiB, Dept Comp Sci, Santiago, Chile.	cecihernandez@udec.cl	Olivera-Nappa, Alvaro/GPS-5388-2022; Olivera-Nappa, Alvaro/H-3769-2013	Olivera-Nappa, Alvaro/0000-0001-6053-7019; Olivera-Nappa, Alvaro/0000-0001-6053-7019; Hernandez, Cecilia/0000-0003-1301-6987	Conicyt, Chile [FB0001, Fondecyt 1141311]; Center for Biotechnology and Bioengineering (CeBiB); Fondecyt, Conicyt, Chile [1141311]	Conicyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Center for Biotechnology and Bioengineering (CeBiB); Fondecyt, Conicyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Funded with basal funds FB0001 Conicyt, Chile, and Fondecyt 1141311 Conicyt, Chile.; Funded by Center for Biotechnology and Bioengineering (CeBiB), Basal Center FB0001, Conicyt, Chile; and Fondecyt Grant 1141311, Conicyt, Chile. We also thank the reviewers for their comments, which helped improve the quality of the presentation.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Ahnert SE, 2015, SCIENCE, V350, DOI 10.1126/science.aaa2245; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Cao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061944; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; del Sol A, 2005, BIOINFORMATICS, V21, P1311, DOI 10.1093/bioinformatics/bti167; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Friedel CC, 2009, J COMPUT BIOL, V16, P971, DOI 10.1089/cmb.2009.0023; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hu AL, 2013, IEEE ACM T COMPUT BI, V10, P780, DOI 10.1109/TCBB.2013.37; Hu LX, 2015, BMC GENOMICS, V16, DOI [10.1186/s12859-015-0583-3, 10.1186/s12864-015-1799-3]; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Ji JZ, 2014, IEEE T KNOWL DATA EN, V26, P261, DOI 10.1109/TKDE.2012.225; Kikugawa S, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S7; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krumsiek J, 2008, BIOINFORMATICS, V24, P2115, DOI 10.1093/bioinformatics/btn376; Li Xiao-Li, 2007, Comput Syst Bioinformatics Conf, V6, P157; Li XY, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0069-z; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marsh JA, 2015, ANNU REV BIOCHEM, V84, P551, DOI 10.1146/annurev-biochem-060614-034142; Marsh JA, 2013, CELL, V153, P461, DOI 10.1016/j.cell.2013.02.044; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Pellegrini M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1191-6; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Rahman MS, 2013, FIT VULNERABLE UNPUB, P1; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tang XW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/354539; Tumuluru P, 2015, SURVEY IDENTIFICATIO, P57; Wang JX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S2-S10; Wuchty S, 2001, MOL BIOL EVOL, V18, P1694, DOI 10.1093/oxfordjournals.molbev.a003957; Wuchty Stefan, 2006, P165; Zhang XF, 2014, BMC BIOINFORMATICS, V15, DOI [10.1186/1471-2105-15-186, 10.1186/1471-2105-15-335]; Zhao F, 2010, BIOINFORMATICS, V26, pi310, DOI 10.1093/bioinformatics/btq193	41	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0183460	10.1371/journal.pone.0183460	http://dx.doi.org/10.1371/journal.pone.0183460			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28937982	Green Submitted, Green Published, gold			2022-12-27	WOS:000411524700002
J	Adams, RA; Carter, RT				Adams, Rick A.; Carter, Richard T.			Megachiropteran bats profoundly unique from microchiropterans in climbing and walking locomotion: Evolutionary implications	PLOS ONE			English	Article							TERRESTRIAL LOCOMOTION; ECHOLOCATION; SHREW; ENERGETICS; MECHANICS; MEGABATS; DYNAMICS; ARBOREAL; PRIMATES	Understandably, most locomotor analyses of bats have focused on flight mechanics and behaviors. However, we investigated nonflight locomotion in an effort to glean deeper insights into the evolutionary history of bats. We used high-speed video (300 Hz) to film and compare walking and climbing mechanics and kinematics between several species of the suborders Megachiroptera (Pteropodidae) versus Microchiroptera (Vespertilionidae and Phyllostomatidae). We found fundamentally distinctive behaviors, functional abilities, and performance outcomes between groups, but nearly homogeneous outcomes within groups. Megachiropterans exhibited climbing techniques and skills not found in microchiropterans and which aligned with other fully arboreal mammals. Megachiropterans climbed readily when placed in a head-up posture on a vertical surface, showed significantly greater ability than microchiropterans to abduct and extend the reach of their limbs, and climbed at a greater pace by using a more aggressive ipsilateral gait, at times being supported by only a single contact point. In addition, megachiropterans showed little ability to employ basic walking mechanics when placed on the ground, also a pattern observed in some highly adapted arboreal mammals. Conversely, microchiropterans resisted climbing vertical surfaces in a head-up posture, showed significantly less extension of their limbs, and employed a less-aggressive, slower contralateral gait with three points of contact. When walking, microchiropterans used the same gait they did when climbing which is representative of basic tetrapod terrestrial mechanics. Curiously, megachiropterans cycled their limbs significantly faster when climbing than when attempting to walk, whereas microchiropterans cycled their limbs at significantly faster rates when walking than when climbing. We contend that nonflight locomotion mechanics give a deep evolutionary view into the ancestral es locomotor platform on which flight was built in each of these groups.	[Adams, Rick A.] Univ Northen Colorado, Sch Biol Sci, Greeley, CO 80639 USA; [Carter, Richard T.] Univ Dayton, Dept Biol, Dayton, OH 45469 USA	University of Northern Colorado; University of Dayton	Adams, RA (corresponding author), Univ Northen Colorado, Sch Biol Sci, Greeley, CO 80639 USA.	rick.adams@unco.edu		Adams, Rick/0000-0002-0119-5052	University of Northern Colorado;  [UNC-FRPB-RAA15]	University of Northern Colorado; 	Funded by UNC-FRPB-RAA15, travel	Achmidt S, 2010, J EXP BIOL, V214, P2544; Adams RA, 2013, TIMES ARROW EVOLUTIO, P21; Alexander R. M., 1971, SIZE SHAPE; Altringham JD, 2011, BATS: FROM EVOLUTION TO CONSERVATION, 2ND EDITION, P1; BUCHLER ER, 1976, ANIM BEHAV, V24, P858, DOI 10.1016/S0003-3472(76)80016-4; Byrnes G, 2011, J MAMMAL, V92, P444, DOI 10.1644/10-MAMM-A-048.1; Carter RT, 2014, ANAT REC, V297, P1270, DOI 10.1002/ar.22934; DEFREES S L, 1988, Mammalian Species, P1, DOI 10.2307/3504095; DIETZ CL, 1973, J MAMMAL, V54, P790, DOI 10.2307/1378988; Fischer MS, 2006, J EXP ZOOL PART A, V305A, P935, DOI 10.1002/jez.a.333; FORSMAN KA, 1988, J ZOOL, V216, P655, DOI 10.1111/j.1469-7998.1988.tb02463.x; Frobisch J, 2009, P ROY SOC B-BIOL SCI, V276, P3611, DOI 10.1098/rspb.2009.0911; Greenhall Arthur M., 1996, Mammalian Species, V533, P1; Halsey LG, 2016, J EXP BIOL, V219, P1424, DOI 10.1242/jeb.133256; Hildebrand M., 1966, Folia Biotheoretica, VNo. 6, P9; Hoffmann AA, 2014, PRINCETON GUIDE EVOL, P247; Jepsen G. L., 1970, P1; LAWRENCE MJ, 1969, J ZOOL, V157, P309; Lim NTL., 2007, COLUGO FLYING LEMUR; McMahon TA, 1983, ON SIZE AND LIFE; MENDEL FC, 1981, J MAMMAL, V62, P413, DOI 10.2307/1380728; Meng QJ, 2015, SCIENCE, V347, P764, DOI 10.1126/science.1260879; Mondajem A, 2001, BATS SO CENTRAL AFRI; PETTIGREW JD, 1989, PHILOS T ROY SOC B, V325, P489, DOI 10.1098/rstb.1989.0102; PETTIGREW JD, 1986, SCIENCE, V231, P1304, DOI 10.1126/science.3945827; Ponzer H, 2004, J HUM EVOL, V46, P315; Reilly SM, 2006, P ROY SOC B-BIOL SCI, V273, P1563, DOI 10.1098/rspb.2006.3489; Riskin DK, 2006, J EXP BIOL, V209, P1725, DOI 10.1242/jeb.02186; Rose KD., 2009, BEGINNING AGE MAMMAL; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Schmitt D, 2010, J EXP BIOL, V213, P3615; Schutt W.A., 2006, FUNCTIONAL EVOLUTION, P145; Siemers BM, 2009, BIOL LETTERS, V5, P593, DOI 10.1098/rsbl.2009.0378; TAYLOR CR, 1982, J EXP BIOL, V97, P1; TOMASI TE, 1979, J MAMMAL, V60, P751, DOI 10.2307/1380190; Van Den Brink F. H, 1967, FIELD GUIDE MAMMALS; Vogel S., 1988, LIFES DEVICES PHYS W; Voigt CC, 2012, J EXP BIOL, V215, P4340, DOI 10.1242/jeb.076224; WATKINS L C, 1972, Mammalian Species, V23, P1; Witte H, 2000, P INT S AD MOT AN MA; Wunderlich RE, 2014, INTEGR COMP BIOL, V54, P1148, DOI 10.1093/icb/icu110	41	3	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185634	10.1371/journal.pone.0185634	http://dx.doi.org/10.1371/journal.pone.0185634			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957404	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200098
J	Kim, SK; Kleimeyer, JP; Ahmed, MA; Avins, AL; Fredericson, M; Dragoo, JL; Ioannidis, JPA				Kim, Stuart K.; Kleimeyer, John P.; Ahmed, Marwa A.; Avins, Andrew L.; Fredericson, Michael; Dragoo, Jason L.; Ioannidis, John P. A.			Two genetic loci associated with ankle injury	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; PREVENTION; REPLICATION; SPRAIN; LOCALIZATION; METAANALYSIS; BASKETBALL; PLAYERS; SPORTS	Ankle injuries, including sprains, strains and other joint derangements and instability, are common, especially for athletes involved in indoor court or jumping sports. Identifying genetic loci associated with these ankle injuries could shed light on their etiologies. A genome-wide association screen was performed using publicly available data from the Research Program in Genes, Environment and Health (RPGEH) including 1,694 cases of ankle injury and 97,646 controls. An indel (chr21:47156779:D) that lies close to a collagen gene, COL18A1, showed an association with ankle injury at genome-wide significance (p = 3.8x10(-8); OR = 1.99; 95% CI = 1.75-2.23). A second DNA variant (rs13286037 on chromosome 9) that lies within an intron of the transcription factor gene NFIB showed an association that was nearly genome-wide significant (p = 5.1x10(-8); OR = 1.63; 95% CI = 1.46-1.80). The ACTN3 R577X mutation was previously reported to show an association with acute ankle sprains, but did not show an association in this cohort. This study is the first genomewide screen for ankle injury that yields insights regarding the genetic etiology of ankle injuries and provides DNA markers with the potential to inform athletes about their genetic risk for ankle injury.	[Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; [Kleimeyer, John P.; Fredericson, Michael; Dragoo, Jason L.] Stanford Univ, Dept Orthopaed Surg, Med Ctr, Stanford, CA 94305 USA; [Ahmed, Marwa A.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Avins, Andrew L.] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Dept Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Div Epidemiol, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA	Stanford University; Stanford University; Harvard University; Harvard Medical School; Kaiser Permanente; Stanford University; Stanford University; Stanford University	Kim, SK (corresponding author), Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA.	stuartkm@stanford.edu	Ioannidis, John P. A./G-9836-2011	Fredericson, Michael/0000-0001-9826-2348; Ioannidis, John P./0000-0003-3118-6859; kim, stuart/0000-0001-8887-5095	NIH [5RO1AG025941]; Robert Wood Johnson Foundation; Ellison Medical Foundation; Wayne and Gladys Valley Foundation; Kaiser Permanente; National Institutes of Health [RC2 AG036607]; NATIONAL INSTITUTE ON AGING [RC2AG036607, R01AG025941] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Ellison Medical Foundation(Lawrence Ellison Foundation); Wayne and Gladys Valley Foundation; Kaiser Permanente; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the NIH (5RO1AG025941) to SKK. Participant enrollment, survey and sample collection for the RPGEH were supported by grants from the Robert Wood Johnson Foundation, the Ellison Medical Foundation, the Wayne and Gladys Valley Foundation, and Kaiser Permanente. Development of genotypic data was supported by grant RC2 AG036607 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Kaiser Permanente Northern California RPGEH team for access to data and assistance in data management. This work was supported by grants from the NIH (5RO1AG025941). Data for this study were provided by the Kaiser Permanente Research Program on Genes, Environment and Health (RPGEH). Participant enrollment, survey and sample collection for the RPGEH were supported by grants from the Robert Wood Johnson Foundation, the Ellison Medical Foundation, the Wayne and Gladys Valley Foundation, and Kaiser Permanente. Development of genotypic data was supported by grant RC2 AG036607 from the National Institutes of Health. Information about data access can be obtained at: http://www.ncbi.nlm.nih.gov/projects/gap/cgibin/study.cgi?study id=phs000674.vl.pl and https://researchbank.kaiserpermanente.org/for-researchers/.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Doherty C, 2014, SPORTS MED, V44, P123, DOI 10.1007/s40279-013-0102-5; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emery CA, 2010, BRIT J SPORT MED, V44, P555, DOI 10.1136/bjsm.2010.074377; Fong DTP, 2007, SPORTS MED, V37, P73, DOI 10.2165/00007256-200737010-00006; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Ioannidis JPA, 2011, EPIDEMIOLOGY, V22, P450, DOI 10.1097/EDE.0b013e31821b506e; Jorgenson E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10130; Kim SK, 2016, PLOS ONE, V12; Kim SK, 2017, INT J SPORT IN PRESS; Kim S, 2017, INT J SPORTS MED, V38, P508, DOI 10.1055/s-0043-106190; Makeyev AV, 2000, GENOMICS, V67, P301, DOI 10.1006/geno.2000.6244; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; McGuine TA, 2011, AM J SPORT MED, V39, P1840, DOI 10.1177/0363546511406242; OH SP, 1994, GENOMICS, V19, P494, DOI 10.1006/geno.1994.1098; Panagiotou OA, 2012, INT J EPIDEMIOL, V41, P273, DOI 10.1093/ije/dyr178; QIAN F, 1995, GENOMICS, V28, P66, DOI 10.1006/geno.1995.1107; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Roos AK, 2017, INT J SPORTS MED, V38, P501, DOI 10.1055/s-0043-104853; Shang XY, 2015, J SPORT SCI, V33, P1775, DOI 10.1080/02640414.2015.1012098; Shawen SB, 2016, CLIN SPORT MED, V35, P697, DOI 10.1016/j.csm.2016.05.012; Siontis KCM, 2010, EUR J HUM GENET, V18, P832, DOI 10.1038/ejhg.2010.26; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Taylor JB, 2015, SPORTS HEALTH, V7, P392, DOI 10.1177/1941738115593441; Thacker SB, 1999, AM J SPORT MED, V27, P753, DOI 10.1177/03635465990270061201; Wedderkopp N, 1999, SCAND J MED SCI SPOR, V9, P41	30	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185355	10.1371/journal.pone.0185355	http://dx.doi.org/10.1371/journal.pone.0185355			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957384	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200050
J	Namukwaya, E; Murray, SA; Downing, J; Leng, M; Grant, L				Namukwaya, Elizabeth; Murray, Scott A.; Downing, Julia; Leng, Mhoira; Grant, Liz			'I think my body has become addicted to those tablets'. Chronic heart failure patients' understanding of and beliefs about their illness and its treatment: A qualitative longitudinal study from Uganda	PLOS ONE			English	Article							HEALTH; LITERACY; OUTCOMES; AFRICA	Background Patients with heart failure in Uganda present for health care with advanced structural heart disease, have repeated hospitalizations and poorly controlled disease symptoms. The reasons for these are unclear. Literature from other settings shows that patients' understanding of their illness and their beliefs influence their health related behaviour. The study aimed to explore the beliefs of patients with heart failure, their understanding of their illness and its treatment, and how this influenced their health related behaviour to inform future health education programs, information and palliative care services. Methods Serial qualitative in-depth interviews were conducted with Heart Failure patients who were purposively sampled and recruited in Mulago National Referral Hospital until thematic saturation was reached. In-depth interviews were conducted at three time points over the course of their illness with intervals of 3 months between interviews. A grounded theory approach was used in data analysis. The University of Edinburgh ethics committee, Mulago Hospital Research Ethics committee and the Uganda National Council of Science and Technology (Reference numbers D/GC/178; MREC 33, SS 3083 respectively) approved the research. Results A total of 40 face to face qualitative longitudinal interviews (36-patient alone, 4 paired-patient and family carer), were conducted with 21 patients. The findings revealed that heart failure patients were unaware of the symptoms of the illness and their definition of illness differed from that of health professionals. Patients understood their diagnosis, cause of illness, prognosis and the importance of the medicines differently from health professionals, and had insufficient information on self-care. Lay beliefs were used to explain many aspects of the illness and treatments. All these influenced where patients sought care and their adherence to treatment, self-care and follow up leading to uncontrolled disease. Conclusion There is a high level of health illiteracy among heart failure patients in Uganda. Patients rely on lay beliefs to make health decisions and medical information is often miscomprehended. There is an urgent need for health education using culturally appropriate information.	[Namukwaya, Elizabeth; Downing, Julia; Leng, Mhoira] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Murray, Scott A.] Univ Edinburgh, Sch Med, Primary Palliat Care Res Grp, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Grant, Liz] Univ Edinburgh, Sch Med, Usher Inst Populat Hlth Sci & Informat, Global Hlth Acad, Edinburgh, Midlothian, Scotland	Makerere University; University of Edinburgh; University of Edinburgh	Namukwaya, E (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda.	liznam2002@yahoo.co.uk		leng, mhoira/0000-0003-1449-0437; Downing, Julia/0000-0002-3450-785X; Namukwaya, Elizabeth/0000-0001-5241-2742; Murray, Scott A/0000-0002-6649-9428; Grant, Liz/0000-0001-7248-7792	University of Edinburgh college of medicine and veterinary medicine student funding services; Diana fund [URN 6649/3220]; palliative care unit in Department of medicine Makerere University college of Health Sciences	University of Edinburgh college of medicine and veterinary medicine student funding services; Diana fund; palliative care unit in Department of medicine Makerere University college of Health Sciences	This work was part of EN PhD research. EN got a Charles Darwin scholarship with a Gordon Lennie bursary (no grant number) from the University of Edinburgh college of medicine and veterinary medicine student funding services and the Diana fund (URN 6649/3220) for tuition and living expenses in Edinburgh. The research was funded by the palliative care unit in Department of medicine Makerere University college of Health Sciences. The funders had no role in study design, data collection, and analysis, decision to publish or preparation of the manuscript.	Arksey H., 1999, INTERVIEWING SOCIAL; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Atulomah BC, 2012, OZEAN J SOCIAL SCI, V3, P95; Braun V., 2022, THEMATIC ANAL PRACTI; Breckenridge JP, 2012, GROUNDED THEORY REV, V11, P64; Burt RS, 2005, BROKERAGE CLOSURE IN; BURY M, 1991, SOCIOL HEALTH ILL, V13, P451, DOI 10.1111/j.1467-9566.1991.tb00522.x; Calnan M, 1987, HLTH AND ILLNESS; Creswell J. W., 2007, QUALITATIVE INQUIRY; Crotty, 1998, FDN SOCIAL RES MEANI; Damasceno Albertino, 2012, Arch Intern Med, V172, P1386; Denzin N, 1998, LANDSCAPE QUALITATIV; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Dixit S, 2008, PSYCHOL DEV SOC, V20, P1, DOI 10.1177/097133360702000101; Gareth W, 2013, LAY KNOWLEDGE; Glaser B.G, 1978, THEORETICAL SENSITIV; Hirani SP, 2005, HEART, V91, P1235, DOI 10.1136/hrt.2003.025262; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Kimani KN, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000077; Kleinman A, 2006, FOCUS; Klindtworth K, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0124-y; Kuule JK, 2009, SAMJ S AFR MED J, V99, P876; Lip GYH, 2004, HEART, V90, P1016, DOI 10.1136/hrt.2003.025742; Liu MH, 2014, J NURS RES, V22, P136, DOI [10.1097/jnr.0000000000000024, 10.1097/JNR.0000000000000024]; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Metra M, 2007, EUR J HEART FAIL, V9, P684, DOI 10.1016/j.ejheart.2007.04.003; Morgan Karen, 2014, BMC Psychol, V2, P50, DOI 10.1186/s40359-014-0050-3; Okello E, 2013, CARDIOVASC J AFR, V24, P80, DOI [10.5830/CVJA-2013-004, 10.5830/cvja-2013-004]; Oyoo GO, 1999, E AFR MED J, V76, P23; Peterson PN, 2011, JAMA-J AM MED ASSOC, V305, P1695, DOI 10.1001/jama.2011.512; Sabuni LP, 2007, QUAL HEALTH RES, V17, P1280, DOI 10.1177/1049732307307864; Saldana J., 2018, QUALITATIVE RES ANAL; Selman L, 2015, CURR OPIN SUPPORT PA, V9, P20, DOI 10.1097/SPC.0000000000000107; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Tabuti JRS, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-35; THOMSON R, 2003, INT J SOCIAL RES MET, V0006; Thurmond VA, 2001, J NURS SCHOLARSHIP, V33, P253, DOI 10.1111/j.1547-5069.2001.00253.x; Uskul AK., 2010, HEALTH PSYCHOL, V2, P347	38	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0182876	10.1371/journal.pone.0182876	http://dx.doi.org/10.1371/journal.pone.0182876			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957338	Green Submitted, Green Published, gold			2022-12-27	WOS:000411985200006
J	Pilling, LC; Atkins, JL; Duff, MO; Beaumont, RN; Jones, SE; Tyrrell, J; Kuo, CL; Ruth, KS; Tuke, MA; Yaghootkar, H; Wood, AR; Murray, A; Weedon, MN; Harries, LW; Kuchel, GA; Ferrucci, L; Frayling, TM; Melzer, D				Pilling, Luke C.; Atkins, Janice L.; Duff, Michael O.; Beaumont, Robin N.; Jones, Samuel E.; Tyrrell, Jessica; Kuo, Chia-Ling; Ruth, Katherine S.; Tuke, Marcus A.; Yaghootkar, Hanieh; Wood, Andrew R.; Murray, Anna; Weedon, Michael N.; Harries, Lorna W.; Kuchel, George A.; Ferrucci, Luigi; Frayling, Timothy M.; Melzer, David			Red blood cell distribution width: Genetic evidence for aging pathways in 116,666 volunteers	PLOS ONE			English	Article							TELOMERE LENGTH; ASSOCIATION; POPULATION; DISEASE; RISK	Introduction Variability in red blood cell volumes (distribution width, RDW) increases with age and is strongly predictive of mortality, incident coronary heart disease and cancer. We investigated inherited genetic variation associated with RDW in 116,666 UK Biobank human volunteers. Results A large proportion RDW is explained by genetic variants (29%), especially in the older group (60+ year olds, 33.8%, < 50 year olds, 28.4%). RDW was associated with 194 independent genetic signals; 71 are known for conditions including autoimmune disease, certain cancers, BMI, Alzheimer's disease, longevity, age at menopause, bone density, myositis, Parkinson's disease, and age-related macular degeneration. Exclusion of anemic participants did not affect the overall findings. Pathways analysis showed enrichment for telomere maintenance, ribosomal RNA, and apoptosis. The majority of RDW-associated signals were intronic (119 of 194), including SNP rs6602909 located in an intron of oncogene GAS6, an eQTL in whole blood. Conclusions Although increased RDW is predictive of cardiovascular outcomes, this was not explained by known CVD or related lipid genetic risks, and a RDW genetic score was not predictive of incident disease. The predictive value of RDW for a range of negative health outcomes may in part be due to variants influencing fundamental pathways of aging.	[Pilling, Luke C.; Atkins, Janice L.; Melzer, David] Univ Exeter, Epidemiol & Publ Hlth Grp, Sch Med, Royal Devon & Exeter Hosp, RILD Level 3, Exeter EX2 5DW, Devon, England; [Duff, Michael O.] Univ Connecticut, Ctr Hlth, Dept Genet & Genome Sci, Inst Syst Genom, Farmington, CT USA; [Beaumont, Robin N.; Jones, Samuel E.; Tyrrell, Jessica; Ruth, Katherine S.; Tuke, Marcus A.; Yaghootkar, Hanieh; Wood, Andrew R.; Murray, Anna; Weedon, Michael N.; Frayling, Timothy M.] Univ Exeter, Genet Complex Traits Grp, Sch Med, Royal Devon & Exeter Hosp, RILD Level 3, Exeter EX2 5DW, Devon, England; [Kuo, Chia-Ling] Univ Connecticut, Ctr Hlth, Dept Community Med & Hlth Care, Connecticut Inst Clin & Translat Sci,Inst Syst Ge, Farmington, CT USA; [Harries, Lorna W.] Univ Exeter, Inst Biomed & Clin Sci, Sch Med, Royal Devon & Exeter Hosp, RILD Level 3, Exeter, Devon, England; [Kuchel, George A.; Melzer, David] Univ Connecticut, Ctr Aging, Farmington, CT USA; [Ferrucci, Luigi] NIA, Baltimore, MD 21224 USA	University of Exeter; University of Connecticut; University of Exeter; University of Connecticut; University of Exeter; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Pilling, LC (corresponding author), Univ Exeter, Epidemiol & Publ Hlth Grp, Sch Med, Royal Devon & Exeter Hosp, RILD Level 3, Exeter EX2 5DW, Devon, England.	L.Pilling@exeter.ac.uk	Atkins, Janice L/R-5886-2019; Ruth, Katherine/K-2745-2019; Wood, Andrew R/AAB-3807-2019; Jones, Samuel/AAF-3100-2019; Pilling, Luke/E-4917-2013	Atkins, Janice L/0000-0003-4919-9068; Ruth, Katherine/0000-0003-4966-9170; Wood, Andrew R/0000-0003-1726-948X; Jones, Samuel/0000-0003-0153-922X; Weedon, Michael/0000-0002-6174-6135; Kuchel, George/0000-0001-8387-7040; Murray, Anna/0000-0002-2351-2522; , Hanieh/0000-0001-9672-9477; Beaumont, Robin/0000-0003-0750-8248; Pilling, Luke/0000-0002-3332-8454	UK Medical Research Council [MR/M023095/1]; Medical Research Council [MR/M005070/1]; Diabetes Research and Wellness Foundation Fellowship; Wellcome Trust; Royal Society [104150/Z/14/Z]; Wellcome Trust Institutional Strategic Support Award [WT097835MF]; European Research Council [323195:GLUCOSEGENES-FP7-IDEAS-ERC]; Intramural Research Program of the National Institute on Aging; U.S. National Institutes of Health; University of Connecticut Health Center; MRC [MR/M023095/1] Funding Source: UKRI; Medical Research Council [MR/M023095/1, MC_qA137853] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes Research and Wellness Foundation Fellowship; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Wellcome Trust Institutional Strategic Support Award(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Connecticut Health Center; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by an award to DM, TF, AM and LH by the UK Medical Research Council (grant number MR/M023095/1). SEJ is funded by the Medical Research Council (grant: MR/M005070/1). JT is funded by a Diabetes Research and Wellness Foundation Fellowship. RB is funded by the Wellcome Trust and Royal Society grant: 104150/Z/14/Z. MAT, MNW and AM are supported by the Wellcome Trust Institutional Strategic Support Award (WT097835MF). ARW, HY, and TF are supported by the European Research Council grant: 323195:GLUCOSEGENES-FP7-IDEAS-ERC. LF is supported by the Intramural Research Program of the National Institute on Aging, U.S. National Institutes of Health. Input from MD, CLK and GK was supported by the University of Connecticut Health Center. This research has been conducted using the UK Biobank Resource under Application Number 14631. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093766; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Burdett T, 2016, NHGRI EBI CATALOG PU; Chakrabarti RS, 2017, ELIFE, V6, DOI 10.7554/eLife.23355; Cheng Calvino Ka-Wing, 2004, Lab Hematol, V10, P42, DOI 10.1532/LH96.04010; Danese E, 2015, J THORAC DIS, V7, pE402, DOI 10.3978/j.issn.2072-1439.2015.10.04; Fyhrquist FY, 2016, OXID STRESS APPL BAS, P67, DOI 10.1007/978-3-319-33486-8_4; Harries LW, 2011, AGING CELL, V10, P868, DOI 10.1111/j.1474-9726.2011.00726.x; Haycock PC, 2017, JAMA ONCOL, V3, P636, DOI 10.1001/jamaoncol.2016.5945; Inuzuka R, 2015, CIRC J, V79, P974, DOI 10.1253/circj.CJ-15-0254; Kato N, 2015, NAT GENET, V47, P1282, DOI 10.1038/ng.3405; Kozlitina J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051046; Lippi G, 2016, INT J CARDIOL, V206, P129, DOI 10.1016/j.ijcard.2016.01.122; Lippi G, 2013, KARDIOL POL, V71, P931, DOI 10.5603/KP.2013.0228; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Manolio TA, 2010, JAMA-J AM MED ASSOC, V304, P2290, DOI 10.1001/jama.2010.1686; Megel C, 2015, INT J MOL SCI, V16, P1873, DOI 10.3390/ijms16011873; NCBI ClinVar, CLINVAR REC RS738409; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp163; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Pilling LC, 2016, AGING-US, V8, P547, DOI 10.18632/aging.100930; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Salvagno GL, 2015, CRIT REV CL LAB SCI, V52, P86, DOI 10.3109/10408363.2014.992064; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Sharma R., 2015, INT CARDIOVASC FORUM, V2, P27, DOI 10.17987/icfj.v2i1.68; Sheard S, 2016, UK BIOBANK HAEMATOLO; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Turcato G, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.06.35; UK Biobank, 2015, UK BIOB IMP 150K PAR; UK Biobank, 2014, UK BIOB GEN COLL QC; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; *WHO, WHO DEF AN HEM CONC; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39	39	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185083	10.1371/journal.pone.0185083	http://dx.doi.org/10.1371/journal.pone.0185083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957414	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200028
J	Midekisa, A; Holl, F; Savory, DJ; Andrade-Pacheco, R; Gething, PW; Bennett, A; Sturrock, HJW				Midekisa, Alemayehu; Holl, Felix; Savory, David J.; Andrade-Pacheco, Ricardo; Gething, Peter W.; Bennett, Adam; Sturrock, Hugh J. W.			Mapping land cover change over continental Africa using Landsat and Google Earth Engine cloud computing	PLOS ONE			English	Article							TIME-SERIES; SURFACE REFLECTANCE; NEXT-GENERATION; FOREST COVER; CLASSIFICATION; MULTISENSOR; SCIENCE; IMAGES; MODIS	Quantifying and monitoring the spatial and temporal dynamics of the global land cover is critical for better understanding many of the Earth's land surface processes. However, the lack of regularly updated, continental-scale, and high spatial resolution (30 m) land cover data limit our ability to better understand the spatial extent and the temporal dynamics of land surface changes. Despite the free availability of high spatial resolution Landsat satellite data, continental-scale land cover mapping using high resolution Landsat satellite data was not feasible until now due to the need for high-performance computing to store, process, and analyze this large volume of high resolution satellite data. In this study, we present an approach to quantify continental land cover and impervious surface changes over a long period of time (15 years) using high resolution Landsat satellite observations and Google Earth Engine cloud computing platform. The approach applied here to overcome the computational challenges of handling big earth observation data by using cloud computing can help scientists and practitioners who lack high-performance computational resources.	[Midekisa, Alemayehu; Holl, Felix; Savory, David J.; Andrade-Pacheco, Ricardo; Bennett, Adam; Sturrock, Hugh J. W.] Univ Calif San Francisco, Global Hlth Grp, Malaria Eliminat Initiat, San Francisco, CA 94143 USA; [Gething, Peter W.] Univ Oxford, Nuffield Dept Med, Big Data Inst, Oxford, England	University of California System; University of California San Francisco; University of Oxford	Midekisa, A (corresponding author), Univ Calif San Francisco, Global Hlth Grp, Malaria Eliminat Initiat, San Francisco, CA 94143 USA.	alemayshu.midekisa@ucsf.edu	Gething, Peter/ABD-2110-2020; Gething, Peter/GQR-1884-2022; Holl, Felix/Y-9648-2019	Gething, Peter/0000-0001-6759-5449; Holl, Felix/0000-0002-4020-9509; Sturrock, Hugh/0000-0002-0029-3101; Midekisa, Alemayehu/0000-0003-2558-6952	Bill and Melinda Gates Foundation [OPP1132900, OPP1089413, OPP1116450, OPP1068048, OPP1106023]; Novartis Foundation for Sustainable Development; UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID; European Union; MRC [MR/K00669X/1] Funding Source: UKRI; Medical Research Council [MR/K00669X/1] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Novartis Foundation for Sustainable Development; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	A.M., F.H., D.J.S., R.A, A.B. and H.J.W.S. and are funded by grants from the Bill and Melinda Gates Foundation (Numbers OPP1132900, OPP1089413, and OPP1116450), the Novartis Foundation for Sustainable Development, and a gift from the Parker Foundation. P.W.G. is a Career Development Fellow (No. K00669X) jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement, also part of the EDCTP2 program supported by the European Union, and receives support from the Bill and Melinda Gates Foundation (No. OPP1068048, No. OPP1106023).	Arino O, 2008, ESA BULL-EUR SPACE, P24; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bwangoy JRB, 2010, REMOTE SENS ENVIRON, V114, P73, DOI 10.1016/j.rse.2009.08.004; Chen J, 2015, ISPRS J PHOTOGRAMM, V103, P7, DOI 10.1016/j.isprsjprs.2014.09.002; Clark ML, 2016, ISPRS J PHOTOGRAMM, V119, P228, DOI 10.1016/j.isprsjprs.2016.06.007; Costa MH, 2003, J HYDROL, V283, P206, DOI 10.1016/S0022-1694(03)00267-1; DeFries R, 1997, REMOTE SENS ENVIRON, V60, P228, DOI 10.1016/S0034-4257(96)00119-8; DeVries B, 2015, REMOTE SENS ENVIRON, V161, P107, DOI 10.1016/j.rse.2015.02.012; Donchyts G, 2016, NAT CLIM CHANGE, V6, P810, DOI 10.1038/nclimate3111; Dong JW, 2015, REMOTE SENS ENVIRON, V160, P99, DOI 10.1016/j.rse.2015.01.004; Dong JW, 2012, REMOTE SENS ENVIRON, V127, P60, DOI 10.1016/j.rse.2012.08.022; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Gessner U, 2015, REMOTE SENS ENVIRON, V164, P282, DOI 10.1016/j.rse.2015.03.029; Giri C, 2013, INT J APPL EARTH OBS, V25, P30, DOI [10, 10.1016/j.jag.2013.03.005]; Gounaridis D, 2016, INT J APPL EARTH OBS, V51, P1, DOI 10.1016/j.jag.2016.04.002; Hansen MC, 2014, REMOTE SENS ENVIRON, V140, P466, DOI 10.1016/j.rse.2013.08.014; Hansen MC, 2011, REMOTE SENS LETT, V2, P279, DOI 10.1080/01431161.2010.519002; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Linard C, 2013, APPL GEOGR, V44, P23, DOI 10.1016/j.apgeog.2013.07.009; Loveland TR, 2000, INT J REMOTE SENS, V21, P1303, DOI 10.1080/014311600210191; Masek JG, 2006, IEEE GEOSCI REMOTE S, V3, P68, DOI 10.1109/LGRS.2005.857030; Mellander C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139779; Midekisa A, 2014, WATER RESOUR RES, V50, P8791, DOI 10.1002/2014WR015634; Nemani R, 2011, INT ARCH PHOTOGRAMM, V38-8, P17; Noor Abdisalan M, 2008, Popul Health Metr, V6, P5, DOI 10.1186/1478-7954-6-5; Patel NN, 2015, INT J APPL EARTH OBS, V35, P199, DOI 10.1016/j.jag.2014.09.005; Patz JA, 2004, GEOPHYS MONOGR SER, V153, P159, DOI 10.1029/153GM13; Pielke RA, 2011, WIRES CLIM CHANGE, V2, P828, DOI 10.1002/wcc.144; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002; Savory DJ, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9070713; Schroeder TA, 2014, REMOTE SENS ENVIRON, V154, P61, DOI 10.1016/j.rse.2014.08.005; Tulbure MG, 2013, ISPRS J PHOTOGRAMM, V79, P44, DOI 10.1016/j.isprsjprs.2013.01.010; Turner BL, 2007, P NATL ACAD SCI USA, V104, P20666, DOI 10.1073/pnas.0704119104; Wright C, 2007, REMOTE SENS ENVIRON, V107, P582, DOI 10.1016/j.rse.2006.10.019; Wulder MA, 2012, REMOTE SENS ENVIRON, V122, P2, DOI 10.1016/j.rse.2012.01.010; Xiong J, 2017, ISPRS J PHOTOGRAMM, V126, P225, DOI 10.1016/j.isprsjprs.2017.01.019; Yan L, 2015, REMOTE SENS ENVIRON, V158, P478, DOI 10.1016/j.rse.2014.11.024; Zhu Z, 2015, REMOTE SENS ENVIRON, V162, P67, DOI 10.1016/j.rse.2015.02.009	40	84	86	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184926	10.1371/journal.pone.0184926	http://dx.doi.org/10.1371/journal.pone.0184926			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953943	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300025
J	Wang, SC; Hu, T; Wang, Z; Li, N; Zhou, LH; Liao, LS; Wang, M; Liao, LB; Wang, H; Zeng, LP; Fan, CL; Zhou, HK; Xiong, K; Huang, JF; Chen, D				Wang, Shuchao; Hu, Tu; Wang, Zhen; Li, Na; Zhou, Lihong; Liao, Lvshuang; Wang, Mi; Liao, Libin; Wang, Hui; Zeng, Leping; Fan, Chunling; Zhou, Hongkang; Xiong, Kun; Huang, Jufang; Chen, Dan			Macroglia-derived thrombospondin 2 regulates alterations of presynaptic proteins of retinal neurons following elevated hydrostatic pressure	PLOS ONE			English	Article							GANGLION-CELLS; UP-REGULATION; ASTROCYTES; GLAUCOMA; SYNAPTOGENESIS; PROGRESSION; MODULATION; PLASTICITY; CHANNELS; SUBUNIT	Many studies on retinal injury and repair following elevated intraocular pressure suggest that the survival ratio of retinal neurons has been improved by various measures. However, the visual function recovery is far lower than expected. The homeostasis of retinal synapses in the visual signal pathway is the key structural basis for the delivery of visual signals. Our previous studies found that complicated changes in the synaptic structure between retinal neurons occurred much earlier than obvious degeneration of retinal ganglion cells in rat retinae. The lack of consideration of these earlier retinal synaptic changes in the rescue strategy may be partly responsible for the limited visual function recovery with the types of protective methods for retinal neurons used following elevated intraocular pressure. Thus, research on the modulatory mechanisms of the synaptic changes after elevated intraocular pressure injury may give new light to visual function rescue. In this study, we found that thrombospondin 2, an important regulator of synaptogenesis in central nervous system development, was distributed in retinal macroglia cells, and its receptor alpha 2 delta-1 was in retinal neurons. Cell cultures including mixed retinal macroglia cells/neuron cultures and retinal neuron cultures were exposed to elevated hydrostatic pressure for 2 h. The expression levels of glial fibrillary acidic protein (the marker of activated macroglia cells), thrombospondin 2, alpha 2 delta-1 and presynaptic proteins were increased following elevated hydrostatic pressure in mixed cultures, but the expression levels of postsynaptic proteins were not changed. SiRNA targeting thrombospondin 2 could decrease the upregulation of presynaptic proteins induced by the elevated hydrostatic pressure. However, in retinal neuron cultures, elevated hydrostatic pressure did not affect the expression of presynaptic or postsynaptic proteins. Rather, the retinal neuron cultures with added recombinant thrombospondin 2 protein upregulated the level of presynaptic proteins. Finally, gabapentin decreased the expression of presynaptic proteins in mixed cultures by blocking the interaction of thrombospondin 2 and alpha 2 delta-1. Taken together, these results indicate that activated macroglia cells may participate in alterations of presynaptic proteins of retinal neurons following elevated hydrostatic pressure, and macroglia-derived thrombospondin 2 may modulate these changes via binding to its neuronal receptora alpha 2 delta-1.	[Wang, Shuchao; Hu, Tu; Wang, Zhen; Li, Na; Zhou, Lihong; Liao, Lvshuang; Wang, Mi; Liao, Libin; Wang, Hui; Zeng, Leping; Fan, Chunling; Zhou, Hongkang; Xiong, Kun; Huang, Jufang; Chen, Dan] Cent S Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha, Hunan, Peoples R China	Central South University	Huang, JF; Chen, D (corresponding author), Cent S Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha, Hunan, Peoples R China.	huangjufang@csu.edu.cn; chendan0101@csu.edu.cn	Jufang, Huang/AAW-1847-2020	Jufang, Huang/0000-0002-9161-1055	National Natural Science Foundation of China [81400399, 81371011]; Project of Innovation-driven Plan of Central South University [2015CXS022]; National Key Technologies Research and Development Program of China [2012BAK14B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Innovation-driven Plan of Central South University; National Key Technologies Research and Development Program of China(National Key Technology R&D Program)	This study was supported by National Natural Science Foundation of China (No. 81400399, NO.81371011). www.nsfc.gov.cn; the Project of Innovation-driven Plan of Central South University (NO. 2015CXS022). http://www.csu.edu.cn; National Key Technologies Research and Development Program of China (No. 2012BAK14B03). http://program.most.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Andresen L, 2014, NEUROBIOL DIS, V71, P305, DOI 10.1016/j.nbd.2014.08.022; Bachleda AR, 2016, INVEST OPHTH VIS SCI, V57, P1488, DOI 10.1167/iovs.15-17994; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Crawford DC, 2012, J NEUROSCI, V32, P13100, DOI 10.1523/JNEUROSCI.2604-12.2012; Crish SD, 2013, NEUROSCIENCE, V229, P55, DOI 10.1016/j.neuroscience.2012.10.069; Crosby ND, 2016, ANN BIOMED ENG, V44, P3215, DOI 10.1007/s10439-016-1639-x; Crosby ND, 2015, EXP NEUROL, V264, P111, DOI 10.1016/j.expneurol.2014.11.015; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Farrell SR, 2014, VISUAL NEUROSCI, V31, P47, DOI 10.1017/S0952523813000588; Farrell SR, 2010, J NEUROPHYSIOL, V104, P1347, DOI 10.1152/jn.00098.2010; Flugel-Koch C, 2004, EXP EYE RES, V79, P649, DOI 10.1016/j.exer.2004.07.005; Fu QL, 2009, CELL MOL NEUROBIOL, V29, P575, DOI 10.1007/s10571-009-9349-7; Garcia O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014200; Harris JJ, 2015, CURR BIOL, V25, P3151, DOI 10.1016/j.cub.2015.10.063; Huang JF, 2013, EXP EYE RES, V111, P36, DOI 10.1016/j.exer.2013.03.012; Huang JF, 2012, NEURAL REGEN RES, V7, P1234, DOI 10.3969/j.issn.1673-5374.2012.16.005; Huang YC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004760; Hughes EG, 2010, MOL CELL NEUROSCI, V43, P136, DOI 10.1016/j.mcn.2009.10.004; Jayakumar AR, 2014, J NEUROCHEM, V131, P333, DOI 10.1111/jnc.12810; Jiang YL, 2009, MOL CELL NEUROSCI, V41, P113, DOI 10.1016/j.mcn.2009.02.006; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Li HF, 2012, NEUROBIOL DIS, V48, P429, DOI 10.1016/j.nbd.2012.06.019; Li N, 2016, NEUROTOX RES, V30, P392, DOI 10.1007/s12640-016-9624-6; Liu CT, 2006, CELL IMMUNOL, V244, P19, DOI 10.1016/j.cellimm.2007.02.003; Lo FS, 2011, J NEUROPHYSIOL, V106, P2876, DOI 10.1152/jn.00312.2011; Luo X, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/864871; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Marrone DF, 2002, BRAIN RES REV, V38, P291, DOI 10.1016/S0165-0173(01)00147-3; McCann P, 2016, INVEST OPHTH VIS SCI, V57, P2729, DOI 10.1167/iovs.15-18595; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Moore KB, 2015, NEURAL REGEN RES, V10, P1013, DOI 10.4103/1673-5374.160092; Morquette JB, 2008, J NEURO-OPHTHALMOL, V28, P144, DOI 10.1097/WNO.0b013e318177edf0; Nunez-Parra A, 2013, P NATL ACAD SCI USA, V110, P14777, DOI 10.1073/pnas.1310686110; Park HYL, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0053-2; Pfrieger FW, 2010, BRAIN RES REV, V63, P39, DOI 10.1016/j.brainresrev.2009.11.002; Phamduong E, 2014, ACS CHEM NEUROSCI, V5, P106, DOI 10.1021/cn400172n; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Risher WC, 2012, MATRIX BIOL, V31, P170, DOI 10.1016/j.matbio.2012.01.004; Shang L, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-63; Shen HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164035; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Takano T, 2009, STROKE, V40, pS8, DOI 10.1161/STROKEAHA.108.533166; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Vieira-Potter VJ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3801570; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Wong T, 2007, LANCET, V369, P425, DOI 10.1016/S0140-6736(07)60198-6; Yang JH, 2016, ELIFE, V5, DOI 10.7554/eLife.15043; Zhou LH, 2014, NEURAL REGEN RES, V9, P385, DOI 10.4103/1673-5374.128240	53	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185388	10.1371/journal.pone.0185388	http://dx.doi.org/10.1371/journal.pone.0185388			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953973	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300058
J	Ernstgard, L; Dwivedi, AM; Lundstrom, JN; Johanson, G				Ernstgard, Lena; Dwivedi, Aishwarya M.; Lundstrom, Johan N.; Johanson, Gunnar			Measures of odor and lateralization thresholds of acrolein, crotonaldehyde, and hexanal using a novel vapor delivery technique	PLOS ONE			English	Article							SENSORY IRRITATION; WOOD PELLETS; ALDEHYDES; TRPA1; FORMALDEHYDE; SENSITIVITY; INTENSITY; EMISSIONS; EXPOSURE; HUMANS	Introduction Humans are exposed to aldehydes in a variety of environmental situations. Aldehydes generally have a strong odor and are highly irritating to the mucous membranes. Knowledge about odor perception and especially irritation potency in humans is thus essential in risk assessment and regulation, e.g. setting occupational exposure limits. However, data on odor and irritation are lacking or limited for several aldehydes. The aim of the study was to determine the odor and lateralization thresholds of some commonly occurring aldehydes. Acrolein and crotonaldehyde where chosen as they are formed when organic material is heated or burned, e. g. during cigarette smoking. n-Hexanal was also included as it is emitted from wood pellets and fibreboard. Material and methods To study odor and lateralization thresholds of these aldehydes, a novel, inexpensive olfactometer was designed to enable delivery of reliable and stable test concentrations and thus valid measures of thresholds. The delivery system consists of seven syringe pumps, each connected to a Tedlar bag containing a predefined concentration of the tested aldehyde vapor. To validate the threshold measures, a test-retest was performed with a separate method, namely odor delivery via amber bottles. Twenty healthy naive individuals were tested. Results The median odor thresholds of acrolein, crotonaldehyde and hexanal were 17, 0.8, and 97 ppb, respectively. No lateralization threshold could be identified for acrolein (highest tested concentration was 2 940 ppb in 5 subjects), whereas the medians were 3 and 390 ppb for the latter two. In addition, odor thresholds for n-hexanal were also determined using two methods where similar results were obtained, suggesting that the olfactometer presentation method is valid. Conclusion We found olfactory detection and lateralization thresholds (except for acrolein) in alliance with, or lower than, previously reported in naive subjects. The new olfactometer allows better control of presentations timing and vapor concentration.	[Ernstgard, Lena; Dwivedi, Aishwarya M.; Johanson, Gunnar] Karolinska Inst, Inst Environm Med, Work Environm Toxicol, Stockholm, Sweden; [Lundstrom, Johan N.] Karolinska Inst, Div Psychol, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Ernstgard, L (corresponding author), Karolinska Inst, Inst Environm Med, Work Environm Toxicol, Stockholm, Sweden.	Lena.Ernstgard@ki.se	Lundström, Johan N./AAK-5002-2020; Lundström, Johan N/E-9482-2014; Johanson, Gunnar/A-3745-2015	Lundström, Johan N./0000-0002-3529-8981; Lundström, Johan N/0000-0002-3529-8981; Ernstgard, Lena/0000-0003-2217-3394; Johanson, Gunnar/0000-0002-8759-9567	Swedish Research Council for Health, Working Life and Welfare, FORTE [2013-0044]	Swedish Research Council for Health, Working Life and Welfare, FORTE	LE was funded by Swedish Research Council for Health, Working Life and Welfare, FORTE, no 2013-0044 (http://forte.se). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta S, 2017, TOXICOL APPL PHARM, V324, P45, DOI 10.1016/j.taap.2017.03.007; Amoore JE, 1983, J APPL TOXICOL, V3, P272, DOI 10.1002/jat.2550030603; Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; [Anonymous], 2003, ODOR MEAS REV; Arshadi M, 2009, ANN OCCUP HYG, V53, P797, DOI 10.1093/annhyg/mep058; BEAUCHAMP RO, 1985, CRC CR REV TOXICOL, V14, P309, DOI 10.3109/10408448509037461; Brown SK, 1999, INDOOR AIR, V9, P209, DOI 10.1111/j.1600-0668.1999.t01-1-00008.x; Cometto-Muniz JE, 1998, INT ARCH OCC ENV HEA, V71, P105, DOI 10.1007/s004200050256; Dwivedi AM, 2015, INHAL TOXICOL, V27, P810, DOI 10.3109/08958378.2015.1115567; Ernstgard L, 2006, J OCCUP ENVIRON MED, V48, P573, DOI 10.1097/01.jom.0000215235.42071.68; Escalera J, 2008, J BIOL CHEM, V283, P24136, DOI 10.1074/jbc.M710280200; FERON VJ, 1991, MUTAT RES, V259, P363, DOI 10.1016/0165-1218(91)90128-9; HALL G, 1983, LEBENSM WISS TECHNOL, V16, P354; KOBAL G, 1991, SMELL TASTE HLTH DIS, P255; Lotsch J, 1998, CHEM SENSES, V23, P755, DOI 10.1093/chemse/23.6.755; Lundstrom JN, 2003, CHEM SENSES, V28, P643, DOI 10.1093/chemse/bjg057; Materazzi S, 2008, P NATL ACAD SCI USA, V105, P12045, DOI 10.1073/pnas.0802354105; Ni JQ, 2012, CHEMOSPHERE, V89, P769, DOI 10.1016/j.chemosphere.2012.04.061; Smeets MAM, 2006, INT ARCH OCC ENV HEA, V79, P299, DOI 10.1007/s00420-005-0053-8; STEINHAGEN WH, 1984, TOXICOL APPL PHARM, V72, P495, DOI 10.1016/0041-008X(84)90126-1; STEVENS JC, 1988, CHEM SENSES, V13, P643, DOI 10.1093/chemse/13.4.643; Svedberg URA, 2004, ANN OCCUP HYG, V48, P339, DOI 10.1093/annhyg/meh015; TROFIMOV L V, 1962, Gig Tr Prof Zabol, V6, P34; WEBERTSCHOPP A, 1977, INT ARCH OCC ENV HEA, V40, P117, DOI 10.1007/BF00575156; Wise PM, 2012, CHEM SENSES, V37, P509, DOI 10.1093/chemse/bjs002; Yrieix C, 2010, CHEMOSPHERE, V79, P414, DOI 10.1016/j.chemosphere.2010.01.062; Zheng L, 2010, PERCEPT MOTOR SKILL, V111, P210, DOI 10.2466/13.24.27.PMS.111.4.210-228	27	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185479	10.1371/journal.pone.0185479	http://dx.doi.org/10.1371/journal.pone.0185479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950007	gold, Green Published, Green Submitted			2022-12-27	WOS:000411671000057
J	Lampa, M; Arlt, H; He, T; Ospina, B; Reeves, J; Zhang, BL; Murtie, J; Deng, GJ; Barberis, C; Hoffmann, D; Cheng, H; Pollard, J; Winter, C; Richon, V; Garcia-Escheverria, C; Adrian, F; Wiederschain, D; Srinivasan, L				Lampa, Michael; Arlt, Heike; He, Timothy; Ospina, Beatriz; Reeves, Jason; Zhang, Bailin; Murtie, Joshua; Deng, Gejing; Barberis, Claude; Hoffmann, Dietmar; Cheng, Hong; Pollard, Jack; Winter, Christopher; Richon, Victoria; Garcia-Escheverria, Carlos; Adrian, Francisco; Wiederschain, Dmitri; Srinivasan, Lakshmi			Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition	PLOS ONE			English	Article							MECHANISM; ACTIVATION; TARGET; GLIOMA; ANALOG	Tumor cells display fundamental changes in metabolism and nutrient uptake in order to utilize additional nutrient sources to meet their enhanced bioenergetic requirements. Glutamine (Gln) is one such nutrient that is rapidly taken up by tumor cells to fulfill this increased metabolic demand. A vital step in the catabolism of glutamine is its conversion to glutamate by the mitochondrial enzyme glutaminase (GLS). This study has identified GLS a potential therapeutic target in breast cancer, specifically in the basal subtype that exhibits a deregulated glutaminolysis pathway. Using inducible shRNA mediated gene knockdown, we discovered that loss of GLS function in triple-negative breast cancer (TNBC) cell lines with a deregulated glutaminolysis pathway led to profound tumor growth inhibition in vitro and in vivo. GLS knockdown had no effect on growth and metabolite levels in non-TNBC cell lines. We rescued the anti-tumor effect of GLS knockdown using shRNA resistant cDNAs encoding both GLS isoforms and by addition of an a-ketoglutarate (aKG) analog thus confirming the critical role of GLS in TNBC. Pharmacological inhibition of GLS with the small molecule inhibitor CB-839 reduced cell growth and led to a decrease in mammalian target of rapamycin (mTOR) activity and an increase in the stress response pathway driven by activating transcription factor 4 (ATF4). Finally, we found that GLS inhibition synergizes with mTOR inhibition, which introduces the possibility of a novel therapeutic strategy for TNBC. Our study revealed that GLS is essential for the survival of TNBC with a deregulated glutaminolysis pathway. The synergistic activity of GLS and mTOR inhibitors in TNBC cell lines suggests therapeutic potential of this combination for the treatment of vulnerable subpopulations of TNBC.	[Lampa, Michael; Arlt, Heike; He, Timothy; Ospina, Beatriz; Reeves, Jason; Zhang, Bailin; Murtie, Joshua; Deng, Gejing; Hoffmann, Dietmar; Cheng, Hong; Pollard, Jack; Winter, Christopher; Richon, Victoria; Adrian, Francisco; Wiederschain, Dmitri; Srinivasan, Lakshmi] Sanofi, Oncol, Cambridge, MA 02139 USA; [Barberis, Claude] Sanofi, Integrated Drug Discovery Platform, Waltham, MA USA; [Garcia-Escheverria, Carlos] Sanofi, Res Platforms, Vitry Sur Seine, France	Sanofi-Aventis; Sanofi-Aventis; Sanofi-Aventis; Sanofi France	Srinivasan, L (corresponding author), Sanofi, Oncol, Cambridge, MA 02139 USA.	luxme508@gmail.com		Srinivasan, Lakshmi/0000-0003-1351-7407	Sanofi	Sanofi(Sanofi-Aventis)	The research was entirely funded by Sanofi. The funder provided support in the form of salaries for authors [ML, HA, TH, BO, JR BZ, JM, GD, CB, DH, HC, JP, CW, VR, CGE, FA, DW and LS] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section	AHLUWALIA GS, 1990, PHARMACOL THERAPEUT, V46, P243, DOI 10.1016/0163-7258(90)90094-I; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Budczies J, 2015, INT J CANCER, V136, P1619, DOI 10.1002/ijc.29152; Budczies J, 2013, J PROTEOMICS, V94, P279, DOI 10.1016/j.jprot.2013.10.002; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; Chia SK, 2012, CLIN CANCER RES, V18, P4465, DOI 10.1158/1078-0432.CCR-12-0286; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; de la Rosa V, 2009, NEUROCHEM INT, V55, P76, DOI 10.1016/j.neuint.2009.02.021; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeLaBarre B, 2011, BIOCHEMISTRY-US, V50, P10764, DOI 10.1021/bi201613d; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Elgadi KM, 1999, PHYSIOL GENOMICS, V1, P51, DOI 10.1152/physiolgenomics.1999.1.2.51; Emadi A, 2014, EXP HEMATOL, V42, P247, DOI 10.1016/j.exphem.2013.12.001; Fathi AT, 2015, SEMIN HEMATOL, V52, P165, DOI 10.1053/j.seminhematol.2015.03.002; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Gaglio D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004715; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gross M CJ, 2016, AACR ANN M NEW ORL U; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARTMAN SC, 1973, J BIOL CHEM, V248, P8506; Hartwick EW, 2012, J ENZYM INHIB MED CH, V27, P861, DOI 10.3109/14756366.2011.622272; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Incorporation CB, 2014, USA patent, Patent No. [US 2014/0369961 A1, 0369961]; Jacque N, 2015, BLOOD; Kung HN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002229; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lyssiotis CA, 2013, CELL CYCLE, V12, P1987, DOI 10.4161/cc.25307; MEDINA MA, 1992, MOL CELL BIOCHEM, V113, P1; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohka F, 2014, TUMOR BIOL, V35, P5911, DOI 10.1007/s13277-014-1784-5; Pieter A, 2012, CANCER BIOL THER, V13, P1185, DOI 10.4161/cbt.21348; Qing GL, 2012, CANCER CELL, V22, P631, DOI 10.1016/j.ccr.2012.09.021; Robert F, 2009, CHEM BIOL DRUG DES, V74, P57, DOI 10.1111/j.1747-0285.2009.00827.x; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; SHAPIRO RA, 1979, J BIOL CHEM, V254, P2835; Singleton DC, 2012, EXPERT OPIN THER TAR, V16, P1189, DOI 10.1517/14728222.2012.728207; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Stalnecker CA, 2015, P NATL ACAD SCI USA, V112, P394, DOI 10.1073/pnas.1414056112; Straetemans R, 2005, BIOMETRICAL J, V47, P299, DOI 10.1002/bimj.200410124; Thomas AG, 2013, BIOCHEM BIOPH RES CO, V438, P243, DOI 10.1016/j.bbrc.2013.06.110; Ulanet DB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115144; van Geldermalsen M, 2016, ONCOGENE, V35, P3201, DOI 10.1038/onc.2015.381; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xiang Y, 2015, J CLIN INVEST, V125, P2293, DOI 10.1172/JCI75836; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099	53	76	78	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185092	10.1371/journal.pone.0185092	http://dx.doi.org/10.1371/journal.pone.0185092			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950000	Green Submitted, Green Published, gold			2022-12-27	WOS:000411671000023
J	Yunga, ST; Kayatani, AK; Fogako, J; Leke, RJI; Leke, RGF; Taylor, DW				Yunga, Samuel Tassi; Kayatani, Alexander K.; Fogako, Josephine; Leke, Robert J. I.; Leke, Rose G. F.; Taylor, Diane W.			Timing of the human prenatal antibody response to Plasmodium falciparum antigens	PLOS ONE			English	Article							CORD BLOOD; IMMUNE-RESPONSES; GERMINAL CENTERS; FC-RECEPTOR; MALARIA; RISK; SYNCYTIOTROPHOBLAST; TRANSMISSION; PREVALENCE; INFECTION	Plasmodium falciparum (Pf)-specific T-and B-cell responses may be present at birth; however, when during fetal development antibodies are produced is unknown. Accordingly, cord blood samples from 232 preterm (20-37 weeks of gestation) and 450 term (>= 37 weeks) babies were screened for IgM to Pf blood-stage antigens MSP1, MSP2, AMA1, EBA175 and RESA. Overall, 25% [95% CI = 22-28%] of the 682 newborns were positive for IgM to >= 1 Pf antigens with the earliest response occurring at 22 weeks. Interestingly, the odds of being positive for cord blood Pf IgM decreased with gestational age (adjusted OR [95% CI] at 20-31 weeks = 2.55 [1.14-5.85] and at 32-36 weeks = 1.97 [0.92-4.29], with >= 37 weeks as reference); however, preterm and term newborns had similar levels of Pf IgM and recognized a comparable breadth of antigens. Having cord blood Pf IgM was associated with placental malaria (adjusted OR [95% CI] = 2.37 [1.25-4.54]). To determine if in utero exposure occurred via transplacental transfer of Pf-IgG immune complexes (IC), IC containing MSP1 and MSP2 were measured in plasma of 242 mother-newborn pairs. Among newborns of ICpositive mothers (77/242), the proportion of cord samples with Pf IC increased with gestational age but was not associated with Pf IgM, suggesting that fetal B cells early in gestation had not been primed by IC. Finally, when cord mononuclear cells from 64 term newborns were cultured in vitro, only 11% (7/64) of supernatants had Pf IgM; whereas, 95% (61/64) contained secreted Pf IgG. These data suggest fetal B cells are capable of making Pf-specific IgM from early in the second trimester and undergo isotype switching to IgG towards term.	[Yunga, Samuel Tassi; Kayatani, Alexander K.; Taylor, Diane W.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA; [Fogako, Josephine; Leke, Rose G. F.] Univ Yaounde I, Biotechnol Ctr, Yaounde, Cameroon; [Leke, Robert J. I.; Leke, Rose G. F.] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon	University of Hawaii System; University of Hawaii Manoa; University of Yaounde I; University of Yaounde I	Taylor, DW (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.	dwtaylor@hawaii.edu	Yunga, Samuel Tassi/I-1936-2019	Yunga, Samuel Tassi/0000-0003-3631-2156	FIC NIH HHS [D43 TW009074] Funding Source: Medline; NIAID NIH HHS [U01 AI043888] Funding Source: Medline; NIGMS NIH HHS [P30 GM114737] Funding Source: Medline; NIMHD NIH HHS [U54 MD007584] Funding Source: Medline	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Abrahams VM, 2008, IMMUNOL INVEST, V37, P427, DOI 10.1080/08820130802191599; Achidi E A, 1997, Afr J Med Med Sci, V26, P167; Achidi EA, 2005, INT J INFECT DIS, V9, P159, DOI 10.1016/j.ijid.2004.06.012; ACHIDI EA, 1995, PARASITE IMMUNOL, V17, P535, DOI 10.1111/j.1365-3024.1995.tb00884.x; ALBARZANJI AJ, 1976, J CLIN PATHOL, V29, P675, DOI 10.1136/jcp.29.8.675; AlNassar KE, 1996, FORENSIC SCI INT, V78, P131, DOI 10.1016/0379-0738(95)01881-6; [Anonymous], 2004, STRATEGIC FRAMEWORK; BARZANJI AJ, 1978, EARLY HUM DEV, V1, P363, DOI 10.1016/0378-3782(78)90044-0; Baskin B, 1998, CLIN EXP IMMUNOL, V112, P44; Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028; BHAT NM, 1992, INT IMMUNOL, V4, P243, DOI 10.1093/intimm/4.2.243; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; BOFILL M, 1985, J IMMUNOL, V134, P1531; Brent L., 2015, IMMUNOLOGY, V1958; Brickley EB, 2015, J INFECT DIS, V211, P436, DOI 10.1093/infdis/jiu454; Brustoski K, 2005, INFECT IMMUN, V73, P7988, DOI 10.1128/IAI.73.12.7988-7995.2005; Carlier Y, 2012, ACTA TROP, V121, P55, DOI 10.1016/j.actatropica.2011.10.018; CORKILL JA, 1989, ARCH DIS CHILD, V64, P541, DOI 10.1136/adc.64.4.541; CostaCarvalho BT, 1996, BRAZ J MED BIOL RES, V29, P201; Crocker IP, 2004, PLACENTA, V25, P273, DOI 10.1016/j.placenta.2003.09.010; DAVIES NP, 1992, ARCH DIS CHILD-FETAL, V67, P399, DOI 10.1136/adc.67.4_Spec_No.399; Deloron P, 1997, CLIN EXP IMMUNOL, V110, P212; Demanou M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002950; Egwunyenga O. A., 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P741; Fievet N, 1996, PARASITE IMMUNOL, V18, P483, DOI 10.1046/j.1365-3024.1996.d01-19.x; FONDJO E, 1992, B SOC PATHOL EXOT, V85, P57; Fouda GG, 2006, CLIN VACCINE IMMUNOL, V13, P1307, DOI 10.1128/CVI.00183-06; Fusunyan RD, 2001, PEDIATR RES, V49, P589, DOI 10.1203/00006450-200104000-00023; GODFREY KM, 1991, BRIT J OBSTET GYNAEC, V98, P886, DOI 10.1111/j.1471-0528.1991.tb13510.x; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; GRANGEOTKEROS L, 1988, J INFECT DIS, V158, P138, DOI 10.1093/infdis/158.1.138; Griffin DO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00122; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Gude NM, 2004, GROWTH FUNCTION NORM, P397; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Hoang M, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115428; Holt PG, 2000, ALLERGY, V55, P688, DOI 10.1034/j.1398-9995.2000.00118.x; Hong M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7588; HORN GT, 1989, NUCLEIC ACIDS RES, V17, P2140, DOI 10.1093/nar/17.5.2140; Ismail MR, 2000, HUM PATHOL, V31, P85, DOI 10.1016/S0046-8177(00)80203-8; Jakobsen PH, 1998, IMMUNOLOGY, V93, P264, DOI 10.1046/j.1365-2567.1998.00421.x; King CL, 2002, J IMMUNOL, V168, P356, DOI 10.4049/jimmunol.168.1.356; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Leke RFG, 2010, AM J TROP MED HYG, V83, P996, DOI 10.4269/ajtmh.2010.10-0249; Leke RGF, 2011, CLIN INFECT DIS, V53, P231, DOI 10.1093/cid/cir383; Macchiaverni P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139064; MAENO Y, 1993, AM J TROP MED HYG, V49, P574, DOI 10.4269/ajtmh.1993.49.574; Malhotra I, 2005, INFECT IMMUN, V73, P3462, DOI 10.1128/IAI.73.6.3462-3470.2005; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; May K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007986; McNamara H, 2014, PAEDIATR PERINAT EP, V28, P97, DOI 10.1111/ppe.12104; Metenou S, 2007, J IMMUNOLOGY; Miller RL, 2001, AM J RESP CRIT CARE, V164, P995, DOI 10.1164/ajrccm.164.6.2011107; Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646; Paloczi K, 1998, BONE MARROW TRANSPL, V22, pS89; Rechavi E, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0072; Redd SC, 1996, AM J TROP MED HYG, V55, P57, DOI 10.4269/ajtmh.1996.55.57; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Rothstein TL, 2013, ANN NY ACAD SCI, V1285, P97, DOI 10.1111/nyas.12137; Simister NE, 1996, EUR J IMMUNOL, V26, P1527, DOI 10.1002/eji.1830260718; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Simister NE, 1998, HUMAN PLACENTAL FC R, P145; Stanisic DI, 2015, INFECT IMMUN, V83, P646, DOI 10.1128/IAI.02398-14; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc; Tena-Tomas C, 2007, PARASITOL RES, V101, P1045, DOI 10.1007/s00436-007-0585-9; THEOFILOPOULOS AN, 1981, AM J REPROD IMMUNOL, V1, P92, DOI 10.1111/j.1600-0897.1981.tb00024.x; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Uneke CJ, 2007, PARASITOL RES, V101, P835, DOI 10.1007/s00436-007-0577-9; Walker PGT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2605; Wittenbrink N, 2002, Dev Immunol, V9, P177, DOI 10.1080/1044667031000137665; World Health Organization, 2015, FACT SHEETS, P363; Xi GL, 2003, INFECT IMMUN, V71, P1242, DOI 10.1128/IAI.71.3.1242-1246.2003	74	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0184571	10.1371/journal.pone.0184571	http://dx.doi.org/10.1371/journal.pone.0184571			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950009	Green Submitted, gold, Green Published			2022-12-27	WOS:000411671000011
J	Battaglia, ME; Martin, MV; Lechner, L; Martinez-Noel, GMA; Salerno, GL				Battaglia, Marina E.; Victoria Martin, Maria; Lechner, Leandra; Martinez-Noel, Giselle M. A.; Salerno, Graciela L.			The riddle of mitochondrial alkaline/neutral invertases: A novel Arabidopsis isoform mainly present in reproductive tissues and involved in root ROS production	PLOS ONE			English	Article							HIGHER-PLANT MITOCHONDRIA; ABIOTIC STRESS TOLERANCE; SUCROSE METABOLISM; ABSCISIC-ACID; CYTOSOLIC INVERTASE; NEUTRAL INVERTASES; IMAGE-ANALYSIS; GROWTH; ROLES; THALIANA	Alkaline/neutral invertases (A/N-Inv), glucosidases that irreversibly hydrolyze sucrose into glucose and fructose, play significant roles in plant growth, development, and stress adaptation. They occur as multiple isoforms located in the cytosol or organelles. In Arabidopsis thaliana, two mitochondrial A/N-Inv genes (A/N-InvA and A/N-InvC) have already been investigated. In this study, we functionally characterized A/N-InvH, a third Arabidopsis gene coding for a mitochondrial-targeted protein. The phenotypic analysis of knockout mutant plants (invh) showed a severely reduced shoot growth, while root development was not affected. The emergence of the first floral bud and the opening of the first flower were the most affected stages, presenting a significant delay. A/N-InvH transcription is markedly active in reproductive tissues. It is also expressed in the elongation and apical meristem root zones. Our results show that A/N-InvH expression is not evident in photosynthetic tissues, despite being of relevance in developmental processes and mitochondrial functional status. NaCl and mannitol treatments increased A/N-InvH expression twofold in the columella root cap. Moreover, the absence of A/N-InvH prevented ROS formation, not only in invh roots of salt-and ABA-treated seedlings but also in invh control roots. We hypothesize that this isoform may take part in the ROS/sugar (sucrose or its hydrolysis products) signaling pathway network, involved in reproductive tissue development, cell elongation, and abiotic stress responses.	[Salerno, Graciela L.] INBIOTEC CONICET, Inst Invest Biodiversidad & Biotecnol, Mar Del Plata, Buenos Aires, Argentina; FIBA, Mar Del Plata, Buenos Aires, Argentina		Salerno, GL (corresponding author), INBIOTEC CONICET, Inst Invest Biodiversidad & Biotecnol, Mar Del Plata, Buenos Aires, Argentina.	gsalerno@fiba.org.ar	Battaglia, Marina E/AAC-1418-2021; martin, viky/GMX-1010-2022; Martínez-Noel, Giselle/AAP-2281-2020	Battaglia, Marina E/0000-0002-4300-4285; Martínez-Noel, Giselle/0000-0001-6468-3013; Salerno, Graciela/0000-0001-9177-4199; Martin, Maria Victoria/0000-0001-6015-7059	ANPCyT [PICT 2012 1288]; Universidad Nacional de Mar del Plata [15/ E693 EXA 743/15]; FIBA	ANPCyT(ANPCyT); Universidad Nacional de Mar del Plata(National University of La Plata); FIBA	This research was funded by grants from ANPCyT (PICT 2012 1288), www.agencia.mincyt.gob.ar/, Universidad Nacional de Mar del Plata (15/ E693 EXA 743/15), www.mdp.edu.ar/, and FIBA, www.fiba.org.ar.; We are very thankful to C. Fernandez, Natalia Almada and Gonzalo Calo for technical assistance. This research was funded by grants from ANPCyT (PICT 1288), Universidad Nacional de Mar del Plata (15/E693 EXA 743/15), and FIBA.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Battaglia M, 2014, PLANT PHYSIOL, V164, P1430, DOI 10.1104/pp.113.230896; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Bocock PN, 2008, PLANTA, V227, P565, DOI 10.1007/s00425-007-0639-3; Bolouri-Moghaddam MR, 2010, FEBS J, V277, P2022, DOI 10.1111/j.1742-4658.2010.07633.x; Bond JE, 1993, PLANT RESPONSES ENV; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Chen Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138540; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COLOMBINI M, 1979, NATURE, V279, P643, DOI 10.1038/279643a0; Dahro B, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0761-0; Dai H, 1998, EUR J CELL BIOL, V75, P198, DOI 10.1016/S0171-9335(98)80062-9; Distefano AM, 2017, J CELL BIOL; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Estrada-Navarrete G, 2007, NAT PROTOC, V2, P1819, DOI 10.1038/nprot.2007.259; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; Graham JWA, 2007, PLANT CELL, V19, P3723, DOI 10.1105/tpc.107.053371; Hawkins John, 2006, Journal of Bioinformatics and Computational Biology, V4, P1, DOI 10.1142/S0219720006001771; He JN, 2012, PLANT CELL, V24, P1815, DOI 10.1105/tpc.112.098707; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huang SB, 2016, PLANT PHYSIOL, V171, P1551, DOI 10.1104/pp.16.00166; Hyun TK, 2011, PLANT OMICS, V4, P391; Ji XM, 2005, J MOL EVOL, V60, P615, DOI 10.1007/s00239-004-0242-1; Keunen E, 2013, PLANT CELL ENVIRON, V36, P1242, DOI 10.1111/pce.12061; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Laluk K, 2011, PLANT PHYSIOL, V156, P2053, DOI 10.1104/pp.111.177501; Lammens W, 2009, J EXP BOT, V60, P727, DOI 10.1093/jxb/ern333; Lo YS, 2004, INT J PLANT SCI, V165, P949, DOI 10.1086/423884; Lou Y, 2007, PLANT CELL, V19, P163, DOI 10.1105/tpc.106.045658; Mackenzie S, 1999, PLANT CELL, V11, P571, DOI 10.1105/tpc.11.4.571; Martin ML, 2013, PLANTA, V237, P813, DOI 10.1007/s00425-012-1794-8; Martin MV, 2014, BIOPROTOCOL, V4; Meschini EP, 2008, MOL PLANT MICROBE IN, V21, P459, DOI 10.1094/MPMI-21-4-0459; Millar AH, 2011, ANNU REV PLANT BIOL, V62, P79, DOI 10.1146/annurev-arplant-042110-103857; Murayama S, 2007, PLANTA, V225, P1193, DOI 10.1007/s00425-006-0430-x; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; Nonis A, 2008, PLANTA, V229, P129, DOI 10.1007/s00425-008-0815-0; Cordoba JP, 2016, J EXP BOT, V67, P1589, DOI 10.1093/jxb/erv556; Pratibha P, 2017, PLANT PHYSIOL, V174, P258, DOI 10.1104/pp.16.01482; Qi XP, 2007, PLANT MOL BIOL, V64, P575, DOI 10.1007/s11103-007-9177-4; Rhoads DM, 2007, MITOCHONDRION, V7, P177, DOI 10.1016/j.mito.2007.01.002; Rhoads DM, 2011, ADVAN PL BIO, V1, P411; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; Ruan YL, 2010, MOL PLANT, V3, P942, DOI 10.1093/mp/ssq044; Sambrook J., 2001, MOL CLONING LAB MANU; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sturm A, 1999, PLANT PHYSIOL, V121, P1, DOI 10.1104/pp.121.1.1; Subbaiah CC, 2006, J BIOL CHEM, V281, P15625, DOI 10.1074/jbc.M600355200; Swanson S, 2010, PHYSIOL PLANTARUM, V138, P384, DOI 10.1111/j.1399-3054.2009.01313.x; Szarka A, 2008, PLANTA, V228, P765, DOI 10.1007/s00425-008-0778-1; Thelander M, 2009, ANNU PLANT REV, V36, P211, DOI 10.1111/b.9781405181891.2009.00009.x; Van Aken O, 2009, MOL PLANT, V2, P1310, DOI 10.1093/mp/ssp053; Vargas W, 2003, PLANTA, V216, P951, DOI 10.1007/s00425-002-0943-x; Vargas WA, 2008, PLANTA, V227, P795, DOI 10.1007/s00425-007-0657-1; Vargas WA, 2007, PLANTA, V226, P1535, DOI 10.1007/s00425-007-0590-3; Vargas WA, 2010, PLANT SCI, V178, P1, DOI 10.1016/j.plantsci.2009.09.015; Martin MV, 2013, PLANT CELL, V25, P1573, DOI 10.1105/tpc.113.109306; Vishwakarma K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00161; Wang Y, 2014, J EXP BOT, V65, P4159, DOI 10.1093/jxb/eru190; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Welham T, 2009, J EXP BOT, V60, P3353, DOI 10.1093/jxb/erp169; Winter H, 2000, CRIT REV PLANT SCI, V19, P31, DOI 10.1016/S0735-2689(01)80002-2; Xiang L, 2011, J EXP BOT, V62, P3849, DOI 10.1093/jxb/err069; Xie J, 2016, J BIOL CHEM, V291, P25667, DOI 10.1074/jbc.M116.759290; Yao Y, 2015, PLANT MOL BIOL REP, V33, P304, DOI 10.1007/s11105-014-0743-z	69	11	13	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185286	10.1371/journal.pone.0185286	http://dx.doi.org/10.1371/journal.pone.0185286			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945799	Green Submitted, Green Published, gold			2022-12-27	WOS:000411645100041
J	Calvert, AE; Biggerstaff, BJ; Tanner, NA; Lauterbach, M; Lanciotti, RS				Calvert, Amanda E.; Biggerstaff, Brad J.; Tanner, Nathan A.; Lauterbach, Molly; Lanciotti, Robert S.			Rapid colorimetric detection of Zika virus from serum and urine specimens by reverse transcription loop-mediated isothermal amplification (RT-LAMP)	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; REAL-TIME DETECTION; MOLECULAR-DETECTION; DENGUE VIRUS; FEVER VIRUS; ASSAY; TRANSMISSION; CHIKUNGUNYA; INFECTION; BRAZIL	Zika virus (ZIKV) has emerged as a major global public health concern in the last two years due to its link as a causative agent of human birth defects. Its rapid expansion into the Western Hemisphere as well as the ability to be transmitted from mother to fetus, through sexual transmission and possibly through blood transfusions has increased the need for a rapid and expansive public health response to this unprecedented epidemic. A non-invasive and rapid ZIKV diagnostic screening assay that can be performed in a clinical setting throughout pregnancy is vital for prenatal care of women living in areas of the world where exposure to the virus is possible. To meet this need we have developed a sensitive and specific reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) assay to detect ZIKV RNA in urine and serum with a simple visual detection. RT-LAMP results were shown to have a limit of detection 10-fold higher than qRT-PCR. As little as 1.2 RNA copies/mu l was detected by RT-LAMP from a panel of 178 diagnostic specimens. The assay was shown to be highly specific for ZIKV RNA when tested with diagnostic specimens positive for dengue virus (DENV) and chikungunya virus (CHIKV). The assay described here illustrates the potential for a fast, reliable, sensitive and specific assay for the detection of ZIKV from urine or serum that can be performed in a clinical or field setting with minimal equipment and technological expertise.	[Calvert, Amanda E.; Biggerstaff, Brad J.; Lauterbach, Molly; Lanciotti, Robert S.] US Ctr Dis Control & Prevent, Arboviral Dis Branch, Div Vector Borne Dis, Ft Collins, CO USA; [Tanner, Nathan A.] New England Biolabs Inc, Ipswich, MA USA	Centers for Disease Control & Prevention - USA; New England Biolabs	Calvert, AE (corresponding author), US Ctr Dis Control & Prevent, Arboviral Dis Branch, Div Vector Borne Dis, Ft Collins, CO USA.	zpz0@cdc.gov		Calvert, Amanda/0000-0002-8237-2654	New England Biolabs	New England Biolabs	New England Biolabs provided support in the form of salary for author NT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Chevalier MS, 2017, EMERG INFECT DIS, V23, P790, DOI 10.3201/eid2305.161873; Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538; Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; Dauner AL, 2015, DIAGN MICR INFEC DIS, V83, P30, DOI 10.1016/j.diagmicrobio.2015.05.004; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Elvira-Gonzalez L, 2017, J VIROL METHODS, V241, P11, DOI 10.1016/j.jviromet.2016.12.004; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Heukelbach J, 2016, LANCET, V388, P846, DOI 10.1016/S0140-6736(16)30931-X; Hu S, 2015, P 2015 ACM INT JOINT, V15, P1, DOI DOI 10.1186/S12866-015-0595-1; Hu Y, 2017, ANAL CHEM, V89, P745, DOI 10.1021/acs.analchem.6b03328; Jangam SR, 2013, BIOSENS BIOELECTRON, V42, P69, DOI 10.1016/j.bios.2012.10.024; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Korhonen Essi Marjana, 2016, Euro Surveill, V21, DOI 10.2807/1560-7917.ES.2016.21.2.30107; Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683; Kwallah AO, 2013, J VIROL METHODS, V193, P23, DOI 10.1016/j.jviromet.2013.05.004; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lau Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0142861, 10.1371/journal.pone.0138694]; Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460; Li SH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-360; Liu CC, 2011, LAB CHIP, V11, P2686, DOI 10.1039/c1lc20345b; Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Musso D, 2014, EURO SURVEILL, V19; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059; Parida M, 2005, J CLIN MICROBIOL, V43, P2895, DOI 10.1128/JCM.43.6.2895-2903.2005; Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06; Parida MM, 2006, J CLIN MICROBIOL, V44, P4172, DOI 10.1128/JCM.01487-06; Pepe MS, 2003, STAT EVALUATION MED, pxvi; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Peyrefitte CN, 2008, J CLIN MICROBIOL, V46, P3653, DOI 10.1128/JCM.01188-08; Poole CB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169011; Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Roze B, 2016, EURO SURVEILL, P21; Sanabani SS, 2017, PLOS CURR, V9; Song JZ, 2017, CLIN CHEM, V63, P714, DOI 10.1373/clinchem.2016.263665; Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632; Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031; Tanner NA, 2015, BIOTECHNIQUES, V58, P59, DOI 10.2144/000114253; Teoh BT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-387; Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085; Toriniwa H, 2006, MICROBIOL IMMUNOL, V50, P379, DOI 10.1111/j.1348-0421.2006.tb03804.x; Venturi G, 2014, EUROSURVEILLANCE, V21; Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010; Wheeler SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147962; Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	56	58	61	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185340	10.1371/journal.pone.0185340	http://dx.doi.org/10.1371/journal.pone.0185340			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945787	gold, Green Published, Green Submitted			2022-12-27	WOS:000411645100049
J	Li, L; Zheng, SH; Brinckmann, JA; Fu, J; Zeng, R; Huang, LF; Chen, SL				Li, Lin; Zheng, Sihao; Brinckmann, Josef A.; Fu, Juan; Zeng, Rui; Huang, Linfang; Chen, Shilin			Chemical and genetic diversity of Astragalus mongholicus grown in different eco-climatic regions	PLOS ONE			English	Article							IDENTIFICATION	Astragalus mongholicus Bunge (Fabaceae) is an important plant source of the herbal drug known as Radix Astragali, which is used worldwide as a medicinal ingredient and a component of food supplement. Russian Federation, Mongolia, Kazakhstan, and China are the main natural distribution areas of A. mongholicus in the world. However, the quality of medicinal plant varies among different locations. As for A. mongholicus, limited literature focused on its biodiversity mechanism. Here, we combined the chemometric analysis of chemical components with genetic variation, as well as climatic and edaphic traits, to reveal the biodiversity mechanism of A. mongholicus. Results showed that the detected chemical, genetic and climatic traits comprehensively contributed to the quality diversity of A. mongholicus. The eight main chemical components, as well as the inorganic elements of P, B and Na were all significant chemical factors. The precipitation and sunshine duration were the main distinguishing climatic factors. The inorganic elements As, Mn, P, Se and Pb were the distinguishing edaphic factors. The systematic method was firstly established for this medicinal plant in order to illustrate the formation of diversity in terms of quality, and provide scientific evidence for geographic indications and climatic adaptation in production and in the clinical application of herbal medicinal plants.	[Li, Lin; Zheng, Sihao; Fu, Juan; Huang, Linfang] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China; [Li, Lin; Zheng, Sihao; Fu, Juan; Huang, Linfang] Peking Union Med Coll, Beijing, Peoples R China; [Brinckmann, Josef A.] Tradit Med, Sustainabil Dept, Sebastopol, CA USA; [Zeng, Rui] Southwest Univ Nationalities, Chengdu, Sichuan, Peoples R China; [Chen, Shilin] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Southwest Minzu University; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS	Huang, LF (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China.; Huang, LF (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	lfhuang@implad.ac.cn	Zeng, Rui/GRY-0646-2022	Zeng, Rui/0000-0003-1188-3198; BRINCKMANN, JOSEF/0000-0002-5944-3776	National Natural Science Foundation of China [81274013, 81473315]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-12M-3-015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Sciences (CIFMS)	Funding from the National Natural Science Foundation of China (Nos. 81274013 and 81473315) and CAMS Innovation Fund for Medical Sciences (CIFMS, No. 2016-12M-3-015) is gratefully acknowledged (website: www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Traditional Medicinals provided support in the form of salaries for author JAB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bai X Z Y., 2012, CHIN J MOD APPL PHAR, V29, P4; BIAN YYJ, 2006, J CHINESE PHARM SCI, V41, P5, DOI DOI 10.1093/MOLBEV/MST197; Brinckmann JA, 2015, WORLD J TRADITIONAL, V1, P16, DOI DOI 10.15806/j.issn.2311-8571.2014.0020; Chen SL, 2015, SCIENCE, V347, pS27; Chen X Z M. R., 2008, TIANJIN PHARM, V20, P2; DUAN LX, MOL PLANT, V5, P376, DOI DOI 10.1186/1471-2164-13-195; Feng Shan-shan, 2014, Yaoxue Xuebao, V49, P260; Fu J, 2013, J ASIAN NAT PROD RES, V15, P687, DOI 10.1080/10286020.2013.778832; GE YLQ, 2009, CHINESE J PHARM ANAL, V29, P7, DOI DOI 10.3964/J.ISSN.1000-0593(2011)05-1258-04; Guo BL Z L. T., 2009, CHINA J CHINESE MAT, V34, P3; He Pan, 2013, Yaoxue Xuebao, V48, P1595; Huang LF L W. T., 2013, ACTA ECOLOGICA SINIC, V33, P12; Huang LF Z S. H., 2014, SCI SINICA, V44, P11; Huang RS Q D. J., 2012, CHINESE TRADITIONAL, V43, P4; JIAO F, 2007, RECOMMENDATIONS PROT; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Lei Lian-Di, 2008, Zhongguo Zhong Yao Za Zhi, V33, P255; LI L, 2016, MOL BASEL SWITZERLAN, V21; Liu BW, 2012, SPECTROSC SPECT ANAL, V32, P2981, DOI 10.3964/j.issn.1000-0593(2012)11-2981-06; Liu J, 2011, BIOL PHARM BULL, V34, P1404, DOI 10.1248/bpb.34.1404; LIU WJS, 2013, J BEIJING U TRAD CHI, V36, P4, DOI DOI 10.1016/J.JEP.2012.01.048; Qian D H L., 2009, CHINA J CHINESE MAT, V34, P4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang ZQ J J. M., 2010, CHINESE J PHARM ANAL, V30, P4; Xiao WL, 2011, J AGR FOOD CHEM, V59, P1548, DOI 10.1021/jf1028174; Yao XL P C. Y, 2012, CHINESE J PHARM ANAL, V32, P4; Yuan YF, 2011, SPECTROSC SPECT ANAL, V31, P1258, DOI 10.3964/j.issn.1000-0593(2011)05-1258-04; Yuan Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-195; Zhang Qiang, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3203; Zhang XM, 2007, LISHIZHEN MED MAT ME, V18, P2; Zhao ZZ, 2012, J ETHNOPHARMACOL, V140, P476, DOI 10.1016/j.jep.2012.01.048; ZHENG S, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1016/J.GENE.2008.10.012; Zheng SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098061	33	15	17	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0184791	10.1371/journal.pone.0184791	http://dx.doi.org/10.1371/journal.pone.0184791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945770	Green Published, gold, Green Submitted			2022-12-27	WOS:000411645100010
J	Serrano-Aroca, A; Deb, S				Serrano-Aroca, Angel; Deb, Sanjukta			Synthesis of irregular graphene oxide tubes using green chemistry and their potential use as reinforcement materials for biomedical applications	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; FILMS; FABRICATION; LIGHTWEIGHT; IONS	Micrometer length tubes of graphene oxide (GO) with irregular form were synthesised following facile and green metal complexation reactions. These materials were obtained by crosslinking of GO with calcium, zinc or strontium chlorides at three different temperatures (24, 34 and 55 degrees C) using distilled water as solvent for the compounds and following a remarkably simple and low-cost synthetic method, which employs no hazardous substances and is conducted without consumption of thermal or sonic energy. These irregular continuous GO networks showed a very particular interconnected structure by Field Emission Scanning Electron Microscopy with Energy-Disperse X-Ray Spectroscopy for elemental analysis and High-resolution Transmission Electron Microscopy with Scanning Transmission Electron Microscope Dark Field Imaging, and were analysed by Raman Spectroscopy. To demonstrate the potential use of these 3D GO networks as reinforcement materials for biomedical applications, two composites of calcium alginate with irregular tubes of GO and with single GO nanosheets were prepared with the same amount of GO and divalent atoms and analysed. Thus, the dynamic-mechanical modulus of the composites synthesised with the 3D crosslinked GO networks showed a very significant mechanical improvement due to marked microstructural changes confirmed by confocal microscopy, differential scanning calorimetry and Fourier transform infrared spectroscopy.	[Serrano-Aroca, Angel] Univ Catolica Valencia San Vicente Martir, Fac Vet & Ciencias Aplicadas, Bioengn & Cellular Therapy Grp, C Guillem Castro 94, Valencia, Spain; [Deb, Sanjukta] Kings Coll London, Div Tissue Engn & Biophoton, Dent Inst, Guys Hosp, Tower Wing, London, England	Universidad Catolica de Valencia San Vicente Martir; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Serrano-Aroca, A (corresponding author), Univ Catolica Valencia San Vicente Martir, Fac Vet & Ciencias Aplicadas, Bioengn & Cellular Therapy Grp, C Guillem Castro 94, Valencia, Spain.	angel.serrano@ucv.es	Serrano-Aroca, Ángel/H-3809-2015	Serrano-Aroca, Ángel/0000-0002-9953-3848	Universidad Catolica de Valencia "San Vicente Martir" [2015-162-001UCV, 2017-231-001UCV]	Universidad Catolica de Valencia "San Vicente Martir"	This work was supported by the 2015-162-001UCV and 2017-231-001UCV grants from the Universidad Catolica de Valencia "San Vicente Martir."	Annabi N, 2016, ADV MATER, V28, P40, DOI 10.1002/adma.201503255; [Anonymous], 2014, GRAPHENE OXIDE PHYS; [Anonymous], GRAPHENE OXIDE; Bai H, 2011, J PHYS CHEM C, V115, P5545, DOI 10.1021/jp1120299; Balandin AA, 2011, NAT MATER, V10, P569, DOI [10.1038/nmat3064, 10.1038/NMAT3064]; Bao HQ, 2011, SMALL, V7, P1569, DOI 10.1002/smll.201100191; Boyd D, 2006, J MATER SCI-MATER M, V17, P489, DOI 10.1007/s10856-006-8930-6; Cancado LG, 2011, NANO LETT, V11, P3190, DOI 10.1021/nl201432g; Cao L, 2017, MAT SCI ENG C-MATER, V79, P697, DOI 10.1016/j.msec.2017.05.056; Cha C., 2014, TISSUE ENG; Criado A, 2015, ANGEW CHEM INT EDIT, V54, P10734, DOI 10.1002/anie.201501473; Doran PM, 2013, BIOPROCESS ENGINEERING PRINCIPLES, 2ND EDITION, P1; DRAGET KI, 1994, CARBOHYD POLYM, V25, P31, DOI 10.1016/0144-8617(94)90159-7; Faghihi S, 2014, J APPL PHYS, P115; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; Foo ME, 2017, BIOMED PHARMACOTHER, V94, P354, DOI 10.1016/j.biopha.2017.07.122; Geng Z, 2016, MAT SCI ENG C-MATER, V58, P467, DOI 10.1016/j.msec.2015.08.061; Ghadim EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079254; Giusca CE, 2015, CARBON, V86, P188, DOI 10.1016/j.carbon.2015.01.035; GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7; Gupta A, 2006, NANO LETT, V6, P2667, DOI 10.1021/nl061420a; He YQ, 2012, CARBOHYD POLYM, V88, P1100, DOI 10.1016/j.carbpol.2012.01.071; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Ionita M, 2013, CARBOHYD POLYM, V94, P339, DOI 10.1016/j.carbpol.2013.01.065; Kahlert JU, 2016, CHEM COMMUN, V52, P1290, DOI 10.1039/c5cc07611k; Kaplan D. L., 1998, BIOPOLYMERS RENEWABL; Kemp KC, 2012, FUNCTIONALIZATION GR, DOI [10.1021/cr3000412, DOI 10.1021/CR3000412]; Li H, 2013, SCIENCE, V342, P95, DOI 10.1126/science.1236686; Lin Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep11662; Liu YT, 2011, CARBON, V49, P3371, DOI 10.1016/j.carbon.2011.03.055; Mecklenburg M, 2012, ADV MATER, V24, P3486, DOI 10.1002/adma.201200491; Novoselov KS, 2012, NATURE, V490, P192, DOI 10.1038/nature11458; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Park M, 2011, CARBON, V49, P811, DOI 10.1016/j.carbon.2010.10.019; Park S, 2008, ACS NANO, V2, P572, DOI 10.1021/nn700349a; Parlak O, 2017, NANO ENERGY, V34, P570, DOI 10.1016/j.nanoen.2017.03.004; Paz E, 2017, MAT SCI ENG C-MATER, V77, P1003, DOI 10.1016/j.msec.2017.03.269; Rao CNR, 2001, CHEMPHYSCHEM, V2, P78, DOI 10.1002/1439-7641(20010216)2:2<78::AID-CPHC78>3.0.CO;2-7; Rao KS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04237; Ratner B.D., 2012, BIOMATERIALS SCI INT; Rhim JW, 2004, LEBENSM-WISS TECHNOL, V37, P323, DOI 10.1016/j.lwt.2003.09.008; Sartori C, 1997, POLYMER, V38, P43, DOI 10.1016/S0032-3861(96)00458-2; Schuchardt A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08839; Serrano-Aroca A, 2017, SCI REP IN PRESS; Shen XP, 2016, GREEN CHEM, V18, P53, DOI 10.1039/c5gc02396c; Shin SR, 2016, ADV DRUG DELIVER REV, V105, P255, DOI 10.1016/j.addr.2016.03.007; Silva EL, 2017, ADV MATER INTERFACES, V4, DOI 10.1002/admi.201700019; Sitko R, 2013, DALTON T, V42, P5682, DOI 10.1039/c3dt33097d; Solanki A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01553; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Stengl V, 2014, CARBON, V67, P336, DOI 10.1016/j.carbon.2013.10.003; Tiginyanu I, 2016, SCI REP-UK, V6, DOI 10.1038/srep32913; Vauchel P, 2008, FOOD BIOPROCESS TECH, V1, P297, DOI 10.1007/s11947-008-0082-x; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059449; Xie H, 2017, DENT MATER, V33, P765, DOI 10.1016/j.dental.2017.04.008; Xie RH, 2016, CARBOHYD POLYM, V138, P222, DOI 10.1016/j.carbpol.2015.11.042; Yadav M, 2014, CARBOHYD POLYM, V110, P18, DOI 10.1016/j.carbpol.2014.03.037; Yin PT, 2015, CHEM REV, V115, P2483, DOI 10.1021/cr500537t; Zactiti EM, 2009, PACKAG TECHNOL SCI, V22, P349, DOI 10.1002/pts.860; Zhang HJ, 2015, RSC ADV, V5, P89073, DOI 10.1039/c5ra19637j; Zhang LM, 2011, SMALL, V7, P460, DOI 10.1002/smll.201001522; Zhao G, 2011, FEW LAYERED GRAPHENE, P10454; Zhao GX, 2011, DALTON T, V40, P10945, DOI 10.1039/c1dt11005e	63	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185235	10.1371/journal.pone.0185235	http://dx.doi.org/10.1371/journal.pone.0185235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934354	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900131
J	de Vries, EM; Oosterman, JE; Eggink, HM; de Goede, P; Sen, S; Foppen, E; Boudzovitch-Surovtseva, O; Boelen, A; Romijn, JA; LaFleur, SE; Kalsbeek, A				de Vries, E. M.; Oosterman, J. E.; Eggink, H. M.; de Goede, P.; Sen, S.; Foppen, E.; Boudzovitch-Surovtseva, O.; Boelen, A.; Romijn, J. A.; LaFleur, S. E.; Kalsbeek, A.			Effects of meal composition and meal timing on the expression of genes involved in hepatic drug metabolism in rats	PLOS ONE			English	Article							HIGH-SUGAR DIET; HIGH-FAT DIET; CIRCADIAN CLOCK; NUCLEAR RECEPTORS; CYTOCHROME-P450 GENES; MOUSE; RHYTHM; LIVER; IDENTIFICATION; ACETAMINOPHEN	Introduction With chronotherapy, drug administration is synchronized with daily rhythms in drug clearance and pharmacokinetics. Daily rhythms in gene expression are centrally mastered by the suprachiasmatic nucleus of the hypothalamus as well as by tissue clocks containing similar molecular mechanisms in peripheral organs. The central timing system is sensitive to changes in the external environment such as those of the light-dark cycle, meal timing and meal composition. We investigated how changes in diet composition and meal timing would affect the daily hepatic expression rhythms of the nuclear receptors PXR and CAR and of enzymes involved in P450 mediated drug metabolism, as such changes could have consequences for the practice of chronotherapy. Materials and methods Rats were subjected to either a regular chow or a free choice high-fat-high-sugar (fcHFHS) diet. These diets were provided ad libitum, or restricted to either the light phase or the dark phase. In a second experiment, rats had access to chow either ad libitum or in 6 meals equally distributed over 24 hours. Results Pxr, Alas1 and Por displayed significant day-night rhythms under ad libitum chow fed conditions, which for Pxr was disrupted under fcHFHS diet conditions. Although no daily rhythms were detected in expression of CAR, Cyp2b2 and Cyp3a2, the fcHFHS diet did affect basal expression of these genes. In chow fed rats, dark phase feeding induced a diurnal rhythm in Cyp2b2 expression while light phase feeding induced a diurnal rhythm in Car expression and completely shifted the peak expression of Pxr, Car, Cyp2b2, Alas1 and Por. The 6-meals-a-day feeding only abolished the Pxr rhythm but not the rhythms of the other genes. Conclusion We conclude that although nuclear receptors and enzymes involved in the regulation of hepatic drug metabolism are sensitive to meal composition, changes in meal timing are mainly effectuated via changes in the molecular clock.	[de Vries, E. M.; Romijn, J. A.] Acad Med Ctr, Dept Med, Amsterdam, Netherlands; [Oosterman, J. E.; Eggink, H. M.; de Goede, P.; Boudzovitch-Surovtseva, O.; Boelen, A.; LaFleur, S. E.; Kalsbeek, A.] Acad Med Ctr, Dept Endocrinol & Metab, Amsterdam, Netherlands; [Sen, S.; Foppen, E.; Kalsbeek, A.] Netherlands Inst Neurosci, Hypothalam Integrat Mech, Amsterdam, Netherlands; [LaFleur, S. E.] Netherlands Inst Neurosci, Metab & Reward Grp, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	de Vries, EM (corresponding author), Acad Med Ctr, Dept Med, Amsterdam, Netherlands.	e.m.devries@amc.uva.nl	Kalsbeek, Andries/H-3076-2019	Kalsbeek, Andries/0000-0001-9606-8453	Technology Foundation STW [12195]; AMC PhD Scholarship	Technology Foundation STW(Technologiestichting STW); AMC PhD Scholarship	This work was supported by the Technology Foundation STW grant "Feeding OnTime" (#12195) for SEF and AK and an AMC PhD Scholarship for JOE.	Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chiba T, 2016, J PHARM PHARMACOL, V68, P1567, DOI 10.1111/jphp.12646; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Froy O, 2009, CURR DRUG METAB, V10, P104, DOI 10.2174/138920009787522179; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Ghoneim RH, 2015, BRIT J NUTR, V113, P507, DOI 10.1017/S0007114514003717; Ghose R, 2011, LIFE SCI, V89, P57, DOI 10.1016/j.lfs.2011.05.005; Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Johnson BP, 2014, P NATL ACAD SCI USA, V111, P18757, DOI 10.1073/pnas.1421708111; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Kumar GN, 2001, MED RES REV, V21, P397, DOI 10.1002/med.1016; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; la Fleur SE, 2007, INT J OBESITY, V31, P1286, DOI 10.1038/sj.ijo.0803570; la Fleur SE, 2014, INT J OBESITY, V38, P643, DOI 10.1038/ijo.2013.159; la Fleur SE, 2011, INT J OBESITY, V35, P595, DOI 10.1038/ijo.2010.164; Lammers LA, 2015, DRUG METAB DISPOS, V43, P819, DOI 10.1124/dmd.114.062299; Lu YF, 2013, CHRONOBIOL INT, V30, P1135, DOI 10.3109/07420528.2013.805762; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Matsunaga N, 2004, J PHARMACOL EXP THER, V311, P594, DOI 10.1124/jpet.104.069062; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Murray M, 2006, CURR DRUG METAB, V7, P67, DOI 10.2174/138920006774832569; OHDO S, 1991, CHRONOBIOL INT, V8, P35, DOI 10.3109/07420529109063917; Ohdo S, 2010, ADV DRUG DELIVER REV, V62, P859, DOI 10.1016/j.addr.2010.01.006; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Oosterman JE, 2015, AM J PHYSIOL-REG I, V308, pR337, DOI 10.1152/ajpregu.00322.2014; Opperhuizen AL, 2016, EUR J NEUROSCI, V44, P2795, DOI 10.1111/ejn.13377; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; SONAWANE B R, 1983, Drug-Nutrient Interactions, V2, P7; STEPHAN FK, 1972, PHYSIOL BEHAV, V8, P315, DOI 10.1016/0031-9384(72)90379-4; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Su Y, 2016, MOL CELL ENDOCRINOL, V422, P125, DOI 10.1016/j.mce.2015.12.011; Takiguchi T, 2007, PHARMACOGENET GENOM, V17, P1047, DOI 10.1097/FPC.0b013e3282f12a61; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Wieneke N, 2007, FEBS LETT, V581, P5617, DOI 10.1016/j.febslet.2007.11.011; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185520	10.1371/journal.pone.0185520	http://dx.doi.org/10.1371/journal.pone.0185520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968417	Green Published, gold, Green Submitted			2022-12-27	WOS:000412029600023
J	van Ettinger-Veenstra, H; Widen, C; Engstrom, M; Karlsson, T; Leijon, I; Nelson, N				van Ettinger-Veenstra, Helene; Widen, Carin; Engstrom, Maria; Karlsson, Thomas; Leijon, Ingemar; Nelson, Nina			Neuroimaging of decoding and language comprehension in young very low birth weight (VLBW) adolescents: Indications for compensatory mechanisms	PLOS ONE			English	Article							SIMPLE VIEW; PRETERM CHILDREN; PREMATURELY BORN; CATCH-UP; BRAIN; FMRI; ORGANIZATION; ABILITIES; DYSLEXIA; DEFICITS	In preterm children with very low birth weight (VLBW <= 1500 g), reading problems are often observed. Reading comprehension is dependent on word decoding and language comprehension. We investigated neural activation-within brain regions important for reading-related to components of reading comprehension in young VLBW adolescents in direct comparison to normal birth weight (NBW) term-born peers, with the use of functional magnetic resonance imaging (fMRI). We hypothesized that the decoding mechanisms will be affected by VLBW, and expect to see increased neural activity for VLBW which may be modulated by task performance and cognitive ability. The study investigated 13 (11 included in fMRI) young adolescents (ages 12 to 14 years) born preterm with VLBW and in 13 NBW controls (ages 12-14 years) for performance on the Block Design and Vocabulary subtests of the Wechsler Intelligence Scale for Children; and for semantic, orthographic, and phonological processing during an fMRI paradigm. The VLBW group showed increased phonological activation in left inferior frontal gyrus, decreased orthographic activation in right supramarginal gyrus, and decreased semantic activation in left inferior frontal gyrus. Block Design was related to altered right-hemispheric activation, and VLBW showed lower WISC Block Design scores. Left angular gyrus showed activation increase specific for VLBW with high accuracy on the semantic test. Young VLBW adolescents showed no accuracy and reaction time performance differences on our fMRI language tasks, but they did exhibit altered neural activation during these tasks. This altered activation for VLBW was observed as increased activation during phonological decoding, and as mainly decreased activation during orthographic and semantic processing. Correlations of neural activation with accuracy on the semantic fMRI task and with decreased WISC Block Design performance were specific for the VLBW group. Together, results suggest compensatory mechanisms by recruiting additional brain regions upon altered neural development of decoding for VLBW.	[van Ettinger-Veenstra, Helene; Engstrom, Maria] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [van Ettinger-Veenstra, Helene; Engstrom, Maria; Karlsson, Thomas] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden; [Widen, Carin; Leijon, Ingemar; Nelson, Nina] Linkoping Univ, Dept Clin & Expt Med, Pediat, Linkoping, Sweden; [Karlsson, Thomas] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Karlsson, Thomas] Linkoping Univ, Linnaeus Ctr HEAD, Linkoping, Sweden; [Nelson, Nina] Karolinska Univ Hosp, Dept Qual & Patient Safety, Stockholm, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University; Linkoping University; Karolinska Institutet; Karolinska University Hospital	van Ettinger-Veenstra, H (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden.; van Ettinger-Veenstra, H (corresponding author), Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden.	helenevanettinger@gmail.com	Van Ettinger-Veenstra, Helene/AAT-7322-2020; Van Ettinger-Veenstra, Helene/ABD-6049-2020	Van Ettinger-Veenstra, Helene/0000-0003-3587-3568; 	FORSS-the Medical Research Council of Southeast Sweden [FORSS-159881]	FORSS-the Medical Research Council of Southeast Sweden	NN received funding from FORSS-the Medical Research Council of Southeast Sweden to perform the current study, grant number FORSS-159881, (http://www.researchweb.org/is/forss/ansokan/159881). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, J ABNORM CHILD PSYCH, V37, P981, DOI 10.1007/s10802-009-9327-z; [Anonymous], 2015, READ RES Q, V50, P151, DOI DOI 10.1002/rrq.99; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barre N, 2011, J PEDIATR-US, V158, P766, DOI 10.1016/j.jpeds.2010.10.032; Bitan T, 2007, HUM BRAIN MAPP, V28, P880, DOI 10.1002/hbm.20313; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Cartwright KB, 2007, J LIT RES, V39, P173, DOI 10.1080/10862960701331902; Catts HW, 2006, J SPEECH LANG HEAR R, V49, P278, DOI 10.1044/1092-4388(2006/023); Coltheart M., 2000, READING PERCEPTUAL P, P475, DOI [DOI 10.1016/B978-008043642-5/50022-X, 10.1016/B978-008043642-5/50022-X]; Crystal David., 2010, CAMBRIDGE ENCY LANGU, V3rd ed.; Gaddlin PO, 2011, ACTA PAEDIATR, V100, P940, DOI 10.1111/j.1651-2227.2011.02288.x; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hartwigsen G, 2010, P NATL ACAD SCI USA, V107, P16494, DOI 10.1073/pnas.1008121107; HOOVER WA, 1990, READ WRIT, V2, P127, DOI 10.1007/BF00401799; Horowitz-Kraus T, 2015, ACTA PAEDIATR, V104, P648, DOI 10.1111/apa.13018; Kovachy VN, 2015, DEV MED CHILD NEUROL, V57, P410, DOI 10.1111/dmcn.12652; Kwon SH, 2016, DEV MED CHILD NEUROL, V58, P28, DOI 10.1111/dmcn.13043; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lee ES, 2011, NEUROPSYCHOLOGIA, V49, P906, DOI 10.1016/j.neuropsychologia.2010.12.038; Leijon I, 2016, ACTA PAEDIATR, V105, P60, DOI 10.1111/apa.13094; Lundberg I, STOCK HOGREFE PSYKOL; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Manis FR, 1996, COGNITION, V58, P157, DOI 10.1016/0010-0277(95)00679-6; Ment LR, 2006, J PEDIATR-US, V149, P490, DOI 10.1016/j.jpeds.2006.06.007; Ment LR, 2003, JAMA-J AM MED ASSOC, V289, P705, DOI 10.1001/jama.289.6.705; Neubauer AC, 2009, NEUROSCI BIOBEHAV R, V33, P1004, DOI 10.1016/j.neubiorev.2009.04.001; Perfetti C.A, 1985, READING ABILITY; Peterson BS, 2002, PEDIATRICS, V110, P1153, DOI 10.1542/peds.110.6.1153; Prat CS, 2007, J COGNITIVE NEUROSCI, V19, P1950, DOI 10.1162/jocn.2007.19.12.1950; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Reidy N, 2013, J PEDIATR-US, V162, P719, DOI 10.1016/j.jpeds.2012.10.017; Rushe T.M., 2004, FETAL NEONATAL EDITI, V89, pF112, DOI DOI 10.1136/ADC.2001.005314; Samuelsson S, 2006, J PEDIATR PSYCHOL, V31, P967, DOI 10.1093/jpepsy/jsj108; Sandak R, 2004, SCI STUD READ, V8, P273, DOI 10.1207/s1532799xssr0803_6; Scheinost D, 2015, CEREB CORTEX, V25, P1858, DOI 10.1093/cercor/bht430; Shaywitz BA, 2006, DEV NEUROPSYCHOL, V30, P613, DOI 10.1207/s15326942dn3001_5; Socialstyrelsen, 2015, OFF STAT SWED STAT H; Luu TM, 2011, PEDIATRICS, V128, P313, DOI 10.1542/peds.2010-2655; Wadsby M, 2014, NORD J PSYCHIAT, V68, P626, DOI 10.3109/08039488.2014.907341	39	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185571	10.1371/journal.pone.0185571	http://dx.doi.org/10.1371/journal.pone.0185571			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968426	Green Published, Green Submitted, gold			2022-12-27	WOS:000412029600026
J	Adamczyk, M; Szatkowska, R				Adamczyk, Malgorzata; Szatkowska, Roza			Low RNA Polymerase III activity results in up regulation of HXT2 glucose transporter independently of glucose signaling and despite changing environment	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; SNF1 PROTEIN-KINASE; HEXOSE TRANSPORTERS; GENE-EXPRESSION; CARBON SOURCE; DNA-BINDING; TRANSCRIPTION FACTOR; IN-VIVO; TERMINAL DOMAIN; MIG1 REPRESSOR	Background Saccharomyces cerevisiae responds to glucose availability in the environment, inducing the expression of the low-affinity transporters and high-affinity transporters in a concentration dependent manner. This cellular decision making is controlled through finely tuned communication between multiple glucose sensing pathways including the Snf1-Mig1, Snf3/Rgt2Rgt1 (SRR) and cAMP-PKA pathways. Results We demonstrate the first evidence that RNA Polymerase III (RNAP III) activity affects the expression of the glucose transporter HXT2 (RNA Polymerase II dependent D RNAP II) at the level of transcription. Down-regulation of RNAP III activity in an rpc128-1007 mutant results in a significant increase in HXT2 mRNA, which is considered to respond only to low extracellular glucose concentrations. HXT2 expression is induced in the mutant regardless of the growth conditions either at high glucose concentration or in the presence of a non-fermentable carbon source such as glycerol. Using chromatin immunoprecipitation (ChIP), we found an increased association of Rgt1 and Tup1 transcription factors with the highly activated HXT2 promoter in the rpc128-1007 strain. Furthermore, by measuring cellular abundance of Mth1 corepressor, we found that in rpc128-1007, HXT2 gene expression was independent from Snf3/Rgt2-Rgt1 (SRR) signaling. The Snf1 protein kinase complex, which needs to be active for the release from glucose repression, also did not appear perturbed in the mutated strain. Conclusions/Significance These findings suggest that the general activity of RNAP III can indirectly affect the RNAP II transcriptional machinery on the HXT2 promoter when cellular perception transduced via the major signaling pathways, broadly recognized as on/off switch essential to either positive or negative HXT gene regulation, remain entirely intact. Further, Rgt1/Ssn6-Tup1 complex, which has a dual function in gene transcription as a repressor-activator complex, contributes to HXT2 transcriptional activation.	[Adamczyk, Malgorzata; Szatkowska, Roza] Warsaw Univ Technol, Inst Biotechnol, Fac Chem, Warsaw, Poland	Warsaw University of Technology	Adamczyk, M (corresponding author), Warsaw Univ Technol, Inst Biotechnol, Fac Chem, Warsaw, Poland.	madamczyk@ch.pw.edu.pl		Adamczyk, Malgorzata/0000-0003-3979-0364; Szatkowska, Roza/0000-0003-4494-5236	National Science Centre, Poland [2012/05/E/NZ2/00583]; Warsaw University of Technology	National Science Centre, Poland(National Science Centre, Poland); Warsaw University of Technology	Funding provided by the National Science Centre, Poland grant 2012/05/E/NZ2/00583, Warsaw University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilles J, 2004, CYTOM PART A, V61A, P88, DOI 10.1002/cyto.a.20035; Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BALASUBRAMANIAN B, 1993, MOL CELL BIOL, V13, P6071, DOI 10.1128/MCB.13.10.6071; Boguta M, 2011, TRENDS BIOCHEM SCI, V36, P451, DOI 10.1016/j.tibs.2011.06.008; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1016/S0168-6445(97)00052-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; Bu Y, 1998, NUCLEIC ACIDS RES, V26, P1002, DOI 10.1093/nar/26.4.1002; Buck MJ, 2006, NAT GENET, V38, P1446, DOI 10.1038/ng1917; Ciesla M, 2007, MOL CELL BIOL, V27, P7693, DOI 10.1128/MCB.01051-07; Ciesla M, 2015, MOL CELL BIOL, V35, P1169, DOI 10.1128/MCB.01230-14; Conlan RS, 1999, J BIOL CHEM, V274, P205, DOI 10.1074/jbc.274.1.205; Conlan RS, 2001, J MOL BIOL, V309, P1007, DOI 10.1006/jmbi.2001.4742; Coons DM, 1997, YEAST, V13, P9, DOI 10.1002/(SICI)1097-0061(199701)13:1<9::AID-YEA51>3.0.CO;2-U; Davie JK, 2003, J BIOL CHEM, V278, P50158, DOI 10.1074/jbc.M309753200; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; Diderich JA, 1999, J BIOL CHEM, V274, P15350, DOI 10.1074/jbc.274.22.15350; Dietzel KL, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-107; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Fernandez-Garcia P, 2012, J BIOL CHEM, V287, P42151, DOI 10.1074/jbc.M112.401679; Ferreira C, 2007, FEBS LETT, V581, P1923, DOI 10.1016/j.febslet.2007.03.086; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Gancedo JM, 2015, BBA-GEN SUBJECTS, V1850, P1362, DOI 10.1016/j.bbagen.2015.03.006; Ghavidel A, 2007, CELL, V131, P915, DOI 10.1016/j.cell.2007.09.042; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Han BK, 2011, GENE DEV, V25, P984, DOI 10.1101/gad.1998611; Hanlon SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019060; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Horak J, 2013, CURR GENET, V59, P1, DOI 10.1007/s00294-013-0388-8; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jouandot D, 2011, J CELL BIOCHEM, V112, P3268, DOI 10.1002/jcb.23253; Kaminska J, 2000, GENE, V242, P133, DOI 10.1016/S0378-1119(99)00535-1; Kaniak A, 2004, EUKARYOT CELL, V3, P221, DOI 10.1128/EC.3.1.221-231.2004; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; Kim D, 2015, APPL ENVIRON MICROB, V81, P8392, DOI 10.1128/AEM.02056-15; Kim JH, 2006, J BIOL CHEM, V281, P26144, DOI 10.1074/jbc.M603636200; Kim JH, 2009, BIOCHIMIE, V91, P300, DOI 10.1016/j.biochi.2008.09.002; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; Kim JW, 2004, MOL CELL BIOL, V24, P8104, DOI 10.1128/MCB.24.18.8104-8112.2004; Kim SJ, 2005, MOL CELL BIOL, V25, P11171, DOI 10.1128/MCB.25.24.11171-11183.2005; Kolkman A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100069; KOMACHI K, 1994, GENE DEV, V8, P2857, DOI 10.1101/gad.8.23.2857; Kresnowati MTAP, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100083; Kruckeberg AL, 1999, BIOCHEM J, V339, P299, DOI 10.1042/0264-6021:3390299; Kwapisz M, 2002, CURR GENET, V42, P147, DOI 10.1007/s00294-002-0342-7; Lafuente MJ, 2000, MOL MICROBIOL, V35, P161, DOI 10.1046/j.1365-2958.2000.01688.x; Lakshmanan J, 2003, CURR GENET, V44, P19, DOI 10.1007/s00294-003-0423-2; Lee SB, 2013, BIOCHEM BIOPH RES CO, V439, P501, DOI 10.1016/j.bbrc.2013.09.015; Liang H, 1996, MOL BIOL CELL, V7, P1953, DOI 10.1091/mbc.7.12.1953; Lin X, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-48; Lin X, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0093-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Maier A, 2002, FEMS YEAST RES; Matsumura H, 2012, J BIOL CHEM, V287, P26528, DOI 10.1074/jbc.M112.369652; McCartney RR, 2014, GENETICS, V198, P635, DOI 10.1534/genetics.114.169060; Metzger DE, 2014, DIABETES, V63, P1804, DOI 10.2337/db13-0867; Mierzejewska J, 2016, FEBS LETT, V590, P93, DOI 10.1002/1873-3468.12033; Morawiec E, 2013, GENE, V526, P16, DOI 10.1016/j.gene.2013.04.055; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; Mosley AL, 2003, J BIOL CHEM, V278, P10322, DOI 10.1074/jbc.M212802200; NEHLIN JO, 1991, EMBO J, V10, P3373, DOI 10.1002/j.1460-2075.1991.tb04901.x; O'Donnell AF, 2015, MOL CELL BIOL, V35, P939, DOI 10.1128/MCB.01183-14; Ostling J, 1998, EUR J BIOCHEM, V252, P162, DOI 10.1046/j.1432-1327.1998.2520162.x; Ozcan S, 1998, EMBO J, V17, P2566, DOI 10.1093/emboj/17.9.2566; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Ozcan S, 1996, MOL CELL BIOL, V16; Palian BM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004789; Palomino A, 2006, NUCLEIC ACIDS RES, V34, P1427, DOI 10.1093/nar/gkl028; Papamichos-Chronakis M, 2002, MOL CELL, V9, P1297, DOI 10.1016/S1097-2765(02)00545-2; Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001; Polish JA, 2005, GENETICS, V169, P583, DOI 10.1534/genetics.104.034512; Proft M, 2002, MOL CELL; Reifenberger E, 1997, EUR J BIOCHEM, V245, P324, DOI 10.1111/j.1432-1033.1997.00324.x; Reijenga KA, 2001, BIOPHYS J, V80, P626, DOI 10.1016/S0006-3495(01)76043-2; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Ronen M, 2006, P NATL ACAD SCI USA, V103, P389, DOI 10.1073/pnas.0509978103; Roy A, 2014, FEBS OPEN BIO, V4, P105, DOI 10.1016/j.fob.2013.12.004; Roy A, 2013, MOL BIOL CELL, V24, P1493, DOI 10.1091/mbc.E13-01-0047; Sabina J, 2009, J BIOL CHEM, V284, P29635, DOI 10.1074/jbc.M109.032102; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schneper L, 2004, CURR OPIN MICROBIOL, V7, P624, DOI 10.1016/j.mib.2004.10.002; Schulte F, 2000, J BACTERIOL, V182, P540, DOI 10.1128/JB.182.2.540-542.2000; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Silveira MCF, 1996, ANAL BIOCHEM, V238, P26, DOI 10.1006/abio.1996.0244; Simpson-Lavy KJ, 2015, CELL REP, V12, P1865, DOI 10.1016/j.celrep.2015.08.025; Slattery MG, 2008, EUKARYOT CELL, V7, P358, DOI 10.1128/EC.00334-07; Smith FC, 1999, FEBS LETT, V453, P219, DOI 10.1016/S0014-5793(99)00725-5; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Snowdon C, 2016, MOL BIOL CELL, V27, P3369, DOI 10.1091/mbc.E16-05-0342; Snowdon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050458; Tanaka N, 2015, BIOCHEM BIOPH RES CO, V468, P32, DOI 10.1016/j.bbrc.2015.11.001; Tao JY, 2016, BIOCHEMISTRY-US, V55, P2578, DOI 10.1021/acs.biochem.5b01286; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; TRUMBLY RJ, 1992, MOL MICROBIOL, V6, P15, DOI 10.1111/j.1365-2958.1992.tb00832.x; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; van Oevelen CJC, 2006, J BIOL CHEM, V281, P4523, DOI 10.1074/jbc.M509330200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vannini A, 2010, CELL, V143, P59, DOI 10.1016/j.cell.2010.09.002; Vega M, 2016, J BIOL CHEM, V291, P7267, DOI 10.1074/jbc.M115.711408; Wang JF, 1997, J BIOL CHEM, V272, P4613, DOI 10.1074/jbc.272.7.4613; Weinhandl K, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-5; WENDELL DL, 1994, J BACTERIOL, V176, P3730, DOI 10.1128/JB.176.12.3730-3737.1994; WILLIAMS FE, 1990, MOL CELL BIOL, V10, P6500, DOI 10.1128/MCB.10.12.6500; Wollman AJM, 2015, FARADAY DISCUSS, V184, P401, DOI 10.1039/c5fd00077g; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; Ye L, 2001, YEAST, V18, P1257, DOI 10.1002/yea.771.abs; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Zaman S, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.2; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127	122	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185516	10.1371/journal.pone.0185516	http://dx.doi.org/10.1371/journal.pone.0185516			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961268	gold, Green Published, Green Submitted			2022-12-27	WOS:000412027700022
J	Bomfim, L; Vieira, P; Fonseca, A; Ramos, I				Bomfim, Larissa; Vieira, Priscila; Fonseca, Ariene; Ramos, Isabela			Eggshell ultrastructure and delivery of pharmacological inhibitors to the early embryo of R. prolixus by ethanol permeabilization of the extraembryonic layers	PLOS ONE			English	Article							INSECT RHODNIUS-PROLIXUS; RNA INTERFERENCE; EMBRYOGENESIS; REDUVIIDAE; HEMIPTERA; DSRNA; INJECTION; ELEGANS; GENE	Most vectors of arthropod-borne diseases produce large eggs with hard and opaque eggshells. In several species, it is still not possible to induce molecular perturbations to the embryo by delivery of molecules using microinjections or eggshell permeabilization without losing embryo viability, which impairs basic studies regarding development and population control. Here we tested the properties and permeability of the eggshell of R. prolixus, a Chagas disease vector, with the aim to deliver pharmacological inhibitors to the egg cytoplasm and allow controlled molecular changes to the embryo. Using field emission scanning and transmission electron microscopy we found that R. prolixus egg is coated by three main layers: exochorion, vitelline layer and the plasma membrane, and that the pores that allow gas exchange (aeropiles) have an average diameter of 10 mu m and are found in the rim of the operculum at the anterior pole of the egg. We tested if different solvents could permeate through the aeropiles and reach the egg cytoplasm/embryo and found that immersions of the eggs in ethanol lead to its prompt penetration through the aeropiles. A single five minute-immersion of the eggs/embryos in pharmacological inhibitors, such as azide, cyanide and cycloheximide, solubilized in ethanol resulted in impairment of embryogenesis in a dose dependent manner and DAPI-ethanol solutions were also able to label the embryo cells, showing that ethanol penetration was able to deliver those molecules to the embryo cells. Multiple immersions of the embryo in the same solutions increased the effect and tests using bafilomycin A1 and Pepstatin A, known inhibitors of the yolk proteolysis, were also able to impair embryogenesis and the yolk protein degradation. Additionally, we found that ethanol pre-treatments of the egg make the aeropiles more permeable to aqueous solutions, so drugs diluted in water can be carried after the eggs are pre-treated with ethanol. Thus, we found that delivery of pharmacological inhibitors to the embryo of R. prolixus can be performed simply by submersing the fertilized eggs in ethanol with no need for additional methods such as microinjections or electroporation. We discuss the potential importance of this methodology to the study of this vector developmental biology and population control.	[Bomfim, Larissa; Vieira, Priscila; Fonseca, Ariene; Ramos, Isabela] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Bioquim Insetos, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Ramos, I (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Bioquim Insetos, Rio De Janeiro, Brazil.	isabela@bioqmed.ufrj.br	Ramos, Isabela B/N-7091-2017	Ramos, Isabela B/0000-0003-0874-7902; Bomfim, Larissa/0000-0003-0901-3118	CNPq, Universal; FAPERJ, APQ1; CNPq/FAPERJ, INCT-EM	CNPq, Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ, APQ1(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq/FAPERJ, INCT-EM	This work was supported by CNPq, Universal to IR; FAPERJ, APQ1 to IR; and CNPq/FAPERJ, INCT-EM to IR.	Andersen S.O., 1985, COMPREHENSIVE INSECT, V3, P59, DOI 10.1016/0020-711X(85)90033-3; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Azambuja P, 2016, J INSECT PHYSL; Balakrishna Pillai A, 2016, INSECT MOL BIOL; Beament JW, 1947, Q J MICROSCOPICAL SC, V87, P393; BEAMENT JWL, 1948, B ENTOMOL RES, V39, P359, DOI 10.1017/S0007485300022471; BEAMENT JWL, 1946, PROC R SOC SER B-BIO, V133, P407, DOI 10.1098/rspb.1946.0021; BEAMENT JWL, 1945, J EXP BIOL, V21, P115; BEAMENT JWL, 1946, NATURE, V157, P370, DOI 10.1038/157370c0; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Berkowitz Laura A, 2008, J Vis Exp, DOI 10.3791/833; Berni M, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-38; Brust-Mascher Ingrid, 2009, J Vis Exp, DOI 10.3791/1382; Dias FA, 2013, J BIOL CHEM, V288, P35058, DOI 10.1074/jbc.M113.522201; GARCIA ES, 1975, AN ACAD BRAS CIENC, V47, P580; Gilbert S.F., 2000, DEV BIOL; HARIDASS ET, 1986, P INDIAN AS-ANIM SCI, V95, P447, DOI 10.1007/BF03179381; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; KELLY GM, 1989, J MORPHOL, V199, P175, DOI 10.1002/jmor.1051990205; KELLY GM, 1986, CAN J ZOOL, V64, P2425, DOI 10.1139/z86-362; KELLY GM, 1987, INSECT BIOCHEM, V17, P1079, DOI 10.1016/0020-1790(87)90124-7; Khila A, 2007, DEV GENES EVOL, V217, P241, DOI 10.1007/s00427-007-0132-9; Lavore A, 2012, DEV BIOL, V361, P147, DOI 10.1016/j.ydbio.2011.06.038; Marre J, 2016, P NATL ACAD SCI USA, V113, P12496, DOI 10.1073/pnas.1608959113; May RC, 2005, METHOD ENZYMOL, V392, P308, DOI 10.1016/S0076-6879(04)92018-6; MERRIL CR, 1981, ANAL BIOCHEM, V110, P201, DOI 10.1016/0003-2697(81)90136-6; Mesquita RD, 2015, P NATL ACAD SCI USA, V112, P14936, DOI 10.1073/pnas.1506226112; Ons S, 2016, J INSECT PHYSL; Paim RMM, 2013, INSECT BIOCHEM MOLEC, V43, P1015, DOI 10.1016/j.ibmb.2013.08.008; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Silva-Neto MAC, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00062; Sive HL, 2010, COLD SPRING HARBOR P, V2010; Sive HL, 2010, COLD SPRING HARBOR P, V2010; Souza-Ferreira PS, 2014, INSECT BIOCHEM MOLEC, V51, P101, DOI 10.1016/j.ibmb.2013.12.004; TUFT PH, 1950, J EXP BIOL, V26, P327; Walter-Nuno AB, 2013, J BIOL CHEM, V288, P29323, DOI 10.1074/jbc.M113.504985; Xu QL, 1999, METH MOL B, V127, P125, DOI 10.1385/1-59259-678-9:125	37	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185770	10.1371/journal.pone.0185770	http://dx.doi.org/10.1371/journal.pone.0185770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961275	Green Published, gold, Green Submitted			2022-12-27	WOS:000412027700037
J	Bernstein, DM; Cooling, A; Fischer, AL; Thornton, WL; Sommerville, JA				Bernstein, Daniel M.; Cooling, Alisha; Fischer, Ashley L.; Thornton, Wendy Loken; Sommerville, Jessica A.			False-belief reasoning from 3 to 92 years of age	PLOS ONE			English	Article							EPISODIC MEMORY; LIFE-SPAN; MIND; PERFORMANCE; ADULTS; REPRESENTATION; KNOWLEDGE; BIAS	False-belief reasoning, defined as the ability to reason about another person's beliefs and appreciate that beliefs can differ from reality, is an important aspect of perspective taking. We tested 266 individuals, at various ages ranging from 3 to 92 years, on a continuous measure of false-belief reasoning (the Sandbox task). All age groups had difficulty suppressing their own knowledge when estimating what a naive person knew. After controlling for task-specific memory, our results showed similar false-belief reasoning abilities across the preschool years and from older childhood to younger adulthood, followed by a small reduction in this ability from younger to older adulthood. These results highlight the relative similarity in false-belief reasoning abilities at different developmental periods across the lifespan.	[Bernstein, Daniel M.] Kwantlen Polytech Univ, Surrey, BC, Canada; [Bernstein, Daniel M.; Cooling, Alisha; Fischer, Ashley L.; Thornton, Wendy Loken] Simon Fraser Univ, Burnaby, BC, Canada; [Sommerville, Jessica A.] Univ Washington, Seattle, WA 98195 USA	Simon Fraser University; University of Washington; University of Washington Seattle	Bernstein, DM (corresponding author), Kwantlen Polytech Univ, Surrey, BC, Canada.; Bernstein, DM (corresponding author), Simon Fraser Univ, Burnaby, BC, Canada.	Daniel.bernstein@kpu.ca		Bernstein, Daniel/0000-0003-2716-2344	Social Sciences and Humanities Research Council of Canada [410-2008-1681, 410-2010-0407]; Canada Research Chairs program [950228407]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canada Research Chairs program(Canada Research Chairs)	This work was supported by the Social Sciences and Humanities Research Council of Canada (410-2008-1681 and 410-2010-0407) and the Canada Research Chairs program (950228407). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey PE, 2008, AGING MENT HEALTH, V12, P499, DOI 10.1080/13607860802224243; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bernstein DM, 2011, EXP AGING RES, V37, P481, DOI 10.1080/0361073X.2011.619466; Berthiaume VG, 2013, COGNITION, V126, P441, DOI 10.1016/j.cognition.2012.11.005; Birch SAJ, 2007, PSYCHOL SCI, V18, P382, DOI 10.1111/j.1467-9280.2007.01909.x; Carlson SM, 1998, CHILD DEV, V69, P672, DOI 10.2307/1132197; Carpendale JI, 1996, CHILD DEV, V67, P1686, DOI 10.2307/1131725; Cocchini G, 2002, MEM COGNITION, V30, P1086, DOI 10.3758/BF03194326; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coolin A, 2017, FRONT DEVELOP SCI, P280; Craik FIM, 2006, TRENDS COGN SCI, V10, P131, DOI 10.1016/j.tics.2006.01.007; CRONBACH LJ, 1970, PSYCHOL BULL, V74, P68, DOI 10.1037/h0029382; Devine RT, 2013, CHILD DEV, V84, P989, DOI 10.1111/cdev.12017; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fischer AL, 2016, J GERONTOL; German TP, 2006, COGNITION, V101, P129, DOI 10.1016/j.cognition.2005.05.007; Gweon H, 2012, CHILD DEV, V83, P1853, DOI 10.1111/j.1467-8624.2012.01829.x; Henry JD, 2013, PSYCHOL AGING, V28, P826, DOI 10.1037/a0030677; Hughes C, 2015, CHILD DEV PERSPECT, V9, P149, DOI 10.1111/cdep.12124; Keenan T., 2003, INDIVIDUAL DIFFERENC, P122; Low J, 2016, CHILD DEV PERSPECT, V10, P184, DOI 10.1111/cdep.12183; Mahy CEV, 2017, J EXP CHILD PSYCHOL, V160, P50, DOI 10.1016/j.jecp.2017.03.010; McGeoch JA, 1932, PSYCHOL REV, V39, P352, DOI 10.1037/h0069819; Miller S.A., 2012, THEORY MIND PRESCHOO; Mitchell P, 1996, COGNITION, V59, P1, DOI 10.1016/0010-0277(95)00683-4; Moran JM, 2013, BEHAV BRAIN RES, V237, P32, DOI 10.1016/j.bbr.2012.09.020; Naito M, 2003, J EXP CHILD PSYCHOL, V85, P312, DOI 10.1016/S0022-0965(03)00075-4; Perner J, 2007, INFANT CHILD DEV, V16, P471, DOI 10.1002/icd.517; Pohl RF, 2010, DEV PSYCHOL, V46, P1268, DOI 10.1037/a0020209; Rakoczy H, 2012, BRIT J PSYCHOL, V103, P58, DOI 10.1111/j.2044-8295.2011.02040.x; Schaafsma SM, 2015, TRENDS COGN SCI, V19, P65, DOI 10.1016/j.tics.2014.11.007; Sobel DM, 2016, COGNITIVE DEV, V40, P9, DOI 10.1016/j.cogdev.2016.08.002; Sommerville JA, 2013, CHILD DEV, V84, P1846, DOI 10.1111/cdev.12110; Triona LM, 2002, P 24 ANN C COGN SCI, P1045; VERHAEGHEN P, 1993, J GERONTOL, V48, pP157, DOI 10.1093/geronj/48.4.P157; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Wilson KM, 2001, J LEARN DISABIL-US, V34, P237, DOI 10.1177/002221940103400304; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Zelazo PD, 2004, ACTA PSYCHOL, V115, P167, DOI 10.1016/j.actpsy.2003.12.005; Zumbo BD, 1999, ADV SOC SCI, V5, P269	40	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185345	10.1371/journal.pone.0185345	http://dx.doi.org/10.1371/journal.pone.0185345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957366	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200046
J	Grimaldo, L; Sandoval, A; Garza-Lopez, E; Felix, R				Grimaldo, Lizbeth; Sandoval, Alejandro; Garza-Lopez, Edgar; Felix, Ricardo			Involvement of Parkin in the ubiquitin proteasome system-mediated degradation of N-type voltage-gated Ca2+ channels	PLOS ONE			English	Article							CALCIUM-CHANNELS; CA(V)2.2	N-type calcium (Ca(V)2.2) channels are widely expressed in the brain and the peripheral nervous system, where they play important roles in the regulation of transmitter release. Although Ca(V)2.2 channel expression levels are precisely regulated, presently little is known regarding the molecules that mediate its synthesis and degradation. Previously, by using a combination of biochemical and functional analyses, we showed that the complex formed by the light chain 1 of the microtubule-associated protein 1B (LC1-MAP1B) and the ubiquitin-proteasome system (UPS) E2 enzyme UBE2L3, may interact with the Ca(V)2.2 channels promoting ubiquitin-mediated degradation. The present report aims to gain further insights into the possible mechanism of degradation of the neuronal Ca(V)2.2 channel by the UPS. First, we identified the enzymes UBE3A and Parkin, members of the UPS E3 ubiquitin ligase family, as novel Ca(V)2.2 channel binding partners, although evidence to support a direct protein-protein interaction is not yet available. Immunoprecipitation assays confirmed the interaction between UBE3A and Parkin with Ca(V)2.2 channels heterologously expressed in HEK-293 cells and in neural tissues. Parkin, but not UBE3A, overexpression led to a reduced Ca(V)2.2 protein level and decreased current density. Electrophysiological recordings performed in the presence of MG132 prevented the actions of Parkin suggesting enhanced channel proteasomal degradation. Together these results unveil a novel functional coupling between Parkin and the Ca(V)2.2 channels and provide a novel insight into the basic mechanisms of Ca-V channels protein quality control and functional expression.	[Grimaldo, Lizbeth; Garza-Lopez, Edgar; Felix, Ricardo] Natl Polytech Inst Cinvestav IPN, Ctr Res & Adv Studies, Dept Cell Biol, Mexico City, DF, Mexico; [Sandoval, Alejandro] UNAM, Fac Super Studies Iztacala, Tlalnepantla, Mexico; [Garza-Lopez, Edgar] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Nacional Autonoma de Mexico; University of Iowa	Felix, R (corresponding author), Natl Polytech Inst Cinvestav IPN, Ctr Res & Adv Studies, Dept Cell Biol, Mexico City, DF, Mexico.	rfelix@cinvestav.mx	Grimaldo, Lizbeth/O-4264-2019; Felix, Ricardo/A-6989-2008	Felix, Ricardo/0000-0002-5383-7176; Garza Lopez-Hinton, Edgar/0000-0003-0243-0816; GRIMALDO, LIZBETH/0000-0003-0410-4192; Sandoval, Alejandro/0000-0002-8558-6033	National Council for Science and Technology (Conacyt, Mexico) [221660]; Conacyt	National Council for Science and Technology (Conacyt, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was entirely supported by funds from The National Council for Science and Technology (Conacyt, Mexico), grant 221660 to RF. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was entirely supported by funds from The National Council for Science and Technology (Conacyt, Mexico), grant 221660 to RF. There was no additional external funding received for this study. We thank Mercedes Urban for expert technical assistance. Doctoral fellowship from Conacyt to LG is gratefully acknowledged.	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Avila G, 2004, CELL MOL NEUROBIOL, V24, P317, DOI 10.1023/B:CEMN.0000022765.52109.26; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Felix R, 2017, GEN PHYSIOL BIOPHYS, V36, P1, DOI 10.4149/gpb_2016037; Felix Ricardo, 2013, Wiley Interdiscip Rev Membr Transp Signal, V2, P207; Fu SJ, 2017, J NEUROSCI, V37, P2485, DOI 10.1523/JNEUROSCI.3070-16.2017; Gandini MA, 2014, COLD SPRING HARB PRO, V4, P389; Gandini MA, 2014, CHANNELS, V8, P452, DOI 10.4161/19336950.2014.949162; Gandini MA, 2014, PFLUG ARCH EUR J PHY, V466, P2113, DOI 10.1007/s00424-014-1476-4; Gregory FD, 2011, NAT NEUROSCI, V14, P1109, DOI 10.1038/nn.2895; Haas KF, 2008, BBA-GENE REGUL MECH, V1779, P495, DOI 10.1016/j.bbagrm.2007.12.010; Henriquez DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053123; Jung T, 2012, PROG MOL BIOL TRANSL, V109, P1, DOI 10.1016/B978-0-12-397863-9.00001-8; Kleiger G, 2014, TRENDS CELL BIOL, V24, P352, DOI 10.1016/j.tcb.2013.12.003; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Lipscombe D, 2013, TRENDS NEUROSCI, V36, P598, DOI 10.1016/j.tins.2013.06.008; Marangoudakis S, 2012, J NEUROSCI, V32, P10365, DOI 10.1523/JNEUROSCI.0851-11.2012; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Page KM, 2016, J BIOL CHEM, V291, P20402, DOI 10.1074/jbc.M116.737270; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rougier JS, 2015, PFLUG ARCH EUR J PHY, V467, P1919, DOI 10.1007/s00424-014-1636-6; Rougier JS, 2011, J BIOL CHEM, V286, P8829, DOI 10.1074/jbc.M110.166520; Sato S, 2006, EMBO J, V25, P211, DOI 10.1038/sj.emboj.7600774; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tsai NP, 2014, BBA-MOL CELL RES, V1843, P2838, DOI 10.1016/j.bbamcr.2014.08.006; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Waithe D, 2011, J BIOL CHEM, V286, P9598, DOI 10.1074/jbc.M110.195909; Weiss N, 2017, NEURONAL SI IN PRESS; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654	35	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185289	10.1371/journal.pone.0185289	http://dx.doi.org/10.1371/journal.pone.0185289			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957379	gold, Green Submitted, Green Published			2022-12-27	WOS:000411985200041
J	Heijmans, N; van Lieshout, J; Wensing, M				Heijmans, Naomi; van Lieshout, Jan; Wensing, Michel			Social network composition of vascular patients and its associations with health behavior and clinical risk factors	PLOS ONE			English	Article							OLDER-ADULTS; PHYSICAL HEALTH; SUPPORT; DEPRESSION; QUALITY; CONSUMPTION; INTEGRATION; MEDICATION; MANAGEMENT; ADHERENCE	Background This study aimed to explore linkages of patients' social network composition with health behaviors and clinical risk factors. Methods/Design This observational study was embedded in a project aimed at improving cardiovascular risk management (CRVM) in primary care. 657 vascular patients (227 with cardiovascular disease, 380 at high vascular risk), mean age 72.4 (SD 9.4) years, were recruited as were individuals patients considered important for dealing with their disease, so called alters (n = 487). Network composition was measured with structured patient questionnaires. Both patients and alters completed questionnaires to measure health behavior (habits for physical activity, diet, and smoking). Clinical risk factors (systolic blood pressure, LDL cholesterol level, and body mass index) were extracted from patients' medical records. Six logistic regression analyses, using generalized estimating equations, were used to test three hypothesized effects of network composition (having alters with healthful behaviors, without depression, and with specialized knowledge) on six outcomes, adjusted for demographic, personal and psychological characteristics. Results Having alters with overall healthful behavior was related to healthful patient diet (OR 2.14, 95% CI: 1.52-3.02). Having non-smoking alters in networks was related to reduced odds for patient smoking (OR 0.17, 95% CI: 0.05-0.60). No effects of presence of non-depressed alters were found. Presence of alters with specialized knowledge on CVRM was inversely related to healthful diet habits of patients (OR 0.47, 95% CI 0.24-0.89). No significant associations between social network composition and clinical risk factors were found. Discussion Diet and smoking, but not physical exercise and clinical risk factors, were associated with social network composition of patients with vascular conditions. In this study of vascular patients, controlling for both personal and psychological factors, fewer network influences were found compared to previous research. Further research is needed to examine network structure characteristics as well as the role of psychological factors to enhance understanding health behavior of patients involved in CVRM.	[Heijmans, Naomi; van Lieshout, Jan] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, Nijmegen, Netherlands; [Wensing, Michel] Heidelberg Univ Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany	Radboud University Nijmegen; Ruprecht Karls University Heidelberg	Heijmans, N (corresponding author), Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, Nijmegen, Netherlands.	Naomi.Heijmans@radboudumc.nl	Van Lieshout, J./L-4490-2015; Wensing, Michel/H-8113-2014	Wensing, Michel/0000-0001-6569-8137	European Union Seventh Framework Programme [258837]; ZonMw [200310011]	European Union Seventh Framework Programme(European Commission); ZonMw(Netherlands Organization for Health Research and Development)	This study is funded by the European Union Seventh Framework Programme (FP7) within the theme HEALTH.2013.3.1-1 under grant agreement no 258837 and by ZonMw, project no 200310011. MW received both fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is funded by the European Union Seventh Framework Programme (FP7) within the theme HEALTH.2013.3.1-1 under grant agreement no 258837 and by ZonMw, project no 200310011.	[Anonymous], 2012, HUISARTS WET, V55, P14; Ashida S, 2008, J AGING HEALTH, V20, P872, DOI 10.1177/0898264308324626; Bauer LK, 2012, AM J CARDIOL, V109, P1266, DOI 10.1016/j.amjcard.2011.12.017; Berkman LF, 2004, AM J EPIDEMIOL, V159, P167, DOI 10.1093/aje/kwh020; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Campbell SM, 2008, EUR J CARDIOV PREV R, V15, P509, DOI 10.1097/HJR.0b013e328302f44d; Chan YK, 2006, J HAPPINESS STUDIES, V7; Chiolero A, 2006, PREV MED, V42, P348, DOI 10.1016/j.ypmed.2006.01.011; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; Christakis Nicholas A, 2009, Nor Epidemiol, V19, P5; Cohen S, 2001, Adv Mind Body Med, V17, P5, DOI 10.1054/ambm.2000.0244; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Dunbar SB, 2008, J CARDIOVASCULAR NUR, V23; Eikelenboom N, 2015, BR J GEN PR IN PRESS; Flatt JD, 2012, FAM COMMUNITY HEALTH, V35, P312, DOI 10.1097/FCH.0b013e3182666650; Gallant MP, 2007, RES AGING, V29, P375, DOI 10.1177/0164027507303169; Golden J, 2009, PSYCHOL HEALTH MED, V14, P280, DOI 10.1080/13548500902730135; Graven LJ, 2014, INT J NURS STUD, V51, P320, DOI 10.1016/j.ijnurstu.2013.06.013; Heijmans N, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-265; Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x; Holt-Lunstad J, 2007, ANN BEHAV MED, V33, P278, DOI 10.1007/BF02879910; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Huntink E, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-433; Kashima Y, 2013, SOC NETWORKS, V35, P711, DOI 10.1016/j.socnet.2013.06.002; Keating NL, 2011, CANCER-AM CANCER SOC, V117, P3045, DOI 10.1002/cncr.25849; Kroenke CH, 2017, PSYCHO-ONCOLOGY, V26, P544, DOI 10.1002/pon.4059; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langford CPH, 1997, J ADV NURS, V25, P95, DOI 10.1046/j.1365-2648.1997.1997025095.x; Lichtman JH, 2014, CIRCULATION, V129, P1350, DOI 10.1161/CIR.0000000000000019; Lin N., 2002, SOCIAL CAPITAL THEOR, V19; Luke DA, 2007, ANNU REV PUBL HEALTH, V28, P69, DOI 10.1146/annurev.publhealth.28.021406.144132; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Moore AR, 2014, J CROSS-CULT GERONTO, V29, P329, DOI 10.1007/s10823-014-9238-5; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Rantanen A, 2004, J CLIN NURS, V13, P158, DOI 10.1046/j.1365-2702.2003.00847.x; Reeves D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098340; Robles TF, 2014, PSYCHOL BULL, V140, P140, DOI 10.1037/a0031859; Rocco L., 2012, IS SOCIAL CAPITAL GO; Rosenquist JN, 2011, MOL PSYCHIATR, V16, P273, DOI 10.1038/mp.2010.13; Segal-Isaacson CJ, 2004, DIABETES EDUCATOR, V30, P774, DOI 10.1177/014572170403000512; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Strully KW, 2012, SOC SCI MED, V74, P1125, DOI 10.1016/j.socscimed.2011.12.033; Topolski T. D., 2006, Preventing Chronic Disease, V3, pA118; Uchino BN, 2009, PERSPECT PSYCHOL SCI, V4, P236, DOI 10.1111/j.1745-6924.2009.01122.x; Vaartjes I, 2013, HART VAATZIEKTEN NED; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; Vassilev I, 2011, CHRONIC ILLN, V7, P60, DOI 10.1177/1742395310383338; Wensing M, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-103	51	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185341	10.1371/journal.pone.0185341	http://dx.doi.org/10.1371/journal.pone.0185341			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957372	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200045
J	Kato, K; Kanosue, K				Kato, Kouki; Kanosue, Kazuyuki			Corticospinal excitability for hand muscles during motor imagery of foot changes with imagined force level	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; VOLUNTARY MOVEMENT; EVOKED-POTENTIALS; CORTICAL PLASTICITY; FOREARM MUSCLES; MENTAL PRACTICE; FUNCTIONAL MRI; CONTRACTION; FACILITATION; MODULATION	The object of this study was to clarify whether corticospinal excitability controlling hand muscles changes concurrently with increases in the imagined contraction level of foot dorsiflexion. Twelve participants performed actual and imagined dorsiflexion of their right foot at three different EMG levels (10, 40 or 80% of the maximum voluntary contraction). During isometric actual-or imagined-dorsiflexion, transcranial magnetic stimulation (TMS) was delivered to the right hand area of the left primary motor cortex. Motor evoked potentials (MEPs) were recorded from the right extensor carpi radialis (ECR) and flexor carpi radialis (FCR). During actual contraction, MEP amplitudes of ECR and FCR increased with an increased EMG level of dorsiflexion. Similarly, during imagery contraction, MEP amplitudes of ECR and FCR increased with the intensity of imagery contraction. Furthermore, a correlation between MEP amplitude during actual contraction and imagery contraction was observed for both ECR and FCR. Motor imagery of foot contraction induced an enhancement of corticospinal excitability for hand muscles that was dependent on the imagined contraction levels, just as what was observed when there was an actual contraction.	[Kato, Kouki; Kanosue, Kazuyuki] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan	Waseda University	Kato, K (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.	kato.k@aoni.waseda.jp		Kato, Kouki/0000-0002-4922-3120	JSPS KAKENHI [15K16494, JP26242065]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant numbers 15K16494 to K Kato and JP26242065 to K Kanosue.; The authors thank Dr. Larry Crawshaw for English editing. This work was supported by JSPS KAKENHI Grant Numbers 15K16494 to K Kato and JP26242065 to K Kanosue. All authors declare no conflicts of interest.	Allami N, 2008, EXP BRAIN RES, V184, P105, DOI 10.1007/s00221-007-1086-x; Allison T, 1996, EVOKED POTENTIAL, V100, P126, DOI 10.1016/0013-4694(95)00226-X; Baldissera F, 2002, J PHYSIOL-LONDON, V539, P903, DOI 10.1113/jphysiol.2001.013282; Borroni P, 2004, BRAIN RES, V1022, P117, DOI 10.1016/j.brainres.2004.07.003; BROWN P, 1991, BRAIN, V114, P2333, DOI 10.1093/brain/114.5.2333; Byblow WD, 2007, J NEUROPHYSIOL, V98, P414, DOI 10.1152/jn.00325.2007; Cauda F, 2011, HUM BRAIN MAPP, V32, P1566, DOI 10.1002/hbm.21132; Dai TH, 2001, EXP BRAIN RES, V140, P290, DOI 10.1007/s002210100815; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; DELWAIDE PJ, 1981, BRAIN, V104, P701, DOI 10.1093/brain/104.4.701; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; EVARTS EV, 1983, J NEUROPHYSIOL, V49, P1199, DOI 10.1152/jn.1983.49.5.1199; FELTZ DL, 1983, J SPORT PSYCHOL, V5, P25, DOI 10.1123/jsp.5.1.25; Fourkas AD, 2006, BEHAV BRAIN RES, V168, P190, DOI 10.1016/j.bbr.2005.10.015; Guillot A, 2009, HUM BRAIN MAPP, V30, P2157, DOI 10.1002/hbm.20658; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Holmes P, 2008, J MOTOR BEHAV, V40, P433, DOI 10.3200/JMBR.40.5.433-445; Hortobagyi T, 2003, J NEUROPHYSIOL, V90, P2451, DOI 10.1152/jn.01001.2002; Huang X, 2017, MOL PSYCHIATR, V22, P1274, DOI 10.1038/mp.2017.143; HUNTLEY GW, 1991, J NEUROPHYSIOL, V66, P390, DOI 10.1152/jn.1991.66.2.390; Isaac AR., 1992, SPORT PSYCHOL, V6, P192, DOI [10.1123/tsp.6.2.192, DOI 10.1123/TSP.6.2.192, DOI 10.1123/tsp.6.2.192]; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Jendr?ssik, 1883, DTSCH ARCH KLIN MED, V33, P177; Kasai T, 1997, BRAIN RES, V744, P147, DOI 10.1016/S0006-8993(96)01101-8; Kato K, 2015, PHYSL REP, V3, P1; Kato K, 2016, FRONT HUM NEUROSCI, V10, DOI [10.3389/fnhum.2016.00218, 10.3389/fnhum.2016.00131]; Kato K, 2016, NEUROSCI LETT, V633, P252, DOI 10.1016/j.neulet.2016.09.019; Kato K, 2015, NEUROSCI RES, V92, P39, DOI 10.1016/j.neures.2014.10.013; Kato K, 2014, EXP BRAIN RES, V232, P181, DOI 10.1007/s00221-013-3730-y; KAWAKITA H, 1991, J ELECTROMYOGR KINES, V1, P96, DOI 10.1016/1050-6411(91)90003-N; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Makary MM, 2017, NEUROREPORT, V28, P610, DOI 10.1097/WNR.0000000000000809; Marconi B, 2007, CLIN NEUROPHYSIOL, V118, P2468, DOI 10.1016/j.clinph.2007.08.021; Mizuguchi N., 2012, J PHYS FIT SPORT MED, V1, P103, DOI 10.7600/jpfsm.1.103; Mizuguchi N, 2013, EXP BRAIN RES, V230, P243, DOI 10.1007/s00221-013-3649-3; Mizuguchi N, 2009, EXP BRAIN RES, V196, P529, DOI 10.1007/s00221-009-1875-5; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Perez MA, 2009, CORTEX, V45, P1065, DOI 10.1016/j.cortex.2008.12.006; Roberts R, 2008, J SPORT EXERCISE PSY, V30, P200, DOI 10.1123/jsep.30.2.200; Shen Y, 2017, BIOL PSYCHIAT, V81, pE49, DOI 10.1016/j.biopsych.2016.06.013; Shen Y, 2016, BIOL PSYCHIAT, V80, pE13, DOI 10.1016/j.biopsych.2016.02.006; Stedman A, 1998, MUSCLE NERVE, V21, P1033, DOI 10.1002/(SICI)1097-4598(199808)21:8<1033::AID-MUS7>3.0.CO;2-9; Stein RB Zehr, 1999, EXP BRAIN RES, V159, P382; Stinear CM, 2004, EXP BRAIN RES, V157, P351, DOI 10.1007/s00221-004-1851-z; Takada Y, 2000, J NEUROPHYSIOL, V83, P2063, DOI 10.1152/jn.2000.83.4.2063; Tazoe T, 2007, CLIN NEUROPHYSIOL, V118, P1204, DOI 10.1016/j.clinph.2007.03.005; Tazoe T, 2009, EUR J NEUROSCI, V30, P1297, DOI 10.1111/j.1460-9568.2009.06895.x; TOULOUSE P, 1980, ARCH PHYS MED REHAB, V61, P511; van Duinen H, 2008, HUM BRAIN MAPP, V29, P281, DOI 10.1002/hbm.20388; WERNER W, 1991, EXP BRAIN RES, V86, P293; Yazawa S, 1999, BRAIN, V122, P1357, DOI 10.1093/brain/122.7.1357	53	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185547	10.1371/journal.pone.0185547	http://dx.doi.org/10.1371/journal.pone.0185547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957398	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200083
J	Lee, HJ; Hong, JS; Lin, CJ; Kao, YH; Chang, FC; Luo, CB; Chu, WF				Lee, Han-Jui; Hong, Jia-Sheng; Lin, Chung-Jung; Kao, Yi-Hsuan; Chang, Feng-Chi; Luo, Chao-Bao; Chu, Wei-Fa			Automatic flow analysis of digital subtraction angiography using independent component analysis in patients with carotid stenosis	PLOS ONE			English	Article							CEREBRAL-CIRCULATION TIME; HYPERPERFUSION SYNDROME; BLOOD-FLOW; HEMODYNAMIC SEGMENTATION; QUANTITATIVE-ANALYSIS; COMPUTED-TOMOGRAPHY; PERFUSION IMAGES; FLAT-DETECTOR; ARTERY; CONTRAST	Purpose Current time D density curve analysis of digital subtraction angiography (DSA) provides intravascular flow information but requires manual vasculature selection. We developed an angiographic marker that represents cerebral perfusion by using automatic independent component analysis. Materials and methods We retrospectively analyzed the data of 44 patients with unilateral carotid stenosis higher than 70% according to North American Symptomatic Carotid Endarterectomy Trial criteria. For all patients, magnetic resonance perfusion (MRP) was performed one day before DSA. Fixed contrast injection protocols and DSA acquisition parameters were used before stenting. The cerebral circulation time (CCT) was defined as the difference in the time to peak between the parietal vein and cavernous internal carotid artery in a lateral angiogram. Both anterior-posterior and lateral DSA views were processed using independent component analysis, and the capillary angiogram was extracted automatically. The full width at half maximum of the time D density curve in the capillary phase in the anterior-posterior and lateral DSA views was defined as the angiographic mean transient time (aMTT; i.e., aMTT(AP) and aMTT(Lat)). The correlations between the degree of stenosis, CCT, aMTT(AP) and aMTT(Lat), and MRP parameters were evaluated. Results The degree of stenosis showed no correlation with CCT, aMTT(AP), aMTT(Lat), or any MRP parameter. CCT showed a strong correlation with aMTT(AP) (r = 0.67) and aMTT(Lat) (r = 0.72). Among the MRP parameters, CCT showed only a moderate correlation with MTT (r = 0.67) and Tmax (r = 0.40). aMTT(AP) showed a moderate correlation with Tmax (r = 0.42) and a strong correlation with MTT (r = 0.77). aMTT(Lat) also showed similar correlations with Tmax (r = 0.59) and MTT (r = 0.73). Conclusion Apart from vascular anatomy, aMTT estimates brain parenchyma hemodynamics from DSA and is concordant with MRP. This process is completely automatic and provides immediate measurement of quantitative peritherapeutic brain parenchyma changes during stenting.	[Lee, Han-Jui; Lin, Chung-Jung; Chang, Feng-Chi; Luo, Chao-Bao; Chu, Wei-Fa] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Lee, Han-Jui; Lin, Chung-Jung; Chang, Feng-Chi; Luo, Chao-Bao; Chu, Wei-Fa] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Hong, Jia-Sheng; Kao, Yi-Hsuan] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lin, CJ (corresponding author), Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan.; Lin, CJ (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	bcjlin@gmail.com		Lin, Chung Jung/0000-0003-2370-6316				Aikawa H, 2010, NEUROL MED-CHIR, V50, P269, DOI 10.2176/nmc.50.269; Alexandrov AV, 2012, J NEUROIMAGING, V22, P215, DOI 10.1111/j.1552-6569.2010.00523.x; Calamante F, 2013, PROG NUCL MAG RES SP, V74, P1, DOI 10.1016/j.pnmrs.2013.04.002; Calamante F, 2010, STROKE, V41, P1169, DOI 10.1161/STROKEAHA.110.580670; Fang H, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0560-0; Golitz P, 2013, CLIN NEURORADIOL, V23, P113, DOI 10.1007/s00062-012-0184-8; Greitz T., 1956, ACTA RADIOLOGICA; Guo WY, 2017, AM J NEURORADIOL, V38, P132, DOI 10.3174/ajnr.A4960; Huang TC, 2012, J VASC SURG, V56, P812, DOI 10.1016/j.jvs.2012.02.041; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Iwata T, 2011, NEUROSURGERY, V68, P649, DOI 10.1227/NEU.0b013e3182077ed8; Kao YH, 2003, MAGNET RESON MED, V49, P885, DOI 10.1002/mrm.10440; Kao YH, 2008, J MAGN RESON IMAGING, V28, P1125, DOI 10.1002/jmri.21537; Kefayati S, 2013, MED ENG PHYS, V35, P898, DOI 10.1016/j.medengphy.2012.08.020; Kudo K, 2009, RADIOLOGY, V251, P241, DOI 10.1148/radiol.2511080983; Lieber BB, 2009, MED PHYS, V36, P5064, DOI 10.1118/1.3243079; Lin CJ, 2014, AM J NEURORADIOL, V35, P1132, DOI 10.3174/ajnr.A3838; Lin CJ, 2012, AM J NEURORADIOL, V33, P1685, DOI 10.3174/ajnr.A3049; Lin CJ, 2016, J NEURORADIOLOGY, V43, P290, DOI 10.1016/j.neurad.2016.02.002; Lin CJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003529; Liu C, 2011, IEEE T PATTERN ANAL, V33, P978, DOI 10.1109/TPAMI.2010.147; Lythgoe DJ, 2000, MAGN RESON IMAGING, V18, P1, DOI 10.1016/S0730-725X(99)00112-5; Martel AL, 2001, MED IMAGE ANAL, V5, P29, DOI 10.1016/S1361-8415(00)00032-3; Narita S, 2013, J STROKE CEREBROVASC, V22, P615, DOI 10.1016/j.jstrokecerebrovasdis.2011.10.015; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pereira VM, 2014, AM J NEURORADIOL, V35, P156, DOI 10.3174/ajnr.A3662; Petkova M, 2009, J MAGN RESON IMAGING, V29, P7, DOI 10.1002/jmri.21483; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; RANEY R, 1949, J NEUROSURG, V6, P222, DOI 10.3171/jns.1949.6.3.0222; Scalzo F, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/2478324; Shpilfoygel SD, 2000, MED PHYS, V27, P2008, DOI 10.1118/1.1288669; Soinne L, 2003, STROKE, V34, P1655, DOI 10.1161/01.STR.0000075605.36068.D9; Strother CM, 2010, AM J NEURORADIOL, V31, P919, DOI 10.3174/ajnr.A2020; Struffert T, 2015, AM J NEURORADIOL, V36, P1964, DOI 10.3174/ajnr.A4383; Struffert T, 2014, EUR RADIOL, V24, P1257, DOI 10.1007/s00330-014-3136-7; Teng MMH, 2016, AM J NEURORADIOL, V37, P1883, DOI 10.3174/ajnr.A4813; WILCOX BR, 1970, ANN SURG, V171, P24, DOI 10.1097/00000658-197001000-00004; Wu TH, 2013, COMPUT METH PROG BIO, V111, P693, DOI 10.1016/j.cmpb.2013.06.012; Xiang J, 2014, AM J NEURORADIOL, V35, P1849, DOI 10.3174/ajnr.A3710; ZUKERBERG LR, 1991, AM J SURG PATHOL, V15, P126, DOI 10.1097/00000478-199102000-00004	41	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185330	10.1371/journal.pone.0185330	http://dx.doi.org/10.1371/journal.pone.0185330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949999	Green Submitted, Green Published, gold			2022-12-27	WOS:000411671000038
J	van Ginkel, WG; van Vliet, D; Burgerhof, JGM; de Blaauw, P; Gozalbo, MER; Heiner-Fokkema, MR; van Spronsen, FJ				van Ginkel, Willem G.; van Vliet, Danique; Burgerhof, Johannes G. M.; de Blaauw, Pim; Gozalbo, M. Estela Rubio; Heiner-Fokkema, M. Rebecca; van Spronsen, Francjan J.			Presumptive brain influx of large neutral amino acids and the effect of phenylalanine supplementation in patients with Tyrosinemia type 1	PLOS ONE			English	Article							TRANSPORT; BARRIER; RESTRICTION; DEFICIENCY; FORMULA; LAT1	Introduction Hereditary Tyrosinemia type 1 (HT1) is a rare metabolic disease caused by a defect in the tyrosine degradation pathway. Current treatment consists of 2-(2-nitro-4-trifluoromethylbenoyl)-1,3-cyclohexanedione (NTBC) and a tyrosine and phenylalanine restricted diet. Recently, neuropsychological deficits have been seen in HT1 patients. These deficits are possibly associated with low blood phenylalanine concentrations and/or high blood tyrosine concentrations. Therefore, the aim of the present study was threefold. Firstly, we aimed to calculate how the plasma amino acid profile in HT1 patients may influence the presumptive brain influx of all large neutral amino acids (LNAA). Secondly, we aimed to investigate the effect of phenylalanine supplementation on presumptive brain phenylalanine and tyrosine influx. Thirdly, we aimed to theoretically determine minimal target plasma phenylalanine concentrations in HT1 patient to ensure adequate presumptive brain phenylalanine influx. Methods Data of plasma LNAA concentrations were obtained. In total, 239 samples of 9 HT1 children, treated with NTBC, diet, and partly with phenylalanine supplementation were collected together with 596 samples of independent control children. Presumptive brain influx of all LNAA was calculated, using Michaelis-Menten parameters (K-m) and V-max-values obtained from earlier articles. Results In HT1 patients, plasma concentrations and presumptive brain influx of tyrosine were higher. However, plasma and especially brain influx of phenylalanine were lower in HT1 patients.Phenylalanine supplementation did not only tend to increase plasma phenylalanine concentrations, but also presumptive brain phenylalanine influx, despite increased plasma tyrosine concentrations. However, to ensure sufficient brain phenylalanine influx in HT1 patients, minimal plasma phenylalanine concentrations may need to be higher than considered thus far. Conclusion This study clearly suggests a role for disturbed brain LNAA biochemistry, which is not well reflected by plasma LNAA concentrations. This could play a role in the pathophysiology of the neuropsychological impairments in HT1 patients and may have therapeutic implications.	[van Ginkel, Willem G.; van Vliet, Danique; van Spronsen, Francjan J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Metab Dis, Groningen, Netherlands; [Burgerhof, Johannes G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [de Blaauw, Pim; Heiner-Fokkema, M. Rebecca] Univ Med Ctr Groningen, Univ Groningen, Dept Lab Med, Groningen, Netherlands; [Gozalbo, M. Estela Rubio] Maastricht Univ, Dept Pediat, Med Ctr, Maastricht, Netherlands; [Gozalbo, M. Estela Rubio] Maastricht Univ, Lab Genet Metab Dis, Med Ctr, Maastricht, Netherlands	University of Groningen; University of Groningen; University of Groningen; Maastricht University; Maastricht University	van Spronsen, FJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Metab Dis, Groningen, Netherlands.	f.j.van.spronsen@umcg.nl	Rubio-Gozalbo, M Estela/H-1833-2011; Burgerhof, Johannes G/B-2455-2013	Burgerhof, Johannes G/0000-0003-3827-9601; Rubio-Gozalbo, M. Estela/0000-0001-7182-4056				Bendadi F, 2014, J PEDIATR-US, V164, P398, DOI 10.1016/j.jpeds.2013.10.001; Coughlin CR, 2015, MOL GENET METAB, V116, P35, DOI 10.1016/j.ymgme.2015.05.011; Daly A, 2012, J HUM NUTR DIET, V25, P111, DOI 10.1111/j.1365-277X.2011.01215.x; de Laet C, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-8; De Laet C, 2011, DEV MED CHILD NEUROL, V53, P962, DOI 10.1111/j.1469-8749.2011.04048.x; del Amo EM, 2008, EUR J PHARM SCI, V35, P161, DOI 10.1016/j.ejps.2008.06.015; FERNSTROM JD, 1972, SCIENCE, V178, P414, DOI 10.1126/science.178.4059.414; HARGREAVES KM, 1988, J BIOL CHEM, V263, P19392; Holme E, 1998, J INHERIT METAB DIS, V21, P507, DOI 10.1023/A:1005410820201; Killian DM, 2001, NEUROSCI LETT, V306, P1, DOI 10.1016/S0304-3940(01)01810-9; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; Masurel-Paulet A, 2008, J INHERIT METAB DIS, V31, P81, DOI 10.1007/s10545-008-0793-1; Pardridge WM, 1998, NEUROCHEM RES, V23, P635, DOI 10.1023/A:1022482604276; Pohorecka Monika, 2012, Pediatr Endocrinol Diabetes Metab, V18, P96; Russo PA, 2001, PEDIATR DEVEL PATHOL, V4, P212, DOI 10.1007/s100240010146; Schulze A, 2001, MOL GENET METAB, V74, P413, DOI 10.1006/mgme.2001.3257; Smith QR, 2000, J NUTR, V130, p1016S, DOI 10.1093/jn/130.4.1016S; SMITH QR, 1987, J NEUROCHEM, V49, P1651, DOI 10.1111/j.1471-4159.1987.tb01039.x; Strauss KA, 2011, MOL GENET METAB, V104, P93, DOI 10.1016/j.ymgme.2011.07.003; Strauss KA, 2010, MOL GENET METAB, V99, P333, DOI 10.1016/j.ymgme.2009.12.007; Thimm E, 2012, J INHERIT METAB DIS, V35, P263, DOI 10.1007/s10545-011-9394-5; Thimm E, 2011, MOL GENET METAB, V102, P122, DOI 10.1016/j.ymgme.2010.11.003; van Ginkel WG, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0472-5; van Vliet D, 2014, JIMD REP; van Vliet D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143833; van Vliet D, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-7; Vogel KR, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-73; Wilson CJ, 2000, J INHERIT METAB DIS, V23, P677, DOI 10.1023/A:1005666426079	28	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185342	10.1371/journal.pone.0185342	http://dx.doi.org/10.1371/journal.pone.0185342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949985	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000040
J	Wang, F; Xu, XX; Yang, JJ; Min, LF; Liang, SD; Chen, Y				Wang, Fang; Xu, Xingxiang; Yang, Junjun; Min, Lingfeng; Liang, Sudong; Chen, Yong			Height and lung cancer risk: A meta-analysis of observational studies	PLOS ONE			English	Article							BODY-MASS INDEX; DIFFERENT ANATOMIC SITES; ADULT HEIGHT; NORWEGIAN MEN; LEG LENGTH; FOLLOW-UP; MORTALITY; COHORT; DISEASE; STATURE	Background The association between height and lung cancer risk has been investigated by epidemiological studies but the results are inconsistent. This meta- analysis was to evaluate whether the height is associated with lung cancer. Methods We identified relevant articles by searching the MEDLINE and EMBASE databases, and reviewed the reference lists of selected papers. A random effect model was used to calculate summary odds ratios (OR) and relative risk (RR) with 95% confidence intervals (95% CI). Publication bias was estimated using Egger's regression asymmetry test. Results We included a total 16 studies (15 prospective studies and one case-control study) on adult height and lung cancer risk in the meta-analysis. Overall, per 10-cm height increases were associated with increased risk of lung cancer (RR 1.06; 95% CI 1.03-1.09, I-2 = 43.6%). Conclusions In this meta-analysis, high adult height is related to increased lung cancer risk. Well-designed, large prospective studies are required to obtain a better indication of the relationship.	[Wang, Fang; Xu, Xingxiang; Yang, Junjun; Min, Lingfeng] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Clin Med Sch, Dept Respirat, Yangzhou, Jiangsu, Peoples R China; [Liang, Sudong] Taizhou Peoples Hosp Jiangsu Prov, Dept Urol, Taizhou, Jiangsu, Peoples R China; [Chen, Yong] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Dept Med Oncol, Clin Med Sch, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University	Xu, XX (corresponding author), Yangzhou Univ, Northern Jiangsu Peoples Hosp, Clin Med Sch, Dept Respirat, Yangzhou, Jiangsu, Peoples R China.	xuxx63@sina.com						ALBANES D, 1988, CANCER RES, V48, P1658; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Aune D, 2012, CANCER CAUSE CONTROL, V23, P1213, DOI 10.1007/s10552-012-9983-0; Batty GD, 2010, ANN ONCOL, V21, P646, DOI 10.1093/annonc/mdp363; Batty GD, 2009, ECON HUM BIOL, V7, P137, DOI 10.1016/j.ehb.2009.06.004; Batty GD, 2006, ANN ONCOL, V17, P157, DOI 10.1093/annonc/mdj018; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bjorge T, 2007, INT J CANCER, V120, P378, DOI 10.1002/ijc.22260; COOK NR, 1994, AM J EPIDEMIOL, V139, P1066, DOI 10.1093/oxfordjournals.aje.a116950; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DRINKARD CR, 1995, AM J EPIDEMIOL, V142, P600, DOI 10.1093/oxfordjournals.aje.a117681; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Emerging Risk Factors Collaboration, 2012, Int J Epidemiol, V41, P1419, DOI 10.1093/ije/dys086; Engeland A, 2003, JNCI-J NATL CANCER I, V95, P1244, DOI 10.1093/jnci/djg010; Engeland A, 2005, CANCER CAUSE CONTROL, V16, P987, DOI 10.1007/s10552-005-3638-3; Engeland A, 2007, AM J EPIDEMIOL, V165, P44, DOI 10.1093/aje/kwj353; Green J, 2011, LANCET ONCOL, V12, P785, DOI 10.1016/S1470-2045(11)70154-1; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; Gunnell D, 2003, NUTR CANCER, V47, P34, DOI 10.1207/s15327914nc4701_4; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Hebert PR, 1997, CANCER CAUSE CONTROL, V8, P591, DOI 10.1023/A:1018442329319; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jousilahti P, 2000, AM J EPIDEMIOL, V151, P1112, DOI 10.1093/oxfordjournals.aje.a010155; Kabat GC, 2014, CANCER CAUSE CONTROL, V25, P1697, DOI 10.1007/s10552-014-0476-1; Kabat GC, 2013, CANCER EPIDEM BIOMAR, V22, P1353, DOI 10.1158/1055-9965.EPI-13-0305; Kabat GC, 2013, INT J CANCER, V132, P1125, DOI 10.1002/ijc.27704; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Khankari NK, 2016, ASS ADULT HEIGHT RIS, V13; LEON DA, 1995, J EPIDEMIOL COMMUN H, V49, P5, DOI 10.1136/jech.49.1.5; Lerro CC, 2010, BRIT J CANCER, V103, P1467, DOI 10.1038/sj.bjc.6605934; Liang SD, 2015, J CANCER RES CLIN, V141, P1799, DOI 10.1007/s00432-014-1870-5; Lynch J, 2005, ANNU REV PUBL HEALTH, V26, P1, DOI 10.1146/annurev.publhealth.26.021304.144505; Mao Y, 2003, AM J EPIDEMIOL, V158, P564, DOI 10.1093/aje/kwg186; Mao YS, 2016, SURG ONCOL CLIN N AM, V25, P439, DOI 10.1016/j.soc.2016.02.001; MARMOT MG, 1984, LANCET, V1, P1003; Minami Y, 2008, JPN J CLIN ONCOL, V38, P205, DOI 10.1093/jjco/hym170; Olsen CM, 2008, INT J CANCER, V122, P1100, DOI 10.1002/ijc.23214; PECK AMN, 1989, J EPIDEMIOL COMMUN H, V43, P380, DOI 10.1136/jech.43.4.380; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Rinaldi S, 2010, INT J CANCER, V126, P1702, DOI 10.1002/ijc.24927; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; Sung J, 2009, AM J EPIDEMIOL, V170, P53, DOI 10.1093/aje/kwp088; Tang R-Q, 2012, TUMOR, V32, P27; THUNE I, 1993, INT J CANCER, V55, P555, DOI 10.1002/ijc.2910550406; Tripaldi R, 2013, BBA-REV CANCER, V1836, P27, DOI 10.1016/j.bbcan.2013.02.002; Walter RB, 2013, JNCI-J NATL CANCER I, V105, P860, DOI 10.1093/jnci/djt102; Welch V, 2000, NEWCASTLE SCALE ASSE; Zuccolo L, 2008, CANCER EPIDEM BIOMAR, V17, P2325, DOI 10.1158/1055-9965.EPI-08-0342	52	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185316	10.1371/journal.pone.0185316	http://dx.doi.org/10.1371/journal.pone.0185316			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949980	Green Published, gold, Green Submitted			2022-12-27	WOS:000411671000036
J	Zhang, X; Hu, WL; Chen, F; Liu, JQ; Yang, YH; Wang, LJ; Duan, HL; Si, JM				Zhang, Xu; Hu, Weiling; Chen, Fei; Liu, Jiquan; Yang, Yuanhang; Wang, Liangjing; Duan, Huilong; Si, Jianmin			Gastric precancerous diseases classification using CNN with a concise model	PLOS ONE			English	Article							CONVOLUTIONAL NEURAL-NETWORKS; CANCER	Gastric precancerous diseases (GPD) may deteriorate into early gastric cancer if misdiagnosed, so it is important to help doctors recognize GPD accurately and quickly. In this paper, we realize the classification of 3-class GPD, namely, polyp, erosion, and ulcer using convolutional neural networks (CNN) with a concise model called the Gastric Precancerous Disease Network (GPDNet). GPDNet introduces fire modules from SqueezeNet to reduce the model size and parameters about 10 times while improving speed for quick classification. To maintain classification accuracy with fewer parameters, we propose an innovative method called iterative reinforced learning (IRL). After training GPDNet from scratch, we apply IRL to fine-tune the parameters whose values are close to 0, and then we take the modified model as a pretrained model for the next training. The result shows that IRL can improve the accuracy about 9% after 6 iterations. The final classification accuracy of our GPDNet was 88.90%, which is promising for clinical GPD recognition.	[Zhang, Xu; Liu, Jiquan; Yang, Yuanhang; Duan, Huilong] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou, Zhejiang, Peoples R China; [Zhang, Xu; Liu, Jiquan; Yang, Yuanhang; Duan, Huilong] Zhejiang Univ, Minist Educ, Key Lab Biomed Engn, Hangzhou, Zhejiang, Peoples R China; [Hu, Weiling; Si, Jianmin] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Hu, Weiling; Chen, Fei; Wang, Liangjing; Si, Jianmin] Zhejiang Univ, Inst Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Chen, Fei; Wang, Liangjing] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Liu, JQ (corresponding author), Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou, Zhejiang, Peoples R China.; Liu, JQ (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Biomed Engn, Hangzhou, Zhejiang, Peoples R China.	liujq@zju.edu.cn		Chen, Fei/0000-0002-6826-7153; liu, jiquan/0000-0001-5994-6472	National Natural Science Foundation of China [31470955, 81401733]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31470955 to Mr Jiquan Liu)(http://www.nsfc.gov.cn/) and the National Natural Science Foundation of China (No. 81401733 to Weiling Hu)(http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 2013, J NATL COMPR CANC NE, V11, P531, DOI 10.6004/jnccn.2013.0070; Albarqouni S, 2016, IEEE T MED IMAGING, V35, P1313, DOI 10.1109/TMI.2016.2528120; Hafner M, 2015, BILDVERARBEITUNG FUR DIE MEDIZIN 2015: ALGORITHMEN - SYSTEME - ANWENDUNGEN, P365, DOI 10.1007/978-3-662-46224-9_63; Han S., ARXIV160704381; Hatner M, 2009, INF TECN APPL BIOM 2; Hatner M, 2010, INF TECHN APPL BIOM; Iandola F.N., ARXIV160207360; Isobe Y, 2011, GASTRIC CANCER, V14, P301, DOI 10.1007/s10120-011-0085-6; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Li B, 2010, AUT LOG ICAL 2010 IE; Li BP, 2009, IMAGE VISION COMPUT, V27, P1336, DOI 10.1016/j.imavis.2008.12.003; Litjens G., ARXIV170205747; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Miao S, 2016, IEEE T MED IMAGING, V35, P1352, DOI 10.1109/TMI.2016.2521800; Paik DS, 2004, IEEE T MED IMAGING, V23, P661, DOI 10.1109/TMI.2004.826362; Pereira S, 2016, IEEE T MED IMAGING, V35, P1240, DOI 10.1109/TMI.2016.2538465; Ribeiro E, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/6584725; Seebock P., 2015, THESIS; Setio AAA, 2016, IEEE T MED IMAGING, V35, P1160, DOI 10.1109/TMI.2016.2536809; Shen D, 2017, ANN REV BIOMEDICAL E; Shen X, 2012, COMM COMP ICSPCC 201; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Summers RM, 2005, GASTROENTEROLOGY, V129, P1832, DOI 10.1053/j.gastro.2005.08.054; Tajbakhsh N, 2015, 2015 IEEE 12 INT S B; Tajbakhsh N, 2016, IEEE T MED IMAGING, V35, P1299, DOI 10.1109/TMI.2016.2535302; Tartar A, 2013, 2013 35 ANN INT C IE; Vilarino F, 2009, BILDVERARBEITUNG MED, V22, P346; Wan L., 2013, ICML; Weck MN, 2006, CANCER EPIDEM BIOMAR, V15, P1083, DOI 10.1158/1055-9965.EPI-05-0931; Yao K, 2013, ANN GASTROENTEROL, V26, P11; Zhang R, 2016, IEEE J BIOMEDICAL HL; Zheng CH, 2009, IEEE T INF TECHNOL B, V13, P599, DOI 10.1109/TITB.2009.2018115; Zhu R, 2015, 2015 8 INT C IM SIGN	34	32	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185508	10.1371/journal.pone.0185508	http://dx.doi.org/10.1371/journal.pone.0185508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950010	Green Submitted, Green Published, gold			2022-12-27	WOS:000411671000061
J	Arevalo-Herrera, M; Rengifo, L; Lopez-Perez, M; Arce-Plata, MI; Garcia, J; Herrera, S				Arevalo-Herrera, Myriam; Rengifo, Lina; Lopez-Perez, Mary; Arce-Plata, Maria I.; Garcia, Jhon; Herrera, Socrates			Complicated malaria in children and adults from three settings of the Colombian Pacific Coast: A prospective study	PLOS ONE			English	Article							PLASMODIUM-VIVAX MALARIA; FALCIPARUM; PROFILE; THROMBOCYTOPENIA; MUNICIPALITIES; INFECTIONS; PREGNANCY; PAPUA	Background Complicated malaria remains an important public health problem, particularly in endemic settings where access to health services is limited and consequently malaria fatal outcomes occur. Few publications describing the clinical course and outcomes of complicated malaria in Latin America are found in the literature. This prospective study approached the clinical and laboratory characteristics of hospitalized patients with complicated malaria in different endemic areas of the Colombian Pacific Coast with the aim to provide epidemiological knowledge and guide to further reducing malaria severity and mortality. Methods and findings A prospective, descriptive hospital-based study was conducted in 323 complicated malaria patients (median age 20 years) enrolled in Quibdo A, Tumaco and Cali between 2014 and 2016. Clinical evaluation was performed and laboratory parameters were assessed during hospitalization. Plasmodium falciparum was the most common parasite species (70%), followed by P. vivax (28%), and mixed malaria (Pf/Pv; 1.9%). Overall, predominant laboratory complications were severe thrombocytopenia (43%), hepatic dysfunction (40%), and severe anaemia (34%). Severe thrombocytopenia was more common in adults (52%) regardless of parasite species. Severe anaemia was the most frequent complication in children <= 10 years (72%) and was most commonly related to P. vivax infection (p < 0.001); whereas liver dysfunction was more frequent in older patients (54%) with P. falciparum (p < 0.001). Two deaths due to P. vivax and P. falciparum each were registered. Treatment provision before recruitment hindered qPCR confirmation of parasite species in some cases. Conclusions The study identified a high prevalence of complicated malaria in the Pacific Coast, together with more frequent severe anaemia in children infected by P. vivax and hepatic dysfunction in adults with P. falciparum. Results indicated the need for earlier diagnosis and treatment to prevent complications development as well as more effective attention at hospital level, in order to rapidly identify and appropriately treat these severe clinical conditions. The study describes epidemiological profiles of the study region and identified the most common complications on which clinicians must focus on to prevent mortality.	[Arevalo-Herrera, Myriam; Rengifo, Lina; Lopez-Perez, Mary; Arce-Plata, Maria I.; Garcia, Jhon; Herrera, Socrates] Caucaseco Sci Res Ctr, Cali, Colombia; [Arevalo-Herrera, Myriam] Univ Valle, Fac Hlth, Cali, Colombia	Universidad del Valle	Arevalo-Herrera, M (corresponding author), Caucaseco Sci Res Ctr, Cali, Colombia.; Arevalo-Herrera, M (corresponding author), Univ Valle, Fac Hlth, Cali, Colombia.	marevalo@inmuno.org	Lopez-Perez, Mary/E-5059-2016	Lopez-Perez, Mary/0000-0002-9876-0248; Garcia Ortiz, Jhon Alexander/0000-0001-7133-3839	NIAID/NIH [U19A1089702]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089702] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored by NIAID/NIH (Contract # U19A1089702) for the establishment of the Latin American ICEMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaspour N, 2014, J RES MED SCI, V19, P164; Abdallah JF, 2013, SEVERE PLASMODIUM TA; [Anonymous], REV BRAS EPIDEMIOL; Arboleda M, 2012, BIOMEDICA, V32, P58, DOI 10.1590/S0120-41572012000500008; Arevalo-Herrera M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0678-3; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Caicedo MA, 2017, CHARACTERIZING MALAR, V11; Chaparro-Narvaez PE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1323-5; Doumbo OK, 2009, AM J TROP MED HYG, V81, P987, DOI 10.4269/ajtmh.2009.09-0406; Forero DA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-165; Pineros JG, 2013, AM J TROP MED HYG, V89, P520, DOI 10.4269/ajtmh.12-0205; Pineros-Jimenez JG, 2008, BIOMEDICA, V28, P471, DOI 10.7705/biomedica.v28i4.53; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Gonzalez L., 2000, ACTA MED COLOMB, V25, P163; Lacerda MVG, 2011, MEM I OSWALDO CRUZ, V106, P52, DOI 10.1590/S0074-02762011000900007; Gupta Narendra Kumar, 2013, Trop Parasitol, V3, P58, DOI 10.4103/2229-5070.113914; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; INS, 2016, B EPIDEMIOLOGICO SEM; INS, 2015, VIG RUT EV MUN; INS, 2015, B EPIDEMIOLOGICO SEM; INS, 2014, B EPIDEMIOLOGICO SEM; IVIGILA, 2016, SEMANA, V52; Jadhav U M, 2004, J Assoc Physicians India, V52, P615; Kochar DK, 2010, PLATELETS, V21, P623, DOI 10.3109/09537104.2010.505308; Kovacs SD, 2015, DRUG SAFETY, V38, P165, DOI 10.1007/s40264-014-0261-9; Kunuanunua TS, 2015, J TROP PEDIATRICS, V61, P272, DOI 10.1093/tropej/fmv029; Lacerda M, 2012, MALARIA J, V11, DOI 10.1186; Laishram DD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-29; Martinez-Salazar EL, 2014, REV SOC BRAS MED TRO, V47, P341, DOI 10.1590/0037-8682-0078-2014; Lopez ML, 2004, ACTA MED COLOMB, V29, P80; Medina-Morales DA, 2016, J INFECT PUBLIC HEAL, V9, P172, DOI 10.1016/j.jiph.2015.09.001; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; [MinSalud Ministerio de la Proteccion Social. Colombia], 2010, GUIA AT CLIN MAL; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; O'Brien AT, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-404; PAHO, 2017, EP AL INCR CAS MAL; Ramirez JF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1554-5; Seednet, 2005, YITP; Siqueira AM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0302-y; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Castano AT, 2006, IATREIA, V19, P339; Tobon-Castano A, 2012, BIOMEDICA, V32, P79, DOI 10.1590/S0120-41572012000500010; Val F, 2017, AM J TROP MED HYG; Wassmer SC, 2015, AM J TROP MED HYG, V93, P42, DOI 10.4269/ajtmh.14-0841; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-278; WHO, 2016, WORLD MAL REP 2016; World Health Organization, 2015, GUID TREATM MAL, Vthird	47	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185435	10.1371/journal.pone.0185435	http://dx.doi.org/10.1371/journal.pone.0185435			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945797	gold, Green Published, Green Submitted			2022-12-27	WOS:000411645100060
J	Lee, SJ; Lee, DG				Lee, Seung-Jae; Lee, Dong-Geun			Distribution of atherosclerotic stenosis determining early neurologic deterioration in acute ischemic stroke	PLOS ONE			English	Article							INTRACRANIAL ATHEROSCLEROSIS; DISEASE; RISK; PREDICTORS; OCCLUSION; IMPACT	Background and purpose Early neurologic deterioration (END) during the acute stage of stroke is clinically important because of its association with poor outcomes. The purpose of this study was (1) to investigate variables associated with END, (2) to determine the distribution of atherosclerotic stenosis associated with END, and (3) to clarify the relationship between END and clinical outcomes. Methods 516 patients with acute ischemic stroke were included. The median follow-up period was 31.7 months. END was defined as a >= 2 point increase in the National Institutes of Health Stroke Scale (NIHSS), >= 1 point increase in level of consciousness or motor item of the NIHSS, or the development of any new neurological deficits during the first 72 hours of hospitalization. A signal loss on 1.5-T magnetic resonance angiography exceeding 50% was considered to be significant for the categorization of stenosis pattern. Results The prevalence of END was 19.0%. END was associated with intracranial atherosclerotic stenosis (IAS) together with large artery atherosclerosis (LAA) subtype. In particular, stenosis of basilar artery or posterior cerebral artery was independently associated with END. Lesion growth or hypoperfusion was more accountable for END in patients with IAS, whereas intracerebral hemorrhage or edema/herniation was more frequently observed in END patients without IAS. Patients with END had a higher rate of mortality, but a similar rate of further vascular events compared to patients without END. Conclusion Pre-stroke IAS and LAA subtype could determine the development of END during the acute stage of ischemic stroke.	[Lee, Seung-Jae] Soonchunhyang Univ, Dept Neurol, Bucheon Hosp, Bucheon, South Korea; [Lee, Dong-Geun] Sejong Gen Hosp, Dept Neurol, Bucheon, South Korea	Soonchunhyang University; Sejong General Hospital	Lee, SJ (corresponding author), Soonchunhyang Univ, Dept Neurol, Bucheon Hosp, Bucheon, South Korea.	neurosj@catholic.ac.kr		Lee, Seung-Jae/0000-0003-2299-4870	Soonchunhyang University	Soonchunhyang University	This work was supported by the Soonchunhyang University Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bang OY, 2014, J STROKE, V16, P27, DOI 10.5853/jos.2014.16.1.27; Cho AH, 2012, J NEUROL SCI, V312, P127, DOI 10.1016/j.jns.2011.08.004; Chung JW, 2015, J HYPERTENS, V33, P2099, DOI 10.1097/HJH.0000000000000675; Jeong HG, 2015, STROKE, V46, P687, DOI 10.1161/STROKEAHA.114.007466; Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kim YD, 2016, J STROKE CEREBROVASC, V25, P819, DOI 10.1016/j.jstrokecerebrovasdis.2015.12.003; Kwan J, 2006, QJM-INT J MED, V99, P625, DOI 10.1093/qjmed/hcl082; Lee SJ, 2015, EUR NEUROL, V73, P271, DOI 10.1159/000381336; Lee SJ, 2011, ARCH GERONTOL GERIAT, V53, pE129, DOI 10.1016/j.archger.2010.07.008; Miyamoto N, 2013, J STROKE CEREBROVASC, V22, P205, DOI 10.1016/j.jstrokecerebrovasdis.2011.07.018; Molina CA, 2001, STROKE, V32, P1079, DOI 10.1161/01.STR.32.5.1079; Ogasawara K, 2002, STROKE, V33, P1857, DOI 10.1161/01.STR.0000019511.81583.A8; Ogata T, 2009, J NEUROL SCI, V287, P147, DOI 10.1016/j.jns.2009.08.006; Ois A, 2008, CEREBROVASC DIS, V25, P151, DOI 10.1159/000113732; Park JH, 2007, EUR J NEUROL, V14, P379, DOI 10.1111/j.1468-1331.2007.01682.x; Park MG, 2016, J STROKE, V18, P73, DOI 10.5853/jos.2015.01417; Petrone L, 2016, CEREBROVASC DIS, V41, P87, DOI 10.1159/000442577; Pu YH, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00125; Ryoo S, 2012, NEUROLOGY, V78, P888, DOI 10.1212/WNL.0b013e31824c4699; Siegler JE, 2016, J STROKE, V18, P203, DOI 10.5853/jos.2016.00073; Siegler JE, 2013, J STROKE CEREBROVASC, V22, pE207, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.006; Thanvi B, 2008, POSTGRAD MED J, V84, P412, DOI 10.1136/pgmj.2007.066118; Wang C, 2015, CLIN APPL THROMB-HEM, V21, P453, DOI 10.1177/1076029614551823; Weimar C, 2005, ARCH NEUROL-CHICAGO, V62, P393, DOI 10.1001/archneur.62.3.393; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x	28	14	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185314	10.1371/journal.pone.0185314	http://dx.doi.org/10.1371/journal.pone.0185314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945817	Green Published, gold, Green Submitted			2022-12-27	WOS:000411645100044
J	Radzikowska, E; Wiatr, E; Langfort, R; Bestry, I; Skoczylas, A; Szczepulska-Wojcik, E; Gawryluk, D; Rudzinski, P; Chorostowska-Wynimko, J; Roszkowski-Sliz, K				Radzikowska, Elibieta; Wiatr, Elzbieta; Langfort, Renata; Bestry, Iwona; Skoczylas, Agnieszka; Szczepulska-Wojcik, Ewa; Gawryluk, Dariusz; Rudzinski, Piotr; Chorostowska-Wynimko, Joanna; Roszkowski-Sliz, Kazimierz			Cryptogenic organizing pneumonia-Results of treatment with clarithromycin versus corticosteroids-Observational study	PLOS ONE			English	Article							BRONCHIOLITIS OBLITERANS; CLINICAL-FEATURES; BAL FLUID; MACROLIDES; SECONDARY; THERAPY; DISEASE; SERUM; IL-6	Background Cryptogenic organizing pneumonia (COP) is a clinicopathological syndrome of unknown origin. Corticosteroids are the standard treatment, but clarithromycin (CAM) is also effective. The aim of this observational retrospective study was to compare the results of CAM versus prednisone (PRE) treatment in patients with biopsy-proven OP without respiratory insufficiency. Material and methods In a 15-year period, 40 patients were treated with CAM (500 mg twice daily orally for 3 months) and 22 with PRE (mean initial dose of 0.67 +/- 0.24 mg/kg/d for a mean of 8.59 +/- 3.05 months). Results The clinical presentation, laboratory, and radiological findings did not differ markedly between patients treated with CAM and PRE, with the exception of a higher frequency of sweats (55% vs. 23%; p < 0.015), ground glass opacities (95% vs. 50%; p < 0.0001) and nodular lesions (45% vs. 18%; p = 0.036) in the CAM group. A complete response was achieved in 35(88%) patients treated with CAM and in all treated with PRE. Patients treated with PRE relapsed more frequently than those treated with CAM (54.5% vs. 10%; p < 0.0001). Corticosteroid-related adverse events were noticed in 8(6.5%) patients (with one death), but CAM caused only one (2.5%) allergic reaction. A FVC > 80% identified patients who might be successfully treated with CAM with a sensitivity of 60% and a specificity of 88.57% (AUC 0.869; 95% CI 0.684-1; p = 0.008); the figures for the FEV1 were > 70%, a sensitivity of 60%, and a specificity of 91.43% (AUC 0.809; 95% CI 0.609-1; p = 0.027). Conclusions CAM can be used to treat COP patients in whom the pulmonary function parameters are within normal limits. Such therapy is shorter, better tolerated, and associated with fewer adverse events and relapses than is PRE. However, the therapy is ineffective in some patients.	[Radzikowska, Elibieta; Wiatr, Elzbieta; Gawryluk, Dariusz; Roszkowski-Sliz, Kazimierz] Natl TB & Lung Dis Res Inst, Dept Lung Dis 3, Warsaw, Poland; [Langfort, Renata; Szczepulska-Wojcik, Ewa] Natl TB & Lung Dis Res Inst, Dept Pathol, Warsaw, Poland; [Bestry, Iwona] Natl TB & Lung Dis Res Inst, Dept Radiol, Warsaw, Poland; [Skoczylas, Agnieszka] Natl Inst Geriatr Rheumatol & Rehabil, Dept Geriatr, Warsaw, Poland; [Rudzinski, Piotr] Natl TB & Lung Dis Res Inst, Dept Thorac Surg, Warsaw, Poland; [Chorostowska-Wynimko, Joanna] Natl TB & Lung Dis Res Inst, Lab Mol Diagnost & Immunol, Warsaw, Poland	National Institute of Geriatrics, Rheumatology & Rehabilitation	Radzikowska, E (corresponding author), Natl TB & Lung Dis Res Inst, Dept Lung Dis 3, Warsaw, Poland.	e.radzikowska@wp.pl	Radzikowska, Elzbieta/AAH-2507-2020	Radzikowska, Elzbieta/0000-0002-2585-8594; Skoczylas, Agnieszka/0000-0001-6311-4820	National Tuberculosis and Lung Diseases Research Institute [7.3]	National Tuberculosis and Lung Diseases Research Institute	This study was supported by National Tuberculosis and Lung Diseases Research Institute grant Nr 7.3.	Amayasu H, 2000, ANN ALLERG ASTHMA IM, V84, P594, DOI 10.1016/S1081-1206(10)62409-X; Arakawa H, 2001, AM J ROENTGENOL, V176, P1053, DOI 10.2214/ajr.176.4.1761053; Asano T, 2003, RESPIROLOGY, V8, P461, DOI 10.1046/j.1440-1843.2003.00496.x; Basarakodu Krishnamohan R, 2007, Am J Ther, V14, P422, DOI 10.1097/01.pap.0000249905.63211.a1; BELLOMO R, 1991, THORAX, V46, P554, DOI 10.1136/thx.46.8.554; Cai MT, 2013, IMMUNOBIOLOGY, V218, P930, DOI 10.1016/j.imbio.2012.10.014; CARRE PC, 1994, AM J RESP CELL MOL, V10, P100, DOI 10.1165/ajrcmb.10.1.8292374; Cazzato S, 2000, RESP MED, V94, P702, DOI 10.1053/rmed.2000.0805; Chou HW, 2015, CLIN INFECT DIS, V60, P566, DOI 10.1093/cid/ciu914; COHEN AJ, 1994, AM J RESP CRIT CARE, V149, P1670, DOI 10.1164/ajrccm.149.6.8004328; Cordier JF, 2006, EUR RESPIR J, V28, P422, DOI 10.1183/09031936.06.00013505; Corris PA, 2015, THORAX, V70, P442, DOI 10.1136/thoraxjnl-2014-205998; COSTABEL U, 1992, CHEST, V102, pS14, DOI 10.1378/chest.102.1_Supplement.14S; Crestani B, 1998, AM J RESP CRIT CARE, V158, P1929, DOI 10.1164/ajrccm.158.6.9711036; Ding QL, 2015, EXP THER MED, V9, P829, DOI 10.3892/etm.2015.2183; Drakopanagiotakis F, 2011, CHEST, V139, P893, DOI 10.1378/chest.10-0883; Epler G R, 1998, Curr Opin Pulm Med, V4, P93, DOI 10.1097/00063198-199803000-00006; EPLER GR, 1985, NEW ENGL J MED, V312, P152, DOI 10.1056/NEJM198501173120304; Gaillet G, 2015, RESPIRATION, V89, P119, DOI 10.1159/000369470; Ichikawa Yoichiro, 1993, Kurume Medical Journal, V40, P65; Ichiyama T, 2001, ANTIMICROB AGENTS CH, V45, P44, DOI 10.1128/AAC.45.1.44-47.2001; IZUMI T, 1992, CHEST, V102, P715, DOI 10.1378/chest.102.3.715; Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09; KING TE, 1992, CHEST, V102, pS8, DOI 10.1378/chest.102.1_Supplement.8S; KING TE, 1995, EUR RESPIR J, V8, P193, DOI 10.1183/09031936.95.08020193; Kudoh S, 1998, Curr Opin Pulm Med, V4, P116, DOI 10.1097/00063198-199803000-00010; Lazor R, 2000, AM J RESP CRIT CARE, V162, P571, DOI 10.1164/ajrccm.162.2.9909015; Lohr RH, 1997, ARCH INTERN MED, V157, P1323, DOI 10.1001/archinte.157.12.1323; Oymak FS, 2005, RESPIRATION, V72, P254, DOI 10.1159/000085366; Pathak Vikas, 2014, Ann Am Thorac Soc, V11, P87, DOI 10.1513/AnnalsATS.201308-261CR; Poletti V, 1996, EUR RESPIR J, V9, P2513, DOI 10.1183/09031936.96.09122513; Radzikowska E, 2016, ADV EXP MED BIOL, V911, P77, DOI 10.1007/5584_2016_223; Radzikowska E, 2016, ADV CLIN EXP MED, V25, P871, DOI 10.17219/acem/61953; Radzikowska Elzbieta, 2004, Pneumonol Alergol Pol, V72, P493; Radzikowska Elzbieta, 2008, Pneumonol Alergol Pol, V76, P334; Southern KW, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002203.pub4; Stover DE, 2005, CHEST, V128, P3611, DOI 10.1378/chest.128.5.3611; Sveinsson OA, 2007, INT J TUBERC LUNG D, V11, P689; Tsang KWT, 1999, EUR RESPIR J, V13, P361, DOI 10.1183/09031936.99.13236199; Watanabe K, 2000, RESPIRATION, V67, P572, DOI 10.1159/000067477; Watanabe K, 1998, CHEST, V114, P1599, DOI 10.1378/chest.114.6.1599; Yoo JW, 2011, RHEUMATOLOGY, V50, P932, DOI 10.1093/rheumatology/keq410	42	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0184739	10.1371/journal.pone.0184739	http://dx.doi.org/10.1371/journal.pone.0184739			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945804	Green Published, gold, Green Submitted			2022-12-27	WOS:000411645100008
J	Traversetti, L; Losito, F; Arienzo, A; Stalio, O; Antonini, G; Scalici, M				Traversetti, Lorenzo; Losito, Francesca; Arienzo, Alyexandra; Stalio, Ottavia; Antonini, Giovanni; Scalici, Massimiliano			Integrating running water monitoring tools with the Micro Biological Survey (MBS) method to improve water quality assessment	PLOS ONE			English	Article							BACTERIAL COMMUNITY COMPOSITION; MEDITERRANEAN RIVER; MACROINVERTEBRATE COMMUNITIES; MICROBIOLOGICAL QUALITY; IMPACT; BIODIVERSITY; THREATS; HEALTH; URBAN	Running water habitats are among the most altered aquatic systems by human activities driving an increase in the organic components and the associated bacterial load as well. To contribute in improving the monitoring activities in running waters, here we tested the validity of the new Micro Biological Survey (MBS) method to specifically assess the bacterial load in running waters focusing on Total Viable Counts (at 22 degrees C and 37 degrees C) and Escherichia coli (at 44 degrees C) in order to propose a new prognostic tool for watercourses. MBS method is an alternative colorimetric method for counting bacterial load in water and food samples that is easy to use and leads to a reliable and simple interpretation of results, being also faster and less expensive than traditional methods. Then, we compared MBS with the traditionally used reference method for the bacterial load, and with the most used biotic index for Italian watercourses based on the benthic invertebrates: the Extended Biotic Index (EBI). The last comparison was performed to validate the use of MBS in biomonitoring activities since the benthic invertebrate multi-species assemblage (and then EBI) alter own structure mainly depending on the organic component variation. During the first part of the study, the assessment of both linearity (regressions among bacterial concentrations) and accuracy (significant correlation between a measured value and a value used as reference) confirmed the validity of the MBS method. Second, the linear regressions between the three investigated microbial parameters vs. both physical-chemical descriptors and EBI, revealed the usefulness of MBS as a valid tool for routine microbiological analyses involved in rapid and easy field monitoring activities. This represents the first attempt to evaluate the river microbial status by exploiting the innovative MBS on running waters to propose it as new valuable monitoring tool in the biomonitoring field.	[Traversetti, Lorenzo; Arienzo, Alyexandra; Stalio, Ottavia; Antonini, Giovanni; Scalici, Massimiliano] Univ Roma Tre, Dept Sci, Rome, Italy; [Losito, Francesca; Antonini, Giovanni] INBB Interuniv Consortium Struct & Syst Biol, Rome, Italy	Italfarmaco; Roma Tre University	Traversetti, L (corresponding author), Univ Roma Tre, Dept Sci, Rome, Italy.	lorenzo.traversetti@uniroma3.it		Antonini, Giovanni/0000-0002-2115-8961; SCALICI, Massimiliano/0000-0002-5677-8837				Antonini G, 2016, AM J FOOD TECHNOL, V11, P29, DOI [10.3923/ajft.2016.29.36, DOI 10.3923/AJFT.2016.29.36]; Arienzo A, 2015, INT J ENV RES PUB HE, V12, P10314, DOI 10.3390/ijerph120910314; Arienzo A, 2014, CLIN CHEM LAB MED, V52, P1507, DOI 10.1515/cclm-2014-0294; Bottini G., 2011, American Journal of Food Technology, V6, P951; Briancesco Rossella, 2005, Ann Ist Super Sanita, V41, P353; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Gasol JM, 2002, LIMNOL OCEANOGR, V47, P62, DOI 10.4319/lo.2002.47.1.0062; Ghetti P.F, 1997, APPL MANUAL EXTENDED; Hachich EM, 2012, BRAZ J MICROBIOL, V43, P675, DOI 10.1590/S1517-83822012000200032; Jansson R, 2000, ECOL APPL, V10, P203; Kent AD, 2010, DNA CELL BIOL, V29, P509, DOI 10.1089/dna.2009.0988; Larsen S, 2015, AQUAT SCI, V77, P455, DOI 10.1007/s00027-014-0390-3; Larsen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051115; Lee DY, 2014, WATER RES, V53, P123, DOI 10.1016/j.watres.2014.01.003; Losito F., 2012, American Journal of Food Technology, V7, P340, DOI 10.3923/ajft.2012.340.351; Mallin MA, 2000, ECOL APPL, V10, P1047, DOI 10.2307/2641016; Malmqvist B, 2002, ENVIRON CONSERV, V29, P134, DOI 10.1017/S0376892902000097; Manfrin A, 2016, J NAT CONSERV, V30, P27, DOI 10.1016/j.jnc.2016.01.002; Manfrin A, 2013, INT REV HYDROBIOL, V98, P155, DOI 10.1002/iroh.201201605; Masin M, 2003, HYDROBIOLOGIA, V504, P99, DOI 10.1023/B:HYDR.0000008512.04563.0b; Moitra M, 2015, HYDROBIOLOGIA, V747, P201, DOI 10.1007/s10750-014-2140-x; Naddeo V, 2005, PROC INT CONF ENV SC, pA1058; Noble PA, 1997, APPL ENVIRON MICROB, V63, P1762, DOI 10.1128/AEM.63.5.1762-1770.1997; Omoigberale MNO, 2013, AM J RES COMMUN, V1; Pall E, 2013, J MED MICROBIOL, V62, P1635, DOI 10.1099/jmm.0.055749-0; Passerat J, 2011, WATER RES, V45, P893, DOI 10.1016/j.watres.2010.09.024; Rai PK, 2010, AQUAT ECOSYST HEALTH, V13, P352, DOI 10.1080/14634988.2010.528739; Rechenburg A, 2006, WATER SCI TECHNOL, V54, P95, DOI 10.2166/wst.2006.454; Rose P, 2008, FRESHWATER BIOL, V53, P2626, DOI 10.1111/j.1365-2427.2008.02074.x; Schneider I, 2009, BIOTECHNOL BIOTEC EQ, V23, P1210, DOI 10.1080/13102818.2009.10817640; Tachet H., 2000, INVERTEBRES EAU DOUC; Traversetti L, 2014, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2014012; Traversetti L, 2015, J LIMNOL, V74, P133, DOI 10.4081/jlimnol.2014.974; Traversetti L, 2014, J ENVIRON BIOL, V35, P497; Ullah Z, 2013, J WATER CHEM TECHNO+, V35, P170, DOI 10.3103/S1063455X1304005X; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; WHITEHURST IT, 1990, WATER RES, V24, P625, DOI 10.1016/0043-1354(90)90195-C; Wootton JT, 1996, SCIENCE, V273, P1558, DOI 10.1126/science.273.5281.1558	38	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185156	10.1371/journal.pone.0185156	http://dx.doi.org/10.1371/journal.pone.0185156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945808	Green Published, Green Submitted, gold			2022-12-27	WOS:000411645100025
J	Vandenbroucke, L; Doyen, M; Le Lous, M; Beuchee, A; Loget, P; Carrault, G; Pladys, P				Vandenbroucke, Laurent; Doyen, Matthieu; Le Lous, Maela; Beuchee, Alain; Loget, Philippe; Carrault, Guy; Pladys, Patrick			Chorioamnionitis following preterm premature rupture of membranes and fetal heart rate variability	PLOS ONE			English	Article							NEONATAL SEPSIS; NECROTIZING ENTEROCOLITIS; INFECTION; INFLAMMATION; INFANTS; WOMEN; PPROM	Introduction The objective of this study was to identify prenatal markers of histological chorioamnionitis (HC) during pPROM using fetal computerized cardiotocography (cCTG). Materials and methods Retrospective review of medical records from pregnant women referred for pPROM between 26 and 34 weeks, in whom placental histology was available, in a tertiary level obstetric service over a 5-year period. Fetal heart rate variability was assessed using cCTG. Patients were included if they were monitored at least six times in the 72 hours preceding delivery. Clinical and biological cCTG parameters during the pPROM latency period were compared between cases with or without HC. Results In total, 222 pPROM cases were observed, but cCTG data was available in only 23 of these cases (10 with and 13 without HC) after exclusion of co-morbidities which may potentially perturb fetal heart rate variability measures. Groups were comparable for maternal age, parity, gestational age at pPROM, pPROM duration and neonatal characteristics (p > 0.1). Baseline fetal heart rate was higher in the HC group [median 147.3 bpm IQR (144.2-149.2) vs. 141.3 bpm (137.1-145.4) in no HC group; p = 0.02]. The number of low variation episodes [6.4, (3.5-15.3) vs. 2.3 (1-5.2); p = 0.04] was also higher in the HC group, whereas short term variations were lower in the HC group [7.1 ms (6-7.4) vs. 8.1 ms (7.4-9); p = 0.01] within 72 hours before delivery. Differences were especially discriminant within 24 hours before delivery, with less short-term variation [5 ms (3.7-5.9) vs. 7.8 ms (5.4-8.7); p = 0.007] and high variation episodes [3.9 (4.9-3.2) vs. 0.8 (1.5-0.2); p < 0.001] in the HC group. Conclusion These results show differences in fetal heart rate variability, suggesting that cCTG could be used clinically to diagnoses chorioamnionitis during the pPROM latency period.	[Vandenbroucke, Laurent; Beuchee, Alain; Carrault, Guy; Pladys, Patrick] INSERM, UMR1099, Signal & Image Proc Lab, SEPIA Team, Rennes, France; [Vandenbroucke, Laurent; Le Lous, Maela] CHU Rennes, Univ Hosp Rennes, Dept Obstet, Rennes, France; [Vandenbroucke, Laurent; Doyen, Matthieu; Carrault, Guy; Pladys, Patrick] INSERM, U1414, Clin Invest Ctr, Rennes, France; [Vandenbroucke, Laurent; Doyen, Matthieu; Le Lous, Maela; Beuchee, Alain; Carrault, Guy; Pladys, Patrick] Univ Rennes 1, Fac Med, Rennes, France; [Beuchee, Alain; Pladys, Patrick] CHU Rennes, Univ Hosp Rennes, Dept Pediat, Rennes, France; [Loget, Philippe] CHU Rennes, Dept Anat Pathol, Univ Hosp Rennes, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes	Vandenbroucke, L (corresponding author), INSERM, UMR1099, Signal & Image Proc Lab, SEPIA Team, Rennes, France.; Vandenbroucke, L (corresponding author), CHU Rennes, Univ Hosp Rennes, Dept Obstet, Rennes, France.; Vandenbroucke, L (corresponding author), INSERM, U1414, Clin Invest Ctr, Rennes, France.; Vandenbroucke, L (corresponding author), Univ Rennes 1, Fac Med, Rennes, France.	laurent.vandenbroucke@chu-rennes.fr	Le Lous, Maela/ABC-6246-2020; carrault, guy/ABC-4463-2020; Beuchée, Alain/AAB-7024-2021; Doyen, Matthieu/ABG-3233-2021	Le Lous, Maela/0000-0001-6823-2279; carrault, guy/0000-0003-1482-2067; Beuchée, Alain/0000-0003-0064-7085; 	CORECT (clinical and translational research committee) of Rennes University Hospital	CORECT (clinical and translational research committee) of Rennes University Hospital	This study received grants from the CORECT (clinical and translational research committee) of Rennes University Hospital for data analysis.	[Anonymous], 2013, Obstet Gynecol, V122, P918, DOI 10.1097/01.AOG.0000435415.21944.8f; Beuchee A, 2009, NEONATOLOGY, V96, P109, DOI 10.1159/000208792; Buhimschi CS, 2008, AM J PERINAT, V25, P359, DOI 10.1055/s-2008-1078761; Buscicchio G, 2006, J MATERN-FETAL NEO M, V19, P39, DOI 10.1080/14767050500361505; Buscicchio G, 2010, J MATERN-FETAL NEO M, V23, P335, DOI 10.3109/14767050903258712; DAWES GS, 1991, J PERINAT MED, V19, P47, DOI 10.1515/jpme.1991.19.1-2.47; Durosier LD, 2015, PHYSIOL MEAS, V36, DOI 10.1088/0967-3334/36/10/2089; Ericson JE, 2015, CLIN PERINATOL, V42, P155, DOI 10.1016/j.clp.2014.10.011; Fehlert E, 2016, BJOG, V37, pS81; Garzoni L, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00057; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Griffin MP, 2007, PEDIATR RES, V61, P222, DOI 10.1203/01.pdr.0000252438.65759.af; Griffin MP, 2005, PEDIATRICS, V116, P1070, DOI 10.1542/peds.2004-2461; Griffin MP, 2003, PEDIATR RES, V53, P920, DOI 10.1203/01.PDR.0000064904.05313.D2; Herry CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153515; Kapaya H, 2015, J MATERN-FETAL NEO M, V28, P1664, DOI 10.3109/14767058.2014.964202; Lake DE, 2014, J CLIN MONIT COMPUT, V28, P329, DOI 10.1007/s10877-013-9530-x; Liu HL, 2016, PEDIATR CRIT CARE ME, V17, pE165, DOI 10.1097/PCC.0000000000000643; Pacora P, 2002, J Matern Fetal Neonatal Med, V11, P18, DOI 10.1080/713605445; Pasquier JC, 2005, EUR J OBSTET GYN R B, V121, P164, DOI 10.1016/j.ejogrb.2004.12.015; Popowski T, 2011, GYNECOL OBSTET FERTI, V39, P302, DOI 10.1016/j.gyobfe.2010.11.006; Shatrov JG, 2010, OBSTET GYNECOL, V116, P387, DOI 10.1097/AOG.0b013e3181e90046; Stone ML, 2013, J PERINATOL, V33, P847, DOI 10.1038/jp.2013.63; Sullivan BA, 2014, J PEDIATR-US, V164, P775, DOI 10.1016/j.jpeds.2013.11.038; Tsiartas P, 2013, J MATERN-FETAL NEO M, V26, P1332, DOI 10.3109/14767058.2013.784741	25	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0184924	10.1371/journal.pone.0184924	http://dx.doi.org/10.1371/journal.pone.0184924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945767	Green Submitted, gold, Green Published			2022-12-27	WOS:000411645100013
J	Minoura, K; Yamada, M; Mizoguchi, T; Kaneko, T; Nishiyama, K; Ozminskyj, M; Koshizuka, T; Wada, I; Suzutani, T				Minoura, Kiyoshi; Yamada, Miho; Mizoguchi, Takashi; Kaneko, Toshihiro; Nishiyama, Kyoko; Ozminskyj, Mari; Koshizuka, Tetsuo; Wada, Ikuo; Suzutani, Tatsuo			Antibacterial effects of the artificial surface of nanoimprinted moth-eye film	PLOS ONE			English	Article							BACTERICIDAL ACTIVITY	The antibacterial effect of a nanostructured film, known as "moth-eyefilm," was investigated. The moth-eye film has artificially formed nano-pillars, consisting of hydrophilic resin with urethane acrylate and polyethylene glycol (PEG) derivatives, all over its surface that replicates a moth's eye. Experiments were performed to compare the moth-eye film with a flat-surfaced film produced from the same materials. The JIS Z2801 film-covering method revealed that the two films produced a decrease in Staphylococcus aureus and Esherichia coli titers of over 5 and 3 logs, respectively. There was no marked difference in the antibacterial effects of the two surfaces. However, the antibacterial effects were reduced by immersion of the films in water. These results indicated that a soluble component(s) of the resin possessed the antibacterial activity, and this component was identified as PEG derivatives by time-of-flight secondary ion mass spectrometry (TOF-SIMS) and Fourier transform infrared spectroscopy (FT-IR). When a small volume of bacterial suspension was dropped on the films as an airborne droplet model, both films showed antibacterial effects, but that of the moth-eye film was more potent. It was considered that the moth-eye structure allowed the bacteria-loaded droplet to spread and allow greater contact between the bacteria and the film surface, resulting in strong adherence of the bacteria to the film and synergistically enhanced bactericidal activity with chemical components. The antibacterial effect of the moth-eye film has been thus confirmed under a bacterial droplet model, and it appears attractive due to its antibacterial ability, which is considered to result not only from its chemical make-up but also from physical adherence.	[Minoura, Kiyoshi; Yamada, Miho] Sharp Co Ltd, Display Device Co, Dev Grp, LCD Technol Dev Ctr, Tenri, Nara, Japan; [Mizoguchi, Takashi] Sharp Co Ltd, Display Device Co, Dev Grp, New Business Promot Ctr, Tenri, Nara, Japan; [Kaneko, Toshihiro] Sharp Co Ltd, Display Device Co, Dev Grp, Next Generat IGZO Technol Dev Ctr, Tenri, Nara, Japan; [Nishiyama, Kyoko; Ozminskyj, Mari; Koshizuka, Tetsuo; Suzutani, Tatsuo] Fukushima Med Univ, Inst Biomed Sci, Dept Microbiol, Sch Med, Fukushima, Japan; [Wada, Ikuo] Fukushima Med Univ, Inst Biomed Sci, Dept Cell Sci, Sch Med, Fukushima, Japan	Hisense; Sharp Corporation; Hisense; Sharp Corporation; Hisense; Sharp Corporation; Fukushima Medical University; Fukushima Medical University	Minoura, K (corresponding author), Sharp Co Ltd, Display Device Co, Dev Grp, LCD Technol Dev Ctr, Tenri, Nara, Japan.	minoura.kiyoshi@sharp.co.jp		Koshizuka, Tetsuo/0000-0003-2783-2520; Minoura, Kiyoshi/0000-0002-5236-3087	Sharp Corporation	Sharp Corporation	Financial statement Sharp Corporation provided support in the form of salaries for authors [KM, MY, TM and T. Kaneko], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405; CLAPHAM PB, 1973, NATURE, V244, P281, DOI 10.1038/244281a0; Desrousseaux C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135632; Dickson MN, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4922157; Graham MV, 2014, COATINGS, V4, P37, DOI 10.3390/coatings4010037; Gunawan C, 2013, SMALL, V9, P3554, DOI 10.1002/smll.201300761; Hasan J, 2013, APPL MICROBIOL BIOT, V97, P9257, DOI 10.1007/s00253-012-4628-5; Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017; Ivanova EP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3838; Ivanova EP, 2012, SMALL, V8, P2489, DOI 10.1002/smll.201200528; Kim S, 2015, ACS APPL MATER INTER, V7, P326, DOI 10.1021/am506254r; Minoura K, 2014, World patent, Patent No. [WO2014/038288 A1, 2014038288]; Nowlin Kyle, 2015, J R Soc Interface, V12, P20140999, DOI 10.1098/rsif.2014.0999; Park B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025880; Rizzello L, 2013, NANOMEDICINE-UK, V8, P807, DOI [10.2217/NNM.13.63, 10.2217/nnm.13.63]; Shirotake S, 2008, CHEM PHARM BULL, V56, P137, DOI 10.1248/cpb.56.137; Taguchi T., 2010, SID S DIG TECH PAP, V41, P1196; WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015; Yamada M, 2015, World patent, Patent No. [WO2015/163018 A1, 2015163018]; Yamada M, 2016, World patent, Patent No. [WO2016/080245 A1, 2016080245]	21	21	22	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185366	10.1371/journal.pone.0185366	http://dx.doi.org/10.1371/journal.pone.0185366			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934372	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900152
J	Cappuccio, G; Pinelli, M; Alagia, M; Donti, T; Day-Salvatore, DL; Veggiotti, P; De Giorgis, V; Lunghi, S; Vari, MS; Striano, P; Brunetti-Pierri, N; Kennedy, AD; Elsea, SH				Cappuccio, Gerarda; Pinelli, Michele; Alagia, Marianna; Donti, Taraka; Day-Salvatore, Debra-Lynn; Veggiotti, Pierangelo; De Giorgis, Valentina; Lunghi, Simona; Vari, Maria Stella; Striano, Pasquale; Brunetti-Pierri, Nicola; Kennedy, Adam D.; Elsea, Sarah H.			Biochemical phenotyping unravels novel metabolic abnormalities and potential biomarkers associated with treatment of GLUT1 deficiency with ketogenic diet	PLOS ONE			English	Article							MUTATIONS; CARNITINE; EPILEPSY; CHILDREN; REVEALS	Global metabolomic profiling offers novel opportunities for the discovery of biomarkers and for the elucidation of pathogenic mechanisms that might lead to the development of novel therapies. GLUT1 deficiency syndrome (GLUT1-DS) is an inborn error of metabolism due to reduced function of glucose transporter type 1. Clinical presentation of GLUT1-DS is heterogeneous and the disorder mirrors patients with epilepsy, movement disorders, or any paroxysmal events or unexplained neurological manifestation triggered by exercise or fasting. The diagnostic biochemical hallmark of the disease is a reduced cerebrospinal fluid (CSF)/blood glucose ratio and the only available treatment is ketogenic diet. This study aimed at advancing our understanding of the biochemical perturbations in GLUT1-DS pathogenesis through biochemical phenotyping and the treatment of GLUT1-DS with a ketogenic diet. Metabolomic analysis of three CSF samples from GLUT1-DS patients not on ketogenic diet was feasible inasmuch as CSF sampling was used for diagnosis before to start with ketogenic diet. The analysis of plasma and urine samples obtained from GLUT1-DS patients treated with a ketogenic diet showed alterations in lipid and amino acid profiles. While subtle, these were consistent findings across the patients with GLUT1-DS on ketogenic diet, suggesting impacts on mitochondrial physiology. Moreover, low levels of free carnitine were present suggesting its consumption in GLUT1-DS on ketogenic diet. 3-hydroxybutyrate, 3-hydroxybutyrylcarnitine, 3-methyladipate, and N-acetylglycine were identified as potential biomarkers of GLUT1-DS on ketogenic diet. This is the first study to identify CSF, plasma, and urine metabolites associated with GLUT1-DS, as well as biochemical changes impacted by a ketogenic diet. Potential biomarkers and metabolic insights deserve further investigation.	[Cappuccio, Gerarda; Pinelli, Michele; Alagia, Marianna; Brunetti-Pierri, Nicola] Univ Naples Federico II, Sect Pediat, Dept Translat Med, Naples, Italy; [Cappuccio, Gerarda; Pinelli, Michele; Alagia, Marianna; Brunetti-Pierri, Nicola] Telethon Inst Genet & Med, Naples, Italy; [Cappuccio, Gerarda; Donti, Taraka; Elsea, Sarah H.] Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA; [Donti, Taraka] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Day-Salvatore, Debra-Lynn] St Peters Univ Hosp, Dept Med Genet & Genom Med, New Brunswick, NJ USA; [Veggiotti, Pierangelo; De Giorgis, Valentina; Lunghi, Simona] Fdn IRCCS C, Dept Brain & Behav Sci, Mondino, Italy; [Vari, Maria Stella; Striano, Pasquale] Univ Genoa, Gaslini Inst, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, G Gaslini Inst,Pediat Neurol & Muscular Dis Unit, Genoa, Italy; [Kennedy, Adam D.] Metabolon, Morrisville, NC USA	University of Naples Federico II; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Baylor College of Medicine; Greenwood Genetic Center; Saint Peter's University Hospital; University of Genoa; IRCCS Istituto Giannina Gaslini; Metabolon	Elsea, SH (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA.	Sarah.Elsea@bcm.edu	De Giorgis, Valentina/AAB-7643-2019; Striano, Pasquale/F-9117-2014; Vari, Maria Stella/AAJ-9154-2020; De Giorgis, Valentina/K-4730-2018; Cappuccio, Gerarda/W-3576-2018; Pinelli, Michele/A-1584-2010; Donti, Taraka/K-5648-2013; Brunetti-Pierri, Nicola/K-8465-2016	De Giorgis, Valentina/0000-0002-5828-7070; Striano, Pasquale/0000-0002-6065-1476; De Giorgis, Valentina/0000-0002-5828-7070; Cappuccio, Gerarda/0000-0003-3934-2342; Pinelli, Michele/0000-0002-5927-1185; Donti, Taraka/0000-0002-3830-155X; Elsea, Sarah/0000-0002-1400-8519; Brunetti-Pierri, Nicola/0000-0002-6895-8819				Amaral AI, 2013, J INHERIT METAB DIS, V36, P621, DOI 10.1007/s10545-012-9553-3; Atwal PS, 2015, MOL GENET METAB, V115, P91, DOI 10.1016/j.ymgme.2015.04.008; Berry-Kravis T, 2001, EPILEPSIA, V42, P1445; Bertoli S, 2015, NUTRITION, V31, P981, DOI 10.1016/j.nut.2015.02.017; Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899; Burrage LC, 2016, J PEDIATR-US, V169, P208, DOI 10.1016/j.jpeds.2015.10.045; Dahlin M, 2007, EPILEPSY RES, V73, P199, DOI 10.1016/j.eplepsyres.2006.10.005; Dashti Hussein M, 2004, Exp Clin Cardiol, V9, P200; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Donti TR, 2016, MOL GENET METAB REP, V8, P61, DOI 10.1016/j.ymgmr.2016.07.007; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Evans M., 2014, METABOLOMICS, V4, P1, DOI DOI 10.4172/2153-0769.1000132; Guay C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077097; Haces ML, 2010, NEUROSCIENCE, V165, P28, DOI 10.1016/j.neuroscience.2009.10.003; Isaev NK, 2007, BIOCHEMISTRY-MOSCOW+, V72, P471, DOI 10.1134/S0006297907050021; Kennedy AD, 2016, GENET TEST MOL BIOMA, V20, P485, DOI 10.1089/gtmb.2015.0291; Klepper J, 2004, PROSTAG LEUKOTR ESS, V70, P321, DOI 10.1016/j.plefa.2003.07.004; Larsen J, 2015, EPILEPSIA, V56, pE203, DOI 10.1111/epi.13222; Leen WG, 2013, JAMA NEUROL, V70, P1440, DOI 10.1001/jamaneurol.2013.3090; Leen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042745; Makowski L, 2009, FASEB J, V23, P586, DOI 10.1096/fj.08-119420; Marin-Valencia I, 2012, NEUROBIOL DIS, V48, P92, DOI 10.1016/j.nbd.2012.04.011; Mescka CP, 2015, METAB BRAIN DIS, V30, P1167, DOI 10.1007/s11011-015-9686-9; Miller M, 2015, J INHERIT METAB DIS, P1; Miller MJ, 2016, J INHERIT METAB DIS, V39, P757, DOI 10.1007/s10545-016-9944-y; Mochel F, 2015, TRIHEPTANOIN DRAMATI, pS479; Mugabo Y, 2016, P NATL ACAD SCI USA, V113, pE430, DOI 10.1073/pnas.1514375113; Neal EG, 2012, EPILEPSY RES, V100, P267, DOI 10.1016/j.eplepsyres.2012.04.021; Nguyen NHT, 2003, J NEUROCHEM, V85, P831, DOI 10.1046/j.1471-4159.2003.01762.x; Roe CR, 2006, J INHERIT METAB DIS, V29, P332, DOI 10.1007/s10545-006-0290-3; Ruskin DN, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00033; Sato T, 2016, METABOLISM, V65, P1646, DOI 10.1016/j.metabol.2016.08.005; Soeters MR, 2012, METABOLISM, V61, P966, DOI 10.1016/j.metabol.2011.11.009; Striano P, 2012, NEUROLOGY, V78, P557, DOI 10.1212/WNL.0b013e318247ff54; Szczepanik E, 2014, DEV PERIOD MED, V19, P454; Veggiotti P, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0291-8; Verbeek MM, 2016, J CEREBR BLOOD F MET, V36, P899, DOI 10.1177/0271678X16637612; Yamada KA, 2005, NEUROSCI LETT, V385, P210, DOI 10.1016/j.neulet.2005.05.038; Yazdani A, 2016, OMICS, V20, P480, DOI 10.1089/omi.2016.0071; Yubero D, 2014, BMC PEDIATR, V14, DOI 10.1186/s12887-014-0284-5	40	18	18	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184022	10.1371/journal.pone.0184022	http://dx.doi.org/10.1371/journal.pone.0184022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961260	Green Published, Green Submitted, gold			2022-12-27	WOS:000412027700003
J	Bechshoft, CL; Schjerling, P; Borno, A; Holm, L				Bechshoft, Cecilie Leidesdorff; Schjerling, Peter; Borno, Andreas; Holm, Lars			Existence of life-time stable proteins in mature rats-Dating of proteins' age by repeated short-term exposure to labeled amino acids throughout age	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; IN-VIVO; COLLAGEN-SYNTHESIS; CONNECTIVE-TISSUE; QUADRICEPS MUSCLE; TENDON; TURNOVER; EXERCISE; MICRODIALYSIS; MYOFIBRILLAR	In vivo turnover rates of proteins covering the processes of protein synthesis and breakdown rates have been measured in many tissues and protein pools using various techniques. Connective tissue and collagen protein turnover is of specific interest since existing results are rather diverging. The aim of this study is to investigate whether we can verify the presence of protein pools within the same tissue with very distinct turnover rates over the life-span of rats with special focus on connective tissue. Male and female Lewis rats (n = 35) were injected with five different isotopically labeled amino acids tracers. The tracers were injected during fetal development (Day - 10 to -2), after birth (Day 5-9), at weaning (Day 25- 32) at puberty (Day 54-58) and at adulthood (Day 447-445). Subgroups of rats were euthanized three days after every injection period, at different time point between injection periods and lastly at day 472. Tissue (liver, muscle, eye lens and patellar tendon) and blood samples were collected after euthanization. The enrichment of the labeled amino acids in the tissue or blood samples was measured using GC-MS-MS. In muscle and liver we demonstrated a rapid decrease of tracer enrichments throughout the rat's life, indicating that myofibrillar and cytoskeleton proteins have a high turnover. In contrast, the connective tissue protein in the eye lens and patellar tendon of the mature rat showed detainment of tracer enrichment injected during fetal development and first living days, indicating very slow turnover. The data support the hypothesis that some proteins synthesized during the early development and growth still exist much later in life of animals and hence has a very slow turnover rate.	[Bechshoft, Cecilie Leidesdorff; Schjerling, Peter; Holm, Lars] Univ Copenhagen, Inst Sports Med, Dept Orthoped Surg M, Bispebjerg Hosp, Copenhagen, Denmark; [Bechshoft, Cecilie Leidesdorff; Schjerling, Peter; Holm, Lars] Univ Copenhagen, Ctr Hlth Aging, Fac Hlth & Med Sci, Copenhagen, Denmark; [Borno, Andreas; Holm, Lars] Rigshosp, Dept Clin Biochem, Clin Metabol Core Facil, Copenhagen, Denmark; [Holm, Lars] Univ Copenhagen, Inst Biomed Sci, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Bechshoft, CL (corresponding author), Univ Copenhagen, Inst Sports Med, Dept Orthoped Surg M, Bispebjerg Hosp, Copenhagen, Denmark.; Bechshoft, CL (corresponding author), Univ Copenhagen, Ctr Hlth Aging, Fac Hlth & Med Sci, Copenhagen, Denmark.	cjleidersdorff@gmail.com	Schjerling, Peter/F-6194-2011; Holm, Lars/AAI-1320-2020	Schjerling, Peter/0000-0001-7138-3211; 	Danish Research Council for Independent Research, Health and Disease [09-073587]; Lundbeck Foundation [R198-2015-207] Funding Source: researchfish; Novo Nordisk Fonden [NNF16OC0022846, NNF14OC0012491] Funding Source: researchfish	Danish Research Council for Independent Research, Health and Disease; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	Danish Research Council for Independent Research, Health and Disease, grant number: 09-073587 to Mr Lars Holm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Britt Tranberg and Ann-Marie Sedstrom for their technical assistance in the laboratory. We would also like to thank the animal facility (The Campus Stable, University of Copenhagen) for taking good care of the animals, answering theoretical questions and assisting with technical challenges. This work was supported by the Danish Research Council for Independent Research, Health and Disease 09-073587.	Alkass K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069597; Babraj J, 2002, BIOCHEM SOC T, V30, P61, DOI 10.1042/bst0300061; Bohe J, 2001, J PHYSIOL-LONDON, V532, P575, DOI 10.1111/j.1469-7793.2001.0575f.x; de Boer MD, 2007, J PHYSIOL-LONDON, V585, P241, DOI 10.1113/jphysiol.2007.142828; Decaris ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123311; Decaris ML, 2014, MOL CELL PROTEOMICS, V13, P1741, DOI 10.1074/mcp.M113.037267; Dideriksen KJ, 2011, SCAND J MED SCI SPOR, V21, pE372, DOI 10.1111/j.1600-0838.2011.01318.x; GARLICK PJ, 1973, BIOCHEM J, V136, P935, DOI 10.1042/bj1360935; Hanada M, 2014, CONNECT TISSUE RES, V55, P378, DOI 10.3109/03008207.2014.957283; Hansen M, 2009, J APPL PHYSIOL, V106, P1435, DOI 10.1152/japplphysiol.90933.2008; Hansen M, 2009, J APPL PHYSIOL, V106, P1385, DOI 10.1152/japplphysiol.90935.2008; Hart W, 1976, CLIN NEPHROLPGY, V6; Heinemeier KM, 2013, FASEB J, V27, P2074, DOI 10.1096/fj.12-225599; HELFMAN PM, 1976, NATURE, V262, P279, DOI 10.1038/262279b0; Holm L, 2017, MUSCLE NERVE, V55, P128, DOI 10.1002/mus.25398; Holm L, 2013, AM J PHYSIOL-ENDOC M, V304, pE895, DOI 10.1152/ajpendo.00579.2012; Holm L, 2010, AM J PHYSIOL-ENDOC M, V298, pE257, DOI 10.1152/ajpendo.00609.2009; Langberg H, 1999, J PHYSIOL-LONDON, V521, P299, DOI 10.1111/j.1469-7793.1999.00299.x; LEWIS SEM, 1984, BIOCHEM J, V217, P517, DOI 10.1042/bj2170517; LIBBY WF, 1964, SCIENCE, V146, P1171; Lynnerup N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001529; Miller BF, 2011, SCAND J MED SCI SPOR, V21, pE1, DOI 10.1111/j.1600-0838.2010.01105.x; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; MOLNAR JA, 1986, BIOCHEM J, V240, P431, DOI 10.1042/bj2400431; Moore DR, 2005, AM J PHYSIOL-ENDOC M, V288, pE1153, DOI 10.1152/ajpendo.00387.2004; MOSONI L, 1993, MECH AGEING DEV, V68, P209, DOI 10.1016/0047-6374(93)90152-H; NEUBERGER A, 1951, BIOCHEM J, V49, P199, DOI 10.1042/bj0490199; Nielsen RH, 1985, J APPL PHYSIOL, V116, P42, DOI DOI 10.1152/JAPPLPHYSI0L.01084.2013; Shinmei M, 1993, Osteoarthritis Cartilage, V1, P121, DOI 10.1016/S1063-4584(05)80027-5; Thorpe CT, 2010, J BIOL CHEM, V285, P15674, DOI 10.1074/jbc.M109.077503; Toffolo G, 2003, AM J PHYSIOL-ENDOC M, V285, pE1142, DOI 10.1152/ajpendo.00106.2003; Weiss PH, 1969, J CLIN INVEST, P48	32	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185605	10.1371/journal.pone.0185605	http://dx.doi.org/10.1371/journal.pone.0185605			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957442	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200092
J	Murakami, M; Tsubokura, M; Ono, K; Nomura, S; Oikawa, T				Murakami, Michio; Tsubokura, Masaharu; Ono, Kyoko; Nomura, Shuhei; Oikawa, Tomoyoshi			Additional risk of diabetes exceeds the increased risk of cancer caused by radiation exposure after the Fukushima disaster	PLOS ONE			English	Article							COST-EFFECTIVENESS; PERCEPTION; JAPAN; ACCIDENT; ANXIETY	The 2011 Fukushima disaster led to increases in multiple risks (e.g., lifestyle diseases and radiation exposure) and fear among the public. Here, we assessed the additional risks of cancer caused by radiation and diabetes related to the disaster and the cost-effectiveness of countermeasures against these conditions. Our study included residents of the cities of Minamisoma and Soma (10-40 km and 35-50 km north of the Fukushima Daiichi (N degrees 1) Nuclear Power Station, respectively). We used the loss of life expectancy (LLE) as an indicator to compare risks between radiation exposure and diabetes. We also estimated the cost-effectiveness of radiation-related countermeasures, including restricted food distribution, decontamination, and whole-body counter tests and interventions. Metformin therapy was selected as a representative management for diabetes. The diabetes-related LLEs among residents were 4.1 (95% confidence interval: 1.4-6.8) x 10(-2) years for the whole population and 8.0 (2.7-13.2) x 10(-2) years for 40s to 70s in a scenario that considered the additional incidence of diabetes during the first 10 years. The cancer-related LLEs caused by lifetime exposure to radiation were 0.69 (2.5-97.5 percentile: 0.61-0.79) x 10(-2) years for the whole population and 0.24 (0.20-0.29) x 10(-2) years for 40s to 70s. The diabetes-related LLEs among residents in the above-mentioned scenario were 5.9-fold and 33-fold higher than those attributed to average radiation among the whole population and among the 40s to 70s age groups, respectively. The costs per life-years saved of the radiation countermeasures (i.e., restricted food distribution, decontamination, and whole-body counter tests and interventions) were >1 to >4 orders of magnitude higher than those of general heath checkups and conventional management for diabetes. Our findings indicate that countermeasures to mitigate diabetes are warranted. Policy-makers' and individuals' understanding of multiple risks after any disaster will be essential to saving the lives of victims.	[Murakami, Michio] Fukushima Med Univ, Sch Med, Dept Hlth Risk Commun, 1 Hikarigaoka, Fukushima, Fukushima, Japan; [Murakami, Michio] Fukushima Med Univ, Radiat Med Sci Ctr, Fukushima Hlth Management Survey, 1 Hikarigaoka, Fukushima, Fukushima, Japan; [Tsubokura, Masaharu; Oikawa, Tomoyoshi] Minamisoma Municipal Gen Hosp, Dept Radiat Protect, 2-54-6 Takami,Haramachi, Minamisoma, Fukushima, Japan; [Tsubokura, Masaharu] Soma Cent Hosp, Dept Radiat Protect, 3-5-18 Okinouchi, Soma, Fukushima, Japan; [Ono, Kyoko] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, 16-1,Onogawa, Tsukuba, Ibaraki, Japan; [Nomura, Shuhei] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, Norfolk Pl, London, England; [Nomura, Shuhei] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, 7-3-1,Hongo, Tokyo, Japan	Fukushima Medical University; Fukushima Medical University; National Institute of Advanced Industrial Science & Technology (AIST); Imperial College London; University of Tokyo	Murakami, M (corresponding author), Fukushima Med Univ, Sch Med, Dept Hlth Risk Commun, 1 Hikarigaoka, Fukushima, Fukushima, Japan.; Murakami, M (corresponding author), Fukushima Med Univ, Radiat Med Sci Ctr, Fukushima Hlth Management Survey, 1 Hikarigaoka, Fukushima, Fukushima, Japan.	michio@fmu.ac.jp	Nomura, Shuhei/HCH-5356-2022; Ono, Kyoko/J-4346-2018; Tsubokura, Masaharu/AAV-4364-2021	Ono, Kyoko/0000-0001-8100-3905; Tsubokura, Masaharu/0000-0001-8027-202X; Nomura, Shuhei/0000-0002-2963-7297	JSPS KAKENHI grant [JP16H05894]	JSPS KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI grant number JP16H05894. https:// www.jsps.go.jp/english/index.html. MM receives the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; Ebner DK, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011641; FISCHHOFF B, 1978, J EXP PSYCHOL HUMAN, V4, P330, DOI 10.1037/0096-1523.4.2.330; FISCHHOFF B, 1995, RISK ANAL, V15, P137, DOI 10.1111/j.1539-6924.1995.tb00308.x; Gigerenzer G, 2006, RISK ANAL, V26, P347, DOI 10.1111/j.1539-6924.2006.00753.x; Graham J. D., 1997, RISK VS RISK TRADEOF; Hacking I, 2006, EMERGENCE PROBABILIT; Hino Y, 2016, TOHOKU J EXP MED, V239, P333, DOI 10.1620/tjem.239.333; ICRP, 1959, ICRP PUBL; Kahneman D., 2011, THINKING FAST SLOW; Kato M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007736; Kishimoto A, 2003, CHEMOSPHERE, V53, P291, DOI 10.1016/S0045-6535(03)00054-7; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Ministry of Education Culture Sports Science and Technology, 2011, RES RAD 134CS 137CS; Ministry of Health Labour and Welfare, 2012, THE 21 LIF TABL; Ministry of Health Labour and Welfare, 2015, BRIEF SUMM NAT HLTH; Miyazaki M, 2016, SCIENCE, V352, P666, DOI 10.1126/science.352.6286.666-b; Murakami M, 2017, ASIA-PAC J PUBLIC HE, V29, p74S, DOI 10.1177/1010539516681841; Murakami M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165594; Murakami M, 2016, RADIAT PROT DOSIM, V171, P156, DOI 10.1093/rpd/ncw211; Murakami M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137906; Murakami M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0112791, 10.1]; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nakayachi K, 2015, J RISK RES, V18, P156, DOI 10.1080/13669877.2013.875936; Nomura S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010080; Nomura S, 2015, ENVIRON SCI TECHNOL, V49, P1009, DOI 10.1021/es503504y; Nomura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060192; Normile D, 2016, SCIENCE, V351, P1022, DOI 10.1126/science.351.6277.1022; Oe M, 2016, PSYCHIAT CLIN NEUROS, V70, P245, DOI 10.1111/pcn.12387; Ohira T, 2017, ASIA-PAC J PUBLIC HE, V29, p47S, DOI 10.1177/1010539517695436; Radiation Medical Science Center for the Fukushima Health Management Survey Fukushima Medical University, 2015, 21 PREF OV COMM M FU; Satoh H, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/627390; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Sugimoto A, 2014, ENVIRON HEALTH PERSP, V122, P587, DOI 10.1289/ehp.1306848; Tsubokura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129114; Tsubokura M, 2012, JAMA-J AM MED ASSOC, V308, P669, DOI 10.1001/jama.2012.9839; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; United Nations Scientific Committee on the Effects of Atomic Radiation, 2014, UNSCEAR 2013 GEN ASS; Wake N, 2000, DIABETES RES CLIN PR, V48, P201, DOI 10.1016/S0168-8227(00)00122-4; World Health Organization, 2012, PREL DOS EST NUCL AC; Yasutaka T, 2016, J ENVIRON RADIOACTIV, V151, P512, DOI 10.1016/j.jenvrad.2015.05.012	41	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185259	10.1371/journal.pone.0185259	http://dx.doi.org/10.1371/journal.pone.0185259			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957385	gold, Green Submitted, Green Published			2022-12-27	WOS:000411985200039
J	Vargas, VE; Gurung, S; Grant, B; Hyatt, K; Singleton, K; Myers, SM; Saunders, D; Njoku, C; Towner, R; Myers, DA				Vargas, Vladimir E.; Gurung, Sunam; Grant, Benjamin; Hyatt, Kimberly; Singleton, Krista; Myers, Sarah M.; Saunders, Debra; Njoku, Charity; Towner, Rheal; Myers, Dean A.			Gestational hypoxia disrupts the neonatal leptin surge and programs hyperphagia and obesity in male offspring in the Sprague-Dawley rat	PLOS ONE			English	Article							DEVELOPMENTAL ORIGINS; NUTRIENT RESTRICTION; PROTEIN RESTRICTION; METABOLIC SYNDROME; MATERNAL HYPOXIA; PLASMA LEPTIN; DIET; EXPRESSION; RESISTANCE; UNDERNUTRITION	The effect of gestational hypoxia on the neonatal leptin surge, development of hypothalamic arcuate nuclei (ARH) projections and appetite that could contribute to the programming of offspring obesity is lacking. We examined the effect of 12% O-2 from gestational days 15-19 in the Sprague-Dawley rat on post-weaning appetite, fat deposition by MRI, adipose tissue cytokine expression, the neonatal leptin surge, ARH response to exogenous leptin, and alpha MSH projections to the paraventricular nucleus (PVN) in response to a high fat (HFD) or control diet (CD) in male offspring. Normoxia (NMX) and Hypoxia (HPX) offspring exhibited increased food intake when fed a HFD from 5-8 weeks post-birth; HPX offspring on the CD had increased food intake from weeks 5-7 vs. NMX offspring on a CD. HPX offspring on a HFD remained hyperphagic through 23 weeks. Body weight were the same between offspring from HPX vs. NMX dams from 4-12 weeks of age fed a CD or HFD. By 14-23 weeks of age, HPX offspring fed the CD or HFD as well as male NMX offspring fed the HFD were heavier vs. NMX offspring fed the CD. HPX offspring fed a CD exhibited increased abdominal adiposity (MRI) that was amplified by a HFD. HPX offspring fed a HFD exhibited the highest abdominal fat cytokine expression. HPX male offspring had higher plasma leptin from postnatal day (PN) 6 through 14 vs. NMX pups. HPX offspring exhibited increased basal c-Fos labeled cells in the ARH vs. NMX pups on PN16. Leptin increased c-Fos staining in the ARH in NMX but not HPX offspring at PN16. HPX offspring had fewer aMSH fibers in the PVN vs. NMX offspring on PN16. In conclusion, gestational hypoxia impacts the developing ARH resulting in hyperphagia contributing to adult obesity on a control diet and exacerbated by a HFD.	[Vargas, Vladimir E.; Grant, Benjamin; Hyatt, Kimberly; Singleton, Krista; Myers, Sarah M.; Myers, Dean A.] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet, Oklahoma City, OK 73019 USA; [Vargas, Vladimir E.; Grant, Benjamin; Hyatt, Kimberly; Singleton, Krista; Myers, Sarah M.; Myers, Dean A.] Univ Oklahoma, Hlth Sci Ctr, Dept Gynecol, Oklahoma City, OK 73019 USA; [Gurung, Sunam] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA; [Saunders, Debra; Njoku, Charity; Towner, Rheal] Oklahoma Med Res Fdn, Adv Magnet Resonance Ctr, 825 NE 13th St, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	Myers, DA (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Obstet, Oklahoma City, OK 73019 USA.; Myers, DA (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Gynecol, Oklahoma City, OK 73019 USA.	Dean-myers@ouhsc.edu		Towner, Rheal/0000-0001-7368-8983	National Institutes of Health [R01-HD050620]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the National Institutes of Health grant number R01-HD050620 to DAM.	Adachi K, 2004, AM J PHYSIOL-REG I, V287, pR209, DOI 10.1152/ajpregu.00701.2003; Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Attig L, 2008, INT J OBESITY, V32, P1153, DOI 10.1038/ijo.2008.39; Barker DJP, 2005, HORM RES, V64, P2, DOI 10.1159/000089311; Benoit C, 2013, J ENDOCRINOL, V218, P35, DOI 10.1530/JOE-12-0561; Bouret SG, 2008, CELL METAB, V7, P179, DOI 10.1016/j.cmet.2007.12.001; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Brawley L, 2003, PEDIATR RES, V54, P83, DOI 10.1203/01.PDR.0000065731.00639.02; Camm EJ, 2011, FASEB J, V25, P420, DOI 10.1096/fj.10-158188; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Desai M, 2007, AM J OBSTET GYNECOL, V196, P555, DOI 10.1016/j.ajog.2006.11.036; Devaskar SU, 1997, BIOCHEM BIOPH RES CO, V238, P44, DOI 10.1006/bbrc.1997.7237; Dolinsky VW, 2011, DIABETES, V60, P2274, DOI 10.2337/db11-0374; Ducsay CA, 2006, AM J PHYSIOL-REG I, V291, pR1406, DOI 10.1152/ajpregu.00077.2006; Ducsay CA, 2013, AM J PHYSIOL-REG I, V304, pR435, DOI 10.1152/ajpregu.00377.2012; Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004; Garteiser P, 2013, METABOLISM, V62, P1686, DOI 10.1016/j.metabol.2013.06.009; Giussani DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031017; Granado M, 2011, ENDOCRINOLOGY, V152, P4116, DOI 10.1210/en.2011-1233; JONES AP, 1984, J NUTR, V114, P1484; Julian CG, 2011, CLIN CHEST MED, V32, P21, DOI 10.1016/j.ccm.2010.10.008; Lai ZB, 2011, HYPERTENSION, V57, P505, DOI 10.1161/HYPERTENSIONAHA.110.163329; Levin BE, 2004, AM J PHYSIOL-REG I, V286, pR143, DOI 10.1152/ajpregu.00393.2003; Li GH, 2003, J SOC GYNECOL INVEST, V10, P265, DOI 10.1016/S1071-5576(03)00074-1; Li HP, 2013, INT J CLIN EXP PATHO, V6, P650; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; MOORE LG, 1986, J APPL PHYSIOL, V60, P1401, DOI 10.1152/jappl.1986.60.4.1401; Myers DA, 2005, AM J PHYSIOL-REG I, V289, pR1707, DOI 10.1152/ajpregu.00343.2005; Myers DA, 2005, AM J PHYSIOL-REG I, V288, pR1178, DOI 10.1152/ajpregu.00697.2004; Myers DA, 2008, AM J PHYSIOL-REG I, V294, pR1312, DOI 10.1152/ajpregu.00004.2008; Myers DA, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/681306; Nathanielsz PW, 2006, ILAR J, V47, P73, DOI 10.1093/ilar.47.1.73; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V271, pE1128, DOI 10.1152/ajpendo.1996.271.6.E1128; Poston L, 2012, BEST PRACT RES CL EN, V26, P627, DOI 10.1016/j.beem.2012.03.010; Rueda-Clausen CF, 2011, DIABETES, V60, P507, DOI 10.2337/db10-1239; Scarpace PJ, 2009, AM J PHYSIOL-REG I, V296, pR493, DOI 10.1152/ajpregu.90669.2008; Shepard JD, 2008, BEHAV BRAIN RES, V186, P239, DOI 10.1016/j.bbr.2007.08.013; Toste FP, 2006, BRIT J NUTR, V95, P830, DOI 10.1079/BJN20061726; VARVARIGOU A, 1994, J PEDIATR-US, V124, P480, DOI 10.1016/S0022-3476(94)70380-9; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Williams SJ, 2005, J PHYSIOL-LONDON, V565, P125, DOI 10.1113/jphysiol.2005.084889; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	44	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185272	10.1371/journal.pone.0185272	http://dx.doi.org/10.1371/journal.pone.0185272			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957383	Green Submitted, Green Published, gold			2022-12-27	WOS:000411985200040
J	Haga, IA; de Andrade, FS; Bruschi, DP; Recco-Pimentel, SM; Giaretta, AA				Haga, Isabelle Aquemi; de Andrade, Felipe Silva; Bruschi, Daniel Pacheco; Recco-Pimentel, Shirlei Maria; Giaretta, Ariovaldo Antonio			Unrevealing the leaf frogs Cerrado diversity: A new species of Pithecopus (Anura, Arboranae, Phyllomedusidae) from the Mato Grosso state, Brazil	PLOS ONE			English	Article							HYPOCHONDRIALIS GROUP; R-PACKAGE; RECOMMENDATIONS; ALIGNMENT; PATTERNS; REGION	The Neotropical frog genus Pithecopus comprises currently 10 species. A recent molecular phylogeny suggested the existence of two subclades within it, one of them including P. palliatus, P. azureus, P. hypochondrialis, and P. nordestinus (lowland species). Herein we describe a new species of this subclade from Pontal do Araguaia, in the Brazilian Cerrado in the Mato Grosso state. Recognition of the new species is supported by adult morphology, advertisement call and molecular data. The new species differs from Pithecopus highland species by its smaller head width and lack of the reticulate pattern on flanks. From lowland species, the new form differs by being significantly smaller in snout vent-length, advertisement call with the greatest number of pulses, and high genetic distance. Interestingly, we also report on occurrence of P. hypochondrialis (its sister species) at an adjacent site (about 3km). Also, we report on the occurrence of the new species in the Chapada dos Guimaraes and Santa Terezinha, both also in the Mato Grosso state.	[Haga, Isabelle Aquemi; de Andrade, Felipe Silva; Giaretta, Ariovaldo Antonio] UFU, LTSAN, Fac Ciencias Integradas Pontal FACIP, Ituiutaba, MG, Brazil; [Haga, Isabelle Aquemi; de Andrade, Felipe Silva] Univ Estadual Campinas UNICAMP, Inst Biol, Programa Posgrad Biol Anim, Campinas, SP, Brazil; [de Andrade, Felipe Silva] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Anim, Lab Hist Nat Anfibios Brasileiros LaHNAB, Campinas, SP, Brazil; [Bruschi, Daniel Pacheco; Recco-Pimentel, Shirlei Maria] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Estrutural & Func, Campinas, SP, Brazil; [Bruschi, Daniel Pacheco] Univ Fed Parana UFPR, Dept Genet, Setor Ciencias Biol, Curitiba, Parana, Brazil	Universidade Federal de Uberlandia; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal do Parana	Haga, IA (corresponding author), UFU, LTSAN, Fac Ciencias Integradas Pontal FACIP, Ituiutaba, MG, Brazil.; Haga, IA (corresponding author), Univ Estadual Campinas UNICAMP, Inst Biol, Programa Posgrad Biol Anim, Campinas, SP, Brazil.	hagaisabelle@gmail.com	de Andrade, Felipe Silva/M-3125-2013; de Andrade, Felipe Silva/M-6253-2019	de Andrade, Felipe Silva/0000-0003-0514-142X; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Sao Paulo Research Foundation (FAPESP) [2015/10728-7, 2010/17464-1, 2012/12169-7, 2006/60055-0, 2008/50325-5, 2011/51694-7, 2014/23388-7]; Conselho Nacional de Desenvolvimento Cientffico e Tecnologico (CNPq) [446935/2014-0, 152548/2011-4]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ- 01724-14]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq);  [305261/2010-0]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientffico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) provided scholarships to IAN and FSA. Sao Paulo Research Foundation (FAPESP) provides a PhD scholarship [Process #2015/10728-7] to FSA. Conselho Nacional de Desenvolvimento Cientffico e Tecnologico (CNPq) gave a research grant [Processes #446935/2014-0, and #152548/2011-4] and a fellowship [Process #305261/2010-0] to AAG. The Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) provided grants [Process #APQ- 01724-14] to MG. Sao Paulo Research Foundation (FAPESP) [Process #2010/17464-1, and #2012/12169-7], Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the grants to DPB. Sao Paulo Research Foundation (FAPESP) provided grants [Processes #2006/60055-0, #2008/50325-5, #2011/51694-7, and #2014/23388-7] to SMRP.	[Anonymous], 2014, TRACER V1 6; [Anonymous], 1999, BONNER ZOOLOGISCHE B; Antoniazzi MM, 2013, J ZOOL, V291, P42, DOI 10.1111/jzo.12044; Berneck BVM, 2017, ZOOKEYS, P115, DOI 10.3897/zookeys.642.10401; Bioacoustics Research Program, 2014, RAV PRO INT SOUND AN; BOKERMANN W. C. A., 1965, REV BRASIL BIOL, V25, P257; Brandao RA, 2002, J HERPETOL, V36, P571, DOI 10.2307/1565926; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bruschi DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105608; Bruschi DP, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-70; Bruschi DP, 2012, HEREDITAS, V149, P34, DOI 10.1111/j.1601-5223.2010.02236.x; Caramaschi Ulisses, 2006, Arquivos do Museu Nacional Rio de Janeiro, V64, P159; Clemente-Carvalho RBG, 2012, HERPETOLOGICA, V68, P365, DOI 10.1655/HERPETOLOGICA-D-11-00085.1; de Andrade FS, 2016, SALAMANDRA, V52, P107; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; deCope P.azurea, 2006, ARQ MUS NAC, V64, P159; DUELLMAN W E, 1974, Herpetologica, V30, P105; Duellman WE, 2016, ZOOTAXA, V4104, P1, DOI 10.11646/zootaxa.4104.1.1; Diniz JAF, 2008, ZOOL STUD, V47, P146; Faivovich J, 2010, CLADISTICS, V26, P227, DOI 10.1111/j.1096-0031.2009.00287.x; Frost D.R., 2017, AMPHIBIAN SPECIES WO; GATESY J, 1993, MOL PHYLOGENET EVOL, V2, P152, DOI 10.1006/mpev.1993.1015; Goebel AM, 1999, MOL PHYLOGENET EVOL, V11, P163, DOI 10.1006/mpev.1998.0538; Goloboff P.A., 2003, TREE ANAL USING NEW; Haga IA, 2017, PHYLLOMEDUSA, V16, P47, DOI 10.11606/issn.2316-9079.v16i1p47-56; Heyer WR, 1990, ARQ ZOOL, V31, P235; Hothorn T, 2008, J STAT SOFTW, V28, P1; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kohler J, 2017, ZOOTAXA, V4251, P1, DOI 10.11646/zootaxa.4251.1.1; Korkmaz S, 2014, R J, V6, P151, DOI 10.32614/rj-2014-031; LUTZ B, 1966, COPEIA, P236; Maja P, 2004, METODOLOSKI ZVEZKI, V1, P143; MONMONIER MS, 1973, GEOGR ANAL, V5, P245; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; R Core Team, 2021, R LANGUAGE ENV STAT; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Silva JF, 2006, J BIOGEOGR, V33, P536, DOI 10.1111/j.1365-2699.2005.01422.x; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdujo PH, 2013, ECOGRAPHY, V36, P708, DOI 10.1111/j.1600-0587.2012.07374.x; Valdujo Paula Hanna, 2012, South American Journal of Herpetology, V7, P63; Watters JL, 2016, ZOOTAXA, V4072, P477, DOI 10.11646/zootaxa.4072.4.6	46	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184631	10.1371/journal.pone.0184631	http://dx.doi.org/10.1371/journal.pone.0184631			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953911	Green Published, gold, Green Submitted			2022-12-27	WOS:000411980300016
J	Qin, J; Zhang, JN; Wang, FM; Wang, JH; Zheng, Z; Yin, CC; Chen, H; Shi, AN; Zhang, B; Chen, PY; Zhang, MC				Qin, Jun; Zhang, Jianan; Wang, Fengmin; Wang, Jinghua; Zheng, Zhi; Yin, Changcheng; Chen, Hao; Shi, Ainong; Zhang, Bo; Chen, Pengyin; Zhang, Mengchen			iTRAQ protein profile analysis of developmental dynamics in soybean [Glycine max (L.) Merr.] leaves	PLOS ONE			English	Article							KYOTO ENCYCLOPEDIA; REVEALS; IDENTIFICATION; TECHNOLOGIES; DATABASE; STRESS; GENES; KEGG	Zao5241 is an elite soybean [Glycine max (L.) Merr.] line and backbone parent. In this study, we employed iTRAQ to analyze the proteomes and protein expression profiles of Zao5241 during leaf development. We identified 1,245 proteins in all experiments, of which only 45 had been previously annotated. Among overlapping proteins between three biological replicates, 598 proteins with 2 unique peptides identified were reliably quantified. The protein datasets were classified into 36 GO functional terms, and the photosynthesis term was most significantly enriched. A total of 113 proteins were defined as being differentially expressed during leaf development; 41 proteins were found to be differently expressed between two and four week old leaves, and 84 proteins were found to be differently expressed between two and six week old leaves, respectively. Cluster analysis of the data revealed dynamic proteomes. Proteins annotated as electron carrier activity were greatly enriched in the peak expression profiles, and photosynthesis proteins were negatively modulated along the whole time course. This dataset will serve as the foundation for a systems biology approach to understanding photosynthetic development.	[Qin, Jun; Wang, Fengmin; Wang, Jinghua; Zhang, Mengchen] Hebei Acad Agr & Forestry Sci, North China Key Lab Biol & Genet Improvement Soyb, Natl Soybean Improvement Ctr,Minist Agr, Cereal & Oil Crop Inst,Shijiazhuang Sub Ctr, Shijiazhuang, Hebei, Peoples R China; [Qin, Jun; Shi, Ainong; Chen, Pengyin] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA; [Zhang, Jianan; Zheng, Zhi] Hebei Acad Agr & Forestry Sci, Minor Cereal Crops Lab Hebei Prov, Inst Millet Crops, Natl Foxtail Millet Improvement Ctr, Shijiazhuang, Hebei, Peoples R China; [Yin, Changcheng; Chen, Hao] Beijing Prot Innovat, B-8 Beijing Airport Ind Zone, Beijing, Peoples R China; [Zhang, Bo] Virginia Tech, Dept Crop Soil & Environm Sci, Blacksburg, VA USA	Hebei Academy of Agricultural & Forestry Sciences; Ministry of Agriculture & Rural Affairs; University of Arkansas System; University of Arkansas Fayetteville; Hebei Academy of Agricultural & Forestry Sciences; Virginia Polytechnic Institute & State University	Zhang, MC (corresponding author), Hebei Acad Agr & Forestry Sci, North China Key Lab Biol & Genet Improvement Soyb, Natl Soybean Improvement Ctr,Minist Agr, Cereal & Oil Crop Inst,Shijiazhuang Sub Ctr, Shijiazhuang, Hebei, Peoples R China.	mengchenzhang@hotmail.com	Zheng, Zhi/C-4110-2017; Shi, Ainong/L-6384-2017	Zheng, Zhi/0000-0002-1493-1995; Shi, Ainong/0000-0002-1066-7920	Natural Science Fund for Distinguished Young Scholars of Hebei Province [C2014301035]; National Natural Science Foundation of China [31100880]; Key Project of the Natural Science Foundation of Hebei Province [C2012301020]	Natural Science Fund for Distinguished Young Scholars of Hebei Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the Natural Science Foundation of Hebei Province	This study was supported by the Natural Science Fund for Distinguished Young Scholars of Hebei Province (C2014301035), National Natural Science Foundation of China (31100880), the Key Project of the Natural Science Foundation of Hebei Province (C2012301020).	Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Chen SX, 2006, PROTEOMICS, V6, P5504, DOI 10.1002/pmic.200600143; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049522; Fountoulakis M, 2004, MASS SPECTROM REV, V23, P231, DOI 10.1002/mas.10075; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Ji W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00573; Lan P, 2011, PLANT PHYSIOL, V155, P821, DOI 10.1104/pp.110.169508; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; [梁宇 Liang Yu], 2004, [植物生态学报, Acta Phytoecologica Sinica], V28, P114; Liu GT, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-110; Messina MJ, 1999, AM J CLIN NUTR, V70, p439S, DOI 10.1093/ajcn/70.3.439s; MEYER Y, 1988, ELECTROPHORESIS, V9, P704, DOI 10.1002/elps.1150091105; Natale DA, 2000, GENOME BIOL, V1; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Peng Z, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-760; Qin J, 2016, MOL GENET GENOMICS, V291, P1595, DOI 10.1007/s00438-016-1202-3; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Sinclair JB, 1982, COMPENDIUM SOYBEAN D; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tacken MGJ, 2000, J GEN VIROL, V81, P209, DOI 10.1099/0022-1317-81-1-209; Tausta SL, 2014, J EXP BOT, V65, P3543, DOI 10.1093/jxb/eru152; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Wang P, 2012, J FOOD AGRIC ENVIRON, V10, P550; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; Xie Xiu-Zhi, 2011, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V27, P616; Yeung KY, 2001, BIOINFORMATICS, V17, P309, DOI 10.1093/bioinformatics/17.4.309; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716	29	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0181910	10.1371/journal.pone.0181910	http://dx.doi.org/10.1371/journal.pone.0181910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953898	gold, Green Published, Green Submitted			2022-12-27	WOS:000411980300002
J	Shields, MC; Bowers, MR; Fulcer, MM; Bollig, MK; Rock, PJ; Sutton, BR; Vrailas-Mortimer, AD; Lochmuller, H; Whittaker, RG; Horvath, R; Reist, NE				Shields, Mallory C.; Bowers, Matthew R.; Fulcer, McKenzie M.; Bollig, Madelyn K.; Rock, Patrick J.; Sutton, Bryan R.; Vrailas-Mortimer, Alysia D.; Lochmuller, Hanns; Whittaker, Roger G.; Horvath, Rita; Reist, Noreen E.			Drosophila studies support a role for a presynaptic synaptotagmin mutation in a human congenital myasthenic syndrome	PLOS ONE			English	Article							SYNAPTIC-TRANSMISSION; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; NEUROMUSCULAR-JUNCTIONS; PHOSPHOLIPID-BINDING; MEMBRANE PENETRATION; CALCIUM-BINDING; NERVOUS-SYSTEM; C(2)A DOMAIN; C-2 DOMAIN	During chemical transmission, the function of synaptic proteins must be coordinated to efficiently release neurotransmitter. Synaptotagmin 2, the Ca2+ sensor for fast, synchronized neurotransmitter release at the human neuromuscular junction, has recently been implicated in a dominantly inherited congenital myasthenic syndrome associated with a non-progressive motor neuropathy. In one family, a proline residue within the C2B Ca2+-binding pocket of synaptotagmin is replaced by a leucine. The functional significance of this residue has not been investigated previously. Here we show that in silico modeling predicts disruption of the C2B Ca2+-binding pocket, and we examine the in vivo effects of the homologous mutation in Drosophila. When expressed in the absence of native synaptotagmin, this mutation is lethal, demonstrating for the first time that this residue plays a critical role in synaptotagmin function. To achieve expression similar to human patients, the mutation is expressed in flies carrying one copy of the wild type synaptotagmin gene. We now show that Drosophila carrying this mutation developed neurological and behavioral manifestations similar to those of human patients and provide insight into the mechanisms underlying these deficits. Our Drosophila studies support a role for this synaptotagmin point mutation in disease etiology.	[Shields, Mallory C.; Bowers, Matthew R.; Fulcer, McKenzie M.; Bollig, Madelyn K.; Reist, Noreen E.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Shields, Mallory C.; Bowers, Matthew R.; Reist, Noreen E.] Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA; [Rock, Patrick J.] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Lubbock, TX 79430 USA; [Sutton, Bryan R.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Ctr Membrane Prot Res, Lubbock, TX 79430 USA; [Vrailas-Mortimer, Alysia D.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Vrailas-Mortimer, Alysia D.] Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA; [Lochmuller, Hanns; Horvath, Rita] Newcastle Univ, Inst Med Genet, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Whittaker, Roger G.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Colorado State University; Colorado State University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of Denver; Illinois State University; Newcastle University - UK; Newcastle University - UK	Reist, NE (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.; Reist, NE (corresponding author), Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA.	reist@colostate.edu	Horvath, Rita/AAY-7042-2020	Horvath, Rita/0000-0002-9841-170X; Reist, Noreen/0000-0002-1647-3166; Shields, Mallory/0000-0002-3331-9910; Whittaker, Roger/0000-0002-3403-0182	Thornburg Graduate Research Excellence Award; National Science Foundation [1257363]; Colorado State University Libraries Open Access Research and Scholarship Fund; Medical Research Council UK [G1002274, ID 98482]; European Union Seventh Framework Programme [(FP7)] [305444, 305121]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR063634]; MRC [MR/N025431/1, G1000848] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063634] Funding Source: NIH RePORTER; Medical Research Council [MR/N025431/1, G1000848, MR/N027302/1] Funding Source: researchfish	Thornburg Graduate Research Excellence Award; National Science Foundation(National Science Foundation (NSF)); Colorado State University Libraries Open Access Research and Scholarship Fund; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union Seventh Framework Programme [(FP7)]; National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MCS is funded by the Thornburg Graduate Research Excellence Award (no available website). NER is funded by the National Science Foundation (1257363) (www.nsf.gov) and the Colorado State University Libraries Open Access Research and Scholarship Fund (libguides.colostate.edu/oars). HL is funded by the Medical Research Council UK (G1002274, ID 98482) (http://www.mrc.ac.uk/), by the European Union Seventh Framework Programme [(FP7/2007-2013) under grant agreement number 305444 (RD-Connect) and 305121 (Neuromics)]. RH is a Wellcome Trust Investigator (109915/Z/15/Z) (https://wellcome.ac.uk/funding/). BRS is funded by National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR063634). The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsen B, 2004, J CELL BIOL, V166, P249, DOI 10.1083/jcb.200312054; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Bai JH, 2002, P NATL ACAD SCI USA, V99, P1665, DOI 10.1073/pnas.032541099; Baker K, 2015, J CLIN INVEST, V125, P1670, DOI 10.1172/JCI79765; BELLEMARE F, 1983, J NEUROPHYSIOL, V50, P1380, DOI 10.1152/jn.1983.50.6.1380; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Cheng Y, 2004, PROTEIN SCI, V13, P2665, DOI 10.1110/ps.04832604; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DIANTONIO A, 1993, J NEUROSCI, V13, P4924; Dodge FA, COOPERATIVE ACTION C; Feng YF, 2004, J NEUROGENET, V18, P377, DOI 10.1080/01677060490894522; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; Herrmann DN, 2014, AM J HUM GENET, V95, P332, DOI 10.1016/j.ajhg.2014.08.007; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Jackman SL, 2017, NEURON, V94, P447, DOI 10.1016/j.neuron.2017.02.047; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Lloyd TE, 2000, NEURON, V26, P45, DOI 10.1016/S0896-6273(00)81136-8; Loewen CA, 2001, GENESIS, V31, P30, DOI 10.1002/gene.10002; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Mackler JM, 2001, J COMP NEUROL, V436, P4, DOI 10.1002/cne.1049; MARQUEZE B, 1995, J NEUROSCI, V15, P4906; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Nishiki T, 2004, J NEUROSCI, V24, P6127, DOI 10.1523/JNEUROSCI.1563-04.2004; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; Paddock BE, 2011, J NEUROSCI, V31, P2248, DOI 10.1523/JNEUROSCI.3153-09.2011; PERIN MS, 1991, J BIOL CHEM, V266, P615; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Regehr WG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005702; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Striegel AR, 2012, J NEUROSCI, V32, P1253, DOI 10.1523/JNEUROSCI.4652-11.2012; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; ULLRICH B, 1994, NEURON, V13, P1281, DOI 10.1016/0896-6273(94)90415-4; Vrailas-Mortimer AD, 2014, J BIOL RHYTHM, V29, P411, DOI 10.1177/0748730414555183; Whittaker RG, 2015, NEUROLOGY, V85, P1964, DOI 10.1212/WNL.0000000000002185; Yao J, 2012, NAT NEUROSCI, V15, P243, DOI 10.1038/nn.3013; YAO KM, 1994, J NEUROCHEM, V63, P41; Yoshihara M, 2010, P NATL ACAD SCI USA, V107, P14869, DOI 10.1073/pnas.1000606107	49	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184817	10.1371/journal.pone.0184817	http://dx.doi.org/10.1371/journal.pone.0184817			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953919	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300023
J	Yu, KZ; Quirk, JG; Djuric, PM				Yu, Kezi; Quirk, J. Gerald; Djuric, Petar M.			Dynamic classification of fetal heart rates by hierarchical Dirichlet process mixture models	PLOS ONE			English	Article								In this paper, we propose an application of non-parametric Bayesian (NPB) models for classification of fetal heart rate (FHR) recordings. More specifically, we propose models that are used to differentiate between FHR recordings that are from fetuses with or without adverse outcomes. In our work, we rely on models based on hierarchical Dirichlet processes (HDP) and the Chinese restaurant process with finite capacity (CRFC). Two mixture models were inferred from real recordings, one that represents healthy and another, non-healthy fetuses. The models were then used to classify new recordings and provide the probability of the fetus being healthy. First, we compared the classification performance of the HDP models with that of support vector machines on real data and concluded that the HDP models achieved better performance. Then we demonstrated the use of mixture models based on CRFC for dynamic classification of the performance of (FHR) recordings in a real-time setting.	[Yu, Kezi; Djuric, Petar M.] SUNY Stony Brook, Dept Elect & Comp Engn, Stony Brook, NY 11794 USA; [Quirk, J. Gerald] SUNY Stony Brook, Dept Obstet Gynecol & Reprod Med, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Djuric, PM (corresponding author), SUNY Stony Brook, Dept Elect & Comp Engn, Stony Brook, NY 11794 USA.	petar.djuric@stonybrook.edu		Djuric, Petar M./0000-0001-7791-3199	National Institutes of Health (US) [1R21HD080025-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD080025] Funding Source: NIH RePORTER	National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health (US) 1R21HD080025-01A1 (https://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, BAYESIAN NONPARAMETR; Banta HD, 2001, OBSTET GYNECOL SURV, V56, P707; Chudacek V, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-16; Dash S, 2014, IEEE T BIO-MED ENG, V61, P2796, DOI 10.1109/TBME.2014.2330556; De Haan J, 1971, EUR J OBSTET GYN R B, V3, P95; Djuric PM, 2015, EUR SIGNAL PR CONF, P2786, DOI 10.1109/EUSIPCO.2015.7362892; Freeman R, 2012, ACS SYM SER, V1112, P1; Garite TJ, 2000, AM J OBSTET GYNECOL, V183, P1049, DOI 10.1067/mob.2000.110632; Georgieva A, 2013, NEURAL COMPUT APPL, V22, P85, DOI 10.1007/s00521-011-0743-y; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Goncalves H, 2006, MED BIOL ENG COMPUT, V44, P847, DOI 10.1007/s11517-006-0105-6; Hruban L, 2015, J EVAL CLIN PRACT, V21, P694, DOI 10.1111/jep.12368; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Karmakar CK, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-17; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Macones GA, 2008, JOGNN-J OBST GYN NEO, V37, P510, DOI 10.1111/j.1552-6909.2008.00284.x; MARTIN JA, 2002, NATL VITAL STAT REP, V52, P1; NEAL RM, 1992, FUND THEOR, V50, P197; PINCUS S, 1995, CHAOS, V5, P110, DOI 10.1063/1.166092; Rooth G, 1987, INT J GYNECOL OBSTET, V25, P159, DOI [DOI 10.1016/0020-7292(87)90012-9, 10.1016/0020-7292 (87)90012-9]; Signorini MG, 2003, IEEE T BIO-MED ENG, V50, P365, DOI 10.1109/TBME.2003.808824; Spilka J, 2012, BIOMED SIGNAL PROCES, V7, P350, DOI 10.1016/j.bspc.2011.06.008; Teh Y. W., 2012, J AM STAT ASSOC, V101, P1566; Wei XM, 2017, 2017 IEEE CONFERENCE ON ENERGY INTERNET AND ENERGY SYSTEM INTEGRATION (EI2); Xu L, 2014, PHYSIOL MEAS, V35, P1357, DOI 10.1088/0967-3334/35/7/1357; Yu KZ, 2016, INT CONF ACOUST SPEE, P4383, DOI 10.1109/ICASSP.2016.7472505; Yu K, 2016, INT CONF ACOUST SPEE, P709, DOI 10.1109/ICASSP.2016.7471767	27	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185417	10.1371/journal.pone.0185417	http://dx.doi.org/10.1371/journal.pone.0185417			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953927	Green Published, gold, Green Submitted			2022-12-27	WOS:000411980300065
J	Doijen, J; Van Loy, T; De Haes, W; Landuyt, B; Luyten, W; Schoofs, L; Schols, D				Doijen, Jordi; Van Loy, Tom; De Haes, Wouter; Landuyt, Bart; Luyten, Walter; Schoofs, Liliane; Schols, Dominique			Signaling properties of the human chemokine receptors CXCR4 and CXCR7 by cellular electric impedance measurements	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MAMMALIAN-CELLS; T-LYMPHOCYTES; BETA-ARRESTIN; LIGAND; ACTIVATION; PATHWAY; PROGRESSION; DISCOVERY; MIGRATION	The chemokine receptor 4 (CXCR4) and 7 (CXCR7) are G-protein-coupled receptors involved in various diseases including human cancer. As such, they have become important targets for therapeutic intervention. Cell-based receptor assays, able to detect agents that modulate receptor activity, are of key importance for drug discovery. We evaluated the potential of cellular electric impedance for this purpose. Dose-dependent and specific stimulation of CXCR4 was detected upon addition of its unique chemokine ligand CXCL12. The response magnitude correlated with the CXCR4 expression level. G(alpha i) coupling and signaling contributed extensively to the impedance response, whereas G alpha q-and G(beta gamma)-related events had only minor effects on the impedance profile. CXCR7 signaling could not be detected using impedance measurements. However, increasing levels of CXCR7 expression significantly reduced the CXCR4-mediated impedance readout, suggesting a regulatory role for CXCR7 on CXCR4-mediated signaling. Taken together, cellular electric impedance spectroscopy can represent a valuable alternative pharmacological cell-based assay for the identification of molecules targeting CXCR4, but not for CXCR7 in the absence of CXCR4.	[Doijen, Jordi; De Haes, Wouter; Landuyt, Bart; Luyten, Walter; Schoofs, Liliane] Katholieke Univ Leuven, Inst Zool, Lab Funct Genom & Prote, Leuven, Belgium; [Doijen, Jordi; Van Loy, Tom; Schols, Dominique] Katholieke Univ Leuven, Rega Inst Med Res, Lab Virol & Chemotherapy, Leuven, Belgium	KU Leuven; KU Leuven	Schols, D (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Lab Virol & Chemotherapy, Leuven, Belgium.	dominique.schols@kuleuven.be	schoofs, liliane/ABD-2943-2020; Schols, Dominique/S-9057-2017; Schols, Dominique/AAC-1309-2021; Van Loy, Tom/E-2374-2018; Schoofs, Liliane/F-2815-2010	Schols, Dominique/0000-0003-3256-5850; Schols, Dominique/0000-0003-3256-5850; Van Loy, Tom/0000-0003-2524-7264; Doijen, Jordi/0000-0002-1707-0174; Schoofs, Liliane/0000-0002-1673-432X	FWO [G.485.08]; KU Leuven [PF/10/018]; KU Leuven Research Council [C14/15/049]; Flemish Research Funds [SB/151105]	FWO(FWO); KU Leuven(KU Leuven); KU Leuven Research Council(KU Leuven); Flemish Research Funds	Jordi Doijen is an SB PhD fellow (SB/151105) at FWO (Flemish Research Funds; http://www.fwo.be). The authors acknowledge research grants from FWO (Grant no. G.485.08), the KU Leuven (PF/10/018), the KU Leuven Research Council (Grant no. C14/15/049; http://www. kuleuven.be) and an European Research Council (ERC) Advanced Grant (Grant no. 340318; https://erc.europa.eu/funding/advanced-grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Barbero S, 2003, CANCER RES, V63, P1969; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Chatterjee S, 2014, ADV CANCER RES, V124, P31, DOI 10.1016/B978-0-12-411638-2.00002-1; Cojoc Monica, 2013, Onco Targets Ther, V6, P1347, DOI 10.2147/OTT.S36109; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Davies SL, 2006, AM J PHYSIOL-CELL PH, V290, pC1543, DOI 10.1152/ajpcell.00482.2005; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Graler MH, 2003, J CELL BIOCHEM, V89, P507, DOI 10.1002/jcb.10537; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Hatse S, 2001, MOL PHARMACOL, V60, P164, DOI 10.1124/mol.60.1.164; Hirshman CA, 2001, AM J PHYSIOL-CELL PH, V281, pC1468, DOI 10.1152/ajpcell.2001.281.5.C1468; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kammermann M, 2011, BIOCHEM BIOPH RES CO, V412, P419, DOI 10.1016/j.bbrc.2011.07.087; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lu DY, 2009, EUR J PHARMACOL, V613, P146, DOI 10.1016/j.ejphar.2009.03.001; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Mishra RK, 2016, SCI REP-UK, V6, DOI 10.1038/srep30155; Nambi P, 2003, ASSAY DRUG DEV TECHN, V1, P305, DOI 10.1089/15406580360545116; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Peters MF, 2009, J BIOMOL SCREEN, V14, P246, DOI 10.1177/1087057108330115; Princen K, 2003, CYTOM PART A, V51A, P35, DOI 10.1002/cyto.a.10008; Promega Corporation, 2009, FUGENE R HD TRANSF R; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Roland J, 2003, BLOOD, V101, P399, DOI 10.1182/blood-2002-03-0978; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Soon CF, 2012, INT IEEE EMBS C BIOM; Stallaert W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029420; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Uemura T, 2006, BRIT J PHARMACOL, V148, P61, DOI 10.1038/sj.bjp.0706711; van Hout A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176057; Verhofstede C, 2012, CURR OPIN HIV AIDS, V7, P432, DOI 10.1097/COH.0b013e328356f6f2; Watts AO, 2012, BIOCHEM BIOPH RES CO, V419, P412, DOI 10.1016/j.bbrc.2012.02.036; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v; Zlotnik A, 2004, SEMIN CANCER BIOL, V14, P181, DOI 10.1016/j.semcancer.2003.10.004	44	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185354	10.1371/journal.pone.0185354	http://dx.doi.org/10.1371/journal.pone.0185354			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945785	Green Published, Green Submitted, gold			2022-12-27	WOS:000411645100050
J	Greenberg, MB; Osigian, CJ; Cavuoto, KM; Chang, TC				Greenberg, Matthew B.; Osigian, Carla J.; Cavuoto, Kara M.; Chang, Ta C.			Clinical management outcomes of childhood glaucoma suspects	PLOS ONE			English	Article							CENTRAL CORNEAL THICKNESS; PEDIATRIC GLAUCOMA; CHILDREN	Purpose To investigate the outcomes of childhood glaucoma suspects. Design Retrospective case series. Methods Records of childhood glaucoma suspects were identified using financial claims data; medical history, baseline biometric and exam findings were recorded. Conversion from suspect to glaucoma was determined based on the Childhood Glaucoma Research Network criteria. The study adheres to the tenets of the Declarations of Helsinki. Results 214 subjects were enrolled, with median age at initial presentation of 6.37 years (interquartertile range: Q1 = 2.46, Q3 = 8.90). 22 (10.2%) subjects developed glaucoma, 64 (29.9%) had ocular hypertension but no glaucoma, 9 (4.2%) had high-risk condition or syndrome without either ocular hypertension or glaucoma after a mean follow up of 39 +/-34 months. Neither a family history of glaucoma nor patient gender was significantly different between the groups. 40.2% of subjects (86 of 214) had two or more episodes of intraocular pressure (IOP) > 21 mmHg, among which 25.6% (22 of 86) developed glaucoma after a mean duration of 32.8 +/-33.5 months. Conclusions Up to 25% of children with 2 or more episodes of elevated IOP may develop glaucoma. In 50% of suspects who converted to glaucoma, elevated IOP was not present at the initial evaluation. There is no significant difference in gender, family history, or baseline central corneal thickness between suspects who developed glaucoma compared to the rest. While suspects who converted to glaucoma had higher average, maximum and minimum IOP measurements, there is no clear cutoff between the groups.	[Greenberg, Matthew B.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Osigian, Carla J.; Cavuoto, Kara M.; Chang, Ta C.] Bascom Palmer Eye Inst, Miami, FL 33136 USA	University of Miami; Bascom Palmer Eye Institute	Chang, TC (corresponding author), Bascom Palmer Eye Inst, Miami, FL 33136 USA.	tchang@med.miami.edu						Bayoumi NHL, 2016, J GLAUCOMA, V25, P497, DOI 10.1097/IJG.0000000000000323; Beck A., 2013, WGA CONSENSUS SERIES, V9, P3; Brandt JD, 2012, OPHTHALMOLOGY, V119, P437, DOI 10.1016/j.ophtha.2011.03.018; Brandt JD, 2004, AM J OPHTHALMOL, V137, P348, DOI 10.1016/j.ajo.2003.09.038; Hoguet A, 2016, INDIAN J OPHTHALMOL, V64, P118, DOI 10.4103/0301-4738.179716; Kong LK, 2012, J AAPOS, V16, P501, DOI 10.1016/j.jaapos.2012.09.004; Lopes JF, 2007, J PEDIAT OPHTH STRAB, V44, P112, DOI 10.3928/01913913-20070301-05; Lopez JP, 2011, J PEDIAT OPHTH STRAB, V48, P108, DOI 10.3928/01913913-20100518-03; Whitson Jess T, 2005, Eye Contact Lens, V31, P221, DOI 10.1097/01.ICL.0000152487.16012.40	9	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185546	10.1371/journal.pone.0185546	http://dx.doi.org/10.1371/journal.pone.0185546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945815	Green Published, Green Submitted, gold			2022-12-27	WOS:000411645100064
J	Musa, BM; Adamu, AL; Galadanci, NA; Zubayr, B; Odoh, CN; Aliyu, MH				Musa, Baba Maiyaki; Adamu, Aishatu L.; Galadanci, Najibah A.; Zubayr, Bashir; Odoh, Chisom N.; Aliyu, Muktar H.			Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis	PLOS ONE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; ANTITUBERCULOSIS DRUGS; NATIONAL-SURVEY; RISK-FACTORS; HIV; SURVEILLANCE; TB; PATTERNS	Background Multidrug resistant tuberculosis (MDR-TB), is an emerging public health problem in subSaharan Africa (SSA). This study aims to determine the trends in prevalence of MDR-TB among new TB cases in sub-Saharan Africa over two decades. Methods We searched electronic data bases and accessed all prevalence studies of MDR-TB within SSA between 2007 and 2017. We determined pooled prevalence estimates using random effects models and determined trends using meta-regression. Results Results: We identified 915 studies satisfying inclusion criteria. Cumulatively, studies reported on MDR-TB culture of 34,652 persons. The pooled prevalence of MDR-TB in new cases was 2.1% (95% CI; 1.7-2.5%). There was a non-significant decline in prevalence by 0.12% per year. Conclusion We found a low prevalence estimate of MDR-TB, and a slight temporal decline over the study period. There is a need for continuous MDR-TB surveillance among patients with TB.	[Musa, Baba Maiyaki] Bayero Univ, Dept Med, Kano, Nigeria; [Musa, Baba Maiyaki] Aminu Kano Teaching Hosp, Dept Med, Kano, Nigeria; [Adamu, Aishatu L.] Bayero Univ, Dept Community Med, Kano, Nigeria; [Adamu, Aishatu L.] Aminu Kano Teaching Hosp, Dept Community Med, Kano, Nigeria; [Galadanci, Najibah A.] Bayero Univ, Dept Hematol, Kano, Nigeria; [Galadanci, Najibah A.] Aminu Kano Teaching Hosp, Dept Hematol, Kano, Nigeria; [Zubayr, Bashir] Inst Human Virol, IHVN Reg Off, Kano, Nigeria; [Odoh, Chisom N.] Univ Louisville, Louisville, KY 40292 USA; [Aliyu, Muktar H.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Aliyu, Muktar H.] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN 37212 USA	Bayero University; Bayero University; Bayero University; University of Louisville; Vanderbilt University; Vanderbilt University	Musa, BM (corresponding author), Bayero Univ, Dept Med, Kano, Nigeria.; Musa, BM (corresponding author), Aminu Kano Teaching Hosp, Dept Med, Kano, Nigeria.	babamaiyaki2000@yahoo.ac.uk		Adamu, Aishatu/0000-0002-6330-1033; Iwundu, Chisom/0000-0002-6702-5363; Musa, Baba/0000-0002-9159-3635; Aliyu, Muktar/0000-0001-9504-4679				Abdelhadi O, 2012, Bull Soc Pathol Exot, V105, P16, DOI 10.1007/s13149-011-0186-9; Abebe Gemeda, 2012, BMC Res Notes, V5, P225, DOI 10.1186/1756-0500-5-225; Abouyannis M, 2014, B WORLD HEALTH ORGAN, V92, P798, DOI 10.2471/BLT.13.126532; Adegbola RA, 2003, INT J TUBERC LUNG D, V7, P390; Affolabi D, 2007, INT J TUBERC LUNG D, V11, P1221; Aliyu Gambo, 2013, Tuberc Res Treat, V2013, P650561, DOI 10.1155/2013/650561; Anastasis D, 1997, INT J TUBERC LUNG D, V1, P220; Asiimwe BB, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-101; Asmamaw Dawit, 2008, Ethiop Med J, V46, P367; Bazira J, 2010, BMC CLIN PATHOL, V10, DOI 10.1186/1472-6890-10-5; Berhan A, 2013, ETHIOP J HEALTH SCI, V23, P271, DOI 10.4314/ejhs.v23i3.10; Bruchfeld J, 2002, SCAND J INFECT DIS, V34, P331, DOI 10.1080/00365540110080025; Calver AD, 2010, EMERG INFECT DIS, V16, P264, DOI 10.3201/eid1602.090968; Chonde TM, 2010, INT J TUBERC LUNG D, V14, P967; Cohn DL, 1997, CLIN INFECT DIS, V24, pS121, DOI 10.1093/clinids/24.Supplement_1.S121; Coker RJ, 2004, TROP MED INT HEALTH, V9, P25, DOI 10.1046/j.1365-3156.2003.01156.x; Cox HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013901; Daniel O, 2011, ASIAN PAC J TROP MED, V4, P148, DOI 10.1016/S1995-7645(11)60057-6; Diande S, 2009, West Afr J Med, V28, P353; Diguimbaye C, 2006, J CLIN MICROBIOL, V44, P1575, DOI 10.1128/JCM.44.4.1575-1577.2006; He X, 2016, EPIDEMIOLOGICAL TREN; Kapata N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146392; Kenyon TA, 1999, INT J TUBERC LUNG D, V3, P4; Kuaban C, 2000, INT J TUBERC LUNG D, V4, P356; Lawson L, 2010, ANN AFR MED, V9, P184, DOI 10.4103/1596-3519.68355; Lukoye D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1614-8; Lukoye D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070763; Lukoye D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016130; Mac-Arthur A, 2001, INT J TUBERC LUNG D, V5, P894; Matee M, 2009, APMIS, V117, P263, DOI 10.1111/j.1600-0463.2008.02429.x; Mekonnen F, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1202-7; Migliori GB, 2010, TROP MED INT HEALTH, V15, P1052, DOI 10.1111/j.1365-3156.2010.02581.x; Minime-Lingoupou F, 2011, INT J TUBERC LUNG D, V15, P657, DOI 10.5588/ijtld.10.0292; Mukinda FK, 2012, INT J TUBERC LUNG D, V16, P196, DOI 10.5588/ijtld.11.0116; Mulenga C, 2010, TUBERC RES TREAT; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; N'guessan K, 2008, MED MALADIES INFECT, V38, P231, DOI 10.1016/j.medmal.2007.11.004; Ndung'u PW, 2012, J INFECT DEV COUNTR, V6, P33, DOI 10.3855/jidc.2281; Nelson LJ, 2005, LANCET, V366, P488, DOI 10.1016/S0140-6736(05)67062-6; Nunes EA, 2005, INT J TUBERC LUNG D, V9, P494; Otu A, 2013, PULM MED, V2013, DOI 10.1155/2013/235190; Owusu-Dabo E, 2006, EMERG INFECT DIS, V12, P1170, DOI 10.3201/eid1207.051028; Pokam BT, 2013, INT J MYCOBACT, V2, P89, DOI 10.1016/j.ijmyco.2013.03.002; Ramarokoto H, 2010, INT J TUBERC LUNG D, V14, P745; Gudo PS, 2011, EUR RESPIR J, V38, P222, DOI 10.1183/09031936.00182010; Sanchez-Padilla E, 2013, INT J TUBERC LUNG D, V17, P1036, DOI 10.5588/ijtld.12.0842; Sanchez-Padilla E, 2012, EMERG INFECT DIS, V18, P29, DOI 10.3201/eid1801.110850; Sanders M, 2006, INT J TUBERC LUNG D, V10, P178; Sangare L., 2011, African Journal of Clinical and Experimental Microbiology, V12, P38; Sangare L, 2010, INT J TUBERC LUNG D, V14, P1424; Tessema B, 2012, INT J TUBERC LUNG D, V16, P805, DOI 10.5588/ijtld.11.0522; Tudo G, 2004, INT J TUBERC LUNG D, V8, P15; Umubyeyi AN, 2007, INT J TUBERC LUNG D, V11, P189; Urassa Willy, 2008, BMC Res Notes, V1, P58, DOI 10.1186/1756-0500-1-58; WHO, 2011, POL STAT AUT REAL TI; Yimer SA, 2012, APMIS, V120, P503, DOI 10.1111/j.1600-0463.2011.02861.x; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585	57	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185105	10.1371/journal.pone.0185105	http://dx.doi.org/10.1371/journal.pone.0185105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945771	Green Submitted, Green Published, gold			2022-12-27	WOS:000411645100023
J	Weissenbacher-Lang, C; Nedorost, N; Knecht, C; Hennig-Pauka, I; Huber, M; Voglmayr, T; Weissenbock, H				Weissenbacher-Lang, Christiane; Nedorost, Nora; Knecht, Christian; Hennig-Pauka, Isabel; Huber, Mathias; Voglmayr, Thomas; Weissenboeck, Herbert			Comparison of Pneumocystis nucleic acid and antibody profiles and their associations with other respiratory pathogens in two Austrian pig herds	PLOS ONE			English	Article							HAEMOPHILUS-PARASUIS; SYNDROME VIRUS; CONCURRENT INFECTIONS; CARINII-PNEUMONIA	Pneumocystis carinii f. sp. suis (PCS) nucleic acid and antibody profiles on two Austrian-farrow-to-finish farms were investigated. Furthermore, associations with other respiratory pathogens were evaluated. Respiratory specimen and sera from pigs of five age classes between the 1st week and the 3rd month of life as well as samples from sows were analyzed. On Farm A, PCS infection occurred early in life. The suckling piglets were already infected in the 1st week of life and the pigs remained positive until the 3rd month of life. On Farm B, pigs were infected later, between 3 and 4 months of age. The maximum PCS nucleic acid load on Farm A was 8.3 log10 genome copies/mL BALF, whereas on Farm B the PCS burden was significantly lower, with 4.0 log10 genome copies/mL BALF. Anti-PCS antibodies were detected in sows, as maternal antibodies in suckling piglets and as an immunological reaction to infection. On both farms, PCS infection was accompanied by several co-infections. On Farm A, there were concurrent infections with PRRSV, a virulent strain of Haemophilus parasuis, and Mycoplasma hyopneumoniae. On Farm B, PCS was accompanied by infections with swine influenza virus, Mycoplasma hyopneumoniae, and a non-virulent strain of Haemophilus parasuis. The results clearly show that the PCS profiles can vary between farms. Younger pigs may be more susceptible as they had higher PCS burdens. It is possible that PCS may contribute to a respiratory disease in pigs and further investigation of its potential role is warranted.	[Weissenbacher-Lang, Christiane; Nedorost, Nora; Weissenboeck, Herbert] Univ Vet Med Vienna, Inst Pathol & Forens Vet Med, Dept Pathobiol, Vienna, Austria; [Knecht, Christian; Hennig-Pauka, Isabel] Univ Vet Med Vienna, Univ Clin Swine, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Huber, Mathias; Voglmayr, Thomas] Traunkreis Vet Clin, Ried Im Traunkreis, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Weissenbacher-Lang, C (corresponding author), Univ Vet Med Vienna, Inst Pathol & Forens Vet Med, Dept Pathobiol, Vienna, Austria.	christiane.weissenbacher-lang@vetmeduni.ac.at		Weissenbock, Herbert/0000-0001-8197-6379; Weissenbacher-Lang, Christiane/0000-0002-1527-7593	University of Veterinary Medicine Vienna, Austria; Verein der Freunde und Forderer der Schweinemedizin	University of Veterinary Medicine Vienna, Austria; Verein der Freunde und Forderer der Schweinemedizin	This work was supported by the profile lines, University of Veterinary Medicine Vienna, Austria (no grant number available; http://www.vetmeduni.ac.at/de/forschung/forschungsservice/) and by the Verein der Freunde und Forderer der Schweinemedizin, University of Veterinary Medicine Vienna, Austria (no grant number available; http://www.schweinmedizin.at/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouat-Denis CM, 2008, INFECT GENET EVOL, V8, P708, DOI 10.1016/j.meegid.2008.05.001; Bishop LR, 2003, J INFECT DIS, V187, P1844, DOI 10.1086/375354; Cho JG, 2006, CAN J VET RES, V70, P297; JORSAL SE, 1988, ACTA VET SCAND, P436; Kelly MN, 2010, FUTURE MICROBIOL, V5, P43, DOI [10.2217/fmb.09.116, 10.2217/FMB.09.116]; Kim KS, 2011, J VET SCI, V12, P15, DOI 10.4142/jvs.2011.12.1.15; Kondo H, 1997, J VET MED SCI, V59, P1161, DOI 10.1292/jvms.59.1161; Kureljusic B, 2016, VET J, V207, P177, DOI 10.1016/j.tvjl.2015.11.003; Lang C, 2011, BERL MUNCH TIERARZTL, V124, P142, DOI 10.2376/0005-9366-124-142; McDowall R, 2014, CAN J VET RES, V78, P150; Medrano FJ, 2005, J EUKARYOT MICRO SS1, V50, P649; Morris A, 2008, J INFECT DIS, V197, P10, DOI 10.1086/523814; Morris A, 2012, CLIN MICROBIOL REV, V25, P297, DOI 10.1128/CMR.00013-12; Mussa T, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-80; Opriessnig T, 2012, VIRUS RES, V164, P20, DOI 10.1016/j.virusres.2011.09.014; Palzer A, 2015, CAN VET J, V56, P285; PHAIR J, 1990, NEW ENGL J MED, V322, P161, DOI 10.1056/NEJM199001183220304; Rooke JA, 2002, LIVEST PROD SCI, V78, P13, DOI 10.1016/S0301-6226(02)00182-3; Rubies X, 1999, VET MICROBIOL, V66, P245, DOI 10.1016/S0378-1135(99)00007-3; Schmidt C, 2016, ZOONOSES PUBLIC HLTH, V63, P234, DOI 10.1111/zph.12223; Sepkowitz KA, 2002, CLIN INFECT DIS, V34, P1098, DOI 10.1086/339548; SHELLITO J, 1990, J CLIN INVEST, V85, P1686, DOI 10.1172/JCI114621; Thacker EL, 2001, VET CLIN N AM-FOOD A, V17, P551, DOI 10.1016/S0749-0720(15)30006-2; Tomas AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep36287; Weissenbacher-Lang C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158479; Weissenbacher-Lang C, 2016, J VET DIAGN INVEST, V28, P257, DOI 10.1177/1040638716641158; Yu J, 2012, VET MICROBIOL, V158, P316, DOI 10.1016/j.vetmic.2012.03.001; Zimmerman J., 2006, DIS SWINE, P387	28	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185387	10.1371/journal.pone.0185387	http://dx.doi.org/10.1371/journal.pone.0185387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945819	Green Published, Green Submitted, gold			2022-12-27	WOS:000411645100057
J	Dadone-Montaudie, B; Ambrosetti, D; Dufour, M; Darcourt, J; Almairac, F; Coyne, J; Virolle, T; Humbert, O; Burel-Vandenbos, F				Dadone-Montaudie, Berengere; Ambrosetti, Damien; Dufour, Maxime; Darcourt, Jacques; Almairac, Fabien; Coyne, John; Virolle, Thierry; Humbert, Olivier; Burel-Vandenbos, Fanny			[18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression	PLOS ONE			English	Article							AMINO-ACID TRANSPORTER-1; PET; MECHANISMS; F-18-DOPA; GLIOMAS; IMPACT	[18F]-FDOPA is a labeled amino acid (AA) analog used for positron emission tomography (PET) which is gaining increasing interest in the evaluation of brain tumors (BT). The AA-transporter LAT1 has been shown to be involved in [18F]-FDOPA uptake. The aim of this study was to determine whether the [18F]-FDOPA uptake was correlated with level of LAT1 expression in BT. Twenty-eight BT (including 19 gliomas and 9 metastases) were investigated by [18F]-FDOPA-PET prior to surgery and by anti-LAT1 immunohistochemistry on surgical specimens. The quantitative [18F]-FDOPA measured parameters were SUVmax, SUVmean and SUVpeak. LAT1 expression was quantified using a score (0 to 400). A significant [18F]-FDOPA uptake was associated with a LAT1 score >= 100 (p = 0.02) but there was no linear correlation between intensity of [18F]-FDOPA uptake and score of LAT1 expression whatever the parameters considered. LAT1 expression alone is not sufficient to explain variation of intensity of [18F]-FDOPA uptake in BT.	[Dadone-Montaudie, Berengere; Ambrosetti, Damien; Coyne, John; Burel-Vandenbos, Fanny] Univ Hosp, Dept Pathol, Nice, France; [Dadone-Montaudie, Berengere; Ambrosetti, Damien; Dufour, Maxime; Darcourt, Jacques; Almairac, Fabien; Coyne, John; Virolle, Thierry; Humbert, Olivier; Burel-Vandenbos, Fanny] Univ Cote Azur, Nice, France; [Dufour, Maxime; Darcourt, Jacques; Humbert, Olivier] Ctr Antoine Lacassagne, Dept Nucl Med, Nice, France; [Dufour, Maxime; Darcourt, Jacques; Humbert, Olivier] Univ Nice Sophia Antipolis, TIRO UMR E 4320, Nice, France; [Almairac, Fabien] Univ Hosp, Dept Neurosurg, Nice, France; [Virolle, Thierry; Burel-Vandenbos, Fanny] Univ Nice Sophia Antipolis, INSERM, CNRS, UMR 7277,UMR 1091,Inst Biol Valrose, Nice, France; [Burel-Vandenbos, Fanny] Hop Louis Pasteur, Lab Cent Anat Pathol, 30 Voie Romaine, Nice, France	CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Burel-Vandenbos, F (corresponding author), Univ Hosp, Dept Pathol, Nice, France.; Burel-Vandenbos, F (corresponding author), Univ Cote Azur, Nice, France.; Burel-Vandenbos, F (corresponding author), Univ Nice Sophia Antipolis, INSERM, CNRS, UMR 7277,UMR 1091,Inst Biol Valrose, Nice, France.; Burel-Vandenbos, F (corresponding author), Hop Louis Pasteur, Lab Cent Anat Pathol, 30 Voie Romaine, Nice, France.	burel-vandenbos.f@chu-nice.fr	Virolle, Thierry/E-5838-2016; Dadone-Montaudié, Bérengère/AAI-3177-2021; Ambrosetti, Damien/E-2131-2015	Ambrosetti, Damien/0000-0001-8665-0546	Centre Antoine Lacassagne; Canceropole PACA	Centre Antoine Lacassagne; Canceropole PACA(Region Grand-Est)	This work was supported by Centre Antoine Lacassagne; Canceropole PACA. The present study is an ancillary study of the prospective trial I MOTEP "Prospective study of the clinical impact of 18F-FDOPA PET in patient management within multidisciplinary neuroncology meetings for primary and metastatic brain tumours." This institutional trial is promoted by the Centre Antoine Lacassagne (the co-author Jacques Darcourt is the principal investigator). The regional institution Canceropole PACA provided a subvention to the University Hospital of Nice to promote research on brain metastases (Axe C "biomarqueurs et evaluation des cibles"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NL, 2016, NEURO-ONCOLOGY, V18, P1199, DOI 10.1093/neuonc/now058; Becherer A, 2003, EUR J NUCL MED MOL I, V30, P1561, DOI 10.1007/s00259-003-1259-1; Bell C, 2015, NUCL MED BIOL, V42, P788, DOI 10.1016/j.nucmedbio.2015.06.001; Bund C, 2017, CLIN NUCL MED, V42, P458, DOI 10.1097/RLU.0000000000001608; BUSTANY P, 1986, J NEURO-ONCOL, V3, P397, DOI 10.1007/BF00165590; Campbell WA, 2001, J BIOL CHEM, V276, P16877, DOI 10.1074/jbc.M008248200; Chiaravalloti A, 2015, NUCL MED BIOL, V42, P355, DOI 10.1016/j.nucmedbio.2015.01.002; DICHIRO G, 1982, NEUROLOGY, V32, P1323, DOI 10.1212/WNL.32.12.1323; Heiss WD, 2014, J NUCL MED, V55, P1219, DOI 10.2967/jnumed.114.142661; Heiss WD, 2011, J NUCL MED, V52, P1585, DOI 10.2967/jnumed.110.084210; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Janvier L, 2015, CLIN NUCL MED, V40, pE429, DOI 10.1097/RLU.0000000000000897; Kobayashi K, 2008, NEUROSURGERY, V62, P493, DOI 10.1227/01.neu.0000316018.51292.19; Miyagawa T, 1998, J CEREBR BLOOD F MET, V18, P500, DOI 10.1097/00004647-199805000-00005; Nawashiro H, 2006, INT J CANCER, V119, P484, DOI 10.1002/ijc.21866; Oka S, 2014, MOL IMAGING BIOL, V16, P322, DOI 10.1007/s11307-013-0693-0; Okubo S, 2010, J NEURO-ONCOL, V99, P217, DOI 10.1007/s11060-010-0117-9; Ono M, 2013, BRAIN RES, V1535, P24, DOI 10.1016/j.brainres.2013.08.037; Papin-Michault C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157139; Sala Q, 2014, CLIN NUCL MED, V39, pE283, DOI 10.1097/RLU.0000000000000383; Takahashi Y, 2014, MOL CLIN ONCOL, V2, P525, DOI 10.3892/mco.2014.287; Watabe T, 2017, EUR J NUCL MED MOL I, V44, P321, DOI 10.1007/s00259-016-3487-1; Weber WA, 2000, EUR J NUCL MED, V27, P542, DOI 10.1007/s002590050541; Youland RS, 2013, J NEURO-ONCOL, V111, P11, DOI 10.1007/s11060-012-0986-1	24	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0184625	10.1371/journal.pone.0184625	http://dx.doi.org/10.1371/journal.pone.0184625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28937983	Green Published, Green Submitted, gold			2022-12-27	WOS:000411524700006
J	Donocik, K; Hartman-Petrycka, M; Lebiedowska, A; Blonska-Fajfrowska, B				Donocik, Karolina; Hartman-Petrycka, Magdalena; Lebiedowska, Agata; Blonska-Fajfrowska, Barbara			Alterations in the ability to maintain balance as a result of stochastic resonance whole body vibration in women	PLOS ONE			English	Article							NOISE; RELIABILITY	Purpose A vertical posture makes it difficult to maintain balance especially in the elderly. Loss of balance leads to falls and injuries. In the present study, we evaluated whether balance maintenance can be improved with the use of stochastic resonance whole body vibration (SRWBV). Methods An examination of balance, involving 187 women aged 19-74 years, was conducted using double-plate posturography pre and post SR-WBV. The SR-WBV trainings were performed using the SRT Zeptor Medical-plus noise device. The entire study lasted 6 weeks, with a total of 12 training sessions, each consisting of nine 45 second series, with a 45 second pause between them. Results Post SR-WBV there was a reduction in the value of: the resultant mean velocity (MV) of the movement of COP (centre of pressure) for both lower limbs (B) and in the right lower limb (R) during the test with eyes closed (EC), the mean velocity and mean amplitude (MA) of the movement of COP along the x-axis (ML) of the left lower limb (L) during the test with eyes open (EO) and closed and some additional parameters. Negative correlations between age/ index of improvement of MV-EC-B, MV-EC-L and MVML-EC-L, and BMI/index of improvement of MV-EC-B, MVML-EC-B appeared. Height correlated positively with the index of improvement of MV-EC-B and MVML-EC-B. Conclusions As a result of SR-WBV, the left leg is more stable along the x-axis and the disproportion between the stability of both legs is reduced. Consequently, body stability is higher. The SRWBV is more effective in younger, taller and slimmer women. SR-WBV parameters should be optimized so that the training is more beneficial for elderly and shorter women, and for women with a higher BMI.	[Donocik, Karolina; Hartman-Petrycka, Magdalena; Lebiedowska, Agata; Blonska-Fajfrowska, Barbara] Med Univ Silesia, Sch Pharm, Dept Basic Biomed Sci, Div Lab Med, Katowice, Poland	Medical University Silesia	Lebiedowska, A (corresponding author), Med Univ Silesia, Sch Pharm, Dept Basic Biomed Sci, Div Lab Med, Katowice, Poland.	alebiedowska@sum.edu.pl		Hartman-Petrycka, Magdalena/0000-0003-3986-3295; Blonska-Fajfrowska, Barbara/0000-0003-4727-1265; Lebiedowska, Agata/0000-0003-3752-4679	Medical University of Silesia [KNW-2001/N/5/N, KNW-2-001/N/6/N, KNW-2-001/N/7/N]	Medical University of Silesia	This work was funded by the Medical University of Silesia, contract numbers: KNW-2001/N/5/N; KNW-2-001/N/6/N; KNW-2-001/N/7/N.	Blaszczyk J.W., 2005, GERONTOLOL POL, V13, P25; Blaszczyk JW, 2009, J BIOMECH, V42, P1295, DOI 10.1016/j.jbiomech.2009.03.006; Chang YC, 2017, J SPORT MED PHYS FIT, V57, P660, DOI 10.23736/S0022-4707.16.05728-5; Cordo P, 1996, NATURE, V383, P769, DOI 10.1038/383769a0; Dittrich M., 2012, DEUTSCHER ARZTE VERL, V1, P60; Elfering A, 2014, WORKPLACE HEALTH SAF, V62, P187, DOI 10.3928/21650799-20140422-04; Elfering A, 2013, WORLD J ORTHOP, V4, P291, DOI 10.5312/wjo.v4.i4.291; Elfering A, 2013, SAF HEALTH WORK, V4, P149, DOI 10.1016/j.shaw.2013.07.002; Fallon JB, 2004, J NEUROPHYSIOL, V91, P2429, DOI 10.1152/jn.00928.2003; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gassner H, 2014, PARKINSONS DIS-US, V2014, DOI 10.1155/2014/386495; Haas C. T., 2008, CURRENT RESULTS STRE, V2, P105; Haas CT, 2006, FORSCHUNG FRANKFURT, V4, P19; Hartmann P, 2012, PHYSOSCIENCE, V8, P6, DOI 10.1055/s-0031-1281836; Held-Ziolkowska M., 2006, MAG ORL, V2, P47; Kowalczyk A, 2015, J ED HLTH SPORT, V5, P413; Kubiczkowa J, 1974, OTOLARYNGOLOGY-POL, V38, P279; Masud T, 2001, AGE AGEING, V30, P3, DOI 10.1093/ageing/30.suppl_4.3; Moghadam M, 2011, GAIT POSTURE, V33, P651, DOI 10.1016/j.gaitpost.2011.02.016; Ocetkiewicz T., 2006, GERONTOL POL, V14, P144; Pajala S, 2008, J GERONTOL A-BIOL, V63, P171, DOI 10.1093/gerona/63.2.171; Piekarzewska M, 2015, HLTH STATUS POLISH P, P6; Pierchala K, 2013, POL PRZ OTORYNOLARYN, V2, P1; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Rogan S, 2016, J GERONTOL GERIATR R, V5, P1; Rogan S, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0021-4; Rogan S, 2014, AGING CLIN EXP RES, V26, P519, DOI 10.1007/s40520-014-0212-4; Rogan S, 2014, RES SPORTS MED, V22, P294, DOI 10.1080/15438627.2014.919504; Schlee G, 2012, NEUROSCI LETT, V506, P70, DOI 10.1016/j.neulet.2011.10.051; Strzelecki A., 2011, GERONTOL POL, V19, P134; Swanenburg J, 2010, GAIT POSTURE, V31, P317, DOI 10.1016/j.gaitpost.2009.11.013; Swanenburg J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-162; Turbanski Stephan, 2005, Res Sports Med, V13, P243; Wilcynski J., 2007, ANTROPOMOTORICS, V17, P97; Wojtyniak B, 2016, HLTH SIT POL POP ITS	38	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185179	10.1371/journal.pone.0185179	http://dx.doi.org/10.1371/journal.pone.0185179			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938021	Green Published, Green Submitted, gold			2022-12-27	WOS:000411524700021
J	Waldron, AL; Cahan, SH; Franklyn, CS; Ebert, AM				Waldron, Ashley L.; Cahan, Sara Helms; Franklyn, Christopher S.; Ebert, Alicia M.			A single Danio rerio hars gene encodes both cytoplasmic and mitochondrial histidyl-tRNA synthetases	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SUBCELLULAR-LOCALIZATION; CELL-MIGRATION; PREDICTION; MYOSITIS	Histidyl tRNA Synthetase (HARS) is a member of the aminoacyl tRNA synthetase (ARS) family of enzymes. This family of 20 enzymes is responsible for attaching specific amino acids to their cognate tRNA molecules, a critical step in protein synthesis. However, recent work highlighting a growing number of associations between ARS genes and diverse human diseases raises the possibility of new and unexpected functions in this ancient enzyme family. For example, mutations in HARS have been linked to two different neurological disorders, Usher Syndrome Type IIIB and Charcot Marie Tooth peripheral neuropathy. These connections raise the possibility of previously undiscovered roles for HARS in metazoan development, with alterations in these functions leading to complex diseases. In an attempt to establish Danio rerio as a model for studying HARS functions in human disease, we characterized the Danio rerio hars gene and compared it to that of human HARS. Using a combination of bioinformatics, molecular biology, and cellular approaches, we found that while the human genome encodes separate genes for cytoplasmic and mitochondrial HARS protein, the Danio rerio genome encodes a single hars gene which undergoes alternative splicing to produce the respective cytoplasmic and mitochondrial versions of Hars. Nevertheless, while the HARS genes of humans and Danio differ significantly at the genomic level, we found that they are still highly conserved at the amino acid level, underscoring the potential utility of Danio rerio as a model organism for investigating HARS function and its link to human diseases in vivo.	[Waldron, Ashley L.; Cahan, Sara Helms; Ebert, Alicia M.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [Franklyn, Christopher S.] Univ Vermont, Dept Biochem, Coll Med, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Ebert, AM (corresponding author), Univ Vermont, Dept Biol, Burlington, VT 05405 USA.	amebert@uvm.edu		Waldron, Ashley/0000-0003-3177-0983	National Institute of General Medical Sciences [GM54899]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences GM54899 (https://www.nigms.nih.gov/Pages/default.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova J, 2015, RNA BIOL; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Briesemeister S, 2010, NUCLEIC ACIDS RES, V38, pW497, DOI 10.1093/nar/gkq477; Briesemeister S, 2010, BIOINFORMATICS, V26, P1232, DOI 10.1093/bioinformatics/btq115; Brozkova SD, BRAIN; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Cunniff B, 2016, MOL BIOL CELL, V27, P2662, DOI 10.1091/mbc.E16-05-0286; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Fukui H, 2009, CIRC RES, V104, P1253, DOI 10.1161/CIRCRESAHA.108.191189; Grallert B, 2013, BIOCHEM SOC T, V41, P1687, DOI 10.1042/BST20130210; Guo M, 2010, NATURE REV MOL CELL; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Kabashi E, 2011, BBA-MOL BASIS DIS, V1812, P335, DOI 10.1016/j.bbadis.2010.09.011; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lee YH, 2017, CELL MOL LIFE SCI, V74, P2663, DOI 10.1007/s00018-017-2491-3; Lee YN, 2004, IMMUNITY, V20, P145, DOI 10.1016/S1074-7613(04)00020-2; Lu JM, 2015, FLY, V9, P53, DOI 10.1080/19336934.2015.1101196; Malissovas N, 2016, HUM MOL GENET, V25, P1528, DOI 10.1093/hmg/ddw031; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MATHEWS MB, 1983, NATURE, V304, P177, DOI 10.1038/304177a0; Mirando AC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13160; Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106; Natsoulis G, 1986, CELL; Park S, P NATL ACAD SCI, V105, P11043; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Puffenberger EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028936; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200; Vester A, 2013, HUM MUTAT, V34, P191, DOI 10.1002/humu.22210; Wei N, 2014, MOL CELL, V56, P323, DOI 10.1016/j.molcel.2014.09.006; Williams TF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01317; Zhang XC, 2014, AM J HUM GENET, V94, P547, DOI 10.1016/j.ajhg.2014.03.003	43	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185317	10.1371/journal.pone.0185317	http://dx.doi.org/10.1371/journal.pone.0185317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934368	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900145
J	Graham, MS; Drobnjak, I; Jenkinson, M; Zhang, H				Graham, Mark S.; Drobnjak, Ivana; Jenkinson, Mark; Zhang, Hui			Quantitative assessment of the susceptibility artefact and its interaction with motion in diffusion MRI	PLOS ONE			English	Article							POINT-SPREAD FUNCTION; IMAGE DISTORTION CORRECTION; FIELD MAP ESTIMATION; ECHO-PLANAR IMAGES; GEOMETRIC DISTORTION; ALZHEIMERS-DISEASE; EPI; TRACTOGRAPHY; RESOLUTION; ALIGNMENT	In this paper we evaluate the three main methods for correcting the susceptibility-induced artefact in diffusion-weighted magnetic-resonance (DW-MR) data, and assess how correction is affected by the susceptibility field's interaction with motion. The susceptibility artefact adversely impacts analysis performed on the data and is typically corrected in post-processing. Correction strategies involve either registration to a structural image, the application of an acquired field-map or the use of additional images acquired with different phase-encoding. Unfortunately, the choice of which method to use is made difficult by the absence of any systematic comparisons of them. In this work we quantitatively evaluate these methods, by extending and employing a recently proposed framework that allows for the simulation of realistic DW-MR datasets with artefacts. Our analysis separately evaluates the ability for methods to correct for geometric distortions and to recover lost information in regions of signal compression. In terms of geometric distortions, we find that registration-based methods offer the poorest correction. Field-mapping techniques are better, but are influenced by noise and partial volume effects, whilst multiple phase-encode methods performed best. We use our simulations to validate a popular surrogate metric of correction quality, the comparison of corrected data acquired with AP and LR phase-encoding, and apply this surrogate to real datasets. Furthermore, we demonstrate that failing to account for the interaction of the susceptibility field with head movement leads to increased errors when analysing DW-MR data. None of the commonly used post-processing methods account for this interaction, and we suggest this may be a valuable area for future methods development.	[Graham, Mark S.; Drobnjak, Ivana; Zhang, Hui] UCL, Ctr Med Image Comp, London, England; [Graham, Mark S.; Drobnjak, Ivana; Zhang, Hui] UCL, Dept Comp Sci, London, England; [Jenkinson, Mark] Univ Oxford, Nuffield Dept Clin Neurosci, Wellcome Ctr Integrat Neuroimaging, FMRIB, Oxford, England	University of London; University College London; University of London; University College London; University of Oxford	Graham, MS (corresponding author), UCL, Ctr Med Image Comp, London, England.; Graham, MS (corresponding author), UCL, Dept Comp Sci, London, England.	mark.graham.13@ucl.ac.uk	Jenkinson, Mark/AAC-8861-2019	Jenkinson, Mark/0000-0001-6043-0166; Drobnjak, Ivana/0000-0002-3989-1715; Zhang, Hui/0000-0002-5426-2140; Graham, Mark/0000-0002-4170-1095	Engineering and Physical Sciences Research Council [EP/L504889/1]; EPSRC Centre for Doctoral Training [EP/L016478/1]; EPSRC [EP/L504889/1, EP/L022680/1]; Medical Research Council [MR/L011530/1]; Royal Academy of Engineering Research Exchanges with China and India; Leverhulme Trust; NIHR Biomedical Research Centre, Oxford; Royal Society International Exchange Scheme with China; MRC [MR/L011530/1]; 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; McDonnell Center for Systems Neuroscience at Washington University; EPSRC [EP/M020533/1, EP/G007748/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L022680/1, 1347953, EP/M020533/1, EP/G007748/1, 1212889] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC Centre for Doctoral Training(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Academy of Engineering Research Exchanges with China and India; Leverhulme Trust(Leverhulme Trust); NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); Royal Society International Exchange Scheme with China; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; McDonnell Center for Systems Neuroscience at Washington University; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	MG is supported by the Engineering and Physical Sciences Research Council (https://www. epsrc.ac.uk) (EP/L504889/1) and the EPSRC Centre for Doctoral Training (EP/L016478/1). HZ is supported by the EPSRC (EP/L022680/1), the Medical Research Council (https://www.mrc.ac.uk/) (MR/L011530/1) and the Royal Academy of Engineering Research Exchanges with China and India. ID is supported by the Leverhulme Trust (https://www.leverhulme.ac.uk/. MJ is supported by the NIHR Biomedical Research Centre, Oxford (https://oxfordbrc.nihr.ac.uk/). MG and HZ are additionally supported by the Royal Society International Exchange Scheme with China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MG is supported by the EPSRC (EP/L504889/1) and the EPSRC Centre for Doctoral Training (EP/L016478/1). HZ is supported by the EPSRC (EP/L022680/1), the MRC (MR/L011530/1) and the Royal Academy of Engineering Research Exchanges with China and India. ID is supported by the Leverhulme Trust. MG and HZ are additionally supported by the Royal Society International Exchange Scheme with China. MJ is supported by the NIHR Biomedical Research Centre, Oxford.; Data were provided [in part] by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University.	Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Alhamud A, 2016, NEUROIMAGE, V126, P60, DOI 10.1016/j.neuroimage.2015.11.022; Andersson J.L., 2004, P INT SOC MAGN RESON, V11, P87; Andersson JLR, 2017, NEUROIMAGE, V152, P450, DOI 10.1016/j.neuroimage.2017.02.085; Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Andersson JLR, 2013, GEOMETRIC DISTORTION; Ardekani S, 2005, MAGN RESON MED, V54, P1163, DOI 10.1002/mrm.20651; Assaf Y, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P127, DOI 10.1016/B978-0-12-374709-9.00007-9; Bhushan C, 2014, MAGN RESON MED, V72, P1218, DOI 10.1002/mrm.25026; CHANG H, 1992, IEEE T MED IMAGING, V11, P319, DOI 10.1109/42.158935; Drobnjak I, 2006, MAGN RESON MED, V56, P364, DOI 10.1002/mrm.20939; Drobnjak I, 2010, MAGN RESON IMAGING, V28, P1014, DOI 10.1016/j.mri.2010.03.029; Embleton KV, 2010, HUM BRAIN MAPP, V31, P1570, DOI 10.1002/hbm.20959; Esteban O, 2014, I S BIOMED IMAGING, P738, DOI 10.1109/ISBI.2014.6867976; Funai AK, 2008, IEEE T MED IMAGING, V27, P1484, DOI 10.1109/TMI.2008.923956; Gholipour A, 2011, IEEE ENG MED BIO, P6997, DOI 10.1109/IEMBS.2011.6091769; Graham MS, 2016, NEUROIMAGE, V125, P1079, DOI 10.1016/j.neuroimage.2015.11.006; Graham MS, 2015, INFORM PROCESSING ME, V9123, P638; Hedouin R, 2017, IEEE T MED IMAGING, V0062, P1; Hughes E., 2017, ORGAN HUMAN BRAIN MA, P25; Hughes EJ, 2016, MAGNETIC RESONANCE M; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Hutton C, 2013, HUM BRAIN MAPP, V34, P3086, DOI 10.1002/hbm.22126; Irfanoglu MO, 2011, LECT NOTES COMPUT SC, V6892, P174, DOI 10.1007/978-3-642-23629-7_22; Irfanoglu MO, 2015, NEUROIMAGE, V106, P284, DOI 10.1016/j.neuroimage.2014.11.042; Irfanoglu MO, 2012, NEUROIMAGE, V61, P275, DOI 10.1016/j.neuroimage.2012.02.054; Jenkinson M, 2004, MAGN RESON MED, V52, P471, DOI 10.1002/mrm.20194; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Jezzard P, 1999, HUM BRAIN MAPP, V8, P80, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<80::AID-HBM2>3.0.CO;2-C; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Jones DK, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P37, DOI 10.1016/B978-0-12-374709-9.00003-1; Kybic J, 2000, IEEE T MED IMAGING, V19, P80, DOI 10.1109/42.836368; Marami B, 2017, NEUROIMAGE; Matakos A, 2014, PHYS MED BIOL, V59, P4945, DOI 10.1088/0031-9155/59/17/4945; Miller K. L., 2016, NATURE NEUROSCIENCE; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Morgan PS, 2004, J MAGN RESON IMAGING, V19, P499, DOI 10.1002/jmri.20032; Reber PJ, 1998, MAGNET RESON MED, V39, P328, DOI 10.1002/mrm.1910390223; Robson MD, 1997, MAGNET RESON MED, V38, P733, DOI 10.1002/mrm.1910380509; Roopchansingh V, 2003, MAGN RESON MED, V50, P839, DOI 10.1002/mrm.10587; Rose SE, 2008, J MAGN RESON IMAGING, V27, P20, DOI 10.1002/jmri.21231; Ruthotto L., 2013, BILDVERARBEITUNG F R, P344, DOI [10.1007/978-3-642-36480-8_60, DOI 10.1007/978-3-642-36480-8_60]; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Studholme C, 2000, IEEE T MED IMAGING, V19, P1115, DOI 10.1109/42.896788; Tao R, 2009, LECT NOTES COMPUT SC, V5636, P664; Taylor PA, 2016, HUM BRAIN MAPP, V37, P4405, DOI 10.1002/hbm.23318; Thompson WK, 2011, NEUROIMAGE, V57, P1, DOI 10.1016/j.neuroimage.2010.11.092; TURNER R, 1990, J MAGN RESON, V86, P445, DOI 10.1016/0022-2364(90)90023-3; Ugurbil K, 2013, NEUROIMAGE, V80, P80, DOI 10.1016/j.neuroimage.2013.05.012; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Wang SJ, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00017; Ward HA, 2002, MAGNET RESON MED, V48, P771, DOI 10.1002/mrm.10259; Weston PSJ, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0132-3; Wu M, 2008, LECT NOTES COMPUT SC, V5242, P321, DOI 10.1007/978-3-540-85990-1_39; Yeo DTB, 2007, MAGN RESON IMAGING, V25, P1263, DOI 10.1016/j.mri.2007.02.001; Zaitsev M, 2004, MAGNET RESON MED, V52, P1156, DOI 10.1002/mrm.20261; Zeng HR, 2002, MAGN RESON MED, V48, P137, DOI 10.1002/mrm.10200; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhou XHJ, 1998, MAGNET RESON MED, V39, P596, DOI 10.1002/mrm.1910390413	64	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185647	10.1371/journal.pone.0185647	http://dx.doi.org/10.1371/journal.pone.0185647			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968429	Green Published, Green Submitted, gold			2022-12-27	WOS:000412029600034
J	Van Slooten, JC; Jahfari, S; Knapen, T; Theeuwes, J				Van Slooten, Joanne C.; Jahfari, Sara; Knapen, Tomas; Theeuwes, Jan			Individual differences in eye blink rate predict both transient and tonic pupil responses during reversal learning	PLOS ONE			English	Article							LOCUS-COERULEUS; PARKINSONS-DISEASE; DOPAMINE FUNCTION; DECISION-MAKING; ADAPTIVE GAIN; REWARD; MODULATION; MODELS; PUPILLOMETRY; SENSITIVITY	The pupil response under constant illumination can be used as a marker of cognitive processes. In the past, pupillary responses have been studied in the context of arousal and decision-making. However, recent work involving Parkinson's patients suggested that pupillary responses are additionally affected by reward sensitivity. Here, we build on these findings by examining how pupil responses are modulated by reward and loss while participants (N = 30) performed a Pavlovian reversal learning task. In fast (transient) pupil responses, we observed arousal-based influences on pupil size both during the expectation of upcoming value and the evaluation of unexpected monetary outcomes. Importantly, after incorporating eye blink rate (EBR), a behavioral correlate of striatal dopamine levels, we observed that participants with lower EBR showed stronger pupil dilation during the expectation of upcoming reward. Subsequently, when reward expectations were violated, participants with lower EBR showed stronger pupil responses after experiencing unexpected loss. Across trials, the detection of a reward contingency reversal was reflected in a slow (tonic) dilatory pupil response observed already several trials prior to the behavioral report. Interestingly, EBR correlated positively with this tonic detection response, suggesting that variability in the arousal-based detection response may reflect individual differences in striatal dopaminergic tone. Our results provide evidence that a behavioral marker of baseline striatal dopamine level (EBR) can potentially be used to describe the differential effects of value-based learning in the arousal-based pupil response.	[Van Slooten, Joanne C.; Jahfari, Sara; Knapen, Tomas; Theeuwes, Jan] Vrije Univ Amsterdam, Dept Appl & Expt Psychol, Amsterdam, Noord Holland, Netherlands	Vrije Universiteit Amsterdam	Van Slooten, JC (corresponding author), Vrije Univ Amsterdam, Dept Appl & Expt Psychol, Amsterdam, Noord Holland, Netherlands.	joannevslooten@gmail.com	Knapen, Tomas/H-4431-2019; Theeuwes, Jan/ABF-3771-2020	Knapen, Tomas/0000-0001-5863-8689; Theeuwes, Jan/0000-0002-5849-7721	European Research Council [ERC-2012-AdG-323413]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by ERC-2012-AdG-323413, https://erc.europa.eu, European Research Council, to JT.	[Anonymous], 1993, INTRO BOOTSTRAP; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; AstonJones G, 1997, NEUROSCIENCE, V80, P697, DOI 10.1016/S0306-4522(97)00060-2; Balleine B. W., 2008, NEUROECONOMICS DECIS, V36, P7; Barbato G, 2000, PSYCHIAT RES, V93, P145, DOI 10.1016/S0165-1781(00)00108-6; Braem S, 2015, COGN AFFECT BEHAV NE, V15, P374, DOI 10.3758/s13415-014-0333-4; Bray S, 2008, J NEUROSCI, V28, P5861, DOI 10.1523/JNEUROSCI.0897-08.2008; Browning M, 2015, NAT NEUROSCI, V18, P590, DOI 10.1038/nn.3961; CASEY DE, 1980, BRAIN RES BULL, V5, P269, DOI 10.1016/0361-9230(80)90044-1; Cavanagh JF, 2014, J EXP PSYCHOL GEN, V143, P1476, DOI 10.1037/a0035813; Cavanagh JF, 2014, NATURE COMMUNICATION, V5, P1; Chen WH, 2003, CLIN NEUROL NEUROSUR, V105, P90, DOI 10.1016/S0303-8467(02)00107-5; Cohen MX, 2014, ISS CLIN COGN NEUROP, P1; Colzato LS, 2008, NEUROPSYCHOLOGIA, V46, P3179, DOI 10.1016/j.neuropsychologia.2008.07.006; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Cools R, 2015, CURR OPIN BEHAV SCI, V4, P152, DOI 10.1016/j.cobeha.2015.05.007; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dang LC, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0211-17.2017; de Gee JW, 2014, P NATL ACAD SCI USA, V111, pE618, DOI 10.1073/pnas.1317557111; Dirnberger G, 2013, J NEUROPSYCHOL, V7, P193, DOI 10.1111/jnp.12028; Doughty Michael J, 2006, Eye Contact Lens, V32, P294, DOI 10.1097/01.icl.0000224359.32709.4d; Doughty MJ, 2001, OPTOMETRY VISION SCI, V78, P712, DOI 10.1097/00006324-200110000-00011; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; Eldar E, 2013, NAT NEUROSCI, V16, P1146, DOI 10.1038/nn.3428; ELSWORTH JD, 1991, J PHARMACOL EXP THER, V259, P595; Frank MJ, 2006, BEHAV NEUROSCI, V120, P497, DOI 10.1037/0735-7044.120.3.497; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Fruend I, 2011, J VISION, V11, DOI 10.1167/11.6.16; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Giza E, 2011, INT J NEUROSCI, V121, P37, DOI 10.3109/00207454.2010.526730; GRAMFORT A, 2013, FRONTIERS NEUROSCI, V7, P1, DOI DOI 10.3389/FNINS.2013.00267; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; Gratwicke J, 2015, BRAIN, V138, P1454, DOI 10.1093/brain/awv104; Groman SM, 2014, J NEUROSCI, V34, P14443, DOI 10.1523/JNEUROSCI.3037-14.2014; HOEKS B, 1993, BEHAV RES METH INSTR, V25, P16, DOI 10.3758/BF03204445; Hupe JM, 2009, J VISION, V9, DOI 10.1167/9.7.10; Jepma M, 2011, J COGNITIVE NEUROSCI, V23, P1587, DOI 10.1162/jocn.2010.21548; Jiang XT, 2013, BEHAV RES METHODS, V45, P656, DOI 10.3758/s13428-012-0294-x; Jongkees BJ, 2016, NEUROSCI BIOBEHAV R, V71, P58, DOI 10.1016/j.neubiorev.2016.08.020; Joshi S, 2016, NEURON, V89, P221, DOI 10.1016/j.neuron.2015.11.028; Jutkiewicz EM, 2004, J PHARMACOL EXP THER, V311, P1008, DOI 10.1124/jpet.104.071092; Kahneman D, 1979, ECONOMETRICA, V2, P1; Kaminer J, 2011, J NEUROSCI, V31, P11256, DOI 10.1523/JNEUROSCI.6218-10.2011; KARSON CN, 1983, BRAIN, V106, P643, DOI 10.1093/brain/106.3.643; Kleven MS, 1996, J PHARMACOL EXP THER, V279, P1211; Knapen T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155574; Korn CW, 2016, J VISION, V16, DOI 10.1167/16.3.28; Kruis A, 2016, PSYCHOPHYSIOLOGY, V53, P749, DOI 10.1111/psyp.12619; LAWRENCE MS, 1991, PHARMACOL BIOCHEM BE, V38, P869, DOI 10.1016/0091-3057(91)90255-Z; Macmillan NA, 2005, DETECTION THEORY USE; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; Manohar SG, 2015, NPJ PARKINSONS DIS, V1, P1; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Micieli G, 1991, Clin Auton Res, V1, P55, DOI 10.1007/BF01826058; Muhammed K, 2016, BRAIN, V139, P2706, DOI 10.1093/brain/aww188; Murphy PR, 2014, HUM BRAIN MAPP, V35, P4140, DOI 10.1002/hbm.22466; Nassar MR, 2012, NAT NEUROSCI, V15, P1040, DOI 10.1038/nn.3130; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2006, NEURON, V49, P157, DOI 10.1016/j.neuron.2005.11.014; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2008, ENCY NEUROSCIENCE, P4158; O'Reilly JX, 2013, P NATL ACAD SCI USA, V110, pE3660, DOI 10.1073/pnas.1305373110; Pauli WM, 2015, J NEUROSCI, V35, P14220, DOI 10.1523/JNEUROSCI.2277-15.2015; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; Prevost C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002918; Raisig S, 2010, INT J PSYCHOPHYSIOL, V76, P1, DOI 10.1016/j.ijpsycho.2010.01.006; Rajkowski J., 1993, Society for Neuroscience Abstracts, V19, P974; Rudebeck PH, 2014, P NATL ACAD SCI USA, V111, P5391, DOI 10.1073/pnas.1317695111; Sadacca BF, 2017, NEUROSCIENCE, V345, P124, DOI 10.1016/j.neuroscience.2016.04.017; SAID SE, 1984, BIOMETRIKA, V71, P599; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Satterthwaite TD, 2007, NEUROIMAGE, V37, P1017, DOI 10.1016/j.neuroimage.2007.04.066; Seymour B, 2007, J NEUROSCI, V27, P4826, DOI 10.1523/JNEUROSCI.0400-07.2007; Sforza C, 2008, OPHTHAL PHYSL OPT, V28, P345, DOI 10.1111/j.1475-1313.2008.00577.x; Slagter HA, 2015, NEUROPSYCHOLOGIA, V71, P126, DOI 10.1016/j.neuropsychologia.2015.03.028; Sun WS, 1997, INVEST OPHTH VIS SCI, V38, P92; Taylor JR, 1999, EXP NEUROL, V158, P214, DOI 10.1006/exnr.1999.7093; Wang CA, 2015, CURR OPIN NEUROBIOL, V33, P134, DOI 10.1016/j.conb.2015.03.018	82	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185665	10.1371/journal.pone.0185665	http://dx.doi.org/10.1371/journal.pone.0185665			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MG	28961277	Green Published, Green Submitted, gold			2022-12-27	WOS:000412027700031
J	Hazarika, M; Borah, D; Bora, P; Silva, AR; Das, P				Hazarika, Munmi; Borah, Debajit; Bora, Popymita; Silva, Ana R.; Das, Pankaj			Biogenic synthesis of palladium nanoparticles and their applications as catalyst and antimicrobial agent	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; CROSS-COUPLING REACTION; PD NANOPARTICLES; IN-SITU; GREEN SYNTHESIS; HETEROGENEOUS CATALYST; METAL NANOPARTICLES; RECYCLABLE CATALYST; SELECTIVE OXIDATION; HEXAVALENT CHROMIUM	This paper describes a simple in-situ process of synthesizing highly dispersed palladium nanoparticles (PdNPs) using aqueous leaf extract of GarciniapedunculataRoxb as bioreductant and starch (0.3%) as bio-stabilizer. The PdNPs are characterized by techniques like FTIR, TEM, SEM-EDX, XRD and XPS analysis. It is worthnoting thatwhen the synthesis of nanoparticles was carried out in absence of starch, agglomeration of particles has been noticed. The starch-assisted PdNPs showed excellent aqueous-phase catalytic activities for three important reactions: the Suzuki-Miyaura cross-coupling reactions of aryl halides (aryl bromides and iodides) with arylboronic acids; selective oxidations of alcohols to corresponding carbonyl compounds; and reduction of toxic Cr(VI) to nontoxic Cr(III). Our catalyst could be reused up to four cycles without much compromising with its activity. Furthermore, the material also demonstrated excellent antimicrobial and anti-biofilm activities against a novel multidrug resistant clinical bacterial isolate Cronobactersakazakii strain AMD04. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of PdNPswere found to be 0.06 and 0.12 mM respectively.	[Hazarika, Munmi; Das, Pankaj] Dibrugarh Univ, Dept Chem, Dibrugarh, Assam, India; [Borah, Debajit; Bora, Popymita] Dibrugarh Univ, Ctr Biotechnol & Bioinformat, Dibrugarh, Assam, India; [Silva, Ana R.] Univ Aveiro, CICECO Aveiro Inst Mat, Aveiro, Portugal	Dibrugarh University; Dibrugarh University; Universidade de Aveiro	Das, P (corresponding author), Dibrugarh Univ, Dept Chem, Dibrugarh, Assam, India.	pankajd29@yahoo.com	Silva, Ana Rosa/F-6174-2011	Silva, Ana Rosa/0000-0002-1673-2164	Department of Biotechnology [MED/2013/23]; UGC, New Delhi	Department of Biotechnology; UGC, New Delhi(University Grants Commission, India)	The Department of Biotechnology is gratefully acknowledged for financial support (Grant no:MED/2013/23) under DBT-Twinning programme and also for providing Delcon as well as IBT hub facility to the Centre for Biotechnology and Bioinformatics, Dibrugarh University. The UGC, New Delhi has also been acknowledged for the SAP-DRS-I grant awarded to the Department of Chemistry.; The Department of Biotechnology is gratefully acknowledged for financial support (Grant no: MED/2013/23) under DBT-Twinning programme and also for providing Delcon as well as IBT hub facility to the Centre for Biotechnology and Bioinformatics, Dibrugarh University. The UGC, New Delhi has also been acknowledged for the SAP-DRS-I grant awarded to the Department of Chemistry. The service of SAIF, NEHU, Shillong was gratefully acknowledged for TEM analysis. Dr. S. Pramanik was acknowledged for English editing in the revised manuscript.	Adams CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085981; Aditya T, 2015, CHEM COMMUN, V51, P9410, DOI 10.1039/c5cc01131k; Akhtar MS, 2013, ACS SUSTAIN CHEM ENG, V1, P591, DOI 10.1021/sc300118u; Bankar A, 2010, MATER LETT, V64, P1951, DOI 10.1016/j.matlet.2010.06.021; Basavegowda N, 2015, NEW J CHEM, V39, P972, DOI 10.1039/c4nj01543f; Brun M, 1999, J ELECTRON SPECTROSC, V104, P55, DOI 10.1016/S0368-2048(98)00312-0; Costa NJS, 2012, NANOSCALE, V4, P5826, DOI 10.1039/c2nr31165h; Das P, 2016, COORDIN CHEM REV, V311, P1, DOI 10.1016/j.ccr.2015.11.010; Dauthal P, 2016, IND ENG CHEM RES, V55, P9557, DOI 10.1021/acs.iecr.6b00861; Davis SE, 2013, GREEN CHEM, V15, P17, DOI 10.1039/c2gc36441g; Duran N, 2007, J BIOMED NANOTECHNOL, V3, P203, DOI 10.1166/jbn.2007.022; Dwivedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111289; Gogoi N, 2017, CATAL LETT, V147, P539, DOI 10.1007/s10562-016-1937-9; Indian Herbal Remedies, 2004, RAT W THER AYURV OTH; Kalidhasan S, 2016, COORDIN CHEM REV, V317, P157, DOI 10.1016/j.ccr.2016.03.004; Kelly MA, 2015, FUNDAMENTALS SCI RES; Khan M, 2014, DALTON T, V43, P9026, DOI 10.1039/c3dt53554a; Lennox AJJ, 2014, CHEM SOC REV, V43, P412, DOI 10.1039/c3cs60197h; Li ZP, 2010, J PHYS CHEM C, V114, P723, DOI 10.1021/jp907745v; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Mondal M, 2016, CHEMISTRYSELECT, V1, P4645, DOI 10.1002/slct.201600385; Mudoi T., 2012, International Journal of PharmTech Research, V4, P334; Narayanan KB, 2011, ADV COLLOID INTERFAC, V169, P59, DOI 10.1016/j.cis.2011.08.004; Nasrollahzadeh M, 2016, J COLLOID INTERF SCI, V469, P191, DOI 10.1016/j.jcis.2016.02.024; Nasrollahzadeh M, 2016, J COLLOID INTERF SCI, V462, P243, DOI 10.1016/j.jcis.2015.09.065; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Papavlassopoulos H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084983; Parker HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087192; Parmeggiani C, 2012, GREEN CHEM, V14, P547, DOI 10.1039/c2gc16344f; Pramanik S, 2017, CHEMISTRYSELECT, V2, P4577, DOI 10.1002/slct.201700714; Qazi F, 2016, RSC ADV, V6, P60277, DOI 10.1039/c6ra11695g; Qazi SJS, 2009, J COLLOID INTERF SCI, V338, P105, DOI 10.1016/j.jcis.2009.06.006; Rana S, 2015, APPL CATAL A-GEN, V505, P539, DOI 10.1016/j.apcata.2015.07.018; Sadik OA, 2014, J CHEM EDUC, V91, P269, DOI 10.1021/ed300229r; Sahu D, 2016, CATAL COMMUN, V86, P32, DOI 10.1016/j.catcom.2016.08.005; Sahu D, 2015, RSC ADV, V5, P3512, DOI 10.1039/c4ra11186a; Saikia PK, 2016, RSC ADV, V6, P110011, DOI 10.1039/c6ra22788k; Sarmah M, 2017, CATAL COMMUN, V90, P31, DOI 10.1016/j.catcom.2016.10.034; Sarmah M, 2016, RSC ADV, V6, P28981, DOI 10.1039/c6ra00454g; Shabbir S, 2017, J ORGANOMET CHEM, V846, P296, DOI 10.1016/j.jorganchem.2017.07.003; Shaik MR, 2017, MOLECULES, V22, DOI 10.3390/molecules22010165; Sheldon RA, 2015, CATAL TODAY, V247, P4, DOI 10.1016/j.cattod.2014.08.024; Singha S, 2011, DALTON T, V40, P7130, DOI 10.1039/c1dt10697j; Takeoka H, 2014, POLYM J, V46, P704, DOI 10.1038/pj.2014.44; U. S. Department of Health and Human Services-Food and Drug Administration, 2015, Q3D EL IMP GUID IND; Vishnukumar P, 2017, CHEMBIOENG REV, V4, P18, DOI 10.1002/cben.201600017; Wahab R, 2016, RSC ADV, V6, P32328, DOI 10.1039/c6ra05297e; Wahab R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19950; Wahab R, 2014, COLLOID SURFACE B, V123, P664, DOI 10.1016/j.colsurfb.2014.10.012; Wahab R, 2014, COLLOID SURFACE B, V117, P267, DOI 10.1016/j.colsurfb.2014.02.038; Xin X, 2014, PLOS ONE, V9; Yu QL, 2016, SCI REP-UK, V6, DOI 10.1038/srep26667	52	69	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184936	10.1371/journal.pone.0184936	http://dx.doi.org/10.1371/journal.pone.0184936			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957342	Green Submitted, gold, Green Published			2022-12-27	WOS:000411985200023
J	Lee, S; Jung, M; Jung, J; Park, K; Ryu, JW; Kim, J; Kim, DS				Lee, Sugi; Jung, Minah; Jung, Jaeeun; Park, Kunhyang; Ryu, Jea-Woon; Kim, Jeongkil; Kim, Dae-soo			Gene selection tool (GST): A R-based tool for genetic disorders based on the sliding-window proportion test using whole-exome sequencing data	PLOS ONE			English	Article							LINKAGE	Whole-exome sequencing (WES) can identify causative mutations in hereditary diseases. However, WES data might have a large candidate variant list, including false positives. Moreover, in families, it is more difficult to select disease-associated variants because many variants are shared among members. To reduce false positives and extract accurate candidates, we used a multilocus variant instead of a single-locus variant (SNV). We set up a specific window to analyze the multilocus variant and devised a sliding-window approach to observe all variants. We developed the gene selection tool (GST) based on proportion tests for linkage analysis using WES data. This tool is R program coded and has high sensitivity. We tested our code to find the gene for hereditary spastic paraplegia using SNVs from a specific family and identified the gene known to cause the disease in a significant gene list. The list identified other genes that might be associated with the disease.	[Lee, Sugi; Jung, Minah; Jung, Jaeeun; Kim, Jeongkil; Kim, Dae-soo] Korea Univ Sci & Technol UST, KRIBB Sch Biosci, Dept Bioinformat, Daejeon, South Korea; [Lee, Sugi; Jung, Minah; Jung, Jaeeun; Ryu, Jea-Woon; Kim, Jeongkil; Kim, Dae-soo] KRIBB, Dept Rare Dis Res Ctr, Daejeon, South Korea; [Park, Kunhyang] KRIBB, Core Facil Management Ctr, Daejeon, South Korea	University of Science & Technology (UST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, DS (corresponding author), Korea Univ Sci & Technol UST, KRIBB Sch Biosci, Dept Bioinformat, Daejeon, South Korea.; Kim, DS (corresponding author), KRIBB, Dept Rare Dis Res Ctr, Daejeon, South Korea.	kds2465@kribb.re.kr			Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2014M3C9A2064618]; KRIBB Research Initiative Program; Ministry of Education, Science and Technology [NRF-2014M3C9A2064618]	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea); KRIBB Research Initiative Program; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2014M3C9A2064618 to DK), and by the KRIBB Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to researchers at KRIBB's Rare Disease Research Center for your help. All authors read and approved the final manuscript. The work was supported by Ministry of Education, Science and Technology NRF-2014M3C9A2064618.	Finch SJ, 2001, GENET EPIDEMIOL, V21, P315, DOI 10.1002/gepi.1037; Flaquer Antonia, 2012, BMC Res Notes, V5, P411, DOI 10.1186/1756-0500-5-411; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; MORTON NE, 1955, AM J HUM GENET, V7, P277; Ott J, 2015, NAT REV GENET, V16, P275, DOI 10.1038/nrg3908; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Penrose LS, 1935, ANN EUGENIC, V4, P133; Rijsdijk FV, 2001, EUR J HUM GENET, V9, P335, DOI 10.1038/sj.ejhg.5200634; Yang HC, 2006, GENET EPIDEMIOL, V30, P531, DOI 10.1002/gepi.20165	9	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185514	10.1371/journal.pone.0185514	http://dx.doi.org/10.1371/journal.pone.0185514			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957403	gold, Green Published, Green Submitted			2022-12-27	WOS:000411985200073
J	Martinez-Martinez, N; Martinez-Alonso, E; Tomas, M; Neumuller, J; Pavelka, M; Martinez-Menarguez, JA				Martinez-Martinez, Narcisa; Martinez-Alonso, Emma; Tomas, Monica; Neumueller, Josef; Pavelka, Margit; Martinez-Menarguez, Jose A.			A new insight into the three-dimensional architecture of the Golgi complex: Characterization of unusual structures in epididymal principal cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; ELECTRON TOMOGRAPHY; MAMMALIAN GOLGI; APPARATUS; RAT; TRANSPORT; DYNAMICS; REVEALS; TUBULES; SITES	Principal epididymal cells have one of the largest and more developed Golgi complex of mammalian cells. In the present study, we have used this cell as model for the study of the three-dimensional architecture of the Golgi complex of highly secretory and endocytic cells. Electron tomography demonstrated the presence in this cell type of some unknown or very unusual Golgi structures such as branched cisternae, pocket-like cisternal invaginations or tubular connections. In addition, we have used this methodology and immunoelectron microscopy to analyze the close relationship between this organelle and both the endoplasmic reticulum and microtubules, and to describe in detail how these elements interact with compact and non-compact regions of the ribbon.	[Martinez-Martinez, Narcisa; Martinez-Alonso, Emma; Martinez-Menarguez, Jose A.] Univ Murcia, Biomed Res Inst Murcia IMIB Arrixaca UMU, Dept Cell Biol & Histol, Murcia, Spain; [Martinez-Martinez, Narcisa] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, York Ave, New York, NY 10021 USA; [Tomas, Monica] Univ Valencia, Med Sch, Dept Human Anat & Embryol, Valencia, Spain; [Neumueller, Josef; Pavelka, Margit] Med Univ Vienna, Dept Cell & Dev Biol, Ctr Anat & Cell Biol, Schwarzspanierstr 17, Vienna, Austria	University of Murcia; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; University of Valencia; Medical University of Vienna	Martinez-Menarguez, JA (corresponding author), Univ Murcia, Biomed Res Inst Murcia IMIB Arrixaca UMU, Dept Cell Biol & Histol, Murcia, Spain.	jamartin@um.es	CABALLERO, MONICA TOMAS/R-1275-2017; ALONSO, EMMA MARTINEZ/L-7468-2014	CABALLERO, MONICA TOMAS/0000-0003-2696-1726; ALONSO, EMMA MARTINEZ/0000-0002-8121-0442				Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Beznoussenko GV, 2014, ELIFE, V3, DOI 10.7554/eLife.02009; Bouchet-Marquis C, 2008, J MICROSC-OXFORD, V230, P308, DOI 10.1111/j.1365-2818.2008.01988.x; Dacheux JL, 2014, REPRODUCTION, V147, pR27, DOI 10.1530/REP-13-0420; Day KJ, 2013, HISTOCHEM CELL BIOL, V140, P239, DOI 10.1007/s00418-013-1128-3; de Forges H, 2012, INT J BIOCHEM CELL B, V44, P266, DOI 10.1016/j.biocel.2011.11.009; De Matteis MA, 2015, CURR OPIN CELL BIOL, V35, P43, DOI 10.1016/j.ceb.2015.04.001; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Frey TG, 2006, ANNU REV BIOPH BIOM, V35, P199, DOI 10.1146/annurev.biophys.35.040405.102039; Glick BS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005215; Gurel PS, 2014, CURR BIOL, V24, pR660, DOI 10.1016/j.cub.2014.05.033; HERMO L, 1991, ANAT RECORD, V229, P159, DOI 10.1002/ar.1092290203; Hermo L, 1998, HISTOCHEM CELL BIOL, V109, P431, DOI 10.1007/s004180050246; JA M-M, 2013, INTRAGOLGI TRANSPORT; Klumperman J, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005181; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Ladinsky MS, 2002, MOL BIOL CELL, V13, P2810, DOI 10.1091/mbc.01-12-0593; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Luini A, 2016, CURR OPIN CELL BIOL, V39, P37, DOI 10.1016/j.ceb.2016.01.014; Marsh BJ, 2005, BBA-MOL CELL RES, V1744, P273, DOI 10.1016/j.bbamcr.2005.04.002; Marsh BJ, 2004, P NATL ACAD SCI USA, V101, P5565, DOI 10.1073/pnas.0401242101; Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998; Marsh BJ, 2013, METHOD CELL BIOL, V118, P259, DOI 10.1016/B978-0-12-417164-0.00016-1; Martinez-Alonso E, 2005, TRAFFIC, V6, P32, DOI 10.1111/j.1600-0854.2004.00242.x; Martinez-Alonso E, 2013, HISTOCHEM CELL BIOL, V140, P327, DOI 10.1007/s00418-013-1114-9; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; MartinezMenarguez JA, 1996, EUR J CELL BIOL, V71, P137; Mironov AA, 2016, TISSUE CELL; Mironov AA, 2008, GOLGI APPARATUS STAT; Mogelsvang S, 2004, TRAFFIC, V5, P338, DOI 10.1111/j.1398-9219.2004.00186.x; Papanikou E, 2014, CURR OPIN CELL BIOL, V29, P74, DOI 10.1016/j.ceb.2014.04.010; Ranftler C, 2016, HIST CHEM CELL BIOLO; Rios RM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0462; Robaire B, 1988, PHYSL REPROD; Fernandez-Fernandez MR, 2017, J CELL SCI, V130, P83, DOI 10.1242/jcs.188060; Zeuschner D, 2006, NAT CELL BIOL, V8, P377, DOI 10.1038/ncb1371	36	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185557	10.1371/journal.pone.0185557	http://dx.doi.org/10.1371/journal.pone.0185557			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957389	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200085
J	Matus, V; Valenzuela, JG; Hidalgo, P; Pozo, LM; Panes, O; Wozniak, A; Mezzano, D; Pereira, J; Saez, CG				Matus, Valeria; Guillermo Valenzuela, J.; Hidalgo, Patricia; Maria Pozo, L.; Panes, Olga; Wozniak, Aniela; Mezzano, Diego; Pereira, Jaime; Saez, Claudia G.			Human platelet interaction with E-coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4	PLOS ONE			English	Article							HEPARIN-INDUCED THROMBOCYTOPENIA; MESSENGER-RNA; BACTERIAL LPS; SHIGA-TOXIN; IN-VIVO; ACTIVATION; EXPRESSION; INFECTION; INFLAMMATION; THROMBIN	Platelets have a major role in clotting activation and contribute to the innate immune response during systemic infections. Human platelets contain tissue factor (TF) and express functional Toll-like receptor 4 (TLR4). However, the role of TLR4 in triggering the procoagulant properties of platelets, upon challenge with bacteria, is yet unknown. Our hypothesis is that E. coli O111-TLR4 interaction activates platelets and elicits their procoagulant activity. We demonstrated that the strain, but not ultrapure LPS, increased surface P-selectin expression, platelet dependent TF procoagulant activity (TF-PCA) and prompted a faster thrombin generation (TG). Blockade of TLR4 resulted in decreased platelet activation, TF-PCA and TG, revealing the participation of this immune receptor on the procoagulant response of platelets. Our results provide a novel mechanism by which individuals with bacterial infections would have an increased incidence of blood clots. Furthermore, the identification of platelet TF and TLR4 as regulators of the effect of E. coli O111 might represent a novel therapeutic target to reduce the devastating consequences of the hemostatic disorder during sepsis.	[Matus, Valeria; Guillermo Valenzuela, J.; Hidalgo, Patricia; Maria Pozo, L.; Panes, Olga; Mezzano, Diego; Pereira, Jaime; Saez, Claudia G.] Pontificia Univ Catolica Chile, Sch Med, Dept Hematol Oncol, Santiago, Chile; [Wozniak, Aniela] Pontificia Univ Catolica Chile, Sch Med, Dept Clin Lab, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Saez, CG (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Dept Hematol Oncol, Santiago, Chile.	saez@med.puc.cl	Saez, Claudia/HCI-4472-2022; Mezzano, Diego/G-4142-2013	Saez, Claudia/0000-0001-7183-1491; Mezzano, Diego/0000-0003-2448-9288	"Fondo Nacional de Desarrollo Cientifico y Tecnologico", FONDECYT Chile [1130835]	"Fondo Nacional de Desarrollo Cientifico y Tecnologico", FONDECYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by "Fondo Nacional de Desarrollo Cientifico y Tecnologico", FONDECYT Chile, Award Number 1130835, Grant Recipient: Valeria Matus R, PhD.	Arbesu I, 2016, J THROMB HAEMOST, V14, P2241, DOI 10.1111/jth.13495; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; Baker M, 2011, NATURE, V475, P123, DOI 10.1038/475123a; Berthet J, 2012, CLIN IMMUNOL, V145, P189, DOI 10.1016/j.clim.2012.09.004; Brambilla M, 2015, THROMB HAEMOSTASIS, V114, P579, DOI 10.1160/TH14-10-0830; Brooks JT, 2004, CLIN INFECT DIS, V38, P190, DOI 10.1086/380634; Camera M, 2003, ARTERIOSCL THROM VAS, V23, P1690, DOI 10.1161/01.ATV.0000085629.23209.AA; Celes MRN, 2013, PATHOBIOLOGY, V80, P70, DOI 10.1159/000341640; Chen D, 2009, J THROMB HAEMOST, V7, P122, DOI 10.1111/j.1538-7836.2009.03413.x; CHONG BH, 1989, BRIT J HAEMATOL, V73, P235, DOI 10.1111/j.1365-2141.1989.tb00258.x; Cognasse F, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00083; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Cox D, 2011, J THROMB HAEMOST, V9, P1097, DOI 10.1111/j.1538-7836.2011.04264.x; Ding N, 2014, CIRC-CARDIOVASC GENE, V7, P615, DOI 10.1161/CIRCGENETICS.113.000398; Ford I, 1997, PLATELETS, V8, P285; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Freudenberg MA, 2001, MICROBES INFECT, V3, P1213, DOI 10.1016/S1286-4579(01)01481-2; Harrison P, 2016, PLATELETS, V27, P1, DOI 10.3109/09537104.2015.1129225; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Italiano JE, 2010, CURR OPIN HEMATOL, V17, P578, DOI 10.1097/MOH.0b013e32833e77ee; Jenne CN, 2015, PLATELETS, V26, P286, DOI 10.3109/09537104.2015.1010441; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kappelmayer J, 2013, J THROMB HAEMOST, V11, P775, DOI 10.1111/jth.12151; Kerrigan SW, 2010, CELL MOL LIFE SCI, V67, P513, DOI 10.1007/s00018-009-0207-z; Kim KS, 2012, CURR OPIN INFECT DIS, V25, P273, DOI 10.1097/QCO.0b013e3283521eb0; Leslie M, 2010, SCIENCE, V328, P562, DOI 10.1126/science.328.5978.562; Levi M, 2006, SEMIN THROMB HEMOST, V32, P33, DOI 10.1055/s-2006-933338; Moriarty RD, 2016, J THROMB HAEMOST, V14, P797, DOI 10.1111/jth.13226; Panes O, 2007, BLOOD, V109, P5242, DOI 10.1182/blood-2006-06-030619; Panes O, 2017, ATHEROSCLEROSIS, V257, P164, DOI 10.1016/j.atherosclerosis.2016.12.019; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Rank A, 2010, THROMB RES, V126, pE255, DOI 10.1016/j.thromres.2010.07.012; Rollin J, 2016, THROMB HAEMOSTASIS, V116, P799, DOI 10.1160/TH16-02-0109; Rondina MT, 2011, J THROMB HAEMOST, V9, P748, DOI 10.1111/j.1538-7836.2011.04208.x; Rosadini CV, 2017, CURR OPIN IMMUNOL, V44, P14, DOI 10.1016/j.coi.2016.10.005; Schwertz H, 2006, J EXP MED, V203, P2433, DOI 10.1084/jem.20061302; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shiraki R, 2004, THROMB RES, V113, P379, DOI 10.1016/j.thromres.2004.03.023; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Vandijck DM, 2010, HEART LUNG, V39, P21, DOI 10.1016/j.hrtlng.2009.07.005; Vidal M, 2005, J CLIN MICROBIOL, V43, P5362, DOI 10.1128/JCM.43.10.5362-5365.2005; Ward JR, 2005, THROMB HAEMOSTASIS, V94, P831, DOI 10.1160/TH05-01-0009; Watahiki M, 2014, J CLIN MICROBIOL, V52, P2757, DOI 10.1128/JCM.00420-14	44	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185431	10.1371/journal.pone.0185431	http://dx.doi.org/10.1371/journal.pone.0185431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957360	Green Submitted, Green Published, gold			2022-12-27	WOS:000411985200057
J	Moran, EV; Reid, A; Levine, JM				Moran, Emily V.; Reid, Andrea; Levine, Jonathan M.			Population genetics and adaptation to climate along elevation gradients in invasive Solidago canadensis	PLOS ONE			English	Article							RANGE EXPANSION; SPECIES RANGE; EXPERIMENTAL DEMOGRAPHY; SEXUAL REPRODUCTION; MICROSATELLITE LOCI; INCREASES FITNESS; FOREST TREES; PLANT; EVOLUTION; FLOW	Gene flow between populations may either support local adaptation by supplying genetic variation on which selection may act, or counteract it if maladapted alleles arrive faster than can be purged by selection. Although both such effects have been documented within plant species' native ranges, how the balance of these forces influences local adaptation in invasive plant populations is less clear, in part because introduced species often have lower genetic variation initially but also tend to have good dispersal abilities. To evaluate the extent of gene flow and adaptation to local climate in invasive populations of Solidago canadensis, and the implications of this for range expansion, we compared population differentiation at microsatellite and chloroplast loci for populations across Switzerland and assessed the effect of environmental transfer distance using common gardens. We found that while patterns of differentiation at neutral genetic markers suggested that populations are connected through extensive pollen and seed movement, common-garden plants nonetheless exhibited modest adaptation to local climate conditions. Growth rate and flower production declined with climatic distance from a plant's home site, with clones from colder home sites performing better at or above the range limit. Such adaptation in invasive species is likely to promote further spread, particularly under climate change, as the genotypes positioned near the range edge may be best able to take advantage of lengthening growing seasons to expand the range.	[Moran, Emily V.] Univ Calif Merced, Life & Environm Sci, Merced, CA 95340 USA; [Reid, Andrea; Levine, Jonathan M.] Swiss Fed Inst Technol, Biol, Zurich, Switzerland	University of California System; University of California Merced; Swiss Federal Institutes of Technology Domain; ETH Zurich	Moran, EV (corresponding author), Univ Calif Merced, Life & Environm Sci, Merced, CA 95340 USA.	emoran5@ucmerced.edu	Levine, Jonathan/A-7167-2014	Moran, Emily/0000-0003-4624-1910	CCES (ETH Competence Center for Environment and Sustainability project GeneMig); Zurich-Basel Plant Science Center	CCES (ETH Competence Center for Environment and Sustainability project GeneMig); Zurich-Basel Plant Science Center	This work was supported by CCES (ETH Competence Center for Environment and Sustainability project GeneMig) and the Plant Fellows program of the Zurich-Basel Plant Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by CCES (ETH Competence Center for Environment and Sustain ability project GeneMig) and the Plant Fellows program of the Zurich-Basel Plant Science Center. We would also like to thank the Gemeinde of Untervaz and BAFU (Swiss Federal Office for the Environment) for allowing us to conduct the common garden experiment, and to Janine Bolliger at WSL for providing the climate data. All molecular work was conducted at the ETH Genetic Diversity Centre (GDC) in Zurich.	Alexander JM, 2009, DIVERS DISTRIB, V15, P502, DOI 10.1111/j.1472-4642.2008.00555.x; Beck JB, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1500014; Becker T, 2005, PERSPECT PLANT ECOL, V7, P173, DOI 10.1016/j.ppees.2005.09.006; Bell G, 2009, ECOL LETT, V12, P942, DOI 10.1111/j.1461-0248.2009.01350.x; Bolliger J, 2000, REG ENVIRON CHANGE, V1, P99, DOI 10.1007/s101130000018; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Bridle JR, 2010, ECOL LETT, V13, P485, DOI 10.1111/j.1461-0248.2010.01442.x; Bridle JR, 2009, P ROY SOC B-BIOL SCI, V276, P1507, DOI 10.1098/rspb.2008.1601; Chun YJ, 2010, NEW PHYTOL, V185, P1100, DOI 10.1111/j.1469-8137.2009.03129.x; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; Colautti RI, 2013, SCIENCE, V342, P364, DOI 10.1126/science.1242121; Dawson MN, 2010, MOL ECOL, V19, P1585, DOI 10.1111/j.1365-294X.2010.04588.x; Diniz JAF, 2013, GENET MOL BIOL, V36, P475, DOI 10.1590/S1415-47572013000400002; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; Dong M, 2006, PLANT SPEC BIOL, V21, P13, DOI 10.1111/j.1442-1984.2006.00146.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Ferrer MM, 2007, NEW PHYTOL, V173, P401, DOI 10.1111/j.1469-8137.2006.01905.x; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; Gelfand AE, 1998, BIOMETRIKA, V85, P1, DOI 10.1093/biomet/85.1.1; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Griffith TM, 2006, AM NAT, V167, P153, DOI 10.1086/498945; Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023; HARTNETT DC, 1985, J ECOL, V73, P407, DOI 10.2307/2260483; Hobbs N.T., 2015, BAYESIAN MODELS, DOI [DOI 10.1515/9781400866557, 10.1515/9781400866557]; Holderegger R, 2006, LANDSCAPE ECOL, V21, P797, DOI 10.1007/s10980-005-5245-9; Holt RD, 2004, AM NAT, V163, P253, DOI 10.1086/381408; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Keller SR, 2010, J EVOLUTION BIOL, V23, P1720, DOI 10.1111/j.1420-9101.2010.02037.x; Kimbrell T, 2007, AM NAT, V169, P370, DOI 10.1086/511314; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lambrinos JG, 2004, ECOLOGY, V85, P2061, DOI 10.1890/03-8013; Leites LP, 2012, ECOL APPL, V22, P154, DOI 10.1890/11-0150.1; Lembrechts JJ, 2016, ECOGRAPHY; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; MELVILLE MR, 1982, CAN J BOT, V60, P976, DOI 10.1139/b82-123; Meyer AH, 1999, J ECOL, V87, P17, DOI 10.1046/j.1365-2745.1999.00315.x; Meyer AH, 1999, J ECOL, V87, P42, DOI 10.1046/j.1365-2745.1999.00317.x; MILLIGAN BG, 1994, MOL ECOL, V3, P423, DOI 10.1111/j.1365-294X.1994.tb00082.x; Moran EV, 2014, ECOL LETT, V17, P637, DOI 10.1111/ele.12262; Muller G., 2013, THESIS; North A, 2011, EVOLUTION, V65, P79, DOI 10.1111/j.1558-5646.2010.01107.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Polechova J, 2015, P NATL ACAD SCI USA, V112, P6401, DOI 10.1073/pnas.1421515112; PONS O, 1995, THEOR APPL GENET, V90, P462, DOI 10.1007/BF00221991; Pons O, 1996, GENETICS, V144, P1237; PORS B, 1989, AM J BOT, V76, P1681, DOI 10.2307/2444406; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Rasanen K, 2008, ECOL LETT, V11, P624, DOI 10.1111/j.1461-0248.2008.01176.x; Rehfeldt GE, 2002, GLOBAL CHANGE BIOL, V8, P912, DOI 10.1046/j.1365-2486.2002.00516.x; REHFELDT GE, 1984, BOT GAZ, V145, P229, DOI 10.1086/337451; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Rousset F, 1997, GENETICS, V145, P1219; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sambatti JBM, 2006, EVOLUTION, V60, P696, DOI 10.1111/j.0014-3820.2006.tb01149.x; Schlaepfer DR, 2008, MOL ECOL, V17, P5245, DOI 10.1111/j.1365-294X.2008.03980.x; Seipel T, 2016, PERSPECT PLANT ECOL, V20, P46, DOI 10.1016/j.ppees.2016.04.001; Seipel T, 2012, GLOBAL ECOL BIOGEOGR, V21, P236, DOI 10.1111/j.1466-8238.2011.00664.x; Sexton JP, 2014, EVOLUTION, V68, P1, DOI 10.1111/evo.12258; Sexton JP, 2011, P NATL ACAD SCI USA, V108, P11704, DOI 10.1073/pnas.1100404108; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Tackenberg O, 2003, ECOL MONOGR, V73, P191, DOI 10.1890/0012-9615(2003)073[0191:AOWDPI]2.0.CO;2; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; Thuillet AC, 2002, MOL BIOL EVOL, V19, P122, DOI 10.1093/oxfordjournals.molbev.a003977; Torriani DS, 2007, CLIM RES, V34, P59, DOI 10.3354/cr034059; Trapnell DW, 2004, MOL ECOL, V13, P2655, DOI 10.1111/j.1365-294X.2004.02281.x; van Kleunen M, 2003, ECOLOGY, V84, P2816, DOI 10.1890/02-0494; van Kleunen M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1487; Wang IJ, 2013, EVOLUTION, V67, P3403, DOI 10.1111/evo.12134; Weber E, 1998, AM J BOT, V85, P1110, DOI 10.2307/2446344; Weber E, 1997, BOT J LINN SOC, V123, P197, DOI 10.1006/bojl.1996.0086; Weber E, 2001, CONSERV BIOL, V15, P122, DOI 10.1046/j.1523-1739.2001.99424.x; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Wieczorek AM, 2002, MOL ECOL NOTES, V2, P554, DOI 10.1046/j.1471-8286.2002.00316.x; YANG SS, 1995, AGR FOREST METEOROL, V74, P61, DOI 10.1016/0168-1923(94)02185-M; Zhang YY, 2013, NEW PHYTOL, V197, P314, DOI 10.1111/nph.12010; Zhang YY, 2010, MOL ECOL, V19, P1774, DOI 10.1111/j.1365-294X.2010.04609.x; Zhao SY, 2012, GENET MOL RES, V11, P421, DOI 10.4238/2012.February.17.4	85	19	19	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185539	10.1371/journal.pone.0185539	http://dx.doi.org/10.1371/journal.pone.0185539			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957402	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200080
J	Nagaoka, T; Uzawa, K; Seki, Y; Chocano, DM				Nagaoka, Tomohito; Uzawa, Kazuhiro; Seki, Yuji; Chocano, Daniel Morales			Pacopampa: Early evidence of violence at a ceremonial site in the northern Peruvian highlands	PLOS ONE			English	Article							ADULT SKELETAL AGE; AURICULAR SURFACE; PUBIC BONE; TRAUMA; DEATH; METAMORPHOSIS; POPULATION; ILIUM; ANDES	Objectives Pacopampa, a ceremonial complex in Peru's northern highlands, reveals early evidence of trauma in the Middle to Late Formative Period coinciding with the emergence of social stratification in the area. We examine the prevalence of trauma in human remains found at the site and present evidence of the circumstances surrounding the deaths of individuals who lived during the early stages of Andean civilization. Materials and methods The materials are the remains of 104 individuals (38 non-adult and 66 adult) from the Middle to Late Formative Periods. We explored trauma macroscopically and recorded patterns based on skeletons' locations, age at death, sex, social class, and chronology. Results We detected trauma in remains over the Middle to Late Formative Periods. While the prevalence of trauma was minimal in the Middle Formative Period, skeletons from the subsequent era exhibit more severe disturbances. However, all the skeletons show signs of healing and affected individuals experienced a low degree of trauma. Discussion Given the archaeological context (the remains were recovered from sites of ceremonial practices), as well as the equal distribution of trauma among both sexes and a lack of defensive architecture, it is plausible that rituals, rather than organized warfare or raids, caused most of the exhibited trauma. Pacopampa was home to a complex society founded on ritual activity in a ceremonial center: this is indicated by the presence of ritual violence in a society that built impressively large, ceremonial architecture and developed social stratification without any political control of surplus agricultural goods.	[Nagaoka, Tomohito] St Marianna Univ, Dept Anat, Sch Med, Kawasaki, Kanagawa, Japan; [Uzawa, Kazuhiro] Univ East Asia, Fac Human Sci, Shimonoseki, Yamaguchi, Japan; [Seki, Yuji] Natl Museum Ethnol, Suita, Osaka, Japan; [Chocano, Daniel Morales] Univ Nacl Mayor San Marcos, Lima, Peru	Saint Marianna University; Universidad Nacional Mayor de San Marcos	Nagaoka, T (corresponding author), St Marianna Univ, Dept Anat, Sch Med, Kawasaki, Kanagawa, Japan.	nagaoka@mananna-u.ac.jp			JSPS KAKENHI [23222003, 16H02729, 16H05639]; Grants-in-Aid for Scientific Research [16H02729, 16H05639] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by JSPS KAKENHI Grant Numbers 23222003, 16H02729 and 16H05639.	Arkush E, 2013, J ARCHAEOL RES, V21, P307, DOI 10.1007/s10814-013-9065-1; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Blom DE, 1999, EARLY SETTLEMENT CHI, p[133, 117]; Brooks S, 1990, HUM EVOL, V5, P227, DOI DOI 10.1007/BF02437238; Bruzek J, 2002, AM J PHYS ANTHROPOL, V117, P157, DOI 10.1002/ajpa.10012; Buckberry JL, 2002, AM J PHYS ANTHROPOL, V119, P231, DOI 10.1002/ajpa.10130; Buikstra JE, 1994, ARKANSAS ARCHEOLOGIC; BURGER R, 1991, J FIELD ARCHAEOL, V18, P275, DOI 10.1179/009346991791548654; Burger R. L., 1992, CHAVIN ORIGINS ANDEA; Burger RL, 2016, LAT AM ANTIQ, V27, P22, DOI 10.7183/1045-6635.27.1.22; Cagigao ET, 2009, NAT SCI ARCHAEOL, P141, DOI 10.1007/978-3-540-87438-6_9; CARNEIRO RL, 1970, SCIENCE, V169, P733, DOI 10.1126/science.169.3947.733; Cook G., 2001, RITUAL SACRIFICE ANC, P1; Donnan C. B., 1976, MOCHE ART ICONOGRAPH; Engel F. A., 1963, T AM PHILOS SOC, V53, P1, DOI DOI 10.2307/1005956; Feldman R.A., 1985, EARLY CEREMONIAL ARC, P71; Gillespie RM, 1998, THESIS; Grauer AL, 1996, AM J PHYS ANTHROPOL, V100, P531, DOI 10.1002/(SICI)1096-8644(199608)100:4<531::AID-AJPA7>3.0.CO;2-T; Grieder T. E., 1988, GALGADA PRECERAMIC C; Izumi S, 1972, BULLETIN, V3; Izumi S., 1972, ANDES 4 EXCAVATIONS; Kellner C. M., 2002, THESIS; Klaus DK, 2016, RITUAL VIOLENCE ANCI, P1; Kunos CA, 1999, AM J PHYS ANTHROPOL, V110, P303, DOI 10.1002/(SICI)1096-8644(199911)110:3<303::AID-AJPA4>3.0.CO;2-O; Larsen C.S, 2015, BIOARCHAEOLOGY INTER, DOI DOI 10.1016/j.bone.2012.05.023; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P15, DOI 10.1002/ajpa.1330680103; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P47, DOI 10.1002/ajpa.1330680105; Lumbreras L., 1981, PREHISTORY AYACUCHO, VII, P167; Matsumura Hirofumi, 1997, Bulletin of the National Science Museum Series D (Anthropology), V23, P1; Morales D, 1980, DIOS FELINO PACOPAMP; Nagaoka T, 2017, ANAT SCI INT; Nagaoka T, 2015, FORENSIC SCI INT, V248, DOI 10.1016/j.forsciint.2015.01.009; Nagaoka T, 2012, ANAT SCI INT, V87, P234, DOI 10.1007/s12565-011-0120-z; Nagaoka T, 2012, INT J LEGAL MED, V126, P703, DOI 10.1007/s00414-012-0718-2; Onuki Y., 1995, KUNTUR WASI CERRO BL; Pearsall DM, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P105, DOI 10.1007/978-0-387-74907-5_7; PHENICE TW, 1969, AM J PHYS ANTHROPOL, V30, P297, DOI 10.1002/ajpa.1330300214; Quilter J., 1989, LIFE DEATH PALOMA SO; Rick John W., 2008, CHAVIN ART ARCHITECT, P3; Rockwood C., 1991, FRACTURES ADULTS; Sakaue K, 2006, ANTHROPOL SCI, V114, P59, DOI 10.1537/ase.00098; SCHEUER JL, 1980, ANN HUM BIOL, V7, P257, DOI 10.1080/03014468000004301; Schniz H, 1951, ROENTGEN DIAGNOSTICS, V1; Seki Y, 2014, SENRI ETHNOLOGICAL S, V89, P1; Seki Y., 2014, CTR CEREMONIAL ANDIN, V89, P175; Seki Y., 2005, PERPECTIVAS LATINOAM, P110; Seki Y, 2010, B ARQUEOLOGIA PUCP, V12, P69; Shady R., 2009, ANDEAN CIVILIZATION, P99; Shimada M., 1982, FORMATIVE PERIOD CAJ, P289; Solis RS, 2001, SCIENCE, V292, P723, DOI 10.1126/science.1059519; Stahl PW, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P121, DOI 10.1007/978-0-387-74907-5_8; Standen VG, 2000, AM J PHYS ANTHROPOL, V112, P239, DOI 10.1002/(SICI)1096-8644(2000)112:2<239::AID-AJPA9>3.0.CO;2-3; Tello J.C., 1956, ARQUEOLOGIA VALLE CA; TELLO JC, 1923, INCA, V1, P93; Terada K., 1985, FORMATIVE PERIOD CAJ; Todd TW, 1921, AM J PHYS ANTHROPOL, V4, P1, DOI 10.1002/ajpa.1330040102; Todd TW, 1920, AM J PHYS ANTHROPOL, V3, P285, DOI 10.1002/ajpa.1330030301; Torres-Rouff C, 2006, AM J PHYS ANTHROPOL, V130, P60, DOI 10.1002/ajpa.20315; Tsurumi E, 2015, MUNDO ANTES, V8, P141; Tung TA, 2008, AM J PHYS ANTHROPOL, V136, P294, DOI 10.1002/ajpa.20812; Tung TA, 2007, AM J PHYS ANTHROPOL, V133, P941, DOI 10.1002/ajpa.20565; Tung Tiffiny A., 2012, VIOLENCE RITUAL WARI; Ubelaker D.H., 1989, MANUALS ARCHEOLOGY S, V2; Uzawa K., 2010, B ARQUEOLOGIA PUCP, V12, P249; Valdez LM, 2009, J ANTHROPOL RES, V65, P389, DOI 10.3998/jar.0521004.0065.302; Verano J. W., 2001, RITUAL SACRIFICE ANC, P165; Vergara Enrique, 1985, EARLY CEREMONIAL ARC, P165; WAKEBE T, 1990, Nagasaki Igakkai Zasshi, V65, P805; Waldron T, 2009, CAMB MAN ARCHAEOL, P1; Walker PL, 2008, AM J PHYS ANTHROPOL, V136, P39, DOI 10.1002/ajpa.20776; WALKER PL, 1989, AM J PHYS ANTHROPOL, V80, P313, DOI 10.1002/ajpa.1330800305	71	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185421	10.1371/journal.pone.0185421	http://dx.doi.org/10.1371/journal.pone.0185421			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957380	gold, Green Published, Green Submitted			2022-12-27	WOS:000411985200055
J	Blixt, NC; Faulkner, BK; Astleford, K; Lelich, R; Schering, J; Spencer, E; Gopalakrishnan, R; Jensen, ED; Mansky, KC				Blixt, Nicholas C.; Faulkner, Bora K.; Astleford, Kristina; Lelich, Rosemary; Schering, Jacob; Spencer, Ekaterina; Gopalakrishnan, Rajaram; Jensen, Eric D.; Mansky, Kim C.			Class II and IV HDACs function as inhibitors of osteoclast differentiation	PLOS ONE			English	Article							MICROTUBULE DYNAMIC INSTABILITY; DEACETYLASE 6 HDAC6; HISTONE DEACETYLASE; TUBULIN DEACETYLASE; IN-VIVO; ACETYLATION; RECEPTOR; PATHWAY; PROTEIN; CELLS	Histone deacetylases (HDACs) are negative regulators of transcription and have been shown to regulate specific changes in gene expression. In vertebrates, eighteen HDACs have thus far been identified and subdivided into four classes (I-IV). Key roles for several HDACs in bone development and biology have been elucidated through in vitro and in vivo models. By comparison, there is a paucity of data on the roles of individual HDACs in osteoclast formation and function. In this study, we investigated the gene expression patterns and the effects of suppressing individual class II (Hdac4, 5, 6, 9, and 10) and class IV (Hdac11) HDACs during osteoclast differentiation. We demonstrated that HDAC class II and IV members are differentially expressed during osteoclast differentiation. Additionally, individual shRNA-mediated suppression of Hdac4, 5, 9, 10 and 11 expression resulted in increased multinucleated osteoclast size and demineralization activity, with little to no change in the overall number of multinucleated osteoclasts formed compared with control shRNA-treated cells. We also detected increased expression of genes highly expressed in osteoclasts, including c-Fos, Nfatc1, Dc-stamp and Cathepsin K. These observations indicate that HDACs cooperatively regulate shared targets in a non-redundant manner.	[Blixt, Nicholas C.; Faulkner, Bora K.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Astleford, Kristina; Lelich, Rosemary; Schering, Jacob; Spencer, Ekaterina; Mansky, Kim C.] Univ Minnesota, Dept Dev & Surg Sci, Minneapolis, MN 55455 USA; [Gopalakrishnan, Rajaram; Jensen, Eric D.] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Mansky, KC (corresponding author), Univ Minnesota, Dept Dev & Surg Sci, Minneapolis, MN 55455 USA.; Jensen, ED (corresponding author), Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA.	jens0709@umn.edu; kmansky@umn.edu		Mansky, Kim/0000-0002-2826-5030	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061352, T32AR050938] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR061352, T32 AR050938] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akisaka T, 2011, J HISTOCHEM CYTOCHEM, V59, P630, DOI 10.1369/0022155411405334; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Asthana J, 2013, J BIOL CHEM, V288, P22516, DOI 10.1074/jbc.M113.489328; Backesjo CM, 2006, J BONE MINER RES, V21, P993, DOI 10.1359/JBMR.060415; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cantley MD, 2011, J CELL PHYSIOL, V226, P3233, DOI 10.1002/jcp.22684; Cheng F, 2014, MOL IMMUNOL, V60, P44, DOI 10.1016/j.molimm.2014.02.019; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Duplan MB, 2014, MOL CELL BIOL, V34, P16, DOI 10.1128/MCB.00578-13; Fischer DD, 2002, J BIOL CHEM, V277, P6656, DOI 10.1074/jbc.M108055200; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Huang EY, 2000, GENE DEV, V14, P45; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jin ZX, 2015, MOL ENDOCRINOL, V29, P730, DOI 10.1210/me.2014-1365; Jin ZX, 2013, MOL ENDOCRINOL, V27, P325, DOI 10.1210/me.2012-1302; Kim JH, 2011, BIOCHEM J, V436, P253, DOI 10.1042/BJ20110062; Kim JH, 2010, J BIOL CHEM, V285, P5224, DOI 10.1074/jbc.M109.042812; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Pham L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216853; Li L, 2015, CELL MOL LIFE SCI, V72, P4237, DOI 10.1007/s00018-015-2000-5; Liu YJ, 2012, J BIOL CHEM, V287, P29168, DOI 10.1074/jbc.M112.371120; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McGee-Lawrence ME, 2011, GENE, V474, P1, DOI 10.1016/j.gene.2010.12.003; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; Morrison BE, 2008, EXP BIOL MED, V233, P980, DOI 10.3181/0802-RM-48; Nakamura T, 2005, J IMMUNOL, V175, P5809, DOI 10.4049/jimmunol.175.9.5809; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Purev E, 2009, MOL BIOL CELL, V20, P4021, DOI 10.1091/mbc.E09-03-0248; Rahman MM, 2003, BLOOD, V101, P3451, DOI 10.1182/blood-2002-08-2622; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Stemig M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123843; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	52	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185441	10.1371/journal.pone.0185441	http://dx.doi.org/10.1371/journal.pone.0185441			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953929	Green Published, gold, Green Submitted			2022-12-27	WOS:000411980300069
J	Mali, T; Kuuskeri, J; Shah, F; Lundell, TK				Mali, Tuulia; Kuuskeri, Jaana; Shah, Firoz; Lundell, Taina Kristina			Interactions affect hyphal growth and enzyme profiles in combinations of coniferous wood-decaying fungi of Agaricomycetes	PLOS ONE			English	Article							WHITE-ROT FUNGI; NORWAY SPRUCE LOGS; DEGRADING ENZYMES; PICEA-ABIES; CERIPORIOPSIS-SUBVERMISPORA; OXALATE DECARBOXYLASE; INHABITING FUNGI; PHLEBIA-RADIATA; OXALIC-ACID; LIGNIN	Fomitopsis pinicola is a species of Polyporales frequently encountered in Nordic temperate and boreal forests. In nature, the fungus causes destructive brown rot in wood, colonizing tree trunks often occupied by other Basidiomycota species. We mimicked these species-species interactions by introducing F. pinicola to five white rot species, all common saprotrophs of Norway spruce. Hyphal interactions and mycelial growth in various combinations were recorded, while activities of lignocellulose-acting CAZymes and oxidoreductases were followed in co-cultures on two different carbon-source media. Of the species, Phlebia radiata and Trichaptum abietinum were the strongest producers of lignin-modifying oxidoreductases (laccase, manganese peroxidase) when evaluated alone, as well as in co-cultures, on the two different growth media (low-nitrogen liquid medium containing ground coniferous wood, and malt extract broth). F. pinicola was an outstanding producer of oxalic acid (up to 61 mM), whereas presence of P. radiata prevented acidification of the growth environment in the liquid malt-extract cultures. When enzyme profiles of the species combinations were clustered, time-dependent changes were observed on wood-supplemented medium during the eight weeks of growth. End-point acidity and production of mycelium, oxalic acid and oxidoreductase activities, in turn clustered the fungal combinations into three distinct functional groups, determined by the presence of F. pinicola and P. radiata, by principal component analysis. Our findings indicate that combinations of wood-decay fungi have dramatic dynamic effects on the production of lignocellulose-active enzymes, which may lead to divergent degradative processes of dead wood and forest litter.	[Mali, Tuulia; Kuuskeri, Jaana; Shah, Firoz; Lundell, Taina Kristina] Univ Helsinki, Microbiol & Biotechnol, Dept Food & Environm Sci, Viikki Campus, Helsinki, Finland	University of Helsinki	Lundell, TK (corresponding author), Univ Helsinki, Microbiol & Biotechnol, Dept Food & Environm Sci, Viikki Campus, Helsinki, Finland.	taina.lundell@helsinki.fi	Shah, Firoz/D-4534-2018; Lundell, Taina/ABA-8393-2021; Shah, Firoz/AAO-7771-2020	Shah, Firoz/0000-0001-7833-7832; Lundell, Taina/0000-0003-3899-1658; Shah, Firoz/0000-0001-7833-7832; Kuuskeri, Jaana/0000-0002-5838-2086; Mali, Tuulia/0000-0002-4283-5482	Academy of Finland [285676]; Finnish Cultural Foundation [161103]	Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This study was supported by the Academy of Finland, grant number 285676 to TL, and the Finnish Cultural Foundation, grant number 161103 to TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MYCOLOGIA, V105, P1428; Arantes V, 2011, J IND MICROBIOL BIOT, V38, P541, DOI 10.1007/s10295-010-0798-2; Arnstadt T, 2016, FOREST ECOL MANAG, V382, P129, DOI 10.1016/j.foreco.2016.10.004; Baldrian P, 2004, FEMS MICROBIOL ECOL, V50, P245, DOI 10.1016/j.femsec.2004.07.005; Baldrian P, 2017, FEMS MICROBIOL REV, V41, P109, DOI 10.1093/femsre/fuw040; Binder M, 2013, MYCOLOGIA, V105, P1350, DOI 10.3852/13-003; Boddy L, 2000, FEMS MICROBIOL ECOL, V31, P185, DOI 10.1111/j.1574-6941.2000.tb00683.x; Chi YJ, 2007, INT BIODETER BIODEGR, V59, P32, DOI 10.1016/j.ibiod.2006.06.025; Dutton MV, 1996, CAN J MICROBIOL, V42, P881, DOI 10.1139/m96-114; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Eichlerova I, 2015, FUNGAL ECOL, V13, P10, DOI 10.1016/j.funeco.2014.08.002; Escutia MR, 2005, APPL ENVIRON MICROB, V71, P3608, DOI 10.1128/AEM.71.7.3608-3616.2005; ESPEJO E, 1991, APPL ENVIRON MICROB, V57, P1980, DOI 10.1128/AEM.57.7.1980-1986.1991; Everitt B, 2011, USE R, P1, DOI 10.1007/978-1-4419-9650-3; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Fox J., 2019, R COMPANION APPL REG, V.; Fukami T, 2010, ECOL LETT, V13, P675, DOI 10.1111/j.1461-0248.2010.01465.x; Goodell B, 1997, J BIOTECHNOL, V53, P133, DOI 10.1016/S0168-1656(97)01681-7; Hilden K, 2005, FUNGAL GENET BIOL, V42, P403, DOI 10.1016/j.fgb.2005.01.008; Hiscox J, 2016, ENVIRON MICROBIOL, V18, P1954, DOI 10.1111/1462-2920.13141; Hiscox J, 2010, FUNGAL GENET BIOL, V47, P562, DOI 10.1016/j.fgb.2010.03.007; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Holmer L, 1997, OIKOS, V79, P77, DOI 10.2307/3546092; Hori C, 2013, MYCOLOGIA, V105, P1412, DOI 10.3852/13-072; Jonsson MT, 2008, J ECOL, V96, P1065, DOI 10.1111/j.1365-2745.2008.01411.x; Jordan CR, 1996, HOLZFORSCHUNG, V50, P312, DOI 10.1515/hfsg.1996.50.4.312; Kaavat Niemela T., 2005, NORRLINIA, V13; Kerem Z, 1999, FEBS LETT, V446, P49, DOI 10.1016/S0014-5793(99)00180-5; Kotiranta H, 2009, NORRLINIA, V19, P1; Kubartova A, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv032; Kubartova A, 2009, MICROB ECOL, V58, P98, DOI 10.1007/s00248-008-9458-8; Kuuskeri J, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0608-9; Kuuskeri J, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0538-x; Lindner DL, 2011, FUNGAL ECOL, V4, P449, DOI 10.1016/j.funeco.2011.07.001; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; LUNDELL T, 1994, FEBS LETT, V348, P291, DOI 10.1016/0014-5793(94)00627-X; Lundell TK, 2014, ADV BOT RES, V70, P329, DOI 10.1016/B978-0-12-397940-7.00011-2; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Maechler M, 2016, FINDING GROUPS DATA; Makela M, 2002, ENZYME MICROB TECH, V30, P542, DOI 10.1016/S0141-0229(02)00012-1; Makela MR, 2010, APPL MICROBIOL BIOT, V87, P801, DOI 10.1007/s00253-010-2650-z; Mattila H, 2017, BIORESOURCE TECHNOL, V225, P254, DOI 10.1016/j.biortech.2016.11.082; Nagy LG, 2016, MOL BIOL EVOL, V33, P959, DOI 10.1093/molbev/msv337; Noll L, 2016, FOREST ECOL MANAG, V378, P181, DOI 10.1016/j.foreco.2016.07.035; Ottosson E, 2014, FUNGAL ECOL, V11, P17, DOI 10.1016/j.funeco.2014.03.003; Ovaskainen O, 2010, ECOLOGY, V91, P2514, DOI 10.1890/10-0173.1; Park N, 2014, INT J BIOL MACROMOL, V70, P583, DOI 10.1016/j.ijbiomac.2014.06.019; Rajala T, 2015, FUNGAL ECOL, V18, P48, DOI 10.1016/j.funeco.2015.08.007; Rajala T, 2012, FEMS MICROBIOL ECOL, V81, P494, DOI 10.1111/j.1574-6941.2012.01376.x; Rajala T, 2011, FUNGAL ECOL, V4, P437, DOI 10.1016/j.funeco.2011.05.005; Rajala T, 2010, CAN J FOREST RES, V40, P2384, DOI 10.1139/X10-176; Rayner ADM, 1988, FUNGAL DECOMPOSITION; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Rytioja J., 2014, MICROBIOL MOL BIOL R, V78, P614, DOI [DOI 10.1128/MMBR.00035-14, 10.1128/MMBR.00035-14]; Rytioja J, 2014, FUNGAL GENET BIOL, V72, P91, DOI 10.1016/j.fgb.2013.12.008; Score AJ, 1997, INT BIODETER BIODEGR, V39, P225, DOI 10.1016/S0964-8305(97)00012-7; Sippola AL, 1999, FOREST ECOL MANAG, V115, P183, DOI 10.1016/S0378-1127(98)00398-3; Steffen KT, 2000, APPL MICROBIOL BIOT, V54, P819, DOI 10.1007/s002530000473; Tang JD, 2013, APPL ENVIRON MICROB, V79, P1523, DOI 10.1128/AEM.02916-12; Team R, 2016, LANG ENV STAT COMP R; Watanabe T, 2005, ENZYME MICROB TECH, V37, P68, DOI 10.1016/j.enzmictec.2005.01.032; Wickham H, 2016, RSTUDIO R CORE TEAM; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woodward S, 2008, BR MYCOL SY, V28, P125	64	25	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185171	10.1371/journal.pone.0185171	http://dx.doi.org/10.1371/journal.pone.0185171			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953947	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300039
J	Shah, FM; Razaq, M; Ali, A; Han, P; Chen, JL				Shah, Farhan Mahmood; Razaq, Muhammad; Ali, Abid; Han, Peng; Chen, Julian			Comparative role of neem seed extract, moringa leaf extract and imidacloprid in the management of wheat aphids in relation to yield losses in Pakistan	PLOS ONE			English	Article							ESSENTIAL OILS; BOTANICAL INSECTICIDES; CEREAL APHIDS; WINTER-WHEAT; BENEFICIAL ARTHROPODS; CHRYSOPERLA-CARNEA; AZADIRACHTA-INDICA; TRITICUM-AESTIVUM; NATURAL ENEMIES; BEMISIA-TABACI	Wheat being staple food of Pakistan is constantly attacked by major wheat aphid species, Schizaphis graminum (R.), Rhopalosiphum padi (L.) and Sitobion avenae (F.). Due to concern on synthetic chemical use in wheat, it is imperative to search for alternative environment-and human-friendly control measures such as botanical pesticides. In the present study, we evaluated the comparative role of neem seed extract (NSE), moringa leaf extract (MLE) and imidacloprid (I) in the management of the aphid as well as the yield losses parameters in late planted wheat fields. Imidacloprid reduced significantly aphids infestation compared to the other treatments, hence resulting in higher yield, particularly when applied with MLE. The percentages of yield increase in I+MLE treated plots over the control were 19.15-81.89% for grains per spike, 5.33-37.62% for thousand grain weight and 27.59-61.12% for yield kg/ha. NSE was the second most effective control measure in suppressing aphid population, but the yield protected by NSE treatment over the control was comparable to that by imidacloprid. Population densities of coccinellids and syrphids in the plots treated with NSE-2 were higher than those treated with imidacloprid in two out of three experiments during 2013-14. Low predator density in imidacloprid-treated plots was attributed to the lower availability of prey aphids. The efficacy of NSE against aphids varied depending on degree of synchronization among the application timing, the activity of aphids, crop variety and environmental conditions. Despite that, we suggested NSE to be a promising alternative botanical insecticide compared to the most commonly recommended imidiacloprid. Further studies should consider the side effects of biopesticides on non-target organisms in order to provide better management practices in the field.	[Shah, Farhan Mahmood; Razaq, Muhammad] Bahauddin Zakariya Univ, Fac Agr Sci & Technol, Dept Entomol, Multan, Pakistan; [Ali, Abid] Univ Agr Faisalabad, Dept Entomol, Faisalabad, Pakistan; [Han, Peng] Univ Nice Sophia Antipolis, CNRS, French Natl Inst Agr Res, Inst Sophia Agrobiotech,INRA,UMR 1355 7254, Sophia Antipolis, France; [Chen, Julian] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Bahauddin Zakariya University; University of Agriculture Faisalabad; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Razaq, M (corresponding author), Bahauddin Zakariya Univ, Fac Agr Sci & Technol, Dept Entomol, Multan, Pakistan.; Chen, JL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	muhammadrazaq@bzu.edu.pk; chenjulian@ippcaas.cn	Chen, Julian/AAB-1846-2022; Han, Peng/Y-4457-2019; Razaq, Muhammad/GYQ-5405-2022; Ali, Abid/AAJ-5282-2020; Ali, Abid/S-7218-2019	Ali, Abid/0000-0003-3674-7811	948 Project in China "Introduction and Utilization of Biological Control Technology to Plant Disease and Insect Pests Management" [2016-X48]; National Key RD Plan in China [2016YFD0300701, 2017YFD0201701]	948 Project in China "Introduction and Utilization of Biological Control Technology to Plant Disease and Insect Pests Management"; National Key RD Plan in China	This study was funded by 948 Project in China "Introduction and Utilization of Biological Control Technology to Plant Disease and Insect Pests Management" (2016-X48), and National Key R&D Plan in China (2016YFD0300701, 2017YFD0201701).r We thank Muhammad Waseem Shahzad and Muhammad Faheem Khalid (Bahauddin Zakariya University, Multan, Pakistan) for their help in the identification of predators and aphid species. We thank ZhaoXue (Tianjin Normal University, China) for improving the language of manuscript. This study was funded by 948 Project in China "Introduction and Utilization of Biological Control Technology to Plant Disease and Insect Pests Management" (2016-X48), and ational Key R&D Plan in China (2016YFD0300701, 2017YFD0201701).N	Agra-Neto AC, 2014, PARASITOL RES, V113, P175, DOI 10.1007/s00436-013-3640-8; Aheer G, 1993, J AGR RES, V31, P307; Akhtar Y., 2008, Phytochemistry Reviews, V7, P77, DOI 10.1007/s11101-006-9048-7; Ali A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24273; Ali A, 2012, J PEST SCI, V85, P359, DOI 10.1007/s10340-012-0426-1; Ali A, 2014, ENTOMOL GEN, V35, P129, DOI 10.1127/0171-8177/2014/0045; Ali H, 2015, AFR J AGR SCI TECHNO, V3, P310; Alyokhin A, 2007, PEST MANAG SCI, V63, P32, DOI 10.1002/ps.1305; Ambrosino MD, 2007, ENTOMOL EXP APPL, V122, P99, DOI 10.1111/j.1570-7458.2006.00499.x; Amin A. A., 2003, EGYPT J APPL SCI, V18, P34; Anita S., 2012, Recent Research in Science and Technology, V4, P19; [Anonymous], 2014, ENTOMOL GEN, V35, P87; Aslam Muhammad, 2005, Pakistan Entomologist, V27, P79; Aziz MA, 2013, INT J AGRIC BIOL, V15, P279; Bacci L, 2015, ENTOMOL EXP APPL, V156, P66, DOI 10.1111/eea.12317; BARDNER R, 1974, B ENTOMOL RES, V64, P141, DOI 10.1017/S0007485300027061; Basra SMA, 2011, INT J AGRIC BIOL, V13, P1006; BELL CH, 1995, J STORED PROD RES, V31, P199, DOI 10.1016/0022-474X(95)00012-V; Belmain SR, 2001, FOOD CHEM TOXICOL, V39, P287, DOI 10.1016/S0278-6915(00)00134-4; Biondi A, 2015, CHEMOSPHERE, V128, P142, DOI 10.1016/j.chemosphere.2015.01.034; Biondi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076548; Biondi A, 2012, PEST MANAG SCI, V68, P1523, DOI 10.1002/ps.3396; Blackman R.L.Eastop, 2006, APHIDS WORLDS HERBAC, V2, P1439; Boursier CM, 2011, CROP PROT, V30, P318, DOI 10.1016/j.cropro.2010.11.022; Brandt A, 2016, J INSECT PHYSIOL, V86, P40, DOI 10.1016/j.jinsphys.2016.01.001; Brathe A, 2002, BIOORGAN MED CHEM, V10, P1581, DOI 10.1016/S0968-0896(01)00427-8; BUTTERWORTH JH, 1968, CHEM COMMUN, P23, DOI 10.1039/c19680000023; Campolo O, 2014, IND CROP PROD, V61, P361, DOI 10.1016/j.indcrop.2014.07.028; Campolo O, 2014, PHYTOPARASITICA, V42, P223, DOI 10.1007/s12600-013-0355-4; Chander S, 2014, P NATL ACAD SCI IN B, V86, P315, DOI DOI 10.1007/40011-014-0439; Coelho JS, 2009, CHEMOSPHERE, V77, P934, DOI 10.1016/j.chemosphere.2009.08.022; Copping LG, 2000, PEST MANAG SCI, V56, P651, DOI 10.1002/1526-4998(200008)56:8<651::AID-PS201>3.0.CO;2-U; Santos NDD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044840; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dively GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118748; Douglas MR, 2015, J APPL ECOL, V52, P250, DOI 10.1111/1365-2664.12372; Fekri MS, 2016, ENTOMOL GEN, V35, P229, DOI 10.1127/entomologia/2016/0020; FENG R, 1995, EXPERIENTIA, V51, P831, DOI 10.1007/BF01922438; FOIDL N., 2001, MIRACLE TREE MULTIPL, P45; Fossen M., 2006, ENV FATE IMIDIACLOPR; Fuglie L.J., 1999, MIRACLE TREE MORINGA, P172; Gahukar RT, 2000, INT J PEST MANAGE, V46, P149, DOI 10.1080/096708700227516; Gontijo PC, 2014, J PEST SCI, V87, P711, DOI 10.1007/s10340-014-0611-5; GOP, 2016, EC SURV PAK 2015 16, P28; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gray SM, 1996, CROP PROT, V15, P687, DOI 10.1016/S0261-2194(96)00040-3; Hagvar E.B., 1991, Biocontrol News and Information, V12, P13; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Han P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102980; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Isman MB, 1996, RECENT ADV PHYTOCHEM, V30, P155; Kannan H. O., 1999, Sudan Journal of Agricultural Research, V2, P65; Khan MB, 2010, PAK J BOT, V42, P1561; Khattak MK, 2007, PAK J ZOOL, V39, P109; Kindler SD, 2002, J ECON ENTOMOL, V95, P89, DOI 10.1603/0022-0493-95.1.89; Krcmar S, 2016, ENTOMOL GEN, V36, P97, DOI 10.1127/entomologia/2016/0121; Krieger R. I, 2001, HDB PESTICIDE TOXICO, V2, P1123; Liang GM, 2003, CROP PROT, V22, P333, DOI 10.1016/S0261-2194(02)00175-8; LOWERY DT, 1993, J ECON ENTOMOL, V86, P864, DOI 10.1093/jee/86.3.864; LOWERY DT, 1995, PHYTOPARASITICA, V23, P297, DOI 10.1007/BF02981422; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Melesse T., 2012, International Journal of Agricultural Technology, V8, P125; Mirande L, 2015, J PEST SCI, V88, P155, DOI 10.1007/s10340-014-0597-z; Miresmailli S, 2014, TRENDS PLANT SCI, V19, P29, DOI 10.1016/j.tplants.2013.10.002; MORDUE AJ, 1993, J INSECT PHYSIOL, V39, P903, DOI 10.1016/0022-1910(93)90001-8; Mujahid Manzoor, 2015, Journal of Biopesticides, V8, P120; Myers SW, 2005, J ECON ENTOMOL, V98, P2006, DOI 10.1603/0022-0493-98.6.2006; Nathan SS, 2005, CROP PROT, V24, P760, DOI 10.1016/j.cropro.2005.01.009; Palmeri V, 2007, J APICULT RES, V46, P105, DOI 10.1080/00218839.2007.11101375; Palumbo JC, 2001, CROP PROT, V20, P739, DOI 10.1016/S0261-2194(01)00117-X; Pansa MG, 2015, J PEST SCI, V88, P201, DOI 10.1007/s10340-014-0572-8; PIKE KS, 1985, J ECON ENTOMOL, V78, P676, DOI 10.1093/jee/78.3.676; Pontual EV, 2012, ARCH INSECT BIOCHEM, V79, P135, DOI 10.1002/arch.21012; Prabhaker N, 2011, J ECON ENTOMOL, V104, P773, DOI 10.1603/EC10362; Qu YY, 2015, ECOTOXICOLOGY, V24, P479, DOI 10.1007/s10646-014-1396-2; de Oliveira CFR, 2011, PROCESS BIOCHEM, V46, P498, DOI 10.1016/j.procbio.2010.09.025; Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554; Roh HS, 2015, J PEST SCI, V88, P621, DOI 10.1007/s10340-014-0631-1; Royer T, 1998, SMALL GRAIN APHIDS O; Royer TA, 2011, CROP PROT, V30, P826, DOI 10.1016/j.cropro.2011.03.002; Saeed NA, 2014, PAK J ZOOL, V46, P1193; Saeed R, 2015, J PEST SCI, V88, P517, DOI 10.1007/s10340-014-0638-7; Saeed R, 2015, PAK J ZOOL, V47, P103; Sallam AA, 2009, J PLANT DIS PROTECT, V116, P283, DOI 10.1007/BF03356325; Saroukolai AT, 2010, J PEST SCI, V83, P3, DOI 10.1007/s10340-009-0261-1; SCHMUTTERER H, 1988, J INSECT PHYSIOL, V34, P713, DOI 10.1016/0022-1910(88)90082-0; Seagraves MP, 2009, BIOL CONTROL, V51, P313, DOI 10.1016/j.biocontrol.2009.05.015; Shaaya E, 1997, J STORED PROD RES, V33, P7, DOI 10.1016/S0022-474X(96)00032-X; Shahzad MW, 2013, PAK J BOT, V45, P2005; Shani E, 2006, CURR OPIN PLANT BIOL, V9, P484, DOI 10.1016/j.pbi.2006.07.008; Sharma-Natu Poonam, 2006, Indian Journal of Plant Physiology, V11, P239; SINGH RP, 1988, PHYTOPARASITICA, V16, P225, DOI 10.1007/BF02979523; Snedecor G. W., 1989, STAT METHODS, P289; Subhan F., 2004, SARHAD J AGR, V20, P51; Tang YQ, 2002, ENVIRON ENTOMOL, V31, P172, DOI 10.1603/0046-225X-31.1.172; Turek C, 2013, COMPR REV FOOD SCI F, V12, P40, DOI 10.1111/1541-4337.12006; Ugarte C, 2007, FIELD CROP RES, V100, P240, DOI 10.1016/j.fcr.2006.07.010; van der Sluijs JP, 2015, ENVIRON SCI POLLUT R, V22, P148, DOI 10.1007/s11356-014-3229-5; Wang SY, 2017, J PEST SCI, V90, P389, DOI 10.1007/s10340-016-0770-7; WEISENBURGER DD, 1993, HUM PATHOL, V24, P571, DOI 10.1016/0046-8177(93)90234-8; Xiao D, 2016, ECOTOXICOLOGY, V25, P1782, DOI 10.1007/s10646-016-1721-z; Yasmeen A, 2013, PLANT GROWTH REGUL, V69, P225, DOI 10.1007/s10725-012-9764-5; Yasmeen A, 2012, CHIL J AGR RES, V72, P92, DOI 10.4067/S0718-58392012000100015; Zhang YX, 2016, INSECT BIOCHEM MOLEC, V79, P50, DOI 10.1016/j.ibmb.2016.10.009	105	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184639	10.1371/journal.pone.0184639	http://dx.doi.org/10.1371/journal.pone.0184639			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953894	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300018
J	Sultan, M; Ben-Ari, Z; Masoud, R; Pappo, O; Harats, D; Kamari, Y; Safran, M				Sultan, Maya; Ben-Ari, Ziv; Masoud, Rula; Pappo, Orit; Harats, Dror; Kamari, Yehuda; Safran, Michel			Interleukin-1 alpha and Interleukin-1 beta play a central role in the pathogenesis of fulminant hepatic failure in mice	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; TUMOR-NECROSIS-FACTOR; RECEPTOR ANTAGONIST; D-GALACTOSAMINE/LIPOPOLYSACCHARIDE; STERILE INFLAMMATION; DISTINCT PATHWAYS; GENE-EXPRESSION; CELLS; APOPTOSIS; INJURY	Background and aims Fulminant hepatitis failure (FHF) is marked by the sudden loss of hepatic function, with a severe life-threatening course in persons with no prior history of liver disease. Interleukin ( IL)-1 alpha and IL-1 beta are key inflammatory cytokines but little is known about their role in the development of FHF. The aim of this study was to assess the involvement of IL-1 alpha and IL1 beta in the progression of LPS/GalN-induced FHF. Methods WT, IL-1 alpha or IL-1 beta deficient mice were injected with LPS/GalN. Blood and liver tissue were collected at different time points, FHF related pathways were examined. Results After FHF induction the survival of both IL-1 alpha and IL-1 beta KO mice was longer than that of WT mice. Lower serum liver enzyme levels, demonstrated reduced hepatic injury in the IL-1 alpha and IL-1 beta KO mice. Histologically detected liver injury and apoptotic hepatocytes were significantly reduced in the IL-1 alpha and IL-1 beta KO mice compared to WT mice. Reduced hepatic I kappa B levels and upregulated NF kappa B activity in WT mice remained inhibited in IL-1 alpha and IL-1 beta KO mice. Hepatic expression levels of TNF alpha and IL-6 were significantly increased in WT mice but not in IL-1 alpha and IL-1 beta KO mice. Conclusions IL-1 alpha and IL-1 beta play a central role in the pathogenesis of LPS/GalN-induced FHF. These interleukins are associated with the activation of NF.B signaling, upregulation of the pro-inflammatory cytokines and liver damage and apoptosis. Since neither IL-1 alpha nor IL-1 beta depletions completely rescued the phenotype, we believe that IL-1 alpha and IL-1 beta have a similar and probably complementary role in FHF progression.	[Sultan, Maya; Ben-Ari, Ziv; Masoud, Rula; Safran, Michel] Chaim Sheba Med Ctr, Liver Res Lab, Ramat Gan, Israel; [Ben-Ari, Ziv] Chaim Sheba Med Ctr, Liver Dis Ctr, Ramat Gan, Israel; [Ben-Ari, Ziv; Harats, Dror; Kamari, Yehuda] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Pappo, Orit] Chaim Sheba Med Ctr, Dept Pathol, Ramat Gan, Israel; [Harats, Dror; Kamari, Yehuda] Chaim Sheba Med Ctr, Bert W Strassburger Lipid Ctr, Ramat Gan, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Safran, M (corresponding author), Chaim Sheba Med Ctr, Liver Res Lab, Ramat Gan, Israel.	Michal.safran@sheba.health.gov.il			Sheba Talipot Medical Leadership program	Sheba Talipot Medical Leadership program	The study was partly supported by the Sheba Talipot Medical Leadership program (Yehuda Kamari). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Aviv Shaish for critical review of the manuscript and Dr. Michal Kandel-Kfir for technical assistance. The study was partly supported by the Sheba Talipot Medical Leadership program (Yehuda Kamari).	Andreakos E, 2004, BLOOD, V103, P2229, DOI 10.1182/blood-2003-04-1356; Bandman O, 2002, ANN NY ACAD SCI, V975, P77, DOI 10.1111/j.1749-6632.2002.tb05943.x; Ben Ari Z, 2012, CELL PHYSIOL BIOCHEM, V29, P41, DOI 10.1159/000337585; Ben-Ari Z, 2011, TRANSPLANTATION, V92, P18, DOI 10.1097/TP.0b013e31821cdea5; Bernal W, 2014, NEW ENGL J MED, V370, P1170, DOI 10.1056/NEJMc1400974; Bernal W, 2013, J HEPATOL, V59, P74, DOI 10.1016/j.jhep.2013.02.010; Chen EQ, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0380-9; Chosay JG, 1997, AM J PHYSIOL-GASTR L, V272, pG1195, DOI 10.1152/ajpgi.1997.272.5.G1195; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; DINARELLO CA, 1987, J IMMUNOL, V139, P1902; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Furuya S, 2015, J SURG RES, V199, P487, DOI 10.1016/j.jss.2015.05.060; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Galun E, 2002, BBA-MOL CELL RES, V1592, P345, DOI 10.1016/S0167-4889(02)00326-9; GRANOWITZ EV, 1992, BLOOD, V79, P2356; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Hoffmann E, 2005, J BIOL CHEM, V280, P9706, DOI 10.1074/jbc.M407071200; Holzberg D, 2003, J BIOL CHEM, V278, P40213, DOI 10.1074/jbc.M304058200; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Kamari Y, 2007, ATHEROSCLEROSIS, V195, P31, DOI 10.1016/j.atherosclerosis.2006.11.026; Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048; Kamari Y, 2011, BIOCHEM BIOPH RES CO, V405, P197, DOI 10.1016/j.bbrc.2011.01.008; LEIST M, 1995, AM J PATHOL, V146, P1220; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; MARTICH GD, 1991, J EXP MED, V173, P1021, DOI 10.1084/jem.173.4.1021; MUTO Y, 1988, LANCET, V2, P72; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Pollock AS, 2003, FASEB J, V17, P203, DOI 10.1096/fj.02-0602com; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Rolando N, 1996, SEMIN LIVER DIS, V16, P389, DOI 10.1055/s-2007-1007252; Sass DA, 2005, LIVER TRANSPLANT, V11, P594, DOI 10.1002/lt.20435; SEKIYAMA KD, 1994, CLIN EXP IMMUNOL, V98, P71; Shemesh S, 2012, ATHEROSCLEROSIS, V222, P329, DOI 10.1016/j.atherosclerosis.2011.12.010; Shinoda M, 2007, J SURG RES, V137, P130, DOI 10.1016/j.jss.2006.08.009; Song XP, 2003, J IMMUNOL, V171, P6448, DOI 10.4049/jimmunol.171.12.6448; Wang K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.499; Waseern T, 2008, SURGERY, V143, P334, DOI 10.1016/j.surg.2007.09.039; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Xiong QB, 1999, LIFE SCI, V65, P421, DOI 10.1016/S0024-3205(99)00263-5; Yan CL, 2008, LIVER INT, V28, P959, DOI 10.1111/j.1478-3231.2008.01775.x; ZHENG H, 1995, IMMUNITY, V3, P9, DOI 10.1016/1074-7613(95)90154-X	41	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184084	10.1371/journal.pone.0184084	http://dx.doi.org/10.1371/journal.pone.0184084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953903	Green Submitted, Green Published, gold			2022-12-27	WOS:000411980300010
J	Teder, T; Lohelaid, H; Samel, N				Teder, Tarvi; Lohelaid, Helike; Samel, Nigulas			Structural and functional insights into the reaction specificity of catalase-related hydroperoxide lyase: A shift from lyase activity to allene oxide synthase by site-directed mutagenesis	PLOS ONE			English	Article							LIPOXYGENASE FUSION PROTEIN; CATALYTIC-ACTIVITY; CORAL; PATHWAY; ACID; PEROXIDASE; MUTATION; IDENTIFICATION; BIOSYNTHESIS; METABOLISM	Two highly identical fusion proteins, an allene oxide synthase-lipoxygenase (AOS-LOX) and a hydroperoxide lyase-lipoxygenase (HPL-LOX), were identified in the soft coral Cap-nella imbricata. Both enzymes initially catalyze the formation of 8R-hydroperoxy-eicosatetraenoic acid (8R-HpETE) from arachidonic acid by the C-terminal lipoxygenase (LOX) domain. Despite the fact that the defined catalytically important residues of N-terminal catalase-related allene oxide synthase (cAOS) domain are also conserved in C. imbricata hydroperoxide lyase (cHPL), their reaction specificities differ. In the present study, we tested which of the amino acid substitutions around the active site of cHPL are responsible for a control in the reaction specificity. The possible candidates were determined via comparative sequence and structural analysis of the substrate channel and the heme region of coral cAOSs and C. imbricata cHPL. The amino acid replacements in cHPL-R56G, ME59-60LK, P65A, F150L, YS176-177NL, I357V, and SSSAGE155-160PVKEGD-with the corresponding residues of cAOS were conducted by site-directed mutagenesis. Although all these mutations influenced the catalytic efficiency of cHPL, only F150L and YS176-177NL substitutions caused a shift in the reaction specificity from HPL to AOS. The docking analysis of P. homomalla cAOS with 8R-HpETE substrate revealed that the Leu150 of cAOS interacts with the C5-C6 double bond and the Leu177 with the hydrophobic tail of 8R-HpETE. We propose that the corresponding residues in cHPL, Phe150 and Ser177, are involved in a proper coordination of the epoxy allylic radical intermediate necessary for aldehyde formation in the hydroperoxide lyase reaction.	[Teder, Tarvi; Lohelaid, Helike; Samel, Nigulas] Tallinn Univ Technol, Dept Chem & Biotechnolgy, Tallinn, Estonia	Tallinn University of Technology	Samel, N (corresponding author), Tallinn Univ Technol, Dept Chem & Biotechnolgy, Tallinn, Estonia.	nigulas.samel@ttu.ee	Samel, Nigulas/A-1420-2019; Lõhelaid, Helike/G-5425-2013; Teder, Tarvi/M-6893-2018	Lõhelaid, Helike/0000-0002-6885-8666; Teder, Tarvi/0000-0002-8489-3955	Institutional Research Funding of the Estonian Ministry of Education and Research [IUT19-9]; Estonian Science Foundation Grant [9410]	Institutional Research Funding of the Estonian Ministry of Education and Research; Estonian Science Foundation Grant	This work was supported by the Institutional Research Funding IUT19-9 of the Estonian Ministry of Education and Research and the Estonian Science Foundation Grant 9410 (both to NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; Brash AR, 2009, PHYTOCHEMISTRY, V70, P1522, DOI 10.1016/j.phytochem.2009.08.005; CROMBIE L, 1991, J CHEM SOC PERK T 1, P581, DOI 10.1039/p19910000581; De Luna P, 2013, J PHYS CHEM B, V117, P14635, DOI 10.1021/jp408486n; Ermilova VS, 2013, DOKL BIOCHEM BIOPHYS, V452, P251, DOI 10.1134/S1607672913050128; FLORIS R, 1995, J AM CHEM SOC, V117, P3907, DOI 10.1021/ja00119a003; Gao B, 2008, ARCH BIOCHEM BIOPHYS, V477, P285, DOI 10.1016/j.abb.2008.07.011; Gerwick WH, 1996, LIPIDS, V31, P1215, DOI 10.1007/BF02587906; Gilbert NC, 2008, BIOCHEMISTRY-US, V47, P10665, DOI 10.1021/bi800751p; Griffiths G, 2015, FREE RADICAL RES, V49, P565, DOI 10.3109/10715762.2014.1000318; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; HAMBERG M, 1989, J AM OIL CHEM SOC, V66, P1445, DOI 10.1007/BF02661968; HECKER M, 1989, J BIOL CHEM, V264, P141; Hillar A, 2000, BIOCHEMISTRY-US, V39, P5868, DOI 10.1021/bi0000059; Hughes RK, 2009, CHEMBIOCHEM, V10, P1122, DOI 10.1002/cbic.200800633; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; Lakshmipathi P, 2002, ORG LETT, V4, P451, DOI 10.1021/ol017164k; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lohelaid H, 2015, CORAL REEFS, V34, P143, DOI 10.1007/s00338-014-1238-y; Lohelaid H, 2008, BBA-GEN SUBJECTS, V1780, P315, DOI 10.1016/j.bbagen.2007.10.010; Lohelaid H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089215; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Mosblech A, 2009, PLANT PHYSIOL BIOCH, V47, P511, DOI 10.1016/j.plaphy.2008.12.011; Nagai M, 2014, CHIRALITY, V26, P438, DOI 10.1002/chir.22273; Neri F, 1999, BIOCHEMISTRY-US, V38, P7819, DOI 10.1021/bi982811+; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; Oliw EH, 2016, J LIPID RES, V57, P1518, DOI 10.1194/jlr.M068981; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roncone R, 2005, J BIOL INORG CHEM, V10, P11, DOI 10.1007/s00775-004-0606-4; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Teder T, 2015, J BIOL CHEM, V290, P19823, DOI 10.1074/jbc.M115.660282; Tijet N, 2002, PROSTAG OTH LIPID M, V68-9, P423, DOI 10.1016/S0090-6980(02)00046-1; Toporkova Ya. Yu., 2010, Moscow University Biological Sciences Bulletin, V65, P155, DOI 10.3103/S0096392510040085; Tosha T, 2006, J BIOL CHEM, V281, P12610, DOI 10.1074/jbc.M600061200; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067	39	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185291	10.1371/journal.pone.0185291	http://dx.doi.org/10.1371/journal.pone.0185291			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953966	Green Submitted, Green Published, gold			2022-12-27	WOS:000411980300052
J	Somayaji, R; Elliott, JA; Persaud, R; Lim, M; Goodman, L; Sibbald, RG				Somayaji, Ranjani; Elliott, James A.; Persaud, Reneeka; Lim, Morgan; Goodman, Laurie; Sibbald, R. Gary			The impact of team based interprofessional comprehensive assessments on the diagnosis and management of diabetic foot ulcers: A retrospective cohort study	PLOS ONE			English	Article							GLOBAL BURDEN; CARE; MORTALITY; PREVALENCE; COSTS	Background Diabetic foot ulcers (DFU) are increasingly prevalent, and associated with significant morbidity, mortality, and cost. An interprofessional approach to DFU management is critical given the etiological complexity involved. This study aimed to assess the impact of an interprofessional team approach on DFU diagnosis and management for a cohort of patients receiving treatment in an Ontario Canada home care setting. Methods A retrospective cohort study of patients attending a large regional Community Care Access Centre (CCAC) between February 11, 2013-September 30, 2014 was conducted. Following CCAC referral, patients were assessed by an interprofessional team at the Toronto Regional Wound Healing Centre (TRWHC). Those aged > 18 years with a DFU of > 6 weeks duration were included. The primary outcome was the precision of the initial diagnosis relating to DFU etiology (i.e. neuropathic, ischemic or mixed etiology). Secondary outcomes included wound healing, and infection parameters. Analysis was completed with STATA 13.1 (College Stn., TX) of pre-determined outcomes with 2 sided a of 0.05. Results A total of 308 patients were screened, and 49 patients (67.3% male) of mean age 64.2 years (SD 13.7) with a diagnosis of DFU > 6 weeks duration were included for analysis. Of these, 95% were referred with unspecified DFU, and were reclassified to a precise diagnosis relating to etiology, including neuropathy, ischemia or neuroischemic etiology following TRWHC assessment (p < 0.001). For secondary outcomes post-assessment, healability assessment was conducted for a greater proportion of patients (100% versus 44%, p < 0.001). Infection was identified in a greater number of patients (p = 0.04), and of the 35 patients, 94.5% had deep and surrounding infection, and 88.0% were initiated on systemic antibiotics. Vascular insufficiency was diagnosed in an additional 14.3% of the cohort (p = 0.03). Offloading/footwear assessment was conducted in all patients compared with 30.6% prior to referral (p < 0.001) Dressing change frequency decreased significantly following TRWHC assessment (pre: 4.31/week; post: 3.54/week; p = 0.03). Pain scores decreased (2.18 to 1.67) on the numerical rating scale but this was not statistically significant at the final TRWHC assessment. Notably, 36.7% (18/49) reported improved quality of life by the second TRWHC encounter. Conclusions Interprofessional care teams are associated with improved diagnostic acumen and wound healing outcomes over conventional community care services. Initiatives including best practice interprofessional diabetic foot care pathways are recommended with timely vascular management of ischemia, treatment of deep and surrounding infection as well as the availability of foot care and footwear.	[Somayaji, Ranjani] Univ Calgary, Dept Med, Calgary, AB, Canada; [Elliott, James A.; Persaud, Reneeka; Sibbald, R. Gary] Toronto Reg Wound Healing Clin, Mississauga, ON, Canada; [Lim, Morgan] Trillium Hlth Partners, Inst Better Hlth, Mississauga, ON, Canada; [Lim, Morgan] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Goodman, Laurie] Humber River Hosp, Toronto, ON, Canada; [Sibbald, R. Gary] Trillium Hlth Partners, Mississauga, ON, Canada; [Sibbald, R. Gary] Univ Toronto, Dalla Lana Fac Publ Hlth, Toronto, ON, Canada; [Sibbald, R. Gary] Womens Coll Hosp, Wound Healing Clin, Div Dermatol, Dept Med, Toronto, ON, Canada	University of Calgary; University of Toronto; Trillium Health Partners; University of Toronto; University of Toronto; Trillium Health Partners; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital	Somayaji, R (corresponding author), Univ Calgary, Dept Med, Calgary, AB, Canada.	ranjani.somayaji@albertahealthservices.ca		Elliott, James/0000-0001-7150-6074	Alberta Innovates [201610405] Funding Source: researchfish	Alberta Innovates		Abbas Zulfiqarali G, 2007, Int Wound J, V4, P305; Alva ML, 2015, DIABETIC MED, V32, P459, DOI 10.1111/dme.12647; [Anonymous], 2014, J WOUND CARE, V23, pS1; Antoniu SA, 2012, EXPERT OPIN DRUG DEL, V9, P333, DOI 10.1517/17425247.2012.660480; Bharara M, 2009, INT WOUND J, V6, P2, DOI 10.1111/j.1742-481X.2009.00587.x; Booth GL, 2003, ARCH INTERN MED, V163, P101, DOI 10.1001/archinte.163.1.101; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Campbell Karen, 2006, Healthc Manage Forum, V19, P16; Frykberg R G, 1998, Adv Wound Care, V11, P71; GIBBONS GW, 1993, ARCH SURG-CHICAGO, V128, P576; Granick M, 1998, ADV WOUND CARE, V11, P3; Harrison MB, 2005, CAN MED ASSOC J, V172, P1447, DOI 10.1503/cmaj.1041441; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; International Diabetes Federation, 2014, IDF DIAB ATL 7 ED, P1; Jeffcoate W, 2005, LANCET, V365, P1527, DOI 10.1016/S0140-6736(05)66437-9; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Lipscombe LL, 2010, CAN MED ASSOC J, V182, pE1, DOI 10.1503/cmaj.090495; Lowe J, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/920124; Moulik PK, 2003, DIABETES CARE, V26, P491, DOI 10.2337/diacare.26.2.491; Narayan KMV, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P591; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Robbins JM, 2008, J AM PODIAT MED ASSN, V98, P489, DOI 10.7547/0980489; Rodrigues I, 2006, OSTOMY WOUND MANAG, V52, P46; Secretariat MA, 2009, ONTARIO HLTH TECHNOL, P9; Shannon RJ, 2007, WOUND CARE CANADA, V5, P53; Sibbald RG, 2015, ADV SKIN WOUND CARE, V28, P466, DOI 10.1097/01.ASW.0000470851.27030.98; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Sumpio BE, 2010, J VASC SURG, V51, P1504, DOI 10.1016/j.jvs.2010.04.010; Trubiani G, 2011, TORONTO HLTH EC TECH, P1; Vu T, 2007, FAM PRACT, V24, P372, DOI 10.1093/fampra/cmm024; World Health Organization, 2014, GLOB HLTH EST DEATHS, DOI 10.1371/journal.pgen.1004412.20; World Health Organization, DIABETES; Wu SC, 2007, VASC HEALTH RISK MAN, V3, P65	33	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185251	10.1371/journal.pone.0185251	http://dx.doi.org/10.1371/journal.pone.0185251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949996	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000031
J	Gschwantler-Kaulich, D; Weingartshofer, S; Grunt, TW; Mairhofer, M; Tan, Y; Gamper, J; Singer, CF				Gschwantler-Kaulich, Daphne; Weingartshofer, Sigrid; Grunt, Thomas W.; Mairhofer, Mario; Tan, Yen; Gamper, Jutta; Singer, Christian F.			Estradiol impairs the antiproliferative and proapoptotic effect of Zoledronic acid in hormone sensitive breast cancer cells in vitro	PLOS ONE			English	Article							INDUCED BONE LOSS; POSTMENOPAUSAL WOMEN; ADJUVANT THERAPY; BISPHOSPHONATE USE; ANTITUMOR-ACTIVITY; ENDOCRINE THERAPY; ZO-FAST; METAANALYSIS; MANAGEMENT; RISK	Background Zoledronic acid (ZA) has antiresorptive effects and protects from bone metastasis in women with early breast cancer. In addition, in postmenopausal women with endocrine responsive breast cancer ZA prolongs DFS. The exact mechanism is still unclear. We have therefore investigated the effect of increasing concentrations of ZA in breast cancer cell lines in the absence or presence of estradiol to mimic the hormonal environment in vitro. Materials and methods Using assays for cell proliferation (EZ4U, BrdU) and cell death (Annexin/PI), we have analyzed the dose-dependent antiproliferative and pro-apoptotic effects of ZA in two hormone sensitive cell lines (MCF-7 and T47D) and a hormone insensitive, triple negative cell line (MDA-MB-231) in the presence of 0, 1 and 10 nM estradiol. Results In the absence of estradiol, ZA exerts dose-dependent antiproliferative and pro-apoptotic antitumor effects in both, hormone sensitive (MCF-7, T47D) and -insensitive (MDA-MB-231) breast cancer cell lines (p<0.0001). In the presence of estradiol, the antitumoral effect of ZA was significantly decreased only in the hormone sensitive MCF-7 and T47D cell lines (p = 0.0008 and p = 0.0008, respectively). Conclusion We have demonstrated that estradiol impairs the antiproliferative and proapoptotic effect of ZA in hormone sensitive, but not in hormone insensitive breast cancer cell lines. Our findings provide a possible explanation for the differential effect of ZA on DFS in pre- and postmenopausal patients with hormone sensitive early breast cancer, which has been demonstrated clinically. We further hypothesize that endocrine insensitive tumors such as triple negative breast cancer (TNBC) should benefit from ZA irrespective of their menopausal status.	[Gschwantler-Kaulich, Daphne; Weingartshofer, Sigrid; Tan, Yen; Singer, Christian F.] Med Univ Vienna, Dept Obstet & Gynecol, Ctr Comprehens Canc, Vienna, Austria; [Grunt, Thomas W.] Med Univ Vienna, Ctr Comprehens Canc, Dept Med 1, Div Clin Oncol, Vienna, Austria; [Grunt, Thomas W.] Med Univ Vienna, Ludwig Boltzmann Cluster Oncol, Vienna, Austria; [Mairhofer, Mario] Ctr Adv Bioanal GmbH CBL, Linz, Austria; [Tan, Yen] QIMR Berghofer Med Res Inst, Herston, Qld, Australia; [Gamper, Jutta] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Med Stat, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Vienna; QIMR Berghofer Medical Research Institute; Medical University of Vienna	Gschwantler-Kaulich, D (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, Ctr Comprehens Canc, Vienna, Austria.	daphne.gschwantler@kaulch.at	Tan, Yen/AAW-2357-2021	Tan, Yen/0000-0003-1063-5352; Mairhofer, Mario/0000-0002-7218-6284; Grunt, Thomas/0000-0002-9899-5063	Austrian Society of Endocrinological Oncology (OEGEO)	Austrian Society of Endocrinological Oncology (OEGEO)	This research has received a research grant from the Austrian Society of Endocrinological Oncology (OEGEO). Center for Advanced Bioanalysis GmbH LTD provided support in the form of salaries for one of our co-authors [MM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Aft R, 2010, LANCET ONCOL, V11, P421, DOI 10.1016/S1470-2045(10)70054-1; Body JJ, 2007, OSTEOPOROSIS INT, V18, P1439, DOI 10.1007/s00198-007-0439-4; Brunner-Kubath C, 2011, BREAST CANCER RES TR, V129, P387, DOI 10.1007/s10549-010-1232-1; Brufsky A, 2008, ONCOLOGIST, V13, P503, DOI 10.1634/theoncologist.2007-0206; Brufsky AM, 2012, CANCER-AM CANCER SOC, V118, P1192, DOI 10.1002/cncr.26313; Chlebowski RT, 2010, J CLIN ONCOL, V28, P3582, DOI 10.1200/JCO.2010.28.2095; Clezardin P, 2012, ANTI-CANCER AGENT ME, V12, P102, DOI 10.2174/187152012799014977; Coleman R, 2015, LANCET, V386, P1353, DOI 10.1016/S0140-6736(15)60908-4; Coleman R, 2013, ANN ONCOL, V24, P398, DOI 10.1093/annonc/mds277; Coleman RE, 2011, NEW ENGL J MED, V365, P1396, DOI 10.1056/NEJMoa1105195; Gnant M, 2015, ANN ONCOL, V26, P313, DOI 10.1093/annonc/mdu544; Gnant M, 2009, CLIN BREAST CANCER, V9, pS18, DOI 10.3816/CBC.2009.s.002; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Gralow JR, 2013, J NATL COMPR CANC NE, V11, pS1; Hadji P, 2011, ANN ONCOL, V22, P2546, DOI 10.1093/annonc/mdr017; HALL DG, 1994, J BONE MINER RES, V9, P221; He MF, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-80; Hillner BE, 2003, J CLIN ONCOL, V21, P4042, DOI 10.1200/JCO.2003.08.017; Hines SL, 2010, BREAST, V19, P92, DOI 10.1016/j.breast.2009.12.001; Hines SL, 2009, BREAST CANCER RES TR, V117, P603, DOI 10.1007/s10549-009-0332-2; Kroep JR, 2016, EUR J CANCER, V54, P57, DOI 10.1016/j.ejca.2015.10.011; Leal T, 2010, CLIN BREAST CANCER, V10, P471, DOI 10.3816/CBC.2010.n.062; Lee SA, 2011, BREAST CANCER RES TR, V130, P863, DOI 10.1007/s10549-011-1728-3; Liu YP, 2012, CLIN BREAST CANCER, V12, P276, DOI 10.1016/j.clbc.2012.04.003; Llombart A, 2012, CLIN BREAST CANCER, V12, P40, DOI 10.1016/j.clbc.2011.08.002; Montaville P, 2002, J BIOL CHEM, V277, P24684, DOI 10.1074/jbc.M109595200; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Neville-Webbe HL, 2006, TUMOR BIOL, V27, P92, DOI 10.1159/000092489; Newcomb PA, 2010, BRIT J CANCER, V102, P799, DOI 10.1038/sj.bjc.6605555; Ormerod MG, 1998, ANAL CELL PATHOL, V17, P103, DOI 10.1155/1998/842306; Ottewell PD, 2014, CLIN CANCER RES, V20, P2922, DOI 10.1158/1078-0432.CCR-13-1246; Reid DM, 2008, CANCER TREAT REV, V34, pS3, DOI 10.1016/j.ctrv.2008.03.007; Rennert G, 2017, CLIN CANCER RES, V23, P1684, DOI 10.1158/1078-0432.CCR-16-0547; Rennert G, 2010, J CLIN ONCOL, V28, P3577, DOI 10.1200/JCO.2010.28.1113; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Valachis A, 2013, ONCOLOGIST, V18, P353, DOI 10.1634/theoncologist.2012-0261; Verdijk R, 2007, CANCER LETT, V246, P308, DOI 10.1016/j.canlet.2006.03.011; Vincenzi B, 2005, J INTERF CYTOK RES, V25, P144, DOI 10.1089/jir.2005.25.144; Winter MC, 2008, CANCER TREAT REV, V34, P453, DOI 10.1016/j.ctrv.2008.02.004; Wong MHF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003474.pub3; Yan TT, 2012, EUR J CANCER, V48, P187, DOI 10.1016/j.ejca.2011.10.021	42	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185566	10.1371/journal.pone.0185566	http://dx.doi.org/10.1371/journal.pone.0185566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945801	Green Published, gold, Green Submitted			2022-12-27	WOS:000411645100065
J	Steinbacher, P; Wanzenbock, J; Brandauer, M; Holper, R; Landertshammer, J; Mayr, M; Platzl, C; Stoiber, W				Steinbacher, Peter; Wanzenboeck, Josef; Brandauer, Magdalena; Holper, Raphael; Landertshammer, Jasmin; Mayr, Magdalena; Platzl, Christian; Stoiber, Walter			Thermal experience during embryogenesis contributes to the induction of dwarfism in whitefish Coregonus lavaretus	PLOS ONE			English	Article							MUSCLE-FIBER RECRUITMENT; GENETIC ARCHITECTURE; TEMPERATURE; GROWTH; PLASTICITY; CELLULARITY; LARVAL; DIVERGENCE; POPULATION; EXPRESSION	Ecotype pairs provide well-suited model systems for study of intraspecific phenotypical diversification of animals. However, little is still known about the processes that account for the development of different forms and sizes within a species, particularly in teleosts. Here, embryos of a normal-growing 'large' form and a dwarf form of whitefish Coregonus lavaretus were incubated at two temperatures that are usually experienced at their own spawning sites (2 degrees C for the normal and 6 degrees C for the dwarf form). All fish were subjected to similar thermal treatment after hatching. The present data demonstrate for the first time that different thermal experience in embryonic life has lasting effects on body and muscle growth of this ecotype pair and contributes to the development of the dwarf form. Thus, juvenile fish of the regular form are much smaller and have less muscle mass when pre-hatching thermal conditions were similar to those typical for the spawning sites of the dwarf form (6 degrees C) than when subjected to conditions of their own spawning sites (2 degrees C). Surprisingly, fish of the dwarf form exhibit a similar pattern of response to thermal history (2 degrees-fish much larger than 6 degrees-fish), indicating that in their case, normal spawning site temperature (6 degrees C) is indeed likely to act as a growth limiting factor. Results also demonstrate that the hypertrophic and hyperplastic muscle growth modes are similarly affected by thermal history. Immunolabelling experiments for Pax7, H3P and Mef2 provide evidence that the cellular mechanisms behind the increased growth rates after cold incubation in both ecotypes are increased proliferation and reduced differentiation rates of muscle precursor cells. This is of major significance to aspects of ecological and developmental biology and from the evolutionary perspective.	[Steinbacher, Peter; Brandauer, Magdalena; Holper, Raphael; Landertshammer, Jasmin; Mayr, Magdalena; Platzl, Christian; Stoiber, Walter] Univ Salzburg, Div Anim Struct & Funct, Dept Cell Biol & Physiol, Salzburg, Austria; [Wanzenboeck, Josef] Univ Innsbruck, Res Inst Limnol Mondsee, Mondsee, Austria	Salzburg University; University of Innsbruck	Steinbacher, P (corresponding author), Univ Salzburg, Div Anim Struct & Funct, Dept Cell Biol & Physiol, Salzburg, Austria.	peter.steinbacher@sbg.ac.at	Wanzenböck, Josef/AFR-9001-2022	Wanzenböck, Josef/0000-0002-9186-5565; Steinbacher, Peter/0000-0001-8033-5190	Austrian Science Foundation [P23739]; Austrian Science Foundation (FWF) [P23739]	Austrian Science Foundation(Austrian Science Fund (FWF)); Austrian Science Foundation (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Foundation, www.tvf.ac.at, P23739. PS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Josef Poigner (Altmunster, Austria) for help in catching the fish and Thomas Oberlercher and Wolfgang Hauer (BAW Institute of Water Ecology, Fisheries Biology and Lake Research, Scharfling, Austria) for help in rearing the fish. Special thanks go to Wolfgang Trutschnigg, Arne Bathke (Department of Mathematics, University of Salzburg, Austria) and Roman Fuchs (Department of Ecology and Evolution, University of Salzburg, Austria) for providing expert assistance in statistics. The work was supported by Austrian Science Foundation (FWF) grant P23739.	Alami-Durante H, 2007, CELL TISSUE RES, V327, P553, DOI 10.1007/s00441-006-0321-2; Albokhadaim I, 2007, J EXP BIOL, V210, P1735, DOI 10.1242/jeb.003194; Ayala MD, 2016, FISH PHYSIOL BIOCHEM, V42, P1027, DOI 10.1007/s10695-015-0194-y; Bernatchez L, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P175; Bock P., 1984, SEMIDUNNSCHNITT; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Campos C, 2013, EPIGENETICS-US, V8, P389, DOI 10.4161/epi.24178; Cingi S, 2010, J FISH BIOL, V76, P502, DOI 10.1111/j.1095-8649.2009.02502.x; Cote J, 2016, J EVOLUTION BIOL, V29, P1593, DOI 10.1111/jeb.12896; Douglas MR, 1999, MOL ECOL, V8, P589, DOI 10.1046/j.1365-294x.1999.00581.x; Douglas MR, 2005, COPEIA, P347, DOI 10.1643/CG-04-128R; Fernandes JMO, 2007, J EXP BIOL, V210, P3461, DOI 10.1242/jeb.009183; Fuentes EN, 2014, COMP BIOCHEM PHYS B, V176, P48, DOI 10.1016/j.cbpb.2014.07.003; Galloway T. F., 1999, Journal of Fish Biology, V55, P26, DOI 10.1111/j.1095-8649.1999.tb01044.x; Georga I, 2010, J MORPHOL, V271, P1319, DOI 10.1002/jmor.10874; Hamann H, 1954, BEITRAGE BIOL ERMITT; Hanel R, 1996, J FISH BIOL, V48, P937; Hudson AG, 2007, ADV LIMNOL, V60, P111; Johnston IA, 2000, J EXP BIOL, V203, P2553; Johnston IA, 1998, J EXP BIOL, V201, P623; Johnston IA, 2005, BIOL LETT-UK, V1, P419, DOI 10.1098/rsbl.2005.0377; Johnston IA, 2001, MAR ECOL PROG SER, V213, P285, DOI 10.3354/meps213285; Johnston IA, 2003, J EXP BIOL, V206, P1337, DOI 10.1242/jeb.00262; Johnston IA, 2004, J EXP BIOL, V207, P4343, DOI 10.1242/jeb.01292; Johnston IA, 2009, J EXP BIOL, V212, P1781, DOI 10.1242/jeb.029918; Kahilainen K, 2006, J FISH BIOL, V68, P63, DOI 10.1111/j.0022-1112.2006.00876.x; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Lahnsteiner B, 2004, ANN ZOOL FENN, V41, P75; Landry L, J EVOL BIOL, V20, P971; Macqueen DJ, 2008, BIOL LETTERS, V4, P294, DOI 10.1098/rsbl.2007.0620; Marschallinger J, 2009, DEV DYNAM, V238, P2442, DOI 10.1002/dvdy.22049; Martell DJ, 2007, J EXP BIOL, V210, P1170, DOI 10.1242/jeb.002188; NATHANAILIDES C, 1995, CAN J FISH AQUAT SCI, V52, P675, DOI 10.1139/f95-068; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Ohlberger J, 2008, FUNCT ECOL, V22, P501, DOI 10.1111/j.1365-2435.2008.01391.x; Ohlberger J, 2013, AM NAT, V182, P359, DOI 10.1086/671169; Rogers SM, 2007, MOL BIOL EVOL, V24, P1423, DOI 10.1093/molbev/msm066; Rogers SM, 2007, GENETICS, V175, P375, DOI 10.1534/genetics.106.061457; St-Cyr J, 2008, MOL ECOL, V17, P1850, DOI 10.1111/j.1365-294X.2008.03696.x; Steinbacher P, 2008, DEV DYNAM, V237, P3233, DOI 10.1002/dvdy.21745; Steinbacher P, 2006, DEV DYNAM, V235, P3132, DOI 10.1002/dvdy.20950; Steinbacher P, 2011, J EXP BIOL, V214, P1791, DOI 10.1242/jeb.050096; Steinmann P., 1950, SCHWEIZ Z HYDROL, V12, P340, DOI DOI 10.1007/BF02489885; Stoiber W, 2002, J EXP BIOL, V205, P2349; Vonlanthen P, 2009, J EVOLUTION BIOL, V22, P498, DOI 10.1111/j.1420-9101.2008.01670.x; WANZENBOCK J., 2002, WATER AIR SOIL POLL, P227, DOI DOI 10.1023/A:1020356008923	47	4	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185384	10.1371/journal.pone.0185384	http://dx.doi.org/10.1371/journal.pone.0185384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945823	gold, Green Published, Green Submitted			2022-12-27	WOS:000411645100056
J	Wang, Y; Hu, YD; He, DQ; Chen, SY; Li, SM; Lan, D; Ren, P; Lin, ZP; Liu, YP				Wang, Ye; Hu, Yaodong; He, Daqian; Chen, Shiyi; Li, Siming; Lan, Dan; Ren, Peng; Lin, Zhenping; Liu, Yiping			Contribution of both positive selection and relaxation of selective constraints to degeneration of flyability during geese domestication	PLOS ONE			English	Article							HIGH-ALTITUDE ADAPTATION; ARTIFICIAL SELECTION; OXYGEN-CONSUMPTION; EVOLUTION; HEMOGLOBIN; BIRDS; POLYMORPHISM; ORIGIN; FLIGHT; GENES	Flyability is the most discrepant trait between modern-day geese and their wild ancestors, and the degeneration of flyability is a key marker of the successful domestication of wild geese. In light of the relatively short history of domestic geese, intense artificial selection is thought to play an important role in the degeneration of flyability. However, the underlying mechanism behind this phenomenon has seldom been investigated. In this study, we applied a molecular evolutionary approach to the evaluation of partial breeds of domestic geese in order to look for genes involved in the selection pressure toward degeneration of flyability. The haplotype networks, pairwise fixation index (FST) values, and analysis of molecular variance results all clearly illustrated a population variance between Landes geese and partial Chinese domestic geese. We also detected signatures of positive artificial selection in the COX2 and COX3 genes, and related selection in the HBB gene. Our results support the independent origins of partial European domestic geese and Chinese domestic geese. In addition, both positive artificial selection and the relaxation of functional constraints appeared to play important roles in the degeneration of flyability in domestic geese.	[Wang, Ye; Hu, Yaodong; Chen, Shiyi; Lan, Dan; Ren, Peng; Liu, Yiping] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu Campus, Chengdu, Sichuan, Peoples R China; [He, Daqian] Shanghai Acad Agr Sci, Inst Anim Husb & Vet Sci, Shanghai, PR, Peoples R China; [Li, Siming] Jiangxi Acad Agr Sci, Inst Anim Husb & Vet Sci, Nanchang, Jiangxi, Peoples R China; [Lin, Zhenping] Shantou Baisha Res Inst Original Species Poultry, Shantou, Guangdong, Peoples R China	Sichuan Agricultural University; Shanghai Academy of Agricultural Sciences	Liu, YP (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu Campus, Chengdu, Sichuan, Peoples R China.	liuyp578@yahoo.com	he, daqian/HGC-6979-2022	Liu, Yi-ping/0000-0003-1477-9097; Wang, Ye/0000-0002-5423-6196	National Natural Science Foundation of China [31172181, 31660663]; National Waterfowl Industrial Technology System [CARS-43-4, 2016YFD0500510]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Waterfowl Industrial Technology System	This work was funded by the National Natural Science Foundation of China (Nos. 31172181 and 31660663) and the National Waterfowl Industrial Technology System (No. CARS-43-4 and 2016YFD0500510).	[Anonymous], 2005, DOC ARCHAEOBIOL, P249; BISHOP CM, 1995, J EXP BIOL, V198, P2153; Bishop KL, 2008, Q REV BIOL, V83, P153, DOI 10.1086/587825; Burga A, 2017, SCIENCE, V356, DOI 10.1126/science.aal3345; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Ericsson Per G.P., 2004, P1; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Follmann K, 1998, BIOCHEM MOL BIOL INT, V45, P1047; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Gifford R, 2005, J VIROL, V79, P6478, DOI 10.1128/JVI.79.10.6478-6486.2005; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hawkes LA, 2011, P NATL ACAD SCI USA, V108, P9516, DOI 10.1073/pnas.1017295108; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li J, 2010, HEREDITY, V105, P274, DOI 10.1038/hdy.2009.191; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maina JN, 2000, J EXP BIOL, V203, P3045; Mannermaa K, 2014, GOOSE DOMESTICATION, P3096; McCracken KG, 2010, MOL PHYLOGENET EVOL, V56, P649, DOI 10.1016/j.ympev.2010.04.034; Moran M, 2012, FREE RADICAL BIO MED, V53, P595, DOI 10.1016/j.freeradbiomed.2012.05.009; Pacelli C, 2011, MITOCHONDRION, V11, P334, DOI 10.1016/j.mito.2010.12.004; Scott GR, 2006, RESP PHYSIOL NEUROBI, V154, P284, DOI 10.1016/j.resp.2006.02.012; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; Shen YY, 2009, GENOME RES, V19, P1760, DOI 10.1101/gr.093138.109; Shi XW, 2006, BIOCHEM GENET, V44, P237, DOI 10.1007/s10528-006-9028-z; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Storz JF, 2008, HIGH ALT MED BIOL, V9, P148, DOI 10.1089/ham.2007.1079; Storz JF, 2007, PLOS GENET, V3, P448, DOI 10.1371/journal.pgen.0030045; Sun J, 2014, J POULT SCI, V51, P130, DOI 10.2141/jpsa.0120152; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMAS SP, 1972, J EXP BIOL, V57, P317; Wang MS, 2016, CELL RES, V26, P556, DOI 10.1038/cr.2016.44; Ward S, 2002, J EXP BIOL, V205, P3347; Weber RE, 2002, AM J PHYSIOL-REG I, V283, pR1052, DOI 10.1152/ajpregu.00292.2002	34	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185328	10.1371/journal.pone.0185328	http://dx.doi.org/10.1371/journal.pone.0185328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945805	Green Published, gold			2022-12-27	WOS:000411645100046
J	Dong, K; Cao, YB; Siercke, B; Wilber, M; McCalla, SG				Dong, Kun; Cao, Yunbai; Siercke, Beatrice; Wilber, Matthew; McCalla, Scott G.			Advising caution in studying seasonal oscillations in crime rates	PLOS ONE			English	Article							SPATIAL-PATTERNS; HUMAN VIOLENCE; MODELS; RAPE; TEMPERATURE; AGGRESSION; BURGLARY; DYNAMICS; HOTSPOTS	Most types of crime are known to exhibit seasonal oscillations, yet the annual variations in the amplitude of this seasonality and their causes are still uncertain. Using a large collection of data from the Houston and Los Angeles Metropolitan areas, we extract and study the seasonal variations in aggravated assault, break in and theft from vehicles, burglary, grand theft auto, rape, robbery, theft, and vandalism for many years from the raw daily data. Our approach allows us to see various long term and seasonal trends and aberrations in crime rates that have not been reported before. We then apply an ecologically motivated stochastic differential equation to reproduce the data. Our model relies only on social interaction terms, and not on any exigent factors, to reproduce both the seasonality, and the seasonal aberrations observed in our data set. Furthermore, the stochasticity in the system is sufficient to reproduce the variations seen in the seasonal oscillations from year to year. Researchers should be very careful about trying to correlate these oscillations with external factors.	[Dong, Kun] Cornell Univ, Ctr Appl Math, Ithaca, NY 14853 USA; [Cao, Yunbai] Univ Wisconsin, Dept Math, Madison, WI 53706 USA; [Siercke, Beatrice] Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA; [Wilber, Matthew] Harvey Mudd Coll, Dept Math, Claremont, CA 91711 USA; [McCalla, Scott G.] Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA	Cornell University; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Los Angeles; Claremont Colleges; Harvey Mudd College; Montana State University System; Montana State University Bozeman	McCalla, SG (corresponding author), Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA.	scott.mccalla@montana.edu		McCalla, Scott/0000-0003-0093-4658	NSF DMS [DMS-1045536, DMS-1312344, DMS-0968309]; ARO MURI [W911NF-11-1-0332, FA9550-10-1-0569]	NSF DMS(National Science Foundation (NSF)); ARO MURI(MURI)	This research was supported by NSF DMS grants DMS-1045536, DMS-1312344, DMS-0968309 (https://www.nsf.gov/div/index.jsp?div=DMS), by ARO MURI grant W911NF-11-1-0332 (https://www.ari.army.mil/www/default.cfm?pagee=472), and by AFOSR MURI grant FA9550-10-1-0569 (http://www.wpatb.af.mil/Welcome/Fact-Sheets/Display/Article/842111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank P.J. Brantingham for leading us towards studying seasonal crime with a stochastic model. The Los Angeles data set was provided courtesy of P.J. Brantingham and the LAPD. Finally, we would like to thank J.H. von Brecht for his support in every aspect of this research program. This research originated as a summer REU in the California Research Training Program in Computational and Applied Mathematics at UCLA. This research was supported by NSF grants DMS-1045536, DMS-1312344, DMS-0968309, by ARO MURI grant W911NF-11-1- 0332, and by AFOSR MURI grant FA9550-10-1-0569.	ANDERSON CA, 1989, PSYCHOL BULL, V106, P74, DOI 10.1037/0033-2909.106.1.74; Baumer E, 1996, BRIT J CRIMINOL, V36, P579; Berglund N., 2002, STOCH DYNAM, V2, P327, DOI DOI 10.1142/S0219493702000455; Brantingham PJ, 2012, CRIMINOLOGY, V50, P851, DOI 10.1111/j.1745-9125.2012.00281.x; Chaturapruek S, 2013, SIAM J APPL MATH, V73, P1703, DOI 10.1137/120895408; COHN EG, 1990, BRIT J CRIMINOL, V30, P51, DOI 10.1093/oxfordjournals.bjc.a047980; Daly K, 2010, CRIME JUSTICE, V39, P565, DOI 10.1086/653101; DEUTSCH SJ, 1978, INT J COMP APPL CRIM, V0002; Eisenman I, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016164; Elsner J., 1996, SINGULAR SPECTRUM AN; FARRELL G, 1994, BRIT J CRIMINOL, V34, P487, DOI 10.1093/oxfordjournals.bjc.a048449; Felson M, 2010, EUR J APPL MATH, V21, P275, DOI 10.1017/S0956792510000070; Hegemann RA, 2011, PHYSICA A, V390, P3894, DOI 10.1016/j.physa.2011.05.040; Hipp JR, 2004, SOC FORCES, V82, P1333, DOI 10.1353/sof.2004.0074; Hird C., 2007, SEASONALITY RECORDED; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Kelly L., 2005, GAP CHASM ATTRITION; KOSS MP, 1992, J SOC ISSUES, V48, P61, DOI 10.1111/j.1540-4560.1992.tb01157.x; Kuske R, 2007, J THEOR BIOL, V245, P459, DOI 10.1016/j.jtbi.2006.10.029; Levitt SD, 2004, J ECON PERSPECT, V18, P163, DOI 10.1257/089533004773563485; Lotka AJ, 1910, J PHYS CHEM-US, V14, P271, DOI 10.1021/j150111a004; McDowall D, 2012, J QUANT CRIMINOL, V28, P389, DOI 10.1007/s10940-011-9145-7; McKane AJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041902; MICHAEL RP, 1983, SOC BIOL, V30, P263; Mohler GO, 2011, J AM STAT ASSOC, V106, P100, DOI 10.1198/jasa.2011.ap09546; Moorcroft PR, 2006, P ROY SOC B-BIOL SCI, V273, P1651, DOI 10.1098/rspb.2005.3439; Newby JM, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.114101; Pino NW, 1999, SEX ROLES, V40, P979, DOI 10.1023/A:1018837524712; Quetelet Lambert Adolphe Jacques, 1842, TREATISE MAN DEV HIS; Short MB, 2010, SIAM J APPL DYN SYST, V9, P462, DOI 10.1137/090759069; Short MB, 2009, J QUANT CRIMINOL, V25, P325, DOI 10.1007/s10940-009-9068-8; Short MB, 2010, P NATL ACAD SCI USA, V107, P3961, DOI 10.1073/pnas.0910921107; Smith LM, 2012, DISCRETE CONT DYN-A, V32, P3223, DOI 10.3934/dcds.2012.32.3223; Sutherland E.H., 1992, PRINCIPLES CRIMINOLO, V1st; VAUTARD R, 1989, PHYSICA D, V35, P395, DOI 10.1016/0167-2789(89)90077-8; Volterra V., 1928, Journal du Conseil Copenhague, P3; Zimring WDSFE, 2006, GREAT AM CRIME DECLI	38	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185432	10.1371/journal.pone.0185432	http://dx.doi.org/10.1371/journal.pone.0185432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH9IR	28938022	gold, Green Published, Green Submitted			2022-12-27	WOS:000411524700033
J	Jakobsen, KK; Gronhoj, C; Jensen, DH; Fischer-Nielsen, A; Hjuler, T; von Buchwald, C				Jakobsen, Kathrine Kronberg; Gronhoj, Christian; Jensen, David H.; Fischer-Nielsen, Anne; Hjuler, Thomas; von Buchwald, Christian			Mesenchymal stem cell therapy for laryngotracheal stenosis: A systematic review of preclinical studies	PLOS ONE			English	Review							SUBGLOTTIC STENOSIS; STROMAL CELLS; MURINE MODEL; AIRWAY; ASTHMA; INFLAMMATION; MOUSE	Background Laryngotracheal stenosis (LTS) can be either congenital or acquired. Laryngeal stenosis is most often encountered after prolonged intubation. The mechanism for stenosis following intubation is believed to be hypertrophic scarring. Mesenchymal stem cells (MSCs) therapy has shown promising results in regenerative medicine. We aimed to systematically review the literature on MSC therapy for stenosis of the conductive airways. Methods PubMed, EMBASE, Google Scholar and the Cochrane Library were systematically searched from January 1980-January 2017 with the purpose of identifying all studies addressing the effect of MSC therapy on the airway. We assessed effect on inflammation, fibrosis, and MSC as a component in tissue engineering for treating defects in the airway. Results We identified eleven studies (n = 256 animals) from eight countries evaluating the effect of MSCs as a regenerative therapy in the upper airways. The studies indicate that MSC therapy may lead to a more constructive inflammatory response as well as support tissue regeneration. Conclusion There may be a favorable effect of MSCs in inhibiting inflammation and as a component in tissue engineering. Given the heterogeneous nature of the included animal studies, any clear conclusion regarding the effect of tracheal stenosis in human subjects cannot be drawn. The included preclinical studies are however encouraging for further research.	[Jakobsen, Kathrine Kronberg; Gronhoj, Christian; Jensen, David H.; Hjuler, Thomas; von Buchwald, Christian] Univ Copenhagen, Rigshosp, Dept Otorhinolaryngol Head & Neck Surg & Audiol, Copenhagen, Denmark; [Fischer-Nielsen, Anne] Univ Copenhagen, Rigshosp, Dept Clin Immunol, Cell Therapy Facil,Blood Bank, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	von Buchwald, C (corresponding author), Univ Copenhagen, Rigshosp, Dept Otorhinolaryngol Head & Neck Surg & Audiol, Copenhagen, Denmark.	christian.von.buchwald@regionh.dk	von Buchwald, Christian/D-5336-2016	von Buchwald, Christian/0000-0001-6753-8129; Jakobsen, Kathrine Kronberg/0000-0003-0336-5411; Hjuler, Thomas/0000-0002-3860-0306	Danish Cancer Society [R165-A10483-16-S7]; University of Copenhagen [A5090]; The Danish Cancer Society [R165-A10483] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); University of Copenhagen; The Danish Cancer Society(Danish Cancer Society)	This work was funded by The Danish Cancer Society (Grant number: R165-A10483-16-S7) and The University of Copenhagen (Grant number: A5090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bracken MB, 2009, J ROY SOC MED, V102, P120, DOI 10.1258/jrsm.2008.08k033; Daly AB, 2012, TISSUE ENG PT A, V18, P1, DOI [10.1089/ten.tea.2011.0301, 10.1089/ten.TEA.2011.0301]; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Firinci F, 2011, INT IMMUNOPHARMACOL, V11, P1120, DOI 10.1016/j.intimp.2011.03.009; Gelbard A, 2015, LARYNGOSCOPE, V125, P1137, DOI 10.1002/lary.24956; Go T, 2010, J THORAC CARDIOV SUR, V139, P437, DOI 10.1016/j.jtcvs.2009.10.002; Gray FL, 2012, J PEDIATR SURG, V47, P1072, DOI 10.1016/j.jpedsurg.2012.03.006; HOLINGER PH, 1976, ANN OTO RHINOL LARYN, V85, P591, DOI 10.1177/000348947608500505; Lee SH, 2011, ALLERGY ASTHMA IMMUN, V3, P205, DOI 10.4168/aair.2011.3.3.205; Mendez JJ, 2014, TISSUE ENG PT A, V20, P1735, DOI [10.1089/ten.tea.2013.0647, 10.1089/ten.TEA.2013.0647]; Mizuno Hiroshi, 2009, Journal of Nippon Medical School, V76, P56; Mohammadian M, 2016, IRAN J BASIC MED SCI, V19, P55; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; MORRISSEY MSC, 1990, ARCH DIS CHILD, V65, P1103, DOI 10.1136/adc.65.10.1103; Ogulur I, 2014, INT IMMUNOPHARMACOL, V20, P101, DOI 10.1016/j.intimp.2014.02.028; Ott LM, 2015, TISSUE ENG PT A, V21, P2390, DOI [10.1089/ten.tea.2015.0157, 10.1089/ten.TEA.2015.0157]; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Sandidache VC, 2007, ARCH OTOLARYNGOL, V133, P365, DOI 10.1001/archotol.133.4.365; Singh T, 2010, ARCH OTOLARYNGOL, V136, P163, DOI 10.1001/archoto.2009.175; Squillaro T, 2016, CELL TRANSPLANT, V25, P829, DOI 10.3727/096368915X689622; Sun YQ, 2012, STEM CELLS, V30, P2692, DOI 10.1002/stem.1241; Wentzel JL, 2014, LARYNGOSCOPE, V124, P1707, DOI 10.1002/lary.24524	24	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185283	10.1371/journal.pone.0185283	http://dx.doi.org/10.1371/journal.pone.0185283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934345	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900140
J	Grabar, S; Selinger-Leneman, H; Abgrall, S; Pialoux, G; Weiss, L; Costagliola, D				Grabar, Sophie; Selinger-Leneman, Hana; Abgrall, Sophie; Pialoux, Gilles; Weiss, Laurence; Costagliola, Dominique			Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4	PLOS ONE			English	Article							MEDICALLY CONTROLLED HIV; ANTIRETROVIRAL THERAPY; ELITE CONTROLLERS; NATURAL-HISTORY; PROGRESSION; INFECTION; SEROCONVERSION; COHORT	Objectives We studied the frequency and risk factors for loss of long-term non-progressor (LTNP) and HIV controller (HIC) status among patients identified as such in 2005 in the French Hospital Database on HIV (FHDH-ANRS CO4). Methods We selected patients who were treatment-naive and asymptomatic in 2005 (baseline). Those with >= 8 years of known HIV infection and a CD4 cell nadir >= 500/mm(3) were classified as LTNP and those with >= 10 years of known HIV infection and 90% of plasma viral load (VL) values <= 500 copies/ml in the absence of cART as HIC. cART initiation without loss of status and death from non AIDS-defining causes were considered as competing events. Results After 5 years of follow-up, 33% (95% CI; 27-42) of 171 LTNP patients and 17% (95% CI; 10-30) of 72 HIC patients had lost their status. In multivariable analyses, loss of LTNP status was associated with lower baseline CD4 cell counts and CD4/CD8 ratios. Only VL was significantly associated with loss of HIC status after adjustment for the baseline CD4 cell count, the CD4/CD8 ratio, and concomitant LTNP status. The hazard ratio for loss of HIC status was 5.5 (95% CI, 1.5-20.1) for baseline VL 50-500 vs <= 50 cp/mL, after adjustment for the baseline CD4 cell count. Conclusions One-third of LTNP and one-fifth of HIC patients lost their status after 5 years of follow-up, raising questions as to the possible benefits and timing of ART initiation in these populations.	[Grabar, Sophie; Selinger-Leneman, Hana; Abgrall, Sophie; Costagliola, Dominique] UPMC Univ Paris 06, Sorbonne Univ, INSERM, IPLESP,UMRS 1136, F-75013 Paris, France; [Grabar, Sophie; Abgrall, Sophie] Grp Hosp Cochin Broca Hotel Dieu, AP HP, Unite Biostat & Epidemiol, Paris, France; [Grabar, Sophie; Abgrall, Sophie; Weiss, Laurence] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Abgrall, Sophie] Hop Beclere, AP HP, Clamart, France; [Abgrall, Sophie] Fac Med Paris Sud, Le Kremlin Bicetre, France; [Abgrall, Sophie] Univ Paris Sud, Ctr Rech Epiderniol & Sante Populat, INSERM, U1018, Le Kremlin Bicetre, France; [Pialoux, Gilles] Hop Tenon, APHP, Paris, France; [Pialoux, Gilles] UPMC Univ Paris 06, Paris, France; [Weiss, Laurence] Hop Europeen Georges Pompidou, APHP, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Grabar, S (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, INSERM, IPLESP,UMRS 1136, F-75013 Paris, France.; Grabar, S (corresponding author), Grp Hosp Cochin Broca Hotel Dieu, AP HP, Unite Biostat & Epidemiol, Paris, France.; Grabar, S (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.	sophie.grabar@iplew.upmc.fr	Costagliola, Dominique/H-5849-2011; WEISS, Laurence/B-1373-2012; Grabar, Sophie/AAM-9857-2020	Costagliola, Dominique/0000-0003-0765-0869; 	Agence Nationale de Recherches sur le Sida et les Hepatites Virales; INSERM; French Ministry of Health	Agence Nationale de Recherches sur le Sida et les Hepatites Virales(ANRSFrench National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Ministry of Health	This study was supported by Agence Nationale de Recherches sur le Sida et les Hepatites Virales, INSERM, and the French Ministry of Health. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Boufassa F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085516; Chereau F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173893; Crowell TA, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20524; Crowell TA, 2015, J INFECT DIS, V211, P1692, DOI 10.1093/infdis/jiu809; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Grabar S, 2009, AIDS, V23, P1163, DOI 10.1097/QAD.0b013e32832b44c8; Groves KC, 2012, JAIDS-J ACQ IMM DEF, V61, P407, DOI 10.1097/QAI.0b013e318269c414; Gurdasani D, 2014, AIDS, V28, P149, DOI 10.1097/QAD.0000000000000049; Hatano H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003691; Karris MY, 2015, J INFECT DIS, V211, P1689, DOI 10.1093/infdis/jiu812; Leon A, 2016, AIDS, V30, P1209, DOI 10.1097/QAD.0000000000001050; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Madec Y, 2013, AIDS, V27, P2451, DOI 10.1097/01.aids.0000431945.72365.01; Mandalia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029844; Mary-Krause M, 2014, INT J EPIDEMIOL, V43, P1425, DOI 10.1093/ije/dyu002; Molina J-M, 2016, 21 INT AIDS C DURB S; Noel N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131922; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Pereyra F, 2012, AIDS, V26, P2409, DOI 10.1097/QAD.0b013e32835a9950; Preau M, 2016, QUAL HEALTH RES, V26, P1483, DOI 10.1177/1049732315617739; Saez-Cirion A, 2011, BLOOD, V118, P955, DOI 10.1182/blood-2010-12-327106; van der Helm JJ, 2014, LANCET HIV, V1, pE41, DOI 10.1016/S2352-3018(14)70016-5	22	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0184441	10.1371/journal.pone.0184441	http://dx.doi.org/10.1371/journal.pone.0184441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968404	Green Published, Green Submitted, gold			2022-12-27	WOS:000412029600008
J	Arbieu, U; Grunewald, C; Schleuning, M; Bohning-Gaese, K				Arbieu, Ugo; Gruenewald, Claudia; Schleuning, Matthias; Boehning-Gaese, Katrin			The importance of vegetation density for tourists' wildlife viewing experience and satisfaction in African savannah ecosystems	PLOS ONE			English	Article							NATIONAL-PARK; CLIMATE-CHANGE; CONSERVATION; LANDSCAPE; ENCROACHMENT; IMPACTS	Southern African protected areas (PAs) harbour a great diversity of animals, which represent a large potential for wildlife tourism. In this region, global change is expected to result in vegetation changes, such as bush encroachment and increases in vegetation density. However, little is known on the influence of vegetation structure on wildlife tourists' wildlife viewing experience and satisfaction. In this study, we collected data on vegetation structure and perceived mammal densities along 196 road transects (each 5 km long) and conducted a social survey with 651 questionnaires across four PAs in three Southern African countries. Our objectives were 1) to assess visitors' attitude towards vegetation, 2) to test the influence of perceived mammal density and vegetation structure on the easiness to spot animals, and 3) on visitors' satisfaction during their visit to PAs. Using a Boosted Regression Tree procedure, we found mostly negative non-linear relationships between vegetation density and wildlife tourists' experience, and positive relationships between perceived mammal densities and wildlife tourists' experience. In particular, wildlife tourists disliked road transects with high estimates of vegetation density. Similarly, the easiness to spot animals dropped at thresholds of high vegetation density and at perceived mammal densities lower than 46 individuals per road transect. Finally, tourists' satisfaction declined linearly with vegetation density and dropped at mammal densities smaller than 26 individuals per transect. Our results suggest that vegetation density has important impacts on tourists' wildlife viewing experience and satisfaction. Hence, the management of PAs in savannah landscapes should consider how tourists perceive these landscapes and their mammal diversity in order to maintain and develop a sustainable wildlife tourism.	[Arbieu, Ugo; Gruenewald, Claudia; Schleuning, Matthias; Boehning-Gaese, Katrin] Senckenberg Biodivers & Climate Res Ctr SBiK F, Frankfurt, Germany; [Arbieu, Ugo; Boehning-Gaese, Katrin] Goethe Univ, Dept Biol Sci, Frankfurt, Germany	Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt	Arbieu, U (corresponding author), Senckenberg Biodivers & Climate Res Ctr SBiK F, Frankfurt, Germany.; Arbieu, U (corresponding author), Goethe Univ, Dept Biol Sci, Frankfurt, Germany.	ugo.arbieu@senckenberg.de	Arbieu, Ugo/Q-3408-2019; Schleuning, Matthias/H-2154-2015; Böhning-Gaese, Katrin/W-2601-2019	Arbieu, Ugo/0000-0002-0655-8756; Schleuning, Matthias/0000-0001-9426-045X; Böhning-Gaese, Katrin/0000-0003-0477-5586	Deutsche Forsch ungsgemeinschaft (DFG) [BO 1221/19-1]; Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE excellence initiative) of Hesse's Ministry of Higher Education, Research, and the Arts	Deutsche Forsch ungsgemeinschaft (DFG)(German Research Foundation (DFG)); Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE excellence initiative) of Hesse's Ministry of Higher Education, Research, and the Arts	This work was supported by the Deutsche Forsch ungsgemeinschaft (DFG, grant number BO 1221/19-1, http://www.dfg.de/) and the Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE excellence initiative) of Hesse's Ministry of Higher Education, Research, and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald S, 2005, ECOL APPL, V15, P96, DOI 10.1890/03-5210; Balmford A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002074; Beerling DJ, 2006, GLOBAL CHANGE BIOL, V12, P2023, DOI 10.1111/j.1365-2486.2006.01239.x; Bellan SE, 2012, J WILDLIFE DIS, V48, P371, DOI 10.7589/0090-3558-48.2.371; Boshoff AF, 2007, S AFR J WILDL RES, V37, P189, DOI 10.3957/0379-4369-37.2.189; Brand R, 2007, EVOL ECOL; Buckley R, 2013, ANIM CONSERV, V16, P259, DOI 10.1111/acv.12057; Buckley R, 2010, NATURE, V467, P1047, DOI 10.1038/4671047d; Buckley R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000143; Caro TM, 1999, ANIM CONSERV, V2, P305, DOI 10.1111/j.1469-1795.1999.tb00077.x; Charles-Dominique T, 2015, S AFR J BOT, V101, P82, DOI 10.1016/j.sajb.2015.05.005; Daniel TC, 2012, P NATL ACAD SCI USA, V109, P8812, DOI 10.1073/pnas.1114773109; Di Minin E, 2013, ANIM CONSERV, V16, P249, DOI 10.1111/j.1469-1795.2012.00595.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Eygelaar D, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0627-y; Frank S, 2013, ECOL INDIC, V32, P222, DOI 10.1016/j.ecolind.2013.03.026; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Fullman TJ, 2013, AFR J ECOL, V51, P235, DOI 10.1111/aje.12026; Gandiwa E, 2014, AFR J ECOL, V52, P274, DOI 10.1111/aje.12114; Gillson L, 2015, ECOL COMPLEX, V21, P78, DOI 10.1016/j.ecocom.2014.12.005; Gossling S, 2012, ANN TOURISM RES, V39, P36, DOI 10.1016/j.annals.2011.11.002; Gray EF, 2013, KOEDOE, V55, DOI 10.4102/koedoe.v55i1.1106; Hempson GP, 2015, SCIENCE, V350, P1056, DOI 10.1126/science.aac7978; Hopcraft JGC, 2010, TRENDS ECOL EVOL, V25, P119, DOI 10.1016/j.tree.2009.08.001; Lee DJ, 2014, TOURISM MANAGE, V45, P171, DOI 10.1016/j.tourman.2014.04.002; Lindemann-Matthies P, 2010, BIOL CONSERV, V143, P195, DOI 10.1016/j.biocon.2009.10.003; Lindsey Peter A., 2007, Journal of Ecotourism, V6, P19, DOI 10.2167/joe133.0; Moncrieff GR, 2015, S AFR J BOT, V101, P16, DOI 10.1016/j.sajb.2015.02.004; Naidoo R, 2011, ENVIRON RESOUR ECON, V48, P321, DOI 10.1007/s10640-010-9412-3; O'Connor TG, 2014, AFR J RANGE FOR SCI, V31, P67, DOI 10.2989/10220119.2014.939996; Owen-Smith N, 2012, J MAMMAL, V93, P698, DOI 10.1644/11-MAMM-A-350.1; Parr CL, 2014, TRENDS ECOL EVOL, V29, P205, DOI 10.1016/j.tree.2014.02.004; Parr CL, 2012, DIVERS DISTRIB, V18, P493, DOI 10.1111/j.1472-4642.2012.00882.x; Pettorelli N, 2012, ECOL INDIC, V20, P269, DOI 10.1016/j.ecolind.2012.02.014; Rossello-Nadal J, 2014, TOURISM MANAGE, V42, P334, DOI 10.1016/j.tourman.2013.11.006; Scheiter S, 2009, GLOBAL CHANGE BIOL, V15, P2224, DOI 10.1111/j.1365-2486.2008.01838.x; Smit IPJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137857; Smith MD, 2013, J PLANT ECOL, V6, P71, DOI 10.1093/jpe/rts014; Steven R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062598; Torres-Sovero C, 2012, TOURISM MANAGE, V33, P545, DOI 10.1016/j.tourman.2011.06.008; Wiegand K, 2006, PERSPECT PLANT ECOL, V7, P229, DOI 10.1016/j.ppees.2005.10.001; Willemen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129785; Winterbach CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135595; Wood SA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02976	44	9	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185793	10.1371/journal.pone.0185793	http://dx.doi.org/10.1371/journal.pone.0185793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957420	gold, Green Published, Green Submitted			2022-12-27	WOS:000411985200115
J	Malaspina, DC; Longo, G; Szleifer, I				Malaspina, David C.; Longo, Gabriel; Szleifer, Igal			Behavior of ligand binding assays with crowded surfaces: Molecular model of antigen capture by antibody-conjugated nanoparticles	PLOS ONE			English	Article							THERAPEUTIC ANTIBODIES; RECEPTOR INTERACTIONS; POLYMERS; AFFINITY; IMMOBILIZATION; TECHNOLOGIES; COVERAGE; KINETICS; HIV-1	Ligand-receptor binding is of utmost importance in several biologically related disciplines. Ligand binding assays (LBA) use the high specificity and high affinity of ligands to detect, target or measure a specific receptors. One particular example of ligand binding assays are Antibody conjugated Nanoparticles (AcNPs), edge-cutting technologies that are present in several novel biomedical approaches for imaging, detection and treatment of diseases. However, the nano-confinement in AcNPs and LBA nanostructures introduces extra complexity in the analysis of ligand-receptor equilibriums. Because antibodies are large voluminous ligands, the effective affinity in AcNPs is often determined by antibody orientation and surface coverage. Moreover, antibodies have two binding sites introducing an extra ligand-receptor binding equilibrium. As consequence of all this, experimental or theoretical studies providing a guidelines for the prediction of the binding behavior in AcNPs are scarce. In this work, we present a set of theoretical calculations to shed light into the complex binding behavior of AcNPs and its implications in biomedical applications. To investigate the ligand-receptor binding on AcNPs, we have used a molecular theory that predicts the probability of different molecular conformations of the system depending on the local environment. We have considered two different pathways for designing these devices: covalently conjugated antibodies and streptavidin-biotin conjugated antibodies. We also explore the effects of surface coverage, bulk concentrations, nanoparticle size and antibody-antigen affinity. Overall, this work offers a series of theoretical predictions that can be used as a guide in the design of antibody conjugated nanoparticles for different applications.	[Malaspina, David C.; Szleifer, Igal] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Longo, Gabriel] UNLP, CONICET, Inst Invest Fisicoquim Teor & Aplicadas INIFTA, La Plata, Buenos Aires, Argentina; [Szleifer, Igal] Dept Chem, Evanston, IL 60208 USA; [Szleifer, Igal] Chem Life Proc Inst, Evanston, IL 60208 USA	Northwestern University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; INIFTA	Szleifer, I (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.; Szleifer, I (corresponding author), Dept Chem, Evanston, IL 60208 USA.; Szleifer, I (corresponding author), Chem Life Proc Inst, Evanston, IL 60208 USA.	igalsz@northwestern.edu	malaspina, david c/I-9578-2016; Szleifer, Igal/B-6920-2009; Longo, Gabriel S./S-5945-2019; Longo, Gabriel S./E-8823-2012	malaspina, david c/0000-0002-5420-9534; Longo, Gabriel S./0000-0001-8353-5163; Longo, Gabriel S./0000-0001-8353-5163	National Institute of Biomedical Imaging and Bio-engineering (NIBIB) at the National Institutes of Health (NIH) [EB005772]; National Science Foundation [CBET-1403058]; ANPCyT; Argentina [PICT-2014-3377]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005772] Funding Source: NIH RePORTER; Directorate For Engineering [1403058] Funding Source: National Science Foundation	National Institute of Biomedical Imaging and Bio-engineering (NIBIB) at the National Institutes of Health (NIH); National Science Foundation(National Science Foundation (NSF)); ANPCyT(ANPCyT); Argentina; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported by Grant No. EB005772 from the National Institute of Biomedical Imaging and Bio-engineering (NIBIB) at the National Institutes of Health (NIH) to IS. This research was supported by National Science Foundation CBET-1403058 (to IS). G.L. thanks the support from the ANPCyT, Argentina (PICT-2014-3377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Grant No. EB005772 from the National Institute of Biomedical Imaging and Bio-engineering (NIBIB) at the National Institutes of Health (NIH). We also thanks the support from the ANPCyT, Argentina (PICT-2014-3377).	Arruebo M, 2009, J NANOMATER, V2009, DOI 10.1155/2009/439389; Bonanno LM, 2007, LANGMUIR, V23, P5817, DOI 10.1021/la063659c; Brogan KL, 2005, LANGMUIR, V21, P3054, DOI 10.1021/la047922q; Cardoso MM, 2012, CURR MED CHEM, V19, P3103; CARIGNANO MA, 1993, J CHEM PHYS, V98, P5006, DOI 10.1063/1.464954; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chinen AB, 2015, CHEM REV, V115, P10530, DOI 10.1021/acs.chemrev.5b00321; Cooper GM, 2000, CELL MOL APPROACH; de Jong LAA, 2005, J CHROMATOGR B, V829, P1, DOI 10.1016/j.jchromb.2005.10.002; Fay F, 2011, IMMUNOTHERAPY-UK, V3, P381, DOI 10.2217/IMT.11.5; Flory PJ, 1969, INTERSCIENCE; GILBERT M, 1991, J CLIN MICROBIOL, V29, P142, DOI 10.1128/JCM.29.1.142-147.1991; Jung LS, 2000, LANGMUIR, V16, P9421, DOI 10.1021/la000144r; Klasse PJ, 2004, VIROLOGY, V323, P1, DOI 10.1016/j.virol.2004.03.003; Klein JS, 2009, P NATL ACAD SCI USA, V106, P7385, DOI 10.1073/pnas.0811427106; Koh I, 2006, J PHYS CHEM B, V110, P1553, DOI 10.1021/jp0556310; Landry JP, 2012, ASSAY DRUG DEV TECHN, V10, P250, DOI 10.1089/adt.2011.0406; Longo G, 2005, LANGMUIR, V21, P11342, DOI 10.1021/la051685p; Longo GS, 2008, LANGMUIR, V24, P10324, DOI 10.1021/la8009699; Montenegro JM, 2013, ADV DRUG DELIVER REV, V65, P677, DOI 10.1016/j.addr.2012.12.003; Moore NW, 2006, LANGMUIR, V22, P8485, DOI 10.1021/la0608462; Mora J, 2014, AAPS J, V16, P1175, DOI 10.1208/s12248-014-9660-1; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Ren CL, 2009, LANGMUIR, V25, P12283, DOI 10.1021/la901735d; Saha B, 2014, ANAL CHEM, V86, P8158, DOI 10.1021/ac501536z; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Soukka T, 2001, ANAL CHEM, V73, P2254, DOI 10.1021/ac001287l; Sperling RA, 2008, CHEM SOC REV, V37, P1896, DOI 10.1039/b712170a; Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3; Tagliazucchi M, 2010, J AM CHEM SOC, V132, P12404, DOI 10.1021/ja104152g; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Zhang HD, 2006, BIOTECHNOL BIOENG, V95, P812, DOI 10.1002/bit.21024; Zhao Z, 2007, SMALL, V3, P1390, DOI 10.1002/smll.200700006; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu CL, 2012, CHEM REV, V112, P4687, DOI 10.1021/cr200263w	36	21	21	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185518	10.1371/journal.pone.0185518	http://dx.doi.org/10.1371/journal.pone.0185518			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957393	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200074
J	Mukhopadhyay, A; Tai, BC; Remani, D; Phua, J; Cove, ME; Kowitlawakul, Y				Mukhopadhyay, Amartya; Tai, Bee Choo; Remani, Deepa; Phua, Jason; Cove, Matthew Edward; Kowitlawakul, Yanika			Age related inverse dose relation of sedatives and analgesics in the intensive care unit	PLOS ONE			English	Article							MECHANICALLY VENTILATED PATIENTS; CRITICALLY-ILL PATIENTS; LONG-TERM MORTALITY; DAILY INTERRUPTION; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; PROPOFOL; PHARMACOKINETICS; MULTICENTER; MIDAZOLAM	Sedative and analgesic practices in intensive care units (ICUs) are frequently based on anesthesia regimes but do not take account of the important patient related factors. Pharmacologic properties of sedatives and analgesics change when used as continuous infusions in ICU compared to bolus or short-term infusions during anesthesia. In a prospective observational cohort study, we investigated the association between patient related factors and sedatives/analgesics doses in patients on mechanical ventilation (MV) and their association with cessation of sedation/analgesia. We included patients expected to receive MV for at least 24 hours and excluded those with difficulty in assessing the depth of sedation. We collected data for the first 72 hours or until extubation, whichever occurred first. Multivariate analysis of variance, multivariate regression as well as logistic regression were used. The final cohort (N = 576) was predominantly male (64%) with mean (SD) age 61.7 (15.6) years, weight 63.4 (18.2) Kg, Acute Physiology and Chronic Health Evaluation II score 28.2 (8) and 30% hospital mortality. Increasing age was associated with reduced propofol and fentanyl doses requirements, adjusted to the weight (p<0.001). Factors associated with higher propofol and fentanyl doses were vasopressor use (Relative mean difference (RMD) propofol 1.56 (95% confidence interval (CI) 1.28-1.90); fentanyl 1.48 (1.25-1.76) and central venous line placement (CVL, RMD propofol 1.64 (1.15-2.33); fentanyl 1.41 (1.03-1.91). Male gender was also associated with higher propofol dose (RMD 1.27 (1.06-1.49). Sedation cessation was less likely to occur in restrained patients (Odds Ratio, OR 0.48 (CI 0.30-0.78) or those receiving higher sedative/analgesic doses (OR propofol 0.98 (CI 0.97-0.99); fentanyl 0.99 (CI 0.98-0.997), independent of depth of sedation. In conclusion, increasing age is associated with the use of lower doses of sedative/analgesic in ICU, whereas CVL and vasopressor use were associated with higher doses.	[Mukhopadhyay, Amartya; Remani, Deepa; Phua, Jason; Cove, Matthew Edward] Natl Univ Hlth Syst, Univ Med Cluster, Div Resp & Crit Care Med, Singapore, Singapore; [Mukhopadhyay, Amartya; Phua, Jason; Cove, Matthew Edward] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Tai, Bee Choo] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Tai, Bee Choo; Kowitlawakul, Yanika] Natl Univ Hlth Syst, Singapore, Singapore; [Kowitlawakul, Yanika] Natl Univ Singapore, Alice Lee Ctr Nursing Studies, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Mukhopadhyay, A (corresponding author), Natl Univ Hlth Syst, Univ Med Cluster, Div Resp & Crit Care Med, Singapore, Singapore.; Mukhopadhyay, A (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.	amartya.mukherjee@gmail.com	Cove, Matthew/AAP-5051-2020	Cove, Matthew/0000-0003-3805-4680; Mukhopadhyay, Amartya/0000-0002-9747-5277				Absalom AR, 2009, BRIT J ANAESTH, V103, P26, DOI 10.1093/bja/aep143; Ahlers SJ, 2008, CRIT CARE, V12, DOI 10.1186/cc6789; Aissaoui Y, 2005, ANESTH ANALG, V101, P1470, DOI 10.1213/01.ANE.0000182331.68722.FF; Barash PG, 2009, CLIN ANESTH, P148; Barr J, 2001, ANESTHESIOLOGY, V95, P286, DOI 10.1097/00000542-200108000-00007; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; BLOUIN RT, 1993, ANESTHESIOLOGY, V79, P1177, DOI 10.1097/00000542-199312000-00007; Boumendil A, 2007, INTENS CARE MED, V33, P1252, DOI 10.1007/s00134-007-0621-3; Carson SS, 2006, CRIT CARE MED, V34, P1326, DOI 10.1097/01.CCM.0000215513.63207.7F; Gelinas C, 2009, J PAIN SYMPTOM MANAG, V37, P58, DOI 10.1016/j.jpainsymman.2007.12.022; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; GREENBLATT DJ, 1984, ANESTHESIOLOGY, V61, P27, DOI 10.1097/00000542-198461010-00006; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Kazama T, 2001, ANESTHESIOLOGY, V94, P205, DOI 10.1097/00000542-200102000-00007; Kollef MH, 1998, CHEST, V114, P541, DOI 10.1378/chest.114.2.541; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P595, DOI 10.1017/S1355617707070749; Lichtenbelt BJ, 2004, CLIN PHARMACOKINET, V43, P577, DOI 10.2165/00003088-200443090-00002; Martin Jorg, 2010, Ger Med Sci, V8, pDoc02, DOI 10.3205/000091; Mehta S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1405-3; Mehta S, 2009, CRIT CARE CLIN, V25, P471, DOI 10.1016/j.ccc.2009.04.001; Ong BKC, 2002, ANN ACAD MED SINGAP, V31, P707; Payen JF, 2007, ANESTHESIOLOGY, V106, P687, DOI 10.1097/01.anes.0000264747.09017.da; Reigle J, 1996, AACN Clin Issues, V7, P585, DOI 10.1097/00044067-199611000-00014; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Schnider TW, 1998, ANESTHESIOLOGY, V88, P1170, DOI 10.1097/00000542-199805000-00006; Schuttler J, 2000, ANESTHESIOLOGY, V92, P727, DOI 10.1097/00000542-200003000-00017; Shehabi Y, 2013, INTENS CARE MED, V39, P910, DOI 10.1007/s00134-013-2830-2; Shehabi Y, 2012, AM J RESP CRIT CARE, V186, P724, DOI 10.1164/rccm.201203-0522OC; Silverstein JH, 2008, GERIATRIC ANESTHESIO, P209; SINGLETON MA, 1988, BRIT J ANAESTH, V60, P619, DOI 10.1093/bja/60.6.619; Tanios MA, 2009, J CRIT CARE, V24, P66, DOI 10.1016/j.jcrc.2008.03.037; Treggiari MM, 2009, CRIT CARE MED, V37, P2527, DOI 10.1097/CCM.0b013e3181a5689f; van Rompaey B, 2009, CRIT CARE, V13, DOI 10.1186/cc7892; Vuyk J, 2001, BRIT J ANAESTH, V86, P183, DOI 10.1093/bja/86.2.183; Wunsch H, 2009, CRIT CARE MED, V37, P3031, DOI 10.1097/CCM.0b013e3181b02eff	36	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185212	10.1371/journal.pone.0185212	http://dx.doi.org/10.1371/journal.pone.0185212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957364	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200033
J	Munteanu, D; Etzion, O; Ben-Yakov, G; Halperin, D; Eidelman, L; Schwartz, D; Novack, V; Abufreha, N; Krugliak, P; Rozenthal, A; Gaspar, N; Moshkalo, A; Dizingof, V; Fich, A				Munteanu, Daniela; Etzion, Ohad; Ben-Yakov, Gil; Halperin, Daniel; Eidelman, Leslie; Schwartz, Doron; Novack, Victor; Abufreha, Naim; Krugliak, Pavel; Rozenthal, Alexander; Gaspar, Nava; Moshkalo, Alexander; Dizingof, Vitaly; Fich, Alexander			Efficacy and safety of sequential versus quadruple therapy as second-line treatment for helicobacter pylori infection-A randomized controlled trial	PLOS ONE			English	Article							TRIPLE THERAPY; ANTIBIOTIC-RESISTANCE; ERADICATION; LEVOFLOXACIN; AMOXICILLIN; CONSENSUS; METAANALYSIS; MANAGEMENT; REGIMEN	Background and aims Quadruple therapy is recommended as second-line treatment for Helicobacter pylori eradication failure. However, high cost, multiple side effects, and low adherence rates are major drawbacks to its routine use. Our aim was to compare the efficacy and safety of sequential versus quadruple regimens as second line treatment for persistent Helicobacter pylori infection. Methods Prospective, randomized, open label trial was conducted at a large academic, tertiary care center in Israel. Patients who previously failed a standard triple treatment eradication course were randomly assigned (1: 1) to receive a 10-day sequential therapy course, or a 14-day quadruple regimen. Compliance and adverse events were evaluated by telephone questionnaires. The primary endpoint for analysis was the rate of Helicobacter pylori eradication as defined by either a negative 13C-urea breath-test, or stool antigen test, 4-16 weeks after treatment assessed under the non-inferiority hypothesis. The trial was terminated prematurely due to low recruitment rates. See S1 Checklist for CONSORT checklist. Results One hundred and one patients were randomized. Per modified intention-to-treat analysis, eradication rate was 49% in the sequential versus 42.5% in the quadruple regimen group (pvalue for non-inferiority 0.02). Forty-two (84.0%) versus 33 (64.7%) patients completed treatment in the sequential and quadruple groups respectively (p 0.027). Gastrointestinal side effects were more common in the quadruple regimen group. Conclusion Sequential treatment when used as a second line regimen, was non-inferior to the standard of care quadruple regimen in achieving Helicobacter pylori eradication, and was associated with better compliance and fewer adverse effects. Both treatment protocols failed to show an adequate eradication rate in the population of Southern Israel.	[Munteanu, Daniela; Etzion, Ohad; Ben-Yakov, Gil; Eidelman, Leslie; Schwartz, Doron; Abufreha, Naim; Krugliak, Pavel; Rozenthal, Alexander; Gaspar, Nava; Moshkalo, Alexander; Dizingof, Vitaly; Fich, Alexander] Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Univ Med Ctr, Inst Gastroenterol & Liver Dis, Beer Sheva, Israel; [Halperin, Daniel; Novack, Victor] Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Univ Med Ctr, Clin Res Ctr, Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center	Etzion, O (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Univ Med Ctr, Inst Gastroenterol & Liver Dis, Beer Sheva, Israel.	ohadet34@yahoo.com	Abu Freha, Naim/AAJ-9585-2020; Yakov, Gil Ben/P-9276-2019; etzion, ohad/N-5927-2019	Abu Freha, Naim/0000-0002-4844-3308; Ben Yakov, Gil/0000-0002-6832-0903; Halperin, Daniel/0000-0002-1598-989X				Aydin A, 2009, HELICOBACTER, V14, P520, DOI 10.1111/j.1523-5378.2009.00720.x; Draeger S, 2015, J ANTIMICROB CHEMOTH, V70, P3141, DOI 10.1093/jac/dkv223; Fallone CA, 2016, GASTROENTEROLOGY, V151, P51, DOI 10.1053/j.gastro.2016.04.006; Federico A, 2012, GASTROENTEROLOGY, V143, P55, DOI 10.1053/j.gastro.2012.03.043; GART JJ, 1990, BIOMETRICS, V46, P637, DOI 10.2307/2532084; Gatta L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4587; Gatta L, 2009, AM J GASTROENTEROL, V104, P3069, DOI 10.1038/ajg.2009.555; Graham DY, 2006, ALIMENT PHARM THER, V24, P845, DOI 10.1111/j.1365-2036.2006.03072.x; Han SR, 1999, J CLIN MICROBIOL, V37, P2740, DOI 10.1128/JCM.37.8.2740-2741.1999; Hojo M, 2001, SCAND J GASTROENTERO, V36, P690, DOI 10.1080/003655201300191941; Kim Sung Bum, 2015, Korean J Gastroenterol, V66, P261, DOI 10.4166/kjg.2015.66.5.261; Krystallis C, 2010, DIGEST DIS SCI, V55, P3630, DOI 10.1007/s10620-010-1199-0; Lahaie RG, 2000, CAN J GASTROENTEROL, V14, P895, DOI 10.1155/2000/218256; Liou JM, 2016, AM J GASTROENTEROL, V111, P381, DOI 10.1038/ajg.2015.439; Liou JM, 2013, LANCET, V381, P205, DOI 10.1016/S0140-6736(12)61579-7; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Malfertheiner P, 2002, ALIMENT PHARM THER, V16, P167, DOI 10.1046/j.1365-2036.2002.01169.x; Malfertheiner P, 2017, GUT, V66, P6, DOI 10.1136/gutjnl-2016-312288; McNicholl AG, 2014, GUT, V63, P244, DOI 10.1136/gutjnl-2013-304820; Nishizawa T, 2013, J GASTROEN HEPATOL, V28, P1608, DOI 10.1111/jgh.12281; Samra Z, 2002, J ANTIMICROB CHEMOTH, V49, P1023, DOI 10.1093/jac/dkf041; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Thung I, 2016, ALIMENT PHARM THER, V43, P514, DOI 10.1111/apt.13497; Vakil N, 2009, AM J GASTROENTEROL, V104, P26, DOI 10.1038/ajg.2008.91; Vergara M, 2003, ALIMENT PHARM THER, V18, P647, DOI 10.1046/j.1365-2036.2003.01746.x; Wu DC, 2010, CLIN GASTROENTEROL H, V8, P36, DOI 10.1016/j.cgh.2009.09.030; Zevit N, 2010, SCAND J GASTROENTERO, V45, P550, DOI 10.3109/00365521003663688	27	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0183302	10.1371/journal.pone.0183302	http://dx.doi.org/10.1371/journal.pone.0183302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957341	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200009
J	Niikura, R; Hirata, Y; Suzuki, N; Yamada, A; Hayakawa, Y; Suzuki, H; Yamamoto, S; Nakata, R; Komatsu, J; Okamoto, M; Kodaira, M; Shinozaki, T; Fujishiro, M; Watanabe, T; Koike, K				Niikura, Ryota; Hirata, Yoshihiro; Suzuki, Nobumi; Yamada, Atsuo; Hayakawa, Yoku; Suzuki, Hirobumi; Yamamoto, Shinzo; Nakata, Ryo; Komatsu, Junko; Okamoto, Makoto; Kodaira, Makoto; Shinozaki, Tomohiro; Fujishiro, Mitsuhiro; Watanabe, Toshiaki; Koike, Kazuhiko			Colonoscopy reduces colorectal cancer mortality: A multicenter, long-term, colonoscopy-based cohort study	PLOS ONE			English	Article							SCREENING COLONOSCOPY; NEGATIVE COLONOSCOPY; RISK; POLYPECTOMY; SURVEILLANCE; ASSOCIATION; PREVENTION; ENDOSCOPY; ADENOMAS; REMOVAL	Background There are limited colonoscopy-based cohort data concerning the effectiveness of colonoscopy in reducing colorectal cancer deaths. The aim of this study was to clarify whether colonoscopy reduces colorectal cancer mortality. Methods A cohort of 18,816 patients who underwent colonoscopy without a diagnosis of colorectal cancer between 2001 and 2010 at high colonoscopy procedure volume centers was selected. Patient characteristics and colonoscopy findings were assessed. The main end-point was colorectal cancer death (all, right-sided, and left-sided cancers), and data were censored at the time of the final visit or the final colonoscopy. The standardized all colorectal, colon, and rectal cancer mortality rates were estimated with reference to those of the general Japanese population. Additional outcome was all-cause death and the standardized all-cause mortality rate was also estimated. Results The total observed person-year mortality for colorectal cancer was 67,119. Of these, 4, 3, and 1 patients died from colorectal, colon, and rectal cancers, respectively; these values were significantly lower than the number of expected deaths in the general population, estimated to be 53.1, 34.0, and 19.1, respectively. The standardized mortalities for all colorectal, colon, and rectal cancers were 0.08 (95% confidence interval (CI), 0.02-0.17), 0.09 (95% CI, 0.02-0.22), and 0.05 (95% CI, 0.0002-0.21), respectively. There were 586 all-cause deaths (3.11%) during the observation period. The standardized all-cause mortality ratios were 0.22 (95% CI, 0.206-0.23). Conclusions The colorectal cancer mortality of patients who received colonoscopy without colorectal cancer diagnosis decreased significantly compared with that of individuals in the general population. These results were compatible even in patients with right-sided colon cancer.	[Niikura, Ryota; Hirata, Yoshihiro; Suzuki, Nobumi; Yamada, Atsuo; Hayakawa, Yoku; Fujishiro, Mitsuhiro; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Suzuki, Nobumi] Asahi Life Fdn, Inst Adult Dis, Div Gastroenterol, Tokyo, Japan; [Suzuki, Hirobumi; Yamamoto, Shinzo; Nakata, Ryo] Japanese Red Cross Med Ctr, Dept Gastroenterol, Tokyo, Japan; [Komatsu, Junko] Japanese Red Cross Med Ctr, Dept Hlth Care, Tokyo, Japan; [Okamoto, Makoto] JR Tokyo Gen Hosp, Dept Gastroenterol, Tokyo, Japan; [Kodaira, Makoto] Yaizu City Hosp, Dept Gastroenterol, Shizuoka, Japan; [Shinozaki, Tomohiro] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo, Japan; [Fujishiro, Mitsuhiro] Univ Tokyo Hosp, Endoscopy & Endoscop Surg, Tokyo, Japan; [Watanabe, Toshiaki] Univ Tokyo, Grad Sch Med, Deapartement Surg Oncol & Vasc Surg, Tokyo, Japan	University of Tokyo; Asahi Life Foundation; Japanese Red Cross Medical Center; University of Tokyo; Japanese Red Cross Medical Center; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Suzuki, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.; Suzuki, N (corresponding author), Asahi Life Fdn, Inst Adult Dis, Div Gastroenterol, Tokyo, Japan.	nsuzuki-ham@umin.ac.jp	Hayakawa, Yoku/AAI-8581-2020; 藤城, 光弘/AAN-3131-2020	Hayakawa, Yoku/0000-0002-3988-2499; 	Asahi Life Foundation	Asahi Life Foundation	This work was supported by grants from the Asahi Life Foundation (http://www.asahi-life.or.pi/) (Nobumi Suzuki). The funders played no role in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Atkin W, 2017, LANCET ONCOL, V1137; Baxter NN, 2012, J CLIN ONCOL, V30, P2664, DOI 10.1200/JCO.2011.40.4772; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Boolchand V, 2006, ANN INTERN MED, V145, P654, DOI 10.7326/0003-4819-145-9-200611070-00007; Brenner H, 2007, GUT, V56, P1585, DOI 10.1136/gut.2007.122739; Brenner H, 2014, GASTROENTEROLOGY, V146, P709, DOI 10.1053/j.gastro.2013.09.001; Brenner H, 2012, GUT, V61, P1576, DOI 10.1136/gutjnl-2011-301531; Brenner H, 2012, J CLIN ONCOL, V30, P2969, DOI 10.1200/JCO.2011.41.3377; Corley DA, 2014, NEW ENGL J MED, V370, P2541, DOI 10.1056/NEJMc1405329; Cottet V, 2012, GUT, V61, P1180, DOI 10.1136/gutjnl-2011-300295; Doubeni CA, 2016, GUT; Doubeni CA, 2013, ANN INTERN MED, V158, P312, DOI 10.7326/0003-4819-158-5-201303050-00003; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Imperiale TF, 2008, NEW ENGL J MED, V359, P1218, DOI 10.1056/NEJMoa0803597; Kahi CJ, 2009, CLIN GASTROENTEROL H, V7, P770, DOI 10.1016/j.cgh.2008.12.030; Lakoff J, 2008, CLIN GASTROENTEROL H, V6, P1117, DOI 10.1016/j.cgh.2008.05.016; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Lieberman DA, 2014, GASTROENTEROLOGY, V147, P343, DOI 10.1053/j.gastro.2014.04.020; Matsuda T, 2009, JPN J CLIN ONCOL, V39, P850, DOI 10.1093/jjco/hyp106; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; Nakada A, 2017, INT J COLORECTAL DIS, V32, P839, DOI 10.1007/s00384-017-2757-0; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Singh H, 2010, AM J GASTROENTEROL, V105, P2588, DOI 10.1038/ajg.2010.390; Singh H, 2010, GASTROENTEROLOGY, V139, P1128, DOI 10.1053/j.gastro.2010.06.052; Stock D, 2016, GASTROINTEST ENDOSC; Tanaka S, 2015, J GASTROENTEROL, V50, P252, DOI 10.1007/s00535-014-1021-4; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	29	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185294	10.1371/journal.pone.0185294	http://dx.doi.org/10.1371/journal.pone.0185294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957370	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200042
J	Rahbar, E; Ainsworth, HC; Howard, TD; Hawkins, GA; Ruczinski, I; Mathias, R; Seeds, MC; Sergeant, S; Hixson, JE; Herrington, DM; Langefeld, CD; Chilton, FH				Rahbar, Elaheh; Ainsworth, Hannah C.; Howard, Timothy D.; Hawkins, Gregory A.; Ruczinski, Ingo; Mathias, Rasika; Seeds, Michael C.; Sergeant, Susan; Hixson, James E.; Herrington, David M.; Langefeld, Carl D.; Chilton, Floyd H.			Uncovering the DNA methylation landscape in key regulatory regions within the FADS cluster	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; CORONARY-ARTERY-DISEASE; GENETIC-VARIANTS; CARDIOVASCULAR-DISEASE; ARACHIDONIC-ACID; PROSTATE-CANCER; RISK-FACTORS; ASSOCIATION; METABOLISM; POLYMORPHISMS	Genetic variants near and within the fatty acid desaturase (FADS) cluster are associated with polyunsaturated fatty acid (PUFA) biosynthesis, levels of several disease biomarkers and risk of human disease. However, determining the functional mechanisms by which these genetic variants impact PUFA levels remains a challenge. Utilizing an Illumina 450K array, we previously reported strong allele-specific methylation (ASM) associations (p = 2.69x10(-29)) between a single nucleotide polymorphism (SNP) rs174537 and DNA methylation of CpG sites located in the putative enhancer region between FADS1 and FADS2, in human liver tissue. However, this array only featured 20 CpG sites within this 12kb region. To better understand the methylation landscape within this region, we conducted bisulfite sequencing of the region between FADS1 and FADS2. Liver tissues from 50 male subjects (27 European Americans, 23 African Americans) were obtained from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study, and used to ascertain the genotype at rs174537 and methylation status across the region of interest. Associations between rs174537 genotype and methylation status of 136 CpG sites were determined. Age-adjusted linear regressions were used to assess ASM associations with rs174537 genotype. The majority of CpG sites (117 out of 136, 86%) exhibited high levels of methylation with the greatest variability observed at three key regulatory regions-the promoter regions for FADS1 and FADS2 and a putative enhancer site between the two genes. Eight CpG sites within the putative enhancer region displayed significant (FDR p < 0.05) ASM associations with rs174537. These data support the concept that both genetic and epigenetic factors regulate PUFA biosynthesis, and raise fundamental questions as to how genetic variants such as rs174537 impact DNA methylation in distant regulatory regions, and ultimately the capacity of tissues to synthesize PUFAs.	[Rahbar, Elaheh] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC 27157 USA; [Ainsworth, Hannah C.; Langefeld, Carl D.] Wake Forest Sch Med, Dept Biostat Sci, Div Publ Hlth Sci, Winston Salem, NC USA; [Howard, Timothy D.; Hawkins, Gregory A.; Langefeld, Carl D.] Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; [Ruczinski, Ingo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Mathias, Rasika] Johns Hopkins Univ, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD USA; [Seeds, Michael C.] Wake Forest Sch Med, Sect Mol Med, Dept Internal Med, Winston Salem, NC USA; [Sergeant, Susan] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Hixson, James E.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Herrington, David M.] Wake Forest Sch Med, Div Cardiol, Dept Internal Med, Winston Salem, NC USA; [Chilton, Floyd H.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Wake Forest University; Wake Forest University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Wake Forest University; Wake Forest University	Rahbar, E (corresponding author), Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC 27157 USA.; Chilton, FH (corresponding author), Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA.	erahbar@wakehealth.edu; schilten@wakehealth.edu		Hixson, James/0000-0002-0849-9315	National Institutes of Health [P50-AT002782, R01-AT008621, 5U01HL080443-04]; WFU Center for Public Health Genomics; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT002782] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT008621] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080443, K25HL133611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WFU Center for Public Health Genomics; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors would like to acknowledge Dr. Rahbar's startup funds and extramural funding from the National Institutes of Health P50-AT002782, R01-AT008621, and 5U01HL080443-04 for supporting this work and to the WFU Center for Public Health Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Dr. Rahbar's startup funds and extramural funding from the National Institutes of Health P50-AT002782, R01-AT008621 and 5U01HL080443-04 for supporting this work; and to the WFU Center for Public Health Genomics. We also acknowledge James E. Hixson and David M. Herrington for their contributions and support of the original PDAY study.	Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Berquin IM, 2011, CANCER METAST REV, V30, P295, DOI 10.1007/s10555-011-9299-7; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Brookes KJ, 2006, BIOL PSYCHIAT, V60, P1053, DOI 10.1016/j.biopsych.2006.04.025; Cheatham CL, 2015, NUTR RES, V35, P948, DOI 10.1016/j.nutres.2015.09.005; Chilton FH, 2014, NUTRIENTS, V6, P1993, DOI 10.3390/nu6051993; Cui T, 2016, PROSTATE, V76, P1182, DOI 10.1002/pros.23205; Freemantle E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042696; Gillingham LG, 2013, AM J CLIN NUTR, V97, P195, DOI 10.3945/ajcn.112.043117; Glaser C, 2010, METABOLISM, V59, P993, DOI 10.1016/j.metabol.2009.10.022; Harslof LBS, 2013, AM J CLIN NUTR, V97, P1403, DOI 10.3945/ajcn.113.058685; Hester AG, 2014, J BIOL CHEM, V289, P22482, DOI 10.1074/jbc.M114.579557; Hoile SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109896; Hong SH, 2013, CLIN INTERV AGING, V8, P585, DOI 10.2147/CIA.S42096; Howard TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097510; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Koletzko B, 2011, AM J CLIN NUTR, V93, P211, DOI 10.3945/ajcn.110.006189; Kwak JH, 2011, ATHEROSCLEROSIS, V214, P94, DOI 10.1016/j.atherosclerosis.2010.10.004; Lattka E, 2013, BRIT J NUTR, V109, P1196, DOI 10.1017/S0007114512003108; Lattka E, 2011, AM J CLIN NUTR, V93, P382, DOI 10.3945/ajcn.110.004515; Li S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073563, 10.1371/journal.pone.0053163, 10.1371/journal.pone.0081438]; Liu TF, 2012, J LEUKOCYTE BIOL, V92, P499, DOI 10.1189/jlb.0212078; Lu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041681; Lupu DS, 2015, NUTR RES, V35, P939, DOI 10.1016/j.nutres.2015.09.004; Malerba G, 2008, LIPIDS, V43, P289, DOI 10.1007/s11745-008-3158-5; Martinelli N, 2008, AM J CLIN NUTR, V88, P941, DOI 10.1093/ajcn/88.4.941; Mathias Rasika A, 2014, Curr Nutr Rep, V3, P139; Mathias RA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-50; Mathias RA, 2010, J LIPID RES, V51, P2766, DOI 10.1194/jlr.M008359; Morales E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017181; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Porenta SR, 2013, CANCER PREV RES, V6, P1212, DOI 10.1158/1940-6207.CAPR-13-0131; Rzehak P, 2009, BRIT J NUTR, V101, P20, DOI 10.1017/S0007114508992564; Rzehak P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013261; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Sergeant S, 2012, BRIT J NUTR, V107, P547, DOI 10.1017/S0007114511003230; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Steer CD, 2012, HUM MOL GENET, V21, P1504, DOI 10.1093/hmg/ddr588; Strong JP, 1997, ANN NY ACAD SCI, V811, P226, DOI 10.1111/j.1749-6632.1997.tb52004.x; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Weaver KL, 2009, J BIOL CHEM, V284, P15400, DOI 10.1074/jbc.M109.004861; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wilson BA, 2012, FASEB J, V26; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156; Xie L, 2009, J NUTRIGENET NUTRIGE, V2, P243, DOI 10.1159/000255636	46	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0180903	10.1371/journal.pone.0180903	http://dx.doi.org/10.1371/journal.pone.0180903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957329	Green Submitted, gold, Green Published			2022-12-27	WOS:000411985200002
J	Carins Murphy, MR; Jordan, GJ; Brodribb, TJ				Carins Murphy, Madeline R.; Jordan, Gregory J.; Brodribb, Timothy J.			Ferns are less dependent on passive dilution by cell expansion to coordinate leaf vein and stomatal spacing than angiosperms	PLOS ONE			English	Article							DICHOTOMOUS VENATION; FOLIAR VENATION; GAS-EXCHANGE; LAND PLANTS; EVOLUTION; SIZE; ACCLIMATION; ONTOGENY; DENSITY; CO2	Producing leaves with closely spaced veins is a key innovation linked to high rates of photosynthesis in angiosperms. A close geometric link between veins and stomata in angiosperms ensures that investment in enhanced venous water transport provides the strongest net carbon return to the plant. This link is underpinned by "passive dilution" via expansion of surrounding cells. However, it is not known whether this 'passive dilution' mechanism is present in plant lineages other than angiosperms and is another key feature of the angiosperms' evolutionary success. Consequently, we sought to determine whether the 'passive dilution' mechanism is; (i) exclusive to the angiosperms, (ii) a conserved mechanism that evolved in the common ancestor of ferns and angiosperms, or (iii) has evolved continuously over time. To do this we first we assessed the plasticity of vein and stomatal density and epidermal cell size in ferns in response to light environment. We then compared the relationships between these traits found among ferns with modelled relationships that assume vein and stomatal density respond passively to epidermal cell expansion, and with those previously observed in angiosperms. Vein density, stomatal density and epidermal cell size were linked in ferns with remarkably similar relationships to those observed in angiosperms, except that fern leaves had fewer veins per stomata. However, plasticity was limited in ferns and stomatal spacing was dependent on active stomatal differentiation as well as passive cell expansion. Thus, ferns (like angiosperms) appear to coordinate vein and stomatal density with epidermal cell expansion to some extent to maintain a constant ratio between veins and stomata in the leaf. The different general relationships between vein density and stomatal density in ferns and angiosperms suggests the groups have different optimum balances between the production of vein tissue dedicated to water supply and stomatal tissue for gas exchange.	[Carins Murphy, Madeline R.; Jordan, Gregory J.; Brodribb, Timothy J.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia	University of Tasmania	Brodribb, TJ (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia.	timothyb@utas.edu.au	Brodribb, Timothy John/C-6797-2013; Murphy, Madeline R Carins/K-8086-2013; Jordan, Gregory/B-3932-2013	Brodribb, Timothy John/0000-0002-4964-6107; Murphy, Madeline R Carins/0000-0003-4370-9485; Jordan, Gregory/0000-0002-6033-2766	Australian Research Council [DP 120101686]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council (http://www.arc.gov.au/) [DP 120101686 to T.J.B]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum S, 2014, ECOLOGICAL OBSERVATI, V140, P1235; [Anonymous], 1960, [No title captured], DOI DOI 10.1097/00010694-196008000-00031; [Anonymous], 2014, R LANG ENV STAT COMP; BENHAM DM, 1992, AM FERN J, V82, P47, DOI 10.2307/1547377; Bennett MD, 2012, PTERIDOPHYTE DNA C V; Bennett MD, 2012, ANGIOSPERM DNA C VAL; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Boyce CK, 2009, P ROY SOC B-BIOL SCI, V276, P1771, DOI 10.1098/rspb.2008.1919; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Brodribb TJ, 2013, NEW PHYTOL, V199, P559, DOI 10.1111/nph.12300; Brodribb TJ, 2010, ECOL LETT, V13, P175, DOI 10.1111/j.1461-0248.2009.01410.x; Brodribb TJ, 2017, PLANT CELL ENVIRON, V40, P872, DOI 10.1111/pce.12817; Brodribb TJ, 2011, NEW PHYTOL, V192, P437, DOI 10.1111/j.1469-8137.2011.03795.x; Brodribb TJ, 2009, NEW PHYTOL, V183, P839, DOI 10.1111/j.1469-8137.2009.02844.x; Cantrill D, 1995, ALCHERINGA, V19, P243, DOI 10.1080/03115519508619508; Carins Murphy MR, 2016, ANN BOT-LONDON, V118, P1127, DOI 10.1093/aob/mcw167; Carins Murphy MR, 2014, PLANT CELL ENVIRON, V37, P124, DOI 10.1111/pce.12136; Carins Murphy MR, 2012, PLANT CELL ENVIRON, V35, P1407, DOI 10.1111/j.1365-3040.2012.02498.x; CHOW WS, 1990, AUST J PLANT PHYSIOL, V17, P665; Clark J, 2016, NEW PHYTOL, V210, P1072, DOI 10.1111/nph.13833; de Boer HJ, 2016, NEW PHYTOL, V210, P1219, DOI 10.1111/nph.13929; Evans-Fitz Gerald C, 2016, FRONT PLANT SCI, V7; Franks PJ, 2007, PLANT PHYSIOL, V143, P78, DOI 10.1104/pp.106.089367; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Hoshizaki BJ, 1999, AM FERN J, V89, P1, DOI 10.2307/1547452; Leitch IJ, 2005, ANN BOT-LONDON, V95, P207, DOI 10.1093/aob/mci014; McElwain JC, 2016, NEW PHYTOL, V209, P94, DOI 10.1111/nph.13579; McGlone MS, 2005, NEW ZEAL J ECOL, V29, P165; MIRSKY AE, 1951, J GEN PHYSIOL, V34, P451, DOI 10.1085/jgp.34.4.451; Page CN, 2004, EVOLUTION PLANT PHYS, P447; Pantin F, 2012, NEW PHYTOL, V196, P349, DOI 10.1111/j.1469-8137.2012.04273.x; Parris BS, 2001, BRITTONIA, V53, P270, DOI 10.1007/BF02812702; POETHIG RS, 1985, PLANTA, V165, P170, DOI 10.1007/BF00395039; POETHIG RS, 1985, PLANTA, V165, P158, DOI 10.1007/BF00395038; PRAY TR, 1955, AM J BOT, V42, P698, DOI 10.2307/2438644; PRAY TR, 1955, AM J BOT, V42, P18, DOI 10.2307/2438589; PRAY TR, 1960, AM J BOT, V47, P319, DOI 10.2307/2439217; PRAY TR, 1962, AM J BOT, V49, P464, DOI 10.2307/2439415; Roth-Nebelsick A, 2001, ANN BOT-LONDON, V87, P553, DOI 10.1006/anbo.2001.1391; Sack L, 2006, ECOLOGY, V87, P483, DOI 10.1890/05-0710; Salisbury EJ, 1928, PHILOS T R SOC LON B, V216, P1, DOI 10.1098/rstb.1928.0001; Sharpe J.M., 2010, FERN ECOLOGY, P1, DOI DOI 10.1017/CBO9780511844898.002; Singh C, 2013, ECOLOGY FERN WEALTH, V2, P327; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; WS R., 1997, IMAGEJ; Zhang SB, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0102724, 10.1371/journal.pone.0084682]; Zhang XC, 2003, PTERIDOLOGY IN THE NEW MILLENNIUM, P65; ZURAKOWSKI KA, 1988, AM J BOT, V75, P1559, DOI 10.2307/2444706	48	3	3	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185648	10.1371/journal.pone.0185648	http://dx.doi.org/10.1371/journal.pone.0185648			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953931	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000411980300078
J	Couch, CS; Burns, JHR; Liu, G; Steward, K; Gutlay, TN; Kenyon, J; Eakin, CM; Kosaki, RK				Couch, Courtney S.; Burns, John H. R.; Liu, Gang; Steward, Kanoelani; Gutlay, Tiffany Nicole; Kenyon, Jean; Eakin, C. Mark; Kosaki, Randall K.			Mass coral bleaching due to unprecedented marine heatwave in Papahanaumokuakea Marine National Monument (Northwestern Hawaiian Islands)	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; CLIMATE-CHANGE; INDIAN-OCEAN; ULTRAVIOLET-RADIATION; THERMAL TOLERANCE; REEF FISHES; IMPACTS; MORTALITY; RECOVERY; COMMUNITIES	2014 marked the sixth and most widespread mass bleaching event reported in the Northwestern Hawaiian Islands, home to the Papahanaumokuakea Marine National Monument (PMNM), the world's second largest marine reserve. This event was associated with an unusual basin-scale warming in the North Pacific Ocean, with an unprecedented peak intensity of around 20 degrees C-weeks of cumulative heat stress at Lisianksi Island. In situ bleaching surveys and satellite data were used to evaluate the relative importance of potential drivers of bleaching patterns in 2014, assess the subsequent morality and its effects on coral communities and 3D complexity, test for signs of regional acclimation, and investigate long-term change in heat stress in PMNM. Surveys conducted at four island/atoll (French Frigate Shoals, Lisianski Island, Pearl and Hermes Atoll, and Midway Atoll) showed that in 2014, percent bleaching varied considerably between islands/atolls and habitats (back reef/fore reef and depth), and was up to 91% in shallow habitats at Lisianski. The percent bleaching during the 2014 event was best explained by a combination of duration of heat stress measured by Coral Reef Watch's satellite Degree Heating Week, relative community susceptibility (bleaching susceptibility score of each taxon * the taxon's abundance relative to the total number of colonies), depth and region. Mean coral cover at permanent Lisianski monitoring sites decreased by 68% due to severe losses of Montipora dilatata complex, resulting in rapid reductions in habitat complexity. Spatial distribution of the 2014 bleaching was significantly different from the 2002 and 2004 bleaching events likely due to a combination of differences in heat stress and local acclimatization. Historical satellite data demonstrated heat stress in 2014 was unlike any previous event and that the exposure of corals to the bleaching-level heat stress has increased significantly in the northern PMNM since 1982, highlighting the increasing threat of climate change to reefs.	[Couch, Courtney S.; Burns, John H. R.; Gutlay, Tiffany Nicole] Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Couch, Courtney S.] NOAA, Ecosyst Sci Div, Pacific Isl Fisheries Sci Ctr, Honolulu, HI 96818 USA; [Liu, Gang; Eakin, C. Mark] NOAA, Coral Reef Watch, NESDIS, STAR, College Pk, MD USA; [Liu, Gang] Global Sci & Technol Inc, Greenbelt, MD USA; [Steward, Kanoelani] Univ Hawaii, Marine Sci Program, Hilo, HI 96720 USA; [Kenyon, Jean] US Fish & Wildlife Serv, Honolulu, HI USA; [Kosaki, Randall K.] NOAA Papahanaumokuakea Marine Natl Monument, Honolulu, HI USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Aeronautics & Space Administration (NASA); University of Hawaii System; University Hawaii Hilo; United States Department of the Interior; US Fish & Wildlife Service; National Oceanic Atmospheric Admin (NOAA) - USA	Couch, CS (corresponding author), Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA.; Couch, CS (corresponding author), NOAA, Ecosyst Sci Div, Pacific Isl Fisheries Sci Ctr, Honolulu, HI 96818 USA.	courtney.s.couch@noaa.gov	Liu, Gang/E-7921-2011; Eakin, C. Mark/F-5585-2010	Kosaki, Randall/0000-0003-1363-5702; Eakin, C. Mark/0000-0002-5987-0858	NOAA/NOS-HIMB [MOA-2009-039]; US Environmental Protection Agency (EPA) [FP-91768001-0]; ESPCoR Hawai'i (EPS-0903833) Track-I research grant; NOAA Coral Reef Conservation Program to Coral Reef Watch to CME; National Environmental Satellite, Data, and Information Service (NESDIS)	NOAA/NOS-HIMB; US Environmental Protection Agency (EPA)(United States Environmental Protection Agency); ESPCoR Hawai'i (EPS-0903833) Track-I research grant; NOAA Coral Reef Conservation Program to Coral Reef Watch to CME; National Environmental Satellite, Data, and Information Service (NESDIS)	This study was supported by NOAA/NOS-HIMB agreement code MOA-2009-039 to provide salary to CSC, the STAR Fellowship Assistance Agreement no. FP-91768001-0 awarded by the US Environmental Protection Agency (EPA) to provide salary to JB. Funding was also provided by the ESPCoR Hawai'i (EPS-0903833) Track-I research grant to The University of Hawaii to provide salary to JB and KS, the NOAA Coral Reef Conservation Program to Coral Reef Watch to CME and the National Environmental Satellite, Data, and Information Service (NESDIS) for CME. This manuscript has not been formally reviewed by the EPA and the EPA does not endorse any products or commercial services mentioned in this publication. The scientific results and conclusions, as well as any views or opinions expressed herein, are those of the authors and do not necessarily reflect the views of NOAA or the Department of Commerce. Global Science & Technology Inc. provided support in the form of salaries for GL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Aeby GS, 2003, CORAL REEFS, V22, P256, DOI 10.1007/s00338-003-0309-2; Alemu JB I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083829; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; BAHR KD, 2015, PEER J, V3, P93148; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Banzon VF, 2014, J CLIMATE, V27, P8221, DOI 10.1175/JCLI-D-14-00293.1; Bay RA, 2014, CURR BIOL, V24, DOI 10.1016/j.cub.2014.10.044; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Burge CA, 2014, ANNU REV MAR SCI, V6, P249, DOI 10.1146/annurev-marine-010213-135029; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burns JHR, 2015, PEERJ, V3, DOI 10.7717/peerj.1077; Burns JHR, 2016, METHODS OCEANOGR, V15, P49, DOI DOI 10.1016/J.MIO.2016.04.001; Carilli J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034418; Castillo KD, 2012, NAT CLIM CHANGE, V2, P756, DOI [10.1038/nclimate1577, 10.1038/NCLIMATE1577]; Castillo KD, 2005, MAR BIOL, V148, P261, DOI 10.1007/s00227-005-0046-x; Cochran WG., 1963, SAMPLING TECHNIQUES; Coffroth M.A., 1990, Elsevier Oceanography Series, V52, P141; COLES SL, 1978, MAR BIOL, V49, P187, DOI 10.1007/BF00391130; Cunning R, 2016, MAR ECOL PROG SER, V551, P131, DOI 10.3354/meps11733; Darling ES, 2017, CORAL REEFS, V36, P561, DOI 10.1007/s00338-017-1539-z; Day T, 2007, AM NAT, V171, pE72; Donlon CJ, 2012, REMOTE SENS ENVIRON, V116, P140, DOI 10.1016/j.rse.2010.10.017; Eakin C., 2016, REEF ENCOUNTER, V31, P20, DOI DOI 10.1007/S00338-019-01844-2; Eakin C. M., 2009, V205, P41; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Edmunds PJ, 2008, MAR ECOL PROG SER, V361, P307, DOI 10.3354/meps07556; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; Forsman ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015021; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; GLEASON DF, 1993, NATURE, V365, P836, DOI 10.1038/365836a0; GLEASON MG, 1993, CORAL REEFS, V12, P193, DOI 10.1007/BF00334479; Glynn P., 2015, BIOEROSION CORAL REE, P67, DOI DOI 10.1007/978-94-017-7249-5_4; Glynn PW, 2001, B MAR SCI, V69, P79; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; GOREAU TJ, 1990, CORAL REEFS, V8, P211, DOI 10.1007/BF00265013; Gove JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061974; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Grottoli AG, 2014, GLOBAL CHANGE BIOL, V20, P3823, DOI 10.1111/gcb.12658; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Heenan A, 2017, FISH MONITORING BRIE; Heron S, 2015, 145 NOAA NESDIS COLL; Heron SF, 2016, SCI REPORTS, P6; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HOEGHGULDBERG O, 1995, MAR ECOL PROG SER, V121, P181, DOI 10.3354/meps121181; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Jokiel PL, 2004, GLOBAL CHANGE BIOL, V10, P1627, DOI 10.1111/j.1365-2486.2004.00836.x; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Kenyon Jean C., 2006, Atoll Research Bulletin, P505; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Lasagna R, 2010, FACIES, V56, P1, DOI 10.1007/s10347-009-0193-5; LESSER MP, 1990, CORAL REEFS, V8, P225, DOI 10.1007/BF00265015; Liu G, 2013, 143 NOAA NESDIS COLL; Liu G, 2014, REMOTE SENS-BASEL, V6, P11579, DOI 10.3390/rs61111579; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Manzello DP, 2007, MAR POLLUT BULL, V54, P1923, DOI 10.1016/j.marpolbul.2007.08.009; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Maynard JA, 2008, MAR BIOL, V155, P173, DOI 10.1007/s00227-008-1015-y; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2004, MAR BIOL, V144, P1239, DOI 10.1007/s00227-003-1271-9; McClanahan TR, 2005, MAR ECOL PROG SER, V298, P131, DOI 10.3354/meps298131; McClanahan TR, 2000, MAR POLLUT BULL, V40, P587, DOI 10.1016/S0025-326X(00)00064-3; Meehan WJ, 1997, J TOXICOL ENV HEALTH, V50, P529; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Morri C, 2015, MAR POLLUT BULL, V98, P188, DOI 10.1016/j.marpolbul.2015.06.050; Muscatine L, 1981, OCEANOGRAPHY, V26; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070443; RODGERS KS, 2017, PEER J, V5, P93148; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Seneca FO, 2015, MOL ECOL, V24, P1467, DOI 10.1111/mec.13125; Sheppard CRC, 2012, AQUAT CONSERV, V22, P232, DOI 10.1002/aqc.1248; Suzuki A, 2003, CORAL REEFS, V22, P357, DOI 10.1007/s00338-003-0323-4; Swain T, 2017, CONFUCIANISM IN CHINA: AN INTRODUCTION, P1; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; [UK Met Office Office PO. DAAC], 2005, GHRSST LEV 4 OSTIA G; van Hooidonk R, 2014, GLOBAL CHANGE BIOL, V20, P103, DOI 10.1111/gcb.12394; Vroom PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009733; Wilkinson C, 1999, AMBIO, V28, P188; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	88	69	69	4	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185121	10.1371/journal.pone.0185121	http://dx.doi.org/10.1371/journal.pone.0185121			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953909	Green Published, gold, Green Submitted			2022-12-27	WOS:000411980300037
J	Markovits, H; Gauthier, E; Gagnon-St-Pierre, E; Benenson, JF				Markovits, Henry; Gauthier, Evelyne; Gagnon-St-Pierre, Emilie; Benenson, Joyce F.			High status males invest more than high status females in lower status same-sex collaborators	PLOS ONE			English	Article							MALE CHIMPANZEES; CONSEQUENCES; COOPERATION; STRATEGIES; DOMINANCE; EVOLUTION; SCIENCE; WOMEN; RANK	Studies on human cooperation using economic games rarely include ecologically relevant factors. In studies on non-human primates however, both status and sex typically influence patterns of cooperation. Across primate species, high status individuals are more likely to cooperate, though this depends on the species-specific social structure of each sex. Based on human social structure, we predict that higher status males who interact more in hierarchical groups than females, will invest more than high status females in valued same-sex peers after successful cooperation. Across three studies, 187 male and 188 female participants cooperated with a (fictitious) same-sex partner who varied in competence. Participants then divided a reward between themselves and their partner. High status was induced in three different ways in each study, social influence, leadership and power. No overall sex difference in reward sharing was observed. Consistent with the hypothesis however, across all three studies, high status males invested more than high status females in cooperative partners, suggesting that high status males intuitively evaluate sharing rewards with samesex partners as more beneficial.	[Markovits, Henry; Gauthier, Evelyne; Gagnon-St-Pierre, Emilie] Univ Quebec, Dept Psychol, Succ Ctr Ville, Montreal, PQ, Canada; [Benenson, Joyce F.] Emmanuel Coll, Fac Sci, Boston, MA USA; [Benenson, Joyce F.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA	University of Quebec; University of Quebec Montreal; Harvard University	Markovits, H (corresponding author), Univ Quebec, Dept Psychol, Succ Ctr Ville, Montreal, PQ, Canada.	henry.markovits@gmail.com			Social Sciences and Humanities Research Council of Canada [24753]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	Preparation of this manuscript was supported by an Insight grant #24753 from the Social Sciences and Humanities Research Council of Canada to H. M. and J. F. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aries E, 1996, MEN WOMEN INTERACTIO; Balliet D, 2011, PSYCHOL BULL, V137, P881, DOI 10.1037/a0025354; BARGH JA, 1995, J PERS SOC PSYCHOL, V68, P768, DOI 10.1037/0022-3514.68.5.768; Bediou B, 2012, SOC JUSTICE RES, V25, P25, DOI 10.1007/s11211-012-0151-1; Benenson JF, 2008, INT J PRIMATOL, V29, P1019, DOI 10.1007/s10764-008-9283-4; Benenson JF, 2014, CURR BIOL, V24, pR190, DOI 10.1016/j.cub.2013.12.047; Benenson JF, 2011, PSYCHOL SCI, V22, P538, DOI 10.1177/0956797611402511; Benenson JF, 2009, P ROY SOC B-BIOL SCI, V276, P2589, DOI 10.1098/rspb.2009.0314; Bissonnette A, 2014, BEHAV ECOLOGY; Bissonnette A, 2015, BEHAVIOUR, V152, P1, DOI 10.1163/1568539X-00003241; Brosnan SF, 2002, HUM NATURE-INT BIOS, V13, P129, DOI 10.1007/s12110-002-1017-2; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; CHARLESWORTH WR, 1987, CHILD DEV, V58, P191, DOI 10.2307/1130301; Cheng JT, 2013, J PERS SOC PSYCHOL, V104, P103, DOI 10.1037/a0030398; Clutton-Brock TH, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0074; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; David-Barrett T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118329; DEWAAL F, 1982, CHIMPANZEE POLITICS; Duffy KG, 2007, CURR BIOL, V17, pR586, DOI 10.1016/j.cub.2007.06.001; Ellemers N, 2004, BRIT J SOC PSYCHOL, V43, P315, DOI 10.1348/0144666042037999; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; Foot Hugh C., 1980, FRIENDSHIP SOCIAL RE, P293; Frohlich N, 2004, PUBLIC CHOICE, V119, P91, DOI 10.1023/B:PUCH.0000024169.08329.eb; Galinsky AD, 2003, J PERS SOC PSYCHOL, V85, P453, DOI 10.1037/0022-3514.85.3.453; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Magee JC, 2005, LEAS ORG MAN SERIES, P275; Markovits H, 2001, CHILD DEV, V72, P879, DOI 10.1111/1467-8624.00321; Mast MS, 2004, SWISS J PSYCHOL, V63, P107, DOI 10.1024/1421-0185.63.2.107; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Muller MN, 2005, ADV STUD BEHAV, V35, P275, DOI 10.1016/S0065-3454(05)35007-8; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Omark D.R., 1975, PSYCHOL ANTHR, P289; Plott Charles R., 2008, HDB EXPT EC RESULTS, V1, P509, DOI DOI 10.1016/S1574-0722(07)00057-1; SAVINWILLIAMS RC, 1979, CHILD DEV, V50, P923, DOI 10.1111/j.1467-8624.1979.tb02451.x; SAVINWILLIAMS RC, 1980, J YOUTH ADOLESCENCE, V9, P75, DOI 10.1007/BF02088381; TESSER A, 1988, J PERS SOC PSYCHOL, V54, P49, DOI 10.1037/0022-3514.54.1.49; Van Schaik CP, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P3; von Neumann J., 2004, THEORY GAMES EC BEHA; Watts DP, 1998, BEHAV ECOL SOCIOBIOL, V44, P43, DOI 10.1007/s002650050513; Wilson ML, 2014, NATURE, V513, P414, DOI 10.1038/nature13727; Wrangham RW, 1999, YEARB PHYS ANTHROPOL, V42, P1	42	3	3	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185408	10.1371/journal.pone.0185408	http://dx.doi.org/10.1371/journal.pone.0185408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4WR	28953938	Green Submitted, Green Published, gold			2022-12-27	WOS:000411980300062
J	Martinez-Vargas, J; Ventura, J; Machuca, A; Munoz-Munoz, F; Fernandez, MC; Soto-Navarrete, MT; Duran, AC; Fernandez, B				Martinez-Vargas, Jessica; Ventura, Jacint; Machuca, Angela; Munoz-Munoz, Francesc; Carmen Fernandez, Maria; Teresa Soto-Navarrete, Maria; Carmen Duran, Ana; Fernandez, Borja			Cardiac, mandibular and thymic phenotypical association indicates that cranial neural crest underlies bicuspid aortic valve formation in hamsters	PLOS ONE			English	Article							MORPHOLOGICAL INTEGRATION; KNOWLEDGE GAPS; CELLS; EVOLUTIONARY; MODULARITY; MALFORMATIONS; INDIVIDUALS; SYSTEM; HETEROGENEITY; MORPHOGENESIS	Bicuspid aortic valve (BAV) is the most prevalent human congenital cardiac malformation. It may appear isolated, associated with other cardiovascular malformations, or forming part of syndromes. Cranial neural crest (NC) defects are supposed to be the cause of the spectrum of disorders associated with syndromic BAV. Experimental studies with an inbred hamster model of isolated BAV showed that alterations in the migration or differentiation of the cardiac NC cells in the embryonic cardiac outflow tract are most probably responsible for the development of this congenital valvular defect. We hypothesize that isolated BAV is not the result of local, but of early alterations in the behavior of the NC cells, thus also affecting other cranial NC-derived structures. Therefore, we tested whether morphological variation of the aortic valve is linked to phenotypic variation of the mandible and the thymus in the hamster model of isolated BAV, compared to a control strain. Our results show significant differences in the size and shape of the mandible as well as in the cellular composition of the thymus between the two strains, and in mandible shape regarding the morphology of the aortic valve. Given that both the mandible and the thymus are cranial NC derivatives, and that the cardiac NC belongs to the cephalic domain, we propose that the causal defect leading to isolated BAV during embryonic development is not restricted to local alterations of the cardiac NC cells in the cardiac outflow tract, but it is of pleiotropic or polytopic nature. Our results suggest that isolated BAV may be the forme fruste of a polytopic syndrome involving the cranial NC in the hamster model and in a proportion of affected patients.	[Martinez-Vargas, Jessica; Ventura, Jacint; Munoz-Munoz, Francesc] Univ Autonoma Barcelona, Fac Biociencies, Dept Biol Anim Biol Vegetal & Ecol, Cerdanyola Del Valles, Spain; [Machuca, Angela; Carmen Fernandez, Maria; Teresa Soto-Navarrete, Maria; Carmen Duran, Ana; Fernandez, Borja] Univ Malaga, Fac Ciencias, Dept Biol Anim, Malaga, Spain; [Carmen Fernandez, Maria; Carmen Duran, Ana; Fernandez, Borja] Inst Invest Biomed Malaga IBIMA, Malaga, Spain; [Fernandez, Borja] CIBERCV Enfermedades Cardiovasc, Malaga, Spain	Autonomous University of Barcelona; Universidad de Malaga; Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV	Ventura, J (corresponding author), Univ Autonoma Barcelona, Fac Biociencies, Dept Biol Anim Biol Vegetal & Ecol, Cerdanyola Del Valles, Spain.	jacint.ventura.queija@uab.cat	Muñoz Muñoz, Francesc/L-1997-2014; /AAG-9282-2020; Corujo, Francisco Borja Fernández/AAG-8258-2020; Soto-Navarrete, Maria Teresa/AAG-7163-2020; Martinez-Vargas, Jessica/G-2064-2019	Muñoz Muñoz, Francesc/0000-0003-2084-0368; Corujo, Francisco Borja Fernández/0000-0001-9179-910X; Fernandez, M. Carmen/0000-0002-9051-8668; Ventura, Jacint/0000-0001-7527-1532; Martinez-Vargas, Jessica/0000-0003-4689-5228	Junta de Andalucia (Sevilla, Spain) [P10-6068/2010, PI-0689/2010]	Junta de Andalucia (Sevilla, Spain)(Junta de Andalucia)	This work was supported by Grants P10-6068/2010 and PI-0689/2010 from Junta de Andalucia (Sevilla, Spain).	Andelfinger G, 2002, AM J HUM GENET, V71, P663, DOI 10.1086/342360; Atchley William R., 1993, P207; ATCHLEY WR, 1991, BIOL REV, V66, P101, DOI 10.1111/j.1469-185X.1991.tb01138.x; BAILEY DW, 1986, J HERED, V77, P17, DOI 10.1093/oxfordjournals.jhered.a110159; Basso C, 2004, AM J CARDIOL, V93, P661, DOI 10.1016/j.amjcard.2003.11.031; BLAU JN, 1965, NATURE, V208, P564, DOI 10.1038/208564a0; Bodey B, 1997, IN VIVO, V11, P61; Bodey B, 2000, IN VIVO, V14, P407; Bodey B, 1996, IN VIVO, V10, P39; BRONNERFRASER M, 1995, EXP CELL RES, V218, P405, DOI 10.1006/excr.1995.1173; Burgio G, 2012, G3-GENES GENOM GENET, V2, P1257, DOI 10.1534/g3.112.003285; Chai Y, 2000, DEVELOPMENT, V127, P1671; Cheverud JM, 1997, EVOLUTION, V51, P2006, DOI [10.1111/j.1558-5646.1997.tb05122.x, 10.2307/2411021]; CHEVERUD JM, 1991, J CRAN GENET DEV BIO, V11, P122; Collins MJ, 2008, J CLIN PATHOL, V61, P530, DOI 10.1136/jcp.2007.051904; Creazzo TL, 1998, ANNU REV PHYSIOL, V60, P267, DOI 10.1146/annurev.physiol.60.1.267; Della Corte A, 2014, J THORAC CARDIOV SUR, V147, P1749, DOI 10.1016/j.jtcvs.2014.01.021; Dryden IL, 1998, STAT SHAPE ANAL, V3820; Duran A C, 1995, J Heart Valve Dis, V4, P581; Duran AC, 2015, J ANAT, V226, P501, DOI 10.1111/joa.12317; Ehrich TH, 2003, J EXP ZOOL PART B, V296B, P58, DOI 10.1002/jez.b.00009; Farr AG, 2002, IMMUNOL REV, V189, P20, DOI 10.1034/j.1600-065X.2002.18903.x; Fernandez B, 2009, J AM COLL CARDIOL, V54, P2312, DOI 10.1016/j.jacc.2009.07.044; Fernandez MC, 2000, LAB ANIM-UK, V34, P145, DOI 10.1258/002367700780457545; Gilbert SF, 1996, DEV BIOL, V173, P357, DOI 10.1006/dbio.1996.0032; GIUSTI S, 1991, Giornale Italiano di Cardiologia, V21, P189; Good P, 1994, PERMUTATION TESTS PR; Janossy G, 1986, Curr Top Pathol, V75, P89; Jiang XB, 2000, DEVELOPMENT, V127, P1607; John AS, 2009, AM J MED GENET A, V149A, P939, DOI 10.1002/ajmg.a.32770; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; KAPPETEIN AP, 1991, J THORAC CARDIOV SUR, V102, P830, DOI 10.1016/S0022-5223(19)33931-5; Keyte AL, 2014, BIRTH DEFECTS RES C, V102, P309, DOI 10.1002/bdrc.21076; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Klingenberg CP, 1998, P ROY SOC B-BIOL SCI, V265, P1255, DOI 10.1098/rspb.1998.0427; Klingenberg CP, 2004, GENETICS, V166, P1909, DOI 10.1534/genetics.166.4.1909; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 2000, EVOLUTION, V54, P1273, DOI 10.1111/j.0014-3820.2000.tb00560.x; KURATANI S, 1990, ARCH HISTOL CYTOL, V53, P267, DOI 10.1679/aohc.53.267; Laforest B, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/180297; Le Douarin N.M., 1982, NEURAL CREST; LEDOUARIN NM, 1993, DEV BIOL, V159, P24, DOI 10.1006/dbio.1993.1219; Lewin MB, 2004, PEDIATRICS, V114, P691, DOI 10.1542/peds.2003-0782-L; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Loffredo CA, 2004, AM J MED GENET A, V124A, P225, DOI 10.1002/ajmg.a.20366; Makki N, 2012, HUM MOL GENET, V21, P26, DOI 10.1093/hmg/ddr434; Mangini A, 2010, EUR J CARDIO-THORAC, V37, P1015, DOI 10.1016/j.ejcts.2009.11.048; Manley NR, 2003, CURR OPIN IMMUNOL, V15, P225, DOI 10.1016/S0952-7915(03)00006-2; Martinez-Maza C, 2012, J ANAT, V220, P472, DOI 10.1111/j.1469-7580.2012.01488.x; Mathieu P, 2015, J PATHOL CLIN RES, V1, P195, DOI 10.1002/cjp2.21; McBride KL, 2008, HUM MOL GENET, V17, P2886, DOI 10.1093/hmg/ddn187; McElhinney DB, 2002, CIRCULATION, V106, P2567, DOI 10.1161/01.CIR.0000037221.45902.69; Michelena HI, 2014, CIRCULATION, V129, P2691, DOI 10.1161/CIRCULATIONAHA.113.007851; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Miyabara S, 1997, AM J MED GENET, V68, P135, DOI 10.1002/(SICI)1096-8628(19970120)68:2<135::AID-AJMG3>3.0.CO;2-O; MOERMAN P, 1987, BRIT HEART J, V58, P274; Monteiro LR, 1999, SYST BIOL, V48, P192, DOI 10.1080/106351599260526; Munoz-Munoz F, 2011, J EVOLUTION BIOL, V24, P1763, DOI 10.1111/j.1420-9101.2011.02312.x; NODEN DM, 1988, DEVELOPMENT, V103, P121; Opitz JM, 1993, BIRTH DEFECTS ORIG A, V29, P1; Phillips HM, 2013, CARDIOVASC RES, V99, P452, DOI 10.1093/cvr/cvt132; Prakash SK, 2014, J AM COLL CARDIOL, V64, P832, DOI 10.1016/j.jacc.2014.04.073; Raica M, 2006, ANN ANAT, V188, P345, DOI 10.1016/j.aanat.2006.01.012; Ramaesh T, 2003, J ANAT, V203, P213, DOI 10.1046/j.1469-7580.2003.00210.x; ROBERTS WC, 1970, AM J CARDIOL, V26, P72, DOI 10.1016/0002-9149(70)90761-7; Roberts WC, 2012, MEDICINE, V91, P287, DOI 10.1097/MD.0b013e3182764b84; Rohlf FJ, 2001, TPSDIG V 1 31 PC PRO, V1; Sans-Coma V., 1993, CARDIOL YOUNG, V3, P132, DOI DOI 10.1017/S1047951100001396; Sans-Coma V, 2012, J ANAT, V220, P92, DOI 10.1111/j.1469-7580.2011.01440.x; SANSCOMA V, 1994, ACTA ANAT, V149, P255; SansComa V, 1996, ANAT RECORD, V244, P490, DOI 10.1002/(SICI)1097-0185(199604)244:4<490::AID-AR7>3.0.CO;2-Z; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; Scambler Peter James, 1994, Seminars in Developmental Biology, V5, P303, DOI 10.1006/sedb.1994.1039; Sievers HH, 2007, J THORAC CARDIOV SUR, V133, P1226, DOI 10.1016/j.jtcvs.2007.01.039; Siman CM, 2000, TERATOLOGY, V61, P355, DOI 10.1002/(SICI)1096-9926(200005)61:5<355::AID-TERA7>3.0.CO;2-W; Sperling JS, 2015, INT J CARDIOL, V184, P1, DOI 10.1016/j.ijcard.2015.02.013; Thomas PS, 2010, DEV BIOL, V340, P613, DOI 10.1016/j.ydbio.2010.02.021; Ward C, 2000, HEART, V83, P81, DOI 10.1136/heart.83.1.81; Zelditch ML, 2004, GEOMETRIC MORPHOMETR	81	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0183556	10.1371/journal.pone.0183556	http://dx.doi.org/10.1371/journal.pone.0183556			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953926	gold, Green Published, Green Submitted			2022-12-27	WOS:000411980300008
J	Wang, S; Li, W; Chang, KK; Liu, J; Guo, QQ; Sun, HF; Jiang, M; Zhang, H; Chen, J; Hu, JD				Wang, Shun; Li, Wei; Chang, Keke; Liu, Juan; Guo, Qingqian; Sun, Haifeng; Jiang, Min; Zhang, Hao; Chen, Jing; Hu, Jiandong			Localized surface plasmon resonance-based abscisic acid biosensor using aptamerfunctionalized gold nanoparticles	PLOS ONE			English	Article							FREE COLORIMETRIC DETECTION; TRAP MASS-SPECTROMETRY; PLANT HORMONES; LABEL-FREE; OPTICAL-PROPERTIES; AU NANOPARTICLES; APTAMER; PHYTOHORMONE; SELECTION; PROTEIN	Abscisic acid (ABA) plays an important role in abiotic stress response and physiological signal transduction resisting to the adverse environment. Therefore, it is very essential for the quantitative detection of abscisic acid (ABA) due to its indispensable role in plant physiological activities. Herein, a new detection method based on localized surface plasmon resonance (LSPR) using aptamer-functionalized gold nanoparticles (AuNPs) is developed without using expensive instrument and antibody. In the presence of ABA, ABA specifically bind with their aptamers to form the ABA-aptamer complexes with G-quadruplex-like structure and lose the ability to stabilize AuNPs against NaCl-induced aggregation. Meanwhile, the changes of the LSPR spectra of AuNP solution occur and therefore the detection of ABA achieved. Under optimized conditions, this method showed a good linear range covering from 5x10(-7) M to 5x10(-5) M with a detection limit of 0.33 mu M. In practice, the usage of this novel method has been demonstrated by its application to detect ABA from fresh leaves of rice with the relative error of 6.59%-7.93% compared with ELISA bioassay. The experimental results confirmed that this LSPR-based biosensor is simple, selective and sensitive for the detection of ABA. The proposed LSPR method could offer a new analytical platform for the detection of other plant hormones by changing the corresponding aptamer.	[Wang, Shun; Chang, Keke; Guo, Qingqian; Sun, Haifeng; Zhang, Hao; Chen, Jing; Hu, Jiandong] Henan Agr Univ, Coll Mech & Elect Engn, Zhengzhou, Henan, Peoples R China; [Wang, Shun; Li, Wei; Chang, Keke; Guo, Qingqian; Sun, Haifeng; Hu, Jiandong] State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Henan, Peoples R China; [Li, Wei] Henan Agr Univ, Coll Sci, Zhengzhou, Henan, Peoples R China; [Liu, Juan] Henan Agr Univ, Coll Agron, Zhengzhou, Henan, Peoples R China; [Jiang, Min] Henan Agr Univ, Coll Life Sci, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Henan Agricultural University; Henan Agricultural University; Henan Agricultural University	Hu, JD (corresponding author), Henan Agr Univ, Coll Mech & Elect Engn, Zhengzhou, Henan, Peoples R China.; Hu, JD (corresponding author), State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Henan, Peoples R China.	jiandonghu@163.com						Ashaduzzaman M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44027; Bosco R, 2013, J AGR FOOD CHEM, V61, P10940, DOI 10.1021/jf4034305; Chen YY, 2011, BIOSENS BIOELECTRON, V26, P3160, DOI 10.1016/j.bios.2010.12.019; Chen ZB, 2013, ANAL CHIM ACTA, V787, P189, DOI 10.1016/j.aca.2013.05.020; Du GS, 2016, ANAL BIOCHEM, V514, P2, DOI 10.1016/j.ab.2016.09.006; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gomez-Cadenas A, 2015, CURR PROTEIN PEPT SC, V16, P413, DOI 10.2174/1389203716666150330130102; Gomez-Grana S, 2015, CHEM MATER, V27, P8310, DOI 10.1021/acs.chemmater.5b03620; Gong X, 2014, ANAL CHIM ACTA, V828, P80, DOI 10.1016/j.aca.2014.04.028; Grozio A, 2013, NUCLEIC ACID THER, V23, P322, DOI 10.1089/nat.2013.0418; Hill HD, 2006, NAT PROTOC, V1, P324, DOI 10.1038/nprot.2006.51; Izumi Y, 2009, ANAL CHIM ACTA, V648, P215, DOI 10.1016/j.aca.2009.07.001; Kim JE, 2016, BIOSENS BIOELECTRON, V80, P543, DOI 10.1016/j.bios.2016.02.015; Kim YS, 2010, BIOSENS BIOELECTRON, V26, P1644, DOI 10.1016/j.bios.2010.08.046; Kojima M, 2009, PLANT CELL PHYSIOL, V50, P1201, DOI 10.1093/pcp/pcp057; Lee YH, 2012, LANGMUIR, V28, P321, DOI 10.1021/la204047a; Li F, 2009, ANALYST, V134, P1355, DOI 10.1039/b900900k; Li HX, 2004, P NATL ACAD SCI USA, V101, P14036, DOI 10.1073/pnas.0406115101; Li HX, 2004, J AM CHEM SOC, V126, P10958, DOI 10.1021/ja048749n; Li HX, 2004, ANAL CHEM, V76, P5414, DOI 10.1021/ac049173n; Li Q, 2010, CHINESE CHEM LETT, V21, P472, DOI 10.1016/j.cclet.2009.12.005; Li YW, 2008, ANAL BIOANAL CHEM, V391, P2869, DOI 10.1007/s00216-008-2214-6; Li ZJ, 2015, BIOSENS BIOELECTRON, V68, P668, DOI 10.1016/j.bios.2015.01.062; Liu X, 2003, J CHROMATOGR A, V1021, P209, DOI 10.1016/j.chroma.2003.09.004; Lopez-Carbonell M, 2009, PLANT PHYSIOL BIOCH, V47, P256, DOI 10.1016/j.plaphy.2008.12.016; Lu QM, 2015, J CHROMATOGR B, V992, P8, DOI 10.1016/j.jchromb.2015.04.014; Luo C, 2015, RSC ADV, V5, P10994, DOI 10.1039/c4ra14833a; Maye MM, 2003, ANAL CHIM ACTA, V496, P17, DOI 10.1016/S0003-2670(03)00986-3; McCarthy JR, 2008, ADV DRUG DELIVER REV, V60, P1241, DOI 10.1016/j.addr.2008.03.014; Miransari M, 2014, ENVIRON EXP BOT, V99, P110, DOI 10.1016/j.envexpbot.2013.11.005; Mishra P, 2017, NANO ENERGY, V39, P601, DOI 10.1016/j.nanoen.2017.06.023; Osborne SE, 1997, CHEM REV, V97, P349, DOI 10.1021/cr960009c; Pavlov V, 2004, J AM CHEM SOC, V126, P11768, DOI 10.1021/ja046970u; Polavarapu L, 2014, J MATER CHEM C, V2, P7460, DOI 10.1039/c4tc01142b; Shiohara A, 2014, NANOSCALE, V6, P9817, DOI 10.1039/c4nr02648a; Song KM, 2011, ANAL BIOCHEM, V415, P175, DOI 10.1016/j.ab.2011.04.007; Storhoff JJ, 1998, J AM CHEM SOC, V120, P1959, DOI 10.1021/ja972332i; Wahab R, 2014, COLLOID SURFACE B, V123, P664, DOI 10.1016/j.colsurfb.2014.10.012; Wang RZ, 2009, ANAL LETT, V42, P2893, DOI 10.1080/00032710903201909; Wei H, 2007, CHEM COMMUN, P3735, DOI 10.1039/b707642h; Wu ZS, 2010, ANAL CHEM, V82, P3890, DOI 10.1021/ac100422h; Zheng Y, 2011, SENSOR ACTUAT B-CHEM, V156, P95, DOI 10.1016/j.snb.2011.03.077	43	9	9	6	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185530	10.1371/journal.pone.0185530	http://dx.doi.org/10.1371/journal.pone.0185530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953934	Green Published, gold, Green Submitted			2022-12-27	WOS:000411980300073
J	Song, QJ; Jiang, H; Song, QH; Zhao, XG; Wu, XX				Song, QingJun; Jiang, HaiYan; Song, Qinghui; Zhao, XieGuang; Wu, Xiaoxuan			Combination of minimum enclosing balls classifier with SVM in coal-rock recognition	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; INTERFACE DETECTION; FEATURE-SELECTION; FAULT-DIAGNOSIS; KERNEL; SIGNALS	Top-coal caving technology is a productive and efficient method in modern mechanized coal mining, the study of coal-rock recognition is key to realizing automation in comprehensive mechanized coal mining. In this paper we propose a new discriminant analysis framework for coal-rock recognition. In the framework, a data acquisition model with vibration and acoustic signals is designed and the caving dataset with 10 feature variables and three classes is got. And the perfect combination of feature variables can be automatically decided by using the multi-class F-score (MF-Score) feature selection. In terms of nonlinear mapping in real-world optimization problem, an effective minimum enclosing ball (MEB) algorithm plus Support vector machine (SVM) is proposed for rapid detection of coal-rock in the caving process. In particular, we illustrate how to construct MEB-SVM classifier in coal-rock recognition which exhibit inherently complex distribution data. The proposed method is examined on UCI data sets and the caving dataset, and compared with some new excellent SVM classifiers. We conduct experiments with accuracy and Friedman test for comparison of more classifiers over multiple on the UCI data sets. Experimental results demonstrate that the proposed algorithm has good robustness and generalization ability. The results of experiments on the caving dataset show the better performance which leads to a promising feature selection and multi-class recognition in coal-rock recognition.	[Song, QingJun; Jiang, HaiYan; Zhao, XieGuang] Shandong Univ Sci & Technol, Taian Sch, Tai An, Shandong, Peoples R China; [Song, Qinghui] Shandong Univ Sci & Technol, Dept Mech & Elect Engn, Qingdao, Shandong, Peoples R China; [Wu, Xiaoxuan] Shandong Univ Sci &Technol, Jinan Sch, Jinan, Shandong, Peoples R China	Shandong University of Science & Technology; Shandong University of Science & Technology; Shandong University of Science & Technology	Jiang, H (corresponding author), Shandong Univ Sci & Technol, Taian Sch, Tai An, Shandong, Peoples R China.	littlsunny@163.com		Song, Qinghui/0000-0003-3631-3749; Zhao, Xieguang/0000-0002-8185-8708; Jiang, Haiyan/0000-0002-6796-2568	Fund of Shandong University of Science & Technology, China [2016RCJJ036]; Project of Natural Science Foundation of Shandong Province, China [ZR2015EM042]	Fund of Shandong University of Science & Technology, China; Project of Natural Science Foundation of Shandong Province, China	This work was supported by the Fund of Shandong University of Science & Technology, China under contract No. 2016RCJJ036 and Project of Natural Science Foundation of Shandong Province, China under Grant No. ZR2015EM042.; The authors gratefully thank anonymous reviewers for their valuable comments to improve the paper quality. This work was supported by the Fund of Shandong University of Science & Technology, China under contract No. 2016RCJJ036 and Project of Natural Science Foundation of Shandong Province, China under Grant No. ZR2015EM042.	Abdoos AA, 2016, APPL SOFT COMPUT, V38, P637, DOI 10.1016/j.asoc.2015.10.038; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chang CC, 2015, PATTERN RECOGN, V48, P3983, DOI 10.1016/j.patcog.2015.06.017; Chung FL, 2009, IEEE T FUZZY SYST, V17, P173, DOI 10.1109/TFUZZ.2008.2006620; Cyganek B, 2015, ENG APPL ARTIF INTEL, V46, P10, DOI 10.1016/j.engappai.2015.08.001; Demssar J., 2016, J MACHINE LEARNING R, V7, P1; Deng ZH, 2011, IEEE T FUZZY SYST, V19, P210, DOI 10.1109/TFUZZ.2010.2091961; Ediz IG, 2006, T I MIN METALL A, V115, P41, DOI 10.1179/174328606X103586; Elangovan M, 2011, EXPERT SYST APPL, V38, P15202, DOI 10.1016/j.eswa.2011.05.081; Elliott AC, 2011, COMPUT METH PROG BIO, V102, P75, DOI 10.1016/j.cmpb.2010.11.002; Feng YH, 2009, MECH SYST SIGNAL PR, V23, P712, DOI 10.1016/j.ymssp.2008.07.002; Frandi E, 2013, INT J PATTERN RECOGN, V27, DOI 10.1142/S0218001413600033; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Frigieri EP, 2016, APPL ACOUST, V113, P230, DOI 10.1016/j.apacoust.2016.06.027; Hadjileontiadis LJ, 2005, IEEE T BIO-MED ENG, V52, P1143, DOI 10.1109/TBME.2005.846706; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; Hao PY, 2009, APPL INTELL, V30, P98, DOI 10.1007/s10489-007-0101-z; Hou W., 2017, INT J COAL PREPARATI; Huang J, 2005, IEEE T KNOWL DATA EN, V17, P299, DOI 10.1109/TKDE.2005.50; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; IMAN RL, 1980, COMMUN STAT A-THEOR, V9, P571, DOI 10.1080/03610928008827904; Jiang XD, 2011, IEEE SIGNAL PROC MAG, V28, P16, DOI 10.1109/MSP.2010.939041; Larsson T, 2016, COMPUT GRAPH-UK, V56, P1, DOI 10.1016/j.cag.2016.01.003; Li YC, 2016, OPTIK, V127, P345, DOI 10.1016/j.ijleo.2015.10.078; Likar J, 2012, J MIN SCI+, V48, P135, DOI 10.1134/S1062739148010157; Lin SW, 2008, EXPERT SYST APPL, V35, P1817, DOI 10.1016/j.eswa.2007.08.088; Ling P, 2008, NEURAL COMPUT APPL, V17, P119, DOI 10.1007/s00521-007-0097-7; Liu XW, 2013, IEEE T CYBERNETICS, V43, P557, DOI 10.1109/TSMCB.2012.2212243; Lopez J, 2016, INFORM SCIENCES, V330, P328, DOI 10.1016/j.ins.2015.10.016; Mohammadi M, 2009, J INTELL FUZZY SYST, V20, P133, DOI 10.3233/IFS-2009-0421; MOWREY GL, 1988, IEEE T IND APPL, V24, P660, DOI 10.1109/28.6118; Reddy KGR, 2013, INT J TECHNOLOGY ENH, V1, P31; Ren Fang, 2003, Chinese Journal of Mechanical Engineering, V16, P321; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; Simsir F, 2010, J MIN SCI+, V46, P404, DOI 10.1007/s10913-010-0050-5; Song Q, 2017, PATTERN ANAL APPL, P3; Sun JP, 2013, INT J MIN SCI TECHNO, V23, P681, DOI 10.1016/j.ijmst.2013.08.011; Tang J, 2016, NEUROCOMPUTING, V216, P296, DOI 10.1016/j.neucom.2016.07.043; Tang XL, 2010, KNOWL-BASED SYST, V23, P486, DOI 10.1016/j.knosys.2010.01.004; Le T, 2013, NEURAL COMPUT APPL, V22, P1309, DOI 10.1007/s00521-012-1001-7; Tsang IW, 2005, J MACH LEARN RES, V6, P363; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wang JG, 2007, NEUROCOMPUTING, V70, P801, DOI 10.1016/j.neucom.2006.10.023; Wang J, 2016, NEURAL NETWORKS, V78, P51, DOI 10.1016/j.neunet.2016.02.005; Wang YF, 2016, 2016 12TH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, FUZZY SYSTEMS AND KNOWLEDGE DISCOVERY (ICNC-FSKD), P1642, DOI 10.1109/FSKD.2016.7603423; Xu J.K., 2013, INTERNATION J SIGNAL, V6, P191, DOI DOI 10.3389/FPSYG.2013.00735; Yang JY, 2007, MECH SYST SIGNAL PR, V21, P2012, DOI 10.1016/j.ymssp.2006.10.005; Yang SL, 2016, INT J ROCK MECH MIN, V85, P92, DOI 10.1016/j.ijrmms.2016.03.004; Yildirim EA, 2008, SIAM J OPTIMIZ, V19, P1368, DOI 10.1137/070690419; Yuan SF, 2006, MECH SYST SIGNAL PR, V20, P939, DOI 10.1016/j.ymssp.2005.09.006; Zheng KH, 2015, POWDER TECHNOL, V278, P223, DOI 10.1016/j.powtec.2015.03.027	52	12	12	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0184834	10.1371/journal.pone.0184834	http://dx.doi.org/10.1371/journal.pone.0184834			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28937987	Green Submitted, Green Published, gold			2022-12-27	WOS:000411524700010
J	Berger, HR; Nyman, AKG; Morken, TS; Vettukattil, R; Brubakk, AM; Wideroe, M				Berger, Hester Rijkje; Nyman, Axel K. G.; Morken, Tora Sund; Vettukattil, Riyas; Brubakk, Ann-Mari; Wideroe, Marius			Early metabolite changes after melatonin treatment in neonatal rats with hypoxic-ischemic brain injury studied by in-vivo H-1 MR spectroscopy	PLOS ONE			English	Article							DIMETHYL-SULFOXIDE DMSO; IMMATURE RAT; WHITE-MATTER; CELL-DEATH; NEUROPROTECTION; GLUTATHIONE; HYPOTHERMIA; MECHANISMS; INFANT; DAMAGE	Melatonin is a promising neuroprotective agent after perinatal hypoxic-ischemic (HI) brain injury. We used in-vivo H-1 magnetic resonance spectroscopy to investigate effects of melatonin treatment on brain metabolism after HI. Postnatal day 7 Sprague-Dawley rats with unilateral HI brain injury were treated with either melatonin 10 mg/kg dissolved in phosphatebuffered saline (PBS) with 5% dimethyl sulfoxide (DMSO) or vehicle (5% DMSO and/or PBS) directly and at 6 hours after HI. H-1 MR spectra from the thalamus in the ipsilateral and contralateral hemisphere were acquired 1 day after HI. Our results showed that injured animals had a distinct metabolic profile in the ipsilateral thalamus compared to sham with low concentrations of total creatine, choline, N-acetyl aspartate (NAA), and high concentrations of lipids. A majority of the melatonin-treated animals had a metabolic profile characterized by higher total creatine, choline, NAA and lower lipid levels than other HI animals. When comparing absolute concentrations, melatonin treatment resulted in higher glutamine levels and lower lipid concentrations compared to DMSO treatment as well as higher macromolecule levels compared to PBS treatment day 1 after HI. DMSO treated animals had lower concentrations of glucose, creatine, phosphocholine and macromolecules compared to sham animals. In conclusion, the neuroprotective effects of melatonin were reflected in a more favorable metabolic profile including reduced lipid levels that likely represents reduced cell injury. Neuroprotective effects may also be related to the influence of melatonin on glutamate/glutamine metabolism. The modulatory effects of the solvent DMSO on cerebral energy metabolism might have masked additional beneficial effects of melatonin.	[Berger, Hester Rijkje; Morken, Tora Sund; Brubakk, Ann-Mari] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway; [Berger, Hester Rijkje] St Olavs Univ Hosp HF, Dept Pediat, Trondheim, Norway; [Nyman, Axel K. G.; Vettukattil, Riyas; Wideroe, Marius] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Morken, Tora Sund] St Olavs Univ Hosp HF, Dept Ophthalmol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Berger, HR (corresponding author), Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway.	hester.berger@ntnu.no		Vettukattil, Riyas/0000-0002-2152-4933	Medical Faculty at the Norwegian University of Science and Technology (NTNU)	Medical Faculty at the Norwegian University of Science and Technology (NTNU)	The work was financially supported by a grant from the Medical Faculty at the Norwegian University of Science and Technology (NTNU).	Ahn SY, 2013, J KOREAN MED SCI, V28, P1071, DOI 10.3346/jkms.2013.28.7.1071; Azzopardi D, 2016, LANCET NEUROL, V15, P145, DOI 10.1016/S1474-4422(15)00347-6; Berger HR, 2016, J NEUROCHEM, V136, P339, DOI 10.1111/jnc.13420; Cheong JLY, 2006, AM J NEURORADIOL, V27, P1546; Colella M, 2016, EARLY HUM DEV, V102, P1, DOI 10.1016/j.earlhumdev.2016.09.001; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Hanslick JL, 2009, NEUROBIOL DIS, V34, P1, DOI 10.1016/j.nbd.2008.11.006; Hardeland R, 2005, ENDOCRINE, V27, P119, DOI 10.1385/ENDO:27:2:119; Hassell K. J., 2013, FETAL MATERN MED REV, V24, P76, DOI DOI 10.1017/S0965539513000089; Husson I, 2002, ANN NEUROL, V51, P82, DOI 10.1002/ana.10072; Jacobs S. E., 2013, COCHRANE DB SYST REV, P1; Jong CJ, 2012, AMINO ACIDS, V42, P2223, DOI 10.1007/s00726-011-0962-7; Li BSY, 2003, MAGN RESON IMAGING, V21, P923, DOI 10.1016/S0730-725X(03)00181-4; Malisza KL, 1999, NMR BIOMED, V12, P31, DOI 10.1002/(SICI)1099-1492(199902)12:1<31::AID-NBM544>3.0.CO;2-M; Mauriz JL, 2013, J PINEAL RES, V54, P1, DOI 10.1111/j.1600-079X.2012.01014.x; McLean C, 2004, SEMIN PERINATOL, V28, P425, DOI 10.1053/j.semperi.2004.10.005; Morken TS, 2014, STROKE, V45, P2777, DOI 10.1161/STROKEAHA.114.005341; MUJSCE DJ, 1990, PEDIATR RES, V27, P450, DOI 10.1203/00006450-199005000-00007; Nasrallah FA, 2008, J NEUROSCI RES, V86, P208, DOI 10.1002/jnr.21477; Osredkar D, 2014, RESUSCITATION, V85, P567, DOI 10.1016/j.resuscitation.2013.12.006; Palmer C, 2003, FETAL NEONATAL BRAIN; Panigrahy A, 2010, PEDIATR RADIOL, V40, P3, DOI 10.1007/s00247-009-1450-z; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; PukaSundvall M, 1997, BRAIN RES, V750, P325, DOI 10.1016/S0006-8993(97)00024-3; Rae CD, 2014, NEUROCHEM RES, V39, P1, DOI 10.1007/s11064-013-1199-5; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Robertson NJ, 2013, BRAIN, V136, P90, DOI 10.1093/brain/aws285; Robertson NJ, 2012, J PEDIATR-US, V160, P544, DOI 10.1016/j.jpeds.2011.12.052; Sanmartin-Suarez C, 2011, J PHARMACOL TOX MET, V63, P209, DOI 10.1016/j.vascn.2010.10.004; Stelmashook EV, 2011, INT J NEUROSCI, V121, P415, DOI 10.3109/00207454.2011.570464; Thayyil S, 2010, PEDIATRICS, V125, pE382, DOI 10.1542/peds.2009-1046; Tkac I, 2003, MAGN RESON MED, V50, P24, DOI 10.1002/mrm.10497; URENJAK J, 1992, J NEUROCHEM, V59, P55, DOI 10.1111/j.1471-4159.1992.tb08875.x; van de Looij Y, 2011, MAGN RESON MED, V65, P305, DOI 10.1002/mrm.22617; Vannucci RC, 2004, J CEREBR BLOOD F MET, V24, P1090, DOI 10.1097/01.WCB.0000133250.03953.63; Volpe J.J., 2008, NEUROLOGY NEWBORN; Wallin C, 2000, DEV BRAIN RES, V125, P51, DOI 10.1016/S0165-3806(00)00112-7; Welin AK, 2007, PEDIATR RES, V61, P153, DOI 10.1203/01.pdr.0000252546.20451.1a; Yuan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107447	40	8	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185202	10.1371/journal.pone.0185202	http://dx.doi.org/10.1371/journal.pone.0185202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934366	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900120
J	Chiu, HY; Huang, WY; Ho, CH; Wang, JJ; Lin, SJ; Hsu, YW; Chen, PJ				Chiu, Hsien-Yi; Huang, Wen-Yen; Ho, Chung-Han; Wang, Jhi-Joung; Lin, Sung-Jan; Hsu, Ya-Wen; Chen, Ping-Jen			Increased risk of chronic kidney disease in patients with rosacea: A nationwide population-based matched cohort study	PLOS ONE			English	Article							METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; INFLAMMATION; MORTALITY; ASSOCIATION; ACTIVATION; PSORIASIS; SEVERITY; TAIWAN	Background Rosacea is a chronic inflammatory skin disorder. Inflammation and oxidative stress are involved in the etiopathogenesis of rosacea and chronic kidney disease (CKD). This study aimed to investigate the association between rosacea and CKD. Methods This population-based cohort study identified 277 patients with rosacea in the Taiwan National Health Insurance Research Database during 2001-2005. These patients were matched for age, sex, and comorbidities with 2216 patients without rosacea. All subjects were individually followed-up for 8-12 years to identify those who subsequently developed CKD Results The incidence rates of CKD per 1000 person-years were 16.02 in patients with rosacea and 10.63 in the non-rosacea reference population. After adjusting for other covariates and considering the competing risk of mortality, patients with rosacea remained at increased risk of CKD (adjusted sub-distribution hazard ratio (aSD-HR) 2.00; 95% confidence interval (CI) 1.05-3.82). The aSD-HRs (95% CI) for CKD were 1.82 (0.83-4.00) and 2.53 (1.11-5.75) for patients with mild and moderate-to-severe rosacea, respectively. Conclusions Rosacea is an independent risk factor for CKD. High rosacea severity and old age further increased CKD risk in patients with rosacea. Careful monitoring for CKD development should be included as part of integrated care for patients with rosacea.	[Chiu, Hsien-Yi; Huang, Wen-Yen; Lin, Sung-Jan] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei, Taiwan; [Chiu, Hsien-Yi; Huang, Wen-Yen; Lin, Sung-Jan] Natl Taiwan Univ, Coll Engn, Taipei, Taiwan; [Chiu, Hsien-Yi] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Dermatol, Hsinchu, Taiwan; [Chiu, Hsien-Yi; Lin, Sung-Jan] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Chiu, Hsien-Yi; Lin, Sung-Jan] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Ho, Chung-Han; Wang, Jhi-Joung; Hsu, Ya-Wen] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Ho, Chung-Han; Hsu, Ya-Wen] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan, Taiwan; [Lin, Sung-Jan] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan; [Chen, Ping-Jen] Chi Mei Med Ctr, Dept Geriatr & Gerontol, Tainan, Taiwan; [Chen, Ping-Jen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chia Nan University of Pharmacy & Science; National Taiwan University; Chi Mei Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chen, PJ (corresponding author), Chi Mei Med Ctr, Dept Geriatr & Gerontol, Tainan, Taiwan.; Chen, PJ (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan.	pingjen.chen@gmail.com	huang, wen/GXW-0661-2022; Chen, Ping-Jen/AAG-8548-2021	Chen, Ping-Jen/0000-0001-7636-0801; Chiu, Hsien-Yi/0000-0002-0493-9707; Ho, Chung-Han/0000-0001-5925-8477; /0000-0001-9625-0802	National Taiwan University Hospital Hsin-Chu Branch [106-HCH002]	National Taiwan University Hospital Hsin-Chu Branch	This work was supported in part by a grant from the National Taiwan University Hospital Hsin-Chu Branch (106-HCH002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Belli AA, 2016, EUR J DERMATOL, V26, P260, DOI 10.1684/ejd.2016.2748; Aldrich N, 2015, JAMA DERMATOL, V151, P1213, DOI 10.1001/jamadermatol.2015.2230; Arici M, 2001, KIDNEY INT, V59, P407, DOI 10.1046/j.1523-1755.2001.059002407.x; Bakar O, 2007, CLIN EXP DERMATOL, V32, P197, DOI 10.1111/j.1365-2230.2006.02322.x; Buhl T, 2015, J INVEST DERMATOL, V135, P2198, DOI 10.1038/jid.2015.141; Carrero JJ, 2009, CLIN J AM SOC NEPHRO, V4, pS49, DOI 10.2215/CJN.02720409; Casas C, 2012, EXP DERMATOL, V21, P906, DOI 10.1111/exd.12030; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Chiu HY, 2015, BRIT J DERMATOL, V173, P146, DOI 10.1111/bjd.13599; Chiu HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136508; Chiu HY, 2012, DERMATOL SIN, V30, P136, DOI 10.1016/j.dsi.2012.08.002; Duman N, 2014, J EUR ACAD DERMATOL, V28, P1165, DOI 10.1111/jdv.12234; Egeberg A, 2016, J AM ACAD DERMATOL, V75, P336, DOI 10.1016/j.jaad.2016.02.1158; Egeberg A, 2016, DERMATOLOGY, V232, P208, DOI 10.1159/000444082; Egeberg A, 2016, JAMA NEUROL, V73, P529, DOI 10.1001/jamaneurol.2016.0022; Granata S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122272; Hua TC, 2015, J AM ACAD DERMATOL, V73, P249, DOI 10.1016/j.jaad.2015.04.028; Hung SC, 2015, LANCET DIABETES ENDO, V3, P605, DOI 10.1016/S2213-8587(15)00123-0; Kang HT, 2012, J KOREAN MED SCI, V27, P630, DOI 10.3346/jkms.2012.27.6.630; Kawaguchi Yoshiaki, 2009, Tokai J Exp Clin Med, V34, P80; Kaysen GA, 2004, J AM SOC NEPHROL, V15, P538, DOI 10.1097/01.ASN.0000111744.00916.E6; Kronbichler A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-95; Li YW, 2007, J FORMOS MED ASSOC, V106, P975, DOI 10.1016/S0929-6646(08)60071-6; Oztas MO, 2003, CLIN EXP DERMATOL, V28, P188, DOI 10.1046/j.1365-2230.2003.01179.x; Rainer BM, 2015, J AM ACAD DERMATOL, V73, P604, DOI 10.1016/j.jaad.2015.07.009; Said Sarmad, 2014, J Nephropathol, V3, P99, DOI 10.12860/jnp.2014.19; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Shankar A, 2006, AM J EPIDEMIOL, V164, P263, DOI 10.1093/aje/kwj173; Small DM, 2012, NEPHROLOGY, V17, P311, DOI 10.1111/j.1440-1797.2012.01572.x; Spoendlin J, 2013, J AM ACAD DERMATOL, V69, P399, DOI 10.1016/j.jaad.2013.03.027; Steinhoff M, 2011, J INVEST DERM SYMP P, V15, P2, DOI 10.1038/jidsymp.2011.7; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Tisma VS, 2009, J AM ACAD DERMATOL, V60, P270, DOI 10.1016/j.jaad.2008.10.014; Tseng CW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169070; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Wan J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5961; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Yamasaki K, 2009, J DERMATOL SCI, V55, P77, DOI 10.1016/j.jdermsci.2009.04.007; Zhong SM, 2015, DERMATOL SIN, V33, P112, DOI 10.1016/j.dsi.2015.04.012	39	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0180446	10.1371/journal.pone.0180446	http://dx.doi.org/10.1371/journal.pone.0180446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968402	Green Published, gold, Green Submitted			2022-12-27	WOS:000412029600003
J	Turnbull, AE; Chessare, CM; Coffin, RK; Needham, DM				Turnbull, Alison E.; Chessare, Caroline M.; Coffin, Rachel K.; Needham, Dale M.			A brief intervention for preparing ICU families to be proxies: A phase I study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; PALLIATIVE CARE; POSTTRAUMATIC STRESS; PATIENT ACTIVATION; DECISION-MAKING; COMMUNICATION; SURROGATES; BARRIERS; OUTCOMES	Background Family members of critically ill patients report high levels of conflict with clinicians, have poor understanding of prognosis, struggle to make decisions, and experience substantial symptoms of anxiety, depression, and post-traumatic stress regardless of patient survival status. Efficient interventions are needed to prepare these families to act as patient proxies. Objectives To assess a brief "patient activation" intervention designed to set expectations and prepare families of adult intensive care unit (ICU) patients to communicate effectively with the clinical team. Design Phase I study of acceptability and immediate side effects. Setting and participants 122 healthcare proxies of 111 consecutive patients with a stay of >= 24 hours in the Johns Hopkins Hospital Medical ICU (MICU), in Baltimore, Maryland. Intervention Reading aloud to proxies from a booklet (Flesch-Kincard reading grade level 3.8) designed with multidisciplinary input including from former MICU proxies. Results Enrolled proxies had a median age of 51 years old with 83 (68%) female, and 55 (45%) African- American. MICU mortality was 18%, and 37 patients (33%) died in hospital or were discharged to hospice. Among proxies 98% (95% CI: 94% - 100%) agreed or strongly agreed that the intervention was appropriate, 98% ( 95% CI: 92% - 99%) agreed or strongly agreed that it is important for families to know the information in the booklet, and 54 ( 44%, 95% CI 35% -54%) agreed or strongly agreed that parts of the booklet are upsetting. Upset vs. nonupset proxies were not statistically or substantially different in terms of age, sex, education level, race, relation to the patient, or perceived decision-making authority. Conclusions This patient activation intervention was acceptable and important to nearly all proxies. Frequently, the intervention was simultaneously rated as both acceptable/important and upsetting. Proxies who rated the intervention as upsetting were not identifiable based on readily available proxy or patient characteristics.	[Turnbull, Alison E.; Chessare, Caroline M.; Needham, Dale M.] Johns Hopkins Univ, Outcomes Crit Illness & Surg OACIS Grp, Baltimore, MD 21218 USA; [Turnbull, Alison E.; Chessare, Caroline M.; Needham, Dale M.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21218 USA; [Turnbull, Alison E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [Coffin, Rachel K.] Johns Hopkins Univ Hosp, Med Intens Care Unit, Baltimore, MD USA; [Needham, Dale M.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Turnbull, AE (corresponding author), Johns Hopkins Univ, Outcomes Crit Illness & Surg OACIS Grp, Baltimore, MD 21218 USA.; Turnbull, AE (corresponding author), Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21218 USA.; Turnbull, AE (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	turnbuil@jhmi.edu		Turnbull, Alison/0000-0002-1564-6547	Johns Hopkins School of Medicine, Division of Pulmonary and Critical Care Medicine	Johns Hopkins School of Medicine, Division of Pulmonary and Critical Care Medicine	This research was supported by the Johns Hopkins School of Medicine, Division of Pulmonary and Critical Care Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KH, 2001, CRIT CARE MED, V29, P197, DOI 10.1097/00003246-200101000-00040; Alonso W, 2017, HEART LUNG, V46, P35, DOI 10.1016/j.hrtlng.2016.09.001; Anderson WG, 2008, J GEN INTERN MED, V23, P1871, DOI 10.1007/s11606-008-0770-2; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Azoulay E, 2002, AM J RESP CRIT CARE, V165, P438, DOI 10.1164/ajrccm.165.4.200108-006oc; Burke C., 2013, ISOTYPE DESIGN CONTE; Cameron JI, 2016, NEW ENGL J MED, V374, P1831, DOI 10.1056/NEJMoa1511160; Carson SS, 2016, JAMA-J AM MED ASSOC, V316, P51, DOI 10.1001/jama.2016.8474; Char SJL, 2010, AM J RESP CRIT CARE, V182, P905, DOI 10.1164/rccm.201002-0262OC; Chavalarias D, 2016, JAMA-J AM MED ASSOC, V315, P1141, DOI 10.1001/jama.2016.1952; Chiarchiaro J, 2015, ANN AM THORAC SOC, V12, P1528, DOI 10.1513/AnnalsATS.201504-253OC; Chiarchiaro J, 2015, CRIT CARE MED, V43, P542, DOI 10.1097/CCM.0000000000000719; Daly K, 1994, Clin Nurs Res, V3, P414, DOI 10.1177/105477389400300409; Davidson JE, 2017, CRIT CARE MED, V45, P103, DOI 10.1097/CCM.0000000000002169; DeKeyser Ganz F, 2015, CRIT CARE MED; DeMartino ES, 2017, NEW ENGL J MED, V376, P1478, DOI 10.1056/NEJMms1611497; Elwyn G, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S14; FAQClinicalTrials, 2017, CLIN TRIAL PHAS; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Hibbard J, 2014, SUPPORTING PEOPLE MA; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Hibbard JH, 2013, HEALTH AFFAIR, V32, P207, DOI 10.1377/hlthaff.2012.1061; Hillman KM, 2015, INTENS CARE MED, V41, P1700, DOI 10.1007/s00134-015-3712-6; Jones C, 2004, INTENS CARE MED, V30, P456, DOI 10.1007/s00134-003-2149-5; Joseph-Williams N, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3178; Joseph-Williams N, 2014, PATIENT EDUC COUNS, V94, P291, DOI 10.1016/j.pec.2013.10.031; Kentish-Barnes N, 2017, INTENS CARE MED, P1; Kohn R, 2017, ANN AM THORAC SOC, V14, P254, DOI 10.1513/AnnalsATS.201607-579OC; Kon AA, 2016, CRIT CARE MED, V44, P188, DOI 10.1097/CCM.0000000000001396; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; LeClaire MM, 2005, CHEST, V128, P1728, DOI 10.1378/chest.128.3.1728; McAdam JL, 2012, AM J CRIT CARE, V21, P386, DOI 10.4037/ajcc2012582; Mistraletti G., 2016, INTENS CARE MED, V1, P1; Nelson JE, 2006, QUAL SAF HEALTH CARE, V15, P264, DOI 10.1136/qshc.2005.017707; Penrod JD, 2012, CRIT CARE MED, V40, P1105, DOI 10.1097/CCM.0b013e3182374a50; Penrod JD, 2011, J PAIN SYMPTOM MANAG, V42, P668, DOI 10.1016/j.jpainsymman.2011.06.012; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Richman PS, 2016, J CRIT CARE, V31, P172, DOI 10.1016/j.jcrc.2015.09.029; Schenker Y, 2012, J GEN INTERN MED, V27, P1657, DOI 10.1007/s11606-012-2129-y; Schuster RA, 2014, CRIT CARE MED, V42, P328, DOI 10.1097/CCM.0b013e3182a27598; Schwartz AAGJS, 2006, WHO CAN MAKE HLTH CA; Schwarze ML, 2016, AM J RESP CRIT CARE, V193, P14, DOI 10.1164/rccm.201508-1592OE; Sullivan AM, 2016, ANN AM THORAC SOC; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Teno JM, 2016, JAMA INTERN MED, V176, P1809, DOI 10.1001/jamainternmed.2016.5964; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Torke AM, 2014, JAMA INTERN MED, V174, P370, DOI 10.1001/jamainternmed.2013.13315; Turnbull AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177741; Turnbull AE, 2016, ANN AM THORAC SOC, V13, P1546, DOI 10.1513/AnnalsATS.201603-212OC; van Beusekom I, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1185-9; Wendler D, 2011, ANN INTERN MED, V154, P336, DOI 10.7326/0003-4819-154-5-201103010-00008; Wysham NG, 2016, CRIT CARE MED; You JJ, 2015, JAMA INTERN MED, V175, P549, DOI 10.1001/jamainternmed.2014.7732	53	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185483	10.1371/journal.pone.0185483	http://dx.doi.org/10.1371/journal.pone.0185483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968409	Green Submitted, Green Published, gold			2022-12-27	WOS:000412029600022
J	Lin, JD; Yang, SF; Wang, YH; Fang, WF; Lin, YC; Liou, BC; Lin, YF; Tang, KT; Cheng, CW				Lin, Jiunn-Diann; Yang, Shun-Fa; Wang, Yuan-Hung; Fang, Wen-Fang; Lin, Ying-Chin; Liou, Bing-Chun; Lin, Yuh-Feng; Tang, Kam-Tsun; Cheng, Chao-Wen			Associations of melatonin receptor gene polymorphisms with Graves' disease	PLOS ONE			English	Article							AUTOIMMUNE THYROID-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROTEIN-COUPLED RECEPTORS; MESSENGER-RNA; IN-VITRO; AUTOANTIBODIES; LYMPHOCYTES; EXPRESSION; MEMBRANE; CANCER	Background Melatonin plays an important role in immunity and has been linked to autoimmune diseases. Possible associations of single-nucleotide polymorphisms (SNPs) of melatonin receptor type 1A (MTNR1A) and 1B (MTNR1B), with autoimmune thyroid disease in an ethnic Chinese (i.e., Taiwanese) population were examined. Materials and methods Totally, 83 Hashimoto's thyroiditis patients, 319 Graves' disease (GD), and 369 controls were recruited. Three SNPs (rs6553010, rs13140012, and rs2119882) of MTNR1A and three SNPs (rs1387153, rs10830963, and rs1562444) of MTNR1B were genotyped. Results There were a reduced frequency of the C allele of rs2119882 and a reduced percentage of the CC+CT genotype in the GD group compared to the control group (p = 0.039, odds ratio (OR) = 0.79, 95% confidence interval (CI) = 0.63 similar to 0.99, and p = 0.032, OR = 0.72, 95% CI = 0.53 similar to 0.97, respectively). There was a significant difference in the percentage of the AT haplotype of the combination of rs13140012 and rs2119882 between the GD and control groups (p = 0.010, OR = 1.34, 95% CI = 1.07 similar to 1.67). In addition, there were significant associations of anti-thyroid peroxidase antibody titers with rs13140012 and rs2119882, and the AATT genotype of the combination of rs13140012 and rs2119882 (p = 0.003, 0.003, and 0.004, respectively). There were no significant associations of SNPs and possible haplotypes of MTNR1B with susceptibility to GD. Conclusions Genetic variants of rs2119882 of MTNR1A and the AT haplotype of the combination of rs2119882 and rs13140012 were associated with GD susceptibility in an ethnic Chinese population. The results support the involvement of the melatonin pathway in the pathogenesis of GD.	[Lin, Jiunn-Diann; Wang, Yuan-Hung; Liou, Bing-Chun; Lin, Yuh-Feng; Cheng, Chao-Wen] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Lin, Jiunn-Diann] Taipei Med Univ, Shuang Ho Hosp, Div Endocrinol, Dept Internal Med, New Taipei, Taiwan; [Lin, Jiunn-Diann] Taipei Med Univ, Sch Med, Div Endocrinol & Metab, Dept Internal Med,Coll Med, Taipei, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Wang, Yuan-Hung] Taipei Med Univ, Shuang Ho Hosp, Dept Med Res, New Taipei, Taiwan; [Fang, Wen-Fang; Lin, Ying-Chin] Taipei Med Univ, Shuang Ho Hosp, Dept Family Med, New Taipei, Taiwan; [Lin, Yuh-Feng] Taipei Med Univ, Shuang Ho Hosp, Div Nephrol, Dept Internal Med, New Taipei, Taiwan; [Tang, Kam-Tsun] Taipei Vet Gen Hosp, Div Endocrinol & Metab, Dept Internal Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Veterans General Hospital	Cheng, CW (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.	ccheng@tmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927	Ministry of Science and Technology of Taiwan [MOST 104-2314-B-038-048, MOST 106-2314-B-038-059]; Taipei Medical University and Shuang-Ho Hospital [104TMU-SHH-09]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University and Shuang-Ho Hospital	This work was supported by a grant from the Ministry of Science and Technology of Taiwan (MOST 104-2314-B-038-048 and MOST 106-2314-B-038-059) to Jiunn-Diann Lin, and was partly supported by a grant from Taipei Medical University and Shuang-Ho Hospital (104TMU-SHH-09) to Chao-Wen Cheng.	BEEVER K, 1989, CLIN CHEM, V35, P1949; Bizzarri M, 2013, EXPERT OPIN THER TAR, V17, P1483, DOI 10.1517/14728222.2013.834890; Carrillo-Vico A, 2003, CELL MOL LIFE SCI, V60, P2272, DOI 10.1007/s00018-003-3207-4; Cernysiov V, 2010, INT IMMUNOL, V22, P25, DOI 10.1093/intimm/dxp109; Chen CR, 2007, ENDOCRINOLOGY, V148, P2375, DOI 10.1210/en.2006-1754; Drazen DL, NEUROENDOCRINOLOGY; Esposito T, 2012, NEPHROL DIAL TRANSPL, V27, P210, DOI 10.1093/ndt/gfr216; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Garcia-Marin R, 2015, J PHYSIOL PHARMACOL, V66, P643; Garcia-Marin R, 2012, HISTOL HISTOPATHOL, V27, P1429, DOI 10.14670/HH-27.1429; GORDON J, 1980, HORM METAB RES, V12, P71, DOI 10.1055/s-2007-996203; Ha EY, 2005, J PINEAL RES, V39, P201, DOI 10.1111/j.1600-079X.2005.00237.x; Iglesias P, 2010, CLIN ENDOCRINOL, V72, P551, DOI 10.1111/j.1365-2265.2009.03682.x; Jimenez-Caliani AJ, 2006, ENDOCRINOLOGY, V147, P1717, DOI 10.1210/en.2005-0648; Jimenez-Caliani AJ, 2005, J PINEAL RES, V38, P93, DOI 10.1111/j.1600-079X.2004.00175.x; LEWINSKI A, 1986, J PINEAL RES, V3, P291, DOI 10.1111/j.1600-079X.1986.tb00752.x; LEWONTIN RC, 1964, GENETICS, V49, P49; Lin FY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121677; Lin GJ, 2013, INT J MOL SCI, V14, P11742, DOI 10.3390/ijms140611742; Lin JD, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.02.26; Lin JD, 2016, CLIN CHIM ACTA, V462, P96, DOI 10.1016/j.cca.2016.09.004; Lin JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154436; Lin JD, 2015, EUR J CLIN INVEST, V45, P711, DOI 10.1111/eci.12463; Malpaux B, 2001, J BIOL RHYTHM, V16, P336, DOI 10.1177/074873001129002051; Manchester LC, 2015, J PINEAL RES, V59, P403, DOI 10.1111/jpi.12267; MARIOTTI S, 1990, J CLIN ENDOCR METAB, V71, P661, DOI 10.1210/jcem-71-3-661; Medrano-Campillo P, 2015, J PINEAL RES, V58, P219, DOI 10.1111/jpi.12208; Miller SC, 2006, INT J EXP PATHOL, V87, P81, DOI 10.1111/j.0959-9673.2006.00474.x; Morcuende JA, 2003, SPINE, V28, P2025, DOI 10.1097/01.BRS.0000083235.74593.49; Nakamura E, 2008, CANCER SCI, V99, P1390, DOI 10.1111/j.1349-7006.2008.00838.x; PANG CS, 1992, J PINEAL RES, V12, P167, DOI 10.1111/j.1600-079X.1992.tb00044.x; PIOLI C, 1993, INT J IMMUNOPHARMACO, V15, P463, DOI 10.1016/0192-0561(93)90060-C; Pozo D, 1997, FASEB J, V11, P466, DOI 10.1096/fasebj.11.6.9194527; RAFIIELIDRISSI M, 1995, J NEUROIMMUNOL, V57, P171, DOI 10.1016/0165-5728(94)00182-N; Raghavendra V, 2001, CLIN EXP IMMUNOL, V124, P414, DOI 10.1046/j.1365-2249.2001.01519.x; Reiter RJ, 2004, J PINEAL RES, V37, P213, DOI 10.1111/j.1600-079X.2004.00165.x; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; Reppert SM, 1997, J BIOL RHYTHM, V12, P528, DOI 10.1177/074873049701200606; RODRIGUEZ IR, 1994, J BIOL CHEM, V269, P31969; Samimi-Fard S, 2011, J PINEAL RES, V51, P400, DOI 10.1111/j.1600-079X.2011.00903.x; Slominski RM, 2012, MOL CELL ENDOCRINOL, V351, P152, DOI 10.1016/j.mce.2012.01.004; Srinivasan V, 2008, NEUROIMMUNOMODULAT, V15, P93, DOI 10.1159/000148191; Tanev D, 2016, ACTA REUMATOL PORT, V41, P62; Tang XL, 2005, PHARMAZIE, V60, P696; Tomer Y, 2003, ENDOCR REV, V24, P694, DOI 10.1210/er.2002-0030; WEETMAN AP, 1982, CLIN EXP IMMUNOL, V48, P196; WEETMAN AP, 1986, IMMUNOL LETT, V13, P335, DOI 10.1016/0165-2478(86)90068-4; Wright ML, 1997, GEN COMP ENDOCR, V108, P298, DOI 10.1006/gcen.1997.6979; Wright ML, 2000, J EXP ZOOL, V286, P625, DOI 10.1002/(SICI)1097-010X(20000501)286:6<625::AID-JEZ9>3.0.CO;2-Q	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185529	10.1371/journal.pone.0185529	http://dx.doi.org/10.1371/journal.pone.0185529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961261	Green Published, gold, Green Submitted			2022-12-27	WOS:000412027700023
J	Saeed, WK; Jun, DW; Jang, K; Chae, YJ; Lee, JS; Kang, HT				Saeed, Wager K.; Jun, Dae Won; Jang, Kiseok; Chae, Yeon Ji; Lee, Jai Sun; Kang, Hyeon Tae			Does necroptosis have a crucial role in hepatic ischemia-reperfusion injury?	PLOS ONE			English	Article							NECROTIC CELL-DEATH; ISCHEMIA/REPERFUSION INJURY; REACTIVE OXYGEN; CYCLOSPORINE-A; NECROSTATIN-1; NECROSIS; CONTRIBUTES; DAMAGE; MODEL	Background Previous studies have demonstrated protective effects of anti-receptor interacting protein kinase 1 (RIP1), a key necroptosis molecule. However, it is uncertain whether necroptosis has a crucial role in hepatic IR injury. Therefore, we evaluated the role of necroptosis in hepatic IR injury. Method The IR mice underwent 70% segmental IR injury induced by the clamping of the hepatic artery and portal vein for 1 hr followed by reperfusion for 4 hr. The key necroptosis molecules (RIP1, RIP3, and MLKL) and other key molecules of regulated necrosis (PGAM5 and caspase-1) were evaluated in the warm IR injury model. A RIP1 inhibitor (necrostain-1s) and/or an anti-mitochondrial permeability transition (MPT)-mediated necrosis mediator (cyclosporine A, CyA) were administered before clamping. Necrotic injury was quantified using Suzuki's scoring system. qRT-PCR and western blot were performed to evaluate RIP1, RIP3, MLKL and PGAM5 expressions. Results RIP1, RIP3, MLKL and PGAM5 expression did not change in the hepatic IR injury model. Moreover, Nec1s pretreatment did not improve histology or biochemical markers. The overall Suzuki score (cytoplasmic vacuolization, sinusoidal congestion and hepatocytes necrosis) was increased in the RIP3((-/-)) mice compared to the IR group (3.5 vs. 5, p = 0.026). CyA pretreatment and/or RIP3((-/-)) mice decreased Bax/Bcl2 expression; however, it did lead to an overall change in the levels of AST, ALT and LDH or necrotic injury. The Bax/Bcl2 ratio and the expression of caspase-1 and caspase-3 did not increase in our hepatic IR injury model. Conclusion Key necroptosis molecules did not increase in the necrosis-dominant hepatic IR injury model. Anti-necroptosis and/or cyclosporine-A treatment did not have an overall protective effect on necrosis-dominant hepatic IR injury.	[Saeed, Wager K.; Jun, Dae Won] Hanyang Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Jun, Dae Won; Chae, Yeon Ji; Lee, Jai Sun; Kang, Hyeon Tae] Hanyang Univ, Grad Sch Biomed Sci & Engn, Dept Translat Med, Seoul, South Korea; [Jang, Kiseok] Hanyang Univ, Sch Med, Dept Pathol, Seoul, South Korea	Hanyang University; Hanyang University; Hanyang University	Jun, DW (corresponding author), Hanyang Univ, Sch Med, Dept Internal Med, Seoul, South Korea.; Jun, DW (corresponding author), Hanyang Univ, Grad Sch Biomed Sci & Engn, Dept Translat Med, Seoul, South Korea.	noshin@hanyang.ac.kr	Jang, Kiseok/P-2048-2015; Jun, Dae Won/O-4529-2017	Jang, Kiseok/0000-0002-6585-3990; Jun, Dae Won/0000-0002-2875-6139; Kang, Hyeon Tae/0000-0002-4771-3388; saeed, waqar khalid/0000-0002-7888-9108	National Research Foundation of Korea [2011-0007127]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from National Research Foundation of Korea 2011-0007127.	Abe Y, 2009, FREE RADICAL BIO MED, V46, P1, DOI 10.1016/j.freeradbiomed.2008.09.029; Arshad MI, 2015, J MOL MED, V93, P867, DOI 10.1007/s00109-015-1270-6; Chavez-Valdez R, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/257563; Dara L, 2015, HEPATOLOGY, V62, P1847, DOI 10.1002/hep.27939; Degterev A, 2013, CELL DEATH DIFFER, V20, P366, DOI 10.1038/cdd.2012.133; Deutsch M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.126; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Galluzzi L, 2014, SEMIN CELL DEV BIOL, V35, P24, DOI 10.1016/j.semcdb.2014.02.006; Gunther C, 2016, J CLIN INVEST, V126, P4346, DOI 10.1172/JCI87545; Gujral JS, 2001, HEPATOLOGY, V33, P397, DOI 10.1053/jhep.2001.22002; Hong JM, 2016, TOXICOL APPL PHARM, V308, P1, DOI 10.1016/j.taap.2016.08.010; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Northington FJ, 2011, J CEREBR BLOOD F MET, V31, P178, DOI 10.1038/jcbfm.2010.72; Oerlemans MIFJ, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0270-8; Rosenbaum DM, 2010, J NEUROSCI RES, V88, P1569, DOI 10.1002/jnr.22314; Rosentreter D, 2015, SHOCK, V44, P72, DOI 10.1097/SHK.0000000000000371; Roychowdhury S, 2013, HEPATOLOGY, V57, P1773, DOI 10.1002/hep.26200; Saeed WK, 2014, WORLD J GASTROENTERO, V20, P12526, DOI 10.3748/wjg.v20.i35.12526; Saxton NE, 2002, J HEPATOL, V36, P241, DOI 10.1016/S0168-8278(01)00248-3; Takemoto K, 2014, FEBS OPEN BIO, V4, P777, DOI 10.1016/j.fob.2014.08.007; Tsoulfas G, 2012, J SURG RES, V176, pE1, DOI 10.1016/j.jss.2011.06.012; Vanden Berghe T, 2013, METHODS, V61, P117, DOI 10.1016/j.ymeth.2013.02.011; Yang M, 2014, LIVER TRANSPLANT, V20, P1372, DOI 10.1002/lt.23958	25	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184752	10.1371/journal.pone.0184752	http://dx.doi.org/10.1371/journal.pone.0184752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957350	Green Submitted, Green Published, gold			2022-12-27	WOS:000411985200018
J	Gonzalez-Moron, D; Vishnopolska, S; Consalvo, D; Medina, N; Marti, M; Cordoba, M; Vazquez-Dusefante, C; Claverie, S; Rodriguez-Quiroga, SA; Vega, P; Silva, W; Kochen, S; Kauffman, MA				Gonzalez-Moron, Dolores; Vishnopolska, Sebastian; Consalvo, Damian; Medina, Nancy; Marti, Marcelo; Cordoba, Marta; Vazquez-Dusefante, Cecilia; Claverie, Santiago; Alejandro Rodriguez-Quiroga, Sergio; Vega, Patricia; Silva, Walter; Kochen, Silvia; Andres Kauffman, Marcelo			Germline and somatic mutations in cortical malformations: Molecular defects in Argentinean patients with neuronal migration disorders	PLOS ONE			English	Article							PERIVENTRICULAR NODULAR HETEROTOPIA; VARIANTS; GENOME; GENE; DISCOVERY; FRAMEWORK; PHENOTYPE; FILAMIN	Neuronal migration disorders are a clinically and genetically heterogeneous group of malformations of cortical development, frequently responsible for severe disability. Despite the increasing knowledge of the molecular mechanisms underlying this group of diseases, their genetic diagnosis remains unattainable in a high proportion of cases. Here, we present the results of 38 patients with lissencephaly, periventricular heterotopia and subcortical band heterotopia from Argentina. We performed Sanger and Next Generation Sequencing (NGS) of DCX, FLNA and ARX and searched for copy number variations by MLPA in PAFAH1B1, DCX, POMT1, and POMGNT1. Additionally, somatic mosaicism at 5% or higher was investigated by means of targeted high coverage NGS of DCX, ARX, and PAFAH1B1. Our approach had a diagnostic yield of 36%. Pathogenic or likely pathogenic variants were identified in 14 patients, including 10 germline (five novel) and 4 somatic mutations in FLNA, DCX, ARX and PAFAH1B1 genes. This study represents the largest series of patients comprehensively characterized in our population. Our findings reinforce the importance of somatic mutations in the pathophysiology and diagnosis of neuronal migration disorders and contribute to expand their phenotype-genotype correlations.	[Gonzalez-Moron, Dolores; Medina, Nancy; Cordoba, Marta; Vazquez-Dusefante, Cecilia; Alejandro Rodriguez-Quiroga, Sergio; Vega, Patricia; Andres Kauffman, Marcelo] UBA, Hosp JM Ramos Mejia, Ctr Univ Neurol Jose Maria Ramos Mejia, Consultorio & Lab Neurogenet,Fac Med, Buenos Aires, DF, Argentina; [Gonzalez-Moron, Dolores; Medina, Nancy; Cordoba, Marta; Vazquez-Dusefante, Cecilia; Alejandro Rodriguez-Quiroga, Sergio; Vega, Patricia; Andres Kauffman, Marcelo] UBA, Hosp JM Ramos Mejia, Div Neurol, Fac Med, Buenos Aires, DF, Argentina; [Gonzalez-Moron, Dolores; Cordoba, Marta] UBA, CONICET, Fac Med, IBCN Eduardo de Robertis, Buenos Aires, DF, Argentina; [Vishnopolska, Sebastian; Marti, Marcelo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Vishnopolska, Sebastian; Marti, Marcelo] Univ Buenos Aires, CONICET, Inst Quim Biol, Fac Ciencias Exactas & Nat IQUIBICEN, Buenos Aires, DF, Argentina; [Consalvo, Damian; Claverie, Santiago] UBA, Hosp JM Ramos Mejia, Fac Med, Ctr Univ Neurol Jose Maria Ramos Mejia, Buenos Aires, DF, Argentina; [Consalvo, Damian; Claverie, Santiago] UBA, Hosp JM Ramos Mejia, Fac Med, Div Neurol, Buenos Aires, DF, Argentina; [Silva, Walter] Hosp Italiano Buenos Aires, Consultorio Epilepsias Refractarias, Secc Neurofisiol & Epilepsia, Serv Neurol Infantil, Buenos Aires, DF, Argentina; [Kochen, Silvia] UBA, Hosp JM Ramos Mejia, Fac Med, Ctr Epilepsia,Div Neurol, Buenos Aires, DF, Argentina; [Andres Kauffman, Marcelo] Univ Austral, CONICET, Programa Med Precis & Genom Clin, Fac Ciencias Biomed,Inst Invest Med Traslac, Derqui, Argentina	Hospital Ramos Mejia; University of Buenos Aires; Hospital Ramos Mejia; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Hospital Ramos Mejia; University of Buenos Aires; Hospital Ramos Mejia; University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires; Hospital Ramos Mejia; University of Buenos Aires; Austral University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Gonzalez-Moron, D (corresponding author), UBA, Hosp JM Ramos Mejia, Ctr Univ Neurol Jose Maria Ramos Mejia, Consultorio & Lab Neurogenet,Fac Med, Buenos Aires, DF, Argentina.; Gonzalez-Moron, D (corresponding author), UBA, Hosp JM Ramos Mejia, Div Neurol, Fac Med, Buenos Aires, DF, Argentina.; Gonzalez-Moron, D (corresponding author), UBA, CONICET, Fac Med, IBCN Eduardo de Robertis, Buenos Aires, DF, Argentina.	doloresgm@gmail.com	Vishnopolska, Sebastian/HDM-8462-2022	Vishnopolska, Sebastian/0000-0002-1729-9948; Cordoba, Marta/0000-0002-2814-1636; Kauffman, Marcelo/0000-0003-1680-5092	Agencia nacional de promocion cientifica y tecnologica (PICT-Probitec with Leloir Institute); Fiorini Foundation; CONICET, Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP)	Agencia nacional de promocion cientifica y tecnologica (PICT-Probitec with Leloir Institute); Fiorini Foundation; CONICET, Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 2012-2014), the Agencia nacional de promocion cientifica y tecnologica (PICT-Probitec with Leloir Institute) and the Fiorini Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for financial support from the CONICET, Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 2012-2014) as well as from the Agencia nacional de promocion cientifica y tecnologica (PICT-Probitec with Leloir Institute) and the Fiorini Foundation.	Kauffman MA, 2012, MOL BIOL REP, V39, P6655, DOI 10.1007/s11033-012-1471-9; Bahi-Buisson N, 2013, BRAIN, V136, P223, DOI 10.1093/brain/aws323; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; D'Agostino MD, 2002, BRAIN, V125, P2507, DOI 10.1093/brain/awf248; de Wit MCY, 2011, CLIN RES CARDIOL, V100, P45, DOI 10.1007/s00392-010-0206-y; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gonzalez G, 2013, AM J NEURORADIOL, V34, P877, DOI 10.3174/ajnr.A3312; Guerrini R, 2010, NEUROBIOL DIS, V38, P154, DOI 10.1016/j.nbd.2009.02.008; Hertecant J, 2016, META GENE, V9, P124, DOI 10.1016/j.mgene.2016.05.004; Jamuar SS, 2015, PEDIATR CLIN N AM, V62, P571, DOI 10.1016/j.pcl.2015.03.002; Jamuar SS, 2014, NEW ENGL J MED, V371, P733, DOI 10.1056/NEJMoa1314432; Ju YS, 2017, NATURE, V543, P714, DOI 10.1038/nature21703; Mandelstam SA, 2013, AM J NEURORADIOL, V34, P432, DOI 10.3174/ajnr.A3427; Matsumoto N, 2001, EUR J HUM GENET, V9, P5, DOI 10.1038/sj.ejhg.5200548; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Parrini E, 2006, BRAIN, V129, P1892, DOI 10.1093/brain/awl125; Parrini E, 2016, MOL SYNDROMOL, V7, P220, DOI 10.1159/000448639; Qin L, 2016, J MOL DIAGN, V18, P446, DOI 10.1016/j.jmoldx.2016.01.002; Quelin C, 2012, NEUROGENETICS, V13, P367, DOI 10.1007/s10048-012-0339-4; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; van Ninnwegen KJM, 2016, CLIN CHEM, V62, P1458, DOI 10.1373/clinchem.2016.258632; Zillhardt JL, 2016, EUR J HUM GENET, V24, P611, DOI 10.1038/ejhg.2015.192	25	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185103	10.1371/journal.pone.0185103	http://dx.doi.org/10.1371/journal.pone.0185103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953922	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300034
J	Nuzhat, S; Ahmed, T; Kawser, CA; Khan, AI; Islam, SMR; Shahrin, L; Shahunja, KM; Shahid, AMSB; Al Imran, A; Chisti, MJ				Nuzhat, Sharika; Ahmed, Tahmeed; Kawser, Chowdhury Ali; Khan, Azharul Islam; Islam, S. M. Rafiqul; Shahrin, Lubaba; Shahunja, K. M.; Shahid, Abu S. M. S. B.; Al Imran, Abdullah; Chisti, Mohammod Jobayer			Age specific fast breathing in under-five diarrheal children in an urban hospital: Acidosis or pneumonia?	PLOS ONE			English	Article							SEVERELY MALNOURISHED CHILDREN; DEVELOPING-COUNTRIES; CLINICAL-FEATURES; BANGLADESH; MANAGEMENT; DIAGNOSIS; MORTALITY; DEHYDRATION; HYPOXEMIA; INFANTS	Background Children with diarrhea often present with fast breathing due to metabolic acidosis from dehydration. On the other hand, age specific fast breathing is the cornerstone for the diagnosis of pneumonia following classification of pneumonia recommended by the World Health Organization (WHO). Correction of metabolic acidosis by rehydrating the diarrheal children requires time, which delays early initiation of appropriate antimicrobials for pneumonia and thereby increases the risk of deaths. We need to further investigate the simple clinical features other than fast breathing which might help us in earliest diagnosis of pneumonia in children with diarrhea Thus, the objective of our study was to identify other contributing clinical features that may independently help for early diagnosis of pneumonia in diarrheal children who present with age specific fast breathing. Methods This was an unmatched case-control study. Diarrheal children aged 0-59 months, admitted to Dhaka Hospital of the International Centre for Diarrheal Disease Research, Bangladesh (icddr, b) during January 2014 to December 2014 having age specific fast breathing (<2 month >= 60 breath/min, 2-11 months >= 50 breaths/min, >11-59 months >= 40 breaths/min) were studied. The study children with clinical and radiological pneumonia constituted the cases (n = 276) and those without pneumonia constituted the controls (n = 446). Comparison of clinical features and outcomes between the cases and the controls was made. Results The distribution of acidosis among the cases and the controls was comparable (35% vs. 41%, p = 0.12). The cases had proportionately higher deaths compared to the controls, however, the difference was not statistically significant (3% vs. 1%; p = 0.23). In logistic regression analysis after adjusting for potential confounders, the cases were independently associated with cough (OR = 62.19, 95% CI = 27.79-139.19; p<0.01) and chest wall indrawing (OR = 31.05, 95% CI = 13.43-71.82; p<0.01) and less often had severe acute malnutrition (OR = 0.33, 95% CI = 0.13-0.79; p<0.01). The sensitivity and specificity of cough were 83% (78-87%) and 93% (91-96%). The sensitivity and specificity for lower chest wall indrawing were 65% (59-71%) and 95% (93-97%). However, the sensitivity and specificity of cough and lower chest wall indrawing combined were 94% (89-97%) and 99% (97 - 100%). Conclusion and significance Thus, diarrheal children having fast breathing who present with cough and/or lower chest wall indrawing, irrespective of presence or absence of metabolic acidosis, are more likely to have radiological pneumonia. The results underscore the importance of early identification of these simple clinical features that may help to minimize potential delay due to rehydration in initiating prompt treatment of pneumonia in order to reduce fatal consequences in such children.	[Nuzhat, Sharika; Ahmed, Tahmeed; Khan, Azharul Islam; Islam, S. M. Rafiqul; Shahrin, Lubaba; Shahunja, K. M.; Shahid, Abu S. M. S. B.; Al Imran, Abdullah; Chisti, Mohammod Jobayer] Icddr B, NCSD, Dhaka, Bangladesh; [Kawser, Chowdhury Ali] BSMMU, Dept Pediat, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Bangabandhu Sheikh Mujib Medical University (BSMMU)	Chisti, MJ (corresponding author), Icddr B, NCSD, Dhaka, Bangladesh.	chisti@icddrb.org	Shahunja, K M/AAR-6229-2020; Chisti, Mohammod J/A-7216-2018; Shahrin, Lubaba/AAF-1019-2020	Shahunja, K M/0000-0002-9345-206X; Shahrin, Lubaba/0000-0002-5676-3280; Chisti, Mohammod/0000-0001-9958-3071	International Centre for Diarrhoeal Disease Research, Bangladesh [Gr-00233]	International Centre for Diarrhoeal Disease Research, Bangladesh	This research study was funded by the International Centre for Diarrhoeal Disease Research, Bangladesh (icddreb; grant no Gr-00233) and its donors, which provide unrestricted support to icddreb for its operations and research. Current donors providing support include: Government of the Peoples Republic of Bangladesh; the Department of Foreign Affairs, Trade and Development (DFATD), Canada; Swedish International Development Cooperation Agency (Sida) and the Department for International Development (UK Aid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SM, 1986, SCAND J INFECT DIS, V18, P65, DOI 10.3109/00365548609032308; Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Alam Nure H, 2003, Paediatr Drugs, V5, P151, DOI 10.2165/00128072-200305030-00002; Bhutta ZA, 2013, PEDIATRICS, V131, P634, DOI 10.1542/peds.2012-3737; Blot SI, 2007, CRIT CARE MED, V35, P2509, DOI 10.1097/01.CCM.0000287587.43801.9C; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Cherian T, 1997, PEDIATR INFECT DIS J, V16, P490, DOI 10.1097/00006454-199705000-00007; Chisti MJ, 2010, ANN TROP PAEDIATR, V30, P311, DOI 10.1179/146532810X12858955921230; Chisti MJ, 2015, LANCET, V386, P1057, DOI 10.1016/S0140-6736(15)60249-5; Chisti MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039164; Chisti MJ, 2012, TROP MED INT HEALTH, V17, P106, DOI 10.1111/j.1365-3156.2011.02890.x; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P174, DOI 10.1097/INF.0b013e3181b9a4d5; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Organization WH, 2013, POCK BOOK HOSP CAR C; Pio A, 2003, B WORLD HEALTH ORGAN, V81, P298; Rambaud-Althaus C, 2015, LANCET INFECT DIS, V15, P439, DOI 10.1016/S1473-3099(15)70017-4; RICHARDS L, 1993, PEDIATR INFECT DIS J, V12, P5, DOI 10.1097/00006454-199301000-00003; Saha D, 2014, J HEALTH POPUL NUTR, V32, P14; UNICEF, 2022, DEM WSPOLCZ DZIETN; WANG F, 1986, NEW ENGL J MED, V315, P1591, DOI 10.1056/NEJM198612183152506; World Health Organization, 2013, POCK BOOK HOSP CAR C	21	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185414	10.1371/journal.pone.0185414	http://dx.doi.org/10.1371/journal.pone.0185414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953928	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300064
J	Gofama, MM; Verma, H; Abdullahi, H; Molodecky, NA; Craig, KT; Urua, UA; Garba, MA; Alhaji, MA; Weldon, WC; Oberste, MS; Braka, F; Muhammad, AJG; Sutter, RW				Gofama, Mustapha Modu; Verma, Harish; Abdullahi, Hamisu; Molodecky, Natalie A.; Craig, Kehinde T.; Urua, Utibe-Abasi; Garba, Mohammed Ashir; Alhaji, Mohammed Arab; Weldon, William C.; Oberste, M. Steven; Braka, Fiona; Muhammad, Ado J. G.; Sutter, Roland W.			Survey of poliovirus antibodies in Borno and Yobe States, North-Eastern Nigeria	PLOS ONE			English	Article							VACCINE; SEROPREVALENCE; TRANSMISSION; INTERRUPTION; CHILDREN; INDIA; KANO	Background Nigeria remains one of only three polio-endemic countries in the world. In 2016, after an absence of 2 years, wild poliovirus serotype 1 was again detected in North-Eastern Nigeria. To better guide programmatic action, we assessed the immunity status of infants and children in Borno and Yobe states, and evaluated the impact of recently introduced inactivated poliovirus vaccine (IPV) on antibody seroprevalence. Methods and findings We conducted a facility-based study of seroprevalence to poliovirus serotypes 1, 2 and 3 among health-seeking patients in two sites each of Borno and Yobe States. Enrolment was conducted amongst children 6-9 and 36-47 months of age attending the paediatrics outpatient department of the selected hospitals in the two states between 11 January and 5 February 2016. Detailed demographic and immunization history of the child was taken and an assessment of the child's health and nutritional state was conducted via physical examination. Blood was collected to test for levels of neutralizing antibody titres against the three poliovirus serotypes. The seroprevalence in the two age groups, potential determinants of seropositivity and the impact of one dose of IPV on humoral immunity were assessed. A total of 583 subjects were enrolled and provided sufficient quantities of serum for testing. Among 6-9-month-old infants, the seroprevalence was 81% (74-87%), 86% (79-91%), and 72% (65-79%) in Borno State, and 75% (67-81%), 74% (66-81%) and 69% (61-76%) in Yobe States, for serotypes-1, 2 and 3, respectively. Among children aged 36-47 months, the seroprevalence was > 90% in both states for all three serotypes, with the exception of type 3 seroprevalence in Borno [ 87% (80-91%)]. Median reciprocal anti-polio neutralizing antibody titers were consistently > 900 for serotypes 1 and 2 across age groups and states; with lower estimates for serotype 3, particularly in Borno. IPV received in routine immunization was found to be a significant determinant of seropositivity and anti-polio neutralizing antibodies among 6-9-month-old infants for serotypes 1 and 3, but demonstrated a nonsignificant positive association for serotype 2. Children receiving IPV through SIAs demonstrated significantly higher anti-polio neutralizing antibodies for serotypes 1 and 3. Conclusions The seroprevalence to poliovirus remains suboptimal in both Borno and Yobe States in Nigeria. The low seroprevalence facilitated the continued transmission of both wild serotype 1 and serotype 2 circulating vaccine-derived poliovirus detected in Borno State in 2016. Further efforts are necessary to improve the immunity status of these populations to ensure sufficient population immunity to interrupt transmission.	[Gofama, Mustapha Modu; Garba, Mohammed Ashir; Alhaji, Mohammed Arab] Univ Maiduguri, Teaching Hosp, Maiduguri, Nigeria; [Verma, Harish; Molodecky, Natalie A.; Sutter, Roland W.] WHO, Geneva, Switzerland; [Abdullahi, Hamisu; Craig, Kehinde T.; Braka, Fiona] WHO, Abuja, Nigeria; [Urua, Utibe-Abasi; Muhammad, Ado J. G.] Natl Primary Hlth Care Dev Agcy, Abuja, Nigeria; [Weldon, William C.; Oberste, M. Steven] Ctr Dis Control & Prevent, Atlanta, GA USA	World Health Organization; World Health Organization; Centers for Disease Control & Prevention - USA	Molodecky, NA (corresponding author), WHO, Geneva, Switzerland.	n.molodecky@imperial.ac.uk		Mustapha, Modu Gofama/0000-0001-8510-0905	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Ahmad M, 2016, INDIA SEROPREVALE S1, V53; El-Sayed N, 2007, VACCINE, V25, P5062, DOI 10.1016/j.vaccine.2007.04.022; Estivariz CF, 2012, LANCET INFECT DIS, V12, P128, DOI 10.1016/S1473-3099(11)70190-6; Etsano A, 2016, MMWR-MORBID MORTAL W, V65, P770, DOI 10.15585/mmwr.mm6530a4; Giwa FJ, 2012, VACCINE, V30, P6759, DOI 10.1016/j.vaccine.2012.09.023; GPEI, 2017, WILD POL; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Iliyasu Z, 2016, VACCINE, V34, P5125, DOI 10.1016/j.vaccine.2016.08.058; Iliyasu Z, 2014, VACCINE, V32, P1414, DOI 10.1016/j.vaccine.2013.08.060; Mangal TD, 2014, LANCET GLOB HEALTH, V2, pE90, DOI 10.1016/S2214-109X(13)70168-2; Nemat A, 2015, PAK J MED SCI, V31, P403, DOI 10.12669/pjms.312.5366; Parker EPK, 2014, J INFECT DIS, V210, P853, DOI 10.1093/infdis/jiu182; R Core Team, 2013, R LANG ENV STAT COMP; Roberts L, 2017, SCIENCE, V356, P18, DOI 10.1126/science.356.6333.18; Sutter RW, 2010, LANCET, V376; US Census Bureau, 2014, CENS SURV PROC SYSGT; Weldon WC, 2016, METHODS MOL BIOL, V1387, P145, DOI 10.1007/978-1-4939-3292-4_8; World Health Organization, 1991, REP WHO INF CONS POL; World Health Organization, 2016, WHO CHILD GROWTH STA	19	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185284	10.1371/journal.pone.0185284	http://dx.doi.org/10.1371/journal.pone.0185284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949979	Green Submitted, Green Published, gold			2022-12-27	WOS:000411671000033
J	Wagner, AL; Boulton, ML; Gillespie, BW; Zhang, Y; Ding, YX; Carlson, BF; Luo, XY; Montgomery, JP; Wang, XX				Wagner, Abram L.; Boulton, Matthew L.; Gillespie, Brenda W.; Zhang, Ying; Ding, Yaxing; Carlson, Bradley F.; Luo, Xiaoyan; Montgomery, JoLynn P.; Wang, Xiexiu			Risk factors for measles among adults in Tianjin, China: Who should be controls in a case-control study?	PLOS ONE			English	Article							POPULATION; PROGRESS	Background Control groups in previous case-control studies of vaccine-preventable diseases have included people immune to disease. This study examines risk factors for measles acquisition among adults 20 to 49 years of age in Tianjin, China, and compares findings using measles IgG antibody-negative controls to all controls, both IgG-negative and IgGpositive. Methods Measles cases were sampled from a disease registry, and controls were enrolled from community registries in Tianjin, China, 2011 - 2015. Through a best subsets selection procedure, we compared which variables were selected at different model sizes when using IgG-negative controls or all controls. We entered risk factors for measles in two separate logistic regression models: one with measles IgG-negative controls and the other with all controls. Results The study included 384 measles cases and 1,596 community controls (194 IgG-negative). Visiting a hospital was an important risk factor. For specialty hospitals, the odds ratio (OR) was 4.53 (95% confidence interval (CI): 1.28, 16.03) using IgG-negative controls, and OR = 5.27 (95% CI: 2.73, 10.18) using all controls. Variables, such as age or length of time in Tianjin, were differentially selected depending on the control group. Individuals living in Tianjin <= 3 years had 2.87 (95% CI: 1.46, 5.66) times greater odds of measles case status compared to all controls, but this relationship was not apparent for IgG-negative controls. Conclusions We recommend that case-control studies examining risk factors for infectious diseases, particularly in the context of transmission dynamics, consider antibody-negative controls as the gold standard.	[Wagner, Abram L.; Boulton, Matthew L.; Carlson, Bradley F.; Montgomery, JoLynn P.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Boulton, Matthew L.] Univ Michigan, Med Sch, Dept Internal Med, Ann Arbor, MI 48109 USA; [Gillespie, Brenda W.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Zhang, Ying; Ding, Yaxing; Luo, Xiaoyan; Wang, Xiexiu] Tianjin Ctr Dis Control & Prevent, Inst Human Communicable Dis Control & Prevent, Tianjin, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Tianjin Center for Disease Control & Prevention	Wagner, AL (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	awag@umich.edu	Wagner, Abram/X-6379-2019	Wagner, Abram/0000-0003-4691-7802; Boulton, Matthew/0000-0002-0565-9010; Carlson, Bradley/0000-0002-9616-5613	National Institutes of Health, National Institute for Allergy and Infectious Diseases [U01-AI-088671]	National Institutes of Health, National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded by the National Institutes of Health, National Institute for Allergy and Infectious Diseases [U01-AI-088671]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulton ML, 2016, VACCINE, V34, P3037, DOI 10.1016/j.vaccine.2016.04.094; Chen JunLei, 2013, Chinese Preventive Medicine, V14, P509; Chen WanGeng, 2011, Occupation and Health, V27, P312; Downes F, 1992, 92 GEN M AM SOC MICR; FURNIVAL GM, 1974, TECHNOMETRICS, V16, P499, DOI 10.2307/1267601; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; House T, 2009, EPIDEMIOL INFECT, V137, P654, DOI 10.1017/S0950268808001416; Liang Z, 2014, POPUL DEV REV, V40, P695, DOI 10.1111/j.1728-4457.2014.00007.x; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ma C, 2014, B WORLD HEALTH ORGAN, V92, P340, DOI 10.2471/BLT.13.130195; Rothman K. J., 2008, MODERN EPIDEMIOLOGY, P116; Standardization Administration of the Peoples Republic of China, 1995, DIAGN CRIT PRINC MAN; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Wang LX, 2003, J INFECT DIS, V187, pS252, DOI 10.1086/368045; Wang ZL, 2009, J TELEMED TELECARE, V15, P23, DOI 10.1258/jtt.2008.080508; Wang ZhongZhan, 2015, Chinese Preventive Medicine, V16, P438; WHO, 2016, MEASL FACT SHEET; Xiong C, 2006, CHINESE J VACCINES I, V10, P350; Zhang DL, 2015, VACCINE, V33, P4100, DOI 10.1016/j.vaccine.2015.06.066; Zhao Y, 2013, CHINESE GEOGR SCI, V23, P492, DOI 10.1007/s11769-013-0616-7; Zheng JS, 2010, VACCINE, V28, pA84, DOI 10.1016/j.vaccine.2010.02.039; ZHU X, 2008, CHIN J VACC IMMUN, V14, P398	22	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185465	10.1371/journal.pone.0185465	http://dx.doi.org/10.1371/journal.pone.0185465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950011	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000054
J	Yan, Y; Williams, SB; Murdock, LL; Baributsa, D				Yan, Yan; Williams, Scott B.; Murdock, Larry L.; Baributsa, Dieudonne			Hermetic storage of wheat and maize flour protects against red flour beetle (Tribolium castaneum Herbst)	PLOS ONE			English	Article							PHOSPHINE RESISTANCE; STORED-PRODUCT; GRAIN	Hermetic storage is used to protect grain against insect pests, but its utility is not limited to whole grains. We evaluated hermetically-sealed, polyethylene terephthalate (PET) bottles for preserving wheat and maize flour against red flour beetle (RFB, Tribolium castaneum, Herbst) population growth. Flours infested with RFB and kept in sealed PET bottles experienced much less weight loss over a three-month storage period than infested flour kept in unsealed bottles. RFB populations in wheat flour kept in sealed bottles did not increase, while populations in unsealed bottles grew about 50-fold during the same three-month period. Flour in sealed bottles had lower levels of oxygen and moisture than flour stored in unsealed bottles. Similar trends were observed for oxygen and moisture levels in maize flour held in hermetically sealed bottles. Hermetically-sealed bottles were effective in preventing RFB population growth and preserving maize and wheat flour. Farmers, consumers and food processors can safely store grain flour in hermetic sealed containers.	[Yan, Yan] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Williams, Scott B.] Spensa Technol Inc, W Lafayette, IN USA; [Murdock, Larry L.; Baributsa, Dieudonne] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA	Vanderbilt University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Baributsa, D (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	dbaribut@purdue.edu		Baributsa, Dieudonne/0000-0003-4170-8948; Yan, Yan/0000-0002-4994-2651	PICS3 Project - by Bill and Melinda Gates Foundation to Purdue University) [43010000 8000061439]	PICS3 Project - by Bill and Melinda Gates Foundation to Purdue University)	This study was supported by funds from the PICS3 Project (Grant number 43010000 8000061439- by Bill and Melinda Gates Foundation to Purdue University). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleki A, 2011, EGYPT J BIOL PEST CO, V21, P159; Arbogast Richard T., 1991, FDA Technical Bulletin, V4, P131; BAILEY S. W., 1965, Journal of Stored Products Research, V1, P25, DOI 10.1016/0022-474X(65)90005-6; Baloch Umar K., 1999, WHEAT POSTHARVEST OP; Banks H.J., 1990, FOOD PRESERVATION MO, P93; Baoua IB, 2012, J STORED PROD RES, V51, P81, DOI 10.1016/j.jspr.2012.07.003; Benhalima H, 2004, J STORED PROD RES, V40, P241, DOI 10.1016/S0022-474X(03)00012-2; Bosly HA, 2012, TOXICOL IND HEALTH, V30, P304; CENKOWSKI S, 2000, CANADIAN AGR ENG, V42, P1; Cheng WN, 2012, J INSECT PHYSIOL, V58, P792, DOI 10.1016/j.jinsphys.2012.02.005; Fardisi M, 2013, J STORED PROD RES, V52, P74, DOI 10.1016/j.jspr.2012.12.001; Fiedler JL, 2014, ANN NY ACAD SCI, V1312, P26, DOI 10.1111/nyas.12266; Fields PG, 2002, ANNU REV ENTOMOL, V47, P331, DOI 10.1146/annurev.ento.47.091201.145217; Flingelli G, 2012, P 9 INT C CONTR ATM; Hamed M, 1985, SARHAD J AGR; International A, APPR METH AN; Lessard F.F., 1990, FOOD PRESERVATION MO, P21; Murdock LL, 2014, J STORED PROD RES, V58, P1, DOI 10.1016/j.jspr.2014.04.007; Murdock LL, 2012, J STORED PROD RES, V49, P166, DOI 10.1016/j.jspr.2012.01.002; Navarro S., 2006, INSECT MANAGEMENT FO, P105, DOI [10.1016/B978-1-891127-46-5.50016-7, DOI 10.1016/B978-1-891127-46-5.50016-7]; Navarro S, 2012, CONTROLLED MODIFIED, P191; Navarro S, 2012, J PEST SCI, V85, P301, DOI 10.1007/s10340-012-0424-3; Pimentel MAG, 2009, J STORED PROD RES, V45, P71, DOI 10.1016/j.jspr.2008.09.001; Sanon A, 2011, J STORED PROD RES, V47, P210, DOI 10.1016/j.jspr.2011.02.003; Subramanyam B, 1999, PEST CONTROL, V67; UNEP, 2006, HDB MONTR PROT SUBST; UNEP, 2002, MONT PROT SUBST DEPL; Williams SB, 2017, J STORED PROD RES, V71, P125, DOI 10.1016/j.jspr.2016.12.008; World Bank, 2011, MISS FOOD CAS POSTH; Yakubu A., 2011, African Journal of Agricultural Research, V6, P3311; Zhang CL, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/918305	31	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185386	10.1371/journal.pone.0185386	http://dx.doi.org/10.1371/journal.pone.0185386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949983	gold, Green Submitted, Green Published			2022-12-27	WOS:000411671000045
J	Liao, HF; Pan, CH; Chou, PY; Chen, YF; Wu, TS; Sheu, MJ; Wo, CH				Liao, Hsien-Feng; Pan, Chun-Hsu; Chou, Pei-Yu; Chen, Yi-Fong; Wu, Tian-Shung; Sheu, Ming-Jyh; Wo, Chieh-Hsi			Toxicological effects of NCKU-21, a phenanthrene derivative, on cell growth and migration of A549 and CL1-5 human lung adenocarcinoma cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PI3K/AKT SIGNALING PATHWAY; MATRIX METALLOPROTEINASES; AKT OVEREXPRESSION; CANCER-CELLS; DENBINOBIN; INHIBITORS; INVASION; TUMOR; PROLIFERATION	Background Chemotherapy insensitivity continues to pose significant challenges for treating non-small cell lung cancer (NSCLC). The purposes of this study were to investigate whether 3,6-dimethoxy-1,4,5,8-phenanthrenetetraone (NCKU-21) has potential activity to induce effective toxicological effects in different ethnic NSCLC cell lines, A549 and CL1-5 cells, and to examine its anticancer mechanisms. Methods Mitochondrial metabolic activity and the cell-cycle distribution were analyzed using an MTT assay and flow cytometry in NCKU-21-treated cells. NCKU-21-induced cell apoptosis was verified by Annexin V-FITC/propidium iodide (PI) double-staining and measurement of caspase-3 activity. Western blotting and wound-healing assays were applied to respectively evaluate regulation of signaling pathways and cell migration by NCKU-21. Molecular interactions between target proteins and NCKU-21 were predicted and performed by molecular docking. A colorimetric screening assay kit was used to evaluate potential regulation of matrix metalloproteinase-9 (MMP-9) activity by NCKU-21. Results Results indicated that NCKU-21 markedly induced cytotoxic effects that reduced cell viability via cell apoptosis in tested NSCLC cells. Activation of AMP-activated protein kinase (AMPK) and p53 protein expression also increased in both NSCLC cell lines stimulated with NCKU-21. However, repression of PI3K-AKT activation by NCKU-21 was found in CL1-5 cells but not in A549 cells. In addition, increases in phosphatidylserine externalization and caspase-3 activity also confirmed the apoptotic effect of NCKU-21 in both NSCLC cell lines. Moreover, cell migration and translational levels of the gelatinases, MMP-2 and MMP-9, were obviously reduced in both NSCLC cell lines after incubation with NCKU-21. Experimental data obtained from molecular docking suggested that NCKU-21 can bind to the catalytic pocket of MMP-9. However, the in vitro enzyme activity assay indicated that NCKU-21 has the potential to increase MMP-9 activity. Conclusions Our results suggest that NCKU-21 can effectively reduce cell migration and induce apoptosis in A549 and CL1-5 cells, the toxicological effects of which may be partly modulated through PI3K-AKT inhibition, AMPK activation, an increase in the p53 protein, and gelatinase inhibition.	[Liao, Hsien-Feng; Chen, Yi-Fong] China Med Univ, Canc Biol & Drug Discovery, Taichung, Taiwan; [Liao, Hsien-Feng; Chen, Yi-Fong] Acad Sinica, Taichung, Taiwan; [Liao, Hsien-Feng] Lees Med Corp, Yuanli Lees Gen Hosp, Dept Pharm, Miaoli, Taiwan; [Pan, Chun-Hsu; Wo, Chieh-Hsi] Taipei Med Univ, Sch Pharm, Taipei, Taiwan; [Chou, Pei-Yu] Hung Kuang Univ, Dept Nursing, Taichung, Taiwan; [Chou, Pei-Yu] Tunghai Univ, Sports Recreat & Hlth Management Continuing Studi, Bachelors Degree Complet Program, Taichung, Taiwan; [Wu, Tian-Shung] Natl Cheng Kung Univ, Dept Chem, Tainan, Taiwan; [Wu, Tian-Shung] Natl Cheng Kung Univ, Dept Pharm, Tainan, Taiwan; [Sheu, Ming-Jyh] China Med Univ, Sch Pharm, Taichung, Taiwan	China Medical University Taiwan; Academia Sinica - Taiwan; Taipei Medical University; Hungkuang University; Tunghai University; National Cheng Kung University; National Cheng Kung University; China Medical University Taiwan	Wo, CH (corresponding author), Taipei Med Univ, Sch Pharm, Taipei, Taiwan.; Wu, TS (corresponding author), Natl Cheng Kung Univ, Dept Chem, Tainan, Taiwan.; Wu, TS (corresponding author), Natl Cheng Kung Univ, Dept Pharm, Tainan, Taiwan.; Sheu, MJ (corresponding author), China Med Univ, Sch Pharm, Taichung, Taiwan.	tswu@mail.ncku.edu.tw; hsumj@mail.cmu.edu.tw; chhswu@tmu.edu.tw	Pan, Chun-Hsu/H-4358-2019	Pan, Chun-Hsu/0000-0001-8700-583X; Chen, Yi-Fong/0000-0002-9545-1191; Liao, Hsien-Feng/0000-0002-8747-5097	National Science Council, Taiwan [NSC 101-2320-B-039-023, NSC102-2113-M006-001]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the grants (NSC 101-2320-B-039-023 and NSC102-2113-M006-001) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; Bae IH, 2009, CANCER LETT, V277, P22, DOI 10.1016/j.canlet.2008.11.022; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Cerezo M, 2013, MOL CANCER THER, V12, P1605, DOI 10.1158/1535-7163.MCT-12-1226-T; Chen JS, 2009, HEPATOL RES, V39, P177, DOI 10.1111/j.1872-034X.2008.00449.x; Chou PY, 2011, AM J CHINESE MED, V39, P803, DOI 10.1142/S0192415X11009214; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Dan S, 2010, CANCER RES, V70, P4982, DOI 10.1158/0008-5472.CAN-09-4172; David O, 2004, CLIN CANCER RES, V10, P6865, DOI 10.1158/1078-0432.CCR-04-0174; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Ebos JML, 2009, CLIN CANCER RES, V15, P5020, DOI 10.1158/1078-0432.CCR-09-0095; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Falasca M, 2010, CURR PHARM DESIGN, V16, P1410, DOI 10.2174/138161210791033950; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Huang CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025928; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kuo CT, 2008, TOXICOL LETT, V177, P48, DOI 10.1016/j.toxlet.2007.12.009; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Liu HE, 2011, SHOCK, V35, P191, DOI 10.1097/SHK.0b013e3181f0e9a8; Lu TL, 2014, AM J CHINESE MED, V42, P1539, DOI 10.1142/S0192415X14500967; Meuillet EJ, 2010, MOL CANCER THER, V9, P706, DOI 10.1158/1535-7163.MCT-09-0985; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Nuti E, 2015, J MED CHEM, V58, P7224, DOI 10.1021/acs.jmedchem.5b00367; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Papazafiropoulou A, 2009, HIPPOKRATIA, V13, P76; Pfannschmidt J, 2007, LUNG CANCER, V55, P371, DOI 10.1016/j.lungcan.2006.10.017; Rahman R, 2010, J ONCOL, V2010, DOI 10.1155/2010/251231; Rehman G, 2014, ARCH PHARM, V347, P457, DOI 10.1002/ardp.201300402; Sanchez-Duffhues G, 2008, BIOCHEM PHARMACOL, V76, P1240, DOI 10.1016/j.bcp.2008.09.006; Sanchez-Duffhues G, 2009, BIOCHEM PHARMACOL, V77, P1401, DOI 10.1016/j.bcp.2009.01.004; Sher T, 2008, MAYO CLIN PROC, V83, P355, DOI 10.4065/83.3.355; Tang JM, 2006, LUNG CANCER, V51, P181, DOI 10.1016/j.lungcan.2005.10.003; Thangaraj S, 2011, TETRAHEDRON, V67, P6166, DOI 10.1016/j.tet.2011.06.054; Tokino T, 2000, CRIT REV ONCOL HEMAT, V33, P1, DOI 10.1016/S1040-8428(99)00051-7; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsai AC, 2011, J NUTR BIOCHEM, V22, P625, DOI 10.1016/j.jnutbio.2010.04.014; Vakana E, 2012, J CELL BIOCHEM, V113, P404, DOI 10.1002/jcb.23369; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang XX, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/908636; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Yang N, 2014, ONCOL REP, V31, P2651, DOI 10.3892/or.2014.3120	45	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185021	10.1371/journal.pone.0185021	http://dx.doi.org/10.1371/journal.pone.0185021			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945763	Green Published, Green Submitted, gold			2022-12-27	WOS:000411645100017
J	Piscitelli, A; Tarallo, V; Guarino, L; Sannia, G; Birolo, L; Pezzella, C				Piscitelli, Alessandra; Tarallo, Vincenzo; Guarino, Lucia; Sannia, Giovanni; Birolo, Leyla; Pezzella, Cinzia			New lipases by mining of Pleurotus ostreatus genome	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; HETEROLOGOUS EXPRESSION; PURIFICATION; ENZYMOLOGY; ELEMENT; CLONING; MOTIF	The analysis of Pleurotus ostreatus genome reveals the presence of automatically annotated 53 lipase and 34 carboxylesterase putative coding-genes. Since no biochemical or physiological data are available so far, a functional approach was applied to identify lipases from P. ostreatus. In the tested growth conditions, four lipases were found expressed, with different patterns depending on the used C source. Two of the four identified proteins (PleoLip241 and PleoLip369), expressed in both analysed conditions, were chosen for further studies, such as an in silico analysis and their molecular characterization. To overcome limits linked to native production, a recombinant expression approach in the yeast Pichia pastoris was applied. Different expression levels were obtained: PleoLip241 reached a maximum activity of 4000 U/L, whereas PleoLip369 reached a maximum activity of 700 U/L. Despite their sequence similarity, these enzymes exhibited different substrate specificity and diverse stability at pH, temperature, and presence of metals, detergents and organic solvents. The obtained data allowed classifying PleoLip241 as belonging to the "true lipase" family. Indeed, by phylogenetic analysis the two proteins fall in different clusters. PleoLip241 was used to remove the hydrophobic layer from wool surface in order to improve its dyeability. The encouraging results obtained with lipase treated wool led to forecast PleoLip241 applicability in this field.	[Piscitelli, Alessandra; Tarallo, Vincenzo; Guarino, Lucia; Sannia, Giovanni; Birolo, Leyla; Pezzella, Cinzia] Univ Napoli Federico II, Dipartimento Sci Chim, Naples, Italy	University of Naples Federico II	Piscitelli, A (corresponding author), Univ Napoli Federico II, Dipartimento Sci Chim, Naples, Italy.	apiscite@unina.it	Pezzella, Cinzia/L-2753-2014; Piscitelli, Alessandra/J-8414-2013	Tarallo, Vincenzo/0000-0001-8158-1326; BIROLO, Leila/0000-0002-0915-7501; SANNIA, Giovanni/0000-0002-7986-6223; Piscitelli, Alessandra/0000-0002-3818-6539	Universita degli Studi di Napoli Federico II	Universita degli Studi di Napoli Federico II	V. T. and L. G. acknowledge Universita degli Studi di Napoli Federico II for doctoral fellowships.; V. T. and L. G. acknowledge University degli Studi di Napoli Federico II for doctoral fellowships. The authors thank Dr. Thierry Tron, Aix Marseille Universite, for hosting Dr. Tarallo in his laboratory. The authors also thank Dr. Frederic Carriere, CNRS, Aix-Marseille Universite, for the helpful discussions.	Abada Emad Abd El-Moniem, 2008, Pak J Biol Sci, V11, P1100, DOI 10.3923/pjbs.2008.1100.1106; Aloulou A, 2006, BBA-MOL CELL BIOL L, V1761, P995, DOI 10.1016/j.bbalip.2006.06.009; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Argenton F, 1996, EUR J BIOCHEM, V238, P591, DOI 10.1111/j.1432-1033.1996.0591w.x; Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; Borrelli GM, 2015, INT J MOL SCI, V16, P20774, DOI 10.3390/ijms160920774; Brabcova J, 2010, YEAST, V27, P1029, DOI 10.1002/yea.1812; Castanera R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006108; Feng J, 2011, MICROBIOL RES, V166, P618, DOI 10.1016/j.micres.2010.12.002; FINK JS, 1988, P NATL ACAD SCI USA, V85, P6662, DOI 10.1073/pnas.85.18.6662; Ghori MI, 2011, BRAZ J MICROBIOL, V42, P22, DOI 10.1590/S1517-83822011000100003; Glogauer A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-54; Griebeler N, 2011, FOOD BIOPROCESS TECH, V4, P578, DOI 10.1007/s11947-008-0176-5; Gurr SJ, 1987, GENE STRUCTURE EUKAR, P93; Kantouch A., 2005, J NAT FIBERS, V2, P35, DOI [10.1300/J395v02n02_03, DOI 10.1300/J395V02N02_03]; Karp SG, 2012, BIORESOURCE TECHNOL, V114, P735, DOI 10.1016/j.biortech.2012.03.058; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Krugener S, 2009, J MOL CATAL B-ENZYM, V57, P16, DOI 10.1016/j.molcatb.2008.06.014; Kumar S, 2005, PROTEIN EXPRES PURIF, V41, P38, DOI 10.1016/j.pep.2004.12.010; Lin ES, 2005, ENZYME MICROB TECH, V37, P261, DOI 10.1016/j.enzmictec.2005.03.012; Litvintseva AP, 2002, APPL ENVIRON MICROB, V68, P1305, DOI 10.1128/AEM.68.3.1305-1311.2002; MAGER WH, 1995, MICROBIOL REV, V59, P506, DOI 10.1128/MMBR.59.3.506-531.1995; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Murillo J, 2012, QUIM NOVA, V35, P1173; Nakagawa Y, 2001, J BACTERIOL, V183, P745, DOI 10.1128/JB.183.2.745-751.2001; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; PADGETT RA, 1984, SCIENCE, V225, P898, DOI 10.1126/science.6206566; Pezzella C, 2009, CURR GENET, V55, P45, DOI 10.1007/s00294-008-0221-y; Pezzella C, 2013, APPL MICROBIOL BIOT, V97, P705, DOI 10.1007/s00253-012-3980-9; Piscitelli A, 2017, BIOSENS BIOELECTRON, V87, P816, DOI 10.1016/j.bios.2016.09.052; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Sanchez-Carbente MDR, 2017, MICROBIOLOGYOPEN; Sanishvili R, 2003, J BIOL CHEM, V278, P26039, DOI 10.1074/jbc.M303867200; Shu CH, 2006, PROCESS BIOCHEM, V41, P734, DOI 10.1016/j.procbio.2005.09.007; Singh MK, 2014, J MOL CATAL B-ENZYM, V110, P92, DOI 10.1016/j.molcatb.2014.10.010; Singh R, 2006, APPL MICROBIOL BIOT, V70, P679, DOI 10.1007/s00253-005-0138-z; Soden DM, 2003, J APPL MICROBIOL, V95, P553, DOI 10.1046/j.1365-2672.2003.02012.x; Su HF, 2016, J MICROBIOL BIOTECHN, V26, P1067, DOI 10.4014/jmb.1511.11068; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Treger JM, 1998, BIOCHEM BIOPH RES CO, V243, P13, DOI 10.1006/bbrc.1997.8061; Verger R, 1997, TRENDS BIOTECHNOL, V15, P32, DOI 10.1016/S0167-7799(96)10064-0; Verma N., 2012, International Research Journal of Biological Sciences, V1, P88; Vici AC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01083; Wang Z.S., 1991, MUSHROOM SCI, V13, P3; Yan QJ, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0501-6; Zelena K, 2009, BIOTECHNOL LETT, V31, P395, DOI 10.1007/s10529-008-9870-7; Zhu J., 2000, FUJIAN J AGR SCI, V15, P46	47	11	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185377	10.1371/journal.pone.0185377	http://dx.doi.org/10.1371/journal.pone.0185377			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945798	Green Submitted, Green Published, gold			2022-12-27	WOS:000411645100055
J	Dockx, R; Peremans, K; Vlerick, L; Van Laeken, N; Saunders, JH; Polis, I; De Vosf, F; Baeken, C				Dockx, Robrecht; Peremans, Kathelijne; Vlerick, Lise; Van Laeken, Nick; Saunders, Jimmy H.; Polis, Ingeborgh; De Vosf, Filip; Baeken, Chris			Anaesthesia, not number of sessions, influences the magnitude and duration of an aHF-rTMS in dogs	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CEREBRAL-BLOOD-FLOW; CORTICAL EFFECTIVE CONNECTIVITY; ACCELERATED HF-RTMS; PREFRONTAL CORTEX; MAJOR DEPRESSION; DOPAMINE RELEASE; BINDING INDEX; BRAIN; IMPACT	Background Currently, the rat has been a useful animal model in brain stimulation research. Nevertheless, extrapolating results from rodent repetitive Transcranial Magnetic Stimulation (rTMS) research to humans contains several hurdles. This suggests the desperate need for a large animal model in translational rTMS research. The dog would be a valid choice, not only due to the fact that humans and dogs share a neurophysiological background, but a similar neuropathological background as well. Hypothesis In order to evaluate the feasibility of the canine rTMS animal model, this study aimed to evaluate the neurophysiological response in dogs on a, clinically used, accelerated high frequency (aHF) rTMS protocol. This aHF-rTMS (20 Hz) protocol was performed under anaesthesia or sedation and either 20 sessions or 5 sessions were given to each dog. Methods 21 healthy dogs were randomly subjected to one of the four aHF-rTMS protocols (1 sham and 3 active protocols). For each dog, the perfusion indices (PI), of a [99m Tc] HMPAO scan at 4 time points, for the left frontal cortex (stimulation target) were calculated for each protocol. Results Concerning sham stimulation, the average PI remained at the baseline level. The main result was the presence of a direct transitory increase in rCBF at the stimulation site, both under anaesthesia and sedation. Nevertheless the measured increase in rCBF was higher but shorter duration under sedation. The magnitude of this increase was not influenced by number of sessions. No changes in rCBF were found in remote brain regions. Conclusion This study shows that, despite the influence of anaesthesia and sedation, comparable and clinically relevant effects on the rCBF can be obtained in dogs. Since less methodological hurdles have to be overcome and comparable results can be obtained, it would be acceptable to put the dog forward as an alternative translational rTMS animal model.	[Dockx, Robrecht; Baeken, Chris] Univ Ghent, Dept Psychiat & Med Psychol, Ghent Expt Psychiat GHEP Lab, Ghent, East Flanders, Belgium; [Peremans, Kathelijne; Vlerick, Lise; Saunders, Jimmy H.] Univ Ghent, Fac Vet Med, Dept Vet Med Imaging & Small Anim Orthopaed, Merelbeke, East Flanders, Belgium; [Van Laeken, Nick; De Vosf, Filip] Univ Ghent, Fac Pharmaceut Sci, Dept Pharmaceut Anal, Lab Radiopharm, Ghent, East Flanders, Belgium; [Polis, Ingeborgh] Univ Ghent, Fac Vet Med, Dept Small Anim, Merelbeke, East Flanders, Belgium	Ghent University; Ghent University; Ghent University; Ghent University	Dockx, R (corresponding author), Univ Ghent, Dept Psychiat & Med Psychol, Ghent Expt Psychiat GHEP Lab, Ghent, East Flanders, Belgium.	robrechtdockx@ugent.be	Baeken, Chris/D-6790-2013		Ghent University Special Research Fund [01J05715]	Ghent University Special Research Fund(Ghent University)	Ghent University Special Research Fund (01J05715) funded this research (DVM Robrecht Dockx).	Adriaens A, 2013, VET RADIOL ULTRASOUN, V54, P403, DOI 10.1111/vru.12028; Amaya F, 2010, CLIN NEUROPHYSIOL, V121, P2143, DOI 10.1016/j.clinph.2010.03.058; Amendt HL, 2016, VET J, V217, P40, DOI 10.1016/j.tvjl.2016.06.006; Avery DH, 2006, BIOL PSYCHIAT, V59, P187, DOI 10.1016/j.biopsych.2005.07.003; Baeken C, 2015, BRAIN STIMUL, V8, P808, DOI 10.1016/j.brs.2015.01.415; Baeken C, 2014, WORLD J BIOL PSYCHIA, V15, P286, DOI 10.3109/15622975.2013.872295; Baeken C, 2013, J AFFECT DISORDERS, V151, P625, DOI 10.1016/j.jad.2013.07.008; Ben-Shachar D, 1999, BRAIN RES, V816, P78, DOI 10.1016/S0006-8993(98)01119-6; BenShachar D, 1997, J NEURAL TRANSM, V104, P191, DOI 10.1007/BF01273180; Brakemeier EL, 2008, J AFFECT DISORDERS, V108, P59, DOI 10.1016/j.jad.2007.09.007; Brakemeier EL, 2007, J PSYCHIATR RES, V41, P395, DOI 10.1016/j.jpsychires.2006.01.013; Catafau AM, 2001, PSYCHIAT RES-NEUROIM, V106, P151, DOI 10.1016/S0925-4927(01)00079-8; Conelea CA, 2017, J AFFECT DISORDERS, V217, P42, DOI 10.1016/j.jad.2017.03.063; De Decker S, 2011, JAVMA-J AM VET MED A, V238, P81, DOI 10.2460/javma.238.1.81; Diefenbach GJ, 2013, J AFFECT DISORDERS, V151, P365, DOI 10.1016/j.jad.2013.05.094; Dockx R, 2015, EUR J NUCL MED MOL I, V42, pS290; Dockx R, 2017, PEERJ IN PRESS; Dockx R, PROOF CONCEPT UNPUB; Dorward NL, 2002, BRIT J NEUROSURG, V16, P110, DOI 10.1080/02688690220131705; Eren I, 2003, PSYCHIAT RES-NEUROIM, V123, P135, DOI 10.1016/S0925-4927(03)00062-3; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; FLEISCHMANN A, 1995, BRAIN RES, V699, P130, DOI 10.1016/0006-8993(95)01018-Q; Fregni F, 2006, INT J NEUROPSYCHOPH, V9, P641, DOI 10.1017/S1461145705006280; George MS, 1999, HUM PSYCHOPHARM CLIN, V14, P161, DOI 10.1002/(SICI)1099-1077(199904)14:3<161::AID-HUP73>3.0.CO;2-2; George MS, 1999, ARCH GEN PSYCHIAT, V56, P300, DOI 10.1001/archpsyc.56.4.300; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Huang CC, 2008, PSYCHONEUROENDOCRINO, V33, P821, DOI 10.1016/j.psyneuen.2008.03.006; Irimajiri M, 2010, J VET MED SCI, V72, P1, DOI 10.1292/jvms.09-0048; Kanno M, 2004, J NEUROL SCI, V217, P73, DOI 10.1016/j.jns.2003.08.013; Keck ME, 2000, EUR J NEUROSCI, V12, P3713, DOI 10.1046/j.1460-9568.2000.00243.x; Keck ME, 2000, J PSYCHIAT RES, V34, P265, DOI 10.1016/S0022-3956(00)00028-5; Knoch D, 2006, NEUROIMAGE, V31, P641, DOI 10.1016/j.neuroimage.2005.12.025; LeBlanc AK, 2014, SEMIN NUCL MED, V44, P47, DOI 10.1053/j.semnuclmed.2013.08.004; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Levkovitz Y, 2001, NEUROBIOL AGING, V22, P255, DOI 10.1016/S0197-4580(00)00195-0; Lisanby SH, 2001, BIOL PSYCHIAT, V49, P460, DOI 10.1016/S0006-3223(00)01110-0; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Moliadze V, 2003, J PHYSIOL-LONDON, V553, P665, DOI 10.1113/jphysiol.2003.050153; Muller MB, 2000, NEUROPSYCHOPHARMACOL, V23, P205, DOI 10.1016/S0893-133X(00)00099-3; Muller PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091065; NEWBERG LA, 1983, ANESTHESIOLOGY, V59, P23, DOI 10.1097/00000542-198307000-00005; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Ohnishi T, 2004, BIOL PSYCHIAT, V55, P484, DOI 10.1016/j.biopsych.2003.09.016; Richieri R, 2011, EUR J NUCL MED MOL I, V38, P1715, DOI 10.1007/s00259-011-1850-9; Roth Y, 2007, J CLIN NEUROPHYSIOL, V24, P31, DOI 10.1097/WNP.0b013e31802fa393; Rumi DO, 2005, BIOL PSYCHIAT, V57, P162, DOI 10.1016/j.biopsych.2004.10.029; Sabesan P, 2015, WORLD J PSYCHIATR, V5, P170, DOI 10.5498/wjp.v5.i2.170; Sachdev PS, 2002, BIOL PSYCHIAT, V51, P474, DOI 10.1016/S0006-3223(01)01298-7; Salinas FS, 2011, NEUROIMAGE, V57, P1393, DOI 10.1016/j.neuroimage.2011.05.065; Shen Y, 2016, BIOL PSYCHIAT, V80, pE13, DOI 10.1016/j.biopsych.2016.02.006; Shively CA, 2009, AM J PRIMATOL, V71, P715, DOI 10.1002/ajp.20720; Su MY, 1998, NEUROBIOL AGING, V19, P479, DOI 10.1016/S0197-4580(98)00081-5; Tang A, 2015, NEUROSCIENTIST, DOI 1073858415618897; Teneback CC, 1999, J NEUROPSYCH CLIN N, V11, P426; Terraneo A, 2016, EUR NEUROPSYCHOPHARM, V26, P37, DOI 10.1016/j.euroneuro.2015.11.011; Vahabzadeh-Hagh AM, 2012, NEUROMODULATION, V15, P296, DOI 10.1111/j.1525-1403.2012.00482.x; Valero-Cabre A, 2005, EXP BRAIN RES, V163, P1, DOI 10.1007/s00221-004-2140-6; Valero-Cabre A, 2007, EXP BRAIN RES, V176, P603, DOI 10.1007/s00221-006-0639-8; Vermeire S, 2009, BRAIN IMAGING BEHAV, V3, P342, DOI 10.1007/s11682-009-9076-1; Vermeire ST, 2009, J NUCL MED, V50, P284, DOI 10.2967/jnumed.108.055731; Waelbers T, 2009, EUR J NUCL MED MOL I, V36, pS469; Waelbers T, 2015, J VET BEHAV, V10, P332, DOI 10.1016/j.jveb.2015.03.009; Wagner T, 2009, CORTEX, V45, P1025, DOI 10.1016/j.cortex.2008.10.002; Wang HY, 2011, J NEUROSCI, V31, P11044, DOI 10.1523/JNEUROSCI.2125-11.2011; Yue L, 2009, BRAIN RES, V1260, P94, DOI 10.1016/j.brainres.2009.01.009	65	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185362	10.1371/journal.pone.0185362	http://dx.doi.org/10.1371/journal.pone.0185362			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH9IR	28937993	Green Published, gold			2022-12-27	WOS:000411524700028
J	Holvast, F; Massoudi, B; Voshaar, RCO; Verhaak, PFM				Holvast, Floor; Massoudi, Btissame; Voshaar, Richard C. Oude; Verhaak, Peter F. M.			Non-pharmacological treatment for depressed older patients in primary care: A systematic review and meta-analysis	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIORAL THERAPY; MENTAL-HEALTH-CARE; CLINICAL EFFECTIVENESS; GENERAL-PRACTITIONER; ELDERLY-PATIENTS; ADULTS; SYMPTOMS; BIBLIOTHERAPY; PEOPLE	Background Late-life depression is most often treated in primary care, and it usually coincides with chronic somatic diseases. Given that antidepressants contribute to polypharmacy in these patients, and potentially to interactions with other drugs, non-pharmacological treatments are essential. In this systematic review and meta-analysis, we aimed to present an overview of the non-pharmacological treatments available in primary care for late-life depression. Method The databases of PubMed, PsychINFO, and the Cochrane Central Register of Controlled Trials were systematically searched in January 2017 with combinations of MeSH-terms and free text words for "general practice," "older adults," "depression," and "non-pharmacological treatment ". All studies with empirical data concerning adults aged 60 years or older were included, and the results were stratified by primary care, and community setting. We narratively reviewed the results and performed a meta-analysis on cognitive behavioral therapy in the primary care setting. Results We included 11 studies conducted in primary care, which covered the following five treatment modalities: cognitive behavioral therapy, exercise, problem-solving therapy, behavioral activation, and bright-light therapy. Overall, the meta-analysis showed a small effect for cognitive behavioral therapy, with one study also showing that bright-light therapy was effective. Another 18 studies, which evaluated potential non-pharmacological interventions in the community suitable for implementation, indicated that bibliotherapy, life-review, problemsolving therapy, and cognitive behavioral therapy were effective at short-term follow-up. Discussion We conclude that the effects of several treatments are promising, but need to be replicated before they can be implemented more widely in primary care. Although more treatment modalities were effective in a community setting, more research is needed to investigate whether these treatments are also applicable in primary care.	[Holvast, Floor; Massoudi, Btissame; Verhaak, Peter F. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [Voshaar, Richard C. Oude] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Groningen, Netherlands; [Verhaak, Peter F. M.] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands	University of Groningen; University of Groningen; Netherlands Institute for Health Services Research	Holvast, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands.	tholvast@umcg.nl		Oude Voshaar, Richard/0000-0003-1501-4774	Netherlands Organization for Health Research and Development [839110009]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	This work was supported by the Netherlands Organization for Health Research and Development (https://www.zonmw.ni/en/, grant number 839110009), and the funding applicant was PV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Apostolo Joao, 2015, JBI Database System Rev Implement Rep, V13, P220, DOI 10.11124/jbisrir-2015-1718; Arean PA, 2005, PSYCHOL AGING, V20, P601, DOI 10.1037/0882-7974.20.4.601; Arean PA, 2002, GERONTOLOGIST, V42, P392, DOI 10.1093/geront/42.3.392; Brodaty H, 2001, J AFFECT DISORDERS, V66, P225, DOI 10.1016/S0165-0327(00)00317-7; Cape J, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-38; Caughey GE, 2010, AGE AGEING, V39, P488, DOI 10.1093/ageing/afq055; Chan MF, 2013, HEALTH SOC CARE COMM, V21, P545, DOI 10.1111/hsc.12043; Ciechanowski P, 2004, JAMA-J AM MED ASSOC, V291, P1569, DOI 10.1001/jama.291.13.1569; Cuijpers P, 2014, MATURITAS, V79, P160, DOI 10.1016/j.maturitas.2014.05.027; Draper B, 2008, DRUG AGING, V25, P501, DOI 10.2165/00002512-200825060-00004; Floyd M, 2006, BEHAV MODIF, V30, P281, DOI 10.1177/0145445503261176; Floyd M, 2004, BEHAV MODIF, V28, P297, DOI 10.1177/0145445503259284; Freudenstein U, 2001, FAM PRACT, V18, P321, DOI 10.1093/fampra/18.3.321; Fried TR, 2014, J AM GERIATR SOC, V62, P2261, DOI 10.1111/jgs.13153; Garcia-Pena C, 2015, SALUD MENT, V38, P33, DOI 10.17711/SM.0185-3325.2015.004; Garrido MM, 2009, J GERONTOL B-PSYCHOL, V64, P704, DOI 10.1093/geronb/gbp073; Gould RL, 2012, J AM GERIATR SOC, V60, P1817, DOI 10.1111/j.1532-5415.2012.04166.x; Gum AM, 2016, SOUTH MED J, V109, P442, DOI 10.14423/SMJ.0000000000000497; Gunn JM, 2012, SOC PSYCH PSYCH EPID, V47, P175, DOI 10.1007/s00127-010-0330-z; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Holvast F, FAMILY PRAC IN PRESS; Holvast F, 2012, J AFFECT DISORDERS, V143, P69, DOI 10.1016/j.jad.2012.05.029; Huang TT, 2015, INT J NURS STUD, V52, P1542, DOI 10.1016/j.ijnurstu.2015.05.013; Imai H, 2015, PSYCHIAT RES, V229, P545, DOI 10.1016/j.psychres.2015.05.054; Janssen N, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1388-x; Joling KJ, 2011, AM J GERIAT PSYCHIAT, V19, P256, DOI 10.1097/JGP.0b013e3181ec8859; Jonsson U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160859; Kiosses DN, 2015, JAMA PSYCHIAT, V72, P22, DOI 10.1001/jamapsychiatry.2014.1305; Kitchen KA, 2013, CLIN GERONTOL, V36; Laidlaw K, 2008, INT J GERIATR PSYCH, V23, P843, DOI 10.1002/gps.1993; Lamers F, 2010, PSYCHOTHER PSYCHOSOM, V79, P217, DOI 10.1159/000313690; Landi F, 2007, CLIN PHARMACOL THER, V81, P235, DOI 10.1038/sj.clpt.6100035; Licht-Strunk E, 2005, INT J GERIATR PSYCH, V20, P1013, DOI 10.1002/gps.1391; Lieverse R, 2011, ARCH GEN PSYCHIAT, V68, P61, DOI 10.1001/archgenpsychiatry.2010.183; Mark TL, 2011, AM J GERIAT PSYCHIAT, V19, P211, DOI 10.1097/JGP.0b013e3181f1803d; MCNEIL JK, 1991, PSYCHOL AGING, V6, P487, DOI 10.1037/0882-7974.6.3.487; Moss K, 2012, AGING MENT HEALTH, V16, P625, DOI 10.1080/13607863.2011.651435; Mulsant BH, 2003, ARCH GEN PSYCHIAT, V60, P198, DOI 10.1001/archpsyc.60.2.198; Preschl B, 2012, AGING MENT HEALTH, V16, P964, DOI 10.1080/13607863.2012.702726; Rosenberg D, 2010, AM J GERIAT PSYCHIAT, V18, P221, DOI 10.1097/JGP.0b013e3181c534b5; SCOGIN F, 1989, J CONSULT CLIN PSYCH, V57, P403, DOI 10.1037/0022-006X.57.3.403; SCOGIN F, 1990, J CONSULT CLIN PSYCH, V58, P665; SCOGIN F, 1987, GERONTOLOGIST, V27, P383, DOI 10.1093/geront/27.3.383; Serfaty MA, 2009, ARCH GEN PSYCHIAT, V66, P1332, DOI 10.1001/archgenpsychiatry.2009.165; Serrano JP, 2004, PSYCHOL AGING, V19, P272, DOI 10.1037/0882-7974.19.2.272; Sims Jane, 2006, BMC Geriatr, V6, P18, DOI 10.1186/1471-2318-6-18; Singh NA, 2005, J GERONTOL A-BIOL, V60, P768, DOI 10.1093/gerona/60.6.768; Singh NA, 1997, J GERONTOL A-BIOL, V52, pM27, DOI 10.1093/gerona/52A.1.M27; Sjosten N, 2006, INT J GERIATR PSYCH, V21, P410, DOI 10.1002/gps.1494; THOMPSON LW, 1987, J CONSULT CLIN PSYCH, V55, P385, DOI 10.1037/0022-006X.55.3.385; Titov N, 2015, BEHAV THER, V46, P193, DOI 10.1016/j.beth.2014.09.008; Van Weel-Baumgarten EM., 2012, HUISARTS WET, V55, P252; Verhaak PFM, 2012, SCAND J PRIM HEALTH, V30, P156, DOI 10.3109/02813432.2012.688707; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Williams JW, 2000, JAMA-J AM MED ASSOC, V284, P1519, DOI 10.1001/jama.284.12.1519; Wuthrich VM, 2013, BEHAV RES THER, V51, P779, DOI 10.1016/j.brat.2013.09.002	57	45	44	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0184666	10.1371/journal.pone.0184666	http://dx.doi.org/10.1371/journal.pone.0184666			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH9IR	28938015	Green Published, gold, Green Submitted			2022-12-27	WOS:000411524700007
J	Scotson, L; Fredriksson, G; Ngoprasert, D; Wong, WM; Fieberg, J				Scotson, Lorraine; Fredriksson, Gabriella; Ngoprasert, Dusit; Wong, Wai-Ming; Fieberg, John			Projecting range-wide sun bear population trends using tree cover and camera-trap bycatch data	PLOS ONE			English	Article							EAST KALIMANTAN; HABITAT; DYNAMICS; DENSITY; MAMMALS; DEFORESTATION; EXTINCTION; ABUNDANCE; IMPACT; THREAT	Monitoring population trends of threatened species requires standardized techniques that can be applied over broad areas and repeated through time. Sun bears Helarctos malayanus are a forest dependent tropical bear found throughout most of Southeast Asia. Previous estimates of global population trends have relied on expert opinion and cannot be systematically replicated. We combined data from 1,463 camera traps within 31 field sites across sun bear range to model the relationship between photo catch rates of sun bears and tree cover. Sun bears were detected in all levels of tree cover above 20%, and the probability of presence was positively associated with the amount of tree cover within a 6-km 2 buffer of the camera traps. We used the relationship between catch rates and tree cover across space to infer temporal trends in sun bear abundance in response to tree cover loss at country and global-scales. Our model-based projections based on this "space for time" substitution suggested that sun bear population declines associated with tree cover loss between 2000- 2014 in mainland southeast Asia were similar to 9%, with declines highest in Cambodia and lowest in Myanmar. During the same period, sun bear populations in insular southeast Asia (Malaysia, Indonesia and Brunei) were projected to have declined at a much higher rate (22%). Cast forward over 30-years, from the year 2000, by assuming a constant rate of change in tree cover, we projected population declines in the insular region that surpassed 50%, meeting the IUCN criteria for endangered if sun bears were listed on the population level. Although this approach requires several assumptions, most notably that trends in abundance across space can be used to infer temporal trends, population projections using remotely sensed tree cover data may serve as a useful alternative (or supplement) to expert opinion. The advantages of this approach is that it is objective, data-driven, repeatable, and it requires that all assumptions be clearly stated.	[Scotson, Lorraine; Fieberg, John] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Fredriksson, Gabriella] Pro Natura Fdn, East Kalimantan, Indonesia; [Ngoprasert, Dusit] King Mongkuts Univ Technol Thonburi, Conservat Ecol Program, Bangkok, Thailand; [Wong, Wai-Ming] Panthera, New York, NY USA	University of Minnesota System; University of Minnesota Twin Cities; King Mongkuts University of Technology Thonburi	Scotson, L (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.	scotsonuk@gmail.com	Fieberg, John/Y-3988-2019	Fieberg, John/0000-0002-3180-7021	University of Minnesota Doctoral Dissertation Fellowship; University of Minnesota Conservation Biology Summer Grant; Perth Zoo's Wildlife Conservation Action Program; Margaret Dawbarn Foundation; state Robin Under Rothwell Account Wildlife Preservation Trust; National Science and Technology Development Agency [NSTDA P-11-00390]; International Association for Bear Research and Management (Research & Conservation grant)	University of Minnesota Doctoral Dissertation Fellowship(University of Minnesota System); University of Minnesota Conservation Biology Summer Grant; Perth Zoo's Wildlife Conservation Action Program; Margaret Dawbarn Foundation; state Robin Under Rothwell Account Wildlife Preservation Trust; National Science and Technology Development Agency; International Association for Bear Research and Management (Research & Conservation grant)	L.S was funded by The University of Minnesota Doctoral Dissertation Fellowship, The University of Minnesota Conservation Biology Summer Grant, Perth Zoo's Wildlife Conservation Action Program, The Margaret Dawbarn Foundation and Estate Robin Under Rothwell Account Wildlife Preservation Trust, managed by Perpetual. D.N was funded by The National Science and Technology Development Agency (NSTDA P-11-00390), International Association for Bear Research and Management (Research & Conservation grant).	Aarts G, 2012, METHODS ECOL EVOL, V3, P177, DOI 10.1111/j.2041-210X.2011.00141.x; Ahumada JA, 2011, COMMUNITY STRUCTURE, p2703 ; Apps CD, 2007, J WILDLIFE MANAGE, V68, P138; Apps CD, 2016, J WILDLIFE MANAGE, V80, P396, DOI 10.1002/jwmg.1037; Avgar T, 2017, ECOL EVOL, V7, P5322, DOI 10.1002/ece3.3122; Banet AI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081025; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Bird JP, 2012, DIVERS DISTRIB, V18, P273, DOI 10.1111/j.1472-4642.2011.00843.x; Blois JL, 2013, P NATL ACAD SCI USA, V110, P9374, DOI 10.1073/pnas.1220228110; Boyce MS, 2012, WILDLIFE SOC B, V31, P670; Buchanan GM, 2008, BIOL CONSERV, V141, P56, DOI 10.1016/j.biocon.2007.08.023; Buckland S. T., 2005, ENCY BIOSTATISTICS; Cheah C.P.I., 2013, THESIS U PUTRA MALAY; Chutipong W, 2014, RAFFLES B ZOOL, V62, P521; Dahle B, 2003, J ZOOL, V260, P329, DOI 10.1017/S0952836903003753; Donald PF, 2015, CONSERV BIOL, V29, P1485, DOI 10.1111/cobi.12501; Erdbrink DP., 1953, REV FOSSIL RECENT BE; Foley KE, 2011, POWERS VIALS FLAKES; Franca F, 2016, J APPL ECOL; Fredrikkson G, 2005, URSUS, V16, P130, DOI 10.2192/1537-6176(2005)016[0130:HBCIEK]2.0.CO;2; Fredriksson GM, 2006, BIOL J LINN SOC, V89, P489, DOI 10.1111/j.1095-8312.2006.00688.x; GRIFFITHS M, 1993, CONSERV BIOL, V7, P623, DOI 10.1046/j.1523-1739.1993.07030623.x; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hilton-Taylor C., 2000, IUCN RED LIST THREAT; Hoffmann M., 2008, Endangered Species Research, V6, P113, DOI 10.3354/esr00087; Islam MA, 2013, URSUS, V24, P83, DOI 10.2192/URSUS-D-12-00010.1; IUCN Standards and Petitions Committee, 2022, GUID US IUCN RED LIS; Jackson HB, 2012, LANDSC ECOL, V27; Joshi AR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501675; Kanchanasakha B, 2010, STATUS LARGE MAMMALS; Keenan RJ, 2015, FOREST ECOL MANAG, V352, P9, DOI 10.1016/j.foreco.2015.06.014; Kendall KC, 2008, J WILDLIFE MANAGE, V72, P1693, DOI 10.2193/2008-007; Kniewel, 2012, THESIS; Linkie M, 2013, BIOL CONSERV, V162, P107, DOI 10.1016/j.biocon.2013.03.028; Mathai J, 2016, RAFFLES B ZOOL, P186; Matthiopoulos J, 2015, ECOL MONOGR, V85, P413, DOI 10.1890/14-2244.1; Matthiopoulos J, 2011, ECOLOGY, V92, P583, DOI 10.1890/10-0751.1; McCullough P, 1989, GEN LINEAR MODELS; MCLELLAN BN, 1989, CAN J ZOOL, V67, P1865, DOI 10.1139/z89-266; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Mormua F, 2004, URSUS, V15, P227; Nazeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048104; Ngoprasert D., 2015, POPULATION DEMOGRAPH; Ngoprasert D, 2012, URSUS, V23, P117, DOI 10.2192/URSUS-D-11-00009.1; PICKETT S T A, 1989, P110; R Development Core T, LANG ENV STAT COMP, V2012; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Riitters K, 2016, LANDSCAPE ECOL, V31, P137, DOI 10.1007/s10980-015-0270-9; Rowcliffe JM, 2008, ANIM CONSERV, V11, P185, DOI 10.1111/j.1469-1795.2008.00180.x; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Scotson L, 2017, REMOTE SENS ECOL CON; Scotson L., 2017, IUCN RED LIST THREAT; Scotson L, 2014, WILDLIFE SOC B, V38, P783, DOI 10.1002/wsb.466; Scotson Lorraine, 2013, International Bear News, V22, P22; Staddon P, 2010, ECOL LETT, V13, P543, DOI 10.1111/j.1461-0248.2010.01450.x; Steinmetz R., 2011, ECOLOGY CONSERVATION; Steinmetz R, 2006, CONSERV BIOL, V20, P1391, DOI 10.1111/j.1523-1739.2006.00505.x; Steinmetz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014509; Tracewski L, 2016, CONSERV BIOL, V30, P1070, DOI 10.1111/cobi.12715; Wen C, 2013, UPDATE STATUS SUN BE; Wong ST, 2004, BIOL CONSERV, V119, P169, DOI 10.1016/j.biocon.2003.10.029; Wong WM, 2013, ANIM CONSERV, V16, P216, DOI 10.1111/j.1469-1795.2012.00587.x; Wong WM, 2013, DIVERS DISTRIB, V19, P700, DOI 10.1111/ddi.12020	65	20	21	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185336	10.1371/journal.pone.0185336	http://dx.doi.org/10.1371/journal.pone.0185336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961243	Green Submitted, Green Published, gold			2022-12-27	WOS:000412027700017
J	Fraaije, RGA; Moinier, S; van Gogh, I; Timmers, R; van Deelen, JJ; Verhoeven, JTA; Soons, MB				Fraaije, Rob G. A.; Moinier, Sophie; van Gogh, Iris; Timmers, Robert; van Deelen, Joost J.; Verhoeven, Jos T. A.; Soons, Merel B.			Spatial patterns of water-dispersed seed deposition along stream riparian gradients	PLOS ONE			English	Article							PLANT-SPECIES RICHNESS; LIFE-HISTORY TRAITS; BENTHIC INVERTEBRATES; VEGETATION PATTERNS; INDICATOR VALUES; WINTER FLOW; DRIFT LINES; RESTORATION; DIVERSITY; RIVERS	Riparian ecosystems along streams naturally harbour a high plant diversity with many increasingly endangered species. In our current heavily modified and fragmented catchments, many of these species are sensitive to dispersal limitation. Better understanding of riparian plant dispersal pathways is required to predict species (re-) colonization potential and improve success rates of stream and riparian zone conservation and restoration. Dispersal by water (hydrochory) is an important mechanism for longitudinal and lateral dispersal of riparian species. Crucially for recruitment potential, it also influences the elevation along the riparian hydrological gradient where seeds become deposited. Due to the complex interplay between abiotic and biotic factors, however, it remains unclear how exactly patterns in seed deposition are formed. We compared hydrochorous and non-hydrochorous seed deposition, and quantified patterns of seed deposition along the bare substrate of newly created stream riparian gradients. Water levels were monitored and seed deposition was measured with seed traps along the full range of riparian hydrological conditions (from permanently flooded to never flooded). Average seed numbers and species richness were significantly higher in flooded than in non-flooded seed traps (5.7 and 1.5 times higher, respectively). Community-weighted trait means indicated that typically water-dispersed seeds were more dominant in flooded than in non-flooded seed traps and gradually decreased in concentration from the channel to the upland. Moreover, highly buoyant seeds accumulated at the average water line, and clear elevational sorting of non-buoyant seeds occurred within the floodplain. These results establish a critical role of flooding in shaping patterns of seed deposition along the riparian gradient, delivering many seeds of typical riparian species to riparian zones and depositing them at species-specific elevations as influenced by seed traits, suggesting species-specific dispersal pathways. This shows that hydrochory likely has important consequences for riparian vegetation development and that flooding forms a key process for successful restoration.	[Fraaije, Rob G. A.; Moinier, Sophie; van Gogh, Iris; Timmers, Robert; van Deelen, Joost J.; Verhoeven, Jos T. A.; Soons, Merel B.] Univ Utrecht, Inst Environm Biol, Ecol & Biodivers Grp, Padualaan 8, Utrecht, Netherlands	Utrecht University	Fraaije, RGA (corresponding author), Univ Utrecht, Inst Environm Biol, Ecol & Biodivers Grp, Padualaan 8, Utrecht, Netherlands.	robfraaije@gmail.com	Soons, Merel/C-6216-2009	Fraaije, Rob/0000-0001-7887-9359; Timmers, Robert/0000-0003-2901-509X	Agentschap NL (Rijksdienst voor Ondernemend Nederland); Foundation for Applied Water Research (STOWA); waterboard 'Aa Maas'; waterboard 'de Dommel'; waterboard 'Vechtstromen'	Agentschap NL (Rijksdienst voor Ondernemend Nederland); Foundation for Applied Water Research (STOWA); waterboard 'Aa Maas'; waterboard 'de Dommel'; waterboard 'Vechtstromen'	This research was supported by the waterboards 'Aa & Maas', 'de Dommel' and 'Vechtstromen' and co-funded by Agentschap NL (Rijksdienst voor Ondernemend Nederland), the Foundation for Applied Water Research (STOWA) and personal grants to M. B. Soons (Netherlands Organization for Scientific Research, NWO-ALW Meervoud and Vidi grants).	Andersson E, 2000, J BIOGEOGR, V27, P1095, DOI 10.1046/j.1365-2699.2000.00481.x; Baattrup-Pedersen A, 2013, RIVER RES APPL, V29, P855, DOI 10.1002/rra.2573; Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; BarratSegretain MH, 1996, VEGETATIO, V123, P13, DOI 10.1007/BF00044885; Bischoff A, 2002, BIOL CONSERV, V104, P25, DOI 10.1016/S0006-3207(01)00151-3; Boedeltje G, 2004, J ECOL, V92, P786, DOI 10.1111/j.0022-0477.2004.00906.x; Boedeltje G, 2003, J ECOL, V91, P855, DOI 10.1046/j.1365-2745.2003.00820.x; Boedeltje G, 2002, AQUAT BOT, V72, P121, DOI 10.1016/S0304-3770(01)00224-8; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brederveld RJ, 2011, J APPL ECOL, V48, P1241, DOI 10.1111/j.1365-2664.2011.02026.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calcada EA, 2015, PERSPECT PLANT ECOL, V17, P434, DOI 10.1016/j.ppees.2015.09.001; Calcada EA, 2015, LANDSCAPE ECOL, V30, P2133, DOI 10.1007/s10980-015-0236-y; Calcada EA, 2013, J APPL ECOL, V50, P1152, DOI 10.1111/1365-2664.12132; Cappers R. T. J, 2006, DIGITAL SEED ATLAS N; Chambert S, 2009, RIVER RES APPL, V25, P48, DOI 10.1002/rra.1093; COOPS H, 1995, FRESHWATER BIOL, V34, P13, DOI 10.1111/j.1365-2427.1995.tb00418.x; DEVRIES JJ, 1976, J HYDROL, V29, P43, DOI 10.1016/0022-1694(76)90004-4; DIEKMANN M, 1995, ECOGRAPHY, V18, P178, DOI 10.1111/j.1600-0587.1995.tb00339.x; Diekmann M, 2003, BASIC APPL ECOL, V4, P493, DOI 10.1078/1439-1791-00185; DIETRICH WE, 1982, WATER RESOUR RES, V18, P1615, DOI 10.1029/WR018i006p01615; Ellenberg H., 1992, SCRIPTA GEOBOT, V18, P1; Ellenberg H., 1988, VEGETATION ECOLOGY C; Fraaije RGA, 2015, J ECOL, V103, P1634, DOI 10.1111/1365-2745.12460; Fraaije RGA, 2015, FUNCT ECOL, V29, P971, DOI 10.1111/1365-2435.12441; Goodson JM, 2003, RIVER RES APPL, V19, P317, DOI 10.1002/rra.707; Gurnell AM, 2006, J VEG SCI, V17, P665, DOI 10.1111/j.1654-1103.2006.tb02490.x; Gurnell A, 2008, J ECOL, V96, P553, DOI 10.1111/j.1365-2745.2008.01358.x; Gurnell A, 2007, EARTH SURF PROC LAND, V32, P1257, DOI 10.1002/esp.1554; Gurnell AM, 2007, GEOMORPHOLOGY, V89, P9, DOI 10.1016/j.geomorph.2006.07.012; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; Hill M. O., 1999, ELLENBERGS INDICATOR; Jahnig SC, 2010, J APPL ECOL, V47, P671, DOI 10.1111/j.1365-2664.2010.01807.x; Jahnig SC, 2009, J APPL ECOL, V46, P406, DOI 10.1111/j.1365-2664.2009.01611.x; Jansson R, 2005, J ECOL, V93, P1094, DOI 10.1111/j.1365-2745.2005.01057.x; Johansson ME, 1996, J VEG SCI, V7, P593, DOI 10.2307/3236309; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Knevel IC, 2003, J VEG SCI, V14, P611, DOI 10.1111/j.1654-1103.2003.tb02188.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lorenz AW, 2013, HYDROBIOLOGIA, V704, P489, DOI 10.1007/s10750-012-1326-3; Malmqvist B, 2002, ENVIRON CONSERV, V29, P134, DOI 10.1017/S0376892902000097; Merritt DM, 2010, ECOL MONOGR, V80, P609, DOI 10.1890/09-1533.1; Merritt DM, 2002, ECOL APPL, V12, P1071, DOI 10.1890/1051-0761(2002)012[1071:PGHARH]2.0.CO;2; Merritt DM, 2006, RIVER RES APPL, V22, P1, DOI 10.1002/rra.890; Moggridge HL, 2010, RIVER RES APPL, V26, P512, DOI 10.1002/rra.1273; Moggridge HL, 2009, J VEG SCI, V20, P465, DOI 10.1111/j.1654-1103.2009.05498.x; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Nilsson C, 2002, ECOLOGY, V83, P2878, DOI 10.1890/0012-9658(2002)083[2878:DIRFBR]2.0.CO;2; NILSSON C, 1990, CAN J BOT, V68, P735, DOI 10.1139/b90-097; NILSSON C, 1991, CAN J BOT, V69, P2631, DOI 10.1139/b91-328; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; Oksanen J, 2015, VEGAN COMMUNITY ECOL, V2, P2; Ozinga WA, 2009, ECOL LETT, V12, P66, DOI 10.1111/j.1461-0248.2008.01261.x; Palmer MA, 2014, ANNU REV ECOL EVOL S, V45, P247, DOI 10.1146/annurev-ecolsys-120213-091935; Poulsen JB, 2014, ECOL ENG, V66, P120, DOI 10.1016/j.ecoleng.2013.05.010; Riis T, 2014, ECOL ENG, V66, P103, DOI 10.1016/j.ecoleng.2013.05.006; Sarneel JM, 2014, J VEG SCI, V25, P262, DOI 10.1111/jvs.12074; Sarneel JM, 2012, J VEG SCI, V23, P517, DOI 10.1111/j.1654-1103.2011.01367.x; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Seiwa K, 2008, PLANT ECOL, V198, P27, DOI 10.1007/s11258-007-9382-x; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; Silvertown J, 2015, J ECOL, V103, P93, DOI 10.1111/1365-2745.12332; Soomers H, 2013, ECOSYSTEMS, V16, P434, DOI 10.1007/s10021-012-9619-y; Soons MB, 2004, ECOLOGY, V85, P3056, DOI 10.1890/03-0522; Soons MB, 2006, APPL VEG SCI, V9, P271, DOI 10.1658/1402-2001(2006)9[271:WDIFWK]2.0.CO;2; Soons MB, 2017, FUNCT ECOL, V31, P499, DOI 10.1111/1365-2435.12771; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Van der Meijden R., 2005, HEUKELS FLORA NEDERL; van Eck WHJM, 2004, OIKOS, V107, P393, DOI 10.1111/j.0030-1299.2004.13083.x; van Leeuwen CHA, 2014, J ECOL, V102, P998, DOI 10.1111/1365-2745.12250; Verdonschot PFM, 2002, HYDROBIOLOGIA, V478, P131, DOI 10.1023/A:1021026630384; Vittoz P, 2007, BOT HELV, V117, P109, DOI 10.1007/s00035-007-0797-8; Vogt K, 2007, AQUAT BOT, V86, P385, DOI 10.1016/j.aquabot.2007.01.009; Vogt K, 2006, BASIC APPL ECOL, V7, P422, DOI 10.1016/j.baae.2006.05.007; Wubs ERJ, 2016, FRESHWATER BIOL, V61, P580, DOI 10.1111/fwb.12736	79	12	12	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185247	10.1371/journal.pone.0185247	http://dx.doi.org/10.1371/journal.pone.0185247			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957365	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200038
J	Kumar, R; Pitcher, TJ; Varkey, DA				Kumar, Rajeev; Pitcher, Tony J.; Varkey, Divya A.			Ecosystem approach to fisheries: Exploring environmental and trophic effects on Maximum Sustainable Yield (MSY) reference point estimates	PLOS ONE			English	Article							MILLE LACS LAKE; STOCK ASSESSMENT; SMALLMOUTH BASS; LONG-TERM; IMPACTS; CLIMATE; TEMPERATURE; SINGLE; BURBOT; CISCO	We present a comprehensive analysis of estimation of fisheries Maximum Sustainable Yield (MSY) reference points using an ecosystem model built for Mille Lacs Lake, the second largest lake within Minnesota, USA. Data from single-species modelling output, extensive annual sampling for species abundances, annual catch-survey, stomach-content analysis for predatory-prey interactions, and expert opinions were brought together within the framework of an Ecopath with Ecosim (EwE) ecosystem model. An increase in the lake water temperature was observed in the last few decades; therefore, we also incorporated a temperature forcing function in the EwE model to capture the influences of changing temperature on the species composition and food web. The EwE model was fitted to abundance and catch time-series for the period 1985 to 2006. Using the ecosystem model, we estimated reference points for most of the fished species in the lake at single-species as well as ecosystem levels with and without considering the influence of temperature change; therefore, our analysis investigated the trophic and temperature effects on the reference points. The paper concludes that reference points such as MSY are not stationary, but change when (1) environmental conditions alter species productivity and (2) fishing on predators alters the compensatory response of their prey. Thus, it is necessary for the management to re-estimate or re-evaluate the reference points when changes in environmental conditions and/or major shifts in species abundance or community structure are observed.	[Kumar, Rajeev; Pitcher, Tony J.; Varkey, Divya A.] Univ British Columbia, Inst Oceans & Fisheries, Vancouver, BC, Canada	University of British Columbia	Kumar, R (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, Vancouver, BC, Canada.	r.kumar@oceans.ubc.ca			Minnesota Department of Natural Resources	Minnesota Department of Natural Resources	This work was supported by the Minnesota Department of Natural Resources (http://www.dnr.state.mn.us/index.html) TJP - HYMT UBC code: 17R69668. MNDNR supported the design of the study, and provided data required for the analyses.	Ahrens RNM, 2012, FISH FISH, V13, P41, DOI 10.1111/j.1467-2979.2011.00432.x; Brunel T, 2010, ICES J MAR SCI, V67, P1051, DOI 10.1093/icesjms/fsp297; Charles AT, 1998, FISH RES, V37, P37, DOI 10.1016/S0165-7836(98)00125-8; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; CHRISTENSEN V, 1992, ECOL MODEL, V61, P169, DOI 10.1016/0304-3800(92)90016-8; COLBY PJ, 1969, LIMNOL OCEANOGR, V14, P958, DOI 10.4319/lo.1969.14.6.0958; Dickey-Collas M, 2014, ICES J MAR SCI, V71, P128, DOI 10.1093/icesjms/fst075; Drake MT, 2007, MILLE LACS LAKE WALL; Dunlop ES, 2006, T AM FISH SOC, V135, P1175, DOI 10.1577/T05-218.1; EDSALL TA, 1970, T AM FISH SOC, V99, P526, DOI 10.1577/1548-8659(1970)99<526:TTOYCC>2.0.CO;2; Edwards EA., 1983, FWSOBS821036 US DEP; Funnell E, 2012, SMALLMOUTH BASS ONTA; Gislason H, 1999, ICES J MAR SCI, V56, P571, DOI 10.1006/jmsc.1999.0492; Haddon M., 2011, MODELLING QUANTITATI; Hilborn R, 2011, FISH RES, V108, P235, DOI 10.1016/j.fishres.2010.12.030; Hofmann N, 2002, T AM FISH SOC, V131, P1164, DOI 10.1577/1548-8659(2002)131<1164:TPACTL>2.0.CO;2; Hollowed AB, 2000, ICES J MAR SCI, V57, P707, DOI 10.1006/jmsc.2000.0734; Hurtado-Ferro F, 2010, ICES J MAR SCI, V67, P2012, DOI 10.1093/icesjms/fsq126; Ivan LN, 2011, T AM FISH SOC, V140, P1078, DOI 10.1080/00028487.2011.603976; Jackson JR, 2008, AM FISH S S, V59, P131; Jacobsen NS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2701; Jacobson PC, 2008, T AM FISH SOC, V137, P1464, DOI 10.1577/T07-148.1; Jones R, 2013, MITIG ADAPT STRAT GL, V18, P731, DOI 10.1007/s11027-012-9385-3; Jones T, 2006, MILLE LACS LAKE CREE; Kahle D, 2013, R J, V5, P144; Kumar R, 2016, ECOL MODEL, V331, P68, DOI 10.1016/j.ecolmodel.2016.01.019; Kumar R, 2013, N AM J FISH MANAGE, V33, P669, DOI 10.1080/02755947.2013.785992; Large SI, 2013, ICES J MAR SCI, V70, P755, DOI 10.1093/icesjms/fst067; LARKIN PA, 1977, T AM FISH SOC, V106, P1, DOI 10.1577/1548-8659(1977)106<1:AEFTCO>2.0.CO;2; Latta W. C., 1995, DISTRIBUTION ABUNDAN; Levin PS, 2013, ICEJ MARINE SCI J; Mace PM, 2001, FISH FISH, V2, P2, DOI 10.1046/j.1467-2979.2001.00033.x; Mackinson S, 2009, ECOL MODEL, V220, P2972, DOI 10.1016/j.ecolmodel.2008.10.021; Madsen R, 2005, PRELIMINARY YELLOW P; MNDNR, 1997, POT TARG CURR YIELD; NCDC, 2014, NAT OC ATM ADM; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pikitch EK, 2014, FISH FISH, V15, P43, DOI 10.1111/faf.12004; Punt A., 2001, CONSERVATION EXPLOIT, P41; Radomski P, 2003, N AM J FISH MANAGE, V23, P1329, DOI 10.1577/M01-231AM; Schwarz CJ, 2006, ANAL MARK RECAPTURE; Scott W.B., 1973, Bulletin Fish Res Bd Canada, V184, P1; Shuter BJ, 2012, AQUAT SCI, V74, P637, DOI 10.1007/s00027-012-0274-3; Sissenwine MM, 2014, ICES J MAR SCI, V71, P153, DOI 10.1093/icesjms/fst236; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Stapanian MA, 2010, FISH FISH, V11, P34, DOI 10.1111/j.1467-2979.2009.00340.x; Travers-Trolet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094286; Walters C, 2000, ECOSYSTEMS, V3, P70, DOI 10.1007/s100210000011; Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; Wayte SE, 2013, FISH RES, V142, P47, DOI 10.1016/j.fishres.2012.07.009; Wolff M, 2012, MAR ECOL PROG SER, V448, P7, DOI 10.3354/meps09542; Wuellner MR, 2010, N AM J FISH MANAGE, V30, P445, DOI 10.1577/M09-066.1	53	3	3	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e018557	10.1371/journal.pone.0185575	http://dx.doi.org/10.1371/journal.pone.0185575			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957387	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200088
J	Monsees, H; Kloas, W; Wuertz, S				Monsees, Hendrik; Kloas, Werner; Wuertz, Sven			Decoupled systems on trial: Eliminating bottlenecks to improve aquaponic processes	PLOS ONE			English	Article							LYCOPERSICON-ESCULENTUM; OREOCHROMIS-NILOTICUS; AMMONIA EXCRETION; NILE TILAPIA; TOMATO; WATER; FISH; PERFORMANCE; TOXICITY; NITROGEN	In classical aquaponics (coupled aquaponic systems, 1-loop systems) the production of fish in recirculating aquaculture systems (RAS) and plants in hydroponics are combined in a single loop, entailing systemic compromises on the optimal production parameters (e.g. pH). Recently presented decoupled aquaponics (2-loop systems) have been awarded for eliminating major bottlenecks. In a pilot study, production in an innovative decoupled aquaponic system was compared with a coupled system and, as a control, a conventional RAS, assessing growth parameters of fish (FCR, SGR) and plants over an experimental period of 5 months. Soluble nutrients (NO3--N, NO2--N, NH4+-N, PO43-, K+, Ca2+, Mg2+, SO42-, Cl2- and Fe2+), elemental composition of plants, fish and sludge (N, P, K, Ca, Mg, Na, C), abiotic factors (temperature, pH, oxygen, and conductivity), fertilizer and water consumption were determined. Fruit yield was 36% higher in decoupled aquaponics and pH and fertilizer management was more effective, whereas fish production was comparable in both systems. The results of this pilot study clearly illustrate the main advantages of decoupled, two-loop aquaponics and demonstrate how bottlenecks commonly encountered in coupled aquaponics can be managed to promote application in aquaculture.	[Monsees, Hendrik; Kloas, Werner; Wuertz, Sven] Leibniz Inst Freshwater Biol & Inland Fisheries, Berlin, Germany; [Monsees, Hendrik; Kloas, Werner; Wuertz, Sven] Humboldt Univ, Albrecht Daniel Thaer Inst Agr & Hort Sci, Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Humboldt University of Berlin	Monsees, H (corresponding author), Leibniz Inst Freshwater Biol & Inland Fisheries, Berlin, Germany.; Monsees, H (corresponding author), Humboldt Univ, Albrecht Daniel Thaer Inst Agr & Hort Sci, Berlin, Germany.	h.monsees@igb-berlin.de	Würtz, Sven/A-6550-2012	Wuertz, Sven/0000-0002-8190-2684; Monsees, Hendrik/0000-0003-2935-1106	Elsa-Neumann Scholarship; EU Aquaponics Hub COST action network [FA1305]	Elsa-Neumann Scholarship; EU Aquaponics Hub COST action network	This work received support from the Elsa-Neumann Scholarship - HM recieved his payment for his PhD through the Elsa-Neumann Scholarship. https://www.hu-berlin.de/de/forschung/szf/wiss_nachwuchs/wn_natoeg_html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Jonas Wagner and Maurice Paul for their help during the study. We are equally grateful for the support of the EU Aquaponics Hub (FA1305) COST action network.	Abdel-Tawwab M, 2010, AQUACULTURE, V298, P267, DOI 10.1016/j.aquaculture.2009.10.027; Andriolo JL, 1996, J PLANT NUTR, V19, P1441, DOI 10.1080/01904169609365211; Bergougnoux V, 2014, BIOTECHNOL ADV, V32, P170, DOI 10.1016/j.biotechadv.2013.11.003; Britto DT, 2002, J PLANT PHYSIOL, V159, P567, DOI 10.1078/0176-1617-0774; Chen SL, 2006, AQUACULT ENG, V34, P179, DOI 10.1016/j.aquaeng.2005.09.004; Chibnall AC, 1943, BIOCHEM J, V37, P354, DOI 10.1042/bj0370354; DeLong DP, 2007, TANK CULTURE TILAPIA, V282, P1; Ebeling JM, 2006, AQUACULTURE, V257, P346, DOI 10.1016/j.aquaculture.2006.03.019; Eding EH, 2006, AQUACULT ENG, V34, P234, DOI 10.1016/j.aquaeng.2005.09.007; Endut A, 2010, BIORESOURCE TECHNOL, V101, P1511, DOI 10.1016/j.biortech.2009.09.040; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; GODDEK S, 2016, WATER SUI, V8; Graber A, 2009, DESALINATION, V246, P147, DOI 10.1016/j.desal.2008.03.048; HANLEY F, 1991, AQUACULTURE, V93, P323, DOI 10.1016/0044-8486(91)90224-U; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Hochmuth G.J, 2001, FERTILIZER MANAGEMEN, V3, P1; Jones D.B., 1941, FACTORS CONVERTING P; Kloas W, 2015, AQUACULT ENV INTERAC, V7, P179, DOI 10.3354/aei00146; KUTTY MN, 1972, MAR BIOL, V16, P126; Lakeh AAB, 2013, ULTRASON SONOCHEM, V20, P1211, DOI 10.1016/j.ultsonch.2013.01.008; Lattauschke G, 2004, HINWEISE ZUM UMWELTG, P51; Le Bot J, 1997, 2 MODELLING PLANT GR, V456, P237; Lopez-Bucio J, 2003, CURR OPIN PLANT BIOL, V6, P280, DOI 10.1016/S1369-5266(03)00035-9; Love DC, 2015, AQUACULTURE, V435, P67, DOI 10.1016/j.aquaculture.2014.09.023; Mangmang J. S., 2016, Organic Agriculture, V6, P65, DOI 10.1007/s13165-015-0115-5; MEADE JW, 1985, PROG FISH CULT, V47, P135, DOI 10.1577/1548-8640(1985)47&lt;135:AAFFC&gt;2.0.CO;2; Monsees H, 2016, AQUACULT RES; Monsees H, 2017, AQUACULT ENV INTERAC, V9, P9, DOI 10.3354/aei00205; NAEGEL LCA, 1977, AQUACULTURE, V10, P17, DOI 10.1016/0044-8486(77)90029-1; Nozzi V, 2016, FISH SHELLFISH IMMUN, V57, P179, DOI 10.1016/j.fsi.2016.07.036; Pantanella E., 2010, ACTA HORTIC, V927, P887, DOI DOI 10.17660/ACTAHORTIC.2012.927.109; PETERSON RH, 1991, J AM SOC HORTIC SCI, V116, P206, DOI 10.21273/JASHS.116.2.206; PICKEN AJF, 1984, J HORTIC SCI, V59, P1; Rakocy J. E., 2006, SRAC Publication - Southern Regional Aquaculture Center, P1; Randall D. J., 2002, Marine Pollution Bulletin, V45, P17, DOI 10.1016/S0025-326X(02)00227-8; Rennert B., 2011, FISCHER TEICHWIRT, V6, P209; Ridha MT, 2006, AQUAC RES, V37, P172, DOI 10.1111/j.1365-2109.2005.01415.x; Shnel N, 2002, AQUACULT ENG, V26, P191, DOI 10.1016/S0144-8609(02)00013-4; Smith O, 1932, J AGRIC RES, V44, P0183; Song WT, 2004, CROP PROT, V23, P243, DOI 10.1016/j.cropro.2003.08.007; Thoman ES, 2001, AQUACULT ENG, V24, P195, DOI 10.1016/S0144-8609(00)00070-4; van Bussel CGJ, 2012, AQUACULTURE, V326, P163, DOI 10.1016/j.aquaculture.2011.11.019; Verdegem MCJ, 2013, REV AQUACULT, V5, P158, DOI 10.1111/raq.12011; von Wiren N, 2000, CURR OPIN PLANT BIOL, V3, P254, DOI 10.1016/S1369-5266(00)00073-X; WATTEN BJ, 1984, AQUACULTURE, V41, P271, DOI 10.1016/0044-8486(84)90290-4; Wheeler R, 1997, INT S GROW MED HYDR, V481, P655; Wilkie MP, 2002, J EXP ZOOL, V293, P284, DOI 10.1002/jez.10123; Wood Chris M., 1993, P379; Wuertz S, 2013, COMP BIOCHEM PHYS C, V157, P352, DOI 10.1016/j.cbpc.2013.01.002	49	33	33	7	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0183056	10.1371/journal.pone.0183056	http://dx.doi.org/10.1371/journal.pone.0183056			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957357	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200008
J	Sumankuuro, J; Crockett, J; Wang, SY				Sumankuuro, Joshua; Crockett, Judith; Wang, Shaoyu			The use of antenatal care in two rural districts of Upper West Region, Ghana	PLOS ONE			English	Article							HEALTH; PREGNANCY; DELIVERY; SERVICES; BARRIERS; BIRTH; LABOR	Background Despite decades of implementation of maternity healthcare programmes, including a focus on increasing the use of antenatal care (ANC) and concomitant birth preparedness and complication readiness (BPCR), the uptake of ANC continues to be below expectations in many developing countries. This has attendant implications for maternal and infant morbidity and mortality rates. Known barriers to ANC use include cost, distance to health care services and forces of various socio-cultural beliefs and practices. As part of a larger study on BPCR in rural Ghana, this paper reflects on the use of ANC in the study areas from rights-based and maternal engagement theoretical perspectives, with a focus on the barriers to ANC use. Methods Mixed methods approach was adopted to collect data from 8 study communities from individual in-depth interviews with 80 expectant mothers and 13 health care professionals, and 24 focus groups comprising 240 community members. The qualitative data followed a thematic analytical method, while the quantitative data was analysed using descriptive statistics. Results The average number of ANC visits were 3.34 +/- 1.292, and the majority of expectant mothers (71.3%) enrolled for ANC at the 8(th) week or later, with the longest delay recorded at the 6 th month of gestation. Traditional norms significantly influenced this delay. Likewise, overall use of ANC during pregnancy was shaped by cultural factors related to perceptions of pregnancy, gender-based roles and responsibilities and concerns that ANC would result in an overweighed baby and culturally inappropriate delivery at a health care facility. Conclusion Greater understanding of the sociocultural barriers to ANC is essential if proposed changes in community-specific health education programs are to facilitate early commencement and increased use of ANC.	[Sumankuuro, Joshua; Crockett, Judith; Wang, Shaoyu] Charles Sturt Univ, Sch Community Hlth, Fac Sci, Orange, NSW, Australia	Charles Sturt University	Sumankuuro, J (corresponding author), Charles Sturt Univ, Sch Community Hlth, Fac Sci, Orange, NSW, Australia.	jsumankuuro@csu.edu.au	Sumankuuro, Joshua/AAD-9951-2019; Wang, Shaoyu/M-5948-2015	Sumankuuro, Joshua/0000-0002-8967-1091; Crockett, Judith/0000-0003-2039-4345; Wang, Shaoyu/0000-0001-8674-8965	Ghana Education Trust Fund (GETFUND) Doctorate Studentship	Ghana Education Trust Fund (GETFUND) Doctorate Studentship	This research was funded by Ghana Education Trust Fund (GETFUND) Doctorate Studentship to JS, http://www.getfund.gov.gh/. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aborigo RA, 2014, AFR J REPROD HEALTH, V18, P78; Afulani PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117996; Amzat J, 2015, J BIOETHIC INQ, V12, P283, DOI 10.1007/s11673-015-9607-y; Andrew EVW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093025; Atekyereza PR, 2014, TANZANIA J HLTH RES, V16; Atuoye KN, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1005-y; Audet CM, 2016, QUAL HEALTH RES, V26, P1721, DOI 10.1177/1049732315580302; Bayu H, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.28082; Bazzano AN, 2008, INT J GYNECOL OBSTET, V102, P91, DOI 10.1016/j.ijgo.2008.02.004; Bohren MA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001847; Caputi Mary, 2013, FEMINISM POWER NEED; Cofie LE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0604-2; D'Ambruoso L, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-140; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Ganle JK, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0590-4; Ganle JK, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0425-8; Government L, 2014, PROF NAODW DISTR ASS; GSS, 2014, 2010 POP HOUS CENS N; GSS (Ghana Statistical Services), 2014, 2010 POP HOUS CENS D; [Issa Bussie Daffiama], 2015, COMP BUDG DAFF BUSS, P55; Jack SM, 2005, J ADV NURS, V49, P182, DOI 10.1111/j.1365-2648.2004.03278.x; KRUEGER RA, 2000, FOCUS GROUPS; Lincetto O, 2006, ANTENATAL CARE OPPOR; Mrisho M, 2007, TROP MED INT HEALTH, V12, P862, DOI 10.1111/j.1365-3156.2007.01855.x; Ochako R, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-1; Peters PJ, 2007, DRUG SAFETY, V30, P481, DOI 10.2165/00002018-200730060-00003; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Sumankuuro J, 2016, INT J COMMUNITY MED, V3, P3297, DOI DOI 10.18203/2394-6040.IJCMPH20164251; Sumankuuro J, 2017, PLOS ONE, V12; Sumankuuro J, 2016, INT J INNOVATION APP, V18, P341; Witter S, 2007, INT J HEALTH PLAN M, V22, P133, DOI 10.1002/hpm.867; World Health Organization, 2017, MAT MORT FACT SHEET; World Health Organization (WHO), 2006, BIRTH EM PREP ANT CA	33	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185537	10.1371/journal.pone.0185537	http://dx.doi.org/10.1371/journal.pone.0185537			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957422	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200079
J	Fukuda, A; Tahara, K; Hane, Y; Matsui, T; Sasaoka, S; Hatahira, H; Motooka, Y; Hasegawa, S; Naganuma, M; Abe, J; Nakao, S; Takeuchi, H; Nakamura, M				Fukuda, Akiho; Tahara, Kohei; Hane, Yuuki; Matsui, Toshinobu; Sasaoka, Sayaka; Hatahira, Haruna; Motooka, Yumi; Hasegawa, Shiori; Naganuma, Misa; Abe, Junko; Nakao, Satoshi; Takeuchi, Hirofumi; Nakamura, Mitsuhiro			Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system	PLOS ONE			English	Article							PHASE-II TRIAL; ACCELERATED BLOOD CLEARANCE; METASTATIC BREAST-CANCER; HAND-FOOT SYNDROME; OVARIAN-CANCER; ANTITUMOR-ACTIVITY; SIGNAL-DETECTION; TOXICITY; CARDIOTOXICITY; INHIBITOR	Doxorubicin (DOX) is an anthracycline widely used for the treatment of solid and hematological tumors. The aim of this study was to assess the adverse event profiles of conventional DOX and liposomal DOX. This is the first study to evaluate the effect of a liposomal formulation of DOX using spontaneous reporting system (SRS) databases. The SRS used was the US Food and Drug Administration Adverse Event Reporting System (FAERS). This study relied on definitions of preferred terms provided by the Medical Dictionary for Regulatory Activities (MedDRA) and the standardized MedDRA Queries (SMQ) database. We also calculated the reporting odds ratios (RORs) of suspected drugs (conventional DOX; PEGylated-liposome DOX; non-PEGylated-liposome DOX). The FAERS database contained 7,561,254 reports from January 2004 to December 2015. The number of reported AE cases for conventional DOX, PEGylated-liposome DOX, and non-PEGylated-liposome DOX was 5039, 3780, and 349, respectively. Conventional DOX and liposomal DOX have potential risks of causing myelosuppression, cardiotoxicity, alopecia, nausea, and vomiting, among other effects. The RORs (95% CI) from SMQ for haematopoietic leucopenia associated with conventional DOX, PEGylated-liposome DOX, and non-PEGylated-liposome DOX were 12.75 (11.89-13.68), 6.43(5.81-7.13), and 14.73 (11.42-18.99), respectively. Liposomal DOX formulations were associated with lower RORs with regard to myelosuppression, cardiotoxicity, and alopecia than the conventional DOX was. The RORs (95% CI) for palmarplantar erythrodysesthesia (PPE) associated with conventional DOX, PEGylated-liposome DOX, and non-PEGylated-liposome DOX were 6.56 (4.74-9.07), 64.77 (56.84-73.80), and 28.76 (15.77-52.45), respectively. This study is the first to evaluate the relationship between DOX liposomal formulations and their adverse event profiles. The results indicate that careful observation for PPE is recommended with the use of liposomal DOX, especially PEGylated- liposome DOX formulations.	[Fukuda, Akiho; Hane, Yuuki; Matsui, Toshinobu; Sasaoka, Sayaka; Hatahira, Haruna; Motooka, Yumi; Hasegawa, Shiori; Naganuma, Misa; Abe, Junko; Nakao, Satoshi; Nakamura, Mitsuhiro] Gifu Pharmaceut Univ, Lab Drug Informat, Gifu, Gifu, Japan; [Tahara, Kohei; Takeuchi, Hirofumi] Gifu Univ, Gifu Pharmaceut Univ, Lab Pharmaceut Engn, Gifu, Gifu, Japan; [Abe, Junko] Med Database Co LTD, Shibuya Ku, Tokyo, Japan	Gifu Pharmaceutical University; Gifu Pharmaceutical University; Gifu University	Nakamura, M (corresponding author), Gifu Pharmaceut Univ, Lab Drug Informat, Gifu, Gifu, Japan.	mnakamura@gifu-pu.ac.jp		Hasegawa, Shiori/0000-0003-0444-7945; Nakao, Satoshi/0000-0001-7413-2637; Nakamura, Mitsuhiro/0000-0002-5062-5522	JSPS KAKENHI [17K08452]; Grants-in-Aid for Scientific Research [17K08452] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partially supported by JSPS KAKENHI Grant Number, 17K08452 to MN. JA was an employee of Medical Database Co., LTD during the time of the study and received a salary. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for the study.	Abe J, 2015, INT J MED SCI, V12, P312, DOI 10.7150/ijms.10703; Abraham SA, 2005, METHOD ENZYMOL, V391, P71, DOI 10.1016/S0076-6879(05)91004-5; Almenoff JS, 2007, CLIN PHARMACOL THER, V82, P157, DOI 10.1038/sj.clpt.6100258; Bate A, 2009, PHARMACOEPIDEM DR S, V18, P427, DOI 10.1002/pds.1742; Bernardi D, 2010, BREAST, V19, P549, DOI 10.1016/j.breast.2010.05.008; Brucker J, 2016, ONCOL LETT, V12, P1211, DOI 10.3892/ol.2016.4740; Chang HI, 2012, INT J NANOMED, V7, P49, DOI 10.2147/IJN.S26766; Company P& U, 2010, DOX HYDR INJ USP; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Gregoire F, 2008, BRIT J CLIN PHARMACO, V66, P142, DOI 10.1111/j.1365-2125.2008.03176.x; Ishida T, 2008, YAKUGAKU ZASSHI, V128, P233, DOI 10.1248/yakushi.128.233; Jacobi U, 2005, ANN ONCOL, V16, P1210, DOI 10.1093/annonc/mdi204; Judson I, 2001, EUR J CANCER, V37, P870, DOI 10.1016/S0959-8049(01)00050-8; Kato Y, 2015, J PHARM HEALTH CARE, V1, DOI 10.1186/s40780-015-0015-6; Kubicka-Wolkowska J, 2016, ONCOL LETT, V12, P5332, DOI 10.3892/ol.2016.5309; Lin E, 2002, ONCOLOGY-NY, V16, P31; Lombardo D, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6070125; Lorusso D, 2007, ANN ONCOL, V18, P1159, DOI 10.1093/annonc/mdl477; Lyass O, 2000, CANCER, V89, P1037, DOI 10.1002/1097-0142(20000901)89:5<1037::AID-CNCR13>3.0.CO;2-Z; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Muggia FM, 1997, J CLIN ONCOL, V15, P987, DOI 10.1200/JCO.1997.15.3.987; O'Brien MER, 2004, ANN ONCOL, V15, P440, DOI 10.1093/annonc/mdh097; Rafiyath SM, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-10; Ranson MR, 1997, J CLIN ONCOL, V15, P3185, DOI 10.1200/JCO.1997.15.10.3185; Raschi E, 2013, ACTA DIABETOL, V50, P569, DOI 10.1007/s00592-011-0340-7; Sakaeda T, 2013, INT J MED SCI, V10, P796, DOI 10.7150/ijms.6048; Sasaoka S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164309; Shiraishi K, 2016, J CONTROL RELEASE, V234, P59, DOI 10.1016/j.jconrel.2016.05.010; Smith JA, 2016, GYNECOL ONCOL, V141, P357, DOI 10.1016/j.ygyno.2016.02.033; Suzuki Y, 2015, BIOL PHARM BULL, V38, P680, DOI 10.1248/bpb.b14-00191; Tomkinson B, 2003, LEUKEMIA RES, V27, P1039, DOI 10.1016/S0145-2126(03)00092-4; Ueda N, 2015, BIOL PHARM BULL, V38, P1638, DOI 10.1248/bpb.b15-00253; Umetsu R, 2015, BIOL PHARM BULL, V38, P1689, DOI 10.1248/bpb.b15-00243; van Puijenbroek EP, 2002, PHARMACOEPIDEM DR S, V11, P3, DOI 10.1002/pds.668; Wang XY, 2007, J CONTROL RELEASE, V119, P236, DOI 10.1016/j.jconrel.2007.02.010; Wittayanukorn S, 2017, J ONCOL PHARM PRACT, V23, P93, DOI 10.1177/1078155215621150	36	36	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185654	10.1371/journal.pone.0185654	http://dx.doi.org/10.1371/journal.pone.0185654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953936	Green Submitted, Green Published, gold			2022-12-27	WOS:000411980300079
J	Lander, JM; Supp, DM; He, H; Martin, LJ; Chen, XT; Weirauch, MT; Boyce, ST; Kopan, R				Lander, Julie M.; Supp, Dorothy M.; He, Hua; Martin, Lisa J.; Chen, Xiaoting; Weirauch, Matthew T.; Boyce, Steven T.; Kopan, Raphael			Analysis of chromatin accessibility in human epidermis identifies putative barrier dysfunction-sensing enhancers	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; GENOME-WIDE ASSOCIATION; AGGRAVATES EXPERIMENTAL ASTHMA; ATOPIC-DERMATITIS; HUMAN KERATINOCYTES; EOSINOPHILIC ESOPHAGITIS; REGULATORY ELEMENTS; NETHERTON SYNDROME; TSLP EXPRESSION; SKIN BARRIER	To identify putative gene regulatory regions that respond to epidermal injury, we mapped chromatin dynamics in a stratified human epidermis during barrier maturation and disruption. Engineered skin substitutes (ESS) cultured at the air-liquid interface were used as a model of developing human epidermis with incomplete barrier formation. The epidermal barrier stabilized following engraftment onto immunocompromised mice, and was compromised again upon injury. Modified formaldehyde-assisted isolation of regulatory elements (FAIRE) was used to identify accessible genomic regions characteristic of monolayer keratinocytes, ESS in vitro, grafted ESS, and tape-stripped ESS graft. We mapped differentiation- and maturation-associated changes in transcription factor binding sites enriched at each stage and observed overrepresentation of AP-1 gene family motifs in barrier-deficient samples. Transcription of TSLP, an important effector of immunological memory in response to allergen exposure, was dramatically elevated in our barrier-deficient samples. We identified dynamic DNA elements that correlated with TSLP induction and may contain enhancers that regulate TSLP. Two dynamic regions were located near the TSLP promoter and overlapped with allergy-associated SNPs rs17551370 and rs2289877, strongly implicating these loci in the regulation of TSLP expression in allergic disease. Additional dynamic chromatin regions similar to 250kb upstream of the TSLP promoter were found to be in high linkage disequilibrium with allergic disease SNPs. Taken together, these results define dynamic chromatin accessibility changes during epidermal development and dysfunction.	[Lander, Julie M.; Weirauch, Matthew T.; Kopan, Raphael] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Dev Biol, Cincinnati, OH 45229 USA; [Supp, Dorothy M.; Boyce, Steven T.] Shriners Hosp Children, Res Dept, Cincinnati, OH USA; [Supp, Dorothy M.; Boyce, Steven T.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA; [He, Hua; Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Dept Pediat, Cincinnati, OH 45229 USA; [Chen, Xiaoting; Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Dept Pediat, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Kopan, R (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Dev Biol, Cincinnati, OH 45229 USA.	rafi.kopan@gmail.com	Supp, Dorothy/ABQ-7999-2022; Kopan, Raphael/AFG-3275-2022; Martin, Lisa/E-2425-2016; Weirauch, Matthew/M-5459-2019; Kopan, Raphael/AAF-1357-2022	Supp, Dorothy/0000-0002-2429-6630; Martin, Lisa/0000-0001-8702-9946; 	National Cancer Institute Award [P50 CA094056]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI127392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM063483] Funding Source: NIH RePORTER	National Cancer Institute Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Cancer Institute (www.cancer.gov) Award P50 CA094056 (RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Agrawal R, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0433-9; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Bao XM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0840-9; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baye TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016522; Birben E, 2014, INT ARCH ALLERGY IMM, V163, P185, DOI 10.1159/000358488; Bjerkan L, 2015, MUCOSAL IMMUNOL, V8, P49, DOI 10.1038/mi.2014.41; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; Boyce S T, 1999, Methods Mol Med, V18, P365, DOI 10.1385/0-89603-516-6:365; Boyce ST, 1998, MED BIOL ENG COMPUT, V36, P791, DOI 10.1007/BF02518886; Boyce St, 2017, PIGMENT CELL MELANOM; Briot A, 2010, J INVEST DERMATOL, V130, P2736, DOI 10.1038/jid.2010.233; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Cavazza A, 2016, STEM CELL REP, V6, P618, DOI 10.1016/j.stemcr.2016.03.003; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Cunningham TJ, 2017, J CLIN INVEST, V127, P106, DOI 10.1172/JCI89820; Danso MO, 2014, J INVEST DERMATOL, V134, P1941, DOI 10.1038/jid.2014.83; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Demehri S, 2016, J CLIN INVEST, V126, P1458, DOI 10.1172/JCI83724; Demehri S, 2012, CANCER CELL, V22, P494, DOI 10.1016/j.ccr.2012.08.017; Demehri S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000067; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ferreira MAR, 2014, J ALLERGY CLIN IMMUN, V133, P1564, DOI 10.1016/j.jaci.2013.10.030; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Furio L, 2014, J EXP MED, V211, P499, DOI 10.1084/jem.20131797; Ganti KP, 2017, P NATL ACAD SCI USA, V114, pE951, DOI 10.1073/pnas.1620697114; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Gerhold CB, 2014, TRENDS CELL BIOL, V24, P619, DOI 10.1016/j.tcb.2014.06.004; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Hanel KH, 2013, INT J MOL SCI, V14, P6720, DOI 10.3390/ijms14046720; Han H, 2012, MUCOSAL IMMUNOL, V5, P342, DOI 10.1038/mi.2012.14; Han HW, 2017, IMMUNOL REV, V278, P116, DOI 10.1111/imr.12546; Harada M, 2011, AM J RESP CELL MOL, V44, P787, DOI 10.1165/rcmb.2009-0418OC; Harada M, 2009, AM J RESP CELL MOL, V40, P368, DOI 10.1165/rcmb.2008-0041OC; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Honzke S, 2016, J INVEST DERMATOL, V136, P631, DOI 10.1016/j.jid.2015.11.007; Howell MD, 2007, J ALLERGY CLIN IMMUN, V120, P150, DOI 10.1016/j.jaci.2007.04.031; Jia XY, 2014, FEBS LETT, V588, P3047, DOI 10.1016/j.febslet.2014.06.018; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Klingenberg JM, 2010, J INVEST DERMATOL, V130, P587, DOI 10.1038/jid.2009.295; KOPAN R, 1987, J CELL BIOL, V105, P427, DOI 10.1083/jcb.105.1.427; Kottyan LC, 2014, NAT GENET, V46, P895, DOI 10.1038/ng.3033; Kumari V, 2015, BRIT J DERMATOL, V172, P951, DOI 10.1111/bjd.13465; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee KH, 2011, EXP DERMATOL, V20, P149, DOI 10.1111/j.1600-0625.2010.01203.x; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Li YJ, 2004, INT J BIOCHEM CELL B, V36, P1411, DOI 10.1016/j.biocel.2003.11.003; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Myers JMB, 2014, J ALLERGY CLIN IMMUN, V134, P891, DOI 10.1016/j.jaci.2014.03.037; Myers JMB, 2010, J INVEST DERMATOL, V130, P430, DOI 10.1038/jid.2009.300; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Oh IY, 2014, J INVEST DERMATOL, V134, P2371, DOI 10.1038/jid.2014.44; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Quigley DA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r5; Quigley DA, 2009, NATURE, V458, P505, DOI 10.1038/nature07683; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Roan F, 2012, J LEUKOCYTE BIOL, V91, P877, DOI 10.1189/jlb.1211622; Roupe KM, 2010, J INVEST DERMATOL, V130, P1167, DOI 10.1038/jid.2009.284; Rubin AJ, 2017, NAT GENET; Samochocki Z, 2013, J AM ACAD DERMATOL, V69, P238, DOI 10.1016/j.jaad.2013.03.014; Sato-Deguchi E, 2012, BRIT J DERMATOL, V167, P77, DOI 10.1111/j.1365-2133.2012.10917.x; Schmuth M, 2015, J DTSCH DERMATOL GES, V13, P1119, DOI 10.1111/ddg.12827; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Simon Jeremy M, 2013, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2126s102; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Stevens TJ, 2017, NATURE, V544, P59, DOI 10.1038/nature21429; Takai T, 2014, METHOD ENZYMOL, V535, P371, DOI 10.1016/B978-0-12-397925-4.00021-3; Takai T, 2012, ALLERGOL INT, V61, P3, DOI 10.2332/allergolint.11-RAI-0395; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uller L, 2010, THORAX, V65, P626, DOI 10.1136/thx.2009.125930; van den Bogaard EH, 2014, J INVEST DERMATOL, V134, P719, DOI 10.1038/jid.2013.417; Verstraete K, 2014, NAT STRUCT MOL BIOL, V21, P375, DOI 10.1038/nsmb.2794; Vu AT, 2011, J INVEST DERMATOL, V131, P2205, DOI 10.1038/jid.2011.185; Vu AT, 2010, J ALLERGY CLIN IMMUN, V126, P985, DOI 10.1016/j.jaci.2010.09.002; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wells A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1262; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Xie Y, 2012, J DERMATOL SCI, V66, P233, DOI 10.1016/j.jdermsci.2012.03.007; Yates S, 2002, WOUND REPAIR REGEN, V10, P5, DOI 10.1046/j.1524-475X.2002.10902.x; Yockey LJ, 2013, J INVEST DERMATOL, V133, P2714, DOI 10.1038/jid.2013.228; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zhang Z, 2009, P NATL ACAD SCI USA, V106, P1536, DOI 10.1073/pnas.0812668106	97	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184500	10.1371/journal.pone.0184500	http://dx.doi.org/10.1371/journal.pone.0184500			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953906	Green Submitted, Green Published, gold			2022-12-27	WOS:000411980300013
J	Moon, MH; Beck, KS; Moon, YK; Park, JK; Sung, SW				Moon, Mi Hyoung; Beck, Kyongmin Sarah; Moon, Young Kyu; Park, Jae Kil; Sung, Sook Whan			Incidence and clinical features of the incidentally found vascular stump thrombus during routine follow up after oncologic lung surgery	PLOS ONE			English	Article							PULMONARY VEIN STUMP; VENOUS THROMBOEMBOLISM; HELICAL CT; LOBECTOMY; RISK	Objectives We aimed to evaluate the incidence and clinical features of vascular stump thrombus after oncologic lung surgery. Methods A retrospective analysis of records from our institutional database dated between 2009 and 2016 was performed. Data regarding demographics, clinical presentation, medication use, operative findings, pathology, and radiologic findings were retrieved. Results The study cohort consisted of 648 oncologic surgeries for primary lung cancer. The incidence of thrombus in the entire population was 5.7% (37/648). Most thrombi were incidentally found on follow-up chest computed tomography scans. Univariate Cox proportional hazard analysis showed that age (p = 0.02), adjuvant therapy (p <0.001), neoadjuvant therapy (p = 0.04), left-sided surgery (p = 0.02), complex surgery greater than simple lobectomy or segmentectomy (p <0.001), advanced stages (p <0.001), non-adenocarcinoma (p = 0.003), and thoracotomy approach (p = 0.009) were associated with an increased risk of vascular stump thrombus. There were no embolic events in our cohort, except for a case of pulmonary thromboembolism. During follow-up, 43.2% (16/37) of thrombi had completely resolved, 48.6% (18/37) showed partial regression and stabilization, and 8.1% (3/37) had progressed. Conclusions The incidence of vascular stump thrombus in our study was not negligible. The clinical course of stump thrombus appears to be benign in most cases. Anticoagulation may be used with caution based on an individual basis depending on each patient's risk factors.	[Moon, Mi Hyoung; Moon, Young Kyu; Park, Jae Kil; Sung, Sook Whan] Catholic Univ Korea, Seoul St Marys Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Beck, Kyongmin Sarah] Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Sung, SW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.	swsung@catholic.ac.kr		Sung, Sook Whan/0000-0002-8480-0915; Beck, Kyongmin/0000-0002-9262-1001				Agzarian J, 2016, J THORAC CARDIOV SUR, V151, P992, DOI 10.1016/j.jtcvs.2015.11.038; Barbetakis N, 2011, ANN THORAC SURG, V91, pE44, DOI 10.1016/j.athoracsur.2010.12.037; Chuang T H, 1966, Ann Thorac Surg, V2, P290; Gosselin MV, 1998, RADIOLOGY, V208, P209, DOI 10.1148/radiology.208.1.9646815; Ichimura H, 2014, ANN THORAC CARDIOVAS, V20, P613, DOI 10.5761/atcs.cr.13-00079; ICHINOSE Y, 1991, CHEST, V100, P693, DOI 10.1378/chest.100.3.693; Joshi M, 2009, THROMB J, V7, DOI 10.1186/1477-9560-7-7; Kilic D, 2007, GEN THORAC CARDIOVAS, V55, P287, DOI 10.1007/s11748-007-0124-8; Kim SY, 2005, AM J ROENTGENOL, V185, P985, DOI 10.2214/AJR.04.1515; Kwek BH, 2005, RADIOLOGY, V237, P338, DOI 10.1148/radiol.2371041686; Lazopoulos A, 2015, ANN THORAC SURG, V100, P330, DOI 10.1016/j.athoracsur.2015.03.048; Ohtaka K, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/s13019-014-0159-8; Ohtaka K, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-5; Ohtaka K, 2013, ANN THORAC SURG, V95, P1924, DOI 10.1016/j.athoracsur.2013.03.005; Ohtaka K, 2012, J THORAC CARDIOV SUR, V143, pE3, DOI 10.1016/j.jtcvs.2011.09.025; Streiff MB, 2010, THROMB RES, V125, pS128, DOI 10.1016/S0049-3848(10)70030-X; Tesselaar MET, 2007, CURR OPIN PULM MED, V13, P362, DOI 10.1097/MCP.0b013e328209413c; Travis William D, 2011, Proc Am Thorac Soc, V8, P381, DOI 10.1513/pats.201107-042ST; Winston CB, 1996, RADIOLOGY, V201, P23, DOI 10.1148/radiology.201.1.8816515; Yang Y, 2012, J SURG ONCOL, V106, P736, DOI 10.1002/jso.23190	20	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185140	10.1371/journal.pone.0185140	http://dx.doi.org/10.1371/journal.pone.0185140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953945	gold, Green Published, Green Submitted			2022-12-27	WOS:000411980300038
J	Ansari, M				Ansari, Mukhtar			Evaluation of community pharmacies regarding dispensing practices of antibiotics in two districts of central Nepal	PLOS ONE			English	Article							SAUDI-ARABIA; KNOWLEDGE; INDIA	Objective To evaluate the status of community pharmacies, their staff, and practices toward dispensing antibiotics. Design Cross-sectional, prospective. Place and duration of study Community pharmacies in two districts of central Nepal, from March 2016 to May 2016. Methods A systematic random sampling approach was adopted to sample 161 community pharmacies. Data on the registration status of pharmacies, qualification or training of dispensing staff, and the practice of dispensing antibiotics were collected using a pre-tested questionnaire. Face to face interviews were carried out by a previously trained interviewer. Data were analyzed for descriptive and inferential statistics using IBM SPSS Statistics 21. Results Among 161 community pharmacies, 25% were not registered and most of them were located in rural areas. It was typical (66.5%) to dispense antibiotics without prescription and most (91.4%) of the staffs involved in dispensing were non-pharmacists. Furthermore, the study revealed common practices of replacing one brand of antibiotic with other brands (66%), dispensing incomplete courses of antibiotics (73%), and not giving any advice regarding antibiotic use (39%) or completion of a full course of therapy (80%). There were significant (p < 0.001) relationships between the location of pharmacies (rural vs urban) and the qualifications of the pharmacy staff. Conclusion Dispensing antibiotics without prescription and by non-pharmacists are common in this region. The study also found several issues regarding the irrational use of antibiotics. Thus, there is an urgent need to address these issues and promote the informed use of antibiotics.	[Ansari, Mukhtar] Univ Hail, Coll Pharm, Dept Clin Pharm, Hail, Saudi Arabia	University Ha'il	Ansari, M (corresponding author), Univ Hail, Coll Pharm, Dept Clin Pharm, Hail, Saudi Arabia.	mukhtaransari@hotmail.com	ansari, mukhtar/A-1506-2017	ansari, mukhtar/0000-0002-5247-6356				Ahmad A, 2014, ANN MED HEALTH SCI R, V4, P73, DOI 10.4103/2141-9248.138012; Alshakka M., 2016, J PHARM PRACT COMMUN, V2, P88, DOI [10.5530/jppcm.2016.3.5, DOI 10.5530/JPPCM.2016.3.5]; [Anonymous], 2011, WORLD HLTH STAT; Ansari M., 2013, INDIAN J PHARM PRACT, V6, P62; Ansari M, 2012, NATL J LAB MED, V1, P29; Belkina T, 2014, J INFECT DEV COUNTR, V8, P424, DOI 10.3855/jidc.3866; Bhuvan KC, 2013, AUSTRALAS MED J, V6, P100, DOI 10.4066/AMJ.2013.1544; Chapman C, 2011, AUST PRESCR, V34, P34; Nga DTT, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-6; Gokcekus L, 2012, INT J CLIN PHARM-NET, V34, P312, DOI 10.1007/s11096-011-9605-z; Gupta R P, 2013, J Nepal Health Res Counc, V11, P144; Gyawali S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-190; Hadi MA, 2016, INT J INFECT DIS, V47, P95, DOI 10.1016/j.ijid.2016.06.003; Kafle K K, 2013, J Nepal Health Res Counc, V11, P198; KAFLE KK, 1992, SOC SCI MED, V35, P1015, DOI 10.1016/0277-9536(92)90241-H; Lowe RF., 2009, S MED REV, V2, P35; Luitel NP, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-014-0030-5; Miller R, 2016, HLTH POLICY PLANNING; Ministry of Health and Population, 2014, NAT ANT TREATM GUID; Palaian Subish, 2010, Pharmacy Pract (Granada), V8, P201; Population Division M. o. H. a. P.  Government of Nepal, 2012, NEP DEM HLTH SURV 20; Poudel A, 2009, J CLIN DIAGN RES, V3, P1408; Roche C, 2014, PHARMACY, V2, P74, DOI 10.3390/pharmacy2010074; Seeberg J, 2012, MED ANTHROPOL Q, V26, P182, DOI 10.1111/j.1548-1387.2012.01200.x; Toklu HZ, 2015, INTEGR PHARM RES PRA, V4, P127, DOI 10.2147/IPRP.S70406; Vu DH, 2012, INT J TUBERC LUNG D, V16, P1625, DOI 10.5588/ijtld.12.0295	26	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							0183907	10.1371/journal.pone.0183907	http://dx.doi.org/10.1371/journal.pone.0183907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949990	Green Submitted, Green Published, gold			2022-12-27	WOS:000411671000005
J	Basak, P; Maitra-Majee, S; Das, JK; Mukherjee, A; Dastidar, SG; Choudhury, PP; Majumder, AL				Basak, Papri; Maitra-Majee, Susmita; Das, Jayanta Kumar; Mukherjee, Abhishek; Dastidar, Shubhra Ghosh; Choudhury, Pabitra Pal; Majumder, Arun Lahiri			An evolutionary analysis identifies a conserved pentapeptide stretch containing the two essential lysine residues for rice L-myo-inositol 1-phosphate synthase catalytic activity	PLOS ONE			English	Article							COARCTATA ROXB. TATEOKA; HALOPHYTIC WILD-RICE; INOSITOL-1-PHOSPHATE SYNTHASE; CRYSTAL-STRUCTURE; SALT TOLERANCE; ARCHAEOGLOBUS-FULGIDUS; MOLECULAR-CLONING; AMINO-GROUPS; MECHANISM; CYCLASE	A molecular evolutionary analysis of a well conserved protein helps to determine the essential amino acids in the core catalytic region. Based on the chemical properties of amino acid residues, phylogenetic analysis of a total of 172 homologous sequences of a highly conserved enzyme, L-myo-inositol 1-phosphate synthase or MIPS from evolutionarily diverse organisms was performed. This study revealed the presence of six phylogenetically conserved blocks, out of which four embrace the catalytic core of the functional protein. Further, specific amino acid modifications targeting the lysine residues, known to be important for MIPS catalysis, were performed at the catalytic site of a MIPS from monocotyledonous model plant, Oryza sativa (OsMIPS1). Following this study, OsMIPS mutants with deletion or replacement of lysine residues in the conserved blocks were made. Based on the enzyme kinetics performed on the deletion/ replacement mutants, phylogenetic and structural comparison with the already established crystal structures from non-plant sources, an evolutionarily conserved peptide stretch was identified at the active pocket which contains the two most important lysine residues essential for catalytic activity.	[Basak, Papri; Maitra-Majee, Susmita; Mukherjee, Abhishek; Majumder, Arun Lahiri] Bose Inst, Div Plant Biol, Centenary Campus, Kolkata, W Bengal, India; [Das, Jayanta Kumar; Choudhury, Pabitra Pal] Indian Stat Inst, Appl Stat Unit, Kolkata, W Bengal, India; [Dastidar, Shubhra Ghosh] Bose Inst, Bioinformat Ctr, Centenary Campus, Kolkata, W Bengal, India; [Maitra-Majee, Susmita] Univ Delhi, Dept Plant Mol Biol, South Campus, New Delhi, India	Department of Science & Technology (India); Bose Institute; Indian Statistical Institute; Indian Statistical Institute Kolkata; Department of Science & Technology (India); Bose Institute; University of Delhi	Majumder, AL (corresponding author), Bose Inst, Div Plant Biol, Centenary Campus, Kolkata, W Bengal, India.	lahiri@mail.jcbose.ac.in		Das, Jayanta Kumar/0000-0002-7630-7194	Department of Atomic Energy [10/25/2010/RRF-RD-II/3118]; Department of Biotechnology [BT/AB/05/02/2007-III]; Council of Scientific & Industrial Research [09/015(0447)/2012-EMR-I]	Department of Atomic Energy(Department of Atomic Energy (DAE)); Department of Biotechnology; Council of Scientific & Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by: 1. Department of Atomic Energy - D.O. No. 10/25/2010/RRF-R&D-II/3118, ALM; 2. Department of Biotechnology- BT/AB/05/02/2007-III, ALM; 3. Council of Scientific & Industrial Research- 09/015(0447)/2012-EMR-I, PB.	BARNETT JEG, 1968, BIOCHEM J, V108, P125, DOI 10.1042/bj1080125; BARNETT JEG, 1970, BIOCHEM J, V119, P183, DOI 10.1042/bj1190183; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Butzin NC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084300; Chen LJ, 2000, BIOCHEMISTRY-US, V39, P12415, DOI 10.1021/bi001517q; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Comeron JM, 1995, J MOL EVOL, V41, P1152, DOI 10.1007/BF00173196; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Das JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167651; Das-Chatterjee A, 2006, FEBS LETT, V580, P3980, DOI 10.1016/j.febslet.2006.06.033; Dastidar KG, 2006, PLANT PHYSIOL, V140, P1279, DOI 10.1104/pp.105.075150; Dayhoff MO., 1978, ATLAS PROTEIN SEQ S3, P29; DOPAZO J, 1994, J MOL EVOL, V38, P300, DOI 10.1007/BF00176092; GHOSH M, 1994, BIOCHEM J, V298, P295, DOI 10.1042/bj2980295; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; Jin XS, 2004, J BIOL CHEM, V279, P13889, DOI 10.1074/jbc.M308986200; Jin XS, 2003, ACTA CRYSTALLOGR D, V59, P1154, DOI 10.1107/S0907444903008205; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LOEWUS MW, 1977, J BIOL CHEM, V252, P7221; Majee M, 2004, J BIOL CHEM, V279, P28539, DOI 10.1074/jbc.M310138200; Majumder AL, 1997, BBA-LIPID LIPID MET, V1348, P245, DOI 10.1016/S0005-2760(97)00122-7; Majumder AL, 2003, FEBS LETT, V553, P3, DOI 10.1016/S0014-5793(03)00974-8; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; Neelon K, 2005, J BIOL CHEM, V280, P11475, DOI 10.1074/jbc.M500469200; Neelon K, 2011, BIOPHYS J, V101, P2816, DOI 10.1016/j.bpj.2011.10.038; Nelson DE, 1998, PLANT CELL, V10, P753; Nesbo CL, 2001, MOL BIOL EVOL, V18, P362, DOI 10.1093/oxfordjournals.molbev.a003812; Norman RA, 2002, STRUCTURE, V10, P393, DOI 10.1016/S0969-2126(02)00718-9; Patra B, 2007, PLANTA, V225, P1547, DOI 10.1007/s00425-006-0441-7; PELTON PD, 1992, J BIOL CHEM, V267, P5916; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PLAPP BV, 1971, J BIOL CHEM, V246, P939; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; SHERMAN WR, 1969, J BIOL CHEM, V244, P5703; Simon AL, 2002, P NATL ACAD SCI USA, V99, P2912, DOI 10.1073/pnas.042692299; Stein AJ, 2002, J BIOL CHEM, V277, P9484, DOI 10.1074/jbc.M109371200; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730	40	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185351	10.1371/journal.pone.0185351	http://dx.doi.org/10.1371/journal.pone.0185351			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950028	gold, Green Published, Green Submitted			2022-12-27	WOS:000411671000041
J	Dudczig, S; Currie, PD; Jusuf, PR				Dudczig, Stefanie; Currie, Peter David; Jusuf, Patricia Regina			Developmental and adult characterization of secretagogin expressing amacrine cells in zebrafish retina	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; CONE BIPOLAR CELLS; CA2+-BINDING PROTEIN; ALZHEIMERS-DISEASE; DANIO-RERIO; CONTAINING NEURONS; MAMMALIAN RETINA; MORPHOLOGICAL CLASSIFICATION; HUMAN HIPPOCAMPUS; NERVOUS-SYSTEM	Calcium binding proteins show stereotypical expression patterns within diverse neuron types across the central nervous system. Here, we provide a characterization of developmental and adult secretagogin-immunolabelled neurons in the zebrafish retina with an emphasis on co-expression of multiple calcium binding proteins. Secretagogin is a recently identified and cloned member of the F-hand family of calcium binding proteins, which labels distinct neuron populations in the retinas of mammalian vertebrates. Both the adult distribution of secretagogin labeled retinal neurons as well as the developmental expression indicative of the stage of neurogenesis during which this calcium binding protein is expressed was quantified. Secretagogin expression was confined to an amacrine interneuron population in the inner nuclear layer, with monostratified neurites in the center of the inner plexiform layer and a relatively regular soma distribution (regularity index > 2.5 across central-peripheral areas). However, only a subpopulation (similar to 60%) co-labeled with gamma-aminobutyric acid as their neurotransmitter, suggesting that possibly two amacrine subtypes are secretagogin immunoreactive. Quantitative co-labeling analysis with other known amacrine subtype markers including the three main calcium binding proteins parvalbumin, calbindin and calretinin identifies secretagogin immunoreactive neurons as a distinct neuron population. The highest density of secretagogin cells of similar to 1800 cells / mm(2) remained relatively evenly along the horizontal meridian, whilst the density dropped of to 125 cells / mm(2) towards the dorsal and ventral periphery. Thus, secretagogin represents a new amacrine label within the zebrafish retina. The developmental expression suggests a possible role in late stage differentiation. This characterization forms the basis of functional studies assessing how the expression of distinct calcium binding proteins might be regulated to compensate for the loss of one of the others.	[Dudczig, Stefanie; Currie, Peter David; Jusuf, Patricia Regina] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Dudczig, Stefanie; Jusuf, Patricia Regina] Univ Melbourne, Sch Biosci, Parkville, Vic, Australia	Australian Regenerative Medicine Institute; Monash University; University of Melbourne	Jusuf, PR (corresponding author), Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia.; Jusuf, PR (corresponding author), Univ Melbourne, Sch Biosci, Parkville, Vic, Australia.	patricia.jusuf@unimelb.edu.au	Jusuf, Patricia/V-3476-2019	Jusuf, Patricia/0000-0003-0747-4084; Currie, Peter/0000-0001-8874-8862	ARC Discovery Project grant [DP130102395]; ARC DECRA [DE120101311]; State Government of Victoria; Australian Federal Government	ARC Discovery Project grant(Australian Research Council); ARC DECRA(Australian Research Council); State Government of Victoria; Australian Federal Government(Australian Government)	This project was supported by an ARC Discovery Project grant (DP130102395) and ARC DECRA (DE120101311). The Australian Regenerative Medicine Institute is supported by funds from the State Government of Victoria and the Australian Federal Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpar A, 2012, CELL SIGNAL, V24, P378, DOI 10.1016/j.cellsig.2011.09.028; ANDRESSEN C, 1993, CELL TISSUE RES, V271, P181, DOI 10.1007/BF00318606; Attems J, 2008, NEUROPATH APPL NEURO, V34, P23, DOI 10.1111/j.1365-2990.2007.00854.x; Attems J, 2007, EXP GERONTOL, V42, P215, DOI 10.1016/j.exger.2006.09.018; Attems J, 2012, P NATL ACAD SCI USA, V109, P6259, DOI 10.1073/pnas.1203843109; Bai YF, 2014, ONCOTARGET, V5, P7760, DOI 10.18632/oncotarget.2305; Bauer MC, 2011, MOL BIOSYST, V7, P2196, DOI 10.1039/c0mb00349b; Braunewell KH, 2005, TRENDS PHARMACOL SCI, V26, P345, DOI 10.1016/j.tips.2005.04.008; Burgoyne RD, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-2; Camandola S, 2011, BBA-MOL CELL RES, V1813, P965, DOI 10.1016/j.bbamcr.2010.10.005; Cederlund ML, 2011, INVEST OPHTH VIS SCI, V52, P1613, DOI 10.1167/iovs.10-5376; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Chen YC, 2009, HISTOCHEM CELL BIOL, V132, P375, DOI 10.1007/s00418-009-0619-8; Chiquet C, 2005, BRAIN RES BULL, V68, P185, DOI 10.1016/j.brainresbull.2005.08.010; Connaughton VP, 2004, J COMP NEUROL, V477, P371, DOI 10.1002/cne.20261; Connaughton VP, 1999, VISUAL NEUROSCI, V16, P483, DOI 10.1017/S0952523899163090; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Di Donato V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053299; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Garas FN, 2016, ELIFE, V5, DOI 10.7554/eLife.16088; Gartner W, 2001, CEREB CORTEX, V11, P1161, DOI 10.1093/cercor/11.12.1161; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Gyengesi E, 2013, BRAIN RES BULL, V94, P1, DOI 10.1016/j.brainresbull.2013.01.009; Hanics J, 2017, P NATL ACAD SCI USA, V114, pE2006, DOI 10.1073/pnas.1700662114; Haverkamp S, 2003, VISUAL NEUROSCI, V20, P589, DOI 10.1017/S0952523803206015; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; HEIZMANN CW, 1992, TRENDS NEUROSCI, V15, P259, DOI 10.1016/0166-2236(92)90067-I; HEIZMANN CW, 1992, GEN PHYSIOL BIOPHYS, V11, P411; Hermes M, 2010, J CELL MOL MED, V14, P30, DOI 10.1111/j.1582-4934.2009.00976.x; Jusuf PR, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-34; Kantor O, 2016, CELL TISSUE RES, V365, P29, DOI 10.1007/s00441-016-2376-z; Kerschensteiner D, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00038; Khandelwal R, 2017, BIOCHEMISTRY-US, V56, P411, DOI 10.1021/acs.biochem.6b00761; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kosaka K, 2013, NEUROSCI RES, V77, P16, DOI 10.1016/j.neures.2013.08.006; Kosaka T, 2017, NEUROSCI RES, V119, P53, DOI 10.1016/j.neures.2017.01.004; Kuscha V, 2012, J COMP NEUROL, V520, P933, DOI 10.1002/cne.22739; Light AC, 2012, J COMP NEUROL, V520, P2864, DOI 10.1002/cne.23068; Maj M, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00084; Maj M, 2010, J ENDOCRINOL, V205, P25, DOI 10.1677/JOE-09-0341; Mangrum WI, 2002, VISUAL NEUROSCI, V19, P767, DOI 10.1017/S0952523802196076; Martin ZS, 2012, J NEUROCHEM, V120, P440, DOI 10.1111/j.1471-4159.2011.07576.x; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Masland RH, 2012, VISUAL NEUROSCI, V29, P3, DOI 10.1017/S0952523811000344; Matsuda K, 2009, COMP BIOCHEM PHYS A, V153, P3, DOI 10.1016/j.cbpa.2008.10.002; Mikhaylova M, 2011, J NEUROCHEM, V118, P695, DOI 10.1111/j.1471-4159.2011.07372.x; Mulder J, 2010, EUR J NEUROSCI, V31, P2166, DOI 10.1111/j.1460-9568.2010.07275.x; Mulder J, 2009, P NATL ACAD SCI USA, V106, P22492, DOI 10.1073/pnas.0912484106; Olsson C, 2008, J COMP NEUROL, V508, P756, DOI 10.1002/cne.21705; PASTEELS B, 1990, VISUAL NEUROSCI, V5, P1, DOI 10.1017/S0952523800000031; Puthussery T, 2011, J COMP NEUROL, V519, P3640, DOI 10.1002/cne.22756; Puthussery T, 2010, J COMP NEUROL, V518, P513, DOI 10.1002/cne.22234; Raju CS, 2017, CEREB CORTEX, P1; Rogstam A, 2007, BIOCHEM J, V401, P353, DOI 10.1042/BJ20060918; Romanov RA, 2015, EMBO J, V34, P36, DOI 10.15252/embj.201488977; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Schwaller B, 2009, CELL MOL LIFE SCI, V66, P275, DOI 10.1007/s00018-008-8564-6; Schwaller B, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00003; Shi TJS, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-80; Skovhus KV, 2006, SCAND J IMMUNOL, V64, P639, DOI 10.1111/j.1365-3083.2006.01854.x; Song PI, 2008, J COMP NEUROL, V506, P328, DOI 10.1002/cne.21549; Uyttebroek L, 2010, J COMP NEUROL, V518, P4419, DOI 10.1002/cne.22464; Vitorino M, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-14; Wagner L, 2000, J BIOL CHEM, V275, P24740, DOI 10.1074/jbc.M001974200; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WASSLE H, 1978, PROC R SOC SER B-BIO, V200, P441, DOI 10.1098/rspb.1978.0026; Wassle H, 1998, CELL TISSUE RES, V292, P211, DOI 10.1007/s004410051052; Weltzien F, 2014, J COMP NEUROL, V522, P435, DOI 10.1002/cne.23420; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Yeo JY, 2009, EXP EYE RES, V88, P553, DOI 10.1016/j.exer.2008.11.014; Yu JT, 2009, PROG NEUROBIOL, V89, P240, DOI 10.1016/j.pneurobio.2009.07.009; Zhang RW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12650	74	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185107	10.1371/journal.pone.0185107	http://dx.doi.org/10.1371/journal.pone.0185107			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949993	Green Published, gold			2022-12-27	WOS:000411671000024
J	Bonadonna, LV; Saunders, MJ; Zegarra, R; Evans, C; Alegria-Flores, K; Guio, H				Bonadonna, Lily Victoria; Saunders, Matthew James; Zegarra, Roberto; Evans, Carlton; Alegria-Flores, Kei; Guio, Heinner			Why wait? The social determinants underlying tuberculosis diagnostic delay	PLOS ONE			English	Article							HEALTH SEEKING BEHAVIOR; PULMONARY TUBERCULOSIS; PERUVIAN AMAZON; CARE-SYSTEM; PATIENT; PERCEPTIONS; COMMUNITY; SEARCH; MEXICO	Background Early detection and diagnosis of tuberculosis remain major global priorities for tuberculosis control. Few studies have used a qualitative approach to investigate the social determinants contributing to diagnostic delay and none have compared data collected from individual, community, and health-system levels. We aimed to characterize the social determinants that contribute to diagnostic delay among persons diagnosed with tuberculosis living in resource-constrained settings. Methods/Principle findings Data were collected in public health facilities with high tuberculosis incidence in 19 districts of Lima, Peru. Semi-structured interviews with persons diagnosed with tuberculosis (n = 105) and their family members (n = 63) explored health-seeking behaviours, community perceptions of tuberculosis and socio-demographic circumstances. Focus groups (n = 6) were conducted with health personnel (n = 35) working in the National Tuberculosis Program. All interview data were transcribed and analysed using a grounded theory approach. The median delay between symptom onset and the public health facility visit that led to the first positive diagnostic sample was 57 days (interquartile range 28-126). The great majority of persons diagnosed with tuberculosis distrusted the public health system and sought care at public health facilities only after exhausting other options. It was universally agreed that persons diagnosed with tuberculosis faced discrimination by public and health personnel. Selfmedication with medicines bought at local pharmacies was reported as the most common initial health-seeking behaviour due to the speed and low-cost of treatment in pharmacies. Most persons diagnosed with tuberculosis initially perceived their illness as a simple virus. Conclusions Diagnostic delay was common and prolonged. When individuals reached a threshold of symptom severity, they addressed their health with the least time-consuming, most economically feasible, and well-known healthcare option available to them. In high-burden settings, more human and material resources are required to promote tuberculosis casefinding initiatives, reduce tuberculosis associated stigma and address the social determinants underlying diagnostic delay.	[Bonadonna, Lily Victoria] Univ Michigan, Ann Arbor, MI 48109 USA; [Bonadonna, Lily Victoria; Zegarra, Roberto; Guio, Heinner] Inst Nacl Salud, Lima, Peru; [Bonadonna, Lily Victoria; Saunders, Matthew James; Evans, Carlton] Asociac Benef PRISMA, IPSYD, Lima, Peru; [Bonadonna, Lily Victoria; Saunders, Matthew James; Evans, Carlton] Univ Peruana Cayetano Heredia, Res & Dev Lab, IFHAD, Lima, Peru; [Saunders, Matthew James; Evans, Carlton] Imperial Coll London, Infect Dis & Immun, London, England; [Saunders, Matthew James; Evans, Carlton] Imperial Coll, Wellcome Trust, Ctr Global Hlth Res, London, England; [Alegria-Flores, Kei] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA	University of Michigan System; University of Michigan; Instituto Nacional de Salud - Peru; Universidad Peruana Cayetano Heredia; Imperial College London; Imperial College London; University of London; University College London; University of North Carolina; University of North Carolina Chapel Hill	Bonadonna, LV (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.; Bonadonna, LV (corresponding author), Inst Nacl Salud, Lima, Peru.; Bonadonna, LV (corresponding author), Asociac Benef PRISMA, IPSYD, Lima, Peru.; Bonadonna, LV (corresponding author), Univ Peruana Cayetano Heredia, Res & Dev Lab, IFHAD, Lima, Peru.	bonalily@umich.edu	Zegarra, Roberto/GZL-1482-2022; Guio, Heinner/G-9874-2017	Zegarra, Roberto/0000-0002-0471-9413; Evans, Carlton/0000-0002-6873-5447; Guio, Heinner/0000-0003-0078-1188; Saunders, Matthew/0000-0003-3033-2367	Raoul Wallenberg Fellowship, granted through the University of Michigan; Joint Global Health Trials consortium of the Wellcome Trust, UK-MRC and DFID [MR/K007467/1]; Bill and Melinda Gates Foundation award [OPP1118545]; IFHAD: Innovation For Health And Development; Wellcome Trust [201251/Z/16/Z, 105788/Z/14/Z]; Imperial College Biomedical Research Centre; Medical Research Council [MR/K007467/1] Funding Source: researchfish; Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative [OPP1118545] Funding Source: researchfish; MRC [MR/K007467/1] Funding Source: UKRI	Raoul Wallenberg Fellowship, granted through the University of Michigan; Joint Global Health Trials consortium of the Wellcome Trust, UK-MRC and DFID(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation award; IFHAD: Innovation For Health And Development; Wellcome Trust(Wellcome TrustEuropean Commission); Imperial College Biomedical Research Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The data collection activities for this research were funded by the 2014 Raoul Wallenberg Fellowship, granted through the University of Michigan. The contributions of LVB, MJS and CAE to this research were funded by: the Joint Global Health Trials consortium of the Wellcome Trust, UK-MRC and DFID (award MR/K007467/1); The Bill and Melinda Gates Foundation award OPP1118545; and IFHAD: Innovation For Health And Development. The contributions of CAE and MJS to this research were also funded by Wellcome Trust (award 201251/Z/16/Z). The contributions of CAE to this research were also funded by the Imperial College Biomedical Research Centre and the Wellcome Trust (award 105788/Z/14/Z).	Alvarez-Gordillo GD, 2000, SALUD PUBLICA MEXICO, V42, P520, DOI 10.1590/S0036-36342000000600008; Baldwin MR, 2004, INT J TUBERC LUNG D, V8, P1484; Baral SC, 2007, CAUSES STIGMA DISCRI, V10, P1; BARNHOORN F, 1992, SOC SCI MED, V34, P291, DOI 10.1016/0277-9536(92)90271-Q; Boccia D, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P37, DOI 10.5588/ijtld.10.0438; Bryman A., 2008, SOCIAL RES METHODS; Bustamante-Montes LP, 2000, INT J TUBERC LUNG D, V4, P208; Chikovore J, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.26292; Chimbatata NBW, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0279-1; District N, 2015, PLOS ONE, V1; Dodor EA, 2010, HEALTH POLICY, V98, P195, DOI 10.1016/j.healthpol.2010.06.017; Farmer P, 1991, Semin Respir Infect, V6, P254; Ford CM, 2009, AM J TROP MED HYG, V81, P1097, DOI 10.4269/ajtmh.2009.08-0627; Golub JE, 2005, INT J TUBERC LUNG D, V9, P392; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; Hu A, 2012, HEALTH CARE WOMEN IN, V33, P29, DOI 10.1080/07399332.2011.630495; Johansson E, 2000, HEALTH POLICY, V52, P33, DOI 10.1016/S0168-8510(00)00062-2; Kawai V, 2006, AM J TROP MED HYG, V75, P1027, DOI 10.4269/ajtmh.2006.75.1027; Kiwuwa MS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-122; Liefooghe R, 1997, TROP MED INT HEALTH, V2, P809, DOI 10.1046/j.1365-3156.1997.d01-380.x; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 1999, INT J TUBERC LUNG D, V3, P992; Martinez L, 2013, AM J TROP MED HYG, V89, P507, DOI 10.4269/ajtmh.13-0005; Onifade DA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-381; Pan American Health Organization, 2014, TUB AM REG REP 2014; Rios H.C. Graciela, 2004, REV PERU MED EXP SAL, V21, P18; Rocha C, 2011, INT J TUBERC LUNG S2, V15; Rojpibulstit M, 2006, INT J TUBERC LUNG D, V10, P422; RUBEL AJ, 1992, PUBLIC HEALTH REP, V107, P626; Sagbakken M, 2008, QUAL HEALTH RES, V18, P1356, DOI 10.1177/1049732308322596; Saunders MJ, 2016, LANCET INFECT DIS, V16, P395, DOI 10.1016/S1473-3099(15)00434-X; Sekandi JN, 2015, BMC INFECT DIS, P1; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Tattevin P, 2012, INT J TUBERC LUNG D, V16, P510, DOI 10.5588/ijtld.11.0420; Ukwaja KN, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-25; Uys PW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000757; Verhagen LM, 2010, INFECTION, V38, P433, DOI 10.1007/s15010-010-0051-y; Wang M, 2011, INT J TUBERC LUNG D, V15, P1062, DOI 10.5588/ijtld.10.0734; Westerlund EE, 2015, J INFECTION, V71, P347, DOI 10.1016/j.jinf.2015.05.010; *WHO, 2004, WHO REP 2004 GLOB TU; WILKINSON D, 1994, LANCET, V343, P647, DOI 10.1016/S0140-6736(94)92640-9; Wingfield T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001675; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2006, DIAGN TREATM DEL TUB; World Health Organization, 2016, PER COUNTR PROF; 2012, GLOB STRAT TARG TUB, P1	47	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185018	10.1371/journal.pone.0185018	http://dx.doi.org/10.1371/journal.pone.0185018			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI0UK	28945782	Green Published, gold			2022-12-27	WOS:000411645100016
J	Akter, R; Naish, S; Hu, WB; Tong, SL				Akter, Rokeya; Naish, Suchithra; Hu, Wenbiao; Tong, Shilu			Socio-demographic, ecological factors and dengue infection trends in Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; AEDES-AEGYPTI; UNHOLY TRINITY; SUBANG JAYA; FEVER; DETERMINANTS; URBAN; URBANIZATION; TRANSMISSION; QUEENSLAND	Dengue has been a major public health concern in Australia. This study has explored the spatio-temporal trends of dengue and potential socio-demographic and ecological determinants in Australia. Data on dengue cases, socio-demographic, climatic and land use types for the period January 1999 to December 2010 were collected from Australian National Notifiable Diseases Surveillance System, Australian Bureau of Statistics, Australian Bureau of Meteorology, and Australian Bureau of Agricultural and Resource Economics and Sciences, respectively. Descriptive and linear regression analyses were performed to observe the spatio-temporal trends of dengue, socio-demographic and ecological factors in Australia. A total of 5,853 dengue cases (both local and overseas acquired) were recorded across Australia between January 1999 and December 2010. Most the cases (53.0%) were reported from Queensland, followed by New South Wales (16.5%). Dengue outbreak was highest (54.2%) during 2008-2010. A highest percentage of overseas arrivals (29.9%), households having rainwater tanks (33.9%), Indigenous population (27.2%), separate houses (26.5%), terrace house types (26.9%) and economically advantage people (42.8%) were also observed during 2008-2010. Regression analyses demonstrate that there was an increasing trend of dengue incidence, potential socio-ecological factors such as overseas arrivals, number of households having rainwater tanks, housing types and land use types (e.g. intensive uses and production from dryland agriculture). Spatial variation of socio-demographic factors was also observed in this study. In near future, significant increase of temperature was also projected across Australia. The projected increased temperature as well as increased socioecological trend may pose a future threat to the local transmission of dengue in other parts of Australia if Aedes mosquitoes are being established. Therefore, upgraded mosquito and disease surveillance at different ports should be in place to reduce the chance of mosquitoes and dengue cases being imported into all over Australia.	[Akter, Rokeya; Naish, Suchithra; Hu, Wenbiao; Tong, Shilu] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia; [Tong, Shilu] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Shanghai, Peoples R China; [Tong, Shilu] Anhui Med Univ, Sch Publ Hlth, Hefei, Anhui, Peoples R China; [Naish, Suchithra] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Rockhampton, Qld, Australia	Queensland University of Technology (QUT); Shanghai Jiao Tong University; Anhui Medical University; Central Queensland University	Akter, R (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia.	rokeya.akter@hdr.qut.edu.au		Hu, Wenbiao/0000-0001-6422-9240	Australian Government Research Training program (RTP); Australian Government	Australian Government Research Training program (RTP); Australian Government(Australian GovernmentCGIAR)	The study was funded by Australian Government Research Training program (RTP) previously known as Australian Postgraduate Award (APA).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Author (RA) is thankful to Australian Government for the financial support provided by Australian Government Research Training program (RTP) previously known as Australian Postgraduate Award (APA). Author acknowledges the contributions of state and territory communicable disease control units, Australia.	ABS, 2016, CENS DAT COMM PROF; Akter R, 2017, TROP MED INT HEALTH, V22, P656, DOI 10.1111/tmi.12868; Araujo RV, 2015, BRAZ J INFECT DIS, V19, P146, DOI 10.1016/j.bjid.2014.10.004; Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892; Astrom C, 2012, ECOHEALTH, V9, P448, DOI 10.1007/s10393-012-0808-0; Bambrick HJ, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.2059; Beebe NW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000429; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Buczak AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002771; Buczak AL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-124; Caprara A, 2009, CAD SAUDE PUBLICA, V25, pS125, DOI 10.1590/S0102-311X2009001300012; Cheong YL, 2014, SPAT SPATIO-TEMPORAL, V10, P75, DOI 10.1016/j.sste.2014.05.002; Cunningham R, 1996, J MED MICROBIOL, V44, P157, DOI 10.1099/00222615-44-3-157; Darbro J, 2017, ECOL ECON, V142, P203, DOI 10.1016/j.ecolecon.2017.06.015; Delmelle E, 2016, ACTA TROP, V164, P169, DOI 10.1016/j.actatropica.2016.08.028; Dom NC, 2013, GEOCARTO INT, V28, P258, DOI 10.1080/10106049.2012.696726; Eastin MD, 2014, AM J TROP MED HYG, V91, P598, DOI 10.4269/ajtmh.13-0303; Ebi KL, 2016, ENVIRON RES, V151, P115, DOI 10.1016/j.envres.2016.07.026; Gubler D, 2012, INT J INFECT DIS, V16, pE2, DOI 10.1016/j.ijid.2012.05.009; Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9; Hu WB, 2012, ENVIRON HEALTH PERSP, V120, P260, DOI 10.1289/ehp.1003270; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kurucz N, 2014, TENNANT CREEK DENGUE; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Landau KI, 2012, J VECTOR ECOL, V37, P407, DOI 10.1111/j.1948-7134.2012.00245.x; Li S, 2013, ASIA-PAC J PUBLIC HE, V25, P239, DOI 10.1177/1010539511418819; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; McBride WJH, 1998, AM J EPIDEMIOL, V148, P1111, DOI 10.1093/oxfordjournals.aje.a009589; Mondini A, 2008, SCI TOTAL ENVIRON, V393, P241, DOI 10.1016/j.scitotenv.2008.01.010; Nazri C, 2011, HUMANITIES SCI ENG C; Nazri Che Dom, 2013, Asian Pacific Journal of Tropical Disease, V3, P352; Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147; Pdnn S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166806; Queensland Health, 2011, QUEENSL DENG MAN PLA, P1; Reiner RC, 2015, T ROY SOC TROP MED H, V109, P171, DOI 10.1093/trstmh/tru194; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; Sarfraz MS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-853; Schmidt WP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001082; SHOPE R, 1991, ENVIRON HEALTH PERSP, V96, P171, DOI 10.2307/3431227; Sloan-Gardner T, 2011, COMMUN DIS INTELL, V35, P61; Teurlai M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004211; Trewin BJ, 2013, INT HEALTH, V5, P251, DOI 10.1093/inthealth/iht023; Troyo A, 2009, SINGAPORE J TROP GEO, V30, P265, DOI 10.1111/j.1467-9493.2009.00367.x; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; TunLin W, 1995, AM J TROP MED HYG, V53, P595, DOI 10.4269/ajtmh.1995.53.595; van den Hurk AF, 2016, ONE HEALTH-AMSTERDAM, V2, P19, DOI 10.1016/j.onehlt.2016.02.001; Vanwambeke SO, 2007, ECOHEALTH, V4, P37, DOI 10.1007/s10393-007-0085-5; Vanwambeke Sophie O, 2006, Int J Health Geogr, V5, P5, DOI 10.1186/1476-072X-5-5; Vanwambeke SO, 2011, TROP MED INT HEALTH, V16, P174, DOI 10.1111/j.1365-3156.2010.02671.x; Whelan Peter, 2001, Arbovirus Research in Australia, V8, P395; Wijayanti SPM, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004964, 10.1371/journal.pntd.0004500]; Woodruff R, 2005, CLIMATE CHANGE HLTH; World Health Organization, 2012, GLOB STRAT DENG PREV; World Health Organization ROfS-EA, 2011, COMPR GUID PREV CONT; Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034	58	24	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185551	10.1371/journal.pone.0185551	http://dx.doi.org/10.1371/journal.pone.0185551			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968420	Green Published, gold, Green Submitted			2022-12-27	WOS:000412029600024
J	Lemez, S; Wattie, N; Baker, J				Lemez, Srdjan; Wattie, Nick; Baker, Joseph			Do "big guys" really die younger? An examination of height and lifespan in former professional basketball players	PLOS ONE			English	Article							MORTALITY; LONGEVITY; MEN; WEIGHT; CANCER; COHORT; WOMEN; BODY; RISK	While factors such as genetics may mediate the relationship between height and mortality, evidence suggests that larger body size may be an important risk indicator of reduced lifespan longevity in particular. This study critically examined this relationship in professional basketball players. We examined living and deceased players who have played in the National Basketball Association (debut between 1946-2010) and/or the American Basketball Association (1967-1976) using descriptive and Kaplan-Meier and Cox regression analyses. The cut-off date for death data collection was December 11, 2015. Overall, 3,901 living and deceased players were identified and had a mean height of 197.78 cm (+/- 9.29, Range: 160.02-231.14), and of those, 787 former players were identified as deceased with a mean height of 193.88 cm (+/- 8.83, Range: 167.6-228.6). Descriptive findings indicated that the tallest players (top 5%) died younger than the shortest players (bottom 5%) in all but one birth decade (1941-1950). Similarly, survival analyses showed a significant relationship between height and lifespan longevity when both dichotomizing [chi(2) (1) = 13.04, p < .05] and trichotomizing [chi(2) (2) = 18.05, p < .05] the predictor variable height per birth decade, where taller players had a significantly higher mortality risk compared to shorter players through median (HR: 1.30, 95% CI: 1.13-1.50, p < .05) and trichotomized tertile split (HR: 1.40, 95% CI: 1.18-1.68, p <. 05; tallest 33.3% compared to shortest 33.3%) analyses. The uniqueness of examining the height-longevity hypothesis in this relatively homogeneous sub-population should be considered when interpreting these results. Further understanding of the potential risks of early mortality can help generate discourse regarding potential at-risk cohorts of the athlete population.	[Lemez, Srdjan] Calif State Univ Los Angeles, Sch Kinesiol & Nutr Sci, Los Angeles, CA 90032 USA; [Wattie, Nick] Univ Ontario Inst Technol, Fac Hlth Sci, Oshawa, ON, Canada; [Baker, Joseph] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada	California State University System; California State University Los Angeles; Ontario Tech University; York University - Canada	Lemez, S (corresponding author), Calif State Univ Los Angeles, Sch Kinesiol & Nutr Sci, Los Angeles, CA 90032 USA.	slemez@calstatela.edu	PAN, ZEQIANG/X-6341-2018	Baker, Joseph/0000-0002-5686-1737; Lemez, Srdjan/0000-0002-6770-7778				[Anonymous], 2016, NATL VITAL STAT REPO, V64; Epstein D., 2016, WHAT DOES HIST HEIGH; EPSTEIN DAVID, 2014, SPORTS GENE INSIDE S; Gavrilov LA, 2012, BIODEMOGR SOC BIOL, V58, P14, DOI 10.1080/19485565.2012.666121; Giovannelli L, 2002, CARCINOGENESIS, V23, P1483, DOI 10.1093/carcin/23.9.1483; He QM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105839; Kabat GC, 2013, CANCER EPIDEM BIOMAR, V22, P1353, DOI 10.1158/1055-9965.EPI-13-0305; Koppett L, 2003, TOTAL BASKETBALL ULT; Lawler T, 2012, ANN EPIDEMIOL, V22, P406, DOI 10.1016/j.annepidem.2012.04.009; Lemez S, 2016, SCAND J MED SCI SPOR, V26, P544, DOI 10.1111/sms.12480; Lemez S, 2015, SPORTS MED OPEN, V1; MacMullan J., 2016, LARRY BIRD WILL DIE; Noymer A, 2000, POPUL DEV REV, V26, P565, DOI 10.1111/j.1728-4457.2000.00565.x; Powell-Morse A., 2015, HIST PROFILE NBA PLA; Salaris L, 2012, BIODEMOGR SOC BIOL, V58, P1, DOI 10.1080/19485565.2012.666118; Samaras TT, 2009, S AFR J CLIN NUTR, V22, P171; Samaras T.T., 2014, J SCI RES REP, V3, P2150, DOI DOI 10.9734/JSRR/2014/11268; Samaras Thomas T., 2012, Nutrition and Health (Bicester), V21, P247, DOI 10.1177/0260106013510996; Samaras TT, 2009, EXP GERONTOL, V44, P83, DOI 10.1016/j.exger.2008.02.002; SAMARAS TT, 1992, B WORLD HEALTH ORGAN, V70, P259; Samaras TT, 2002, WESTERN J MED, V176, P206, DOI 10.1136/ewjm.176.3.206; Samaras TT, 2012, INDIAN HEART J, V65, P66; Samaras TT, 1996, TOWNSEND LETT DOCTOR, V159, P78; Samaras TT, 2007, HUMAN BODY SIZE LAWS; Samaras TT., 2017, JSRR, V15, P1; SAMARAS TT, 1996, J WASHINGTON ACAD SC, V84, P131; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; Suzuki M, 2001, ASIA PAC J CLIN NUTR, V10, P165, DOI 10.1046/j.1440-6047.2001.00219.x; Willcox BJ, 2004, J GERONTOL A-BIOL, V59, P789	29	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185617	10.1371/journal.pone.0185617	http://dx.doi.org/10.1371/journal.pone.0185617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968418	Green Submitted, Green Published, gold			2022-12-27	WOS:000412029600029
J	Willmore, J; Marko, TL; Taing, D; Sampasa-Kanyinga, H				Willmore, Jacqueline; Marko, Terry-Lynne; Taing, Darcie; Sampasa-Kanyinga, Hugues			The burden of alcohol-related morbidity and mortality in Ottawa, Canada	PLOS ONE			English	Article							DRINKING PATTERNS; SOCIOECONOMIC-STATUS; GENDER-DIFFERENCES; CONSUMPTION; CONSEQUENCES; OUTLETS; DENSITY	Objectives Alcohol-related morbidity and mortality are significant public health issues. The purpose of this study was to describe the prevalence and trends over time of alcohol consumption and alcohol-related morbidity and mortality; and public attitudes of alcohol use impacts on families and the community in Ottawa, Canada. Methods Prevalence (2013-2014) and trends (2000-2001 to 2013-2014) of alcohol use were obtained from the Canadian Community Health Survey. Data on paramedic responses (2015), emergency department (ED) visits (2013-2015), hospitalizations (2013-2015) and deaths (2007-2011) were used to quantify the acute and chronic health effects of alcohol in Ottawa. Qualitative data were obtained from the "Have Your Say" alcohol survey, an online survey of public attitudes on alcohol conducted in 2016. Results In 2013-2014, an estimated 595,300 (83%) Ottawa adults 19 years and older drank alcohol, 42% reported binge drinking in the past year. Heavy drinking increased from 15% in 2000-2001 to 20% in 2013-2014. In 2015, the Ottawa Paramedic Service responded to 2,060 calls directly attributable to alcohol. Between 2013 and 2015, there were an average of 6,100 ED visits and 1,270 hospitalizations per year due to alcohol. Annually, alcohol use results in at least 140 deaths in Ottawa. Men have higher rates of alcohol-attributable paramedic responses, ED visits, hospitalizations and deaths than women, and young adults have higher rates of alcohol-attributable paramedic responses. Qualitative data of public attitudes indicate that alcohol misuse has greater repercussions not only on those who drink, but also on the family and community. Conclusions Results highlight the need for healthy public policy intended to encourage a culture of drinking in moderation in Ottawa to support lower risk alcohol use, particularly among men and young adults.	[Willmore, Jacqueline; Marko, Terry-Lynne; Taing, Darcie; Sampasa-Kanyinga, Hugues] Ottawa Publ Hlth, Ottawa, ON, Canada		Taing, D (corresponding author), Ottawa Publ Hlth, Ottawa, ON, Canada.	Darcie.Taing@ottawa.ca	Sampasa-Kanyinga, Hugues/ABE-8565-2020	Sampasa-Kanyinga, Hugues/0000-0002-7195-8086				Agic B, 2016, DRUG ALCOHOL REV, V35, P196, DOI 10.1111/dar.12250; Alcohol and Gaming Commission of Ontario, 2013, REG MOD ONT BEV ALC; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Balabanova D, 1999, ALCOHOL ALCOHOLISM, V34, P622, DOI 10.1093/alcalc/34.4.622; Beland Yves, 2002, Health Rep, V13, P9; Bloomfield K, 2006, ALCOHOL ALCOHOLISM, V41, pI26, DOI 10.1093/alcalc/agl073; Bobak M, 2004, J EPIDEMIOL COMMUN H, V58, P238, DOI 10.1136/jech.2003.011825; Caldwell TM, 2008, DRUG ALCOHOL DEPEN, V95, P269, DOI 10.1016/j.drugalcdep.2008.01.014; CAMH Health Promotion Resource Centre, 2013, MAK CAS TOOLS SUPP L; Erskine S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-99; Gmel G., 2004, CONTEMP DRUG PROBL, V31, P467, DOI [10.1177/009145090403100304, DOI 10.1177/009145090403100304, DOI 10.1111/J.1360-0443.2005.01224.X]; Hao W, 2004, ALCOHOL ALCOHOLISM, V39, P43, DOI 10.1093/alcalc/agh018; Hart CL, 2010, BMC PUBLIC HEALTH, V10, P1; Helasoja V, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-241; Ialomieanu AR, 2014, CAMH RES DOCUMENT SE, V40; Jones L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1720-7; Laslett A-M, 2010, RANGE MAGNITUDE ALCO, P29; Leslie K, 2008, CAN MED ASSOC J, V178, P149, DOI 10.1503/cmaj.071622; Makela P, 2008, J EPIDEMIOL COMMUN H, V62, P728, DOI 10.1136/jech.2007.065672; Miller JW, 2007, PEDIATRICS, V119, P76, DOI 10.1542/peds.2006-1517; Mulia N, 2012, ALCOHOL ALCOHOLISM, V47, P178, DOI 10.1093/alcalc/agr168; Mulia N, 2011, ALCOHOL CLIN EXP RES, V35, P1557, DOI 10.1111/j.1530-0277.2011.01501.x; National Institute on Alcohol Abuse and Alcoholism (NIAAA), 2006, UND DRINK WHY DO AD; National Institute on Alcohol Abuse and Alcoholism (NIAAA), 2016, UND DRINK FACT SHEET; Nolen-Hoeksema S, 2004, CLIN PSYCHOL REV, V24, P981, DOI 10.1016/j.cpr.2004.08.003; Ottawa Public Health, 2016, CULT ALC MOD; Ottawa Public Health, 2013, SUBST MIS OTT; Patra J, 2007, CAN J PUBLIC HEALTH, V98, P228, DOI 10.1007/BF03403718; Popova S, 2012, DRUG ALCOHOL REV, V31, P4, DOI 10.1111/j.1465-3362.2010.00276.x; Popova S, 2009, ALCOHOL ALCOHOLISM, V44, P500, DOI 10.1093/alcalc/agp054; [Public Health Branch Region of Waterloo Public Health York Region Community and Health Services Halton Region Health Department Durham Region Health Department], 2014, CYCL 2 LOC DRIV COL; Rehm J, 2006, ADDICTION, V101, P373, DOI 10.1111/j.1360-0443.2005.01338.x; Rehm J, 2003, ALCOHOL RES HEALTH, V140, pC00; Rehm J, 2006, COSTS SUBSTANCE ABUS, P1; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Shield K. D., 2013, ALCOHOL RES, V85, P2; Stahre M, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130293; Statistics Canada, 2015, SUMM RES 2013 CAN TO; Stockwell T, 2011, ADDICTION, V106, P768, DOI 10.1111/j.1360-0443.2010.03331.x; Stockwell T, 2009, ADDICTION, V104, P1827, DOI 10.1111/j.1360-0443.2009.02658.x; Thomas G., 2012, ALCOHOL PRICE POLICY; Thomas G, 2011, MYTHS FACTS ALCOHOL; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilsnack RW, 2009, ADDICTION, V104, P1487, DOI 10.1111/j.1360-0443.2009.02696.x; Wilsnack RW, 2000, ADDICTION, V95, P251, DOI 10.1046/j.1360-0443.2000.95225112.x; World Health Organization, 2009, EV EFF COST EFF INT; Zhao JH, 2015, CAN J PUBLIC HEALTH, V106, pE204, DOI 10.17269/cjph.106.4753	48	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185457	10.1371/journal.pone.0185457	http://dx.doi.org/10.1371/journal.pone.0185457			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957368	Green Submitted, gold, Green Published			2022-12-27	WOS:000411985200061
J	Bai, ZQ; Xia, PG; Wang, RL; Jiao, J; Ru, M; Liu, JL; Liang, ZS				Bai, Zhenqing; Xia, Pengguo; Wang, Ruilin; Jiao, Jie; Ru, Mei; Liu, Jingling; Liang, Zongsuo			Molecular cloning and characterization of five SmGRAS genes associated with tanshinone biosynthesis in Salvia miltiorrhiza hairy roots	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; SCARECROW-LIKE 3; GRAS-GENE; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; FAMILY; ARABIDOPSIS; ACCUMULATION; PHYTOCHROME; EXPRESSION	The gibberellin-responsive element binding factor ( GRAS) family of proteins plays an important role in the transcriptional regulation of plant development and hormone signaling. To date, there are no reports on GRAS family proteins expressed in Salvia miltiorrhiza. In this study, 28 ESTs that contained the GRAS domain were identified from a S. miltiorrhiza cDNA library. Of these, full-length sequences of five genes were cloned and sequence analysis indicated that all five proteins contain only one GRAS domain and therefore, belong to the GRAS family. The five genes were designated S. miltiorrhiza GRAS1-5 (SmGRAS1-5), which belong to groups I (SmGRAS2 and SmGRAS4), II (SmGRAS3), III (SmGRAS1), and VIII (SmGRAS5) respectively. Additionally, SmGRAS1-5 have different expression patterns in the reed head, stems, leaves, flowers, and roots of S. miltiorrhiza. In this study, the expression of SmGRAS1-5 was sensitive to Gibberellin (GA) stress and that of SmGRAS1, SmGRAS4 and SmGRAS5 was sensitive to Ethephon (Eth) stress respectively. Moreover, S. miltiorrhiza copalyl diphosphate synthases 1 (SmCPS1) and S. miltiorrhiza kaurene synthase like 1 (SmKSL1), which are two key enzymes gene in the diterpenoid biosynthesis pathway, were also response to GA and Eth stress. In addition, Dihydrotanshinone (DT-I) and Tanshinone I (T-I) content were enhanced by GA and Eth stress, Tanshinone IIA (T-IIA) content was increased by GA stress, and the accumulation of Cryptotanshinone (CT) was insensitive to both GA and Eth stress. Together, these results provide insights into functional conservation and diversification of SmGRASs and are useful information for further elucidating SmGRAS functions.	[Bai, Zhenqing; Wang, Ruilin; Jiao, Jie; Ru, Mei; Liu, Jingling; Liang, Zongsuo] Northwest A&F Univ, Coll Life Sci, Yangling, Peoples R China; [Xia, Pengguo; Liang, Zongsuo] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Northwest A&F University - China; Zhejiang Sci-Tech University	Liang, ZS (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Peoples R China.; Liang, ZS (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	liangzs@ms.iswc.ac.cn			National Natural Science Foundation of China [81373908]; National "Twelfth Five-Year" Plan for Science Technology [2015BAC01B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "Twelfth Five-Year" Plan for Science Technology	These researches were supported by National Natural Science Foundation of China (81373908) and National "Twelfth Five-Year" Plan for Science & Technology Support (2015BAC01B03).	Abarca D, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0354-8; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bolle C, 2000, GENE DEV, V14, P1269; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; Czikkel BE, 2007, J PLANT PHYSIOL, V164, P1220, DOI 10.1016/j.jplph.2006.07.010; De Geyter N, 2012, TRENDS PLANT SCI, V17, P349, DOI 10.1016/j.tplants.2012.03.001; Du Q., 2015, THESIS; Fode B, 2008, PLANT CELL, V20, P3122, DOI 10.1105/tpc.108.058974; Fujii H, 2007, PLANT SCI, V173, P340, DOI 10.1016/j.plantsci.2007.06.006; Gao W, 2015, ORGANIC LETT, V11, P5170; Gao Wei, 2015, Zhongguo Zhong Yao Za Zhi, V40, P2486; Guo HJ JY, 2009, CHIN B BOT, V1399, P901; Guoyin Kai AZ, 2012, MOL BIOSYST, V8, P2883; Hao XL, 2015, BIOTECHNOL APPL BIOC, V62, P24, DOI 10.1002/bab.1236; Heo JO, 2011, P NATL ACAD SCI USA, V108, P2166, DOI 10.1073/pnas.1012215108; Hirsch S, 2009, PLANT SIGNAL BEHAV, V4, P698, DOI 10.4161/psb.4.8.9176; Huang W, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0590-6; Kai GY, 2012, ACTA PHYSIOL PLANT, V34, P1421, DOI 10.1007/s11738-012-0940-z; Kai GY, 2011, METAB ENG, V13, P319, DOI 10.1016/j.ymben.2011.02.003; Kim GB, 2013, PLANT GROWTH REGUL, V71, P77, DOI 10.1007/s10725-013-9814-7; Lee H, 2008, PLANT MOL BIOL, V67, P659, DOI 10.1007/s11103-008-9345-1; Lee SC, 2002, GENE DEV, V16, P646, DOI 10.1101/gad.969002; Li G., 2014, J ANHUI AGR SCI, V42, P4207; [李卿 Li Qing], 2015, [中草药, Chinese Traditional and Herbal Drugs], V46, P887; Lijie Cui XN, 2015, SCI REPORTS; Lili Dai, 2015, THESIS; Lim J, 2000, PLANT CELL, V12, P1307, DOI 10.1105/tpc.12.8.1307; Liu W, 2011, PLANT CELL, V23, P3853, DOI 10.1105/tpc.111.089771; Liu XY, 2014, PLANT MOL BIOL REP, V32, P1129, DOI 10.1007/s11105-014-0721-5; Lu JX, 2015, MOL GENET GENOMICS, V290, P303, DOI 10.1007/s00438-014-0918-1; Meng XiangChun, 2011, Scientia Agricultura Sinica, V44, P538; Morohashi K, 2003, J BIOL CHEM, V278, P20865, DOI 10.1074/jbc.M301712200; PATSCHINSKY T, 1982, P NATL ACAD SCI-BIOL, V79, P973, DOI 10.1073/pnas.79.4.973; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Riechmann JL, 1998, BIOL CHEM, V379, P633; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Shi M, 2016, J AGR FOOD CHEM, V64, P2523, DOI 10.1021/acs.jafc.5b04697; Shi M, 2014, FUNCT INTEGR GENOMIC, V14, P603, DOI 10.1007/s10142-014-0385-0; Song XM, 2014, GENOMICS, V103, P135, DOI 10.1016/j.ygeno.2013.12.004; Stuurman J, 2002, GENE DEV, V16, P2213, DOI 10.1101/gad.230702; Tian CG, 2004, PLANT MOL BIOL, V54, P519, DOI 10.1023/B:PLAN.0000038256.89809.57; Torres-Galea P, 2006, MOL GENET GENOMICS, V276, P13, DOI 10.1007/s00438-006-0123-y; Torres-Galea P, 2013, PLANT PHYSIOL, V161, P291, DOI 10.1104/pp.112.206607; Verma V, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0771-y; Wang XH, 2007, MED RES REV, V27, P133, DOI 10.1002/med.20077; Xue L, 2015, PLANT PHYSIOL, V167, P854, DOI 10.1104/pp.114.255430; Yang CQ, 2012, J INTEGR PLANT BIOL, V54, P703, DOI 10.1111/j.1744-7909.2012.01161.x; Yang Deqiang, 2012, THESIS; Yang DF, 2012, PHYSIOL PLANTARUM, V146, P173, DOI 10.1111/j.1399-3054.2012.01603.x; Yoshida H, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29726; Yuan Y, 2016, PLANT CELL REP, V35, P1; Zhang ZL, 2011, P NATL ACAD SCI USA, V108, P2160, DOI 10.1073/pnas.1012232108; Zhou JY, 2010, SCI HORTIC-AMSTERDAM, V126, P229, DOI 10.1016/j.scienta.2010.07.019; Zhou W, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0550-3	55	12	16	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185322	10.1371/journal.pone.0185322	http://dx.doi.org/10.1371/journal.pone.0185322			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953930	gold, Green Published, Green Submitted			2022-12-27	WOS:000411980300056
J	Lopez, JLB; Estrada, CEE; Mendez, UR; Rodriguez, JJS; Goyenechea, IGM; Ceron, JMC				Becerra Lopez, Jorge Luis; Esparza Estrada, Citlalli Edith; Romero Mendez, Ulises; Sigala Rodriguez, Jose Jesus; Mayer Goyenechea, Irene Goyenechea; Castillo Ceron, Jesus Martin			Evidence of niche shift and invasion potential of Lithobates catesbeianus in the habitat of Mexican endemic frogs	PLOS ONE			English	Article							MODEL COMPLEXITY; CONSERVATISM; ECOLOGY; PREDICTION; RANGE; SPACE; RISK	Invasive alien species are one of most severe threats to biodiversity and natural resources. These biological invasions have been studied from the niche conservatism and niche shifts perspective. Niche differentiation may result from changes in fundamental niche or realized niche or both; in biological invasions, niche differences between native and non-native ranges can appear through niche expansion, niche unfilling and niche stability. The American bullfrog Lithobates catesbeianus is an invasive species that can have negative impacts on native amphibian populations. This research examines the climate niche shifts of this frog, its potential range of expansion in Mexico and the risk of invasion by bullfrog in the habitats of 82 frog species endemic to Mexico, that based on their climatic niche similarity were divided in four ecological groups. The results indicate that species in two ecological groups were the most vulnerable to invasion by bullfrog. However, the climate niche shifts of L. catesbeianus may allow it to adapt to new environmental conditions, so species from the two remaining groups cannot be dismissed as not vulnerable. This information is valuable for decision making in prioritizing areas for conservation of Mexican endemic frogs.	[Becerra Lopez, Jorge Luis] Univ Autonoma Noreste, Ctr Invest Sustentabilidad Energet & Ambiental No, Tamaulipas, Mexico; [Esparza Estrada, Citlalli Edith; Mayer Goyenechea, Irene Goyenechea] Univ Autonoma Estado Hidalgo, Ctr Invest Biol, Lab Sistemat Mol, Hidalgo, Mexico; [Romero Mendez, Ulises] Univ Juarez Estado Durango, Fac Ciencias Biol, Lab Sistemas Informac Geog, Durango, Mexico; [Sigala Rodriguez, Jose Jesus] Univ Autonoma Aguascalientes, Colecc Zool, Aguascalientes, Mexico; [Castillo Ceron, Jesus Martin] Univ Autonoma Estado Hidalgo, Museo Paleontol, Hidalgo, Mexico	Universidad Autonoma del Estado de Hidalgo; Universidad Juarez del Estado de Durango; Universidad Autonoma de Aguascalientes; Universidad Autonoma del Estado de Hidalgo	Estrada, CEE (corresponding author), Univ Autonoma Estado Hidalgo, Ctr Invest Biol, Lab Sistemat Mol, Hidalgo, Mexico.	calli.edithsita@gmail.com	Goyenechea, Irene/AAR-7074-2021; Sigala-Rodriguez, J. Jesus/B-3617-2013	ROMERO MENDEZ, ULISES/0000-0002-6062-8874; Sigala-Rodriguez, J. Jesus/0000-0002-5895-1568	Universidad Autonoma del Estado de Hidalgo IGMG	Universidad Autonoma del Estado de Hidalgo IGMG	This work was supported by the Universidad Autonoma del Estado de Hidalgo IGMG to JMCC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Romero JG, 2008, ANIMALES EXOTICOS ME; [Anonymous], 2007, ANFIBIOS REPTILES ES; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Becerra-Lopez JL, 2016, REV CIENTIFICA BIOL, V5, P1514; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Buckley LB, 2008, ECOLOGY, V89, P48, DOI 10.1890/07-0845.1; Casas-Andreu G, 2001, CIENCIA ERGO SUM, V8, P277; CASPER GS, 2005, AMPHIBIAN DECLINES C, P540; da Mata RA, 2010, BIOL INVASIONS, V12, P1231, DOI 10.1007/s10530-009-9542-0; Dambach J, 2011, AQUAT CONSERV, V21, P92, DOI 10.1002/aqc.1160; Dickerson MC, 1931, THE FROG BOOK; Dietz H, 2006, ECOLOGY, V87, P1359, DOI 10.1890/0012-9658(2006)87[1359:RTCPCD]2.0.CO;2; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Estrada-Rodriguez JL, 2004, ANFIBIOS Y REPTILES; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Flores-Villela O., 1993, HERPETOFAUNA MEXICAN; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Gervasi SS, 2013, ECOHEALTH, V10, P166, DOI 10.1007/s10393-013-0832-8; Giovanelli JGR, 2008, BIOL INVASIONS, V10, P585, DOI 10.1007/s10530-007-9154-5; Glennon KL, 2014, ECOL LETT, V17, P574, DOI 10.1111/ele.12259; Govindarajulu P, 2006, J HERPETOL, V40, P249, DOI 10.1670/68-05A.1; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guisan A, 2014, TRENDS ECOL EVOL, V29, P260, DOI 10.1016/j.tree.2014.02.009; Hernandez-Austria R, 2015, REV MEX BIODIVERS, V86, P269, DOI 10.7550/rmb.45631; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090121; Holt RD, 2005, OIKOS, V108, P18, DOI 10.1111/j.0030-1299.2005.13147.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; INEGI, 2017, COMP INF GEOGR; Iniguez Carlos A., 2012, South American Journal of Herpetology, V7, P85; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Latombe G., 2016, BIOL CONSERV; Laufer G, 2008, BIOL INVASIONS, V10, P1183, DOI 10.1007/s10530-007-9178-x; Lauzeral C, 2011, GLOBAL ECOL BIOGEOGR, V20, P407, DOI 10.1111/j.1466-8238.2010.00611.x; Lever C, 2003, NATURALIZED REPTILES; Levin DA, 2005, SYST BOT, V30, P9, DOI 10.1600/0363644053661869; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Moreno-Amat E, 2015, ECOL MODEL, V312, P308, DOI 10.1016/j.ecolmodel.2015.05.035; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Nori J, 2011, BIODIVERS CONSERV, V20, P1125, DOI 10.1007/s10531-011-0014-3; Parra-Olea G, 2014, REV MEX BIODIVERS, V85, pS460, DOI 10.7550/rmb.32027; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; R Core Team, 2013, R LANG ENV STAT COMP; Ramos-Guerra S, 2014, ESPECIES INVASORAS A, P411; Rivas C, 2014, HERPETOL REV, V45, P273; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Sanabria E, 2011, REV MEX BIODIVERS, V82, P311; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P476; Soberon J, 2011, REV MEX BIODIVERS, V82, P1348; Stebbins R.C., 1985, FIELD GUIDE W REPTIL, V2nd; Strubbe D, 2015, ECOGRAPHY, V38, P321, DOI 10.1111/ecog.00632; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Tingley R, 2014, P NATL ACAD SCI USA, V111, P10233, DOI 10.1073/pnas.1405766111; Urbina-Cardona J. N., 2010, BIODIVERSIDAD CAMBIO, P65; Ward DF, 2007, BIOL INVASIONS, V9, P723, DOI 10.1007/s10530-006-9072-y; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wright A, 1949, HDB FROGS TOADS US C; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x	72	15	15	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185086	10.1371/journal.pone.0185086	http://dx.doi.org/10.1371/journal.pone.0185086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953907	Green Published, gold			2022-12-27	WOS:000411980300033
J	Craig, MA; Richeson, JA				Craig, Maureen A.; Richeson, Jennifer A.			Information about the US racial demographic shift triggers concerns about anti-White discrimination among the prospective White "minority"	PLOS ONE			English	Article							COLOR-BLINDNESS; THREAT; BIAS; ATTITUDES; IDEOLOGY; PROGRESS; BLACK	The United States is undergoing a demographic shift in which White Americans are predicted to comprise less than 50% of the US population by mid-century. The present research examines how exposure to information about this racial shift affects perceptions of the extent to which different racial groups face discrimination. In four experiments, making the growing national racial diversity salient led White Americans to predict that Whites will face increasing discrimination in the future, compared with control information. Conversely, regardless of experimental condition, Whites estimated that discrimination against various racial minority groups will decline. Explorations of several psychological mechanisms potentially underlying the effect of the racial shift information on perceived anti-White discrimination suggested a mediating role of concerns about American culture fundamentally changing. Taken together, these findings suggest that reports about the changing national demographics enhance concerns among Whites that they will be the victims of racial discrimination in the future.	[Craig, Maureen A.] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA; [Richeson, Jennifer A.] Yale Univ, Dept Psychol, New Haven, CT USA; [Richeson, Jennifer A.] Yale Univ, Inst Social & Policy Studies, New Haven, CT USA; [Richeson, Jennifer A.] Northwestern Univ, Dept Psychol, Evanston, IL USA; [Richeson, Jennifer A.] Northwestern Univ, Inst Policy Res, Evanston, IL USA	New York University; Yale University; Yale University; Northwestern University; Northwestern University	Craig, MA (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	maureen.craig@nyu.edu						Abascal M, 2015, AM SOCIOL REV, V80, P789, DOI 10.1177/0003122415587313; Alabama Department of Public Health, 2013, SEL HLTH STAT IND SH; Alexander M., 2012, NEW JIM CROW MASS IN; [Anonymous], WASHINGTON POST 0528; [Anonymous], 2006, MED APARTHEID DARK H; Apfelbaum EP, 2012, CURR DIR PSYCHOL SCI, V21, P205, DOI 10.1177/0963721411434980; Apfelbaum EP, 2010, PSYCHOL SCI, V21, P1587, DOI 10.1177/0956797610384741; Cousineau D, 2014, BEHAV RES METHODS, V46, P1149, DOI 10.3758/s13428-013-0441-z; Craig MA, SOC PSYCHOL IN PRESS; Craig MA, 2014, PSYCHOL SCI, V25, P1189, DOI 10.1177/0956797614527113; Craig MA, 2014, PERS SOC PSYCHOL B, V40, P750, DOI 10.1177/0146167214524993; Danbold F, 2015, SOC PSYCHOL PERS SCI, V6, P210, DOI 10.1177/1948550614546355; Dover TL, 2016, J EXP SOC PSYCHOL, V62, P58, DOI 10.1016/j.jesp.2015.10.006; Eibach RP, 2006, J PERS SOC PSYCHOL, V90, P453, DOI 10.1037/0022-3514.90.3.453; Enos RD, 2016, AM J POLIT SCI, V60, P123, DOI 10.1111/ajps.12156; FOSSETT MA, 1989, SOC SCI QUART, V70, P820; GILES MW, 1977, SOC SCI QUART, V58, P412; GILES MW, 1994, AM POLIT SCI REV, V88, P317, DOI 10.2307/2944706; Hoffman KM, 2016, P NATL ACAD SCI USA, V113, P4296, DOI 10.1073/pnas.1516047113; Knowles ED, 2009, J PERS SOC PSYCHOL, V96, P857, DOI 10.1037/a0013595; Lopez Tomas, 2014, SHELBY COUNTY ONE YE; Major B, GROUP PROCE IN PRESS; Margolin E., 2016, NBC NEWS; Norton MI, 2011, PERSPECT PSYCHOL SCI, V6, P215, DOI 10.1177/1745691611406922; Outten HR, 2012, PERS SOC PSYCHOL B, V38, P14, DOI 10.1177/0146167211418531; Pager D, 2008, ANNU REV SOCIOL, V34, P181, DOI 10.1146/annurev.soc.33.040406.131740; PETTIGREW TF, 1959, J ABNORM SOC PSYCH, V59, P28, DOI 10.1037/h0047133; Pew Research Center, 2016, VIEWS RAC IN BLACKS; Pincus, 2003, REVERSE DISCRIMINATI; Republican National Committee, 2016, REP PLATF 2016; Republican National Committee, 2012, WE BEL AM REP PLATF; Rupar Aaron, 2016, THINK PROGR; Skinner AL, 2016, SOC COGNITION, V34, P544, DOI 10.1521/soco.2016.34.6.544; U.S. Census Bureau, 2015, NEW CENS BUR REP AN; Wilkins CL, GROUP PROCE IN PRESS; Wilkins CL, 2014, PSYCHOL SCI, V25, P439, DOI 10.1177/0956797613508412; Willer R, 2016, SOCIAL SCI RES NETWO	37	51	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185389	10.1371/journal.pone.0185389	http://dx.doi.org/10.1371/journal.pone.0185389			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4WR	28953971	Green Submitted, Green Published, gold			2022-12-27	WOS:000411980300059
J	Kim, J; Montagne, K; Nemoto, H; Ushida, T; Furukawa, KS				Kim, Jeonghyun; Montagne, Kevin; Nemoto, Hidetoshi; Ushida, Takashi; Furukawa, Katsuko S.			Hypergravity down-regulates c-fos gene expression via ROCK/Rho-GTP and the PI3K signaling pathway in murine ATDC5 chondroprogenitor cells	PLOS ONE			English	Article							PARABOLIC FLIGHT MANEUVERS; HYDROSTATIC-PRESSURE; MECHANICAL-PROPERTIES; HUMAN CHONDROCYTES; UP-REGULATION; IN-VITRO; RHO; PROLIFERATION; CYTOSKELETON; INDUCTION	Chondrocytes are known to be physiologically loaded with diverse physical factors such as compressive stress, shear stress and hydrostatic pressure. Although the effects of those mechanical stimuli onto various cell models have been widely studied, those of hypergravity have not yet been revealed clearly. Hereby, we hypothesized that the hypergravity affects relative positions of intracellular elements including nucleus and cytoskeletons due to their density differences, triggering mechanotransduction in the cell. The aim of this study was to investigate the effect of hypergravity on c-fos expression in the murine ATDC5 chondroprogenitor cells, as c-fos is a well known key regulator of cell proliferation and differentiation, including in chondrocytes. We first found that hypergravity down-regulated c-fos expression transiently via ROCK/Rho-GTP and PI3K signaling, and the down-regulation was suppressed by inhibition of actin polymerization.	[Kim, Jeonghyun; Montagne, Kevin; Ushida, Takashi; Furukawa, Katsuko S.] Univ Tokyo, Grad Sch Engn, Dept Mech Engn, Tokyo, Japan; [Nemoto, Hidetoshi] Univ Tokyo, Div Regenerat Med Engn, Ctr Dis Biol & Integrat Med, Sch Med, Tokyo, Japan; [Furukawa, Katsuko S.] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Furukawa, KS (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Mech Engn, Tokyo, Japan.; Furukawa, KS (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Bioengn, Tokyo, Japan.	furukawa@mech.t.u-tokyo.ac.jp	, Jeonghyun/GNW-4610-2022	, Jeonghyun/0000-0002-3157-3878	Japanese Ministry of Education, Culture, Sports, Science and Technology; Translational Systems Biology and Medicine Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Naito Foundation; Japan Agency for Medical Research and Development (AMED; Development of Manufacturing System for Regenerative Medicinal Cells from Human Mesenchymal Stem Cells), and 5) JSPS KAKENHI [17J07735]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Translational Systems Biology and Medicine Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Naito Foundation(Naito Memorial Foundation); Japan Agency for Medical Research and Development (AMED; Development of Manufacturing System for Regenerative Medicinal Cells from Human Mesenchymal Stem Cells), and 5) JSPS KAKENHI(Japan Agency for Medical Research and Development (AMED))	This work was supported by 1) grants-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology, 2) a grant for the Translational Systems Biology and Medicine Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan, 3) the Naito Foundation, 4) Japan Agency for Medical Research and Development (AMED; Development of Manufacturing System for Regenerative Medicinal Cells from Human Mesenchymal Stem Cells), and 5) JSPS KAKENHI (Grant Number 17J07735).	Albi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098250; Aleshcheva G, 2015, FASEB J, V29, P2303, DOI 10.1096/fj.14-268151; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; CAIOZZO VJ, 1994, J APPL PHYSIOL, V76, P1764, DOI 10.1152/jappl.1994.76.4.1764; Dreger M, 2003, EUR J BIOCHEM, V270, P589, DOI 10.1046/j.1432-1033.2003.03426.x; Ferraro JT, 2004, AM J PHYSIOL-CELL PH, V286, pC831, DOI 10.1152/ajpcell.00224.2003; Fidelina O V, 2004, J Gravit Physiol, V11, pP35; Govoni M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/918640; HOLT JT, 1986, P NATL ACAD SCI USA, V83, P4794, DOI 10.1073/pnas.83.13.4794; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; JANKNECHT R, 1995, CARCINOGENESIS, V16, P443, DOI 10.1093/carcin/16.3.443; JANSSEN YMW, 1995, CANCER RES, V55, P2085; Kasas S, 2005, CELL MOTIL CYTOSKEL, V62, P124, DOI 10.1002/cm.20086; Kim J, 2015, BIOSCI BIOTECH BIOCH, V79, P239, DOI 10.1080/09168451.2014.975184; Kim JY, 2014, INT IMMUNOPHARMACOL, V20, P213, DOI 10.1016/j.intimp.2014.03.001; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Kumahashi N, 2004, CELL TISSUE RES, V317, P117, DOI 10.1007/s00441-004-0893-7; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Montagne K, 2014, J BIOMECH, V47, P354, DOI 10.1016/j.jbiomech.2013.11.027; Nagayama K, 2008, AM J PHYSIOL-CELL PH, V295, pC1569, DOI 10.1152/ajpcell.00098.2008; Newton PT, 2012, INT J MOL MED, V30, P1187, DOI 10.3892/ijmm.2012.1114; O'Conor CJ, 2013, STEM CELL RES THER, V4, P1, DOI DOI 10.1186/SCRT211; Peake MA, 2000, J APPL PHYSIOL, V89, P2498, DOI 10.1152/jappl.2000.89.6.2498; Ranjan V, 1996, BIOTECHNOL BIOENG, V49, P383, DOI 10.1002/(SICI)1097-0290(19960220)49:4<383::AID-BIT4>3.0.CO;2-L; Shiu YT, 2003, BIOCHEM BIOPH RES CO, V303, P548, DOI 10.1016/S0006-291X(03)00388-7; Silberman M, 2009, ANGIOGENESIS, V12, P231, DOI 10.1007/s10456-009-9143-7; Tavakolinejad A, 2015, BIOCHEM BIOPH RES CO, V464, P473, DOI 10.1016/j.bbrc.2015.06.160; Thomas DP, 2000, J CELL SCI, V113, P439; Thomas RS, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3536; Ting SYW, 2015, TISSUE ENG PART C-ME, V21, P1005, DOI [10.1089/ten.tec.2014.0428, 10.1089/ten.TEC.2014.0428]; Todd P, 1989, ASGSB Bull, V2, P95; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wehland M, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0095-9; Yao YC, 2013, J CELL BIOCHEM, V114, P1223, DOI 10.1002/jcb.24467; Zayzafoon M, 2005, IMMUNOL REV, V208, P267, DOI 10.1111/j.0105-2896.2005.00330.x; Zhou S, 2015, BIOCHEM BIOPH RES CO, V463, P928, DOI 10.1016/j.bbrc.2015.06.037	38	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185394	10.1371/journal.pone.0185394	http://dx.doi.org/10.1371/journal.pone.0185394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953959	Green Published, gold, Green Submitted			2022-12-27	WOS:000411980300060
J	Danyuttapolchai, J; Kittimunkong, S; Nateniyom, S; Painujit, S; Klinbuayaem, V; Maipanich, N; Maokamnerd, Y; Pevzner, E; Whitehead, S; Kanphukiew, A; Monkongdee, P; Martin, M				Danyuttapolchai, Junya; Kittimunkong, Somyot; Nateniyom, Sriprapa; Painujit, Sutthapa; Klinbuayaem, Virat; Maipanich, Nuanpun; Maokamnerd, Yongyut; Pevzner, Eric; Whitehead, Sara; Kanphukiew, Apiratee; Monkongdee, Patama; Martin, Michael			Implementing an isoniazid preventive therapy program for people living with HIV in Thailand	PLOS ONE			English	Article							TUBERCULOSIS; ANTIRETROVIRALS; INFECTION; AFRICA	Treatment of people living with HIV (PLHIV) with latent tuberculosis (TB) infection using isoniazid preventive therapy (IPT) can reduce the risk of TB disease, however, the scale-up of IPT among PLHIV in Thailand and worldwide has been slow. To hasten the implementation of IPT in Thailand, we developed IPT implementation training curricula and tools for health care providers and implemented IPT services in seven large government hospitals. Of the 659 PLHIV enrolled, 272 (41.3%) reported symptoms of TB and 39 (14.3% of those with TB symptoms) were diagnosed with TB. A total of 346 (52.4%) participants were eligible for IPT; 318 (91.9%) of these participants opted to have a tuberculin skin test (TST) and 52 (16.3% of those who had a TST) had a positive TST result. Among the 52 participants with a positive TST, 46 (88.5%) initiated and 39 (75.0%) completed 9 months of IPT: physicians instructed three participants to stop IPT, two participants were lost to follow-up, one chose to stop therapy, and one developed TB. IPT can be implemented among PLHIV in Thailand and could reduce the burden of TB in the country.	[Danyuttapolchai, Junya; Whitehead, Sara; Kanphukiew, Apiratee; Monkongdee, Patama; Martin, Michael] Thailand Minist Publ Hlth US Ctr Dis Control & Pr, Bangkok, Nonthaburi Prov, Thailand; [Kittimunkong, Somyot] Thailand Minist Publ Hlth, Bur Vector Borne Dis, Dept Dis Control, Bangkok, Nonthaburi Prov, Thailand; [Nateniyom, Sriprapa] Thailand Minist Publ Hlth, Bur TB, Dept Dis Control, Bangkok, Thailand; [Painujit, Sutthapa] Nakhon Si Thammarat Hosp, Bangkok, Nakhon Si Thamm, Thailand; [Klinbuayaem, Virat] Sanpatong Hosp, Bangkok, Chiang Mai Prov, Thailand; [Maipanich, Nuanpun] Vachira Phuket Hosp, Bangkok, Phuket Province, Thailand; [Maokamnerd, Yongyut] Somdejprajaotaksin Maharaj Hosp, Bangkok, Tak Province, Thailand; [Pevzner, Eric; Martin, Michael] US Ctr Dis Control & Prevent, Atlanta, GA USA	Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA	Danyuttapolchai, J (corresponding author), Thailand Minist Publ Hlth US Ctr Dis Control & Pr, Bangkok, Nonthaburi Prov, Thailand.	hqd2@cdc.gov			President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [5U19GH000004]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work has been supported by the Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of grant number 5U19GH000004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], 1996, AM FAM PHYSICIAN, V54, P1115; [Anonymous], WHO POL COLL TB HIV; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Briggs MA, 2015, JAIDS-J ACQ IMM DEF, V68, pS297, DOI 10.1097/QAI.0000000000000497; Bureau of AIDS TB and STIs Department of Disease Control Ministry of Public Health Thailand., 2017, THAIL NAT GUID HIV A; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Khongphatthanayothin M, 2012, AIDS RES HUM RETROV, V28, P270, DOI 10.1089/aid.2011.0041; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lobue P, 2010, RESPIROLOGY, V15, P603, DOI 10.1111/j.1440-1843.2010.01751.x; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Moolphate Saiyud, 2013, Glob J Health Sci, V5, P60, DOI 10.5539/gjhs.v5n4p60; Ngamvithayapong J, 1997, AIDS, V11, P107, DOI 10.1097/00002030-199701000-00016; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Thailand Ministry of Public Health, 2003, THAIL MIN PUBL HLTH; Thailand Ministry of Public Health, 2013, NAT TUB CONTR PROGR; Thailand Ministry of Public Health, 2009, NAT TB HIV GUID; Thailand Ministry of Public Health, 2008, THAIL MIN PUBL HLTH; UNAIDS, 2015, HIV AIDS EST; WHO, 2016, GLOB TUB REP; World Health Organization, GUID INT TUB CAS FIN	23	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0184986	10.1371/journal.pone.0184986	http://dx.doi.org/10.1371/journal.pone.0184986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949995	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000021
J	Soria, I; Quattrocchi, V; Langellotti, C; Gammella, M; Digiacomo, S; de la Torre, BG; Andreu, D; Montoya, M; Sobrino, F; Blanco, E; Zamorano, P				Soria, Ivana; Quattrocchi, Valeria; Langellotti, Cecilia; Gammella, Mariela; Digiacomo, Sebastian; Garcia de la Torre, Beatriz; Andreu, David; Montoya, Maria; Sobrino, Francisco; Blanco, Esther; Zamorano, Patricia			Dendrimeric peptides can confer protection against foot-and-mouth disease virus in cattle	PLOS ONE			English	Article							B-CELL; RESPIRATORY-TRACT; SOLID PROTECTION; IMMUNE-RESPONSE; ANTIBODIES; VACCINE; EPITOPE; TRANSMISSION; CHALLENGE; VP1	Foot-and-mouth disease virus (FMDV) causes a highly contagious disease in cloven-hoofed animals. A synthetic vaccine candidate consisting of dendrimeric peptides harbouring two copies of a B-epitope [VP1(136-154)] linked to a T-cell epitope [3A(21-35)] of FMDV confers protection to type O FMDV challenge in pigs. Herein we show in cattle that novel dendrimeric peptides bearing a T-cell epitope [VP1(21-40] and two or four copies of a B-cell epitope [VP1(135-160)] from type O1 Campos FMDV (termed B2T and B4T, respectively) elicited FMDV specific immune responses to similar levels to a commercial vaccine. Animals were challenged with FMDV and 100% of vaccinated cattle with B2T or B4T were protected to podal generalization. Moreover, bovines immunized with B4T were completely protected (with no clinical signs) against FMDV challenge after three vaccine doses, which was associated with titers of viral neutralizing antibodies in serum higher than those of B2T group (p< 0.05) and levels of opsonic antibodies similar to those of animals immunized with one dose of FMDV commercial vaccine. Bovines vaccinated with both dendrimeric peptides presented high levels of IgG1 anti FMDV in sera and in mucosa. When IgA in nasal secretions was measured, 20% or 40% of the animals in B2T or B4T groups respectively, showed antiFMDV IgA titers. In addition, B2T and B4T peptides evoked similar consistent T cell responses, being recognized in vitro by lymphocytes from most of the immunized cattle in the proliferation assay, and from all animals in the IFN-. production assay. Taken together, these results support the potential of dendrimers B2T or B4T in cattle as a highly valuable, cost-effective FMDV candidate vaccine with DIVA potential.	[Soria, Ivana; Quattrocchi, Valeria; Langellotti, Cecilia; Gammella, Mariela; Digiacomo, Sebastian; Zamorano, Patricia] Inst Nacl Tecnol Agr INTA Castelar, Inst Virol, Ctr Invest Ciencias Vet, Buenos Aires, DF, Argentina; [Soria, Ivana; Langellotti, Cecilia; Zamorano, Patricia] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Garcia de la Torre, Beatriz; Andreu, David] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Montoya, Maria] Pirbright Inst, Ash Rd, Woking, Surrey, England; [Sobrino, Francisco] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Blanco, Esther] Ctr Invest Sanidad Anim CISA INIA, Madrid, Spain	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Pompeu Fabra University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Soria, I; Zamorano, P (corresponding author), Inst Nacl Tecnol Agr INTA Castelar, Inst Virol, Ctr Invest Ciencias Vet, Buenos Aires, DF, Argentina.; Soria, I; Zamorano, P (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.; Sobrino, F (corresponding author), Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain.	soria.ivana@inta.gob.ar; fsobrino@cbm.csic.es; zamorano.patricia@inta.gob.ar	de la Torre, Beatriz G./N-6995-2019; Montoya, Maria/G-3430-2015; Blanco, Esther/C-1245-2013; de la Torre, Beatriz G/AAF-1419-2020	de la Torre, Beatriz G./0000-0001-8521-9172; Montoya, Maria/0000-0002-5703-7360; Blanco, Esther/0000-0001-8413-4222; Sobrino, Francisco/0000-0003-4968-8291	National Institute of Agricultural Technology [PNSA 1115052]; INTA-INIA (Argentina-Spain) [SA 20938]; MINECO, Spain [AGL2014-52395-C2]	National Institute of Agricultural Technology; INTA-INIA (Argentina-Spain); MINECO, Spain	Work at INTA was supported by the National Institute of Agricultural Technology (grant number PNSA 1115052) and cooperation agreement INTA-INIA (Argentina-Spain SA 20938). Evaluation of vaccine immunogenicity and protection in cattle. Work at Universitat Pompeu Fabra and CBMSO was supported by MINECO, Spain (grant number AGL2014-52395-C2). Dendrimeric peptides synthesis and article submission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Romera SA, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-8; Alexandersen S, 2005, CURR TOP MICROBIOL, V288, P9; Lavoria MA, 2012, VACCINE, V30, P6845, DOI 10.1016/j.vaccine.2012.09.011; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Barteling SJ, 2004, DEV BIOLOGICALS, V119, P449; BITTLE JL, 1982, NATURE, V298, P30, DOI 10.1038/298030a0; Blanco E, 2016, ANTIVIR RES, V129, P74, DOI 10.1016/j.antiviral.2016.03.005; Blanco E, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/475960; Bouvet JP, 2002, TRENDS IMMUNOL, V23, P209, DOI 10.1016/S1471-4906(02)02186-5; Brocchi E, 2006, VACCINE, V24, P6966, DOI 10.1016/j.vaccine.2006.04.050; Capozzo AVE, 1997, VACCINE, V15, P624, DOI 10.1016/S0264-410X(96)00284-8; COLLEN T, 1991, J IMMUNOL, V146, P749; Cubillos C, 2008, J VIROL, V82, P7223, DOI 10.1128/JVI.00401-08; Diaz-San Segundo F, 2016, VET MICROBIOL; DIMARCHI R, 1986, SCIENCE, V232, P639, DOI 10.1126/science.3008333; GLASS EJ, 1991, IMMUNOLOGY, V74, P594; Goddeeris B, 1998, HANDBOOK OF INVERTEBRATE IMMUNOLOGY, P439; Heegaard PMH, 2010, BIOCONJUGATE CHEM, V21, P405, DOI 10.1021/bc900290d; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Law M, 2008, CURR OPIN IMMUNOL, V20, P486, DOI 10.1016/j.coi.2008.06.005; Maradei E, 2008, VACCINE, V26, P6577, DOI 10.1016/j.vaccine.2008.09.033; MCCULLOUGH KC, 1992, J VIROL, V66, P1835, DOI 10.1128/JVI.66.4.1835-1840.1992; MCCULLOUGH KC, 1988, IMMUNOLOGY, V65, P187; Monso M, 2013, BIOCONJUGATE CHEM, V24, P578, DOI 10.1021/bc300515t; Moraes MP, 2002, VACCINE, V20, P1631, DOI 10.1016/S0264-410X(01)00483-2; OIE] World Organisation for Animal Health, 2017, MANUAL DIAGNOSTIC TE; Orsel K, 2007, VACCINE, V25, P6381, DOI 10.1016/j.vaccine.2007.06.010; Orsel K, 2005, VACCINE, V23, P4887, DOI 10.1016/j.vaccine.2005.05.014; Orsel K, 2009, CAN VET J, V50, P1059; Pega J, 2015, J VIROL, V89, P9581, DOI 10.1128/JVI.01082-15; Pega J, 2013, J VIROL, V87, P2489, DOI 10.1128/JVI.02879-12; Porta C, 2013, J VIROL METHODS, V187, P406, DOI 10.1016/j.jviromet.2012.11.011; Quattrocchi V, 2014, VACCINE, V32, P2167, DOI 10.1016/j.vaccine.2014.02.061; Quattrocchi V, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00037; Rodriguez LL, 2003, VACCINE, V21, P3751, DOI 10.1016/S0264-410X(03)00364-5; Sadler Kristen, 2002, J Biotechnol, V90, P195; SELLERS RF, 1971, LANCET, V1, P1238; STABEL JR, 1995, VET IMMUNOL IMMUNOP, V45, P211, DOI 10.1016/0165-2427(94)05348-V; Taboga O, 1997, J VIROL, V71, P2606, DOI 10.1128/JVI.71.4.2606-2614.1997; Tekleghiorghis T, 2014, CLIN VACCINE IMMUNOL, V21, P674, DOI 10.1128/CVI.00034-14; ZAMORANO P, 1994, VIROLOGY, V201, P383, DOI 10.1006/viro.1994.1305; Zamorano PI, 1998, VACCINE, V16, P558, DOI 10.1016/S0264-410X(97)00244-2; Zinkernagel RM, 2003, ANNU REV IMMUNOL, V21, P515, DOI 10.1146/annurev.immunol.21.120601.141045	43	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185184	10.1371/journal.pone.0185184	http://dx.doi.org/10.1371/journal.pone.0185184			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949998	Green Submitted, Green Published, gold			2022-12-27	WOS:000411671000029
J	Hirabayashi, F; Iwanaga, K; Okinaga, T; Takahashi, O; Ariyoshi, W; Suzuki, R; Sugii, M; Maruyama, K; Tominaga, K; Nishihara, T				Hirabayashi, Fumika; Iwanaga, Kenjiro; Okinaga, Toshinori; Takahashi, Osamu; Ariyoshi, Wataru; Suzuki, Ryo; Sugii, Mutsumi; Maruyama, Kazuo; Tominaga, Kazuhiro; Nishihara, Tatsuji			Epidermal growth factor receptor-targeted sonoporation with microbubbles enhances therapeutic efficacy in a squamous cell carcinoma model	PLOS ONE			English	Article							DRUG-DELIVERY SYSTEM; PLASMID DNA; CANCER-CELLS; EGF RECEPTOR; IN-VITRO; ULTRASOUND; LIPOSOMES; BLEOMYCIN; ANTIBODY; GENE	Sonoporation is a drug and gene delivery system using ultrasonication that allows the intracellular delivery of foreign molecules that cannot enter cells under normal conditions. We previously reported that sonoporation with microbubbles (MBs) could achieve effective intracellular drug delivery to human gingival squamous carcinoma Ca9-22 cells. In this study, we developed anti-epidermal growth factor receptor (EGFR) antibody-conjugated MBs (EGFRMBs) and evaluated their capacity to enhance anti-cancer drug toxicity in vitro and in vivo. We first assessed the effect of sonoporation with EGFR-MBs on Ca9-22 cells by the WST-8 assay, flow cytometry and Hoechst's staining in vitro. Sonoporation and EGFR-MB had a strong cytotoxic effect on Ca9-22 cells with low-dose bleomycin. Furthermore, bleomycin delivery using sonoporation with EGFR-MBs remarkably increased the number of apoptotic cells. We next examined the effect of EGFR-MBs in a murine squamous cell carcinoma model. Bleomycin delivery by sonoporation with EGFR-MBs exhibited remarkable antitumor activity. Together, our results show that EGFR-MBs and ultrasound treatment increases the efficacy and specificity of intracellular drug uptake, suggesting this could be a novel drug-targeting modality for oral squamous cell carcinoma chemotherapy treatment.	[Hirabayashi, Fumika; Okinaga, Toshinori; Ariyoshi, Wataru; Nishihara, Tatsuji] Kyushu Dent Univ, Div Infect & Mol Biol, Dept Hlth Promot, Kitakyushu, Fukuoka, Japan; [Hirabayashi, Fumika; Iwanaga, Kenjiro; Takahashi, Osamu; Tominaga, Kazuhiro] Kyushu Dent Univ, Dept Sci Phys Funct, Div Oral & Maxillofacial Surg, Kitakyushu, Fukuoka, Japan; [Suzuki, Ryo; Sugii, Mutsumi; Maruyama, Kazuo] Teikyo Univ, Fac Pharma Sci, Lab Drug Delivery Syst, Tokyo, Japan	Kyushu Dental University; Kyushu Dental University; Teikyo University	Iwanaga, K (corresponding author), Kyushu Dent Univ, Dept Sci Phys Funct, Div Oral & Maxillofacial Surg, Kitakyushu, Fukuoka, Japan.	kenjiro.iwanaga.a2@tohoku.ac.jp		Nishihara, Tatsuji/0000-0001-7075-9678; Suzuki, Ryo/0000-0001-6614-4486	JSPS KAKENHI [JP16K11698]; Grants-in-Aid for Scientific Research [17H00864] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP16K11698.	Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Armstrong JK, 2007, CANCER-AM CANCER SOC, V110, P103, DOI 10.1002/cncr.22739; Bai WK, 2016, ONCOL LETT, V11, P3829, DOI 10.3892/ol.2016.4477; Burger RM, 1998, CHEM REV, V98, P1153, DOI 10.1021/cr960438a; Dewitte H, 2014, J CONTROL RELEASE, V194, P28, DOI 10.1016/j.jconrel.2014.08.011; Endo-Takahashi Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03883; Fan XZ, 2016, INT J NANOMED, V11, P3585, DOI 10.2147/IJN.S111808; FECHHEIMER M, 1987, P NATL ACAD SCI USA, V84, P8463, DOI 10.1073/pnas.84.23.8463; Garg A, 2011, CURR PHARM BIOTECHNO, V12, P1135, DOI 10.2174/138920111796117328; Gothelf A, 2003, CANCER TREAT REV, V29, P371, DOI 10.1016/S0305-7372(03)00073-2; Iwanaga K, 2007, CANCER GENE THER, V14, P354, DOI 10.1038/sj.cgt.7701026; Joshi A, 2017, ONCOTARGETS THER, V10, P1859, DOI 10.2147/OTT.S125397; KAMATA N, 1986, CANCER RES, V46, P1648; Lamanauskas N, 2013, J DRUG TARGET, V21, P407, DOI 10.3109/1061186X.2012.761223; Lee EJ, 2005, EXP MOL MED, V37, P379, DOI 10.1038/emm.2005.48; Liang BJ, 2015, CLIN CANCER RES, V21, P1183, DOI 10.1158/1078-0432.CCR-14-1194; Liao AH, 2015, J MED BIOL ENG, V35, P156, DOI 10.1007/s40846-015-0032-9; Maeda H, 2009, J ORAL PATHOL MED, V38, P572, DOI 10.1111/j.1600-0714.2009.00759.x; Napolitano S, 2017, ONCOTARGET; Nejad SM, 2016, THERANOSTICS, V6, P446, DOI 10.7150/thno.13518; Perera RH, 2015, WIRES NANOMED NANOBI, V7, P593, DOI 10.1002/wnan.1326; ROY SN, 1984, CANCER RES, V44, P1541; Sano K, 2014, MOL CANCER THER, V13, P426, DOI 10.1158/1535-7163.MCT-13-0633; Sato T, 2014, ULTRASOUND MED BIOL, V40, P1237, DOI 10.1016/j.ultrasmedbio.2013.12.012; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Shen ZP, 2008, GENE THER, V15, P1147, DOI 10.1038/gt.2008.51; Solbach C, 2002, INT J CANCER, V101, P390, DOI 10.1002/ijc.10615; Tachibana K, 1999, JPN J APPL PHYS 1, V38, P3014, DOI 10.1143/JJAP.38.3014; Taniyama Y, 2002, GENE THER, V9, P372, DOI 10.1038/sj.gt.3301678; TOUNEKTI O, 1993, CANCER RES, V53, P5462; VanOsdol J, 2017, J CONTROL RELEASE, V247, P55, DOI 10.1016/j.jconrel.2016.12.033; Wang X, 2014, INT J NANOMED, V9, P4899, DOI 10.2147/IJN.S69845; Yang T, 2014, THERANOSTICS, V4, P1096, DOI 10.7150/thno.9423; Yin TH, 2014, BIOMATERIALS, V35, P5932, DOI 10.1016/j.biomaterials.2014.03.072; Yoon YI, 2014, THERANOSTICS, V4, P1133, DOI 10.7150/thno.9945	35	19	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185293	10.1371/journal.pone.0185293	http://dx.doi.org/10.1371/journal.pone.0185293			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938010	Green Submitted, Green Published, gold			2022-12-27	WOS:000411524700025
J	Beda, A; Simpson, DM; Faes, L				Beda, Alessandro; Simpson, David M.; Faes, Luca			Estimation of confidence limits for descriptive indexes derived from autoregressive analysis of time series: Methods and application to heart rate variability	PLOS ONE			English	Article							MENTAL STRESS; COMPLEXITY; DECOMPOSITION; REPEATABILITY; BOOTSTRAP; ENTROPY	The growing interest in personalized medicine requires making inferences from descriptive indexes estimated from individual recordings of physiological signals, with statistical analyses focused on individual differences between/within subjects, rather than comparing supposedly homogeneous cohorts. To this end, methods to compute confidence limits of individual estimates of descriptive indexes are needed. This study introduces numerical methods to compute such confidence limits and perform statistical comparisons between indexes derived from autoregressive (AR) modeling of individual time series. Analytical approaches are generally not viable, because the indexes are usually nonlinear functions of the AR parameters. We exploit Monte Carlo (MC) and Bootstrap (BS) methods to reproduce the sampling distribution of the AR parameters and indexes computed from them. Here, these methods are implemented for spectral and information-theoretic indexes of heart-rate variability (HRV) estimated from AR models of heart-period time series. First, the MS and BC methods are tested in a wide range of synthetic HRV time series, showing good agreement with a gold-standard approach (i.e. multiple realizations of the "true" process driving the simulation). Then, real HRV time series measured from volunteers performing cognitive tasks are considered, documenting (i) the strong variability of confidence limits' width across recordings, (ii) the diversity of individual responses to the same task, and (iii) frequent disagreement between the cohort-average response and that of many individuals. We conclude that MC and BS methods are robust in estimating confidence limits of these AR-based indexes and thus recommended for short-term HRV analysis. Moreover, the strong inter-individual differences in the response to tasks shown by AR-based indexes evidence the need of individual-by-individual assessments of HRV features. Given their generality, MC and BS methods are promising for applications in biomedical signal processing and beyond, providing a powerful new tool for assessing the confidence limits of indexes estimated from individual recordings.	[Beda, Alessandro] Univ Fed Minas Gerais, Dept Elect Engn, Belo Horizonte, MG, Brazil; [Beda, Alessandro] Univ Fed Minas Gerais, Postgrad Program Elect Engn, Belo Horizonte, MG, Brazil; [Simpson, David M.] Univ Southampton, Inst Sound & Vibrat Res, Southampton, Hants, England; [Faes, Luca] Univ Trento, Bruno Kessler Fdn & BlOtech, Trento, Italy	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of Southampton; University of Trento	Beda, A (corresponding author), Univ Fed Minas Gerais, Dept Elect Engn, Belo Horizonte, MG, Brazil.; Beda, A (corresponding author), Univ Fed Minas Gerais, Postgrad Program Elect Engn, Belo Horizonte, MG, Brazil.	ale.beda@gmail.com	Faes, Luca/E-5156-2012; Beda, Alessandro/AAC-5519-2019	Faes, Luca/0000-0002-3271-5348; Beda, Alessandro/0000-0002-1867-9846	Fundacao de amparo a pesquisa do estado de Minas Gerais (Brazil) [PPM-00158-15]; Fundacao de amparo a pesquisa do estado de Minas Gerais (Brazil); University of Sothampton [APQ-0388714]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil) [400461/2013-7]; Autonomous Province of Trento (Italy) (IRCS); EPSRC (UK) [EP/K036157/1]; Engineering and Physical Sciences Research Council [EP/K036157/1, EP/G010420/1] Funding Source: researchfish; EPSRC [EP/K036157/1, EP/G010420/1] Funding Source: UKRI	Fundacao de amparo a pesquisa do estado de Minas Gerais (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de amparo a pesquisa do estado de Minas Gerais (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); University of Sothampton; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Autonomous Province of Trento (Italy) (IRCS); EPSRC (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the following grants, but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.: - AB: Fundacao de amparo a pesquisa do estado de Minas Gerais (Brazil, www.fapemig.br), grant nr PPM-00158-15 -AB and DMS: Fundacao de amparo a pesquisa do estado de Minas Gerais (Brazil, www.fapemig.br) and University of Sothampton (www.soton.a.c.uk), grant nr APQ-0388714-AB and DMS: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil, www.cnpq.br) grant nr 400461/2013-7 - LF: Autonomous Province of Trento (Italy, www.provincia.tn.it) IRCS program funding - The financial support from EPSRC (UK), grant number EP/K036157/1 is gratefully acknowledged.	[Anonymous], 1987, DIGITAL SPECTRAL ANA; Baselli G, 1997, IEEE T BIO-MED ENG, V44, P1092, DOI 10.1109/10.641336; Beda A, 2007, PSYCHOPHYSIOLOGY, V44, P767, DOI 10.1111/j.1469-8986.2007.00542.x; Beda A, 2014, PSYCHOPHYSIOLOGY, V51, P197, DOI 10.1111/psyp.12163; Bernardi L, 2000, J AM COLL CARDIOL, V35, P1462, DOI 10.1016/S0735-1097(00)00595-7; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Brown MJ, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4697; BUCKLAND ST, 1984, BIOMETRICS, V40, P811, DOI 10.2307/2530926; Camm AJ, 1996, EUR HEART J, V17, P354; Cohen MA, 2002, J PHYSIOL-LONDON, V542, P669, DOI 10.1113/jphysiol.2002.017483; Eckberg DL, 2003, J PHYSIOL-LONDON, V548, P339, DOI 10.1113/jphysiol.2002.037192; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Faes L, 2015, ENTROPY-SWITZ, V17, P277, DOI 10.3390/e17010277; Goldberger JJ, 2001, CIRCULATION, V103, P1977; Hyvarinen A, 2010, J MACH LEARN RES, V11, P1709; Jauregui-Renaud K, 2001, ARCH MED RES, V32, P21, DOI 10.1016/S0188-4409(00)00255-1; Kuipers NT, 2008, J APPL PHYSIOL, V104, P1129, DOI 10.1152/japplphysiol.01285.2007; Ljung L., 1987, SYSTEM IDENTIFICATIO; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; MARDIA KV, 1984, BIOMETRIKA, V71, P135, DOI 10.1093/biomet/71.1.135; Pinna GD, 1996, MED BIOL ENG COMPUT, V34, P142, DOI 10.1007/BF02520019; Politis DN, 2003, STAT SCI, V18, P219, DOI 10.1214/ss/1063994977; Porta A, 2001, IEEE T BIO-MED ENG, V48, P1282, DOI 10.1109/10.959324; Porta A, 2007, J APPL PHYSIOL, V103, P1143, DOI 10.1152/japplphysiol.00293.2007; Porta A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132851; Schroeder EB, 2004, J ELECTROCARDIOL, V37, P163, DOI 10.1016/j.jelectrocard.2004.04.004; SLOAN RP, 1991, PHYSIOL BEHAV, V50, P1039, DOI 10.1016/0031-9384(91)90434-P; Tandon N, 1999, TRIBOL INT, V32, P469, DOI 10.1016/S0301-679X(99)00077-8; Visnovcova Z, 2014, PHYSIOL MEAS, V35, P1319, DOI 10.1088/0967-3334/35/7/1319; Widjaja D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129112; Zoubir AM, 1998, IEEE SIGNAL PROC MAG, V15, P56, DOI 10.1109/79.647043	32	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0183230	10.1371/journal.pone.0183230	http://dx.doi.org/10.1371/journal.pone.0183230			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968394	gold, Green Published, Green Accepted			2022-12-27	WOS:000412029600005
J	Guo, YJ; Fu, SH; Li, LL				Guo, Ya-Jun; Fu, Shi-Hui; Li, Lu-Lin			Autographa californica multiple nucleopoly-hedrovirus ac75 is required for egress of nucleocapsids from the nucleus and formation of de novo intranuclear membrane microvesicles	PLOS ONE			English	Article							OCCLUSION-DERIVED VIRUS; POLYHEDROSIS-VIRUS; BUDDED-VIRUS; CELLULAR-LOCALIZATION; STRUCTURAL PROTEINS; ESCHERICHIA-COLI; EFFICIENT EGRESS; BODY FORMATION; CORE GENE; BACULOVIRUS	In this study, Autographa californica multiple nucleopolyhedrovirus ac75 was functionally characterized. Ac75 has homologs in all sequenced genomes of alphabaculoviruses, betabaculoviruses, and gammabaculoviruses. It was determined to encode a protein that is associated with the nucleocapsid of budded virus and with both envelope and nucleocapsids of occlusion-derived virus. Sf9 cells transfected by an ac75-knockout bacmid resulted in the infection being restricted to single cells. No budded virus were detected although viral DNA replication and late gene expression were unaffected. Electron microscopy revealed that the virogenic stroma, nucleocapsids and occlusion bodies appeared normal in the cells transfected by an ac75-knockout bacmid. However, the nucleocapsids were unenveloped, the occlusion bodies did not contain any virions or nucleocapsids, and no nucleocapsids were found outside the nucleus or spanning the nuclear membrane. In addition, de novo intranuclear membrane microvesicles that are the precursor of occlusion-derived virus envelopes were absent in the nuclei of transfected cells. Confocal microscopy showed that AC75 protein appeared in the cytoplasm as early as 6 hours post infection. It localized to the ring zone at the periphery of the nucleus from 15 to 24 hours post infection and demonstrated light blocky cloud-like distribution in the center of the nucleus. AC75 was found to co-immunoprecipitate with BV and ODV associated envelope protein ODV-E25. The data from this study suggest that ac75 is essential for induction of the intranuclear membrane microvesicles, it appears to be required for the intranuclear envelopment of nucleocapsids, and is also essential for egress of nucleocapsids from the nuclei, in infected cells.	[Guo, Ya-Jun; Fu, Shi-Hui; Li, Lu-Lin] Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Hubei, Peoples R China	Central China Normal University	Li, LL (corresponding author), Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Hubei, Peoples R China.	lilulin@mail.ccnu.edu.cn	LULIN, LI/W-3785-2019		National Key R&D Program of China [2017YFD0200400]	National Key R&D Program of China	This study was funded by a grant from National Key R&D Program of China, 2017YFD0200400, (service.most.gov.cn) to Lu-Lin Li.	AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Beniya H, 1998, VIROLOGY, V240, P64, DOI 10.1006/viro.1997.8903; Braunagel SC, 2003, P NATL ACAD SCI USA, V100, P9797, DOI 10.1073/pnas.1733972100; Braunagel SC, 1996, VIROLOGY, V217, P97, DOI 10.1006/viro.1996.0097; Braunagel SC, 1996, VIROLOGY, V222, P100, DOI 10.1006/viro.1996.0401; Braunagel SC, 2007, CURR DRUG TARGETS, V8, P1084, DOI 10.2174/138945007782151315; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fang M, 2007, J VIROL, V81, P9859, DOI 10.1128/JVI.00588-07; Fang MG, 2009, VIROLOGY, V389, P66, DOI 10.1016/j.virol.2009.04.003; HONG T, 1994, VIROLOGY, V204, P210, DOI 10.1006/viro.1994.1525; Hong T, 1997, P NATL ACAD SCI USA, V94, P4050, DOI 10.1073/pnas.94.8.4050; Hou DH, 2013, J VIROL, V87, P829, DOI 10.1128/JVI.02329-12; Hu ZY, 2010, J VIROL, V84, P7437, DOI 10.1128/JVI.02103-09; Kawasaki Y, 2004, J GEN VIROL, V85, P3575, DOI 10.1099/vir.0.80418-0; Ke JH, 2008, VIROLOGY, V374, P421, DOI 10.1016/j.virol.2007.12.033; KNUDSON DL, 1976, J VIROL, V17, P254, DOI 10.1128/JVI.17.1.254-268.1976; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; Luo XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065635; Nie YC, 2011, VIROLOGY, V409, P38, DOI 10.1016/j.virol.2010.09.023; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Ren HL, 2016, VIROL SIN, V31, P229, DOI 10.1007/s12250-015-3675-3; Rohrmann GF, 2013, BACULOVIRUS MOL BIOL, V3rd; Sambrook J., 2001, MOL CLONING LAB MANU; Shen HX, 2012, FEBS LETT, V586, P990, DOI 10.1016/j.febslet.2011.12.040; Shen HX, 2009, CURR MICROBIOL, V59, P65, DOI 10.1007/s00284-009-9399-6; Tao XY, 2013, J VIROL, V87, P8441, DOI 10.1128/JVI.01290-13; Vanarsdall AL, 2004, VIROLOGY, V326, P191, DOI 10.1016/j.virol.2004.06.003; Wang RR, 2010, J VIROL, V84, P7233, DOI 10.1128/JVI.00040-10; Wei DH, 2014, J VIROL, V88, P1090, DOI 10.1128/JVI.02392-13; Yang M, 2014, J VIROL, V88, P12586, DOI 10.1128/JVI.01313-14; Yang M, 2014, VIROLOGY, V464, P341, DOI 10.1016/j.virol.2014.07.030; Yuan MJ, 2008, VIROLOGY, V379, P87, DOI 10.1016/j.virol.2008.06.015; Yuan MJ, 2011, J VIROL, V85, P11664, DOI 10.1128/JVI.05275-11	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185630	10.1371/journal.pone.0185630	http://dx.doi.org/10.1371/journal.pone.0185630			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968422	Green Submitted, gold, Green Published			2022-12-27	WOS:000412029600032
J	Fredriksson-Lidman, K; Van Itallie, CM; Tietgens, AJ; Anderson, JM				Fredriksson-Lidman, Karin; Van Itallie, Christina M.; Tietgens, Amber J.; Anderson, James M.			Sorbin and SH3 domain-containing protein 2 (SORBS2) is a component of the acto-myosin ring at the apical junctional complex in epithelial cells	PLOS ONE			English	Article							VINCULIN-BINDING PROTEIN; TIGHT JUNCTION; STRESS FIBERS; CYTOSKELETAL ORGANIZATION; INTERACTING PROTEIN; ADAPTER PROTEIN; ZONULA ADHERENS; ALPHA-ACTININ; LIPID RAFTS; E-CADHERIN	SORBS2 is a scaffolding protein associated with Abl/Arg non-receptor tyrosine kinase pathways and is known to interact with actin and several other cytoskeletal proteins in various cell types. Previous BioID proximity labeling of tight and adherens junction proteins suggested that SORBS2 is a component of the apical junction complex of epithelial cells. We asked whether SORBS2 plays a previously unappreciated role in controlling perijunctional actin and tight junction barrier function. Using super resolution imaging we confirmed that SORBS2 is localized at the apical junction complex but farther from the membrane than ZO-1 and located partially overlapping both the tight- and adherens junctions with a periodic concentration that alternates with myosin IIB in polarized epithelial cells. Overexpression of GFP-SORBS2 recruited alpha-actinin, vinculin and N-WASP, and possibly CIP4 to cellular junctions. However, CRISPR-Cas9 knock-out of SORBS2 did not alter the localization- or immunofluorescent staining intensity of these or several other junctional- and cytoskeletal proteins. SORBS2 knock-out also did not affect the barrier function as measured by TER and dextran flux; nor did it change actin-dependent junction re-assembly as measured by Ca2+-switch and Latrunculin-B wash-out assays. The kinetics of HGF-induced cell scattering and wound healing, and dextran flux increase induced by PDGF also were unaffected by SORBS2 knock-out. SORBS2 concentrates with apical junctional actin that accumulates in response to knock-down of ZO-1 and ZO-2. In spite of our finding that SORBS2 is clearly a component of the apical junction complex, it does not appear to be required for either normal tight- or adherens junction assembly, structure or function or for growth factor-mediated changes in tight junction dynamics.	[Fredriksson-Lidman, Karin; Van Itallie, Christina M.; Tietgens, Amber J.; Anderson, James M.] NHLBI, Lab Tight Junct Struct & Funct, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Fredriksson-Lidman, K (corresponding author), NHLBI, Lab Tight Junct Struct & Funct, NIH, Bldg 10, Bethesda, MD 20892 USA.	karin.fredriksson@nih.gov			Division of Intramural Research, National Institutes of Health (US) [ZIA HL006207]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006207] Funding Source: NIH RePORTER	Division of Intramural Research, National Institutes of Health (US); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the Division of Intramural Research, National Institutes of Health (US), ZIA HL006207, Dr. James M. Anderson.	ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141; Anekal PV, 2015, J BIOL CHEM, V290, P2112, DOI 10.1074/jbc.M114.610725; Anekal PV, 2014, J BIOL CHEM; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; Cestra G, 2005, P NATL ACAD SCI USA, V102, P1731, DOI 10.1073/pnas.0409376102; Chang YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107961; Chen VC, 2006, J PROTEOME RES, V5, P2123, DOI 10.1021/pr060216l; Choi W, 2016, J CELL BIOL, V213, P243, DOI 10.1083/jcb.201506115; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; Ebrahim S, 2013, CURR BIOL, V23, P731, DOI 10.1016/j.cub.2013.03.039; Etournay R, 2007, J CELL SCI, V120, P2838, DOI 10.1242/jcs.002568; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Fredriksson K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117074; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Guo ZH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005473; Haglund K, 2004, J CELL SCI, V117, P2557, DOI 10.1242/jcs.01148; Hallock PT, 2016, MOL CELL BIOL, V36, P262, DOI 10.1128/MCB.00775-15; Harhaj NS, 2002, J CELL PHYSIOL, V193, P349, DOI 10.1002/jcp.10183; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hu SQ, 2017, NAT CELL BIOL, V19, P133, DOI 10.1038/ncb3466; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Kassianidou E, 2015, BBA-MOL CELL RES, V1853, P3065, DOI 10.1016/j.bbamcr.2015.04.006; Kawabe H, 1999, J BIOL CHEM, V274, P30914, DOI 10.1074/jbc.274.43.30914; Kimura A, 2001, P NATL ACAD SCI USA, V98, P9098, DOI 10.1073/pnas.151252898; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kioka N, 2002, CELL STRUCT FUNCT, V27, P1, DOI 10.1247/csf.27.1; Lechuga S, 2015, AM J PHYSIOL-GASTR L, V308, pG745, DOI 10.1152/ajpgi.00446.2014; Li R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124960; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Murase K, 2012, MED MOL MORPHOL, V45, P22, DOI 10.1007/s00795-010-0537-9; Peterson LJ, 2004, MOL BIOL CELL, V15, P3497, DOI 10.1091/mbc.E03-09-0696; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roignot J, 2010, CANCER LETT, V288, P116, DOI 10.1016/j.canlet.2009.06.030; Ronty M, 2005, EXP CELL RES, V310, P88, DOI 10.1016/j.yexcr.2005.06.026; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Sanger JM, 2010, CYTOSKELETON, V67, P808, DOI 10.1002/cm.20490; Sheff DR, 2002, MOL BIOL CELL, V13, P262, DOI 10.1091/mbc.01-07-0320; Soubeyran P, 2003, BIOCHEM J, V370, P29, DOI 10.1042/BJ20021539; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Taieb D, 2008, CANCER RES, V68, P4588, DOI 10.1158/0008-5472.CAN-08-0958; Tang VW, 2012, J CELL BIOL, V196, P115, DOI 10.1083/jcb.201103116; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Van Itallie CM, 2015, MOL BIOL CELL, V26, P2769, DOI 10.1091/mbc.E15-04-0232; Van Itallie CM, 2014, J CELL SCI, V127, P885, DOI 10.1242/jcs.140475; Van Itallie CM, 2013, J BIOL CHEM, V288, P13775, DOI 10.1074/jbc.M113.466193; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wang BL, 1997, J BIOL CHEM, V272, P17542, DOI 10.1074/jbc.272.28.17542; Yuan ZQ, 2005, J BIOL CHEM, V280, P21483, DOI 10.1074/jbc.M500097200; Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3	56	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185448	10.1371/journal.pone.0185448	http://dx.doi.org/10.1371/journal.pone.0185448			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961272	Green Submitted, Green Published, gold			2022-12-27	WOS:000412027700019
J	Geurts, M; de Kort, FAS; de Kort, PLM; van Tuijl, JH; Kappelle, LJ; van der Worp, HB				Geurts, Marjolein; de Kort, Floor A. S.; de Kort, Paul L. M.; van Tuijl, Julia H.; Kappelle, L. Jaap; van der Worp, H. Bart			Predictive accuracy of physicians' estimates of outcome after severe stroke	PLOS ONE			English	Article							QUALITY-OF-LIFE; INTRACEREBRAL HEMORRHAGE; EXTERNAL VALIDATION; CEREBRAL INFARCTION; DISABILITY; SCORE; WITHDRAWAL; CLINICIAN; ORDERS; TRIAL	Introduction End-of-life decisions after stroke should be guided by accurate estimates of the patient's prognosis. We assessed the accuracy of physicians' estimates regarding mortality, functional outcome, and quality of life in patients with severe stroke. Methods Treating physicians predicted mortality, functional outcome (modified Rankin scale (mRS)), and quality of life (visual analogue scale (VAS)) at six months in patients with major disabling stroke who had a Barthel Index <= 6 (of 20) at day four. Unfavorable functional outcome was defined as mRS >3, non-satisfactory quality of life as VAS <60. Patients were followed-up at six months after stroke. We compared physicians' estimates with actual outcomes. Results Sixty patients were included, with a mean age of 72 years. Of fifteen patients who were predicted to die, one actually survived at six months (positive predictive value (PPV), 0.93; 95% CI, 0.66-0.99). Of thirty patients who survived, one was predicted to die (false positive rate (FPR), 0.03; 95% CI 0.00-0.20). Of forty-six patients who were predicted to have an unfavorable outcome, four had a favorable outcome (PPV, 0.93; 95% CI, 0.81-0.98; FPR, 0.30; 95% CI; 0.08-0.65). Prediction of non-satisfactory quality of life was less accurate (PPV, 0.63; 95% CI, 0.26-0.90; FPR, 0.18; 95% CI 0.05-0.44). Conclusions In patients with severe stroke, treating physicians' estimation of the risk of mortality or unfavorable functional outcome at six months is relatively inaccurate. Prediction of quality of life is even more imprecise.	[Geurts, Marjolein; de Kort, Floor A. S.; Kappelle, L. Jaap; van der Worp, H. Bart] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands; [de Kort, Paul L. M.; van Tuijl, Julia H.] Elisabeth Twee Steden Ziekenhuis, Dept Neurol, Tilburg, Netherlands	Utrecht University; Utrecht University Medical Center; Elisabeth-TweeSteden Ziekenhuis (ETZ)	Geurts, M (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands.	m.geurts-2@umcutrecht.nl	Geurts, Marjolein/AAP-4148-2020		Dutch Heart Foundation [20106239, 2010T075]	Dutch Heart Foundation(Netherlands Heart Foundation)	Marjolein Geurts and Bart van der Worp are supported by the Dutch Heart Foundation (20106239 and 2010T075, respectively). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Caulfield AF, 2010, NEUROLOGY, V74, P1096, DOI 10.1212/WNL.0b013e3181d8197f; Cerniauskaite M, 2012, AM J PHYS MED REHAB, V91, pS39, DOI 10.1097/PHM.0b013e31823d4df7; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clarke JL, 2004, NEUROCRIT CARE, V1, P53, DOI 10.1385/NCC:1:1:53; Geurts M, EUROPEAN STROKE J; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Geurts M, 2013, STROKE, V44, P2506, DOI 10.1161/STROKEAHA.113.002014; Hemphill JC, 2004, STROKE, V35, P1130, DOI 10.1161/01.STR.0000125858.71051.ca; Hwang DY, 2016, NEUROLOGY, V86, P126, DOI 10.1212/WNL.0000000000002266; Indredavik B, 1998, STROKE, V29, P895, DOI 10.1161/01.STR.29.5.895; Kelly AG, 2012, NEUROLOGY, V79, P941, DOI 10.1212/WNL.0b013e318266fc40; Luengo-Fernandez R, 2013, STROKE, V44, P2854, DOI 10.1161/STROKEAHA.113.001584; MAHONEY F I, 1965, Md State Med J, V14, P61; Navi BB, 2012, STROKE, V43, P702, DOI 10.1161/STROKEAHA.111.639161; Saposnik G, 2013, NEUROLOGY, V81, P448, DOI 10.1212/WNL.0b013e31829d874e; Saposnik G, 2011, CIRCULATION, V123, P739, DOI 10.1161/CIRCULATIONAHA.110.983353; Silvennoinen K, 2014, INT J STROKE, V9, P53, DOI 10.1111/ijs.12161; Ubel PA, 2005, HEALTH PSYCHOL, V24, pS57, DOI 10.1037/0278-6133.24.4.S57; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Ware J., 1993, SF 36 HLTH SURVEY MA; Weimar C, 2004, STROKE, V35, P158, DOI 10.1161/01.STR.0000106761.94985.8B; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd	24	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184894	10.1371/journal.pone.0184894	http://dx.doi.org/10.1371/journal.pone.0184894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961255	Green Published, gold, Green Submitted			2022-12-27	WOS:000412027700012
J	Ross-Degnan, D; Chalker, J; Liana, J; Kajoka, MD; Valimba, R; Kimatta, S; Dillip, A; Vialle-Valentin, C; Embrey, M; Lieber, R; Johnson, K				Ross-Degnan, Dennis; Chalker, John; Liana, Jafary; Kajoka, Mwikemo Deborah; Valimba, Richard; Kimatta, Suleiman; Dillip, Angel; Vialle-Valentin, Catherine; Embrey, Martha; Lieber, Rachel; Johnson, Keith			A group randomized trial using an appointment system to improve adherence to ART at reproductive and child health clinics implementing Option B plus in Tanzania	PLOS ONE			English	Article							TIME-SERIES ANALYSES; ANTIRETROVIRAL THERAPY; RETENTION; WOMEN; PROGRAM; CARE; CHALLENGES; DESIGN; COHORT	Introduction In October 2013, Tanzania adopted Option B+ under which HIV-positive pregnant women are initiated on antiretroviral therapy in reproductive and child health clinics at diagnosis. Studies have shown that adherence and retention to antiretroviral treatment can be problematic. Methods We implemented a group randomized controlled trial in 24 reproductive and child health clinics in eight districts in Mbeya region. The trial tested the impact of implementing paper-based appointment tracking and community outreach systems on the rate of missed appointments and number of days covered by dispensed antiretroviral medications among women previously established on antiretroviral therapy. We used interrupted time series analysis to assess study outcomes. Clinic staff and patients in intervention clinics were aware of the intervention because of change in clinic procedures; data collectors knew the study group assignment. Results Three months pre-intervention, we identified 1924 and 1226 patients established on antiretroviral therapy for six months or more in intervention and control clinics, respectively, of whom 83.4% and 86.9% had one or more post-intervention visits. The unadjusted rate of missed visits declined from 36.5% to 34.4% in intervention clinics and increased from 38.9% to 45.5% in control clinics following the intervention. Interrupted time series analyses demonstrated a net decrease of 13.7% (95% CI [-15.4,-12.1]) for missed visits at six months post-intervention. Similar differential changes were observed for visits missed by 3, 7, 15, or 60 days. Conclusion Appointment-tracking and community outreach significantly improved appointment-keeping for women on antiretroviral therapy. The facility staff controlled their workload better, identified missing patients rapidly, and worked with existing community organizations. There is now enough evidence to scale up this approach to all antiretroviral therapy and Option B+ reproductive and child health clinics in Tanzania as well as to evaluate the intervention in medical clinics that treat other chronic health conditions.	[Ross-Degnan, Dennis; Vialle-Valentin, Catherine] Harvard Med Sch, Boston, MA USA; [Ross-Degnan, Dennis; Vialle-Valentin, Catherine] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Chalker, John; Embrey, Martha; Lieber, Rachel; Johnson, Keith] Management Sci Hlth, Pharmaceut & Hlth Technol Grp, Arlington, VA 22203 USA; [Liana, Jafary] Apotheker Consultancy Ltd, Dar Es Salaam, Tanzania; [Kajoka, Mwikemo Deborah] Minist Hlth Community Dev Gender Elderly & Childr, Dar Es Salaam, Tanzania; [Valimba, Richard; Kimatta, Suleiman] Management Sci Hlth, Dar Es Salaam, Tanzania; [Dillip, Angel] Ifakara Hlth Inst, Dar Es Salaam, Tanzania	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Ifakara Health Institute	Chalker, J (corresponding author), Management Sci Hlth, Pharmaceut & Hlth Technol Grp, Arlington, VA 22203 USA.	John.chalker@ymail.com			International Initiative for Impact Evaluation (3ie); Apotheker Consultancy (T) Limited	International Initiative for Impact Evaluation (3ie); Apotheker Consultancy (T) Limited	The study was funded by the International Initiative for Impact Evaluation (3ie). The funder provided support in the form of salaries for authors [DRD, JC, JL, RV, SK, AD, CW, ME, RL and KJ]. The funders commented on the study design but had no role in data collection and analysis, decision to publish, or preparation of the manuscript. Author JL is employed by Apotheker Consultancy (T) Limited. Apotheker Consultancy (T) Limited provided support in the form of salary for author JL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the Author Contributions section.	Atanga PN, 2017, TROP MED INT HEALTH, V22, P161, DOI 10.1111/tmi.12816; Boruett P, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-242; Chalker JC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-43; Elwell K, 2016, AIDS CARE, V28, P971, DOI 10.1080/09540121.2016.1153586; Fayorsey RN, 2016, JAIDS-J ACQ IMM DEF, V72, pS137, DOI 10.1097/QAI.0000000000001060; Geldsetzer P, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20679; Haas AD, 2016, CLIN INFECT DIS, V63, P1227, DOI 10.1093/cid/ciw500; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Helova A, 2017, HEALTH POLICY PLANN, V32, P283, DOI 10.1093/heapol/czw122; Kim MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149527; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Kruk ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160764; Linden A, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-119; Llenas-Garcia J, 2016, TROP MED INT HEALTH, V21, P1003, DOI 10.1111/tmi.12728; Mitiku I, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20662; Mwatawala S, 2012, INT J PERS CTR MED, V2, P825; Napua M, 2016, JAIDS-J ACQ IMM DEF, V72, pS181, DOI 10.1097/QAI.0000000000001061; Ross-Degnan D, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-42; StataCorp, 2015, STAT STAT SOFTW REL; Woelk GB, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.5.20837; World Health Organization, 2010, NEW GUID PREV MOTH T; Zhang F, 2011, J CLIN EPIDEMIOL, V64, P1252, DOI 10.1016/j.jclinepi.2011.02.007; Zhang F, 2009, J CLIN EPIDEMIOL, V62, P143, DOI 10.1016/j.jclinepi.2008.08.007	23	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184591	10.1371/journal.pone.0184591	http://dx.doi.org/10.1371/journal.pone.0184591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957381	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200015
J	Szikora, B; Hiripi, L; Bender, B; Kacskovics, I; Ilias, A				Szikora, Bence; Hiripi, Laszlo; Bender, Balazs; Kacskovics, Imre; Ilias, Attila			Characterization of the interactions of rabbit neonatal Fc receptor (FcRn) with rabbit and human IgG isotypes	PLOS ONE			English	Article							PH-DEPENDENT BINDING; I-RELATED RECEPTOR; SITE-DIRECTED MUTAGENESIS; PLACENTAL-TRANSFER; CRYSTAL-STRUCTURE; IMMUNOGLOBULIN-G; MONOCLONAL-ANTIBODY; NONHUMAN-PRIMATES; YOLK-SAC; COMPLEX	Despite the increasing importance of rabbit as an animal model in pharmacological studies like investigating placental transfer of therapeutic IgGs, little is known about the molecular interaction of the rabbit neonatal Fc receptor (FcRn) with rabbit and human IgG molecules. We analyzed the interactions of the rabbit and human FcRn with rabbit and human IgG isotypes using surface plasmon resonance assay. Similar to FcRn of other species, rabbit FcRn functions in pH-dependent manner, as it binds IgGs at pH 6.0, but no binding occurs at pH 7.4. We also showed that rabbit FcRn binds rabbit IgG and human IgG1 with nearly identical affinity, whereas it has stronger interactions with the other human IgG isotypes. The similar affinity of rabbit IgG and human IgG1 for rabbit FcRn was confirmed by in vitro FcRn-mediated recycling assay. These data verify that rabbit is an appropriate animal model for analyzing the pharmacokinetics of human therapeutic monoclonal antibodies.	[Szikora, Bence; Kacskovics, Imre; Ilias, Attila] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Hiripi, Laszlo] Natl Agr Res & Innovat Ctr, Dept Anim Biotechnol, Godollo, Hungary; [Bender, Balazs; Kacskovics, Imre] ImmunoGenes ABS Ltd, Budakeszi, Hungary	Eotvos Lorand University	Ilias, A (corresponding author), Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary.	attila.ilias@ttk.elte.hu	Hiripi, Laszlo/AAL-8243-2021; Szikora, Bence/AAG-3544-2021; Kacskovics, Imre/J-8449-2013; Ilias, Attila/I-7072-2017	Hiripi, Laszlo/0000-0002-1023-0112; Kacskovics, Imre/0000-0002-0402-3862; Ilias, Attila/0000-0003-3196-0795; Szikora, Bence/0000-0002-0766-5684	Hungarian National Development Agency [KMOP-4.2.1./B-10-2011-0002]	Hungarian National Development Agency	This work was supported by the grant from the Hungarian National Development Agency [KMOP-4.2.1./B-10-2011-0002]. The funder provided support in the form of purchasing the ProteOn XPR36 biosensor instrument, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. BB is scientific researcher, IK is CEO of ImmunoGenes-ABS Ltd, Budakeszi, Hungary. The funder provided support in the form of salaries for authors BB and IK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdiche YN, 2015, MABS-AUSTIN, V7, P331, DOI 10.1080/19420862.2015.1008353; Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Baker K, 2014, FRONT IMMUNOL, V5, DOI [10.3389/fimmu.2014.00664, 10.3389/fimmu.2014.00408]; Bitonti AJ, 2004, P NATL ACAD SCI USA, V101, P9763, DOI 10.1073/pnas.0403235101; Bowman CJ, 2013, BIRTH DEFECTS RES B, V98, P459, DOI 10.1002/bdrb.21089; Brambell FWR., 1970, N HOLL RES MONOGR FR, V18; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Cervenak J, 2015, IMMUNOL REV, V268, P269, DOI 10.1111/imr.12364; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; DeSesso JM, 2012, CRIT REV TOXICOL, V42, P185, DOI 10.3109/10408444.2011.653487; GATES FT, 1979, BIOCHEMISTRY-US, V18, P2267, DOI 10.1021/bi00578a021; Gaton E, 1984, MACROPHAGE ACTIVATIO, P15; Ghetie V, 1997, NAT BIOTECHNOL, V15, P637, DOI 10.1038/nbt0797-637; HUBER AH, 1993, J MOL BIOL, V230, P1077, DOI 10.1006/jmbi.1993.1220; Kacskovics I, 2006, INT IMMUNOL, V18, P525, DOI 10.1093/intimm/dxh393; KIM JK, 1994, EUR J IMMUNOL, V24, P542, DOI 10.1002/eji.1830240308; KOBAYASHI Y, 1989, EUR J DRUG METAB PH, V14, P35, DOI 10.1007/BF03190840; Kuo TT, 2011, MABS-AUSTIN, V3, P422, DOI 10.4161/mabs.3.5.16983; Lemos APC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028869; Martin PL, 2010, INT J TOXICOL, V29, P552, DOI 10.1177/1091581810378896; Martin PL, 2010, BIRTH DEFECTS RES B, V89, P116, DOI 10.1002/bdrb.20232; Martin WL, 1999, BIOCHEMISTRY-US, V38, P12639, DOI 10.1021/bi9913505; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; MEADS TJ, 1994, PLACENTA, V15, P525, DOI 10.1016/S0143-4004(05)80421-7; Moffat GJ, 2014, BIRTH DEFECTS RES B, V101, P178, DOI 10.1002/bdrb.21105; Mohty M, 2007, LEUKEMIA, V21, P1387, DOI 10.1038/sj.leu.2404683; Nicholas KB., 1997, GENEDOC TOOL EDITING; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201; Popov S, 1996, MOL IMMUNOL, V33, P521, DOI 10.1016/0161-5890(96)00004-1; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; RODEWALD R, 1976, J CELL BIOL, V71, P666, DOI 10.1083/jcb.71.2.666; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; SABISTON BH, 1976, J IMMUNOL, V116, P106; Sanchez LM, 1999, BIOCHEMISTRY-US, V38, P9471, DOI 10.1021/bi9907330; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider Z, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00357; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; SMITH AES, 1962, DEV BIOL, V4, P339, DOI 10.1016/0012-1606(62)90047-7; SPIEGELB.HL, 1965, J EXP MED, V121, P323, DOI 10.1084/jem.121.3.323; Wang XD, 2017, MABS-AUSTIN, V9, P319, DOI 10.1080/19420862.2016.1261774; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m; Zhou JC, 2003, J MOL BIOL, V332, P901, DOI 10.1016/S0022-2836(03)00952-5; Zhou JC, 2005, J MOL BIOL, V345, P1071, DOI 10.1016/j.jmb.2004.11.014	46	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185662	10.1371/journal.pone.0185662	http://dx.doi.org/10.1371/journal.pone.0185662			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957416	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200102
J	Umakoshi, H; Iwano, S; Inoue, T; Li, YZ; Naganawa, S				Umakoshi, Hiroyasu; Iwano, Shingo; Inoue, Tsutomu; Li, Yuanzhong; Naganawa, Shinji			Quantitative evaluation of interstitial pneumonia using 3D-curved high-resolution CT imaging parallel to the chest wall: A pilot study	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; COMPUTED-TOMOGRAPHY; CLASSIFICATION; EMPHYSEMA; DIAGNOSIS; DENSITY; INDEXES	Objectives To quantify the imaging findings of patients with interstitial pneumonia (IP) and emphysema using three-dimensional curved high-resolution computed tomography (3D-cHRCT) at a constant depth from the chest wall, and compare the results to visual assessment of IP and each patient's diffusing capacity of the lungs for carbon monoxide (DLco). Methods We retrospectively reviewed the axial CT findings and pulmonary function test results of 95 patients with lung cancer (72 men and 23 women, aged 45-84 years) with or without IP, as follows: non-IP (n = 47), mild IP (n = 31), and moderate IP (n = 17). The 3D-cHRCT images of the lung at a 1-cm depth from the chest wall were reconstructed automatically using original software; total area (TA), high-attenuation area (HAA) >-500 HU, and low-attenuation area (LAA) <-950 HU were calculated on a workstation. The % HAA and % LAA were calculated as follows: % HAA = HAA/TA x 100, and % LAA = LAA/TA x100. Results The % HAA and % LAA respective values were 3.2 +/- 0.9 and 27.7 +/- 8.2, 3.9 +/- 1.2 and 27.6 +/- 5.9, and 6.9 +/- 2.2 and 25.4 +/- 8.7 in non-IP, mild IP, and moderate IP patients, respectively. There were significant differences in % HAA between the 3 groups of patients (P<0.001), but no differences in % LAA (P = 0.558). Multiple linear regression analysis revealed that % HAA and % LAA were negatively correlated with predicted DLco (standard partial regression coefficient [b*] = -0.453, P<0.001; b* = -0.447, P<0.001, respectively). Conclusions The % HAA and % LAA values computed using 3D-cHRCT were significantly correlated with DLco and may be important quantitative parameters for both IP and emphysema.	[Umakoshi, Hiroyasu; Iwano, Shingo; Naganawa, Shinji] Nagoya Univ, Grad Sch Med, Dept Radiol, Nagoya, Aichi, Japan; [Inoue, Tsutomu; Li, Yuanzhong] Fujifilm Corp, Imaging Technol Ctr, Tokyo, Japan	Nagoya University; Fujifilm Corporation	Iwano, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Radiol, Nagoya, Aichi, Japan.	iwano45@med.nagoya-u.ac.jp	Naganawa, Shinji/I-1572-2012; Iwano, Shingo/I-7355-2014	Naganawa, Shinji/0000-0002-0214-613X; Iwano, Shingo/0000-0002-3256-0390	Japan Society for the Promotion of Science (JSPS); JSPS KAKENHI [15H01115, 17H05292]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study has received funding by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research on Innovative Areas (Multidisciplinary Computational Anatomy), JSPS KAKENHI Grant Number 15H01115; Grant Number 17H05292 to SI.) This study was also funded by Fujifilm corporation. Fujifilm corporation provided support in the form of salaries for authors [TI, YL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	ADAMS H, 1991, CLIN RADIOL, V43, P238, DOI 10.1016/S0009-9260(05)80245-4; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Ash SY, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0527-8; Bartholmai BJ, 2013, J THORAC IMAG, V28, P298, DOI 10.1097/RTI.0b013e3182a21969; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653, DOI 10.1164/ajrccm.152.2.7633722; GODDARD PR, 1982, CLIN RADIOL, V33, P379, DOI 10.1016/S0009-9260(82)80301-2; Iwano S, 2009, ACAD RADIOL, V16, P250, DOI 10.1016/j.acra.2008.09.019; Iwasawa T, 2009, J THORAC IMAG, V24, P216, DOI 10.1097/RTI.0b013e3181a6527d; Jacob J, 2016, J THORAC IMAG, V31, P304, DOI 10.1097/RTI.0000000000000220; Jankowich MD, 2012, CHEST, V141, P222, DOI 10.1378/chest.11-1062; Koyama Hisanobu, 2016, Eur J Radiol, V85, P352, DOI 10.1016/j.ejrad.2015.11.026; Koyama H, 2010, EUR J RADIOL, V74, P142, DOI 10.1016/j.ejrad.2009.02.006; Lynch DA, 2007, CHEST, V131, P643, DOI 10.1378/chest.06-2955; Margaritopoulos GA, 2015, EUR RESPIR REV, V24, P428, DOI 10.1183/16000617.0050-2015; Matsuoka S, 2015, J COMPUT ASSIST TOMO, V39, P153, DOI 10.1097/RCT.0000000000000184; Mimae T, 2015, ANN SURG ONCOL, V22, pS1371, DOI 10.1245/s10434-015-4577-1; Nambu A, 2015, EUR J RADIOL, V84, P980, DOI 10.1016/j.ejrad.2015.01.010; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Shin KE, 2011, J COMPUT ASSIST TOMO, V35, P266, DOI 10.1097/RCT.0b013e31820ccf18; Sverzellati N, 2007, RADIOL MED, V112, P1160, DOI 10.1007/s11547-007-0213-x; Sverzellati N, 2015, RADIOGRAPHICS, V35, P1849, DOI 10.1148/rg.2015140334; Tominaga J, 2015, EUR J RADIOL, V84, P2640, DOI 10.1016/j.ejrad.2015.08.016; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Watadani T, 2013, RADIOLOGY, V266, P936, DOI 10.1148/radiol.12112516; Yoon RG, 2013, EUR RADIOL, V23, P692, DOI 10.1007/s00330-012-2634-8	26	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185532	10.1371/journal.pone.0185532	http://dx.doi.org/10.1371/journal.pone.0185532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957390	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200078
J	Ahmad, J; Bashir, H; Bagheri, R; Baig, A; Al-Huqail, A; Ibrahim, MM; Qureshi, MI				Ahmad, Javed; Bashir, Humayra; Bagheri, Rita; Baig, Affan; Al-Huqail, Asma; Ibrahim, Mohamed M.; Qureshi, M. Irfan			Drought and salinity induced changes in ecophysiology and proteomic profile of Parthenium hysterophorus	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; RESPONSIVE PROTEINS; HYDROGEN-PEROXIDE; WATER-DEFICIT; ASCORBIC-ACID; STRESS; SALT; GLUTATHIONE; TOLERANCE; PLANT	Parthenium hysterophorus is a plant that tolerates drought and salinity to an extremely high degree. Higher expression of stress-responsive proteome contributes for greater defence against abiotic stresses. Thus, P. hysterophorus could be a rich source of genes that encode stress-imparting mechanisms and systems. The present study utilizes comparative physiological and proteomic approaches for identification of key proteins involved in stress-defence of P. hysterophorus. Thirty-days-old plants were exposed to drought (10% PEG 6000) and salinity (160 mM NaCl) for 10 days duration. Both stresses induced oxidative stress estimated in terms of TBARS and H2O2. Levels of both enzymatic and non-enzymatic antioxidants were elevated, more by drought than salinity. Particularly, SOD, GR, CAT and GST proved to be assisting as very commendable defence under drought, as well as salinity. Levels of ascorbate, glutathione and proline were also increased by both stresses, more in response to drought. Comparative proteomics analysis revealed a significant change in relative abundance of 72 proteins under drought and salinity. Drought and salinity increased abundance of 45 and 41 proteins and decreased abundance of 24 and 26 proteins, respectively. Drought and salinity increased and decreased abundance of 31 and 18 proteins, respectively. The functions of identified proteins included those related to defence response (26%), signal transduction (13%), transcription and translation (10%), growth and development (8.5%), photosynthesis (8.5%), metabolism (7%), terpenoid biosynthesis (5.5%), protein modification and transport (7%), oxido-reductase (4%) and Miscellaneous (11%). Among the defence related proteins, antioxidants and HSPs constituted 26% and 21%, respectively. Present study suggests a potential role of defence proteins. Proteins involved in molecular stabilization, formation of osmolytes and wax and contributing to stress-avoiding anatomical features emerged as key and complex mechanisms for imparting stress tolerance to P. hysterophorus.	[Ahmad, Javed; Bashir, Humayra; Bagheri, Rita; Baig, Affan; Qureshi, M. Irfan] Jamia Millie Islamia Cent Univ, Dept Biotechnol, New Delhi, India; [Al-Huqail, Asma] King Saud Univ, Dept Bot & Microbiol, Sci Coll, Riyadh, Saudi Arabia; [Ibrahim, Mohamed M.] Alexandria Univ, Dept Bot & Microbiol, Fac Sci, Alexandria, Egypt; [Ibrahim, Mohamed M.] Bergen Community Coll, Dept Biol & Hort, Paramus, NJ USA	Jamia Millia Islamia; King Saud University; Egyptian Knowledge Bank (EKB); Alexandria University	Qureshi, MI (corresponding author), Jamia Millie Islamia Cent Univ, Dept Biotechnol, New Delhi, India.	mirfanq@gmail.com	Qureshi, M Irfan/CAF-0824-2022	Qureshi, M Irfan/0000-0001-9625-0036; Baig, Affan/0000-0002-6203-2097	KSU Deanship Funding [RGP-231]; Deanship of scientific research at King Saud University [RGP-231]	KSU Deanship Funding; Deanship of scientific research at King Saud University(King Saud University)	This work was supported by KSU Deanship Funding to RGP-231.; The authors would like to extend their sincere appreciation to the Deanship of scientific research at King Saud University for its funding of research project to group no. RGP-231.	Acevedo RM, 2013, PLANT PHYSIOL BIOCH, V65, P48, DOI 10.1016/j.plaphy.2012.12.016; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Al-Huqail AA, 2017, SCI HORTIC-AMSTERDAM, V217, P226, DOI 10.1016/j.scienta.2017.02.007; ANDERSON ME, 1985, ARCH BIOCHEM BIOPHYS, V239, P538, DOI 10.1016/0003-9861(85)90723-4; Arthur CA, 1910, B TORREY BOT CLUB, V37, P569; Bagheri R, 2016, PROTOPLASMA, P1; Bagheri R, 2015, PLANT PHYSIOL BIOCH, V97, P235, DOI 10.1016/j.plaphy.2015.10.012; Bajwa AA, 2017, ENV SCI POLLUT RES; Bajwa AA, 2016, PLANTA, V244, P39, DOI 10.1007/s00425-016-2510-x; Bashir H, 2013, ENVIRON EXP BOT, V94, P19, DOI 10.1016/j.envexpbot.2012.05.004; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bhowmik P.C., 2007, ECOPRINT INT J ECOL, V14, P1, DOI [10.3126/eco.v14i0.4824, DOI 10.3126/ECO.V14I0.4824]; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carra S, 2017, CELL STRESS CHAPERON, V22, P601, DOI 10.1007/s12192-017-0787-8; Caverzan A, 2016, GENET MOL BIOL, V39, P1, DOI 10.1590/1678-4685-GMB-2015-0109; Chen ZJ, 2015, PLANT PHYSIOL, V167, P176, DOI 10.1104/pp.114.251017; Cuypers A, 2011, J PLANT PHYSIOL, V168, P309, DOI 10.1016/j.jplph.2010.07.010; Dai XY, 2016, J EXP BOT, V67, P947, DOI 10.1093/jxb/erv515; Das A, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6021047; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; EPPO, 2014, PEST RISK AN PARTH H; Eva C, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2118-6; Fasoli E, 2011, J PROTEOMICS, V74, P127, DOI 10.1016/j.jprot.2010.10.009; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Fu Y, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0471-8; Gao F, 2013, PLANT BIOTECHNOL J, V11, P921, DOI 10.1111/pbi.12083; Gazanchian A, 2007, J EXP BOT, V58, P291, DOI 10.1093/jxb/erl226; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hoagland DR, 1950, CIRC CALIF AGR EXPT, V347; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Humbert S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039023; Javed Ahmad, 2016, African Journal of Biotechnology, V15, P1035; Jiang Y, 2007, J EXP BOT, V58, P3591, DOI 10.1093/jxb/erm207; Kaur M, 2014, INT SCH RES NOTICES; Kaur Manpreet, 2014, Int Sch Res Notices, V2014, P368647, DOI 10.1155/2014/368647; Kim YH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00510; Krasensky J, 2014, ANTIOXID REDOX SIGN, V21, P1289, DOI 10.1089/ars.2013.5693; Kuroha T, 2009, PLANT CELL, V21, P3152, DOI 10.1105/tpc.109.068676; Lane TS, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0277-6; LAW MY, 1983, BIOCHEM J, V210, P899, DOI 10.1042/bj2100899; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Lezhneva L, 2004, PLANT J, V37, P174, DOI 10.1046/j.1365-313X.2003.01952.x; Li MY, 2016, SCI REP, V6; Li XN, 2015, PLANT SOIL, V393, P307, DOI 10.1007/s11104-015-2499-0; Li Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep38539; Liu N, 2014, NUCLEIC ACIDS RES, V42, P5556, DOI 10.1093/nar/gku220; Luo X, 2013, J EXP BOT, V64, P2155, DOI 10.1093/jxb/ert073; Ma HY, 2012, J PROTEOMICS, V75, P1529, DOI 10.1016/j.jprot.2011.11.026; Manna S, 2015, BIOCHIMIE, V113, P93, DOI 10.1016/j.biochi.2015.04.004; Mulekar JJ, 2014, J EXP BOT, V65, P2883, DOI 10.1093/jxb/ert401; Muneer S, 2013, AUST J CROP SCI, V7; Muneer S, 2012, PLANT GROWTH REGUL, V68, P421, DOI 10.1007/s10725-012-9731-1; Mustroph A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00125; Naik H. K., 2016, American Journal of Plant Sciences, V7, P980, DOI 10.4236/ajps.2016.76093; Noctor G, 2012, PLANT CELL ENVIRON, V35, P454, DOI 10.1111/j.1365-3040.2011.02400.x; Parveen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31218; Patel S, 2004, PLANT CELL, V16, P3260, DOI 10.1105/tpc.104.026740; Per TS, 2017, PLANT PHYSIOL BIOCH, V115, P126, DOI 10.1016/j.plaphy.2017.03.018; Qureshi MH, 2010, J PLANT PHYSIOL, V167, P761, DOI 10.1016/j.jplph.2010.01.017; Qureshi MI, 2007, BIOL PLANTARUM, V51, P121, DOI 10.1007/s10535-007-0024-x; Qureshi MI, 2005, ENVIRON EXP BOT, V53, P185, DOI 10.1016/j.envexpbot.2004.03.014; Reddy PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089125; Ren J, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9851095; Salekdeh G. H., 2016, AGR PROTEOMICS; Salma I, ANN BOT, V115, P433; Sampaio BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29265; Schlesier Bernhard, 2006, V323, P381; Schwenkert S, 2010, BIOCHEM J, V425, P207, DOI 10.1042/BJ20091290; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shinde VN, 2016, IJAR, V2, P730; Sibert BS, 2012, NUCLEIC ACIDS RES, V40, P2107, DOI 10.1093/nar/gkr1017; Stone SL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00135; Sugihara K, 2000, PLANT CELL PHYSIOL, V41, P1279, DOI 10.1093/pcp/pcd061; Sun CX, 2016, AGR WATER MANAGE, V172, P62, DOI 10.1016/j.agwat.2016.04.016; Sun L, 2011, J EXP BOT, V62, P5659, DOI 10.1093/jxb/err252; Suzuki M, 2006, PLANT J, V45, P264, DOI 10.1111/j.1365-313X.2005.02620.x; Tada Y, 2009, PLANT CELL PHYSIOL, V50, P439, DOI 10.1093/pcp/pcp002; Tang D, 2011, NAT COMMUN, V50, P439; Nguyen T, 2017, ENVIRON SCI POLLUT R, V24, P10727, DOI 10.1007/s11356-017-8737-7; Toscano S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00645; Ullah A, 2017, PLANT BIOTECHNOL J, V15, P271, DOI 10.1111/pbi.12688; Upadhyay S.K., 2013, INT J SCIENTIFICAND, V3, P1; Vighi IL, BIOL PLANT; Viotti C, 2005, FEBS J, V272, P5864, DOI 10.1111/j.1742-4658.2005.04985.x; Watson BS, 2003, PLANT PHYSIOL, V131, P1104, DOI 10.1104/pp.102.019034; Wu B, 2017, PLOS ONE, V13; Xu ZR, 2016, ENERGIES, V9, DOI 10.3390/en9050372; Yu CW, 2003, FUNCT PLANT BIOL, V30, P955, DOI 10.1071/FP03091; Zhang HY, 2016, MOL GENET GENOMICS, V291, P1293, DOI 10.1007/s00438-016-1188-x; Zhao PJ, 2015, J EXP BOT, V66, P1477, DOI 10.1093/jxb/eru507	91	30	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185118	10.1371/journal.pone.0185118	http://dx.doi.org/10.1371/journal.pone.0185118			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953916	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300036
J	Thomas, LM; Jorgenson, ZG; Brigham, ME; Choy, SJ; Moore, JN; Banda, JA; Gefell, DJ; Minarik, TA; Schoenfuss, HL				Thomas, Linnea M.; Jorgenson, Zachary G.; Brigham, Mark E.; Choy, Steven J.; Moore, Jeremy N.; Banda, Jo A.; Gefell, Daniel J.; Minarik, Thomas A.; Schoenfuss, Heiko L.			Contaminants of emerging concern in tributaries to the Laurentian Great Lakes: II. Biological consequences of exposure	PLOS ONE			English	Article							WASTE-WATER TREATMENT; TREATMENT-PLANT EFFLUENTS; MEDAKA ORYZIAS-LATIPES; SEWAGE-TREATMENT PLANTS; ZEBRAFISH DANIO-RERIO; CARE PRODUCTS PPCPS; ORGANIC CONTAMINANTS; PIMEPHALES-PROMELAS; SURFACE WATERS; IN-VITRO	The Laurentian Great Lakes contain one fifth of the world's surface freshwater and have been impacted by human activity since the Industrial Revolution. In addition to legacy contaminants, nitrification and invasive species, this aquatic ecosystem is also the recipient of Contaminants of Emerging Concern (CECs) with poorly understood biological consequences. In the current study, we documented the presence, concentrations, and biological effects of CECs across 27 field sites in six Great Lakes tributaries by examining over 2250 resident and caged sunfish (Lepomis ssp.) for a variety of morphological and physiological endpoints and related these results to CEC occurrence. CEC were ubiquitous across studies sites and their presence and concentrations in water and sediment were highest in effluent dominated rivers and downstream of municipal wastewater treatment plant discharges. However, even putative upstream reference sites were not free of CEC presence and fish at these sites exhibited biological effects consistent with CEC exposure. Only the Fox River exhibited consistent adverse biological effects, including increased relative liver size, greater prominence of hepatocyte vacuoles and increased plasma glucose concentrations. Canonical Redundancy Analysis revealed consistent patterns of biological consequences of CEC exposure across all six tributaries. Increasing plasma glucose concentrations, likely as a result of pollutant-induced metabolic stress, were associated with increased relative liver size and greater prominence of hepatocyte vacuoles. These indicators of pollutant exposure were inversely correlated with indicators of reproductive potential including smaller gonad size and less mature gametes. The current study highlights the need for greater integration of chemical and biological studies and suggests that CECs in the Laurentian Great Lakes Basin may adversely affect the reproductive potential of exposed fish populations.	[Thomas, Linnea M.; Jorgenson, Zachary G.; Schoenfuss, Heiko L.] St Cloud State Univ, Aquat Toxicol Lab, St Cloud, MN 56301 USA; [Jorgenson, Zachary G.] US Fish & Wildlife Serv, St Cloud, MN USA; [Brigham, Mark E.] US Geol Survey, Mounds View, MN USA; [Choy, Steven J.] US Fish & Wildlife Serv, Madison, WI USA; [Moore, Jeremy N.] US Fish & Wildlife Serv, E Lansing, MI USA; [Banda, Jo A.] US Fish & Wildlife Serv, Columbus, OH USA; [Gefell, Daniel J.] US Fish & Wildlife Serv, Cortland, NY USA; [Minarik, Thomas A.] Metropolitan Water Reclamat Dist Greater Chicago, Cicero, IL USA	Minnesota State Colleges & Universities; Saint Cloud State University; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service	Schoenfuss, HL (corresponding author), St Cloud State Univ, Aquat Toxicol Lab, St Cloud, MN 56301 USA.	hschoenfuss@stcloudstate.edu		Brigham, Mark/0000-0001-7412-6800; Schoenfuss, Heiko/0000-0001-5464-992X	US Fish & Wildlife Service; Great Lakes Restoration Initiative through the U.S. Fish and Wildlife Service's CEC Team; National Science Foundation grant [CBET 1336062]	US Fish & Wildlife Service(US Fish & Wildlife Service); Great Lakes Restoration Initiative through the U.S. Fish and Wildlife Service's CEC Team; National Science Foundation grant(National Science Foundation (NSF))	HLS (St Cloud State University) and MEB (U.S. Geological Survey) received funding from the US Fish & Wildlife Service for this project. Funding was provided from the Great Lakes Restoration Initiative through the U.S. Fish and Wildlife Service's CEC Team. Additional support for field work in Chicago was provided to HLS by a National Science Foundation grant (CBET 1336062). In-kind support from the Metropolitan Water Reclamation District of Greater Chicago is acknowledged.	Adams SM, 2002, ECOL APPL, V12, P1510, DOI 10.1890/1051-0761(2002)012[1510:ARIASE]2.0.CO;2; AVISE JC, 1984, GENETICS, V108, P237; BAKER DB, 1985, J SOIL WATER CONSERV, V40, P125; Baldwin AK, 2016, SCI TOTAL ENVIRON, V554, P42, DOI 10.1016/j.scitotenv.2016.02.137; Barber LB, 2015, SCI TOTAL ENVIRON, V517, P195, DOI 10.1016/j.scitotenv.2015.02.035; Barber LB, 2011, SCI TOTAL ENVIRON, V409, P4720, DOI 10.1016/j.scitotenv.2011.06.039; Bartelt-Hunt SL, 2012, ENVIRON SCI TECHNOL, V46, P1352, DOI 10.1021/es202680q; Bartlett JA, 2010, J FISH BIOL, V77, P890, DOI 10.1111/j.1095-8649.2010.02724.x; Barucca M, 2006, ENVIRON RES, V101, P68, DOI 10.1016/j.envres.2005.07.002; Bendz D, 2005, J HAZARD MATER, V122, P195, DOI 10.1016/j.jhazmat.2005.03.012; Bevelhimer MS, 2014, ENVIRON TOXICOL CHEM, V33, P1903, DOI 10.1002/etc.2622; Biales AD, 2007, ENVIRON TOXICOL CHEM, V26, P2679, DOI 10.1897/07-101.1; Blazer VS, 2007, J AQUAT ANIM HEALTH, V19, P242, DOI 10.1577/H07-031.1; Bracewell P, 2004, J FISH BIOL, V64, P65, DOI 10.1111/j.1095-8649.2004.00281.x; Brian JV, 2005, ENVIRON HEALTH PERSP, V113, P721, DOI 10.1289/ehp.7598; Burkhardt MR, 2006, BOOK, V5; Burki R, 2006, ENVIRON TOXICOL CHEM, V25, P2077, DOI 10.1897/05-545R.1; Carrara C, 2008, ENVIRON SCI TECHNOL, V42, P2805, DOI 10.1021/es070344q; Carson FL, 1997, HISTOTECHNOLOGY; Cheek AO, 2004, COMP BIOCHEM PHYS C, V137, P249, DOI 10.1016/j.cca.2004.01.005; Cheng MC, 2016, ANIM REPROD SCI, V174, P114, DOI 10.1016/j.anireprosci.2016.09.014; Choy SJ, 2017, BTPR30172013; Crago J, 2011, CHEMOSPHERE, V82, P1669, DOI 10.1016/j.chemosphere.2010.11.011; Dammann AA, 2011, AQUAT TOXICOL, V105, P559, DOI 10.1016/j.aquatox.2011.08.011; Davies R, 2012, PHYSIOL BIOCHEM ZOOL, V85, P321, DOI 10.1086/666058; Deblonde T, 2011, INT J HYG ENVIR HEAL, V214, P442, DOI 10.1016/j.ijheh.2011.08.002; Dougherty JA, OCCURRENCE HERBICIDE; Elliott SM, 2016, CHEM EMERGING WATER; Elliott SM, 2015, CHEM EMERGING WATER; Ellis JB, 2006, ENVIRON POLLUT, V144, P184, DOI 10.1016/j.envpol.2005.12.018; Fanta E, 2003, ECOTOX ENVIRON SAFE, V54, P119, DOI 10.1016/S0147-6513(02)00044-1; Ferrey M., 2017, PHARM CHEM RIVERS OC; Ferrey ML, 2015, ENVIRON TOXICOL CHEM, V34, P2475, DOI 10.1002/etc.3125; Fick J, 2010, ENVIRON SCI TECHNOL, V44, P2661, DOI 10.1021/es903440m; Filby AL, 2007, AQUAT TOXICOL, V81, P219, DOI 10.1016/j.aquatox.2006.12.003; Fischer J.M., 2015, US GEOLOGICAL SURVEY, V905, P42, DOI DOI 10.3133/DS905; Foreman WT, 2015, BOOK, V5; Fry J, 2011, PHOTOGRAMM ENG REMOT, V77, P858; Fulton TW, 1904, ANN REPORT, V22, P141; Furlong E.T., 2014, BOOK, V5, DOI DOI 10.3133/TM5B10; Gabe M, 1976, HISTOLOGICAL TECHNIQ; Gerrity D, 2011, WATER RES, V45, P5399, DOI 10.1016/j.watres.2011.07.020; Giebultowicz J, 2014, ECOTOX ENVIRON SAFE, V104, P103, DOI 10.1016/j.ecoenv.2014.02.020; Gravel A, 2007, AQUAT TOXICOL, V85, P87, DOI 10.1016/j.aquatox.2007.07.001; Gros M, 2007, ENVIRON TOXICOL CHEM, V26, P1553, DOI 10.1897/06-495R.1; Gutendorf B, 2001, TOXICOLOGY, V166, P79, DOI 10.1016/S0300-483X(01)00437-1; Han S, 2010, AQUAT TOXICOL, V98, P256, DOI 10.1016/j.aquatox.2010.02.013; Hanson N, 2011, ENVIRON TOXICOL, V26, P315, DOI 10.1002/tox.20559; Harris PM, 2005, COPEIA, P340, DOI 10.1643/CG-04-035R1; Hassanin A, 2002, J VET MED SCI, V64, P921, DOI 10.1292/jvms.64.921; Hemming JM, 2004, ECOTOX ENVIRON SAFE, V57, P303, DOI 10.1016/S0147-6513(03)00025-3; Hill JW, 2008, AM J PHYSIOL-ENDOC M, V294, pE827, DOI 10.1152/ajpendo.00670.2007; Huggett DB, 2002, ARCH ENVIRON CON TOX, V43, P229, DOI 10.1007/s00244-002-1182-7; ICES-Institute Franc E ais de Recherche pour l'Exploitation de la Mer, 2004, ICES TECHN MAR ENV S, V38; Jaynes DB, 1999, J ENVIRON QUAL, V28, P45, DOI 10.2134/jeq1999.00472425002800010005x; Joss A, 2004, ENVIRON SCI TECHNOL, V38, P3047, DOI 10.1021/es0351488; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Klaper R., 2011, EMERGING CONTAMINANT; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; LAGLER KARL F., 1957, COPEIA, V1957, P290, DOI 10.2307/1439156; Lee KE, 2012, US GEOLOGICAL SURVEY; Legendre P, 1988, NUMERICAL ECOLOGY, P2; Lei BL, 2013, CHEMOSPHERE, V93, P1104, DOI 10.1016/j.chemosphere.2013.06.025; Leonard JA, 2017, COMP BIOCHEM PHYS C, V191, P14, DOI 10.1016/j.cbpc.2016.09.002; Lin AYC, 2008, CHEMOSPHERE, V74, P131, DOI 10.1016/j.chemosphere.2008.08.027; Lozano N, 2012, SCI TOTAL ENVIRON, V420, P191, DOI 10.1016/j.scitotenv.2011.12.059; Luo YL, 2014, SCI TOTAL ENVIRON, V473, P619, DOI 10.1016/j.scitotenv.2013.12.065; Macnab V, 2016, AQUAT TOXICOL, V174, P92, DOI 10.1016/j.aquatox.2016.02.010; Martinovic D, 2008, ENVIRON SCI TECHNOL, V42, P3421, DOI 10.1021/es0708013; Martinovic-Weigelt D, 2013, ENVIRON INT, V61, P127, DOI 10.1016/j.envint.2013.07.018; MCMASTER ME, 1991, AQUAT TOXICOL, V21, P199, DOI 10.1016/0166-445X(91)90073-I; Metcalfe CD, 2003, ENVIRON TOXICOL CHEM, V22, P2881, DOI 10.1897/02-627; Metcalfe CD, 2001, ENVIRON TOXICOL CHEM, V20, P297, DOI [10.1897/1551-5028(2001)020&lt;0297:EPOCDI&gt;2.0.CO;2, 10.1002/etc.5620200210]; Miller MC, 2001, TOXICOL LETT, V120, P269, DOI 10.1016/S0378-4274(01)00279-X; Minarik TA, 2014, J AM WATER RESOUR AS, V50, P358, DOI 10.1111/jawr.12167; Nakari T, 2004, ENVIRON TOXICOL, V19, P207, DOI 10.1002/tox.20013; Narra MR, 2016, CHEMOSPHERE, V144, P966, DOI 10.1016/j.chemosphere.2015.09.065; Nash JP, 2004, ENVIRON HEALTH PERSP, V112, P1725, DOI 10.1289/ehp.7209; Nassef M, 2010, CHEMOSPHERE, V80, P1095, DOI 10.1016/j.chemosphere.2010.04.073; Newton S, 2014, ENVIRON SCI-PROC IMP, V16, P298, DOI 10.1039/c3em00590a; Oksanen J, 2016, VEGAN INTRO ORDINATI; Olsen KH, 2014, AQUAT TOXICOL, V148, P113, DOI 10.1016/j.aquatox.2013.12.032; Organization for Economic Co-operation and Development (OECD), 2013, PHARM CONS HLTH GLAN; Pal A, 2010, SCI TOTAL ENVIRON, V408, P6062, DOI 10.1016/j.scitotenv.2010.09.026; Palermo FA, 2008, ARCH ENVIRON CON TOX, V55, P295, DOI 10.1007/s00244-007-9113-2; Parks LG, 1999, COMP BIOCHEM PHYS C, V123, P113, DOI 10.1016/S0742-8413(99)00010-9; Paukert CP, 2004, N AM J FISH MANAGE, V24, P154, DOI 10.1577/M03-004; Phillips PJ, 2010, ENVIRON SCI TECHNOL, V44, P4910, DOI 10.1021/es100356f; Reid NM, 2016, SCIENCE, V354, P1305, DOI 10.1126/science.aah4993; Richardson BJ, 2005, MAR POLLUT BULL, V50, P913, DOI 10.1016/j.marpolbul.2005.06.034; Santos EM, 2007, AQUAT TOXICOL, V83, P134, DOI 10.1016/j.aquatox.2007.03.019; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; Schultz MM, 2013, ENVIRON INT, V61, P138, DOI 10.1016/j.envint.2013.08.006; Schultz MM, 2010, ENVIRON SCI TECHNOL, V44, P1918, DOI 10.1021/es9022706; Shala L, 2010, ARCH ENVIRON CON TOX, V58, P551, DOI 10.1007/s00244-009-9463-z; Shappell NW, 2010, AQUAT TOXICOL, V100, P1, DOI 10.1016/j.aquatox.2010.07.005; Smolders R, 2003, ENVIRON TOXICOL CHEM, V22, P890, DOI [10.1897/1551-5028(2003)022&lt;0890:CICEBA&gt;2.0.CO;2, 10.1002/etc.5620220429]; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Soto AM, 2004, ENVIRON HEALTH PERSP, V112, P346, DOI 10.1289/ehp.6590; Stehr CM, 1998, DIS AQUAT ORGAN, V32, P119, DOI 10.3354/dao032119; Swackhamer DL, 2005, J ENVIRON MONITOR, V7, P540, DOI 10.1039/b506709j; Teles M, 2004, CHEMOSPHERE, V57, P147, DOI 10.1016/j.chemosphere.2004.02.023; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF; Ternes TA, 1999, SCI TOTAL ENVIRON, V225, P81, DOI 10.1016/S0048-9697(98)00334-9; THURMAN EM, 1991, ENVIRON SCI TECHNOL, V25, P1794, DOI 10.1021/es00022a018; USGS (U.S. Geological Survey), 1999, 1225 USGS, P1; Vajda AM, 2008, ENVIRON SCI TECHNOL, V42, P3407, DOI 10.1021/es0720661; Vajda AM, 2015, ENVIRON TOXICOL CHEM, V34, P1078, DOI 10.1002/etc.2895; Van den Belt K, 2004, AQUAT TOXICOL, V66, P183, DOI 10.1016/j.aquatox.2003.09.004; Walker SL, 2005, WATER QUAL RES J CAN, V40, P251, DOI 10.2166/wqrj.2005.031; WAUCHOPE RD, 1978, J ENVIRON QUAL, V7, P459, DOI 10.2134/jeq1978.00472425000700040001x; Weinberger J, 2014, AQUAT TOXICOL, V151, P77, DOI 10.1016/j.aquatox.2013.10.012; Writer JH, 2013, SCI TOTAL ENVIRON, V461, P519, DOI 10.1016/j.scitotenv.2013.04.099; Writer JH, 2010, SCI TOTAL ENVIRON, V409, P100, DOI 10.1016/j.scitotenv.2010.07.018; Yamauchi R, 2008, AQUAT TOXICOL, V90, P261, DOI 10.1016/j.aquatox.2008.09.007; Zaugg SD, 2006, BOOK, V5	116	17	17	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184725	10.1371/journal.pone.0184725	http://dx.doi.org/10.1371/journal.pone.0184725			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953953	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300021
J	Hakkila, M; Le Tortorec, E; Brotons, L; Rajasarkka, A; Tornberg, R; Monkkonen, M				Hakkila, Matti; Le Tortorec, Eric; Brotons, Lluis; Rajasarkka, Ari; Tornberg, Risto; Monkkonen, Mikko			Degradation in landscape matrix has diverse impacts on diversity in protected areas	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; PHYLOGENETIC DIVERSITY; FRAGMENTED LANDSCAPES; SPECIES RICHNESS; NORTHERN FINLAND; CLIMATE-CHANGE; BIODIVERSITY; HABITAT; BIRDS; COMMUNITIES	Introduction A main goal of protected areas is to maintain species diversity and the integrity of biological assemblages. Intensifying land use in the matrix surrounding protected areas creates a challenge for biodiversity conservation. Earlier studies have mainly focused on taxonomic diversity within protected areas. However, functional and especially phylogenetic diversities are less studied phenomena, especially with respect to the impacts of the matrix that surrounds protected areas. Phylogenetic diversity refers to the range of evolutionary lineages, the maintenance of which ensures that future evolutionary potential is safeguarded. Functional diversity refers to the range of ecological roles that members of a community perform. For ecosystem functioning and long-term resilience, they are at least as important as taxonomic diversity. Aim We studied how the characteristics of protected areas and land use intensity in the surrounding matrix affect the diversity of bird communities in protected boreal forests. We used line-transect count and land-cover data from 91 forest reserves in Northern Finland, and land-cover data from buffer zones surrounding these reserves. We studied if habitat diversity and productivity inside protected areas, and intensity of forest management in the matrix have consistent effects on taxonomic, functional and phylogenetic diversities, and community specialization. Results We found that habitat diversity and productivity inside protected areas have strong effects on all diversity metrics, but matrix effects were inconsistent. The proportion of old forest in the matrix, reflecting low intensity forest management, had positive effects on community specialization. Interestingly, functional diversity increased with increasing logging intensity in the matrix. Conclusions Our results indicate that boreal forest reserves are not able to maintain their species composition and abundances if embedded in a severely degraded matrix. Our study also highlights the importance of focusing on different aspects of biodiversity.	[Hakkila, Matti; Le Tortorec, Eric; Monkkonen, Mikko] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Brotons, Lluis] InForest JRU, Ctr Tecnol Forestal Catalunya, Ctr Mediterranean Forest Res, Solsona, Spain; [Rajasarkka, Ari] Metsahallitus Pk & Wildlife Finland, Oulu, Finland; [Tornberg, Risto] Univ Oulu, Oulu, Finland	University of Jyvaskyla; Centre Tecnologic Forestal de Catalunya (CTFC); University of Oulu	Hakkila, M (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	matti.i.hakkila@jyu.fi	Brotons, Lluís/D-1570-2009; Le Tortorec, Eric/K-3190-2014	Brotons, Lluís/0000-0002-4826-4457; Le Tortorec, Eric/0000-0003-4051-8691; Monkkonen, Mikko/0000-0001-8897-3314; Hakkila, Matti/0000-0003-0583-332X				Allouche O, 2012, P NATL ACAD SCI USA, V109, P17495, DOI 10.1073/pnas.1208652109; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Brotons L, 2003, LANDSCAPE ECOL, V18, P377, DOI 10.1023/A:1026148825138; Burnham K.P, 2002, PRACTICAL INFORM THE; Cadotte MW, 2012, ECOLOGY, V93, pS223, DOI 10.1890/11-0426.1; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Cottee-Jones HEW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123952; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; de Bello F, 2010, J VEG SCI, V21, P992, DOI 10.1111/j.1654-1103.2010.01195.x; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Driscoll DA, 2013, TRENDS ECOL EVOL, V28, P605, DOI 10.1016/j.tree.2013.06.010; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Haila Y, 2002, ECOL APPL, V12, P321, DOI 10.1890/1051-0761(2002)012[0321:ACGOFR]2.0.CO;2; Honkanen M, 2010, GLOBAL ECOL BIOGEOGR, V19, P61, DOI 10.1111/j.1466-8238.2009.00491.x; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; JARVINEN O, 1976, Ornis Fennica, V53, P115; Jarvinen O., 1981, Studies in Avian Biology, P146; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jetz W, 2014, CURR BIOL, V24, P919, DOI 10.1016/j.cub.2014.03.011; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Laaksonen T, 2013, BIOL CONSERV, V168, P99, DOI 10.1016/j.biocon.2013.09.007; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; LEDERER RJ, 1975, AUK, V92, P385, DOI 10.2307/4084573; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; MILES DB, 1984, ECOLOGY, V65, P1629, DOI 10.2307/1939141; Moilanen A, 1998, ECOLOGY, V79, P2503, DOI 10.1890/0012-9658(1998)079[2503:MDEOHQ]2.0.CO;2; Monkkonen L, 1997, ECOGRAPHY, V20, P634, DOI 10.1111/j.1600-0587.1997.tb00432.x; Monkkonen M, 2014, BIODIVERS CONSERV, V23, P3287, DOI 10.1007/s10531-014-0780-9; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Peltola A., 2014, FINNISH STAT YB FORE, V2014; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Ricotta C, 2005, BASIC APPL ECOL, V6, P479, DOI 10.1016/j.baae.2005.02.008; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tomppo E., 1993, FINNISH FOREST RES I, V444, P53; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Vaisanen R., 1998, MUUTTUVA PESIMALINNU; Watling JI, 2011, GLOBAL ECOL BIOGEOGR, V20, P209, DOI 10.1111/j.1466-8238.2010.00586.x	53	19	19	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0184792	10.1371/journal.pone.0184792	http://dx.doi.org/10.1371/journal.pone.0184792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950017	gold, Green Published, Green Submitted			2022-12-27	WOS:000411671000016
J	Raoufi-Rad, N; McRobb, LS; Lee, VS; Bervini, D; Grace, M; Ukath, J; Mchattan, J; Sreenivasan, VKA; Duong, H; Zhao, ZJ; Stoodley, MA				Raoufi-Rad, Newsha; McRobb, Lucinda S.; Lee, Vivienne S.; Bervini, David; Grace, Michael; Ukath, Jaysree; Mchattan, Joshua; Sreenivasan, Varun K. A.; Duong, Hong; Zhao, Zhenjun; Stoodley, Marcus A.			In vivo imaging of endothelial cell adhesion molecule expression after radiosurgery in an animal model of arteriovenous malformation	PLOS ONE			English	Article							IONIZING-RADIATION; ICAM-1 EXPRESSION; GENE-EXPRESSION; MESSENGER-RNA; TISSUE FACTOR; BRAIN; IRRADIATION; NANOCARRIERS; THROMBOSIS; AGENTS	Focussed radiosurgery may provide a means of inducing molecular changes on the luminal surface of diseased endothelium to allow targeted delivery of novel therapeutic compounds. We investigated the potential of ionizing radiation to induce surface expression of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) on endothelial cells (EC) in vitro and in vivo, to assess their suitability as vascular targets in irradiated arteriovenous malformations (AVMs). Cultured brain microvascular EC were irradiated by linear accelerator at single doses of 0, 5, 15 or 25 Gy and expression of ICAM-1 and VCAM-1 measured by qRT-PCR, Western, ELISA and immunocytochemistry. In vivo, near-infrared (NIR) fluorescence optical imaging using Xenolight 750-conjugated ICAM-1 or VCAM-1 antibodies examined luminal biodistribution over 84 days in a rat AVM model after Gamma Knife surgery at a single 15 Gy dose. ICAM-1 and VCAM-1 were minimally expressed on untreated EC in vitro. Doses of 15 and 25 Gy stimulated expression equally; 5 Gy was not different from the unirradiated. In vivo, normal vessels did not bind or retain the fluorescent probes, however binding was significant in AVM vessels. No additive increases in probe binding were found in response to radiosurgery at a dose of 15 Gy. In summary, radiation induces adhesion molecule expression in vitro but elevated baseline levels in AVM vessels precludes further induction in vivo. These molecules may be suitable targets in irradiated vessels without hemodynamic derangement, but not AVMs. These findings demonstrate the importance of using flow-modulated, pre-clinical animal models for validating candidate proteins for vascular targeting in irradiated AVMs.	[Raoufi-Rad, Newsha; McRobb, Lucinda S.; Lee, Vivienne S.; Bervini, David; Sreenivasan, Varun K. A.; Duong, Hong; Zhao, Zhenjun; Stoodley, Marcus A.] Macquarie Univ, Fac Med & Hlth Sci, Dept Clin Med, Sydney, NSW, Australia; [Bervini, David] Univ Bern, Neurosurg Dept, Inselspital, Bern, Switzerland; [Grace, Michael; Ukath, Jaysree] Macquarie Univ Hosp, Genesis Canc Care, Sydney, NSW, Australia; [Mchattan, Joshua] Carestream Mol Imaging, Sydney, NSW, Australia; [Sreenivasan, Varun K. A.] Macquarie Univ, Dept Phys & Astron, Sydney, NSW, Australia	Macquarie University; University of Bern; Macquarie University; Macquarie University	Stoodley, MA (corresponding author), Macquarie Univ, Fac Med & Hlth Sci, Dept Clin Med, Sydney, NSW, Australia.	marcus.stoodley@mq.edu.au		Stoodley, Marcus/0000-0002-4207-8493; Bervini, David/0000-0003-4873-4452; Zhao, Zhenjun/0000-0002-8370-1659; Sreenivasan, Varun/0000-0002-8667-8394; McRobb, Lucinda/0000-0001-5492-1903	National Health and Medical Research Foundation of Australia [APP1047302]; National Heart Foundation of Australia [G10S5202]; Brain Foundation (Australia); John Mitchell Crouch Fellowship (Australia); Macquarie University Research Fellowship (Australia)	National Health and Medical Research Foundation of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Brain Foundation (Australia); John Mitchell Crouch Fellowship (Australia); Macquarie University Research Fellowship (Australia)	This work was supported by the National Health and Medical Research Foundation of Australia (APP1047302) (to MAS), the National Heart Foundation of Australia (#G10S5202) (to MAS), and the Brain Foundation (Australia) (to TTHD, MAS). MAS was supported by a John Mitchell Crouch Fellowship (Australia). VKAS was supported by a Macquarie University Research Fellowship (Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang SD, 1997, CLIN NEUROPATHOL, V16, P111; Chang TC, 2004, INT J RADIAT ONCOL, V60, P861, DOI 10.1016/j.ijrobp.2004.04.041; Chappell DC, 1998, CIRC RES, V82, P532, DOI 10.1161/01.RES.82.5.532; Epperly MW, 2002, BIOL BLOOD MARROW TR, V8, P175, DOI 10.1053/bbmt.2002.v8.pm12014807; Gaugler MH, 1997, INT J RADIAT BIOL, V72, P201, DOI 10.1080/095530097143428; Gaugler MH, 1998, BRIT J HAEMATOL, V103, P980, DOI 10.1046/j.1365-2141.1998.01119.x; Hallahan DE, 1997, CANCER RES, V57, P2096; Hashimoto T, 2005, NEUROSURGERY, V56, P1058; Haubner F, 2013, CLIN HEMORHEOL MICRO, V54, P371, DOI 10.3233/CH-2012-1626; Heckmann M, 1998, EXP CELL RES, V238, P148, DOI 10.1006/excr.1997.3826; Howard M, 2014, ACS NANO, V8, P4100, DOI 10.1021/nn500136z; Howard MD, 2014, ANNU REV PHARMACOL, V54, P205, DOI 10.1146/annurev-pharmtox-011613-140002; Jabbour MN, 2009, NEUROSURGERY, V64, P139, DOI 10.1227/01.NEU.0000334417.56742.24; Jones Jesse, 2007, Neurosurg Focus, V23, pE7; Kashba SR, 2015, J NEUROSURG, V123, P954, DOI 10.3171/2014.10.JNS1435; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATSUMURA T, 1979, J GERONTOL, V34, P328, DOI 10.1093/geronj/34.3.328; McRobb LS, 2017, AGING-US, V9, P1248, DOI 10.18632/aging.101225; Moftakhar P, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.2.FOCUS09317; Molla M, 2003, INT J RADIAT ONCOL, V57, P264, DOI 10.1016/S0360-3016(03)00523-6; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Muro S, 2005, CURR PHARM DESIGN, V11, P2383, DOI 10.2174/1381612054367274; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; ONDRA SL, 1990, J NEUROSURG, V73, P387, DOI 10.3171/jns.1990.73.3.0387; Ran S, 1998, CANCER RES, V58, P4646; Reddy R, 2014, J NEUROSURG, V120, P113, DOI 10.3171/2013.9.JNS122056; Sharp CD, 2003, NEUROSURGERY, V53, P154, DOI 10.1227/01.NEU.0000068840.84484.DA; Shenkar R, 2003, NEUROSURGERY, V52, P465, DOI 10.1227/01.NEU.0000044131.03495.22; Storer K, 2007, NEUROSURGERY, V61, P604, DOI 10.1227/01.NEU.0000290909.32600.A8; Storer KP, 2010, NEUROSURGERY, V67, P976, DOI 10.1227/NEU.0b013e3181ee36bc; Storer KR, 2008, J CLIN NEUROSCI, V15, P179, DOI 10.1016/j.jocn.2006.10.013; Thorpe PE, 2004, CLIN CANCER RES, V10, P415, DOI 10.1158/1078-0432.CCR-0642-03; Van der Meeren A, 1999, CYTOKINE, V11, P831, DOI 10.1006/cyto.1999.0497; Wang Huan-Chih, 2012, Surg Neurol Int, V3, pS105, DOI 10.4103/2152-7806.95421; Weiser S, 2007, CYTOKINE, V37, P84, DOI 10.1016/j.cyto.2007.02.021; Yassari R, 2004, ACTA NEUROCHIR, V146, P495, DOI 10.1007/s00701-004-0248-x; Zhao ZJ, 2016, J NEUROSURG, V124, P1780, DOI 10.3171/2015.4.JNS142129	37	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185393	10.1371/journal.pone.0185393	http://dx.doi.org/10.1371/journal.pone.0185393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949989	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000046
J	Zondler, L; Kostka, M; Garidel, P; Heinzelmann, U; Hengerer, B; Mayer, B; Weishaupt, JH; Gillardon, F; Danzer, KM				Zondler, Lisa; Kostka, Marcus; Garidel, Patrick; Heinzelmann, Udo; Hengerer, Bastian; Mayer, Benjamin; Weishaupt, Jochen H.; Gillardon, Frank; Danzer, Karin M.			Proteasome impairment by alpha-synuclein	PLOS ONE			English	Article							PARKINSONS-DISEASE; LEWY BODIES; PROTEIN; OLIGOMERS; SYSTEM; INCLUSIONS; EXPRESSION; MEMBRANE	Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder worldwide and characterized by the loss of dopaminergic neurons in the patients' midbrains. Both the presence of the protein alpha-synuclein in intracellular protein aggregates in surviving neurons and the genetic linking of the alpha-synuclein encoding gene point towards a major role of alpha-synuclein in PD etiology. The exact pathogenic mechanisms of PD development are not entirely described to date, neither is the specific role of alpha-synuclein in this context. Previous studies indicate that one aspect of alpha-synuclein-related cellular toxicity might be direct proteasome impairment. The 20/26S proteasomal machinery is an important instrument of intracellular protein degradation. Thus, direct proteasome impairment by alpha-synuclein might explain or at least contribute to the formation of intracellular protein aggregates. Therefore this study investigates direct proteasomal impairment by alpha-synuclein both in vitro using recombinant alpha-synuclein and isolated proteasomes as well as in living cells. Our experiments demonstrate that the impairment of proteasome activity by alpha-synuclein is highly dependent upon the cellular background and origin. We show that recombinant alpha-synuclein oligomers and fibrils scarcely affect 20S proteasome function in vitro, neither does transient alpha-synuclein expression in U2OS ps 2042 (Ubi(G76V)-GFP) cells. However, stable expression of both wild-type and mutant alpha-synuclein in dopaminergic SH-SY5Y and PC12 cells results in a prominent impairment of the chymotrypsin-like 20S/26S proteasomal protein cleavage. Thus, our results support the idea that alpha-synuclein in a specific cellular environment, potentially present in dopaminergic cells, cannot be processed by the proteasome and thus contributes to a selective vulnerability of dopaminergic cells to alpha-synuclein pathology.	[Zondler, Lisa; Weishaupt, Jochen H.; Danzer, Karin M.] Ulm Univ, Dept Neurol, Ulm, Germany; [Kostka, Marcus; Garidel, Patrick; Heinzelmann, Udo; Hengerer, Bastian; Gillardon, Frank] Boehringer Ingelheim Pharma GmbH Co KG, Biberach, Germany; [Mayer, Benjamin] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany	Ulm University; Boehringer Ingelheim; Ulm University	Danzer, KM (corresponding author), Ulm Univ, Dept Neurol, Ulm, Germany.	karin.danzer@uni-ulm.de		Zondler, Lisa/0000-0001-6760-4499				Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bedford L, 2008, BBA-MOL BASIS DIS, V1782, P683, DOI 10.1016/j.bbadis.2008.10.009; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Deger JM, 2015, AGING CELL, V14, P715, DOI 10.1111/acel.12359; Dong J, 2011, J COLLOID INTERF SCI, V362, P33, DOI 10.1016/j.jcis.2011.04.050; Emmanouilidou E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022225; Feng LR, 2010, EUR J NEUROSCI, V32, P10, DOI 10.1111/j.1460-9568.2010.07266.x; Fernagut PO, 2004, NEUROBIOL DIS, V17, P123, DOI 10.1016/j.nbd.2004.07.001; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Haasen D, 2006, METHOD ENZYMOL, V414, P121, DOI 10.1016/S0076-6879(06)14008-2; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; Lee SS, 2003, NEUROBIOL AGING, V24, P687, DOI 10.1016/S0197-4580(02)00196-3; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Mezey E, 1998, MOL PSYCHIATR, V3, P493, DOI 10.1038/sj.mp.4000446; MOOS P, 2004, J BIOL CHEM, V279, P12924; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Olanow CW, 2006, MOVEMENT DISORD, V21, P1806, DOI 10.1002/mds.21013; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Paleologou Katerina E, 2012, Subcell Biochem, V65, P109, DOI 10.1007/978-94-007-5416-4_6; Parihar MS, 2009, INT J BIOCHEM CELL B, V41, P2015, DOI 10.1016/j.biocel.2009.05.008; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stckl MT, 2013, MOL NEUROBIOL, V47, P613, DOI 10.1007/s12035-012-8331-4; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Trojanowski JQ, 1998, ARCH NEUROL-CHICAGO, V55, P151, DOI 10.1001/archneur.55.2.151; Vekrellis K, 2011, LANCET NEUROL, V10, P1041, DOI 10.1016/S1474-4422(11)70213-7; Wales P, 2013, J PARKINSON DIS, V3, P415, DOI 10.3233/JPD-130216	38	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0184040	10.1371/journal.pone.0184040	http://dx.doi.org/10.1371/journal.pone.0184040			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945746	Green Published, gold, Green Submitted			2022-12-27	WOS:000411645100005
J	Rosbrook, K; Erythropel, HC; DeWinter, TM; Falinski, M; O'Malley, S; Krishnan-Sarin, S; Anastas, PT; Zimmerman, JB; Green, BG				Rosbrook, Kathryn; Erythropel, Hanno C.; DeWinter, Tamara M.; Falinski, Mark; O'Malley, Stephanie; Krishnan-Sarin, Suchitra; Anastas, Paul T.; Zimmerman, Julie B.; Green, Barry G.			The effect of sucralose on flavor sweetness in electronic cigarettes varies between delivery devices	PLOS ONE			English	Article							TASTE; ODORS; MAGNITUDE; SCALE; ADOLESCENTS; PERCEPTION; SWEETENERS; SENSATIONS; DERIVATION; INTENSITY	The appeal of sweet electronic cigarette flavors makes it important to identify the chemical compounds that contribute to their sweetness. While volatile chemicals that produce sweet aromas have been identified in e-liquids, there are no published reports of sugars or artificial sweeteners in commercial e-liquids. However, the sweetener sucralose is marketed as an e-liquid additive to commercial flavors. The primary aims of the study were to determine if sucralose is delivered in sufficient concentration in the inhaled aerosol to enhance flavor sweetness, and whether the amount delivered depends on the e-liquid delivery system. Thirty-two adult smokers rated flavor intensity, sweetness, harshness and liking/disliking for 4 commercial flavors with and without sucralose (1%) using 2 e-cigarette delivery systems (cartridge and tank). Participants alternately vaped normally or with the nose pinched closed to block perception of volatile flavor components via olfaction. LC/MS was used to measure the concentration of sucralose in the e-liquid aerosols using a device that mimicked vaping. Sweetness and flavor intensity were perceived much more strongly when olfaction was permitted. The contribution of sucralose to sweetness was significant only for the cartridge system, and the chemical analysis showed that the concentration of sucralose in the aerosol was higher when the cartridge was used. Together these findings indicate that future regulation of sweet flavor additives should focus first on the volatile constituents of e-liquids with the recognition that artificial sweeteners may also contribute to flavor sweetness depending upon e-cigarette design.	[Rosbrook, Kathryn; Green, Barry G.] John B Pierce Lab, New Haven, CT 06519 USA; [Erythropel, Hanno C.; DeWinter, Tamara M.; Falinski, Mark; Anastas, Paul T.; Zimmerman, Julie B.] Yale Univ, Ctr Green Chem & Green Engn, New Haven, CT USA; [Erythropel, Hanno C.; Falinski, Mark; Zimmerman, Julie B.] Yale Univ, Dept Chem & Environm Engn, New Haven, CT USA; [DeWinter, Tamara M.; Anastas, Paul T.; Zimmerman, Julie B.] Yale Univ, Dept Forestry & Environm Studies, New Haven, CT USA; [O'Malley, Stephanie; Krishnan-Sarin, Suchitra] Yale Sch Med, Dept Psychiat, New Haven, CT USA; [Green, Barry G.] Yale Sch Med, Dept Surg Otolaryngol, New Haven, CT 06510 USA	Yale University; The John B Pierce Laboratory, Inc; Yale University; Yale University; Yale University; Yale University; Yale University	Green, BG (corresponding author), John B Pierce Lab, New Haven, CT 06519 USA.; Green, BG (corresponding author), Yale Sch Med, Dept Surg Otolaryngol, New Haven, CT 06510 USA.	green@jbpierce.org	Erythropel, Hanno/T-5737-2017; Anastas, Paul/L-3258-2013	Erythropel, Hanno/0000-0003-3443-9794; Krishnan-Sarin, Suchitra/0000-0002-3272-9782; Zimmerman, Julie/0000-0002-5392-312X; Anastas, Paul/0000-0003-4777-5172	Yale Tobacco Center of Regulatory Sciences (TCORS) of the National Institute of Health [P50-DA-036151]; Center for Tobacco products (CTP) of the Food and Drug Administration	Yale Tobacco Center of Regulatory Sciences (TCORS) of the National Institute of Health; Center for Tobacco products (CTP) of the Food and Drug Administration	This work was supported by the Yale Tobacco Center of Regulatory Sciences (TCORS) of the National Institute of Health (P50-DA-036151) and the Center for Tobacco products (CTP) of the Food and Drug Administration. The Co-PIs of the P50 are SKS and SO. An Administrative Supplement was awarded to BGG and JBZ to conduct the study reported in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvray M, 2008, CONSCIOUS COGN, V17, P1016, DOI 10.1016/j.concog.2007.06.005; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Berg CJ, 2016, INT J PUBLIC HEALTH, V61, P225, DOI 10.1007/s00038-015-0764-x; Bold K.W., 2016, NICOTINE TOB RES; Bonhomme MG, 2016, TOB CONTROL, V25, pii4, DOI 10.1136/tobaccocontrol-2016-053373; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P7272, DOI 10.3390/ijerph10127272; Fernstrom JD, 2012, J NUTR, V142, p1134S, DOI 10.3945/jn.111.149567; Ford A, 2016, INT J PUBLIC HEALTH, V61, P215, DOI 10.1007/s00038-015-0769-5; FRANK RA, 1993, PERCEPT PSYCHOPHYS, V54, P343, DOI 10.3758/BF03205269; Goldenson NI, 2016, DRUG ALCOHOL DEPEN, V168, P176, DOI 10.1016/j.drugalcdep.2016.09.014; Grana RA, 2014, AM J PREV MED, V46, P395, DOI 10.1016/j.amepre.2013.12.010; Green BG, 2012, CHEM SENSES, V37, P77, DOI 10.1093/chemse/bjr068; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; GREEN BG, 1993, CHEM SENSES, V18, P683, DOI 10.1093/chemse/18.6.683; GREEN BG, 1993, PAIN, V53, P323, DOI 10.1016/0304-3959(93)90228-H; Harrell M B, 2017, Prev Med Rep, V5, P33; Kim H, 2016, TOB CONTROL, V25, pii55, DOI 10.1136/tobaccocontrol-2016-053221; Kosmider L, 2016, THORAX, V71, P376, DOI 10.1136/thoraxjnl-2015-207895; Krishnan-Sarin S, 2015, NICOTINE TOB RES, V17, P810, DOI 10.1093/ntr/ntu243; Lim JY, 2013, CHEM SENSES, V38, P45, DOI 10.1093/chemse/bjs080; Lim J, 2009, CHEM SENSES, V34, P739, DOI 10.1093/chemse/bjp054; Lisko JG, 2015, NICOTINE TOB RES, V17, P1270, DOI 10.1093/ntr/ntu279; Miao S, 2016, NICOTINE TOB RES, V18, P2169, DOI 10.1093/ntr/ntw141; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; PFAFFMANN C, 1954, J COMP PHYSIOL PSYCH, V47, P93, DOI 10.1037/h0053778; Schiffman SS, 2003, CHEM SENSES, V28, P219, DOI 10.1093/chemse/28.3.219; Sherwood CL, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0369-9; Small DM, 2005, EXP BRAIN RES, V166, P345, DOI 10.1007/s00221-005-2376-9; Soh L, 2011, ENVIRON SCI TECHNOL, V45, P1363, DOI 10.1021/es102719d; Spence C, 2016, FOOD QUAL PREFER, V50, P117, DOI 10.1016/j.foodqual.2016.02.006; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; STEVENSON RJ, 1995, LEARN MOTIV, V26, P433, DOI 10.1016/S0023-9690(05)80006-2; Talih S, 2015, NICOTINE TOB RES, V17, P150, DOI 10.1093/ntr/ntu174; Tieman D, 2012, CURR BIOL, V22, P1035, DOI 10.1016/j.cub.2012.04.016; Tierney PA, 2016, TOB CONTROL, V25, pE10, DOI 10.1136/tobaccocontrol-2014-052175; Yeomans MR, 2006, J EXP PSYCHOL ANIM B, V32, P215, DOI 10.1037/0097-7403.32.3.215	36	18	19	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185334	10.1371/journal.pone.0185334	http://dx.doi.org/10.1371/journal.pone.0185334			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968411	Green Published, gold, Green Submitted			2022-12-27	WOS:000412029600020
J	Di Franco, A; Kim, J; Rodriguez-Diego, S; Khalique, O; Siden, JY; Goldburg, SR; Mehta, NK; Srinivasan, A; Ratcliffe, MB; Levine, RA; Crea, F; Devereux, RB; Weinsaft, JW				Di Franco, Antonino; Kim, Jiwon; Rodriguez-Diego, Sara; Khalique, Omar; Siden, Jonathan Y.; Goldburg, Samantha R.; Mehta, Neil K.; Srinivasan, Aparna; Ratcliffe, Mark B.; Levine, Robert A.; Crea, Filippo; Devereux, Richard B.; Weinsaft, Jonathan W.			Multiplanar strain quantification for assessment of right ventricular dysfunction and non-ischemic fibrosis among patients with ischemic mitral regurgitation	PLOS ONE			English	Article							TIME 3-DIMENSIONAL ECHOCARDIOGRAPHY; EJECTION FRACTION; PROGNOSTIC IMPLICATIONS; SYSTOLIC DYSFUNCTION; HEART-FAILURE; INFARCTION; MORTALITY; VOLUMES; PATTERN; RECOMMENDATIONS	Background Ischemic mitral regurgitation (iMR) predisposes to right ventricular (RV) pressure and volume overload, providing a nidus for RV dysfunction (RVDYS) and non-ischemic fibrosis (NIF). Echocardiography (echo) is widely used to assess iMR, but performance of different indices as markers of RVDYS and NIF is unknown. Methods iMR patients prospectively underwent echo and cardiac magnetic resonance (CMR) within 72 hours. Echo quantified iMR, assessed conventional RV indices (TAPSE, RV-S', fractional area change [FAC]), and strain via speckle tracking in apical 4-chamber (global longitudinal strain [RV-GLS]) and parasternal long axis orientation (transverse strain). CMR volumetrically quantified RVEF, and assessed ischemic pattern myocardial infarction (MI) and septal NIF. Results 73 iMR patients were studied; 36% had RVDYS (EF<50%) on CMR among whom LVEF was lower, PA systolic pressure higher, and MI size larger (all p<0.05). CMR RVEF was paralleled by echo results; correlations were highest for RV-GLS (r = 0.73) and lowest for RV-S' (r = 0.43; all p<0.001). RVDYS patients more often had CMR-evidenced NIF (54% vs. 7%; p<0.001). Whereas all RV indices were lower among NIF-affected patients (all p <= 0.006), percent change was largest for transverse strain (48.3%). CMR RVEF was independently associated with RV-GLS (partial r = 0.57, p<0.001) and transverse strain (r = 0.38, p = 0.002) (R = 0.78, p<0.001). Overall diagnostic performance of RV-GLS and transverse strain were similar (AUC = 0.93[0.87-0.99]|0.91[0.84-0.99], both p<0.001), and yielded near equivalent sensitivity and specificity (85%| 83% and 80%|79% respectively). Conclusion Compared to conventional echo indices, RV strain parameters yield stronger correlation with CMR-defined RVEF and potentially constitute better markers of CMR-evidenced NIF in iMR.	[Di Franco, Antonino; Kim, Jiwon; Rodriguez-Diego, Sara; Siden, Jonathan Y.; Goldburg, Samantha R.; Mehta, Neil K.; Srinivasan, Aparna; Devereux, Richard B.; Weinsaft, Jonathan W.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Khalique, Omar] Columbia Univ, Dept Med, New York, NY USA; [Ratcliffe, Mark B.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Levine, Robert A.] Massachusetts Gen Hosp, Dept Cardiol, Boston, MA 02114 USA; [Crea, Filippo] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, Dept Cardiol, Rome, Italy	Cornell University; Columbia University; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Weinsaft, JW (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	jww2001@med.cornell.edu		Kim, Jiwon/0000-0002-8420-8604; Rodriguez Diego, Sara/0000-0002-1942-0457; Siden, Yoni/0000-0003-2743-6712	National Institutes of Health [1R01HL128278-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128278, R01HL128099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by National Institutes of Health, grant # 1R01HL128278-01 (PI: Weinsaft M.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpendurada F, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-68; Beeri R, 2008, J AM COLL CARDIOL, V51, P476, DOI 10.1016/j.jacc.2007.07.093; Beeri R, 2007, CIRCULATION, V116, pI288, DOI 10.1161/CIRCULATIONAHA.106.681114; Codella NCF, 2008, RADIOLOGY, V248, P1004, DOI 10.1148/radiol.2482072016; Codella NCF, 2010, J MAGN RESON IMAGING, V31, P845, DOI 10.1002/jmri.22080; Devereux RB, 2004, JAMA-J AM MED ASSOC, V292, P2350, DOI 10.1001/jama.292.19.2350; Devereux RB, 2003, AM HEART J, V146, P527, DOI 10.1016/S0002-8703(03)00229-1; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Duncan AE, 2017, ANESTH ANALG, V124, P406, DOI 10.1213/ANE.0000000000001108; Freed BH, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-11; Grewal J, 2010, J AM SOC ECHOCARDIOG, V23, P127, DOI 10.1016/j.echo.2009.11.002; Grothues F, 2004, AM HEART J, V147, P218, DOI 10.1016/j.ahj.2003.10.005; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Jones EC, 2001, AM J CARDIOL, V87, P298, DOI 10.1016/S0002-9149(00)01362-X; Kawut SM, 2011, CIRCULATION, V123, P2542, DOI 10.1161/CIRCULATIONAHA.110.985515; Kim J, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.005115; Kim J, 2016, J AM SOC ECHOCARDIOG, V29, P861, DOI 10.1016/j.echo.2016.05.002; Kim J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147349; Kim J, 2015, ECHOCARDIOGR-J CARD, V32, P805, DOI 10.1111/echo.12715; Kim J, 2014, INT J CARDIOVAS IMAG, V30, P1559, DOI 10.1007/s10554-014-0487-8; Kjaergaard J, 2006, EUR J ECHOCARDIOGR, V7, P430, DOI 10.1016/j.euje.2005.10.009; Lai WW, 2008, INT J CARDIOVAS IMAG, V24, P691, DOI 10.1007/s10554-008-9314-4; Leibundgut G, 2010, J AM SOC ECHOCARDIOG, V23, P116, DOI 10.1016/j.echo.2009.11.016; Lemarie J, 2015, J AM SOC ECHOCARDIOG, V28, P818, DOI 10.1016/j.echo.2015.02.019; Lindqvist P, 2003, Eur J Echocardiogr, V4, P29, DOI 10.1053/euje.2002.0177; MCKENZIE JC, 1994, J MOL CELL CARDIOL, V26, P753, DOI 10.1006/jmcc.1994.1090; Muraru D, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.003866; Palmieri V, 1999, J AM COLL CARDIOL, V34, P1625, DOI 10.1016/S0735-1097(99)00396-4; Palmieri V, 2008, J AM SOC ECHOCARDIOG, V21, P66, DOI 10.1016/j.echo.2007.05.008; Park Jae-Hyeong, 2014, J Cardiovasc Ultrasound, V22, P113, DOI 10.4250/jcu.2014.22.3.113; Pavlicek M, 2011, EUR J ECHOCARDIOGR, V12, P871, DOI 10.1093/ejechocard/jer138; Pennell DJ, 2010, CIRCULATION, V121, P692, DOI 10.1161/CIRCULATIONAHA.108.811547; POLAK JF, 1983, J AM COLL CARDIOL, V2, P217, DOI 10.1016/S0735-1097(83)80156-9; Prakken NHJ, 2012, BRIT J SPORT MED, V46, P348, DOI 10.1136/bjsm.2010.077669; Rosner A, 2015, ECHOCARDIOGR-J CARD, V32, P1809, DOI 10.1111/echo.12973; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sievers B, 2007, CIRCULATION, V115, P236, DOI 10.1161/CIRCULATIONAHA.106.635409; Srinivasan A, 2017, ECHOCARDIOGR-J CARD, V34, P348, DOI 10.1111/echo.13438; Swift AJ, 2014, JACC-CARDIOVASC IMAG, V7, P1209, DOI 10.1016/j.jcmg.2014.08.014; Taylor RJ, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-015-0221-2; Volo SC, 2014, AM J CARDIOL, V114, P355, DOI 10.1016/j.amjcard.2014.05.008; Weinsaft JW, 2016, JACC-CARDIOVASC IMAG, V9, P505, DOI 10.1016/j.jcmg.2015.06.017; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3; Zornoff LAM, 2002, J AM COLL CARDIOL, V39, P1450, DOI 10.1016/S0735-1097(02)01804-1	44	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185657	10.1371/journal.pone.0185657	http://dx.doi.org/10.1371/journal.pone.0185657			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961271	Green Published, gold, Green Submitted			2022-12-27	WOS:000412027700030
J	Li, XD; Yang, YJ; Wang, LY; Qiao, SB; Lu, XF; Wu, YJ; Xu, B; Lie, HF; Gu, DF				Li, Xiang-Dong; Yang, Yue-Jin; Wang, Lai-Yuan; Qiao, Shu-Bin; Lu, Xiang-Feng; Wu, Yong-Jian; Xu, Bo; Lie, Hong-Fan; Gu, Dong-Feng			Elevated plasma miRNA-122,-140-3p,-720,-2861, and-3149 during early period of acute coronary syndrome are derived from peripheral blood mononuclear cells	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CIRCULATING MICRORNAS; EARLY-DIAGNOSIS; EXPRESSION; BIOMARKERS; CANCER	Objective Our previous study has found that circulating microRNA (miRNA, or miR) -122, -140-3p, -720, -2861, and -3149 are significantly elevated during early stage of acute coronary syndrome (ACS). This study was conducted to determine the origin of these elevated plasma miRNAs in ACS. Methods qRT-PCR was performed to detect the expression profiles of these 5 miRNAs in liver, spleen, lung, kidney, brain, skeletal muscles, and heart. To determine their origins, these miRNAs were detected in myocardium of acute myocardial infarction (AMI), and as well in platelets and peripheral blood mononuclear cells (PBMCs, including monocytes, circulating endothelial cells (CECs) and lymphocytes) of the AMI pigs and ACS patients. Results MiR-122 was specifically expressed in liver, and miR-140-3p, -720, -2861, and -3149 were highly expressed in heart. Compared with the sham pigs, miR-122 was highly expressed in the border zone of the ischemic myocardium in the AMI pigs without ventricular fibrillation (P < 0.01), miR-122 and -720 were decreased in platelets of the AMI pigs, and miR-122, -140-3p, -720, -2861, and -3149 were increased in PBMCs of the AMI pigs (all P < 0.05). Compared with the non-ACS patients, platelets miR-720 was decreased and PBMCs miR122, -140-3p, -720, -2861, and -3149 were increased in the ACS patients (all P < 0.01). Furthermore, PBMCs miR-122, -720, and -3149 were increased in the AMI patients compared with the unstable angina (UA) patients (all P < 0.05). Further origin identification revealed that the expression levels of miR-122 in CECs and lymphocytes, miR-140-3p and -2861 in monocytes and CECs, miR-720 in monocytes, and miR-3149 in CECs were greatly up-regulated in the ACS patients compared with the non-ACS patients, and were higher as well in the AMI patients than that in the UA patients except for the miR-122 in CECs (all P < 0.05). Conclusion The elevated plasma miR-122, -140-3p, -720, -2861, and -3149 in the ACS patients were mainly originated from CECs and monocytes.	[Li, Xiang-Dong; Yang, Yue-Jin; Qiao, Shu-Bin; Wu, Yong-Jian; Xu, Bo] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Cardiol, Beijing, Peoples R China; [Li, Xiang-Dong; Yang, Yue-Jin; Wang, Lai-Yuan; Qiao, Shu-Bin; Lu, Xiang-Feng; Wu, Yong-Jian; Xu, Bo; Lie, Hong-Fan; Gu, Dong-Feng] Peking Union Med Coll, Beijing, Peoples R China; [Wang, Lai-Yuan; Lu, Xiang-Feng; Lie, Hong-Fan; Gu, Dong-Feng] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp,Dept Epidemiol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Gu, DF (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Gu, DF (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp,Dept Epidemiol, Beijing, Peoples R China.	gudongfeng@vip.sina.com		Wu, Yongjian/0000-0002-5590-8396; Li, Xiangdong/0000-0001-6009-7105	National Basic Research Program (973 Program) in China [2011CB503901, 2012CB518602]; China Postdoctoral Science Foundation [2012M510355]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-009]; National Science Foundation of China [81270334]	National Basic Research Program (973 Program) in China(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); CAMS Innovation Fund for Medical Sciences (CIFMS); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Basic Research Program (973 Program) in China (No. 2011CB503901 to Dong-Feng Gu and 2012CB518602 to Yue-Jin Yang), China Postdoctoral Science Foundation (No. 2012M510355) to Xiang-Dong Li, CAMS Innovation Fund for Medical Sciences (CIFMS) (No. 2016-I2M-1-009) to Yue-Jin Yang, and the National Science Foundation of China (No. 81270334) to Lai-Yuan Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson P, 2012, SHOCK, V37, P234, DOI 10.1097/SHK.0b013e31823f1811; Caporali A, 2011, VASC PHARMACOL, V55, P79, DOI 10.1016/j.vph.2011.06.006; Collares Cristhianna V A, 2013, BMC Res Notes, V6, P491, DOI 10.1186/1756-0500-6-491; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Coskunpinar E, 2016, GENE, V591, P90, DOI 10.1016/j.gene.2016.06.059; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Donners MMPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035877; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gacon J, 2016, KARDIOL POL, V74, P280, DOI 10.5603/KP.a2015.0174; Gao W, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-55; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Haver VG, 2010, TRENDS CARDIOVAS MED, V20, P65, DOI 10.1016/j.tcm.2010.04.002; Hoekstra M, 2010, BIOCHEM BIOPH RES CO, V394, P792, DOI 10.1016/j.bbrc.2010.03.075; Hu R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176099; Huang RS, 2010, J INVEST MED, V58, P961, DOI 10.231/JIM.0b013e3181ff46d7; Imamura T, 2011, CIRC J, V75, P1322, DOI 10.1253/circj.CJ-11-0382; Kelly AM, 2011, EMERG MED AUSTRALAS, V23, P181, DOI 10.1111/j.1742-6723.2011.01388.x; Kones R, 2010, VASC HEALTH RISK MAN, V6, P635; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Li LZ, 2014, CARCINOGENESIS, V35, P469, DOI 10.1093/carcin/bgt330; Li S, 2017, ONCOTARGET; Li XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125430; Liu W, 2015, SCI REP-UK, V5, DOI 10.1038/srep16099; Long GW, 2012, INT J BIOL SCI, V8, P811, DOI 10.7150/ijbs.4439; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Pfutzner A, 2011, PPAR RES, V2011, DOI 10.1155/2011/647017; Pleister A, 2013, BIOMARK MED, V7, P287, DOI [10.2217/bmm.13.8, 10.2217/BMM.13.8]; Salem O, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2869-x; Sand M, 2012, BRIT J DERMATOL, V167, P847, DOI 10.1111/j.1365-2133.2012.11022.x; Satoh M, 2012, IMMUNOBIOLOGY, V217, P533, DOI 10.1016/j.imbio.2011.08.005; Taurino C, 2010, CLIN SCI, V119, P335, DOI 10.1042/CS20100043; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang Y, 2013, MOL MED REP, V7, P1506, DOI 10.3892/mmr.2013.1384; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12159; Wang ZH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0577-9; Woywodt A, 2006, J THROMB HAEMOST, V4, P671, DOI 10.1111/j.1538-7836.2006.01794.x; Wu XY, 2017, INFLAMMATION, V40, P708, DOI 10.1007/s10753-016-0488-y; Xu JF, 2016, SCI REP-UK, V6, DOI 10.1038/srep28968; Xue YX, 2015, ATHEROSCLEROSIS, V241, P671, DOI 10.1016/j.atherosclerosis.2015.06.031; Yao XL, 2015, INT J CLIN EXP PATHO, V8, P16014; Zernecke A, 2012, THROMB HAEMOSTASIS, V107, P626, DOI 10.1160/TH11-08-0603; Zhong Y, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160105; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697; Zhu N, 2011, ATHEROSCLEROSIS, V215, P286, DOI 10.1016/j.atherosclerosis.2010.12.024	46	20	21	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184256	10.1371/journal.pone.0184256	http://dx.doi.org/10.1371/journal.pone.0184256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961259	Green Published, gold, Green Submitted			2022-12-27	WOS:000412027700005
J	Morishita, Y; Nomura, Y; Fukui, C; Kawakami, T; Ikeda, T; Mukai, T; Yuba, T; Inamura, K; Yamaoka, H; Miyazaki, K; Okazaki, H; Haishima, Y				Morishita, Yuki; Nomura, Yusuke; Fukui, Chie; Kawakami, Tsuyoshi; Ikeda, Toshiyuki; Mukai, Tomokazu; Yuba, Toshiyasu; Inamura, Ken-ichi; Yamaoka, Hisatoki; Miyazaki, Ken-ichi; Okazaki, Hitoshi; Haishima, Yuji			Pilot study on novel blood containers with alternative plasticizers for red cell concentrate storage	PLOS ONE			English	Article							PVC MEDICAL DEVICES; DI(2-ETHYLHEXYL) PHTHALATE; DI-2-ETHYLHEXYL PHTHALATE; POLYVINYL-CHLORIDE; IN-VITRO; TOXICITY; PRODUCTS; SYSTEMS; DEHP	Di (2-ethylhexyl) phthalate (DEHP), a typical plasticizer used for polyvinyl chloride (PVC) blood containers, is eluted from the blood containers and exerts protective effects on red blood cells. However, a concern for detrimental effects of DEHP on human health has led to the development of potential DEHP substitutes. Here, we compared the red blood cell preservation ability of two types of non-DEHP blood containers with safe alternative plasticizers to that of DEHP blood containers. Red cell concentrates in mannitol-adenine-phosphate solution (MAP/RCC) were stored for 6 weeks in PVC blood bags containing DEHP, diisononyl- cyclohexane-1,2-dicarboxylate (DINCH) and di (2-ethylhexyl) 4-cyclohexene-1,2-dicarboxylate (DOTH), or 4-cyclohexene-1,2-dicarboxylic acid dinonyl ester (DL9TH) and DOTH. There was no significant difference in the total amount of plasticizer eluted into MAP/RCC (till 3 weeks from the beginning of the experiment), hemolysis of MAP/RCC, and osmotic fragility of MAP/RCC between the non-DEHP blood containers and DEHP blood containers. Hematological and blood chemical indices of MAP/RCC in all containers were nearly the same. Thus, DOTH/DINCH and DOTH/DL9TH blood containers demonstrate the same quality of MAP/RCC storing as the DEHP blood containers. Since DOTH, DINCH, and DL9TH were reported to be safe, DOTH/DINCH and DOTH/DL9TH blood containers are promising candidate substitutes for DEHP blood containers.	[Morishita, Yuki; Nomura, Yusuke; Fukui, Chie; Haishima, Yuji] Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, Tokyo, Japan; [Kawakami, Tsuyoshi] Natl Inst Hlth Sci, Div Environm Chem, Setagaya Ku, Tokyo, Japan; [Ikeda, Toshiyuki; Okazaki, Hitoshi] Univ Tokyo, Dept Transfus Med, Bunkyo Ku, Tokyo, Japan; [Mukai, Tomokazu; Yuba, Toshiyasu; Inamura, Ken-ichi; Yamaoka, Hisatoki] Kawasumi Labs Inc, Corp Res & Dev Div, Minato Ku, Tokyo, Japan; [Miyazaki, Ken-ichi] New Japan Chem Co Ltd, Chuo Ku, Osaka, Japan	National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; University of Tokyo	Haishima, Y (corresponding author), Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, Tokyo, Japan.	haishima@nihs.go.jp	Ikeda, Toshiyuki/GVS-5588-2022	Morishita, Yuki/0000-0001-5482-9701; Kawakami, Tsuyoshi/0000-0002-3661-7657	Japanese Ministry of Health, Labor, and Welfare; Health and Labor Sciences Research [H25-CHIKYUKIBO-SHITEI-008, H26-SOUYAKU-IPPAN-008]; Japan Agency for Medical Research and Development; Research on Development of New Drugs [15ak0101029h2602, 16ak0101029j2603]	Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Health and Labor Sciences Research(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Research on Development of New Drugs	This study was supported by funding to YH from the Japanese Ministry of Health, Labor, and Welfare (http://www.mhim.go.jp/english/); Health and Labor Sciences Research Grants (H25-CHIKYUKIBO-SHITEI-008 and H26-SOUYAKU-IPPAN-008), and from the Japan Agency for Medical Research and Development (http://www.amed.go.jp/en/); a grant for Research on Development of New Drugs (15ak0101029h2602, 16ak0101029j2603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Kawasumi Laboratories, Inc and New Japan Chemical Co., Ltd. are commercial companies. The companies did not provide research funds for this study. The companies provided salaries for authors [employees of the companies: TM, TY, KI, HY, and KM]. The specific roles of these authors are articulated in the 'Author Contributions' section.	Agency for Toxic Substances and Disease Registry, 2002, TOX PROF DI 2 ETH PH; Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101; AUBUCHON JP, 1988, BLOOD, V71, P448; Dumont LJ, 2012, TRANSFUSION, V52, P1439, DOI 10.1111/j.1537-2995.2011.03506.x; Haishima Y, 2005, INT J PHARM, V298, P126, DOI 10.1016/j.ijpharm.2005.04.009; Haishima Y, 2004, INT J PHARMACEUT, V274, P119, DOI 10.1016/j.ijpharm.2004.01.009; Haishima Y, 2016, J VINYL ADDIT TECHN, V22, P520, DOI 10.1002/vnl.21472; Haishima Y, 2014, J BIOMED MATER RES B, V102, P721, DOI 10.1002/jbm.b.33052; Hayashi Y, 2002, J PHARMACEUT BIOMED, V28, P421, DOI 10.1016/S0731-7085(01)00698-7; HOGMAN CF, 1987, VOX SANG, V53, P84; HOGMAN CF, 1991, TRANSFUSION, V31, P26, DOI 10.1046/j.1537-2995.1991.31191096180.x; Ito R, 2005, INT J PHARMACEUT, V303, P104, DOI 10.1016/j.ijpharm.2005.07.009; Kawakami T, 2011, J ENVIRON SCI HEAL A, V46, P855, DOI 10.1080/10934529.2011.579870; Lagerberg JW, 2015, TRANSFUSION, V55, P522, DOI 10.1111/trf.12870; Lamb JCt, 1987, APPL PHARM, V88, P255; Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202; Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852; Morishita Y, 2017, J BIOMED MAT RES B; National Industrial Chemicals Notification and Assessment Scheme (NICNAS), 2008, STD1259 NICNAS; Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6; Prowse CV, 2014, VOX SANG, V106, P1, DOI 10.1111/vox.12084; Sampson J, 2011, TRANSFUSION MED, V21, P73, DOI 10.1111/j.1365-3148.2010.01056.x; Sasakawa S, 1991, JPN J TRANSFUS MED, V37, P398; Scientific Committee on Emerging and Newly-Identified Health Risks (SCENIHR), FIN OP SAF MED DEV C; Simmchen J, 2012, TRANSFUS MED REV, V26, P27, DOI 10.1016/j.tmrv.2011.06.001; Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.3.CO;2-H; TYL RW, 1988, FUND APPL TOXICOL, V10, P395, DOI 10.1016/0272-0590(88)90286-2; US Food and Drug Administration, 2002, PUBL HLTH NOT PVC DE	28	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185737	10.1371/journal.pone.0185737	http://dx.doi.org/10.1371/journal.pone.0185737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957448	gold, Green Published, Green Submitted			2022-12-27	WOS:000411985200113
J	Watson, SA; Fabricius, KE; Munday, PL				Watson, Sue-Ann; Fabricius, Katharina E.; Munday, Philip L.			Quantifying pCO(2) in biological ocean acidification experiments: A comparison of four methods	PLOS ONE			English	Article							HIGH-FREQUENCY MEASUREMENTS; CO2; PH	Quantifying the amount of carbon dioxide (CO2) in seawater is an essential component of ocean acidification research; however, equipment for measuring CO2 directly can be costly and involve complex, bulky apparatus. Consequently, other parameters of the carbonate system, such as pH and total alkalinity (A(T)), are often measured and used to calculate the partial pressure of CO2 (pCO(2)) in seawater, especially in biological CO2-manipulation studies, including large ecological experiments and those conducted at field sites. Here we compare four methods of pCO(2) determination that have been used in biological ocean acidification experiments: 1) Versatile INstrument for the Determination of Total inorganic carbon and titration Alkalinity (VINDTA) measurement of dissolved inorganic carbon (C-T) and A(T), 2) spectrophotometric measurement of pH(T) and A(T), 3) electrode measurement of pH(NBS) and A(T), and 4) the direct measurement of CO2 using a portable CO2 equilibrator with a non-dispersive infrared (NDIR) gas analyser. In this study, we found these four methods can produce very similar pCO(2) estimates, and the three methods often suited to field-based application (spectrophotometric pHT, electrode pHNBS and CO2 equilibrator) produced estimated measurement uncertainties of 3.5-4.6% for pCO(2). Importantly, we are not advocating the replacement of established methods to measure seawater carbonate chemistry, particularly for high-accuracy quantification of carbonate parameters in seawater such as open ocean chemistry, for real-time measures of ocean change, nor for the measurement of small changes in seawater pCO(2). However, for biological CO2-manipulation experiments measuring differences of over 100 mu atm pCO(2) among treatments, we find the four methods described here can produce similar results with careful use.	[Watson, Sue-Ann; Munday, Philip L.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia; [Fabricius, Katharina E.] Australian Inst Marine Sci, Townsville, Qld, Australia	James Cook University; Australian Institute of Marine Science	Watson, SA (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia.	sueann.watson@jcu.edu.au	Munday, Philip L/F-5443-2011; Watson, Sue-Ann/C-3172-2013; Fabricius, Katharina/F-1759-2010	Munday, Philip L/0000-0001-9725-2498; Watson, Sue-Ann/0000-0002-9818-7429; Fabricius, Katharina/0000-0001-7671-4358	Australian Research Council Centre of Excellence for Coral Reef Studies; Australian Institute of Marine Science; Yulgilbar Foundation Fellowship at Lizard Island	Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); Australian Institute of Marine Science; Yulgilbar Foundation Fellowship at Lizard Island	This research was funded by the Australian Research Council Centre of Excellence for Coral Reef Studies (https://www.coralcoe.org.au/), Australian Institute of Marine Science (http://www.aims.gov.au/) and a Yulgilbar Foundation Fellowship at Lizard Island (http://lirrf.org/) (S.-A.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIMS. Australian Institute of Marine Science, DAT GEN 12 JAN 2016; Bandstra L, 2006, MAR CHEM, V100, P24, DOI 10.1016/j.marchem.2005.10.009; Chai T, 2014, GEOSCI MODEL DEV, V7, P1247, DOI 10.5194/gmd-7-1247-2014; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Dickson A., 2010, GUIDE BEST PRACTICES, P17, DOI DOI 10.2777/58454; Dickson A.G., 2007, GUIDE BEST PRACTICES; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Gattuso J.-P., 2010, GUIDE BEST PRACTICES, P41, DOI DOI 10.1016/J.JOMS.2003.10.009; Hari P, 2008, LIMNOL OCEANOGR-METH, V6, P347, DOI 10.4319/lom.2008.6.347; HINGA KR, 1992, MAR ECOL PROG SER, V86, P181, DOI 10.3354/meps086181; Hoegh-Guldberg O, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1655; Honisch B, 2012, SCIENCE, V335, P1058, DOI 10.1126/science.1208277; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Liu XW, 2011, ENVIRON SCI TECHNOL, V45, P4862, DOI 10.1021/es200665d; McLaughlin K, 2014, GUIDANCE MANUAL ESTA; McNeil BI, 2016, NATURE, V529, P383, DOI 10.1038/nature16156; Munday PL, 2014, NAT CLIM CHANGE, V4, P487, DOI [10.1038/nclimate2195, 10.1038/NCLIMATE2195]; Munday PL, 2014, J EXP BIOL, V217, P1828, DOI 10.1242/jeb.105890; Nagelkerken I, 2016, NAT CLIM CHANGE, V6, P89, DOI [10.1038/NCLIMATE2757, 10.1038/nclimate2757]; Pierrot D, 2006, ORNLCDIAC105A USA DE; Pierrot D, 2009, DEEP-SEA RES PT II, V56, P512, DOI 10.1016/j.dsr2.2008.12.005; R Development Core Team, 2017, R LANG ENV STAT COMP; Ridgwell A, 2010, NAT GEOSCI, V3, P196, DOI 10.1038/NGEO755; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Shaw EC, 2013, GLOBAL CHANGE BIOL, V19, P1632, DOI 10.1111/gcb.12154; Watson SA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2377; Zeebe RE, 2008, SCIENCE, V321, P51, DOI 10.1126/science.1159124	28	11	11	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185469	10.1371/journal.pone.0185469	http://dx.doi.org/10.1371/journal.pone.0185469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957378	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000411985200066
J	White, N; Benton, M; Kennedy, D; Fox, A; Griffiths, L; Lea, R; Mengersen, K				White, Nicole; Benton, Miles; Kennedy, Daniel; Fox, Andrew; Griffiths, Lyn; Lea, Rodney; Mengersen, Kerrie			Accounting for cell lineage and sex effects in the identification of cell-specific DNA methylation using a Bayesian model selection algorithm	PLOS ONE			English	Article							T-CELLS; BLOOD	Cell- and sex-specific differences in DNA methylation are major sources of epigenetic variation in whole blood. Heterogeneity attributable to cell type has motivated the identification of cell-specific methylation at the CpG level, however statistical methods for this purpose have been limited to pairwise comparisons between cell types or between the cell type of interest and whole blood. We developed a Bayesian model selection algorithm for the identification of cell-specific methylation profiles that incorporates knowledge of shared cell lineage and allows for the identification of differential methylation profiles in one or more cell types simultaneously. Under the proposed methodology, sex-specific differences in methylation by cell type are also assessed. Using publicly available, cell-sorted methylation data, we show that 51.3% of female CpG markers and 61.4% of male CpG markers identified were associated with differential methylation in more than one cell type. The impact of cell lineage on differential methylation was also highlighted. An evaluation of sex-specific differences revealed differences in CD56(+) NK methylation, within both single and multi-cell dependent methylation patterns. Our findings demonstrate the need to account for cell lineage in studies of differential methylation and associated sex effects.	[White, Nicole; Kennedy, Daniel; Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld, Australia; [Benton, Miles; Griffiths, Lyn; Lea, Rodney] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Genom Res Ctr, Brisbane, Qld, Australia; [Fox, Andrew] Florey Dept Neurosci & Mental Hlth, Melbourne, Vic, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Mengersen, K (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld, Australia.	ksnengersen@qut.edu.au	Mengersen, Kerrie/AHC-4096-2022	Mengersen, Kerrie/0000-0001-8625-9168; Benton, Miles/0000-0003-3442-965X; Lea, Rodney/0000-0002-1148-5862; White, Nicole/0000-0002-9292-0773	QUT; Australian Research Council; Australian Government Research Training Program Scholarship; ARC Centre of Excellence for Mathematical and Statistical Frontiers top-up scholarship; Multiple Sclerosis Research Australia; Australian Government Research Training Program (RTP) Scholarship; ARC Centre of Excellence for Mathematical and Statistical Frontiers (ACEMS) top-up scholarship	QUT; Australian Research Council(Australian Research Council); Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); ARC Centre of Excellence for Mathematical and Statistical Frontiers top-up scholarship(Australian Research Council); Multiple Sclerosis Research Australia; Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); ARC Centre of Excellence for Mathematical and Statistical Frontiers (ACEMS) top-up scholarship	MB and NW were supported by a collaborative development grant from QUT. NW was further supported by the Australian Research Council working under a Laureate Fellowship held by KM (http://www.arc.gov.au/). DK is supported by an Australian Government Research Training Program Scholarship (https://www.education.gov.au/research-training-program), and an ARC Centre of Excellence for Mathematical and Statistical Frontiers top-up scholarship (http://acems.org.au/). AF and RL are partially supported by Multiple Sclerosis Research Australia (http://www.msra.org.au/) funding for bioinformatics.; We thank Peter Donnelly for his helpful feedback on the methodology developed in this paper. MB and NW were supported by a collaborative development grant from QUT. NW was further supported by the Australian Research Council (ARC) working under a Laureate Fellowship held by KM. DK is supported by an Australian Government Research Training Program (RTP) Scholarship, and an ARC Centre of Excellence for Mathematical and Statistical Frontiers (ACEMS) top-up scholarship. AF and RL are partially supported by Multiple Sclerosis Research Australia funding for bioinformatics.	Abdullah M, 2012, CELL IMMUNOL, V272, P214, DOI 10.1016/j.cellimm.2011.10.009; Adalsteinsson BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046705; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bocker MT, 2011, BLOOD, V117, pE182, DOI 10.1182/blood-2011-01-331926; Chen DP, 2016, BRIEF FUNCT GENOMICS, V15, P485, DOI 10.1093/bfgp/elw018; Dedeurwaerder S, 2014, BRIEF BIOINFORM, V15, P929, DOI 10.1093/bib/bbt054; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; Fernandez C, 2001, J ECONOMETRICS, V100, P381, DOI 10.1016/S0304-4076(00)00076-2; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Friel N, 2012, STAT NEERL, V66, P288, DOI 10.1111/j.1467-9574.2011.00515.x; Glossop JR, 2013, EPIGENETICS-US, V8, P1188, DOI 10.4161/epi.26265; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; Houseman E Andres, 2015, Curr Environ Health Rep, V2, P145, DOI 10.1007/s40572-015-0050-3; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Inoshita M, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0029-7; Jeffries MA, 2011, EPIGENETICS-US, V6, P593, DOI 10.4161/epi.6.5.15374; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Koestler DC, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0943-7; Liang F, 2008, J AM STAT ASSOC, V103, P410, DOI 10.1198/016214507000001337; Liu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010028; Mamrut S, 2015, EPIGENETICS-US, V10, P943, DOI 10.1080/15592294.2015.1084462; McCarthy NS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-981; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Muers M, 2013, NAT REV GENET, V14, P3535, DOI 10.1038/nrg3535; Newton MA, 2004, BIOSTATISTICS, V5, P155, DOI 10.1093/biostatistics/5.2.155; Rakyan VK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002300; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Triche Jr T., ILLUMINAHUMANMETHYLA; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Yousefi P, 2015, ENVIRON MOL MUTAGEN, V56, P751, DOI 10.1002/em.21966; Zellner, 1986, BAYESIAN INFERENCE D, P233, DOI DOI 10.4236/OJS.2013.34031	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0182455	10.1371/journal.pone.0182455	http://dx.doi.org/10.1371/journal.pone.0182455			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957352	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200004
J	Bhat, M; Tazari, M; Sebastiani, G				Bhat, Mamatha; Tazari, Mahmood; Sebastiani, Giada			Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: A meta-analysis	PLOS ONE			English	Article							HEPATITIS-C; CLINICAL-OUTCOMES; GRAFT FIBROSIS; DISEASE; RECIPIENTS; MARKERS; BIOPSY; TESTS; FIB-4; PROGRESSION	Recurrent fibrosis after liver transplantation (LT) impacts on long-term graft and patient survival. We performed a meta-analysis to compare the accuracy of non-invasive methods to diagnose significant recurrent fibrosis (stage F2-F4) following LT. Studies comparing serum fibrosis biomarkers, namely AST-to-platelet ratio index (APRI), fibrosis score 4 (FIB-4), or transient elastography (TE) with liver biopsy in LT recipients were systematically identified through electronic databases. In the meta-analysis, we calculated the weighted pooled odds ratio and used a fixed effect model, as there was no significant heterogeneity between studies. Eight studies were included for APRI, four for FIB-4, and twelve for TE. The mean prevalence of significant liver fibrosis was 37.4%. The summary odds ratio was significantly higher for TE (21.17, 95% CI confidence interval 14.10-31.77, p = 1X10(-30)) as compared to APRI (9.02, 95% CI 5.79-14.07; p = 1X10(-30)) and FIB-4 (7.08, 95% CI 4.00-12.55; p = 1.93X10(-11)). In conclusion, TE performs best to diagnose recurrent fibrosis in LT recipients. APRI and FIB-4 can be used as an estimate of significant fibrosis at centres where TE is not available. Longitudinal assessment of fibrosis by means of these non-invasive tests may reduce the need for liver biopsy.	[Bhat, Mamatha; Tazari, Mahmood] Univ Network, Multi Organ Transplant Program, Toronto, ON, Canada; [Bhat, Mamatha] Univ Toronto, Div Gastroenterol & Hepatol, Toronto, ON, Canada; [Sebastiani, Giada] McGill Univ, Div Gastroenterol & Hepatol, Hlth Ctr, Montreal, PQ, Canada	University of Toronto; McGill University	Bhat, M (corresponding author), Univ Network, Multi Organ Transplant Program, Toronto, ON, Canada.; Bhat, M (corresponding author), Univ Toronto, Div Gastroenterol & Hepatol, Toronto, ON, Canada.	Mamatha.bhat@uhn.ca	Bhat, Mamatha/AAC-4333-2020	Sebastiani, Giada/0000-0003-2655-8283; Bhat, Mamatha/0000-0003-1960-8449	Fonds de recherche du Quebec - Sante (FRQ-S); Canadian Institutes of Health Research (CIHR) Fellowship for Health Professionals	Fonds de recherche du Quebec - Sante (FRQ-S); Canadian Institutes of Health Research (CIHR) Fellowship for Health Professionals	GS holds a Chercheur-Boursier career award from the Fonds de recherche du Quebec - Sante (FRQ-S). MB is the recipient of a Canadian Institutes of Health Research (CIHR) Fellowship for Health Professionals.	Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Angulo P, 2013, GASTROENTEROLOGY, V145, P782, DOI 10.1053/j.gastro.2013.06.057; [Anonymous], REC TEST MAN TREAT H; [Anonymous], 2015, J HEPATOL, V63, P237, DOI DOI 10.1016/j.jhep.2015.04.006; Barrault C, 2013, CLIN RES HEPATOL GAS, V37, P347, DOI 10.1016/j.clinre.2012.11.003; Berenguer M, 2001, LIVER TRANSPLANT, V7, P790, DOI 10.1053/jlts.2001.23794; Bhat M, 2015, LIVER TRANSPLANT, V21, P1383, DOI 10.1002/lt.24217; Bosch W, 2012, TRANSPLANTATION, V93, P723, DOI 10.1097/TP.0b013e3182472876; Charlton M, 1998, HEPATOLOGY, V28, P823, DOI 10.1002/hep.510280333; Cholongitas E, 2010, TRANSPL INT, V23, P861, DOI 10.1111/j.1432-2277.2010.01142.x; Corradi F, 2009, DIGEST LIVER DIS, V41, P217, DOI 10.1016/j.dld.2008.06.009; Crespo G, 2016, TRANSPL INFECT DIS, V18, P471, DOI 10.1111/tid.12526; Crespo G, 2014, AM J TRANSPLANT, V14, P375, DOI 10.1111/ajt.12594; Crespo G, 2012, J HEPATOL, V57, P281, DOI 10.1016/j.jhep.2012.03.016; Della-Guardia B, 2017, DIGEST DIS SCI, V62, P264, DOI 10.1007/s10620-016-4349-1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dyson JK, 2014, FRONTLINE GASTROENTE, V5, P211, DOI 10.1136/flgastro-2013-100403; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Firpi RJ, 2009, LIVER TRANSPLANT, V15, P1063, DOI 10.1002/lt.21784; Goldschmidt I, 2013, PEDIATR TRANSPLANT, V17, P525, DOI 10.1111/petr.12116; Harada N, 2008, TRANSPLANTATION, V85, P69, DOI 10.1097/01.tp.0000297248.18483.16; Imbert-Bismut F, 2004, CLIN CHEM LAB MED, V42, P323, DOI 10.1515/CCLM.2004.058; Kamphues C, 2010, CLIN TRANSPLANT, V24, P652, DOI 10.1111/j.1399-0012.2009.01152.x; Kim BK, 2014, HEPATOLOGY, V60, P1911, DOI 10.1002/hep.27389; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Lutz HH, 2015, DIGEST DIS SCI, V60, P2825, DOI 10.1007/s10620-015-3682-0; Marchetti P, 2000, J ENDOCRINOL INVEST, V23, P482, DOI 10.1007/BF03343761; Melita SH, 2009, J HEPATOL, V50, P36, DOI 10.1016/j.jhep.2008.07.039; Mikotajczyk-Korniak N, 2016, TRANSPL P, V48, P1725, DOI 10.1016/j.transproceed.2016.01.081; Neumann UP, 2004, J HEPATOL, V41, P830, DOI 10.1016/j.jhep.2004.06.029; Pinto J, 2014, J PEDIATR GASTR NUTR, V58, P382, DOI 10.1097/MPG.0000000000000226; Pissaia A, 2009, TRANSPL P, V41, P679, DOI 10.1016/j.transproceed.2008.12.014; Rigamonti C, 2008, GUT, V57, P821, DOI 10.1136/gut.2007.135046; Rigamonti C, 2012, LIVER TRANSPLANT, V18, P566, DOI 10.1002/lt.23391; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Sebastiani G, 2009, WORLD J GASTROENTERO, V15, P2190, DOI 10.3748/wjg.15.2190; Segovia MC, 2008, HEPATOLOGY, V48, p576A; Seo S, 2007, LIVER TRANSPLANT, V13, P844, DOI 10.1002/lt.20932; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Toniutto P, 2007, J GASTROEN HEPATOL, V22, P1904, DOI 10.1111/j.1440-1746.2006.04628.x; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	43	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185192	10.1371/journal.pone.0185192	http://dx.doi.org/10.1371/journal.pone.0185192			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953939	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300040
J	Chung, YJ; Frye, TJ; Aplan, PD				Chung, Yang Jo; Frye, Terry J.; Aplan, Peter D.			Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndrome	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; MINOR HISTOCOMPATIBILITY BARRIERS; DONOR LYMPHOCYTE INFUSIONS; TERM-FOLLOW-UP; ALLOGENEIC TRANSPLANTATION; SYNDROME MDS; MOUSE MODEL; T-CELLS	Allogeneic hematopoietic stem cell transplantation (A-HSCT) remains the only curative option for patients with myelodysplastic syndrome (MDS). We used the NUP98-HOXD13 (NHD13) murine model for MDS to study HSCT in a pre-clinical setting. NHD13 recipients transplanted with syngeneic bone marrow (S-HSCT) following myeloablative irradiation showed disease remission, with normalization of peripheral blood parameters and marked decrease in circulating leukocytes derived from the MDS clone. Despite the disease remission and improved survival compared to non-transplanted NHD13 controls, all mice eventually relapsed, indicating persistence of a long-lived radio-resistant MDS clone. In an effort to induce a graft versus leukemia (GVL) effect, A-HSCT with donor bone marrow that was mismatched at minor histocompatibility loci was compared to S-HSCT. Although recipients in the A-HSCT showed a lower early relapse rate than in S-HSCT, all mice in both groups eventually relapsed and died by 54 weeks post-transplant. To obtain a more significant GVL effect, donor splenocytes containing reactive T-cells were transplanted with allogeneic bone marrow. Although the relapse rate was only 20% at post-transplantation week 38, suggesting a GVL effect, this was accompanied by a severe graft versus host disease (GVHD) Taken together, these findings indicate that a myeloablative dose of ionizing radiation is insufficient to eradicate the MDS initiating cell, and that transplantation of donor splenocytes leads to decreased relapse rates, at the cost of severe GVHD. We suggest that NHD13 mice represent a feasible pre-clinical model for the study of HSCT for MDS.	[Chung, Yang Jo; Aplan, Peter D.] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Frye, Terry J.] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Aplan, PD (corresponding author), NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	aplanp@mail.nih.gov			Intramural Research Program of the National Cancer Institute, National Institutes of Health [ZIA SC 010378, BC 010983]; NATIONAL CANCER INSTITUTE [Z01BC010983, ZIASC010378, ZIABC011295] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health (grant numbers ZIA SC 010378 and BC 010983). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Michael Kuehl, Crystal Mackall, and current and former members of Aplan lab for insightful discussions. We also thank the NCI Sequencing core for Sanger sequencing, the NCI Transgenic Core for generation of transgenic mice, Bobbi Smith of the NCI Pathohistology Lab for CBC acquisition, and Maria Jorge for excellent animal husbandry. This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health (grant numbers ZIA SC 010378 and BC 010983).	Anderson JE, 1996, J CLIN ONCOL, V14, P220, DOI 10.1200/JCO.1996.14.1.220; Atallah E, 2010, AM J HEMATOL, V85, P579, DOI 10.1002/ajh.21761; Balderman SR, 2016, BLOOD, V127, P616, DOI 10.1182/blood-2015-06-653113; Barrett AJ, 2008, SEMIN HEMATOL, V45, P49, DOI 10.1053/j.seminhematol.2007.10.005; Brierley CK, 2016, CURR OPIN HEMATOL, V23, P167, DOI 10.1097/MOH.0000000000000217; Campregher PV, 2007, BONE MARROW TRANSPL, V40, P965, DOI 10.1038/sj.bmt.1705840; Chung YJ, 2008, P NATL ACAD SCI USA, V105, P14088, DOI 10.1073/pnas.0804507105; Clift RA, 1998, BLOOD, V92, P1455, DOI 10.1182/blood.V92.4.1455; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; de Witte T, 2017, BLOOD, V129, P1753, DOI 10.1182/blood-2016-06-724500; Deeg H Joachim, 2015, Am Soc Clin Oncol Educ Book, pe375, DOI 10.14694/EdBook_AM.2015.35.e375; Deeg HJ, 2010, BLOOD, V116, P4762, DOI 10.1182/blood-2010-07-259358; Del Papa B, 2017, BIOL BLOOD MARROW TR; Duran-Struuck R, 2009, J AM ASSOC LAB ANIM, V48, P11; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; FEIG SA, 1993, BONE MARROW TRANSPL, V12, P65; FONTAINE P, 1990, TRANSPLANTATION, V49, P1177, DOI 10.1097/00007890-199006000-00032; Ganan-Gomez I, 2015, LEUKEMIA, V29, P1458, DOI 10.1038/leu.2015.69; Ingram W, 2007, BLOOD REV, V21, P61, DOI 10.1016/j.blre.2006.03.003; Khabori MA, 2011, BONE MARROW TRANSPL, V46, P516, DOI 10.1038/bmt.2010.164; KORNGOLD R, 1987, J EXP MED, V165, P1552, DOI 10.1084/jem.165.6.1552; Lin YW, 2005, BLOOD, V106, P287, DOI 10.1182/blood-2004-12-4794; Ma XM, 2012, AM J MED, V125, pS2, DOI 10.1016/j.amjmed.2012.04.014; Marin GH, 1999, J EXP CLIN CANC RES, V18, P201; Martelli MF, 2014, BLOOD, V124, P638, DOI 10.1182/blood-2014-03-564401; Medyouf H, 2014, CELL STEM CELL, V14, P824, DOI 10.1016/j.stem.2014.02.014; Mori S, 2003, BONE MARROW TRANSPL, V31, P865, DOI 10.1038/sj.bmt.1704021; Mukherjee S, 2015, BIOL BLOOD MARROW TR, V21, P412, DOI 10.1016/j.bbmt.2014.07.027; Nimer Stephen D, 2008, Hematology Am Soc Hematol Educ Program, P43, DOI 10.1182/asheducation-2008.1.43; Nishiyama M, 1999, GENE CHROMOSOME CANC, V26, P215, DOI 10.1002/(SICI)1098-2264(199911)26:3<215::AID-GCC5>3.3.CO;2-T; Orti G, 2017, EXP HEMATOL, V48, P1, DOI 10.1016/j.exphem.2016.12.004; Parmar S, 2011, CURR OPIN HEMATOL, V18, P98, DOI 10.1097/MOH.0b013e328343b858; Phillips GL, 2012, LEUKEMIA RES, V36, P1490, DOI 10.1016/j.leukres.2012.08.004; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Raza-Egilmez SZ, 1998, CANCER RES, V58, P4269; Riesner K, 2016, BONE MARROW TRANSPL, V51, P410, DOI 10.1038/bmt.2015.279; Ringden O, 2017, BRIT J HAEMATOL, V176, P431, DOI 10.1111/bjh.14428; Sintes J, 2007, TISSUE ANTIGENS, V70, P355, DOI 10.1111/j.1399-0039.2007.00909.x; Tefferi A, 2015, AM J HEMATOL, V90, P831, DOI 10.1002/ajh.24102; van Besien K, 2013, HEMATOL-AM SOC HEMAT, P56, DOI 10.1182/asheducation-2013.1.56; Xu HM, 2012, BLOOD, V120, P3089, DOI 10.1182/blood-2012-01-405332; Zhang P, 2011, IMMUNOL RES, V49, P49, DOI 10.1007/s12026-010-8193-7	43	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185219	10.1371/journal.pone.0185219	http://dx.doi.org/10.1371/journal.pone.0185219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953912	gold, Green Published, Green Submitted			2022-12-27	WOS:000411980300046
J	Trapanese, M; Buglione, M; Maselli, V; Petrelli, S; Aceto, S; Fulgione, D				Trapanese, Martina; Buglione, Maria; Maselli, Valeria; Petrelli, Simona; Aceto, Serena; Fulgione, Domenico			The first transcriptome of Italian wall lizard, a new tool to infer about the Island Syndrome	PLOS ONE			English	Article							LEPTIN GENE-EXPRESSION; RNA-SEQ DATA; ANOLIS-LIZARDS; FREEZE TOLERANCE; EVOLUTION; GENOME; BRAIN; DIVERSIFICATION; POPULATION; GENERATION	Some insular lizards show a high degree of differentiation from their conspecific mainland populations, like Licosa island lizards, which are described as affected by Reversed Island Syndrome (RIS). In previous works, we demonstrated that some traits of RIS, as melanization, depend on a differential expression of gene encoding melanocortin receptors. To better understand the basis of syndrome, and providing raw data for future investigations, we generate the first de novo transcriptome of the Italian wall lizard. Comparing mainland and island transcriptomes, we link differences in life-traits to differential gene expression. Our results, taking together testis and brain sequences, generated 275,310 and 269,885 transcripts, 18,434 and 21,606 proteins in Gene Ontology annotation, for mainland and island respectively. Variant calling analysis identified about the same number of SNPs in island and mainland population. Instead, through a differential gene expression analysis we found some putative genes involved in syndrome more expressed in insular samples like Major Histocompatibility Complex class I, Immunoglobulins, Melanocortin 4 receptor, Neuropeptide Y and Proliferating Cell Nuclear Antigen.	[Trapanese, Martina; Buglione, Maria; Maselli, Valeria; Petrelli, Simona; Aceto, Serena; Fulgione, Domenico] Univ Naples Federico II, Dept Biol, Campus Monte St Angelo, Naples, Italy	University of Naples Federico II	Fulgione, D (corresponding author), Univ Naples Federico II, Dept Biol, Campus Monte St Angelo, Naples, Italy.	fulgione@unina.it	Buglione, Maria/ABH-1103-2021	Aceto, Serena/0000-0003-3906-4872; Maselli, Valeria/0000-0002-1452-8063; FULGIONE, DOMENICO/0000-0002-5121-3298; BUGLIONE, MARIA/0000-0001-6022-707X				Bohme W., 1993, ZOOGEOGRAPHY LACERTI, P17; Bolger A, 2014, TRIMMOMATIC FLEXIBLE; Burke RL, 2002, COPEIA, P836; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chieffi P, 2001, ZYGOTE, V9, P317, DOI 10.1017/S0967199401001368; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Eckalbar WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-49; FAITH RE, 1973, IMMUNOLOGY, V25, P151; FELLAH JS, 1993, IMMUNOGENETICS, V38, P311; Flajnik M., 2003, FUNDAMENTAL IMMUNOLO, P519; Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fulgione D, 2015, J ZOOL, V296, P278, DOI 10.1111/jzo.12242; Fulgione D, 2008, ZOOL SCI, V25, P465, DOI 10.2108/zsj.25.465; Gambon-Deza F, 2008, MOL IMMUNOL, V45, P3470, DOI 10.1016/j.molimm.2008.02.027; Georges A, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0085-2; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Jensen J, 2001, COMP BIOCHEM PHYS A, V128, P471, DOI 10.1016/S1095-6433(00)00329-9; Johnson MA, 2010, EVOLUTION, V64, P1151, DOI 10.1111/j.1558-5646.2009.00881.x; Klaczko J, 2015, J ZOOL, V295, P44, DOI 10.1111/jzo.12178; Leng N, 2013, EBSEQ EMPIRICAL BAYE; LESLIE GA, 1972, J IMMUNOL, V108, P1656; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Losos Jonathan B., 2010, P309; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Mahler DL, 2010, EVOLUTION, V64, P2731, DOI 10.1111/j.1558-5646.2010.01026.x; Marchanolis JJ, 1977, MARCHALONIS IMMUNITY; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Monti DM, 2013, BIOL J LINN SOC, V108, P144, DOI 10.1111/j.1095-8312.2012.02019.x; Morash B, 1999, ENDOCRINOLOGY, V140, P5995, DOI 10.1210/en.140.12.5995; Morash B, 2001, MOL CELL ENDOCRINOL, V185, P151, DOI 10.1016/S0303-7207(01)00626-8; MORRIS YA, 1990, BRAIN RES, V530, P339, DOI 10.1016/0006-8993(90)91307-3; O'Grady SP, 2006, MORPHOLOGICAL PHYSIO; Pereira AGT, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0148947, 10.1371/journal.pone.0158165]; Perez-Mellado Valentin, 1993, Bonner Zoologische Beitraege, V44, P193; Raia P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-289; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Sagonas K, 2015, SCI NAT-HEIDELBERG, V102, DOI 10.1007/s00114-015-1301-8; Sagonas K, 2014, BIOL J LINN SOC, V112, P469, DOI 10.1111/bij.12290; Sanseverino W, 2015, MOL BIOL EVOL, V32, P2760, DOI 10.1093/molbev/msv152; Secor SM, 2009, J COMP PHYSIOL B, V179, P1, DOI 10.1007/s00360-008-0283-7; Smit A, 1996, REPEATMASKER OPEN 30; Smith-Unna RD, 2015, TRANSRATE REFERENCE; Storey KB, 2006, CRYOBIOLOGY, V52, P1, DOI 10.1016/j.cryobiol.2005.09.005; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Suzu S, 2002, BIOCHEM BIOPH RES CO, V296, P1215, DOI 10.1016/S0006-291X(02)02025-9; Tzika AC, 2015, GENOME BIOL EVOL, V7, P1827, DOI 10.1093/gbe/evv106; Wakayama T, 2001, MOL REPROD DEV, V60, P158, DOI 10.1002/mrd.1072; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Wegener JE, 2014, BIOL J LINN SOC, V113, P570, DOI 10.1111/bij.12380; Zhang Z, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-44	58	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185227	10.1371/journal.pone.0185227	http://dx.doi.org/10.1371/journal.pone.0185227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953924	Green Published, gold			2022-12-27	WOS:000411980300047
J	Ainelo, H; Lahesaare, A; Teppo, A; Kivisaar, M; Teras, R				Ainelo, Hanna; Lahesaare, Andrio; Teppo, Annika; Kivisaar, Maia; Teras, Riho			The promoter region of lapA and its transcriptional regulation by Fis in Pseudomonas putida	PLOS ONE			English	Article							ESCHERICHIA-COLI; BIOFILM FORMATION; GENE-EXPRESSION; PROTEIN FIS; RPOS GENE; DI-GMP; IDENTIFICATION; TRANSPOSITION; AERUGINOSA; ADHESION	LapA is the biggest protein in Pseudomonas putida and a key factor for biofilm formation. Its importance and posttranslational regulation is rather thoroughly studied but less is known about the transcriptional regulation. Here we give evidence that transcription of lapA in LB-grown bacteria is initiated from six promoters, three of which display moderate RpoS-dependence. The global transcription regulator Fis binds to the lapA promoter area at six positions in vitro, and Fis activates the transcription of lapA while overexpressed in cells. Two of the six Fis binding sites, Fis-A7 and Fis-A5, are necessary for the positive effect of Fis on the transcription of lapA in vivo. Our results indicate that Fis binding to the Fis-A7 site increases the level of transcription from the most distal promoter of lapA, whereas Fis binding to the Fis-A5 site could be important for modifying the promoter area topology.	[Ainelo, Hanna; Lahesaare, Andrio; Teppo, Annika; Kivisaar, Maia; Teras, Riho] Univ Tartu, Inst Mol & Cell Biol, Chair Genet, Tartu, Estonia	University of Tartu	Teras, R (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Chair Genet, Tartu, Estonia.	riho.leras@ut.ee	Teras, Riho/ABA-8761-2021	Ainelo, Hanna/0000-0003-3340-9120	Targeted Financing Project [SF0180031s08]; Estonian Research Council [IUT20-19]	Targeted Financing Project; Estonian Research Council	This work was supported by the funding of the Targeted Financing Project SF0180031s08; the Institutional Research Funding IUT20-19 from Estonian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzallag GN, 2004, J THEOR BIOL, V229, P361, DOI 10.1016/j.jtbi.2004.04.001; ANTOINE R, 1992, MOL MICROBIOL, V6, P1785, DOI 10.1111/j.1365-2958.1992.tb01351.x; Bradley MD, 2007, MICROBIOL-SGM, V153, P2922, DOI 10.1099/mic.0.2007/008565-0; Cameron ADS, 2011, MOL MICROBIOL, V80, P85, DOI 10.1111/j.1365-2958.2011.07560.x; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Conway T, 2014, MBIO, V5, DOI 10.1128/mBio.01442-14; D'Arrigo I, 2016, ENVIRON MICROBIOL, V18, P3466, DOI 10.1111/1462-2920.13326; Duque E, 2013, ENVIRON MICROBIOL, V15, P36, DOI 10.1111/j.1462-2920.2012.02732.x; El-Kirat-Chatel S, 2014, ACS CHEM BIOL, V9, P485, DOI 10.1021/cb400794e; Espinosa-Urgel M, 2000, J BACTERIOL, V182, P2363, DOI 10.1128/JB.182.9.2363-2369.2000; Fazli M, 2014, ENVIRON MICROBIOL, V16, P1961, DOI 10.1111/1462-2920.12448; FINKEL SE, 1992, MOL MICROBIOL, V6, P3257, DOI 10.1111/j.1365-2958.1992.tb02193.x; Gaal T, 2001, MOL MICROBIOL, V42, P939, DOI 10.1046/j.1365-2958.2001.02703.x; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Gjermansen M, 2010, MOL MICROBIOL, V75, P815, DOI 10.1111/j.1365-2958.2009.06793.x; GonzalezGil G, 1996, MOL MICROBIOL, V22, P21, DOI 10.1111/j.1365-2958.1996.tb02652.x; Gutierrez-Rios RM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-53; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Ilves H, 2001, J BACTERIOL, V183, P5445, DOI 10.1128/JB.183.18.5445-5448.2001; Jakovleva J, 2012, MICROBIOL-SGM, V158, P708, DOI 10.1099/mic.0.053355-0; Jimenez-Fernandez A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163142; Jovcic B, 2008, J MICROBIOL, V46, P56, DOI 10.1007/s12275-007-0127-2; Jyot J, 2002, J BACTERIOL, V184, P5251, DOI 10.1128/JB.184.19.5251-5260.2002; Kivistik PA, 2006, J BACTERIOL, V188, P8109, DOI 10.1128/JB.01262-06; Kojic M, 2001, J BACTERIOL, V183, P3712, DOI 10.1128/JB.183.12.3712-3720.2001; KUES U, 1989, MICROBIOL REV, V53, P491; Lahesaare A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166078; Lahesaare A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115901; Lenz DH, 2007, MOL MICROBIOL, V63, P859, DOI 10.1111/j.1365-2958.2006.05545.x; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Martinez-Garcia E, 2011, ENVIRON MICROBIOL, V13, P2702, DOI 10.1111/j.1462-2920.2011.02538.x; Martinez-Gil M, 2014, J BACTERIOL, V196, P1484, DOI 10.1128/JB.01287-13; Martinez-Gil M, 2010, MOL MICROBIOL, V77, P549, DOI 10.1111/j.1365-2958.2010.07249.x; Medina-Rivera A, 2015, NUCLEIC ACIDS RES, V43, pW50, DOI 10.1093/nar/gkv362; MENDOZAVARGAS A, 2009, PLOS ONE, V4, P76403, DOI DOI 10.1073/PNAS.0511100103; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Moor H, 2014, MICROBIOL-SGM, V160, P2681, DOI 10.1099/mic.0.082503-0; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Newell P. D., 2011, PLOS BIOL, V9; Prigent-Combaret C, 2012, MOL MICROBIOL, V86, P172, DOI 10.1111/j.1365-2958.2012.08182.x; Ramos-Gonzalez MI, 2005, J BACTERIOL, V187, P4033, DOI 10.1128/JB.187.12.4033-4041.2005; Ramos-Gonzalez MI, 1998, J BACTERIOL, V180, P3421; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; Sambrook J., 2001, MOL CLONING LAB MANU; Shao YP, 2008, J MOL BIOL, V376, P771, DOI 10.1016/j.jmb.2007.11.101; Sharma RC, 1996, BIOTECHNIQUES, V20, P42; TANAKA K, 1993, P NATL ACAD SCI USA, V90, P8303; Teras R, 2000, J BACTERIOL, V182, P589, DOI 10.1128/JB.182.3.589-598.2000; Teras R, 2009, MICROBIOL-SGM, V155, P1203, DOI 10.1099/mic.0.022830-0; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; Waite RD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-162; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Wolska KI, 2015, J APPL GENET; Wong SM, 2000, P NATL ACAD SCI USA, V97, P10191, DOI 10.1073/pnas.97.18.10191; Xiao YJ, 2016, ENV MICROBIOL REP, V8, P659, DOI 10.1111/1758-2229.12419; Yousef-Coronado F, 2008, FEMS MICROBIOL LETT, V288, P118, DOI 10.1111/j.1574-6968.2008.01339.x; Yousef-Coronado F, 2011, MICROBIOL-SGM, V157, P2257, DOI 10.1099/mic.0.047787-0; Yuste L, 2006, ENVIRON MICROBIOL, V8, P165, DOI 10.1111/j.1462-2920.2005.00890.x	61	9	9	7	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185482	10.1371/journal.pone.0185482	http://dx.doi.org/10.1371/journal.pone.0185482			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945818	Green Published, Green Submitted, gold			2022-12-27	WOS:000411645100063
J	Monsted, B; Sapiezynski, P; Ferrara, E; Lehmann, S				Monsted, Bjarke; Sapiezynski, Piotr; Ferrara, Emilio; Lehmann, Sune			Evidence of complex contagion of information in social media: An experiment using Twitter bots	PLOS ONE			English	Article								It has recently become possible to study the dynamics of information diffusion in techno-social systems at scale, due to the emergence of online platforms, such as Twitter, with millions of users. One question that systematically recurs is whether information spreads according to simple or complex dynamics: does each exposure to a piece of information have an independent probability of a user adopting it (simple contagion), or does this probability depend instead on the number of sources of exposure, increasing above some threshold (complex contagion)? Most studies to date are observational and, therefore, unable to disentangle the effects of confounding factors such as social reinforcement, homophily, limited attention, or network community structure. Here we describe a novel controlled experiment that we performed on Twitter using 'social bots' deployed to carry out coordinated attempts at spreading information. We propose two Bayesian statistical models describing simple and complex contagion dynamics, and test the competing hypotheses. We provide experimental evidence that the complex contagion model describes the observed information diffusion behavior more accurately than simple contagion. Future applications of our results include more effective defenses against malicious propaganda campaigns on social media, improved marketing and advertisement strategies, and design of effective network intervention techniques.	[Monsted, Bjarke; Sapiezynski, Piotr; Lehmann, Sune] Tech Univ Denmark, Appl Math & Comp Sci, DK-2800 Lyngby, Denmark; [Ferrara, Emilio] Univ Southern Calif, Informat Sci Inst, Marina Del Rey, CA 90292 USA; [Ferrara, Emilio] Indiana Univ, Network Sci Inst, Bloomington, IN USA	Technical University of Denmark; University of Southern California; Indiana University System; Indiana University Bloomington	Lehmann, S (corresponding author), Tech Univ Denmark, Appl Math & Comp Sci, DK-2800 Lyngby, Denmark.	sko@dtu.dk	Ferrara, Emilio/F-6136-2012	Ferrara, Emilio/0000-0002-1942-2831; Lehmann, Sune/0000-0001-6099-2345	Danish Council for Independent Research [4184-00556a]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This work was funded by the Danish Council for Independent Research (http://ufm.dk/forskning-og-innovation/rad-og-udvalg/det-frie-forskningsrad), grant number 4184-00556a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Campbell E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01905; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Daley D., 1965, IMA J APPL MATH, V1, P42, DOI [DOI 10.1093/IMAMAT/1.1.42, 10.1093/imamat/1.1.42]; DALEY DJ, 1964, NATURE, V204, P1118, DOI 10.1038/2041118a0; Davis CA, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16 COMPANION), P273, DOI 10.1145/2872518.2889302; Ferrara E, 2016, COMMUN ACM, V59, P96, DOI 10.1145/2818717; Ferrara E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142390; Goel S, 2016, MANAGE SCI, V62, P180, DOI 10.1287/mnsc.2015.2158; GOFFMAN W, 1964, NATURE, V204, P225, DOI 10.1038/204225a0; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Hodas NO, 2014, SCI REP-UK, V4, DOI 10.1038/srep04343; Karsai M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0694; Lehman S, 2014, BANKSYINBOSTON BOTSI; Lerman K, 2016, FUTURE INTERNET, V8, DOI 10.3390/fi8020021; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Raftery A., 1995, SOCIOLOGICAL METHODO; Romero D. M., 2011, P 20 INT C WORLD WID, P695, DOI [10.1145/1963405.1963503, DOI 10.1145/1963405.1963503]; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Shi YH, 1999, IEEE T FUZZY SYST, V7, P109, DOI 10.1109/91.755393; Subrahmanian VS, 2016, COMPUTER, V49, P38, DOI 10.1109/MC.2016.183; Ugander J, 2012, P NATL ACAD SCI USA, V109, P5962, DOI 10.1073/pnas.1116502109; WANG YH, 1993, STAT SINICA, V3, P295; Weng L, 2013, SCI REP-UK, V3, DOI [10.1038/srep02304, 10.1038/srep02522]	33	109	109	6	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0184148	10.1371/journal.pone.0184148	http://dx.doi.org/10.1371/journal.pone.0184148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH9IR	28937984	Green Published, Green Submitted, gold			2022-12-27	WOS:000411524700004
J	Yasuda, M; Takayama, K; Kanda, T; Taguchi, M; Someya, H; Takeuchi, M				Yasuda, Mami; Takayama, Kei; Kanda, Takayuki; Taguchi, Manzo; Someya, Hideaki; Takeuchi, Masaru			Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension	PLOS ONE			English	Article							TRABECULAR-MESHWORK CELLS; INDUCED ANTERIOR UVEITIS; OPEN-ANGLE GLAUCOMA; BRIMONIDINE; PHAGOCYTOSIS	Ocular hypertension (OHT) caused by inflammation or corticosteroid treatment is a common complication of uveitis. Ripasudil hydrochloride hydrate (K-115) is reportedly efficacious for lowering intraocular pressure (IOP). We retrospectively compared the IOP-lowering effect of K-115 for inflammatory and corticosteroid-induced OHT associated with uveitis. Thirty-six consecutive eyes of 27 patients with uveitis-associated OHT (20 and 16 eyes with inflammation- and corticosteroid-induced OHT, respectively) were treated with K-115 with or without other anti-glaucoma agents. In the inflammation-induced OHT, mean IOP and aqueous flare significantly decreased (P < 0.001 and P = 0.035, respectively), changing from 26.4 +/- 7.5 mmHg and 28.1 +/- 15.0 photon counts per millisecond (pc/ms) at the initial assessment to 17.9 +/- 5.4 mmHg and 17.1 +/- 10.7 pc/ms at the last visit, respectively. In the corticosteroid- induced OHT, mean IOP significantly decreased (P = 0.0005), changing from 26.7 +/- 7.8 mmHg and 18.7 +/- 11.2 pc/ms to 18.6 +/- 8.8 mmHg and 22.6 +/- 15.3 pc/ms, respectively; conversely, aqueous flare remained unchanged. In the inflammation-induced OHT, K-115 was more efficacious in the eyes with higher IOP. Neither remarkable adverse effects nor exacerbation of uveitis were observed in the eyes of either group during the observation period. K-115 decreased IOP in both inflammation-and corticosteroid-induced OHT associated with uveitis and played a synergistic role in reducing ocular inflammation in uveitis treatment.	[Yasuda, Mami; Takayama, Kei; Kanda, Takayuki; Taguchi, Manzo; Someya, Hideaki; Takeuchi, Masaru] Natl Def Med Coll, Dept Ophthalmol, Tokorozawa, Saitama, Japan	National Defense Medical College - Japan	Takeuchi, M (corresponding author), Natl Def Med Coll, Dept Ophthalmol, Tokorozawa, Saitama, Japan.	masatake@ndmc.ac.jp		Takayama, Kei/0000-0002-1477-9014; Takeuchi, Masaru/0000-0002-4913-7089	Japan Society for the Promotion of Science [17K16964];  [16K11337]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	The study was supported by grants from the Grants-in-Aid for Scientific Research C (M. Takeuchi, 16K11337) and Grant-in-Aid for Young Scientists B (K. Takayama, 17K16964) from the Japan Society for the Promotion of Science. There are no conflicts of interest to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHEAMPONG AA, 1995, DRUG METAB DISPOS, V23, P708; ALVARADO JA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1769, DOI 10.1001/archopht.1992.01080240109042; Beltz J, 2016, OCUL IMMUNOL INFLAMM, V24, P128, DOI 10.3109/09273948.2015.1037845; Chen JK, 2017, J NEUROIMMUNOL, V305, P108, DOI 10.1016/j.jneuroim.2017.02.010; de Velde SV, 2014, INVEST OPHTH VIS SCI, V55, P1006, DOI 10.1167/iovs.13-13157; Deschenes J, 2008, OCUL IMMUNOL INFLAMM, V16, P1, DOI 10.1080/09273940801899822; Garnock-Jones K, 2014, DRUGS, V74, P2211, DOI 10.1007/s40265-014-0333-2; Honjo M, 2007, INVEST OPHTH VIS SCI, V48, P5549, DOI 10.1167/iovs.07-0878; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Kanda T, 2014, BRIT J OPHTHALMOL, V98, P932, DOI 10.1136/bjophthalmol-2013-304416; Liao DK, 2007, J CARDIOVASC PHARM, V50, P17, DOI 10.1097/FJC.0b013e318070d1bd; Moorthy RS, 1997, SURV OPHTHALMOL, V41, P361, DOI 10.1016/S0039-6257(97)00006-4; Nguyen EV, 2008, J GLAUCOMA, V17, P40, DOI 10.1097/IJG.0b013e3181132188; Okumura N, 2015, INVEST OPHTH VIS SCI, V56, P7560, DOI 10.1167/iovs.15-17887; Raghunathan VK, 2015, INVEST OPHTH VIS SCI, V56, P4447, DOI 10.1167/iovs.15-16739; Rozo C, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-209850; SHERWOOD ME, 1988, EXP EYE RES, V46, P881, DOI 10.1016/S0014-4835(88)80040-X; SHIRATO S, 1989, INVEST OPHTH VIS SCI, V30, P2499; Siddique SS, 2013, SURV OPHTHALMOL, V58, P1, DOI 10.1016/j.survophthal.2012.04.006; Takayama K, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000559; Takeuchi M, 2017, OCUL IMMUNOL INFLAMM, V25, P105, DOI 10.3109/09273948.2015.1092559; Tanihara H, 2016, ACTA OPHTHALMOL, V94, pE26, DOI 10.1111/aos.12829; Underwood JL, 1999, AM J PHYSIOL-CELL PH, V277, pC330, DOI 10.1152/ajpcell.1999.277.2.C330; Yamada H, 2017, J OCUL PHARMACOL TH, V33, P176, DOI 10.1089/jop.2016.0085; YUE BYJT, 1987, EXP EYE RES, V44, P891, DOI 10.1016/S0014-4835(87)80051-9; Zhuo YH, 2010, MOL VIS, V16, P61	26	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185305	10.1371/journal.pone.0185305	http://dx.doi.org/10.1371/journal.pone.0185305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968412	Green Published, gold, Green Submitted			2022-12-27	WOS:000412029600018
J	Gharouni, A; Barbeau, MA; Chasse, J; Wang, L; Watmough, J				Gharouni, Ali; Barbeau, Myriam A.; Chasse, Joel; Wang, Lin; Watmough, James			Stochastic dispersal increases the rate of upstream spread: A case study with green crabs on the northwest Atlantic coast	PLOS ONE			English	Article							LARVAL DISPERSAL; ST-LAWRENCE; POPULATION PERSISTENCE; SENSITIVITY-ANALYSIS; BIOLOGICAL INVASION; VERTICAL MIGRATION; CARCINUS-MAENAS; CLIMATE-CHANGE; MARINE; GULF	Dispersal heterogeneity is an important process that can compensate for downstream advection, enabling aquatic organisms to persist or spread upstream. Our main focus was the effect of year-to-year variation in larval dispersal on invasion spread rate. We used the green crab, Carcinus maenas, as a case study. This species was first introduced over 200 years ago to the east coast of North America, and once established has maintained a relatively consistent spread rate against the dominant current. We used a stage-structured, integro- difference equation model that couples a demographic matrix for population growth and dispersal kernels for spread of individuals within a season. The kernel describing larval dispersal, the main dispersive stage, was mechanistically modeled to include both drift and settlement rate components. It was parameterized using a 3-dimensional hydrodynamic model of the Gulf of St Lawrence, which enabled us to incorporate larval behavior, namely vertical swimming. Dispersal heterogeneity was modeled at two temporal scales: within the larval period (months) and over the adult lifespan (years). The kernel models variation within the larval period. To model the variation among years, we allowed the kernel parameters to vary by year. Results indicated that when dispersal parameters vary with time, knowledge of the time-averaged dispersal process is insufficient for determining the upstream spread rate of the population. Rather upstream spread is possible over a number of years when incorporating the yearly variation, even when there are only a few "good years" featured by some upstream dispersal among many "bad years" featured by only downstream dispersal. Accounting for annual variations in dispersal in population models is important to enhance understanding of spatial dynamics and population spread rates. Our developed model also provides a good platform to link the modeling of larval behavior and demography to large-scale hydrodynamic models.	[Gharouni, Ali; Wang, Lin; Watmough, James] Univ New Brunswick, Dept Math & Stat, Fredericton, NB, Canada; [Barbeau, Myriam A.] Univ New Brunswick, Dept Biol, Fredericton, NB, Canada; [Chasse, Joel] Fisheries & Oceans Canada, Gulf Fisheries Ctr, Moncton, NB, Canada	University of New Brunswick; University of New Brunswick; Fisheries & Oceans Canada	Gharouni, A (corresponding author), Univ New Brunswick, Dept Math & Stat, Fredericton, NB, Canada.	a.gharouni@unb.ca	Wang, Lin/ABF-1622-2020	Watmough, James/0000-0002-0126-0504; Gharouni, Ali/0000-0003-4427-7688	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 238365-2012, RGPIN-2015-05686]; Atlantic Ecosystem Initiative from Environment and Climate Change Canada [GCXE17P009]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Atlantic Ecosystem Initiative from Environment and Climate Change Canada	The research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC Discovery Grants to JW and LW; RGPIN 238365-2012, RGPIN-2015-05686), and an Atlantic Ecosystem Initiative grant from Environment and Climate Change Canada (Project Number: GCXE17P009). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MATL VER R2012 7 14; ARONSON DG, 1978, ADV MATH, V30, P33, DOI 10.1016/0001-8708(78)90130-5; BERRILL M, 1982, Journal of Crustacean Biology, V2, P31, DOI 10.2307/1548108; Blakeslee AMH, 2010, DIVERS DISTRIB, V16, P879, DOI 10.1111/j.1472-4642.2010.00703.x; BONARDELLI JC, 1993, ATMOS OCEAN, V31, P541, DOI 10.1080/07055900.1993.9649485; Brickman D, 2014, MAR POLLUT BULL, V85, P235, DOI 10.1016/j.marpolbul.2014.05.034; Brickman D., 2012, CANADIAN TECHNICAL R, V278; Byers JE, 2006, MAR ECOL PROG SER, V313, P27, DOI 10.3354/meps313027; Caswell H, 2003, ECOLOGY, V84, P1968, DOI 10.1890/02-0100; Caswell H, 2011, THEOR ECOL-NETH, V4, P407, DOI 10.1007/s12080-010-0091-z; Chasse J, 2010, FISH OCEANOGR, V19, P319, DOI 10.1111/j.1365-2419.2010.00548.x; Chiswell SM, 2012, AQUAT BIOL, V16, P203, DOI 10.3354/ab00466; CONNELL JH, 1961, ECOL MONOGR, V31, P61, DOI 10.2307/1950746; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Daigle RM, 2016, PROG OCEANOGR, V144, P93, DOI 10.1016/j.pocean.2016.04.001; Ellner SP, 2012, THEOR POPUL BIOL, V82, P283, DOI 10.1016/j.tpb.2012.03.005; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Gharouni A, 2015, MAR ECOL PROG SER, V541, P135, DOI 10.3354/meps11508; Grosholz ED, 2005, P NATL ACAD SCI USA, V102, P1088, DOI 10.1073/pnas.0308547102; Grosholz ED, 1996, BIOL CONSERV, V78, P59, DOI 10.1016/0006-3207(94)00018-2; Han GQ, 1999, J PHYS OCEANOGR, V29, P1279, DOI 10.1175/1520-0485(1999)029<1279:SMHACI>2.0.CO;2; Hardy, 1935, DISCOVERY REP, V11, P273; HAWKINS SJ, 1982, J EXP MAR BIOL ECOL, V62, P271, DOI 10.1016/0022-0981(82)90207-6; HOBBS RC, 1992, MAR BIOL, V112, P417, DOI 10.1007/BF00356287; Hrycik JM, 2013, ESTUAR COAST SHELF S, V133, P11, DOI 10.1016/j.ecss.2013.06.023; Jongejans E, 2011, ECOLOGY, V92, P86, DOI 10.1890/09-2226.1; Klassen G., 2007, CANADIAN REPOR UNPUB, V2818, P75, DOI DOI 10.1007/BF00348935; Largier JL, 2003, ECOL APPL, V13, pS71; LAUZIER LM, 1965, J FISH RES BOARD CAN, V22, P353, DOI 10.1139/f65-035; Lavoie D, 2016, ATMOS OCEAN, V54, P299, DOI 10.1080/07055900.2015.1082965; Long ZX, 2016, ATMOS OCEAN, V54, P337, DOI 10.1080/07055900.2015.1029869; Lutscher F, 2005, SIAM REV, V47, P749, DOI 10.1137/050636152; Madec G, 2012, NEMO OCEAN ENGINE; Maps F, 2015, LIMNOL OCEANOGR, V60, P1965, DOI 10.1002/lno.10145; Maps F, 2014, ICES J MAR SCI, V71, P282, DOI 10.1093/icesjms/fst021; Marculis NG, 2016, J BIOL DYNAM, V10, P140, DOI 10.1080/17513758.2015.1115563; MULLER K, 1982, OECOLOGIA, V52, P202, DOI 10.1007/BF00363837; Munday PL, 2009, CORAL REEFS, V28, P379, DOI 10.1007/s00338-008-0461-9; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; OKUBO A, 2001, DIFFUSION ECOLOGICAL; Ouellet P, 2013, CAN J FISH AQUAT SCI, V70, P1508, DOI 10.1139/cjfas-2013-0227; Pachepsky E, 2005, THEOR POPUL BIOL, V67, P61, DOI 10.1016/j.tpb.2004.09.001; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Pineda J, 2000, OCEANOGR E PAC, V1, P84; Pringle JM, 2009, MAR ECOL PROG SER, V377, P13, DOI 10.3354/meps07836; Pringle JM, 2011, P NATL ACAD SCI USA, V108, P15288, DOI 10.1073/pnas.1100473108; Queiroga H, 1997, MAR ECOL PROG SER, V149, P121, DOI 10.3354/meps149121; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Ruiz GM, 1997, AM ZOOL, V37, P621; Saucier FJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000686; Schreiber SJ, 2011, THEOR ECOL-NETH, V4, P423, DOI 10.1007/s12080-010-0098-5; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Snyder RE, 2014, AM NAT, V184, P523, DOI 10.1086/677925; Speirs DC, 2001, ECOLOGY, V82, P1219, DOI 10.2307/2679984; Stover JP, 2014, B MATH BIOL, V76, P2681, DOI 10.1007/s11538-014-0014-z; Therriault T.W., 2008, 2008042 CAN SCI ADV; Tuljapurkar S.D., 1990, POPULATION DYNAMICS; Watson JR, 2012, AM NAT, V180, P99, DOI 10.1086/665992; Williams PD, 2013, AM NAT, V182, P271, DOI 10.1086/671059; Yamamura K, 2002, POPUL ECOL, V44, P93, DOI 10.1007/s101440200011	61	6	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185671	10.1371/journal.pone.0185671	http://dx.doi.org/10.1371/journal.pone.0185671			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961269	gold, Green Published, Green Submitted			2022-12-27	WOS:000412027700032
J	Chen, L; Hatti-Kaul, R				Chen, Lu; Hatti-Kaul, Rajni			Exploring Lactobacillus reuteri DSM20016 as a biocatalyst for transformation of longer chain 1,2-diols: Limits with microcompartment	PLOS ONE			English	Article							B-12-DEPENDENT 1,2-PROPANEDIOL DEGRADATION; DEPENDENT DIOL DEHYDRATASE; SEROVAR TYPHIMURIUM LT2; KLEBSIELLA-PNEUMONIAE; 3-HYDROXYPROPIONIC ACID; GLYCEROL DEHYDRATASE; MICROBIAL-PRODUCTION; BACTERIAL MICROCOMPARTMENTS; CLOSTRIDIUM-BUTYRICUM; RESTING CELLS	Lactobacillus reuteri metabolises glycerol efficiently to form 3-hydroxypropionic acid (3-HP) and 1,3-propanediol (1,3PDO) by the same mechanism as that for 1,2-propanediol (1,2PDO) conversion to propionic acid and propanol via its propanediol utilization (pdu) pathway. Pdu enzymes are encoded by the pdu-operon, which also contain genes encoding the shell proteins of the microcompartment housing the metabolic pathway. In this work the selectivity and kinetics of the reactions catalysed by L. reuteri DSM20016 Pdu enzymes glycerol dehydratase (GDH), 1,3-propanediol oxidoreductase (PduQ) and coenzyme-A acylating propionaldehyde dehydrogenase (PduP), produced recombinantly, was investigated against corresponding substrates of different chain lengths. Glycerol dehydratase exhibited activity against C2-C4 polyols, with the highest activity against glycerol and 1,2-propanediol (1,2PDO). A double mutant of the pduC gene of GDH (PduC-S302A/Q337A) was constructed that displayed lowered activity against glycerol and 1,2PDO but extended the substrate range upto C6-diol. The best substrate for both PduQ and PduP was 3-hydroxypropanal (3HPA), although PduP exhibited nearly 10-fold higher specific activity. The enzymes also showed some activity against C3-C10 aliphatic aldehydes, with PduP having higher relative activity. Subsequently, transformation of polyols using whole cells of L. reuteri containing the wild type-and mutated GDH, respectively, confirmed the reduced activity of the mutant against glycerol and 1,2PDO, but its activity against longer substrates was negligible. In contrast, recombinant Escherichia coli BL21(DE3) cells harboring the GDH variant converted diols with up to C6 carbon chain length to their respective aldehydes, suggesting that the protein shell of the microcompartment in L. reuteri posed a barrier to the passage of longer chain substrate.	[Chen, Lu; Hatti-Kaul, Rajni] Lund Univ, Ctr Chem & Chem Engn, Div Biotechnol, Lund, Sweden	Lund University	Chen, L (corresponding author), Lund Univ, Ctr Chem & Chem Engn, Div Biotechnol, Lund, Sweden.	lu.chen@blotek.lu.se		CHEN, LU/0000-0001-8867-5851	Erasmus Mundus Action 2 programme	Erasmus Mundus Action 2 programme	This work was supported by the Erasmus Mundus Action 2 programme Lu Chen. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Erasmus Mundus Action 2 programme is acknowledged for financial support to Lu Chen.	Banat IM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00697; BIEBL H, 1991, APPL MICROBIOL BIOT, V35, P701; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bobik TA, 1997, J BACTERIOL, V179, P6633, DOI 10.1128/jb.179.21.6633-6639.1997; Chen Hanmin, 2010, CEM ENG, V1, P3; Chen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168107; Chen Z, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0625-8; Cheng SQ, 2011, J BACTERIOL, V193, P1385, DOI 10.1128/JB.01473-10; Chowdhury C, 2015, P NATL ACAD SCI USA, V112, P2990, DOI 10.1073/pnas.1423672112; Chowdhury C, 2014, MICROBIOL MOL BIOL R, V78, P438, DOI 10.1128/MMBR.00009-14; CIRCLE SJ, 1945, IND ENG CHEM, V17, P259, DOI 10.1021/i560140a021; Crowley CS, 2010, J BIOL CHEM, V285, P37838, DOI 10.1074/jbc.M110.160580; da Silva GP, 2009, BIOTECHNOL ADV, V27, P30, DOI 10.1016/j.biotechadv.2008.07.006; Dishisha T, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0388-0; Dishisha T, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-76; Doitomi K, 2014, B CHEM SOC JPN, V87, P950, DOI 10.1246/bcsj.20140115; Drozdzynska A, 2014, NEW BIOTECHNOL, V31, P402, DOI 10.1016/j.nbt.2014.04.002; Frank MS, PHARMACOTHERAPY, V1, P147; Gopi GR, 2015, FOOD TECHNOL BIOTECH, V53, P331; Kerfeld CA, 2015, TRENDS MICROBIOL, V23, P22, DOI 10.1016/j.tim.2014.10.003; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Kinney JN, 2011, PHOTOSYNTH RES, V109, P21, DOI 10.1007/s11120-011-9624-6; Leal NA, 2003, ARCH MICROBIOL, V180, P353, DOI 10.1007/s00203-003-0601-0; Li Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep26932; Maervoet VET, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0421-y; Makkar RS, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-5; Mori K, 1999, BIOCHEMISTRY-US, V38, P13170, DOI 10.1021/bi9911738; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; O'Brien JR, 2004, BIOCHEMISTRY-US, V43, P4635, DOI 10.1021/bi035930k; Pang A, 2012, ACTA CRYSTALLOGR D, V68, P1642, DOI 10.1107/S0907444912039315; Przystalowska H, 2015, ACTA BIOCHIM POL, V62, P23, DOI 10.18388/abp.2014_885; Qi XH, 2006, CHINESE SCI BULL, V51, P2977, DOI 10.1007/s11434-006-2219-5; Ramakrishnan GG, 2015, CURR MICROBIOL, V71, P517, DOI 10.1007/s00284-015-0878-7; REID MF, 1994, CRIT REV MICROBIOL, V20, P13, DOI 10.3109/10408419409113545; Ricci MA, 2015, J MICROBIOL BIOTECHN, V25, P893, DOI 10.4014/jmb.1411.11078; Sabet-Azad R, 2013, ENZYME MICROB TECH, V53, P235, DOI 10.1016/j.enzmictec.2013.05.007; Sardari RRR, 2013, J BIOTECHNOL, V168, P534, DOI 10.1016/j.jbiotec.2013.09.009; SCHUTZ H, 1984, SYST APPL MICROBIOL, V5, P169, DOI 10.1016/S0723-2020(84)80018-1; Shibata N, 1999, STRUCTURE, V7, P997, DOI 10.1016/S0969-2126(99)80126-9; Sinha S, 2014, J MOL BIOL, V426, P2328, DOI 10.1016/j.jmb.2014.04.012; Sriramulu DD, 2008, J BACTERIOL, V190, P4559, DOI 10.1128/JB.01535-07; SUZUKI T, 1994, J FERMENT BIOENG, V78, P194, DOI 10.1016/0922-338X(94)90265-8; TALARICO TL, 1990, APPL ENVIRON MICROB, V56, P943, DOI 10.1128/AEM.56.4.943-948.1990; TALARICO TL, 1990, APPL ENVIRON MICROB, V56, P1195, DOI 10.1128/AEM.56.4.1195-1197.1990; Tokuyama K, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-64; TORAYA T, 1977, J BIOL CHEM, V252, P963; TORAYA T, 1979, J BACTERIOL, V139, P39, DOI 10.1128/JB.139.1.39-47.1979; Toraya T, 2016, BIOCHEMISTRY-US, V55, P69, DOI 10.1021/acs.biochem.5b01023; van Pijkeren JP, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S10; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; Wang JW, 2017, J ROBOT NETW ARTIF L, V4, P1, DOI 10.15226/2374-815X/4/2/00186; Yamanishi M, 2012, FEBS J, V279, P793, DOI 10.1111/j.1742-4658.2012.08470.x; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Zeng AP, 2011, CURR OPIN BIOTECH, V22, P749, DOI 10.1016/j.copbio.2011.05.005; ZENG AP, 1993, ENZYME MICROB TECH, V15, P770, DOI 10.1016/0141-0229(93)90008-P; Zhao L, 2009, BIOPROC BIOSYST ENG, V32, P313, DOI 10.1007/s00449-008-0250-4; Zhao YN, 2006, BIOCHEM ENG J, V32, P93, DOI 10.1016/j.bej.2006.09.007	57	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185734	10.1371/journal.pone.0185734	http://dx.doi.org/10.1371/journal.pone.0185734			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957423	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200112
J	Gkika, E; Vach, W; Adebahr, S; Schimeck-Jasch, T; Brenner, A; Brunner, TB; Kaier, K; Prasse, A; Muller-Quernheim, J; Grosu, AL; Zissel, G; Nestle, U				Gkika, Eleni; Vach, Werner; Adebahr, Sonja; Schimeck-Jasch, Tanja; Brenner, Anton; Brunner, Thomas Baptist; Kaier, Klaus; Prasse, Antje; Mueller-Quernheim, Joachim; Grosu, Anca-Ligia; Zissel, Gernot; Nestle, Ursula			Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; PULMONARY-FIBROSIS; CANCER PATIENTS; BREAST-CANCER; CCL18; PNEUMONITIS; THERAPY; RADIOTHERAPY; INDICATOR; CYTOKINES	The CC chemokine ligand 18 (CCL18) is produced by alveolar macrophages in patients with fibrosing lung disease and its concentration is increased in various fibrotic lung diseases. Furthermore CCL18 is elevated in several malignancies as it is produced by tumor associated macrophages. In this study we aimed to analyze the role of CCL18 as a prognostic biomarker for the development of early radiation induced lung toxicity (RILT), i.e. radiation pneumonitis after thoracic irradiation and its significance in the course of the disease. Sixty seven patients were enrolled prospectively in the study. Patients were treated with irradiation for several thoracic malignancies (lung cancer, esophageal cancer, thymoma), either with conventionally fractionated or hypo-fractionated radiotherapy. The CCL18 serum levels were quantified with ELISA (enzyme-linked immunosorbent assay) at predefined time points: before, during and at the end of treatment as well as in the first and second follow-up. Treatment parameters and functional tests were also correlated with the development of RILT. Fifty three patients were evaluable for this study. Twenty one patients (39%) developed radiologic signs of RILT Grade > 1 but only three of them (5.6%) developed clinical symptoms (Grade 2). We could not find any association between the different CCL18 concentrations and a higher incidence of RILT. Statistical significant factors were the planning target volume (odds ratio OR: 1.003, p = 0.010), the volume of the lung receiving > 20 Gy (OR: 1.132 p = 0.004) and age (OR: 0.917, p = 0.008). There was no association between serial CCL18 concentrations with tumor response and overall survival. In our study the dosimetric parameters remained the most potent predictors of RILT. Further studies are needed in order to estimate the role of CCL18 in the development of early RILT.	[Gkika, Eleni; Adebahr, Sonja; Schimeck-Jasch, Tanja; Brenner, Anton; Brunner, Thomas Baptist; Grosu, Anca-Ligia; Nestle, Ursula] Univ Hosp Freiburg, Med Ctr, Dept Radiat Oncol, Freiburg, Germany; [Vach, Werner; Kaier, Klaus] Univ Freiburg, Med Fac, Inst Med Biometry & Stat, Freiburg, Germany; [Vach, Werner; Kaier, Klaus] Univ Freiburg, Med Ctr, Freiburg, Germany; [Adebahr, Sonja; Brunner, Thomas Baptist; Grosu, Anca-Ligia; Nestle, Ursula] German Canc Consortium DKTK, Partner Site Freiburg, Heidelberg, Germany; [Adebahr, Sonja; Brunner, Thomas Baptist; Grosu, Anca-Ligia; Nestle, Ursula] German Canc Res Ctr, Heidelberg, Germany; [Brunner, Thomas Baptist; Grosu, Anca-Ligia; Nestle, Ursula] Univ Freiburg, Fac Med, Freiburg, Germany; [Prasse, Antje] Hannover Med Sch, Dept Pneumol, Hannover, Germany; [Mueller-Quernheim, Joachim; Zissel, Gernot] Univ Med Ctr Freiburg, Dept Pneumol, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; Hannover Medical School; University of Freiburg	Gkika, E (corresponding author), Univ Hosp Freiburg, Med Ctr, Dept Radiat Oncol, Freiburg, Germany.	eleni.gkika@uniklinik-freiburg.de	Prasse, Antje/AAM-7521-2021; Vach, Werner/F-2512-2011; Prasse, Antje/AAY-6279-2020; Kaier, Klaus/B-4227-2009; Nestle, Ursula/ABG-2339-2021; Zissel, Gernot/B-1208-2010	Prasse, Antje/0000-0002-7336-7458; Vach, Werner/0000-0003-1865-8399; Kaier, Klaus/0000-0003-0837-6945; Zissel, Gernot/0000-0001-8021-9798				Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Crohns M, 2010, CYTOKINE, V50, P30, DOI 10.1016/j.cyto.2009.11.017; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fleckenstein K, 2007, SEMIN RADIAT ONCOL, V17, P89, DOI 10.1016/j.semradonc.2006.11.004; Gao J, 2015, PATHOL BIOL, V63, P199, DOI 10.1016/j.patbio.2015.07.001; Hieshima K, 1997, J IMMUNOL, V159, P1140; Hou X, 2015, TUMOUR BIOL J INT SO; Khalil AA, 2015, ACTA ONCOL, V54, P1343, DOI 10.3109/0284186X.2015.1061216; Kong FM, 2005, SEMIN ONCOL, V32, pS42, DOI 10.1053/j.seminoncol.2005.03.009; Leung SY, 2004, GASTROENTEROLOGY, V127, P457, DOI 10.1053/j.gastro.2004.05.031; Lin L C Y, 2015, ONCOTARGET; Lota HK, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/121439; Mantovani A, 2004, EUR J CANCER, V40, P1660, DOI 10.1016/j.ejca.2004.03.016; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marks LB, 2010, INT J RADIAT ONCOL, V76, pS70, DOI 10.1016/j.ijrobp.2009.06.091; Mehta V, 2005, INT J RADIAT ONCOL, V63, P5, DOI 10.1016/j.ijrobp.2005.03.047; Palma DA, 2013, INT J RADIAT ONCOL, V85, P444, DOI 10.1016/j.ijrobp.2012.04.043; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Ploenes T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053068; Plones T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041746; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Prasse A, 2007, ARTHRITIS RHEUM-US, V56, P1685, DOI 10.1002/art.22559; Prasse A, 2009, RESPIROLOGY, V14, P788, DOI 10.1111/j.1440-1843.2009.01600.x; Prassel A, 2009, AM J RESP CRIT CARE, V179, P717, DOI 10.1164/rccm.200808-1201OC; Rube CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002898; Schmid S, 2016, ANTICANCER RES, V36, P4667, DOI 10.21873/anticanres.11018; Schupp JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116775; Schutyser E, 2005, J LEUKOCYTE BIOL, V78, P14, DOI 10.1189/jlb.1204712; Schutyser E, 2002, J BIOL CHEM, V277, P24584, DOI 10.1074/jbc.M112275200; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yuan RX, 2013, J SURG RES, V183, P163, DOI 10.1016/j.jss.2013.01.017	33	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185350	10.1371/journal.pone.0185350	http://dx.doi.org/10.1371/journal.pone.0185350			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957436	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200049
J	Kim, SY; Bang, W; Choi, HG				Kim, So Young; Bang, Woojin; Choi, Hyo Geun			Analysis of the prevalence of and factors associated with overactive bladder in adult Korean women	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; QUALITY-OF-LIFE; RISK-FACTORS; STRESS-INCONTINENCE; UNITED-STATES; IMPACT; SMOKING; BURDEN	Background Overactive bladder (OAB) is one of the most prevalent lower urinary tract conditions and has been suggested to be related to various factors. We assessed the prevalence of and factors associated with OAB in women based on a large cross-sectional, population-based study of adult Korean women. Methods The Korean community health survey (KCHS) of 2012 was reviewed, and 107,950 female participants aged 19 to 107 years were identified for inclusion in this study. The overactive bladder symptom score (OABSS) was used to define and classify OAB as mild, moderate, or severe. Numerous variables, including marital status; physical activity; education and income levels; type of occupation; body mass index (BMI); smoking; alcohol; sleep time; and medical history of hypertension, diabetes mellitus, hyperlipidemia, or cerebral stroke, were evaluated. The correlation of these variables with the prevalence of OAB was analyzed using simple and multiple logistic regression analyses with complex sampling. Results The results showed that 5.2% of adult women experienced OAB. Multiple regression analyses showed a significant correlation between the following variables and OAB: older age (adjusted odds ratio [AOR] = 1.44, 95% confidence interval [CI] = 1.39-1.50, P < 0.001 as 10 years older); married status (AOR = 0.83, 95%CI = 0.70-0.96, P = 0.016); lower level of income (AOR = 1.50, 95%CI = 1.34-1.68, P < 0.001); high BMI (AOR = 1.33, 95%CI = 1.23-1.44, P < 0.001); smoking (AOR = 1.24, 95%CI = 1.04-1.47, P < 0.001); long sleep time (AOR = 1.95, 95%CI = 1.69-2.26); and medical history of hypertension (AOR = 1.11, 95%CI = 1.03-1.21, P = 0.011), diabetes mellitus (AOR = 1.38, 95%CI = 1.25-1.53, P < 0.001), hyperlipidemia (AOR = 1.27, 95%CI = 1.16-1.39, P < 0.001), and cerebral stroke (AOR = 2.04, 95%CI = 1.73-2.41, P < 0.001). The level of stress showed a dose-dependent association with OAB (AOR [95%CI] = 3.28 [2.81-3.83] > 2.11 [1.91-2.33] >1.28 [1.16-1.41] for severe > moderate > some stress, respectively, P < 0.001). Conclusion The prevalence of OAB was approximately 5.2% among adult Korean women. Older age; high BMI; stress level; sleep duration; levels of income and education; marital status; smoking; and medical history of hypertension, diabetes mellitus, hyperlipidemia, and cerebral stroke were significantly related to OAB in women.	[Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Bang, Woojin] Hallym Univ, Coll Med, Dept Urol, Seoul, South Korea; [Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Pochon Cha University; Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation (NRF) of Korea [NRF-2015-R1D1A1A01060860, 2017R1C1B1007696]; Hallym University Sacred Heart Hospital [HURF-2016-38]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Hallym University Sacred Heart Hospital	This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860 to HGC and 2017R1C1B1007696 to SYK) from the National Research Foundation (NRF) of Korea and a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2016-38) to HGC.; This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860 and 2017R1C1B1007696) from the National Research Foundation (NRF) of Korea and a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2016-38).	Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Antunes-Lopes T, 2011, ADV UROL, V2011, DOI 10.1155/2011/382431; Azadzoi KM, 1999, J UROLOGY, V162, P1768, DOI 10.1016/S0022-5347(05)68236-5; Bauer RM, 2013, WORLD J UROL, V31, P1081, DOI 10.1007/s00345-013-1132-1; Brubaker L, 2010, BJU INT, V105, P1283, DOI 10.1111/j.1464-410X.2009.09035.x; Coyne KS, 2012, UROLOGY, V80, P97, DOI 10.1016/j.urology.2012.03.039; Coyne KS, 2011, BJU INT, V108, P1459, DOI 10.1111/j.1464-410X.2010.10013.x; Dallosso HM, 2003, BJU INT, V92, P69, DOI 10.1046/j.1464-410X.2003.04271.x; de Boer TA, 2011, INT UROGYNECOL J, V22, P569, DOI 10.1007/s00192-010-1323-x; de Groat WC, 1997, UROLOGY, V50, P36, DOI 10.1016/S0090-4295(97)00587-6; Dmochowski RR, 2007, CURR MED RES OPIN, V23, P64, DOI 10.1185/030079907X159533; Eapen Renu S, 2016, Can J Urol, V23, P2; Findik RB, 2012, ADV CLIN EXP MED, V21, P207; Gold EB, 2001, AM J EPIDEMIOL, V153, P865, DOI 10.1093/aje/153.9.865; Handa VL, 2015, NEUROUROL URODYNAM, V34, P356, DOI 10.1002/nau.22583; Hill SR, 2008, NEUROUROL URODYNAM, V27, P362, DOI 10.1002/nau.20533; Hirayama A, 2012, UROLOGY, V80, P71, DOI 10.1016/j.urology.2012.04.019; Homma Y, 2006, UROLOGY, V68, P318, DOI 10.1016/j.urology.2006.02.042; Irwin DE, 2008, BJU INT, V101, P1381, DOI 10.1111/j.1464-410X.2008.07573.x; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Jeong Seong Jin, 2011, Int Neurourol J, V15, P135, DOI 10.5213/inj.2011.15.3.135; Kajioka Shunichi, 2010, Fukuoka Acta Medica, V101, P94; Kim HJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-195; Kim SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175641; Kim Y, 2016, UNINARY INCONTINENCE, P1; Kinsey D, 2016, J HEALTH PSYCHOL, V21, P69, DOI 10.1177/1359105314522084; Korea Centers for Disease Control and Prevention, COMM HLTH SURV 2013; Largo RH, 1999, EUR J PEDIATR, V158, P115; Madhu C, 2015, UROL INT, V95, P478, DOI 10.1159/000438928; Maserejian NN, 2012, J UROLOGY, V188, P490, DOI 10.1016/j.juro.2012.03.128; Masuda H, 2006, J UROLOGY, V176, P374, DOI 10.1016/S0022-5347(06)00581-7; Milsom I, 2001, BJU INT, V87, P760, DOI 10.1046/j.1464-410x.2001.02228.x; Milsom I, 2014, EUR UROL, V65, P79, DOI 10.1016/j.eururo.2013.08.031; Milsom I, 2012, UROLOGY, V80, P90, DOI 10.1016/j.urology.2012.04.004; Oh DH, 2013, J KOREAN MED SCI, V28, P128, DOI 10.3346/jkms.2013.28.1.128; Patra Phani B, 2013, Curr Urol, V6, P179, DOI 10.1159/000343536; Rim H, 2011, J KOREAN MED SCI, V26, P1409, DOI 10.3346/jkms.2011.26.11.1409; Savolainen S, 2005, MOL CELL ENDOCRINOL, V230, P17, DOI 10.1016/j.mce.2004.11.008; Sexton Chris C, 2009, Am J Manag Care, V15, pS98; Shen J, 2007, NEUROSCI LETT, V416, P193, DOI 10.1016/j.neulet.2007.02.003; Smith AL, 2016, INT UROGYNECOL J, V27, P1383, DOI 10.1007/s00192-016-2988-6; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; TAMPAKOUDIS P, 1995, EUR J OBSTET GYN R B, V63, P27, DOI 10.1016/0301-2115(95)02212-P; Taskforce IO, 2000, AS PAC PERSP RED OB; Uzun H, 2012, INT NEUROUROL J, V16, P181, DOI 10.5213/inj.2012.16.4.181; Valentino RJ, 2011, NAT REV UROL, V8, P19, DOI 10.1038/nrurol.2010.203; Wang R, 2015, FEMALE PELVIC MED RE, V21, P293, DOI 10.1097/SPV.0000000000000193; Wang YL, 2011, NEUROUROL URODYNAM, V30, P1448, DOI 10.1002/nau.21072; Wood SK, 2009, AM J PHYSIOL-REG I, V296, pR1671, DOI 10.1152/ajpregu.91013.2008	49	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185592	10.1371/journal.pone.0185592	http://dx.doi.org/10.1371/journal.pone.0185592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957446	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200089
J	Meisterernst, J; Klinger-Gratz, PP; Leidolt, L; Lang, MF; Schroth, G; Mordasini, P; Heldner, MR; Mono, ML; Kurmann, R; Buehlmann, M; Fischer, U; Arnold, M; Gralla, J; Mettle, HP; El-Koussy, M; Jung, SM				Meisterernst, Julia; Klinger-Gratz, Pascal P.; Leidolt, Lars; Lang, Matthias F.; Schroth, Gerhard; Mordasini, Pasquale; Heldner, Mirjam R.; Mono, Marie-Luise; Kurmann, Rebekka; Buehlmann, Monika; Fischer, Urs; Arnold, Marcel; Gralla, Jan; Mettle, Heinrich P.; El-Koussy, Marwan; Jung, Simon			Focal T2 and FLAIR hyperintensities within the infarcted area: A suitable marker for patient selection for treatment?	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; INVERSION-RECOVERY HYPERINTENSITY; WEIGHTED IMAGING LESIONS; HEMORRHAGIC TRANSFORMATION; INTRAARTERIAL THROMBOLYSIS; INTRACEREBRAL HEMORRHAGE; MULTICENTER; MISMATCH; THERAPY; PREDICT	Background and purpose Some authors use FLAIR imaging to select patients for stroke treatment. However, the effect of hyperintensity on FLAIR images on outcome and bleeding has been addressed in only few studies with conflicting results. Methods 466 patients with anterior circulation strokes were included in this study. They all were examined with MRI before intravenous or endovascular treatment. Baseline data and 3 months outcome were recorded prospectively. Focal T2 and FLAIR hyperintensities within the ischemic lesion were evaluated by two raters, and the PROACT II classification was applied to assess bleeding complications on follow up imaging. Logistic regression analysis was used to determine predictors of bleeding complications and outcome and to analyze the influence of T2 or FLAIR hyperintensity on outcome. Results Focal hyperintensities were found in 142 of 307 (46.3%) patients with T2 weighted imaging and in 89 of 159 (56%) patients with FLAIR imaging. Hyperintensity in the basal ganglia, especially in the lentiform nucleus, on T2 weighted imaging was the only independent predictor of any bleeding after reperfusion treatment (33.8% in patients with vs. 18.2% in those without; p = 0.003) and there was a non-significant trend for more bleedings in patients with FLAIR hyperintensity within the basal ganglia (p = 0.069). However, there was no association of hyperintensity on T2 weighted or FLAIR images and symptomatic bleeding or worse outcome. Conclusion Our results question the assumption that T2 or FLAIR hyperintensities within the ischemic lesion should be used to exclude patients from reperfusion therapy, especially not from endovascular treatment.	[Meisterernst, Julia; Heldner, Mirjam R.; Mono, Marie-Luise; Kurmann, Rebekka; Buehlmann, Monika; Fischer, Urs; Arnold, Marcel; Mettle, Heinrich P.; Jung, Simon] Univ Hosp Bern, Inselspital, Dept Neurol, Bern, Switzerland; [Meisterernst, Julia; Klinger-Gratz, Pascal P.; Leidolt, Lars; Lang, Matthias F.; Schroth, Gerhard; Mordasini, Pasquale; Heldner, Mirjam R.; Mono, Marie-Luise; Kurmann, Rebekka; Buehlmann, Monika; Fischer, Urs; Arnold, Marcel; Gralla, Jan; Mettle, Heinrich P.; El-Koussy, Marwan; Jung, Simon] Univ Bern, Bern, Switzerland; [Klinger-Gratz, Pascal P.; Leidolt, Lars; Lang, Matthias F.; Schroth, Gerhard; Mordasini, Pasquale; Gralla, Jan; El-Koussy, Marwan] Univ Hosp Bern, Inselspital, Dept Diagnost & Intervent Neuroradiol, Bern, Switzerland; [Klinger-Gratz, Pascal P.] Univ Basel, Univ Basel Hosp, Dept Radiol, Basel, Switzerland; [Lang, Matthias F.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Diagnost Intervent & Pediat Radiol, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Basel; University of Bern; University Hospital of Bern	Jung, SM (corresponding author), Univ Hosp Bern, Inselspital, Dept Neurol, Bern, Switzerland.	simon.jung@insel.ch	Mordasini, Pasquale/H-8321-2015	Fischer, Urs/0000-0003-0521-4051; Heldner, Mirjam R/0000-0002-3594-2159	Swiss Heart Foundation	Swiss Heart Foundation	This work was supported by the Swiss Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2011, CEREBROVASC DIS, V31, P435, DOI 10.1159/000323850; Aoki J, 2010, J NEUROL SCI, V293, P39, DOI 10.1016/j.jns.2010.03.011; Campbell BCV, 2011, CEREBROVASC DIS, V32, P401, DOI 10.1159/000331467; Cho AH, 2008, STROKE, V39, P3424, DOI 10.1161/STROKEAHA.108.516740; Chung JW, 2013, CEREBROVASC DIS, V35, P461, DOI 10.1159/000350201; Dzialowski I, 2007, STROKE, V38, P75, DOI 10.1161/01.STR.0000251644.76546.62; Ebinger M, 2012, STROKE, V43, P539, DOI 10.1161/STROKEAHA.111.632026; Ebinger M, 2010, STROKE, V41, P1823, DOI 10.1161/STROKEAHA.110.583971; Emeriau S, 2015, J NEURORADIOLOGY, V42, P269, DOI 10.1016/j.neurad.2015.04.008; Gilgen MD, 2015, STROKE, V46, P2510, DOI 10.1161/STROKEAHA.115.010250; Gratz PP, 2014, STROKE, V45, P1684, DOI 10.1161/STROKEAHA.114.004796; Hobohm C, 2014, ACTA NEUROL SCAND, V130, P338, DOI 10.1111/ane.12272; Jha R, 2014, STROKE, V45, P1040, DOI 10.1161/STROKEAHA.113.004627; Jung S, 2013, BRAIN, V136, P3554, DOI 10.1093/brain/awt246; Jung S, 2012, STROKE, V43, P1584, DOI 10.1161/STROKEAHA.111.645358; Jung S, 2011, STROKE, V42, P1946, DOI 10.1161/STROKEAHA.110.606038; Kang DW, 2012, STROKE, V43, P3278, DOI 10.1161/STROKEAHA.112.675926; Kase CS, 2001, NEUROLOGY, V57, P1603, DOI 10.1212/WNL.57.9.1603; Kufner A, 2013, EUR J NEUROL, V20, P281, DOI 10.1111/j.1468-1331.2012.03841.x; Luedi R, 2014, J NEUROL, V261, P1622, DOI 10.1007/s00415-014-7401-0; Park JH, 2012, NEUROLOGY, V78, P421, DOI 10.1212/WNL.0b013e318245d22c; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Thomalla G, 2011, LANCET NEUROL, V10, P978, DOI 10.1016/S1474-4422(11)70192-2; Thomalla G, 2009, ANN NEUROL, V65, P724, DOI 10.1002/ana.21651; Witkowski G, 2014, NEURORADIOLOGY, V56, P825, DOI 10.1007/s00234-014-1407-2; Wouters A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00153	26	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185158	10.1371/journal.pone.0185158	http://dx.doi.org/10.1371/journal.pone.0185158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957339	gold, Green Published, Green Submitted			2022-12-27	WOS:000411985200031
J	Garcia, M; Harris, AL				Garcia, Moctezuma; Harris, Allyssa L.			PrEP awareness and decision-making for Latino MSM in San Antonio, Texas	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; HIV; POSTEXPOSURE	Pre-Exposure Prophylaxis (PrEP) has been promoted among high-risk populations as an effective HIV biomedical intervention. However, limited research is available on the significance of culturally informed biomedical interventions for Latino MSM. A total of 159 selfadministered Internet surveys were completed by Latino MSM ages 21 - 30 in San Antonio, Texas. The purpose of this research was to develop an instrument that measured Latino MSM attitudes and beliefs towards PrEP, identify associations between demographic factors and PrEP related factors and to suggest culturally appropriate strategies for the promotion of PrEP among the Latino MSM population. Research findings revealed implications for PrEP at the structural and individual level for Latino MSM. Structural level indicators emphasized the importance for raising PrEP awareness among Latino MSM in regards to PrEP related expenses, ameliorating stigmatization of high-risk populations, enhancing access to PrEP informed medical providers, and address mistrust of the government and medical providers role on addressing health disparities among Latino MSM. Overall, the findings for individual factors emphasize the need for patient-centered interventions for Latino MSM. Latino MSM currently on PrEP require supplemental resources to enhance PrEP adherence. Latino MSM not on PrEP require alternate options for PrEP delivery and/or cognitive behavioral approaches minimizing HIV risk behavior for Latino MSM concerned with PrEP toxicity, which may require non-biomedical interventions. Integration of Latino MSM currently on PrEP as peer educators provides a valuable resource for developing culturally informed PrEP interventions for Latino MSM. Peer educators are able to share their experiential knowledge of PrEP contextualized through cultural norms, beliefs, and values.	[Garcia, Moctezuma] Texas State Univ, Sch Social Work, San Marcos, TX 78666 USA; [Harris, Allyssa L.] Boston Coll, Connell Sch Nursing, Chestnut Hill, MA 02167 USA	Texas State University System; Texas State University San Marcos; Boston College	Garcia, M (corresponding author), Texas State Univ, Sch Social Work, San Marcos, TX 78666 USA.	m_g558@txstate.edu	Garcia, Moctezuma/I-9860-2019	Garcia, Moctezuma/0000-0002-8703-4929; Harris, Allyssa/0000-0002-5001-1483	Texas State University	Texas State University	Research funding was provided through an internal grant at Texas State University.	Adams J., 1995, RISK, V1st ed.; Arnold T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172354; Ayala George, 2013, J Sex Transm Dis, V2013, P953123, DOI 10.1155/2013/953123; Bauermeister J, 2013, CURRENT HIV RES, V11; Blumenthal J, 2015, AIDS BEHAV, V19, P802, DOI 10.1007/s10461-015-0996-z; Calabrese SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157324; Calabrese SK, 2014, AIDS BEHAV, V18, P226, DOI 10.1007/s10461-013-0675-x; Calabrese SK, 2016, AIDS BEHAV, V20; CDC, 2014, CDCS NEW HIGH IMP AP; CDC, 2016, PREEXP PROPH PREP; Chen Y, 2016, AIDS BEHAV, V20; Collins S, 2016, INT J SEXUAL HLTH, V29; Dolezal C, 2015, AIDS ED PREVENTION, V27; Drabo EF, 2016, CLIN INFECT DIS, V63, P1495, DOI 10.1093/cid/ciw578; Eaton LA, 2015, AIDS PATIENT CARE ST, V29, P423, DOI 10.1089/apc.2014.0303; Elopre L, 2017, JAIDS J ACQUIRED IMM, V74; Elsesser SA, 2016, AIDS BEHAV, V20, P1400, DOI 10.1007/s10461-015-1238-0; Galvan FH, 2017, J BEHAV MED, P1; Gamble VN, 1997, AM J PUBLIC HEALTH, V87, P1773, DOI 10.2105/AJPH.87.11.1773; Gersh JK, 2014, J AIDS CLIN RES, V5; Goedel WC, 2016, AIDS BEHAV, V20, P1435, DOI 10.1007/s10461-016-1353-6; Golub SA, 2013, AIDS PATIENT CARE ST, V27; Gomez GB, 2013, PLOS ONE, V10; Graham J., 1998, INJURY PREVENTION, V4; Greene GJ, 2016, AIDS BEHAV, V21; Grov C, 2015, AIDS BEHAV, V19, P2234, DOI 10.1007/s10461-015-1030-1; Heller J, 2015, AM J PUBLIC HEALTH, V105, pE43, DOI 10.2105/AJPH.2014.302284; Hojilla JC, 2016, AIDS BEHAV, V20, P1461, DOI 10.1007/s10461-015-1055-5; Jacobs RJ, 2015, J HIV AIDS SOCIAL SE, V14; Jayakumaran JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145670; Joint Economic Committee, 2015, EC STAT LAT COMM AM; Koechlin FM, 2017, AIDS BEHAV, V21, P1325, DOI 10.1007/s10461-016-1627-z; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Kubicek K, 2015, ARCH SEXUAL BEHAV, V44; Lelutiu-Weinberger C, 2016, J ACQUIRED IMMUNE DE, V73; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Marcus JL, 2016, J ACQUIRED IMMUNE DE, V73; Mayer KH, 2017, AIDS BEHAV, V21, P1350, DOI 10.1007/s10461-016-1606-4; McLaughlin ML, 2016, HEALTH COMMUN, V31, P998, DOI 10.1080/10410236.2015.1027033; Merchant RC, 2016, J GAY LESBIAN MENTAL, V20; Mimiaga MJ, 1999, J ACQUIRED IMMUNE DE, V50; Molina JM, C RETR OPP INF; Oldenburg C, 2014, AIDS RES HUM RETROV, V30, pA22, DOI 10.1089/aid.2014.5031.abstract; Parsons J, 2016, AIDS BEHAV, V20; Pines HA, 1999, J ACQUIRED IMMUNE DE, V65; Pritchard A, 2000, LEISURE STUDIES, V19; Raifman JR, 2016, AM J PREVENTIVE MED, V52; Ryan CL, 2016, ED ATTAINMENT US 201; Smith DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156592; Spinner CD, 2016, INFECTION, V44, P151, DOI 10.1007/s15010-015-0850-2; Taylor SW, 2014, AIDS BEHAV, V18, P871, DOI 10.1007/s10461-013-0617-7; Taylor SW, 2017, COGNITIVE BEHAV PRAC, V24; Underhill K, 2016, AIDS BEHAV, V20; Westergaard RP, 2014, J GEN INTERN MED, V29, P140, DOI 10.1007/s11606-013-2554-6	54	47	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184014	10.1371/journal.pone.0184014	http://dx.doi.org/10.1371/journal.pone.0184014			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4WR	28953905	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300009
J	Pawson, SM; Marcot, BG; Woodberry, OG				Pawson, Stephen M.; Marcot, Bruce G.; Woodberry, Owen G.			Predicting forest insect flight activity: A Bayesian network approach	PLOS ONE			English	Article							HYLURGUS-LIGNIPERDA; BELIEF NETWORKS; COLEOPTERA; BEETLES; SCOLYTIDAE; BARK; MANAGEMENT; UNCERTAINTY; PATTERNS; PINE	Daily flight activity patterns of forest insects are influenced by temporal and meteorological conditions. Temperature and time of day are frequently cited as key drivers of activity; however, complex interactions between multiple contributing factors have also been proposed. Here, we report individual Bayesian network models to assess the probability of flight activity of three exotic insects, Hylurgus ligniperda, Hylastes ater, and Arhopalus ferus in a managed plantation forest context. Models were built from 7,144 individual hours of insect sampling, temperature, wind speed, relative humidity, photon flux density, and temporal data. Discretized meteorological and temporal variables were used to build naive Bayes tree augmented networks. Calibration results suggested that the H. ater and A. ferus Bayesian network models had the best fit for low Type I and overall errors, and H. ligniperda had the best fit for low Type II errors. Maximum hourly temperature and time since sunrise had the largest influence on H. ligniperda flight activity predictions, whereas time of day and year had the greatest influence on H. ater and A. ferus activity. Type II model errors for the prediction of no flight activity is improved by increasing the model's predictive threshold. Improvements in model performance can be made by further sampling, increasing the sensitivity of the flight intercept traps, and replicating sampling in other regions. Predicting insect flight informs an assessment of the potential phytosanitary risks of wood exports. Quantifying this risk allows mitigation treatments to be targeted to prevent the spread of invasive species via international trade pathways.	[Pawson, Stephen M.] Scion, Christchurch, New Zealand; [Marcot, Bruce G.] US Forest Serv, Pacific Northwest Res Stn, Portland, OR 97208 USA; [Woodberry, Owen G.] Monash Univ LPO, Bayesian Intelligence, Melbourne, Vic, Australia	Scion; United States Department of Agriculture (USDA); United States Forest Service	Pawson, SM (corresponding author), Scion, Christchurch, New Zealand.	steve.pawson@scionresearch.com			New Zealand Ministry for Business, Innovation, and Employment [C04X1204]; Stakeholders in Methyl Bromide Reduction Inc.	New Zealand Ministry for Business, Innovation, and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Stakeholders in Methyl Bromide Reduction Inc.	This work was funded by the New Zealand Ministry for Business, Innovation, and Employment (C04X1204) and the Stakeholders in Methyl Bromide Reduction Inc. An Agmardt grant enabled the participation of Bruce Marcot with in kind contribution through U.S. Forest Service, Pacific Northwest Research Station. The manuscript was reviewed by STIMBR prior to publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Environment Canterbury and RayonieriMatariki for access to forest stands to conduct this experiment, and Brooke O'Connor, Jessica Kerr, and Jeremy Burnett for the establishment of the trial, daily maintenance of the separator traps and identification of samples. Martin Bader for assistance with GAM modelling. This work was funded by the New Zealand Ministry for Business, Innovation, and Employment (C04X1204) and the Stakeholders in Methyl Bromide Reduction Inc. An Agmardt grant enabled the participation of Bruce Marcot with in-kind contribution through U.S. Forest Service, Pacific Northwest Research Station.	Amstrup SC, 2008, GEOPHYS MONOGR SER, V180, P213, DOI 10.1029/180GM14; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Aven T., 2003, FDN RISK ANAL KNOWLE; Bivand R., 2015, MAPTOOLS TOOLS READI; BLACKBURN TM, 1992, OIKOS, V65, P107, DOI 10.2307/3544892; Boets P, 2015, ENVIRON MODELL SOFTW, V74, P92, DOI 10.1016/j.envsoft.2015.09.005; Brazzale AR, 2014, PACKAGE NLREG HIGHER; Brockerhoff EG, 2006, CAN J FOREST RES, V36, P289, DOI [10.1139/x05-250, 10.1139/X05-250]; Brockerhoff EG, 2001, FOREST TIMBER INSECT, V27, P1; Byers JA, 2008, J CHEM ECOL, V34, P1134, DOI 10.1007/s10886-008-9509-0; Cawley GC, 2007, J MACH LEARN RES, V8, P841; Chen YP, 2014, J INSECT BEHAV, V27, P657, DOI 10.1007/s10905-014-9454-4; Chen YR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103676; Darwiche A, 2009, MODELING AND REASONING WITH BAYESIAN NETWORKS, P1, DOI 10.1017/CBO9780511811357; Daterman GE, 1965, FLIGHT PATTERNS BARK; Duda R. O., 1973, PATTERN CLASSIFICATI; Fayyad U., 1993, INT JOINT C ART INT; Fenton N, 2012, RISK ASSESSMENT DECI, DOI 10.1201/b13102; Fettig CJ, 2004, J ENTOMOL SCI, V39, P453, DOI 10.18474/0749-8004-39.3.453; FOA MPI, 2016, 2015 16 FACTS FIG NZ; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Goodwin P., 2004, DECISION ANAL MANAGE; HAACK RA, 1985, FLA ENTOMOL, V68, P658, DOI 10.2307/3494870; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Han M, 2014, J INF SCI ENG, V30, P371; Hanson N, 2011, J ENVIRON MANAGE, V92, P610, DOI 10.1016/j.jenvman.2010.09.026; Holland JD, 2010, LANDSCAPE ECOL, V25, P1349, DOI 10.1007/s10980-010-9499-5; HOSKING GP, 1977, NEW ZEAL J FOR SCI, V7, P137; IPPC, 2005, ISPM22 REQ EST AR LO; Iwata R, 2007, EUR J ENTOMOL, V104, P341, DOI 10.14411/eje.2007.049; Jakulin A, 2006, LECT NOTES COMPUT SC, V4212, P198; Kerr JL, 2016, J CHEM ECOLOGY; Korb K.B., 2004, COM SCI DAT; Landuyt D, 2013, ENVIRON MODELL SOFTW, V46, P1, DOI 10.1016/j.envsoft.2013.03.011; Leathwick J.R., 2002, LC9798126; Marcot BG, 2006, ECOLOGY SOC, V11; Marcot BG, 2006, CAN J FOREST RES, V36, P3063, DOI 10.1139/X06-135; Marcot BG, 2012, ECOL MODEL, V230, P50, DOI 10.1016/j.ecolmodel.2012.01.013; Mausel DL, 2007, CAN J FOREST RES, V37, P156, DOI 10.1139/X06-215; Maxwell SL, 2015, J APPL ECOL, V52, P12, DOI 10.1111/1365-2664.12373; Meeus JH., 1991, ASTRONOMICAL ALGORIT; MENDEL Z, 1991, PHYTOPARASITICA, V19, P23, DOI 10.1007/BF02981008; Milligan RH, 1978, FOREST TIMBER INSECT, V29, P1; MPI, 2013, BIOS RISK MAN ENTR P; Myers J. L., 2010, RES DESIGN STAT ANAL; Nadel RL, 2012, ANN FOREST SCI, V69, P757, DOI 10.1007/s13595-012-0200-9; Neapolitan R.E., 2003, LEARNING BAYESIAN NE; Ostrand F, 2003, AGRIC FOR ENTOMOL, V5, P163, DOI 10.1046/j.1461-9563.2003.00174.x; Pinheiro J, R PACKAGE VERSION; R Development Core Team, 2013, LANG ENV STAT COMP; Rassati D, 2015, J APPL ECOL, V52, P50, DOI 10.1111/1365-2664.12347; Reay Stephen D., 2001, New Zealand Entomologist, V24, P79; Rouse HL, 2010, AUSTRALAS J ENV MAN, V17, P66, DOI 10.1080/14486563.2010.9725252; Russell S.J., 2010, ARTIFICIAL INTELLIGE; Ryan J.A., 2008, XTS EXTENSIBLE TIME; Sopow SL, 2015, J APPL ECOL, V52, P220, DOI 10.1111/1365-2664.12368; STARZYK J R, 1968, Folia Biologica (Cracow), V16, P267; Suckling DM, 2001, J CHEM ECOL, V27, P1091, DOI 10.1023/A:1010355710509; TRIBE GD, 1991, J ENTOMOL SOC S AFR, V54, P1; Wallace C.S., 1999, CAUSAL MODELS INTELL, P89; Wang Q, 2002, J INSECT BEHAV, V15, P527, DOI 10.1023/A:1016333317564; Williams BK, 2011, ECOL MODEL, V222, P3429, DOI 10.1016/j.ecolmodel.2011.07.003; Wood S., 2015, VERSION, V1, P8	63	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0183464	10.1371/journal.pone.0183464	http://dx.doi.org/10.1371/journal.pone.0183464			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953904	Green Published, gold, Green Submitted			2022-12-27	WOS:000411980300007
J	Herath, TK; Ashby, AJ; Jayasuriya, NS; Bron, JE; Taylor, JF; Adams, A; Richards, RH; Weidmann, M; Ferguson, HW; Taggart, JB; Migaud, H; Fordyce, MJ; Thompson, KD				Herath, Tharangani K.; Ashby, Angela J.; Jayasuriya, Nilantha S.; Bron, James E.; Taylor, John F.; Adams, Alexandra; Richards, Randolph H.; Weidmann, Manfred; Ferguson, Hugh W.; Taggart, John B.; Migaud, Herve; Fordyce, Mark J.; Thompson, Kim D.			Impact of Salmonid alphavirus infection in diploid and triploid Atlantic salmon (Salmo salar L.) fry	PLOS ONE			English	Article							PANCREAS DISEASE PD; POST-SMOLTS; RAINBOW-TROUT; HOST RESPONSE; FRESH-WATER; CHALLENGE; VIRUS; HEART; SUSCEPTIBILITY; PREVALENCE	With increasing interest in the use of triploid salmon in commercial aquaculture, gaining an understanding of how economically important pathogens affect triploid stocks is important. To compare the susceptibility of diploid and triploid Atlantic salmon (Salmo salar L.) to viral pathogens, fry were experimentally infected with Salmonid alphavirus sub-type 1 (SAV1), the aetiological agent of pancreas disease (PD) affecting Atlantic salmon aquaculture in Europe. Three groups of fry were exposed to the virus via different routes of infection: intraperitoneal injection (IP), bath immersion, or cohabitation (co-hab) and untreated fry were used as a control group. Mortalities commenced in the co-hab challenged diploid and triploid fish from 11 days post infection (dpi), and the experiment was terminated at 17 dpi. Both diploid and triploid IP challenged groups had similar levels of cumulative mortality at the end of the experimental period (41.1% and 38.9% respectively), and these were significantly higher (p < 0.01) than for the other challenge routes. A TaqMan-based quantitative PCR was used to assess SAV load in the heart, a main target organ of the virus, and also liver, which does not normally display any pathological changes during clinical infections, but exhibited severe degenerative lesions in the present study. The median viral RNA copy number was higher in diploid fish compared to triploid fish in both the heart and the liver of all three challenged groups. However, a significant statistical difference (p < 0.05) was only apparent in the liver of the co-hab groups. Diploid fry also displayed significantly higher levels of pancreatic and myocardial degeneration than triploids. This study showed that both diploid and triploid fry are susceptible to experimental SAV1 infection. The lower virus load seen in the triploids compared to the diploids may possibly be related to differences in cell metabolism between the two groups, however, further investigation is necessary to confirm this and also to assess the outcome of PD outbreaks in other developmental stages of the fish when maintained in commercial production systems.	[Herath, Tharangani K.; Ashby, Angela J.; Jayasuriya, Nilantha S.; Bron, James E.; Taylor, John F.; Adams, Alexandra; Richards, Randolph H.; Weidmann, Manfred; Taggart, John B.; Migaud, Herve; Thompson, Kim D.] Univ Stirling, Inst Aquaculture, Stirling, Scotland; [Herath, Tharangani K.] Harper Adams Univ, Dept Anim Prod Welf & Vet Sci, Newport, Shrops, England; [Ashby, Angela J.] Fish Vet Grp, Inverness, Scotland; [Ferguson, Hugh W.] St Georges Univ, Sch Vet Med, Marine Med Programme, True Blue, Grenada; [Fordyce, Mark J.] Marine Scotland Sci, Aberdeen, Scotland; [Thompson, Kim D.] Moredun Res Inst, Edinburgh, Midlothian, Scotland	University of Stirling; Marine Scotland Science (MSS); Moredun Research Institute	Herath, TK (corresponding author), Univ Stirling, Inst Aquaculture, Stirling, Scotland.; Herath, TK (corresponding author), Harper Adams Univ, Dept Anim Prod Welf & Vet Sci, Newport, Shrops, England.	therath@harper-adams.ac.uk	Thompson, Kim/GLU-8547-2022; Weidmann, Manfred/G-1817-2015; Bron, James E/B-6231-2018; Migaud, Herve/C-5647-2009; Thompson, Kim/O-7707-2015	Weidmann, Manfred/0000-0002-7063-7491; Bron, James E/0000-0003-3544-0519; Migaud, Herve/0000-0002-5404-7512; Thompson, Kim/0000-0003-3550-4842; Taggart, John/0000-0002-3843-9663; Fordyce, Mark/0000-0002-7899-5445; Adams, Alexandra/0000-0002-2469-3310	Scottish Government, Strategic Partnership for Animal Science Excellence (SPASE) consortium; Innovate UK (AgriTech/0 [101908]; Biotechnology and Biological Sciences Research Council [BB/M013049/1] Funding Source: researchfish; BBSRC [BB/M013049/1] Funding Source: UKRI	Scottish Government, Strategic Partnership for Animal Science Excellence (SPASE) consortium; Innovate UK (AgriTech/0; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Scottish Government, Strategic Partnership for Animal Science Excellence (SPASE) consortium, http://spasepartnership.org/index.html, Received funding RR (PI), KT, AA, JB, JBT, and the Innovate UK (AgriTech; 101908) project on triploid salmon, https://connect.innovateuk.org/web/biosciencesktn/agri-tech-catalyst, Received funding- HM and JFT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, DIS AQUAT ORGAN, V59, P217; Benfey T. J., 2015, REV AQUAC; Biacchesi S, 2016, VET RES, V47, DOI 10.1186/s13567-015-0301-1; Braceland M, 2013, J PROTEOMICS, V94, P423, DOI 10.1016/j.jprot.2013.10.016; Cano I, 2015, J FISH DIS, V38, P271, DOI 10.1111/jfd.12310; Cavrini F, 2009, J INFECT DEV COUNTR, V3, P744, DOI 10.3855/jidc.169; Ching B, 2010, HEREDITY, V104, P224, DOI 10.1038/hdy.2009.108; Christie KE, 2007, DIS AQUAT ORGAN, V75, P13, DOI 10.3354/dao075013; Crane M, 2011, VIRUSES-BASEL, V3, P2025, DOI 10.3390/v3112025; Falk T, 2000, J SMALL ANIM PRACT, V41, P97, DOI 10.1111/j.1748-5827.2000.tb03173.x; FERGUSON HW, 1986, J FISH DIS, V9, P95, DOI 10.1111/j.1365-2761.1986.tb00987.x; Frenzl B, 2014, PEST MANAG SCI, V70, P982, DOI 10.1002/ps.3639; Fronhoffs S, 2002, MOL CELL PROBE, V16, P99, DOI 10.1006/mcpr.2002.0405; Graham DA, 2011, J FISH DIS, V34, P273, DOI 10.1111/j.1365-2761.2010.01234.x; Herath T, 2009, ICELAND AGR SCI, V22, P19; Herath TK, 2013, VET IMMUNOL IMMUNOP, V155, P9, DOI 10.1016/j.vetimm.2013.05.011; Herath TK, 2012, FISH SHELLFISH IMMUN, V32, P796, DOI 10.1016/j.fsi.2012.02.001; Hodneland K, 2006, J VIROL METHODS, V131, P184, DOI 10.1016/j.jviromet.2005.08.012; Jansen MD, 2010, J FISH DIS, V33, P391, DOI 10.1111/j.1365-2761.2009.01131.x; Kawa S, 2007, HEPATOL RES, V37, pS487, DOI 10.1111/j.1872-034X.2007.00235.x; Kilburn R, 2012, AQUACULTURE, V368, P89, DOI 10.1016/j.aquaculture.2012.09.004; Larsson T, 2012, AQUACULTURE, V330, P82, DOI 10.1016/j.aquaculture.2011.12.016; Leclercq E, 2011, COMP BIOCHEM PHYS A, V158, P116, DOI 10.1016/j.cbpa.2010.09.018; McCleary S, 2014, DIS AQUAT ORGAN, V109, P1, DOI 10.3354/dao02719; McLoughlin MF, 2006, DIS AQUAT ORGAN, V72, P125, DOI 10.3354/dao072125; McLoughlin MF, 2007, J FISH DIS, V30, P511, DOI 10.1111/j.1365-2761.2007.00848.x; McLoughlin M. F., 1995, Journal of Aquatic Animal Health, V7, P104, DOI 10.1577/1548-8667(1995)007&lt;0104:POEPDI&gt;2.3.CO;2; McLoughlin MF, 1996, DIS AQUAT ORGAN, V26, P117, DOI 10.3354/dao026117; McLoughlin MF, 2002, J FISH DIS, V25, P33, DOI 10.1046/j.1365-2761.2002.00334.x; NELSON RT, 1995, DIS AQUAT ORGAN, V22, P25, DOI 10.3354/dao022025; Nichols Krista M., 2009, P195, DOI 10.1002/9780813807379.ch8; Noguera PA, 2010, J FISH DIS, V33, P819, DOI 10.1111/j.1365-2761.2010.01193.x; Norris A, 2008, J FISH DIS, V31, P913, DOI 10.1111/j.1365-2761.2008.00982.x; Ozerov MY, 2010, DIS AQUAT ORGAN, V91, P129, DOI 10.3354/dao02242; Phillips AT, 2014, J VIROL, V88, P1771, DOI 10.1128/JVI.02297-13; Rimstad E, 2011, AQUAC RES, V42, P86, DOI 10.1111/j.1365-2109.2010.02670.x; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Sadler J, 2000, AQUACULTURE, V184, P349, DOI 10.1016/S0044-8486(99)00321-X; Taksdal T, 2007, J FISH DIS, V30, P545, DOI 10.1111/j.1365-2761.2007.00845.x; Taylor JF, 2013, AQUACULTURE, V410, P41, DOI 10.1016/j.aquaculture.2013.06.004; Watson PJ, 2010, J SMALL ANIM PRACT, V51, P566, DOI 10.1111/j.1748-5827.2010.00996.x; Weber GM, 2013, AQUACULTURE, V410, P66, DOI 10.1016/j.aquaculture.2013.06.014; Yousaf MN, 2013, VET IMMUNOL IMMUNOP, V151, P49, DOI 10.1016/j.vetimm.2012.10.004	43	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0179192	10.1371/journal.pone.0179192	http://dx.doi.org/10.1371/journal.pone.0179192			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949966	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000411671000001
J	Rioualen, C; Da Costa, Q; Chetrit, B; Charafe-Jauffret, E; Ginestier, C; Bidaut, G				Rioualen, Claire; Da Costa, Quentin; Chetrit, Bernard; Charafe-Jauffret, Emmanuelle; Ginestier, Christophe; Bidaut, Ghislain			HTS-Net: An integrated regulome-interactome approach for establishing network regulation models in high-throughput screenings	PLOS ONE			English	Article							MOLECULAR INTERACTION DATABASE; TRANSCRIPTION FACTORS; GENE-REGULATION; STEM-CELLS; UPDATE; CANCER; REPLICATION; MUTATIONS; COMPLEXES; PATHWAYS	High-throughput RNAi screenings (HTS) allow quantifying the impact of the deletion of each gene in any particular function, from virus-host interactions to cell differentiation. However, there has been less development for functional analysis tools dedicated to RNAi analyses. HTS-Net, a network-based analysis program, was developed to identify gene regulatory modules impacted in high-throughput screenings, by integrating transcription factors-target genes interaction data (regulome) and protein-protein interaction networks (interactome) on top of screening z-scores. HTS-Net produces exhaustive HTML reports for results navigation and exploration. HTS-Net is a new pipeline for RNA interference screening analyses that proves better performance than simple gene rankings by z-scores, by re-prioritizing genes and replacing them in their biological context, as shown by the three studies that we reanalyzed. Formatted input data for the three studied datasets, source code and web site for testing the system are available from the companion web site at http://htsnet. marseille. inserm. fr/. We also compared our program with existing algorithms (CARD and hotnet2).	[Rioualen, Claire; Da Costa, Quentin; Chetrit, Bernard; Charafe-Jauffret, Emmanuelle; Ginestier, Christophe; Bidaut, Ghislain] Aix Marseille Univ, Marseille, France; [Rioualen, Claire; Da Costa, Quentin; Chetrit, Bernard; Charafe-Jauffret, Emmanuelle; Ginestier, Christophe; Bidaut, Ghislain] Ctr Rech Cancerol Marseille, U1068, INSERM, Marseille, France; [Rioualen, Claire; Da Costa, Quentin; Chetrit, Bernard; Charafe-Jauffret, Emmanuelle; Ginestier, Christophe; Bidaut, Ghislain] Inst Paoli Calmettes, Marseille, France; [Rioualen, Claire; Da Costa, Quentin; Chetrit, Bernard; Charafe-Jauffret, Emmanuelle; Ginestier, Christophe; Bidaut, Ghislain] Ctr Rech Cancerol Marseille, CNRS, UMR7258, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Bidaut, G (corresponding author), Aix Marseille Univ, Marseille, France.; Bidaut, G (corresponding author), Ctr Rech Cancerol Marseille, U1068, INSERM, Marseille, France.; Bidaut, G (corresponding author), Inst Paoli Calmettes, Marseille, France.; Bidaut, G (corresponding author), Ctr Rech Cancerol Marseille, CNRS, UMR7258, Marseille, France.	ghislain.bidaut@inserm.fr	Ginestier, Christophe/M-8828-2017	Ginestier, Christophe/0000-0002-7477-3837; Rioualen, Claire/0000-0002-7684-8679; Bidaut, Ghislain/0000-0001-8502-2361; Da Costa, Quentin/0000-0001-8904-9131	Institut National du Cancer (FR) [INCA_5911]; Ghislain Bidaut	Institut National du Cancer (FR); Ghislain Bidaut	Institut National du Cancer (FR) grant INCA_5911 to Christophe Ginestier and Ghislain Bidaut funded the project.	Amberkar SS, 2015, ALGORITHM MOL BIOL, V10, DOI 10.1186/s13015-015-0035-7; Bankhead A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-80; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brown KV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r95; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Conway E, 2015, CURR OPIN CELL BIOL, V37, P42, DOI 10.1016/j.ceb.2015.10.003; Corda D, 2009, J BIOL CHEM, V284, P24848, DOI 10.1074/jbc.M109.035444; Dao P, 2011, BIOINFORMATICS, V27, pI205, DOI 10.1093/bioinformatics/btr245; De Giorgi V, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-85; Deguchi Matsuo, 2002, Kansenshogaku Zasshi, V76, P711; Douard C, 2009, FASEB J OFF PUBL FED, V23, P3780; Dutta B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10578; Garcia M, 2012, BIOINFORMATICS, V28, P672, DOI 10.1093/bioinformatics/bts025; Gitter A, 2013, BIOINFORMATICS, V29, P227, DOI 10.1093/bioinformatics/btt241; Goktug AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049386; Gonzalez O, 2011, BIOINFORMATICS, V27, P2707, DOI 10.1093/bioinformatics/btr469; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Gu J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-47; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Kandasamy K, 2009, NUCLEIC ACIDS RES, V37, pD773, DOI 10.1093/nar/gkn701; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Lu H, 2004, J PROTEOME RES, V3, P949, DOI 10.1021/pr0499592; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860; Mohr SE, 2012, WIRES RNA, V3, P145, DOI 10.1002/wrna.110; Mpindi J- P, 2015, BIOINFORMA OXF ENGL; Murali TM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002164; Mysickova A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S2; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Ochs Michael F, 2007, Methods Mol Biol, V377, P243; Portales-Casamar E, 2009, NUCLEIC ACIDS RES, V37, pD54, DOI 10.1093/nar/gkn783; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taguwa S, 2008, J VIROL, V82, P2631, DOI 10.1128/JVI.02153-07; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tuncbag N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004879; Vizan P, 2015, FEBS J, V282, P1723, DOI 10.1111/febs.13083; Wang L, 2009, BMC GENOMICS, V10, DOI [10.1186/1471-2164-10-220, 10.1186/1471-2164-10-S1-S1]; Wilson JL, 2016, INTEGR BIOL-UK, V8, P761, DOI 10.1039/c6ib00040a; Wolf J, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3576; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595; Zhang XHD, 2006, PHARMACOGENOMICS, V7, P299, DOI 10.2217/14622416.7.3.299; Zhang XD, 2007, GENOMICS, V89, P552, DOI 10.1016/j.ygeno.2006.12.014; Zheng GY, 2008, BIOINFORMATICS, V24, P2416, DOI 10.1093/bioinformatics/btn439	51	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185400	10.1371/journal.pone.0185400	http://dx.doi.org/10.1371/journal.pone.0185400			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949986	Green Submitted, Green Published, gold			2022-12-27	WOS:000411671000049
J	Labiran, C; Rowen, D; Clarke, IN; Marsh, P				Labiran, Clare; Rowen, David; Clarke, Ian Nicholas; Marsh, Peter			Detailed molecular epidemiology of Chlamydia trachomatis in the population of Southampton attending the genitourinary medicine clinic in 2012-13 reveals the presence of long established genotypes and transitory sexual networks	PLOS ONE			English	Article							STRAINS; CLUSTERS; MEN	Chlamydia trachomatis is the most common sexually transmitted infection (STI) in England. Our objective was to perform a detailed survey of the molecular epidemiology of C. trachomatis in the population of Southampton UK attending the genitourinary medicine clinic (GUM) to seek evidence of sexual network activity. Our hypothesis was that certain genotypes can be associated with specific demographic determinants. 380 positive samples were collected from 375 C. trachomatis positive GUM attendees out of the 3118 who consented to be part of the survey. 302 of the positive samples were fully genotyped. All six of the predominant genotypes possessed ompA locus type E. One ward of Southampton known to contain a large proportion of students had a different profile of genotypes compared to other areas of the city. Some genotypes appeared embedded in the city population whilst others appeared transient. Predominant circulating genotypes remain stable within a city population whereas others are sporadic. Sexual networks could be inferred but not conclusively identified using the data from this survey.	[Labiran, Clare; Clarke, Ian Nicholas] Univ Southampton, Fac Med, Mol Microbiol, Clin & Expt Sci, Southampton, Hants, England; [Rowen, David] Royal South Hants Hosp, Dept GU Med, Southampton, Hants, England; [Marsh, Peter] Southampton Gen Hosp, Publ Hlth England, Publ Hlth Lab Southampton, Southampton, Hants, England	University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Royal South Hants Hospital; Public Health England; University of Southampton	Marsh, P (corresponding author), Southampton Gen Hosp, Publ Hlth England, Publ Hlth Lab Southampton, Southampton, Hants, England.	Peter.Marsh@suht.swest.nhs.uk		Marsh, Peter/0000-0001-7073-7268; Clarke, Ian/0000-0002-4938-1620	Health Protection Agency PhD fund [2010/001]	Health Protection Agency PhD fund	This work was funded by the Health Protection Agency PhD fund in 2010, reference number 2010/001.	Batteiger BE, 2010, J INFECT DIS, V201, P42, DOI 10.1086/648734; Bom RJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053869; Bom RJM, 2011, J CLIN MICROBIOL, V49, P2844, DOI 10.1128/JCM.00128-11; Christerson L, 2012, J CLIN MICROBIOL, V50, P3548, DOI 10.1128/JCM.01713-12; de Vries HJC, 2015, CURR OPIN INFECT DIS, V28, P61, DOI 10.1097/QCO.0000000000000129; DEAN D, 1995, J INFECT DIS, V172, P1013, DOI 10.1093/infdis/172.4.1013; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Vaulet LG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153511; Geisler WM, 2006, SEX TRANSM DIS, V33, P621, DOI 10.1097/01.olq.0000216027.71144.74; Gharsallah H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-333; Harris SR, 2012, NATURE GENETICS; Herrmann B, 2015, J CLIN MICROBIOL, V53, P2172, DOI 10.1128/JCM.00249-15; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jurstrand M, 2001, J CLIN MICROBIOL, V39, P3915, DOI 10.1128/JCM.39.11.3915-3919.2001; Klint M, 2007, J CLIN MICROBIOL, V45, P1410, DOI 10.1128/JCM.02301-06; Labiran C, 2016, SEX TRANSM INFECT, V92, P299, DOI 10.1136/sextrans-2015-052261; Labiran C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00068; Martin IMC, 2004, J INFECT DIS, V189, P1497, DOI 10.1086/383047; Moslonka-Lefebvre M, 2012, J THEOR BIOL, V311, P46, DOI 10.1016/j.jtbi.2012.06.031; OfNSd, 2001, PORTSW WARD NAT STAT; ONS, 2014, CONC STAT ENG WAL; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Pedersen LN, 2008, CLIN MICROBIOL INFEC, V14, P644, DOI 10.1111/j.1469-0691.2008.02011.x; Peuchant O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031538; PHE, 2016, HLTH PROTECTION REPO, V10; Qin X, 2016, PLOS ONE, V11; Ripa T, 2007, SEX TRANSM DIS, V34, P255, DOI 10.1097/OLQ.0b013e31805ce2b9; Satoh M, 2014, J INFECT CHEMOTHER, V20, P656, DOI 10.1016/j.jiac.2014.06.010; UCdd, 2011, UK CENS DAT PORTSW 2; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016971	30	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9								10.1371/journal.pone.0185059	http://dx.doi.org/10.1371/journal.pone.0185059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945766	Green Published, Green Accepted, gold			2022-12-27	WOS:000411645100018
J	Sarabdjitsingh, RA; Loi, M; Joels, M; Dijkhuizen, RM; van der Toorn, A				Sarabdjitsingh, R. Angela; Loi, Manila; Joels, Marian; Dijkhuizen, Rick M.; van der Toorn, Annette			Early life stress-induced alterations in rat brain structures measured with high resolution MRI	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; HIPPOCAMPAL VOLUME; MATTER VOLUME; WHITE-MATTER; MAJOR DEPRESSION; CHILDHOOD TRAUMA; SEXUAL-ABUSE; DISORDER; MALTREATMENT; BEHAVIOR	Adverse experiences early in life impair cognitive function both in rodents and humans. In humans this increases the vulnerability to develop mental illnesses while in the rodent brain early life stress (ELS) abnormalities are associated with changes in synaptic plasticity, excitability and microstructure. Detailed information on the effects of ELS on rodent brain structural integrity at large and connectivity within the brain is currently lacking; this information is highly relevant for understanding the mechanism by which early life stress predisposes to mental illnesses. Here, we exposed rats to 24 hours of maternal deprivation (MD) at postnatal day 3, a paradigm known to increase corticosterone levels and thereby activate glucocorticoid receptors in the brain. Using structural magnetic resonance imaging we examined: i) volumetric changes and white/grey matter properties of the whole cerebrum and of specific brain areas; and ii) whether potential alterations could be normalized by blocking glucocorticoid receptors with mifepristone during the critical developmental window of early adolescence, i.e. between postnatal days 26 and 28. The results show that MD caused a volumetric reduction of the prefrontal cortex, particularly the ventromedial part, and the orbitofrontal cortex. Within the whole cerebrum, white (relative to grey) matter volume was decreased and region-specifically in prefrontal cortex and dorsomedial striatum following MD. A trend was found for the hippocampus. Grey matter fractions were not affected. Treatment with mifepristone did not normalize these changes. This study indicates that early life stress in rodents has long lasting consequences for the volume and structural integrity of the brain. However, changes were relatively modest and-unlike behavior-not mitigated by blockade of glucocorticoid receptors during a critical developmental period.	[Sarabdjitsingh, R. Angela; Loi, Manila; Joels, Marian] Univ Utrecht, Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands; [Joels, Marian] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Dijkhuizen, Rick M.; van der Toorn, Annette] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Images Sci, Biomed MR Imaging & Spect Grp, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Groningen; Utrecht University; Utrecht University Medical Center	Sarabdjitsingh, RA (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands.	r.a.sarabdjitsingh@umcutrecht.nl	Joëls, Marian/P-6415-2016	Joels, Marian/0000-0002-4826-6209; Dijkhuizen, Rick/0000-0002-4623-4078	Netherlands Organization for Scientific Research with Veni [863.13.021, 024.001.003]	Netherlands Organization for Scientific Research with Veni	This work was supported by the Netherlands Organization for Scientific Research with Veni grant 863.13.021 to RAS, Gravitation grant 024.001.003 to MJ (www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admon R, 2013, HUM BRAIN MAPP, V34, P2808, DOI 10.1002/hbm.22100; Andersen SL, 2008, J NEUROPSYCH CLIN N, V20, P292, DOI 10.1176/appi.neuropsych.20.3.292; Ansell EB, 2012, BIOL PSYCHIAT, V72, P57, DOI 10.1016/j.biopsych.2011.11.022; Arp JM, 2016, NEUROBIOL LEARN MEM, V133, P30, DOI 10.1016/j.nlm.2016.05.009; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Brunson KL, 2005, J NEUROSCI, V25, P9328, DOI 10.1523/JNEUROSCI.2281-05.2005; Carrion VG, 2001, BIOL PSYCHIAT, V50, P943, DOI 10.1016/S0006-3223(01)01218-5; Cirulli F, 2003, NEUROSCI BIOBEHAV R, V27, P73, DOI 10.1016/S0149-7634(03)00010-1; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; De Bellis MD, 2002, BIOL PSYCHIAT, V52, P1066, DOI 10.1016/S0006-3223(02)01459-2; Palacios RDY, 2011, BIOL PSYCHIAT, V70, P449, DOI 10.1016/j.biopsych.2011.05.014; Fan Y, 2015, NEUROPSYCHOPHARMACOL, V40, P2736, DOI 10.1038/npp.2015.123; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Flores BH, 2006, NEUROPSYCHOPHARMACOL, V31, P628, DOI 10.1038/sj.npp.1300884; Frodl T, 2010, J PSYCHIATR RES, V44, P799, DOI 10.1016/j.jpsychires.2010.01.006; Gorka AX, 2014, BIOL MOOD ANXIETY DI, V4, DOI 10.1186/2045-5380-4-12; Halligan SL, 2007, BIOL PSYCHIAT, V62, P40, DOI 10.1016/j.biopsych.2006.09.011; Hanson JL, 2015, BIOL PSYCHIAT, V77, P314, DOI 10.1016/j.biopsych.2014.04.020; Hanson JL, 2013, CHILD DEV, V84, P1566, DOI 10.1111/cdev.12069; Hedges DW, 2011, PSYCHOPHARMACOLOGY, V214, P121, DOI 10.1007/s00213-010-2090-6; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Henckens MJAG, 2015, NEUROIMAGE, V105, P312, DOI 10.1016/j.neuroimage.2014.10.037; Herpfer I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046004; Martinez-Tellez RI, 2009, SYNAPSE, V63, P794, DOI 10.1002/syn.20664; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Koolschijn PCMP, 2013, EUR NEUROPSYCHOPHARM, V23, P622, DOI 10.1016/j.euroneuro.2012.07.001; Leao P, 2007, SYNAPSE, V61, P40, DOI 10.1002/syn.20341; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Maras PM, 2012, TRENDS NEUROSCI, V35, P315, DOI 10.1016/j.tins.2012.01.005; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; Mehta MA, 2009, J CHILD PSYCHOL PSYC, V50, P943, DOI 10.1111/j.1469-7610.2009.02084.x; Molet J, 2016, HIPPOCAMPUS, V26, P1618, DOI 10.1002/hipo.22661; Naninck EFG, 2015, HIPPOCAMPUS, V25, P309, DOI 10.1002/hipo.22374; Nishi M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00166; Oomen CA, 2007, EUR J NEUROSCI, V26, P3395, DOI 10.1111/j.1460-9568.2007.05972.x; Oomen CA, 2011, PSYCHOPHARMACOLOGY, V214, P249, DOI 10.1007/s00213-010-1922-8; Oomen CA, 2010, J NEUROSCI, V30, P6635, DOI 10.1523/JNEUROSCI.0247-10.2010; Oomen CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003675; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Rao U, 2010, BIOL PSYCHIAT, V67, P357, DOI 10.1016/j.biopsych.2009.10.017; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Tse YC, 2014, HIPPOCAMPUS, V24, P1120, DOI 10.1002/hipo.22296; Tsoory M, 2006, INT J NEUROPSYCHOPH, V9, P713, DOI 10.1017/S1461145705006255; van Harmelen AL, 2010, BIOL PSYCHIAT, V68, P832, DOI 10.1016/j.biopsych.2010.06.011; Villarreal G, 2002, BIOL PSYCHIAT, V52, P119, DOI 10.1016/S0006-3223(02)01359-8; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Vyas A, 2002, J NEUROSCI, V22, P6810; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Walsh ND, 2014, NEUROIMAGE-CLIN, V4, P308, DOI 10.1016/j.nicl.2014.01.001; Weinberg MS, 2010, NEUROSCIENCE, V168, P744, DOI 10.1016/j.neuroscience.2010.04.006; Wellman CL, 2001, J NEUROBIOL, V49, P245, DOI 10.1002/neu.1079; Whittle S, 2011, DEV PSYCHOPATHOL, V23, P115, DOI 10.1017/S0954579410000684; Yan CG, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.276; Young AH, 2004, NEUROPSYCHOPHARMACOL, V29, P1538, DOI 10.1038/sj.npp.1300471; Zhang LX, 2002, DEV BRAIN RES, V133, P1, DOI 10.1016/S0926-6410(01)00118-5	61	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185061	10.1371/journal.pone.0185061	http://dx.doi.org/10.1371/journal.pone.0185061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI0UK	28945761	Green Published, gold, Green Submitted			2022-12-27	WOS:000411645100019
J	Lager, M; Faller, M; Wilhelmsson, P; Kjelland, V; Andreassen, A; Dargis, R; Quarsten, H; Dessau, R; Fingerle, V; Margos, G; Noraas, S; Ornstein, K; Petersson, AC; Matussek, A; Lindgren, PE; Henningsson, AJ				Lager, Malin; Faller, Maximilian; Wilhelmsson, Peter; Kjelland, Vivian; Andreassen, Ashild; Dargis, Rimtas; Quarsten, Hanne; Dessau, Ram; Fingerle, Volker; Margos, Gabriele; Noraas, Solvi; Ornstein, Katharina; Petersson, Ann-Cathrine; Matussek, Andreas; Lindgren, Per-Eric; Henningsson, Anna J.			Molecular detection of Borrelia burgdorferi sensu lato - An analytical comparison of real-time PCR protocols from five different Scandinavian laboratories	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; LYME-BORRELIOSIS; ERYTHEMA MIGRANS; DIAGNOSIS; NEUROBORRELIOSIS; DISEASE; CULTIVATION; INFECTIONS; MANAGEMENT; SWEDEN	Introduction Lyme borreliosis (LB) is the most common tick transmitted disease in Europe. The diagnosis of LB today is based on the patient A s medical history, clinical presentation and laboratory findings. The laboratory diagnostics are mainly based on antibody detection, but in certain conditions molecular detection by polymerase chain reaction (PCR) may serve as a complement. Aim The purpose of this study was to evaluate the analytical sensitivity, analytical specificity and concordance of eight different real-time PCR methods at five laboratories in Sweden, Norway and Denmark. Method Each participating laboratory was asked to analyse three different sets of samples (reference panels; all blinded) i) cDNA extracted and transcribed from water spiked with cultured Borrelia strains, ii) cerebrospinal fluid spiked with cultured Borrelia strains, and iii) DNA dilution series extracted from cultured Borrelia and relapsing fever strains. The results and the method descriptions of each laboratory were systematically evaluated. Results and conclusions The analytical sensitivities and the concordance between the eight protocols were in general high. The concordance was especially high between the protocols using 16S rRNA as the target gene, however, this concordance was mainly related to cDNA as the type of template. When comparing cDNA and DNA as the type of template the analytical sensitivity was in general higher for the protocols using DNA as template regardless of the use of target gene. The analytical specificity for all eight protocols was high. However, some protocols were not able to detect Borrelia spielmanii, Borrelia lusitaniae or Borrelia japonica.	[Lager, Malin] Reg Jonkoping Cty, Lab Med, Jonkoping, Sweden; [Lager, Malin; Wilhelmsson, Peter; Lindgren, Per-Eric] Linkoping Univ, Div Med Microbiol, Dept Clin & Expt Med, Linkoping, Sweden; [Faller, Maximilian; Fingerle, Volker; Margos, Gabriele] German Natl Reference Ctr Borrelia, Bavarian Hlth & Food Safety Author, Oberschleissheim, Germany; [Wilhelmsson, Peter; Matussek, Andreas; Lindgren, Per-Eric; Henningsson, Anna J.] Reg Jonkoping Cty, Lab Med, Clin Microbiol, Jonkoping, Sweden; [Kjelland, Vivian] Univ Agder, Fac Sci & Engn, Dept Nat Sci, Kristiansand, Norway; [Kjelland, Vivian] Hosp Southern Norway Trust, Res Unit, Kristiansand, Norway; [Andreassen, Ashild] Norwegian Inst Publ Hlth, Div Infect Dis Control, Dept Virol, Oslo, Norway; [Dargis, Rimtas; Dessau, Ram] Slagelse Hosp, Dept Clin Microbiol, Slagelse, Denmark; [Quarsten, Hanne; Noraas, Solvi] Hosp Southern Norway Trust, Dept Med Microbiol, Kristiansand, Norway; [Ornstein, Katharina] Skanevard Kryh, Div Med, Kristianstad, Sweden; [Petersson, Ann-Cathrine] Dept Clin Microbiol, Div Lab Med, Lund, Sweden; [Matussek, Andreas] Karolinska Univ Lab, Stockholm, Sweden; [Matussek, Andreas] Karolinska Inst, Karolinska Univ Hosp Huddinge, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden	Linkoping University; Bavarian Health & Food Safety Authority; University of Agder; Norwegian Institute of Public Health (NIPH); Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Lager, M (corresponding author), Reg Jonkoping Cty, Lab Med, Jonkoping, Sweden.; Lager, M (corresponding author), Linkoping Univ, Div Med Microbiol, Dept Clin & Expt Med, Linkoping, Sweden.	malin.lager@rjl.se	Matussek, Andreas/AAB-3629-2021	MARGOS, Gabriele/0000-0001-5304-9615; Dessau, Ram/0000-0002-1497-6309; Wilhelmsson, Peter/0000-0002-9200-2964	Futurum Academy for Healthcare; Region Jonkoping County; Division of Medical Diagnostics; Region of Jonkoping County; Interreg IVA Program ScandTick [167226]; Interreg V program ScandTick Innovation [20200422, 2015-000167]; NSTAND [PN 13-28]	Futurum Academy for Healthcare; Region Jonkoping County; Division of Medical Diagnostics; Region of Jonkoping County; Interreg IVA Program ScandTick; Interreg V program ScandTick Innovation; NSTAND	Part of this work has received financial support from Futurum Academy for Healthcare, Region Jonkoping County, Division of Medical Diagnostics, Region of Jonkoping County, Interreg IVA Program ScandTick (grant no. 167226), Interreg V program ScandTick Innovation t (project ID. 20200422, reference no. 2015-000167) and NSTAND (PN 13-28). Founders had no role in the study design, data collection, analysis and interpretation of data, writing and preparation of the report and in decision to submit the article for publication.	Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BERGLUND J, 1995, NEW ENGL J MED, V333, P1319, DOI 10.1056/NEJM199511163332004; Cerar T, 2008, J CLIN MICROBIOL, V46, P3375, DOI 10.1128/JCM.00410-08; de Leeuw BHCGM, 2014, J MICROBIOL METH, V107, P41, DOI 10.1016/j.mimet.2014.09.001; Dessau RB, 2011, REPORT SURVEY LAB ME; Fingerle V, 2008, INT J MED MICROBIOL, V298, P279, DOI 10.1016/j.ijmm.2007.05.002; Fryland L, 2011, INT J INFECT DIS, V15, pE174, DOI 10.1016/j.ijid.2010.10.006; GOLIGHTLY MG, 1993, AM J CLIN PATHOL, V99, P168, DOI 10.1093/ajcp/99.2.168; Gooskens J, 2006, CLIN MICROBIOL INFEC, V12, P894, DOI 10.1111/j.1469-0691.2006.01509.x; HAMMERSBERGGREN S, 1993, NEUROLOGY, V43, P169, DOI 10.1212/WNL.43.1_Part_1.169; Jenkins A, 2012, EXP APPL ACAROL, V58, P431, DOI 10.1007/s10493-012-9585-2; Lebech AM, 2000, MOL DIAGN, V5, P139, DOI 10.1016/S1084-8592(00)80031-4; Li X, 2011, ARTHRITIS RHEUM-US, V63, P2238, DOI 10.1002/art.30384; MAGNARELLI LA, 1987, J INFECT DIS, V156, P183, DOI 10.1093/infdis/156.1.183; Mantke OD, 2007, J CLIN VIROL, V38, P73, DOI 10.1016/j.jcv.2006.09.001; Margos G, 2015, TICKS TICK-BORNE DIS, V6, P181, DOI 10.1016/j.ttbdis.2014.12.001; Mygland A, 2010, EUR J NEUROL, V17, P8, DOI 10.1111/j.1468-1331.2009.02862.x; Nolte Oliver, 2012, Open Neurol J, V6, P129, DOI 10.2174/1874205X01206010129; Ornstein K, 2006, VECTOR-BORNE ZOONOT, V6, P103, DOI 10.1089/vbz.2006.6.103; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; PERSING DH, 1994, J INFECT DIS, V169, P668, DOI 10.1093/infdis/169.3.668; Rettinger A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-185; Schmidt BL, 1997, CLIN MICROBIOL REV, V10, P185, DOI 10.1128/CMR.10.1.185; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P69, DOI 10.1111/j.1469-0691.2010.03175.x; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Tjernberg I, 2007, EUR J CLIN MICROBIOL, V26, P37, DOI 10.1007/s10096-006-0239-3; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Wilhelmsson P, 2010, J CLIN MICROBIOL, V48, P4169, DOI 10.1128/JCM.01061-10; Wilking H, 2015, EMERG INFECT DIS, V21, P107, DOI 10.3201/eid2101.140009	30	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185434	10.1371/journal.pone.0185434	http://dx.doi.org/10.1371/journal.pone.0185434			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28937997	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000411524700034
J	Prajzlerova, K; Grobelna, K; Husakova, M; Forejtova, S; Jungel, A; Gay, S; Vencovsky, J; Pavelka, K; Senolt, L; Filkova, M				Prajzlerova, Klara; Grobelna, Kristyna; Husakova, Marketa; Forejtova, Sarka; Juengel, Astrid; Gay, Steffen; Vencovsky, Jiri; Pavelka, Karel; Senolt, Ladislav; Filkova, Maria			Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis	PLOS ONE			English	Article							SOCIETY CLASSIFICATION CRITERIA; DISEASE-ACTIVITY; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; ANKYLOSING-SPONDYLITIS; BONE-FORMATION; EXPRESSION; MICRORNAS; BIOMARKERS; ARTHRITIS	Objectives Dysregulation of miRNAs and their target genes contributes to the pathophysiology of autoimmune diseases. Circulating miRNAs may serve as diagnostic/prognostic biomarkers. We aimed to investigate the association between circulating miRNAs, disease activity and spinal involvement in patients with axial spondyloarthritis (AxSpA). Methods Total RNA was isolated from the plasma of patients with non-radiographic (nr) AxSpA, patients with ankylosing spondylitis (AS) and healthy controls (HC) via phenol-chloroform extraction. A total of 760 miRNAs were analysed with TaqMan (R) Low Density Arrays, and the expression of 21 miRNAs was assessed using single assays. Results Comprehensive analysis demonstrated the differential expression of miRNAs among patients with progressive spinal disease. Of the 21 miRNAs selected according to their expression patterns, the levels of miR-625-3p were significantly different between nr-AxSpA patients and HCs. We found no correlation between miRNA levels and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in nr-AxSpA patients. Selected miRNAs, such as miR-29a-3p, miR-146a-5p or miR-222-3p with an established role in extracellular matrix formation and inflammation were associated with spinal changes and/or disease activity assessed by BASDAI in AS patients, including miR-625-3p reflecting disease activity in AS with spinal involvement. Conclusions Our data indicate that circulating miRNAs play a role in the pathogenesis of AxSpA and are also suggestive of their potential as biomarkers of disease progression. We hypothesize that differential systemic levels of miRNA expression reflect miRNA dysregulation at sites of spinal inflammation or bone formation where these molecules contribute to the development of pathophysiological features typical of AxSpA.	[Prajzlerova, Klara; Grobelna, Kristyna; Husakova, Marketa; Forejtova, Sarka; Vencovsky, Jiri; Pavelka, Karel; Senolt, Ladislav; Filkova, Maria] Charles Univ Prague, Fac Med 1, Inst Rheumatol, Prague, Czech Republic; [Prajzlerova, Klara; Grobelna, Kristyna; Husakova, Marketa; Forejtova, Sarka; Vencovsky, Jiri; Pavelka, Karel; Senolt, Ladislav; Filkova, Maria] Charles Univ Prague, Fac Med 1, Dept Rheumatol, Prague, Czech Republic; [Juengel, Astrid; Gay, Steffen] Univ Hosp Zurich, Ctr Expt Rheumatol, Zurich, Switzerland	Charles University Prague; Institute of Rheumatology; Charles University Prague; University of Zurich; University Zurich Hospital	Prajzlerova, K (corresponding author), Charles Univ Prague, Fac Med 1, Inst Rheumatol, Prague, Czech Republic.; Prajzlerova, K (corresponding author), Charles Univ Prague, Fac Med 1, Dept Rheumatol, Prague, Czech Republic.	prajzierova@revma.cz	Pavelka, Karel/E-6578-2017; Bubova, Kristyna/AAD-2275-2019; Vencovsky, Jiri/G-6094-2017; Husakova, Marketa/C-6687-2019; Filkova, Maria/M-9307-2017	Pavelka, Karel/0000-0003-1952-8422; Bubova, Kristyna/0000-0002-4903-1022; Vencovsky, Jiri/0000-0002-0851-0713; Husakova, Marketa/0000-0002-6867-4373; Filkova, Maria/0000-0002-8488-9227	Ministry of Health of the Czech Republic for conceptual research development [023728, 17-33127A]	Ministry of Health of the Czech Republic for conceptual research development	This work was financially supported by a project of the Ministry of Health of the Czech Republic for conceptual research development number 023728 and grant project 17-33127A. There is no financial support or other benefits from commercial sources for the work reported on in the manuscript.	Azevedo VF, 2013, RHEUMATOL INT, V33, P1779, DOI 10.1007/s00296-012-2631-x; Braun J, 2011, ANN RHEUM DIS, V70, P896, DOI 10.1136/ard.2011.151027; Braun J, 2002, ANN RHEUM DIS     S3, V61, piii9; Cai JC, 2013, J CLIN INVEST, V123, P566, DOI 10.1172/JCI65871; Carlsen AL, 2013, ARTHRITIS RHEUM-US, V65, P1324, DOI 10.1002/art.37890; Castro-Villegas C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0555-z; de la Rica L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0561-5; Dougados M, 2011, LANCET, V377, P2127, DOI 10.1016/S0140-6736(11)60071-8; Filkova M, 2014, ANN RHEUM DIS, V73, P1898, DOI 10.1136/annrheumdis-2012-202815; Filkova M, 2012, BIODRUGS, V26, P131, DOI 10.2165/11631480-000000000-00000; Fukuda T, 2015, FEBS LETT, V589, P3302, DOI 10.1016/j.febslet.2015.09.024; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hong Z, 2015, MEDIAT INFLAMM, V2015; Huang JX, 2014, MOD RHEUMATOL, V24, P331, DOI 10.3109/14397595.2013.854077; Landskroner-Eiger S, 2015, P NATL ACAD SCI USA, V112, P12812, DOI 10.1073/pnas.1507094112; Le LT, 2015, J MOL MED; Li HL, 2013, STEM CELL RES, V10, P313, DOI 10.1016/j.scr.2012.11.007; Lories RJU, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2642; Lv Q, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/504208; M'Baya-Moutoula E, 2015, BBA-MOL BASIS DIS, V1852, P2202, DOI 10.1016/j.bbadis.2015.08.003; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Nakasa T, 2011, ARTHRITIS RHEUM-US, V63, P1582, DOI 10.1002/art.30321; NODA M, 1989, ENDOCRINOLOGY, V124, P2991, DOI 10.1210/endo-124-6-2991; Peng JS, 2016, ARTHRITIS RHEUMATOL, V68, P370, DOI 10.1002/art.39446; Prajzlerova K, 2016, AUTOIMMUN REV, V15, P501, DOI 10.1016/j.autrev.2016.02.002; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P770, DOI 10.1136/ard.2009.108217; Sieper J, 2008, ARTHRITIS RHEUM-US, V58, P649, DOI 10.1002/art.23260; Sieper J, 2013, ANN RHEUM DIS, V72, P815, DOI 10.1136/annrheumdis-2012-201766; Song J, 2015, BBA CLIN, V3, P79, DOI 10.1016/j.bbacli.2014.11.009; Wang T, 2010, BIOCHEM BIOPH RES CO, V402, P186, DOI 10.1016/j.bbrc.2010.08.031; Xie Y, 2015, MOLECULES, V20, P19433, DOI 10.3390/molecules201019433; Xu HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124425; Yu FC, 2011, BIOSCI TRENDS, V5, P46, DOI 10.5582/bst.2011.v5.2.46; Zhao WG, 2015, INT J MOL SCI, V16, P11699, DOI 10.3390/ijms160511699	38	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185323	10.1371/journal.pone.0185323	http://dx.doi.org/10.1371/journal.pone.0185323			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938006	gold, Green Published, Green Accepted			2022-12-27	WOS:000411524700026
J	Rocheleau, G; Franco-Villalobos, C; Oliveira, N; Brumme, ZL; Rusch, M; Shoveller, J; Brumme, CJ; Harrigan, PR				Rocheleau, Genevieve; Franco-Villalobos, Conrado; Oliveira, Natalia; Brumme, Zabrina L.; Rusch, Melanie; Shoveller, Jeannie; Brumme, Chanson J.; Harrigan, P. Richard			Sociodemographic correlates of HIV drug resistance and access to drug resistance testing in British Columbia, Canada	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; RISK-FACTORS; ADHERENCE; HEALTH; TUBERCULOSIS; CARE; PREDICTORS; MUTATIONS; RESPONSES	Sociodemographic correlates of engagement in human immunodeficiency virus (HIV) care are well studied, however the association with accessing drug resistance testing (DRT) and the development of drug resistance have not been characterized. Between 1996 - 2014, 11 801 HIV patients accessing therapy in British Columbia were observed longitudinally. A subset of 9456 patients had testable viral load; of these 8398 were linked to census data. Sociodemographic (census tract-level) and clinical (individual-level) correlates of DRT were assessed using multivariable General Estimating Equation logistic regression adjusted odds ratios (aOR). The mean number of tests per patient was 2.1 (Q1-Q3; 0-3). Separately, any drug resistance was determined using IAS-USA (2013) list for 5703 initially treatment naive patients without baseline resistance; 5175 were census-linked (mean of 1.5 protease-reverse transcriptase sequences/patient, Q1-Q3; 0-2). Correlates of detecting drug resistance in this subset were analyzed using Cox PH regression adjusted hazard ratios (aHR). Our results indicate baseline CD4 < 200 cells/L (aOR: 1.5, 1.3-1.6), nRTIonly baseline regimens (aOR: 1.4, 1.3 -1.6), and unknown (therapy initiation before routine pVL in BC) baseline pVL (aOR: 1.8, 1.5 - 2.1) were among individual-level clinical covariates strongly associated with having accessed DRT; while imperfect adherence (aHR: 2.2, 1.9- 2.5), low baseline CD4 count (aHR: 1.9, 1.6 -2.3), and high baseline pVL (aHR: 2.0, 1.6 - 2.6) were associated with a higher likelihood of developing drug resistance. A higher median income (aOR: 0.83, 0.77 - 0.89) and higher percentage of those with aboriginal ancestry (aOR: 0.85, 0.76 - 0.95) were census tract-level sociodemographic covariates associated with decreased access to DRT. Similarly, aboriginal ancestry (aHR: 1.2, 1.1 - 1.5) was associated with development of drug resistance. In conclusion, clinical covariates continue to be the strongest correlates of development of drug resistance and access to DRT for individuals. Regions of high median income and high aboriginal ancestry were weak census-level sociodemographic indicators of reduced DRT uptake, however high aboriginal ancestry was the only sociodemographic indicator for development of drug resistance.	[Rocheleau, Genevieve; Harrigan, P. Richard] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Rocheleau, Genevieve; Franco-Villalobos, Conrado; Oliveira, Natalia; Brumme, Zabrina L.; Shoveller, Jeannie; Brumme, Chanson J.; Harrigan, P. Richard] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Brumme, Zabrina L.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Rusch, Melanie] Vancouver Isl Hlth Author, Victoria, BC, Canada; [Shoveller, Jeannie] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada	University of British Columbia; B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; Vancouver Island Health Authority; University of British Columbia	Harrigan, PR (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.; Harrigan, PR (corresponding author), BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	prharrigan@cfenet.ubc.ca		Brumme, Chanson/0000-0003-2722-5288; Rocheleau, Genevieve/0000-0003-4347-8015; Brumme, Zabrina/0000-0002-8157-1037	Providence Health Care; Genome BC; Genome Canada; Genome Quebec; Canadian Institutes of Health Research; Partnership in Genomics and Personalized Health [HIV142]; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research Postdoctoral Fellowship [MFE-146750]	Providence Health Care; Genome BC; Genome Canada(Genome Canada); Genome Quebec; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Partnership in Genomics and Personalized Health; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR))	This work received support from Providence Health Care (http://www.providencehealthcare.org/) for providing operational funding; Genome BC (https://www.genomebc.ca/), Genome Canada (https://www.genomecanada.ca/), Genome Quebec (http://www.genomequebec.com/en/home.html), and Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) Partnership in Genomics and Personalized Health provided a Large-Scale Applied Research Project HIV142 contract to RH; the Scholar Award from Michael Smith Foundation for Health Research (http://www.msfhr.org/our-work/activities/scholar-awards) for salary support provided to ZB; and the Canadian Institutes of Health Research Postdoctoral Fellowship (http://www.cihr-irsc.gc.ca/e/44244.html) for stipend support provided to CB (MFE-146750).	Alexander CS, 2001, AIDS, V15, P601, DOI 10.1097/00002030-200103300-00009; Barroso Elizabeth Clara, 2003, J. Pneumologia, V29, P89, DOI 10.1590/S0102-35862003000200008; Baxter JD, 2000, AIDS, V14, pF83, DOI 10.1097/00002030-200006160-00001; Bolsewicz K, 2015, AIDS CARE, V27, P570, DOI 10.1080/09540121.2014.986050; British Columbia Center for Excellence in HIV/AIDS, 2015, PRIM CAR GUID MAN HI; British Columbia Centre for Excellence in HIV/AIDS, 2006, THER GUID ANT THER H; British Columbia Centre for Excellence in HIV/AIDS, 1999, THER GUID TREATM HIV; Brumme C, 2017, CLIN MICROBIOL INFEC; Chambers LA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2197-0; Cunningham CO, 2007, AIDS PATIENT CARE ST, V21, P177, DOI 10.1089/apc.2006.103; DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents Office of AIDS Research Advisory Council (OARAC), 2016, GUID US ANT AG HIV 1; DiNenno E., 2015, COMMUNITIES CRISIS I; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; *GEN COD CORP, SEQ VERS 5 4 6 DNA S; Giordano TP, 2010, TOP ANTIVIR MED, V19, P12; Godin G, 2005, AIDS CARE, V17, P493, DOI 10.1080/09540120412331291715; Gordillo V, 1999, AIDS, V13, P1763, DOI 10.1097/00002030-199909100-00021; Gwadz M, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00062; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Harrigan PR, 1999, AIDS, V13, P1863, DOI 10.1097/00002030-199910010-00008; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Joy R, 2008, JAIDS-J ACQ IMM DEF, V47, P500, DOI 10.1097/QAI.0b013e3181648dfd; Kinsler JJ, 2007, AIDS PATIENT CARE ST, V21, P584, DOI 10.1089/apc.2006.0202; Leaver CA, 2007, AIDS BEHAV, V11, pS85, DOI 10.1007/s10461-007-9246-3; Long C, 2014, INT J DRUG POLICY, V25, P458, DOI 10.1016/j.drugpo.2013.11.011; Low-Beer S, 2000, J ACQ IMMUN DEF SYND, V23, P360; Miller V, 2000, AIDS, V14, P163, DOI 10.1097/00002030-200001280-00012; Montaner JSG, 2000, J INFECT DIS, V181, P729, DOI 10.1086/315243; Montaner JSG, 2001, AIDS, V15, P61, DOI 10.1097/00002030-200101050-00010; NIH, 2014, GUID US ANT AG HIV 1; Nosyk B, 2014, LANCET INFECT DIS, V14, P40, DOI 10.1016/S1473-3099(13)70254-8; Pande JN, 2005, CHEST, V128, p404S, DOI 10.1378/chest.128.4_MeetingAbstracts.404S-a; R Core Team, 2018, R LANG ENV STAT COMP; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; SAS Institute Inc, 2013, SAS 9 4 SOFTW; Smith WR, 2015, STATCAN BLOG; Statistics Canada, 2011, 2011 CENS AB PEOPL C; Suarez-Garcia I, 2009, EUR J CLIN MICROBIOL, V28, P325, DOI 10.1007/s10096-008-0627-y; Vandenbroucke J.P., 2007, STRENGTHENING REPORT; Walmsley SL, 2001, ANTIVIR THER, V6, P47; Wood E, 2003, CAN MED ASSOC J, V169, P656; Woods CK, 2012, J CLIN MICROBIOL, V50, P1936, DOI 10.1128/JCM.06689-11	44	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							0184848	10.1371/journal.pone.0184848	http://dx.doi.org/10.1371/journal.pone.0184848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH9IR	28937991	Green Published, Green Submitted, gold			2022-12-27	WOS:000411524700011
J	Hodge-Hanson, KM; Downs, DM				Hodge-Hanson, Kelsey M.; Downs, Diana M.			Members of the Rid protein family have broad imine deaminase activity and can accelerate the Pseudomonas aeruginosa D-arginine dehydrogenase (DauA) reaction in vitro	PLOS ONE			English	Article							CONSERVED YJGF FAMILY; SALMONELLA-ENTERICA; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; YJGF/YER057C/UK114 FAMILY; SACCHAROMYCES-CEREVISIAE; ISOLEUCINE BIOSYNTHESIS; UK114; MAINTENANCE; MECHANISM	The Rid (YjgF/YER057c/UK114) protein family is a group of small, sequence diverse proteins that consists of eight subfamilies. The archetypal RidA subfamily is found in all domains, while the Rid1-7 subfamilies are present only in prokaryotes. Bacterial genomes often encode multiple members of the Rid superfamily. The best characterized member of this protein family, RidA from Salmonella enterica, is a deaminase that quenches the reactive metabolite 2-aminoacrylate generated by pyridoxal 5 '-phosphate-dependent enzymes and ultimately spares certain enzymes from damage. The accumulation of 2-aminoacrylate can damage enzymes and lead to growth defects in bacteria, plants, and yeast. While all subfamily members have been annotated as imine deaminases based on the RidA characterization, experimental evidence to support this annotation exists for a single protein outside the RidA subfamily. Here we report that six proteins, spanning Rid subfamilies 1-3, deaminate a variety of imine/enamine substrates with differing specific activities. Proteins from the Rid2 and Rid3 subfamilies, but not from the RidA and Rid1 subfamilies deaminated iminoarginine, generated in situ by the Pseudomonas aeruginosa D-arginine dehydrogenase DauA. These data biochemically distinguished the subfamilies and showed Rid proteins have activity on a metabolite that is physiologically relevant in Pseudomonas and other bacteria.	[Hodge-Hanson, Kelsey M.; Downs, Diana M.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Downs, DM (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	dmdowns@uga.edu			National Institute of General Medical Sciences [R01 GM095837]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095837] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (https.//www.nigms.nih.gov/Pages/default.aspx), grant R01 GM095837 to DMD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi R, 2004, YEAST, V21, P539, DOI 10.1002/yea.1121; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; Borchert AJ, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00140-17; Browne BA, 2006, J BACTERIOL, V188, P6786, DOI 10.1128/JB.00745-06; Burman JD, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-30; Bussolati G, 1997, INT J ONCOL, V10, P779; Ceciliani F, 1996, FEBS LETT, V393, P147, DOI 10.1016/0014-5793(96)00850-2; Chong CL, 2008, CANCER EPIDEM BIOMAR, V17, P535, DOI 10.1158/1055-9965.EPI-07-0506; Christopherson MR, 2008, J BACTERIOL, V190, P3057, DOI 10.1128/JB.01700-07; Deaconescu AM, 2002, PROTEINS, V48, P431, DOI 10.1002/prot.10151; Deriu D, 2003, ACTA CRYSTALLOGR D, V59, P1676, DOI 10.1107/S0907444903014306; Downs DM, 2015, MOL MICROBIOL, V96, P211, DOI 10.1111/mmi.12945; ElRamlawy KG, 2016, J BIOL CHEM, V291, P21607, DOI 10.1074/jbc.M116.728006; Enos-Berlage JL, 1998, J BACTERIOL, V180, P6519, DOI 10.1128/JB.180.24.6519-6528.1998; Ernst DC, 2016, MOL MICROBIOL, V101, P210, DOI 10.1111/mmi.13384; Ernst DC, 2016, J BACTERIOL, V198, P536, DOI 10.1128/JB.00804-15; Ernst DC, 2014, J BACTERIOL, V196, P3335, DOI 10.1128/JB.01960-14; Flynn JM, 2013, MOL MICROBIOL, V89, P751, DOI 10.1111/mmi.12313; Flynn JM, 2013, J BACTERIOL, V195, P3603, DOI 10.1128/JB.00463-13; Galloway NR, 2013, CRYST GROWTH DES, V13, P2833, DOI 10.1021/cg400171z; HAFNER EW, 1979, BIOCHEMISTRY-US, V18, P411, DOI 10.1021/bi00570a004; HILLEBRAND GG, 1979, BIOCHEMISTRY-US, V18, P1751, DOI 10.1021/bi00576a018; JANN A, 1988, J GEN MICROBIOL, V134, P1043; Kim JM, 2001, GENES CELLS, V6, P507, DOI 10.1046/j.1365-2443.2001.00443.x; Lambrecht JA, 2013, MBIO, V4, DOI 10.1128/mBio.00033-13; Lambrecht JA, 2012, J BIOL CHEM, V287, P3454, DOI 10.1074/jbc.M111.304477; Lambrecht JA, 2010, J BIOL CHEM, V285, P34401, DOI 10.1074/jbc.M110.160515; Leitner-Dagan Y, 2006, PLANTA, V225, P89, DOI 10.1007/s00425-006-0332-y; Li C, 2009, P NATL ACAD SCI USA, V106, P906, DOI 10.1073/pnas.0808269106; Manjasetty BA, 2004, PROTEINS, V54, P797, DOI 10.1002/prot.10619; Miyakawa T, 2005, ACTA CRYSTALLOGR F, V61, P828, DOI 10.1107/S1744309105023808; Niehaus TD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1584-3; Niehaus TD, 2014, PLANT CELL, V26, P3010, DOI 10.1105/tpc.114.126854; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Oxelmark E, 2000, MOL CELL BIOL, V20, P7784, DOI 10.1128/MCB.20.20.7784-7797.2000; Parsons L, 2003, BIOCHEMISTRY-US, V42, P80, DOI 10.1021/bi020541w; Racca S, 1997, VIRCHOWS ARCH, V431, P323, DOI 10.1007/s004280050106; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sinha S, 1999, P NATL ACAD SCI USA, V96, P13074, DOI 10.1073/pnas.96.23.13074; VanDrisse CM, 2016, PLASMID, V86, P1, DOI 10.1016/j.plasmid.2016.05.001; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Volz K, 1999, PROTEIN SCI, V8, P2428; WAY JC, 1984, GENE, V32, P369, DOI 10.1016/0378-1119(84)90012-X; Yuan HL, 2011, J AM CHEM SOC, V133, P18957, DOI 10.1021/ja2082729; Yuan H, 2010, BIOCHEMISTRY-US, V49, P9542, DOI 10.1021/bi101420w	45	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185544	10.1371/journal.pone.0185544	http://dx.doi.org/10.1371/journal.pone.0185544			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957411	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200082
J	Modi, HR; Wang, Q; Sahithi, GD; Sherman, D; Greenwald, E; Savonenko, AV; Geocadin, RG; Thakor, NV				Modi, Hiren R.; Wang, Qihong; Sahithi, G. D.; Sherman, David; Greenwald, Elliot; Savonenko, Alena V.; Geocadin, Romergryko G.; Thakor, Nitish V.			Intranasal post-cardiac arrest treatment with orexin-A facilitates arousal from coma and ameliorates neuroinflammation	PLOS ONE			English	Article							TARGETED TEMPERATURE MANAGEMENT; GLOBAL CEREBRAL-ISCHEMIA; THERAPEUTIC HYPOTHERMIA; INFLAMMATORY RESPONSE; QUANTITATIVE EEG; NEURONAL GLYCOCALYX; PARVALBUMIN NEURONS; BRAIN-INJURY; SLEEP-WAKE; TNF-ALPHA	Cardiac arrest (CA) entails significant risks of coma resulting in poor neurological and behavioral outcomes after resuscitation. Significant subsequent morbidity and mortality in post-CA patients are largely due to the cerebral and cardiac dysfunction that accompanies prolonged whole-body ischemia post-CA syndrome (PCAS). PCAS results in strong inflammatory responses including neuroinflammation response leading to poor outcome. Currently, there are no proven neuroprotective therapies to improve post-CA outcomes apart from therapeutic hypothermia. Furthermore, there are no acceptable approaches to promote cortical or cognitive arousal following successful return of spontaneous circulation (ROSC). Hypothalamic orexinergic pathway is responsible for arousal and it is negatively affected by neuroinflammation. However, whether activation of the orexinergic pathway can curtail neuroinflammation is unknown. We hypothesize that targeting the orexinergic pathway via intranasal orexin-A (ORXA) treatment will enhance arousal from coma and decrease the production of proinflammatory cytokines resulting in improved functional outcome after resuscitation. We used a highly validated CA rat model to determine the effects of intranasal ORXA treatment 30-minute post resuscitation. At 4hrs post-CA, the mRNA levels of proinflammatory markers (IL1 beta, iNOS, TNF-alpha, GFAP, CD11b) and orexin receptors (ORX1R and ORX2R) were examined in different brain regions. CA dramatically increased proinflammatory markers in all brain regions particularly in the prefrontal cortex, hippocampus and hypothalamus. Post-CA intranasal ORXA treatment significantly ameliorated the CA-induced neuroinflammatory markers in the hypothalamus. ORXA administration increased production of orexin receptors (ORX1R and ORX2R) particularly in hypothalamus. In addition, ORXA also resulted in early arousal as measured by quantitative electroencephalogram (EEG) markers, and recovery of the associated behavioral neurologic deficit scale score (NDS). Our results indicate that intranasal delivery of ORXA post-CA has an anti-inflammatory effect and accelerates cortical EEG and behavioral recovery. Beneficial outcomes from intranasal ORXA treatment lay the groundwork for therapeutic clinical approach to treating post-CA coma.	[Modi, Hiren R.; Wang, Qihong; Sahithi, G. D.; Sherman, David; Greenwald, Elliot; Thakor, Nitish V.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Savonenko, Alena V.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Savonenko, Alena V.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Geocadin, Romergryko G.] Johns Hopkins Univ, Sch Med, Neurol & Anesthesiol Crit Care Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Thakor, NV (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	nitish@jhu.edu	Thakor, Nitish V/A-5878-2008; Savonenko, Alena/AAT-2274-2021	Modi, Hiren/0000-0003-1731-7111	NHLBI, NIH [R01HL071568]	NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was sponsored by NHLBI, NIH grant R01HL071568, https://projectreponter.nit.gov/project_into_description.ctm?aid =90853718&icde=33528322&daparama=&ddavalue= &dasuba=&cr=1 &csn=detault&cs-ASC8ipball=.	Adrie Christophe, 2004, Curr Opin Crit Care, V10, P208, DOI 10.1097/01.ccx.0000126090.06275.fe; Akbari Y, 2012, CIRCULATION, V126, pA2; Bendel S, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/1471-2253-15-2; Benson DM, 2005, RESUSCITATION, V64, P209, DOI 10.1016/j.resuscitation.2003.03.001; Bro-Jeppesen J, 2015, CRIT CARE MED, V43, P1223, DOI 10.1097/CCM.0000000000000937; Bro-Jeppesen J, 2014, RESUSCITATION, V85, P1480, DOI 10.1016/j.resuscitation.2014.08.007; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Callaway CW, 2008, CRIT CARE MED, V36, P2607, DOI 10.1097/CCM.0b013e318184443b; Cantero JL, 2004, NEUROIMAGE, V22, P1271, DOI 10.1016/j.neuroimage.2004.03.014; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chaudhry H, 2013, IN VIVO, V27, P669; Claassen J, 2016, ANN NEUROL, V80, P541, DOI 10.1002/ana.24752; de la Tremblaye PB, 2017, PROG NEURO-PSYCHOPH, V79, P234, DOI 10.1016/j.pnpbp.2017.06.021; Deng RX, 2015, NEUROCRIT CARE, V23, P262, DOI 10.1007/s12028-015-0157-2; Deutschman CS, 2013, CRIT CARE MED, V41, pE368, DOI 10.1097/CCM.0b013e31828e9843; Drabek T, 2015, THER HYPOTHERMIA TEM, V5, P26, DOI 10.1089/ther.2014.0013; Duffy CM, 2015, NEUROSCI LETT, V606, P140, DOI 10.1016/j.neulet.2015.08.033; Espana RA, 2005, J COMP NEUROL, V481, P160, DOI 10.1002/cne.20369; Fries M, 2009, J CRIT CARE, V24, P453, DOI 10.1016/j.jcrc.2008.10.012; Gaieski DF, 2009, RESUSCITATION, V80, P418, DOI 10.1016/j.resuscitation.2008.12.015; Geocadin RG, 2000, CLIN NEUROPHYSIOL, V111, P1779, DOI 10.1016/S1388-2457(00)00379-5; Geocadin RG, 2000, MOVEMENT DISORD, V15, P14, DOI 10.1002/mds.870150704; Geocadin RG, 2008, NEUROL CLIN, V26, P487, DOI 10.1016/j.ncl.2008.03.015; Janata A, 2014, RESUSCITATION, V85, P694, DOI 10.1016/j.resuscitation.2014.01.033; Jia XF, 2008, RESUSCITATION, V78, P367, DOI 10.1016/j.resuscitation.2008.04.011; Jia XF, 2008, RESUSCITATION, V76, P431, DOI 10.1016/j.resuscitation.2007.08.014; Jia XF, 2006, BRAIN RES, V1111, P166, DOI 10.1016/j.brainres.2006.04.121; Jones BE, 2013, SLEEP, V36, P1769, DOI 10.5665/sleep.3188; Kang XX, 2009, IEEE T BIO-MED ENG, V56, P1023, DOI 10.1109/TBME.2008.2011917; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; Kim T, 2015, P NATL ACAD SCI USA, V112, P3535, DOI 10.1073/pnas.1413625112; Kim YJ, 2006, J NEUROSCI RES, V84, P1037, DOI 10.1002/jnr.21011; Koenig MA, 2009, BRAIN RES, V1255, P153, DOI 10.1016/j.brainres.2008.11.102; Kostin A, 2013, NEUROSCIENCE, V254, P275, DOI 10.1016/j.neuroscience.2013.09.022; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Linnartz B, 2013, GLIA, V61, P37, DOI 10.1002/glia.22359; Linnartz B, 2012, J NEUROSCI, V32, P946, DOI 10.1523/JNEUROSCI.3830-11.2012; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchant DJ, 2012, CIRC RES, V110, P126, DOI 10.1161/CIRCRESAHA.111.243170; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; Murakami Y, 2005, J NEUROCHEM, V93, P1616, DOI 10.1111/j.1471-4159.2005.03163.x; Nagao K, 2012, CURR OPIN CRIT CARE, V18, P239, DOI 10.1097/MCC.0b013e3283523f4a; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Saito K, 1996, NEUROSCI LETT, V206, P149, DOI 10.1016/S0304-3940(96)12460-5; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Samborska-Sablik A, 2011, ARCH MED SCI, V7, P619, DOI 10.5114/aoms.2011.24131; Schmidt MR, 2013, CIRC RES, V113, P1278, DOI 10.1161/CIRCRESAHA.113.302942; Sherman DL, 1998, PROCEEDINGS OF THE IEEE-SP INTERNATIONAL SYMPOSIUM ON TIME-FREQUENCY AND TIME-SCALE ANALYSIS, P561, DOI 10.1109/TFSA.1998.721486; Sinton CM, 2011, SLEEP MED REV, V15, P197, DOI 10.1016/j.smrv.2010.12.003; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008; Wang YF, 2016, CIRC RES, V119, P222, DOI 10.1161/CIRCRESAHA.116.308559; Xiang YX, 2016, BIOMED REP, V5, P11, DOI 10.3892/br.2016.677; Xiao F, 2013, NEUROPHARMACOLOGY, V67, P16, DOI 10.1016/j.neuropharm.2012.10.021; Xiong XX, 2013, STROKE, V44, P764, DOI 10.1161/STROKEAHA.112.681700; Yasuda Y, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-70; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e; Zuercher P, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0565-8	65	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0182707	10.1371/journal.pone.0182707	http://dx.doi.org/10.1371/journal.pone.0182707			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957432	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200005
J	Shudo, Y; Yamamoto, T				Shudo, Yusuke; Yamamoto, Tatsuya			Assessing the relationship between quality of life and behavioral activation using the Japanese Behavioral Activation for Depression Scale-Short Form	PLOS ONE			English	Article							ADULTS; METAANALYSIS; THERAPY; TRIAL	Quality of life (QOL) is an important health-related concept. Identifying factors that affect QOL can help develop and improve health-promotion interventions. Previous studies suggest that behavioral activation fosters subjective QOL, including well-being. However, the mechanism by which behavioral activation improves QOL is not clear. Considering that QOL improves when depressive symptoms improve post-treatment and that behavioral activation is an effective treatment for depression, it is possible that behavioral activation affects QOL indirectly rather than directly. To clarify the mechanism of the influence of behavioral activation on QOL, it is necessary to examine the relationships between factors related to behavioral activation, depressive symptoms, and QOL. Therefore, we attempted to examine the relationship between these factors. Participants comprised 221 Japanese undergraduate students who completed questionnaires on behavioral activation, QOL, and depressive symptoms: the Japanese versions of the Behavioral Activation for Depression Scale-Short Form (BADS-SF), WHO Quality of Life-BREF (WHOQOL-26), and Center for Epidemiologic Studies Depression Scale (CES-D). The BADS-SF comprises two subscales, Activation and Avoidance, and the WHOQOL-26 measures overall QOL and four domains, Physical Health, Psychological Health, Social Relationships, and Environment. Mediation analyses were conducted with BADS-SF activation and avoidance as independent variables, CES-D as a mediator variable, and each WHO-QOL as an outcome variable. Results indicated that depression completely mediated the relationship between Avoidance and QOL, and partially mediated the relationship between Activation and QOL. In addition, analyses of each domain of QOL showed that Activation positively affected all aspects of QOL directly and indirectly, but Avoidance had a negative influence on only part of QOL mainly through depression. The present study provides behavioral activation strategies aimed at QOL enhancement.	[Shudo, Yusuke] Hiroshima Int Univ, Fac Psychol, Hiroshima, Japan; [Yamamoto, Tatsuya] Chukyo Univ, Sch Psychol, Nagoya, Aichi, Japan	Chukyo University	Shudo, Y (corresponding author), Hiroshima Int Univ, Fac Psychol, Hiroshima, Japan.	y-shudo@he.hirokoku-u.ac.jp	Yamamoto, Tatsuya/AAD-5929-2021	Yamamoto, Tatsuya/0000-0002-4218-099X				[Anonymous], 2015, JAPANESE J COGNITIVE; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barrera TL, 2009, J ANXIETY DISORD, V23, P1086, DOI 10.1016/j.janxdis.2009.07.011; Berlim Marcelo T., 2007, P241, DOI 10.1007/978-1-4020-5779-3_12; Chartier IS, 2013, J AFFECT DISORDERS, V145, P292, DOI 10.1016/j.jad.2012.07.023; Cuijpers P, 2011, NORD J PSYCHIAT, V65, P354, DOI 10.3109/08039488.2011.596570; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Galuppi A, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-31; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; HERRMAN H, 1993, QUAL LIFE RES, V2, P153; Hopko DR, 2003, CLIN PSYCHOL REV, V23, P699, DOI 10.1016/S0272-7358(03)00070-9; Kanter JW, 2007, J PSYCHOPATHOL BEHAV, V29, P191, DOI 10.1007/s10862-006-9038-5; Kennedy SH, 2001, J PSYCHIATR NEUROSCI, V26, pS23; Manos RC, 2011, BEHAV THER, V42, P726, DOI 10.1016/j.beth.2011.04.004; Manos RC, 2010, CLIN PSYCHOL REV, V30, P547, DOI 10.1016/j.cpr.2010.03.008; Martell C.R., 2010, BEHAV ACTIVATION DEP; Mazzucchelli T, 2009, CLIN PSYCHOL-SCI PR, V16, P383, DOI 10.1111/j.1468-2850.2009.01178.x; Mazzucchelli TG, 2009, COGN BEH THER, V2, P256, DOI 10.1017/S1754470X09990201; Mazzucchelli TG, 2010, J POSIT PSYCHOL, V5, P105, DOI 10.1080/17439760903569154; Nakane Y, 1997, WHOQOL 26 INFORM; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Shima S, 1985, PSYCHIATRY, V27, P717, DOI DOI 10.11477/MF.1405203967	23	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185221	10.1371/journal.pone.0185221	http://dx.doi.org/10.1371/journal.pone.0185221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957346	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200035
J	von Volkmann, HL; Bronstad, I; Gilja, OH; Tronstad, RR; Sangnes, DA; Nortvedt, R; Hausken, T; Dimcevski, G; Fiskerstrand, T; Nylund, K				von Volkmann, Hilde L.; Bronstad, Ingeborg; Gilja, Odd Helge; Tronstad, Rune R.; Sangnes, Dag Andre; Nortvedt, Ragnar; Hausken, Trygve; Dimcevski, Georg; Fiskerstrand, Torunn; Nylund, Kim			Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; GUANYLATE-CYCLASE-C; COLONIC TRANSIT; GASTROINTESTINAL MOTILITY; CONSTIPATION; PH; CAPSULE; PAIN; TIME; LINACLOTIDE	Introduction Increased intestinal hydration by activation of the epithelial enzyme linked receptor guanylate cyclase C (GC-C) is a pharmacological principle for treating constipation. Activating mutations in the GUCY2C gene encoding GC-C cause Familial GUCY2C diarrhea syndrome (FGDS) which has been diagnosed with severe dysmotility. Aim To investigate gut motility and hormones before and after a meal in FGDS patients and compare with healthy controls (HC). Subjects and methods Bristol stool chart and stool frequency was assessed. Before and after a meal occlusive and non-occlusive contractions were obtained using ultrasound. A wireless motility capsule (WMC) recorded gut transit time, pH, contractions and pressure. Plasma levels of selected gut hormones were measured at different time points. Results The FGDS patients had 4 (range 1-10) loose stools/day and prolonged total gut transit time compared to HC, 55.5 h vs 28.5 h, respectively, with significantly increased colon transit time. In FGDS patients, pH in duodenum, small bowel and colon was increased and the number of contractions and the intraluminal pressure were significantly decreased, measured by WMC. Ultrasound showed in small bowel increased number of non-occlusive contractions in the FGDS patients. Serotonin (5-HT) plasma levels in the HC peaked 30 min after the meal, while the FGDS patients had no response. Conclusion Despite having diarrhea, the FGDS patients have prolonged transit time through the gut compared to HC, particularly in colon. The reduced number of intestinal contractions and lack of 5-HT release after a meal in FGDS patients surprisingly resemble colonic motility disturbances seen in patients with constipation.	[von Volkmann, Hilde L.; Bronstad, Ingeborg; Gilja, Odd Helge; Sangnes, Dag Andre; Nortvedt, Ragnar; Hausken, Trygve; Dimcevski, Georg; Nylund, Kim] Haukeland Hosp, Natl Ctr Ultrasound Gastroenterol, Bergen, Norway; [von Volkmann, Hilde L.; Bronstad, Ingeborg; Gilja, Odd Helge; Hausken, Trygve; Dimcevski, Georg] Univ Bergen, Dept Clin Med, Bergen, Norway; [Tronstad, Rune R.] Haukeland Hosp, Dept Pediat, Bergen, Norway; [Tronstad, Rune R.; Fiskerstrand, Torunn] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Fiskerstrand, Torunn] Haukeland Hosp, Ctr Med Genet, Bergen, Norway; [Fiskerstrand, Torunn] Haukeland Hosp, Ctr Mol Med, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	von Volkmann, HL (corresponding author), Haukeland Hosp, Natl Ctr Ultrasound Gastroenterol, Bergen, Norway.; von Volkmann, HL (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	Hilda.loland.von.volkmann@helse-bergen.no	Dimcevski, Georg/F-2860-2018; Nylund, Kim/AAB-7785-2019	Dimcevski, Georg/0000-0003-2864-5129; 	Norsk Gastroenterologisk forening; Norsk forening for Ultralyd-diagnostikk; Karla og Arne Oddmars medisinske fond; Inclino AS	Norsk Gastroenterologisk forening; Norsk forening for Ultralyd-diagnostikk; Karla og Arne Oddmars medisinske fond; Inclino AS	The stipendium for HLvV was provided by Helse Vest, the Regional Health Autority. The research was supported with funding from: Norsk Gastroenterologisk forening (www.Legeforeningen. no/NGF); Norsk forening for Ultralyd-diagnostikk (www.Nfud.no); Karla og Arne Oddmars medisinske fond. Inclino AS (www.Incline.no) has supported this study with WMC recorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson W, 2006, GASTROENTEROLOGY, V130, P34, DOI 10.1053/j.gastro.2005.09.031; Barreto SG, 2016, DIG DIS SCI; Basu N, 2014, J BIOL CHEM, V289, P581, DOI 10.1074/jbc.M113.511311; Basu N, 2010, MOL CELL BIOCHEM, V334, P67, DOI 10.1007/s11010-009-0324-x; Bertrand PP, 2006, J PHYSIOL-LONDON, V577, P689, DOI 10.1113/jphysiol.2006.117804; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Brierley SM, 2012, CURR OPIN PHARMACOL, V12, P632, DOI 10.1016/j.coph.2012.10.005; Bryant AP, 2010, LIFE SCI, V86, P760, DOI 10.1016/j.lfs.2010.03.015; Cabrera-Pastor A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33124; Camilleri M, 2010, NEUROGASTROENT MOTIL, V22, P874, DOI 10.1111/j.1365-2982.2010.01517.x; Castro J, 2013, GASTROENTEROLOGY, V145, P1334, DOI 10.1053/j.gastro.2013.08.017; Degen LP, 1996, GUT, V39, P109, DOI 10.1136/gut.39.1.109; Drossman DA, 2011, AM J GASTROENTEROL, V106, P1749, DOI 10.1038/ajg.2011.201; Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x; DuPont AW, 2014, DIGESTION, V89, P119, DOI 10.1159/000356314; EVANS DF, 1988, GUT, V29, P1035, DOI 10.1136/gut.29.8.1035; Feng B, 2013, J NEUROSCI, V33, P9831, DOI 10.1523/JNEUROSCI.5114-12.2013; Fiskerstrand T, 2012, NEW ENGL J MED, V366, P1586, DOI 10.1056/NEJMoa1110132; Francis CY, 1997, ALIMENT PHARM THERAP, V11, P395, DOI 10.1046/j.1365-2036.1997.142318000.x; Gilja Odd Helge, 2008, Expert Rev Gastroenterol Hepatol, V2, P5, DOI 10.1586/17474124.2.1.5; Hannig G, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00031; Hasler WL, 2009, AM J PHYSIOL-GASTR L, V297, pG1107, DOI 10.1152/ajpgi.00136.2009; HVEEM K, 1994, SCAND J GASTROENTERO, V29, P786, DOI 10.3109/00365529409092511; Kuhn M, 2016, PHYSIOL REV, V96, P751, DOI 10.1152/physrev.00022.2015; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Lies B, 2014, NEUROGASTROENT MOTIL, V26, P901, DOI 10.1111/nmo.12367; Malagelada Carolina, 2017, Curr Gastroenterol Rep, V19, P26, DOI 10.1007/s11894-017-0565-x; Nylund K, 2012, Ultraschall Med, V33, pE225, DOI 10.1055/s-0031-1299329; Nylund K, 2017, ULTRASCHALL MED, V38, pE1, DOI 10.1055/s-0042-115853; Nylund Kim, 2010, Ultraschall Med, V31, P438, DOI 10.1055/s-0030-1263234; Odegaard S, 2015, SCAND J GASTROENTERO, V50, P698, DOI 10.3109/00365521.2015.1028436; ODONNELL LJD, 1990, BMJ-BRIT MED J, V300, P439, DOI 10.1136/bmj.300.6722.439; Pattison AM, 2016, WORLD J GASTROENTERO, V22, P8070, DOI 10.3748/wjg.v22.i36.8070; Ringel-Kulka T, 2015, AM J GASTROENTEROL, V110, P1339, DOI 10.1038/ajg.2015.220; Rodriguez A, 2016, INT J OBESITY, V40, P1405, DOI 10.1038/ijo.2016.66; Roland BC, 2014, JCLINGASTROENTEROL; Saad Richard J, 2016, Curr Gastroenterol Rep, V18, P14, DOI 10.1007/s11894-016-0489-x; Saad Richard J, 2011, Gastroenterol Hepatol (N Y), V7, P795; Saad RJ, 2010, AM J GASTROENTEROL, V105, P403, DOI 10.1038/ajg.2009.612; Silos-Santiago I, 2013, PAIN, V154, P1820, DOI 10.1016/j.pain.2013.05.044; Sindic Aleksandra, 2013, ISRN Nephrol, V2013, P813648, DOI 10.5402/2013/813648; Spencer NJ, 2016, ADV EXP MED BIOL, V891, P113, DOI 10.1007/978-3-319-27592-5_11; Tillou J, 2017, CLIN COLON RECT SURG, V30, P76, DOI 10.1055/s-0036-1593436; Tornblom H, 2012, AM J GASTROENTEROL, V107, P754, DOI 10.1038/ajg.2012.5; Tronstad RR., 2016, SCAND J GASTROENTERO, P1; Valentin N, 2015, EXPERT OPIN INV DRUG, V24, P769, DOI 10.1517/13543784.2015.1025132; Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618; Wang YT, 2015, ALIMENT PHARM THER, V42, P761, DOI 10.1111/apt.13329; Zietek T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00154	49	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185496	10.1371/journal.pone.0185496	http://dx.doi.org/10.1371/journal.pone.0185496			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957388	gold, Green Published, Green Submitted			2022-12-27	WOS:000411985200070
J	Yeh, TN; Lin, MC				Yeh, Thao N.; Lin, Meng C.			Risk factors for severe Meibomian gland atrophy in a young adult population: A cross-sectional study	PLOS ONE			English	Article							NONCONTACT INFRARED MEIBOGRAPHY; FILM LIPID LAYER; CONTACT-LENS WEARERS; DRY EYE SYMPTOMS; TEAR FILM; GENE-EXPRESSION; INTERNATIONAL WORKSHOP; ORAL-CONTRACEPTIVES; LOGISTIC-REGRESSION; DYSFUNCTION REPORT	Purpose Assess potential risk factors for severe Meibomian gland atrophy (SMGA) in a young adult population. Methods Cross-sectional study using medical history and ocular surface examination to evaluate relationships with study outcomes: SMGA, tear lipid layer (TLL) thickness, non-invasive (NITBUT) and fluorescein (FTBUT) tear breakup times, and symptoms using the Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire. Results One hundred one participants (101; 202 eyes; Age: mean +/- SD = 22.3 +/- 4.0 years) completed the study. Hormonal birth control (HBC) use was the only significant risk factor for SMGA (p = 0.028). Female HBC users had 4.8 times greater odds of having SMGA compared to female HBC non-users (p = 0.028), but the odds of having SMGA was similar between female HBC non-users and males (p = 0.885). Multivariable analysis suggested that the relationship between SMGA and TLL thickness was dependent on HBC use. Compared to female HBC non-users without SMGA, TLL thickness for HBC users was estimated to be 10 nm thinner if SMGA was absent (p = 0.007) and 21 nm thinner if SMGA was present (p<0.001). SMGA status had no significant impact on TLL thickness among female HBC non-users (p = 0.552). The effect of TLL thickness on FTBUT was small but significant (p = 0.026). TLL thickness was not significantly associated with NITBUT (p = 0.349). Neither FTBUT nor NITBUT was significantly associated with the SPEED score. Conclusion HBC use may be associated with SMGA, supporting the hypothesis that SMGA could lead to thinner TLL. However, less evidence was present to support that thin TLL could lead to clinically detectable tear film instability and subsequently to increased ocular dryness symptoms. Further investigation with a larger sample size is warranted to confirm these findings.	[Yeh, Thao N.; Lin, Meng C.] Univ Calif Berkeley, Sch Optometry, Clin Res Ctr, Berkeley, CA 94720 USA; [Yeh, Thao N.; Lin, Meng C.] Univ Calif Berkeley, Vis Sci Grad Grp, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lin, MC (corresponding author), Univ Calif Berkeley, Sch Optometry, Clin Res Ctr, Berkeley, CA 94720 USA.; Lin, MC (corresponding author), Univ Calif Berkeley, Vis Sci Grad Grp, Berkeley, CA 94720 USA.	mlin@berkeley.edu			National Institute of Health/National Eye Institute [5K12EY017269-05]; Roberta Smith Research Fund; NATIONAL EYE INSTITUTE [K23EY026655] Funding Source: NIH RePORTER	National Institute of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Roberta Smith Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work received support from the National Institute of Health/National Eye Institute, 5K12EY017269-05, to TNY and the Roberta Smith Research Fund, to MCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghamdi WM, 2016, OPHTHAL PHYSL OPT, V36, P120, DOI 10.1111/opo.12278; Argiles M, 2015, INVEST OPHTH VIS SCI, V56, P6679, DOI 10.1167/iovs.15-16967; Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI 10.1016/j.ophtha.2007.06.031; Arita R, 2009, OPHTHALMOLOGY, V116, P379, DOI 10.1016/j.ophtha.2008.10.012; Asiedu K, 2016, CORNEA, V35, P175, DOI 10.1097/ICO.0000000000000712; Ban Y, 2013, OCUL SURF, V11, P47, DOI 10.1016/j.jtos.2012.09.005; BROWN SI, 1969, ARCH OPHTHALMOL-CHIC, V82, P537, DOI 10.1001/archopht.1969.00990020539019; Cardona G, 2011, CURR EYE RES, V36, P190, DOI 10.3109/02713683.2010.544442; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Eom Y, 2013, AM J OPHTHALMOL, V155, P1104, DOI 10.1016/j.ajo.2013.01.008; Finis D, 2015, CURR EYE RES, V40, P982, DOI 10.3109/02713683.2014.971929; Finis D, 2013, CORNEA, V32, P1549, DOI 10.1097/ICO.0b013e3182a7f3e1; Gipson IK, 2007, OCUL SURF, V5, P179; Greiner JV, 2012, CURR EYE RES, V37, P272, DOI 10.3109/02713683.2011.631721; Greiner JV, 2002, ADV EXP MED BIOL, V506, P507; Herok GH, 2009, CURR EYE RES, V34, P589, DOI 10.1080/02713680902972366; Himebaugh NL, 2009, OPTOMETRY VISION SCI, V86, P106, DOI 10.1097/OPX.0b013e318194e962; Hirota M, 2013, OPTOMETRY VISION SCI, V90, P650, DOI 10.1097/OPX.0b013e31829962ec; HOLLY FJ, 1973, EXP EYE RES, V15, P515, DOI 10.1016/0014-4835(73)90064-X; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Ji YW, 2017, CORNEA, V36, P176, DOI 10.1097/ICO.0000000000001101; Kawashima M, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-34; King-Smith PE, 2013, OCUL SURF, V11, P236, DOI 10.1016/j.jtos.2013.05.003; Knop E, 2011, INVEST OPHTH VIS SCI, V52, P1938, DOI 10.1167/iovs.10-6997c; Korb Donald R, 2005, Eye Contact Lens, V31, P2, DOI 10.1097/01.ICL.0000140910.03095.FA; Korb DR, 2010, CORNEA, V29, P377, DOI 10.1097/ICO.0b013e3181ba0cb2; Lin MC, 2016, INVESTIGATIVE OPHTHA, V57; Lin MC, 2014, AM AC OPT ANN C DENV; Machalinska A, 2015, CORNEA, V34, P1098, DOI 10.1097/ICO.0000000000000511; Matsumoto Y, 2008, MOL VIS, V14, P1263; Napoli PE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165558; Ousler GW, 2014, CLIN OPHTHALMOL, V8, P869, DOI 10.2147/OPTH.S56783; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pucker AD, 2015, OPTOMETRY VISION SCI, V92, pE206, DOI 10.1097/OPX.0000000000000650; Pult H, 2013, OPTOMETRY VISION SCI, V90, P1034, DOI 10.1097/OPX.0000000000000029; Pult H, 2012, OPTOMETRY VISION SCI, V89, pE310, DOI 10.1097/OPX.0b013e318244e487; Satjawatcharaphong P, 2015, OPTOMETRY VISION SCI, V92, pE334, DOI 10.1097/OPX.0000000000000670; Schaumberg DA, 2011, INVEST OPHTH VIS SCI, V52, P1994, DOI 10.1167/iovs.10-6997e; Schirra F, 2005, INVEST OPHTH VIS SCI, V46, P3666, DOI 10.1167/iovs.05-0426; Sullivan DA, 2002, ANN NY ACAD SCI, V966, P211, DOI 10.1111/j.1749-6632.2002.tb04217.x; Sullivan DA, 2009, MOL VIS, V15, P1553; Suzuki T, 2008, INVEST OPHTH VIS SCI, V49, P1797, DOI 10.1167/iovs.07-1458; TIFFANY JM, 1987, ADV LIPID RES, V22, P1; VANDERVANGE N, 1990, CONTRACEPTION, V41, P345, DOI 10.1016/0010-7824(90)90034-S; Wan T, 2015, CURR EYE RES, V19, P1; Whitcher JP, 2010, AM J OPHTHALMOL, V149, P405, DOI 10.1016/j.ajo.2009.09.013; Wiegratz I, 2003, CONTRACEPTION, V67, P25, DOI 10.1016/S0010-7824(02)00436-5; Yamaguchi M, 2006, AM J OPHTHALMOL, V141, P669, DOI 10.1016/j.ajo.2005.11.004; Yeh TN, 2015, OPTOMETRY VISION SCI, V92, pE264, DOI 10.1097/OPX.0000000000000649	49	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185603	10.1371/journal.pone.0185603	http://dx.doi.org/10.1371/journal.pone.0185603			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957399	Green Published, gold			2022-12-27	WOS:000411985200091
J	Guan, RH; Zhou, H; Li, JW; Xiao, SY; Pang, CL; Chen, YF; Du, XR; Ke, SX; Tang, QY; Su, JG; Zhan, Y; An, HL				Guan, Ronghua; Zhou, Hui; Li, Junwei; Xiao, Shaoying; Pang, Chunli; Chen, Yafei; Du, Xiangrong; Ke, Shaoxi; Tang, Qiongyao; Su, Jiguo; Zhan, Yong; An, Hailong			Allosteric-activation mechanism of BK channel gating ring triggered by calcium ions	PLOS ONE			English	Article							PLANAR LIPID BILAYERS; LARGE-CONDUCTANCE; MOLECULAR-DYNAMICS; CA2+; IDENTIFICATION; QUALITY; MUSCLE; PRODY	Calcium ions bind at the gating ring which triggers the gating of BK channels. However, the allosteric mechanism by which Ca2+ regulates the gating of BK channels remains obscure. Here, we applied Molecular Dynamics ( MD) and Targeted MD to the integrated gating ring of BK channels, and achieved the transition from the closed state to a half-open state. Our date show that the distances of the diagonal subunits increase from 41.0 angstrom at closed state to 45.7 angstrom or 46.4 angstrom at a half-open state. It is the rotatory motion and flower-opening like motion of the gating rings which are thought to pull the bundle crossing gate to open ultimately. Compared with the 'Ca2+ bowl' at RCK2, the RCK1 Ca2+ sites make more contribution to opening the channel. The allosteric motions of the gating ring are regulated by three group of interactions. The first weakened group is thought to stabilize the close state; the second strengthened group is thought to stabilize the open state; the third group thought to lead AC region forming the CTD pore to coordinated motion, which exquisitely regulates the conformational changes during the opening of BK channels by Ca2+.	[Guan, Ronghua; Zhou, Hui] North China Elect Power Univ, Sch Math & Phys Sci, Baoding, Peoples R China; [Li, Junwei; Pang, Chunli; Chen, Yafei; Zhan, Yong; An, Hailong] Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Mol Biophys, Tianjin, Hebei, Peoples R China; [Xiao, Shaoying] Hebei Univ Technol, Sch Architecture & Art Design, Tianjin, Peoples R China; [Du, Xiangrong; Ke, Shaoxi; Tang, Qiongyao] Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China; [Su, Jiguo] Yanshan Univ, Coll Sci, Qinhuangdao, Peoples R China	North China Electric Power University; Hebei University of Technology; Hebei University of Technology; Xuzhou Medical University; Yanshan University	Zhan, Y; An, HL (corresponding author), Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Mol Biophys, Tianjin, Hebei, Peoples R China.	zhany@hebut.edu.cn; hailong_an@hebut.edu.cn	Li, Junwei/B-6936-2019	Li, Junwei/0000-0002-1724-4752; Zhou, Hui/0000-0002-0916-8200	National Natural Science Fund of China [11647121, 31600594, 31400711, 81450064, 31671212, 11247010, 11475053]; Natural Science Fund for Distinguished Young Scholars of Hebei Province of China [C2015202340]; Fund for Outstanding Talents of Hebei Province of China [C201400305]; Natural Science Foundation of Hebei Province [C2017202208]; Fund for the Science and Technology Program of Higher Education Institutions of Hebei Province [QN2016113]; Scientific Innovation Grant for Excellent Young Scientists of Hebei University of Technology [2015010]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund for Distinguished Young Scholars of Hebei Province of China; Fund for Outstanding Talents of Hebei Province of China; Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Fund for the Science and Technology Program of Higher Education Institutions of Hebei Province; Scientific Innovation Grant for Excellent Young Scientists of Hebei University of Technology	This work was supported by the National Natural Science Fund of China (11647121, 31600594, 31400711, 81450064, 31671212, 11247010 and 11475053), Natural Science Fund for Distinguished Young Scholars of Hebei Province of China (C2015202340), Fund for Outstanding Talents of Hebei Province of China (C201400305), Natural Science Foundation of Hebei Province (C2017202208), Fund for the Science and Technology Program of Higher Education Institutions of Hebei Province (QN2016113), Scientific Innovation Grant for Excellent Young Scientists of Hebei University of Technology (2015010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg GC, 2003, J CLIN INVEST, V112, P717, DOI 10.1172/JC1200318684; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bakan A, 2014, BIOINFORMATICS, V30, P2681, DOI 10.1093/bioinformatics/btu336; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Barzegar A, 2008, J PEPT SCI, V14, P1173, DOI 10.1002/psc.1055; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fodor AA, 2006, J GEN PHYSIOL, V127, P755, DOI 10.1085/jgp.200509419; Hong J, 2011, BMC MED GENOMICS, V4, P1; Hou SW, 2009, CHANNELS, V3, P249; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivetac A, 2009, J MOL BIOL, V388, P644, DOI 10.1016/j.jmb.2009.03.037; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Kursula P, 2014, AMINO ACIDS, V46, P2295, DOI 10.1007/s00726-014-1795-y; LATORRE R, 1982, P NATL ACAD SCI-BIOL, V79, P805, DOI 10.1073/pnas.79.3.805; LATORRE R, 1983, J MEMBRANE BIOL, V71, P11, DOI 10.1007/BF01870671; Li J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090225, 10.1371/journal.pone.0105508]; Li JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11289; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MOCZYDLOWSKI E, 1983, J GEN PHYSIOL, V82, P511, DOI 10.1085/jgp.82.4.511; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Orio P, 2002, NEWS PHYSIOL SCI, V17, P156, DOI 10.1152/nips.01387.2002; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Seibold MA, 2008, HUM MOL GENET, V17, P2681, DOI 10.1093/hmg/ddn168; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Surhone L. M., 2010, SELECTIVE CATALYTIC; Sweet TB, 2008, J GEN PHYSIOL, V132, P491, DOI 10.1085/jgp.200810094; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang HG, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00029; Yang JQ, 2010, NEURON, V66, P871, DOI 10.1016/j.neuron.2010.05.009; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414	44	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0182067	10.1371/journal.pone.0182067	http://dx.doi.org/10.1371/journal.pone.0182067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953901	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300003
J	Budge, GE; Hodgetts, J; Jones, EP; Ostoja-Starzewski, JC; Hall, J; Tomkies, V; Semmence, N; Brown, M; Wakefield, M; Stainton, K				Budge, Giles E.; Hodgetts, Jennifer; Jones, Eleanor P.; Ostoja-Starzewski, Jozef C.; Hall, Jayne; Tomkies, Victoria; Semmence, Nigel; Brown, Mike; Wakefield, Maureen; Stainton, Kirsty			The invasion, provenance and diversity of Vespa velutina Lepeletier (Hymenoptera: Vespidae) in Great Britain	PLOS ONE			English	Article							SPREAD	The yellow-legged or Asian hornet (Vespa velutina colour form nigrithorax) was introduced into France from China over a decade ago. Vespa velutina has since spread rapidly across Europe, facilitated by suitable climatic conditions and the ability of a single nest to disperse many mated queens over a large area. Yellow-legged hornets are a major concern because of the potential impact they have on populations of many beneficial pollinators, most notably the western honey bee (Apis mellifera), which shows no effective defensive behaviours against this exotic predator. Here, we present the first report of this species in Great Britain. Actively foraging hornets were detected at two locations, the first around a single nest in Gloucestershire, and the second a single hornet trapped 54 km away in Somerset. The foraging activity observed in Gloucestershire was largely restricted to within 700 m of a single nest, suggesting highly localised movements. Genetic analyses of individuals from the Gloucestershire nest and the single hornet from Somerset suggest that these incursions represent an expansion of the European population, rather than a second incursion from Asia. The founding queen of the Gloucestershire nest mated with a single male, suggesting that sexual reproduction may have occurred in an area of low nest density. Whilst the nest contained diploid adult males, haploid 'true' males were only present at the egg stage, indicating that the nest was detected and removed before the production of queens. Members of the public reported additional dead hornets associated with camping equipment recently returned from France and imported timber products, highlighting possible pathways of incursion. The utility of microsatellites to inform surveillance during an incursion and the challenge of achieving eradication of this damaging pest are discussed.	[Budge, Giles E.; Hodgetts, Jennifer; Jones, Eleanor P.; Ostoja-Starzewski, Jozef C.; Hall, Jayne; Tomkies, Victoria; Wakefield, Maureen; Stainton, Kirsty] Fera, Natl Agrifood Innovat Campus, York, N Yorkshire, England; [Budge, Giles E.] Newcastle Univ, Inst Agri Food Res & Innovat, Newcastle Upon Tyne, Tyne & Wear, England; [Semmence, Nigel; Brown, Mike] Anim & Plant Hlth Agcy, Natl Bee Unit, Natl Agrifood Innovat Campus, York, N Yorkshire, England	Food & Environment Research Agency; Newcastle University - UK; Animal & Plant Health Agency UK	Budge, GE (corresponding author), Fera, Natl Agrifood Innovat Campus, York, N Yorkshire, England.; Budge, GE (corresponding author), Newcastle Univ, Inst Agri Food Res & Innovat, Newcastle Upon Tyne, Tyne & Wear, England.	giles.budge@ncl.ac.uk		Wakefield, Maureen/0000-0003-0127-0988; stainton, kirsty/0000-0002-2024-2010	Department for Environment, Food & Rural Affairs (Defra) [PH0533]; Welsh Government	Department for Environment, Food & Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Welsh Government	This work was funded with the support of the Department for Environment, Food & Rural Affairs (Defra; project number PH0533) and the Welsh Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arca M, 2015, BIOL INVASIONS, V17, P2357, DOI 10.1007/s10530-015-0880-9; Archer ME, 1989, KEY WORLD SPECIES 1; Archer Michael E., 1994, Entomologist's Monthly Magazine, V130, P149; Beggs JR, 2011, BIOCONTROL, V56, P505, DOI 10.1007/s10526-011-9389-z; CABI, 2013, INV SPEC COMP VESP V; Chauzat MP, 2009, BIOLOGIST, V56, P6; Darrouzet E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136680; Dong DZ, 1989, ZOOL RES, V10, P8; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Faria LRR, 2016, THEOR BIOSCI, V135, P111, DOI 10.1007/s12064-016-0226-x; Folmer O, 1994, MOL MARINE BIOL BIOT, V3, P6; Franklin DN, 2017, APPL ENTOMOL ZOOL, V52, P8; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grosso-Silva JM, 2012, ARQUIVOS ENTOMOLOXIC, P53; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim J, 2006, ENTOMOLOGY RES, V36, P4; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kovacs JL, 2010, INSECT SOC, V57, P53, DOI 10.1007/s00040-009-0050-0; Lopez S., 2011, Bulletin OEPP, V41, P439, DOI 10.1111/j.1365-2338.2011.02513.x; Marris G, 2011, GB NONNATIVE ORGNISM; Moilanen A, 2004, MOL ECOL NOTES, V4, P795, DOI 10.1111/j.1471-8286.2004.00779.x; Monceau K, 2014, INSECT SCI, V21, P765, DOI 10.1111/1744-7917.12090; Monceau K, 2014, J PEST SCI, V87, P1, DOI 10.1007/s10340-013-0537-3; Orlov M., 2014, VESPA VELUTINA HAS A; Perrard A, 2009, ANN SOC ENTOMOL FR, V45, P119, DOI 10.1080/00379271.2009.10697595; Pritchard JK, 2000, GENETICS, V155, P945; Robinet C., 2016, J APPL ECOLOGY; Rome Q, 2015, J APPL ENTOMOL, V139, P771, DOI 10.1111/jen.12210; Rome Quentin, 2013, Bulletin de la Societe Entomologique de France, V118, P21; Ueno T, 2014, INT J CHEM ENV BIOL, V2, P3; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Villemant C, 2006, INSECTES, V143, P5; Villemant Claire, 2006, Bulletin de la Societe Entomologique de France, V111, P535; Williams F., 2010, EC COST INVASIVE NON	36	55	58	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185172	10.1371/journal.pone.0185172	http://dx.doi.org/10.1371/journal.pone.0185172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950004	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000028
J	Engelbrecht, T; Kock, A; Waries, S; O'Riain, MJ				Engelbrecht, Tamlyn; Kock, Alison; Waries, Sarah; O'Riain, M. Justin			Shark Spotters: Successfully reducing spatial overlap between white sharks (Carcharodon carcharias) and recreational water users in False Bay, South Africa	PLOS ONE			English	Article							ARCTOCEPHALUS-PUSILLUS-PUSILLUS; CONTROL PROGRAMS; PREDATION RISK; BEHAVIOR; AUSTRALIA; MESOPREDATOR; QUEENSLAND; WALES	White sharks (Carcharodon carcharias) are apex predators that play an important role in the structure and stability of marine ecosystems. Despite their ecological importance and protected status, white sharks are still subject to lethal control to reduce the risk of shark bites for recreational water users. The Shark Spotters program, pioneered in Cape Town, South Africa, provides a non-lethal alternative for reducing the risk of human-shark conflict. In this study we assessed the efficacy of the Shark Spotters program in reducing overlap between water users and white sharks at two popular beaches in False Bay, South Africa. We investigated seasonal and diel patterns in water use and shark presence at each beach, and thereafter quantified the impact of different shark warnings from shark spotters on water user abundance. We also assessed the impact of a fatal shark incident on patterns of water use. Our results revealed striking diel and seasonal overlap between white sharks and water users at both beaches. Despite this, there was a low rate of shark-human incidents (0.5/annum) which we attribute partly to the success of the Shark Spotters program. Shark spotters use visual (coloured flags) and auditory (siren) cues to inform water users of risk associated with white shark presence in the surf zone. Our results showed that the highest risk category (denoted by a white flag and accompanying siren) caused a significant reduction in water user abundance; however the secondary risk category (denoted by a red flag with no siren) had no significant effect on water users. A fatal shark incident was shown to negatively impact the number of water users present for at least three months following the incident. Our results indicate that the Shark Spotters program effectively reduces spatial overlap between white sharks and water users when the risk of conflict is highest.	[Engelbrecht, Tamlyn; Kock, Alison; O'Riain, M. Justin] Univ Cape Town, Inst Communities & Wildlife Africa, Dept Biol Sci, Cape Town, South Africa; [Engelbrecht, Tamlyn; Waries, Sarah] Shark Spotters, Cape Town, South Africa; [Kock, Alison] Cape Res Ctr, South African Natl Pk, Cape Town, South Africa; [Kock, Alison] SAIAB, Grahamstown, South Africa	University of Cape Town; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity	Engelbrecht, T (corresponding author), Univ Cape Town, Inst Communities & Wildlife Africa, Dept Biol Sci, Cape Town, South Africa.; Engelbrecht, T (corresponding author), Shark Spotters, Cape Town, South Africa.	engelbrecht.tamlyn@gmail.com		O'Riain, M. Justin/0000-0001-5233-8327; Kock, Alison/0000-0001-9981-1652	National Research Foundation of South Africa; City of Cape Town; Save Our Seas Foundation	National Research Foundation of South Africa(National Research Foundation - South Africa); City of Cape Town; Save Our Seas Foundation	Funding was provided to TE for her BSc (Hons) research by the National Research Foundation of South Africa (www.nrf.ac.za). The primary sponsors of the Shark Spotters Program are the City of Cape Town (www.capetown.gov.za) and Save Our Seas Foundation (www.saveourseas. corn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, RESOLVING HUMAN WILD; Burgess GH, 2017, ISAF 2016 WORLDWIDE; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Cliff G., 2006, WWF S AFRICA REPORT, V1; Cliff G, 2011, MAR FRESHWATER RES, V62, P700, DOI 10.1071/MF10182; Cortes Enric, 2000, Reviews in Fisheries Science, V8, P299, DOI 10.1080/10641260008951115; Curtis T, 2012, GLOBAL PERSPECTIVES, VFirst, P477; De Vos A, 2015, MAR MAMMAL SCI, V31, P1118, DOI 10.1111/mms.12208; De Vos A, 2015, MAR MAMMAL SCI, V31, P1234, DOI 10.1111/mms.12215; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Dudley SFJ, 1997, OCEAN COAST MANAGE, V34, P1, DOI 10.1016/S0964-5691(96)00061-0; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Graham K, 2005, BIOL CONSERV, V122, P159, DOI 10.1016/j.biocon.2004.06.006; Green M, 2009, REPORT NSW SHARK MES; Hammerschlag N, 2017, B MAR SCI, V93, P355, DOI 10.5343/bms.2016.1046; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Jacobs Herbert A., 1967, COLUMBIA JOURNALISM, V6, P37; Kock AA, 2012, GLOBAL PERSPECTIVES, P447; Kock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055048; Krogh M, 1996, BIOL CONSERV, V77, P219, DOI 10.1016/0006-3207(95)00141-7; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1121, DOI 10.1017/S002531540501218X; McComas KA, 2006, J HEALTH COMMUN, V11, P75, DOI 10.1080/10810730500461091; Neff C, 2012, COAST MANAGE, V40, P88, DOI 10.1080/08920753.2011.639867; Neff CL, 2013, MAR POLICY, V38, P545, DOI 10.1016/j.marpol.2012.06.017; PATERSON RA, 1990, BIOL CONSERV, V52, P147, DOI 10.1016/0006-3207(90)90123-7; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Redpath S.M., 2015, CONFLICTS CONSERVATI; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thirgood S, 2005, CONSERV BIOL SER, V9, P13; Wetherbee Bradley M., 1994, Pacific Science, V48, P95; Woodroffe R, 2005, CONSERV BIOL SER, V9, P1	35	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185335	10.1371/journal.pone.0185335	http://dx.doi.org/10.1371/journal.pone.0185335			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945806	Green Published, Green Submitted, gold			2022-12-27	WOS:000411645100048
J	Taniguchi, D; LoGerfo, J; van Pelt, M; Mielcarek, B; Huster, K; Haider, M; Thomas, B				Taniguchi, Dawn; LoGerfo, James; van Pelt, Maurits; Mielcarek, Bessie; Huster, Karin; Haider, Mahri; Thomas, Bernadette			Evaluation of a multi-faceted diabetes care program including community-based peer educators in Takeo province, Cambodia, 2007-2013	PLOS ONE			English	Article							SELF-MANAGEMENT; SUPPORT; PREVENTION; OUTCOMES; INDIA	Introduction Early detection and treatment for diabetes are essential for reducing disability and death from the disease. Finding effective screening and treatment for individuals living with diabetes in resource-limited countries is a challenge. MoPoTsyo, a Cambodian non-governmental organization, addressed this gap by utilizing a multi-pronged approach with community-based peer educators, access to laboratory procedures, local outpatient medical consultation, and a revolving drug fund. This study evaluated outcomes of MoPoTsyo's diabetes program in Takeo Province by assessing glycemic and blood pressure outcomes for individuals diagnosed with diabetes over a 24-month follow-up period between 2007-2013. Methods This is a retrospective cohort analysis of records without a comparison group. We calculated the mean fasting blood glucose (FBG) and blood pressure (BP) at regular intervals of followup. The proportion of patients reaching recommended treatment targets for FBG and BP was assessed. Results Of the 3411 patients enrolled in the program, 2230 were included in the study. The cohort was predominantly female (68.9%) with a median age of 54 years. Median follow-up time in the program was 16 months (4.9-38.4 months). Mean FBG decreased 63.9 mg/dl in mean FBG (95% CI 58.5 to 69.3) at one year of follow-up (p< 0.001). After one year, 45% (321/708) of patients achieved goal FBG < 126. Of the 41.6% (927/2230) with elevated BP at enrollment, systolic and diastolic BP levels significantly decreased (p< 0.001) by 16.9 mmHg (95% CI 1.2 to 22.9) and 10 mm Hg (95% CI 0.7 to 12.9) respectively between enrollment and one year of follow-up. At one year of follow-up, 51.1%% (183/355) of these patients reached the BP goal < 140/90. Conclusion The improved outcome indicators of diabetes care for MoPoTsyo's Takeo program evaluation showed promise. The program demonstrated a reasonable and practical approach to delivering effective diabetes care in a rural area and may serve as a model for other lowincome communities. Future prospective evaluations with more complete data are necessary for longer-term outcomes.	[Taniguchi, Dawn; LoGerfo, James; Haider, Mahri] Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA 98195 USA; [LoGerfo, James; Huster, Karin; Thomas, Bernadette] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [van Pelt, Maurits] MoPoTsyo Patient Informat Ctr, Phnom Penh, Cambodia; [Mielcarek, Bessie] Univ Washington, Dept Publ Hlth, Div Hlth Serv, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Taniguchi, D (corresponding author), Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA 98195 USA.	dawntani@uw.edu			MoPoTsyo Information Centre	MoPoTsyo Information Centre	Maurits van Pelt is the Director of MoPoTsyo Patient Information Centre, a nonprofit organization. MoPoTsyo Information Centre provided support in the form of salaries for author MVP and played a role in data collection. The organization did not have any additional role in the study design, analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Assah FK, 2015, DIABETIC MED, V32, P886, DOI 10.1111/dme.12720; Balagopal P, 2008, DIABETES CARE, V31, P1097, DOI 10.2337/dc07-1680; Balagopal P, 2012, DIABETES EDUCATOR, V38, P822, DOI 10.1177/0145721712459890; Baumann LC, 2015, INT J BEHAV MED, V22, P374, DOI 10.1007/s12529-014-9412-8; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Chalermsri Chalobol, 2014, Journal of the Medical Association of Thailand, V97, pS197; Fisher EB, 2012, HEALTH AFFAIR, V31, P130, DOI 10.1377/hlthaff.2011.0914; Funnell MM, 2010, FAM PRACT, V27, pI17, DOI 10.1093/fampra/cmp027; International Diabetes Federation, 2014, IDF DIAB ATLS 6 ED; International Diabetes Federation, 2013, IDF DIABETES ATLAS; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jayawardena MHDS, 2007, DIABETES RES CLIN PR, V75, P249, DOI 10.1016/j.diabres.2006.06.030; Jung CH, 2014, DIABETES RES CLIN PR, V104, pE34, DOI 10.1016/j.diabres.2014.02.008; Mafauzy M., 2011, MED J MALAYSIA, V66, P175; Men C, 2012, QUALITATIVE STUDY AC, P1; Otgontuya D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-254; Oum S, 2010, PREVALENCE NONCOMMUN; Raguenaud ME, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-33; Shivashankar R, 2015, DIABETES RES CLIN PR, V107, P203, DOI 10.1016/j.diabres.2014.11.004; Thomas B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086123; van Olmen Josefien, 2016, J Pharm Policy Pract, V9, P1, DOI 10.1186/s40545-016-0050-1; Van Olmen J, 2015, PRIM CARE DIABETES, V9, P196, DOI 10.1016/j.pcd.2014.09.001; Van Pelt M., 2009, DIABETES VOICE, V54, P15; Wei N, 2014, DIABETES CARE, V37, P1048, DOI 10.2337/dc13-2173; World Health Organization, 2008, PEER SUPP PROGR DIAB; World Health Organization, 2013, NONC DIS FACT SHEET; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE	27	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0181582	10.1371/journal.pone.0181582	http://dx.doi.org/10.1371/journal.pone.0181582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945753	Green Published, Green Submitted, gold			2022-12-27	WOS:000411645100002
J	Holterman, M; Karegar, A; Mooijman, P; van Megen, H; van den Elsen, S; Vervoort, MTW; Quist, CW; Karssen, G; Decraemer, W; Opperman, CH; Bird, DM; Kammenga, J; Goverse, A; Smant, G; Helder, J				Holterman, Martijn; Karegar, Akbar; Mooijman, Paul; van Megen, Hanny; van den Elsen, Sven; Vervoort, Mariette T. W.; Quist, Casper W.; Karssen, Gerrit; Decraemer, Wilfrida; Opperman, Charles H.; Bird, David M.; Kammenga, Jan; Goverse, Aska; Smant, Geert; Helder, Johannes			Disparate gain and loss of parasitic abilities among nematode lineages	PLOS ONE			English	Article							TOBACCO RATTLE VIRUS; LONGIDORIDAE NEMATODA; PHYLOGENETIC APPROACH; N. SP; EVOLUTION; DIPHTHEROPHORINA; TYLENCHOMORPHA; IDENTIFICATION; TRANSMISSION; COEVOLUTION	Plant parasitism has arisen time and again in multiple phyla, including bacteria, fungi, insects and nematodes. In most of these organismal groups, the overwhelming diversity hampers a robust reconstruction of the origins and diversification patterns of this trophic lifestyle. Being a moderately diversified phylum with approximate to 4,100 plant parasites (15% of total biodiversity) subdivided over four independent lineages, nematodes constitute a major organismal group for which the genesis of plant parasitism could be mapped. Since substantial crop losses worldwide have been attributed to less than 1% of these plant parasites, research efforts are severely biased towards this minority. With the first molecular characterisation of numerous basal and supposedly harmless plant parasites as well as their non-parasitic relatives, we were able to generate a comprehensive molecular framework that allows for the reconstruction of trophic diversification for a complete phylum. In each lineage plant parasites reside in a single taxonomic grouping (family or order), and by taking the coverage of the next lower taxonomic level as a measure for representation, 50, 67, 100 and 85% of the known diversity was included. We revealed distinct gain and loss patterns with regard to plant parasitism per se as well as host exploitation strategies between these lineages. Our map of parasitic nematode biodiversity also revealed an unanticipated time reversal in which the two most ancient lineages showed the lowest level of ecological diversification and vice versa.	[Holterman, Martijn; Mooijman, Paul; van Megen, Hanny; van den Elsen, Sven; Vervoort, Mariette T. W.; Quist, Casper W.; Kammenga, Jan; Goverse, Aska; Smant, Geert; Helder, Johannes] Wageningen Univ, Dept Plant Sci, Lab Nematol, Wageningen, Netherlands; [Karegar, Akbar] Shiraz Univ, Sch Agr, Dept Plant Protect, Shiraz, Iran; [Karssen, Gerrit] Wageningen Nematode Collect, Natl Plant Protect Org, Wageningen, Netherlands; [Decraemer, Wilfrida] Univ Ghent, Dept Biol, Nematol Res Unit, Ghent, Belgium; [Opperman, Charles H.; Bird, David M.] North Carolina State Univ, Dept Plant Pathol, Box 7616, Raleigh, NC 27695 USA	Wageningen University & Research; Shiraz University; Ghent University; University of North Carolina; North Carolina State University	Helder, J (corresponding author), Wageningen Univ, Dept Plant Sci, Lab Nematol, Wageningen, Netherlands.	Hans.Helder@wur.nl	Karegar, Akbar/V-1579-2018; Holterman, Martijn/GYQ-8578-2022; Karegar, Akbar/W-8047-2018; Decraemer, Wilfrida/AAD-2639-2020	Karegar, Akbar/0000-0002-2041-816X; Karegar, Akbar/0000-0002-2041-816X; Bird, David/0000-0002-1041-6769	Technology Foundation STVV; WBI [4725]	Technology Foundation STVV; WBI	Funding provided by the Technology Foundation STVV, WBI 4725.	[Anonymous], 2010, P GATEWAY COMPUTING; AYALA A, 1966, NEMATOLOGICA, V12, P87; B'CHIR M M, 1988, Revue de Nematologie, V11, P213; Blaxter M, 2015, PARASITOLOGY, V142, pS26, DOI 10.1017/S0031182014000791; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Bragard C, 2013, ANNU REV PHYTOPATHOL, V51, P177, DOI 10.1146/annurev-phyto-082712-102346; COOMANS A, 1985, AGR ECOSYST ENVIRON, V12, P335, DOI 10.1016/0167-8809(85)90006-4; Danchin EGJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003745; Davies KA, 2015, NEMATOLOGY, V17, P761, DOI 10.1163/15685411-00002907; de Almeida MTM, 2005, NEMATOLOGY, V7, P343, DOI 10.1163/156854105774355572; Decraemer W., 2013, Plant nematology, P179, DOI 10.1079/9781780641515.0179; Decraemer W, 2006, PLANT NEMATOLOGY, P3, DOI [10.1079/9781845930561.0003, 10.1079/9781780641515.0003]; Decraemer W, 2012, NEMATOLOGY, V14, P151, DOI 10.1163/138855411X581703; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; Forge T, 2012, CAN J PLANT PATHOL, V34, P277, DOI 10.1080/07060661.2012.689261; Giblin-Davis RM, 2001, J NEMATOL, V33, P239; GIBLINDAVIS RM, 1995, J NEMATOL, V27, P1; de Oliveira CMG, 2011, TROP PLANT PATHOL, V36, P65, DOI 10.1590/S1982-56762011000200001; He Y, 2005, NEMATOLOGY, V7, P111, DOI 10.1163/1568541054192108; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Huang RE, 2012, NEMATOLOGY, V14, P93, DOI 10.1163/138855411X579418; Hunt D. J., 2007, Journal of Nematode Morphology and Systematics, V10, P99; Hunt DJ, 1993, APHELENCHIDA LONGIDO; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Kanzaki N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099241; Kanzaki N, 2010, NEMATOLOGY, V12, P803, DOI 10.1163/138855410X499067; Karanastasi E, 2001, NEMATOLOGY, V3, P525, DOI 10.1163/156854101753389130; Kenrick P, 2012, PHILOS T R SOC B, V367, P519, DOI 10.1098/rstb.2011.0271; Knogge W, 1996, PLANT CELL, V8, P1711, DOI 10.1105/tpc.8.10.1711; Martinson EO, 2012, MICROB ECOL, V64, P1073, DOI 10.1007/s00248-012-0079-x; Nelson LA, 2014, BIOL J LINN SOC, V111, P699, DOI 10.1111/bij.12237; Oehlschlager AC, 2002, FLA ENTOMOL, V85, P507, DOI 10.1653/0015-4040(2002)085[0507:CORRDB]2.0.CO;2; Palomares-Rius JE, 2010, NEMATOLOGY, V12, P649, DOI 10.1163/138855410X489338; Paton AJ, 2008, TAXON, V57, P602, DOI 10.2307/25066027; Ragsdale EJ, 2011, ZOOL J LINN SOC-LOND, V161, P1, DOI 10.1111/j.1096-3642.2009.00632.x; Replogle A, 2013, MOL PLANT MICROBE IN, V26, P87, DOI 10.1094/MPMI-05-12-0118-FI; ROBBINS R T, 1985, Revue de Nematologie, V8, P215; Rota-Stabelli O, 2013, CURR BIOL, V23, P392, DOI 10.1016/j.cub.2013.01.026; Schellenberger P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002034; Shahina F., 1996, PAKISTAN J NEMATOL, V14, P1; Siddiqi M. R., 2000, TYLENCHIDA PARASITES; Simon JC, 2015, BRIEF FUNCT GENOMICS, V14, P413, DOI 10.1093/bfgp/elv015; Sturhan D, 2005, NEMATOLOGY, V7, P249, DOI 10.1163/1568541054879593; Taylor C.E., 1997, NEMATODE VECTORS PLA; Thines M, 2010, CURR OPIN PLANT BIOL, V13, P427, DOI 10.1016/j.pbi.2010.04.001; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Vellios E, 2002, VIROLOGY, V300, P118, DOI 10.1006/viro.2002.1511; Wubben MJ, 2010, J NEMATOL, V42, P342; YEATES GW, 1993, J NEMATOL, V25, P315; Zhang YC, 2001, CAN J ZOOL, V79, P16, DOI 10.1139/cjz-79-1-16	50	23	23	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185445	10.1371/journal.pone.0185445	http://dx.doi.org/10.1371/journal.pone.0185445			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934343	gold, Green Submitted, Green Published			2022-12-27	WOS:000411339900153
J	Chae, S; Kayembe, PK; Philbin, J; Mabika, C; Bankole, A				Chae, Sophia; Kayembe, Patrick K.; Philbin, Jesse; Mabika, Crispin; Bankole, Akinrinola			The incidence of induced abortion in Kinshasa, Democratic Republic of Congo, 2016	PLOS ONE			English	Article							MISOPROSTOL; TERMINATION; PREGNANCY	Background In the Democratic Republic of Congo, the penal code prohibits the provision of abortion. In practice, however, it is widely accepted that the procedure can be performed to save the life of a pregnant woman. Although abortion is highly restricted, anecdotal evidence indicates that women often resort to clandestine abortions, many of which are unsafe. However, to date, there are no official statistics or reliable data to support this assertion. Objectives Our study provides the first estimates of the incidence of abortion and unintended pregnancy in Kinshasa. Methods We applied the Abortion Incidence Complications Method (AICM) to estimate the incidence of abortion and unintended pregnancy. We used data from a Health Facilities Survey and a Prospective Morbidity Survey to determine the annual number of women treated for abortion complications at health facilities. We also employed data from a Health Professionals Survey to calculate a multiplier representing the number of abortions for every induced abortion complication treated in a health facility. Results In 2016, an estimated 37,865 women obtained treatment for induced abortion complications in health facilities in Kinshasa. For every woman treated in a facility, almost four times as many abortions occurred. In total, an estimated 146,713 abortions were performed, yielding an abortion rate of 56 per 1,000 women aged 15-49. Furthermore, more than 343,000 unintended pregnancies occurred, resulting in an unintended pregnancy rate of 147 per 1,000 women aged 15-49. Conclusions Increasing contraceptive uptake can reduce the number of women who experience unintended pregnancies, and as a consequence, result in fewer women obtaining unsafe abortions, suffering abortion complications, and dying needlessly from unsafe abortion. Increasing access to safe abortion and improving post-abortion care are other measures that can be implemented to reduce unsafe abortion and/or its negative consequences, including maternal mortality.	[Chae, Sophia; Philbin, Jesse; Bankole, Akinrinola] Guttmacher Inst, New York, NY USA; [Kayembe, Patrick K.] Univ Kinshasa, Sch Publ Hlth, Dept Epidemiol & Biostat, Kinshasa, DEM REP CONGO; [Mabika, Crispin] Univ Kinshasa, Dept Populat Sci & Dev, Kinshasa, DEM REP CONGO; [Chae, Sophia] Populat Council, 1230 York Ave, New York, NY 10021 USA	Universite de Kinshasa; Universite de Kinshasa; Population Council	Kayembe, PK (corresponding author), Univ Kinshasa, Sch Publ Hlth, Dept Epidemiol & Biostat, Kinshasa, DEM REP CONGO.	patkayembe@gmail.com	Chae, Sophia/AAU-8160-2020; Dangal, Ganesh/O-1989-2017	Chae, Sophia/0000-0002-9232-4779; Dangal, Ganesh/0000-0002-5834-5525	David and Lucile Packard Foundation [2014-40476]; Swedish International Development Cooperation Agency [61050130]; UK Government [203177-101]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Swedish International Development Cooperation Agency; UK Government	This study was funded by the David and Lucile Packard Foundation (https://www.packard.org), grant number 2014-40476; the Swedish International Development Cooperation Agency (http://www.sida.se/English/), grant number ID 61050130; and the UK Government (https://www.gov.uk/government/organisations/department-for-international-development), grant number 203177-101.	[Anonymous], 2014, ENQ DEM SANT REP DEM; Anyangwe Stella C E, 2007, Int J Environ Res Public Health, V4, P93, DOI 10.3390/ijerph2007040002; Bankole A, 2015, INT PERSPECT SEX R H, V41, P170, DOI 10.1363/4117015; Basinga P, 2012, STUD FAMILY PLANN, V43, P11, DOI 10.1111/j.1728-4465.2012.00298.x; Bongaarts J, 2013, FERTILITY BIOL BEHAV; Borgatta L, 2004, CONTRACEPTION, V70, P121, DOI 10.1016/j.contraception.2004.03.007; Bruckner TA, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1397-2; CARE, 2007, VOIC VILL IMPR LIV C; Coast E, 2016, SOC SCI MED, V153, P201, DOI 10.1016/j.socscimed.2016.02.025; Elul B, 1999, CONTRACEPTION, V59, P107, DOI 10.1016/S0010-7824(99)00003-7; Fernandez MM, 2009, INT J GYNECOL OBSTET, V105, P180, DOI 10.1016/j.ijgo.2008.12.016; Ganle JK, 2016, AFR J REPROD HEALTH, V20, P43, DOI 10.29063/ajrh2016/v20i2.5; Gomperts R, 2012, ACTA OBSTET GYN SCAN, V91, P226, DOI 10.1111/j.1600-0412.2011.01285.x; Institut National de la Statistique, 2014, RES ENQ EMPL SEC INF; Jewkes R, 2005, SCI LETT; Juarez F, 2008, INT FAM PLAN PERSPEC, V34, P158, DOI [10.1363/3415808, 10.1363/ifpp.34.158.08]; Kalonda J C Omba, 2012, Rev Med Brux, V33, P482; Kayembe PK, 2006, CONTRACEPTION, V74, P400, DOI 10.1016/j.contraception.2006.06.006; Levandowski BA, 2013, INT PERSPECT SEX R H, V39, P88, DOI 10.1363/3908813; Lupwana K., 2011, 6 AFR POP C OUAG BUR; Newhall Elizabeth Pirruccello, 2000, American Journal of Obstetrics and Gynecology, V183, pS44; Ngoc Nguyen Thi Nhu, 2011, Contraception, V83, P410, DOI 10.1016/j.contraception.2010.09.002; Paluku LJ, 2010, AFR J PRIM HEALTH CA, V2, DOI 10.4102/phcfm.v2i1.78; Parnell AM, 1998, J BIOSOC SCI, V30, P321, DOI 10.1017/S0021932098003216; PMA2020, 2017, PMA 2016 KINSH R4 PE; Porter Ian, 1980, HUMAN EMBRYONIC FETA; Prada E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165812; Prada E, 2011, INT PERSPECT SEX R H, V37, P114, DOI 10.1363/3711411; Puri M, 2016, INT PERSPECTIVES SEX; RDC, 2009, GENR FAM ENF, P86; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sedgh G, 2016, LANCET, V388, P258, DOI 10.1016/S0140-6736(16)30380-4; Sedgh G, 2015, INT PERSPECT SEX R H, V41, P11, DOI 10.1363/4101115; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; SERBANESCU F, 1995, STUD FAMILY PLANN, V26, P76, DOI 10.2307/2137933; SHAPIRO D, 1994, STUD FAMILY PLANN, V25, P96, DOI 10.2307/2138087; Sherris J, 2005, INT J GYNECOL OBSTET, V88, P76, DOI 10.1016/j.ijgo.2004.09.006; Singh S, 2012, INT PERSPECT SEX R H, V38, P122, DOI 10.1363/3812212; UN Population Division, 2014, AB POL REPR HLTH WOR; United Nation Population Division, 2015, WORLD URB PROSP 2014; United Nations, 2015, 2030 AG SUST DEV; United Nations Population Division, 2002, ABORT POL GLOB REV; von Hertzen H, 2007, LANCET, V369, P1938, DOI 10.1016/S0140-6736(07)60914-3; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; Women's Refugee Commission, 2012, ADOLESCENT SEXUAL RE	45	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0184389	10.1371/journal.pone.0184389	http://dx.doi.org/10.1371/journal.pone.0184389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968414	Green Published, Green Submitted, gold			2022-12-27	WOS:000412029600007
J	Wozniak, P; Kontek, B; Rozanski, W; Olas, B				Wozniak, Pawel; Kontek, Bogdan; Rozanski, Waldemar; Olas, Beata			Evaluation of hemostasis parameters and the role of the oxidative damage to plasma proteins in the modulation of hemostasis in patients with nephrolithiasis before and after extracorporeal shock wave lithotripsy	PLOS ONE			English	Article							PLATELET MEMBRANES; DISULFIDE GROUPS; STRESS; SULFHYDRYL; RAT	Purpose Extracorporeal shock wave lithotripsy (ESWL) is a commonly-used method in urology, which may modulate hemostasis and may induce lipid peroxidation in patients with nephrolithiasis. However, previous studies only examine changes occurring in patients 30-240 min after ESWL. The main aim of the present study was to determine whether oxidative stress may modulate the hemostatic activity of plasma in patients with nephrolithiasis before ESWL and the day after treatment ESWL. This will be performed by measuring selected parameters of hemostasis in these patients, both before ESWL and the following day, and assessing the level of oxidative damage to plasma proteins in these patients by measuring two biomarkers. Methods Twelve patients with nephrolithiasis and 10 healthy participants were included. The following parameters of hemostasis were measured: the activated partial thromboplastin time (APTT), prothrombin time (PT), and thrombin time (TT) of plasma, the level of fibrinogen, the level of D-dimer and blood platelet count. In addition, two selected biomarkers of oxidative stress were measured: protein carbonylation level and the number of protein thiol groups. Results No difference was observed between patients with nephrolithiasis before and after ESWL and healthy controls with regard to PT, TT or APTT. Fibrinogen concentration and blood platelet count were lower in the nephrolithiasis patients in the period after ESWL than before ESWL. The nephrolithiasis patients demonstrated elevated D-dimer concentration after ESWL. However, although oxidative damage was observed in the plasma proteins in the nephrolithiasis patients, this was not influenced by ESWL. Conclusion Oxidative stress may induce changes of hemostasis in patients with nephrolithiasis, both before and after ESWL. In addition, changes of hemostasis parameters such as fibrinogen, blood platelet count and D-dimer level can be observed in these patients, especially after ESWL, and this may suggest that ESWL modulates hemostasis. By having a better understanding of the influence of ESWL on hemostasis, this could lead to modifying patient care for those patients at increased risk of bleeding.	[Wozniak, Pawel; Rozanski, Waldemar] Med Univ Lodz, Dept Urol 2, Pabianicka 62, Lodz, Poland; [Kontek, Bogdan; Olas, Beata] Univ Lodz, Fac Biol & Environm Protect, Dept Gen Biochem, Pomorska 141-3, Lodz, Poland	Medical University Lodz; University of Lodz	Olas, B (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Gen Biochem, Pomorska 141-3, Lodz, Poland.	beata.olas@biol.uni.lodz.pl		Olas, Beata/0000-0002-7048-2952; Kontek, Bogdan/0000-0002-6098-2494	University of Lodz [506/1136]	University of Lodz	This work was supported by grant 506/1136 from the University of Lodz to BO.	ANDO Y, 1973, BIOCHIM BIOPHYS ACTA, V311, P26, DOI 10.1016/0005-2736(73)90251-4; ANDO Y, 1973, BIOCHIM BIOPHYS ACTA, V311, P38, DOI 10.1016/0005-2736(73)90252-6; Bartosz G., 2008, DRUGA TWARZ TLENU, V1.7, P99; Boonla C, 2007, UROL RES, V35, P185, DOI 10.1007/s00240-007-0098-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ceban E, 2016, J Med Life, V9, P259; Dedej T, 2013, G CHIR, V34, P202, DOI 10.11138/gchir/2013.34.7.202; Garca MF, 2014, TOXICOL IND HEALTH, V30, P454, DOI 10.1177/0748233712457452; Gecit I, 2012, CELL BIOCHEM FUNCT, V30, P303, DOI 10.1002/cbf.2802; Hughes SF, 2015, PLOS ONE, P1; Khan SR, 2013, MINERVA MED, V104, P23; Khan SR, 2014, TRANSL ANDROL UROL, V3, P256, DOI 10.3978/j.issn.2223-4683.2014.06.04; Khan SR, 2013, J UROLOGY, V189, P803, DOI 10.1016/j.juro.2012.05.078; Khan SR, 2012, UROL RES, V40, P95, DOI 10.1007/s00240-011-0448-9; Khan SR, 2005, UROL RES, V33, P349, DOI 10.1007/s00240-005-0492-4; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Ma M- C, 2014, UROLOGY, V8, P1; Moyes AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179599; Nowak Pawel, 2010, Postepy Biochem, V56, P239; SHACTER E, 1995, FREE RADICAL BIO MED, V18, P815, DOI 10.1016/0891-5849(95)93872-4; Shacter E, 1994, FREE RADIC BIOL MED, V36, P316; UMEKAWA T, 1993, UROL INT, V50, P159, DOI 10.1159/000282475	22	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185157	10.1371/journal.pone.0185157	http://dx.doi.org/10.1371/journal.pone.0185157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968428	Green Published, gold, Green Submitted			2022-12-27	WOS:000412029600015
J	Magliozzi, L; Almada, F; Robalo, J; Mollo, E; Polese, G; Goncalves, EJ; Felline, S; Terlizzi, A; D'Aniello, B				Magliozzi, Laura; Almada, Frederico; Robalo, Joana; Mollo, Ernesto; Polese, Gianluca; Goncalves, Emanuel J.; Felline, Serena; Terlizzi, Antonio; D'Aniello, Biagio			Cryptic effects of biological invasions: Reduction of the aggressive behaviour of a native fish under the influence of an "invasive" biomolecule	PLOS ONE			English	Article							RACEMOSA VAR. CYLINDRACEA; CAULERPA-RACEMOSA; MACROALGAL ASSEMBLAGES; MULTIVARIATE-ANALYSIS; MEDITERRANEAN SEA; PERMUTATION TESTS; MIRROR TESTS; DENSITY; GROWTH; LATERALIZATION	The invasive green alga Caulerpa cylindracea has become an important component of the diet of the Mediterranean white seabream Diplodus sargus. As a consequence of this "exotic diet", the algal bisindolic alkaloid caulerpin accumulates in the fish tissues. Although the compound shows structural similarity to endogenous indolamines that modulate animal behaviour, the potential impact of caulerpin on fish behaviour still remains unexplored. In this report, behavioural experiments both on groups and on single fish responding towards a mirror were performed under different doses of dietary caulerpin. Differences between treated and control groups for each behaviour and for the overall aggressive pattern during the different experimental phases showed that the aggressiveness of D. sargus decreased with the administration of caulerpin. These results call the attention to a still unexplored potential ability of bioactive metabolites from marine invasive species, to alter the behaviour on native species, with putative negative effects on patterns of fish growth and population dynamics.	[Magliozzi, Laura; Felline, Serena] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, Lecce, Italy; [Magliozzi, Laura; Polese, Gianluca; D'Aniello, Biagio] Univ Napoli Federico II, Dipartimento Biol, Naples, Italy; [Almada, Frederico; Robalo, Joana; Goncalves, Emanuel J.] ISPA Inst Univ, MARE Marine & Environm Sci Ctr, Lisbon, Portugal; [Mollo, Ernesto] CNR, Ist Chim Biomol, Naples, Italy; [Terlizzi, Antonio] Univ Trieste, Dipartimento Sci Vita, CoNISMa, Trieste, Italy; [Terlizzi, Antonio] Staz Zool A Dohrn, Naples, Italy	University of Salento; University of Naples Federico II; Instituto Superior Psicologia Aplicada (ISPA); Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); CoNISMa; University of Trieste; Stazione Zoologica Anton Dohrn di Napoli	D'Aniello, B (corresponding author), Univ Napoli Federico II, Dipartimento Biol, Naples, Italy.	biagio.daniello@unina.it	Terlizzi, Antonio/B-6131-2015; Polese, Gianluca/P-4444-2019; Almada, Frederico/AAC-4340-2020; Mollo, Ernesto/F-7842-2013; Polese, Gianluca/F-3496-2013; Robalo, Joana Isabel/N-9960-2014; Robalo, Joana I./HIK-2365-2022; D'Aniello, Biagio/N-5287-2019	Terlizzi, Antonio/0000-0001-5968-4548; Polese, Gianluca/0000-0002-6322-7769; Almada, Frederico/0000-0002-1389-8951; Mollo, Ernesto/0000-0001-7379-1788; Polese, Gianluca/0000-0002-6322-7769; Robalo, Joana Isabel/0000-0002-7470-0574; Robalo, Joana I./0000-0002-7470-0574; D'Aniello, Biagio/0000-0002-1176-946X; Goncalves, Emanuel/0000-0002-3918-6215; Felline, Serena/0000-0003-1221-7306	Fundacao para a Ciencia e a Tecnologia - FCT; FEDER; MARE [UID/MAR/04292/2013]; MIUR (The Italian Ministry of Education, Universities and Research) (PRIN); EU; Unisalento BIOFORIU infrastructure; FCT [SFRH/BPD/63170/2009]; MARE/ISPA-IU project; Environmental Municipal Company of Cascais (EMAC, SA) [009.DMT.2016]	Fundacao para a Ciencia e a Tecnologia - FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER(European Commission); MARE; MIUR (The Italian Ministry of Education, Universities and Research) (PRIN)(Ministry of Education, Universities and Research (MIUR)); EU(European Commission); Unisalento BIOFORIU infrastructure; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); MARE/ISPA-IU project; Environmental Municipal Company of Cascais (EMAC, SA)	This study was funded by the Fundacao para a Ciencia e a Tecnologia - FCT (partially FEDER funded), now included in MARE (UID/MAR/04292/2013) (MARE/ISPA-IU), by MIUR (The Italian Ministry of Education, Universities and Research) (PRIN 2012, CAULERFISH project), and by the EU FP7 PERSEUS Project. L.M. PhD grant was supported by Unisalento BIOFORIU infrastructure. F.A. postdoctoral fellowship was supported by FCT (SFRH/BPD/63170/2009). This work was also supported by a MARE/ISPA-IU project aiming for the biological monitoring of the Marine Protected Area of Avencas, financed by the Environmental Municipal Company of Cascais (EMAC,SA)(http://www.cm-cascais.pt/empresa-municipal/cascais-ambtente), through direct invitation following public contract procedures (int. reference 009.DMT.2016). The funder or individuals employed or contracted by the funder played no role in the research.	Cavalcante-Silva LHA, 2013, MAR DRUGS, V11, P1553, DOI 10.3390/md11051553; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Ariyomo TO, 2013, ANIM BEHAV, V86, P617, DOI 10.1016/j.anbehav.2013.06.019; Balzarini V, 2014, BEHAV ECOL SOCIOBIOL, V68, P871, DOI 10.1007/s00265-014-1698-7; Box A, 2009, J EXP MAR BIOL ECOL, V380, P11, DOI 10.1016/j.jembe.2009.08.010; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Desjardins JK, 2010, BIOL LETTERS, V6, P744, DOI 10.1098/rsbl.2010.0247; Deudero S, 2011, ESTUAR COAST SHELF S, V93, P106, DOI 10.1016/j.ecss.2011.03.017; Estabrook G.F., 2002, Acta Ethologica, V4, P73; Felline S, 2014, MAR BIOL, V161, P1275, DOI 10.1007/s00227-014-2417-7; Felline S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038763; Goncalves AR, 2015, ENVIRON BIOL FISH, V98, P1015, DOI 10.1007/s10641-014-0334-8; Gorbi S, 2014, MAR ENVIRON RES, V96, P2, DOI 10.1016/j.marenvres.2014.01.010; Gorley C.K., 2006, GETTING STARTED PRIM; HOLM JC, 1990, AQUACULTURE, V89, P225, DOI 10.1016/0044-8486(90)90128-A; Huntingford F, 2012, PHYSIOL BIOCHEM ZOOL, V85, P585, DOI 10.1086/668204; JORGENSEN EH, 1993, AQUACULTURE, V110, P191, DOI 10.1016/0044-8486(93)90272-Z; Killen SS, 2014, FUNCT ECOL, V28, P1367, DOI 10.1111/1365-2435.12296; Killen SS, 2013, TRENDS ECOL EVOL, V28, P651, DOI 10.1016/j.tree.2013.05.005; Klein J, 2008, MAR POLLUT BULL, V56, P205, DOI 10.1016/j.marpolbul.2007.09.043; Kochanowska-Karamyan AJ, 2010, CHEM REV, V110, P4489, DOI 10.1021/cr900211p; Madison BN, 2015, CAN J FISH AQUAT SCI, V72, P673, DOI 10.1139/cjfas-2014-0409; Maiti BC, 1978, J CHEM RES SYNOP, P126; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McCormick MI, 2012, P ROY SOC B-BIOL SCI, V279, P3899, DOI 10.1098/rspb.2012.0854; McCormick MI, 2010, MAR ECOL PROG SER, V407, P173, DOI 10.3354/meps08583; Mollo E, 2008, P NATL ACAD SCI USA, V105, P4582, DOI 10.1073/pnas.0709355105; Mollo E, 2015, BIOL INVASIONS, V17, P941, DOI 10.1007/s10530-014-0835-6; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Oliveira RF, 2005, NATURE, V437, P207, DOI 10.1038/437207a; Papoutsoglou SE, 2006, AQUAC RES, V37, P87, DOI 10.1111/j.1365-2109.2005.01401.x; Piazzi L, 2005, ESTUAR COAST SHELF S, V64, P467, DOI 10.1016/j.ecss.2005.03.010; Piazzi L, 2001, BOT MAR, V44, P509, DOI 10.1515/BOT.2001.057; Piazzi L, 2008, MAR ENVIRON RES, V65, P50, DOI 10.1016/j.marenvres.2007.07.002; Piazzi L, 2006, ESTUAR COAST SHELF S, V68, P455, DOI 10.1016/j.ecss.2006.02.011; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Raniello R, 2007, BIOL INVASIONS, V9, P361, DOI 10.1007/s10530-006-9044-2; Scherer U, 2016, J FISH BIOL, V89, P1866, DOI 10.1111/jfb.13069; Scott GR, 2004, AQUAT TOXICOL, V68, P369, DOI 10.1016/j.aquatox.2004.03.016; Terlizzi A, 2011, AQUAT BIOL, V12, P109, DOI 10.3354/ab00330; Vazquez-Luis M, 2009, ESTUAR COAST SHELF S, V84, P161, DOI 10.1016/j.ecss.2009.04.016; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Winberg S, 1996, BRAIN BEHAV EVOLUT, V48, P213, DOI 10.1159/000113199	48	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185620	10.1371/journal.pone.0185620	http://dx.doi.org/10.1371/journal.pone.0185620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961266	Green Published, Green Submitted, gold			2022-12-27	WOS:000412027700027
J	Vinod, N; Noh, HB; Oh, S; Ji, S; Park, HJ; Lee, KS; Kim, SC; Park, HO; Yang, JS; Choi, CW				Vinod, Nagarajan; Noh, Han Byul; Oh, Sung; Ji, Seongmi; Park, Hyun Jung; Lee, Ki-Sung; Kim, Sei Chang; Park, Han-Oh; Yang, Joo-Sung; Choi, Chang Won			A Salmonella typhimurium ghost vaccine induces cytokine expression in vitro and immune responses in vivo and protects rats against homologous and heterologous challenges	PLOS ONE			English	Article							EDWARDSIELLA-TARDA GHOSTS; NADPH PHAGOCYTE OXIDASE; DETOXIFIED LIPOPOLYSACCHARIDE; ANTIBIOTIC SUSCEPTIBILITY; VIRULENT CHALLENGE; DENDRITIC CELLS; DOSE-RESPONSE; LIVE; INFECTION; MACROPHAGES	Salmonella enteritidis and Salmonella typhimurium are important food-borne bacterial pathogens, which are responsible for diarrhea and gastroenteritis in humans and animals. In this study, S. typhimurium bacterial ghost (STG) was generated based on minimum inhibitory concentration (MIC) of sodium hydroxide (NaOH). Experimental studies performed using in vitro and in vivo experimental model systems to characterize effects of STG as a vaccine candidate. When compared with murine macrophages (RAW 264.7) exposed to PBS buffer (98.1%), the macrophages exposed to formalin-killed inactivated cells (FKC), live wild-type bacterial cells and NaOH-induced STG at 1 x 10(8) CFU/mL showed 85.6%, 66.5% and 84.6% cell viability, respectively. It suggests that STG significantly reduces the cytotoxic effect of wild-type bacterial cells. Furthermore, STG is an excellent inducer for mRNAs of pro-inflammatory cytokine (TNF-alpha, IL-1 beta) and factor (iNOS), anti-inflammatory cytokine (IL-10) and dual activities (IL-6) in the stimulated macrophage cells. In vivo, STG vaccine induced humoral and cellular immune responses and protection against homologous and heterologous challenges in rats. Furthermore, the immunogenicity and protective efficacy of STG vaccine were compared with those of FKC and non-vaccinated PBS control groups. The vaccinated rats from STG group exhibited higher levels of serum IgG antibody responses, serum bactericidal antibodies, and CD4(+) and CD8(+) T-cell populations than those of the FKC and PBS control groups. Most importantly, after challenge with homologous and heterologous strains, the bacterial loads in the STG group were markedly lower than the FKC and PBS control groups. In conclusion, these findings suggest that the STG vaccine induces protective immunity against homologous and heterologous challenges.	[Vinod, Nagarajan; Noh, Han Byul; Oh, Sung; Ji, Seongmi; Park, Hyun Jung; Lee, Ki-Sung; Kim, Sei Chang; Park, Han-Oh; Choi, Chang Won] Pai Chai Univ, Dept Biol & Med Sci, Daejeon, South Korea; [Park, Han-Oh; Yang, Joo-Sung] Bioneer Corp, New Drug R&D Ctr, Daejeon, South Korea	Pai Chai University	Choi, CW (corresponding author), Pai Chai Univ, Dept Biol & Med Sci, Daejeon, South Korea.	choicw@pcu.ac.kr		Nagarajan, Vinod/0000-0002-3765-8194; Choi, Chang Won/0000-0002-6175-2455	Human Resource Training Program for Regional Innovation and Creativity through the Ministry of Education and National Research Foundation of Korea [2015035949]	Human Resource Training Program for Regional Innovation and Creativity through the Ministry of Education and National Research Foundation of Korea(Ministry of Education (MOE), Republic of Korea)	This work was supported by the Human Resource Training Program for Regional Innovation and Creativity through the Ministry of Education and National Research Foundation of Korea (2015035949). As shown in the title of this government project, a final goal of the project is basically fostering graduate students to fit for industries and to have a job experience for a month with a partner company. Of course, graduate students should have performed R&D research to get salaries from the project. After graduation, some qualified graduate students can have a job in the company involved in the project. In this respect, the government requires principal investigators to include a commercial company in this project as a partner. The government and company support 90% and 10% of the fund, respectively. "The commercial funder provided support in the form of salaries for authors [HBN, SO, SJ, HJP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amara AA, 2013, THESCIENTIFICWORLDJO, V2013, P1; Amara AA, 2013, SAUDI PHARM J, V22, P273; BARROW PA, 1990, EPIDEMIOL INFECT, V104, P413, DOI 10.1017/S0950268800047439; Breuil J, 1996, MED MALADIES INFECT, V26, P420, DOI 10.1016/S0399-077X(96)80186-7; Casin I, 1996, MED MALADIES INFECT, V26, P426, DOI 10.1016/S0399-077X(96)80187-9; Chaudhari AA, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-44; CIZNAR I, 1970, Infection and Immunity, V2, P549; COOPER GL, 1992, VACCINE, V10, P247, DOI 10.1016/0264-410X(92)90160-L; DARODEN L, 1992, AM J VET RES, V53, P1895; Eko FO, 2000, J BIOTECHNOL, V83, P115, DOI 10.1016/S0168-1656(00)00315-1; HABASHA FG, 1985, AM J VET RES, V46, P1415; Harrison JA, 1997, IMMUNOLOGY, V90, P618, DOI 10.1046/j.1365-2567.1997.00158.x; HASSAN JO, 1994, INFECT IMMUN, V62, P5519, DOI 10.1128/IAI.62.12.5519-5527.1994; Havelaar AH, 2001, J APPL MICROBIOL, V91, P442, DOI 10.1046/j.1365-2672.2001.01399.x; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; HORMAECHE CE, 1991, MICROB PATHOGENESIS, V10, P149, DOI 10.1016/0882-4010(91)90075-L; Hormaeche CE, 1996, VACCINE, V14, P251, DOI 10.1016/0264-410X(95)00249-Z; Hossain M. M. M., 2012, Bangladesh Veterinarian, V29, P31, DOI 10.3329/bvet.v29i1.11889; HOUGEN HP, 1989, APMIS, V97, P825, DOI 10.1111/j.1699-0463.1989.tb00484.x; Hu MM, 2013, CLIN VACCINE IMMUNOL, V20, P795, DOI 10.1128/CVI.00676-12; Jawale CV, 2012, INFECT IMMUN, V80, P1502, DOI 10.1128/IAI.06264-11; Kwon SR, 2005, AQUACULTURE, V250, P16, DOI 10.1016/j.aquaculture.2005.02.052; Langemann Timo, 2010, Bioeng Bugs, V1, P326, DOI 10.4161/bbug.1.5.12540; Lillehoj Hyun, 2003, Journal of Poultry Science, V40, P151, DOI 10.2141/jpsa.40.151; Lubitz P, 2009, ADV EXP MED BIOL, V655, P159, DOI 10.1007/978-1-4419-1132-2_12; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Martel JL, 1996, MED MALADIES INFECT, V26, P415, DOI 10.1016/S0399-077X(96)80185-5; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Mastroeni Pietro, 2002, Current Molecular Medicine (Hilversum), V2, P393, DOI 10.2174/1566524023362492; Mayr UB, 2012, MICROB BIOTECHNOL, V5, P283, DOI 10.1111/j.1751-7915.2011.00316.x; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; PALVA ET, 1978, J BACTERIOL, V136, P286, DOI 10.1128/JB.136.1.286-294.1978; PALVA ET, 1980, EUR J BIOCHEM, V107, P137, DOI 10.1111/j.1432-1033.1980.tb04634.x; Park H.J., 2016, INT J MOL SCI, V17; Peng W, 2011, IMMUNOBIOLOGY, V216, P558, DOI 10.1016/j.imbio.2010.10.001; Rabsch W, 2001, MICROBES INFECT, V3, P237, DOI 10.1016/S1286-4579(01)01375-2; REDMAN TK, 1995, INFECT IMMUN, V63, P2004, DOI 10.1128/IAI.63.5.2004-2011.1995; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Rosenberger CM, 2000, J IMMUNOL, V164, P5894, DOI 10.4049/jimmunol.164.11.5894; Salerno-Goncalves R, 2002, J IMMUNOL, V169, P2196, DOI 10.4049/jimmunol.169.4.2196; SCHAT KA, 1994, POULTRY SCI, V73, P1077, DOI 10.3382/ps.0731077; SEID RC, 1981, J BIOL CHEM, V256, P7305; SMITH BP, 1993, AM J VET RES, V54, P1249; STUBBS AD, 1994, J CLIN MICROBIOL, V32, P199, DOI 10.1128/JCM.32.1.199-201.1994; Svensson M, 2001, MICROB PATHOGENESIS, V31, P91, DOI 10.1006/mpat.2001.0448; Vazquez-Torres A, 2001, TRENDS MICROBIOL, V9, P29, DOI 10.1016/S0966-842X(00)01897-7; Vazquez-Torres A, 2001, P NATL ACAD SCI USA, V98, P2561, DOI 10.1073/pnas.041618998; VillarrealRamos B, 1998, VACCINE, V16, P45, DOI 10.1016/S0264-410X(97)00156-4; Vinod N, 2015, INFECT IMMUN, V83, P2957, DOI 10.1128/IAI.00009-15; Vinod N, 2014, VACCINE, V32, P3249, DOI 10.1016/j.vaccine.2014.03.090; VONESCHEN KB, 1976, J IMMUNOL, V116, P8; Wang XP, 2009, VACCINE, V27, P1571, DOI 10.1016/j.vaccine.2009.01.002; Yrlid U, 2001, MICROBES INFECT, V3, P1239, DOI 10.1016/S1286-4579(01)01484-8; Zhao CF, 2006, EUR J IMMUNOL, V36, P2939, DOI 10.1002/eji.200636179; Zhu WX, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/760730	57	17	18	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185488	10.1371/journal.pone.0185488	http://dx.doi.org/10.1371/journal.pone.0185488			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961267	Green Submitted, gold, Green Published			2022-12-27	WOS:000412027700021
J	Voxeur, A; Soubigou-Taconnat, L; Legee, F; Sakai, K; Antelme, S; Durand-Tardif, M; Lapierre, C; Sibout, R				Voxeur, Aline; Soubigou-Taconnat, Ludivine; Legee, Frederic; Sakai, Kaori; Antelme, Sebastien; Durand-Tardif, Mylene; Lapierre, Catherine; Sibout, Richard			Altered lignification in mur1-1 a mutant deficient in GDP-L-fucose synthesis with reduced RG-II cross linking	PLOS ONE			English	Article							POLYSACCHARIDE RHAMNOGALACTURONAN-II; PLANT-CELL; PECTIC POLYSACCHARIDE; ARABIDOPSIS-THALIANA; FUNCTIONAL GENOMICS; WALLS; BORON; JASMONATE; CELLULOSE; GROWTH	In the plant cell wall, boron links two pectic domain rhamnogalacturonan II (RG-II) chains together to form a dimer and thus contributes to the reinforcement of cell adhesion. We studied the mur1-1 mutant of Arabidopsis thaliana which has lost the ability to form GDP-fucose in the shoots and show that the extent of RG-II cross-linking is reduced in the lignified stem of this mutant. Surprisingly, MUR1 mutation induced an enrichment of resistant interunit bonds in lignin and triggered the overexpression of many genes involved in lignified tissue formation and in jasmonic acid signaling. The defect in GDP-fucose synthesis induced a loss of cell adhesion at the interface between stele and cortex, as well as between interfascicular fibers. This led to the formation of regenerative xylem, where tissue detachment occurred, and underlined a loss of resistance to mechanical forces. Similar observations were also made on bor1-3 mutant stems which are altered in boron xylem loading, leading us to suggest that diminished RG-II dimerization is responsible for regenerative xylem formation.	[Voxeur, Aline; Legee, Frederic; Sakai, Kaori; Antelme, Sebastien; Durand-Tardif, Mylene; Lapierre, Catherine; Sibout, Richard] Univ Paris Saclay, CNRS, Inst Jean Pierre Bourgin, AgroParisTech,INRA, Versailles, France; [Soubigou-Taconnat, Ludivine] Univ Paris Saclay, Univ Evry, Univ Paris Sud, Inst Plant Sci Paris Saclay IPS2,CNRS,INRA, Orsay, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay	Sibout, R (corresponding author), Univ Paris Saclay, CNRS, Inst Jean Pierre Bourgin, AgroParisTech,INRA, Versailles, France.	richard.sibout@inra.fr	Lapierre, Catherine/AAD-9209-2020; Voxeur, Aline/O-7149-2015	Voxeur, Aline/0000-0001-9452-6756; Mylene, Durand-Tardif/0000-0003-1568-6941; Kaori, SAKAI/0000-0001-9007-1192; Lapierre, Catherine/0000-0002-6757-1524	ANR Projects NoStressWall [ANR-12-ADAP-0011]; BFF project	ANR Projects NoStressWall(French National Research Agency (ANR)); BFF project	This work was supported in part by the ANR Projects NoStressWall (ANR-12-ADAP-0011) and by the BFF project.	ADLER E, 1977, WOOD SCI TECHNOL, V11, P169, DOI 10.1007/BF00365615; Ahn JW, 2006, J BIOL CHEM, V281, P13708, DOI 10.1074/jbc.M512403200; Asahina M, 2011, P NATL ACAD SCI USA, V108, P16128, DOI 10.1073/pnas.1110443108; BELL E, 1993, PLANT PHYSIOL, V103, P1133, DOI 10.1104/pp.103.4.1133; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Cabane A M, 2004, PLANT PHYSIOL, V134, P586; Caldelari D, 2011, PLANT MOL BIOL, V75, P25, DOI 10.1007/s11103-010-9701-9; Chormova D, 2014, PLANT J, V77, P534, DOI 10.1111/tpj.12403; clade L. A, 2010, PLANT MOL BIOL, V73, P605; Daher FB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00523; Delmas F, 2008, J EXP BOT, V59, P2639, DOI 10.1093/jxb/ern118; Dence CW, 1992, METHODS LIGNIN CHEM, P33, DOI DOI 10.1007/978-3-642-74065-7_3; Donaldson LA, 2001, PHYTOCHEMISTRY, V57, P859, DOI 10.1016/S0031-9422(01)00049-8; Dumont M, 2014, ANN BOT-LONDON, V114, P1177, DOI 10.1093/aob/mcu093; Flaishman MA, 2003, J PLANT GROWTH REGUL, V22, P253, DOI 10.1007/s00344-003-0030-y; Gagnot S, 2008, NUCLEIC ACIDS RES, V36, pD986, DOI 10.1093/nar/gkm757; Ge YC, 2003, TEST-SPAIN, V12, P1, DOI 10.1007/BF02595811; Glushka JN, 2003, CARBOHYD RES, V338, P341, DOI 10.1016/S0008-6215(02)00461-5; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; JARVIS MC, 1984, PLANT CELL ENVIRON, V7, P153, DOI 10.1111/1365-3040.ep11614586; Ko JH, 2004, PLANT MOL BIOL, V55, P433, DOI 10.1007/s11103-004-1051-z; Lapierre C, 1999, PLANT PHYSIOL, V119, P153, DOI 10.1104/pp.119.1.153; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Lerouxel O, 2002, PLANT PHYSIOL, V130, P1754, DOI 10.1104/pp.011965; LEWIS DH, 1980, NEW PHYTOL, V84, P209, DOI 10.1111/j.1469-8137.1980.tb04423.x; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Matoh T, 1998, PLANT CELL PHYSIOL, V39, P483, DOI 10.1093/oxfordjournals.pcp.a029395; Matsunaga T, 2004, PLANT PHYSIOL, V134, P339, DOI 10.1104/pp.103.030072; Melida H, 2015, J INTEGR PLANT BIOL, V57, P357, DOI 10.1111/jipb.12346; Miwa K, 2013, PLANT PHYSIOL, V163, P1699, DOI 10.1104/pp.113.225995; Nakamura A, 2001, BIOSCI BIOTECH BIOCH, V65, P2249, DOI 10.1271/bbb.65.2249; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Noguchi K, 1997, PLANT PHYSIOL, V115, P901, DOI 10.1104/pp.115.3.901; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Obayashi T, 2010, J PLANT RES, V123, P311, DOI 10.1007/s10265-010-0333-6; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Pabst M, 2013, PLANT J, V76, P61, DOI 10.1111/tpj.12271; Popper ZA, 2008, CURR OPIN PLANT BIOL, V11, P286, DOI 10.1016/j.pbi.2008.02.012; RALPH J, 1991, J AGR FOOD CHEM, V39, P1426, DOI 10.1021/jf00008a014; Reid JB, 2011, P NATL ACAD SCI USA, V108, P17241, DOI 10.1073/pnas.1114432108; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; Reuhs BL, 2004, PLANTA, V219, P147, DOI 10.1007/s00425-004-1205-x; Rolando C., 1992, METHODS LIGNIN CHEM, P334, DOI DOI 10.1007/978-3-642-74065-7_23; Ryden P, 2003, PLANT PHYSIOL, V132, P1033, DOI 10.1104/pp.103.021873; Santino A, 2013, PLANT CELL REP, V32, P1085, DOI 10.1007/s00299-013-1441-2; Schaller F, 2000, PLANTA, V210, P979, DOI 10.1007/s004250050706; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Taylor-Teeples M, 2015, NATURE, V517, P571, DOI 10.1038/nature14099; TERASHIMA N, 1993, FORAGE CELL WALL STRUCTURE AND DIGESTIBILITY, P247; Touzel JP, 2003, J AGR FOOD CHEM, V51, P981, DOI 10.1021/jf020200p; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Voxeur A, 2011, J BIOL CHEM, V286, P8014, DOI 10.1074/jbc.M110.198614; Wu YY, 2010, J BIOL CHEM, V285, P13638, DOI 10.1074/jbc.M110.102715	57	11	11	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184820	10.1371/journal.pone.0184820	http://dx.doi.org/10.1371/journal.pone.0184820			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961242	Green Published, gold, Green Submitted			2022-12-27	WOS:000412027700010
J	Hsu, JL; Liao, MF; Hsu, HC; Weng, YC; Lo, AL; Chang, KH; Chang, HS; Kuo, HC; Huang, CC; Ro, LS				Hsu, Jung-Lung; Liao, Ming-Feng; Hsu, Hui-Ching; Weng, Yi-Ching; Lo, Ai-Lun; Chang, Kuo-Hsuan; Chang, Hong-Shiu; Kuo, Hung-Chou; Huang, Chin-Chang; Ro, Long-Sun			A prospective, observational study of patients with uncommon distal symmetric painful small-fiber neuropathy	PLOS ONE			English	Article							FABRY-DISEASE; SKIN BIOPSY; DIAGNOSTIC-CRITERIA; DRIED BLOOD; PREVALENCE; QUESTIONNAIRE; DENERVATION; DENSITY	Objective To investigate the clinical characteristics of patients with uncommon distal symmetric painful small-fiber neuropathy (DSPSFN). Methods From September 2012 to September 2014, participants between 18-70 years of age that had DSPSFN defined by clinical signs/symptoms and ID pain > 2 or DN4 > 4 on questionnaires for more than 1 month were included. Participants who had previous historical or laboratory evidence of common etiologies of DSPSFN were excluded. Enzyme activity and genetic studies for Fabry diseaseand familial amyloid polyneuropathy were performed after participants fulfilled the inclusion and exclusion criteria. The cryoglobulin test, autoantibodies studies and electrophysiological studies were performed in these participants. Results In total, 100 cases were enrolled in the current study. Three cases of subclinical diabetes mellitus and two cases of fibromyalgia were found. Fabry disease (1%) and familial amyloid polyneuropathy (3%) with Ala97Ser transthyretin (TTR) mutations were also detected. The cryoglobulin test was positive in 30% of participants, and these participants had higher DN4 scores than the negative group. In the autoantibodies studies, 59% of the participants had abnormal anti-Ro/SSA and/or anti-La/SSB antibodies. Conclusions Cryoglobulinemia is not a rare etiology of uncommon DSPSFN. The long-term prognosis is quite good in these participants. From our structuralized protocol, Fabry disease and familial amyloid polyneuropathy could be easily detected in these cases of uncommon DSPSFN.	[Hsu, Jung-Lung; Liao, Ming-Feng; Weng, Yi-Ching; Lo, Ai-Lun; Chang, Kuo-Hsuan; Chang, Hong-Shiu; Kuo, Hung-Chou; Huang, Chin-Chang; Ro, Long-Sun] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurol, Taipei, Taiwan; [Hsu, Jung-Lung; Liao, Ming-Feng; Hsu, Hui-Ching; Weng, Yi-Ching; Lo, Ai-Lun; Chang, Kuo-Hsuan; Chang, Hong-Shiu; Kuo, Hung-Chou; Huang, Chin-Chang; Ro, Long-Sun] Chang Gung Univ, Coll Med, Taipei, Taiwan; [Hsu, Jung-Lung] Taipei Med Univ, Grad Inst Humanities Med, Taipei, Taiwan; [Hsu, Jung-Lung] Taipei Med Univ, Res Ctr Brain & Consciousness, Shuang Ho Hosp, New Taipei, Taiwan; [Hsu, Hui-Ching] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Tradit Chinese Med, Div Chinese Acupuncture & Traumatol, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Chang Gung Memorial Hospital	Ro, LS (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurol, Taipei, Taiwan.; Ro, LS (corresponding author), Chang Gung Univ, Coll Med, Taipei, Taiwan.	cgrols@adm.cgmh.org.tw			Chang Gung Medical Research Program [CMRPG3C0371, CMRPG3C0372, CMRPG3C0373]	Chang Gung Medical Research Program	This study was supported by a grant from the Chang Gung Medical Research Program (CMRPG3C0371, CMRPG3C0372, CMRPG3C0373). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2001, J NEUROL, V248, P647, DOI 10.1007/s004150170109; Bakkers M, 2014, MUSCLE NERVE, V49, P329, DOI 10.1002/mus.23910; Bednarik J, 2009, J PERIPHER NERV SYST, V14, P177, DOI 10.1111/j.1529-8027.2009.00229.x; Biasiotta A, 2014, J NEUROL, V261, P725, DOI 10.1007/s00415-014-7261-7; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Chamoles NA, 2001, CLIN CHIM ACTA, V308, P195, DOI 10.1016/S0009-8981(01)00478-8; Chan ACY, 2016, MUSCLE NERVE, V53, P671, DOI 10.1002/mus.25082; Chao CC, 2011, ARCH NEUROL-CHICAGO, V68, P200, DOI 10.1001/archneurol.2010.372; Devigili G, 2008, BRAIN, V131, P1912, DOI 10.1093/brain/awn093; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Gemignani F, 2005, J NEUROL NEUROSUR PS, V76, P1410, DOI 10.1136/jnnp.2004.057620; Hoeijmakers JG, 2012, NAT REV NEUROL, V8, P369, DOI 10.1038/nrneurol.2012.97; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Kallemuchikkal U, 1999, ARCH PATHOL LAB MED, V123, P119; KATIMS JJ, 1991, ARCH ENVIRON HEALTH, V46, P207, DOI 10.1080/00039896.1991.9937449; Koike H, 2003, ANN NEUROL, V54, P19, DOI 10.1002/ana.10550; Kubo T, 2016, J CARDIOLOGY; Lacomis D, 1997, ARTHRITIS RHEUM, V40, P1173, DOI 10.1002/art.1780400624; Lauria G, 2007, NAT CLIN PRACT NEURO, V3, P546, DOI 10.1038/ncpneuro0630; Lukacs Z, 2005, J INHERIT METAB DIS, V28, P803, DOI 10.1007/s10545-005-0039-4; Magri F, 2010, EUR J ENDOCRINOL, V163, P279, DOI 10.1530/EJE-10-0285; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Padua L, 2013, NEUROL SCI, V34, P373, DOI 10.1007/s10072-012-1011-3; Peters MJH, 2013, NEUROLOGY, V81, P1356, DOI 10.1212/WNL.0b013e3182a8236e; Polydefkis M, 2002, NEUROLOGY, V58, P115, DOI 10.1212/WNL.58.1.115; Portenoy R, 2006, CURR MED RES OPIN, V22, P1555, DOI 10.1185/030079906X115702; Ranieri M, 2016, CURR TREAT OPTION NE, V18, DOI 10.1007/s11940-016-0414-5; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Saito O, 2016, CLIN EXP NEPHROL, V20, P284, DOI 10.1007/s10157-015-1146-7; Sargur R, 2010, ANN CLIN BIOCHEM, V47, P8, DOI 10.1258/acb.2009.009180; Scott LJC, 1999, NEUROLOGY, V52, P1249, DOI 10.1212/WNL.52.6.1249; Shihabi ZK, 2006, ANN CLIN LAB SCI, V36, P395; Shukla G, 2005, CLIN NEUROL NEUROSUR, V107, P486, DOI 10.1016/j.clineuro.2004.12.016; Sommer C, 2008, CURR OPIN NEUROL, V21, P563, DOI 10.1097/WCO.0b013e328309000c; Takada S, 2012, MOL MED REP, V6, P3, DOI 10.3892/mmr.2012.861; Tan IL, 2012, ARCH NEUROL-CHICAGO, V69, P265, DOI 10.1001/archneurol.2011.1120; Tembl JI, 1999, NEUROLOGY, V53, P861, DOI 10.1212/WNL.53.4.861; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Uceyler N, 2010, NEUROLOGY, V74, P1806, DOI 10.1212/WNL.0b013e3181e0f7b3; Vallat JM, 2008, MUSCLE NERVE, V38, P904, DOI 10.1002/mus.21057; Wheeler RD, 2007, ANN CLIN BIOCHEM, V44, P566, DOI 10.1258/000456307782268138; Yang NCC, 2010, NEUROLOGY, V75, P532, DOI 10.1212/WNL.0b013e3181ec7fda; YEE WC, 1989, ACTA NEUROPATHOL, V78, P57, DOI 10.1007/BF00687403; Zis P, 2016, J NEUROL, V263, P1903, DOI 10.1007/s00415-016-8082-7	44	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0183948	10.1371/journal.pone.0183948	http://dx.doi.org/10.1371/journal.pone.0183948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957343	Green Submitted, Green Published, gold			2022-12-27	WOS:000411985200011
J	Shan, S; She, J; Xue, ZQ; Su, CX; Ren, SX; Wu, FY				Shan, Shan; She, Jun; xue, Zhi-qiang; Su, Chun-xia; Ren, Shen-xiang; Wu, Feng-ying			Clinical characteristics and survival of lung cancer patients associated with multiple primary malignancies	PLOS ONE			English	Article							RISK; SINGLE; NEOPLASMS; AGE	Objectives To investigate the characteristics and survival of lung cancer patients with additional malignant primary cancers. Methods Records of lung cancer patients newly diagnosed in Shanghai Pulmonary Hospital between January 2000 and January 2010 were retrospectively reviewed. Patients with second primary lung cancer and those with lung cancer only were included for detailed analysis. Results Of 27642 newly diagnosed lung cancer patients, 283 patients (1.02%) suffered previous additional primary cancers. Compared with single primary lung cancer, patients with secondary lung cancer associated other primary cancers were more often women (female to male ratio 1:1.72 vs 1:2.58, P = 0.018), older (64.2 vs 60.5 years old, P<0.001), more squamous cell type (30.7% vs 20.5%, P = 0.004), less small cell (3.9% vs 15.5%, P<0.001) type, at earlier stages (17.7% vs 11.0% for stage I, P = 0.014), and more frequently with family history of cancers (7.8% vs 3.9%, P = 0.038). The most common previous primary cancers observed were colorectal (22.0%), breast (18.4%), gastric (14.4%) and larynx cancers (11.9%). Approximately 42.9% of patients were diagnosed with lung cancer 2 to 6 years after diagnosis of initial primary cancers. The survival of patients with secondary lung cancer associated other malignancies was not significantly different from those with single lung cancer (P = 0.491), while synchronous multiple primary malignancies showed worse prognosis compared with those with metachronous ones or single lung cancer (p = 0.012). Conclusion The possibility of second primary lung cancer should always be considered during the follow-up of related cancer types, especially those with family history of cancers. secondary lung cancer associated other primary malignancies have non-inferior survival than those with single lung cancer.	[Shan, Shan] Shanghai Jiao Tong Univ, Dept Respirol, Shanghai Peoples Hosp 6, Shanghai, Peoples R China; [She, Jun] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai, Peoples R China; [xue, Zhi-qiang] Peoples Liberat Army Gen Hosp, Dept Thorac Surg, Shanghai, Peoples R China; [Su, Chun-xia; Ren, Shen-xiang; Wu, Feng-ying] Tongji Univ, Shanghai Pulm Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Fudan University; Chinese People's Liberation Army General Hospital; Tongji University	Wu, FY (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R China.	fywu@163.com			National Natural Science Foundation of China [81402381]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, Grant number:81402381 (http://www.nsfc.gov.cn/)to Fengying Wu. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-138; Amer MH, 2014, CANCER MANAG RES, V6, P119, DOI 10.2147/CMAR.S57378; Armstrong GT, 2011, J CLIN ONCOL, V29, P3056, DOI 10.1200/JCO.2011.34.6585; Chirila DN, 2013, CHIRURGIA-BUCHAREST, V108, P498; Geryk Edvard, 2010, Cas Lek Cesk, V149, P178; Hemminki K, 2005, EXP LUNG RES, V31, P205, DOI 10.1080/01902140490495606; Hsieh WC, 1997, JPN J CLIN ONCOL, V27, P63, DOI 10.1093/jjco/27.2.63; Irimie A, 2010, J GASTROINTEST LIVER, V19, P69; Koubkova L, 2014, Klin Onkol, V27, P11; Kricker A, 2013, JAMA DERMATOL, V149, P921, DOI 10.1001/jamadermatol.2013.4581; Kuligina E, 2010, EPIDEMIOLOGY, V21, P366, DOI 10.1097/EDE.0b013e3181cc8871; Lee JW, 2014, ANN COLOPROCTOL, V30, P18, DOI 10.3393/ac.2014.30.1.18; Liu LF, 2011, INT J CANCER, V128, P1659, DOI 10.1002/ijc.25480; Liu YY, 2002, LUNG CANCER, V35, P189, DOI 10.1016/S0169-5002(01)00408-1; Lortet-Tieulent J, 2014, LUNG CANCER, V84, P13, DOI 10.1016/j.lungcan.2014.01.009; LYNCH HT, 1977, CANCER, V40, P1849, DOI 10.1002/1097-0142(197710)40:4+<1849::AID-CNCR2820400813>3.0.CO;2-U; Milano MT, 2012, HEAD NECK-J SCI SPEC, V34, P1782, DOI 10.1002/hed.22006; Orlow I, 2008, J CLIN ONCOL, V26, P3560, DOI 10.1200/JCO.2007.13.2654; Pages PB, 2013, ANN THORAC SURG, V95, P1000, DOI 10.1016/j.athoracsur.2012.11.072; Rosso Stefano, 2009, Popul Health Metr, V7, P5, DOI 10.1186/1478-7954-7-5; Rosso S, 2009, EUR J CANCER, V45, P1080, DOI 10.1016/j.ejca.2008.11.030; She J, 2013, CHEST, V143, P1117, DOI 10.1378/chest.11-2948; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Soerjomataram Isabelle, 2009, V471, P85, DOI 10.1007/978-1-59745-416-2_5; Swerdlow AJ, 2000, J CLIN ONCOL, V18, P498, DOI 10.1200/JCO.2000.18.3.498; TUCKER MA, 1988, NEW ENGL J MED, V318, P76, DOI 10.1056/NEJM198801143180203; WATANABE S, 1984, J NATL CANCER I, V72, P1021	27	18	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185485	10.1371/journal.pone.0185485	http://dx.doi.org/10.1371/journal.pone.0185485			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957405	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200068
J	Utochkin, IS; Vostrikov, KO				Utochkin, Igor S.; Vostrikov, Konstantin O.			The numerosity and mean size of multiple objects are perceived independently and in parallel	PLOS ONE			English	Article							VISUAL WORKING-MEMORY; ENSEMBLE STATISTICS; AVERAGE SIZE; INDIVIDUAL-DIFFERENCES; PERCEPTUAL GROUPS; ATTENTION; REPRESENTATION; NUMBER; CAPACITY; SETS	It is well documented that people are good at the rapid representation of multiple objects in the form of ensemble summary statistics of different types (numerosity, the average feature, the variance of features, etc.). However, there is not enough clarity regarding the links between statistical domains. The relations between different-type summaries (numerosity and the mean) are of particular interest, since they can shed light on (1) a very general functional organization of ensemble processing and (2) mechanisms of statistical computations (whether averaging takes into account numerical information, as in regular statistics). Here, we show no correlation between the precision of estimated numerosity and that of the estimated mean. We also found that people are very good at dividing attention between numerosity and the mean size of a single set (Experiment 1); however, they show some cost of dividing attention between two same-type (two numerosities or two mean sizes, Experiment 2) and two different-type (one numerosity and one mean size, Experiment 3) summaries when each summary is ascribed to a different set. These results support the idea of domain specificity of numerosity and mean size perception, which also implies that, unlike regular statistics, computing the mean does not require numerosity information. We also conclude that computational capacity of ensemble statistics is more limited by encoding several ensembles than computing several summaries.	[Utochkin, Igor S.; Vostrikov, Konstantin O.] Natl Res Univ, Higher Sch Econ, Moscow, Russia	HSE University (National Research University Higher School of Economics)	Utochkin, IS (corresponding author), Natl Res Univ, Higher Sch Econ, Moscow, Russia.	isutochkin@inbox.ru	Utochkin, Igor/D-3725-2016	Utochkin, Igor/0000-0001-8433-446X	Basic Research Program at HSE [TZ-64]	Basic Research Program at HSE	This work was supported by Basic Research Program at HSE, grant TZ-64 in 2016. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allik J, 2012, VISION RES, V83, P25; Alvarez GA, 2005, J EXP PSYCHOL HUMAN, V31, P643, DOI 10.1037/0096-1523.31.4.643; Alvarez GA, 2008, PSYCHOL SCI, V19, P392, DOI 10.1111/j.1467-9280.2008.02098.x; Alvarez GA, 2011, TRENDS COGN SCI, V15, P122, DOI 10.1016/j.tics.2011.01.003; Alvarez GA, 2009, P NATL ACAD SCI USA, V106, P7345, DOI 10.1073/pnas.0808981106; Ariely D, 2001, PSYCHOL SCI, V12, P157, DOI 10.1111/1467-9280.00327; Ariely D, 2008, PERCEPT PSYCHOPHYS, V70, P1325, DOI 10.3758/PP.70.7.1325; Attarha M, 2015, J VISION, V15, DOI 10.1167/15.4.9; Attarha M, 2015, ATTEN PERCEPT PSYCHO, V77, P1116, DOI 10.3758/s13414-015-0870-0; Attarha M, 2014, J EXP PSYCHOL HUMAN, V40, P1440, DOI 10.1037/a0036206; Balas B, 2009, J VISION, V9, DOI [10.1167/9.2.16, 10.1167/9.12.13]; Bauer B, 2009, PSYCHOL REC, V59, P171, DOI 10.1007/BF03395657; Brady TF, 2011, J VISION, V11, DOI 10.1167/11.5.4; Brady TF, 2011, PSYCHOL SCI, V22, P384, DOI 10.1177/0956797610397956; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; Cant JS, 2012, J NEUROSCI, V32, P7685, DOI 10.1523/JNEUROSCI.3325-11.2012; Chong SC, 2011, WIRES COGN SCI, V2, P634, DOI 10.1002/wcs.136; Chong SC, 2008, PERCEPT PSYCHOPHYS, V70, P1327, DOI 10.3758/PP.70.7.1327; Chong SC, 2003, VISION RES, V43, P393, DOI 10.1016/S0042-6989(02)00596-5; Chong SC, 2005, VISION RES, V45, P891, DOI 10.1016/j.visres.2004.10.004; Cohen MA, 2016, TRENDS COGN SCI, V20, P324, DOI 10.1016/j.tics.2016.03.006; Corbett JE, 2012, VIS COGN, V20, P211, DOI 10.1080/13506285.2012.657261; Corbett JE, 2011, ACTA PSYCHOL, V138, P289, DOI 10.1016/j.actpsy.2011.08.002; Dakin SC, 1997, VISION RES, V37, P3181, DOI 10.1016/S0042-6989(97)00133-8; de Gardelle V, 2011, P NATL ACAD SCI USA, V108, P13341, DOI 10.1073/pnas.1104517108; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; Emmanouil TA, 2008, PERCEPT PSYCHOPHYS, V70, P946, DOI 10.3758/PP.70.6.946; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Fodor J. A, 1983, MODULARITY MIND; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; Haberman J., 2012, PERCEPTION CONSCIOUS, P339, DOI DOI 10.1093/ACPROF:OSOBL/9780199734337.003.0030; Haberman J, 2007, CURR BIOL, V17, pR751, DOI 10.1016/j.cub.2007.06.039; Haberman J, 2015, J EXP PSYCHOL GEN, V144, P432, DOI 10.1037/xge0000053; Haberman J, 2009, J EXP PSYCHOL HUMAN, V35, P718, DOI 10.1037/a0013899; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2006, PSYCHOL SCI, V17, P572, DOI 10.1111/j.1467-9280.2006.01746.x; Huang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131191; Huang LQ, 2012, J EXP PSYCHOL HUMAN, V38, P414, DOI 10.1037/a0026314; Im HY, 2015, J COGN PSYCHOL, V27, P114, DOI 10.1080/20445911.2014.985301; Im HY, 2014, PERCEPTION, V43, P663, DOI 10.1068/p7719; Jackson-Nielsen M, 2017, CONSCIOUS COGN, V48, P149, DOI 10.1016/j.concog.2016.11.007; JASP Team, 2017, JASP VERS 0 8 1 2 CO; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kahneman D., 1973, ATTENTION EFFORT; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Lee H, 2016, J VISION, V16, DOI 10.1167/16.3.12; Marchant AP, 2013, ACTA PSYCHOL, V142, P245, DOI 10.1016/j.actpsy.2012.11.002; Maule J, 2016, J OPT SOC AM A, V33, pA22, DOI 10.1364/JOSAA.33.000A22; Maule J, 2015, J VISION, V15, DOI 10.1167/15.4.6; Morgan M, 2008, J VISION, V8, DOI 10.1167/8.11.9; Myczek K, 2008, PERCEPT PSYCHOPHYS, V70, P772, DOI 10.3758/PP.70.5.772; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Norman LJ, 2015, J VISION, V15, DOI 10.1167/15.4.3; Parkes L, 2001, NAT NEUROSCI, V4, P739, DOI 10.1038/89532; Pavlovskaya M, 2015, J COGNITIVE NEUROSCI, V27, P1397, DOI 10.1162/jocn_a_00791; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Poltoratski S, 2013, J VISION, V13, DOI 10.1167/13.8.6; Robitaille N, 2011, J VISION, V11, DOI 10.1167/11.12.18; Rosenholtz R, 2016, ANNU REV VIS SCI, V2, P437, DOI 10.1146/annurev-vision-082114-035733; Rosenholtz R, 2012, J VISION, V12, DOI 10.1167/12.4.14; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Simons DJ, 2008, PERCEPT PSYCHOPHYS, V70, P1335, DOI 10.3758/PP.70.7.1335; Solomon JA, 2010, J VISION, V10, DOI 10.1167/10.14.19; SPERLING G, 1978, SCIENCE, V202, P315, DOI 10.1126/science.694536; Treisman A, 2006, VIS COGN, V14, P411, DOI 10.1080/13506280500195250; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985; Utochkin IS, 2014, ACTA PSYCHOL, V146, P7, DOI 10.1016/j.actpsy.2013.11.012; WATAMANIUK SNJ, 1992, VISION RES, V32, P931, DOI 10.1016/0042-6989(92)90036-I; Whiting BF, 2011, PSYCHON B REV, V18, P484, DOI 10.3758/s13423-011-0071-3; Wickens C. D., 2002, THEORETICAL ISSUES E, V3, P159, DOI [10.1080/14639220210123806, DOI 10.1080/14639220210123806]; Wilmer JB, 2008, SPATIAL VISION, V21, P561, DOI 10.1163/156856808786451408; Yantis S., 2014, SENSATION PERCEPTION	74	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185452	10.1371/journal.pone.0185452	http://dx.doi.org/10.1371/journal.pone.0185452			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957361	Green Submitted, Green Published, gold			2022-12-27	WOS:000411985200059
J	Hall, SS; Wright, HF; Mills, DS				Hall, Sophie S.; Wright, Hannah F.; Mills, Daniel S.			Parent perceptions of the quality of life of pet dogs living with neuro-typically developing and neuro-atypically developing children: An exploratory study	PLOS ONE			English	Article							SEPARATION ANXIETY; HEALTH-BENEFITS; DOMESTIC DOGS; RISK-FACTORS; BEHAVIOR; STRESS; AUTISM; OWNERSHIP; DIRECTIONS; STRENGTHS	There is growing scientific and societal recognition of the role that pet dogs can play in healthy development of children; both those who are neuro-typically developing and those who live with a neuro-developmental disorder, such as autism or attention deficit hyperactivity disorder. However, little attention has been paid to how living with children positively and negatively affects quality of life of a pet dog. In this exploratory study we conducted semi-structured interviews with parents of neuro-typically developing children (n = 18) and those with a neuro-developmental disorder (n = 18) who owned a pet dog, until no new factors were identified. Living with children brought potentially positive benefits to the dog's life including: imposition of a routine, participation in recreational activities and the development of a strong bond between the child and the dog. The importance of maintaining a routine was particularly prevalent in families with children with neuro-developmental disorders. Potential negative factors included having to cope with child meltdowns and tantrums, over stimulation from child visitors, harsh contact and rough and tumble play with the child. The regularity and intensity of meltdowns and tantrums was particularly evident in responses from parents with children with a neuro-developmental disorder. However, child visitors and rough play and contact were mentioned similarly across the groups. Protective factors included having a safe haven for the dog to escape to, parent's awareness of stress signs and child education in dog-interaction. Parents were also asked to complete a stress response scale to provide an initial quantitative comparison of stress responses between dogs living with the two family-types. Parents with neuro-typically developing children more frequently observed their dog rapidly running away from a situation and less frequently observed their dog widening their eyes, than parents with children with a neuro-developmental disorder. We propose the development of a stress audit based on the findings reported here, to prevent potential dangerous situations, which may lead to dog bites and dog relinquishment and allow owners to maximise the benefits of dog ownership.	[Hall, Sophie S.; Wright, Hannah F.; Mills, Daniel S.] Univ Lincoln, Sch Life Sci, Lincoln, England	University of Lincoln	Hall, SS (corresponding author), Univ Lincoln, Sch Life Sci, Lincoln, England.	shall@lincoln.ac.uk		Hall, Sophie/0000-0002-9847-8269	Dogs Trust Canine Welfare Grant	Dogs Trust Canine Welfare Grant	This project was funded by a Dogs Trust Canine Welfare Grant, awarded to SH and DM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by a Dogs Trust Canine Welfare grant.	Ainsworth MD., 1964, MERRILL PALMER QUART, V10, P51, DOI DOI 10.2307/23082925; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; ANDERSON WP, 1992, MED J AUSTRALIA, V157, P298, DOI 10.5694/j.1326-5377.1992.tb137178.x; [Anonymous], 2012, QUALITATIVE RES METH; Arhant C, 2016, J VET BEHAV, V14, P10, DOI 10.1016/j.jveb.2016.06.007; Beck AM, 2003, AM BEHAV SCI, V47, P79, DOI 10.1177/0002764203255214; Beerda B, 1999, PHYSIOL BEHAV, V66, P243, DOI 10.1016/S0031-9384(98)00290-X; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Beerda B, 2000, ANIM WELFARE, V9, P49; Beetz A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00352; Beetz A, 2011, ANTHROZOOS, V24, P349, DOI 10.2752/175303711X13159027359746; Belshaw Z, 2015, VET J, V206, P203, DOI 10.1016/j.tvjl.2015.07.016; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burgoyne L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004786; Burrows KE, 2008, J APPL ANIM WELF SCI, V11, P42, DOI 10.1080/10888700701555550; Cooper JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102722; CORSON SA, 1976, PSYCHOPATHOLOGY HUMA, P77; Custance D, 2012, ANIM COGN, V15, P851, DOI 10.1007/s10071-012-0510-1; Endenburg N, 2011, VET J, V190, P208, DOI 10.1016/j.tvjl.2010.11.020; Esposito L, 2011, CHILD DEV PERSPECT, V5, P205, DOI 10.1111/j.1750-8606.2011.00175.x; FRIEDMANN E, 1980, PUBLIC HEALTH REP, V95, P307; Golinko MS, 2016, CLIN PEDIATR; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Grandgeorge M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041739; Guy NC, 2001, APPL ANIM BEHAV SCI, V74, P29, DOI 10.1016/S0168-1591(01)00154-X; Hall SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149759; Headey B, 1999, SOC INDIC RES, V47, P233, DOI 10.1023/A:1006892908532; HUBRECHT RC, 1992, APPL ANIM BEHAV SCI, V34, P365, DOI 10.1016/S0168-1591(05)80096-6; Kerswell KJ, 2009, ANTHROZOOS, V22, P183, DOI 10.2752/175303709X434202; Kertes DA, 2016, SOC DEV; Kiddie JL, 2014, APPL ANIM BEHAV SCI, V158, P57, DOI 10.1016/j.applanim.2014.05.008; Landsberg GM., 2003, HDB BEHAV PROBLEMS C, P227; Le Roux MC, 2009, PSYCHOGERIATRICS, V9, P23, DOI 10.1111/j.1479-8301.2009.00268.x; Levine GN, 2013, CIRCULATION, V127, P2353, DOI 10.1161/CIR.0b013e31829201e1; Mariti C, 2012, J VET BEHAV, V7, P213, DOI 10.1016/j.jveb.2011.09.004; MATHEWS JR, 1994, J DEV BEHAV PEDIATR, V15, P44, DOI 10.1097/00004703-199402000-00008; Mills D.S., 2012, STRESS PHEROMONATHER; Mills D, 2014, VET CLIN N AM-SMALL, V44, P525, DOI 10.1016/j.cvsm.2014.01.005; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; Myers SM, 2007, PEDIATRICS, V120, P1162, DOI 10.1542/peds.2007-2362; O'Haire M, 2010, J VET BEHAV, V5, P226, DOI 10.1016/j.jveb.2010.02.002; Overall KL, 2001, J AM VET MED ASSOC, V219, P467, DOI 10.2460/javma.2001.219.467; Pirrone F, 2015, J VET BEHAV, V10, P295, DOI 10.1016/j.jveb.2015.03.004; Purewal R, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030234; Reisner IR, 2007, INJURY PREV, V13, P348, DOI 10.1136/ip.2007.015396; Reisner IR, 2011, INJ PREV; Rhoades H, 2015, CHILD PSYCHIAT HUM D, V46, P237, DOI 10.1007/s10578-014-0463-5; Russell G, 2014, J AUTISM DEV DISORD, V44, P31, DOI 10.1007/s10803-013-1849-0; Sacks J J, 1996, Inj Prev, V2, P52, DOI 10.1136/ip.2.1.52; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Sheppard G, 2003, VET REC, V152, P432, DOI 10.1136/vr.152.14.432; Sherman BL, 2008, VET CLIN N AM-SMALL, V38, P1081, DOI 10.1016/j.cvsm.2008.04.012; Smyth C., 2010, LEARNING DISABILITY, V13, P12, DOI [https://doi.org/10.7748/ldp2010.05.13.4.12.c7758, DOI 10.7748/LDP2010.05.13.4.12.C7758, DOI 10.7748/LDP2010.05.13.4]; Solomon O, 2010, ETHOS, V38, P143, DOI 10.1111/j.1548-1352.2010.01085.x; Solomon RL, 1953, PSYCHOL MONOGR-GEN A, V67, P1, DOI 10.1037/h0093649; Viau R, 2010, PSYCHONEUROENDOCRINO, V35, P1187, DOI 10.1016/j.psyneuen.2010.02.004; Wells DL, 2002, ANIM WELFARE, V11, P385; Wright H, 2016, HUM ANIM INTERACT B, V1, P38; Wright HF, 2015, J AUTISM DEV DISORD, V45, P2531, DOI 10.1007/s10803-015-2418-5; Wright H, 2015, ANTHROZOOS, V28, P611, DOI 10.1080/08927936.2015.1070003	61	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185300	10.1371/journal.pone.0185300	http://dx.doi.org/10.1371/journal.pone.0185300			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4WR	28953961	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000411980300054
J	Kammerle, JL; Brieger, F; Kroschel, M; Hagen, R; Storch, I; Suchant, R				Kammerle, Jim-Lino; Brieger, Falko; Kroeschel, Max; Hagen, Robert; Storch, Ilse; Suchant, Rudi			Temporal patterns in road crossing behaviour in roe deer (Capreolus capreolus) at sites with wildlife warning reflectors	PLOS ONE			English	Article							VEHICLE COLLISIONS; HABITAT SELECTION; HOME-RANGE; LANDSCAPE; MIGRATION; AVOIDANCE; GRADIENT; SPACE; BOAR	Every year, there are millions of documented vehicle collisions involving cervids across Europe and North America. While temporal patterns in collision occurrence are relatively well described, few studies have targeted deer behaviour as a critical component of collision prevention. In this study, we investigated weekly and daily patterns in road crossing behaviour in roe deer. Using road crossing events and movement data obtained from GPS telemetry, we employed mixed-effect models to explain frequency and timing of crossings at five road segments by a number of predictors including traffic volume, deer movement activity and the presence of wildlife warning reflectors. We analysed 13,689 road crossing events by 32 study animals. Individual variation in crossing frequency was high but daily patterns in crossing events were highly consistent among animals. Variation in the intensity of movement activity on a daily and seasonal scale was the main driver of road crossing behaviour. The seasonal variation in crossing frequency reflected differences in movement activity throughout the reproductive cycle, while daily variation in the probability to cross exhibited a clear nocturnal emphasis and reflected crepuscular activity peaks. The frequency of road crossings increased as a function of road density in the home-range, while traffic volume only exerted marginal effects. Movement activity of roe deer in our study coincided with commuter traffic mainly in the early morning and late afternoon during winter and during periods of high spatial activity such as the rut. Both timing and frequency of crossing events remained unchanged in the presence of reflectors. Our results emphasise the importance of behavioural studies for understanding roe deer vehicle-collision patterns and thus provide important information for collision prevention. We suggest that mitigation of collision risk should focus on strategic seasonal measures and animal warning systems targeting drivers.	[Kammerle, Jim-Lino; Brieger, Falko; Kroeschel, Max; Storch, Ilse] Univ Freiburg, Chair Wildlife Ecol & Wildlife Management, Freiburg, Germany; [Kammerle, Jim-Lino; Brieger, Falko; Kroeschel, Max; Hagen, Robert; Suchant, Rudi] Forest Res Inst Baden Wurttemberg, Div Wildlife Ecol, Freiburg, Germany	University of Freiburg	Brieger, F (corresponding author), Univ Freiburg, Chair Wildlife Ecol & Wildlife Management, Freiburg, Germany.; Brieger, F (corresponding author), Forest Res Inst Baden Wurttemberg, Div Wildlife Ecol, Freiburg, Germany.	falko.brieger@forst.bwl.d	Storch, Ilse/N-7478-2019; Storch, Ilse/P-6806-2019	Storch, Ilse/0000-0002-3252-2036	federal state of Baden-Wurttemberg; foundation Dr. Joachim und Hanna Schmidt Stiftung fur Umwelt und Verkehr; German Research Foundation (DFG); University of Freiburg	federal state of Baden-Wurttemberg; foundation Dr. Joachim und Hanna Schmidt Stiftung fur Umwelt und Verkehr; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	This study was funded by the federal state of Baden-Wurttemberg (Landesjagdabgabe). FB was supported with a PhD Scholarship by the foundation Dr. Joachim und Hanna Schmidt Stiftung fur Umwelt und Verkehr (http://www.dr-schmidt-stiftung.de). The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing.	Angelo GD, 2015, HANDBOOK OF ROAD ECOLOGY, P213; Barton K., 2015, MULTIMODEL INFERENCE; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Bivand R., 2016, MAPTOOLS TOOLS READI; Blackwell BF, 2009, J WILDLIFE MANAGE, V73, P128, DOI 10.2193/2008-014; Bongi P, 2008, J ZOOL, V276, P242, DOI 10.1111/j.1469-7998.2008.00481.x; Brieger F, 2017, EUR J WILDLIFE RES, V63, DOI 10.1007/s10344-017-1130-5; Brieger F, 2016, ACCIDENT ANAL PREV, V97, P242, DOI 10.1016/j.aap.2016.08.030; Brown DD, 2012, WILDLIFE SOC B, V36, P139, DOI 10.1002/wsb.111; Bruinderink GWTAG, 1996, CONSERV BIOL, V10, P1059, DOI 10.1046/j.1523-1739.1996.10041059.x; Cagnacci F, 2011, OIKOS, V120, P1790, DOI 10.1111/j.1600-0706.2011.19441.x; Clair CCS, 2009, BEHAVIOUR, V146, P393, DOI 10.1163/156853909X410973; Coe PK, 2015, WILDLIFE SOC B, V39, P256, DOI 10.1002/wsb.544; CONOVER MR, 1995, WILDLIFE SOC B, V23, P407; D'Angelo GJ, 2006, WILDLIFE SOC B, V34, P1175, DOI 10.2193/0091-7648(2006)34[1175:EOWWRF]2.0.CO;2; Dal Compare L, 2007, ITAL J ANIM SCI, V6, P848, DOI 10.4081/ijas.2007.1s.848; Danks ZD, 2010, J WILDLIFE MANAGE, V74, P1229, DOI 10.2193/2008-358; Dodd NL, 2005, P 2005 INT C EC TRAN, P461; Dussault C, 2007, J WILDLIFE MANAGE, V71, P2338, DOI 10.2193/2006-499; Fahrig L, 2009, ECOL SOC, V14; Found R, 2011, J ENVIRON MANAGE, V92, P2486, DOI 10.1016/j.jenvman.2011.05.010; Gagnon JW, 2007, J WILDLIFE MANAGE, V71, P2324, DOI 10.2193/2006-445; Gladfelter L., 1984, EFFECT WILDLIFE HIGH; Hothorn T, 2015, ACCIDENT ANAL PREV, V81, P143, DOI 10.1016/j.aap.2015.04.037; Hothorn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029510; Huijser MP, 2009, ECOL SOC, V14; Iuell B, 2003, COST 341 HABITAT FRA; Jacobson SL, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1345; Jepsen JU, 2004, CAN J ZOOL, V82, P1528, DOI 10.1139/Z04-131; Krop-Benesch A, 2013, ITAL J ZOOL, V80, P69, DOI 10.1080/11250003.2012.725777; Lagos L, 2012, EUR J WILDLIFE RES, V58, P661, DOI 10.1007/s10344-012-0614-6; Lamberti P, 2006, J ETHOL, V24, P181, DOI 10.1007/s10164-005-0179-x; Langbein Jochen, 2011, P215; Leblond M, 2013, J ZOOL, V289, P32, DOI 10.1111/j.1469-7998.2012.00959.x; Lima SL, 2015, BIOL REV, V90, P60, DOI 10.1111/brv.12093; Maublanc ML, 2012, CR BIOL, V335, P735, DOI 10.1016/j.crvi.2012.11.003; Meisingset EL, 2014, J WILDLIFE MANAGE, V78, P679, DOI 10.1002/jwmg.712; Meisingset EL, 2013, J WILDLIFE MANAGE, V77, P181, DOI 10.1002/jwmg.469; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Neumann W, 2012, BIOL CONSERV, V145, P70, DOI 10.1016/j.biocon.2011.10.011; Ng Janet W., 2008, Human-Wildlife Conflicts, V2, P34; Pagon N, 2013, CHRONOBIOL INT, V30, P772, DOI 10.3109/07420528.2013.765887; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pokorny Bostjan, 2006, Veterinarski Arhiv, V76, pS177; Proppe DS, 2016, ANIM COGN, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Ramanzin M, 2007, CAN J ZOOL, V85, P280, DOI 10.1139/Z06-210; Rodriguez-Morales B, 2013, ACCIDENT ANAL PREV, V60, P121, DOI 10.1016/j.aap.2013.07.032; Romin LA, 1996, WILDLIFE SOC B, V24, P276; SCHAFER JA, 1985, J WILDLIFE MANAGE, V49, P774, DOI 10.2307/3801710; Schwabe KA, 1999, USDA NAT RESC S HUM, V10, P14; Sivic A., 2001, WILDLIFE WARNING REF; Spellerberg IF, 1998, GLOBAL ECOL BIOGEOGR, V7, P317, DOI 10.1046/j.1466-822x.1998.00308.x; Steiner W, 2014, ACCIDENT ANAL PREV, V66, P168, DOI 10.1016/j.aap.2014.01.020; Thurfjell H, 2015, LANDSCAPE URBAN PLAN, V133, P98, DOI 10.1016/j.landurbplan.2014.09.015; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Tufto J, 1996, J ANIM ECOL, V65, P715, DOI 10.2307/5670; Ujvari M, 1998, J WILDLIFE MANAGE, V62, P1094, DOI 10.2307/3802562; Ware HE, 2015, P NATL ACAD SCI USA, V112, P12105, DOI 10.1073/pnas.1504710112; WARING GH, 1991, APPL ANIM BEHAV SCI, V29, P215, DOI 10.1016/0168-1591(91)90249-W; Zacks JL, 1986, 1075 TRB NAT RES COU; Zuberogoitia I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107713	63	23	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184761	10.1371/journal.pone.0184761	http://dx.doi.org/10.1371/journal.pone.0184761			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4WR	28953951	gold, Green Submitted, Green Published			2022-12-27	WOS:000411980300022
J	Song, Y; Kim, JG; Cho, HJ; Kim, JK; Suh, DC				Song, Yunsun; Kim, Joong-goo; Cho, Hong-Jun; Kim, Jae Kyun; Suh, Dae Chul			Evaluation of cerebral blood flow change after cigarette smoking using quantitative MRA	PLOS ONE			English	Article							CAROTID-ARTERY; HEART-DISEASE; RISK-FACTORS; NICOTINE; STROKE; AGE; CESSATION; ANGIOGRAPHY; PRESSURE; EXPOSURE	Background and objective Changes in cerebral blood flow (CBF) immediately after cigarette smoking (CS) are still unclear. Our purpose was to evaluate the hemodynamic changes in each intracranial vessel after CS by using quantitative magnetic resonance angiography (MRA). Material and methods Fifteen healthy male smokers less than 45 years old with more than 3 pack-year smoking history were enrolled in this study. The hemodynamic change in the vessels, represented by cerebral flow rate (CFR, ml/s) and flow velocity (FV, cm/s), was quantitatively measured in eleven vascular segments of the brain using phase-contrast MRA. Two sets of data at each vessel before and after CS were statistically analyzed by paired t-test. Three of 15 participants, as a control group, followed all the procedures but did not smoke. Results Total CFR of the distal intracranial vessels (anterior, middle, and posterior cerebral arteries; ACA, MCA, and PCA) was significantly reduced after CS by 7.3% (847 vs. 785 ml/s, p = 0.024). Such flow changes were statistically more significant in the anterior circulation (ACA and MCA) compared to the posterior circulation (PCA). All distal intracranial vessels did not have significant FV change while peak systolic velocity and mean velocity dropped 7.4 and 4.3% and pulsatility index decreased 10.9% in the internal carotid artery. Regarding cross-sectional areas, all distal intracranial vessels showed diminished, and only MCA had a statistical significance (9.9 vs. 9.3 mm(2), p = 0.016). Conclusions There was a significant decrease of CFR after CS especially in the anterior circulation of twelve young male smokers. Considering the changes of FV and cross-sectional area all together, it can be suggested that cerebrovascular impedance increased after CS especially at the main trunk level of the distal intracranial vessels (ACA, MCA, and PCA).	[Song, Yunsun; Kim, Joong-goo; Suh, Dae Chul] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol,Inst Radiol, Seoul, South Korea; [Song, Yunsun; Kim, Joong-goo; Suh, Dae Chul] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Res,Inst Radiol, Seoul, South Korea; [Cho, Hong-Jun] Univ Ulsan, Dept Family Med, Coll Med, Asan Med Ctr, Seoul, South Korea; [Kim, Jae Kyun] Chung Ang Univ, Dept Radiol, Coll Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Chung Ang University; Chung Ang University Hospital	Suh, DC (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol,Inst Radiol, Seoul, South Korea.; Suh, DC (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Res,Inst Radiol, Seoul, South Korea.	desuh@amc.seoul.kr	Suh, Dae Chul/F-5949-2014	Suh, Dae Chul/0000-0003-1561-5596; Kim, Joong-Goo/0000-0002-4166-6023	Soelim, Inc. of Korea [2015-0735]; Korean Society of Ginseng	Soelim, Inc. of Korea; Korean Society of Ginseng	This work was supported by the Soelim, Inc. of Korea (project number 2015-0735) to DCS and was partly supported by the 2016 research project of the Korean Society of Ginseng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly supported by 2016 research project of the Korean Society of Ginseng.	Amin-Hanjani S, 2005, STROKE, V36, P1140, DOI 10.1161/01.STR.0000166195.63276.7c; Babizhayev MA, 2011, AM J THER, V18, pE209, DOI 10.1097/MJT.0b013e3181cf8ebb; Barutcu I, 2004, CIRC J, V68, P1127, DOI 10.1253/circj.68.1127; Boyajian RA, 2000, J NEUROIMAGING, V10, P204, DOI 10.1111/jon2000104204; Buijs PC, 1998, RADIOLOGY, V209, P667, DOI 10.1148/radiology.209.3.9844657; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Choi JW, 2010, CEREBROVASC DIS, V29, P297, DOI 10.1159/000275508; CRUICKSHANK JM, 1989, J HUM HYPERTENS, V3, P443; Csordas A, 2013, NAT REV CARDIOL, V10, P219, DOI 10.1038/nrcardio.2013.8; D'Armiento FP, 2001, STROKE, V32, P2472, DOI 10.1161/hs1101.098520; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Domino EF, 2000, SYNAPSE, V38, P313, DOI 10.1002/1098-2396(20001201)38:3<313::AID-SYN10>3.0.CO;2-6; Domino EF, 2004, PROG NEURO-PSYCHOPH, V28, P319, DOI 10.1016/j.pnpbp.2003.10.011; GLANTZ SA, 1991, CIRCULATION, V83, P1, DOI 10.1161/01.CIR.83.1.1; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Kim JS, 2012, STROKE, V43, P3313, DOI 10.1161/STROKEAHA.112.658500; Kim S, 2010, NICOTINE TOB RES, V12, P1246, DOI 10.1093/ntr/ntq189; Kochanowicz J, 2015, BIOL RES NURS, V17, P8, DOI 10.1177/1099800413512175; Kodaira K, 1993, Yakubutsu Seishin Kodo, V13, P157; Krejza J, 2005, RADIOLOGY, V236, P621, DOI 10.1148/radiol.2362031662; Kweon SS, 2012, CIRC J, V76, P2041, DOI 10.1253/circj.CJ-11-1353; Lapenna D, 2015, ATHEROSCLEROSIS, V238, P190, DOI 10.1016/j.atherosclerosis.2014.11.028; Liu Hairi, 2014, Neurointervention, V9, P89, DOI 10.5469/neuroint.2014.9.2.89; Lu PH, 2011, STROKE, V42, P3470, DOI 10.1161/STROKEAHA.111.622282; Morioka C, 1997, PSYCHOPHARMACOLOGY, V131, P220, DOI 10.1007/s002130050287; Organisation for Economic Co-operation and Development (OECD), 2014, SOURC SYMB STAT; Powell J T, 1998, Vasc Med, V3, P21, DOI 10.1191/135886398670269973; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Redgrave JNE, 2010, STROKE, V41, P2288, DOI 10.1161/STROKEAHA.110.587006; RODRIGUEZ BL, 1994, HYPERTENSION, V24, P779, DOI 10.1161/01.HYP.24.6.779; ROGERS RL, 1983, JAMA-J AM MED ASSOC, V250, P2796, DOI 10.1001/jama.250.20.2796; Rose JE, 2003, AM J PSYCHIAT, V160, P323, DOI 10.1176/appi.ajp.160.2.323; Silvestrini M, 1996, J CEREBR BLOOD F MET, V16, P746, DOI 10.1097/00004647-199607000-00027; Suh DC, 2003, AM J NEURORADIOL, V24, P239; TAYLOR AE, 1992, CIRCULATION, V86, P699, DOI 10.1161/01.CIR.86.2.699; Vafaee MS, 2015, J CEREBR BLOOD F MET, V35, P699, DOI 10.1038/jcbfm.2014.246; Yamamoto Y, 2003, EUR J NUCL MED MOL I, V30, P612, DOI 10.1007/s00259-003-1119-z; Yamashita K, 2000, INTERNAL MED, V39, P891, DOI 10.2169/internalmedicine.39.891; Zubieta JK, 2005, AM J PSYCHIAT, V162, P567, DOI 10.1176/appi.ajp.162.3.567; Zubieta JK, 2001, BIOL PSYCHIAT, V49, P906, DOI 10.1016/S0006-3223(00)01070-2	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184551	10.1371/journal.pone.0184551	http://dx.doi.org/10.1371/journal.pone.0184551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953897	Green Submitted, Green Published, gold			2022-12-27	WOS:000411980300015
J	Xu, RZ; Lin, LB; Li, Y; Li, Y				Xu, Rongzhong; Lin, Liubing; Li, Yong; Li, Yan			ShenQi FuZheng Injection combined with chemotherapy in the treatment of colorectal cancer: A meta-analysis	PLOS ONE			English	Article							CHINESE MEDICINAL HERBS	Objective This study aims to investigate cellular immunity and clinical efficacy of ShenQi FuZheng Injection (SFI) in the associated chemotherapy of colorectal cancer (CRC). Methods PubMed, Cochrane Library, EMBASE, China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals Full-text Database (VIP), WanFang Database and Chinese Biomedical Literature Database (CBM) searches were undertaken to identify randomized controlled trials of SFI plus chemotherapy versus chemotherapy alone in CRC patients. The quality of each trial was assessed according to the Jadad's scale, and Review Manager 5 was used to statisitically analyze the outcomes. Results Eight studies involving 722 patients were included in this review. The meta-analyses suggested there was a significantly higher overall response rate (OR 1.89; CI: 1.10-3.24; p = 0.02), grades of KPS (OR 2.35; CI: 1.55-3.56; p<0.01), CD3+cells (MD 10.29; CI: 8.46-12.12; p<0.01), CD4+cells (MD 7.06; CI: 5.33-8.794; p<0.01), CD4/CD8+ cells (MD 0.32; CI: 0.25-0.40; p<0.01), NK+ (MD 7.20; CI: 2.02-12.37, p = 0.006), WBC (MD 1.24; CI: 0.59-1.89; p<0.01), HB (MD 14.55; CI: 7.47-21.63; p<0.01), and PLT (MD 19.05; CI: 4.29-33.81; p = 0.01), but lower severe toxicity for leukocytopenia (OR 0.37; CI: 0.17-0.80; p = 0.01), thrombocytopenia (OR 0.32; CI: 0.14-0.74; p = 0.008), gastrointestinal toxicity (OR 0.48; CI: 0.24-0.96; p = 0.04), when chemotherapy combined with SFI was compared with chemotherapy alone. There were similarities between two groups in liver dysfunction (OR 0.44; CI: 0.18-1.08; p = 0.07) and CD8+ (MD 0.54; CI: -1.89-2.96; p = 0.66). Also, there was presence of heterogeneity in the CD8 results; after the sensitivity analysis, the result of CD8+ was reversed (MD 1.57; CI: 0.32-2.81; p = 0.01). There was no significant publication bias across studies according to the Egger's (P = 0.19) and Begg's test (P = 0.23). Conclusion SFI enhances chemotherapy efficiency as they are combined and used in the treatment of colorectal cancer patients. At the same time, SFI also improves patients' immunity function.	[Xu, Rongzhong; Li, Yan] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, Dept Oncol, Shanghai, Peoples R China; [Lin, Liubing; Li, Yong] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, Digest Dept, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Li, Y (corresponding author), Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, Dept Oncol, Shanghai, Peoples R China.	18916767226@163.com			National Natural Science Foundation of China [81473627]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by National Natural Science Foundation of China (grant 81473627).	Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; [Anonymous], 2003, Altern Med Rev, V8, P72; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Dai Zhen, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P598; Dedong C, 2016, PLOS ONE, V11; Dekker JWT, 2014, EJSO-EUR J SURG ONC, V40, P1481, DOI 10.1016/j.ejso.2014.05.010; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Fan Xiao-hua, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P307; Goi T, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0704-5; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Li J, 2015, CHIN J INTEGR MED, V21, P71, DOI 10.1007/s11655-014-1768-8; Liang Qi-Lian, 2009, Zhongguo Zhong Xi Yi Jie He Za Zhi, V29, P439; Liu DW, 2009, ANTI-CANCER AGENT ME, V9, P392, DOI 10.2174/1871520610909040392; Liu G Z, 1988, J Tradit Chin Med, V8, P41; Luo HX, 2007, J FOOD PROTECT, V70, P1440, DOI 10.4315/0362-028X-70.6.1440; Shan BE, 1999, INT J IMMUNOPHARMACO, V21, P149, DOI 10.1016/S0192-0561(98)00074-5; Song M, 2015, GUIDING J TRADITIONA, V21, P46, DOI DOI 10.13862/J.CNKI.CN43-1446/R.2015.02.017; Takayama T, 2006, J GASTROENTEROL, V41, P185, DOI 10.1007/s00535-006-1801-6; Wang CB, 2010, ZHEJIANG J TRADITION, V45, P801; Wang JX, 2014, J ETHNOPHARMACOL, V155, P405, DOI 10.1016/j.jep.2014.05.038; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; Xu C, 2012, INT J BIOL MACROMOL, V50, P891, DOI 10.1016/j.ijbiomac.2012.01.013; [燕飞 Yan Fei], 2014, [中国现代医学杂志, China Journal of Modern Medicine], V24, P72; Yoshida Y, 1997, INT J IMMUNOPHARMACO, V19, P359, DOI 10.1016/S0192-0561(97)00076-3; Zhang W., 2015, MODERN PRACTICAL MED, V27, P358; Zhang X. H., 2009, CHINA PRACTICAL MED, V4, P129; Zhang Yan, 2010, Zhongguo Zhong Xi Yi Jie He Za Zhi, V30, P280; [邹劲林 Zou Jinlin], 2012, [中国现代应用药学, Chinese Journal of Modern Applied Pharmacy], V29, P755	30	18	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185254	10.1371/journal.pone.0185254	http://dx.doi.org/10.1371/journal.pone.0185254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953950	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300050
J	Cherry, JD; Stein, TD; Tripodis, Y; Alvarez, VE; Huber, BR; Au, R; Kiernan, PT; Daneshvar, DH; Mez, J; Solomon, TM; Alosco, ML; McKee, AC				Cherry, Jonathan D.; Stein, Thor D.; Tripodis, Yorghos; Alvarez, Victor E.; Huber, Bertrand R.; Au, Rhoda; Kiernan, Patrick T.; Daneshvar, Daniel H.; Mez, Jesse; Solomon, Todd M.; Alosco, Michael L.; McKee, Ann C.			CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer's disease	PLOS ONE			English	Article							NATIONAL INSTITUTE; NEUROPATHOLOGIC ASSESSMENT; ASSOCIATION GUIDELINES; BRAIN-INJURY; TAU; CRITERIA; RELIABILITY; MICROGLIA; DIAGNOSIS; CONSENSUS	CCL11, a protein previously associated with age-associated cognitive decline, is observed to be increased in the brain and cerebrospinal fluid (CSF) in chronic traumatic encephalopathy (CTE) compared to Alzheimer's disease (AD). Using a cohort of 23 deceased American football players with neuropathologically verified CTE, 50 subjects with neuropathologically diagnosed AD, and 18 non-athlete controls, CCL11 was measured with ELISA in the dorsolateral frontal cortex (DLFC) and CSF. CCL11 levels were significantly increased in the DLFC in subjects with CTE (fold change = 1.234, p < 0.050) compared to non-athlete controls and AD subjects with out a history of head trauma. This increase was also seen to correlate with years of exposure to American football (beta = 0.426, p = 0.048) independent of age (beta = -0.046, p = 0.824). Preliminary analyses of a subset of subjects with available post-mortem CSF showed a trend for increased CCL11 among individuals with CTE (p = 0.069) mirroring the increase in the DLFC. Furthermore, an association between CSF CCL11 levels and the number of years exposed to football (beta = 0.685, p = 0.040) was observed independent of age (beta = -0.103, p = 0.716). Finally, a receiver operating characteristic (ROC) curve analysis demonstrated CSF CCL11 accurately distinguished CTE subjects from non-athlete controls and AD subjects (AUC = 0.839, 95% CI 0.62 - 1.058, p = 0.028). Overall, the current findings provide preliminary evidence that CCL11 may be a novel target for future CTE biomarker studies.	[Cherry, Jonathan D.; Stein, Thor D.; Alvarez, Victor E.; Huber, Bertrand R.; Kiernan, Patrick T.; Daneshvar, Daniel H.; Mez, Jesse; Solomon, Todd M.; Alosco, Michael L.; McKee, Ann C.] Boston Univ, Sch Med, Boston Univ Alzheimers Dis, Boston, MA 02118 USA; [Cherry, Jonathan D.; Stein, Thor D.; Alvarez, Victor E.; Huber, Bertrand R.; Kiernan, Patrick T.; Daneshvar, Daniel H.; Mez, Jesse; Solomon, Todd M.; Alosco, Michael L.; McKee, Ann C.] Boston Univ, Sch Med, CTE Ctr, Boston, MA 02118 USA; [Cherry, Jonathan D.; Stein, Thor D.; Alvarez, Victor E.; Huber, Bertrand R.; Au, Rhoda; Mez, Jesse; Alosco, Michael L.; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Cherry, Jonathan D.; Alvarez, Victor E.; Huber, Bertrand R.; McKee, Ann C.] VA Boston Healthcare Syst, Boston, MA 02130 USA; [Stein, Thor D.; Alvarez, Victor E.; McKee, Ann C.] Dept Vet Affairs Med Ctr, Bedford, MA USA; [Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Au, Rhoda] Boston Univ, Sch Med, Framingham Heart Study, Boston, MA 02118 USA; [McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Boston University; Boston University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Boston University; Framingham Heart Study; Boston University	Cherry, JD (corresponding author), Boston Univ, Sch Med, Boston Univ Alzheimers Dis, Boston, MA 02118 USA.; Cherry, JD (corresponding author), Boston Univ, Sch Med, CTE Ctr, Boston, MA 02118 USA.; Cherry, JD (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.; Cherry, JD (corresponding author), VA Boston Healthcare Syst, Boston, MA 02130 USA.	Jdcherry@bu.edu	Tripodis, Yorghos/GRY-0583-2022	Tripodis, Yorghos/0000-0003-2190-7608; Stein, Thor/0000-0001-6954-4477; Daneshvar, Daniel/0000-0003-3691-9513	Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development [I01-CX001038]; Alzheimer's Association [NIRG-305779]; Veterans Affairs Biorepository [CSP 501]; National Institute of Aging [1RF1AG054156-01]; National Institute of Aging Boston University AD Center [P30AG13846, 0572063345-5]; Department of Defense Peer Reviewed Alzheimer's Research Program [DoD-PRARP 13267017]; National Heart, Lung, and Blood Institute, Framingham Heart Study, (NHLBI/NIH) [N01-HC-25195, R01AG08122]; NINDS [1F32NS096803-01]; Concussion Legacy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG057902, RF1AG054156, K23AG046377, P30AG013846] Funding Source: NIH RePORTER; Veterans Affairs [I01CX001038] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development(US Department of Veterans Affairs); Alzheimer's Association(Alzheimer's Association); Veterans Affairs Biorepository; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Aging Boston University AD Center; Department of Defense Peer Reviewed Alzheimer's Research Program; National Heart, Lung, and Blood Institute, Framingham Heart Study, (NHLBI/NIH); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Concussion Legacy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award (I01-CX001038 to TDS); Alzheimer's Association (NIRG-305779 to TDS); Veterans Affairs Biorepository (CSP 501 to ACM); National Institute of Aging (1RF1AG054156-01); National Institute of Aging Boston University AD Center (P30AG13846; supplement 0572063345-5 to ACM); Department of Defense Peer Reviewed Alzheimer's Research Program (DoD-PRARP #13267017 to ACM); National Heart, Lung, and Blood Institute, Framingham Heart Study, (NHLBI/NIH #N01-HC-25195 and R01AG08122 to RA); NINDS (1F32NS096803-01 to MLA); Concussion Legacy Foundation to ACM. This work was also supported by unrestricted gifts from the Andlinger Foundation and WWE to ACM. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PLOS CURR; Bachstetter AD, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0209-z; Baruch K, 2013, P NATL ACAD SCI USA, V110, P2264, DOI 10.1073/pnas.1211270110; Belkhelfa M, 2014, J INTERFERON CYTOKIN; Bigio EH, 2008, J NEUROPATH EXP NEUR, V67, P635, DOI 10.1097/NEN.0b013e31817d751c; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Castellano JM, 2015, JAMA NEUROL, V72, P1191, DOI 10.1001/jamaneurol.2015.1616; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Flynn G, 2003, J NEUROIMMUNOL, V136, P84, DOI 10.1016/S0165-5728(03)00009-2; Furukawa T, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000138; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Huber A. K., 2016, CLIN IMMUNOL; Huber AK, 2014, NEUROLOGY, V83, P1500, DOI 10.1212/WNL.0000000000000908; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Kanaan NM, 2016, J NEUROPATH EXP NEUR, V75, P19, DOI 10.1093/jnen/nlv001; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kovac A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-139; Leung R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064971; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Love S, 2008, GREENFIELDS NEUROPAT, DOI 10.1201/b22602; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKeith IG, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P417; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Mielke MM, 2014, CLIN EPIDEMIOL, V6, P37, DOI 10.2147/CLEP.S37929; Mishra A, 1999, J CLIN INVEST, V103, P1719, DOI 10.1172/JCI6560; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Nedergaard M, 2013, SCIENCE, V340, P1529, DOI 10.1126/science.1240514; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1147, DOI 10.1097/00005072-199911000-00004; Okamura N, 2016, AGEING RES REV, V30, P107, DOI 10.1016/j.arr.2015.12.010; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Parajuli B, 2015, GLIA, V63, P2274, DOI 10.1002/glia.22892; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Shahim P, 2017, JAMA NEUROL; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Spergel JM, 1999, J CLIN INVEST, V103, P1103, DOI 10.1172/JCI5669; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Szmydynger-Chodobska J, 2012, J CEREBR BLOOD F MET, V32, P93, DOI 10.1038/jcbfm.2011.111; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; van der Meer P, 2000, EXP MOL PATHOL, V69, P192, DOI 10.1006/exmp.2000.2336; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9; VONSATTEL JPG, 1995, J NEUROPATH EXP NEUR, V54, P42; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411; Yang LP, 2007, MOL VIS, V13, P1083; Zhu C, 2016, MOL NEUROBIOL	63	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185541	10.1371/journal.pone.0185541	http://dx.doi.org/10.1371/journal.pone.0185541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950005	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000062
J	Olivera, MJ; Cucunuba, ZM; Valencia-Hernandez, CA; Herazo, R; Agreda-Rudenko, D; Florez, C; Duque, S; Nicholls, RS				Olivera, Mario J.; Cucunuba, Zulma M.; Valencia-Hernandez, Carlos A.; Herazo, Rafael; Agreda-Rudenko, Diana; Florez, Carolina; Duque, Sofia; Nicholls, Ruben S.			Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease	PLOS ONE			English	Article							TOLERANCE; SAFETY; NIFURTIMOX; TRIAL; MODEL	Background Etiological treatment of Chagas disease in chronic asymptomatic patients is still in debate and the adverse effects of traditional drugs are one of the main concerns in clinical practice. This study evaluated retrospectively the safety profile of benznidazole (BZN) and identified predictive factors for definite treatment interruption and development of severe reactions in adult patients treated with BZN in Colombia. Methods Retrospective follow-up study conducted by review of medical records of adults with chronic Chagas disease treated with BZN in Colombia. A parametric survival analysis based on a generalized gamma distribution was used for assessing risk factors for treatment interruption. A multinomial logistic regression model was used to estimate the probability of severe adverse drug reactions (ADRs). Statistical associations were expressed as time ratios (TR) and adjusted odds ratios (aOR) respectively. Results In total 224 adults patients treated with BZN were included; 172 (76.8%) completed the standard therapy (60 days of treatment), 205 (91.5%) presented ADRs and 52 cases (23.2%) required treatment interruption. The predominant symptoms were: rash (37.9%), itching (33.7%), epigastric pain (26.4%), abdominal bloating (24.2%) and nausea (22.1%). ADRs were mild (57.4%), moderate (35.5%) and severe (7.3%). Time to treatment interruption was significantly shorter when using doses of BZN >= 6 mg/ kg/ day (TR 0.55; 95% CI 0.39-0.76), presenting severe ADRs (TR 0.12; 95% CI: 0.07-0.19) and eosinophilia (TR 0.68; 95% CI: 0.49-0.94). Female sex (aOR 3.98; 95% CI 1.56-10.16), dose of BZN >= 6 mg/ kg/ day (aOR 1.41; 95% CI 1.17-1.70) and presence of > 3 ADRs (aOR 6.47; 95% CI 1.24-34.34) were considered as risk factors for developing severe ADRs. Conclusions Dose, severity of ADRs, eosinophilia and female sex were the main predictors for treatment interruption or severe ADRs. The potential implications of these findings are discussed.	[Olivera, Mario J.; Cucunuba, Zulma M.; Valencia-Hernandez, Carlos A.; Herazo, Rafael; Agreda-Rudenko, Diana] Red Chagas Colombia, Bogota, Colombia; [Olivera, Mario J.; Cucunuba, Zulma M.; Valencia-Hernandez, Carlos A.; Herazo, Rafael; Agreda-Rudenko, Diana; Florez, Carolina; Duque, Sofia; Nicholls, Ruben S.] Inst Nacl Salud, Grp Parasitol, Bogota, Colombia	Instituto Nacional de Salud (Colombia)	Olivera, MJ (corresponding author), Red Chagas Colombia, Bogota, Colombia.; Olivera, MJ (corresponding author), Inst Nacl Salud, Grp Parasitol, Bogota, Colombia.	moliverajr@gmail.com	Cucunuba, Zulma M/X-5670-2019; Olivera, Mario/T-5486-2018	Cucunuba, Zulma M/0000-0002-8165-3198; Olivera, Mario/0000-0002-6885-6353				Altcheh J, 2011, PEDIATRICS, V127, pE212, DOI 10.1542/peds.2010-1172; Anderson GD, 2008, INT REV NEUROBIOL, V83, P1, DOI 10.1016/S0074-7742(08)00001-9; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; [Anonymous], 2010, GUIA AT CLIN INT PAC; Antinori S, 2015, CLIN INFECT DIS, V60, P1873, DOI 10.1093/cid/civ230; CANÇADO J. Romeu, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P29, DOI 10.1590/S0036-46652002000100006; Villar JC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003463.pub2; Carrilero B, REV ESPANOLA QUIMIOT; Coelho H L, 1999, Cad Saude Publica, V15, P631, DOI 10.1590/S0102-311X1999000300021; Cox C, 2007, STAT MED, V26, P4352, DOI 10.1002/sim.2836; Croft SL, 2005, TRENDS PARASITOL, V21, P508, DOI 10.1016/j.pt.2005.08.026; de Graauw E, 2015, IMMUNOL ALLERGY CLIN, V35, P545, DOI 10.1016/j.iac.2015.05.005; Fabbro de Suasnabar Diana, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P99; Alvarez MG, 2016, ANTIMICROB AGENTS CH, V60, P833, DOI 10.1128/AAC.00745-15; Hasslocher-Moreno AM, 2012, J ANTIMICROB CHEMOTH, V67, P1261, DOI 10.1093/jac/dks027; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jackson Y, 2010, CLIN INFECT DIS, V51, pE69, DOI 10.1086/656917; Olivera MJ, 2015, AM J TROP MED HYG, V93, P1224, DOI 10.4269/ajtmh.15-0256; Olivera MJ, 2015, REV SOC BRAS MED TRO, V48, P343, DOI 10.1590/0037-8682-0251-2014; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee BY, 2013, LANCET INFECT DIS, V13, P342, DOI 10.1016/S1473-3099(13)70002-1; Lee EW, 2003, STAT METHODS SURVIVA, Vthird, DOI DOI 10.1002/0471458546; Meibohm B, 2002, CLIN PHARMACOKINET, V41, P329, DOI 10.2165/00003088-200241050-00002; Miller DA, 2015, CLIN INFECT DIS, V60, P1237, DOI 10.1093/cid/civ005; Morillo CA, 2015, NEW ENGL J MED, V373, P1295, DOI 10.1056/NEJMoa1507574; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Ng ES-W, 2015, PHARM STAT; de Pontes VMO, 2010, REV SOC BRAS MED TRO, V43, P182, DOI 10.1590/S0037-86822010000200015; Pinazo MJ, 2010, ANTIMICROB AGENTS CH, V54, P4896, DOI 10.1128/AAC.00537-10; R Development Core Team, 2013, LANG ENV STAT COMP; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Silva G. M. S. da, 2014, Antimicrobial Agents and Chemotherapy, V58, P6371, DOI 10.1128/AAC.02842-14; Sosa-Estani S, 2004, MEDICINA-BUENOS AIRE, V64, P1; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; White KD, 2015, J ALLERGY CLIN IMMUN, V136, P219, DOI 10.1016/j.jaci.2015.05.050	36	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185033	10.1371/journal.pone.0185033	http://dx.doi.org/10.1371/journal.pone.0185033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949997	gold, Green Published, Green Submitted			2022-12-27	WOS:000411671000022
J	Cherry, JJ; DiDonato, CJ; Androphy, EJ; Calo, A; Potter, K; Custer, SK; Du, S; Foley, TL; Gopalsamy, A; Reedich, EJ; Gordo, SM; Gordon, W; Hosea, N; Jones, LH; Krizay, DK; LaRosa, G; Li, HX; Mathur, S; Menard, CA; Patel, P; Ramos-Zayas, R; Rietz, A; Rong, HJ; Zhang, BH; Tones, MA				Cherry, Jonathan J.; DiDonato, Christine J.; Androphy, Elliot J.; Calo, Alessandro; Potter, Kyle; Custer, Sara K.; Du, Sarah; Foley, Timothy L.; Gopalsamy, Ariamala; Reedich, Emily J.; Gordo, Susana M.; Gordon, William; Hosea, Natalie; Jones, Lyn H.; Krizay, Daniel K.; LaRosa, Gregory; Li, Hongxia; Mathur, Sachin; Menard, Carol A.; Patel, Paraj; Ramos-Zayas, Rebeca; Rietz, Anne; Rong, Haojing; Zhang, Baohong; Tones, Michael A.			In vitro and in vivo effects of 2,4 diaminoquinazoline inhibitors of the decapping scavenger enzyme DcpS: Context-specific modulation of SMN transcript levels	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; MOTOR-NEURON GENE; MOUSE MODEL; 2,4-DIAMINOQUINAZOLINE DERIVATIVES; LYSOSOMOTROPIC AGENTS; PROTEIN-LEVELS; SURVIVAL; EXPRESSION; MICE; RNA	`C5-substituted 2,4-diaminoquinazoline inhibitors of the decapping scavenger enzyme DcpS (DAQ-DcpSi) have been developed for the treatment of spinal muscular atrophy (SMA), which is caused by genetic deficiency in the Survival Motor Neuron (SMN) protein. These compounds are claimed to act as SMN2 transcriptional activators but data underlying that claim are equivocal. In addition it is unclear whether the claimed effects on SMN2 are a direct consequence of DcpS inhibitor or might be a consequence of lysosomotropism, which is known to be neuroprotective. DAQ-DcpSi effects were characterized in cells in vitro utilizing DcpS knockdown and 7-methyl analogues as probes for DcpS vs non-DcpS-mediated effects. We also performed analysis of Smn transcript levels, RNA-Seq analysis of the transcriptome and SMN protein in order to identify affected pathways underlying the therapeutic effect, and studied lysosomotropic and non-lysosomotropic DAQ-DCpSi effects in 2B/-SMA mice. Treatment of cells caused modest and transient SMN2 mRNA increases with either no change or a decrease in SMN.7 and no change in SMN1 transcripts or SMN protein. RNA-Seq analysis of DAQ-DcpSi-treated N2a cells revealed significant changes in expression (both up and down) of approximately 2,000 genes across a broad range of pathways. Treatment of 2B/-SMA mice with both lysomotropic and non-lysosomotropic DAQ-DcpSi compounds had similar effects on disease phenotype indicating that the therapeutic mechanism of action is not a consequence of lysosomotropism. In striking contrast to the findings in vitro, Smn transcripts were robustly changed in tissues but there was no increase in SMN protein levels in spinal cord. We conclude that DAQ-DcpSi have reproducible benefit in SMA mice and a broad spectrum of biological effects in vitro and in vivo, but these are complex, context specific, and not the result of simple SMN2 transcriptional activation.	[Cherry, Jonathan J.; Calo, Alessandro; Gordo, Susana M.; Krizay, Daniel K.; LaRosa, Gregory; Patel, Paraj; Ramos-Zayas, Rebeca; Tones, Michael A.] Pfizer Worldwide Res & Dev, Rare Dis Res Unit, Cambridge, MA USA; [DiDonato, Christine J.; Potter, Kyle; Reedich, Emily J.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60208 USA; [DiDonato, Christine J.; Potter, Kyle; Reedich, Emily J.] Ann & Robert Lurie Childrens Hosp, Stanley Manne Res Inst, Human Mol Genet Program, Chicago, IL 60640 USA; [Androphy, Elliot J.; Custer, Sara K.; Li, Hongxia; Rietz, Anne] Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA; [Du, Sarah; Gordon, William] Pfizer Worldwide Res & Dev, Precis Med, Cambridge, MA 02139 USA; [Foley, Timothy L.; Menard, Carol A.] Pfizer Worldwide Res & Dev, Pharmaceut Sci, Groton, CT USA; [Foley, Timothy L.; Menard, Carol A.] Pfizer Worldwide Res & Dev, Primary Pharmacol Grp, Groton, CT USA; [Gopalsamy, Ariamala; Jones, Lyn H.] Pfizer Worldwide Res & Dev, Med Design, Cambridge, MA USA; [Hosea, Natalie; Rong, Haojing] Pfizer Worldwide Res & Dev, Pharmacokinet & Drug Metab, Cambridge, MA USA; [Mathur, Sachin] Pfizer Worldwide Res & Dev, Business Technol, Cambridge, MA USA; [Zhang, Baohong] Pfizer Worldwide Res & Dev, Clin Genet, Cambridge, MA USA; [Cherry, Jonathan J.; Gordo, Susana M.] RaNA Therapeut Inc, Cambridge, MA USA; [Hosea, Natalie] Takeda Calif, Global DMPK, San Diego, CA USA	Pfizer; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Indiana University System; Indiana University Bloomington; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc	DiDonato, CJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60208 USA.; DiDonato, CJ (corresponding author), Ann & Robert Lurie Childrens Hosp, Stanley Manne Res Inst, Human Mol Genet Program, Chicago, IL 60640 USA.; Gordon, W (corresponding author), Pfizer Worldwide Res & Dev, Precis Med, Cambridge, MA 02139 USA.	c-didonato@northwestern.edu; william.gordon@pfizer.com	Foley, Timothy/O-7281-2018	Foley, Timothy/0000-0002-5987-5253; Jones, Lyn/0000-0002-8388-5865	Pfizer Inc. EJR is a Dr. Virginia Mullins Investigator; Ann & Robert H. Lurie Children's Hospital of Chicago Foundation; National Institutes of Health [5T32NS041234-15, 1ROIN5060926]; Muscular Dystrophy Association [255785]; Cure SMA [DiD1214]; Lurie Children's Hospital; Pfizer; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS041234] Funding Source: NIH RePORTER	Pfizer Inc. EJR is a Dr. Virginia Mullins Investigator; Ann & Robert H. Lurie Children's Hospital of Chicago Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Cure SMA; Lurie Children's Hospital; Pfizer(Pfizer); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Pfizer Inc. EJR is a Dr. Virginia Mullins Investigator, Ann & Robert H. Lurie Children's Hospital of Chicago Foundation and was supported by a National Institutes of Health training grant [#5T32NS041234-15] with additional support provided by National Institutes of Health [#1ROIN5060926], Muscular Dystrophy Association [255785], Cure SMA [DiD1214] and Lurie Childrens Hospital to CJD. Employees of Pfizer who are named in this manuscript participated in all or portions of this research. Pfizer provided support in the form of salaries for authors (JJC, AC, SD,TLF, AG, SMG, WG, NH, LHJ, DKK, GL, HL, SM, CAM,PP, RR-Z, HR, BZ, and MAT), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript beyond the contributions of the individual authors who were Pfizer employees at the time the work was performed, as detailed in the 'authors contributions' section.	Ahmad S, 2012, HUM MOL GENET, V21, P2745, DOI 10.1093/hmg/dds102; Bosse GD, 2013, MOL CELL, V50, P281, DOI 10.1016/j.molcel.2013.02.023; Butchbach MER, 2010, HUM MOL GENET, V19, P454, DOI 10.1093/hmg/ddp510; Cherry JJ, 2013, EMBO MOL MED, V5, P1103, DOI 10.1002/emmm.201202305; Cherry JJ, 2012, J BIOMOL SCREEN, V17, P481, DOI 10.1177/1087057111431605; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Gogliotti RG, 2013, HUM MOL GENET, V22, P4084, DOI 10.1093/hmg/ddt258; Gopalsamy A, 2017, J MED CHEM, V60, P3094, DOI 10.1021/acs.jmedchem.7b00124; Hett EC, 2016, ACS COMB SCI; Jarecki J, 2005, HUM MOL GENET, V14, P2003, DOI 10.1093/hmg/ddi205; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Meziane O, 2015, SCI REP-UK, V5, DOI 10.1038/srep16688; Murray LM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0231-1; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Reinhardt P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059252; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rochette CF, 2001, HUM GENET, V108, P255, DOI 10.1007/s004390100473; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Singh J, 2008, ACS CHEM BIOL, V3, P711, DOI 10.1021/cb800120t; Sinturel F, 2012, P NATL ACAD SCI USA, V109, P8264, DOI 10.1073/pnas.1120090109; Thurmond J, 2008, J MED CHEM, V51, P449, DOI 10.1021/jm061475p; Van Meerbeke JP, 2013, HUM MOL GENET, V22, P4074, DOI 10.1093/hmg/ddt257; Wang Y, 2015, MOL NEUROBIOL, V52, P64, DOI 10.1007/s12035-014-8846-y; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9; Xu H, 2016, ORG BIOMOL CHEM, V14, P6179, DOI 10.1039/c6ob01078d; Zhou M, 2015, RNA, V21, P1306, DOI 10.1261/rna.051573.115	33	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9								10.1371/journal.pone.0185079	http://dx.doi.org/10.1371/journal.pone.0185079			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945765	Green Published, Green Submitted, gold			2022-12-27	WOS:000411645100021
J	Koyama, D; Murata, M; Hanajiri, R; Okuno, S; Kamoshita, S; Julamanee, J; Takagi, E; Hirano, D; Miyao, K; Sakemura, R; Goto, T; Hayakawa, F; Seto, A; Ozawa, Y; Miyamura, K; Terakura, S; Nishida, T; Kiyoi, H				Koyama, Daisuke; Murata, Makoto; Hanajiri, Ryo; Okuno, Shingo; Kamoshita, Sonoko; Julamanee, Jakrawadee; Takagi, Erina; Hirano, Daiki; Miyao, Kotaro; Sakemura, Reona; Goto, Tatsunori; Hayakawa, Fumihiko; Seto, Aika; Ozawa, Yukiyasu; Miyamura, Koichi; Terakura, Seitaro; Nishida, Tetsuya; Kiyoi, Hitoshi			High incidence of extensive chronic graft-versus-host disease in patients with the REG3A rs7588571 non-GG genotype	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; INTESTINAL MICROBIOTA; METABOLITE BUTYRATE; COMPETING RISK; T-CELLS; GUT; INTERLEUKIN-22; INFLAMMATION; EXPRESSION; BIOMARKERS	Regenerating islet-derived protein 3 alpha (REG3A) is a biomarker of lower gastrointestinal graft-versus-host disease (GVHD); however, the biological role of REG3A in the pathophysiology of GVHD is not understood. Here, we examined the association between a single nucleotide polymorphism in the REG3A gene, rs7588571, which is located upstream and within 2 kb of the REG3A gene, and transplant outcomes including the incidence of GVHD. The study population consisted of 126 adult Japanese patients who had undergone bone marrow transplantation from a HLA-matched sibling. There was no association between rs7588571 polymorphism and the incidence of acute GVHD. However, a significantly higher incidence of extensive chronic GVHD was observed in patients with the rs7588571 non-GG genotype than in those with the GG genotype (Odds ratio 2.6; 95% confidence interval, 1.1-6.0; P = 0.029). Semi-quantitative reverse transcription PCR demonstrated that the rs7588571 non-GG genotype exhibited a significantly lower REG3A mRNA expression level than the GG genotype (P = 0.032), and Western blot analysis demonstrated that the rs7588571 non-GG genotype exhibited a trend toward lower REG3A protein expression level than the GG genotype (P = 0.053). Since REG proteins have several activities that function to control intestinal microbiota, and since intestinal dysbiosis is in part responsible for the development of GVHD, our findings lead to the novel concept that REG3A could have some protective effect in the pathogenesis of GVHD through the regulation of gut microbiota.	[Koyama, Daisuke; Murata, Makoto; Hanajiri, Ryo; Okuno, Shingo; Kamoshita, Sonoko; Julamanee, Jakrawadee; Takagi, Erina; Hirano, Daiki; Miyao, Kotaro; Sakemura, Reona; Goto, Tatsunori; Hayakawa, Fumihiko; Terakura, Seitaro; Nishida, Tetsuya; Kiyoi, Hitoshi] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Seto, Aika; Ozawa, Yukiyasu; Miyamura, Koichi] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan	Nagoya University; Red Cross Nagoya Daiichi Hospital	Murata, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi, Japan.	mmurata@med.nagoya-u.ac.jp	Julamanee, Jakrawadee/AAQ-5827-2021; Julamanee, Jakrawadee/AAQ-7762-2021; Terakura, Seitaro/A-6188-2011	Julamanee, Jakrawadee/0000-0002-6526-9479; 	Japan Agency for Medical Research and Development (AMED) [17ek0510022h0001 to M. Murata) from the]; Japan Society for the Promotion of Science (JSPS) [15K09498]; Grants-in-Aid for Scientific Research [17K09921, 16H06868] Funding Source: KAKEN	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Practical Research Project for Allergic Diseases and Immunology (17ek0510022h0001 to M. Murata) from the Japan Agency for Medical Research and Development (AMED; http://www.amed.go.jp/en/) and a Grant-in-Aid for Scientific Research (KAKENHI) (15K09498 to M. Murata) from the Japan Society for the Promotion of Science (JSPS; https://www.jsps.go.jp/english/index.html).	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Beilhack A, 2008, BLOOD, V111, P2919, DOI 10.1182/blood-2007-09-112789; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Byun JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163998; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Cohen JL, 2002, J EXP MED, V196, P401, DOI 10.1084/jem.20020090; COX DR, 1958, J R STAT SOC B, V20, P215; Docampo MD, 2015, BIOL BLOOD MARROW TR, V21, P1360, DOI 10.1016/j.bbmt.2015.02.016; Eriguchi Y, 2013, BIOL BLOOD MARROW TR, V19, P1525, DOI 10.1016/j.bbmt.2013.07.027; Ferrara JLM, 2011, BLOOD, V118, P6702, DOI 10.1182/blood-2011-08-375006; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Holler E, 2014, BIOL BLOOD MARROW TR, V20, P640, DOI 10.1016/j.bbmt.2014.01.030; Inamoto Y, 2010, BONE MARROW TRANSPL, V45, P363, DOI 10.1038/bmt.2009.131; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Klein JP, 2001, BONE MARROW TRANSPL, V28, P1001, DOI 10.1038/sj.bmt.1703271; Koenecke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038252; Kojima Y, 2017, PHARMACOL RES, V120, P242, DOI 10.1016/j.phrs.2017.04.006; Levine JE, 2015, LANCET HAEMATOL, V2, pE21, DOI 10.1016/S2352-3026(14)00035-0; Levine JE, 2012, BLOOD, V119, P3854, DOI 10.1182/blood-2012-01-403063; Martin PJ, 2016, BLOOD, V128, P2450, DOI 10.1182/blood-2016-07-728063; Mathewson ND, 2016, NAT IMMUNOL, V17, P505, DOI 10.1038/ni.3400; Paczesny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000406; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Shono Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2311; Shono Y, 2015, INT J HEMATOL, V101, P428, DOI 10.1007/s12185-015-1781-5; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Sugimoto K, 2009, J IMMUNOL, V183, P5991, DOI 10.4049/jimmunol.0804310; SULLIVAN KM, 1991, SEMIN HEMATOL, V28, P250; Taur Y, 2014, BLOOD, V124, P1174, DOI 10.1182/blood-2014-02-554725; Tumino M, 2015, BRIT J HAEMATOL, V168, P142, DOI 10.1111/bjh.13068; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vander Lugt MT, 2013, NEW ENGL J MED, V369, P529, DOI 10.1056/NEJMoa1213299; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Zama D, 2017, BONE MARROW TRANSPL, V52, P7, DOI 10.1038/bmt.2016.173	42	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185213	10.1371/journal.pone.0185213	http://dx.doi.org/10.1371/journal.pone.0185213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945764	Green Published, gold, Green Submitted			2022-12-27	WOS:000411645100029
J	Puozaa, DK; Jaiswal, SK; Dakora, FD				Puozaa, Doris K.; Jaiswal, Sanjay K.; Dakora, Felix D.			African origin of Bradyrhizobium populations nodulating Bambara groundnut (Vigna subterranea L. Verdc) in Ghanaian and South African soils	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; NITROGEN-FIXING BACTERIUM; SP NOV.; RHIZOBIUM-MELILOTI; ROOT-NODULES; NOD GENES; FLAVONOIDS; SEEDS; PLANT; DIVERSITY	Flavonoids secreted by legumes play a major role as signal molecules for attracting compatible rhizobia. The aim of this study was to assess and understand the diversity of micro-symbionts nodulating Bambara groundnut (Vigna subterranea L. Verdc.) landraces of different seedcoat colours using restriction fragment length polymorphism and phylogenetic analysis. Seedcoat pigmentation of landraces had effect on the diversity of microsymbionts of Bambara groundnut. Even when planted together in one hole, nodulating bradyrhizobia clustered differently. For example, 16S rDNA-RFLP typing of rhizobial samples TUTVSBLM. I, TUTVSCRM. I and TUTVSRDM. I originating respectively from Black, Cream and Red landraces that were co-planted in the same hole at Manga in the Sudano-sahelian savanna, as well as TUTVSCRK. I and TUTVSRDK. I respectively from Cream and Red landraces co-planted at Kpalisogu in the Guinea savanna, revealed different 16S rDNA-RFLP types. Phylogenetic analysis of 16S rDNA, glnII, recA and atpD sequences showed that Vigna subterranea was nodulated specifically by a diverse group of Bradyrhizobium species (e.g. Bradyrhizobium vignae, and a novel group of Bradyrhizobium spp.) in soils from Ghana and South Africa. The recA gene phylogeny showed incongruency with the other housekeeping genes, indicating the possibility of lateral gene transfer and/or recombination events. The grouping of isolates according to symbiotic gene (nifH and nodD) phylogenies revealed inter-and intra-specific symbiotic plasmid transfer and different evolutionary history. The results also showed that a cropping history and physico-chemical environment of soils increased bradyrhizobial diversity in Ghana and South Africa.	[Puozaa, Doris K.] Univ Technol, Dept Crop Sci, Pretoria, South Africa; [Jaiswal, Sanjay K.; Dakora, Felix D.] Univ Technol, Dept Chem, Arcadia Campus, Pretoria, South Africa		Jaiswal, SK; Dakora, FD (corresponding author), Univ Technol, Dept Chem, Arcadia Campus, Pretoria, South Africa.	sanjaysiswa@gmail.com; dakorafd@tut.ac.za	JAISWAL, SANJAY/AAI-8262-2021; Dakora, Felix/AAI-4090-2020; Jaiswal, Sanjay K/AAB-6076-2022	JAISWAL, SANJAY/0000-0003-2745-9949; Dakora, Felix/0000-0002-9070-6896; 	Bill and Melinda Gates Foundation in Africa; South African Department of Science and Technology; Tshwane University of Technology; National Research Foundation in Pretoria; South African Research Chair in Agrochemurgy and Plant Symbioses	Bill and Melinda Gates Foundation in Africa; South African Department of Science and Technology; Tshwane University of Technology; National Research Foundation in Pretoria; South African Research Chair in Agrochemurgy and Plant Symbioses	This work was supported with grants from the Bill and Melinda Gates Foundation Project on Capacity Building in Legume Sciences in Africa, the South African Department of Science and Technology, the Tshwane University of Technology, the National Research Foundation in Pretoria, and the South African Research Chair in Agrochemurgy and Plant Symbioses	AGUILAR JMM, 1988, J GEN MICROBIOL, V134, P2741; Begum AA, 2001, J EXP BOT, V52, P1537, DOI 10.1093/jexbot/52.360.1537; Benoit LF, 1997, PHYSIOL PLANTARUM, V99, P588, DOI 10.1034/j.1399-3054.1997.990410.x; Dakora FD, 2003, NEW PHYTOL, V158, P39, DOI 10.1046/j.1469-8137.2003.00725.x; Deaker R, 2004, SOIL BIOL BIOCHEM, V36, P1275, DOI 10.1016/j.soilbio.2004.04.009; Degefu T, 2012, INT J SYST EVOL MICR, V62, P2286, DOI 10.1099/ijs.0.039230-0; Depret G, 2004, FEMS MICROBIOL ECOL, V51, P87, DOI 10.1016/j.femsec.2004.07.009; Desbrosses GJ, 2011, CELL HOST MICROBE, V10, P348, DOI 10.1016/j.chom.2011.09.005; Doku EV, 1995, CONSERVATION IMPROVE, P72; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gronemeyer JL, 2014, APPL ENVIRON MICROB, V80, P7244, DOI 10.1128/AEM.02417-14; Gronemeyer JL, 2015, INT J SYST EVOL MICR, V65, P4886, DOI 10.1099/ijsem.0.000666; Gronemeyer JL, 2015, INT J SYST EVOL MICR, V65, P3241, DOI 10.1099/ijsem.0.000403; Gronemeyer JL, 2016, INT J SYST EVOL MICR, V66, P62, DOI 10.1099/ijsem.0.000674; GUEYE M, 1988, MIRCEN Journal of Applied Microbiology and Biotechnology, V4, P365, DOI 10.1007/BF01096142; Hall T., 2005, BIOEDIT VERSION 7 0; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; HARTWIG UA, 1991, PLANT PHYSIOL, V95, P797, DOI 10.1104/pp.95.3.797; HARTWIG UA, 1990, PLANT PHYSIOL, V92, P116, DOI 10.1104/pp.92.1.116; Hassan S, 2012, J EXP BOT, V63, P3429, DOI 10.1093/jxb/err430; HUNGRIA M, 1993, MOL PLANT MICROBE IN, V6, P418, DOI 10.1094/MPMI-6-418; HUNGRIA M, 1991, PLANT PHYSIOL, V97, P751, DOI 10.1104/pp.97.2.751; Kishinevsky BD, 1996, FIELD CROP RES, V48, P57, DOI 10.1016/0378-4290(96)00037-8; KUMAGA F, 1994, BIOL FERT SOILS, V18, P231, DOI 10.1007/BF00647672; Kuykendall LD, 1982, CAN J MICROBIOL, V1992, P501; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; Delamuta JRM, 2012, BRAZ J MICROBIOL, V43, P698, DOI 10.1590/S1517-83822012000200035; MartinezRomero E, 1996, CRIT REV PLANT SCI, V15, P113, DOI 10.1080/713608131; Mazahib A. M., 2013, International Food Research Journal, V20, P1165; Mohale KC, 2014, BIOL FERT SOILS, V50, P307, DOI 10.1007/s00374-013-0841-3; Moise JA, 2005, IN VITRO CELL DEV-PL, V41, P620, DOI 10.1079/IVP2005686; Naamala J, 2016, SYST APPL MICROBIOL, V39, P336, DOI 10.1016/j.syapm.2016.05.009; Ndakidemi PA, 2003, FUNCT PLANT BIOL, V30, P729, DOI 10.1071/FP03042; Nkot LN, 2008, APPL SOIL ECOL, V40, P411, DOI 10.1016/j.apsoil.2008.06.007; Nyemba RC, 2010, BIOL FERT SOILS, V46, P461, DOI 10.1007/s00374-010-0451-2; PETERS NK, 1986, SCIENCE, V233, P977, DOI 10.1126/science.3738520; Pueppke SG, 1998, PLANT PHYSIOL, V117, P599, DOI 10.1104/pp.117.2.599; Pueppke SG, 1996, CRIT REV BIOTECHNOL, V16, P1, DOI 10.3109/07388559609146599; Redmond J. W., 1986, RECOGNITION MICROBE, P115, DOI 10.1007/978-3-642-71652-2_11; Rivas R, 2009, SYST APPL MICROBIOL, V32, P101, DOI 10.1016/j.syapm.2008.12.005; ROHLF F. J., 2009, NTSYSPC NUMERICAL TA; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shirley BW, 1998, SEED SCI RES, V8, P415, DOI 10.1017/S0960258500004372; Somasegaran P., 1994, HDB RHIZOBIA, DOI [10.1007/978-1-4613-8375-8, DOI 10.1007/978-1-4613-8375-8]; Steenkamp ET, 2008, MOL PHYLOGENET EVOL, V48, P1131, DOI 10.1016/j.ympev.2008.04.032; Subramanian S, 2007, TRENDS PLANT SCI, V12, P282, DOI 10.1016/j.tplants.2007.06.006; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THIES JE, 1995, SOIL BIOL BIOCHEM, V27, P633, DOI 10.1016/0038-0717(95)98643-3; van Berkum P, 2012, MOL PLANT MICROBE IN, V25, P321, DOI 10.1094/MPMI-09-11-0241; Venkateswarlu B, 1997, APPL SOIL ECOL, V7, P1, DOI 10.1016/S0929-1393(97)00030-9; Vinuesa P, 2005, SYST APPL MICROBIOL, V28, P702, DOI 10.1016/j.syapm.2005.05.007; Wang M. L., 2008, Plant Genetic Resources Characterization and Utilization, V6, P62, DOI 10.1017/S1479262108923807; YOUNG JPW, 2006, GENOME BIOL, V7, P234, DOI DOI 10.1016/J.SYAPM.2005.05.007	54	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0184943	10.1371/journal.pone.0184943	http://dx.doi.org/10.1371/journal.pone.0184943			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945783	Green Submitted, gold, Green Published			2022-12-27	WOS:000411645100014
J	Wang, J; Ramette, A; Jurca, M; Goutaki, M; Beardsmore, CS; Kuehni, CE				Wang, Jingying; Ramette, Alban; Jurca, Maja; Goutaki, Myrofora; Beardsmore, Caroline S.; Kuehni, Claudia E.			Association between breastfeeding and eczema during childhood and adolescence: A cohort study	PLOS ONE			English	Article							ATOPIC-DERMATITIS; RISK-FACTOR; CHILDREN; DISEASE; METAANALYSIS; PROPHYLAXIS; MODELS; ASTHMA	Background Breastfeeding is said to protect children from eczema (atopic dermatitis), but the available evidence is conflicting and subject to the influences of parental atopy and reverse causation (when mothers extended duration of breastfeeding because their children had eczema). Methods In the prospective, population-based Leicester Respiratory Cohort study, we assessed duration of breastfeeding in children aged 1-4 years. Prevalence of eczema was determined by questionnaire surveys that were repeated until the children were 17 years old. We investigated the association between having been breastfed and current eczema using generalized estimating equations, adjusting for potential confounders, and tested for effect modification by parental atopy. We also assessed the association between having been breastfed and incident eczema at ages 2, 4, and 6 years using multivariable logistic regression. Results Among the 5,676 children in the study, 2,284 (40%) had never been breastfed, while 1,610 (28%), 705 (12%), and 1,077 (19%) had been breastfed for 0-3, 4-6, and > 6 months, respectively. Prevalence of current eczema decreased from 36% in 1-year-olds to 18% in children aged 10-17 years. Breastfeeding was not associated with current eczema. Compared with children who had never been breastfed, the adjusted odds ratios for current eczema at any age were 1.02 (95% confidence interval 0.90-1.15) for children who had been breastfed for 0-3 months, 0.97 (0.82-1.13) for children breastfed for 4-6 months, and 0.98 (0.85-1.14) for children breastfed for > 6 months. There was no strong evidence for an effect modification by parental atopy (p-value for interaction term was 0.061) and no association between having been breastfed and incident eczema later in childhood. Conclusions This population-based cohort study found no evidence for protection of breastfeeding against childhood eczema at any age, from infancy through adolescence.	[Wang, Jingying; Ramette, Alban; Jurca, Maja; Goutaki, Myrofora; Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Goutaki, Myrofora; Kuehni, Claudia E.] Childrens Univ Hosp Bern, Paediat Resp Med, Bern, Switzerland; [Beardsmore, Caroline S.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Beardsmore, Caroline S.] Univ Leicester, Leicester Resp Biomed Res Unit, Leicester, Leics, England	University of Bern; University of Bern; University Hospital of Bern; University of Leicester; University of Leicester	Kuehni, CE (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.; Kuehni, CE (corresponding author), Childrens Univ Hosp Bern, Paediat Resp Med, Bern, Switzerland.	claudia.kuehni@ispm.unibe.ch	Ramette, Alban/E-9197-2016; Goutaki, Myrofora/J-2869-2019	Ramette, Alban/0000-0002-3437-4639; Goutaki, Myrofora/0000-0001-8036-2092; /0000-0002-0231-5036	Swiss National Science Foundation [32003B-144068, 32003B_162820, PDFMP3 137033]; China Scholarship Council [CSC201308340039]; Bern Lung League; Asthma UK [07/048]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); China Scholarship Council(China Scholarship Council); Bern Lung League; Asthma UK	C. E. Kuehni has received research support from the Swiss National Science Foundation (grant nos. 32003B-144068; 32003B_162820; PDFMP3 137033; www.snf.ch). J. Wang has received support from China Scholarship Council (CSC201308340039; http://en.csc.edu.cn/). M. Goutaki has received research support from Bern Lung League. C.S. Beardsmore was in the receipt of grant 07/048 from Asthma UK (www.asthma.org.uk). The remaining authors have no financial relationship relevant to this article to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Barnetson RS, 2002, BRIT MED J, V324, P1376, DOI 10.1136/bmj.324.7350.1376; Benn CS, 2004, AM J EPIDEMIOL, V160, P217, DOI 10.1093/aje/kwh208; Bergmann RL, 2002, CLIN EXP ALLERGY, V32, P205, DOI 10.1046/j.1365-2222.2002.01274.x; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Carroll CL, 2005, PEDIATR DERMATOL, V22, P192, DOI 10.1111/j.1525-1470.2005.22303.x; Deckers IAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039803; Dharmage SC, 2014, ALLERGY, V69, P17, DOI 10.1111/all.12268; Fitzmaurice GM., 2004, APPL LONGITUDINAL DA; Flohr C, 2014, ALLERGY, V69, P3, DOI 10.1111/all.12270; Flohr C, 2011, BRIT J DERMATOL, V165, P1280, DOI 10.1111/j.1365-2133.2011.10588.x; Gdalevich M, 2001, J AM ACAD DERMATOL, V45, P520, DOI 10.1067/mjd.2001.114741; Grulee CG, 1936, J PEDIATR-US, V9, P223, DOI 10.1016/S0022-3476(36)80058-4; Horimukai K, 2014, J ALLERGY CLIN IMMUN, V134, P824, DOI 10.1016/j.jaci.2014.07.060; Horta B. L., 2013, SHORT TERM EFFECTS B; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Jelding-Dannemand E, 2015, J ALLERGY CLIN IMMUN, V136, P1302, DOI 10.1016/j.jaci.2015.02.023; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Kuehni CE, 2007, INT J EPIDEMIOL, V36, P977, DOI 10.1093/ije/dym090; Madhok V, 2015, CLIN EXP DERMATOL, V40, P349, DOI 10.1111/ced.12591; Matheson MC, 2012, CLIN EXP ALLERGY, V42, P827, DOI 10.1111/j.1365-2222.2011.03925.x; Matheson MC, 2007, J ALLERGY CLIN IMMUN, V120, P1051, DOI 10.1016/j.jaci.2007.06.030; Purvis DJ, 2005, BRIT J DERMATOL, V152, P742, DOI 10.1111/j.1365-2133.2005.06540.x; SAARINEN UM, 1995, LANCET, V346, P1065, DOI 10.1016/S0140-6736(95)91742-X; SAARINEN UM, 1979, LANCET, V2, P163; Santorelli G, 2014, BRIT J NUTR, V111, P1891, DOI 10.1017/S0007114514000099; Sariachvili M, 2007, PEDIATR ALLERGY IMMU, V18, P410, DOI 10.1111/j.1399-3038.2007.00543.x; Sears MR, 2002, LANCET, V360, P901, DOI 10.1016/S0140-6736(02)11025-7; Siltanen M, 2003, ALLERGY, V58, P524, DOI 10.1034/j.1398-9995.2003.00150.x; Silverberg IT, 2013, J INVEST DERMATOL, V133, pS179; Strippoli MPF, 2007, ARCH DIS CHILD, V92, P861, DOI 10.1136/adc.2007.117978; Taylor-Robinson DC, 2016, BRIT J DERMATOL, V174, P569, DOI 10.1111/bjd.14310; Townsend PP., 1988, HLTH DEPRIVATION INE; Yang YW, 2009, BRIT J DERMATOL, V161, P373, DOI 10.1111/j.1365-2133.2009.09049.x; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	36	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185066	10.1371/journal.pone.0185066	http://dx.doi.org/10.1371/journal.pone.0185066			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945812	Green Published, Green Submitted, gold			2022-12-27	WOS:000411645100020
J	Zhao, A; Chen, FH; Ning, CH; Wu, HM; Song, HF; Wu, YQ; Chen, R; Zhou, KH; Xu, XL; Lu, YX; Gao, JM				Zhao, Ai; Chen, Fahai; Ning, Chunhong; Wu, Haiming; Song, Huanfang; Wu, Yanqing; Chen, Rong; Zhou, Kaihua; Xu, Xiaoling; Lu, Yinxiang; Gao, Jimin			Use of real-time cellular analysis and Plackett-Burman design to develop the serum-free media for PC-3 prostate cancer cells	PLOS ONE			English	Article							IN-VITRO CULTURE; OPTIMIZATION; PROLIFERATION; MEMBRANE	In this study, we developed a rapid strategy to screen a serum-free medium for culturing the anchorage-dependent PC-3 prostate cancer cells, which was going to be prepared in large scale to generate GM-CSF/TNF alpha-surface-modified whole cell prostate cancer vaccine. Automated real-time cellular analysis as a rapid and non-invasive technology was used to monitor the growth of PC-3 cells in 16-well plates. At the same time, Plackett-Burman design was employed to identify the most influential formulation by integrating relevant information statistically. The effects of the 16 selected factors were evaluated during exponential cell growth and three medium constituents (EGF, FGF and linoleic acid) were identified to have significant effects on the cell growth. Subsequently, the response surface methodology with central composite design was applied to determine the interactions among the three factors so that these factors were optimized to improve cell growth. Finally, the prediction of the best combination was made under the maximal response to optimize cell growth by Design-Expert software 7.0. A total of 20 experiments were conducted to construct a quadratic model and a second-order polynomial equation. With the optimized combination validated by the stability test of serial passaging PC-3 cells, the serum-free medium had similar cell density and cell viability to the original serum medium. In summary, this high-throughput scheme minimized the screening time and may thus provide a new platform to efficiently develop the serum-free media for adherent cells.	[Zhao, Ai; Chen, Fahai; Ning, Chunhong; Wu, Haiming; Song, Huanfang; Wu, Yanqing; Zhou, Kaihua; Xu, Xiaoling; Lu, Yinxiang; Gao, Jimin] Wenzhou Med Univ, Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Zhejiang, Peoples R China; [Chen, Rong] Hosp 212 Nucl Ind, Wuwei, Gansu, Peoples R China	Wenzhou Medical University	Xu, XL; Lu, YX; Gao, JM (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Zhejiang, Peoples R China.	xuxiaoling1983828@l6.com; 18905856000@189.cn; jimingao@yahoo.com	jielixia, jielixia/AAM-4829-2020		Natural Science Foundation of China [NSFC81573110]; Chinese National 863 plan [2012AA02A407]; Natural Science Foundation of Zhejiang Province [LY14H190004, LY13H100003, LY15H160066]; Key Science and Technology Innovation Team of Zhejiang Province; Zhejiang Provincial Program for the Cultivation of Highlevel Innovative Health Talents	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National 863 plan(National High Technology Research and Development Program of China); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Key Science and Technology Innovation Team of Zhejiang Province; Zhejiang Provincial Program for the Cultivation of Highlevel Innovative Health Talents	This work was partially supported by the Natural Science Foundation of China (NSFC81573110 to Jimin Gao), Chinese National 863 plan (2012AA02A407 to Jimin Gao), the Natural Science Foundation of Zhejiang Province (LY14H190004 to Xiaoling Xu, LY13H100003 to Jimin Gao, LY15H160066 to Yinxiang Lu), Key Science and Technology Innovation Team of Zhejiang Province to Jimin Gao, Zhejiang Provincial Program for the Cultivation of Highlevel Innovative Health Talents.r This work was partially supported by the Natural Science Foundation of China (NSFC81573110), Chinese National 863 plan (2012AA02A407), the Natural Science Foundation of Zhejiang Province (LY14H190004, LY13H100003, LY15H160066), Key Science and Technology Innovation Team of Zhejiang Province, Zhejiang Provincial Program for the Cultivation of High level Innovative Health Talents.	Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011; Chaiyaso T, 2011, BIOSCI BIOTECH BIOCH, V75, P531, DOI 10.1271/bbb.100756; Chen PC, 2017, ENZYME MICROB TECH, V98, P34, DOI 10.1016/j.enzmictec.2016.12.004; Dash RN, 2016, SAUDI PHARM J, V24, P92, DOI 10.1016/j.jsps.2015.03.004; Ferella M, 2014, MOL BIOCHEM PARASIT, V197, P21, DOI 10.1016/j.molbiopara.2014.09.007; Gonzalez-Leal IJ, 2011, BIOTECHNOL PROGR, V27, P1709, DOI 10.1002/btpr.674; Gupta AJ, 2015, BIOTECHNOL PROGR, V31, P1396, DOI 10.1002/btpr.2121; Han MJ, 2003, PROTEOMICS, V3, P2317, DOI 10.1002/pmic.200300508; Hanselmann RG, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00121; Helmy MH, 2000, TOXICOLOGY, V144, P57, DOI 10.1016/S0300-483X(99)00190-0; Hwang HJ, 2015, J BIOTECHNOL, V193, P130, DOI 10.1016/j.jbiotec.2014.11.028; Jeon MK, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-70; Kim MS, 2015, EXP DERMATOL, V24, P543, DOI 10.1111/exd.12695; KOVAR J, 1984, IMMUNOL LETT, V7, P339, DOI 10.1016/0165-2478(84)90092-0; Lai SH, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0175-8; LJUNGGREN J, 1995, J BIOTECHNOL, V42, P163, DOI 10.1016/0168-1656(95)00077-4; Mandl EW, 2004, MATRIX BIOL, V23, P231, DOI 10.1016/j.matbio.2004.06.004; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Papeleu P, 2004, ATLA-ALTERN LAB ANIM, V32, P57, DOI 10.1177/026119290403201s10; Richardson J, 2015, BIOTECHNOL PROGR, V31, P522, DOI 10.1002/btpr.2050; Riesco A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1809513; Rodriguez-Berriguete G, 2016, GROWTH FACTORS, V34, P5, DOI 10.3109/08977194.2015.1132712; Martinez CR, 2016, EXP PARASITOL, V170, P214, DOI 10.1016/j.exppara.2016.10.002; Rojas-Martinez C, 2017, EXP PARASITOL, V175, P79, DOI 10.1016/j.exppara.2017.01.010; SAHU AK, 2016, ARTIF CELL NANOMED B, P1; Schlom J, 2012, JNCI-J NATL CANCER I, V104, P599, DOI 10.1093/jnci/djs033; Sharma P, 2012, J BASIC MICROB, V52, P314, DOI 10.1002/jobm.201100060; Sheng R, 2015, IN VITRO CELL DEV-AN, V51, P381, DOI 10.1007/s11626-014-9847-x; Singh B, 2016, GENS CANC, V5, P900; Singh D, 2012, J BASIC MICROB, V52, P590, DOI 10.1002/jobm.201100255; Singh SK, 2011, MICROB CELL FACT, V10, DOI [10.1186/1475-2859-10-114, 10.1186/1475-2859-10-55]; Stefanowicz-Hajduk J, 2016, BIOTECHNIQUES, V61, P117, DOI 10.2144/000114450; Sung YH, 2004, APPL MICROBIOL BIOT, V63, P527, DOI 10.1007/s00253-003-1389-1; TAUB M, 1990, TOXICOL IN VITRO, V4, P213, DOI 10.1016/0887-2333(90)90025-O; van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016; van Dodewaard-de Jong JM, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1105431; Vasiee A, 2016, MICROB PATHOGENESIS, V101, P36, DOI 10.1016/j.micpath.2016.10.020; Wang YH, 2015, MOL CELL ONCOL, V2, DOI DOI 10.1016/J.MATBIO.2004.06.004; Wei XX, 2016, CANCER IMMUNOL RES, V4, P948, DOI 10.1158/2326-6066.CIR-16-0042; Xiao ZJ, 2007, APPL MICROBIOL BIOT, V74, P61, DOI 10.1007/s00253-006-0646-5; Yousef GM, 1999, GENOMICS, V62, P251, DOI 10.1006/geno.1999.6012	41	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185470	10.1371/journal.pone.0185470	http://dx.doi.org/10.1371/journal.pone.0185470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945791	Green Submitted, gold, Green Published			2022-12-27	WOS:000411645100062
J	Forti, LR; Becker, CG; Tacioli, L; Pereira, VR; Santos, ACFA; Oliveira, I; Haddad, CFB; Toledo, LF				Forti, Lucas Rodriguez; Becker, C. Guilherme; Tacioli, Leandro; Pereira, Vania Rosa; Santos, Andre Cid F. A.; Oliveira, Igor; Haddad, Celio F. B.; Toledo, Luis Felipe			Perspectives on invasive amphibians in Brazil	PLOS ONE			English	Article							AMERICAN BULLFROG; BATRACHOCHYTRIUM-DENDROBATIDIS; LITHOBATES-CATESBEIANUS; ELEUTHERODACTYLUS-JOHNSTONEI; SELECTING THRESHOLDS; PHYLLODYTES-LUTEOLUS; INFECTIOUS-DISEASE; GENETIC-VARIATION; XENOPUS-LAEVIS; NORTH-AMERICAN	Introduced species have the potential to become invasive and jeopardize entire ecosystems. The success of species establishing viable populations outside their original extent depends primarily on favorable climatic conditions in the invasive ranges. Species distribution modeling (SDM) can thus be used to estimate potential habitat suitability for populations of invasive species. Here we review the status of six amphibian species with invasive populations in Brazil (four domestic species and two imported species). We (i) modeled the current habitat suitability and future potential distribution of these six focal species, (ii) reported on the disease status of Eleutherodactylus johnstonei and Phyllodytes luteolus, and (iii) quantified the acoustic overlap of P. luteolus and Leptodactylus labyrinthicus with three cooccurring native species. Our models indicated that all six invasive species could potentially expand their ranges in Brazil within the next few decades. In addition, our SDMs predicted important expansions in available habitat for 2 out of 6 invasive species under future (2100) climatic conditions. We detected high acoustic niche overlap between invasive and native amphibian species, underscoring that acoustic interference might reduce mating success in local frogs. Despite the American bullfrog Lithobates catesbeianus being recognized as a potential reservoir for the frog-killing fungus Batrachochytrium dendrobatidis (Bd) in Brazil, we did not detect Bd in the recently introduced population of E. johnstonei and P. luteolus in the State of Sao Paulo. We emphasize that the number of invasive amphibian species in Brazil is increasing exponentially, highlighting the urgent need to monitor and control these populations and decrease potential impacts on the locally biodiverse wildlife.	[Forti, Lucas Rodriguez; Tacioli, Leandro; Oliveira, Igor; Toledo, Luis Felipe] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Lab Multiusuario Bioacust LMBio, Campinas, SP, Brazil; [Forti, Lucas Rodriguez; Tacioli, Leandro; Oliveira, Igor; Toledo, Luis Felipe] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Lab Hist Nat Anfibios Brasileiros LaHNAB, Campinas, SP, Brazil; [Becker, C. Guilherme] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA; [Pereira, Vania Rosa] Univ Estadual Campinas, Ctr Pesquisas Meteorol & Climat Aplicadas Agr CEP, Cidade Univ Zeferino Vaz, Campinas, SP, Brazil; [Santos, Andre Cid F. A.] Pontificia Univ Catolica Sao Paulo, Praca Dr Ermirio Morais, Sorocaba, SP, Brazil; [Haddad, Celio F. B.] Univ Estadual Paulista, Inst Biociencias, Dept Zool, Rio Claro, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; University of Alabama System; University of Alabama Tuscaloosa; Universidade Estadual de Campinas; Pontificia Universidade Catolica de Sao Paulo; Universidade Estadual Paulista	Forti, LR (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Lab Multiusuario Bioacust LMBio, Campinas, SP, Brazil.; Forti, LR (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Lab Hist Nat Anfibios Brasileiros LaHNAB, Campinas, SP, Brazil.	lucas_forti@yahoo.com.br	Oliveira, Igor/AAQ-3342-2020; Fapesp, Biota/F-8655-2017; Toledo, Luís Felipe/I-4017-2012; Oliveira, Igor/B-5538-2014; Haddad, Célio F. B./C-4267-2012	Oliveira, Igor/0000-0002-3230-3837; Fapesp, Biota/0000-0002-9887-8449; Toledo, Luís Felipe/0000-0002-4929-9598; Oliveira, Igor/0000-0002-3230-3837; Haddad, Célio F. B./0000-0002-7044-5764; Pereira, Vania Rosa/0000-0002-7466-7655	Sao Paulo Research Foundation (FAPESP) [2011/51694-7, 2011/52070-7, 2014/23388-7, 2013/21519-4, 2013/02219-0, 2013/50741-7, 2014/50342-8]; National Council for Scientific and Technological Development (CNPq) [302589/2013-9, 405285/2013-2, 312895/2014-3, 161812/2011-2, 438675/2016-9]; CNPq [302518/2013-4]; Coordination for the Improvement of Higher Education Personnel (CAPES) [3855/13-9]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The Sao Paulo Research Foundation (FAPESP) provided financial support (grant #2011/51694-7, #2011/52070-7, #2014/23388-7) to LFT. The National Council for Scientific and Technological Development (CNPq) provided support for LFT (#302589/2013-9; #405285/2013-2), to CGB (#312895/2014-3), to ISO (#161812/2011-2), and to LRF (#438675/2016-9). LRF and LT were supported by grants #2013/21519-4 and #2013/02219-0, Sao Paulo Research Foundation (FAPESP). CFBH was supported by grants #2013/50741-7 and #2014/50342-8, Sao Paulo Research Foundation (FAPESP) and CNPq (302518/2013-4) for a research fellowship. Coordination for the Improvement of Higher Education Personnel (CAPES) provided support to ISO (#3855/13-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Denis O. V. Andrade provided museum records for sampling sites in Rio Claro, Brazil; Roseli Maria Foratto provided field assistance; The administration of Residential Iporanga allowed us to collect data in Guaruja, Brazil. The Sao Paulo Research Foundation (FAPESP) provided financial support (grant #2011/51694-7, #2011/52070-7, #2014/23388-7) to LFT. The National Council for Scientific and Technological Development (CNPq) provided support for LFT (#302589/2013-9; #405285/2013-2), to CGB (#312895/2014-3), to ISO (#161812/2011-2), and to LRF (#438675/2016-9). LRF and LT were supported by grants #2013/21519-4 and #2013/02219-0, Sao Paulo Research Foundation (FAPESP). CFBH was supported by grants #2013/50741-7 and #2014/50342-8, Sao Paulo Research Foundation (FAPESP) and CNPq (302518/2013-4) for a research fellowship. Coordination for the Improvement of Higher Education Personnel (CAPES) provided support to ISO (#3855/13-9).	Alho CJR, 2011, BRAZ J BIOL, V71, P321, DOI 10.1590/S1519-69842011000200011; Alves-Silva R, 2009, J NAT HIST, V43, P205, DOI 10.1080/00222930802568808; AmphibiaWeb, 2014, INF AMPH BIOL CONS; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Batista Cristiane G., 2002, Herpetological Review, V33, P131; Bivand R, 2014, RGDAL BINDINGS GEOSP; Boelter RA, 2012, ANIM BIOL, V62, P397, DOI 10.1163/157075612X634111; Both C, 2012, BIOL LETTERS, P1; Both C, 2014, AUSTRAL ECOL, V39, P864, DOI 10.1111/aec.12155; Both Camila, 2011, South American Journal of Herpetology, V6, P127; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Cantor SB, 1999, J CLIN EPIDEMIOL, V52, P885, DOI 10.1016/S0895-4356(99)00075-X; Cardoso A.J., 1977, Ciencia e Cultura (Sao Paulo), V29, P1130; Carey C, 1999, DEV COMP IMMUNOL, V23, P459, DOI 10.1016/S0145-305X(99)00028-2; Colautti RI, 2004, DIVERS DISTRIB, V10, P135, DOI 10.1111/j.1366-9516.2004.00061.x; Costa MH, 2010, INT J CLIMATOL, V30, P1970, DOI 10.1002/joc.2048; Cribb AY, 2013, MANUAL TECNICO RANIC, P73; Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151; da Silva Emanuel Teixeira, 2011, South American Journal of Herpetology, V6, P1; da Silva Emanuel Teixeira, 2009, South American Journal of Herpetology, V4, P286; Darwin C., 1871, NATURAL HIST GEOLOGY, P549; de Carvalho Vinicius T., 2013, Check List, V9, P849; de Oliveira IS, 2016, STUD NEOTROP FAUNA E, V51, P45, DOI 10.1080/01650521.2016.1160610; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Duellman WE, 1994, BIOL AMPHIBIANS; EASTEAL S, 1981, BIOL J LINN SOC, V16, P93, DOI 10.1111/j.1095-8312.1981.tb01645.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ernst R, 2011, BIOL INVASIONS, V13, P1767, DOI 10.1007/s10530-010-9930-5; Eterovick PC, 1999, J HERPETOL, V33, P17, DOI 10.2307/1565538; Fearnside PM, 2005, CONSERV BIOL, V19, P680, DOI 10.1111/j.1523-1739.2005.00697.x; FERREIRA C. M., 2002, BOL INST PESCA, V33, P1; Ferreira LV, 2005, ESTUD AV-SAO PAULO, V19, P157, DOI DOI 10.1590/S0103-40142005000100010; Ferreira RB, 2012, J HERPETOL, V46, P19, DOI 10.1670/09-040; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Frost D.R., 2020, AMPHIBIAN SPECIES WO, DOI [10.5531/db.vz.0001, DOI 10.5531/DB.VZ.0001]; Fukuda Y., 2015, ANIMAL CONSERVATION, V19, P75, DOI DOI 10.1111/ACV.12218; Gahl MK, 2010, CAN J ZOOL, V88, P108, DOI 10.1139/Z09-124; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Gehara M., 2012, HERPETOLOGY NOTES, V5, P167; GERHARDT HC, 1988, J COMP PHYSIOL A, V162, P261, DOI 10.1007/BF00606090; Giovanelli JGR, 2008, BIOL INVASIONS, V10, P585, DOI 10.1007/s10530-007-9154-5; Grapputo A, 2005, MOL ECOL, V14, P4207, DOI 10.1111/j.1365-294X.2005.02740.x; Gurdon JB, 2000, INT J DEV BIOL, V44, P43; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; HADDAD CFB, 1994, J HERPETOL, V28, P425, DOI 10.2307/1564953; Hijmans R.J., 2016, RASTER GEOGRAPHIC DA; HODL W, 1977, OECOLOGIA, V28, P351, DOI 10.1007/BF00345990; Holway DA, 2002, ECOLOGY, V83, P1610, DOI 10.1890/0012-9658(2002)083[1610:ROAFIG]2.0.CO;2; Hughes J, 2003, CONSERV BIOL, V17, P1007, DOI 10.1046/j.1523-1739.2003.01636.x; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; IUCN, 2014, IUCN RED LIST THREAT; Izecksohn E, 2001, ANFIBIOS MUNICIPIO R; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Kaiser H, 1997, BIODIVERS CONSERV, V6, P1391, DOI 10.1023/A:1018341814510; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Kraus Fred, 2002, Biological Invasions, V4, P327, DOI 10.1023/A:1020909205908; Kraus Fred, 1999, Herpetological Review, V30, P21; Kraus Fred, 2009, V4, P1; Kriger KM, 2007, DIS AQUAT ORGAN, V73, P257, DOI 10.3354/dao073257; Lafarge T, 2016, IMPLEMENTATION 3D AL; Leivas Peterson Trevisan, 2013, Herpetology Notes, V6, P603; Lesbarreres D, 2011, BIOL LETTERS, P1; Lever C., 2003, NATURALIZED REPTILES; Lever C, 2001, CANE TOAD HIST ECOLO, P230; Lima AP, 2008, GUIA SAPOS RESERVA A; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobos G, 2013, STUD NEOTROP FAUNA E, V48, P1, DOI 10.1080/01650521.2012.746050; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Longo AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059499; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Maciel NM, 2010, MOL PHYLOGENET EVOL, V57, P787, DOI 10.1016/j.ympev.2010.08.025; Magnusson WE, 2006, BIOL CONSERVACAO ESS, P211; MALAGODI M, 1986, Ciencia e Cultura (Sao Paulo), V38, P1700; Marshall VT, 2006, ANIM BEHAV, V72, P449, DOI 10.1016/j.anbehav.2006.02.001; Martel A, 2014, SCIENCE, V346, P630, DOI 10.1126/science.1258268; Measey GJ, 2012, BIOL INVASIONS, V14, P2255, DOI 10.1007/s10530-012-0227-8; Measey GJ, 2005, HERPETOL J, V15, P291; Medeiros CI, 2017, BIOL INVASIONS, V19, P675, DOI 10.1007/s10530-016-1327-7; Melo MA, 1914, 1 RECORD INVASIVE FR; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Neckel-Oliveira S, 2000, AMPHIBIA-REPTILIA, V21, P317, DOI 10.1163/156853800507516; Nori J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025718; Oliveira IS, 2016, OECOLOGIA AUSTRALIS, V20, P70; OLSON S.L, 1981, NATL GEOGRAPHIC SOC, V13, P481; OREN D C, 1984, Boletim do Museu Paraense Emilio Goeldi Serie Zoologia, V1, P19; Ortega JE, 2005, COPEIA, P642; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pemberton, 1933, NEW GUINEA PARASITE; Peterson AT, 2012, NAT CONSERVACAO, V10, P102, DOI 10.4322/natcon.2012.019; Phillips BL, 2004, P NATL ACAD SCI USA, V101, P17150, DOI 10.1073/pnas.0406440101; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; POUGH FH, 1977, OECOLOGIA, V27, P285, DOI 10.1007/BF00345561; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ridley HN, 1890, J LINN SOC LOND, V20, P473; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; Ruiz GM, 1997, AM ZOOL, V37, P621; RYAN MJ, 1993, EVOLUTION, V47, P647, DOI 10.1111/j.1558-5646.1993.tb02118.x; SALLES ROL, 2010, HERPETOLOGY NOTES, V3, P257; Sanders NJ, 2003, P NATL ACAD SCI USA, V100, P2474, DOI 10.1073/pnas.0437913100; Santos AT., 1950, FERNANDO NORONHA ILH, P154; Schloegel LM, 2010, ANIM CONSERV, V13, P53, DOI 10.1111/j.1469-1795.2009.00307.x; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Shine R, 2010, Q REV BIOL, V85, P253, DOI 10.1086/655116; Shine R, 2012, EVOL APPL, V5, P107, DOI 10.1111/j.1752-4571.2011.00201.x; Silva ET, 2010, DIET HERPETOL REV, V41, P475; Silva ET, 2009, HERPETOL NOTES, V2, P215; Silva MBL, 2007, FERNANDO NORONHA 5 S; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Tacioli L, 2014, WASIS WILDLIFE ANIMA; Toledo LF, 2007, J ZOOL, V271, P170, DOI 10.1111/j.1469-7998.2006.00195.x; Toledo L.F., 2014, BIOACUSTICS, V2014, P1; Toledo LF, 2009, ECOHEALTH, V6, P351, DOI 10.1007/s10393-010-0277-2; Tolledo J, 2015, J ZOOL, V296, P167, DOI 10.1111/jzo.12233; Tolledo J, 2014, HERPETOL J, V24, P237; Tozetti AM, 2005, J HERPETOL, V39, P640, DOI 10.1670/155-04N.1; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Vaz-Silva Wilian, 2003, Herpetological Review, V34, P359; Verdade Vanessa K., 2012, Alytes (Paris), V29, P28; Vespucci A., 1885, VESPUCCI AMERIGO LET; Vicente J.J., 1990, Revista Brasileira de Zoologia, V7, P549; Vitousek Peter M., 1996, SCOPE, V55, P245; Von Holle B, 2005, ECOLOGY, V86, P3212, DOI 10.1890/05-0427; Vredenburg VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063791; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; Wells KD, 2007, SPR HDB AUD, V28, P44; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY, V2nd; Williamson M., 1996, BIOL INVASIONS; WILSON E O, 1992; Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361; Xie GY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160746	138	13	14	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0184703	10.1371/journal.pone.0184703	http://dx.doi.org/10.1371/journal.pone.0184703			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938024	Green Published, Green Submitted, gold			2022-12-27	WOS:000411524700008
J	Zainabadi, K; Liu, CJ; Caldwell, ALM; Guarente, L				Zainabadi, Kayvan; Liu, Cassie J.; Caldwell, Alison L. M.; Guarente, Leonard			SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; CALORIE RESTRICTION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; HISTONE DEACETYLASE; IMPROVES HEALTH; STANDARD DIET; BETA-CATENIN; MALE RATS; MICE; EXPRESSION	Overexpression or pharmacological activation of SIRT1 has been shown to extend the lifespan of mice and protect against aging-related diseases. Here we show that pharmacological activation of SIRT1 protects in two models of osteoporosis. Ovariectomized female mice and aged male mice, models for post-menopausal and aging-related osteoporosis, respectively, show significant improvements in bone mass upon treatment with SIRT1 agonist, SRT1720. Further, we find that calorie restriction (CR) results in a two-fold upregulation of sirt1 mRNA expression in bone tissue that is associated with increased bone mass in CR mice. Reciprocally, SIRT1 whole-body knockout (KO) mice, as well as osteoblast and osteoclast specific KOs, show a low bone mass phenotype; though double knockout mice (containing SIRT1 deleted in both osteoblasts and osteoclasts) do not show a more severe phenotype. Altogether, these findings provide strong evidence that SIRT1 is a positive regulator of bone mass and a promising target for the development of novel therapeutics for osteoporosis.	[Zainabadi, Kayvan; Liu, Cassie J.; Caldwell, Alison L. M.; Guarente, Leonard] MIT, Dept Biol, Koch Inst, Glenn Ctr Sci Aging, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Zainabadi, K (corresponding author), MIT, Dept Biol, Koch Inst, Glenn Ctr Sci Aging, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	kayvan@alum.mit.edu			NIH; Glenn Foundation for Medical Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research	This work was supported by grants from the NIH and The Glenn Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artsi H, 2014, ENDOCRINOLOGY, V155, P3508, DOI 10.1210/en.2014-1334; Baksi A, 2014, BRIT J CLIN PHARMACO, V78, P69, DOI 10.1111/bcp.12327; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cohen-Kfir E, 2011, ENDOCRINOLOGY, V152, P4514, DOI 10.1210/en.2011-1128; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Edwards JR, 2013, J BONE MINER RES, V28, P960, DOI 10.1002/jbmr.1824; Gong H, 2014, MOL MED REP, V10, P3296, DOI 10.3892/mmr.2014.2648; Graff J, 2013, J NEUROSCI, V33, P8951, DOI 10.1523/JNEUROSCI.5657-12.2013; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Gurt I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134391; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Iyer S, 2014, J BIOL CHEM, V289, P24069, DOI 10.1074/jbc.M114.561803; KALU DN, 1984, MECH AGEING DEV, V26, P103, DOI 10.1016/0047-6374(84)90169-6; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim HN, 2015, MOL ENDOCRINOL, V29, P1498, DOI 10.1210/me.2015-1133; Kolthur-Seetharam U, 2009, BIOL REPROD, V80, P384, DOI 10.1095/biolreprod.108.070193; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Krueger JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142081; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Lowe DA, 2000, J GERONTOL A-BIOL, V55, pB160, DOI 10.1093/gerona/55.3.B160; Maran A, 2004, CALCIFIED TISSUE INT, V74, P204, DOI 10.1007/s00223-002-1098-2; Mercken EM, 2014, AGING CELL, V13, P787, DOI 10.1111/acel.12220; Mercken EM, 2014, AGING CELL, V13, P193, DOI 10.1111/acel.12151; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Mohelnikova-Duchonova B, 2012, DIS MARKERS, V32, P203, DOI [10.1155/2012/582107, 10.3233/DMA-2011-0875]; Mozdziak PE, 2003, NUTRITION, V19, P438, DOI 10.1016/S0899-9007(02)01006-7; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Ornstrup MJ, 2014, J CLIN ENDOCR METAB, V99, P4720, DOI 10.1210/jc.2014-2799; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Redman LM, 2008, ARCH INTERN MED, V168, P1859, DOI 10.1001/archinte.168.17.1859; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sanderson JP, 1997, J GERONTOL A-BIOL, V52, pB20, DOI 10.1093/gerona/52A.1.B20; Sands BE, 2016, INFLAMM BOWEL DIS, V22, P607, DOI 10.1097/MIB.0000000000000597; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Tatsumi S, 2008, ENDOCRINOLOGY, V149, P634, DOI 10.1210/en.2007-1089; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Toorie AM, 2016, J BIOL CHEM, V291, P5844, DOI 10.1074/jbc.M115.675264; Warren LA, 2007, AGING CELL, V6, P775, DOI 10.1111/j.1474-9726.2007.00337.x; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Zainabadi K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178520; Zhou LH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-75	59	37	44	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185236	10.1371/journal.pone.0185236	http://dx.doi.org/10.1371/journal.pone.0185236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28937996	Green Published, gold, Green Submitted			2022-12-27	WOS:000411524700024
J	Johnston, CD; Skeete, CA; Fomenkov, A; Roberts, RJ; Rittling, SR				Johnston, Christopher D.; Skeete, Chelsey A.; Fomenkov, Alexey; Roberts, Richard J.; Rittling, Susan R.			Restriction-modification mediated barriers to exogenous DNA uptake and incorporation employed by Prevotella intermedia	PLOS ONE			English	Article							MODIFICATION SYSTEMS; SINGLE-MOLECULE; S-MODIFICATION; CRISPR RNA; WEB TOOL; METHYLTRANSFERASES; INTERFERENCE; PHAGE; CLASSIFICATION; ENDONUCLEASES	Prevotella intermedia, a major periodontal pathogen, is increasingly implicated in human respiratory tract and cystic fibrosis lung infections. Nevertheless, the specific mechanisms employed by this pathogen remain only partially characterized and poorly understood, largely due to its total lack of genetic accessibility. Here, using Single Molecule, Real-Time ( SMRT) genome and methylome sequencing, bisulfite sequencing, in addition to cloning and restriction analysis, we define the specific genetic barriers to exogenous DNA present in two of the most widespread laboratory strains, P. intermedia ATCC 25611 and P. intermedia Strain 17. We identified and characterized multiple restriction-modification (R-M) systems, some of which are considerably divergent between the two strains. We propose that these R-M systems are the root cause of the P. intermedia transformation barrier. Additionally, we note the presence of conserved Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) systems in both strains, which could provide a further barrier to exogenous DNA uptake and incorporation. This work will provide a valuable resource during the development of a genetic system for P. intermedia, which will be required for fundamental investigation of this organism's physiology, metabolism, and pathogenesis in human disease.	[Johnston, Christopher D.; Skeete, Chelsey A.; Rittling, Susan R.] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA 02142 USA; [Johnston, Christopher D.; Rittling, Susan R.] Harvard Sch Dent Med, Boston, MA 02115 USA; [Fomenkov, Alexey; Roberts, Richard J.] New England Biolabs Inc, Ipswich, MA USA	Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine; New England Biolabs	Johnston, CD (corresponding author), Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA 02142 USA.; Johnston, CD (corresponding author), Harvard Sch Dent Med, Boston, MA 02115 USA.	cjohnston@forsyth.org		Johnston, Christopher D/0000-0002-6765-2383	Forsyth Institute Pilot Grant Program; National Institute of Dental and Craniofacial Research of the National Institutes of Health [R01-DE22380]; New England Biolabs, Inc.; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022380] Funding Source: NIH RePORTER	Forsyth Institute Pilot Grant Program; National Institute of Dental and Craniofacial Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); New England Biolabs, Inc.; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was carried out with internal financial support from The Forsyth Institute Pilot Grant Program and by the National Institute of Dental and Craniofacial Research of the National Institutes of Health under award number #R01-DE22380, www.nidcr.nih.gov. The funder provided support in the form of salaries for authors (CDJ and SRR), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. AF and RJR also acknowledge and New England Biolabs, Inc. for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accetto T, 2005, FEMS MICROBIOL LETT, V247, P177, DOI 10.1016/j.femsle.2005.05.016; Alkhnbashi OS, 2016, BIOINFORMATICS, V32, P576, DOI 10.1093/bioinformatics/btw454; Anton BP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127446; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barrangou R., 2009, MICROBE, V4, P224, DOI [10.1128/microbe.4.224.1, DOI 10.1128/microbe.4.224.1, DOI 10.1128/MICROBE.4.224.1]; Beaulaurier J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8438; Biswas A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2627-0; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Blumenthal RM, 1988, GENE, V74, P269; Brook I, 2003, CHEST, V124, P832, DOI 10.1378/chest.124.3.832; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Clark TA, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-4; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Croucher NJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6471; Davis BM, 2013, CURR OPIN MICROBIOL, V16, P192, DOI 10.1016/j.mib.2013.01.011; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dorn BR, 1998, INFECT IMMUN, V66, P6054, DOI 10.1128/IAI.66.12.6054-6057.1998; Dupuis ME, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3087; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Froger A., 2007, J VISUALIZED EXPT JO; Genereux DP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn691; Goldfarb T, 2015, EMBO J, V34, P169, DOI 10.15252/embj.201489455; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; He W, 2015, SCI REP-UK, V5, DOI 10.1038/srep12368; He X, 2007, MOL MICROBIOL, V65, P1034, DOI 10.1111/j.1365-2958.2007.05846.x; Hille F, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0496; Ibrahim M, 2017, FUNCT INTEGR GENOMIC, V17, P513, DOI 10.1007/s10142-017-0550-3; Iyer D, 2010, INFECT IMMUN, V78, P2385, DOI 10.1128/IAI.00510-09; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Jorth P, 2012, MBIO, V3, DOI 10.1128/mBio.00309-12; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Lees J, 2015, NAT REV MICROBIOL, V13, DOI 10.1038/nrmicro3435; Leung KP, 2002, PLASMID, V48, P64, DOI 10.1016/S0147-619X(02)00011-2; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Loenen WA, 2013, NUCLEIC ACIDS RES; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P56, DOI 10.1093/nar/gkt747; Makarova KS, 2017, CELL, V168, P946, DOI [10.1016/j.cell.2016.12.038, 10.1016/j.cell.2017.02.018]; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Matsui A, 2014, INFECT IMMUN, V82, P4068, DOI 10.1128/IAI.02256-14; Murphy J, 2013, APPL ENVIRON MICROB, V79, P7547, DOI 10.1128/AEM.02229-13; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Nagaoka K, 2014, INFECT IMMUN, V82, P587, DOI 10.1128/IAI.00943-13; Naito M, 2016, DNA RES, V23, P11, DOI 10.1093/dnares/dsv032; Naville M, 2011, RNA BIOL, V8, P11, DOI 10.4161/rna.8.1.13346; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Ou HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005132; Piknova M, 2004, LETT APPL MICROBIOL, V38, P311, DOI 10.1111/j.1472-765X.2004.01483.x; Pingoud A, 2014, NUCLEIC ACIDS RES, V42, P7489, DOI 10.1093/nar/gku447; Price VJ, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00064-16; RALEIGH EA, 1988, NUCLEIC ACIDS RES, V16, P1563, DOI 10.1093/nar/16.4.1563; Rath D, 2015, BIOCHIMIE, V117, P119, DOI 10.1016/j.biochi.2015.03.025; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot3944; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Seshasayee ASN, 2012, NUCLEIC ACIDS RES, V40, P7066, DOI 10.1093/nar/gks390; Siqueira JF, 2009, J DENT RES, V88, P969, DOI 10.1177/0022034509346549; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Sukackaite R, 2012, NUCLEIC ACIDS RES, V40, P7552, DOI 10.1093/nar/gks332; Suzuki H, 2012, HOST MIMICKING STRAT; Teles R, 2013, PERIODONTOL 2000, V62, P95, DOI 10.1111/prd.12010; Tock MR, 2005, CURR OPIN MICROBIOL, V8, P466, DOI 10.1016/j.mib.2005.06.003; Ulrich M, 2010, THORAX, V65, P978, DOI 10.1136/thx.2010.137745; Vasu K, 2013, MICROBIOL MOL BIOL R, V77, P53, DOI 10.1128/MMBR.00044-12; Vasu K, 2012, P NATL ACAD SCI USA, V109, pE1287, DOI 10.1073/pnas.1119226109; Wei YZ, 2015, NUCLEIC ACIDS RES, V43, P1749, DOI 10.1093/nar/gku1407; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; Xu TG, 2010, NUCLEIC ACIDS RES, V38, P7133, DOI 10.1093/nar/gkq610; Yoshimoto H, 1997, FEMS MICROBIOL LETT, V152, P175, DOI 10.1111/j.1574-6968.1997.tb10425.x; Zhang GQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002987; Zhang Q, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1512-4; Zhu DK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3040-4; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	79	12	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185234	10.1371/journal.pone.0185234	http://dx.doi.org/10.1371/journal.pone.0185234			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934361	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900130
J	Mashima, I; Theodorea, CF; Thaweboon, B; Thaweboon, S; Scannapieco, FA; Nakazawa, F				Mashima, Izumi; Theodorea, Citra F.; Thaweboon, Boonyanit; Thaweboon, Sroisiri; Scannapieco, Frank A.; Nakazawa, Futoshi			Exploring the salivary microbiome of children stratified by the oral hygiene index	PLOS ONE			English	Article							GUT MICROBIOME; POPULATION; DIVERSITY; BIOFILMS; BACTERIA; HEALTH	Poor oral hygiene often leads to chronic diseases such as periodontitis and dental caries resulting in substantial economic costs and diminished quality of life in not only adults but also in children. In this study, the salivary microbiome was characterized in a group of children stratified by the Simplified Oral Hygiene Index (OHI-S). Illumina MiSeq high-throughput sequencing based on the 16S rRNA was utilized to analyze 90 salivary samples (24 Good, 31 Moderate and 35 Poor oral hygiene) from a cohort of Thai children. A total of 38,521 OTUs (Operational Taxonomic Units) with a 97% similarity were characterized in all of the salivary samples. Twenty taxonomic groups (Seventeen genera, two families and one class; Streptococcus, Veillonella, Gemellaceae, Prevotella, Rothia, Porphyromonas, Granulicatella, Actinomyces, TM-7-3, Leptotrichia, Haemophilus, Selenomonas, Neisseria, Megasphaera, Capnocytophaga, Oribacterium, Abiotrophia, Lachnospiraceae, Peptostreptococcus, and Atopobium) were found in all subjects and constituted 94.5-96.5% of the microbiome. Of these twenty genera, the proportion of Streptococcus decreased while Veillonella increased with poor oral hygiene status (P < 0.05). Furthermore, an unassigned species of Veillonella, Veillonella dispar and Veillonella parvula tended to be elevated in the Poor oral hygiene group. This is the first study demonstrating an important association between increase of Veillonella and poor oral hygiene status in children. However, further studies are required to identify the majority of Veillonella at species level in salivary microbiome of the Poor oral hygiene group.	[Mashima, Izumi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Mashima, Izumi; Nakazawa, Futoshi] SUNY Buffalo, Dept Oral Biol, Sch Dent Med, Buffalo, NY USA; [Mashima, Izumi; Theodorea, Citra F.; Nakazawa, Futoshi] Hlth Sci Univ Hokkaido, Sch Dent, Dept Microbiol, Ishikari, Hokkaido, Japan; [Theodorea, Citra F.] Univ Indonesia, Fac Dent, Dept Oral Biol, Jakarta, Indonesia; [Thaweboon, Boonyanit; Thaweboon, Sroisiri] Mahidol Univ, Fac Dent, Dept Oral Microbiol, Bangkok, Thailand	Japan Society for the Promotion of Science; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Health Sciences University of Hokkaido; University of Indonesia; Mahidol University	Nakazawa, F (corresponding author), Hlth Sci Univ Hokkaido, Sch Dent, Dept Microbiol, Ishikari, Hokkaido, Japan.	nakazawa@hoku-iryo-u.ac.jp	Theodorea, Citra Fragrantia/AAD-4106-2021; Scannapieco, Frank A./AAE-1584-2020	Scannapieco, Frank A./0000-0002-8804-6593; Theodorea, Citra Fragrantia/0000-0002-9310-9659; Mashima, Izumi/0000-0001-6436-1268	Japan Society for the Promotion of Science [15J30007, 26462793]; Research Institute of Personalized Health Sciences, Health Sciences University of Hokkaido [2014-200-3, 2016-200-4]; Institute for Fermentation, Osaka; Mahidol University Faculty of Dentistry [0517.033/62]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Institute of Personalized Health Sciences, Health Sciences University of Hokkaido; Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); Mahidol University Faculty of Dentistry	This study was supported by the Japan Society for the Promotion of Science (15J30007 to I M, 26462793 to FN; https://www.jsps.go.jp/j-grantsinaid/), Research Institute of Personalized Health Sciences, Health Sciences University of Hokkaido (2014-200-3, 2016-200-4 to FN; http://www.hoku-iryo-u.acjp/similar to kotaisa/index.html), The Institute for Fermentation, Osaka (Research grant 2016 and 2017 to IM; http://www.ifo.or.jp/ research/re_02.html), and the Mahidol University Faculty of Dentistry (0517.033/62 to BT; www.dt. mahidal.ac.th/eng/). The funders had no role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Ahn J., 2015, PLOS ONE, V6; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Belstrom D, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.23609; Bo T, 2017, MICROBIOLOG IN PRESS; Byun R, 2007, INT J SYST EVOL MICR, V57, P2844, DOI 10.1099/ijs.0.65096-0; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; DELWICHE EA, 1985, ANNU REV MICROBIOL, V39, P175, DOI 10.1146/annurev.mi.39.100185.001135; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Furquim CP, 2017, J DENT RES, V96, P292, DOI 10.1177/0022034516678169; Gao R, 2017, EUR J CLIN IN PRESS; GREENE JC, 1964, J AM DENT ASSOC, V68, P7, DOI 10.14219/jada.archive.1964.0034; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; Jahangir GZ, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3158-5; Jiang S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121978; Jo JH, 2016, VIRULENCE IN PRESS; Johansson I, 2016, J DENT RES, V95, P80, DOI 10.1177/0022034515609554; Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lazarevic V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067699; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mager DL, 2003, J CLIN PERIODONTOL, V30, P644, DOI 10.1034/j.1600-051X.2003.00376.x; Marchandin H, 2005, RES MICROBIOL, V156, P603, DOI 10.1016/j.resmic.2005.01.013; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Mashima I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157516; Mashima I, 2014, ANAEROBE, V28, P54, DOI 10.1016/j.anaerobe.2014.05.003; McCune, 2002, MJM SOFTWARE DESIGN, V289, P448; Mielke PW, 2010, SANKHYA, V3, P350; Nasidze I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023352; Nieto-Pelegrin E, 2015, TRANSBOUND EMERG DIS, V62, P594, DOI 10.1111/tbed.12429; Nishiwaki M, 2017, NIPPON SAIKINGAKU ZA, V72, P57; Palmer RJ, 2006, J BACTERIOL, V188, P4117, DOI 10.1128/JB.01958-05; Pereira Juliana Vianna, 2012, Braz. Dent. J., V23, P409, DOI 10.1590/S0103-64402012000400017; Prabhu S, 2015, IOSR J DENT MED SCI, V14, P101; Rajendhran J, 2011, MICROBIOL RES, V166, P99, DOI 10.1016/j.micres.2010.02.003; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; RITZ HL, 1967, ARCH ORAL BIOL, V12, P1561, DOI 10.1016/0003-9969(67)90190-2; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Saravanan P, 2010, J BACTERIOL, V192, P2965; Seirawan H, 2012, AM J PUBLIC HEALTH, V102, P1729, DOI 10.2105/AJPH.2011.300478; Shanahan F, 2017, GUT IN PRESS; Takeshita T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06990; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Vesty A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169877; Yu GQ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0226-6; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141310; Zhou JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147039	56	39	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185274	10.1371/journal.pone.0185274	http://dx.doi.org/10.1371/journal.pone.0185274			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934367	gold, Green Submitted, Green Published			2022-12-27	WOS:000411339900137
J	Shemesh, N; Rosenberg, JT; Dumez, JN; Grant, SC; Frydman, L				Shemesh, Noam; Rosenberg, Jens T.; Dumez, Jean-Nicolas; Grant, Samuel C.; Frydman, Lucio			Distinguishing neuronal from astrocytic subcellular microstructures using in vivo Double Diffusion Encoded H-1 MRS at 21.1 T	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; N-ACETYL-ASPARTATE; LONGITUDINAL RELAXATION ENHANCEMENT; COMPARTMENT SHAPE ANISOTROPY; FIELD-GRADIENT NMR; RAT-BRAIN; H-1-NMR SPECTROSCOPY; WEIGHTED MR; INTRACELLULAR METABOLITES; TENSOR SPECTROSCOPY	Measuring cellular microstructures non-invasively and achieving specificity towards a celltype population within an interrogated in vivo tissue, remains an outstanding challenge in brain research. Magnetic Resonance Spectroscopy (MRS) provides an opportunity to achieve cellular specificity via the spectral resolution of metabolites such as N-Acetylaspartate (NAA) and myo-Inositol (mI), which are considered neuronal and astrocytic markers, respectively. Yet the information typically obtained with MRS describes metabolic concentrations, diffusion coefficients or relaxation rates rather than microstructures. Understanding how these metabolites are compartmentalized is a challenging but important goal, which so far has been mainly addressed using diffusion models. Here, we present direct in vivo evidence for the confinement of NAA and mI within sub-cellular components, namely, the randomly oriented process of neurons and astrocytes, respectively. Our approach applied Relaxation Enhanced MRS at ultrahigh (21.1 T) field, and used its high H-1 sensitivity to measure restricted diffusion correlations for NAA and mI using a Double Diffusion Encoding (DDE) filter. While very low macroscopic anisotropy was revealed by spatially localized Diffusion Tensor Spectroscopy, DDE displayed characteristic amplitude modulations reporting on confinements in otherwise randomly oriented anisotropic microstructures for both metabolites. This implies that for the chosen set of parameters, the DDE measurements had a biased sensitivity towards NAA and mI sited in the more confined environments of neurites and astrocytic branches, than in the cell somata. These measurements thus provide intrinsic diffusivities and compartment diameters, and revealed subcellular neuronal and astrocytic morphologies in normal in vivo rat brains. The relevance of these measurements towards human applications- which could in turn help understand CNS plasticity as well as diagnose brain diseases- is discussed.	[Shemesh, Noam] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal; [Rosenberg, Jens T.; Grant, Samuel C.; Frydman, Lucio] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Dumez, Jean-Nicolas] Inst Chim Subst Nat, CNRS UPR2301, Gif Sur Yvette, France; [Grant, Samuel C.] Florida State Univ, Chem & Biomed Engn, Tallahassee, FL 32306 USA; [Frydman, Lucio] Weizmann Inst Sci, Dept Chem Phys, Rehovot, Israel	Fundacao Champalimaud; State University System of Florida; Florida State University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); State University System of Florida; Florida State University; Weizmann Institute of Science	Shemesh, N (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal.; Frydman, L (corresponding author), Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA.; Frydman, L (corresponding author), Weizmann Inst Sci, Dept Chem Phys, Rehovot, Israel.	Noam.Shemesh@neuro.fchampalimaud.org; Lucio.Frydman@weizmann.ac.il	Shemesh, Noam/GPK-7972-2022; Grant, Samuel Colles/D-8744-2013; Dumez, Jean-Nicolas/C-1080-2009	Grant, Samuel Colles/0000-0001-7738-168X; Dumez, Jean-Nicolas/0000-0002-5394-8001; Shemesh, Noam/0000-0001-6681-5876; Frydman, Lucio/0000-0001-8208-3521	NSF [DMR-1157490]; State of Florida; NHMFL User Collaboration Grants Program; Israel Science Foundation [795/13]; Minerva Foundation from the Federal German Ministry for Education and Research [712277]; Kimmel Institute for Magnetic Resonance; generosity of the Perlman Family Foundation; NHMFL [12456]	NSF(National Science Foundation (NSF)); State of Florida; NHMFL User Collaboration Grants Program; Israel Science Foundation(Israel Science Foundation); Minerva Foundation from the Federal German Ministry for Education and Research; Kimmel Institute for Magnetic Resonance; generosity of the Perlman Family Foundation; NHMFL	This work was performed at the National High Magnetic Field Laboratory (NHMFL), which is supported by NSF DMR-1157490 and the State of Florida. Funding was also provided by the NHMFL User Collaboration Grants Program (to SCG). The authors also thank the Israel Science Foundation (Grant 795/13), the Minerva Foundation (Grant No. 712277) from the Federal German Ministry for Education and Research, the Kimmel Institute for Magnetic Resonance and the generosity of the Perlman Family Foundation (to LF). NS gratefully acknowledges a Visiting Scientist Grant from NHMFL, Project Number 12456. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JJH, 2010, NMR BIOMED, V23, P725, DOI 10.1002/nbm.1530; Assaf Y, 1998, NMR BIOMED, V11, P67, DOI 10.1002/(SICI)1099-1492(199804)11:2<67::AID-NBM503>3.0.CO;2-5; Bar-Shir A, 2008, J MAGN RESON, V194, P230, DOI 10.1016/j.jmr.2008.07.009; Bernabeu A, 2009, NEUROIMAGE, V47, P1172, DOI 10.1016/j.neuroimage.2009.04.080; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Cheng Y, 1999, J AM CHEM SOC, V121, P7935, DOI 10.1021/ja9843324; Cusack CL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2910; de Graaf RA, 2006, MAGN RESON MED, V56, P386, DOI 10.1002/mrm.20946; de Graaf RA, 2014, NMR BIOMED, V27, P802, DOI 10.1002/nbm.3121; Demougeot C, 2001, J NEUROCHEM, V77, P408, DOI 10.1046/j.1471-4159.2001.00285.x; Dijkhuizen RM, 1999, J CEREBR BLOOD F MET, V19, P341, DOI 10.1097/00004647-199903000-00012; Dreher W, 2001, MAGN RESON MED, V45, P383, DOI 10.1002/1522-2594(200103)45:3<383::AID-MRM1050>3.0.CO;2-G; Drobnjak I, 2013, MICROPOR MESOPOR MAT, V178, P11, DOI 10.1016/j.micromeso.2013.03.004; Drobnjak I, 2010, J MAGN RESON, V206, P41, DOI 10.1016/j.jmr.2010.05.017; Duarte JMN, 2012, NEUROIMAGE, V61, P342, DOI 10.1016/j.neuroimage.2011.12.038; Eriksson S, 2013, J MAGN RESON, V226, P13, DOI 10.1016/j.jmr.2012.10.015; Finsterbusch J, 2008, J MAGN RESON, V195, P23, DOI 10.1016/j.jmr.2008.08.003; Finsterbusch J, 2010, ANNU REP NMR SPECTRO, V72, P225, DOI 10.1016/B978-0-12-385857-3.00006-2; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; Frullano L, 2011, J AM CHEM SOC, V133, P1611, DOI 10.1021/ja1040896; Fu R, 2005, J MAGN RESON, V177, P1, DOI 10.1016/j.jmr.2005.07.013; Garwood M, 2001, J MAGN RESON, V153, P155, DOI 10.1006/jmre.2001.2340; Grossman EJ, 2015, NEUROIMAGE, V118, P334, DOI 10.1016/j.neuroimage.2015.05.061; Harada M, 2002, NMR BIOMED, V15, P69, DOI 10.1002/nbm.759; Hattingen E, 2008, NMR BIOMED, V21, P233, DOI 10.1002/nbm.1186; Ianus A, 2013, J MAGN RESON, V227, P25, DOI 10.1016/j.jmr.2012.11.021; Jespersen SN, 2013, NMR BIOMED, V26, P1647, DOI 10.1002/nbm.2999; Jespersen SN, 2012, NMR BIOMED, V25, P813, DOI 10.1002/nbm.1808; Kandel E., 2000, PRINCIPLES NEURAL SC; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kawai Y, 2010, NEUROIMAGE, V49, P3122, DOI 10.1016/j.neuroimage.2009.11.005; Kim H, 2004, MAGNET RESON MED, V51, P263, DOI 10.1002/mrm.10697; Koch MA, 2008, MAGN RESON MED, V60, P90, DOI 10.1002/mrm.21514; Koch MA, 2011, NMR BIOMED, V24, P1422, DOI 10.1002/nbm.1711; Koch MA, 2009, MAGN RESON MED, V62, P247, DOI 10.1002/mrm.21976; Lasic S, 2014, FRONT PHYS-LAUSANNE, V2, DOI 10.3389/fphy.2014.00011; Lawrenz M, 2015, NEUROIMAGE, V109, P283, DOI 10.1016/j.neuroimage.2015.01.025; Lawrenz M, 2015, MAGN RESON MED, V73, P773, DOI 10.1002/mrm.25140; Lawrenz M, 2011, MAGN RESON MED, V66, P1405, DOI 10.1002/mrm.22934; Le Belle JE, 2002, NMR BIOMED, V15, P37, DOI 10.1002/nbm.740; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Marchadour C, 2012, J CEREBR BLOOD F MET, V32, P2153, DOI 10.1038/jcbfm.2012.119; Markiewicz WD, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2014.2364540; Martins JPD, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.087601; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; MITRA PP, 1995, PHYS REV B, V51, P15074, DOI 10.1103/PhysRevB.51.15074; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Na HB, 2007, ANGEW CHEM INT EDIT, V46, P5397, DOI 10.1002/anie.200604775; Najac C, 2016, BRAIN STRUCT FUNCT, V221, P1245, DOI 10.1007/s00429-014-0968-5; Najac C, 2014, NEUROIMAGE, V90, P374, DOI 10.1016/j.neuroimage.2013.12.045; Nicolay K, 1995, NMR BIOMED, V8, P365, DOI 10.1002/nbm.1940080710; Nicolay K, 2001, NMR BIOMED, V14, P94, DOI 10.1002/nbm.686; Ozarslan E, 2009, J MAGN RESON, V199, P56, DOI 10.1016/j.jmr.2009.04.002; Palombo M, 2016, P NATL ACAD SCI USA, V113, P6671, DOI 10.1073/pnas.1504327113; Pervushin K, 2002, J AM CHEM SOC, V124, P12898, DOI 10.1021/ja027149q; Ronen I, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00013; Rosenberg JT, MAGN RESON MED; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Schanda P, 2009, PROG NUCL MAG RES SP, V55, P238, DOI 10.1016/j.pnmrs.2009.05.002; Serkova N, 1996, BBA-MOL CELL RES, V1314, P93, DOI 10.1016/S0167-4889(96)00081-X; Shemesh N, 2016, MAGN RESON MED, V75, P82, DOI 10.1002/mrm.25901; Shemesh N, 2014, J CEREBR BLOOD F MET, V34, P1810, DOI 10.1038/jcbfm.2014.149; Shemesh N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5958; Shemesh N, 2013, CHEM-EUR J, V19, P13002, DOI 10.1002/chem.201300955; Shemesh N, 2012, MAGN RESON MED, V68, P794, DOI 10.1002/mrm.23300; Shemesh N, 2012, NMR BIOMED, V25, P236, DOI 10.1002/nbm.1737; Shemesh N, 2011, J MAGN RESON, V212, P362, DOI 10.1016/j.jmr.2011.07.015; Shemesh N, 2011, J AM CHEM SOC, V133, P6028, DOI 10.1021/ja200303h; Shemesh N, 2011, MAGN RESON MED, V65, P1216, DOI 10.1002/mrm.22738; SIMMONS ML, 1991, NEUROSCIENCE, V45, P37, DOI 10.1016/0306-4522(91)90101-S; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Szczepankiewicz F, 2015, NEUROIMAGE, V104, P241, DOI 10.1016/j.neuroimage.2014.09.057; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tu C, 2009, ANGEW CHEM INT EDIT, V48, P6547, DOI 10.1002/anie.200900984; Upadhyay J, 2007, MAGN RESON MED, V58, P1045, DOI 10.1002/mrm.21372; Upadhyaya J, 2008, NEUROIMAGE, V39, P1, DOI 10.1016/j.neuroimage.2007.08.046; vanderToorn A, 1996, MAGN RESON MED, V36, P914, DOI 10.1002/mrm.1910360614; Westin CF, 2016, NEUROIMAGE, V135, P345, DOI 10.1016/j.neuroimage.2016.02.039; WICK M, 1995, STROKE, V26, P1930, DOI 10.1161/01.STR.26.10.1930; Wood ET, 2012, J NEUROSCI, V32, P6665, DOI 10.1523/JNEUROSCI.0044-12.2012; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zheng G, 2007, CONCEPT MAGN RESON A, V30A, P261, DOI 10.1002/cmr.a.20092	84	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185232	10.1371/journal.pone.0185232	http://dx.doi.org/10.1371/journal.pone.0185232			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968410	Green Submitted, Green Published, gold			2022-12-27	WOS:000412029600016
J	Araujo, DFS; Guerra, GCB; Pintado, MME; Sousa, YRF; Algieri, F; Rodriguez-Nogales, A; Araujo, RF; Galvez, J; Queiroga, RDRE; Rodriguez-Cabezas, ME				Araujo, Daline F. S.; Guerra, Gerlane C. B.; Pintado, Maria Manuela E.; Sousa, Yasmim R. F.; Algieri, Francesca; Rodriguez-Nogales, Alba; Araujo, Raimundo F., Jr.; Galvez, Julio; Queiroga, Rita de Cassia R. E.; Rodriguez-Cabezas, Maria Elena			Intestinal anti-inflammatory effects of goat whey on DNBS-induced colitis in mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MILK OLIGOSACCHARIDES; CHRONIC INFLAMMATION; RAT MODEL; CYTOKINES; EXPRESSION; MANAGEMENT; DISEASE; IL-6	This study evaluated the intestinal anti-inflammatory effects of goat whey in a mouse model of colitis induced by 2,4-dinitrobenzenesulfonic acid that resembles human IBD. At a concentration of 4 g/kg/day, the goat whey improved the symptoms of intestinal inflammation, namely by decreasing the disease activity index, colonic weight/length, and leukocyte infiltration. Moreover, goat whey inhibited NF-kappa B p65 and p38 MAPK signaling pathways and consequently down-regulated the gene expression of various proinflammatory markers such as IL-1 beta, IL-6, IL-17, TNF-alpha, iNOS, MMP-9, ICAM-1. Also, goat whey increased the expression of proteins such as mucins, occludin proteins and cytokine signalling suppressors. The immunomodulatory properties of goat whey were also evaluated in vitro using the murine macrophage cell line Raw 264 and CMT-93 cells derived from mouse rectum carcinomas. The results revealed the ability of goat whey to inhibit the production of NO and reduce IL-6 production in LPS-stimulated cells. In conclusion, goat whey exhibited antiinflammatory effects in the DNBS model of intestinal inflammation, and these observations were confirmed by its immunomodulatory properties in vitro. Together, our results indicate that goat whey could have applications for the treatment of IBD.	[Araujo, Daline F. S.] Univ Fed Rio Grande do Norte, Fac Hlth Sci Trairi, Santa Cruz, Brazil; [Guerra, Gerlane C. B.] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Biosci Ctr, Natal, RN, Brazil; [Pintado, Maria Manuela E.] Catholic Univ Portugal, Sch Biotechnol, Porto, Portugal; [Sousa, Yasmim R. F.] Univ Fed Paraiba, Technol Ctr, Joao Pessoa, Paraiba, Brazil; [Algieri, Francesca; Rodriguez-Nogales, Alba; Galvez, Julio; Rodriguez-Cabezas, Maria Elena] Univ Granada, Dept Pharmacol, Ctr Biomed Res CIBM, Ibs GRANADA,CIBER EHD, Granada, Spain; [Araujo, Raimundo F., Jr.] Univ Fed Rio Grande do Norte, Dept Morphol, Histol & Basic Pathol Biosci Ctr, Natal, RN, Brazil; [Queiroga, Rita de Cassia R. E.] Univ Fed Paraiba, Dept Nutr, Hlth Sci Ctr, Joao Pessoa, Paraiba, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Catolica Portuguesa; Universidade Federal da Paraiba; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Universidade Federal do Rio Grande do Norte; Universidade Federal da Paraiba	Guerra, GCB (corresponding author), Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Biosci Ctr, Natal, RN, Brazil.	gerlaneguerra@hotmail.com	Rodríguez-Nogales, Alba/J-2782-2017; rodriguez-cabezas, maria elena/L-3086-2014; Araújo Júnior, Raimundo Fernandes/D-2354-2014; Pintado, Maria Manuela/AAW-6709-2021; Algieri, Francesca F/J-4281-2017; Pintado, Maria Manuela/ABE-2085-2021; Gálvez, Julio/K-6875-2014	Rodríguez-Nogales, Alba/0000-0003-1927-0628; rodriguez-cabezas, maria elena/0000-0001-9085-8147; Araújo Júnior, Raimundo Fernandes/0000-0003-2349-2354; Pintado, Maria Manuela/0000-0002-0760-3184; Gálvez, Julio/0000-0001-6876-3782	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq; European Union [AGL2015-67995-C3-3-R, CTS 164]; Institute de Salud Carlos III	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); European Union(European Commission); Institute de Salud Carlos III(Instituto de Salud Carlos III)	The authors are grateful to the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq for funding the research, the Laboratory Food Chemistry-UFPB, Brazil, for drying the goat whey, the Federal University of Rio Grande do Norte for technical-scientific support, the Junta de Andalucia (CTS 164) and the Spanish Ministry of Economy and Competitiveness (AGL2015-67995-C3-3-R) with funds from the European Union. A. Rodriguez-Nogales and F. Algieri are postdoctoral fellows at the University of Granada; M.E. Rodriguez-Cabezas is a postdoctoral fellow at the CIBER-EHD. The CIBER-EHD is funded by the Institute de Salud Carlos III.	Acosta MB, 2016, REV ED SUPER, V12, P227; Ahmed AS, 2015, FOOD RES INT, V74, P80, DOI 10.1016/j.foodres.2015.04.032; Ala A, 2003, INT J EXP PATHOL, V84, P1, DOI 10.1046/j.1365-2613.2003.00235.x; de Assis POA, 2016, INT DAIRY J, V56, P45, DOI 10.1016/j.idairyj.2015.11.002; Araujo RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092177; Ardizzone S, 2005, DRUGS, V65, P2253, DOI 10.2165/00003495-200565160-00002; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bassaganya-Riera J, 2006, CLIN NUTR, V25, P454, DOI 10.1016/j.clnu.2005.12.008; Bassaganya-Riera J, 2012, CLIN NUTR, V31, P721, DOI 10.1016/j.clnu.2012.03.002; Beringer A, 2016, TRENDS MOL MED, V22, P230, DOI 10.1016/j.molmed.2016.01.001; Bressler B, 2015, GASTROENTEROLOGY, V148, P1035, DOI 10.1053/j.gastro.2015.03.001; Broom OJ, 2009, CLIN EXP IMMUNOL, V158, P272, DOI 10.1111/j.1365-2249.2009.04033.x; Chaturvedi P, 2001, ADV EXP MED BIOL, V501, P315; Daddaoua A, 2006, J NUTR, V136, P672, DOI 10.1093/jn/136.3.672; Folch J., 1957, J BIOL CHEM, V55, P999, DOI DOI 10.1016/J.ULTRASMEDBIO.2011.03.005; de Sousa YRF, 2015, LIVEST SCI, V177, P175, DOI 10.1016/j.livsci.2015.04.005; de Oliveira MEG, 2012, SCI AGR, V69, P370, DOI 10.1590/S0103-90162012000600005; Granger DL, 1999, METHOD ENZYMOL, V301, P49; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Greicius G, 2004, GASTROENTEROLOGY, V127, P994, DOI 10.1053/j.gastro.2004.07.038; Guerra GCB, 2015, PHARMACOL REP, V67, P520, DOI 10.1016/j.pharep.2014.12.011; Hansson GC, 2010, GUT MICROBES, V1, P51, DOI 10.4161/gmic.1.1.10470; Hontecillas R, 2002, J NUTR, V132, P2019, DOI 10.1093/jn/132.7.2019; Kanwar JR, 2016, J DAIRY SCI, V99, P2488, DOI 10.3168/jds.2015-10122; Kelly G S, 2001, Altern Med Rev, V6, P367; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Koelink PJ, 2014, GUT, V63, P578, DOI 10.1136/gutjnl-2012-303252; Kozuch PL, 2008, WORLD J GASTROENTERO, V14, P354, DOI 10.3748/wjg.14.354; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Kunz C, 2006, INT DAIRY J, V16, P1341, DOI 10.1016/j.idairyj.2006.06.020; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; KUO PC, 1995, ANN SURG, V221, P220, DOI 10.1097/00000658-199503000-00003; Lara-Villostada F, 2006, CLIN NUTR, V25, P477, DOI 10.1016/j.clnu.2005.11.004; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Martinez-Ferez A, 2006, INT DAIRY J, V16, P173, DOI 10.1016/j.idairyj.2005.02.003; Matsumoto S, 2004, CLIN EXP IMMUNOL, V136, P432, DOI 10.1111/j.1365-2249.2004.02462.x; Meyrand M, 2013, SMALL RUMINANT RES, V113, P411, DOI 10.1016/j.smallrumres.2013.03.014; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Ng SC, 2009, INFLAMM BOWEL DIS, V15, P935, DOI 10.1002/ibd.20797; Nicola NA, 2000, EXP HEMATOL, V28, P1105, DOI 10.1016/S0301-472X(00)00525-7; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Palatka K, 2005, SCAND J GASTROENTERO, V40, P670, DOI 10.1080/00365520510015539; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; RACHMILEWITZ D, 1995, GUT, V37, P247, DOI 10.1136/gut.37.2.247; Rakesh K, 2005, BIOCHEM PHARMACOL, V70, P649, DOI 10.1016/j.bcp.2005.04.042; Reddy JG, 2006, GASTROENTEROL CLIN N, V35, P837, DOI 10.1016/j.gtc.2006.09.008; Ren TH, 2015, SCI REP-UK, V5, DOI 10.1038/srep09047; Safdari BK, 2016, CYTOKINE, V83, P231, DOI 10.1016/j.cyto.2016.04.017; Sitaraman SV, 2001, J CLIN INVEST, V107, P861, DOI 10.1172/JCI11783; Spichtig V, 2010, ANAL BIOCHEM, V405, P28, DOI 10.1016/j.ab.2010.06.010; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Taniguchi K, 2014, SEMIN IMMUNOL, V26, P54, DOI 10.1016/j.smim.2014.01.001; Thum C, 2015, J FOOD COMPOS ANAL, V42, P30, DOI 10.1016/j.jfca.2015.01.022; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Waldner MJ, 2014, SEMIN IMMUNOL, V26, P75, DOI 10.1016/j.smim.2013.12.003; ZeaIriarte WL, 1996, SCAND J GASTROENTERO, V31, P985, DOI 10.3109/00365529609003118	58	16	18	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185382	10.1371/journal.pone.0185382	http://dx.doi.org/10.1371/journal.pone.0185382			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957373	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200052
J	Li, ZW; Xin, YZ; Cui, XR; Liu, X; Wang, LQ; Zhang, WS; Lu, QH; Zhu, H				Li, Zhongwei; Xin, Yuezhen; Cui, Xuerong; Liu, Xin; Wang, Leiquan; Zhang, Weishan; Lu, Qinghua; Zhu, Hu			Optimization to the Phellinus experimental environment based on classification forecasting method	PLOS ONE			English	Article							NEURAL P SYSTEMS; IMBALANCED DATA; ALGORITHM; DESIGN; SMOTE	Phellinus is a kind of fungus and known as one of the elemental components in drugs to avoid cancer. With the purpose of finding optimized culture conditions for Phellinus production in the lab, plenty of experiments focusing on single factor were operated and large scale of experimental data was generated. In previous work, we used regression analysis and GA Gene-set based Genetic Algorithm (GA) to predict the production, but the data we used depended on experimental experience and only little part of the data was used. In this work we use the values of parameters involved in culture conditions, including inoculum size, PH value, initial liquid volume, temperature, seed age, fermentation time and rotation speed, to establish a high yield and a low yield classification model. Subsequently, a prediction model of BP neural network is established for high yield data set. GA is used to find the best culture conditions. The forecast accuracy rate more than 90% and the yield we got have a slight increase than the real yield.	[Li, Zhongwei; Xin, Yuezhen; Cui, Xuerong; Liu, Xin; Wang, Leiquan; Zhang, Weishan; Lu, Qinghua] China Univ Petr, Coll Comp & Commun Engn, Qingdao 266580, Shandong, Peoples R China; [Zhu, Hu] Fujian Normal Univ, Coll Chem & Mat, Fuzhou 350007, Fujian, Peoples R China	China University of Petroleum; Fujian Normal University	Zhu, H (corresponding author), Fujian Normal Univ, Coll Chem & Mat, Fuzhou 350007, Fujian, Peoples R China.	zhuhu@fjnu.edu.cn	zhu, hu/GQQ-8365-2022	Wang, Leiquan/0000-0003-4314-0030	863 program [2015AA020925]; National Natural Science Foundation of China [61402187, 61502535, 61572522, 61572523, 61672033, 61672248]; China Postdoctoral Science Foundation funded project [2016M592267]; PetroChina Innovation Foundation [2016D-5007-0305]; Fundamental Research Funds for the Central Universities [R1607005A, 16CX02006A]; Key Research and Development Program of Shandong Province [2017GGX10147]	863 program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation funded project(China Postdoctoral Science Foundation); PetroChina Innovation Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Research and Development Program of Shandong Province	This work was supported by 863 program (2015AA020925 to HZ), National Natural Science Foundation of China (61402187, 61502535, 61572522, 61572523, 61672033 and 61672248 to HZ), China Postdoctoral Science Foundation funded project (2016M592267 to HZ), PetroChina Innovation Foundation (2016D-5007-0305 to ZL), Fundamental Research Funds for the Central Universities (R1607005A and 16CX02006A to HZ), Key Research and Development Program of Shandong Province (No. 2017GGX10147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Natural Science Foundation of China (61402187, 61502535, 61572522, 61572523, 61672033 and 61672248), China Postdoctoral Science Foundation funded project (2016M592267), PetroChina Innovation Foundation (2016D-5007-0305), Fundamental Research Funds for the Central Universities (R1607005A), Key Research and Development Program of Shandong Province (No. 2017GGX10147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazzan ALC, 2009, LECT NOTES COMPUT SC, V5680, P3, DOI 10.1007/978-3-642-03603-3_1; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen BJ, 2017, NEUROCOMPUTING, V266, P293, DOI 10.1016/j.neucom.2017.05.047; Cohen G, 2006, ARTIF INTELL MED, V37, P7, DOI 10.1016/j.artmed.2005.03.002; David S.K., 2013, COMPUT ENG INTELL SY, V4, P28; Davis L., 1991, HDB GENETIC ALGORITH, DOI DOI 10.1.1.87.3586; Ding SF, 2011, ARTIF INTELL REV, V36, P153, DOI 10.1007/s10462-011-9208-z; Dogan HH, 2009, TURK J BOT, V33, P239, DOI 10.3906/bot-0808-9; Fu ZJ, 2017, IEEE T INF FOREN SEC, V12, P1874, DOI 10.1109/TIFS.2017.2692728; GALLETLY JE, 1992, KYBERNETES, V21, P26, DOI 10.1108/eb005943; Goldber D. E., 1988, Machine Learning, V3, P95, DOI 10.1023/A:1022602019183; Han H, 2005, LECT NOTES COMPUT SC, V3644, P878, DOI 10.1007/11538059_91; Hong TP, 2007, IEEE SYS MAN CYBERN, P2628; Ju Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep33870; Kang J, 2015, INT J RADIAT ONCOL, V93, P1127, DOI 10.1016/j.ijrobp.2015.07.2286; Khaouane L, 2012, BIOTECHNOL BIOPROC E, V17, P1048, DOI 10.1007/s12257-012-0254-4; Lavecchia A, 2015, DRUG DISCOV TODAY, V20, P318, DOI 10.1016/j.drudis.2014.10.012; [李朔 LI Shuo], 2006, [食品科学, Food Science], V27, P236; Li Z, 2016, BIOMED RES INT, V2016; Li Z, 2016, BIOMED RES INT, V2016, P6; Liu Q, 2016, SECUR COMMUN NETW, V9, P4002, DOI 10.1002/sec.1582; Liu S Q., 2003, COMPUTER ENG DESIGN; Liu W, 2012, STUDY METABOLIC REGU; Ma TH, 2015, COMPUTING, V97, P1165, DOI 10.1007/s00607-015-0453-x; Man K.F., 1989, PERSPECT NEURAL COMP, V83, P55; [邵杰 Shao Jie], 2012, [食品科学, Food Science], V33, P121; Shen J, 2017, IEEE T INF FOREN SEC, V12, P2402, DOI 10.1109/TIFS.2017.2705620; Sliva D, 2008, BRIT J CANCER, V98, P1348, DOI 10.1038/sj.bjc.6604319; Song T, 2014, NEURAL COMPUT APPL, P24; Song T, 2016, IEEE T NANOBIOSCI, V15, P666, DOI 10.1109/TNB.2016.2598879; Song T, 2016, INFORM SCIENCES, V372, P380, DOI 10.1016/j.ins.2016.08.055; Song T, 2016, NEUROCOMPUTING, V193, P193, DOI 10.1016/j.neucom.2016.02.023; Song T, 2015, IEEE T NANOBIOSCI, V14, P960, DOI 10.1109/TNB.2015.2503603; Tsai MF, 2015, J MED BIOL ENG, V35, P775, DOI 10.1007/s40846-015-0094-8; Wang R, 2015, IEEE T CYBERNETICS, V45, P1262, DOI 10.1109/TCYB.2014.2348012; Wang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep27624; Wang Y, 2012, FOOD CHEM, V131, P206, DOI 10.1016/j.foodchem.2011.08.061; Xia GuoHua, 2010, Journal of Jiangsu University - Medicine Edition, V20, P40; Xia ZH, 2016, IEEE T INF FOREN SEC, V11, P2594, DOI 10.1109/TIFS.2016.2590944; Xia ZH, 2016, IEEE T PARALL DISTR, V27, P340, DOI 10.1109/TPDS.2015.2401003; Xue Y, 2018, SOFT COMPUT, V22, P2935, DOI 10.1007/s00500-017-2547-1; Zeng XX, 2015, FRONT COMPUT SCI-CHI, V9, P643, DOI 10.1007/s11704-014-4089-3; Zhang L, 2017, IEEE T CYBERNETICS, V47, P2703, DOI 10.1109/TCYB.2017.2711038; Zhang X, PATTERN RECOMMENDATI; Zhang X, 2016, IEEE T EVOLUTIONARY; Zhang XY, 2015, IEEE T EVOLUT COMPUT, V19, P761, DOI 10.1109/TEVC.2014.2378512; Zhu T, 2007, BRIT J CANCER, V96, P583, DOI 10.1038/sj.bjc.6603595	47	1	1	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185444	10.1371/journal.pone.0185444	http://dx.doi.org/10.1371/journal.pone.0185444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957375	Green Submitted, Green Published, gold			2022-12-27	WOS:000411985200058
J	Zuliani, G; Volpato, S; Dugo, M; Vigna, GB; Morieri, ML; Maggio, M; Cherubini, A; Bandinelli, S; Gurainik, JM; Ferrucci, L				Zuliani, Giovanni; Volpato, Stefano; Dugo, Marco; Vigna, Giovanni B.; Morieri, Mario Luca; Maggio, Marcello; Cherubini, Antonio; Bandinelli, Stefania; Gurainik, Jack M.; Ferrucci, Luigi			Combining LDL-C and HDL-C to predict survival in late life: The InChianti study	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; SERUM-CHOLESTEROL; CANCER INCIDENCE; MORTALITY RISK; OLDER-ADULTS; FOLLOW-UP; APOLIPOPROTEINS; LIPIDS	Background While the relationship between total cholesterol (TC) and cardiovascular disease (CVD) progressively weakens with aging, several studies have shown that low TC is associated with increased mortality in older individuals. However, the possible additive/synergic contribution of the two most important cholesterol rich fractions (LDL-C and HDL-C) to mortality risk has not been previously investigated. Our study aimed to investigate the relationship between baseline LDL-C and HDL-C, both separately and combined, and 9-years mortality in a sample of community dwelling older individuals from the InCHIANTI study. Methods and findings 1044 individuals over 64 years were included. CVD and cancer mortality were defined by ICD-9 codes 390-459 and 140-239, respectively. LDL-C <130 mg/dL (3.36 mmol/L) was defined as "optimal/near optimal". Low HDL-C was defined as <40/50 mg/dL (1.03/1.29 mmol/L) in males/females, respectively. Nine-years mortality risk was calculated by multivariate Cox proportional hazards model. We found that, compared to subjects with high LDL-C and normal HDL-C (reference group), total mortality was significantly increased in subjects with optimal/near optimal LDL-C and low HDL-C (H.R.:1.58; 95% CI:1.11-2.25). As regards the specific cause of death, CVD mortality was not affected by LDL-C/HDL-C levels, while cancer mortality was significantly increased in all subjects with optimal/near optimal LDL-C (with normal HDL-C: H.R.:2.49; with low HDL-C: H.R.:4.52). Results were unchanged after exclusion of the first three years of follow-up, and of subjects with low TC (<160 g/dL-4.13 mmol/L). Conclusions Our findings suggest that, in community dwelling older individuals, the combined presence of optimal/near optimal LDL-C and low HDL-C represents a marker of increased future mortality.	[Zuliani, Giovanni; Volpato, Stefano; Dugo, Marco; Vigna, Giovanni B.; Morieri, Mario Luca] Univ Ferrara, Sect Internal & Cardiopulm Med, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Maggio, Marcello] Univ Parma, Sect Geriatr, Dept Clin & Expt Med, Parma, Italy; [Cherubini, Antonio] INNRCA, Inst Gerontol & Geriatr, Ancona, Italy; [Bandinelli, Stefania] Azienda Sanit Firenze, Florence, Italy; [Gurainik, Jack M.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Clin Res Branch, NIH, Baltimore, MD 21224 USA	University of Ferrara; University of Parma; University Hospital of Parma; Azienda Sanitaria di Firenze; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Zuliani, G (corresponding author), Univ Ferrara, Sect Internal & Cardiopulm Med, Dept Morphol Surg & Expt Med, Ferrara, Italy.	giovanni.zuliani@unife.it	Morieri, Mario Luca/K-3238-2018; bandinelli, stefania/AAL-4570-2020; Cherubini, Antonio/AAL-4632-2020; Vigna, Giovanni/H-2826-2015	Morieri, Mario Luca/0000-0001-6864-0547; Vigna, Giovanni/0000-0001-8640-7052; dugo, Marco/0000-0002-7822-4587; Bandinelli, Stefania/0000-0002-6491-0850; Zuliani, Giovanni/0000-0003-0969-3184	Italian Ministry of Health [ICS110.1/RF97.71]; U.S. National Institute on Aging [263 MD 9164, 263 MD 821336, N.1-AG-1-1, N.1-AG-1-2111, N01-AG-5-0002]; National Institute on Aging, National Institutes of Health, Baltimore, Maryland	Italian Ministry of Health(Ministry of Health, Italy); U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging, National Institutes of Health, Baltimore, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The InCHIANTI study baseline (19982000) was supported as a "targeted project" (ICS110.1/RF97.71) by the Italian Ministry of Health, and in part by the U.S. National Institute on Aging (Contracts: 263 MD 9164 and 263 MD 821336). The Follow-up 1 (2001-2003) was funded by the U.S. National Institute on Aging (Contracts: N.1-AG-1-1 and N.1-AG-1-2111); the Follow-up 2 and 3 studies (2004-2010) were financed by the U.S. National Institute on Aging (Contract: N01-AG-5-0002). Supported in part by the Intramural research program of the National Institute on Aging, National Institutes of Health, Baltimore, Maryland.	Ahn J, 2009, CANCER EPIDEM BIOMAR, V18, P2814, DOI 10.1158/1055-9965.EPI-08-1248; Assmann G, 1998, EUR HEART J, V19, pA2; Barzilai N, 2001, J AM GERIATR SOC, V49, P76, DOI 10.1046/j.1532-5415.2001.49013.x; Benn M, 2011, JNCI-J NATL CANCER I, V103, P508, DOI 10.1093/jnci/djr008; Brescianini S, 2003, J AM GERIATR SOC, V51, P991, DOI 10.1046/j.1365-2389.2003.51313.x; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Clarke R, 2007, ARCH INTERN MED, V167, P1373, DOI 10.1001/archinte.167.13.1373; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; GLUECK CJ, 1977, ATHEROSCLEROSIS, V27, P387, DOI 10.1016/0021-9150(77)90159-9; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; ISLES CG, 1989, BMJ-BRIT MED J, V298, P920, DOI 10.1136/bmj.298.6678.920; JACOBS D, 1992, CIRCULATION, V86, P1046, DOI 10.1161/01.CIR.86.3.1046; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karlamangla AS, 2004, J AM GERIATR SOC, V52, P487, DOI 10.1111/j.1532-5415.2004.52152.x; KREGER BE, 1992, CANCER-AM CANCER SOC, V70, P1038, DOI 10.1002/1097-0142(19920901)70:5<1038::AID-CNCR2820700505>3.0.CO;2-M; KRONMAL RA, 1993, ARCH INTERN MED, V153, P1065, DOI 10.1001/archinte.153.9.1065; Nofer JR, 2001, J BIOL CHEM, V276, P34480, DOI 10.1074/jbc.M103782200; Nofer JR, 2001, THROMB HAEMOSTASIS, V85, P730; Raiha I, 1997, ARTERIOSCL THROM VAS, V17, P1224, DOI 10.1161/01.ATV.17.7.1224; Ravnskov U, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010401; SALMOND CE, 1985, BMJ-BRIT MED J, V290, P422, DOI 10.1136/bmj.290.6466.422; Cabrera MAS, 2012, SCI WORLD J, DOI 10.1100/2012/930139; SCHAEFER EJ, 1989, METABOLISM, V38, P293, DOI 10.1016/0026-0495(89)90113-3; SCHATZKIN A, 1987, LANCET, V2, P298; Schupf N, 2005, J AM GERIATR SOC, V53, P219, DOI 10.1111/j.1532-5415.2005.53106.x; SIMONS LA, 1986, AM J CARDIOL, V57, pG5, DOI 10.1016/0002-9149(86)90659-4; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; TORNBERG SA, 1989, JNCI-J NATL CANCER I, V81, P1917, DOI 10.1093/jnci/81.24.1917; Volpato S, 2001, J AM GERIATR SOC, V49, P1142, DOI 10.1046/j.1532-5415.2001.49229.x; von Eckardstein A, 2005, CURR OPIN CLIN NUTR, V8, P147, DOI 10.1097/00075197-200503000-00007; Weverling-Rijnsburger AWE, 2003, ARCH INTERN MED, V163, P1549, DOI 10.1001/archinte.163.13.1549; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9; WILLIAMS RR, 1981, JAMA-J AM MED ASSOC, V245, P247, DOI 10.1001/jama.245.3.247; Yang XL, 2008, CAN MED ASSOC J, V179, P427, DOI 10.1503/cmaj.071474; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zamanian-Daryoush M, 2013, J BIOL CHEM, V288, P21237, DOI 10.1074/jbc.M113.468967; Zuliani G, 1999, GERONTOLOGY, V45, P317, DOI 10.1159/000022112; Zuliani G, 2007, ATHEROSCLEROSIS, V192, P384, DOI 10.1016/j.atherosclerosis.2006.05.024	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185307	10.1371/journal.pone.0185307	http://dx.doi.org/10.1371/journal.pone.0185307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957382	gold, Green Published, Green Submitted			2022-12-27	WOS:000411985200043
J	Grimaldi, G; Teva, A; dos-Santos, CB; Santos, FN; Pinto, ID; Fux, B; Leite, GR; Falqueto, A				Grimaldi, Gabriel, Jr.; Teva, Antonio; dos-Santos, Claudiney B.; Santos, Fernanda Nunes; Pinto, Israel de-Souza; Fux, Blima; Leite, Gustavo Rocha; Falqueto, Aloisio			Field trial of efficacy of the Leish-tec((R)) vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; LONG-LASTING PROTECTION; IMPREGNATED DOG COLLARS; VISCERAL LEISHMANIASIS; BRAZILIAN DOGS; INFECTIONS; CHAGASI; A2; SERODIAGNOSIS; EPIDEMIOLOGY	Background Because domestic dogs are reservoir hosts for visceral leishmaniasis (VL) in Brazil, one of the approaches used to reduce human disease incidence is to cull infected dogs. However, the results of controlled intervention trials based on serological screening of dogs and killing of seropositive animals are equivocal. A prophylactic vaccine to protect dogs from being infectious to the sand fly vector could be an effective strategy to provide sustained control. Here, we investigated whether a currently licensed commercial subunit rA2 protein-saponin vaccine (Leish-tec((R))) had an additional effect to dog culling on reducing the canine infectious populations. Methodology/Principal findings This prospective study was conducted in an L. infantum highly endemic area of southeast Brazil. At the onset of the intervention, all of the eligible dogs received through subcutaneous route a three-dose vaccine course at 21-day intervals and a booster on month 12. For the purpose of comparison, newly recruited healthy dogs were included as the exposed control group. To ascertain vaccine-induced protection, dogs were screened on clinical and serological criteria every 6 months for a 2-year follow-up period. Antibody-based tests and histopathological examination of post-mortem tissue specimens from euthanized animals were used as a marker of infection. The standardized vaccine regime, apart from being safe, was immunogenic as immunized animals responded with a pronounced production of anti-A2-specific IgG antibodies. It should be noted the mean seroconversion time for infection obtained among immunized exposed dogs (similar to 18 months), which was twice as high as that for unvaccinated ones (similar to 9 months). After two transmission cycles completed, the cumulative incidence of infection did differ significantly (P = 0.016) between the vaccinated ( 27%) and unvaccinated ( 42%) dogs. However, the expected efficacy for the vaccine in inducing clinical protection was not evident since 43% of vaccine recipients developed disease over time. Our estimates also indicated that immunoprophylaxis by Leish- tec r vaccine in addition to dog culling might not have an impact on bringing down the incidence of canine infection with L. infantum in areas of high transmission rates. Conclusions/Significance Leish-tec((R)) as a prophylactic vaccine showed promise but needs to be further optimized to be effective in dogs under field conditions, and thereby positively impacts human incidence.	[Grimaldi, Gabriel, Jr.] Fiocruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil; [Teva, Antonio; Santos, Fernanda Nunes] Fiocruz MS, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil; [dos-Santos, Claudiney B.; Pinto, Israel de-Souza; Fux, Blima; Leite, Gustavo Rocha; Falqueto, Aloisio] Univ Fed Espirito Santos, Ctr Ciencias Saude, Vitoria, ES, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Espirito Santo	Grimaldi, G (corresponding author), Fiocruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.	grimaldi@bahia.fiocruz.br	Fux, Blima/AAO-2941-2020	Fux, Blima/0000-0002-5038-3551; de Souza Pinto, Israel/0000-0001-8924-640X; Grimaldi Jr, Gabriel/0000-0001-5189-9763				ALVAR J, 1994, ANN TROP MED PARASIT, V88, P371, DOI 10.1080/00034983.1994.11812879; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Andrade HM, 2002, VET PARASITOL, V103, P71, DOI 10.1016/S0304-4017(01)00552-0; Baneth G, 2002, VET PARASITOL, V106, P315, DOI 10.1016/S0304-4017(02)00115-2; Baneth G, 2008, TRENDS PARASITOL, V24, P324, DOI 10.1016/j.pt.2008.04.001; Berrahal F, 1996, AM J TROP MED HYG, V55, P273, DOI 10.4269/ajtmh.1996.55.273; Borj-Cabrera GP, 2002, VACCINE, V20, P3277, DOI 10.1016/S0264-410X(02)00294-3; Carrillo E, 2009, VET IMMUNOL IMMUNOP, V128, P67, DOI 10.1016/j.vetimm.2008.10.310; Ciaramella P, 1997, VET REC, V141, P539, DOI 10.1136/vr.141.21.539; CORREDOR A, 1989, AM J TROP MED HYG, V40, P480, DOI 10.4269/ajtmh.1989.40.480; Costa CHN, 2000, J INFECT DIS, V182, P997, DOI 10.1086/315795; Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312; de Amorim IFG, 2010, VET PARASITOL, V173, P55, DOI 10.1016/j.vetpar.2010.06.021; Testasicca MCDS, 2014, VET PARASITOL, V204, P169, DOI 10.1016/j.vetpar.2014.04.025; DEANE LEONIDaS M., 1962, REV INST MED TROP SAO PAULO, V4, P198; Duthie MS, 2012, VACCINE, V30, P134, DOI 10.1016/j.vaccine.2011.11.005; Evans KJ, 2011, J TROP MED, V2012, P1; Falqueto A, 2009, AM J TROP MED HYG, V80, P559, DOI 10.4269/ajtmh.2009.80.559; Fernandes AP, 2008, VACCINE, V26, P5888, DOI 10.1016/j.vaccine.2008.05.095; Fernandes CB, 2014, VACCINE, V32, P1287, DOI 10.1016/j.vaccine.2013.12.046; Ghosh A, 2001, VACCINE, V20, P59, DOI 10.1016/S0264-410X(01)00322-X; Gomes RB, 2002, J INFECT DIS, V186, P1530, DOI 10.1086/344733; Gradoni L, 2005, VACCINE, V23, P5245, DOI 10.1016/j.vaccine.2005.07.001; Grimaldi G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002853; Grimaldi G, 2012, AM J TROP MED HYG, V86, P966, DOI 10.4269/ajtmh.2012.12-0040; Grimaldi G, 2012, T ROY SOC TROP MED H, V106, P54, DOI 10.1016/j.trstmh.2011.10.001; Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155; LACERDA MM, 1994, MEM I OSWALDO CRUZ, V89, P489, DOI 10.1590/S0074-02761994000300036; LAINSON R, 1969, T ROY SOC TROP MED H, V63, P741, DOI 10.1016/0035-9203(69)90118-7; Lemesre JL, 2007, VACCINE, V25, P4223, DOI 10.1016/j.vaccine.2007.02.083; Leontides LS, 2002, VET PARASITOL, V109, P19, DOI 10.1016/S0304-4017(02)00201-7; Mackinnon MJ, 2008, VACCINE, V26, pC42, DOI 10.1016/j.vaccine.2008.04.012; Maroli M, 2001, MED VET ENTOMOL, V15, P358, DOI 10.1046/j.0269-283x.2001.00321.x; Michalsky EM, 2007, VET PARASITOL, V147, P67, DOI 10.1016/j.vetpar.2007.03.004; Oliva G, 2006, J CLIN MICROBIOL, V44, P1318, DOI 10.1128/JCM.44.4.1318-1322.2006; Palatnik-de-Sousa CB, 2001, AM J TROP MED HYG, V65, P510, DOI 10.4269/ajtmh.2001.65.510; Palatnik-De-Sousa CB, 2009, VACCINE, V27, P3505, DOI 10.1016/j.vaccine.2009.03.045; Peters NC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000484; Porrozzi R, 2007, CLIN VACCINE IMMUNOL, V14, P544, DOI 10.1128/CVI.00420-06; Reguera RM, 2016, VET PARASITOL, V227, P98, DOI 10.1016/j.vetpar.2016.07.011; Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001; Reithinger R, 2004, INT J PARASITOL, V34, P55, DOI 10.1016/j.ijpara.2003.09.006; Ritmeijer K, 2007, TROP MED INT HEALTH, V12, P404, DOI 10.1111/j.1365-3156.2006.01807.x; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Rosypal AC, 2005, J PARASITOL, V91, P970, DOI 10.1645/GE-483R.1; Sherlock I.A., 1984, Memorias do Instituto Oswaldo Cruz, V79, P511, DOI 10.1590/S0074-02761984000400020; SILVA V. O, 2001, VACCINE, P1082; Ward R. D., 1985, Leishmaniasis. (Human Parasitic Diseases Vol.1.), P199; Werneck GL, 2007, EPIDEMIOL INFECT, V135, P195, DOI 10.1017/S0950268806006881; WHO, 2010, WHO TECH REP SER, V949, P1; Zanin FHC, 2007, MICROBES INFECT, V9, P1070, DOI 10.1016/j.micinf.2007.05.012	51	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185438	10.1371/journal.pone.0185438	http://dx.doi.org/10.1371/journal.pone.0185438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953944	gold, Green Published, Green Submitted			2022-12-27	WOS:000411980300068
J	Long, K; Prothero, D; Madan, M; Syverson, VJP				Long, Katherine; Prothero, Donald; Madan, Meena; Syverson, Valerie J. P.			Did saber-tooth kittens grow up musclebound? A study of postnatal limb bone allometry in felids from the Pleistocene of Rancho La Brea	PLOS ONE			English	Article							MAMMALS; BEHAVIOR	Previous studies have demonstrated that the Pleistocene saber-toothed cat Smilodon fatalis had many forelimb adaptations for increased strength, presumably to grapple with and subdue prey. The Rancho La Brea tar pits yield large samples of juvenile limb bones forming a growth series that allow us to examine how Smilodon kittens grew up. Almost all available juvenile limb bones were measured, and reduced major axis fits were calculated to determine the allometric growth trends. Contrary to expectations based on their robust limbs, Smilodon kittens show the typical pattern of growth found in other large felids (such as the Ice Age lion, Panthera atrox, as well as living tigers, cougars, servals, and wildcats) where the limb grows longer and more slender faster than they grow thick. This adaptation is thought to give felids greater running speed. Smilodon kittens do not grow increasingly more robust with age. Instead, they start out robust and follow the ancestral felid growth pattern, while maintaining their robustness compared to other felids. Apparently, the growth of felid forelimbs is highly canalized and their ontogeny is tightly constrained.	[Long, Katherine; Prothero, Donald] Calif State Polytech Univ Pomona, Dept Geol Sci, Pomona, CA 91768 USA; [Prothero, Donald] Nat Hist Museum Los Angeles Cty, Dept Vertebrate Paleontol, Los Angeles, CA 90007 USA; [Madan, Meena] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Syverson, Valerie J. P.] Univ Wisconsin, Dept Geol Sci, Madison, WI USA	California State University System; California State Polytechnic University Pomona; University of Bristol; University of Wisconsin System; University of Wisconsin Madison	Prothero, D (corresponding author), Calif State Polytech Univ Pomona, Dept Geol Sci, Pomona, CA 91768 USA.; Prothero, D (corresponding author), Nat Hist Museum Los Angeles Cty, Dept Vertebrate Paleontol, Los Angeles, CA 90007 USA.	donaldprothero@att.net	Syverson, Val/GOK-1758-2022	Syverson, Val/0000-0002-6076-5326				AKERSTEN W A, 1985, Contributions in Science (Los Angeles), P1; Ant?n M., 2013, SABERTOOTH; Anyonge W, 1996, J ZOOL, V238, P395, DOI 10.1111/j.1469-7998.1996.tb05402.x; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Christiansen P, 2002, ZOOL J LINN SOC-LOND, V136, P685, DOI 10.1046/j.1096-3642.2002.00041.x; GONYEA W J, 1976, Paleobiology, V2, P332; Kilbourne BM, 2012, J MORPHOL, V273, P1111, DOI 10.1002/jmor.20048; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Meachen-Samuels JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011412; Merriam J.C., 1932, CARNEGIE I WASHINGTO, V442, P1; SCHULTZ C B, 1970, Bulletin of the University of Nebraska State Museum, V9, P33; Turner A., 1997, BIG CATS THEIR FOSSI; Wroe S, 2008, ZOOLOGY, V111, P196, DOI 10.1016/j.zool.2007.07.008	13	0	0	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0183175	10.1371/journal.pone.0183175	http://dx.doi.org/10.1371/journal.pone.0183175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953899	Green Submitted, Green Published, gold			2022-12-27	WOS:000411980300006
J	Roure, S; Valerio, L; Perez-Quilez, O; Fernandez-Rivas, G; Martinez-Cuevas, O; Alcantara-Roman, A; Viasus, D; Pedro-Botet, ML; Sabria, M; Clotet, B				Roure, Silvia; Valerio, Lluis; Perez-Quilez, Olga; Fernandez-Rivas, Gema; Martinez-Cuevas, Octavio; Alcantara-Roman, Albert; Viasus, Diego; Pedro-Botet, M. Luisa; Sabria, Miguel; Clotet, Bonaventura			Epidemiological, clinical, diagnostic and economic features of an immigrant population of chronic schistosomiasis sufferers with long-term residence in a nonendemic country (North Metropolitan area of Barcelona, 2002-2016)	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; UROGENITAL SCHISTOSOMIASIS; HAEMATOBIUM; TRAVELERS; DISEASES; MANSONI; AFRICA	Background Schistosomiasis, one of the neglected tropical diseases (NTD) listed by the WHO, is an acute and chronic parasitic disease caused by blood flukes (trematode worms) of the genus Schistosoma. Complications of long-term infestation include liver cirrhosis, bladder tumors and kidney failure. The objective of this study was to carry out a clinical and epidemiological characterization of a schistosomiasis-diagnosed immigrant population with long-term residencein the EU as well as to evaluate the diagnostic methods available to date. Methods and results A total of 61 individuals with Schistosoma infection who received medical attention between June 2002 and June 2016 at the North Metropolitan International Health Unit in Barcelona (Catalonia, Spain), were included in the study. All patients were sub-Saharan African immigrants. The majority were male (91.8%) with a median age of 34 years. Symptoms attributable to infection such as haematuria, abdominal pain and dysuria were recorded in up to 90% of patients. The percentage of eosinophils decreased amongst older patients (p = 0.002) and those with symptoms associated with urinary tract infections (p = 0.017). Serology was used for diagnosis in 80.3% of the cases, with microscopic examination showing the remaining 9.8% positive for parasite eggs. Direct microbiological diagnosis was more useful in patients with less than 5 years of residence in the EU (p = 0.05). Chronic complications were present in 22 (36%) of the patients, with renal failure affecting 20 (33%). Of these 20, 6(10%) developed terminal renal failure and required hemodialysis, while 3 (5%) received a renal transplantation. Conclusion Morbidity associated with chronic long-term schistosomiasis is frequent among African immigrants in non-endemic countries. Better diagnostic tools and appropriate early treatment would prevent the development of visceral damage. Thorough screening in selected patients would also be useful to avoid chronic complications.	[Roure, Silvia] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, North Metropolitan Int Hlth Unit PROSICS, Barcelona, Spain; [Roure, Silvia; Pedro-Botet, M. Luisa; Sabria, Miguel; Clotet, Bonaventura] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Dept Internal Med, Infect Dis Unit, Barcelona, Spain; [Valerio, Lluis; Perez-Quilez, Olga; Martinez-Cuevas, Octavio; Alcantara-Roman, Albert] Serv Atencio Primaria, North Metropolitan Int Hlth Unit PROSICS, Barcelona, Spain; [Fernandez-Rivas, Gema] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Dept Microbiol, Barcelona, Spain; [Viasus, Diego] Hosp Univ Norte, Fac Med, Div Hlth Sci, Barranquilla, Colombia; [Viasus, Diego] Univ Norte, Barranquilla, Colombia; [Clotet, Bonaventura] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, AIDS Res Inst IrsiCaixa, Badalona, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Universidad del Norte; Universidad del Norte; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa	Roure, S (corresponding author), Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, North Metropolitan Int Hlth Unit PROSICS, Barcelona, Spain.; Roure, S (corresponding author), Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Dept Internal Med, Infect Dis Unit, Barcelona, Spain.	sroura.mn.ics@gencat.cat	Rivas, Gema Fernández G Fernandez/C-6022-2018; Viasus, Diego/HDN-6634-2022	Roure, Silvia/0000-0002-7982-0890				Agbessi CA, 2006, REV MED INTERNE, V27, P595, DOI 10.1016/j.revmed.2006.05.006; Andrade JR, 2014, T ROY SOC TROP MED H, V108, P159, DOI 10.1093/trstmh/tru010; AZEVEDO LS, 1987, TRANSPLANTATION, V44, P795, DOI 10.1097/00007890-198712000-00015; Barrou B, 1997, J UROLOGY, V157, P1232, DOI 10.1016/S0022-5347(01)64932-2; Becker S L, 2015, Euro Surveill, V20; Boissier J, 2016, LANCET INFECT DIS, V16, P971, DOI 10.1016/S1473-3099(16)00175-4; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Coltart C, 2015, CLIN MED, V15, P67, DOI 10.7861/clinmedicine.15-1-67; Coltart CEM, 2015, T ROY SOC TROP MED H, V109, P214, DOI 10.1093/trstmh/tru195; Deniaud F, 2006, Bull Soc Pathol Exot, V99, P110; Deniaud Francois, 2010, Sante, V20, P201; Gandasegui J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003963; Gray Darren J, 2011, BMJ, V342, pd2651, DOI 10.1136/bmj.d2651; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Inobaya MT, 2014, RES REP TROP MED, V5, P65, DOI 10.2147/RRTM.S44274; Khyatti M, 2014, EUR J PUBLIC HEALTH, V24, P47, DOI 10.1093/eurpub/cku109; Kinkel HF, 2012, CLIN VACCINE IMMUNOL, V19, P948, DOI 10.1128/CVI.05680-11; Kjetland EF, 2008, TROP MED INT HEALTH, V13, P1509, DOI 10.1111/j.1365-3156.2008.02161.x; Knopp S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003752; Meurs L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003959; Onile OS, 2016, J TROP MED-US, V2016, DOI 10.1155/2016/5405207; Rambau PF, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-19; Roca C, 2002, EUR J CLIN MICROBIOL, V21, P219, DOI 10.1007/s10096-001-0683-z; Sady H, 2015, INT J MOL SCI, V16, P16085, DOI 10.3390/ijms160716085; Salas-Coronas J, 2013, ENFERM INFEC MICR CL, V31, P205, DOI 10.1016/j.eimc.2012.04.003; Salawu OT, 2014, J PEDIATR UROL, V10, P88, DOI 10.1016/j.jpurol.2013.06.010; Shokeir AA, 2001, BJU INT, V88, P915, DOI 10.1046/j.1464-4096.2001.01549.x; Tukahebwa EM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002268; Utzinger J, CLIN MICROBIOLOGY IN; Valerio L, CAMFIC GUIA ATENCION; Whitty CJM, 2000, T ROY SOC TROP MED H, V94, P531, DOI 10.1016/S0035-9203(00)90077-4; Yirenya-Tawiah D, 2011, Ghana Med J, V45, P16	32	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185245	10.1371/journal.pone.0185245	http://dx.doi.org/10.1371/journal.pone.0185245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953954	gold, Green Published, Green Submitted			2022-12-27	WOS:000411980300049
J	Shin, DH; Lee, YK; Oh, J; Yoon, JW; Rhee, SY; Kim, EJ; Ryu, J; Cho, A; Jeon, HJ; Choi, MJ; Noh, JW				Shin, Dong Ho; Lee, Young-Ki; Oh, Jieun; Yoon, Jong-Woo; Rhee, So Yon; Kim, Eun-Jung; Ryu, Jiwon; Cho, Ajin; Jeon, Hee Jung; Choi, Myung-Jin; Noh, Jung-Woo			Vascular calcification and cardiac function according to residual renal function in patients on hemodialysis with urination	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PERITONEAL-DIALYSIS PATIENTS; PROTEIN-BOUND SOLUTES; PULSE-WAVE VELOCITY; CARDIOVASCULAR-DISEASE; PHOSPHATE CONTROL; AORTIC STIFFNESS; BLOOD-PRESSURE; BETA-2-MICROGLOBULIN; MORTALITY	Background Vascular calcification is common and may affect cardiac function in patients with end-stage renal disease (ESRD). However, little is known about the effect of residual renal function on vascular calcification and cardiac function in patients on hemodialysis. Methods This study was conducted between January 2014 and January 2017. One hundred six patients with residual renal function on maintenance hemodialysis for 3 months were recruited. We used residual renal urea clearance (KRU) to measure residual renal function. First, abdominal aortic calcification score (AACS) and brachial-ankle pulse wave velocity (baPWV) were measured in patients on hemodialysis. Second, we performed echocardiography and investigated new cardiovascular events after study enrollment. Results The median KRU was 0.9 (0.3-2.5) mL/min/1.73m(2). AACS (4.0 [1.0-10.0] vs. 3.0 [0.0-8.0], p = 0.05) and baPWV (1836.1 +/- 250.4 vs. 1676.8 +/- 311.0 cm/s, p = 0.01) were significantly higher in patients with a KRU < 0.9 mL/min/1.73m(2) than a KRU >= 0.9 mL/min/1.73m(2). Log-KRU significantly negatively correlated with log-AACS (beta = -0.29, p = 0.002) and baPWV (beta = -0.19, P = 0.05) after factor adjustment. The proportion of left ventricular diastolic dysfunction was significantly higher in patients with a KRU < 0.9 mL/min/1.73m(2) than with a KRU < 0.9 mL/min/1.73m(2) (67.9% vs. 49.1%, p = 0.05). Patients with a KRU < 0.9 mL/min/1.73m(2) showed a higher tendency of cumulative cardiovascular events compared to those with a KRU >= 0.9 ml/min/1.73m(2) (P = 0.08). Conclusions Residual renal function was significantly associated with vascular calcification and left ventricular diastolic dysfunction in patients on hemodialysis.	[Shin, Dong Ho; Oh, Jieun; Rhee, So Yon; Kim, Eun-Jung; Jeon, Hee Jung] Hallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Young-Ki; Cho, Ajin; Noh, Jung-Woo] Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea; [Yoon, Jong-Woo; Ryu, Jiwon; Choi, Myung-Jin] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Internal Med, Chunchon, Gangwon Do, South Korea	Hallym University; Hallym University; Hallym University	Oh, J (corresponding author), Hallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea.; Lee, YK (corresponding author), Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea.; Yoon, JW (corresponding author), Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Internal Med, Chunchon, Gangwon Do, South Korea.	km2071@naver.com; jieunmd@gmail.com; yoonjw@hallym.or.kr	Oh, Jieun/ABA-4669-2020	Oh, Jieun/0000-0001-9429-9602; CHOI, MYUNG JIN/0000-0002-2761-7161	Hallym Research Fund [HURF-2014-09]	Hallym Research Fund	This study was supported by Hallym Research Fund 2014 (HURF-2014-09).	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Bammens B, 2003, KIDNEY INT, V64, P2238, DOI 10.1046/j.1523-1755.2003.00310.x; BARENBROCK M, 1994, KIDNEY INT, V45, P1397, DOI 10.1038/ki.1994.182; Birkenhager AM, 2007, NETH J MED, V65, P127; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Bragg-Gresham JL, 2007, AM J KIDNEY DIS, V49, P426, DOI 10.1053/j.ajkd.2006.12.012; Chen NX, 2012, CURR HYPERTENS REP, V14, P228, DOI 10.1007/s11906-012-0265-8; Daugirdas J.T., 2012, HDB DIALYSIS; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Fry AC, 2007, BLOOD PURIFICAT, V25, P295, DOI 10.1159/000104870; Goodman WG, 2004, AM J KIDNEY DIS, V43, P572, DOI 10.1053/j.ajkd.2003.12.005; Honkanen E, 2008, NEPHROL DIAL TRANSPL, V23, P4009, DOI 10.1093/ndt/gfn403; Hruska KA, 2009, SEMIN NEPHROL, V29, P156, DOI 10.1016/j.semnephrol.2009.01.008; Kauppila LI, 1997, ATHEROSCLEROSIS, V132, P245, DOI 10.1016/S0021-9150(97)00106-8; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Levin A, 2003, SEMIN DIALYSIS, V16, P101, DOI 10.1046/j.1525-139X.2003.16025.x; Liabeuf S, 2012, KIDNEY INT, V82, P1297, DOI 10.1038/ki.2012.301; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P1, DOI 10.1093/ndt/gfh1024; Marquez IO, 2011, CLIN J AM SOC NEPHRO, V6, P290, DOI 10.2215/CJN.06100710; Neven E, 2011, NEPHROL DIAL TRANSPL, V26, P1137, DOI 10.1093/ndt/gfq858; Oh JK, 1997, J AM SOC ECHOCARDIOG, V10, P246, DOI 10.1016/S0894-7317(97)70062-2; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Pecoits R, 2003, AM J KIDNEY DIS, V41, P1212, DOI 10.1016/S0272-6386(03)00353-6; Penne EL, 2011, CLIN J AM SOC NEPHRO, V6, P281, DOI 10.2215/CJN.04480510; Rroji M, 2014, INT UROL NEPHROL, V46, P175, DOI 10.1007/s11255-013-0438-7; Shafi T, 2010, AM J KIDNEY DIS, V56, P348, DOI 10.1053/j.ajkd.2010.03.020; Shemin D, 2001, AM J KIDNEY DIS, V38, P85, DOI 10.1053/ajkd.2001.25198; Stompor T, 2006, INT J ARTIF ORGANS, V29, P736, DOI 10.1177/039139880602900802; Stompor T, 2002, PERITON DIALYSIS INT, V22, P670; Suda T, 2000, NEPHROL DIAL TRANSPL, V15, P396, DOI 10.1093/ndt/15.3.396; Velasquez MT, 2016, KIDNEY INT REP, V1, P94, DOI 10.1016/j.ekir.2016.05.001; Wang AYM, 2006, KIDNEY INT, V69, P1726, DOI 10.1038/sj.ki.5000382; Wang AYM, 2002, KIDNEY INT, V62, P639, DOI 10.1046/j.1523-1755.2002.00471.x; Wang AYM, 2005, NEPHROL DIAL TRANSPL, V20, P396, DOI 10.1093/ndt/gfh331; Wang AYM, 2004, AM J KIDNEY DIS, V43, P712, DOI 10.1053/j.ajkd.2003.12.032; Wang X, 2009, CHINESE MED J-PEKING, V122, P2103, DOI 10.3760/cma.j.issn.0366-6999.2009.18.005; Wheeler DC, 1996, LANCET, V348, P1673, DOI 10.1016/S0140-6736(05)65816-3; Won HS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/731296; Wong J, 2016, KIDNEY INT, V89, P1090, DOI 10.1016/j.kint.2015.12.042; Zhang MM, 2014, AM J NEPHROL, V40, P140, DOI 10.1159/000365819	41	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185296	10.1371/journal.pone.0185296	http://dx.doi.org/10.1371/journal.pone.0185296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953969	Green Published, gold, Green Submitted			2022-12-27	WOS:000411980300053
J	Circu, M; Cardelli, J; Barr, M; O'Byrne, K; Mills, G; El-Osta, H				Circu, Magdalena; Cardelli, James; Barr, Martin; O'Byrne, Kenneth; Mills, Glenn; El-Osta, Hazem			Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells	PLOS ONE			English	Article							TARGETING AUTOPHAGY; INDUCED APOPTOSIS; CARCINOMA-CELLS; WILD-TYPE; RESISTANCE; CHEMOTHERAPY; INHIBITION; INDUCTION; DEATH; P53	Lung cancer is the leading cause of cancer-related deaths. Most patients develop resistance to platinum within several months of treatment. We investigated whether triggering lysosomal membrane permeabilization (LMP) or suppressing autophagy can restore cisplatin susceptibility in lung cancer with acquired chemoresistance. Cisplatin IC50 in A549Pt (parental) and A549cisR (cisplatin resistant) cells was 13 mu M and 47 mu M, respectively. Following cisplatin exposure, A549cisR cells failed to elicit an apoptotic response. This was manifested by diminished Annexin-V staining, caspase 3 and 9, BAX and BAK activation in resistant but not in parental cells. Chloroquine preferentially promoted LMP in A549cisR cells, revealed by leakage of FITC-dextran into the cytosol as detected by immunofluorescence microscopy. This was confirmed by increased cytosolic cathepsin D signal on Immunoblot. Cell viability of cisplatin-treated A549cisR cells was decreased when co-treated with chloroquine, corresponding to a combination index below 0.8, suggesting synergism between the two drugs. Notably, chloroquine activated the mitochondrial cell death pathway as indicated by increase in caspase 9 activity. Interestingly, inhibition of lysosomal proteases using E64 conferred cytoprotection against cisplatin and chloroquine co-treatment, suggesting that chloroquine-induced cell death occurred in a cathepsin-mediated mechanism. Likewise, blockage of caspases partially rescued A549cisR cells against the cytotoxicity of cisplatin and chloroquine combination. Cisplatin promoted a dose-dependent autophagic flux induction preferentially in A549cisR cells, as evidenced by a surge in LC3-II/alpha-tubulin following pre-treatment with E64 and increase in p62 degradation. Compared to untreated cells, cisplatin induced an increase in cyto-ID-loaded autophagosomes in A549cisR cells that was further amplified by chloroquine, pointing toward autophagic flux activation by cisplatin. Interestingly, this effect was less pronounced in A549Pt cells. Blocking autophagy by ATG5 depletion using siRNA markedly enhances susceptibility to cisplatin in A549cisR cells. Taken together, our results underscore the utility of targeting lysosomal function in overcoming acquired cisplatin refractoriness in lung cancer.	[Circu, Magdalena; Mills, Glenn; El-Osta, Hazem] Louisiana State Univ, Hlth Sci Ctr Shreveport, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA; [Cardelli, James] Segue Therapeut LLC, Shreveport, LA USA; [Barr, Martin] St James Hosp, Trinity Ctr Hlth Sci, Trinity Translat Med Inst, Thorac Oncol Res Grp, Dublin, Ireland; [Barr, Martin] Trinity Coll Dublin, Dublin, Ireland; [O'Byrne, Kenneth] Queensland Univ Technol, Canc & Ageing Res Program, Brisbane, Qld, Australia; [El-Osta, Hazem] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Trinity College Dublin; Trinity College Dublin; Queensland University of Technology (QUT); University of Texas System; University of Texas Health Science Center Houston	El-Osta, H (corresponding author), Louisiana State Univ, Hlth Sci Ctr Shreveport, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA.; El-Osta, H (corresponding author), Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA.	hazemelosta@yahoo.com		Barr, Martin/0000-0001-5202-9655; O'Byrne, Kenneth/0000-0002-6754-5633	Feist-Weiller Cancer Center	Feist-Weiller Cancer Center	This research was funded by Feist-Weiller Cancer Center. It provided support in the form of buying equipment and materials necessary for the conduction of the project, and salary to MC (coauthor), but didn't have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Barr MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054193; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Cervia D, 2016, ONCOTARGET, V7, P24995, DOI 10.18632/oncotarget.8735; Cetintas VB, 2012, CELL BIOL INT, V36, P261, DOI 10.1042/CBI20110329; Chee JLY, 2013, CELL CYCLE, V12, P278, DOI 10.4161/cc.23054; Chen QY, 2012, MOL CELL BIOCHEM, V359, P389, DOI 10.1007/s11010-011-1033-9; Circu ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146931; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; DeFeudis P, 1997, BRIT J CANCER, V76, P474, DOI 10.1038/bjc.1997.412; Dong XQ, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.87; Enzenmuller S, 2013, ANTI-CANCER DRUG, V24, P14, DOI 10.1097/CAD.0b013e32835a36db; Erdal H, 2005, P NATL ACAD SCI USA, V102, P192, DOI 10.1073/pnas.0408592102; Fehrenbacher N, 2005, CANCER RES, V65, P2993, DOI 10.1158/0008-5472.CAN-05-0476; Fukuda T, 2015, GYNECOL ONCOL, V137, P538, DOI 10.1016/j.ygyno.2015.03.053; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Garcia-Cano J, 2015, ONCOTARGET, V6, P15551, DOI 10.18632/oncotarget.3902; Gewirtz DA, 2014, CANCER RES, V74, P647, DOI 10.1158/0008-5472.CAN-13-2966; Groth-Pedersen L, 2013, CANCER LETT, V332, P265, DOI 10.1016/j.canlet.2010.05.021; Hsin IL, 2016, PHYTOMEDICINE, V23, P1566, DOI 10.1016/j.phymed.2016.09.003; Jaattela Marja, 2015, Cold Spring Harb Protoc, V2015, P975, DOI 10.1101/pdb.top070367; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Larsen AK, 2000, PHARMACOL THERAPEUT, V85, P217, DOI 10.1016/S0163-7258(99)00073-X; Liu FF, 2013, ONCOL LETT, V5, P1261, DOI 10.3892/ol.2013.1154; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Matsumoto M, 2016, BIOCHEM BIOPH RES CO, V473, P490, DOI 10.1016/j.bbrc.2016.03.053; Mijatovic T, 2006, NEOPLASIA, V8, P402, DOI 10.1593/neo.05850; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Pan YZ, 2011, CLIN CANCER RES, V17, P3248, DOI 10.1158/1078-0432.CCR-10-0890; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Park Deokbae, 2014, Dev Reprod, V18, P225, DOI 10.12717/devrep.2014.18.4.225; Qin L, 2016, DRUG DES DEV THER, V10, P1035, DOI 10.2147/DDDT.S101701; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Ren JH, 2010, CANCER BIOTHER RADIO, V25, P75, DOI 10.1089/cbr.2009.0701; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Seitz C, 2013, INT J CANCER, V132, P2682, DOI 10.1002/ijc.27935; Sharma N, 2012, CANCER LETT, V326, P143, DOI 10.1016/j.canlet.2012.07.029; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Sukhai MA, 2013, J CLIN INVEST, V123, P315, DOI 10.1172/JCI64180; Verrier F, 2001, J VIROL, V75, P9177, DOI 10.1128/JVI.75.19.9177-9186.2001; White E, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-14; Wu HM, 2015, SCI REP-UK, V5, DOI 10.1038/srep12291; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yao WL, 2015, CANCER LETT, V364, P70, DOI 10.1016/j.canlet.2015.04.028; Yu L, 2014, CANCER LETT, V355, P34, DOI 10.1016/j.canlet.2014.09.020; Zhao XG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126147	59	37	39	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0184922	10.1371/journal.pone.0184922	http://dx.doi.org/10.1371/journal.pone.0184922			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945807	Green Published, gold			2022-12-27	WOS:000411645100012
J	Ferron, HG				Ferron, Humberto G.			Regional endothermy as a trigger for gigantism in some extinct macropredatory sharks	PLOS ONE			English	Article							CRETACEOUS LAMNIFORM SHARK; TUNA SWIMMING PERFORMANCE; BONITO SARDA-CHILIENSIS; STABLE OXYGEN ISOTOPES; TOOTHED WHITE SHARKS; LARGE WATER TUNNEL; CRETOXYRHINA-MANTELLI; NIOBRARA CHALK; CARCHARODON LAMNIFORMES; ECOLOGICAL IMPLICATIONS	Otodontids include some of the largest macropredatory sharks that ever lived, the most extreme case being Otodus (Megaselachus) megalodon. The reasons underlying their gigantism, distribution patterns and extinction have been classically linked with climatic factors and the evolution, radiation and migrations of cetaceans during the Paleogene. However, most of these previous proposals are based on the idea of otodontids as ectothermic sharks regardless of the ecological, energetic and body size constraints that this implies. Interestingly, a few recent studies have suggested the possible existence of endothermy in these sharks thus opening the door to a series of new interpretations. Accordingly, this work proposes that regional endothermy was present in otodontids and some closely related taxa (cretoxyrhinids), playing an important role in the evolution of gigantism and in allowing an active mode of live. The existence of regional endothermy in these groups is supported here by three different approaches including isotopic-based approximations, swimming speed inferences and the application of a novel methodology for assessing energetic budget and cost of swimming in extinct taxa. In addition, this finding has wider implications. It calls into question some previous paleotemperature estimates based partially on these taxa, suggests that the existing hypothesis about the evolution of regional endothermy in fishes requires modification, and provides key evidence for understanding the evolution of gigantism in active macropredators.	[Ferron, Humberto G.] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Burjassot, Spain	University of Valencia	Ferron, HG (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Burjassot, Spain.	Humberto.Ferron@uv.es	Ferron, Humberto/ABH-9895-2020	Ferron, Humberto/0000-0003-2254-8424	Spanish Ministry of Economy and Competitiveness [CGL2014-52662-P]; Valencian Generality [GV/2016/102]; FPU Spanish Research Programme [FPU13/02660]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Valencian Generality; FPU Spanish Research Programme	This work has been funded by the Spanish Ministry of Economy and Competitiveness http://www.mineco.gob.es/portal/site/mineco/ (CGL2014-52662-P) and the Valencian Generality littp://www.ceice.gva.es/web/ciencia/becas-ayudas-y-subvencionescientificas (GV/2016/102). HGF is a recipient of a Fellowship from the FPU Spanish Research Programme (FPU13/02660) http://www.mecd.gob.es/mecd/servicios-alciudadanomecd/catalogo/general/educacion/998758/ficha.html.	Aguilera O, 2004, CARIBB J SCI, V40, P368; Aguilera OA, 2008, PALAEONTOL Z, V82, P204, DOI 10.1007/BF02988410; Alexander RL, 1996, ZOOL J LINN SOC-LOND, V118, P151, DOI 10.1111/j.1096-3642.1996.tb00224.x; ALEXANDER RL, 1995, J ZOOL, V237, P377, DOI 10.1111/j.1469-7998.1995.tb02768.x; Alexander RM, 1998, PALAEONTOLOGY, V41, P1231; ALTRINGHAM JD, 1990, J EXP BIOL, V151, P453; ALTRINGHAM JD, 1991, J EXP BIOL, V157, P381; Amiot R, 2008, PALAEOGEOGR PALAEOCL, V264, P85, DOI 10.1016/j.palaeo.2008.04.001; Amiot R, 2006, EARTH PLANET SC LETT, V246, P41, DOI 10.1016/j.epsl.2006.04.018; Anderson SD, 2001, COPEIA, P794; Aoki K, 2012, MAR ECOL PROG SER, V444, P289, DOI 10.3354/meps09371; Applegate RW, 1996, GREAT WHITE SHARKS B, P19; BAINBRIDGE R, 1958, J EXP BIOL, V35, P109; Balter V, 2004, GEOCHIM COSMOCHIM AC, V68, P423, DOI 10.1016/S0016-7037(03)00453-8; BARRICK RE, 1994, SCIENCE, V265, P222, DOI 10.1126/science.265.5169.222; Barrick RE, 1995, PALEOBIOLOGY, V21, P552, DOI 10.1017/S0094837300013531; Beamish F.W., 1979, FISH PHYSL LOCOMOTIO, P101, DOI DOI 10.1139/cjfas-2015-0209; BEAMISH FWH, 1990, ENVIRON BIOL FISH, V27, P309; BENDIX-ALMGREEN S E, 1983, Bulletin of the Geological Society of Denmark, V32, P1; Bernal D, 2005, NATURE, V437, P1349, DOI 10.1038/nature04007; Bernal D, 2005, COPEIA, P146; Bernal D, 2003, J EXP BIOL, V206, P2845, DOI 10.1242/jeb.00504; Bernard A, 2010, SCIENCE, V328, P1379, DOI 10.1126/science.1187443; Biology Siversson M., 1992, PALAEONTOLOGY, V35, P519; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; BLOCK BA, 1994, ENVIRON BIOL FISH, V40, P283, DOI 10.1007/BF00002518; Bowden DL, 2016, MITOCHONDRIAL DNA A, V27, P4328, DOI 10.3109/19401736.2015.1089486; BRILL RW, 1979, ENVIRON BIOL FISH, V4, P199, DOI 10.1007/BF00005478; Buckley LB, 2012, GLOBAL ECOL BIOGEOGR, V21, P873, DOI 10.1111/j.1466-8238.2011.00737.x; BUSHNELL PG, 1989, EXP BIOL, V48, P279; Cairns DK, 2008, MAR ECOL PROG SER, V356, P239, DOI 10.3354/meps07286; Capetta H., 1987, CHONDRICHTHYES, V2; Capetta H., 2012, HDB PALEOICHTHYOLO E, V3E; CAREY FG, 1971, AM ZOOL, V11, P137; CAREY FG, 1982, COPEIA, P254; Carlson JK, 1999, COPEIA, P34; Claireaux G, 2006, J EXP BIOL, V209, P3420, DOI 10.1242/jeb.02346; Clarke A, 2013, AM NAT, V182, P283, DOI 10.1086/671259; Collareta A, 2017, PALAEOGEOGR PALAEOCL, V469, P84, DOI 10.1016/j.palaeo.2017.01.001; COMPAGNO LJV, 1990, ENVIRON BIOL FISH, V28, P33, DOI 10.1007/BF00751027; Cook TD, 2008, CAN J EARTH SCI, V45, P1185, DOI 10.1139/E08-064; Cumbaa SL, 2010, PALAEOGEOGR PALAEOCL, V295, P199, DOI 10.1016/j.palaeo.2010.05.038; Dera G, 2009, EARTH PLANET SC LETT, V286, P198, DOI 10.1016/j.epsl.2009.06.027; DEWAR H, 1994, J EXP BIOL, V192, P13; DEWAR H, 1994, J EXP BIOL, V192, P45; Dickson KA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P998, DOI 10.1086/423743; DICKSON KA, 1994, J EXP BIOL, V190, P79; Dickson KA, 2000, J EXP BIOL, V203, P3077; Diedrich C. G., 2013, NAT SCI, V5, P1203; Diedrich CG, 2014, PALEONTOLOGY J, P93423; Diedrich CG, 2012, VERTEBRATE COPROLITE, V57, P301; Domenici P, 2001, COMP BIOCHEM PHYS A, V131, P169, DOI 10.1016/S1095-6433(01)00465-2; Domenici P, 1997, J EXP BIOL, V200, P1165; Dowd WW, 2003, METABOLIC RATES BIOE; Dowis HJ, 2003, J EXP BIOL, V206, P2749, DOI 10.1242/jeb.00496; Eagle RA, 2011, SCIENCE, V333, P443, DOI 10.1126/science.1206196; Ebert DA, 2013, SHARKS WORLD, P256; Ehret DJ, 2012, PALAEONTOLOGY, V55, P1139, DOI 10.1111/j.1475-4983.2012.01201.x; Ehret DJ, 2009, J VERTEBR PALEONTOL, V29, P1; Ehret DJ, 2010, THESIS; Everhart M. J., 1999, Journal of Vertebrate Paleontology, V19, p43A; Everhart M. J., 2005, OCEANS KANSAS NATURA; Everhart M.J., 2005, PALARCH, V2, P14; Everhart M.J., 2005, TATE 2005 11 ANN S P, P16; Ezcurra Juan M., 2012, P17; Ferron H, 2014, J IBER GEOL, V40, P87, DOI 10.5209/rev_JIGE.2014.v40.n1.44089; Ferron HG, 2017, HIST BIOL; Ferron HG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172781; Fischer J, 2013, CHEM GEOL, V342, P44, DOI 10.1016/j.chemgeo.2013.01.022; Fischer J, 2012, PALAEOGEOGR PALAEOCL, V353, P60, DOI 10.1016/j.palaeo.2012.07.002; Fitzgerald EMG, 2006, P ROY SOC B-BIOL SCI, V273, P2955, DOI 10.1098/rspb.2006.3664; Fricke HC, 2000, GEOLOGY, V28, P799, DOI 10.1130/0091-7613(2000)028<0799:MTMLAT>2.3.CO;2; Gerstein ER, 2002, AM SCI, V90, P154, DOI 10.1511/2002.2.154; Giorgioni M, 2015, GLOBAL PLANET CHANGE, V126, P46, DOI 10.1016/j.gloplacha.2015.01.005; Godfrey Stephen J., 2005, Jeffersoniana, V16, P1; Goldman KJ, 2004, ENVIRON BIOL FISH, V71, P403, DOI 10.1007/s10641-004-6588-9; Gottfried MD, 1996, GREAT WHITE SHARKS, P55, DOI 10.1016/B978-012415031-7/50008-2; Gottfried MD, 2001, J VERTEBR PALEONTOL, V21, P730, DOI 10.1671/0272-4634(2001)021[0730:AASOCA]2.0.CO;2; Grady JM, 2014, SCIENCE, V344, P1268, DOI 10.1126/science.1253143; Graham BS, 2007, MAR BIOL, V150, P647, DOI 10.1007/s00227-006-0360-y; HALL CAS, 1992, OIKOS, V65, P377, DOI 10.2307/3545553; Harrell TL, 2016, PALAEONTOLOGY, V59, P351, DOI 10.1111/pala.12240; HUBER BT, 1995, GEOL SOC AM BULL, V107, P1164, DOI 10.1130/0016-7606(1995)107<1164:MLCCOT>2.3.CO;2; Humphries MM, 2002, NATURE, V418, P313, DOI 10.1038/nature00828; Iosilevskii G, 2008, J R SOC INTERFACE, V5, P329, DOI 10.1098/rsif.2007.1073; Jacoby DM, 2016, BIOL LETT, P12; Jefferson T.A., 2015, MARINE MAMMALS WORLD; JEFFERSON TA, 1991, MAMMAL REV, V21, P151, DOI 10.1111/j.1365-2907.1991.tb00291.x; Kallal RJ, 2012, INT J OSTEOARCHAEOL, V22, P253, DOI 10.1002/oa.1199; Kent Bretton W., 1999, Mosasaur, V6, P11; Kim SH, 2013, ANAT REC, V296, P433, DOI 10.1002/ar.22647; Knower T, 1999, J EXP BIOL, V202, P2127; Koch PL, 2007, ECOL METHOD CONCEPT, P99, DOI 10.1002/9780470691854.ch5; Kocsis L, 2012, AGU FALL M, V1, P2116; Kocsis L, 2014, PALAEOGEOGR PALAEOCL, V394, P74, DOI 10.1016/j.palaeo.2013.11.002; KOLODNY Y, 1988, PALAEOGEOGR PALAEOCL, V64, P59, DOI 10.1016/0031-0182(88)90142-3; Kolodny Y, 1991, GEOCHEM SOC SPEC PUB, V3, P105; Korsmeyer KE, 2002, J EXP BIOL, V205, P1253; Lecuyer C, 1996, PALAEOGEOGR PALAEOCL, V126, P61, DOI 10.1016/S0031-0182(96)00070-3; LECUYER C, 1993, PALAEOGEOGR PALAEOCL, V105, P235, DOI 10.1016/0031-0182(93)90085-W; Lecuyer C, 2004, CHEM GEOL, V204, P63, DOI 10.1016/j.chemgeo.2003.11.003; LERICHE MAURICE, 1926, MEM MUS ROY HIST NAT BELGIQUE, V32, P365; Lowe CG, 2001, ENVIRON BIOL FISH, V60, P251, DOI 10.1023/A:1007650502269; Lowe CG, 2001, MAR BIOL, V139, P447, DOI 10.1007/s002270100585; MacFadden BJ, 2015, J GEOL, V123, P491, DOI 10.1086/684006; Magnuson JJ, 1979, FISH PHYSIOL, V7, P240; Maisey JG, 2012, J FISH BIOL, V80, P918, DOI 10.1111/j.1095-8649.2012.03245.x; Maisey JG, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1325369; Martin AP, 1996, GREAT WHITE SHARKS, P49, DOI 10.1016/B978-012415031-7/50007-0; Martin JE, 2015, CHEM GEOL, V415, P118, DOI 10.1016/j.chemgeo.2015.09.011; Martin RA, 2012, MAR BIOL RES, V8, P90, DOI 10.1080/17451000.2011.614255; Mas Guillem, 2003, Bolleti de la Societat d'Historia Natural de les Balears, V46, P85; McClain CR, 2015, PEERJ, V2, DOI 10.7717/peerj.715; Mollet HF, 1996, GREAT WHITE SHARKS, P81, DOI 10.1016/B978-012415031-7/50010-0; Motani Ryosuke., 2009, Evolution Education and Outreach, V2, P224; Myers CE, 2010, P ROY SOC LOND B BIO, V278; Nyberg KG, 2006, J VERTEBR PALEONTOL, V26, P806, DOI 10.1671/0272-4634(2006)26[806:TTAOTG]2.0.CO;2; Ohlberger J, 2007, J COMP PHYSIOL B, V177, P905, DOI 10.1007/s00360-007-0189-9; Pelc A., 2011, MINERALOGIA, V42, P53, DOI DOI 10.2478/V10002-011-0006-7; PETERSON CC, 1990, P NATL ACAD SCI USA, V87, P2324, DOI 10.1073/pnas.87.6.2324; Picard S, 1998, GEOLOGY, V26, P975, DOI 10.1130/0091-7613(1998)026<0975:OVOCBA>2.3.CO;2; Pimiento C, 2017, NATURE ECOLOGY EVOLU; Pimiento C, 2016, J BIOGEOGR, V43, P1645, DOI 10.1111/jbi.12754; Pimiento C, 2015, PALEOBIOLOGY, V41, P479, DOI 10.1017/pab.2015.16; Pimiento C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111086; Pimiento C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010552; PONGANIS PJ, 1990, CAN J ZOOL, V68, P2105, DOI 10.1139/z90-293; Pontzer H, 2009, PLOS ONE, V4, pA127, DOI 10.1371/journal.pone.0007783; Puceat E, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000823; Puceat E, 2007, GEOLOGY, V35, P107, DOI 10.1130/G23103A.1; Purdy RW, 1996, GREAT WHITE SHARKS, P67, DOI 10.1016/B978-012415031-7/50009-4; Purdy RW, 2001, SM C PALEOB, V90, P71; RADTKE RL, 1987, COMP BIOCHEM PHYS A, V87, P797, DOI 10.1016/0300-9629(87)90403-8; RANDALL JE, 1973, SCIENCE, V181, P169, DOI 10.1126/science.181.4095.169; RASCHI W, 1992, AUST J MAR FRESH RES, V43, P123, DOI 10.1071/MF9920123; Reif W.-E., 1982, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V164, P172; Reif W.-E., 1982, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V164, P184; Reif WE., 1985, COURIER FORSCHUNGSIN; Roelofs B, 2017, PALAEOGEOGR PALAEOCL, V465, P79, DOI 10.1016/j.palaeo.2016.10.018; Rohr JJ, 2002, MAR MAMMAL SCI, V18, P1, DOI 10.1111/j.1748-7692.2002.tb01014.x; ROOT T, 1988, ECOLOGY, V69, P330, DOI 10.2307/1940431; Sambilay V.C.J., 1990, FISHBYTE, V8, P16; Semmens JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01471; Sepulveda C, 2000, J EXP BIOL, V203, P3089; Sepulveda CA, 2007, MAR BIOL, V152, P1087, DOI 10.1007/s00227-007-0757-2; Sepulveda CA, 2007, J FISH BIOL, V70, P1720, DOI 10.1111/j.1095-8649.2007.01446.x; Sepulveda CA, 2005, J EXP BIOL, V208, P4255, DOI 10.1242/jeb.01898; Sepulveda CA, 2003, J EXP BIOL, V206, P2739, DOI 10.1242/jeb.00497; Shimada K, 2004, J PALEONTOL, V78, P205, DOI 10.1666/0022-3360(2004)078<0205:SPTFTU>2.0.CO;2; Shimada K, 1997, J VERTEBR PALEONTOL, V17, P642, DOI 10.1080/02724634.1997.10011014; Shimada K, 1997, J PALEONTOL, V71, P926, DOI 10.1017/S002233600003585X; Shimada K., 2002, J FOSSIL RES, V35, P28, DOI DOI 10.3390/GEOSCIENCES2020109; Shimada K, 2007, J VERTEBR PALEONTOL, V27, P584, DOI 10.1671/0272-4634(2007)27[584:SADAOL]2.0.CO;2; Shimada Kenshu, 2005, Paleontological Research, V9, P55, DOI 10.2517/prpsj.9.55; Shimada Kenshu, 2004, Mosasaur, V7, P35; Shimada K, 2017, HIST BIOL, V29, P704, DOI 10.1080/08912963.2016.1236795; Shimada Kenshu, 2006, Bulletin of the New Mexico Museum of Natural History and Science, P185; Siverson M, 2005, ACTA PALAEONTOL POL, V50, P301; Siverson M, 1999, T ROY SOC EDIN-EARTH, V90, P49, DOI 10.1017/S0263593300002509; Siversson M, 2015, ACTA PALAEONTOL POL, V60, P339, DOI 10.4202/app.2012.0137; Sundstrom LF, 1998, HYDROBIOLOGIA, V372, P241; Tabor CR, 2016, GEOLOGY, V44, P963, DOI 10.1130/G38363.1; THOMSON KS, 1977, AM ZOOL, V17, P343; Tubbesing VA, 2000, ACTA ZOOL-STOCKHOLM, V81, P49, DOI 10.1046/j.1463-6395.2000.00037.x; UYENO T, 1989, B SAITAMA MUSEUM NAT, V7, P73; Van Damme R, 1999, ANIM BEHAV, V57, P347, DOI 10.1006/anbe.1998.0980; Vennemann TW, 2001, GEOCHIM COSMOCHIM AC, V65, P1583, DOI 10.1016/S0016-7037(00)00629-3; Videler J. J, 1993, FISH SWIMMING, V10; Ward David J., 2001, Central Mediterranean Naturalist, V3, P131; Ward DJ, 2009, FOSSILS GAULT CLAY, P275; Wardle C.S., 1980, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V35, P519; WARDLE CS, 1975, NATURE, V255, P725, DOI 10.1038/255725a0; Watanabe YY, 2015, P NATL ACAD SCI USA, V112, P6104, DOI 10.1073/pnas.1500316112; Watanabe YY, 2012, J EXP MAR BIOL ECOL, V426, P5, DOI 10.1016/j.jembe.2012.04.021; WEBB PW, 1984, J EXP BIOL, V109, P77; WEBB PW, 1976, J EXP BIOL, V65, P157; Webb PW, 1979, FISH PHYSIOL, V7, P190; Wegner NC, 2015, SCIENCE, V348, P786, DOI 10.1126/science.aaa8902; Welsh JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033187; Weng KC, 2004, FISH B-NOAA, V102, P221; Willmer P., 2009, ENV PHYSL ANIMALS; Zacke A, 2009, J GEOL SOC LONDON, V166, P969, DOI 10.1144/0016-76492008-068; Zhelezko V., 2000, MAT STRATIGRAPHY PAL, V4, P136; Zhelezko VI, 1999, MAT STRATIGRAPHY PAL, V3, P403; Zigaite Z, 2014, GFF, V136, P337, DOI 10.1080/11035897.2013.878747	185	21	21	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185185	10.1371/journal.pone.0185185	http://dx.doi.org/10.1371/journal.pone.0185185			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938002	gold, Green Published, Green Submitted			2022-12-27	WOS:000411524700022
J	Hakobyan, D; Gerke, V; Heuer, A				Hakobyan, Davit; Gerke, Volker; Heuer, Andreas			Modeling of annexin A2-Membrane interactions by molecular dynamics simulations	PLOS ONE			English	Article							CA2+-INDUCED CONFORMATIONAL-CHANGES; MEMBRANE-BINDING; PHOSPHOLIPID-BINDING; TYROSINE KINASE; FORCE-FIELD; CIRCULAR-DICHROISM; CRYSTAL-STRUCTURE; CALCIUM-BINDING; LIPID-MEMBRANES; CALPACTIN-I	The annexins are a family of Ca2+-regulated phospholipid binding proteins that are involved in membrane domain organization and membrane trafficking. Although they are widely studied and crystal structures are available for several soluble annexins their mode of membrane association has never been studied at the molecular level. Here we obtained molecular information on the annexin-membrane interaction that could serve as paradigm for the peripheral membrane association of cytosolic proteins by Molecular Dynamics simulations. We analyzed systems containing the monomeric annexin A2 (AnxA2), a membrane with negatively charged phosphatidylserine ( POPS) lipids as well as Ca2+ ions. On the atomic level we identify the AnxA2 orientations and the respective residues which display the strongest interaction with Ca2+ ions and the membrane. The simulation results fully agree with earlier experimental findings concerning the positioning of bound Ca2+ ions. Furthermore, we identify for the first time a significant interaction between lysine residues of the protein and POPS lipids that occurs independently of Ca2+ suggesting that AnxA2-membrane interactions can also occur in a low Ca2+ environment. Finally, by varying Ca2+ concentrations and lipid composition in our simulations we observe a calcium-induced negative curvature of the membrane as well as an AnxA2-induced lipid ordering.	[Hakobyan, Davit; Heuer, Andreas] Univ Munster, Inst Phys Chem, Munster, Germany; [Hakobyan, Davit; Heuer, Andreas] Univ Munster, CMTC, Munster, Germany; [Gerke, Volker] Univ Munster, Inst Med Biochem, Ctr Mol Biol Inflammat ZMBE, Munster, Germany	University of Munster; University of Munster; University of Munster	Hakobyan, D (corresponding author), Univ Munster, Inst Phys Chem, Munster, Germany.; Hakobyan, D (corresponding author), Univ Munster, CMTC, Munster, Germany.	dhako_01@uni-muenster.de			German Research foundation (DFG) [SFB 858]	German Research foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research foundation (DFG) via SFB 858 ("Synergetic Effects in Chemistry - From Additivity towards Cooperativity"). https://www.unimuenster.de/SFB858/research.htrnl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PF, 2011, BIOPHYS J, V101, P1930, DOI 10.1016/j.bpj.2011.09.015; Ayala-Sanmartin J, 2000, BIOCHEMISTRY-US, V39, P15179, DOI 10.1021/bi000501x; Ayala-Sanmartin J, 2008, BBA-BIOMEMBRANES, V1778, P472, DOI 10.1016/j.bbamem.2007.11.004; BLACKWOOD RA, 1990, BIOCHEM J, V266, P195, DOI 10.1042/bj2660195; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chasserot-Golaz S, 2005, MOL BIOL CELL, V16, P1108, DOI 10.1091/mbc.E04-07-0627; Chen ZX, 2014, PROTEINS, V82, P312, DOI 10.1002/prot.24389; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; CONCHA NO, 1993, SCIENCE, V261, P1321, DOI 10.1126/science.8362244; Donohue MP, 2014, PROTEINS, V82, P2936, DOI 10.1002/prot.24623; Drucker P, 2013, J BIOL CHEM, V288, P24764, DOI 10.1074/jbc.M113.474023; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fisette O, 2016, J AM CHEM SOC, V138, P11526, DOI 10.1021/jacs.6b07005; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GERKE V, 1985, J BIOL CHEM, V260, P1688; Gerke V, 2016, BIOL CHEM, V397, P995, DOI 10.1515/hsz-2016-0207; GLENNEY J, 1986, J BIOL CHEM, V261, P7247; GLENNEY JR, 1987, J CELL BIOL, V104, P503, DOI 10.1083/jcb.104.3.503; Graber ZT, 2017, PHYS CHEM CHEM PHYS, V19, P15285, DOI 10.1039/c7cp00718c; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JOHNSSON N, 1986, FEBS LETT, V198, P361, DOI 10.1016/0014-5793(86)80437-9; Jost M, 1997, J CELL SCI, V110, P221; JOST M, 1994, BIOCHEM J, V298, P553, DOI 10.1042/bj2980553; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koerdt SN, 2017, BBA-MOL CELL RES, V1864, P1046, DOI 10.1016/j.bbamcr.2016.12.007; Kucerka N, 2017, LANGMUIR, V33, P3134, DOI 10.1021/acs.langmuir.6b03228; Lambert O, 2004, J BIOL CHEM, V279, P10872, DOI 10.1074/jbc.M313657200; Lambert O, 1997, J MOL BIOL, V272, P42, DOI 10.1006/jmbi.1997.1183; Magarkar A, 2017, J PHYS CHEM LETT, V8, P518, DOI 10.1021/acs.jpclett.6b02818; MEERS P, 1990, BIOCHEMISTRY-US, V29, P3325, DOI 10.1021/bi00465a025; Melcrova A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38035; Menke M, 2005, BIOCHEMISTRY-US, V44, P15296, DOI 10.1021/bi051585i; Merzel F, 2006, J COMPUT CHEM, V27, P446, DOI 10.1002/jcc.20340; Miyagi A, 2016, NAT NANOTECHNOL, V11, P783, DOI [10.1038/nnano.2016.89, 10.1038/NNANO.2016.89]; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; PIGAULT C, 1990, BIOCHIM BIOPHYS ACTA, V1037, P106, DOI 10.1016/0167-4838(90)90108-R; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Roberts VA, 2013, J COMPUT CHEM, V34, P1743, DOI 10.1002/jcc.23304; Rosengarth A., 2004, ANNEXINS, V1, P129; Shesham RD, 2008, PROTEIN ENG DES SEL, V21, P115, DOI 10.1093/protein/gzm094; Simpkins B, 2014, PROTEINS, V82, P3327, DOI 10.1002/prot.24684; Singharoy A, 2016, J AM CHEM SOC, V138, P12077, DOI 10.1021/jacs.6b01193; SOPKOVA J, 1994, BIOCHEMISTRY-US, V33, P4490, DOI 10.1021/bi00181a008; Sopkova J, 1998, BIOCHEMISTRY-US, V37, P11962, DOI 10.1021/bi980773o; SWAIRJO MA, 1995, NAT STRUCT BIOL, V2, P968, DOI 10.1038/nsb1195-968; THIEL C, 1992, J CELL SCI, V103, P733; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; ZOKAS L, 1987, J CELL BIOL, V105, P2111, DOI 10.1083/jcb.105.5.2111	59	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185440	10.1371/journal.pone.0185440	http://dx.doi.org/10.1371/journal.pone.0185440			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28937994	Green Submitted, Green Published, gold			2022-12-27	WOS:000411524700035
J	Farahmand, S; Foroughmand-Araabi, MH; Goliaei, S; Razaghi-Moghadam, Z				Farahmand, S.; Foroughmand-Araabi, M. H.; Goliaei, S.; Razaghi-Moghadam, Z.			CytoGTA: A cytoscape plugin for identifying discriminative subnetwork markers using a game theoretic approach	PLOS ONE			English	Article							BREAST-CANCER; HUMAN-DISEASE; NETWORKS	In recent years, analyzing genome-wide expression profiles to find genetic markers has received much attention as a challenging field of research aiming at unveiling biological mechanisms behind complex disorders. The identification of reliable and reproducible markers has lately been achieved by integrating genome-scale functional relationships and transcriptome datasets, and a number of algorithms have been developed to support this strategy. In this paper, we present a promising and easily applicable tool to accomplish this goal, namely CytoGTA, which is a Cytoscape plug-in that relies on an optimistic game theoretic approach (GTA) for identifying subnetwork markers. Given transcriptomic data of two phenotype classes and interactome data, this plug-in offers discriminative markers for the two classes. The high performance of CytoGTA would not have been achieved if the strategy of GTA was not implemented in Cytoscape. This plug-in provides a simple-to-use platform, convenient for biological researchers to interactively work with and visualize the structure of subnetwork markers. CytoGTA is one of the few available Cytoscape plug-ins for marker identification, which shows superior performance to existing methods.	[Farahmand, S.; Razaghi-Moghadam, Z.] Univ Tehran, Fac New Sci & Technol, Tehran, Iran; [Farahmand, S.] Univ Massachusetts Boston, Coll Sci & Math, Boston, MA USA; [Foroughmand-Araabi, M. H.] Sharif Univ Technol, Dept Math Sci, Tehran, Iran; [Goliaei, S.] Univ Tehran, Tehran, Iran	University of Tehran; University of Massachusetts System; University of Massachusetts Boston; Sharif University of Technology; University of Tehran	Razaghi-Moghadam, Z (corresponding author), Univ Tehran, Fac New Sci & Technol, Tehran, Iran.	razzaghi@ut.ac.ir	farahmand, saman/K-8759-2019	farahmand, saman/0000-0001-8999-2322				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; [Anonymous], 2017, APACHE COMMONS MATH; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Dao P, 2010, BIOINFORMATICS, V26, pi625, DOI 10.1093/bioinformatics/btq393; Farahmand S, 2016, MOL BIOSYST, V12, P818, DOI 10.1039/c5mb00684h; Guo Z, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-58; Holt CA, 2004, P NATL ACAD SCI USA, V101, P3999, DOI 10.1073/pnas.0308738101; Hwang T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-128; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jahid MJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S8; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mitra K, 2013, NAT REV GENET, V14, P719, DOI 10.1038/nrg3552; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Qiu YQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-26; RDC T, 2004, R LANG ENV STAT; Sadikovic B, 2008, CURR GENOMICS, V9, P394, DOI 10.2174/138920208785699580; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Su JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008161; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yao C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-151	26	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185016	10.1371/journal.pone.0185016	http://dx.doi.org/10.1371/journal.pone.0185016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968407	Green Submitted, Green Published, gold			2022-12-27	WOS:000412029600012
J	Ye, JW; Li, J; Li, ZG; Han, SC				Ye, Jingwen; Li, Jun; Li, Zhigang; Han, Shichou			Rearing of Mallada basalis (Neuroptera: Chrysopidae) on modified artificial diets	PLOS ONE			English	Article							REPRODUCTION	Mallada basalis (Walker) has the potential to be a valuable biological control agent because of its predatory abilities, strong reproductive capacity, and broad prey range. This study aimed to improve on a previously used artificial diet for M. basalis, to achieve a longer oviposition period and greater survival rate and fecundity. We analyzed the development, survival, longevity, and reproduction of M. basalis (F1 and F2 generations) fed two artificial diets (AD1 and AD2). Both diets contained chicken egg yolk, beer yeast powder, honey, trehalose, seawater spirulina, and potassium sorbate. AD1 also contained sucrose and vitamin C. The duration of F1 1st larvae, F1 2nd larvae, F1 pupae, F2 egg, and F2 2nd larvae reared on AD1 were significantly shorter than those reared on AD2. F1 adult longevity and F2 oviposition period for AD1 (45.40 d and 31.00 d) were significantly longer than for AD2 (30.74 d and 20.80 d). All the following were significantly greater for AD1 compared with AD2: F1 female proportion, F1 daily oviposition, F1 female oviposition, F2 daily oviposition, F2 female oviposition, F1 emergence rate, F2 pupation rate, and F3 egg hatching rate. Moreover, for M. basalis fed AD2, the duration of F2 2nd and 3rd larvae (9.00 d and 8.64 d) were significantly longer than for F1 (4.70 d and 4.92 d). The F1 oviposition period (31.57 d) was significantly longer than F2 (20.80 d). The F2 female oviposition (189.20 egg/female) was significantly less than F1 (307.14 egg/female). We found that the oviposition period and female longevity of F1 reared on AD1 was longer than that reared on the artificial diet in a previous study. The daily oviposition and female oviposition of F1 from AD1 was larger, while the F2 egg hatching rate was greater compared with that from the previous diet. However, the offspring of M. basalis fed AD2 were less thrifty. We found diet AD1 supported development and reproduction better than AD2 and the diets in our previous study. These findings may contribute to the mass rearing of this economically important predatory green lacewing.	[Ye, Jingwen; Li, Jun; Li, Zhigang; Han, Shichou] Guangdong Inst Appl Biol Resources, Dept Invas Biol Control, Guangzhou, Guangdong, Peoples R China; [Ye, Jingwen; Li, Jun; Li, Zhigang; Han, Shichou] Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China; [Ye, Jingwen; Li, Jun; Li, Zhigang; Han, Shichou] Guangdong Key Lab Anim Conservat & Resource Utili, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Han, SC (corresponding author), Guangdong Inst Appl Biol Resources, Dept Invas Biol Control, Guangzhou, Guangdong, Peoples R China.; Han, SC (corresponding author), Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China.; Han, SC (corresponding author), Guangdong Key Lab Anim Conservat & Resource Utili, Guangzhou, Guangdong, Peoples R China.	hansc@gdei.gd.cn			National Key Research & Development Program of China [2016YFC1201100]; Science & Technology Planning Project of Guangdong [2015A030302059, 2013B050800024]; Funds for Environment Construction & Capacity Building of GDAS' Research Platform [2016GDASPT-0305]; GDAS Special Project of Science and Technology Development [2017GDASCX-0107]	National Key Research & Development Program of China; Science & Technology Planning Project of Guangdong; Funds for Environment Construction & Capacity Building of GDAS' Research Platform; GDAS Special Project of Science and Technology Development	This study was supported by National Key Research & Development Program of China (2016YFC1201100), Science & Technology Planning Project of Guangdong (2015A030302059, 2013B050800024), Funds for Environment Construction & Capacity Building of GDAS' Research Platform (2016GDASPT-0305), and GDAS Special Project of Science and Technology Development (2017GDASCX-0107).	Albuquerque GS, 1997, J ANIM ECOL, P7; Boo KS, 1998, J CHEM ECOL, V24, P631, DOI 10.1023/A:1022386001722; Chen Chien-Chung, 2014, Journal of Taiwan Agricultural Research, V63, P91; Cheng LL, 2010, BIOL CONTROL, V53, P267, DOI 10.1016/j.biocontrol.2010.02.006; Cohen AC, 1998, BIOL CONTROL, V13, P49, DOI 10.1006/bcon.1998.0636; De Clercq P, 2005, BIOCONTROL SCI TECHN, V15, P467, DOI 10.1080/09583150500086706; De Clercq P. T. A., 2014, MASS PRODUCTION BENE, P57, DOI DOI 10.1016/B978-0-12-391453; Grenier S, 2003, QUALITY CONTROL AND PRODUCTION OF BIOLOGICAL CONTROL AGENTS: THEORY AND TESTING PROCEDURES, P115, DOI 10.1079/9780851996882.0115; Grenier S, 2009, B INSECTOL, V62, P1; Hou RF, 1994, ENTOMOLOGIA EXPT APP, V35, P49; Jiang L, 2013, FOREST PESTS DIS, V32, p[23, 13]; LAMUNYON CW, 1987, ANN ENTOMOL SOC AM, V80, P804, DOI 10.1093/aesa/80.6.804; Lee W. T, 2003, Plant Protection Bulletin (Taichung), V45, P45; Li Zhi-Gang, 2011, Huanjing Kunchong Xuebao, V33, P209; Liu F, 2013, BIOCONTROL, V58, P789, DOI 10.1007/s10526-013-9529-8; Lo N.C., 2002, FORMOSAN ENTOMOL SPE, V3, P1; Lo PKC, 2002, ACTA HORTIC, P201, DOI 10.17660/ActaHortic.2002.578.24; Lu ChiuTung, 2006, Journal of Taiwan Agricultural Research, V55, P111; Nguyen DT, 2015, J APPL ENTOMOL, V139, P1; Riddick EW, 2009, BIOCONTROL, V54, P325, DOI 10.1007/s10526-008-9171-z; Tauber Maurice J., 2000, American Entomologist, V46, P26; Tzeng C. C., 1996, Plant Protection Bulletin (Taichung), V38, P203; Wu TzeKann, 1995, Chinese Journal of Entomology, V15, P113; Ye Jing-Wen, 2013, Huanjing Kunchong Xuebao, V35, P67; Ye JW, 2015, FLA ENTOMOL, V98, P1072; Ye Jingwen, 2012, Chinese Journal of Biological Control, V28, P289; Ye Z. C., 1986, Chinese Journal of Biological Control, V2, P132	27	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185223	10.1371/journal.pone.0185223	http://dx.doi.org/10.1371/journal.pone.0185223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961246	Green Published, gold, Green Submitted			2022-12-27	WOS:000412027700016
J	Freedman, S; Nikpay, S; Carroll, A; Simon, K				Freedman, Seth; Nikpay, Sayeh; Carroll, Aaron; Simon, Kosali			Changes in inpatient payer-mix and hospitalizations following Medicaid expansion: Evidence from all-capture hospital discharge data	PLOS ONE			English	Article							COVERAGE	Context The Affordable Care Act resulted in unprecedented reductions in the uninsured population through subsidized private insurance and an expansion of Medicaid. Early estimates from the beginning of 2014 showed that the Medicaid expansion decreased uninsured discharges and increased Medicaid discharges with no change in total discharges. Objective To provide new estimates of the effect of the ACA on discharges for specific conditions. Design, setting, and participants We compared outcomes between states that did and did not expand Medicaid using statelevel all-capture discharge data from 2009-2014 for 42 states from the Healthcare Costs and Utilization Project's FastStats database; for a subset of states we used data through 2015. We stratified the analysis by baseline uninsured rates and used difference-in-differences and synthetic control methods to select comparison states with similar baseline characteristics that did not expand Medicaid. Main outcome Our main outcomes were total and condition-specific hospital discharges per 1,000 population and the share of total discharges by payer. Conditions reported separately in FastStats included maternal, surgical, mental health, injury, and diabetes. Results The share of uninsured discharges fell in Medicaid expansion states with below (-4.39 percentage points (p. p.), -6.04--2.73) or above (-7.66 p. p., -9.07--6.24) median baseline uninsured rates. The share of Medicaid discharges increased in both small (6.42 p. p. 4.22-6.62) and large (10.5 p. p., 8.48-12.5) expansion states. Total and most condition-specific discharges per 1,000 residents did not change in Medicaid expansion states with high or low baseline uninsured rates relative to non-expansion states (0.418, p = 0.225), with one exception: diabetes. Discharges for that condition per 1,000 fell in states with high baseline uninsured rates relative to non-expansion states (-0.038 95% p = 0.027). Conclusions Early changes in payer mix identified in the first two quarters of 2014 continued through the Medicaid expansion's first year and are distributed across all condition types studied. We found no change in total discharges between Medicaid expansion and non-expansion states, however residents of states that should have been most affected by the Medicaid expansion were less likely to be hospitalized for diabetes.	[Freedman, Seth; Simon, Kosali] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA; [Nikpay, Sayeh] Vanderbilt Univ, Med Ctr, Dept Hlth Policy, Nashville, TN USA; [Carroll, Aaron] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Vanderbilt University; Indiana University System; Indiana University-Purdue University Indianapolis	Simon, K (corresponding author), Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA.	simonkos@indiana.edu						Abadie A, 2010, J AM STAT ASSOC, V105, P493, DOI 10.1198/jasa.2009.ap08746; Agency for Healthcare Research and Quality, 2017, HLTH COST UT PROJ FA, V7; Cameron A.C., 2013, J HUM RESOU IN PRESS, P221; Casagrande SS, 2012, DIABETES CARE, V35, P2243, DOI 10.2337/dc12-0257; Center for Medicare and Medicaid Services, 2016, ACT REP FIN OUTL MED; Fisher RA, 1935, DESIGN EXPT; Frean M, 2016, PREMIUM SUBSIDIES MA; Ghosh A, 2017, EFFECT STATE MEDICAI; Hempstead K, 2016, NEW ENGL J MED, V374, P196, DOI 10.1056/NEJMc1507366; Hu L., 2016, EFFECT PATIENT PROTE; Kaestner R., 2015, EFFECTS ACA MEDICAID; Kaiser Family Foundation, 2017, STAT STAT ACT MED EX, V1, P1; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Muhlstein D, 2016, 2016 PRIVATE PUBLIC; Myerson R, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0712-z; Nikpay S, 2016, HEALTH AFFAIR, V35, P106, DOI 10.1377/hlthaff.2015.1144; Wherry LR, 2016, ANN INTERN MED, V164, P795, DOI 10.7326/M15-2234	17	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0183616	10.1371/journal.pone.0183616	http://dx.doi.org/10.1371/journal.pone.0183616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957347	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200010
J	Gibson, BL; Rochat, P; Tone, EB; Baron, AS				Gibson, Bentley L.; Rochat, Philippe; Tone, Erin B.; Baron, Andrew S.			Sources of implicit and explicit intergroup race bias among African-American children and young adults	PLOS ONE			English	Article							SOCIAL CATEGORIZATION; SELF-ESTEEM; SYSTEM-JUSTIFICATION; RACIAL SOCIALIZATION; ATTITUDES; BLACK; WHITE; STEREOTYPES; IDENTITY; PREJUDICE	Implicit intergroup bias emerges early in development, are typically pro-ingroup, and remain stable across the lifespan. Such findings have been interpreted in terms of an automatic ingroup bias similar to what is observed with minimal groups paradigms. These studies are typically conducted with groups of high cultural standing (e.g., Caucasians in North America and Europe). Research conducted among culturally lower status groups (e.g., AfricanAmericans, Latino-Americans) reveals a notable absence of an implicit ingroup bias. Understanding the environmental factors that contribute to the absence of an implicit ingroup bias among people from culturally lower status groups is critical for advancing theories of implicit intergroup cognition. The present study aimed to elucidate the factors that shape racial group bias among African-American children and young adults by examining their relationship with age, school composition (predominantly Black schools or racially mixed schools), parental racial attitudes and socialization messages among African-American children (N = 86) and young adults (N = 130). Age, school-type and parents' racial socialization messages were all found to be related to the strength of pro-Black (ingroup) bias. We also found that relationships between implicit and explicit bias and frequency of parents' racial socialization messages depended on the type of school participants attended. Our results highlight the importance of considering environmental factors in shaping the magnitude and direction of implicit and explicit race bias among African-Americans rather than treating them as a monolithic group.	[Gibson, Bentley L.] Georgia Highlands Coll, Dept Psychol, Rome, GA 30161 USA; [Rochat, Philippe] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; [Tone, Erin B.] Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA; [Baron, Andrew S.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University System of Georgia; Georgia Highlands College; Emory University; University System of Georgia; Georgia State University; University of British Columbia	Gibson, BL (corresponding author), Georgia Highlands Coll, Dept Psychol, Rome, GA 30161 USA.	bgibson@highlands.edu		Tone, Erin/0000-0003-4021-1673	Social Sciences and Humanities Research Council of Canada [435-2013-0286]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was funded by a Social Sciences and Humanities Research Council of Canada grant number 435-2013-0286 awarded to Dr. Andrew Scott Baron. There were no additional external or internal funding sources.	Aboud F., 1988, CHILDREN PREJUDICE; Apfelbaurn EP, 2008, J PERS SOC PSYCHOL, V95, P918, DOI 10.1037/a0011990; Ashburn-Nardo L, 2003, SOC COGNITION, V21, P61, DOI 10.1521/soco.21.1.61.21192; Baron A., 2009, SOCIAL PERSONALITY P, V3, P1; Baron AS, 2015, CHILD DEV PERSPECT, V9, P50, DOI 10.1111/cdep.12105; Baron AS, 2015, J COGN DEV, V16, P780, DOI 10.1080/15248372.2014.1000459; Baron AS, 2006, PSYCHOL SCI, V17, P53, DOI 10.1111/j.1467-9280.2005.01664.x; Bigler RS, 2006, ADV CHILD DEV BEHAV, V34, P39, DOI 10.1016/S0065-2407(06)80004-2; Bigler RS, 1997, CHILD DEV, V68, P530, DOI 10.1111/j.1467-8624.1997.tb01956.x; Blakely Edward J., 2007, BLACK METROPOLIS 21; BRANCH CW, 1986, CHILD DEV, V57, P712; Brewer MB, 2007, SOCIAL PSYCHOL HDB B, P695; Campbell Angus, 1968, RACIAL ATTITUDES 15; Clendinen D, 1986, ATLANTA MECCA MIDDLE; Cokley K, 1999, J COLL STUDENT DEV, V40, P235; CROSBY F, 1980, PSYCHOL BULL, V87, P546, DOI 10.1037/0033-2909.87.3.546; Cvencek D., 2012, COGNITIVE CONSISTENC, P157; Devine P, 2001, CLASSIC CONT ANAL RA, P198; Dovidio JF, 2002, J PERS SOC PSYCHOL, V82, P62, DOI 10.1037//0022-3514.82.1.62; DOYLE AB, 1995, MERRILL PALMER QUART, V41, P209; Dunham Y, 2008, TRENDS COGN SCI, V12, P248, DOI 10.1016/j.tics.2008.04.006; Dunham Y, 2007, SELF IDENTITY, V6, P238, DOI 10.1080/15298860601115344; Dunham Y, 2011, CHILD DEV, V82, P793, DOI 10.1111/j.1467-8624.2011.01577.x; Dutton SE, 1998, J SOC PSYCHOL, V138, P41, DOI 10.1080/00224549809600352; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; Fitzroy S, 2010, EUR J SOC PSYCHOL, V40, P679, DOI 10.1002/ejsp.746; Fouche R, 2006, AM QUART, V58, P639, DOI 10.1353/aq.2006.0059; Gaetner L, 2000, EUROPEAN J SOCIAL PS, V31, P143; Gibson-Wallace B, 2015, COGNITION CULTURE, V3, P344; Gonzalez A, 2016, CHILD DEV, P1; Greenwald AG, 2002, PSYCHOL REV, V109, P3, DOI 10.1037/0033-295X.109.1.3; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hardiman R., 1997, TEACHING DIVERSITY S, P16; Heiphetz L, 2013, J EXP SOC PSYCHOL, V49, P559, DOI 10.1016/j.jesp.2012.09.005; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; Hughes D, 2006, DEV PSYCHOL, V42, P747, DOI 10.1037/0012-1649.42.5.747; JOST JT, 1994, BRIT J SOC PSYCHOL, V33, P1, DOI 10.1111/j.2044-8309.1994.tb01008.x; Jost JT, 2004, POLIT PSYCHOL, V25, P881, DOI 10.1111/j.1467-9221.2004.00402.x; JUDD CM, 1995, J PERS SOC PSYCHOL, V69, P460, DOI 10.1037/0022-3514.69.3.460; KNIGHT GP, 1993, J CROSS CULT PSYCHOL, V24, P99, DOI 10.1177/0022022193241007; Kotkin J., 2015, CITIES AFRICAN AM AR; Lai C, 2015, SOCIAL PERSONALITY C, V7, P315; Livingston RW, 2002, J EXP SOC PSYCHOL, V38, P405, DOI 10.1016/S0022-1031(02)00002-1; MARSHALL S, 1995, J YOUTH ADOLESCENCE, V24, P377, DOI 10.1007/BF01537187; McConnell AR, 2001, J EXP SOC PSYCHOL, V37, P435, DOI 10.1006/jesp.2000.1470; McGlothlin H, 2010, EUR J SOC PSYCHOL, V40, P625, DOI 10.1002/ejsp.733; Newheiser AK, 2014, DEV PSYCHOL, V50, P1081, DOI 10.1037/a0035054; Newheiser AK, 2012, J EXP SOC PSYCHOL, V48, P264, DOI 10.1016/j.jesp.2011.08.011; NOBLES WW, 1973, J SOC ISSUES, V29, P11, DOI 10.1111/j.1540-4560.1973.tb00055.x; Nosek BA, 2002, GROUP DYN-THEOR RES, V6, P101, DOI 10.1037//1089-2699.6.1.101; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; Peters M.F., 1985, BLACK CHILDREN SOCIA, P159; Phinney JS, 1997, J YOUTH ADOLESCENCE, V26, P165, DOI 10.1023/A:1024500514834; POWLISHTA KK, 1995, DEV PSYCHOL, V31, P781, DOI 10.1037/0012-1649.31.5.781; Rutland A, 1999, BRIT J SOC PSYCHOL, V38, P55, DOI 10.1348/014466699164031; Rutland A, 2005, CHILD DEV, V76, P451, DOI 10.1111/j.1467-8624.2005.00856.x; Sinclair S, 2005, J EXP SOC PSYCHOL, V41, P283, DOI 10.1016/j.jesp.2004.06.003; SPENCER MB, 1983, DEV REV, V3, P351, DOI 10.1016/0273-2297(83)90020-5; Spurgeon S. L., 2008, J BLACK STUD, V40, P527; Stevenson H.C., 1995, J BLACK PSYCHOL, V21, P49, DOI DOI 10.1177/00957984950211005; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Tajfel H., 1979, SOCIAL PSYCHOL INTER; Thornton M.C., 1997, FAMILY LIFE BLACK AM; THORNTON MC, 1990, CHILD DEV, V61, P401, DOI 10.1111/j.1467-8624.1990.tb02786.x; Verkuyten M, 2001, BRIT J DEV PSYCHOL, V19, P559, DOI 10.1348/026151001166254	67	8	8	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0183015	10.1371/journal.pone.0183015	http://dx.doi.org/10.1371/journal.pone.0183015			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957353	gold, Green Submitted, Green Published			2022-12-27	WOS:000411985200007
J	Mohanakrishnan, A; Tran, TVM; Kumar, M; Chen, H; Posner, BA; Schmid, SL				Mohanakrishnan, Aparna; Tran, Triet Vincent M.; Kumar, Meera; Chen, Hong; Posner, Bruce A.; Schmid, Sandra L.			A highly-sensitive high throughput assay for dynamin's basal GTPase activity	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; MEMBRANE FISSION; DYNASORE; INHIBITOR	Clathrin-mediated endocytosis is the major pathway by which cells internalize materials from the external environment. Dynamin, a large multidomain GTPase, is a key regulator of clathrin-mediated endocytosis. It assembles at the necks of invaginated clathrin-coated pits and, through GTP hydrolysis, catalyzes scission and release of clathrin-coated vesicles from the plasma membrane. Several small molecule inhibitors of dynamin's GTPase activity, such as Dynasore and Dyngo-4a, are currently available, although their specificity has been brought into question. Previous screens for these inhibitors measured dynamin's stimulated GTPase activity due to lack of sufficient sensitivity, hence the mechanisms by which they inhibit dynamin are uncertain. We report a highly sensitive fluorescence-based assay capable of detecting dynamin's basal GTPase activity under conditions compatible with high throughput screening. Utilizing this optimized assay, we conducted a pilot screen of 8000 compounds and identified several "hits" that inhibit the basal GTPase activity of dynamin-1. Subsequent dose-response curves were used to validate the activity of these compounds. Interestingly, we found neither Dynasore nor Dyngo-4a inhibited dynamin's basal GTPase activity, although both inhibit assembly-stimulated GTPase activity. This assay provides the basis for a more extensive search for more potent and chemically desirable dynamin inhibitors.	[Mohanakrishnan, Aparna; Tran, Triet Vincent M.; Schmid, Sandra L.] UT Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Kumar, Meera] BellBrook Labs, Madison, WI USA; [Chen, Hong; Posner, Bruce A.] UT Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX USA		Schmid, SL (corresponding author), UT Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	sandra.schmid@utsouthwestern.edu		Schmid, Sandra/0000-0002-1690-7024; Tran, Triet Vincent/0000-0001-7481-9914	NIH [GM42455-2651]; Texas Cancer Prevention and Research HIHR [RP150573]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042455] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Cancer Prevention and Research HIHR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by NIH R01 grant GM42455-2651 and Texas Cancer Prevention and Research HIHR Grant RP150573 to Sandra Schmid. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Meera Kumar, an employee of Bellbrook labs, assisted in early establishment of the Transcreener GDP FP assay conditions for dynamin. Otherwise, we received no funding from Bellbrook labs and purchased all reagents.	Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Barylko B, 1998, J BIOL CHEM, V273, P3791, DOI 10.1074/jbc.273.6.3791; Basagiannis D, 2017, SCI REP-UK, V7, DOI 10.1038/srep45035; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Lea WA, 2011, EXPERT OPIN DRUG DIS, V6, P17, DOI 10.1517/17460441.2011.537322; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Liu YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055691; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; Morlot S, 2013, ANNU REV BIOPHYS, V42, P629, DOI 10.1146/annurev-biophys-050511-102247; Neumann S, 2013, J BIOL CHEM, V288, P25119, DOI 10.1074/jbc.M113.490474; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Preta G, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0102-1; Reis CR, 2015, EMBO J, V34, P2132, DOI 10.15252/embj.201591518; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sun W, 2011, J BIOMOL SCREEN, V16, P717, DOI 10.1177/1087057111408420; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Wu ZJ, 2008, J BIOMOL SCREEN, V13, P159, DOI 10.1177/1087057107312628	25	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185639	10.1371/journal.pone.0185639	http://dx.doi.org/10.1371/journal.pone.0185639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957392	Green Submitted, Green Published, gold			2022-12-27	WOS:000411985200099
J	Su, DD; Hu, XX; Wang, DS; Cui, T; Yao, RY; Sun, HB				Su, Dandan; Hu, Xingxue; Wang, Dashan; Cui, Ting; Yao, Ruyong; Sun, Huibin			Semiconductor laser irradiation improves root canal sealing during routine root canal therapy	PLOS ONE			English	Article							KILL ENTEROCOCCUS-FAECALIS; POWER DIODE-LASER; SMEAR LAYER; IN-VITRO; APICAL PERIODONTITIS; ENDODONTIC TREATMENT; DENTINAL TUBULES; IRRIGATION; BACTERIA; DISINFECTION	Objective To evaluate the effect of semiconductor laser irradiation on root canal sealing after routine root canal therapy (RCT). Methods Sixty freshly extracted single-rooted human teeth were randomly divided into six groups (n = 10). The anatomic crowns were sectioned at the cementoenamel junction and the remaining roots were prepared endodontically with conventional RCT methods. Groups A and B were irradiated with semiconductor laser at 1W for 20 seconds; Groups C and D were ultrasonically rinsed for 60 seconds as positive control groups; Groups E and F without treatment of root canal prior to RCT as negative control groups. Root canal sealing of Groups A, C and E were evaluated by measurements of apical microleakage. The teeth from Groups B, D and F were sectioned, and the micro-structures were examined with scanning electron microscopy (SEM). One way ANOVA and LSD- t test were used for statistical analysis (alpha =.05). Results The apical sealing of both the laser irradiated group and the ultrasonic irrigated group were significantly different from the control group (p 0.5). There was no significant difference between the laser irradiated group and the ultrasonic irrigated group (p>0.5). SEM observation showed that most of the dentinal tubules in the laser irradiation group melted, narrowed or closed, while most of the dentinal tubules in the ultrasonic irrigation group were filled with tooth paste. Conclusion The application of semiconductor laser prior to root canal obturation increases the apical sealing of the roots treated.	[Su, Dandan; Wang, Dashan; Cui, Ting; Sun, Huibin] Qingdao Univ, Dept Stomatol, Affiliated Hosp, Qingdao, Peoples R China; [Hu, Xingxue] Ohio State Univ, Div Gen Practice & Mat Sci, Coll Dent, Columbus, OH 43210 USA; [Yao, Ruyong] Qingdao Univ, Cent Lab, Affiliated Hosp, Qingdao, Peoples R China	Qingdao University; University System of Ohio; Ohio State University; Qingdao University	Sun, HB (corresponding author), Qingdao Univ, Dept Stomatol, Affiliated Hosp, Qingdao, Peoples R China.	shb353.qindao@163.com	su, dan/GYJ-1940-2022					Alfredo E, 2008, J DENT, V36, P529, DOI 10.1016/j.jdent.2008.03.009; Bawazir OA, 2007, J DENT CHILD, V74, P46; BECKER SA, 1989, J ENDODONT, V15, P246, DOI 10.1016/S0099-2399(89)80217-1; Berutti E, 1997, J ENDODONT, V23, P725, DOI 10.1016/S0099-2399(97)80342-1; de Souza EB, 2008, ORAL SURG ORAL MED O, V106, pE68, DOI 10.1016/j.tripleo.2008.02.032; Eldeniz AU, 2007, INT ENDOD J, V40, P329, DOI 10.1111/j.1365-2591.2007.01211.x; Fan Mingwen, 2012, ENDODONTICS, P260; Fan Mingwen, 2012, ENDODONTICS, P317; Fleming CH, 2010, J ENDODONT, V36, P414, DOI 10.1016/j.joen.2009.11.013; Gutknecht N, 2004, J CLIN LASER MED SUR, V22, P9, DOI 10.1089/104454704773660912; Hui Zhao, 2015, SHANDONG MED J, V55, P86; Kuah HG, 2009, J ENDODONT, V35, P393, DOI 10.1016/j.joen.2008.12.007; Lee SJ, 2004, INT ENDOD J, V37, P672, DOI 10.1111/j.1365-2591.2004.00848.x; Li Wanghong, 2001, ZHEJIANG MED J, V23, P726; Li Yuliang, 2011, J PRACTICAL MED TECH, V18, P1153; [刘畅 Liu Chang], 2010, [实用口腔医学杂志, Journal of Practical Stomatology], V26, P650; Lottanti S, 2009, INT ENDOD J, V42, P335, DOI 10.1111/j.1365-2591.2008.01514.x; Meire MA, 2009, INT ENDOD J, V42, P351, DOI 10.1111/j.1365-2591.2008.01532.x; MOR C, 1995, ENDOD DENT TRAUMATOL, V11, P169; Moritz A, 2000, LASER SURG MED, V26, P250, DOI 10.1002/(SICI)1096-9101(2000)26:3<250::AID-LSM2>3.0.CO;2-H; Nair PNR, 2005, ORAL SURG ORAL MED O, V99, P231, DOI 10.1016/j.tripleo.2004.10.005; Niu W, 2002, INT ENDOD J, V35, P934, DOI 10.1046/j.1365-2591.2002.00594.x; Ozata F, 1999, J ENDODONT, V25, P603, DOI 10.1016/S0099-2399(99)80317-3; Peters LB, 2001, J ENDODONT, V27, P76, DOI 10.1097/00004770-200102000-00002; Peters OA, 2001, INT ENDOD J, V34, P221, DOI 10.1046/j.1365-2591.2001.00373.x; Pirnat S, 2011, LASER MED SCI, V26, P755, DOI 10.1007/s10103-010-0808-7; Preethee Thomas, 2012, J Conserv Dent, V15, P46, DOI 10.4103/0972-0707.92606; Radaelli CM, 2003, INT CONGR SER, V1248, P273, DOI 10.1016/S0531-5131(02)01308-0; Rohde TR, 1996, J ENDODONT, V22, P365, DOI 10.1016/S0099-2399(96)80220-2; Romeo U, 2015, AUST ENDOD J, V41, P17, DOI 10.1111/aej.12057; Schoop U, 2004, LASER SURG MED, V35, P111, DOI 10.1002/lsm.20026; Siqueira JF, 2000, J ENDODONT, V26, P331, DOI 10.1097/00004770-200006000-00006; SJOGREN U, 1990, J ENDODONT, V16, P498; Stabholz Adam, 2008, Alpha Omegan, V101, P195, DOI 10.1016/j.aodf.2008.07.029; Townsend C, 2009, J ENDODONT, V35, P1040, DOI 10.1016/j.joen.2009.04.007; Upadya MH, 2010, INT ENDOD J, V43, P978, DOI 10.1111/j.1365-2591.2010.01717.x; Violich DR, 2010, INT ENDOD J, V43, P2, DOI 10.1111/j.1365-2591.2009.01627.x; Wu Xiaozhen, 2014, J CLIN STOMATOLOGY, V30, P294; [张晓 Zhang Xiao], 2013, [实用口腔医学杂志, Journal of Practical Stomatology], V29, P101	39	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185512	10.1371/journal.pone.0185512	http://dx.doi.org/10.1371/journal.pone.0185512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957407	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200072
J	Winsvold, BS; Bettella, F; Witoelar, A; Anttila, V; Gormley, P; Kurth, T; Terwindt, GM; Freilinger, TM; Frei, O; Shadrin, A; Wang, YP; Dale, AM; van den Maagdenberg, AMJM; Chasman, DI; Nyholt, DR; Palotie, A; Andreassen, OA; Zwart, JA				Winsvold, Bendik S.; Bettella, Francesco; Witoelar, Aree; Anttila, Verneri; Gormley, Padhraig; Kurth, Tobias; Terwindt, Gisela M.; Freilinger, Tobias M.; Frei, Oleksander; Shadrin, Alexey; Wang, Yunpeng; Dale, Anders M.; van den Maagdenberg, Am M. J. M.; Chasman, Daniel I.; Nyholt, Dale R.; Palotie, Aarno; Andreassen, Ole A.; Zwart, John-Anker		Int Headache Genetics Consortium	Shared genetic risk between migraine and coronary artery disease: A genome-wide analysis of common variants	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; PROSTATE-CANCER; ASSOCIATION; METAANALYSIS; SCHIZOPHRENIA; PLEIOTROPY; CHANNELS; GENOTYPE; PROTEIN; CELLS	Migraine is a recurrent pain condition traditionally viewed as a neurovascular disorder, but little is known of its vascular basis. In epidemiological studies migraine is associated with an increased risk of cardiovascular disease, including coronary artery disease (CAD), suggesting shared pathogenic mechanisms. This study aimed to determine the genetic overlap between migraine and CAD, and to identify shared genetic risk loci, utilizing a conditional false discovery rate approach and data from two large-scale genome-wide association studies (GWAS) of CAD (C4D, 15,420 cases, 15,062 controls; CARDIoGRAM, 22,233 cases, 64,762 controls) and one of migraine (22,120 cases, 91,284 controls). We found significant enrichment of genetic variants associated with CAD as a function of their association with migraine, which was replicated across two independent CAD GWAS studies. One shared risk locus in the PHACTR1 gene (conjunctional false discovery rate for index SNP rs9349379 < 3.90 x 10(-5)), which was also identified in previous studies, explained much of the enrichment. Two further loci (in KCNK5 and AS3MT) showed evidence for shared risk (conjunctional false discovery rate < 0.05). The index SNPs at two of the three loci had opposite effect directions in migraine and CAD. Our results confirm previous reports that migraine and CAD share genetic risk loci in excess of what would be expected by chance, and highlight one shared risk locus in PHACTR1. Understanding the biological mechanisms underpinning this shared risk is likely to improve our understanding of both disorders.	[Winsvold, Bendik S.; Zwart, John-Anker] Oslo Univ Hosp, FORMI, Oslo, Norway; [Winsvold, Bendik S.; Zwart, John-Anker] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Winsvold, Bendik S.; Bettella, Francesco; Witoelar, Aree; Frei, Oleksander; Shadrin, Alexey; Wang, Yunpeng; Andreassen, Ole A.; Zwart, John-Anker] Univ Oslo, Inst Clin Med, Oslo, Norway; [Bettella, Francesco; Witoelar, Aree; Frei, Oleksander; Shadrin, Alexey; Wang, Yunpeng; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, NORMENT KG Jebsen Ctr, Oslo, Norway; [Anttila, Verneri] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Anttila, Verneri; Chasman, Daniel I.] Harvard Med Sch, Boston, MA USA; [Anttila, Verneri; Gormley, Padhraig; Palotie, Aarno] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Anttila, Verneri; Gormley, Padhraig; Palotie, Aarno] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Gormley, Padhraig; Palotie, Aarno] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Kurth, Tobias] Charite Univ Med Berlin, Inst Publ Hlth, Berlin, Germany; [Kurth, Tobias; Chasman, Daniel I.] Harvard Med Sch, Brigham & Womens Hosp, Div Prevent Med, Boston, MA USA; [Terwindt, Gisela M.; van den Maagdenberg, Am M. J. M.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Freilinger, Tobias M.] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Germany; [Freilinger, Tobias M.] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Dale, Anders M.] Univ Calif San Diego, Ctr Multimodal Imaging & Genet, La Jolla, CA 92093 USA; [van den Maagdenberg, Am M. J. M.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Nyholt, Dale R.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Stat & Genom Epidemiol Lab, Kelvin Grove, Australia; [Int Headache Genetics Consortium] Int Headache Genet Consortium, Helsinki, Finland	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; University of California System; University of California San Diego; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Queensland University of Technology (QUT)	Winsvold, BS (corresponding author), Oslo Univ Hosp, FORMI, Oslo, Norway.; Winsvold, BS (corresponding author), Oslo Univ Hosp, Dept Neurol, Oslo, Norway.; Winsvold, BS (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	bendik.s.winsvold@gmail.com	Kurth, Tobias/A-9243-2012; Andreassen, Ole A./AAY-7531-2020; Belin, Andrea Carmine/AAV-9933-2021; Winsvold, Bendik/ABF-7839-2021; Nyholt, Dale Robert/J-3174-2017; van den Maagdenberg, Arn M.J.M./AAE-9052-2019; Gormley, Padhraig/L-1949-2018; Wang, Yunpeng/W-8871-2018; Hansen, Thomas Folkmann/O-5965-2014	Kurth, Tobias/0000-0001-7169-2620; Belin, Andrea Carmine/0000-0001-6668-3172; Winsvold, Bendik/0000-0003-4171-8919; Nyholt, Dale Robert/0000-0001-7159-3040; Gormley, Padhraig/0000-0002-8908-6968; Wang, Yunpeng/0000-0001-9831-1090; Hansen, Thomas Folkmann/0000-0001-6703-7762; vila-pueyo, marta/0000-0003-0652-2988; Palotie, Aarno/0000-0002-2527-5874	Research Council of Norway [231187/F20, 248778, 223273]; KG Jebsen Stiftelsen; EU [6026337]; 23AMP;Me Inc. (Mountain View, USA); Decode genetics Inc. (Reykjavik, Iceland); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS092963] Funding Source: NIH RePORTER; Medical Research Council [MR/N01104X/2, MR/N01104X/1, G1001799] Funding Source: researchfish; MRC [G1001799, MR/N01104X/2, MR/N01104X/1] Funding Source: UKRI	Research Council of Norway(Research Council of Norway); KG Jebsen Stiftelsen; EU(European Commission); 23AMP;Me Inc. (Mountain View, USA); Decode genetics Inc. (Reykjavik, Iceland); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Research Council of Norway (grant # 231187/F20 to BSW, grant # 248778, # 223273 to OAA), KG Jebsen Stiftelsen (OAA) and EU-funded FP7 "EUROHEADPAIN" grant (nr. 6026337 to AMvdM & AP). Data on coronary artery disease have been contributed by CARDloGRAMplusC4D investigators and have been downloaded from www.CARDIOGRAMPLUSG4D.ORG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 23&Me Inc. (Mountain View, USA) provided support in the form of salaries for authors NF, NL, CN (see Acknowledgments), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Decode genetics Inc. (Reykjavik, Iceland) provided support in the form of salaries for authors Al, KS, HS and SS (see Acknowledgments), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain B, 2012, CELL SIGNAL, V24, P214, DOI 10.1016/j.cellsig.2011.09.003; Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andreassen OA, 2015, MOL PSYCHIATR, V20, P207, DOI 10.1038/mp.2013.195; Andreassen OA, 2014, INT J EPIDEMIOL, V43, P1205, DOI 10.1093/ije/dyu090; Andreassen OA, 2014, HYPERTENSION, V63, P819, DOI 10.1161/HYPERTENSIONAHA.113.02077; Andreassen OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003455; Andreassen OA, 2013, AM J HUM GENET, V92, P197, DOI 10.1016/j.ajhg.2013.01.001; Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Cazals Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9780; Debette S, 2015, NAT GENET, V47, P78, DOI 10.1038/ng.3154; Debette S, 2009, LANCET NEUROL, V8, P668, DOI 10.1016/S1474-4422(09)70084-5; Desikan RS, 2015, CIRCULATION, V131, P2061, DOI 10.1161/CIRCULATIONAHA.115.015489; Freilinger T, 2012, NAT GENET, V44, P777, DOI 10.1038/ng.2307; Gestreau C, 2010, P NATL ACAD SCI USA, V107, P2325, DOI 10.1073/pnas.0910059107; Gonczi M, 2006, BRIT J PHARMACOL, V147, P496, DOI 10.1038/sj.bjp.0706649; Gormley P, 2016, NAT GENET, V48, P856, DOI 10.1038/ng.3598; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Kurth T, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2610; Lehner B, 2013, NAT REV GENET, V14, P168, DOI 10.1038/nrg3404; Li M, 2016, NAT MED, V22, P649, DOI 10.1038/nm.4096; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; MACHIELA MJ, 2015, BIOINFORMATICS, V31, P3555, DOI DOI 10.1093/BI0INF0RMATICS/BTV402; Malik R, 2015, NEUROLOGY, V84, P2132, DOI 10.1212/WNL.0000000000001606; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Patel RS, 2012, AM J HYPERTENS, V25, P797, DOI 10.1038/ajh.2012.41; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Pietrobon D, 2013, ANNU REV PHYSIOL, V75, P365, DOI 10.1146/annurev-physiol-030212-183717; Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285; Rodriguez-Osorio X, 2012, NEUROLOGY, V79, P474, DOI 10.1212/WNL.0b013e31826170ce; Sacco S, 2015, EUR J NEUROL, V22, P1001, DOI 10.1111/ene.12701; Schork AJ, 2016, CURR OPIN NEUROBIOL, V36, P89, DOI 10.1016/j.conb.2015.10.008; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Spector JT, 2010, AM J MED, V123, P612, DOI 10.1016/j.amjmed.2009.12.021; Tajti J, 2011, J NEURAL TRANSM, V118, P511, DOI 10.1007/s00702-010-0515-3; Tietjen GE, 2009, CEPHALALGIA, V29, P989, DOI 10.1111/j.1468-2982.2009.01937.x; Verhaaren BFJ, 2015, CIRC-CARDIOVASC GENE, V8, P398, DOI 10.1161/CIRCGENETICS.114.000858; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Winsvold BS, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000010; Winsvold BS, 2013, PAIN, V154, P1305, DOI 10.1016/j.pain.2013.04.007; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563	51	29	30	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185663	10.1371/journal.pone.0185663	http://dx.doi.org/10.1371/journal.pone.0185663			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957430	gold, Green Published, Green Submitted			2022-12-27	WOS:000411985200103
J	Eseberri, I; Lasa, A; Miranda, J; Gracia, A; Portillo, MP				Eseberri, Itziar; Lasa, Arrate; Miranda, Jonatan; Gracia, Ana; Portillo, Maria P.			Potential miRNA involvement in the anti-adipogenic effect of resveratrol and its metabolites	PLOS ONE			English	Article							3T3-L1 PREADIPOCYTE DIFFERENTIATION; ACTIVATED-RECEPTOR-GAMMA; ADIPOCYTE DIFFERENTIATION; PPAR-GAMMA; INHIBITS ADIPOGENESIS; TRANSCRIPTIONAL CONTROL; REGULATED EXPRESSION; ADIPOSE-TISSUE; MICRORNAS; GENE	Objective Scientific research is constantly striving to find molecules which are effective against excessive body fat and its associated complications. Taking into account the beneficial effects that resveratrol exerts on other pathologies through miRNA, the aim of the present work was to analyze the possible involvement of miRNAs in the regulation of adipogenic transcription factors peroxisome proliferator-activated receptor y (ppar gamma), CCAAT enhancer-binding proteins a and beta (cebp beta and cebpa) induced by resveratrol and its metabolites. Methods 3T3-L1 maturing pre-adipocytes were treated during differentiation with 25 mu M of trans-resveratrol (RSV), trans-resveratrol-3-O-sulfate (3S), trans-resveratrol-3'-O-glucuronide (3G) and trans-resveratrol-4'-O-glucuronide (4G). After computational prediction and bibliographic search of miRNAs targeting ppar gamma, cebp beta and cebpa, the expression of microRNA-130b-3p (miR-130b-3p), microRNA-155-5p (miR-155-5p), microRNA-27b-3p (miR-27b-3p), microRNA-31-5p (miR-31-5p), microRNA-326-3p (miR-326-3p), microRNA-27a-3p (miR27a-3p), microRNA-144-3p (miR-144-3p), microRNA-205-5p (miR-205-5p) and microRNA224-3p (miR-224-3p) was analyzed. Moreover, other adipogenic mediators such as sterol regulatory element binding transcription factor 1 (srebfl), kriippel-like factor 5 (k1f5), liver x receptor a (lxra) and cAMP responding element binding protein 1 (crebl), were measured by Real Time RT-PCR. As a confirmatory assay, cells treated with RSV were transfected with anti-miR-155 in order to measure cebp beta gene and protein expressions. Results Of the miRNAs analyzed only miR-155 was modified after resveratrol and glucuronide metabolite treatment. In transfected cells with anti-miR-155, RSV did not reduce cebp beta gene and protein expression. 3S decreased gene expression of crebl, klf5, srebfl and lxra. Conclusions While RSV and glucuronide metabolites exert their inhibitory effect on adipogenesis through miR-155 up-regulation, the anti-adipogenic effect of 3S is not mediated via miRNAs.	[Eseberri, Itziar; Lasa, Arrate; Miranda, Jonatan; Gracia, Ana; Portillo, Maria P.] Univ Basque Country, UPV EHU, Dept Nutr & Food Sci, Nutr & Obes Grp, Vitoria, Spain; [Eseberri, Itziar; Lasa, Arrate; Miranda, Jonatan; Gracia, Ana; Portillo, Maria P.] Lucio Lascaray Res Ctr, Vitoria, Spain; [Eseberri, Itziar; Lasa, Arrate; Miranda, Jonatan; Gracia, Ana; Portillo, Maria P.] Inst Salud Carlos III, Ctr Invest Biomed Fisiopatol Obesidad & Nutr CIBE, Madrid, Spain	University of Basque Country; Instituto de Salud Carlos III	Lasa, A (corresponding author), Univ Basque Country, UPV EHU, Dept Nutr & Food Sci, Nutr & Obes Grp, Vitoria, Spain.; Lasa, A (corresponding author), Lucio Lascaray Res Ctr, Vitoria, Spain.; Lasa, A (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Fisiopatol Obesidad & Nutr CIBE, Madrid, Spain.	arrate.lasa@ehu.eus	Portillo, Maria Puy/ABH-2374-2020; Miranda, Jonatan/F-3289-2011; Eseberri, Itziar/ABE-7228-2020; Miranda, Jonatan/L-4511-2014; Eseberri, Itziar/AAA-8168-2021	Portillo, Maria Puy/0000-0003-0210-6549; Miranda, Jonatan/0000-0002-5484-2671; Eseberri, Itziar/0000-0001-5036-963X; LASA ELGUEZUA, ARRATE/0000-0002-8309-8212; PORTILLO BAQUEDANO, MARIA PUY/0000-0003-2290-592X	Ministerio de Economia y Competitividad [AGL2011-27406-ALI]; Institute de Salud Carlos III (CIBERObn), Government of the Basque Country [IT-572-13]; University of the Basque Country (UPV/EHU) [ELDUNANOTEK UFI11/32]; University of the Basque Country	Ministerio de Economia y Competitividad(Spanish Government); Institute de Salud Carlos III (CIBERObn), Government of the Basque Country; University of the Basque Country (UPV/EHU); University of the Basque Country	This study was supported by grants from the Ministerio de Economia y Competitividad (AGL2011-27406-ALI), Institute de Salud Carlos III (CIBERObn), Government of the Basque Country (IT-572-13) and University of the Basque Country (UPV/EHU) (ELDUNANOTEK UFI11/32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. I. Eseberri is a recipient of a doctoral fellowship from the University of the Basque Country.	Aguirre L, 2014, MOLECULES, V19, P18632, DOI 10.3390/molecules191118632; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andres-Lacueva C, 2009, PLANT PHENOLICS HUMA; Asensi M, 2002, FREE RADICAL BIO MED, V33, P387, DOI 10.1016/S0891-5849(02)00911-5; Azorin-Ortuno M, 2011, MOL NUTR FOOD RES, V55, P1154, DOI 10.1002/mnfr.201100140; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bracken CP, 2016, NAT REV GENET, V17, P719, DOI 10.1038/nrg.2016.134; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chan LS, 2012, HORM METAB RES, V44, P819, DOI 10.1055/s-0032-1321909; Chen SF, 2011, CAN J PHYSIOL PHARM, V89, P793, DOI 10.1139/Y11-077; Chen Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2742; Chen Z., 2015, SHOCK VIB, V2015, P1, DOI DOI 10.1155/2015/390134; Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581; Dweep H, 2015, MIRWALK2 0 COMPREHEN; Juan ME, 2010, J PHARMACEUT BIOMED, V51, P391, DOI 10.1016/j.jpba.2009.03.026; Eseberri I, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/480943; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gan CC, 2017, EUR J PHARMACOL, V797, P45, DOI 10.1016/j.ejphar.2017.01.009; Gaudet AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep22862; Hilton C, 2013, INT J OBESITY, V37, P325, DOI 10.1038/ijo.2012.59; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kawai Y, 2008, J BIOL CHEM, V283, P9424, DOI 10.1074/jbc.M706571200; Kawai Y, 2011, BIOSCI BIOTECH BIOCH, V75, P609, DOI 10.1271/bbb.100785; Kim MA, 2014, LIFE SCI, V101, P64, DOI 10.1016/j.lfs.2014.02.012; Kim M, 2015, NUTRIENTS, V7, P277, DOI 10.3390/nu7010277; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kobori M, 2011, MOL NUTR FOOD RES, V55, P530, DOI 10.1002/mnfr.201000392; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Lancon A, 2013, J SCI FOOD AGR, V93, P3155, DOI 10.1002/jsfa.6228; Lasa A, 2012, MOL NUTR FOOD RES, V56, P1559, DOI 10.1002/mnfr.201100772; Lee EK, 2011, MOL CELL BIOL, V31, P626, DOI 10.1128/MCB.00894-10; Lindroos J, 2013, CELL METAB, V18, P62, DOI 10.1016/j.cmet.2013.05.020; Liu LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01294-2; Liu SH, 2011, BIOCHEM BIOPH RES CO, V414, P618, DOI 10.1016/j.bbrc.2011.09.131; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma CF, 2017, INT J MOL MED, V39, P231, DOI 10.3892/ijmm.2016.2802; Marques AP, 2017, BBA-GEN SUBJECTS, V1861, P673, DOI 10.1016/j.bbagen.2016.12.005; Martin PJ, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0057-5; Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Pan SF, 2014, J CELL PHYSIOL, V229, P631, DOI 10.1002/jcp.24486; Pang WJ, 2013, J CELL BIOCHEM, V114, P2500, DOI 10.1002/jcb.24595; Peng YD, 2013, INT J BIOCHEM CELL B, V45, P1585, DOI 10.1016/j.biocel.2013.04.029; Phuah NH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/804510; Poy MN, 2007, DIABETES OBES METAB, V9, P67, DOI 10.1111/j.1463-1326.2007.00775.x; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Rayalam S, 2008, PHYTOTHER RES, V22, P1367, DOI 10.1002/ptr.2503; Rohm B, 2015, J CELL BIOCHEM, V116, P1153, DOI 10.1002/jcb.25052; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Son YH, 2014, ENDOCRINOL METAB, V29, P122, DOI 10.3803/EnM.2014.29.2.122; Sonkoly E, 2009, INT REV IMMUNOL, V28, P535, DOI 10.3109/08830180903208303; Stefanon B, 2015, EXP BIOL MED, V240, P884, DOI 10.1177/1535370214562341; Sun FY, 2009, BIOCHEM BIOPH RES CO, V380, P660, DOI 10.1016/j.bbrc.2009.01.161; Szkudelska K, 2010, EUR J PHARMACOL, V635, P1, DOI 10.1016/j.ejphar.2010.02.054; Takanabe R, 2008, BIOCHEM BIOPH RES CO, V376, P728, DOI 10.1016/j.bbrc.2008.09.050; Tang QQ, 1999, MOL CELL BIOL, V19, P4855; Tang YF, 2009, OMICS, V13, P331, DOI 10.1089/omi.2009.0017; Tao C, 2015, BIOCHEM BIOPH RES CO, V463, P193, DOI 10.1016/j.bbrc.2015.05.014; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Tome-Carneiro J, 2013, PHARMACOL RES, V72, P69, DOI 10.1016/j.phrs.2013.03.011; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wang T, 2011, INT J MOL SCI, V12, P7950, DOI 10.3390/ijms12117950; Yang JY, 2008, LIFE SCI, V82, P1032, DOI 10.1016/j.lfs.2008.03.003; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Yu JW, 2014, BIOTECHNOL LETT, V36, P1233, DOI 10.1007/s10529-014-1491-8; Zhang J, 2016, BIOMED PHARMACOTHER, V86, P292; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Zhang T, 2014, ARCH BIOCHEM BIOPHYS, V554, P44, DOI 10.1016/j.abb.2014.05.008; Zhu JG, 2012, CELL BIOCHEM BIOPHYS, V63, P1, DOI 10.1007/s12013-012-9336-3; Zhu W, 2015, J NUTR BIOCHEM, V26, P1124, DOI 10.1016/j.jnutbio.2015.05.006; Zou B, 2015, EUR J NUTR, V54, P1333, DOI 10.1007/s00394-014-0814-9	77	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184875	10.1371/journal.pone.0184875	http://dx.doi.org/10.1371/journal.pone.0184875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953910	Green Published, gold, Green Submitted			2022-12-27	WOS:000411980300024
J	Ko, BJ; Chang, Y; Ryu, S; Kim, EM; Lee, MY; Hyun, YY; Lee, KB				Ko, Byung-Joon; Chang, Yoosoo; Ryu, Seungho; Kim, Eun Mi; Lee, Mi Yeon; Hyun, Young Youl; Lee, Kyu-Beck			Dietary acid load and chronic kidney disease in elderly adults: Protein and potassium intake	PLOS ONE			English	Article							METABOLIC-ACIDOSIS; SODIUM; RISK; CKD; CONSUMPTION; EXCRETION; EQUATION; FRUIT	Background Dietary net endogenous acid production (NEAP), which represents total dietary load of nonvolatile acid, may affect kidney function. Estimated NEAP (eNEAP) is calculated indirectly by the ratio of protein and potassium intake. A few studies are available assessing the association between eNEAP and chronic kidney disease (CKD), and its relation to dietary protein and potassium intake in the elderly. Methods A total 1,369 community-dwelling elderly Koreans in the Kangbuk Samsung Cohort Study (KSCS) were evaluated using a food frequency questionnaire (FFQ) and comprehensive health examination. We evaluated the association between eNEAP and the CKD. We also examined their relation to protein and potassium intake. Results eNEAP was correlated with potassium intake (r = -0.410, P < 0.001), but was not correlated with protein intake (r = -0.004, P = 0.879). In a full multivariate adjustment for sociodemographic factors, dietary factors, and comorbidities, the participants with higher eNEAP quartiles (Q2, Q3, Q4) had higher odds of CKD compared to the lowest eNEAP quartile (Q1); OR (95% CI) were 1.47 (0.78-2.72), 1.66 (0.85-3.23), and 2.30 (1.16-4.60) respectively (P for trend = 0.019). The odds of CKD decreased for participants with higher potassium intake quartiles (Q2, Q3, Q4) compared to the lowest potassium intake quartile (Q1); OR (95% CI) were 0.52 (0.28-0.95), 0.50 (0.26-0.96), and 0.50 (0.21-0.99) respectively (P for trend = 0.050). Protein intake was not associated with CKD. The association between eNEAP and CKD was similar in subgroup analysis. Conclusion Dietary acid load was associated with CKD. Among the nutrients related to dietary acid load, potassium intake was negatively associated with CKD, but protein intake was not associated with CKD in elderly adults.	[Ko, Byung-Joon; Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Occupat & Environm Med, Seoul, South Korea; [Ko, Byung-Joon; Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Ctr Cohort Studies,Total Healthcare Ctr, Seoul, South Korea; [Kim, Eun Mi] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Dietet, Seoul, South Korea; [Lee, Mi Yeon] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Biostat, Sch Med, Seoul, South Korea; [Hyun, Young Youl; Lee, Kyu-Beck] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Internal Med,Div Nephrol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, KB (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Internal Med,Div Nephrol, Seoul, South Korea.	kyubeck.lee@samsung.com		Chang, Yoosoo/0000-0002-6945-9050; Lee, kyu-Beck/0000-0002-3904-5404				Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1378; Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Banerjee T, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-137; Blanch N, 2015, NUTR METAB CARDIOVAS, V25, P253, DOI 10.1016/j.numecd.2014.10.001; Chiavaroli L, 2015, EUR J CLIN NUTR, V69, P761, DOI 10.1038/ejcn.2014.237; Choi Y, 2015, ATHEROSCLEROSIS, V241, P305, DOI 10.1016/j.atherosclerosis.2015.05.036; Choi Y, 2015, HEART, V101, P686, DOI 10.1136/heartjnl-2014-306663; Fagherazzi G, 2014, DIABETOLOGIA, V57, P313, DOI 10.1007/s00125-013-3100-0; Fenton TR, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-41; Frassetto LA, 1998, AM J CLIN NUTR, V68, P576, DOI 10.1093/ajcn/68.3.576; Hariharan D, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0529-6; Jacobs DR, 2009, AM J CLIN NUTR, V89, pS1543, DOI 10.3945/ajcn.2009.26736B; Ji E, 2016, KOREAN J INTERN MED, V31, P1120, DOI 10.3904/kjim.2015.193; Kieneker LM, 2016, KIDNEY INT, V90, P888, DOI 10.1016/j.kint.2016.07.012; Korean Nutrition Society, 2006, FOOD VAL NUTR COMP T; Kraut JA, 2016, AM J KIDNEY DIS, V67, P307, DOI 10.1053/j.ajkd.2015.08.028; Leonberg-Yoo AK, 2016, AM J KIDNEY DIS; Levey AS, 2006, AM J KIDNEY DIS, V48, P879, DOI 10.1053/j.ajkd.2006.08.023; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lew QLJ, 2017, J AM SOC NEPHROL, V28, P304, DOI [10.1681/ASN.2016030248, 10.1681/asn.2016030248]; Lim H, 2014, NUTR RES, V34, P760, DOI 10.1016/j.nutres.2014.08.002; Millen BE, 2016, ADV NUTR, V7, P438, DOI 10.3945/an.116.012120; Rebholz CM, 2015, AM J NEPHROL, V42, P427, DOI 10.1159/000443746; Scialla JJ, 2013, ADV CHRONIC KIDNEY D, V20, P141, DOI 10.1053/j.ackd.2012.11.001; Sharma S, 2013, AM J NEPHROL, V37, P526, DOI 10.1159/000351178; Smyth A, 2014, KIDNEY INT, V86, P1205, DOI 10.1038/ki.2014.214; Tonelli M, 2014, AM J KIDNEY DIS, V63, P349, DOI 10.1053/j.ajkd.2014.01.003; Weaver CM, 2013, ADV NUTR, V4, p368S, DOI 10.3945/an.112.003533; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; Wesson DE, 2012, KIDNEY INT, V82, P1184, DOI 10.1038/ki.2012.267; Wesson DE, 2009, KIDNEY INT, V75, P929, DOI 10.1038/ki.2009.6; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Williams RS, 2016, BIOCHIMIE, V124, P171, DOI 10.1016/j.biochi.2015.09.012	34	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185069	10.1371/journal.pone.0185069	http://dx.doi.org/10.1371/journal.pone.0185069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953915	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300031
J	Saak, CC; Zepeda-Rivera, MA; Gibbs, KA				Saak, Christina C.; Zepeda-Rivera, Martha A.; Gibbs, Karine A.			A single point mutation in a TssB/VipA homolog disrupts sheath formation in the type VI secretion system of Proteus mirabilis	PLOS ONE			English	Article							SWISS-MODEL; DIENES PHENOMENON; SELF-IDENTITY; IDENTIFICATION; WEB; DETERMINANTS; MUTAGENESIS; COMPETITION; EFFECTORS; REQUIRES	The type VI secretion (T6S) system is a molecular device for the delivery of proteins from one cell into another. T6S function depends on the contractile sheath comprised of TssB/VipA and TssC/VipB proteins. We previously reported on a mutant variant of TssB that disrupts T6S-dependent export of the self-identity protein, IdsD, in the bacterium Proteus mirabilis. Here we determined the mechanism underlying that initial observation. We show that T6S-dependent export of multiple self-recognition proteins is abrogated in this mutant strain. We have mapped the mutation, which is a single amino acid change, to a region predicted to be involved in the formation of the TssB-TssC sheath. We have demonstrated that this mutation does indeed inhibit sheath formation, thereby explaining the global disruption of T6S activity. We propose that this mutation could be utilized as an important tool for studying functions and behaviors associated with T6S systems.	[Saak, Christina C.; Zepeda-Rivera, Martha A.; Gibbs, Karine A.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Gibbs, KA (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kagibbs@mcb.harvard.edu	Zepeda Rivera, Martha/AAE-2524-2022	Zepeda Rivera, Martha/0000-0002-2408-8719; Saak, Christina Caroline/0000-0001-7041-8531; Gibbs, Karine/0000-0002-1246-6401				Alteri CJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003608; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BELAS R, 1991, J BACTERIOL, V173, P6289, DOI 10.1128/jb.173.19.6289-6293.1991; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Brooks TM, 2013, J BIOL CHEM, V288, P7618, DOI 10.1074/jbc.M112.436725; Brunet YR, 2015, INFECT IMMUN, V83, P2738, DOI 10.1128/IAI.00198-15; Brunet YR, 2014, EMBO REP, V15, P315, DOI 10.1002/embr.201337936; Brunet YR, 2013, CELL REP, V3, P36, DOI 10.1016/j.celrep.2012.11.027; Budding AE, 2009, J BACTERIOL, V191, P3892, DOI 10.1128/JB.00975-08; Cardarelli L, 2015, MBIO, V6, DOI 10.1128/mBio.00251-15; Clemens DL, 2015, CELL, V160, P940, DOI 10.1016/j.cell.2015.02.005; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; DIENES L, 1947, P SOC EXP BIOL MED, V66, P97; Durand E, 2015, NATURE, V523, P555, DOI 10.1038/nature14667; Durand E, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.390153; Gerc AJ, 2015, CELL REP, V12, P2131, DOI 10.1016/j.celrep.2015.08.053; Gibbs KA, 2008, SCIENCE, V321, P256, DOI 10.1126/science.1160033; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hachani A, 2014, J BIOL CHEM, V289, P17872, DOI 10.1074/jbc.M114.563429; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; HOENIGER JF, 1965, J GEN MICROBIOL, V40, P29, DOI 10.1099/00221287-40-1-29; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Jones BV, 2004, INFECT IMMUN, V72, P3941, DOI 10.1128/IAI.72.7.3941-3950.2004; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kapitein N, 2013, MOL MICROBIOL, V87, P1013, DOI 10.1111/mmi.12147; Kube S, 2014, CELL REP, V8, P20, DOI 10.1016/j.celrep.2014.05.034; Kudryashev M, 2015, CELL, V160, P952, DOI 10.1016/j.cell.2015.01.037; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Ma LS, 2014, CELL HOST MICROBE, V16, P94, DOI 10.1016/j.chom.2014.06.002; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Pearson MM, 2008, J BACTERIOL, V190, P4027, DOI 10.1128/JB.01981-07; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Rauprich O, 1996, J BACTERIOL, V178, P6525, DOI 10.1128/jb.178.22.6525-6538.1996; Russell AB, 2013, NATURE, V496, P508, DOI 10.1038/nature12074; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Saak CC, 2016, J BACTERIOL, V198, P3278, DOI 10.1128/JB.00402-16; Schrodinger L.L.C., 2015, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S13398-014-0173-7.2; Sei E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004652; SENIOR BW, 1977, J GEN MICROBIOL, V102, P235, DOI 10.1099/00221287-102-2-235; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sturgill GM, 2002, FEMS MICROBIOL LETT, V217, P43, DOI 10.1016/S0378-1097(02)01043-1; Sullivan NL, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00024-13; Unterweger D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4549; Vallejo AN, 2008, CSH PROTOC 2008; WARREN JW, 1982, J INFECT DIS, V146, P719, DOI 10.1093/infdis/146.6.719; Wenren LM, 2013, MBIO, V4, DOI 10.1128/mBio.00374-13; Whitney JC, 2013, J BIOL CHEM, V288, P26616, DOI 10.1074/jbc.M113.488320; WU Q-R, 1991, Zhonghua Jiehe He Huxi Zazhi, V14, P173; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081074; Zoued A, 2013, J BIOL CHEM, V288, P27031, DOI 10.1074/jbc.M113.499772	65	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0184797	10.1371/journal.pone.0184797	http://dx.doi.org/10.1371/journal.pone.0184797			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949977	Green Submitted, Green Published, gold			2022-12-27	WOS:000411671000017
J	Ouimet, M; Lalancette, P; Racine, A				Ouimet, Mathieu; Lalancette, Pascal; Racine, Alexandre			Health technology assessments conducted in health care facilities: A strategic practice? Findings from a content analysis of HTA reports	PLOS ONE			English	Article							INFORMATION-TRANSMISSION; CHEAP TALK; COMMUNICATION; EVOLUTION; GAMES	In this paper, we test the hypothesis that health technology assessment units located in hospitals tend to be more optimistic toward technologies that are currently in use in their organization than technologies that are not. The data include 108 health technologies assessed in 87 full-scale health technology assessment reports produced by the four main local health technology assessment units in Quebec (Canada) on behalf of decision makers from the same facility. We found that 58 (53.7 percent) of the 108 technologies were currently in use within the hospital during their assessment. Based on the assessors' interpretation of the scientific evidence regarding the efficacy of the technologies, 67.3 percent of the technologies that were in use in the hospital during the evaluation were effective (56 percent for those that were not currently being used), but the difference is not statistically significant (chi-square 1.38; p = 0.24). Controlling for the efficacy judgment, the type of technologies (i.e. preventive, diagnostic, therapeutic or organizational), the number of technologies assessed in the report and the assessment unit, we found that the technologies that were currently in use in the facility during the evaluation were 62 percent more likely to be recommended favorably by the assessment unit than the technologies that were not currently being used (RR = 1.62; 95 percent CI = 1.06-1.88). This suggests that the local health technology units that were examined in the study tended to be more optimistic toward technologies that were currently in use in their hospital at the time of the evaluation.	[Ouimet, Mathieu; Lalancette, Pascal; Racine, Alexandre] Univ Laval, Fac Social Sci, Dept Polit Sci, Quebec City, PQ, Canada	Laval University	Ouimet, M (corresponding author), Univ Laval, Fac Social Sci, Dept Polit Sci, Quebec City, PQ, Canada.	mathieu.ouimet@pol.ulaval.ca						ARTHUR WB, 1989, ECON J, V99, P116, DOI 10.2307/2234208; Battaglini M, 2014, GAME ECON BEHAV, V83, P147, DOI 10.1016/j.geb.2013.11.004; Blume A, 1998, AM ECON REV, V88, P1323; Blume A, 2001, GAME ECON BEHAV, V37, P79, DOI 10.1006/game.2000.0830; Cai HB, 2006, GAME ECON BEHAV, V56, P7, DOI 10.1016/j.geb.2005.04.001; Chung W, 2012, BIASED RECOMMENDATIO; CRAWFORD VP, 1982, ECONOMETRICA, V50, P1431, DOI 10.2307/1913390; De Haan T, 2015, INT ECON REV, V56, P1385, DOI 10.1111/iere.12141; Duffy S, 2014, THEOR DECIS, V76, P395, DOI 10.1007/s11238-013-9380-5; EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P57, DOI 10.2307/258191; Fattal J, 2008, INT J TECHNOL ASSESS, V24, P473, DOI 10.1017/S0266462308080628; Gagnon M.P., 2006, IMPLEMENT SCI, V1, P1; Gagnon S, 2016, CARTOGRAPHIE RESSOUR; Guston David H, 2003, SCI PUBL POLICY, V30, P347; Hempel C., 1948, PHILOS SCI, V15, P135, DOI DOI 10.1086/286983; Hempel C. G., 1988, ERKENNTNIS, V28, P147, DOI DOI 10.1007/BF00166441; Hilbe JM, 2007, ODDSRISK STATA MODUL; Hivon M, 2005, INT J TECHNOL ASSESS, V21, P268, DOI 10.1017/S0266462305050361; Holmtrom B., 1980, 438 NW U; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Lafortune L, 2008, INT J TECHNOL ASSESS, V24, P76, DOI 10.1017/S0266462307080105; Lehoux P., 2006, PROBLEM HLTH TECHNOL; Merton RK, 1940, SOC FORCES, V18, P560, DOI 10.2307/2570634; Selznick P, 1943, AM SOCIOL REV, V8, P47, DOI 10.2307/2085448	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185183	10.1371/journal.pone.0185183	http://dx.doi.org/10.1371/journal.pone.0185183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI0UK	28945772	Green Published, gold, Green Submitted			2022-12-27	WOS:000411645100027
J	Gayda, M; Gremeaux, V; Bherer, L; Juneau, M; Drigny, J; Dupuy, O; Lapierre, G; Labelle, V; Fortier, A; Nigam, A				Gayda, Mathieu; Gremeaux, Vincent; Bherer, Louis; Juneau, Martin; Drigny, Joffrey; Dupuy, Olivier; Lapierre, Gabriel; Labelle, Veronique; Fortier, Annik; Nigam, Anil			Cognitive function in patients with stable coronary heart disease: Related cerebrovascular and cardiovascular responses	PLOS ONE			English	Article							CARDIAC-OUTPUT; CARDIORESPIRATORY FITNESS; CEREBRAL OXYGENATION; ARTERY-DISEASE; OLDER-ADULTS; IMPEDANCE CARDIOGRAPHY; METABOLIC SYNDROME; EXERCISE; PERFORMANCE; DECLINE	Chronic exercise has been shown to prevent or slow age-related decline in cognitive functions in otherwise healthy, asymptomatic individuals. We sought to assess cognitive function in a stable coronary heart disease (CHD) sample and its relationship to cerebral oxygenation-perfusion, cardiac hemodynamic responses, and VO2 peak compared to age-matched and young healthy control subjects. Twenty-two young healthy controls (YHC), 20 age-matched old healthy controls (OHC) and 25 patients with stable CHD were recruited. Cognitive function assessment included short term- working memory, perceptual abilities, processing speed, cognitive inhibition and flexibility and long-term verbal memory. Maximal cardiopulmonary function (gas exchange analysis), cardiac hemodynamic (impedance cardiography) and left frontal cerebral oxygenation-perfusion (near-infra red spectroscopy) were measured during and after a maximal incremental ergocycle test. Compared to OHC and CHD, YHC had higher VO2 peak, maximal cardiac index (CI max), cerebral oxygenation-perfusion (Delta O-2 Hb, Delta tHb: exercise and recovery) and cognitive function (for all items) (P< 0.05). Compared to OHC, CHD patients had lower VO2 peak, CI max, cerebral oxygenation- perfusion (during recovery) and short term-working memory, processing speed, cognitive inhibition and flexibility and long-term verbal memory (P< 0.05). VO2 peak and CI max were related to exercise cerebral oxygenation-perfusion and cognitive function (P< 0.005). Cerebral oxygenation-perfusion (exercise) was related to cognitive function (P< 0.005). Stable CHD patients have a worse cognitive function, a similar cerebral oxygenation/ perfusion during exercise but reduced one during recovery vs. their aged-matched healthy counterparts. In the all sample, cognitive functions correlated with VO2 peak, CI max and cerebral oxygenation-perfusion.	[Gayda, Mathieu; Bherer, Louis; Juneau, Martin; Drigny, Joffrey; Dupuy, Olivier; Lapierre, Gabriel; Nigam, Anil] Montreal Heart Inst, Cardiovasc Prevent & Rehabil Ctr EPIC, Montreal, PQ, Canada; [Gayda, Mathieu; Bherer, Louis; Juneau, Martin; Drigny, Joffrey; Dupuy, Olivier; Lapierre, Gabriel; Nigam, Anil] Univ Montreal, Montreal, PQ, Canada; [Gayda, Mathieu; Bherer, Louis; Juneau, Martin; Lapierre, Gabriel; Nigam, Anil] Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada; [Gayda, Mathieu; Bherer, Louis; Juneau, Martin; Lapierre, Gabriel; Nigam, Anil] Univ Montreal, Fac Med, Dept Med, Montreal, PQ, Canada; [Gremeaux, Vincent] INSERM, Cognit Act & Plast Sensorimotrice U1093, Dijon, France; [Dupuy, Olivier] Concordia Univ, PERFORM Ctr, Dept Psychol, Montreal, PQ, Canada; [Dupuy, Olivier; Labelle, Veronique] Inst Univ Geriatr Montreal, Res Ctr, Montreal, PQ, Canada; [Dupuy, Olivier] Univ Poitiers, Fac Sport Sci, Lab, MOVE EA6314, Poitiers, France; [Fortier, Annik] Montreal Heart Inst, Montreal Hlth Innovat Coordinating Ctr, Div A, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Concordia University - Canada; Universite de Montreal; Universite de Poitiers; Universite de Montreal	Nigam, A (corresponding author), Montreal Heart Inst, Cardiovasc Prevent & Rehabil Ctr EPIC, Montreal, PQ, Canada.; Nigam, A (corresponding author), Univ Montreal, Montreal, PQ, Canada.; Nigam, A (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada.; Nigam, A (corresponding author), Univ Montreal, Fac Med, Dept Med, Montreal, PQ, Canada.	anil.nigam@icm-mhi.org	drigny, joffrey/AAD-4046-2020; Dupuy, Olivier/AAT-4275-2020; Gayda, Mathieu/U-8520-2019	Gayda, Mathieu/0000-0003-1721-2299; Drigny, Joffrey/0000-0001-7670-8791; Dupuy, Olivier/0000-0001-7273-8272	Cardiovascular Prevention and Rehabilitation Centre Foundation; Montreal Heart Institute Foundation; Reseau Quebecois de Recherche sur le Vieillissement	Cardiovascular Prevention and Rehabilitation Centre Foundation; Montreal Heart Institute Foundation; Reseau Quebecois de Recherche sur le Vieillissement	This work was supported by Cardiovascular Prevention and Rehabilitation Centre Foundation (MG, VG, MJ, GL, AN), Montreal Heart Institute Foundation (MG, VG, MJ, GL, AN) and Reseau Quebecois de Recherche sur le Vieillissement (LB, VL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Alosco ML, 2013, BRAIN BEHAV, V3, P626, DOI 10.1002/brb3.171; Alosco ML, 2012, CEREBROVASC DIS EXTR, V2, P88, DOI 10.1159/000343222; Avadhani R, 2015, AM J MED, V128, P46, DOI 10.1016/j.amjmed.2014.08.025; Barekatain M, 2014, J RES MED SCI, V19, P739; Belardinelli R, 1996, AM J CARDIOL, V77, P1293, DOI 10.1016/S0002-9149(97)89153-9; Bherer Louis, 2013, J Aging Res, V2013, P197326, DOI [10.1155/2013/657508, 10.1155/2013/197326]; Bolduc V, 2013, AM J PHYSIOL-HEART C, V305, pH620, DOI 10.1152/ajpheart.00624.2012; Boots EA, 2014, BRAIN IMAGING BEHAV; Charloux A, 2000, EUR J APPL PHYSIOL, V82, P313, DOI 10.1007/s004210000226; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Davenport MH, 2012, EXERC SPORT SCI REV, V40, P153, DOI 10.1097/JES.0b013e3182553430; Drigny J, 2014, J REHABIL MED, V46, P1050, DOI 10.2340/16501977-1905; Fisher JP, 2013, J PHYSIOL-LONDON, V591, P1859, DOI 10.1113/jphysiol.2012.244905; Fu TC, 2013, INT J CARDIOL, V167, P41, DOI 10.1016/j.ijcard.2011.11.086; Fu TC, 2011, AM J PHYSIOL-HEART C, V300, pH1545, DOI 10.1152/ajpheart.00867.2010; Galioto RM, 2013, AGING NEUROPSYCHOL C, V20, P684, DOI 10.1080/13825585.2012.762972; Gayda M, 2015, CAN J CARDIOL; Gayda M, 2008, NUTR METAB CARDIOVAS, V18, P142, DOI 10.1016/j.numecd.2006.07.003; Gayda M, 2016, CAN J CARDIOL, V32, P539, DOI 10.1016/j.cjca.2015.07.011; Gayda M, 2012, APPL PHYSIOL NUTR ME, V37, P1171, DOI 10.1139/h2012-109; Gayda M, 2010, EUR J APPL PHYSIOL, V109, P191, DOI 10.1007/s00421-009-1312-2; Gremeaux V, 2012, CAN J CARDIOL, V28, pS386, DOI 10.1016/j.cjca.2012.07.676; Guiraud T, 2011, MED SCI SPORT EXER, V43, P211, DOI 10.1249/MSS.0b013e3181ebc5de; Hutter I, 2014, INT ANGIOL; Jefferson AL, 2007, NEUROBIOL AGING, V28, P477, DOI 10.1016/j.neurobiolaging.2006.01.001; Koike A, 2004, AM J CARDIOL, V94, P821, DOI 10.1016/j.amjcard.2004.06.013; Labelle V, 2013, BRAIN COGNITION, V81, P10, DOI 10.1016/j.bandc.2012.10.001; Langlois F, 2013, J GERONTOL B-PSYCHOL, V68, P400, DOI 10.1093/geronb/gbs069; Longstreth WT, 2005, STROKE, V36, P56, DOI 10.1161/01.STR.0000149625.99732.69; Lucas SJE, 2012, EXP GERONTOL, V47, P541, DOI 10.1016/j.exger.2011.12.002; Moser D J, 1999, J Cardiopulm Rehabil, V19, P91, DOI 10.1097/00008483-199903000-00002; NORTHRIDGE DB, 1990, BRIT HEART J, V63, P93; Perez-Belmonte LM, 2014, MED CLIN-BARCELONA, V143, P109, DOI 10.1016/j.medcli.2013.06.031; Prakash RS, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00229; Reis JP, 2013, ATHEROSCLEROSIS, V231, P72, DOI 10.1016/j.atherosclerosis.2013.08.038; Richard R, 2001, EUR J APPL PHYSIOL, V85, P202, DOI 10.1007/s004210100458; Scherhag A, 2005, KIDNEY BLOOD PRESS R, V28, P77, DOI 10.1159/000083695; Selnes OA, 2009, ANN THORAC SURG, V88, P445, DOI 10.1016/j.athoracsur.2009.04.061; Singh-Manoux A, 2003, J AM GERIATR SOC, V51, P1445, DOI 10.1046/j.1532-5415.2003.51464.x; Swardfager W, 2010, J AM GERIATR SOC, V58, P1519, DOI 10.1111/j.1532-5415.2010.02966.x; Tseng BY, 2013, J MAGN RESON IMAGING, V38, P1169, DOI 10.1002/jmri.24085; van der Veen PH, 2013, J NEUROL SCI; Vinkers DJ, 2005, NEUROLOGY, V65, P107, DOI 10.1212/01.wnl.0000167544.54228.95; Weinstein G, 2014, INT J STROKE, V9, P48, DOI 10.1111/ijs.12275; Welsman J, 2005, EUR J APPL PHYSIOL, V94, P228, DOI 10.1007/s00421-004-1300-5; Wendell CR, 2014, J GERONTOL A-BIOL, V69, P455, DOI 10.1093/gerona/glt144; Zheng L, 2012, J AM GERIATR SOC, V60, P499, DOI 10.1111/j.1532-5415.2011.03839.x; Zhu N, 2014, NEUROLOGY, V82, P1339, DOI 10.1212/WNL.0000000000000310	48	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0183791	10.1371/journal.pone.0183791	http://dx.doi.org/10.1371/journal.pone.0183791			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH9IR	28937981	gold, Green Submitted, Green Published			2022-12-27	WOS:000411524700003
J	Rahman, MM; Hussain, MM; Asiri, AM				Rahman, Mohammed M.; Hussain, Mohammad Musarraf; Asiri, Abdullah M.			Fabrication of 3-methoxyphenol sensor based on Fe3O4 decorated carbon nanotube nanocomposites for environmental safety: Real sample analyses	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; CHEMICAL SENSOR; ELECTROCHEMICAL DETECTION; MAGNETIC NANOCOMPOSITES; FACILE SYNTHESIS; ELECTRODE; AEROGRAPHITE; 4-AMINOPHENOL; NANOSHEETS; REDUCTION	Iron oxide ornamented carbon nanotube nanocomposites (Fe3O4. CNT NCs) were prepared by a wet-chemical process in basic means. The optical, morphological, and structural characterizations of Fe3O4. CNT NCs were performed using FTIR, UV/Vis., FESEM, TEM; XEDS, XPS, and XRD respectively. Flat GCE had been fabricated with a thin-layer of NCs using a coating binding agent. It was performed for the chemical sensor development by a dependable I-V technique. Among all interfering analytes, 3-methoxyphenol (3-MP) was selective towards the fabricated sensor. Increased electrochemical performances for example elevated sensitivity, linear dynamic range (LDR) and continuing steadiness towards selective 3-MP had been observed with chemical sensor. The calibration graph found linear (R R-2 = 0.9340) in a wide range of 3-MP concentration (90.0 pM similar to 90.0 mM). The limit of detection and sensitivity were considered as 1.0 pM and 9x10(-4) mu A mu M-1 cm(-2) respectively. The prepared of Fe3O4. CNT NCs by a wet-chemical progression is an interesting route for the development of hazardous phenolic sensor based on nanocomposite materials. It is also recommended that 3-MP sensor is exhibited a promising performances based on Fe3O4. CNT NCs by a facile I-V method for the significant applications of toxic chemicals for the safety of environmental and health-care fields.	[Rahman, Mohammed M.; Hussain, Mohammad Musarraf; Asiri, Abdullah M.] King Abdulaziz Univ, Chem Dept, Jeddah, Saudi Arabia; [Rahman, Mohammed M.; Hussain, Mohammad Musarraf; Asiri, Abdullah M.] King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah, Saudi Arabia	King Abdulaziz University; King Abdulaziz University	Rahman, MM (corresponding author), King Abdulaziz Univ, Chem Dept, Jeddah, Saudi Arabia.; Rahman, MM (corresponding author), King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah, Saudi Arabia.	mmrahman@kau.edu.sa	Asiri, Abdullah M./C-3458-2009; Rahman, Mohammed M./H-5823-2012; Hussain, Mohammad Musarraf/P-9590-2016	Asiri, Abdullah M./0000-0001-7905-3209; Rahman, Mohammed M./0000-0003-2773-1244; Hussain, Mohammad Musarraf/0000-0001-9270-0474				Alam MK, 2017, J ELECTROANAL CHEM, V788, P66, DOI 10.1016/j.jelechem.2017.02.004; Amstad E, 2011, NANOSCALE, V3, P2819, DOI 10.1039/c1nr10173k; Anju M, 2015, RSC ADV, V5, P78648, DOI 10.1039/c5ra16954b; Balkhoyor HB, 2016, RSC ADV, V6, P58236, DOI 10.1039/c6ra10863f; Balkhoyor HB, 2017, CHEM SENSORS BASED N, P1; Chen SL, 2009, J MATER CHEM, V19, P6387, DOI 10.1039/b902170a; Easterday R, 2015, CATAL SCI TECHNOL, V5, P1902, DOI 10.1039/c4cy01277a; Faisal M, 2011, APPL SURF SCI, V258, P672, DOI 10.1016/j.apsusc.2011.07.067; Fan Y, 2011, SENSOR ACTUAT B-CHEM, V157, P669, DOI 10.1016/j.snb.2011.05.053; Garlof S, 2017, CARBON, V111, P103, DOI 10.1016/j.carbon.2016.09.046; Garlof S, 2016, COMPOS SCI TECHNOL, V134, P226, DOI 10.1016/j.compscitech.2016.08.019; Ge JW, 2013, GREEN CHEM, V15, P2064, DOI 10.1039/c3gc40712h; Herman DAJ, 2011, CHEM COMMUN, V47, P9221, DOI 10.1039/c1cc13416g; Hussain MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166265; Hussain MM, 2017, J ENVIRON SCI, V53, P27, DOI 10.1016/j.jes.2016.03.028; Hussain MM, 2016, MICROCHIM ACTA, V183, P3265, DOI 10.1007/s00604-016-1983-4; Hussain MM, 2016, RSC ADV, V6, P80511, DOI 10.1039/c6ra12256f; Jang B, 2013, J MATER CHEM A, V1, P15442, DOI 10.1039/c3ta13717a; Jianying Qu, 2015, Sensing and Bio-Sensing Research, V3, P74, DOI 10.1016/j.sbsr.2014.10.009; Khan SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085290; Khayatian G, 2013, J BRAZIL CHEM SOC, V24, P1808, DOI 10.5935/0103-5053.20130226; Lin CY, 2015, SENSOR ACTUAT B-CHEM, V220, P695, DOI 10.1016/j.snb.2015.06.022; Lin TY, 2014, RSC ADV, V4, P29357, DOI 10.1039/c4ra03505d; Liu CY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09498; Liu JX, 2010, ANAL CHEM, V82, P7380, DOI 10.1021/ac101510b; Lupan O, 2017, SMALL, V13, DOI 10.1002/smll.201602868; Mitchell E, 2014, NEW J CHEM, V38, P4344, DOI 10.1039/c4nj00741g; Nallathamby PD, 2015, NANOSCALE, V7, P6545, DOI 10.1039/c4nr06441k; Nissim R, 2014, ANALYST, V139, P5911, DOI 10.1039/c4an01417k; Nolan M, 2011, PHYS CHEM CHEM PHYS, V13, P18194, DOI 10.1039/c1cp21418g; Oliveira HS, 2015, NEW J CHEM, V39, P3051, DOI 10.1039/c4nj02063d; Prakash R, 2013, BEILSTEIN J NANOTECH, V4, P699, DOI 10.3762/bjnano.4.79; Qiao RR, 2009, J MATER CHEM, V19, P6274, DOI 10.1039/b902394a; Rahman MM, 2011, NANOMATERIALS, P1, DOI 10.5772/1371; Rahman MM, 2017, ELECTROCHEMICAL SENS; Rahman MM, 2017, TALANTA, V170, P215, DOI 10.1016/j.talanta.2017.04.017; Rahman MM, 2017, SENSOR ACTUAT B-CHEM, V242, P167, DOI 10.1016/j.snb.2016.11.053; Rahman MM, 2017, J ENVIRON MANAGE, V188, P228, DOI 10.1016/j.jenvman.2016.12.008; Rahman MM, 2016, MICROCHIM ACTA, V183, P3255, DOI 10.1007/s00604-016-1987-0; Rahman MM, 2016, RSC ADV, V6, P65338, DOI 10.1039/c6ra11582a; Rahman MM, 2016, J TAIWAN INST CHEM E, V64, P157, DOI 10.1016/j.jtice.2016.04.009; Rahman MM, 2016, RSC ADV, V6, P48435, DOI 10.1039/c6ra04124h; Rahman MM, 2015, RSC ADV, V5, P71370, DOI 10.1039/c5ra10793h; Rahman MM, 2015, RSC ADV, V5, P63252, DOI 10.1039/c5ra08224b; Rahman MM, 2015, MICROCHIM ACTA, V182, P487, DOI 10.1007/s00604-014-1345-z; Rahman MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085036; Rahman MM, 2013, ELECTROCHIM ACTA, V112, P422, DOI 10.1016/j.electacta.2013.08.164; Rahman MM, 2011, J PHYS CHEM C, V115, P9503, DOI 10.1021/jp202252j; Saber O, 2015, RSC ADV, V5, P72863, DOI 10.1039/c5ra13051d; Schuchardt A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08839; Snure M, 2007, J NANOSCI NANOTECHNO, V7, P481, DOI 10.1166/jnn.2007.139; Snure M, 2008, J APPL PHYS, V104, DOI 10.1063/1.2988131; Su YX, 2015, FUEL, V160, P80, DOI 10.1016/j.fuel.2015.07.077; Sundar S, 2015, RSC ADV, V5, P74408, DOI 10.1039/c5ra15166j; Tian K, 2015, MAT SCI ENG C-MATER, V46, P548, DOI 10.1016/j.msec.2014.10.064; Tiginyanu I, 2016, SCI REP-UK, V6, DOI 10.1038/srep32913; Vilian ATE, 2015, ANAL METHODS-UK, V7, P5627, DOI [10.1039/C5AY01005E, 10.1039/c5ay01005e]; Wawrzynczak A, 2016, DYES PIGMENTS, V124, P27, DOI 10.1016/j.dyepig.2015.08.025; Xiong R, 2014, RSC ADV, V4, P22632, DOI 10.1039/c4ra01397b; Xu JQ, 2008, SENSOR ACTUAT B-CHEM, V132, P334, DOI 10.1016/j.snb.2008.01.062; Xu JJ, 2010, ACS NANO, V4, P5019, DOI 10.1021/nn1006539; Xu YL, 2014, J MATER CHEM B, V2, P6198, DOI 10.1039/c4tb00840e; Yang X, 2012, RSC ADV, V2, P8821, DOI 10.1039/c2ra20885g; Zhang C, 2016, CHEM ENG J, V284, P247, DOI 10.1016/j.cej.2015.08.096; Zhang Y, 2015, PHYS CHEM CHEM PHYS, V17, P14656, DOI 10.1039/c5cp00373c	65	47	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0177817	10.1371/journal.pone.0177817	http://dx.doi.org/10.1371/journal.pone.0177817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938019	Green Published, Green Submitted, gold			2022-12-27	WOS:000411524700001
J	Rodionova, NN; Allakhverdiev, ES; Maksimov, GV				Rodionova, Natalia N.; Allakhverdiev, Elvin S.; Maksimov, Georgy V.			Study of myelin structure changes during the nerve fibers demyelination	PLOS ONE			English	Article							SODIUM CONDUCTANCE INACTIVATION; POTASSIUM CHANNELS; PRONASE; AXONS; DESTRUCTION; CAROTENOIDS; MEMBRANES	Raman, NMR and EPR spectroscopy and electrophysiology methods were used to investigate the excitability and the packaging of myelin lipid layers and its viscosity during nerve exposure to pronase E. It was established that during exposure of nerve to pronase E the action potential (AP) conduction velocity and the Schwann cell (SC) (or myelin) water ordering increases, but the nerve myelin refractive index and internode incisions numbers decrease. This effect included two periods-short-and long-time period, probably, because the first one depends on SC protein changes and the second one-on the nerve fiber internode demyelination. It was concluded that high electrical resistance of myelin, which is important for a series of AP conduction velocity, not only depends on nerve fiber diameter and the myelin lipid composition, but also on the regularity of myelin lipid fatty acids and myelin lipid layer packing during the axoglial interaction.	[Rodionova, Natalia N.; Maksimov, Georgy V.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Allakhverdiev, Elvin S.] Moscow MV Lomonosov State Univ, Fac Fundamental Med, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University	Maksimov, GV (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia.	gmaksimov@mail.ru						ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; BENOIT E, 1986, BRAIN RES, V377, P374, DOI 10.1016/0006-8993(86)90884-X; Brazhe NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041990; CAHALAN MD, 1978, BIOPHYS J, V23, P285, DOI 10.1016/S0006-3495(78)85449-6; CHIU SY, 1994, GLIA, V11, P191, DOI 10.1002/glia.440110213; DUBOIS JM, 1981, J PHYSIOL-LONDON, V318, P297; Hermann PM, 1997, EUR J NEUROSCI, V9, P2624, DOI 10.1111/j.1460-9568.1997.tb01692.x; Kutuzov N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142084; Kutuzov NP, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.5.050501; Kutuzov NP, 2014, BIOPHYS J, V107, P891, DOI 10.1016/j.bpj.2014.07.002; LAMOTTE CC, 1989, J COMP NEUROL, V288, P311, DOI 10.1002/cne.902880209; Maksimov G. V., 2014, Biophysics, V59, P81, DOI 10.1134/S0006350914010072; MAKSIMOV GV, 1986, BIOFIZIKA+, V31, P456; MERLIN JC, 1985, PURE APPL CHEM, V57, P785, DOI 10.1351/pac198557050785; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Rodionova N. N., 2014, Biofizika, V59, P108, DOI 10.1134/S0006350914010163; ROJAS E, 1976, J PHYSIOL-LONDON, V262, P501, DOI 10.1113/jphysiol.1976.sp011608; ROPER J, 1989, J PHYSIOL-LONDON, V416, P93; SCHREIERMUCCILLO S, 1976, ARCH BIOCHEM BIOPHYS, V172, P1, DOI 10.1016/0003-9861(76)90041-2; Sezginer A, 1969, J MAGN RESON, V92, P504; SMITH KJ, 1982, J NEUROL SCI, V54, P13, DOI 10.1016/0022-510X(82)90215-5; Verdiyan EE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158083; Waxman SG, 1995, AXON STRUCTURE FUNCT, P325; Yusipovich AI, 2008, B EXP BIOL MED+, V145, P382, DOI 10.1007/s10517-008-0097-3	24	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185170	10.1371/journal.pone.0185170	http://dx.doi.org/10.1371/journal.pone.0185170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934355	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900111
J	Winther, M; Holdfeldt, A; Sundqvist, M; Rajabkhani, Z; Gabl, M; Bylund, J; Dahlgren, C; Forsman, H				Winther, Malene; Holdfeldt, Andre; Sundqvist, Martina; Rajabkhani, Zahra; Gabl, Michael; Bylund, Johan; Dahlgren, Claes; Forsman, Huamei			Formyl peptide derived lipopeptides disclose differences between the receptors in mouse and men and call the pepducin concept in question	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; HUMAN NEUTROPHILS; RESPIRATORY BURST; NADPH-OXIDASE; ACTIVATION; INFLAMMATION; LIGAND; FPR2; MODULATION; PHAGOCYTES	A pepducin is a lipopeptide containing a peptide sequence that is identical to one of the intracellular domains of the G-protein coupled receptor (GPCR) assumed to be the target. Neutrophils express two closely related formyl peptide receptors belonging to the family of GPCRs; FPR1 and FPR2 in human and their respective orthologue Fpr1 and Fpr2 in mouse. By applying the pepducin concept, we have earlier identified FPR2 activating pepducins generated from the third intracellular loop of FPR2. The third intracellular loop of FPR2 differs in two amino acids from that of FPR1, seven from Fpr2 and three from Fpr1. Despite this, we found that pepducins generated from FPR1, FPR2, Fpr1 and Fpr2 all targeted FPR2 in human neutrophils and Fpr2 in mouse, but with different modulating outcomes. Whereas the FPR1/Fpr1 derived pepducins inhibited the FPR2 function in human neutrophils, they activated Fpr2 in mouse. The FPR2 derived pepducin activated FPR2/Fpr2, whereas the pepducin generated from Fpr2 inhibited both FPR2 and Fpr2. In summary, our data demonstrate that pepducins generated from the third intracellular loop of human FPR1/2 and mouse Fpr1/2, all targeted FPR2 in human and Fpr2 in mouse. With respect to the modulating outcomes, pepducin inhibitors identified for FPR2 are in fact activators for Fpr2 in mouse neutrophils. Our data thus questions the validity of pepducin concept regarding their receptor selectivity but supports the notion that FPR2/Fpr2 may recognize a lipopeptide molecular pattern, and highlight the differences in ligand recognition profile between FPR2 and its mouse orthologue Fpr2.	[Winther, Malene; Holdfeldt, Andre; Sundqvist, Martina; Rajabkhani, Zahra; Gabl, Michael; Dahlgren, Claes; Forsman, Huamei] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Bylund, Johan] Univ Gothenburg, Sahlgrenska Acad, Inst Odontol, Dept Oral Microbiol & Immunol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Forsman, H (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	huamei.forsman@rheuma.gu.se	Sundqvist, Martina/AAA-8412-2019; Sundqvist, Martina/HCI-9371-2022	Sundqvist, Martina/0000-0002-0859-0792; 	Swedish Research Council; Sahlgrenska University; Swedish government under the agreement concerning research and education of physicians	Swedish Research Council(Swedish Research CouncilEuropean Commission); Sahlgrenska University; Swedish government under the agreement concerning research and education of physicians	The project was supported by grants from the Swedish Research Council and the Sahlgrenska University and the Swedish government under the agreement concerning research and education of physicians (ALF).	[Anonymous], 2012, Drug Discov Today Technol, V9, pe1, DOI 10.1016/j.ddtec.2011.07.002; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; Bylund J, 2014, METHODS MOL BIOL, V1124, P321, DOI 10.1007/978-1-62703-845-4_21; Carr R, 2014, J BIOL CHEM, V289, P35668, DOI 10.1074/jbc.M114.618819; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Dahlgren C, 2016, BIOCHEM PHARMACOL, V114, P22, DOI 10.1016/j.bcp.2016.04.014; Dimond P, 2011, ANN NY ACAD SCI, V1226, P34, DOI 10.1111/j.1749-6632.2011.06039.x; Forsman H, 2015, BBA-MOL CELL RES, V1853, P192, DOI 10.1016/j.bbamcr.2014.10.021; Forsman H, 2013, BBA-MOL CELL RES, V1833, P1914, DOI 10.1016/j.bbamcr.2013.03.026; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; Gabl M, 2016, BBA-MOL CELL RES, V1863, P1228, DOI 10.1016/j.bbamcr.2016.03.014; Gabl M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109516; Gao JL, 1998, GENOMICS, V51, P270, DOI 10.1006/geno.1998.5376; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; Holdfeldt A, 2016, J BIOL CHEM; Holdfeldt A, 2016, J BIOL CHEM, V291, P19888, DOI 10.1074/jbc.M116.736850; Holdfeldt A, 2016, DATA BRIEF, V8, P411, DOI 10.1016/j.dib.2016.05.065; Itou T, 2006, CLIN VACCINE IMMUNOL, V13, P575, DOI 10.1128/CVI.13.5.575-583.2006; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lee HY, 2010, FEBS LETT, V584, P4102, DOI 10.1016/j.febslet.2010.08.036; Li L, 2015, J LEUKOC BIOL; Liu HT, 2004, RHEUM DIS CLIN N AM, V30, P19, DOI 10.1016/S0889-857X(03)00107-8; Lundqvist H, 1996, FREE RADICAL BIO MED, V20, P785, DOI 10.1016/0891-5849(95)02189-2; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller J, 2009, ANN NY ACAD SCI, V1180, pE1, DOI 10.1111/j.1749-6632.2009.05326.x; Nemeth T, 2012, IMMUNOL LETT, V143, P9, DOI 10.1016/j.imlet.2012.01.013; O'Callaghan K, 2012, J BIOL CHEM, V287, P12787, DOI 10.1074/jbc.R112.355461; Onnheim K, 2008, IMMUNOLOGY, V125, P591, DOI 10.1111/j.1365-2567.2008.02873.x; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Seifert R, 2013, BIOCHEM PHARMACOL, V86, P853, DOI 10.1016/j.bcp.2013.07.029; Skovbakke SL, 2017, J MED CHEM, V60, P6991, DOI 10.1021/acs.jmedchem.7b00489; Skovbakke SL, 2016, BIOCHEM PHARMACOL, V119, P56, DOI 10.1016/j.bcp.2016.09.004; Skovbakke SL, 2015, BIOCHEM PHARMACOL, V93, P182, DOI 10.1016/j.bcp.2014.11.004; Winther M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167529; Winther M, 2015, FEBS LETT, V589, P1832, DOI 10.1016/j.febslet.2015.05.050; Winther M, 2014, ANTIMICROB AGENTS CH, V58, P2985, DOI 10.1128/AAC.02716-13; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	39	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185132	10.1371/journal.pone.0185132	http://dx.doi.org/10.1371/journal.pone.0185132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934373	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900100
J	Becker, AD; Grenfell, BT				Becker, Alexander D.; Grenfell, Bryan T.			tsiR: An R package for time-series Susceptible-Infected-Recovered models of epidemics	PLOS ONE			English	Article							MEASLES EPIDEMICS; DYNAMICAL-SYSTEMS; INFERENCE	tsiR is an open source software package implemented in the R programming language designed to analyze infectious disease time-series data. The software extends a well-studied and widely-applied algorithm, the time-series Susceptible-Infected-Recovered (TSIR) model, to infer parameters from incidence data, such as contact seasonality, and to forward simulate the underlying mechanistic model. The tsiR package aggregates a number of different fitting features previously described in the literature in a user-friendly way, providing support for their broader adoption in infectious disease research. Also included in tsiR are a number of diagnostic tools to assess the fit of the TSIR model. This package should be useful for researchers analyzing incidence data for fully-immunizing infectious diseases.	[Becker, Alexander D.; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Grenfell, Bryan T.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA	Princeton University; Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Becker, AD (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	adbecker@princeton.edu			National Science Foundation Graduate Research Fellowship; Center for Health and Wellbeing at Princeton University; Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Bill and Melinda Gates Foundation; U.S. Centers for Disease Control and Prevention; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Center for Health and Wellbeing at Princeton University(Princeton University); Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	A.D.B. was supported by a National Science Foundation Graduate Research Fellowship and the Center for Health and Wellbeing at Princeton University. B.T.G. was supported by the Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security, the Fogarty International Center, National Institutes of Health, the Bill and Melinda Gates Foundation, and the U.S. Centers for Disease Control and Prevention.	Anderson RM, 1992, INFECT DIS HUMANS DY, V15; [Anonymous], 2016, BAYESIAN GRAPHICAL M; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Breto C, 2009, ANN APPL STAT, V3, P319, DOI 10.1214/08-AOAS201; Caudron Q, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1125; Dalziel BD, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004655; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Freckleton R., 1999, J APPL ECOL, V36, P842; Glass K, 2003, J THEOR BIOL, V223, P19, DOI 10.1016/S0022-5193(03)00031-6; Grenfell BT, 2002, ECOL MONOGR, V72, P185, DOI 10.1890/0012-9615(2002)072[0185:DOMESN]2.0.CO;2; Groendyke C, 2012, BIOMETRICS, V68, P755, DOI 10.1111/j.1541-0420.2012.01748.x; Hadley W., 2009, ELEGANT GRAPHICS DAT; He DH, 2011, THEOR ECOL-NETH, V4, P283, DOI 10.1007/s12080-011-0123-3; He DH, 2010, J R SOC INTERFACE, V7, P271, DOI 10.1098/rsif.2009.0151; HOLLAND PW, 1981, J AM STAT ASSOC, V76, P33, DOI 10.2307/2287037; Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; King AA, 2015, POMP STAT INFERENCE; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Metcalf CJE, 2009, P ROYAL SOC LONDON B, V276; Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414; Takahashi S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001958; Wallinga J, 2001, EPIDEMIOL INFECT, V127, P281, DOI 10.1017/S095026880100601X; Wickham H., 2007, RESHAPING DATA RESHA; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341	27	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185528	10.1371/journal.pone.0185528	http://dx.doi.org/10.1371/journal.pone.0185528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957408	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200077
J	Kim, SH; Oh, D; Jung, KS; Lee, JE; Kim, H; Kim, HJ; Kim, BS; Park, HC; Lee, BK; Choi, HY				Kim, Seok-hyung; Oh, Donghwan; Jung, Kwon Soo; Lee, Jung Eun; Kim, Hyunwook; Kim, Hyung Jong; Kim, Beom Seok; Park, Hyeong Cheon; Lee, Byoung Kwon; Choi, Hoon Young			The association between the apolipoprotein B/A-I ratio and coronary calcification may differ depending on kidney function in a healthy population	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; ARTERY CALCIUM SCORE; MILD RENAL-INSUFFICIENCY; HEART-DISEASE EVENTS; CARDIOVASCULAR-DISEASE; A-I; MYOCARDIAL-INFARCTION; COMPUTED-TOMOGRAPHY; STATIN TREATMENT; RISK	Background The apolipoprotein B/A-1 ratio has been reported to be one of the strongest risk predictors of cardiovascular events. However, its prognostic value for cardiovascular disease is still uncertain, especially in patients with chronic kidney disease. This study aimed to investigate whether the association between the apolipoprotein B/A-I ratio and coronary artery calcification differed according to kidney function in a healthy population. Methods Of the data from 7,780 participants from the medical records database in Gangnam Severance Hospital from 2005 through 2016, a cross-sectional analysis included participants with an estimated glomerular filtration rate (eGFR) >= 60 mL/min/1.73 m(2) determined based on the Chronic Kidney Disease-Epidemiology Collaboration equation (n = 1,800). Mild renal insufficiency was defined as an eGFR of 60-90 mL/min/1.73 m(2). Coronary artery calcification measured with computed tomography was defined as an above-zero score. Logistic regression analyses were used to determine the association between coronary calcification and the apolipoprotein B/A-I ratio according to eGFR by adjusting for the influence of confounders. Results The mean apolipoprotein B/A-I level was significantly higher in the participants with coronary artery calcification than in the participants without coronary artery calcification. The apolipoprotein B/A-I ratio was significantly different according to coronary artery calcification in the participants with normal kidney function, but in the participants with mild renal insufficiency, it was not different. After adjusting for age, male sex, systolic blood pressure, body mass index, current smoking status, and fasting plasma glucose, the apolipoprotein B/A-I ratio was significantly associated with an increased risk of coronary artery calcification in participants with normal kidney function (odds ratio = 2.411, p = 0.011), while in the participants with mild renal insufficiency, the apolipoprotein B/A-I ratio was not associated with coronary artery calcification. Conclusion Our study showed that the predictive value of apolipoprotein B/A-I ratio for coronary artery calcification may differ according to kidney function.	[Kim, Seok-hyung; Oh, Donghwan; Jung, Kwon Soo; Kim, Hyunwook; Park, Hyeong Cheon; Lee, Byoung Kwon; Choi, Hoon Young] Yonsei Univ, Coll Med, Dept Internal Med, Gangnam Severance Hosp, Seoul, South Korea; [Lee, Jung Eun] Yonsei Univ, Coll Med, Dept Internal Med, Yongin Severance Hosp, Seoul, South Korea; [Kim, Hyung Jong] CHA Univ, Dept Internal Med, CHA Bundang Med Ctr, Seongnam, South Korea; [Kim, Beom Seok] Yonsei Univ, Coll Med, Dept Internal Med, Severance Hosp, Seoul, South Korea; [Park, Hyeong Cheon; Choi, Hoon Young] Yonsei Univ, Severance Inst Vasc & Metab Res, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Choi, HY (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Gangnam Severance Hosp, Seoul, South Korea.; Choi, HY (corresponding author), Yonsei Univ, Severance Inst Vasc & Metab Res, Coll Med, Seoul, South Korea.	hychoi.dr@gmail.com		Kim, Beom Seok/0000-0002-5732-2583; Lee, Byoung Kwon/0000-0001-9259-2776; Kim, Hyunwook/0000-0002-4274-7562; CHOI, HOON YOUNG/0000-0002-4245-0339; Jung, Kwon Soo/0000-0003-3238-5139; Park, Hyeong-Cheon/0000-0002-1550-0812; LEE, JUNG EUN/0000-0003-0917-2872				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Bashir A, 2015, AM J KIDNEY DIS, V65, P937, DOI 10.1053/j.ajkd.2015.01.012; Carl A, 2006, BRUNS TIETZ TXB CLIN; Chou YC, 2015, ENDOCRINE, V49, P404, DOI 10.1007/s12020-014-0447-z; Demer LL, 2014, ARTERIOSCL THROM VAS, V34, P715, DOI 10.1161/ATVBAHA.113.302070; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Faergeman O, 2006, J INTERN MED, V259, P434, DOI 10.1111/j.1365-2796.2006.01650.x; Florens N, 2016, TOXINS, V8, DOI 10.3390/toxins8120376; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goek ON, 2012, NEPHROL DIAL TRANSPL, V27, P2839, DOI 10.1093/ndt/gfr795; Goupil R, 2016, CENTRAL BLOOD PRESSU; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Henry RMA, 2002, KIDNEY INT, V62, P1402, DOI 10.1046/j.1523-1755.2002.00571.x; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Joosen IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047267; Jung CH, 2013, J KOREAN MED SCI, V28, P709, DOI 10.3346/jkms.2013.28.5.709; Kastelein JJP, 2008, CIRCULATION, V117, P3002, DOI 10.1161/CIRCULATIONAHA.107.713438; LaMonte MJ, 2005, AM J EPIDEMIOL, V162, P421, DOI 10.1093/aje/kwi228; Lamprea-Montealegre JA, 2014, ATHEROSCLEROSIS, V234, P42, DOI 10.1016/j.atherosclerosis.2014.02.006; Lamprea-Montealegre JA, 2013, ARTERIOSCL THROM VAS, V33, P652, DOI 10.1161/ATVBAHA.112.300624; Levey AS, 2014, AM J KIDNEY DIS, V63, P820, DOI 10.1053/j.ajkd.2013.12.006; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114397; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Moody WE, 2013, HEART, V99, P365, DOI 10.1136/heartjnl-2012-302818; Nakamura S, 2009, CLIN J AM SOC NEPHRO, V4, P1892, DOI 10.2215/CJN.04320709; Nakazato Ryo, 2009, J Cardiovasc Comput Tomogr, V3, P394, DOI 10.1016/j.jcct.2009.10.002; Peng Y, 2017, J RENAL NUTR, V27, P187, DOI 10.1053/j.jrn.2017.01.018; Pletcher MJ, 2004, ARCH INTERN MED, V164, P1285, DOI 10.1001/archinte.164.12.1285; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; SAMUELSSON O, 1994, NEPHROL DIAL TRANSPL, V9, P1580; Schianca GPC, 2011, NUTR METAB CARDIOVAS, V21, P406, DOI 10.1016/j.numecd.2009.11.002; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Shareghi S, 2007, YOUNG, V1, P155, DOI [DOI 10.1016/j.jcct.2007.10.001, DOI 10.1016/J.JCCT.2007.10.001]; Sniderman AD, 2005, CIRCULATION, V112, P3366, DOI 10.1161/CIRCULATIONAHA.105.583336; Sniderman AD, 2003, LANCET, V361, P777, DOI 10.1016/S0140-6736(03)12663-3; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Thompson A, 2006, J INTERN MED, V259, P481, DOI 10.1111/j.1365-2796.2006.01644.x; Vaziri ND, 2014, CLIN EXP NEPHROL, V18, P265, DOI 10.1007/s10157-013-0847-z; Walldius G, 2006, J INTERN MED, V259, P493, DOI 10.1111/j.1365-2796.2006.01643.x; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Wilkins JT, 2016, J AM COLL CARDIOL, V67, P193, DOI 10.1016/j.jacc.2015.10.055; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	45	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185522	10.1371/journal.pone.0185522	http://dx.doi.org/10.1371/journal.pone.0185522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957410	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200075
J	Malmlov, A; Seetahal, J; Carrington, C; Ramkisson, V; Foster, J; Miazgowicz, KL; Quackenbush, S; Rovnak, J; Negrete, O; Munster, V; Schountz, T				Malmlov, Ashley; Seetahal, Janine; Carrington, Christine; Ramkisson, Vernie; Foster, Jerome; Miazgowicz, Kerri L.; Quackenbush, Sandra; Rovnak, Joel; Negrete, Oscar; Munster, Vincent; Schountz, Tony			Serological evidence of arenavirus circulation among fruit bats in Trinidad	PLOS ONE			English	Article							GUANARITO VIRUS ARENAVIRIDAE; TACARIBE VIRUS; EXPERIMENTAL-INFECTION; HOST ASSOCIATIONS; ETIOLOGIC AGENT; IMMUNOLOGY; MURIDAE	Tacaribe virus (TCRV) was isolated in the 1950s from artibeus bats captured on the island of Trinidad. The initial characterization of TCRV suggested that artibeus bats were natural reservoir hosts. However, nearly 60 years later experimental infections of Jamaican fruit bats (Artibeus jamaicensis) resulted in fatal disease or clearance, suggesting artibeus bats may not be a reservoir host. To further evaluate the TCRV reservoir host status of artibeus bats, we captured bats of six species in Trinidad for evidence of infection. Bats of all four fruigivorous species captured had antibodies to TCRV nucleocapsid, whereas none of the insectivore or nectarivore species did. Many flat-faced fruit-eating bats (A. planirostris) and great fruit-eating bats (A. literatus) were seropositive by ELISA and western blot to TCRV nucleocapsid antigen, as were two of four Seba's fruit bats (Carollia perspicillata) and two of three yellow-shouldered fruit bats (Sturnira lilium). Serum neutralization tests failed to detect neutralizing antibodies to TCRV from these bats. TCRV RNA was not detected in lung tissues or lung homogenates inoculated onto Vero cells. These data indicate that TCRV or a similar arenavirus continues to circulate among fruit bats of Trinidad but there was no evidence of persistent infection, suggesting artibeus bats are not reservoir hosts.	[Malmlov, Ashley; Schountz, Tony] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA; [Malmlov, Ashley; Quackenbush, Sandra; Rovnak, Joel; Schountz, Tony] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Seetahal, Janine; Carrington, Christine; Ramkisson, Vernie; Foster, Jerome] Univ West Indies, Fac Med Sci, Dept Preclin Sci, St Augustine, Trinidad Tobago; [Miazgowicz, Kerri L.; Negrete, Oscar] Sandia Natl Labs, Biotechnol & Bioengn, Livermore, CA USA; [Munster, Vincent] NIAID, Virus Ecol Unit, Virol Lab, Rocky Mt Labs,NIH, Hamilton, MT USA	Colorado State University; Colorado State University; University West Indies Mona Jamaica; University West Indies Saint Augustine; United States Department of Energy (DOE); Sandia National Laboratories; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Schountz, T (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.; Schountz, T (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	tony.schountz@colostat.edu	Munster, Vincent/I-7607-2018	Munster, Vincent/0000-0002-2288-3196; Foster, Jerome/0000-0001-5699-3791; Carrington, Christine/0000-0001-6533-9302	NIH [AI089419]; NIH Emerging Virus Diseases Unit [AI25489]; University of Northern Colorado Provost Fund; Colorado State University; NIAID intramural research program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI089419, N01AI025489, ZIAAI001179, ZIAAI001190] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Emerging Virus Diseases Unit; University of Northern Colorado Provost Fund; Colorado State University; NIAID intramural research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by NIH grant AI089419 (TS), NIH Emerging Virus Diseases Unit contract AI25489 (TS), and the University of Northern Colorado Provost Fund (TS), Colorado State University, NIAID intramural research program (VM).; This work was supported by NIH grant AI089419 (TS), NIH Emerging Virus Diseases Unit contract AI25489 (TS), and the University of Northern Colorado Provost Fund (TS), Colorado State University, NIAID intramural research program (VM). We also thank Partap Seenath and Kirk Amour of the Anti-Rabies Unit of the Ministry of Agriculture, Trinidad and Tobago.	ALLISON LMC, 1991, J GEN VIROL, V72, P2025, DOI 10.1099/0022-1317-72-8-2025; Amman BR, 2015, J WILDLIFE DIS, V51, P113, DOI 10.7589/2014-08-198; Basu Asoke K., 2017, pXIII; Bowen MD, 1996, VIROLOGY, V219, P285, DOI 10.1006/viro.1996.0248; Bratsch S, 2011, DEV COMP IMMUNOL, V35, P421, DOI 10.1016/j.dci.2010.06.004; Cogswell-Hawkinson A, 2012, J VIROL, V86, P5791, DOI 10.1128/JVI.00201-12; DOWNS WG, 1963, AM J TROP MED HYG, V12, P640, DOI 10.4269/ajtmh.1963.12.640; Easterbrook JD, 2007, P NATL ACAD SCI USA, V104, P15502, DOI 10.1073/pnas.0707453104; Easterbrook JD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000172; Fulhorst CF, 1997, AM J TROP MED HYG, V56, P548; Fulhorst CF, 2001, AM J TROP MED HYG, V65, P147, DOI 10.4269/ajtmh.2001.65.147; Fulhorst CF, 1999, J INFECT DIS, V180, P966, DOI 10.1086/315029; Fulhorst CF, 1999, AM J TROP MED HYG, V61, P325, DOI 10.4269/ajtmh.1999.61.325; Gard G., 2009, COMMUNICATION; Gomes G.A., 2015, BATS TRINIDAD TOBAGO; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Harmon B, 2013, J BIOL CHEM, V288, P8702, DOI 10.1074/jbc.M112.444760; JUSTINES G, 1969, NATURE, V222, P1090, DOI 10.1038/2221090a0; Kollars TM, 2000, J PARASITOL, V86, P1156, DOI 10.1645/0022-3395(2000)086[1156:HAASAO]2.0.CO;2; Larsen PA, 2010, P NATL ACAD SCI USA, V107, P11447, DOI 10.1073/pnas.1000133107; McGuire A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100286; MORRISON DW, 1980, J MAMMAL, V61, P20, DOI 10.2307/1379953; Paweska JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045479; PRICE JL, 1978, AM J TROP MED HYG, V27, P162, DOI 10.4269/ajtmh.1978.27.162; Sayler KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115769; Schountz T, 2007, EMERG INFECT DIS, V13, P1604, DOI 10.3201/eid1310.070383; Schountz T, 2007, P NATL ACAD SCI USA, V104, P15496, DOI 10.1073/pnas.0707454104; Schountz T, 2014, VIRUSES-BASEL, V6, P4880, DOI 10.3390/v6124880; Schountz T, 2014, VIRUSES-BASEL, V6, P1317, DOI 10.3390/v6031317; Spengler JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055310; TESH RB, 1994, AM J TROP MED HYG, V50, P452, DOI 10.4269/ajtmh.1994.50.452	31	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185308	10.1371/journal.pone.0185308	http://dx.doi.org/10.1371/journal.pone.0185308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953976	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300055
J	Bazie, GW; Adimassie, MT				Bazie, Getaw Walle; Adimassie, Mhiret Teshome			Modern health services utilization and associated factors in North East Ethiopia	PLOS ONE			English	Article								Background Ethiopia is one of the developing countries with the poorest health status and the health services utilization is generally low with different patterns in different regions of the country. Therefore, the aim of this study was to assess utilization of modern health services and associated factors in Dessie, Ethiopia. Methods A cross sectional study design was employed from January to March, 2015 in Dessie City. The total sample was 420 adults. Adults were selected by stratified random sampling. The strata were made using residence as urban and rural residents. The data was collected using pre- tested, interviewer administered questionnaire. The data was entered into Epi info TM7 software and exported to Statistical Package for Social Sciences ( SPSS) version 20 Software for analysis. Binary logistic regression was used to evaluate independent effect of each variable on modern health service utilization by controlling the effect of others. The strength of association between dependent variable and independent variables was expressed by odds ratio with 95% confidence interval. Results The overall modern health services utilization rate was 41.8%. Being Female sex, annual income greater than poverty line, poor perception of health status, high perceived severity of illness, two or more than two number of illnesses in the last 12 months prior to the survey and presence of chronic health problem were found to have a significant association with utilization of modern health services. Conclusion Modern health services utilization was found to be low. Being female sex, annual income above poverty line, having poor perceived health status, having two or more than two illnesses, severe perceived severity of illness and having chronic health problem were found to have a statistically significant association with utilization. Therefore, efforts have to be made to increase utilization of modern health services through establishing systems like health extension workers and health development army.	[Bazie, Getaw Walle] Wollo Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Dessie, Ethiopia; [Adimassie, Mhiret Teshome] Care Ethiopia, Afar, Ethiopia	University of Gondar	Bazie, GW (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Dessie, Ethiopia.	getaw4jesus@gmail.com	Bazie, Getaw Walle/AAU-6668-2021; Dangal, Ganesh/O-1989-2017	Dangal, Ganesh/0000-0002-5834-5525; Bazie, Getaw/0000-0002-0372-8537				[Anonymous], 2000, WORLD HLTH REP; Balcha A., 2005, CHARTING HIST DESSIE; Bonfrer IEJ, 2012, DOES HLTH CARE UTILI; Central statistical agency, 2010, ETH DEM HLTH SURV RE, P2000; Dessie City Administration Finance and Economic Development Department, 2015, 2006 ETH YEAR REP; Fantahun M, 2003, ETH JHEAL DEV, V17, P141; Fitsum G, 2011, ETHIOP J HLTH SCI, V21, P1112; Kufi M, 2013, J PUBLIC HLTH AFRICA, V13; Raul M., 2000, INT J HLTH SERVICES, V1; Reniers G, 2009, HEALTH POLICY PLANN, V24, P312, DOI 10.1093/heapol/czp015; Shah A, 2011, GLOBAL HLTH OVERVIEW; The Ethiopian federal ministry of health, 2008, HLTH SECT DEV 2005 6; Trish B., 2007, UTILIZATION HLTH MED; WHO, MAN HOUS SURV MEAS A; WHO(World Health Organization), 1946, CONST; World Health Organization, 2007, HLTH SYST SUBS AFR W; Young Jennifer Rene, 2004, THESIS	17	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185381	10.1371/journal.pone.0185381	http://dx.doi.org/10.1371/journal.pone.0185381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949978	Green Published, gold, Green Submitted			2022-12-27	WOS:000411671000044
J	Brooks, HM; Paul, MKJ; Claude, KM; Mocanu, V; Hawkes, MT				Brooks, Hannah Myfanwy; Paul, Makelele Katsuva Jean; Claude, Kasereka Masumbuko; Mocanu, Victor; Hawkes, Michael T.			Use and disuse of malaria bed nets in an internally displaced persons camp in the Democratic Republic of the Congo: A mixed methods study	PLOS ONE			English	Article							REFUGEE CAMPS; INSECTICIDE; MORTALITY	Introduction Malaria is a major cause of morbidity and mortality among displaced populations in tropical zones. Bed nets are widely used to prevent malaria; however, few data are available on bed net distribution within displaced populations. Methods Mixed methods study in a single internally displaced persons (IDP) camp and neighboring community in Eastern Democratic Republic of the Congo (DRC). Qualitative data (focus group discussions, FGDs) and quantitative data (door-to-door survey and individual testing using malaria rapid diagnostic test, RDT) were collected. Results Ten FGDs were conducted with 55 individuals. Although malaria was widely recognized as a significant threat and bed nets were freely distributed in the camp, many households did not own or use them. IDPs converged on the following reasons for low bed net ownership and use: inconvenience of net installation and sale of nets to meet immediate needs such as food. One hundred households, comprised of 411 individuals, were surveyed in Birambizo. The burden of malaria was high (45/78 (58%) of children < 5 were positive for malaria by RDT) and bed net utilization was low (29/100 (29%) households owned a bed net, and 85/411 (20%) individuals slept under a bed net the previous night). Children < 5 were more likely to use a bed net than older children or adults (OR 3.4 (95% CI 2.0-5.8), p< 0.0001). Compared to 29 bed nets currently in use by study participants, 146 bed nets had been sold (82%) or exchanged (18%) either in the camp (27%) or in the neighbouring village market (73%). Conclusions Qualitative descriptions and quantitative analysis revealed pragmatic barriers to bed net usage and widespread sale of freely distributed bed nets within IDP camps, despite a high burden of malaria. Additional strategies, beyond bed net distribution, are warranted to combat malaria in vulnerable and hard-to-reach population.	[Brooks, Hannah Myfanwy; Hawkes, Michael T.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Paul, Makelele Katsuva Jean] Med Sans Frontieres, Goma, DEM REP CONGO; [Claude, Kasereka Masumbuko] Univ Catholique Graben, Butembo, DEM REP CONGO; [Mocanu, Victor] Univ Alberta, Dept Sci, Edmonton, AB, Canada; [Hawkes, Michael T.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Hawkes, MT (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.	mthawkes@ualberta.ca	, Michael/AAP-3049-2020	Hawkes, Michael/0000-0002-4122-0937; Kasereka, Masumbuko/0000-0003-1367-3426				[Anonymous], 1998, COCHRANE DB SYST REV; [Anonymous], 2010, GUID TREATM MAL; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Birganie AB, 2010, HUM RIGHTS LAW REV, V10, P179, DOI 10.1093/hrlr/ngp042; Brooks HMJP, 2017, MALARIA INTERNALLY D; Burns M, 2012, AM J TROP MED HYG, V87, P242, DOI 10.4269/ajtmh.2012.11-0744; Carlsen B, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-26; Charchuk R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1479-z; CHOI HW, 1995, AM J TROP MED HYG, V52, P377, DOI 10.4269/ajtmh.1995.52.377; CIA, 2016, REF INT DISPL PERS; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; Coghlan B, 2009, DISASTER MED PUBLIC, V3, P88, DOI 10.1097/DMP.0b013e3181a6e952; Democratic Republic of the Congo, 2015, WORLD FACTBOOK; Eijk AM, 2015, LANCET GLOB HLTH, V3; Filmer D., 1998, ESTIMATING WEALTH EF; Gobena T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-914; Graham K, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-25; Graham K, 2002, MED VET ENTOMOL, V16, P404, DOI 10.1046/j.1365-2915.2002.00395.x; Hamze H, 2016, PATHOGENS GLOBAL HLT; Hawkes M, 2009, MALAR J, V8; Huong NM, 2002, TROP MED INT HEALTH, V7, P304, DOI 10.1046/j.1365-3156.2002.00869.x; IDMC, 2016, GLOB INT DISPL DAT; INTERNAL DISPLACEMENT MONITORING CENTRE (IDMC), 2015, INF GLOB 2015 DESPL; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Koenker H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097496; Malaria RB, 2013, MIS PACKAGE HOUSEHOL; Martin AIC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003181; Mattern C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151068; Messenger LA, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1867-z; Njau JD, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-245; Obembe A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-514; Obol JH, 2013, AFR HEALTH SCI, V13, P962, DOI 10.4314/ahs.v13i4.15; Olack B, 2015, RISK FACTORS HYPERTE; Ordinioha B, 2012, ANN AFR MED, V11, P163, DOI 10.4103/1596-3519.96879; Pluess B, 2010, INDOOR RESIDUAL SPRA; Rowland M, 2001, ANN TROP MED PARASIT, V95, P741, DOI 10.1080/00034980120103405; Sadasivaiah S, 2007, AM J TROP MED HYG, V77, P249, DOI 10.4269/ajtmh.2007.77.249; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Sexton AR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-157; Sharifi-Mood B, 2015, INT J INFECT, V2; Singh M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-268; Spencer S, 2004, T ROY SOC TROP MED H, V98, P719, DOI 10.1016/j.trstmh.2004.01.012; Swarthout TD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-58; Tiono AB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-30; UNHCR, 2016, REF FLOW BORD; UNHCR, 2016, OFF UN HIGH COMM REF; United Nations High Commissioner for Refugees (UNHCR), 2014, WORLD WAR; World Health Organization (WHO), 2016, WORLD MAL REP 2016, P186, DOI DOI 10.4135/9781452276151.N221; Zhou GF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1512-2	49	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185290	10.1371/journal.pone.0185290	http://dx.doi.org/10.1371/journal.pone.0185290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950001	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000035
J	Ermakov, EA; Smirnova, LP; Bokhan, NA; Semke, AV; Ivanova, SA; Buneva, VN; Nevinsky, GA				Ermakov, Evgeny A.; Smirnova, Ludmila P.; Bokhan, Nikolay A.; Semke, Arkadiy V.; Ivanova, Svetlana A.; Buneva, Valentina N.; Nevinsky, Georgy A.			Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia	PLOS ONE			English	Article							ERYTHEMATOSUS MOLECULAR-CLONING; MYELIN BASIC-PROTEIN; KAPPA LIGHT-CHAINS; CATALYTIC ANTIBODIES; OXIDOREDUCTASE ACTIVITIES; MULTIPLE-SCLEROSIS; LIPID-PEROXIDATION; SYNAPTIC PROTEINS; IMMUNE-SYSTEM; AUTOIMMUNITY	We present first evidence showing that some electrophoretically homogeneous IgGs from the sera of patients with schizophrenia (36.4%) and their Fab and F(ab)(2) fragments as well as from healthy donors (33.3%) possess catalase activity. The relative catalase activity of IgGs from the sera of individual schizophrenia patients (and healthy donors) significantly varied from patient to patient, but the activity of IgGs from healthy donors is on average 15.8-fold lower than that for schizophrenia patients. After extensive dialysis of purified IgGs against EDTA chelating metal ions, the relative catalase activity of IgGs decreases on average approximately 2.5-3.7-fold; all IgGs possess metal-dependent and independent catalase activity. The addition of external Me2+ ions to dialyzed and non-dialyzed IgGs leads to a significant increase in their activity. The best activator of dialyzed and non-dialyzed IgGs is Co2+, the activation by Cu2+, Mn2+, and Ni2+ ions were rare and always lower than by Co2+. Every IgG preparation demonstrates several individual sets of very well expressed pH optima in the pH range from 4.0 to 9.5. These data speak for the individual repertoire of catalase IgGs in every person and an extreme diversity of abzymes in their pH optima and activation by different metal ions. It is known that antioxidant enzymes such as superoxide dismutases, catalases, and glutathione peroxidases represent critical defense mechanisms preventing oxidative modifications of DNA, proteins, and lipids. Catalase activity of human IgGs could probably also play a major role in the protection of organisms from oxidative stress and toxic compounds.	[Ermakov, Evgeny A.; Buneva, Valentina N.; Nevinsky, Georgy A.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Div, Novosibirsk, Russia; [Ermakov, Evgeny A.; Buneva, Valentina N.; Nevinsky, Georgy A.] Novosibirsk State Univ, Novosibirsk, Russia; [Smirnova, Ludmila P.; Bokhan, Nikolay A.; Semke, Arkadiy V.; Ivanova, Svetlana A.] Russian Acad Sci, Mental Hlth Res Inst, Tomsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; Russian Academy of Sciences; Tomsk National Research Medical Center; Mental Health Research Institute, Tomsk	Nevinsky, GA (corresponding author), Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Div, Novosibirsk, Russia.; Nevinsky, GA (corresponding author), Novosibirsk State Univ, Novosibirsk, Russia.	nevinsky@niboch.nsc.ru	Semke, Arkady/GPS-6258-2022; Nevinsky, Georgy/E-6053-2012; Ivanova, Svetlana/C-5333-2012; Buneva, Valentina Nikolaevna/I-6329-2012; Semke, Arkady V./B-1714-2016; Smirnova, Liudmila Pavlovna/C-9026-2012; Bokhan, Nikolai/P-1720-2014; Ermakov, Evgeny E.A./D-8982-2015	Ivanova, Svetlana/0000-0001-7078-323X; Buneva, Valentina Nikolaevna/0000-0003-2556-979X; Smirnova, Liudmila Pavlovna/0000-0003-0083-9124; Bokhan, Nikolai/0000-0002-1052-855X; Ermakov, Evgeny E.A./0000-0002-1084-6419; Semke, Arkady V./0000-0002-8698-0251	SB RAS omplex Scientific Program [II.2Pi/VI.57-5 (0309-2015-0022)]; Russian Foundation for Basic Research [16-04-00603]; RSF [14-15-00480]	SB RAS omplex Scientific Program; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); RSF(Russian Science Foundation (RSF))	This research was made possible in part by grants from partially under SB RAS omplex Scientific Program, II.2 Pi/VI.57-5 (0309-2015-0022), Russian Foundation for Basic Research (16-04-00603), Grant of RSF (14-15-00480: a part of work corresponding to collection of the sera of schizophrenia patients, purification of antibodies and their partial characterization was done). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was made possible in part by grants from partially under SB RAS Complex scientific program, II.2 Pi/VI.57-5 (0309-2015-0022), Russian Foundation for Basic Research (16-04-00603), Grant of RSF (14-15-00480: a part of work corresponding to collection of the sera of schizophrenia patients, purification of antibodies and their partial characterization was done).	AEBI H, 1984, METHOD ENZYMOL, V105, P121; AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; Andrievskaya O A, 2000, Med Sci Monit, V6, P460; Andrievskaya OA, 2002, IMMUNOL LETT, V81, P191, DOI 10.1016/S0165-2478(02)00006-8; Andryushkova AA, 2007, J CELL MOL MED, V11, P531, DOI 10.1111/j.1582-4934.2007.00048.x; [Anonymous], 2000, DIAGN STAT MAN MENT, P299; Baranovskii AG, 1998, BIOCHEMISTRY-MOSCOW+, V63, P1239; Beasley CL, 2006, PROTEOMICS, V6, P3414, DOI 10.1002/pmic.200500069; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bergink V, 2014, BIOL PSYCHIAT, V75, P324, DOI 10.1016/j.biopsych.2013.09.037; Bezuglova AM, 2012, INT IMMUNOL, V24, P759, DOI 10.1093/intimm/dxs071; Bezuglova AM, 2011, J MOL RECOGNIT, V24, P960, DOI 10.1002/jmr.1143; Boksha I, 2012, SPECIFIC METABOLISM, P1; Burbaeva GS, 2002, PROG NEURO-PSYCHOPH, V26, P427, DOI 10.1016/S0278-5846(01)00273-1; Carson VB, 1995, MENTAL HLTH NURSING, P368; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; CUTLER RG, 1991, AM J CLIN NUTR, V53, pS373, DOI 10.1093/ajcn/53.1.373S; Deakin J, 2014, BIOL PSYCHIAT, V75, P284, DOI 10.1016/j.biopsych.2013.07.018; Drexhage RC, 2011, INT J NEUROPSYCHOPH, V14, P746, DOI 10.1017/S1461145710001653; Ermakov EA, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150064; Eschenko ND, 2004, BIOCH PSYCHIAT NEURO, P1; Fedorenko O, 2009, PSYCHOPHARMACOLOGY, V206, P429, DOI 10.1007/s00213-009-1621-5; Fersht A., 1985, ENZYME STRUCTURE MEC; FEUERS RJ, 1993, MUTAT RES, V295, P191, DOI 10.1016/0921-8734(93)90020-4; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; Generalov II, 1999, SERYYA BIYALAGICHNYK, V1, P90; Ghadermarzi M, 1996, J ENZYM INHIB, V10, P167, DOI 10.3109/14756369609030310; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Goldner EM, 2002, CAN J PSYCHIAT, V47, P833, DOI 10.1177/070674370204700904; Harlow T, 1988, ANTIBODIES ALABORATO, P630; Harris D.C., 2002, QUANTITATIVE CHEM AN, V6th ed.; Hifumi E, 2017, FASEB J, V31, P1668, DOI 10.1096/fj.201600819R; Hifumi E, 2016, FASEB J, V30, P895, DOI 10.1096/fj.15-276394; Ikhmyangan EN, 2005, FEBS LETT, V579, P3960, DOI 10.1016/j.febslet.2005.06.020; Ikhmyangan EN, 2006, IMMUNOPATHOLOGY ALLE, V2, P32; Ikhmyangan EN, 2006, J MOL RECOGNIT, V19, P432, DOI 10.1002/jmr.787; Ivanova SA, 2014, PROCEDIA CHEM, V10, P80, DOI 10.1016/j.proche.2014.10.015; Ivanova SA, 2014, NEUROCHEM J+, V8, P66, DOI 10.1134/S1819712414010061; Jenkins TA, 2009, BEHAV BRAIN RES, V205, P355, DOI 10.1016/j.bbr.2009.07.014; KALAGA R, 1995, J IMMUNOL, V155, P2695; Keinan E, 2021, ASIACHEM, V2, P96; KIRKMAN HN, 1984, P NATL ACAD SCI-BIOL, V81, P4343, DOI 10.1073/pnas.81.14.4343; Kliushnik TP, 2007, ZH NEVROL PSIKHIATR, V108, P61; Kneisl C, 2009, CONT PSYCHIAT MENTAL; Koch M, 2007, EUR J NEUROL, V14, P529, DOI 10.1111/j.1468-1331.2007.01739.x; Kohda K, 1997, FEBS LETT, V407, P280, DOI 10.1016/S0014-5793(97)00338-4; Konradi C, 2003, PHARMACOL THERAPEUT, V97, P153, DOI 10.1016/S0163-7258(02)00328-5; Kostrikina IA, 2014, BBA-GEN SUBJECTS, V1840, P1725, DOI 10.1016/j.bbagen.2014.01.027; Krotenko NV, 2007, ACTUAL PROBLEMS PSYC, V13, P108; Lahti AC, 2001, NEUROPSYCHOPHARMACOL, V25, P455, DOI 10.1016/S0893-133X(01)00243-3; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; LIEBERMAN JA, 1990, SCHIZOPHRENIA BULL, V16, P97, DOI 10.1093/schbul/16.1.97; Mates J M, 1999, Front Biosci, V4, pD339; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Morkovkin VM, 1988, PATHOCHEMISTRY SCHIZ, P1; Nevinsky GA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P945, DOI 10.1134/S0006297909090028; Nevinsky G.A., 2017, LUPUS; Nevinsky G.A., 2010, AUTOIMMUNE DIS SYMPT, P1; Nevinsky G.A., 2011, UNDERSTANDING HIVAID, P151, DOI DOI 10.5772/22294; Nevinsky G.A., 2005, CATALYTIC ANTIBODIES, P503; Nevinsky GA, 2003, J CELL MOL MED, V7, P265, DOI 10.1111/j.1582-4934.2003.tb00227.x; Nevinsky GA, 2016, MULT SCLER, P151; Nevinsky GA, 2012, ADV NEUROIMMUNE BIOL, V3, P157, DOI 10.3233/NIB-2012-012042; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Paul S, 2012, ADV EXP MED BIOL, V750, P56, DOI 10.1007/978-1-4614-3461-0_5; Planque SA, 2014, J BIOL CHEM, V289, P13243, DOI 10.1074/jbc.M114.557231; Polosukhina DI, 2005, MED SCI MONITOR, V11, pBR266; Polosukhina DI, 2004, J CELL MOL MED, V8, P359, DOI 10.1111/j.1582-4934.2004.tb00325.x; PRILIPKO LL, 1982, VESTN AKAD MED NAUK+, P33; Reynolds LM, 2011, J PSYCHIATR RES, V45, P54, DOI 10.1016/j.jpsychires.2010.05.001; Ryazantseva NV, 2004, PATHOLOGY CELL MEMBR, P1; Savel'ev AN, 1999, PROTEIN PEPTIDE LETT, V6, P179; [Щеглова Т.В. Shcheglova T.V.], 2011, [Российский иммунологический журнал, Russian Journal of Immunology, Rossiiskii immunologicheskii zhurnal], V5, P11; Sies H., 1991, OXIDATIVE STRESS OXI; Smirnova LP, 2011, BIOCHEM MOSC-SUPPL S, V5, P76, DOI 10.1134/S1990750811010136; Smirnova LP, 2008, SIBERIAN HERALD PSYC, V1, P133; Steiner J, 2015, CNS DRUGS, V29, P197, DOI 10.1007/s40263-015-0233-3; Strous RD, 2006, AUTOIMMUN REV, V6, P54, DOI 10.1016/j.autrev.2006.07.002; Strous RD, 2006, J AUTOIMMUN, V27, P71, DOI 10.1016/j.jaut.2006.07.006; Timofeeva AM, 2016, MOL BIOSYST, V12, P3556, DOI 10.1039/c6mb00573j; Timofeeva AM, 2015, INT IMMUNOL, V27, P633, DOI 10.1093/intimm/dxv042; Timofeeva AM, 2015, J MOL RECOGNIT, V28, P614, DOI 10.1002/jmr.2476; Tolmacheva AS, 2015, J MOL RECOGNIT, V28, P565, DOI 10.1002/jmr.2474; Tolmacheva AS, 2009, J MOL RECOGNIT, V22, P26, DOI 10.1002/jmr.923; Velligan DI, 2008, PSYCHIAT TIMES, V25, P3; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Waziri R, 1999, SCHIZOPHR RES, V37, P205, DOI 10.1016/S0920-9964(98)00169-8; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722; Wood SJ, 2009, ANN ACAD MED SINGAP, V38, P396; Yao JK, 2011, ANTIOXID REDOX SIGN, V15, P1999, DOI 10.1089/ars.2010.3646; YUDELEVICH IG, 1984, SPECTROCHIM ACTA B, V39, P777, DOI 10.1016/0584-8547(84)80086-5; Zenkov N.K., 2001, OXIDATIVE STRESS BIO, P3; Zhil'tsov I V, 1998, Zh Mikrobiol Epidemiol Immunobiol, P73	96	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0183867	10.1371/journal.pone.0183867	http://dx.doi.org/10.1371/journal.pone.0183867			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI0UK	28945759	Green Published, gold, Green Submitted			2022-12-27	WOS:000411645100004
J	Kepchia, D; Sherman, B; Haddad, R; Luetje, CW				Kepchia, Devin; Sherman, Benjamin; Haddad, Rafi; Luetje, Charles W.			Mammalian odorant receptor tuning breadth persists across distinct odorant panels	PLOS ONE			English	Article							MOUSE OLFACTORY RECEPTOR; KEY FOOD ODORANT; FUNCTIONAL EXPRESSION; RANGE; BROAD; IDENTIFICATION; CONDUCTANCE; MOR256-17; SYSTEM	The molecular receptive range (MRR) of a mammalian odorant receptor (OR) is the set of odorant structures that activate the OR, while the distribution of these odorant structures across odor space is the tuning breadth of the OR. Variation in tuning breadth is thought to be an important property of ORs, with the MRRs of these receptors varying from narrowly to broadly tuned. However, defining the tuning breadth of an OR is a technical challenge. For practical reasons, a screening panel that broadly covers odor space must be limited to sparse coverage of the many potential structures in that space. When screened with such a panel, ORs with different odorant specificities, but equal tuning breadths, might appear to have different tuning breadths due to chance. We hypothesized that ORs would maintain their tuning breadths across distinct odorant panels. We constructed a new screening panel that was broadly distributed across an estimated odor space and contained compounds distinct from previous panels. We used this new screening panel to test several murine ORs that were previously characterized as having different tuning breadths. ORs were expressed in Xenopus laevis oocytes and assayed by two-electrode voltage clamp electrophysiology. MOR256-17, an OR previously characterized as broadly tuned, responded to nine novel compounds from our new screening panel that were structurally diverse and broadly dispersed across an estimated odor space. MOR256-22, an OR previously characterized as narrowly tuned, responded to a single novel compound that was structurally similar to a previously known ligand for this receptor. MOR174-9, a well-characterized receptor with a narrowly tuned MRR, did not respond to any novel compounds in our new panel. These results support the idea that variation in tuning breadth among these three ORs is not an artifact of the screening protocol, but is an intrinsic property of the receptors.	[Kepchia, Devin; Sherman, Benjamin; Luetje, Charles W.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Haddad, Rafi] Bar Ilan Univ, Leslie & Susan Goldschmied Gonda Multidisciplinar, Ramat Gan, Israel	University of Miami; Bar Ilan University	Luetje, CW (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	cluetje@med.miami.edu			National Institutes of Health [R01 DC008119]; Israel Science Foundation as part of the ISF-UGC joint program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation as part of the ISF-UGC joint program	This work was supported by a grant from the National Institutes of Health [R01 DC008119 to CWL] and by the Israel Science Foundation as part of the ISF-UGC joint program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaffy T, 2006, J NEUROCHEM, V97, P1506, DOI 10.1111/j.1471-4159.2006.03859.x; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Baud O, 2011, BIOCHEMISTRY-US, V50, P843, DOI 10.1021/bi1017396; Bavan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092064; Bohbot JD, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00039; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Dahoun T, 2011, BIOCHEMISTRY-US, V50, P7228, DOI 10.1021/bi2008596; Dunkel A, 2014, ANGEW CHEM INT EDIT, V53, P7124, DOI 10.1002/anie.201309508; FIRESTEIN S, 1993, J PHYSIOL-LONDON, V468, P1; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Geithe C, 2017, CHEM SENSES, V42, P181, DOI 10.1093/chemse/bjw117; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Grosmaitre X, 2009, J NEUROSCI, V29, P14545, DOI 10.1523/JNEUROSCI.2752-09.2009; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Haddad R, 2010, J NEUROSCI, V30, P9017, DOI 10.1523/JNEUROSCI.0398-10.2010; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Li JY, 2015, J NEUROCHEM, V134, P47, DOI 10.1111/jnc.13095; Li JY, 2012, J NEUROCHEM, V121, P881, DOI 10.1111/j.1471-4159.2012.07740.x; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Ma TH, 2002, J BIOL CHEM, V277, P37235, DOI 10.1074/jbc.M205932200; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Nara K, 2011, J NEUROSCI, V31, P9179, DOI 10.1523/JNEUROSCI.1282-11.2011; Noe F, 2017, CHEM SENSES, V42, P195, DOI 10.1093/chemse/bjw118; Repicky SE, 2009, J NEUROCHEM, V109, P193, DOI 10.1111/j.1471-4159.2009.05925.x; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; SICARD G, 1984, BRAIN RES, V292, P283, DOI 10.1016/0006-8993(84)90764-9; Tazir B, 2016, EUR J NEUROSCI, V43, P608, DOI 10.1111/ejn.13153; Trimmer C, 2017, CHEM SENSES, V42, P177, DOI 10.1093/chemse/bjx002; UEZONO Y, 1993, RECEPTOR CHANNEL, V1, P233; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Yu YQ, 2015, P NATL ACAD SCI USA, V112, P14966, DOI 10.1073/pnas.1517510112; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	41	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185329	10.1371/journal.pone.0185329	http://dx.doi.org/10.1371/journal.pone.0185329			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945824	gold, Green Submitted, Green Published			2022-12-27	WOS:000411645100047
J	Seo, M; Heo, J; Yoon, J; Kim, SY; Kang, YM; Yu, J; Cho, S; Kim, H				Seo, Minseok; Heo, Jaeyoung; Yoon, Joon; Kim, Se-Young; Kang, Yoon-Mo; Yu, Jihyun; Cho, Seoae; Kim, Heebal			Methanobrevibacter attenuation via probiotic intervention reduces flatulence in adult human: A non-randomised paired-design clinical trial of efficacy	PLOS ONE			English	Article							CITROBACTER-RODENTIUM INFECTION; IRRITABLE-BOWEL-SYNDROME; RIBOSOMAL-RNA SEQUENCES; HUMAN GUT MICROBIOTA; WEIGHT-GAIN; OBESITY; DISEASE; DIET; INFLAMMATION; METAANALYSIS	Trial design The aim of this study was to investigate which of the gut microbes respond to probiotic intervention, as well as study whether they are associated with gastrointestinal symptoms in a healthy adult human. For the experimental purpose, twenty-one healthy adults were recruited and received probiotic mixture, which is composed of five Lactobacilli strains and two Bifidobacteria strains, once a day for 60 days. Defecation survey and Bioelectrical Impedance Analysis were conducted pre-and post-administration to measure phenotypic differences. Stool samples of the subjects were collected twice. Methods The statistical analysis was performed for pair designed metagenome data with 11 phenotypic records of the bioelectrical impedance body composition analyzer and 6 responses of the questionnaires about gastrointestinal symptom. Furthemore, correlation-based network analysis was conducted for exploring complex relationships among microbiome communities. Results The abundances of Citrobacter, Klebsiella, and Methanobrevibacter were significantly reduced, which are strong candidates to be highly affected by the probiotic administration. In addition, interaction effects were observed between flatulence symptom attenuation and decreasing patterns of the Methanobrevibacter abundance. Conclusions These results reveal that probiotic intervention modulated the composition of gut microbiota and reduced the abundance of potential pathogens (i.e. Citrobacter and Klebsiella). In addition, methanogens (i.e. Methanobrevibacter)associated with the gastrointestinal symptom in an adult human.	[Seo, Minseok; Cho, Seoae; Kim, Heebal] Seoul Natl Univ, C&K Genom, Res Pk, Seoul, South Korea; [Heo, Jaeyoung; Kim, Heebal] Chonbuk Natl Univ, Dept Anim Biotechnol, Jeonju, South Korea; [Yoon, Joon] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Kim, Se-Young; Kang, Yoon-Mo] CTCBIO Inc, R&D Ctr, Hwaseong Si, Gyeonggi Do, South Korea; [Yu, Jihyun; Kim, Heebal] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Yu, Jihyun; Kim, Heebal] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Seo, Minseok] Harvard Med Sch, Dept Med, Boston, MA USA; [Seo, Minseok] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA	Seoul National University (SNU); Jeonbuk National University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Cho, S; Kim, H (corresponding author), Seoul Natl Univ, C&K Genom, Res Pk, Seoul, South Korea.; Kim, H (corresponding author), Chonbuk Natl Univ, Dept Anim Biotechnol, Jeonju, South Korea.; Kim, H (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.; Kim, H (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea.	seoae@cnkgenomic.com; heebal@snu.ac.kr	Kim, SeYoung/GSE-5296-2022; Kim, Heebal/A-8889-2016	Kim, SeYoung/0000-0001-9188-868X; Kim, Heebal/0000-0003-3064-1303	CTCBIO Inc.; CK Genomics; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ01115901]; CTCBIO	CTCBIO Inc.; CK Genomics; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; CTCBIO	The funder (CTCBIO Inc.) and commercial affiliation (C&K Genomics) provided support in the form of salaries for authors SK and YK and MS, JH, and SC, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This work was also supported by a grant from the Next-Generation BioGreen 21 Program (PJ01115901), Rural Development Administration, Republic of Korea.; This work was supported by the innovative scientific research grant from CTCBIO and by a grant from the Next-Generation BioGreen 21 Program (PJ01115901), Rural Development Administration, Republic of Korea.	Angelakis E, 2012, FUTURE MICROBIOL, V7, P91, DOI [10.2217/FMB.11.142, 10.2217/fmb.11.142]; Bartosch S, 2005, CLIN INFECT DIS, V40, P28, DOI 10.1086/426027; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen CC, 2005, PEDIATR RES, V58, P1185, DOI 10.1203/01.pdr.0000183660.39116.83; Collins JW, 2014, NAT REV MICROBIOL, V12, P612, DOI 10.1038/nrmicro3315; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Delzenne N, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2209-c2; Delzenne NM, 2011, ANNU REV NUTR, V31, P15, DOI 10.1146/annurev-nutr-072610-145146; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dridi B, 2011, J ANTIMICROB CHEMOTH, V66, P2038, DOI 10.1093/jac/dkr251; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Ford AC, 2014, AM J GASTROENTEROL, V109, P1547, DOI 10.1038/ajg.2014.202; Gerritsen J, 2011, GENES NUTR, V6, P209, DOI 10.1007/s12263-011-0229-7; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Heo J., 2016, SCI REPORTS, V6; Hungin APS, 2013, ALIMENT PHARM THER, V38, P864, DOI 10.1111/apt.12460; Johnson-Henry KC, 2005, J INFECT DIS, V191, P2106, DOI 10.1086/430318; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Kramer N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-384; Krober M, 2009, J BIOTECHNOL, V142, P38, DOI 10.1016/j.jbiotec.2009.02.010; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lievin-Le Moal V, 2014, CLIN MICROBIOL REV, V27, P167, DOI 10.1128/CMR.00080-13; Llewellyn CH, 2013, INT J OBESITY, V37, P1506, DOI 10.1038/ijo.2013.30; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marques TM, 2010, CURR OPIN BIOTECH, V21, P149, DOI 10.1016/j.copbio.2010.03.020; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Million M, 2012, MICROB PATHOGENESIS, V53, P100, DOI 10.1016/j.micpath.2012.05.007; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Pimentel M., 2012, AM J GASTROENTEROL, V1, P28, DOI [10.1038/ajgsup.2012.6, DOI 10.1038/AJGSUP.2012.6]; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sahakian AB, 2010, DIGEST DIS SCI, V55, P2135, DOI 10.1007/s10620-009-1012-0; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Sanders ME, 2013, GUT, V62, P787, DOI 10.1136/gutjnl-2012-302504; Scanlan PD, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-79; Seo M, 2016, SCI REPORTS, V6; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Triantafyllou K, 2014, J NEUROGASTROENTEROL, V20, P31, DOI 10.5056/jnm.2014.20.1.31; Venturi A, 1999, ALIMENT PHARM THER, V13; Vieira AT, 2015, MICROBES INFECT; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whelan K, 2013, CURR OPIN GASTROEN, V29, P184, DOI 10.1097/MOG.0b013e32835d7bba; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352	48	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0184547	10.1371/journal.pone.0184547	http://dx.doi.org/10.1371/journal.pone.0184547			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28937980	gold, Green Published, Green Submitted			2022-12-27	WOS:000411524700005
J	Merk, S; Rosman, T; Ruess, J; Syring, M; Schneider, J				Merk, Samuel; Rosman, Tom; Ruess, Julia; Syring, Marcus; Schneider, Juergen			Pre-service teachers' perceived value of general pedagogical knowledge for practice: Relations with epistemic beliefs and source beliefs	PLOS ONE			English	Article							EPISTEMOLOGICAL BELIEFS; PROFESSIONAL KNOWLEDGE; PERSONAL EPISTEMOLOGY; CLASSROOM MANAGEMENT; DOMAIN-SPECIFICITY; FIT INDEXES; STUDENTS; EDUCATION; CONSISTENCY; REFLECTIONS	Pre-service teachers tend to devalue general pedagogical knowledge (GPK) as a valid source for deriving successful teaching practices. The present study investigated beliefs about knowledge sources and epistemic beliefs as predictors for students' perceived value of GPK. Three pre-registered hypotheses were tested. We expected beliefs that GPK originates from scientific sources to entail a devaluation of GPK (Hypothesis 1). Concerning epistemic beliefs, we expected absolute beliefs to positively, and multiplistic beliefs to negatively predict pre-service teachers' perceived practical value of GPK (Hypothesis 2). Finally, we expected relationships between epistemic beliefs and pre-service teachers' perceived practical value of GPK to be confounded by epistemic trustworthiness, perceived topic-specific consistency and topic-specific familiarity (Hypothesis 3). In a study using a split plot design, 365 pre-service teachers were presented with four texts on different educational research topics. For each topic, three text versions were constructed. Even though they were invariant in content, these versions varied in a way that the results were allegedly generated by a practitioner, an expert or by means of a scientific study. Unexpectedly, results showed that research findings allegedly generated by means of a scientific study were associated with a higher perceived value of (topic-specific) GPK for practice (Hypothesis 1). As expected, the perceived value of GPK for practice was predicted by topic-specific multiplism and domain-specific absolutism (Hypothesis 2). These predictive effects were confounded by expertise evaluations of the source and the consistency of prior beliefs with the presented research results (Hypothesis 3). In summary, our results suggest that source beliefs might not be responsible for the devaluation of GPK, but that beliefs on the nature and structure of GPK (i.e., epistemic beliefs) might play an even more important role in this respect. Implications for research and practice are discussed.	[Merk, Samuel; Schneider, Juergen] Univ Tubingen, Inst Educ, Tubingen, Germany; [Rosman, Tom] Leibniz Inst Psychol Informat ZPID, Trier, Germany; [Ruess, Julia] Humboldt Univ, Bologna Lab, Berlin, Germany; [Syring, Marcus] Ludwig Maximilians Univ Munchen, Dept Sch Educ & Rehabil, Munich, Germany	Eberhard Karls University of Tubingen; Leibniz Institute for Psychology Information & Documentation; Humboldt University of Berlin; University of Munich	Merk, S (corresponding author), Univ Tubingen, Inst Educ, Tubingen, Germany.	samuel.merk@uni-tuebingen.de		Schneider, Jurgen/0000-0002-3772-4198; Merk, Samuel/0000-0003-2594-5337	Institutional Strategy of the University of TuEbingen (Deutsche Forschungsgemeinschaft) [ZUK63]	Institutional Strategy of the University of TuEbingen (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The work of the authors is supported by the Institutional Strategy of the University of TuEbingen (Deutsche Forschungsgemeinschaft ZUK63). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JM, 2009, TEACH TEACH EDUC, V25, P647, DOI 10.1016/j.tate.2008.11.011; Altman N, 2015, NAT METHODS, V12, P165, DOI 10.1038/nmeth.3293; [Anonymous], 2002, AM PSYCHOL, V57, P1060, DOI DOI 10.1037/0003-066X.57.12.1060; Australian Institute for Teaching and School Leadership, 2006, AUSTR PROF STAND TEA; Barzilai S, 2015, CONTEMP EDUC PSYCHOL, V42, P141, DOI 10.1016/j.cedpsych.2015.06.006; Barzilai S, 2015, LEARN INSTR, V36, P86, DOI 10.1016/j.learninstruc.2014.12.003; Bauer J, 2012, SCIENCE, V336, P1642, DOI 10.1126/science.1218387; Baumert Jurgen., 2013, COGNITIVE ACTIVATION, P25; Bjornsson C.-H., 1968, LESBARKEIT DURCH LIX; Blomeke S, 2015, INT J SCI MATH EDUC, V13, P287, DOI 10.1007/s10763-015-9619-4; Bondy E., 2007, TEACH EDUC SPEC EDUC, V30, P67, DOI [DOI 10.1177/088840640703000202, 10.1177/088840640703000202]; Braten I., 2009, SOC PSYCHOL EDUC, V12, P529, DOI [DOI 10.1007/S11218-009-9097-Z, 10.1007/s11218-009-9097-z]; Braten I, 2008, CONTEMP EDUC PSYCHOL, V33, P814, DOI 10.1016/j.cedpsych.2008.02.001; Braten I, 2010, INSTR SCI, V38, P635, DOI 10.1007/s11251-008-9091-4; Braten I, 2015, TEACH TEACH EDUC, V50, P13, DOI 10.1016/j.tate.2015.04.003; Braten I, 2014, LEARN INSTR, V30, P9, DOI 10.1016/j.learninstruc.2013.11.002; Braten I, 2013, EUR J PSYCHOL EDUC, V28, P879, DOI 10.1007/s10212-012-0145-2; British Educational Research Association, 2014, ROL RES TEACH ED REV; Bromme R., 2010, PERSONAL EPISTEMOLOG, P163, DOI DOI 10.1017/CBO9780511691904.006; Brown T.A., 2006, CONFIRMATORY FACTOR, V1st; Buehl M. M., 2016, HDB EPISTEMIC COGNIT; Buehl MM, 2009, J EXP EDUC, V77, P367, DOI 10.3200/JEXE.77.4.367-408; Buehl MM, 2002, CONTEMP EDUC PSYCHOL, V27, P415, DOI 10.1006/ceps.2001.1103; CALDERHEAD J, 1991, TEACH TEACH EDUC, V7, P1, DOI 10.1016/0742-051X(91)90053-R; Campbell W. K., 1999, REV GEN PSYCHOL, V3, P23, DOI DOI 10.1037/1089-2680.3.1.23; Cano F, 2005, BRIT J EDUC PSYCHOL, V75, P203, DOI 10.1348/000709904X22683; CHINN CA, 1993, REV EDUC RES, V63, P1, DOI 10.3102/00346543063001001; Cramer C, 2013, Z PADAGOGIK, V59, P66; Darling-Hammond L., 2005, PREPARING TEACHERS C; Dunn TJ, 2014, BRIT J PSYCHOL, V105, P399, DOI 10.1111/bjop.12046; Elby A, 2001, SCI EDUC, V85, P554, DOI 10.1002/sce.1023; European Commision, 2013, SUPP TEACH COMP DEV; Fenstermacher G. D., 1979, REV RES ED, V6, P157; Fives H, 2012, ED PSYCHOL HDB, P471; Gaudin C, 2015, EDUC RES REV-NETH, V16, P41, DOI 10.1016/j.edurev.2015.06.001; Gawronski B, 2012, SOC COGNITION, V30, P652, DOI 10.1521/soco.2012.30.6.652; Gitlin A, 1999, TEACH TEACH EDUC, V15, P753, DOI 10.1016/S0742-051X(99)00015-3; Gordon M., 2007, BRIDGING THEORY PRAC, P119; Gordon Mordechai, 2007, BRIDGING THEORY PRAC; GROSSMAN PL, 1988, TEACH TEACH EDUC, V4, P53, DOI 10.1016/0742-051X(88)90024-8; Hargreaves D.H., 2007, ED RES EVIDENCE BASE, P3; Hendriks F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139309; Hofer BK, 1997, REV EDUC RES, V67, P88, DOI 10.2307/1170620; HOLTREYNOLDS D, 1992, AM EDUC RES J, V29, P325, DOI 10.3102/00028312029002325; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Hox JJ, 2010, STAT NEERL, V64, P157, DOI 10.1111/j.1467-9574.2009.00445.x; Hoy AW, 2001, EDUC PSYCHO, P145; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Joram E, 2007, TEACH TEACH EDUC, V23, P123, DOI 10.1016/j.tate.2006.04.032; Kardash CM, 2000, J EDUC PSYCHOL, V92, P524, DOI 10.1037//0022-0663.92.3.524; Kline P., 2000, HDB PSYCHOL TESTING; Knight R, 2015, J ED TEACH ROUTLEDGE, V41:, P1; Konig J, 2016, ZDM-MATH EDUC, V48, P139, DOI 10.1007/s11858-015-0705-4; Konig J, 2014, TEACH TEACH EDUC, V38, P76, DOI 10.1016/j.tate.2013.11.004; Konig J, 2011, J TEACH EDUC, V62, P188, DOI 10.1177/0022487110388664; Korthagen FA., 1999, ED RES, V28, P4, DOI [10.3102/0013189X028004004, DOI 10.3102/0013189X028004004]; Korthagen FAJ, 2007, EDUC RES EVAL, V13, P303, DOI 10.1080/13803610701640235; Krettenauer T, 2005, Z ENTWICKL PADAGOGIS, V37, P69, DOI 10.1026/0049-8637.37.2.69; Kuhn D, 2002, PERSONAL EPISTEMOLOGY: THE PSYCHOLOGY OF BELIEFS ABOUT KNOWLEDGE KNOWING, P121; Kuhn D, 2000, COGNITIVE DEV, V15, P309, DOI 10.1016/S0885-2014(00)00030-7; Kunter M, 2014, DATENSATZ; Kunter M, 2013, J EDUC PSYCHOL, V105, P805, DOI 10.1037/a0032583; Lenske G, 2016, Z ERZIEHWISS, V19, P211, DOI 10.1007/s11618-015-0659-x; Ludtke O, 2007, PSYCHOL RUNDSCH, V58, P103, DOI 10.1026/0033-3042.58.2.103; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; Mansfield CF, 2014, J EDUC TEACHING, V40, P155, DOI 10.1080/02607476.2013.869967; Marsh HW, 2004, STRUCT EQU MODELING, V11, P320, DOI 10.1207/s15328007sem1103_2; Mason L, 2008, J EDUC PSYCHOL, V100, P291, DOI 10.1037/0022-0663.100.2.291; Mason L, 2011, LEARN INSTR, V21, P137, DOI 10.1016/j.learninstruc.2010.01.001; Mehta PD, 2005, PSYCHOL METHODS, V10, P259, DOI 10.1037/1082-989X.10.3.259; Merk S, 2016, UNTERRICHTSWISSENSCH; Merk S, 2016, DENKEN WISSCHUNG; Merk S, 2016, RIER PSYCHOLOGISCHES; Muis KR, 2006, EDUC PSYCHOL REV, V18, P3, DOI 10.1007/s10648-006-9003-6; Muis KR, 2013, J EDUC PSYCHOL, V105, P213, DOI 10.1037/a0029690; Munby H., 2001, HDB RES TEACHING, V4, P877; MUTHEN BO, 1994, SOCIOL METHOD RES, V22, P376, DOI 10.1177/0049124194022003006; Muthen L.K., MPLUS USERS GUIDE, V8th; Nagengast B, 2013, MULTIVAR BEHAV RES, V48, P428, DOI 10.1080/00273171.2013.775060; OECD, 2005, OECD ED WORKING PAPE; Parr JM, 2008, ASSESS EDUC, V15, P57, DOI 10.1080/09695940701876151; Paulick I, 2016, J TEACH EDUC, V67, P173, DOI 10.1177/0022487116639263; Pendry A., 2000, CAMB J EDUC, V30, P321, DOI DOI 10.1080/03797720600625275; Peter J, 2016, BRIT J EDUC PSYCHOL, V86, P204, DOI 10.1111/bjep.12098; Peterson S. E., 2011, TEACHING ED PSYCHOL, V7, P27; Petty G., 2009, EVIDENCE BASED TEACH; Richardson V., 1996, HDB RES TEACHER ED, P102; RICHARDSONKOEHLER V, 1988, J TEACH EDUC, V39, P28, DOI 10.1177/002248718803900206; Rosman T., 2016, STUD HIGH ED, P1; Rosman T, 2017, LEARN INSTR, V49, P166, DOI 10.1016/j.learninstruc.2017.01.006; Rosman T, 2016, LEARN INDIVID DIFFER, V49, P406, DOI 10.1016/j.lindif.2016.05.017; Ryu E, 2014, BRIT J MATH STAT PSY, V67, P172, DOI 10.1111/bmsp.12014; Sandoval WA, 2016, HDB EPISTEMIC COGNIT, P247; Schneider J, EPISTEMOLOGISCHE UBE; SCHOMMER M, 1995, J EDUC PSYCHOL, V87, P424, DOI 10.1037/0022-0663.87.3.424; SCHOMMER M, 1993, J EDUC PSYCHOL, V85, P406, DOI 10.1037/0022-0663.85.3.406; SHULMAN LS, 1987, HARVARD EDUC REV, V57, P1, DOI 10.17763/haer.57.1.j463w79r56455411; Shulman LS., 1986, EDUC RESEARCHER, V15, P4, DOI [10.3102/0013189X015002004, 10.3102%2F0013189X015002004, DOI 10.3102/0013189X015002004]; Sjolie E, 2014, J CURRICULUM STUD, V46, P729, DOI 10.1080/00220272.2013.871754; Slavin R.E., 2002, EDUC RES-UK, V31, P15, DOI [10.3102/0013189X031007015, DOI 10.3102/0013189X031007015]; Smith K., 2005, ASIA PACIFIC J TEACH, V33, P289, DOI [DOI 10.1080/13598660500286333, https://doi.org/10.1080/13598660500286333]; Stahl E, 2007, LEARN INSTR, V17, P773, DOI 10.1016/j.learninstruc.2007.09.016; Stromso HI, 2011, EDUC PSYCHOL-UK, V31, P177, DOI 10.1080/01443410.2010.538039; Taboada A, 2009, READ WRIT, V22, P85, DOI 10.1007/s11145-008-9133-y; Tatto MT, POLICY PRACTICE READ; Trautwein U, 2004, Z PADAGOG PSYCHOL, V18, P187, DOI 10.1024/1010-0652.18.34.187; Trautwein U, 2007, BRIT J EDUC PSYCHOL, V77, P907, DOI 10.1348/000709906X169012; U. S. National Board for Professional Teaching Standards, 2002, WHAT TEACH SHOULD KN; van der Linden W, 2012, EUR J TEACH EDUC, V35, P401, DOI 10.1080/02619768.2011.643401; Voss T, 2011, J EDUC PSYCHOL, V103, P952, DOI 10.1037/a0025125; Williams D, 2007, J DOC, V63, P812, DOI 10.1108/00220410710836376; WUBBELS T, 1992, TEACH TEACH EDUC, V8, P137, DOI 10.1016/0742-051X(92)90004-M	112	18	18	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184971	10.1371/journal.pone.0184971	http://dx.doi.org/10.1371/journal.pone.0184971			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934358	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900068
J	Ashrafzadeh, S; Leung, DWM				Ashrafzadeh, Seyedardalan; Leung, David W. M.			Novel potato plants with enhanced cadmium resistance and antioxidative defence generated after in vitro cell line selection	PLOS ONE			English	Article							OXIDATIVE STRESS; LIPID-PEROXIDATION; PROLINE CONTENT; CULTIVARS; ACCUMULATION; TOLERANT; RESPONSES; ENZYMES; GROWTH; PB	It is of interest to apply plant tissue culture to generate plants resistant to toxic effects of cadmium (Cd) on plant growth. Callus cultures were initiated from leaf explants of micropropagated potato plantlets (Solanum tuberosum L., cv. Iwa) for in vitro selection comprising 18 different Cd treatments varying in Cd exposure timing and duration. Plantlets regenerated from two different lines of Cd-selected calli, L9 and L11, were found to exhibit enhanced resistance to 218 mu M Cd compared to control (source plantlets for leaf explants used to initiate callus cultures for Cd resistance). In response to 218 mu M Cd, L11 plantlets had lower levels of lipid peroxidation and hydrogen peroxide than control and L9 plantlets. In addition, antioxidative enzyme activities in L11 were generally higher than control. L11 also had a higher level of proline than control.	[Ashrafzadeh, Seyedardalan; Leung, David W. M.] Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch, New Zealand	University of Canterbury	Leung, DWM (corresponding author), Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch, New Zealand.	david.leung@canterbuy.ac.nz		Leung, David/0000-0002-9572-2465				Albiski Fahed, 2012, Physiology and Molecular Biology of Plants, V18, P315, DOI 10.1007/s12298-012-0127-5; Ashrafadeh S, 2015, BIOLOGIA, V70, P581, DOI 10.1515/biolog-2015-0067; Ashrafzadeh S, 2017, J FOOD COMPOS ANAL, V59, P55, DOI 10.1016/j.jfca.2017.02.008; Ashrafzadeh S, 2016, J CROP IMPROV, V30, P107, DOI 10.1080/15427528.2015.1134743; Ashrafzadeh S, 2015, HORTIC ENVIRON BIOTE, V56, P131, DOI 10.1007/s13580-015-0128-8; Atwell BJ, 1999, PLANTS ACTION ADAPTA; Baisakhi B, 2003, ACTA PHYSIOL PLANT, V25, P357, DOI 10.1007/s11738-003-0017-0; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Charfeddine M, 2017, PLANT CELL TISS ORG, V128, P521, DOI 10.1007/s11240-016-1130-2; Clemens S, 2001, PLANTA, V212, P475, DOI 10.1007/s004250000458; Cuypers A, 2010, BIOMETALS, V23, P927, DOI 10.1007/s10534-010-9329-x; Demiral T, 2005, ENVIRON EXP BOT, V53, P247, DOI 10.1016/j.envexpbot.2004.03.017; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Grant CA, 2008, SCI TOTAL ENVIRON, V390, P301, DOI 10.1016/j.scitotenv.2007.10.038; Hayat S, 2012, PLANT SIGNAL BEHAV, V7, P1456, DOI 10.4161/psb.21949; Hell R., 2003, J PLANT PHYSL, V160, P706; Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011; Koca H, 2007, ENVIRON EXP BOT, V60, P344, DOI 10.1016/j.envexpbot.2006.12.005; Lachman J, 2009, FOOD CHEM, V114, P836, DOI 10.1016/j.foodchem.2008.10.029; MADAN S, 1995, ANN BOT-LONDON, V76, P51, DOI 10.1006/anbo.1995.1077; Martins LL, 2014, ACTA PHYSIOL PLANT, V36, P755, DOI 10.1007/s11738-013-1453-0; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nadgorska-Socha A, 2013, ECOTOXICOLOGY, V22, P1422, DOI 10.1007/s10646-013-1129-y; Nehnevajova E, 2007, PLANT CELL REP, V26, P429, DOI 10.1007/s00299-006-0264-9; Phang IC, 2011, PLANT GROWTH REGUL, V64, P17, DOI 10.1007/s10725-010-9527-0; Predieri S, 2001, PLANT CELL TISS ORG, V64, P185, DOI 10.1023/A:1010623203554; Rai MK, 2011, ENVIRON EXP BOT, V71, P89, DOI 10.1016/j.envexpbot.2010.10.021; Ranieri A, 1997, ENVIRON EXP BOT, V37, P125, DOI 10.1016/S0098-8472(96)01040-4; Sharma P, 2004, PLANT SCI, V167, P541, DOI 10.1016/j.plantsci.2004.04.028; Singh N, 2006, PLANT SCI, V170, P274, DOI 10.1016/j.plantsci.2005.08.013; Sun JY, 2013, ARCH ENVIRON CON TOX, V64, P243, DOI 10.1007/s00244-012-9824-x; van der Vyver C, 2013, IN VITRO CELL DEV-PL, V49, P198, DOI 10.1007/s11627-013-9493-0; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Wilson CR, 2010, PHYTOPATHOLOGY, V100, P460, DOI 10.1094/PHYTO-100-5-0460; Yoon KS, 2004, ACTA PHYSIOL PLANT, V26, P47, DOI 10.1007/s11738-004-0043-6; Zhang YL, 1997, POTATO RES, V40, P285, DOI 10.1007/BF02358010; Zhu Y, 2007, J AGR FOOD CHEM, V55, P1045, DOI 10.1021/jf062971p	37	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185621	10.1371/journal.pone.0185621	http://dx.doi.org/10.1371/journal.pone.0185621			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968406	Green Published, gold, Green Submitted			2022-12-27	WOS:000412029600030
J	Brazier, L; Elguero, E; Koumavor, CK; Renaud, N; Prugnolle, F; Thomas, F; Ategbo, S; Engoba, M; Obengui; Leroy, EM; Durand, P; Renaud, F; Becquart, P				Brazier, Lionel; Elguero, Eric; Koumavor, Claudine Kombila; Renaud, Nicolas; Prugnolle, Franck; Thomas, Frederic; Ategbo, Simon; Engoba, Moyen; Obengui; Leroy, Eric M.; Durand, Patrick; Renaud, Francois; Becquart, Pierre			Evolution in fecal bacterial/viral composition in infants of two central African countries (Gabon and Republic of the Congo) during their first month of life	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; HUMAN GUT MICROBIOME; 5 YEARS OLD; MOLECULAR EPIDEMIOLOGY; CAUSATIVE AGENTS; ENTERIC VIRUSES; BODY HABITATS; ROTAVIRUS; CHILDREN; ADENOVIRUS	Few studies have analyzed the gut microbiota of child in unindustrialized countries, but none during the first month of life. Stool samples were collected from healthy newborns in hospitals of Gabon (n = 6) and Republic of the Congo (n = 9) at different time points during the first month of life: meconium, day 2 (D02), day 7 (D07) and day 28 (D28). In addition, one fecal sample was collected from each mother after delivery. Metagenomic sequencing was performed to determine the bacterial communities, and multiplex real-time PCR was used to detect the presence of seven enteric viruses (rotavirus a, adenovirus, norovirus I and II, sapovirus, astrovirus, enterovirus) in these samples. Bacterial diversity was high in the first days of life, and was dominated by the genus Prevotella. Then, it rapidly decreased and remained low up to D28 when the gut flora was composed almost exclusively of strictly anaerobic bacteria. Each infant's fecal bacterial microbiota composition was significantly closer to that of their mother than to that of any other woman in the mothers' group, suggesting an intrauterine, placental or amniotic fluid origin of such bacteria. Moreover, bacterial communities differed according to the delivery mode. Overall, the bacterial microbiota communities displayed a similar diversification and expansion in newborns within and between countries during the first four weeks of life. Moreover, six of the fifteen infants of this study harbored enteric viruses (rotavirus, enterovirus and adenovirus) in fecal samples, but never in the meconium. A maternal source for the viruses detected at D02 and D07 can be excluded because none of them was found also in the child's mother. These findings improve our knowledge on the gut bacterial and viral communities of infants from two Sub-Saharan countries during their first month of life.	[Brazier, Lionel; Elguero, Eric; Prugnolle, Franck; Thomas, Frederic; Leroy, Eric M.; Durand, Patrick; Renaud, Francois; Becquart, Pierre] IRD, UMR MIVEGEC 5290, Montpellier, France; [Koumavor, Claudine Kombila; Leroy, Eric M.] Ctr Int Rech Med Franceville, Franceville, Gabon; [Renaud, Nicolas] Labco Midi, Montpellier, France; [Ategbo, Simon] Ctr Hosp Univ Angondje, Libreville, Gabon; [Engoba, Moyen] Ctr Hosp Univ Brazzaville, Brazzaville, Rep Congo	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Brazier, L (corresponding author), IRD, UMR MIVEGEC 5290, Montpellier, France.	lionel.brazier@ird.fr	LEROY, Eric M/I-4347-2016; Becquart, Pierre/GLT-0845-2022	LEROY, Eric M/0000-0003-0022-0890; Prugnolle, Franck/0000-0001-8519-1253; Becquart, Pierre/0000-0002-0980-1678; THOMAS, Frederic/0000-0003-2238-1978	Centre National de la Recherche Scientifique (CNRS); Centre International de Recherche Medicales de Franceville (CIRMF); Institut de Recherche pour le Developpement (IRD); Laboratoire mixte international (LMI) ZOFAC (IRD)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Centre International de Recherche Medicales de Franceville (CIRMF); Institut de Recherche pour le Developpement (IRD); Laboratoire mixte international (LMI) ZOFAC (IRD)	The authors thank Centre National de la Recherche Scientifique (CNRS), Centre International de Recherche Medicales de Franceville (CIRMF) and Institut de Recherche pour le Developpement (IRD) for general support. This work was supported by the Laboratoire mixte international (LMI) ZOFAC (IRD) to Eric Leroy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001; Anderson EJ, 2010, EXPERT REV ANTI-INFE, V8, P205, DOI [10.1586/eri.10.1, 10.1586/ERI.10.1]; Ardissone AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090784; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BETTELHEIM KA, 1974, J HYG-CAMBRIDGE, V72, P67, DOI 10.1017/S0022172400023226; Breitbart M, 2008, RES MICROBIOL, V159, P367, DOI 10.1016/j.resmic.2008.04.006; Collado MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23129; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Chu DKW, 2008, J VIROL, V82, P9107, DOI 10.1128/JVI.00857-08; Chu DM, 2017, NATURE MED; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Coppa GV, 2004, J CLIN GASTROENTEROL, V38, pS80, DOI 10.1097/01.mcg.0000128926.14285.25; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; De Palma G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-63; Dehingia M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18563; Dey RS, 2011, J CLIN MICROBIOL, V49, P500, DOI 10.1128/JCM.01834-10; Dinan TG, 2015, CURR OPIN CLIN NUTR, V18, P552, DOI 10.1097/MCO.0000000000000221; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gomez A, 2016, CELL REP, V14, P2142, DOI 10.1016/j.celrep.2016.02.013; Gosalbes MJ, 2013, CLIN EXP ALLERGY, V43, P198, DOI 10.1111/cea.12063; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Han YPW, 2006, J CLIN MICROBIOL, V44, P1475, DOI 10.1128/JCM.44.4.1475-1483.2006; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Hoehne M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-69; Hu JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078257; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Janda J.M., 2006, THE ENTEROBACTERIA, P115; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Kanungo S, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2016.e00223; Kapusinszky B, 2012, J CLIN MICROBIOL, V50, P3427, DOI 10.1128/JCM.01589-12; Koleva PT, 2015, BIRTH DEFECTS RES C, V105, P265, DOI 10.1002/bdrc.21117; Lekana-Douki SE, 2015, INT J INFECT DIS, V34, P90, DOI 10.1016/j.ijid.2015.03.009; LENNOX-KING S M J, 1976, Infection, V4, P139, DOI 10.1007/BF01638940; Lin AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063550; Logan C, 2007, J VIROL METHODS, V146, P36, DOI 10.1016/j.jviromet.2007.05.031; Logan C, 2006, J CLIN MICROBIOL, V44, P3189, DOI 10.1128/JCM.00915-06; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Martinez I, 2015, CELL REP, V11, P527, DOI 10.1016/j.celrep.2015.03.049; Mayindou G, 2016, J MED VIROL, V88, P596, DOI 10.1002/jmv.24382; Milani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068739; Morton ER, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005658; Nagpal R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01997; Nasri D, 2007, J CLIN MICROBIOL, V45, P2370, DOI 10.1128/JCM.00093-07; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Pereira E, 2007, J MED MICROBIOL, V56, P313, DOI 10.1099/jmm.0.46685-0; Perez-Munoz ME, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0268-4; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Ramani S, 2009, CURR OPIN INFECT DIS, V22, P477, DOI 10.1097/QCO.0b013e328330662f; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Richardson S, 1998, LANCET, V351, P1844, DOI 10.1016/S0140-6736(97)11257-0; Rutayisire E, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0498-0; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schnorr S. L., 2014, NAT COMMUN, V15, P5; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; SHINOZAKI T, 1991, SCAND J INFECT DIS, V23, P543, DOI 10.3109/00365549109105175; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Tissier H., 1900, RECHERCHES FLORE INT; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WILDE J, 1991, LANCET, V337, P323, DOI 10.1016/0140-6736(91)90945-L; Wold WSM, 2007, ADENOVIRUSES; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05001	80	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185569	10.1371/journal.pone.0185569	http://dx.doi.org/10.1371/journal.pone.0185569			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968427	gold, Green Published, Green Submitted			2022-12-27	WOS:000412029600025
J	Giusti, A; Armani, A; Sotelo, CG				Giusti, Alice; Armani, Andrea; Sotelo, Carmen G.			Advances in the analysis of complex food matrices: Species identification in surimi-based products using Next Generation Sequencing technologies	PLOS ONE			English	Article							AQUACULTURE; COD	The Next Generation Sequencing (NGS) technologies represent a turning point in the food inspection field, particularly for species identification in matrices composed of a blend of two or more species. In this study NGS technologies were applied by testing the usefulness of the Ion Torrent Personal Genome Machine (PGM) in seafood traceability. Sixteen commercial surimi samples produced both in EU and non-EU countries were analysed. Libraries were prepared using a universal primer pair able to amplify a short 16SrRNA fragment from a wide range of fish and cephalopod species. The mislabelling rate of the samples was also evaluated. Overall, DNA from 13 families, 19 genera and 16 species of fish, and from 3 families, 3 genera and 3 species of cephalopods was found with the analysis. Samples produced in non-EU countries exhibited a higher variability in their composition. 37.5% of the surimi products were found to be mislabelled. Among them, 25% voluntary declared a species different from those identified and 25% (all produced in non-EU countries) did not report the presence of molluscs on the label, posing a potential health threat for allergic consumers. The use of vulnerable species was also proved. Although the protocol should be further optimized, PGM platform proved to be a useful tool for the analysis of complex, highly processed products.	[Giusti, Alice; Armani, Andrea] Univ Pisa, Dept Vet Sci, FishLab, Pisa, Italy; [Sotelo, Carmen G.] CSIC, IIM, Vigo, Spain	University of Pisa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Armani, A (corresponding author), Univ Pisa, Dept Vet Sci, FishLab, Pisa, Italy.; Sotelo, CG (corresponding author), CSIC, IIM, Vigo, Spain.	andrea.armani@unipi.it; carmen@iim.csic.es	Sotelo, Carmen Gonzalez/L-3696-2014; Giusti, Alice/AAB-9688-2022	Sotelo, Carmen Gonzalez/0000-0002-0726-4370; Armani, Andrea/0000-0002-9614-2032; Palhares, Rafael/0000-0003-2512-8273; Giusti, Alice/0000-0001-9693-5721	Atlantic Area Programme (INTERREG IVB) [2011-1/163 REF 1070134]	Atlantic Area Programme (INTERREG IVB)	LABELFISH. ATLANTIC NETWORK ON GENETIC CONTROL OF FISH AND SEAFOOD LABELLING AND TRACEABILITY, funded by Atlantic Area Programme (INTERREG IVB) 2011-1/163 REF 1070134; URL: http://www.atlanticarea.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3894; Andrea A, 2014, FOOD ANAL METHOD, V7, P946, DOI 10.1007/s12161-014-9792-z; Bertolini F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121701; Brennan MA, 2013, INT J FOOD SCI TECH, V48, P893, DOI 10.1111/ijfs.12055; Carvalho DC, 2017, FOOD CONTROL, V80, P183, DOI 10.1016/j.foodcont.2017.04.049; Chapela MJ, 2002, J FOOD SCI, V67, P1672, DOI 10.1111/j.1365-2621.2002.tb08703.x; D'Amico P, 2016, MAR POLICY, V71, P147, DOI 10.1016/j.marpol.2016.05.026; D'Amico P, 2014, FOOD CONTROL, V35, P7, DOI 10.1016/j.foodcont.2013.06.029; Ehara T, 2004, FISHERIES SCI, V70, P306, DOI 10.1111/j.1444-2906.2003.00805.x; Galal-Khallaf A, 2016, FOOD CONTROL, V61, P62, DOI 10.1016/j.foodcont.2015.09.027; Giusti A, 2017, J AGR FOOD CHEM, V65, P2902, DOI 10.1021/acs.jafc.6b05802; Kappel K, 2017, FOOD CHEM, V234, P212, DOI 10.1016/j.foodchem.2017.04.178; Keskin E, 2012, J APPL ICHTHYOL, V28, P811, DOI 10.1111/j.1439-0426.2012.02031.x; Lopata AL, 2009, CURR OPIN ALLERGY CL, V9, P270, DOI 10.1097/ACI.0b013e32832b3e6f; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Munoz-Colmenero M, 2017, FOOD CHEM, V214, P631, DOI 10.1016/j.foodchem.2016.07.121; Musmand JJ, 1996, J ALLERGY CLIN IMMUN, V98, P697, DOI 10.1016/S0091-6749(96)70104-5; Park JY, 2012, BIOCHIP J, V6, P354, DOI 10.1007/s13206-012-6407-x; Park JW, 2012, J FOOD ENG, V108, P557; Pedrosa M, 2015, CLIN REV ALLERG IMMU, V49, P203, DOI 10.1007/s12016-014-8429-8; Pepe T, 2007, J AGR FOOD CHEM, V55, P3681, DOI 10.1021/jf063321o; Suarez Daniela Mariel, 2014, Braz. J. Food Technol., V17, P8, DOI 10.1590/bjft.2014.003; Swoboda I, 2002, J IMMUNOL, V168, P4576, DOI 10.4049/jimmunol.168.9.4576; Tillmar AO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083761; Vidal-Giraud B., 2007, GLOBEFISH RES PROGRA, V89; Xiong X, 2016, MAR POLICY, V68, P123, DOI 10.1016/j.marpol.2016.02.024; Zaiko A, 2015, MAR ENVIRON RES, V112, P64, DOI 10.1016/j.marenvres.2015.07.002	27	32	33	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185586	10.1371/journal.pone.0185586	http://dx.doi.org/10.1371/journal.pone.0185586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968423	Green Published, Green Submitted, gold			2022-12-27	WOS:000412029600027
J	De Rechter, S; Kringen, J; Janssens, P; Liebau, MC; Devriendt, K; Levtchenko, E; Bergmann, C; Jouret, F; Bammens, B; Borry, P; Schaefer, F; Mekahli, D				De Rechter, Stephanie; Kringen, Jonathan; Janssens, Peter; Liebau, Max Christoph; Devriendt, Koenraad; Levtchenko, Elena; Bergmann, Carsten; Jouret, Francois; Bammens, Bert; Borry, Pascal; Schaefer, Franz; Mekahli, Djalila			Clinicians' attitude towards family planning and timing of diagnosis in autosomal dominant polycystic kidney disease	PLOS ONE			English	Article							RENAL-DISEASE; CHILDREN; VOLUME; RISK; INDIVIDUALS; MINORS; ADPKD	Several ethical aspects in the management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) are still controversial, including family planning and testing for disease presence in at-risk individuals. We performed an online survey aiming to assess the opinion and current clinical practice of European pediatric and adult nephrologists, as well as geneticists. A total of 410 clinicians (53% male, mean (SD) age of 48 (10) years) responded, including 216 pediatric nephrologists, 151 adult nephrologists, and 43 clinical geneticists. While the 3 groups agreed to encourage clinical testing in asymptomatic ADPKD minors and adults, only geneticists would recommend genetic testing in asymptomatic at-risk adults (P<0.001). Statistically significant disagreement between disciplines was observed regarding the ethical justification of prenatal genetic diagnosis, termination of pregnancy and pre-implantation genetic diagnosis (PGD) for ADPKD. Particularly, PGD is ethically justified according to geneticists (4.48 (1.63)), whereas pediatric (3.08 (1.78); P<0.001) and adult nephrologists (3.66(1.88); P<0.05) appeared to be less convinced. Our survey suggests that most clinicians support clinical testing of at-risk minors and adults in ADPKD families. However, there is no agreement for genetic testing in asymptomatic offspring and for family planning, including PGD. The present data highlight the need for a consensus among clinicians, to avoid that ADPKD families are being given conflicting information.	[De Rechter, Stephanie; Levtchenko, Elena; Mekahli, Djalila] Univ Hosp Leuven, Dept Pediat Nephrol, Leuven, Belgium; [De Rechter, Stephanie; Janssens, Peter; Levtchenko, Elena; Mekahli, Djalila] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Kringen, Jonathan] Univ New Haven, New Haven, CT USA; [Janssens, Peter] Univ Hosp Brussels, Dept Nephrol, Brussels, Belgium; [Liebau, Max Christoph] Univ Hosp Cologne, Dept Pediat, Cologne, Germany; [Liebau, Max Christoph] Univ Hosp Cologne, Ctr Mol Med, Cologne, Germany; [Devriendt, Koenraad] Katholieke Univ Leuven, Dept Genet, Univ Hosp Leuven, Leuven, Belgium; [Bergmann, Carsten] Bioscientia, Ctr Human Genet, Ingelheim, Germany; [Bergmann, Carsten] Univ Hosp Freiburg, Dept Med, Freiburg, Germany; [Jouret, Francois] Univ Liege Hosp ULg CHU, Div Nephrol, Liege, Belgium; [Jouret, Francois] Univ Liege, GIGA, Cardiovasc Sci, Liege, Belgium; [Bammens, Bert] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Bammens, Bert] Univ Hosp Leuven, Dept Nephrol Dialysis & Renal Transplantat, Leuven, Belgium; [Borry, Pascal] Univ Leuven, Dept Publ Hlth & Primary Care, Ctr Biomed Eth & Law, Leuven, Belgium; [Schaefer, Franz] Heidelberg Univ, Div Pediat Nephrol, Ctr Pediat & Adolescent Med, Med Ctr, Heidelberg, Germany	KU Leuven; University Hospital Leuven; KU Leuven; University New Haven; University Hospital Brussels; University of Cologne; University of Cologne; KU Leuven; University Hospital Leuven; University of Freiburg; University of Liege; University of Liege; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; Ruprecht Karls University Heidelberg	De Rechter, S (corresponding author), Univ Hosp Leuven, Dept Pediat Nephrol, Leuven, Belgium.; De Rechter, S (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium.	stephanie.derechter@uzleuven.be	Levtchenko, Elena/AAO-7125-2020; Janssens, Peter/ABD-3251-2020; Liebau, Max Christoph/K-3470-2019; Bammens, Bert/D-4659-2018; Borry, Pascal/B-5836-2012	Liebau, Max Christoph/0000-0003-0494-9080; Bammens, Bert/0000-0002-2477-2633; Janssens, Peter/0000-0002-0981-8621; Mekahli, Djalila/0000-0003-0954-6088; Borry, Pascal/0000-0002-4931-9560	German Research Fund (DFG Collaborative Research Centre (SFB)) [KIDGEM 1140]; Federal Ministry of Education and Research (BMBF) [01GM1515C]; UZ Leuven; Fund for Scientific Research (FWO) [GOB1313N]; European Society for Pediatric Nephrology; Fund for Scientific Research, Flanders (FWO) [ZKC5782, 11M5214N]; European Commission (EU 7th Framework ProgramFme) [2012-305608]; German Federal Ministry of Education and Research (NEOCYST) [FKZ 01GM1515]	German Research Fund (DFG Collaborative Research Centre (SFB)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); UZ Leuven(KU Leuven); Fund for Scientific Research (FWO)(FWO); European Society for Pediatric Nephrology; Fund for Scientific Research, Flanders (FWO)(FWO); European Commission (EU 7th Framework ProgramFme); German Federal Ministry of Education and Research (NEOCYST)	CB receives support from the German Research Fund (DFG Collaborative Research Centre (SFB) KIDGEM 1140) and the Federal Ministry of Education and Research (BMBF, 01GM1515C). DM is supported by the Clinical Research Fund of UZ Leuven and by the Fund for Scientific Research (FWO) GOB1313N. DM and MCL are supported by a research grant from the European Society for Pediatric Nephrology. EL is supported by the Fund for Scientific Research, Flanders (FWO) ZKC5782. FJ is a Fellow of the Belgian Fonds National de la Recherche Scientifique (FNRS). FS receives support by the European Commission (EU 7th Framework ProgramFme grant no. 2012-305608 (EURenOmics)). MCL, CB and FS receive funding from the German Federal Ministry of Education and Research (NEOCYST consortium FKZ 01GM1515). SDR is supported by the Fund for Scientific Research, Flanders (FWO) 11M5214N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, EUR J HUM GENET, V17, P720; Bellone E, 1991, Boll Soc Ital Biol Sper, V67, P915; Benohr-Laqueur Susanne, 2011, Poiesis Prax, V8, P3; Bergmann C, 2011, J AM SOC NEPHROL, V22, P2047, DOI 10.1681/ASN.2010101080; Borry P, 2008, MT SINAI J MED, V75, P287, DOI 10.1002/msj.20038; Borry P, 2008, AM J MED GENET C, V148C, P78, DOI 10.1002/ajmg.c.30165; Brun M, 2004, ULTRASOUND OBST GYN, V24, P55, DOI 10.1002/uog.1098; Cadnapaphornchai MA, 2014, CLIN J AM SOC NEPHRO, V9, P889, DOI 10.2215/CJN.08350813; Cadnapaphornchai MA, 2011, CLIN J AM SOC NEPHRO, V6, P369, DOI 10.2215/CJN.03780410; Chapman AB, 2015, KIDNEY INT, V88, P17, DOI 10.1038/ki.2015.59; Chapman AB, 2011, SEMIN NEPHROL, V31, P237, DOI 10.1016/j.semnephrol.2011.05.003; Chebib FT, 2016, AM J KIDNEY DIS, V67, P792, DOI 10.1053/j.ajkd.2015.07.037; Cornec- Le Gall E, 2015, J AM SOC NEPHROLOGY; DALGAARD O Z, 1957, Acta Med Scand Suppl, V328, P1; De Rycke M, 2005, MOL HUM REPROD, V11, P65, DOI 10.1093/molehr/gah128; Division UNS, 2016, COMP MACR CONT REG G; Eisenberger T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116680; Fick-Brosnahan G, 1999, AM J KIDNEY DIS, V34, P639, DOI 10.1016/S0272-6386(99)70387-2; Flahault A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153176; Forum EA, 2015, TRANSLATING SCI POLI; Gabow PA, 1997, J AM SOC NEPHROL, V8, P105; GABOW PA, 1992, KIDNEY INT, V41, P1311, DOI 10.1038/ki.1992.195; Gansevoort RT, 2016, NEPHROL DIAL TRANSPL, V31, P337, DOI 10.1093/ndt/gfv456; Gentechnikgesetz GTG, 5101994 GTG BGBI; German Society of Human Genetics, 2013, STAT GEN DIAGN CHILD; Golin CO, 1996, AM J KIDNEY DIS, V27, P220, DOI 10.1016/S0272-6386(96)90544-2; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Grantham JJ, 2015, PEDIATR NEPHROL, V30, P1053, DOI 10.1007/s00467-014-2882-8; Grantham JJ, 2010, CLIN J AM SOC NEPHRO, V5, P889, DOI 10.2215/CJN.00550110; Harper J, 2014, HUM REPROD, V29, P1603, DOI 10.1093/humrep/deu130; Marsick R, 1998, AM J KIDNEY DIS, V32, P934, DOI 10.1016/S0272-6386(98)70087-3; Nys H DI, GENETIC TESTING PATI; Pei Y, 2015, J AM SOC NEPHROL, V26, P746, DOI 10.1681/ASN.2014030297; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Perrone RD, 2005, AM J KIDNEY DIS, V46, P557, DOI 10.1053/j.ajkd.2005.07.016; Reddy BV, 2017, PEDIATR NEPHROL, V32, P31, DOI 10.1007/s00467-016-3364-y; Reed B, 2010, AM J KIDNEY DIS, V56, P50, DOI 10.1053/j.ajkd.2010.02.349; Rule AD, 2006, J AM SOC NEPHROL, V17, P854, DOI 10.1681/ASN.2005070697; Sans L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005595; Seeman T, 2003, BLOOD PRESS MONIT, V8, P107, DOI 10.1097/00126097-200306000-00003; Soini S, 2012, J COMMUN GENET, V3, P143, DOI 10.1007/s12687-012-0078-0; SUJANSKY E, 1990, AM J MED GENET, V35, P510, DOI 10.1002/ajmg.1320350413; Swift O, 2016, GENETIC TESTING MOL; Torres VE, 2017, KIDNEY INT, V91, P493, DOI 10.1016/j.kint.2016.10.018; Tuffs Annette, 2011, BMJ, V343, pd4425, DOI 10.1136/bmj.d4425; TURCO A, 1992, PRENATAL DIAG, V12, P513, DOI 10.1002/pd.1970120606; Turillazzi E, 2015, MED SCI LAW, V55, P194, DOI 10.1177/0025802414532245; Wuthrich RP, 2015, POLYCYSTIC KIDNEY DISEASE, P95; Zidovska J, 1994, Cas Lek Cesk, V133, P184	49	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185779	10.1371/journal.pone.0185779	http://dx.doi.org/10.1371/journal.pone.0185779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961265	Green Published, Green Submitted, gold			2022-12-27	WOS:000412027700038
J	Mani, U; Sankareswaran, SA; Goutham, RNA; Mohan, SS				Mani, Udayakumar; Sankareswaran, Alagu S.; Goutham, Arun R. N.; Mohan, Suma S.			SWI/SNF Infobase-An exclusive information portal for SWI/SNF remodeling complex subunits	PLOS ONE			English	Article							CHROMATIN; YEAST; DATABASE; GENE	Chromatin remodeling complexes facilitate the access of condensed genomic DNA during transcription, replication, and repair, by altering the histone-DNA contacts in the nucleosome structures. SWI/SNF (SWItch/Sucrose Non-Fermentable) family of ATP dependent chromatin remodeling complexes have been documented for their tumour suppressor function. Recent studies have reported the high frequency of cancer causing mutations in this protein family. There exist multiple subunits for this complex and can form context-dependent sub-complexes. The cataloguing of individual subunits of this complex is essential for understanding their specific functions and their mechanism of action during chromatin remodeling. This would also facilitate further studies to characterize cancer causing mutations in SWI/SNF subunits. In the current study, a database containing information on the subunits of SWI/SNF-alpha (BRG1/BRM-Associated Factors (BAF)) and SWI/SNF-beta (Poly-bromo-Associated BAF (PBAF)) sub classes of SWI/SNF family has been curated and catalogued. The database hosts information on 27 distinct SWI/SNF subunits from 20 organisms spanning a wide evolutionary range of eukaryotes. A non-redundant set of 522 genes coding for SWI/SNF subunits have been documented in the database. A detailed annotation on each subunit, including basic protein/gene information, protein sequence, functional domains, homologs and missense mutations of human proteins have been provided with a user-friendly graphical interface. The SWI/SNF Infobase presented here, would be a first of its kind exclusive information portal on SWI/SNF complex subunits and would be a valuable resource for the research community working on chromatin remodeling.	[Mani, Udayakumar; Sankareswaran, Alagu S.; Goutham, Arun R. N.; Mohan, Suma S.] SASTRA Univ, Sch Chem & Biotechnol, Tirumalaisamudram, Thanjavur, India	Shanmugha Arts, Science, Technology & Research Academy (SASTRA)	Mohan, SS (corresponding author), SASTRA Univ, Sch Chem & Biotechnol, Tirumalaisamudram, Thanjavur, India.	sumamohan@scbt.sastra.edu	Mohan S, Suma/GNW-4180-2022; Upper, Outstanding/V-9652-2018	Mohan S, Suma/0000-0001-7692-163X; Upper, Outstanding/0000-0003-3774-2158	Department of Science & Technology, Science Engineering Research Board(DST-SERB), Government of India [YSS/2015/000016]	Department of Science & Technology, Science Engineering Research Board(DST-SERB), Government of India	This work was funded by the grant from Department of Science & Technology, Science Engineering Research Board(DST-SERB), Government of India (YSS/2015/000016). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Goljanek-Whysall K, 2014, DEVELOPMENT, V141, P3378, DOI 10.1242/dev.108787; HIRSCHHORN JN, 1992, GENE DEV, V6, P2288, DOI 10.1101/gad.6.12a.2288; Hota SK, 2016, DEVELOPMENT, V143, P2882, DOI 10.1242/dev.128892; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; Medvedeva YA, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav067; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Mohrmann L, 2004, MOL CELL BIOL, V24, P3077, DOI 10.1128/MCB.24.8.3077-3088.2004; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Sarnowska E, 2016, TRENDS PLANT SCI, V21, P594, DOI 10.1016/j.tplants.2016.01.017; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Shipra A, 2006, BIOINFORMATICS, V22, P2940, DOI 10.1093/bioinformatics/btl509; Simone C, 2006, J CELL PHYSIOL, V207, P309, DOI 10.1002/jcp.20514; STERN M, 1984, J MOL BIOL, V178, P853, DOI 10.1016/0022-2836(84)90315-2; Tando T, 2010, J BIOL CHEM, V285, P21951, DOI 10.1074/jbc.M109.087783; Wang XF, 2014, CLIN CANCER RES, V20, P21, DOI 10.1158/1078-0432.CCR-13-0280; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; WINSTON F, 1992, TRENDS GENET, V8, P387, DOI 10.1016/0168-9525(92)90167-3; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597; Yan L, 2017, J MOL BIOL, V429, P1650, DOI 10.1016/j.jmb.2017.04.008	28	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184445	10.1371/journal.pone.0184445	http://dx.doi.org/10.1371/journal.pone.0184445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961249	Green Submitted, Green Published, gold			2022-12-27	WOS:000412027700006
J	Padala, C; Tupurani, MA; Puranam, K; Gantala, S; Shyamala, N; Kondapalli, MS; Gundapaneni, KK; Mudigonda, S; Galimudi, RK; Kupsal, K; Nancharil, SR; Chavan, U; Chinta, SK; Mukta, S; Satti, V; Hanumanth, SR				Padala, Chiranjeevi; Tupurani, Mohini Aiyengar; Puranam, Kaushik; Gantala, Srilatha; Shyamala, Nivas; Kondapalli, Mrudula Spurthi; Gundapaneni, Kishore Kumar; Mudigonda, Saraswati; Galimudi, Rajesh Kumar; Kupsal, Keerthi; Nancharil, Santoshi Rani; Chavan, Uday; Chinta, Sanjeeva Kumari; Mukta, Srinivasulu; Satti, Vishnupriya; Hanumanth, Surekha Rani			Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-1 PROMOTER; SINGLE NUCLEOTIDE POLYMORPHISM; 5A/6A POLYMORPHISM; RISK; LUNG; ASSOCIATION; PROGRESSION; EXPRESSION; REGIONS	Background Extracellular matrix degradation by matrix metalloproteinases (MMPs) is an important mechanism involved in tumor invasion and metastasis. Genetic variations of MMPs have shown association with multiple cancers. The present study is focused to elucidate the association of MMP-1, 3 and 9 genetic variants with respect to epidemiological and clinicopathological variables by haplotype, LD, MDR, survival in silico analyses among South Indian women. Material and methods MMP3-1171 5A/6A and MMP9-1562 C/T SNPs were genotyped by Allele specific polymerase chain reaction and MMP1-1607 1G/2G polymorphism by restriction fragment length polymorphism assays respectively, in 300 BC patients and age-matched 300 healthy controls. Statistical analysis was performed using the SNPStats and SPSS software. Linkage disequilibrium and gene-gene interactions were performed using Haploview and MDR software respectively. Further, transcription factor binding sites in the promoter regions of SNPs under study were carried out using AliBaba2.1 software. Results We have observed an increased frequency of 2G-allele of MMP1, 6A-allele of MMP3 and Tallele of MMP9 (p<0.05) respectively in BC subjects. The 2G-6A haplotype (minor alleles of MMP-1 and MMP-3 respectively) has shown an increased susceptibility to BC. Further, MMP polymorphisms were associated with the clinical characteristics of BC patients such as steroid hormone receptor status, lymph node involvement and metastasis. SNP combinations were in perfect LD in controls. MDR analysis revealed a positive interaction between the SNPs. 5-years survival rate and cox-regression analysis showed a significant association with clinicopathological variables. Conclusion Our results suggest that MMP1-1607 1G/2G, MMP3-1171 5A/6A and MMP9-1562 C/T gene polymorphisms have synergistic effect on breast cancer. The interactions of MMPs clinical risk factors such as lymph node involvement has shown a strong correlation and might influence the 5-years survival rate, suggesting their potential role in the breast carcinogenesis.	[Padala, Chiranjeevi; Tupurani, Mohini Aiyengar; Puranam, Kaushik; Gantala, Srilatha; Shyamala, Nivas; Kondapalli, Mrudula Spurthi; Gundapaneni, Kishore Kumar; Mudigonda, Saraswati; Galimudi, Rajesh Kumar; Kupsal, Keerthi; Nancharil, Santoshi Rani; Satti, Vishnupriya; Hanumanth, Surekha Rani] Osmania Univ, Dept Genet, Hyderabad, Telangana State, India; [Chavan, Uday; Chinta, Sanjeeva Kumari; Mukta, Srinivasulu] MNJ Inst Oncol & Reg Canc Ctr, Red Hills, Hyderabad, Telangana State, India	Osmania University	Hanumanth, SR (corresponding author), Osmania Univ, Dept Genet, Hyderabad, Telangana State, India.	surekharanih@gmail.com	Hanumanth, SUREKHA/Z-5518-2019; G.Kumar, Dr.Rajesh/ABD-1925-2021	G.Kumar, Dr.Rajesh/0000-0003-3042-5141; Padala, Chiranjeevi/0000-0003-0662-7800; Shyamala, Nivas/0000-0003-3586-6050				Back M, 2010, PROG CARDIOVASC DIS, V52, P410, DOI 10.1016/j.pcad.2009.12.002; Bayram S, 2015, FAM CANCER, V14, P561, DOI 10.1007/s10689-015-9813-0; Beeghly-Fadiel A, 2009, CANCER EPIDEM BIOMAR, V18, P1925, DOI 10.1158/1055-9965.EPI-09-0244; Brinckerhoff CE, 2000, CLIN CANCER RES, V6, P4823; Buttici G, 1998, CANCER RES, P5321; Chaudhary AK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-369; Che YL, 2015, CANCER LETT, V359, P241, DOI 10.1016/j.canlet.2015.01.019; Chiranjeevi P, 2014, TUMOR BIOL, V35, P1351, DOI 10.1007/s13277-013-1181-5; Decock J, 2008, CLIN GENET, V73, P197, DOI 10.1111/j.1399-0004.2007.00946.x; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Ding C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11667; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fang SM, 2005, CARCINOGENESIS, V26, P481, DOI 10.1093/carcin/bgh327; Ghilardi G, 2002, CLIN CANCER RES, V8, P3820; Gonzalez-Villasana V, 2015, CLIN CANCER RES, V21, P2127, DOI 10.1158/1078-0432.CCR-14-2279; Hirata H, 2003, INT J CANCER, V106, P372, DOI 10.1002/ijc.11229; Hughes S, 2007, CLIN CANCER RES, V13, P6673, DOI 10.1158/1078-0432.CCR-07-0884; Ishimaru H, 2002, ACTA ONCOL, V41, P289, DOI 10.1080/02841860260088845; Ivkovic I, 2006, J NEUROIMMUNOL, V39, P630; Johansson N, 1997, DEV DYNAM, V208, P387, DOI 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E; Key TJ, 2011, BRIT J CANCER, V105, P709, DOI 10.1038/bjc.2011.254; Kishore Kumar G, 2016, POLYMORPHISMS EXTRIN, V21, P558; Krippl P, 2004, CLIN CANCER RES, V10, P3518, DOI 10.1158/1078-0432.CCR-04-0010; Lei HX, 2007, BREAST CANCER RES TR, V103, P61, DOI 10.1007/s10549-006-9345-2; Li HX, 2015, SCI REP-UK, V5, DOI 10.1038/srep10056; Liu L, 2011, CANCER-AM CANCER SOC, V117, P5172, DOI 10.1002/cncr.26154; Maller O, 2010, J MAMMARY GLAND BIOL, V15, P301, DOI 10.1007/s10911-010-9189-6; Morosova EB, 2012, GENET TEST MOL BIOMA, V16, P1032, DOI 10.1089/gtmb.2011.0376; Murray GI, 1996, NAT MED, V2, P461, DOI 10.1038/nm0496461; Nishioka Y, 2003, CANCER LETT, V200, P49, DOI 10.1016/S0304-3835(03)00411-7; Peng B, 2010, MUTAGENESIS, V25, P41, DOI 10.1093/mutage/gep041; Price SJ, 2001, J BIOL CHEM, V276, P7549, DOI 10.1074/jbc.M010242200; Przybylowska K, 2006, BREAST CANCER RES TR, V95, P65, DOI 10.1007/s10549-005-9042-6; Przybylowska K, 2004, J EXP CLIN CANC RES, V23, P121; Roeb E, 2004, INT J COLORECTAL DIS, V19, P518, DOI 10.1007/s00384-004-0592-6; Sinn HP, 2013, BREAST CARE, V8, P149, DOI 10.1159/000350774; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Sparano JA, 2015, NEW ENGL J MED, V373, P2005, DOI 10.1056/NEJMoa1510764; Srivastava P, 2010, DIS MARKERS, V29, P37, DOI [10.3233/DMA-2010-0724, 10.1155/2010/149651]; Wieczorek E, 2013, BJU INT, V112, P1207, DOI 10.1111/bju.12230; Woo M, 2007, J GASTROEN HEPATOL, V22, P1064, DOI 10.1111/j.1440-1746.2006.04424.x; Yang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087562; Ye S, 1996, J BIOL CHEM, V271, P13055, DOI 10.1074/jbc.271.22.13055; Zhu Y, 2001, CANCER RES, V61, P7825	44	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184448	10.1371/journal.pone.0184448	http://dx.doi.org/10.1371/journal.pone.0184448			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961241	gold, Green Submitted, Green Published			2022-12-27	WOS:000412027700007
J	Kethiri, AR; Basu, S; Shukla, S; Sangwan, VS; Singh, V				Kethiri, Abhinav Reddy; Basu, Sayan; Shukla, Sachin; Sangwan, Virender Singh; Singh, Vivek			Optimizing the role of limbal explant size and source in determining the outcomes of limbal transplantation: An in vitro study	PLOS ONE			English	Article							EPITHELIAL PROGENITOR CELLS; AMNIOTIC MEMBRANE; NICHE; CULTURE	Purpose Simple limbal epithelial transplantation (SLET) and cultivated limbal epithelial transplantation (CLET) are proven clinical techniques for treating limbal stem cell deficiency (LSCD). However, the ideal size and number of the limbal explants required for transplantation has not been clearly elucidated. This in vitro study aimed to determine the optimal limbal explant size required for complete corneal epithelialization by characterizing the cell expansion. Methods Limbal explants obtained from both live and cadaveric biopsies were cultured on the denuded amniotic membrane. Explant size and the explant cell outgrowth (expansion) were measured using ImageJ software with respect to days. Cultures were characterized by assessing the rate of proliferation of cells with 5-bromo-2'-deoxyuridine (BrdU) assay along with the expression of different stem cell markers (ABCG2, p63 alpha), corneal epithelial (CK3+12) and adherens junction molecules (E-Cadherin) by immunofluorescence. Results Explants from live biopsies had 80% growth potential in vitro whereas 40% of the cadaveric tissue failed to grow. Minimum explant sizes of 0.3 mm(2) for live and >= 0.5 mm(2) for cadaveric tissue had a mean expansion areas of 182.39 +/- 17.06 mm(2) and 217.59 +/- 16.91 mm(2) respectively suggesting adequate growth potential of the explants. Mean total percentage of proliferative cells was 31.80 +/- 3.81 in live and 33.49 +/- 4.25 in cadaveric tissue expansion. The expression was noted to be similar in cells cultured from cadaveric compared to cells cultured from live limbal tissue with respect to ABCG2, p63 alpha, CK(3+12) and E-cadherin. Conclusion Our findings show that a minimal amount of 0.3 mm(2) live tissue would be sufficient for ample limbal cell expansion in vitro. Cadaveric explants <0.5 mm(2) had poor growth potential. However, larger explants (>= 0.5 mm(2)) had growth rate and proliferative potential similar to the live tissue. These findings could prove to be critical for clinical success especially while attempting cadaveric limbal transplantation. This study provides a novel clinical strategy for enhancing efficacy of the limbal transplantation surgery and opens the probability of even using the cadaveric tissue by considering the size of explant.	[Kethiri, Abhinav Reddy; Basu, Sayan; Shukla, Sachin; Sangwan, Virender Singh; Singh, Vivek] LV Prasad Eye Inst, SSR Stem Cell Biol Lab, Hyderabad, Telangana, India; [Kethiri, Abhinav Reddy; Basu, Sayan; Shukla, Sachin; Sangwan, Virender Singh; Singh, Vivek] LV Prasad Eye Inst, Ctr Ocular Regenerat, Hyderabad, Telangana, India; [Kethiri, Abhinav Reddy; Basu, Sayan; Shukla, Sachin; Sangwan, Virender Singh; Singh, Vivek] LV Prasad Eye Inst, Tej Kohli Cornea Inst, Hyderabad, Telangana, India; [Kethiri, Abhinav Reddy] Manipal Univ, Manipal, Karnataka, India	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; Manipal Academy of Higher Education (MAHE)	Singh, V (corresponding author), LV Prasad Eye Inst, SSR Stem Cell Biol Lab, Hyderabad, Telangana, India.; Singh, V (corresponding author), LV Prasad Eye Inst, Ctr Ocular Regenerat, Hyderabad, Telangana, India.; Singh, V (corresponding author), LV Prasad Eye Inst, Tej Kohli Cornea Inst, Hyderabad, Telangana, India.	viveksingh@lvpei.org	Singh, Vivek/C-4574-2013; Sangwan, Virender Singh/AAA-1091-2022; Basu, Sayan/R-9454-2019; SHUKLA, SACHIN/N-1274-2017	Singh, Vivek/0000-0003-3958-5635; Sangwan, Virender Singh/0000-0002-8229-4158; SHUKLA, SACHIN/0000-0003-2113-6073; Basu, Sayan/0000-0001-5030-5003; Kethiri, Abhinav Reddy/0000-0001-9286-4591	Science and Engineering Research Board [SB/YS/LS-263/2013]; Center for Ocular Regeneration, L V Prasad Eye Institute, Hyderabad, Telangana, India	Science and Engineering Research Board; Center for Ocular Regeneration, L V Prasad Eye Institute, Hyderabad, Telangana, India	This work was supported by 1. Science and Engineering Research Board SB/YS/LS-263/2013, Dr. Vivek Singh; 2. Center for Ocular Regeneration, L V Prasad Eye Institute, Hyderabad, Telangana, India.	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Basu S, 2016, OPHTHALMOLOGY, V123, P1000, DOI 10.1016/j.ophtha.2015.12.042; Chen SY, 2015, STEM CELLS, V33, P3341, DOI 10.1002/stem.2091; Choudhary P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130379; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Fatima A, 2006, J POSTGRAD MED, V52, P257; Ghoubay-Benallaoua D, 2011, MOL VIS, V17, P341; Grieve K, 2015, EXP EYE RES, V140, P75, DOI 10.1016/j.exer.2015.08.003; Haagdorens M, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9798374; Han ES, 2007, GRAEF ARCH CLIN EXP, V245, P745, DOI 10.1007/s00417-006-0453-9; KINOSHITA S, 1982, INVEST OPHTH VIS SCI, V23, P73; Kolli S, 2008, REGEN MED, V3, P329, DOI 10.2217/17460751.3.3.329; KWOK LS, 1984, J THEOR BIOL, V108, P295, DOI 10.1016/S0022-5193(84)80072-7; Lal I, 2013, BMJ CASE REPORTS, V2013; Li De-Quan, 2014, J Stem Cells, V9, P79; Li W, 2007, CELL RES, V17, P26, DOI 10.1038/sj.cr.7310137; Li W, 2007, INVEST OPHTH VIS SCI, V48, P605, DOI 10.1167/iovs.06-0514; Mariappan I, 2014, STEM CELL TRANSL MED, V3, P1331, DOI 10.5966/sctm.2014-0120; Mariappan I, 2010, NAT PROTOC, V5, P1470, DOI 10.1038/nprot.2010.115; Miri A, 2011, OPHTHALMOLOGY, V118, P1265, DOI 10.1016/j.ophtha.2010.11.030; Mittal V, 2015, CORNEA, V34, P1227, DOI 10.1097/ICO.0000000000000573; Notara M, 2010, STEM CELL RES, V5, P188, DOI 10.1016/j.scr.2010.07.002; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Rufer F, 2005, CORNEA, V24, P259; Sangwan Virender S., 2006, Indian Journal of Ophthalmology, V54, P29; Sangwan VS, 2014, INDIAN J OPHTHALMOL, V62, P29, DOI 10.4103/0301-4738.126173; Sangwan VS, 2012, BRIT J OPHTHALMOL, V96, P931, DOI 10.1136/bjophthalmol-2011-301164; Sejpal K, 2013, JAMA OPHTHALMOL, V131, P731, DOI 10.1001/jamaophthalmol.2013.2308; Singh V, 2015, INT REV CEL MOL BIO, V319, P45, DOI 10.1016/bs.ircmb.2015.07.001; Singh V, 2013, EXP EYE RES, V115, P27, DOI 10.1016/j.exer.2013.06.006; Tan EK, 2011, INVEST OPHTH VIS SCI, V52, P4534, DOI 10.1167/iovs.10-6376; THOFT RA, 1983, INVEST OPHTH VIS SCI, V24, P1442; Vazirani J, 2016, BRIT J OPHTHALMOL, V100, P1416, DOI 10.1136/bjophthalmol-2015-307348; Vemuganti Geeta K., 2004, Indian Journal of Ophthalmology, V52, P113	35	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185623	10.1371/journal.pone.0185623	http://dx.doi.org/10.1371/journal.pone.0185623			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957444	gold, Green Published, Green Submitted			2022-12-27	WOS:000411985200095
J	Wang, T; Moon, JY; Wu, YQ; Amos, CI; Hung, RJ; Tardon, A; Andrew, A; Chen, C; Christiani, DC; Albanes, D; van der Heijdendr, EHFM; Duell, E; Rennert, G; Goodman, G; Liu, G; Mckay, JD; Yuan, JM; Field, JK; Manjer, J; Grankvist, K; Kiemeney, LA; Le Marchand, L; Teare, MD; Schabath, MB; Johansson, M; Aldrich, MC; Davies, M; Johansson, M; Tsao, MS; Caporaso, N; Lazarus, P; Lam, S; Bojesen, SE; Arnold, S; Wu, XF; Zong, XC; Hong, YC; Ho, GYF				Wang, Tao; Moon, Jee-Young; Wu, Yiqun; Amos, Christopher I.; Hung, Rayjean J.; Tardon, Adonina; Andrew, Angeline; Chen, Chu; Christiani, David C.; Albanes, Demetrios; van der Heijdendr, Erik H. F. M.; Duell, Eric; Rennert, Gadi; Goodman, Gary; Liu, Geoffrey; Mckay, James D.; Yuan, Jian-Min; Field, John K.; Manjer, Jonas; Grankvist, Kjell; Kiemeney, Lambertus A.; Le Marchand, Loic; Teare, M. Dawn; Schabath, Matthew B.; Johansson, Mattias; Aldrich, Melinda C.; Davies, Michael; Johansson, Mikael; Tsao, Ming-Sound; Caporaso, Neil; Lazarus, Philip; Lam, Stephen; Bojesen, Stig E.; Arnold, Susanne; Wu, Xifeng; Zong, Xuchen; Hong, Yun-Chul; Ho, Gloria Y. F.			Pleiotropy of genetic variants on obesity and smoking phenotypes: Results from the Oncoarray Project of The International Lung Cancer Consortium	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; NEUROTROPHIC FACTOR BDNF; CELL-ADHESION MOLECULES; SYNAPTIC PLASTICITY; CIGARETTE-SMOKING; SEQUENCE VARIANTS; TOBACCO SMOKING; COMMON SNPS; BRAIN	Obesity and cigarette smoking are correlated through complex relationships. Common genetic causes may contribute to these correlations. In this study, we selected 241 loci potentially associated with body mass index (BMI) based on the Genetic Investigation of ANthropometric Traits (GIANT) consortium data and calculated a BMI genetic risk score (BMI-GRS) for 17,037 individuals of European descent from the Oncoarray Project of the International Lung Cancer Consortium (ILCCO). Smokers had a significantly higher BMI-GRS than never-smokers (p = 0.016 and 0.010 before and after adjustment for BMI, respectively). The BMI-GRS was also positively correlated with pack-years of smoking (p<0.001) in smokers. Based on causal network inference analyses, seven and five of 241 SNPs were classified to pleiotropic models for BMI/smoking status and BMI/pack-years, respectively. Among them, three and four SNPs associated with smoking status and pack-years (p<0.05), respectively, were followed up in the ever-smoking data of the Tobacco, Alcohol and Genetics (TAG) consortium. Among these seven candidate SNPs, one SNP (rs11030104, BDNF) achieved statistical significance after Bonferroni correction for multiple testing, and three suggestive SNPs (rs13021737, TMEM18; rs11583200, ELAVL4; and rs6990042, SGCZ) achieved a nominal statistical significance. Our results suggest that there is a common genetic component between BMI and smoking, and pleiotropy analysis can be useful to identify novel genetic loci of complex phenotypes.	[Wang, Tao; Moon, Jee-Young; Wu, Yiqun] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Wu, Yiqun] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China; [Amos, Christopher I.] Dartmouth Coll, Community & Family Med, Geisel Sch Med, Hanover, NH 03755 USA; [Hung, Rayjean J.; Liu, Geoffrey; Zong, Xuchen] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Hung, Rayjean J.; Liu, Geoffrey; Zong, Xuchen] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Tardon, Adonina] Univ Oviedo, IUOPA, Oviedo, Spain; [Tardon, Adonina] CIBERESP, Oviedo, Spain; [Andrew, Angeline] Norris Cotton Canc Ctr, Hanover, NH USA; [Chen, Chu; Goodman, Gary] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Christiani, David C.] Harvard Sch Publ Hlth, Boston, MA USA; [Albanes, Demetrios; Caporaso, Neil] NCI, Bethesda, MD USA; [van der Heijdendr, Erik H. F. M.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands; [Duell, Eric] Catalan Inst Oncol ICO, Barcelona, Spain; [Rennert, Gadi] Carmel Hosp, Haifa, Israel; [Mckay, James D.; Johansson, Mattias] Int Agcy Res Canc, Lyon, France; [Yuan, Jian-Min] Univ Pittsburgh, Canc Inst, Pittsburgh, PA USA; [Field, John K.; Davies, Michael] Univ Liverpool, Dept Mol & Clin Canc Med, Roy Castle Lung Canc Res Programme, Liverpool, Merseyside, England; [Manjer, Jonas] Lund Univ, Unit Breast Surg, Dept Surg, Malmo, Sweden; [Manjer, Jonas] Skane Univ Hosp Malmo, Malmo, Sweden; [Grankvist, Kjell; Johansson, Mikael] Umea Univ, Dept Med Biosci, Umea, Sweden; [Le Marchand, Loic] Univ Hawaii, Canc Ctr, Honolulu, HI USA; [Teare, M. Dawn] Univ Sheffield, Sheffield, S Yorkshire, England; [Schabath, Matthew B.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Aldrich, Melinda C.] Vanderbilt Univ, Med Ctr, Div Epidemiol, Dept Thorac Surg, Nashville, TN USA; [Tsao, Ming-Sound] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Lazarus, Philip] Washington State Univ, Coll Pharm, Washington, DC USA; [Lam, Stephen] British Columbia Canc Agcy, Vancouver, BC, Canada; [Bojesen, Stig E.] Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark; [Bojesen, Stig E.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Bojesen, Stig E.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Arnold, Susanne] Markey Canc Ctr, Lexington, KY USA; [Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Hong, Yun-Chul] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Ho, Gloria Y. F.] Feinstein Inst Med Res, Merinoff Ctr Patient Oriented Res, New York, NY USA; [Ho, Gloria Y. F.] Northwell Hlth, Epidemiol & Res, New York, NY USA; [Ho, Gloria Y. F.] Hofstra Northwell Sch Med, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Peking University; Dartmouth College; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Oviedo; Instituto Universitario de Oncologia de Asturias; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Norris Cotton Cancer Center; Fred Hutchinson Cancer Center; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Radboud University Nijmegen; Catalan Institute of Oncology; Clalit Health Services; Carmel Medical Center; World Health Organization; International Agency for Research on Cancer (IARC); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Liverpool; Lund University; Lund University; Skane University Hospital; Umea University; Cancer Research Center of Hawaii; University of Hawaii System; University of Sheffield; H Lee Moffitt Cancer Center & Research Institute; Vanderbilt University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Washington State University; British Columbia Cancer Agency; University of Copenhagen; University of Copenhagen; University of Texas System; UTMD Anderson Cancer Center; Seoul National University (SNU); Northwell Health; Northwell Health; Northwell Health	Wang, T (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.; Ho, GYF (corresponding author), Feinstein Inst Med Res, Merinoff Ctr Patient Oriented Res, New York, NY USA.; Ho, GYF (corresponding author), Northwell Hlth, Epidemiol & Res, New York, NY USA.; Ho, GYF (corresponding author), Hofstra Northwell Sch Med, New York, NY USA.	tao.wang@einstein.yu.edu; gho1@northwell.edu	van der Heijden, Erik H.F.M/D-3774-2009; Hong, Yun-Chul/J-5725-2012; Tsao, Ming Sound/AFQ-7332-2022; Johansson, Mikael/AAI-7688-2020; Johansson, Mattias/ABF-3365-2020; Tsao, Ming-Sound/M-3503-2017; Davies, Michael/GWV-2527-2022; Schabath, Matthew B./J-3763-2016; TARDON, ADONINA/B-6563-2014; Kiemeney, Lambertus A./D-3357-2009; Hung, Rayjean J/A-7439-2013; Field, John K./AAD-5674-2020	van der Heijden, Erik H.F.M/0000-0003-3596-518X; Tsao, Ming Sound/0000-0002-9160-5405; Schabath, Matthew B./0000-0003-3241-3216; TARDON, ADONINA/0000-0001-5150-1209; Kiemeney, Lambertus A./0000-0002-2368-1326; Field, John K./0000-0003-3951-6365; Bojesen, Stig/0000-0002-4061-4133; Arnold, Susanne/0000-0001-6542-9551; Liu, Geoffrey/0000-0002-2603-7296; Rennert, Gad/0000-0002-8512-068X; Grankvist, Kjell/0000-0003-4289-2097; Hung, Rayjean/0000-0002-4486-7496; Johansson, Mattias/0000-0002-3116-5081; Davies, Michael Peter Alan/0000-0002-7609-4977; Wu, Yiqun/0000-0002-5554-1678	National Cancer Institution [R21 CA202529]; R21 grant [CA202529]; NATIONAL CANCER INSTITUTE [UM1CA167462, K07CA172294, P30CA023108, R21CA202529, R35CA197449, ZIACP010195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541] Funding Source: NIH RePORTER	National Cancer Institution; R21 grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by National Cancer Institution (https://www.cancer.gov, R21 CA202529, TWG YFH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by an R21 grant (CA202529, Wang/Ho).	Amos CI, 2017, CANCER EPIDEM BIOMAR, V26, P126, DOI 10.1158/1055-9965.EPI-16-0106; Aubin HJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4439; Audrain-McGovern J, 2011, CLIN PHARMACOL THER, V90, P164, DOI 10.1038/clpt.2011.105; Bamia C, 2004, INT J OBESITY, V28, P1091, DOI 10.1038/sj.ijo.0802697; Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Chiolero A, 2007, OBESITY, V15, P1311, DOI 10.1038/oby.2007.153; Conner JM, 1997, J NEUROSCI, V17, P2295; David SP, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.41; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gandini S, 2008, INT J CANCER, V122, P155, DOI 10.1002/ijc.23033; Gearhardt AN, 2011, ADDICTION, V106, P1208, DOI 10.1111/j.1360-0443.2010.03301.x; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Grimm JW, 2003, J NEUROSCI, V23, P742; Guillin O, 2001, NATURE, V411, P86, DOI 10.1038/35075076; Gunstad J, 2006, NEUROPSYCHOBIOLOGY, V53, P153, DOI 10.1159/000093341; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC MONOGR EVAL CAR, V100, P1; Janhunen S, 2007, NEUROSCI BIOBEHAV R, V31, P287, DOI 10.1016/j.neubiorev.2006.09.008; Justice AE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14977; KatohSemba R, 1997, J NEUROCHEM, V69, P34; Kenny PJ, 2000, J NEUROCHEM, V75, P2409, DOI 10.1046/j.1471-4159.2000.0752409.x; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Liu QR, 2006, AM J MED GENET B, V141B, P918, DOI 10.1002/ajmg.b.30436; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; McKay JD, 2017, NAT GENET, V49, P1126, DOI 10.1038/ng.3892; McMichael AJ, 2008, PUBLIC HEALTH NUTR, V11, P762, DOI 10.1017/S1368980008002358; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Mossner R, 2000, NEUROCHEM INT, V36, P197, DOI 10.1016/S0197-0186(99)00122-9; Nicklas BJ, 1999, METABOLISM, V48, P804, DOI 10.1016/S0026-0495(99)90183-X; Noureddine MA, 2005, HUM GENET, V117, P27, DOI 10.1007/s00439-005-1259-2; Qiu SF, 2006, NEUROBIOL LEARN MEM, V85, P16, DOI 10.1016/j.nlm.2005.08.009; Renehan AG, 2015, NAT REV CANCER, V15, P484, DOI 10.1038/nrc3967; SAMET JM, 1990, AM REV RESPIR DIS, V142, P993, DOI 10.1164/ajrccm/142.5.993; Seth P, 2002, PHARMACOL BIOCHEM BE, V71, P795, DOI 10.1016/S0091-3057(01)00715-8; Song MY, 2016, J CLIN ONCOL, V34, P3237, DOI 10.1200/JCO.2016.67.6916; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thorgeirsson TE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.81; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Uhl GR, 2004, NEUROPHARMACOLOGY, V47, P140, DOI 10.1016/j.neuropharm.2004.07.029; Vink JM, 2009, AM J HUM GENET, V84, P367, DOI 10.1016/j.ajhg.2009.02.001; Volkow ND, 2008, PHILOS T R SOC B, V363, P3191, DOI 10.1098/rstb.2008.0107; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welzl H, 2003, NEWS PHYSIOL SCI, V18, P147, DOI 10.1152/nips.01422.2002; Yang J, 2016, MOL PSYCHIATR, V21, P992, DOI 10.1038/mp.2016.67; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yoon D, 2012, HUM GENET, V131, P1009, DOI 10.1007/s00439-011-1102-x; Zhao W, 2012, OBESITY, V20, P2431, DOI 10.1038/oby.2012.162; Zheng WH, 2002, J NEUROCHEM, V80, P1049, DOI 10.1046/j.0022-3042.2002.00783.x; Zhu WW, 2004, MOL BRAIN RES, V126, P45, DOI 10.1016/j.molbrainres.2004.03.019; Ziauddeen H, 2013, EUR NEUROPSYCHOPHARM, V23, pS156, DOI 10.1016/S0924-977X(13)70233-5	59	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185660	10.1371/journal.pone.0185660	http://dx.doi.org/10.1371/journal.pone.0185660			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957450	Green Published, gold, Green Accepted			2022-12-27	WOS:000411985200101
J	Yeh, ML; Huang, CI; Huang, CF; Hsieh, MY; Lin, ZY; Huang, JF; Dai, CY; Yu, ML; Chen, SC; Chuang, WL				Yeh, Ming-Lun; Huang, Ching-I; Huang, Chung-Feng; Hsieh, Ming-Yen; Lin, Zu-Yau; Huang, Jee-Fu; Dai, Chia-Yen; Yu, Ming-Lung; Chen, Shinn-Cherng; Chuang, Wan-Long			The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma	PLOS ONE			English	Article							CANCER	Background The impact of additional extra-hepatic primary cancer (EHPC) on the outcomes of patients with hepatocellular carcinoma (HCC) remains uncertain. Methods We retrospectively analyzed the cancer registration database from a tertiary hospital in Southern Taiwan. Patients who were diagnosed with HCC from 2008 to 2012 were enrolled. Overall survival (OS), HCC-specific survival and recurrence after curative therapy were analyzed and compared between the patients with and the patients without EHPC. Results EHPC was found in 121/1506 (8.0%) patients. HCC patients with EHPC were older, more likely to be classified as Child-Pugh A, less likely to have viral hepatitis B or C, more likely to be single, had early stage HCC and received curative therapy for HCC. The OS did not significantly differ between the patients with and without EHPC(p = 0.061). However, significantly higher HCC-specific survival was observed in patients with EHPC (p< 0.001), and a higher rate of non-HCC mortality was demonstrated in patients with EHPC (54.4% vs 9.3%). The subgroup analysis revealed better OS in patients with EHPC who were older than 65, had viral hepatitis B or C, had non-stage 1 HCC, had non-early stage BCLC and received non-curative therapy. Conversely, patients with HCC stage 1 who received curative therapy exhibited worse OS if they also had EHPC. The analysis of recurrence after curative therapy showed no difference between the two groups. Conclusions Our results implied that EHPC did not affect OS, but HCC-related survival was better in patients with EHPC. Based on these findings, the management of additional primary cancer is warranted.	[Yeh, Ming-Lun; Huang, Ching-I; Huang, Chung-Feng; Hsieh, Ming-Yen; Lin, Zu-Yau; Huang, Jee-Fu; Dai, Chia-Yen; Yu, Ming-Lung; Chen, Shinn-Cherng; Chuang, Wan-Long] Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatitis Ctr, Kaohsiung, Taiwan; [Yeh, Ming-Lun; Huang, Ching-I; Huang, Chung-Feng; Hsieh, Ming-Yen; Lin, Zu-Yau; Huang, Jee-Fu; Dai, Chia-Yen; Yu, Ming-Lung; Chen, Shinn-Cherng; Chuang, Wan-Long] Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan; [Yeh, Ming-Lun; Huang, Chung-Feng; Lin, Zu-Yau; Huang, Jee-Fu; Dai, Chia-Yen; Yu, Ming-Lung; Chen, Shinn-Cherng; Chuang, Wan-Long] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan; [Dai, Chia-Yen] Kaohsiung Med Univ Hosp, Hlth Management Ctr, Kaohsiung, Taiwan; [Chen, Shinn-Cherng] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chen, SC (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatitis Ctr, Kaohsiung, Taiwan.; Chen, SC (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan.; Chen, SC (corresponding author), Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan.; Chen, SC (corresponding author), Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan.	chshch@cc.kmu.edu.tw	Yu, Ming-Lung/AAZ-4306-2020; Chuang, Wan-Long/ABF-7427-2021; Huang, Jee-Fu/AAX-4622-2020	Yu, Ming-Lung/0000-0001-8145-1900; Chuang, Wan-Long/0000-0002-2376-421X; Huang, Jee-Fu/0000-0002-2752-7051; Yeh, Ming-Lun/0000-0003-3728-7618				BARBARA L, 1992, HEPATOLOGY, V16, P132, DOI 10.1002/hep.1840160122; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chang YS, HEPATOGASTROENTEROLO, V62, P1011; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; El-Serag HB, N ENGL J MED, V365, P1118; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandez-Ruiz M, 2009, J GASTROEN HEPATOL, V24, P1424, DOI 10.1111/j.1440-1746.2009.05793.x; Hong S, BMC CANC, V15, P146; Huang CF, MEDICINE BALTIMORE, V95; Huang CF, 2014, J HEPATOL, V61, P67, DOI 10.1016/j.jhep.2014.02.022; Huang JF, J GASTROENTEROL HEPA, V30, P1768; Jembere N, PLOS ONE, V7; Nanashima A, 2015, ANTICANCER RES, V35, P1073; NZEAKO UC, 1994, CANCER, V74, P2765, DOI 10.1002/1097-0142(19941115)74:10<2765::AID-CNCR2820741005>3.0.CO;2-Q; ONITSUKA A, 1995, INT SURG, V80, P128; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Shimada M, 1996, AM J GASTROENTEROL, V91, P754; TAKAYASU K, 1992, CANCER, V69, P45, DOI 10.1002/1097-0142(19920101)69:1<45::AID-CNCR2820690110>3.0.CO;2-G; Yeh ML, 2015, KAOHSIUNG J MED SCI, V31, P77, DOI 10.1016/j.kjms.2014.11.003; Zeng QA, BMC CANC, V12, P148	21	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184878	10.1371/journal.pone.0184878	http://dx.doi.org/10.1371/journal.pone.0184878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957337	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200021
J	Clapp, JD; Madden, DR; Mooney, DD; Dahlquist, KE				Clapp, John D.; Madden, Danielle R.; Mooney, Douglas D.; Dahlquist, Kristin E.			Examining the social ecology of a bar-crawl: An exploratory pilot study	PLOS ONE			English	Article							BLOOD-ALCOHOL CONCENTRATIONS; COLLEGE-STUDENTS; CONTINGENCY MANAGEMENT; PUBLIC-HEALTH; FIELD; INTOXICATION; DRINKING; CONSUMPTION; PREDICTORS; MULTILEVEL	Many of the problems associated with alcohol occur after a single drinking event (e.g. drink driving, assault). These acute alcohol problems have a huge global impact and account for a large percentage of unintentional and intentional injuries in the world. Nonetheless, alcohol research and preventive interventions rarely focus on drinking at the event-level since drinking events are complex, dynamic, and methodologically challenging to observe. This exploratory study provides an example of how event-level data may be collected, analyzed, and interpreted. The drinking behavior of twenty undergraduate students enrolled at a large Midwestern public university was observed during a single bar crawl event that is organized by students annually. Alcohol use was monitored with trans-dermal alcohol devices coupled with ecological momentary assessments and geospatial data. "Small N, Big Data" studies have the potential to advance health behavior theory and to guide real-time interventions. However, such studies generate large amounts of within subject data that can be challenging to analyze and present. This study examined how to visually display event-level data and also explored the relationship between some basic indicators and alcohol consumption.	[Clapp, John D.; Madden, Danielle R.; Dahlquist, Kristin E.] Univ Southern Calif, Suzanne Dworak Peck Sch Social Work, Los Angeles, CA 90007 USA; [Mooney, Douglas D.] EarlyMoon LLP, Columbus, OH USA	University of Southern California	Madden, DR (corresponding author), Univ Southern Calif, Suzanne Dworak Peck Sch Social Work, Los Angeles, CA 90007 USA.	rudymadden8@gmail.com			College of Social Work at the Ohio State University; Ohio State University	College of Social Work at the Ohio State University; Ohio State University(Ohio State University)	This work was funded by a seed grant from the College of Social Work at the Ohio State University. EarlyMoon LLP provided support in the form of salaries for authors [DDM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.; We would like to thank, the Ohio State University for providing financial support and Brent Leonard and the Ohio AMS Company for their generous assistance with the transdermal alcohol devices utilized in this study.	Babor TF., 2001, AUDIT ALCOHOL USE DI; Barnett NP, 2011, DRUG ALCOHOL DEPEN, V118, P391, DOI 10.1016/j.drugalcdep.2011.04.023; Carlini C, 2014, DRUG ALCOHOL REV, V33, P358, DOI 10.1111/dar.12155; Clapp JD, 2017, SYST RES BE IN PRESS; Clapp JD, 2008, ALCOHOL CLIN EXP RES, V32, P100, DOI 10.1111/j.1530-0277.2007.00547.x; Clapp JD, 2007, EVALUATION REV, V31, P469, DOI 10.1177/0193841X07303582; Clapp JD, 2009, DRUG ALCOHOL DEPEN, V102, P41, DOI 10.1016/j.drugalcdep.2008.12.015; Croff JM, 2012, J STUD ALCOHOL DRUGS, V73, P285, DOI 10.15288/jsad.2012.73.285; DeMartini KS, 2009, J AM COLL HEALTH, V58, P233, DOI 10.1080/07448480903295342; Dougherty DM, 2014, DRUG ALCOHOL DEPEN, V142, P301, DOI 10.1016/j.drugalcdep.2014.06.039; Dougherty DM, 2012, EXP CLIN PSYCHOPHARM, V20, P373, DOI 10.1037/a0029021; Giraldo LF, 2016, IEEE T CYBERNETICS, P1; Giraldo LF, 2017, IEEE T CYBERNETICS, V47, P165, DOI 10.1109/TCYB.2015.2509444; Gmel G., 2004, CONTEMP DRUG PROBL, V31, P467, DOI [10.1177/009145090403100304, DOI 10.1177/009145090403100304, DOI 10.1111/J.1360-0443.2005.01224.X]; Hammond RA, 2009, PREV CHRONIC DIS, V6; Hawe P, 2009, AM J COMMUN PSYCHOL, V43, P267, DOI 10.1007/s10464-009-9229-9; Homer JB, 2006, AM J PUBLIC HEALTH, V96, P452, DOI 10.2105/AJPH.2005.062059; Kaestle CE, 2018, ADDICT BEHAV, V76, P195, DOI 10.1016/j.addbeh.2017.08.018; Karns-Wright TE, 2017, ALCOHOL ALCOHOLISM, V52, P35, DOI 10.1093/alcalc/agw058; Kuntsche E, 2014, DRUG ALCOHOL REV, V33, P335, DOI 10.1111/dar.12171; Leffingwell TR, 2013, ALCOHOL CLIN EXP RES, V37, P16, DOI 10.1111/j.1530-0277.2012.01869.x; Luczak SE, 2015, ALCOHOL ALCOHOLISM, V50, P180, DOI 10.1093/alcalc/agu100; Marques PR, 2009, ALCOHOL CLIN EXP RES, V33, P703, DOI 10.1111/j.1530-0277.2008.00887.x; McClatchley K, 2014, DRUG ALCOHOL REV, V33, P367, DOI 10.1111/dar.12150; McKnight AS., 2012, 811603 DOT HS; Miller JH, 2007, PRINC STUD COMPLEX, P1, DOI 10.1007/1-4020-5602-8_1; National Institute on Alcohol Abuse and Alcoholism (NIAAA), 2015, NESARC 3 QUEST; Neal DJ, 2006, ALCOHOL CLIN EXP RES, V30, P282, DOI 10.1111/j.1530-0277.2006.00025.x; Neville FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067386; Patrick ME, 2010, J STUD ALCOHOL DRUGS, V71, P554, DOI 10.15288/jsad.2010.71.554; Pyne S., 2016, BIG DATA ANAL METHOD; Quinn PD, 2011, ALCOHOL CLIN EXP RES, V35, P484, DOI 10.1111/j.1530-0277.2010.01365.x; Reed MB, 2013, DRUG ALCOHOL DEPEN, V133, P198, DOI 10.1016/j.drugalcdep.2013.05.004; Reed MB, 2011, AM J HEALTH BEHAV, V35, P535; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Riley WT, 2011, TRANSL BEHAV MED, V1, P53, DOI 10.1007/s13142-011-0021-7; Rossheim ME, 2016, AM J PUBLIC HEALTH, V106, P1761, DOI 10.2105/AJPH.2016.303321; Rossheim ME, 2015, ALCOHOL CLIN EXP RES, V39, P1547, DOI 10.1111/acer.12795; Sakai JT, 2006, ALCOHOL CLIN EXP RES, V30, P26, DOI 10.1111/j.1530-0277.2006.00004.x; Santos MGR, 2015, ALCOHOL CLIN EXP RES, V39, P1243, DOI 10.1111/acer.12756; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Sobell L., 1995, ASSESSING ALCOHOL PR, P55; Stokols D., 2000, PROMOTING HUMAN WELL, P135; Stone Arthur S., 1994, Annals of Behavioral Medicine, V16, P199; Thombs DL, 2009, J STUD ALCOHOL DRUGS, V70, P206, DOI 10.15288/jsad.2009.70.206; Trickett EJ, 2011, AM J PUBLIC HEALTH, V101, P1410, DOI 10.2105/AJPH.2010.300113; Wechsler H, 2002, J AM COLL HEALTH, V50, P203, DOI 10.1080/07448480209595713; Wells S, 2015, PSYCHOL ADDICT BEHAV, V29, P683, DOI 10.1037/adb0000065	48	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185238	10.1371/journal.pone.0185238	http://dx.doi.org/10.1371/journal.pone.0185238			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4WR	28953932	Green Published, gold, Green Submitted			2022-12-27	WOS:000411980300048
J	Hicheur, H; Chauvin, A; Chassot, S; Cheneviere, X; Taube, W				Hicheur, Halim; Chauvin, Alan; Chassot, Steve; Cheneviere, Xavier; Taube, Wolfgang			Effects of age on the soccer-specific cognitivemotor performance of elite young soccer players: Comparison between objective measurements and coaches' evaluation	PLOS ONE			English	Article							DECISION-MAKING; SKILL; ANTICIPATION; RELIABILITY; VALIDATION; EXPERTISE; VALIDITY; TESTS	The cognitive-motor performance (CMP), defined here as the capacity to rapidly use sensory information and transfer it into efficient motor output, represents a major contributor to performance in almost all sports, including soccer. Here, we used a high-technology system (COGNIFOOT) which combines a visual environment simulator fully synchronized with a motion capture system. This system allowed us to measure objective real-time CMP parameters (passing accuracy/speed and response times) in a large turf-artificial grass playfield. Forty-six (46) young elite soccer players (including 2 female players) aged between 11 and 16 years who belonged to the same youth soccer academy were tested. Each player had to pass the ball as fast and as accurately as possible towards visual targets projected onto a large screen located 5.32 meters in front of him (a short pass situation). We observed a linear age-related increase in the CMP: the passing accuracy, speed and reactiveness of players improved by 4 centimeters, 2.3 km/h and 30 milliseconds per year of age, respectively. These data were converted into 5 point-scales and compared to the judgement of expert coaches, who also used a 5 point-scale to evaluate the same CMP parameters but based on their experience with the players during games and training. The objectively-measured age-related CMP changes were also observed in expert coaches' judgments although these were more variable across coaches and age categories. This demonstrates that high-technology systems like COGNIFOOT can be used in complement to traditional approaches of talent identification and to objectively monitor the progress of soccer players throughout a cognitive-motor training cycle.	[Hicheur, Halim; Chassot, Steve; Cheneviere, Xavier; Taube, Wolfgang] Univ Fribourg, Dept Med, Sport & Movement Sci, Fribourg, Switzerland; [Chauvin, Alan] Univ Grenoble Alpes, CNRS UMR 5105, Lab Psychol & NeuroCognit, Grenoble, France	University of Fribourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Hicheur, H (corresponding author), Univ Fribourg, Dept Med, Sport & Movement Sci, Fribourg, Switzerland.	halim.hicheur@gmail.com	Taube, Wolfgang/E-4018-2012; Chauvin, Alan/AAJ-8531-2020	Taube, Wolfgang/0000-0002-8802-2065; Chauvin, Alan/0000-0002-6498-2766; Cheneviere, Xavier/0000-0003-4755-840X				Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Ali A, 2008, INT J SPORTS MED, V29, P917, DOI 10.1055/s-2008-1038622; Ali A, 2011, SCAND J MED SCI SPOR, V21, P170, DOI 10.1111/j.1600-0838.2010.01256.x; Ali A, 2007, J SPORT SCI, V25, P1461, DOI 10.1080/02640410601150470; Bishop DT, 2013, J SPORT EXERCISE PSY, V35, P98, DOI 10.1123/jsep.35.1.98; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Casanova F, 2013, MED SCI SPORT EXER, V45, P1610, DOI 10.1249/MSS.0b013e31828b2ce9; Causer J, 2013, SCAND J MED SCI SPOR, V23, P627, DOI 10.1111/j.1600-0838.2011.01440.x; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Faubert J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01154; Huijgen BCH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144580; Kleiner M, 2007, PERCEPTION, V36, P14; Krustrup P, 2003, MED SCI SPORT EXER, V35, P697, DOI 10.1249/01.MSS.0000058441.94520.32; Le Moal E, 2014, J STRENGTH COND RES, V28, P1418, DOI 10.1519/JSC.0000000000000296; Liu HY, 2016, J SPORT SCI, V34, P509, DOI 10.1080/02640414.2015.1117121; Makris S, 2015, SOC COGN AFFECT NEUR, V10, P342, DOI 10.1093/scan/nsu052; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Roca A, 2014, BEHAV RES METHODS, V46, P173, DOI 10.3758/s13428-013-0359-5; Roca A, 2013, J SPORT EXERCISE PSY, V35, P144, DOI 10.1123/jsep.35.2.144; Roca A, 2012, J SPORT SCI, V30, P1643, DOI 10.1080/02640414.2012.701761; Roca A, 2011, COGN PROCESS, V12, P301, DOI 10.1007/s10339-011-0392-1; Romeas T, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01343; Romo R, 2012, CURR OPIN NEUROBIOL, V22, P914, DOI 10.1016/j.conb.2012.08.002; Russell M, 2011, INT J SPORT PHYSIOL, V6, P221, DOI 10.1123/ijspp.6.2.221; Russell M, 2010, J SPORT SCI, V28, P1399, DOI 10.1080/02640414.2010.511247; Sasaki Y, 2012, WIRES COGN SCI, V3, P293, DOI 10.1002/wcs.1175; Schaefer S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01167; Smeeton NJ, 2012, BRIT J PSYCHOL, V103, P539, DOI 10.1111/j.2044-8295.2011.02092.x; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Thompson J, 2012, NEUROIMAGE, V59, P4, DOI 10.1016/j.neuroimage.2011.05.044; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Ward P, 2003, J SPORT EXERCISE PSY, V25, P93, DOI 10.1123/jsep.25.1.93; Williams AM, 2000, J SPORT SCI, V18, P737, DOI 10.1080/02640410050120113; Wright MJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00851	34	10	11	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185460	10.1371/journal.pone.0185460	http://dx.doi.org/10.1371/journal.pone.0185460			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4WR	28953958	Green Published, gold, Green Submitted			2022-12-27	WOS:000411980300070
J	Zheng, X; Zhan, Z; Naren, D; Li, J; Yan, TY; Gong, YP				Zheng, Xue; Zhan, Zhi; Naren, Duolan; Li, Jing; Yan, Tianyou; Gong, Yuping			Prognostic value of SRSF2 mutations in patients with de novo myelodysplastic syndromes: A meta-analysis	PLOS ONE			English	Article							SCORING SYSTEM; SPLICEOSOME; MACHINERY; STABILITY; PATHWAY; IMPACT; U2AF1	Background The recent application of gene-sequencing technology has identified many new somatic mutations in patients with myelodysplastic syndromes (MDS). Among them, serine and arginine rich splicing factor 2 (SRSF2) mutations belonging to the RNA splicing pathway were of interest. Many studies have already reported the potential prognostic value of SRSF2 mutations in MDS patients, with controversial results. Therefore, a meta-analysis was performed to investigate their prognostic impact on MDS. Methods Databases, including PubMed, Embase and the Cochrane Library, were searched for relevant studies published up to 14 October 2016. Overall survival (OS) was selected as the primary endpoint, and acute myeloid leukemia (AML) transformation was the secondary endpoint. We extracted the corresponding hazard ratios (HRs) and their 95% confidence intervals (Cis) for OS and AML transformation from multivariate Cox proportional hazards models. The combined HRs with their 95% Cls were calculated using fixed or random effect models. Results A total of 10 cohort studies, covering 1864 patients with de novo MDS and 294 patients with SRSF2 mutations, were included in the final meta-analysis. Our results indicated that SRSF2 mutations had an adverse prognostic impact on OS (p<0.0001) and AML transformation (p = 0.0005) in the total population. Among the MDS patients with low or intermediate-1 risk defined according to the International Prognostic Scoring System (IPSS), SRSF2 mutations predicted a shorter OS (p = 0.009) and were more likely to transform to AML (p = 0.007). Conclusions This meta-analysis indicates an independent, adverse prognostic impact of SRSF2 mutations on OS and AML transformation in patients with de novo MDS. This also applies to the subgroup of low- or intermediate-1-IPSS risk MDS. The identification of mutations in SRSF2 can improve current risk stratification and help make treatment decisions.	[Zheng, Xue; Naren, Duolan; Yan, Tianyou; Gong, Yuping] Sichuan Univ, West China Hosp, Dept Hematol, Chengdu, Sichuan, Peoples R China; [Zhan, Zhi] Fu Dan Univ, Zhong Shan Hosp, Dept Cardiol, Shanghai, Peoples R China; [Li, Jing] Sichuan Univ, West China Hosp, Dept Evidence Based Med & Clin Epidemiol, Chengdu, Sichuan, Peoples R China	Sichuan University; Fudan University; Sichuan University	Gong, YP (corresponding author), Sichuan Univ, West China Hosp, Dept Hematol, Chengdu, Sichuan, Peoples R China.	gongyuping2010@aliyun.com			Foundation of the Science & Technology Department of Sichuan Province [2015SZ0234-5]; Foundation of Administration of traditional Chinese medicine of Sichuan Province [2014A038]; Foundation of Science and Technology Bureau of Chengdu [2016-HM0100001-SF]	Foundation of the Science & Technology Department of Sichuan Province; Foundation of Administration of traditional Chinese medicine of Sichuan Province; Foundation of Science and Technology Bureau of Chengdu	The work was supported by the Foundation of the Science & Technology Department of Sichuan Province (No. 2015SZ0234-5), Foundation of Administration of traditional Chinese medicine of Sichuan Province (No. 2014A038) and the Foundation of Science and Technology Bureau of Chengdu (No. 2016-HM0100001-SF), http://www.scst.gov.cn/. YPG received these funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades L, 2014, LANCET, V383, P2239, DOI 10.1016/S0140-6736(13)61901-7; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bejar R, 2012, J CLIN ONCOL, V30, P3376, DOI 10.1200/JCO.2011.40.7379; Boultwood Jacqueline, 2014, Advances in Biological Regulation, V54, P153, DOI 10.1016/j.jbior.2013.09.005; Cui YJ, 2015, EXP HEMATOL ONCOL, V4, DOI 10.1186/s40164-015-0009-y; Damm F, 2012, BLOOD, V119, P3211, DOI 10.1182/blood-2011-12-400994; Dehm SM, 2013, CLIN CANCER RES, V19, P6064, DOI 10.1158/1078-0432.CCR-13-2461; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ganguly BB, 2016, MUTAT RES-REV MUTAT, V769, P47, DOI 10.1016/j.mrrev.2016.04.009; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoskins AA, 2012, TRENDS BIOCHEM SCI, V37, P179, DOI 10.1016/j.tibs.2012.02.009; Itzykson R, 2013, J CLIN ONCOL, V31, P2428, DOI 10.1200/JCO.2012.47.3314; Kang MG, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1493-5; Karimi M, 2015, HAEMATOLOGICA, V100, pE223, DOI 10.3324/haematol.2014.118034; Kim E, 2015, CANCER CELL, V27, P617, DOI 10.1016/j.ccell.2015.04.006; Kim M, 2015, BONE MARROW TRANSPL, V50, P1132, DOI 10.1038/bmt.2015.110; Lin Jing, 2014, PLOS ONE; Maciejewski JP, 2012, BRIT J HAEMATOL, V158, P165, DOI 10.1111/j.1365-2141.2012.09158.x; Mian SA, 2013, HAEMATOLOGICA, V98, P1058, DOI 10.3324/haematol.2012.075325; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Thol F, 2012, BLOOD, V119, P3578, DOI 10.1182/blood-2011-12-399337; Walter MJ, 2013, LEUKEMIA, V27, P1275, DOI 10.1038/leu.2013.58; Wells G.A., NEWCASTLE OTTAWA SCA; Wu LY, 2016, TUMOR BIOL, V37, P4633, DOI 10.1007/s13277-015-4305-2; Wu SJ, 2012, BLOOD, V120, P3106, DOI 10.1182/blood-2012-02-412296; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	29	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185053	10.1371/journal.pone.0185053	http://dx.doi.org/10.1371/journal.pone.0185053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953917	gold, Green Submitted, Green Published			2022-12-27	WOS:000411980300030
J	Dong, XL; Al Awak, M; Tomlinson, N; Tang, YG; Sun, YP; Yang, LJ				Dong, Xiuli; Al Awak, Mohamad; Tomlinson, Nicholas; Tang, Yongan; Sun, Ya-Ping; Yang, Liju			Antibacterial effects of carbon dots in combination with other antimicrobial reagents	PLOS ONE			English	Article							QUANTUM DOTS; LISTERIA-MONOCYTOGENES; CELLS; NANOPARTICLES; MECHANISM; PATHOGENS; GRAPHENE; BIOFILM; NISIN; ACID	This study was designed to investigate the antimicrobial effects of CDots in combination with other antimicrobial reagents, including H2O2, Na2CO3, and AcOH (acetic acid). CDots were synthesized and passivated with 2,2'-(ethylenedioxy) bis(ethylamine) (EDA). The minimal inhibitory concentration (MIC) of CDots was 64 mu g/mL on both Gram negative bacteria E. coli cells and Gram positive bacteria Bacillus subtilis cells. When CDots were combined with H2O2, antibacterial synergistic effects were observed based on the fractional inhibitory concentration (FIC) index, and further confirmed by an isobologram analysis and viable cell number counting methods. With the combination treatment of 10 mu g/mL CDots with 8.82 mM H2O2, the viable E. coli cell numbers decreased 2.46 log, which was significant lower than the log reduction from 8.82 mM H2O2 (1.57 log) or 10 mu g/mL CDots (0.14 log) treatment alone. However, the combination of CDots with Na2CO3 or AcOH did not show synergistic effects, instead, exhibiting indifference effects according to the FIC index. This study indicated that the combination of CDots with their synergistic antimicrobial reagents, such as H2O2, could reach the goal of inhibiting bacteria growth by using lower concentration of each individual chemical in the combination than using one chemical treatment alone, reduce the risks imposed on environmental health and the possibilities of the development of microbial resistances.	[Dong, Xiuli; Al Awak, Mohamad; Yang, Liju] North Carolina Cent Univ, BRITE, Durham, NC 27707 USA; [Tomlinson, Nicholas; Sun, Ya-Ping] Clemson Univ, Dept Chem, Clemson, SC 29634 USA; [Tomlinson, Nicholas; Sun, Ya-Ping] Clemson Univ, Lab Emerging Mat & Technol, Clemson, SC 29634 USA; [Tang, Yongan] North Carolina Cent Univ, Dept Math & Phys, Durham, NC USA	University of North Carolina; North Carolina Central University; Clemson University; Clemson University; University of North Carolina; North Carolina Central University	Yang, LJ (corresponding author), North Carolina Cent Univ, BRITE, Durham, NC 27707 USA.; Sun, YP (corresponding author), Clemson Univ, Dept Chem, Clemson, SC 29634 USA.; Sun, YP (corresponding author), Clemson Univ, Lab Emerging Mat & Technol, Clemson, SC 29634 USA.	syaping@clemson.edu; lyang@nccu.edu			NIH [R15GM114752]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM114752] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the NIH grant R15GM114752.	Arias LR, 2009, LANGMUIR, V25, P3003, DOI 10.1021/la802769m; Baldeck JD, 2008, CAN J MICROBIOL, V54, P868, DOI 10.1139/w08-078; BRANDI G, 1989, MICROBIOL IMMUNOL, V33, P991, DOI 10.1111/j.1348-0421.1989.tb03157.x; Cai Y, 2007, J ANTIBIOT, V60, P335, DOI 10.1038/ja.2007.45; Cao L, 2013, ACCOUNTS CHEM RES, V46, P171, DOI 10.1021/ar300128j; Cao L, 2011, J AM CHEM SOC, V133, P4754, DOI 10.1021/ja200804h; Cleveland J, 2001, INT J FOOD MICROBIOL, V71, P1, DOI 10.1016/S0168-1605(01)00560-8; Dong XL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00675-x; Fernando KAS, 2015, ACS APPL MATER INTER, V7, P8363, DOI 10.1021/acsami.5b00448; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GEORGE M, 1996, ANTIMICROBIAL COMBIN; Jarvis GN, 2001, LETT APPL MICROBIOL, V33, P196, DOI 10.1046/j.1472-765x.2001.00976.x; Joller N, 2010, P NATL ACAD SCI USA, V107, P20441, DOI 10.1073/pnas.1013827107; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; Ko KY, 2008, POULTRY SCI, V87, P2660, DOI 10.3382/ps.2007-00503; Kumar KA, 2004, BIOL PHARM BULL, V27, P1116, DOI 10.1248/bpb.27.1116; Lapenna D, 1996, GEN PHARMACOL, V27, P1145, DOI 10.1016/S0306-3623(96)00063-8; LeCroy GE, 2016, COORDIN CHEM REV, V320, P66, DOI 10.1016/j.ccr.2016.02.017; LeCroy GE, 2014, ACS NANO, V8, P4522, DOI 10.1021/nn406628s; Li JX, 2014, ACS NANO, V8, P11118, DOI 10.1021/nn505029k; Lim SY, 2015, CHEM SOC REV, V44, P362, DOI 10.1039/c4cs00269e; Luo PJG, 2014, RSC ADV, V4, P10791, DOI 10.1039/c3ra47683a; Luo PJG, 2013, J MATER CHEM B, V1, P2116, DOI 10.1039/c3tb00018d; Meziani MJ, 2016, ACS APPL MATER INTER, V8, P10761, DOI 10.1021/acsami.6b01765; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Mu HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep18877; Murdock CA, 2007, LETT APPL MICROBIOL, V44, P255, DOI 10.1111/j.1472-765X.2006.02076.x; Najjar MB, 2007, LETT APPL MICROBIOL, V45, P13, DOI 10.1111/j.1472-765X.2007.02157.x; Narband N, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/44/445102; Roks G, 1999, J PHARMACOL EXP THER, V288, P472; Samia ACS, 2003, J AM CHEM SOC, V125, P15736, DOI 10.1021/ja0386905; Singh VV, 2015, ADV FUNCT MATER, V25, P2147, DOI 10.1002/adfm.201500033; Sun C, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1326-8; Sun HJ, 2014, ACS NANO, V8, P6202, DOI 10.1021/nn501640q; Sun YP, 2006, J AM CHEM SOC, V128, P7756, DOI 10.1021/ja062677d; Swathy JR, 2014, SCI REP-UK, V4, DOI 10.1038/srep07161; Wang YF, 2014, J MATER CHEM C, V2, P6921, DOI 10.1039/c4tc00988f; Xiuli Dong, 2015, J NANOMEDICINE NANOT, V6, P1; Yuan H, 2016, RSC ADV, V6, P15192, DOI 10.1039/c5ra26870b	39	46	46	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185324	10.1371/journal.pone.0185324	http://dx.doi.org/10.1371/journal.pone.0185324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934346	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900146
J	Weber, D; Frauenschlager, K; Ghimire, S; Peter, K; Panzer, I; Hiergeist, A; Weber, M; Kutny, D; Wolff, D; Grube, M; Huber, E; Oefner, P; Gessner, A; Hehlgans, T; Herr, W; Holler, E				Weber, Daniela; Frauenschlaeger, Katrin; Ghimire, Sakhila; Peter, Katrin; Panzer, Isabella; Hiergeist, Andreas; Weber, Markus; Kutny, Daniel; Wolff, Daniel; Grube, Matthias; Huber, Elisabeth; Oefner, Peter; Gessner, Andre; Hehlgans, Thomas; Herr, Wolfgang; Holler, Ernst			The association between acute graft-versus-host disease and antimicrobial peptide expression in the gastrointestinal tract after allogeneic stem cell transplantation	PLOS ONE			English	Article							ALPHA-DEFENSINS; GVHD; MORTALITY; INTERLEUKIN-22	Intestinal microbiota disruption is associated with acute gastrointestinal (GI) Graft-versus-Host Disease (GvHD) and poor outcome after allogeneic stem cell transplantation (ASCT). Here, in a retrospective analysis of 200 patients undergoing ASCT at the Regensburg University Medical Center, we assessed the relative expression of Paneth cell antimicrobial peptides (AMPs), Human Defensins (HD) 5 and 6 and regenerating islet-derived 3 alpha (Reg3 alpha), in 292 human intestinal biopsies as well as Reg3a serum levels in relation to acute GI GvHD. In the absence of GI GvHD, the relative expression of Paneth cell AMPs was significantly higher in the small intestine (duodenum to ileum) than in the stomach and large intestine (cecum to rectum) for Reg3a (p <= 0.001), HD5 (p <= 0.002) and HD6 (p <= 0.02). Acute stage 2-4 GI GvHD was associated with reduced expression of AMPs in the small intestine (p <= 0.01) in comparison to stage 0-1 disease, accompanied by a decrease in Paneth cell count in case of severe acute GI GvHD (p<0.001). The opposite held true for the large intestine as we found stage 2-4 GI GvHD correlated with significantly higher expression of HD5, HD6, and Reg3a compared to mild or no acute GI GvHD (p <= 0.002). Severe GI GvHD in both the lower and the upper GI tract also correlated with higher serum concentrations of Reg3a (p = 0.002). As indirect markers of intestinal microbiome diversity low levels of urinary 3-indoxyl sulfate levels were associated with severe stages of acute GI GvHD compared to mild stage or no acute GI GvHD (p = 0.05). In conclusion, acute GI GvHD correlates with intestinal expression of HD5, HD6 and Reg3a as well as Reg3a serum levels and is associated with intestinal dysbiosis.	[Weber, Daniela; Ghimire, Sakhila; Peter, Katrin; Panzer, Isabella; Kutny, Daniel; Wolff, Daniel; Grube, Matthias; Herr, Wolfgang; Holler, Ernst] Univ Med Ctr, Dept Hematol & Oncol, Internal Med 3, Regensburg, Germany; [Frauenschlaeger, Katrin; Huber, Elisabeth] Univ Regensburg, Dept Pathol, Regensburg, Germany; [Hiergeist, Andreas; Gessner, Andre] Univ Med Ctr, Inst Clin Microbiol & Hyg, Regensburg, Germany; [Weber, Markus] Univ Med Ctr, Dept Orthoped Surg, Regensburg, Germany; [Oefner, Peter] Univ Regensburg, Inst Funct Genom, Regensburg, Germany; [Hehlgans, Thomas] Regensburg Ctr Intervent Immunol RCI, Inst Immunol, Regensburg, Germany; [Hehlgans, Thomas] Univ Med Ctr Regensburg, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg	Weber, D (corresponding author), Univ Med Ctr, Dept Hematol & Oncol, Internal Med 3, Regensburg, Germany.	daniela.weber@ukr.de	Hiergeist, Andreas/P-5408-2019	Hiergeist, Andreas/0000-0002-3154-0638	DFG [SFB 1066, KF0262, 315963, KFO 243, HE 3116/7-2]; German Jose Carreras Foundation project "GVHD Competence center Regensburg"; German Research Foundation [DFG GE 671/14-1]	DFG(German Research Foundation (DFG)); German Jose Carreras Foundation project "GVHD Competence center Regensburg"; German Research Foundation(German Research Foundation (DFG))	This work was supported DFG SFB 1066, Project B9: Transfection of tumor-reactive T cells with RNA -loaded nanoparticles; DFG KF0262, Project P9: IDH mutations in the interplay of metabolism and antileukemic immune response; DFG KF0262, Project P12: Impact of drugs targeting tumor metabolism on human CD8 T cell effector functions europenan comission: Project Number 315963; DFG KFO 243 (HE 3116/7-2); German Jose Carreras Foundation project "GVHD Competence center Regensburg" and the German Research Foundation (DFG GE 671/14-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Bevins CL, 2013, DIGEST DIS, V31, P299, DOI 10.1159/000354681; Cahn JY, 2005, BLOOD, V106, P1495, DOI 10.1182/blood-2004-11-4557; Courth LF, 2015, P NATL ACAD SCI USA, V112, P14000, DOI 10.1073/pnas.1510084112; Elphick DA, 2005, GUT, V54, P1802, DOI 10.1136/gut.2005.068601; Eriguchi Y, 2015, TRANSPL INFECT DIS, V17, P702, DOI 10.1111/tid.12423; Eriguchi Y, 2012, BLOOD, V120, P223, DOI 10.1182/blood-2011-12-401166; Ferrara JLM, 2011, BLOOD, V118, P6702, DOI 10.1182/blood-2011-08-375006; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Holler E, 2004, BLOOD, V104, P889, DOI 10.1182/blood-2003-10-3543; Holler E, 2014, BIOL BLOOD MARROW TR; Jenq RR, 2015, BIOL BLOOD MARROW TR, V21, P1373, DOI 10.1016/j.bbmt.2015.04.016; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Landfried K, 2011, BLOOD, V118, P6971, DOI 10.1182/blood-2011-06-357814; Levine JE, 2013, BLOOD, V122, P1505, DOI 10.1182/blood-2013-02-485813; Li M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00692; Masuda K, 2011, J INNATE IMMUN, V3, P315, DOI 10.1159/000322037; Miles DR, 2016, J INFLAMM BOWEL DIS, V1; Nakamura K, 2016, BIOSCI MICROB FOOD H, V35, P57, DOI 10.12938/bmfh.2015-019; Ostaff MJ, 2013, EMBO MOL MED, V5, P1465, DOI 10.1002/emmm.201201773; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Tan G, 2015, EUR J CELL BIOL, V94, P60, DOI 10.1016/j.ejcb.2014.10.007; Taur Y, 2014, BLOOD, V124, P1174, DOI 10.1182/blood-2014-02-554725; Vigorito AC, 2009, BLOOD, V114, P702, DOI 10.1182/blood-2009-03-208983; Weber D, 2015, BLOOD; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	26	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185265	10.1371/journal.pone.0185265	http://dx.doi.org/10.1371/journal.pone.0185265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934349	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900135
J	Yao, PC; Gao, HY; Wei, YN; Zhang, JH; Chen, XY; Li, HQ				Yao, Peng-Cheng; Gao, Hai-Yan; Wei, Ya-Nan; Zhang, Jian-Hang; Chen, Xiao-Yong; Li, Hong-Qing			Evaluating sampling strategy for DNA barcoding study of coastal and inland halotolerant Poaceae and Chenopodiaceae: A case study for increased sample size	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; SPECIES IDENTIFICATION; BIOGEOGRAPHY; PLANT; DIVERSITY; EVOLUTION; DISTANCE; MORACEAE; GENOME; FLOWER	Environmental conditions in coastal salt marsh habitats have led to the development of specialist genetic adaptations. We evaluated six DNA barcode loci of the 53 species of Poaceae and 15 species of Chenopodiaceae from China's coastal salt marsh area and inland area. Our results indicate that the optimum DNA barcode was ITS for coastal salt-tolerant Poaceae and matK for the Chenopodiaceae. Sampling strategies for ten common species of Poaceae and Chenopodiaceae were analyzed according to optimum barcode. We found that by increasing the number of samples collected from the coastal salt marsh area on the basis of inland samples, the number of haplotypes of Arundinella hirta, Digitaria ciliaris, Eleusine indica, Imperata cylindrica, Setaria viridis, and Chenopodium glaucum increased, with a principal coordinate plot clearly showing increased distribution points. The results of a Mann- Whitney test showed that for Digitaria ciliaris, Eleusine indica, Imperata cylindrica, and Setaria viridis, the distribution of intraspecific genetic distances was significantly different when samples from the coastal salt marsh area were included (P < 0.01). These results suggest that increasing the sample size in specialist habitats can improve measurements of intraspecific genetic diversity, and will have a positive effect on the application of the DNA barcodes in widely distributed species. The results of random sampling showed that when sample size reached 11 for Chloris virgata, Chenopodium glaucum, and Dysphania ambrosioides, 13 for Setaria viridis, and 15 for Eleusine indica, Imperata cylindrica and Chenopodium album, average intraspecific distance tended to reach stability. These results indicate that the sample size for DNA barcode of globally distributed species should be increased to 11-15.	[Yao, Peng-Cheng; Gao, Hai-Yan; Wei, Ya-Nan; Zhang, Jian-Hang; Li, Hong-Qing] East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China; [Chen, Xiao-Yong] East China Normal Univ, Sch Ecol & Environm Sci, Tiantong Natl Stn Forest Ecosyst, Shanghai, Peoples R China	East China Normal University; East China Normal University	Li, HQ (corresponding author), East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China.; Chen, XY (corresponding author), East China Normal Univ, Sch Ecol & Environm Sci, Tiantong Natl Stn Forest Ecosyst, Shanghai, Peoples R China.	xychen@des.ecnu.edu.cn; hqli@bio.ecnu.edu.cn	Chen, Xiao-Yong/B-1467-2009	Chen, Xiao-Yong/0000-0002-4795-8940	Foundation of Science and Technology Ministry, National Science and Technology Works Special [2014FY130300]	Foundation of Science and Technology Ministry, National Science and Technology Works Special	This study was funded by the Foundation of Science and Technology Ministry, National Science and Technology Works Special (Grant No. 2014FY130300). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubriot X, 2013, MOL ECOL RESOUR, V13, P57, DOI 10.1111/1755-0998.12028; Avise JC, 2000, PHYLOGEOGRAPHY, P47; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bafeel S.O., 2012, INT J BIOL, V4, P66, DOI [10.5539/ijb.v4n4p66, DOI 10.5539/ijb.v4n4p66]; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blyton M, 2006, COMPREHENSIVE GUIDE; BOKHARI UG, 1990, J RANGE MANAGE, V43, P202, DOI 10.2307/3898672; Brandt R, 2015, PLANT SYST EVOL, V301, P2351, DOI 10.1007/s00606-015-1233-y; Burland T G, 2000, Methods Mol Biol, V132, P71; Cai ZM, 2012, J SYST EVOL, V50, P527, DOI 10.1111/j.1759-6831.2012.00216.x; Candek K, 2015, MOL ECOL RESOUR, V15, P268, DOI 10.1111/1755-0998.12304; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Costion CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155118; De la Fuente V, 2016, PLANT BIOSYST, V150, P343, DOI 10.1080/11263504.2015.1022239; de Vere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037945; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Elizabeth A. K., 2015, FAMILIES GENERA VASC, P1; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Fuentes-Bazan S, 2012, MOL PHYLOGENET EVOL, V62, P359, DOI 10.1016/j.ympev.2011.10.006; Galimberti A, 2013, FOOD RES INT, V50, P55, DOI 10.1016/j.foodres.2012.09.036; Gao LM, 2017, J SYST EVOL, V55, P16, DOI 10.1111/jse.12207; Gedan KB, 2011, MAR ECOL PROG SER, V434, P229, DOI 10.3354/meps09084; Gregory TR, 2005, NATURE, V434, P1067, DOI 10.1038/4341067b; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; IBM Corp, 2011, IBM SPSS STAT WIND V; Ito Y, 2010, AM J BOT, V97, P1156, DOI 10.3732/ajb.0900168; Kadereit G, 2006, TAXON, V55, P617, DOI 10.2307/25065639; Kadereit G, 2010, AM J BOT, V97, P1664, DOI 10.3732/ajb.1000169; Kamal AHM, 2010, AUST J CROP SCI, V4, P196; Kapralov MV, 2006, SYST BOT, V31, P571, DOI 10.1600/036364406778388674; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kuhn U, 1993, FAMILIES GENERA VASC, P253, DOI DOI 10.1007/978-3-662-02899-5_26; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lee JeongRan, 2014, Journal of Agricultural Science and Technology B, V4, P533; Lee SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154631; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li HQ, 2012, MOL ECOL RESOUR, V12, P783, DOI 10.1111/j.1755-0998.2012.03147.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Little DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081008; Lopez-Alvarez D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051058; Lu J, 2016, PHYTOTAXA, V261, P121, DOI 10.11646/phytotaxa.261.2.2; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Murakeozy EP, 2007, PLANT SYST EVOL, V264, P217, DOI 10.1007/s00606-006-0511-0; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Pang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048833; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parveen I, 2012, MOL ECOL RESOUR, V12, P82, DOI 10.1111/j.1755-0998.2011.03071.x; Peterson Paul M., 2014, Webbia, V69, P1, DOI 10.1080/00837792.2014.927555; Peterson PM, 2010, MOL PHYLOGENET EVOL, V55, P580, DOI 10.1016/j.ympev.2010.01.018; Ragupathy S, 2009, MOL ECOL RESOUR, V9, P164, DOI 10.1111/j.1755-0998.2009.02641.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousseau-Gueutin M, 2015, MOL PHYLOGENET EVOL, V93, P5, DOI 10.1016/j.ympev.2015.06.013; Saarela JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077982; Schutze P, 2003, PLANT SYST EVOL, V239, P257, DOI 10.1007/s00606-003-0013-2; Spangler R, 1999, SYST BOT, V24, P267, DOI 10.2307/2419552; Spangler R. E., 2000, Grasses: systematics and evolution., P167; Su XF, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/7279361; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Triest L, 2010, AQUAT BOT, V93, P68, DOI 10.1016/j.aquabot.2010.03.007; Wang M, 2013, GENE, V528, P206, DOI 10.1016/j.gene.2013.07.009; Wright S, 1943, GENETICS, V28, P114; Xu SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115168; Yan HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122903; Yan LJ, 2015, MOL ECOL RESOUR, V15, P932, DOI 10.1111/1755-0998.12353; Yang ZH, 2017, MOL ECOL, V26, P3028, DOI 10.1111/mec.14093; Yu WB, 2011, J SYST EVOL, V49, P425, DOI 10.1111/j.1759-6831.2011.00154.x; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055927; Zhao KF, 1998, TYPES CHINESE HALOPH, P76	71	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185311	10.1371/journal.pone.0185311	http://dx.doi.org/10.1371/journal.pone.0185311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934362	Green Submitted, gold, Green Published			2022-12-27	WOS:000411339900143
J	Wang, TT; Liu, Y; Lie, ZZ; Liu, KH; Xu, Y; Shi, WP; Chen, LZ				Wang, Tingting; Liu, Yuan; Lie, Zhanzhan; Liu, Kaihua; Xu, Yang; Shi, Wenpei; Chen, Lizhang			Prevalence of intimate partner violence (IPV) during pregnancy in China: A systematic review and meta-analysis	PLOS ONE			English	Review							DOMESTIC VIOLENCE; PHYSICAL ABUSE; RISK-FACTORS; WOMEN; HEALTH; DEPRESSION; OUTCOMES; IMPACT; BIRTH	Background Intimate partner violence (IPV) is the most common form of violence against women worldwide. IPV during pregnancy is an important risk factor for adverse health outcomes for women and their offspring. However, the prevalence of IPV during pregnancy is not well understood in China. The objective of this study was to estimate the pooled prevalence of IPV during pregnancy in China using a systematic review and meta-analysis. Methods Systematic literature searches were conducted in PubMed, Web of Science, CNKI, Wanfang, Weipu and CBM databases to identify relevant articles published from the inception of each database to January 31, 2016 that reported data on the prevalence of IPV during pregnancy in China. The Risk of Bias Tool for prevalence studies was used to assess the risk of bias in individual studies. Owing to significant between-study heterogeneity, a random-effects model was used to calculate the pooled prevalence and corresponding 95% confidence interval, and then univariate meta-regression analyses were performed to investigate the sources of heterogeneity. Subgroup analysis was conducted to explore the risk factors associated with IPV during pregnancy. Results Thirteen studies with a total of 30,665 individuals were included in this study. The overall pooled prevalence of IPV during pregnancy was 7.7% (95% CI: 5.6-10.1%) with significant heterogeneity (I-2 = 97.8%, p < 0.001). The results of the univariate meta-regression analyses showed that only the variable "sample source" explained part of the heterogeneity in this study (p < 0.05). The characteristics "number of children" and "unplanned pregnancy" were determined as risk factors for experiencing violence during pregnancy. Conclusions The prevalence of IPV during pregnancy in China is considerable and one of the highest reported in Asia, which suggests that issues of violence against women during pregnancy should be included in efforts to improve the health of pregnant women and their offspring. In addition, a nationwide epidemiological study is needed to confirm the prevalence estimates and identify more risk factors for IPV during pregnancy.	[Wang, Tingting; Liu, Yuan; Shi, Wenpei; Chen, Lizhang] Cent S Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Lie, Zhanzhan] Cent S Univ, Xiangya Hosp, Dept Oncol, Changsha, Hunan, Peoples R China; [Liu, Kaihua] Cent S Univ, Xiangya Sch Publ Hlth, Dept Toxicol, Changsha, Hunan, Peoples R China; [Xu, Yang] Deyang Ctr Dis Control & Prevent, Deyang, Sichuan, Peoples R China	Central South University; Central South University; Central South University	Chen, LZ (corresponding author), Cent S Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.	liche4005@126.com	wang, tingting/AAK-2640-2020					Altarac Maja, 2002, J Am Med Womens Assoc (1972), V57, P208; Bacchus L, 2006, VIOLENCE AGAINST WOM, V12, P588, DOI 10.1177/1077801206289131; Bergman K, 2007, J AM ACAD CHILD PSY, V46, P1454, DOI 10.1097/chi.0b013e31814a62f6; Campbell J, 2004, VIOLENCE AGAINST WOM, V10, P770, DOI 10.1177/1077801204265551; Campbell JC, 2003, AM J PUBLIC HEALTH, V93, P1089, DOI 10.2105/AJPH.93.7.1089; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Chan EKL, 2000, STUDY IMPACT FAMILY; [崔轶 Cui Yi], 2012, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V20, P360; Datner EM, 2007, J INTERPERS VIOLENCE, V22, P124, DOI 10.1177/0886260506295000; Deveci S. Erhan, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P754; Devries K, 2011, SOC SCI MED, V73, P79, DOI 10.1016/j.socscimed.2011.05.006; Devries KM, 2010, REPROD HEALTH MATTER, V18, P158, DOI 10.1016/S0968-8080(10)36533-5; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Dunn LL, 2004, JOGNN, V33, P54, DOI 10.1177/0884217503261080; Fan L, 2006, MATERN CHILD HLTH J, V21, P2632; Fanslow J, 2008, AUST NZ J OBSTET GYN, V48, P391, DOI 10.1111/j.1479-828X.2008.00866.x; Farid M, 2008, INT J GYNECOL OBSTET, V101, P141, DOI 10.1016/j.ijgo.2007.11.015; Fawole AO, 2008, AUST NZ J OBSTET GYN, V48, P405, DOI 10.1111/j.1479-828X.2008.00868.x; Gao WZ, 2008, INT J GYNECOL OBSTET, V100, P109, DOI 10.1016/j.ijgo.2007.08.004; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Gazmararian JA, 1996, JAMA-J AM MED ASSOC, V275, P1915, DOI 10.1001/jama.275.24.1915; Goodwin M M, 2000, Matern Child Health J, V4, P85; Guo SF, 2004, CHIN J PERINAT MED, V7, P265; Guo SF, 2002, CHIN J FAM PLAN, V10, P70; [郭素芳 Guo Sufang], 2003, [中国心理卫生杂志, Chinese Mental Health Journal], V17, P629; Heaman MI, 2005, JOGNN-J OBST GYN NEO, V34, P721, DOI 10.1177/0884217505281906; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang Y., 2008, THESIS; Janssen PA, 2003, AM J OBSTET GYNECOL, V188, P1341, DOI 10.1067/mob.2003.274; Jasinski Jana L, 2004, Trauma Violence Abuse, V5, P47, DOI 10.1177/1524838003259322; Jejeebhoy SJ, 1998, STUD FAMILY PLANN, V29, P300, DOI 10.2307/172276; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Johnson H., 2007, VIOLENCE WOMEN INT P; Langan D, 2012, J CLIN EPIDEMIOL, V65, P511, DOI 10.1016/j.jclinepi.2011.10.009; Lau Ying, 2007, J Midwifery Womens Health, V52, pe15, DOI 10.1016/j.jmwh.2006.09.001; Leung WC, 2002, INT J GYNECOL OBSTET, V79, P159, DOI 10.1016/S0020-7292(02)00236-9; Leung WC, 1999, INT J GYNECOL OBSTET, V66, P23, DOI 10.1016/S0020-7292(99)00053-3; Lipsky Sherry, 2005, Violence Vict, V20, P69; Liu BH, 2016, CHINESE J WOMEN CHIL, V7, P49; [罗美玲 Luo Meiling], 2013, [循证医学, The Journal of Evidence-Based Medicine], V13, P181; Mahenge B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164376; Martin SL, 2004, J FAM VIOLENCE, V19, P201, DOI 10.1023/B:JOFV.0000032630.50593.93; Moher David, 2009, Open Med, V3, pe123; Muhajarine N, 1999, CAN MED ASSOC J, V160, P1007; National Health and Family Planing Commission of the People's Republic of China, NOT MIN HLTH ISS PRE; NOEL NL, 1992, NURS CLIN N AM, V27, P871; Ntaganira Joseph, 2008, BMC Womens Health, V8, P17, DOI 10.1186/1472-6874-8-17; Olagbuji B, 2010, INT J GYNECOL OBSTET, V108, P101, DOI 10.1016/j.ijgo.2009.09.024; Pallitto CC, 2005, TRAUMA VIOLENCE ABUS, V6, P217, DOI 10.1177/1524838005277441; Peedicayil A, 2004, BJOG-INT J OBSTET GY, V111, P682, DOI 10.1111/j.1471-0528.2004.00151.x; Perales MT, 2009, VIOLENCE AGAINST WOM, V15, P224, DOI 10.1177/1077801208329387; Rodrigues T, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.015; Saltzman Linda E, 2003, Matern Child Health J, V7, P31, DOI 10.1023/A:1022589501039; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; STEWART DE, 1993, CAN MED ASSOC J, V149, P1257; Taillieu TL, 2010, AGGRESS VIOLENT BEH, V15, P14, DOI 10.1016/j.avb.2009.07.013; Thananowan N, 2008, VIOLENCE AGAINST WOM, V14, P509, DOI 10.1177/1077801208315525; Tiwari A, 2007, BJOG-INT J OBSTET GY, V114, P1065, DOI 10.1111/j.1471-0528.2007.01441.x; Tiwari A, 2008, BJOG-INT J OBSTET GY, V115, P377, DOI 10.1111/j.1471-0528.2007.01593.x; Valladares E, 2002, OBSTET GYNECOL, V100, P700, DOI 10.1016/S0029-7844(02)02093-8; World Health Organization, 2011, INT PARTN VIOL PREG; World Health Organization, 2002, WORLD REPORT VIOLENC; Wu JL, 2005, CONTRACEPTION, V72, P117, DOI 10.1016/j.contraception.2005.02.010; Wu Q, 2012, ARCH WOMEN MENT HLTH, V15, P107, DOI 10.1007/s00737-011-0248-9; Xu SH, 2008, CHINA PRACT MED, V3, P40; Yang MS, 2006, INT J NURS STUD, V43, P21, DOI 10.1016/j.ijnurstu.2004.12.005; Ye ZH, 2005, CHINESE PUBLIC HLTH, V21, P1012; Zhang Y., 2008, THESIS	68	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0175108	10.1371/journal.pone.0175108	http://dx.doi.org/10.1371/journal.pone.0175108			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968397	Green Published, gold, Green Submitted			2022-12-27	WOS:000412029600001
J	de Michele, M; Ergintav, S; Aochi, H; Raucoules, D				de Michele, Marcello; Ergintav, Semih; Aochi, Hideo; Raucoules, Daniel			An L-band interferometric synthetic aperture radar study on the Ganos section of the north Anatolian fault zone between 2007 and 2011: Evidence for along strike segmentation and creep in a shallow fault patch	PLOS ONE			English	Article							SAN-ANDREAS FAULT; STRAIN ACCUMULATION; WESTERN TURKEY; SURFACE CREEP; EARTHQUAKE; INSAR; EVOLUTION; MARMARA; REGION; SAROS	We utilize L-band interferometric synthetic aperture radar (InSAR) data in this study to retrieve a ground velocity map for the near field of the Ganos section of the north Anatolian fault (NAF) zone. The segmentation and creep distribution of this section, which last ruptured in 1912 to generate a moment magnitude (Mw) 7.3 earthquake, remains incompletely understood. Because InSAR processing removes the mean orbital plane, we do not investigate large scale displacements due to regional tectonics in this study as these can be determined using global positioning system (GPS) data, instead concentrating on the close-tothe- fault displacement field. Our aim is to determine whether, or not, it is possible to retrieve robust near field velocity maps from stacking L-band interferograms, combining both single and dual polarization SAR data. In addition, we discuss whether a crustal velocity map can be used to complement GPS observations in an attempt to discriminate the present-day surface displacement of the Ganos fault (GF) across multiple segments. Finally, we characterize the spatial distribution of creep on shallow patches along multiple along-strike segments at shallow depths. Our results suggest the presence of fault segmentation along strike as well as creep on the shallow part of the fault (i.e. the existence of a shallow creeping patch) or the presence of a smoother section on the fault plane. Data imply a heterogeneous fault plane with more complex mechanics than previously thought. Because this study improves our knowledge of the mechanisms underlying the GF, our results have implications for local seismic hazard assessment.	[de Michele, Marcello; Aochi, Hideo; Raucoules, Daniel] French Geol Survey BRGM, Nat Risks Dept, Orleans, France; [Ergintav, Semih] Bogazici Univ, Dept Geodesy, Kandilli Observ, Istanbul, Turkey; [Ergintav, Semih] Earthquake Res Inst, Istanbul, Turkey	Bureau de Recherches Geologiques et Minieres (BRGM); Bogazici University; Bogazici University	de Michele, M (corresponding author), French Geol Survey BRGM, Nat Risks Dept, Orleans, France.	m.demichele@brgm.fr	ergintav, semih/P-9315-2015; Aochi, Hideo/A-3281-2011; Raucoules, Daniel/G-6366-2010	ergintav, semih/0000-0001-7080-183X; Aochi, Hideo/0000-0001-9405-9596; Raucoules, Daniel/0000-0003-1715-3743	EU [308417]	EU(European Commission)	This study was conducted within the context of the EU 7th framework program project MARSite: New Directions in Seismic Hazard assessment through Focused Earth Observation in the Marmara Supersite (Grant agreement no: 308417).; This study was conducted within the context of the EU 7 th framework program project 'MARSite: New Directions in Seismic Hazard assessment through Focused Earth Observation in the Marmara Supersite' (Grant agreement no: 308417). ALOS PALSAR radar data are available from the Japanese Aerospace Exploration Agency (JAXA). We are thankful to JAXA for providing ALOS PALSAR data. Original ALOS radar data are copyright JAXA and were provided under Marmara Supersite Grant agreement no: 308417. We made raw interferograms available to the public on the MARsite.eu/publications website.	Aksoy ME, 2010, GEOLOGY, V38, P991, DOI 10.1130/G31447.1; AMBRASEYS NN, 1987, EARTHQUAKE ENG STRUC, V15, P189, DOI 10.1002/eqe.4290150204; Armijo R, 1999, GEOLOGY, V27, P267, DOI 10.1130/0091-7613(1999)027<0267:WPOTNA>2.3.CO;2; Barbot S, 2013, J GEOPHYS RES-SOL EA, V118, P6311, DOI 10.1002/2013JB010442; BARKA AA, 1988, TECTONICS, V7, P663, DOI 10.1029/TC007i003p00663; Barka AA, 1992, ANN TECTONICAE, P164; Bilham R, 2016, J GEOPHYS RES-SOL EA, V121, P7409, DOI 10.1002/2016JB013394; Cakir Z, 2005, EARTH PLANET SC LETT, V238, P225, DOI 10.1016/j.epsl.2005.06.044; Costantini M., 1999, IEEE 1999 International Geoscience and Remote Sensing Symposium. IGARSS'99 (Cat. No.99CH36293), P267, DOI 10.1109/IGARSS.1999.773467; de Michele M, 2011, EARTH PLANET SC LETT, V308, P141, DOI 10.1016/j.epsl.2011.05.049; De Michele M, 2013, REMOTE SENS LETT, V4, P863, DOI 10.1080/2150704X.2013.808777; Doin MP, 2009, J APPL GEOPHYS, V69, P35, DOI 10.1016/j.jappgeo.2009.03.010; Ergintav S, 2014, GEOPHYS RES LETT, V41, P5783, DOI 10.1002/2014GL060985; Farr T.G., 2000, EOS T AM GEOPHYS UN, V81, P583, DOI [DOI 10.1029/EO081I048P00583, 10.1029/EO081i048p00583]; Hussain E, 2016, J GEOPHYS RES-SOL EA, V121, P9000, DOI 10.1002/2016JB013108; Janssen C, 2009, J STRUCT GEOL, V31, P9, DOI 10.1016/j.jsg.2008.09.010; Le Mouelic S, 2005, PHOTOGRAMM ENG REM S, V71, P197, DOI 10.14358/PERS.71.2.197; Massonnet D, 1998, REV GEOPHYS, V36, P441, DOI 10.1029/97RG03139; Meghraoui M, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003960; Meyer FJ, 2013, IEEE T GEOSCI REMOTE, V51, P4961, DOI 10.1109/TGRS.2013.2252469; Motagh M, 2007, EARTH PLANET SC LETT, V255, P432, DOI 10.1016/j.epsl.2007.01.003; Okay AI, 2004, TECTONOPHYSICS, V391, P259, DOI 10.1016/j.tecto.2004.07.016; Puyssegur B, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004352; Reilinger RE, 2000, SCIENCE, V289, P1519, DOI 10.1126/science.289.5484.1519; Rousset B, 2016, GEOPHYS RES LETT, V43, P3254, DOI 10.1002/2016GL068250; Smith-Konter BR, 2011, J GEOPHYS RES-SOL EA, V116, DOI [10.1029/2010JB00S117, 10.1029/2010JB008117]; Stein RS, 1997, GEOPHYS J INT, V128, P594, DOI 10.1111/j.1365-246X.1997.tb05321.x; Tuysuz O, 1998, TECTONOPHYSICS, V293, P105, DOI 10.1016/S0040-1951(98)00085-7; Wegmuuller U., 2009, P ALOS PI S 2009 NOV; Werner C. L., 2002, P EUSAR C JUN 4 6 CO; Yaltirak C, 2002, MAR GEOL, V190, P351, DOI 10.1016/S0025-3227(02)00354-7; Zebker HA, 1997, J GEOPHYS RES-SOL EA, V102, P7547, DOI 10.1029/96JB03804	32	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185422	10.1371/journal.pone.0185422	http://dx.doi.org/10.1371/journal.pone.0185422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961264	Green Published, gold, Green Submitted			2022-12-27	WOS:000412027700018
J	Panayi, E; Peters, GW; Kyriakides, G				Panayi, Efstathios; Peters, Gareth W.; Kyriakides, George			Statistical modelling for precision agriculture: A case study in optimal environmental schedules for Agaricus Bisporus production via variable domain functional regression	PLOS ONE			English	Article							FOOD-INDUSTRY; MUSHROOM; CULTIVATION; SUBSTRATE; TIME	Quantifying the effects of environmental factors over the duration of the growing process on Agaricus Bisporus (button mushroom) yields has been difficult, as common functional data analysis approaches require fixed length functional data. The data available from commercial growers, however, is of variable duration, due to commercial considerations. We employ a recently proposed regression technique termed Variable-Domain Functional Regression in order to be able to accommodate these irregular-length datasets. In this way, we are able to quantify the contribution of covariates such as temperature, humidity and water spraying volumes across the growing process, and for different lengths of growing processes. Our results indicate that optimal oxygen and temperature levels vary across the growing cycle and we propose environmental schedules for these covariates to optimise overall yields.	[Panayi, Efstathios; Peters, Gareth W.; Kyriakides, George] UCL, Dept Stat Sci, London, England; [Kyriakides, George] Kyiakides Mushrooms Ltd, Larnaka, Cyprus	University of London; University College London	Peters, GW (corresponding author), UCL, Dept Stat Sci, London, England.	gareth.peters@ucl.ac.uk		Peters, Gareth/0000-0003-2768-8979	Kyiakides Mushrooms Ltd.	Kyiakides Mushrooms Ltd.	The author(s) received no specific funding for this work. Kyiakides Mushrooms Ltd. provided support in the form of salaries for author GK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the `author contributions' section.	[Anonymous], 1993, NONPARAMETRIC REGRES; [Anonymous], 2004, MUSHROOMS CULTIVATIO; Aqeel-ur-Rehman, 2014, COMPUT STAND INTER, V36, P263, DOI 10.1016/j.csi.2011.03.004; ATKEY PT, 1983, J APPL BACTERIOL, V55, P293, DOI 10.1111/j.1365-2672.1983.tb01326.x; Braaksma A, 1999, POSTHARVEST BIOL TEC, V16, P195, DOI 10.1016/S0925-5214(99)00019-8; CAREY A T, 1991, P673; Chang ST, 1978, BIOL CULTIVATION EDI; Chaudhary D.D., 2011, INT J WIRELESS MOBIL, V3, P140, DOI [DOI 10.5121/IJWMN.2011.3113, 10.5121/ijwmn.2011.3113140]; Coffey N, 2011, HUM MOVEMENT SCI, V30, P1144, DOI 10.1016/j.humov.2010.11.005; de Boor C, 2001, MATH MOD METH APPL S, V11, P33, DOI 10.1142/S0218202501000726; Duchon J, 1977, CONSTRUCTIVE THEORY, P85, DOI DOI 10.1007/BFB0086566; FLEGG PB, 1956, J SOIL SCI, V7, P168, DOI 10.1111/j.1365-2389.1956.tb00872.x; Gao ZK, 2017, CHAOS, V27, DOI 10.1063/1.4977950; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35622; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gellar JE, 2014, J AM STAT ASSOC, V109, P1425, DOI 10.1080/01621459.2014.940044; GERRITS J. P. G., 1967, Mushroom Science, V6, P225; Gulser CK, 2003, BIORESOURCE TECHNOL, V88, P153, DOI 10.1016/S0960-8524(02)00279-1; James GM, 2002, J ROY STAT SOC B, V64, P411, DOI 10.1111/1467-9868.00342; Lin FC, 2000, SCIENCE AND CULTIVATION OF EDIBLE FUNGI, VOLS 1 AND 2, P955; Morris JS, 2015, ANNU REV STAT APPL, V2, P321, DOI 10.1146/annurev-statistics-010814-020413; Muller HG, 2005, ANN STAT, V33, P774, DOI 10.1214/009053604000001156; NOBLE R, 1991, SCI HORTIC-AMSTERDAM, V46, P177, DOI 10.1016/0304-4238(91)90040-6; Panayi E, 2015, LIQUIDITY C IN PRESS; Peyvast G, 2007, BIOSCIENCES BIOTECHN, V4; Ramsay J. O, 2006, FUNCTIONAL DATA ANAL; RAMSAY JO, 1991, J ROY STAT SOC B MET, V53, P539; Ramsay JO, 2002, APPL FUNCTIONAL DATA, V77; RICE JA, 1991, J ROY STAT SOC B MET, V53, P233; Royse D. J., 2014, Proceedings of 8th International Conference on Mushroom Biology and Mushroom Products (ICMBMP8), New Delhi, India, 19-22 November 2014. Volume I & II, P1; Ruiz-Garcia L, 2009, SENSORS-BASEL, V9, P4728, DOI 10.3390/s90604728; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Sassine Y., 2005, J APPL SCI RES, V1, P277; Sharma HS, 2000, CAN J MICROBIOL, V46, P515, DOI 10.1139/cjm-46-6-515; Singh P, 2010, J SCI FOOD AGR, V90, P1393, DOI 10.1002/jsfa.3971; STAMETS P., 1983, MUSHROOM CULTIVATOR; Taherzadeh L., 2013, International Journal of Agriculture and Crop Sciences (IJACS), V5, P656; Tuhy L, 2015, ECOL ENG, V84, P370, DOI 10.1016/j.ecoleng.2015.09.032; Vedder P.J.C., 1978, MODERN MUSHROOM GROW; Vellidis G, 2008, COMPUT ELECTRON AGR, V61, P44, DOI 10.1016/j.compag.2007.05.009; Visscher H.R., 1988, CULTIVATION MUSHROOM, P29; Wang N, 2006, COMPUT ELECTRON AGR, V50, P1, DOI 10.1016/j.compag.2005.09.003; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood S.N., 2001, R R NEWS, V1, P20; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; Wuest P.J., 1996, MUSHROOM NEWS, V44, P16; Zhang YQ, 2014, SUSTAINABILITY-BASEL, V6, P2961, DOI 10.3390/su6052961	47	3	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0181921	10.1371/journal.pone.0181921	http://dx.doi.org/10.1371/journal.pone.0181921			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961254	Green Published, Green Submitted, gold			2022-12-27	WOS:000412027700002
J	Ha, YR; Kim, JH; Ryu, J; Lee, SJ				Ha, Young Ran; Kim, Jun Ho; Ryu, Jeongeun; Lee, Sang Joon			Superb feeding behavior of Aedes albopictus transmitting Zika virus	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ANOPHELES-SINENSIS; MOSQUITOS; TRANSMISSION; INGESTION; ADHESION; SPREAD; SUSCEPTIBILITY; SPOROZOITES; INFECTION	Disease-mediated mosquitoes have been receiving much attention, as the World Health Organization recently declared the Zika virus a global public health emergency. Mosquitoes transmit pathogens that cause various tropical diseases including malaria, dengue fever and yellow fever as well as Zika virus. The vector efficiency of mosquitoes depends on their blood-feeding characteristics and the mechanics of their blood-sucking pump system, but only a few studies have attempted to investigate these key issues. In this study, we demonstrate the rapid and gluttonous liquid-feeding characteristics of Ae. albopictus which transmits Zika virus can be explained by similar proportion of two blood-sucking pumps and accelerated liquid intake driven by fast expanding of pumps. Our results provide insight into the vector efficiency of Ae. albopictus in terms of feeding velocity, pumping frequency, liquid-intake rate, and wall shear stress.	[Ha, Young Ran; Lee, Sang Joon] Pohang Univ Sci & Technol, Ctr Biofluid & Biomim Res, Pohang, South Korea; [Kim, Jun Ho; Ryu, Jeongeun; Lee, Sang Joon] Pohang Univ Sci & Technol, Dept Mech Engn, Ctr Biofluid & Biomim Res, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Lee, SJ (corresponding author), Pohang Univ Sci & Technol, Ctr Biofluid & Biomim Res, Pohang, South Korea.; Lee, SJ (corresponding author), Pohang Univ Sci & Technol, Dept Mech Engn, Ctr Biofluid & Biomim Res, Pohang, South Korea.	sjlee@postech.ac.kr	Lee, Sang Joon/AAG-2448-2019	LEE, SANG JOON/0000-0003-3286-5941	National Research Foundation of Korea grant - Korean government (MSIP) [2008-0061991]	National Research Foundation of Korea grant - Korean government (MSIP)	This work was supported by a National Research Foundation of Korea grant funded by the Korean government (MSIP) (No. 2008-0061991). URL: http://www.nrf.re.kr/eng/main. The funder had no role in study design, data collection and analysis, decsion to publish, or preparation of the manuscript.	Anderson RA, 1999, P ROY SOC B-BIOL SCI, V266, P1729, DOI 10.1098/rspb.1999.0839; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Cator LJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0711; Cavalcante RR, 2006, MEM I OSWALDO CRUZ, V101, P85, DOI 10.1590/S0074-02762006000100016; El-Kirat-Chatel S, 2016, NANOSCALE HORIZ, V1, P69, DOI 10.1039/c5nh00049a; Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Harada F, 1975, JAP J SANIT ZOOL; Hegge S, 2010, FASEB J, V24, P2222, DOI 10.1096/fj.09-148700; Jinj Y, 2007, INFECT IMMUN, V75, P5532, DOI 10.1128/IAI.00600-07; Junkum A, 2003, MEM I OSWALDO CRUZ, V98, P481, DOI 10.1590/S0074-02762003000400009; KASHIN P, 1966, J INSECT PHYSIOL, V12, P281, DOI 10.1016/0022-1910(66)90143-0; Kebaier C, 2006, AM J TROP MED HYG, V75, P1200, DOI 10.4269/ajtmh.2006.75.1200; Kikuchi K, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/6/064002; Kim BH, 2014, SENSOR ACTUAT A-PHYS, V209, P133, DOI 10.1016/j.sna.2014.01.016; Kim BH, 2013, J EXP BIOL, V216, P952, DOI 10.1242/jeb.072710; Kim BH, 2011, J EXP BIOL, V214, P1163, DOI 10.1242/jeb.048793; Koella JC, 1998, P ROY SOC B-BIOL SCI, V265, P763, DOI 10.1098/rspb.1998.0358; Lee SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20464; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; MITCHELL CJ, 1995, J VECTOR ECOL, V20, P44; Park JH, 2012, EMERG INFECT DIS, V18, P1525, DOI 10.3201/eid1809.111811; Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001; Poole-Smith BK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003462; ROSEN L, 1978, SCIENCE, V199, P909, DOI 10.1126/science.203035; Saeung A, 2014, SE ASIAN J TROP MED, V45, P588; Sant'Anna MRV, 2001, J INSECT PHYSIOL, V47, P1459, DOI 10.1016/S0022-1910(01)00136-6; SCHMIDT JM, 1991, J INSECT PHYSIOL, V37, P817, DOI 10.1016/0022-1910(91)90078-E; Schwarz US, 2015, SEMIN CELL DEV BIOL, V46, P82, DOI 10.1016/j.semcdb.2015.09.025; Sota T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131230; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; WEKESA JW, 1992, AM J TROP MED HYG, V47, P484, DOI 10.4269/ajtmh.1992.47.484; World Health Organization, 2016, ZIKA STRATEGIC RESPO	35	1	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184871	10.1371/journal.pone.0184871	http://dx.doi.org/10.1371/journal.pone.0184871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957351	Green Submitted, Green Published, gold			2022-12-27	WOS:000411985200020
J	Ito, T; Suzaki, K				Ito, Takao; Suzaki, Koichi			Universal detection of phytoplasmas and Xylella spp. by TaqMan singleplex and multiplex real-time PCR with dual priming oligonucleotides	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; RT-PCR; FASTIDIOSA; PLANT; ASSAYS	Phytoplasmas and Xylella spp. are bacteria that cause many economically important plant diseases worldwide. TaqMan probe-based quantitative real-time polymerase chain reaction (qPCR) assays have been utilized to universally detect phytoplasmas or Xylella fastidiosa. To develop a superior universal qPCR method, we used a dual priming oligonucleotide (DPO) with two annealing sites as a reverse primer to target the well-conserved bacterial 16S rDNA. The new qPCR assays universally detected various species of phytoplasmas and subspecies of X. fastidiosa as well as Xylella taiwanensis, and generally showed superior threshold cycle values when amplifying specific or non-specific products compared to current universal qPCR assays. The proposed qPCR assays were integrated to develop a multiplex qPCR assay that simultaneously detected phytoplasmas, Xylella spp., and an internal plant DNA positive control within 1 hour. This assay could detect a minimum of ten bacterial cells and was compatible with crude extractions used in the rapid screening of various plants. The amplicons were of sufficient lengths to be directly sequenced for preliminary identification, and the primers could be used in universal conventional PCR assays. Additionally, reverse DPO primers can be utilized to improve other probe-based qPCR assays.	[Ito, Takao; Suzaki, Koichi] Natl Agr & Food Res Org NARO, Inst Fruit Tree & Tea Sci, Div Grape & Persimmon Res, Higashihiroshima, Hiroshima, Japan	National Agriculture & Food Research Organization - Japan	Ito, T (corresponding author), Natl Agr & Food Res Org NARO, Inst Fruit Tree & Tea Sci, Div Grape & Persimmon Res, Higashihiroshima, Hiroshima, Japan.	itotaka@affrc.go..jp		Ito, Takao/0000-0002-2338-126X	Ministry of Agriculture, Forestry, and Fisheries of Japan [2508]	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This study was supported by a Grant-in-Aid for "Regulatory research projects for food safety, animal health and plant protection, no. 2508." from the Ministry of Agriculture, Forestry, and Fisheries of Japan.	Almeida RPP, 2015, PLANT DIS, V99, P1457, DOI 10.1094/PDIS-02-15-0159-FE; Anonymous, 2016, Bulletin OEPP, V46, P463, DOI 10.1111/epp.12327; Bertaccini A., 2014, American Journal of Plant Sciences, V5, P1763, DOI 10.4236/ajps.2014.512191; Chen JC, 2000, CURR MICROBIOL, V40, P29, DOI 10.1007/s002849910006; Christensen NM, 2004, MOL PLANT MICROBE IN, V17, P1175, DOI 10.1094/MPMI.2004.17.11.1175; Christensen Nynne Meyn, 2013, Methods Mol Biol, V938, P245, DOI 10.1007/978-1-62703-089-2_21; Chun JY, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm051; EUPHRESCO FruitPhytoInterlab Group, 2011, B INSECTOL, V64, P281; Firrao G., 1994, Phytopathologia Mediterranea, V33, P90; Forster RJ, 1997, APPL ENVIRON MICROB, V63, P1256, DOI 10.1128/AEM.63.4.1256-1260.1997; Francis M, 2006, EUR J PLANT PATHOL, V115, P203, DOI 10.1007/s10658-006-9009-4; Fujiwara K, 2016, J PLANT PATHOL, V98, P441, DOI 10.4454/JPP.V98I3.061; Harper SJ, 2010, PHYTOPATHOLOGY, V100, P1282, DOI 10.1094/PHYTO-06-10-0168; Hodgetts J, 2009, APPL ENVIRON MICROB, V75, P2945, DOI 10.1128/AEM.02610-08; IPPC, 2016, ISPM 27 ANN 12 PHYT; Kommedal O, 2012, J CLIN MICROBIOL, V50, P1289, DOI 10.1128/JCM.06269-11; Kube M, 2014, J MOL MICROB BIOTECH, V24, P19, DOI 10.1159/000354322; Li WB, 2013, J MICROBIOL METH, V92, P79, DOI 10.1016/j.mimet.2012.10.008; Loconsole G, 2014, J PLANT PATHOL, V96, P7; Maejima K, 2014, J GEN PLANT PATHOL, V80, P210, DOI 10.1007/s10327-014-0512-8; Malandraki I, 2015, J VIROL METHODS, V213, P12, DOI 10.1016/j.jviromet.2014.11.010; Marcelletti S, 2016, ARCH MICROBIOL, V198, P803, DOI 10.1007/s00203-016-1245-1; MINSAVAGE GV, 1994, PHYTOPATHOLOGY, V84, P456, DOI 10.1094/Phyto-84-456; Nakaune R, 2006, J VIROL METHODS, V134, P244, DOI 10.1016/j.jviromet.2006.01.016; Rodrigues JLM, 2003, APPL ENVIRON MICROB, V69, P4249, DOI 10.1128/AEM.69.7.4249-4255.2003; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Su CC, 2016, INT J SYST EVOL MICR, V66, P4766, DOI 10.1099/ijsem.0.001426; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zhao Y, 2016, INT J SYST EVOL MICR, V66, P2121, DOI 10.1099/ijsem.0.000999	29	10	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185427	10.1371/journal.pone.0185427	http://dx.doi.org/10.1371/journal.pone.0185427			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957362	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200056
J	Nguyen, MQ; Wu, YM; Bonilla, LS; von Buchholtz, LJ; Ryba, NJP				Nguyen, Minh Q.; Wu, Youmei; Bonilla, Lauren S.; von Buchholtz, Lars J.; Ryba, Nicholas J. P.			Diversity amongst trigeminal neurons revealed by high throughput single cell sequencing	PLOS ONE			English	Article							TRPM8-EXPRESSING SENSORY NEURONS; RNA-SEQ; TRANSCRIPTOME ANALYSIS; MOLECULAR SIGNATURES; TRP CHANNELS; PAIN; COLD; RECEPTOR; TOUCH; THERMOSENSATION	The trigeminal ganglion contains somatosensory neurons that detect a range of thermal, mechanical and chemical cues and innervate unique sensory compartments in the head and neck including the eyes, nose, mouth, meninges and vibrissae. We used single-cell sequencing and in situ hybridization to examine the cellular diversity of the trigeminal ganglion in mice, defining thirteen clusters of neurons. We show that clusters are well conserved in dorsal root ganglia suggesting they represent distinct functional classes of somatosensory neurons and not specialization associated with their sensory targets. Notably, functionally important genes (e.g. the mechanosensory channel Piezo2 and the capsaicin gated ion channel Trpv1) segregate into multiple clusters and often are expressed in subsets of cells within a cluster. Therefore, the 13 genetically-defined classes are likely to be physiologically heterogeneous rather than highly parallel (i.e., redundant) lines of sensory input. Our analysis harnesses the power of single-cell sequencing to provide a unique platform for in silico expression profiling that complements other approaches linking gene-expression with function and exposes unexpected diversity in the somatosensory system.	[Nguyen, Minh Q.; Wu, Youmei; Bonilla, Lauren S.; von Buchholtz, Lars J.; Ryba, Nicholas J. P.] Natl Inst Dent & Craniofacial Res, Taste & Smell Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ryba, NJP (corresponding author), Natl Inst Dent & Craniofacial Res, Taste & Smell Sect, NIH, Bethesda, MD 20892 USA.	nick.ryba@nih.gov		Ryba, Nicholas/0000-0002-2060-8393; Bonilla, Lauren/0000-0002-9151-9603	National Institutes of Health, National Institute of Dental and Craniofacial Research [ZIA-DE000561]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Intramural program of the National Institutes of Health, National Institute of Dental and Craniofacial Research (N.J.P.R.) ZIA-DE000561. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Cao J, 2017, BIORXIV; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Chiu IM, 2014, ELIFE, V3, DOI 10.7554/eLife.04660; Coste B, 2010, SCIENCE NEW YORK NY, V330; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; Goswami SC, 2014, J PAIN, V15, P1338, DOI 10.1016/j.jpain.2014.09.010; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Knowlton WM, 2013, J NEUROSCI, V33, P2837, DOI 10.1523/JNEUROSCI.1943-12.2013; Lacar B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11022; Li CL, 2016, CELL RES, V26, P83, DOI 10.1038/cr.2015.149; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; McGlone F, 2014, NEURON, V82, P737, DOI 10.1016/j.neuron.2014.05.001; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Osteen JD, 2016, NATURE, V534, P494, DOI 10.1038/nature17976; Pogorzala LA, 2013, J NEUROSCI, V33, P5533, DOI 10.1523/JNEUROSCI.5788-12.2013; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Viana F, 2011, ACS CHEM NEUROSCI, V2, P38, DOI 10.1021/cn100102c; Waltman L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40829-0; Weng HJ, 2015, NEURON, V85, P833, DOI 10.1016/j.neuron.2014.12.065; Xing H, 2006, J NEUROPHYSIOL, V95, P1221, DOI 10.1152/jn.01035.2005; Yarmolinsky DA, 2016, NEURON, V92, P1079, DOI 10.1016/j.neuron.2016.10.021	39	83	82	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185543	10.1371/journal.pone.0185543	http://dx.doi.org/10.1371/journal.pone.0185543			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957441	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200081
J	Stepanova, EV; Kondrashin, AV; Sergiev, VP; Morozova, LF; Turbabina, NA; Maksimova, MS; Brazhnikov, AI; Shevchenko, SB; Morozov, EN				Stepanova, Ekaterina V.; Kondrashin, Anatoly V.; Sergiev, Vladimir P.; Morozova, Lola F.; Turbabina, Natalia A.; Maksimova, Maria S.; Brazhnikov, Alexey I.; Shevchenko, Sergei B.; Morozov, Evgeny N.			Significance of chronic toxoplasmosis in epidemiology of road traffic accidents in Russian Federation	PLOS ONE			English	Article							LATENT TOXOPLASMOSIS; HUMAN PERSONALITY; GONDII; BEHAVIOR; PARASITE; HUMANS; RISK	Studies carried out in Moscow residents have revealed that the prevalence of chronic toxoplasmosis is very close to those in countries of Eastern and Central Europe. Our findings also demonstrated a statistically significant relationship between the rate of traffic accidents and the seroprevalence of chronic toxoplasmosis in drivers who were held responsible for accidents. The latter was 2.37 times higher in drivers who were involved in road accidents compared with control groups. These results suggest that the consequences of chronic toxoplasmosis (particularly a slower reaction time and decreased concentration) might contribute to the peculiarities of the epidemiology of road traffic accidents in the Russian Federation and might interfere with the successful implementation of the Federal Programme named "Increase road traffic safety" . Suggestions for how to address overcome this problem are discussed in this paper.	[Stepanova, Ekaterina V.; Kondrashin, Anatoly V.; Turbabina, Natalia A.; Maksimova, Maria S.; Shevchenko, Sergei B.] IM Sechenov First Moscow State Med Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia; [Sergiev, Vladimir P.; Morozova, Lola F.; Morozov, Evgeny N.] IM Sechenov First Moscow State Med Univ, Dept Trop Med & Parasit Dis, Moscow, Russia; [Brazhnikov, Alexey I.] IM Sechenov First Moscow State Med Univ, Dept Epidemiol & Evidence Based Med, Moscow, Russia; [Morozov, Evgeny N.] Russian Med Acad Continuous Profess Educ, Dept Trop Parasit Dis & Disinfectol, Moscow, Russia	Sechenov First Moscow State Medical University; Sechenov First Moscow State Medical University; Sechenov First Moscow State Medical University	Morozov, EN (corresponding author), IM Sechenov First Moscow State Med Univ, Dept Trop Med & Parasit Dis, Moscow, Russia.; Morozov, EN (corresponding author), Russian Med Acad Continuous Profess Educ, Dept Trop Parasit Dis & Disinfectol, Moscow, Russia.	emorozov@mail.ru	Morozova, Lola/C-7721-2014; Stepanova, Ekaterina/U-5837-2017; Morozova, Lola/M-4181-2019; Sergiev, Vladimir P./U-5520-2017; Morozov, Evgeny N./B-8483-2016; Turbabina, Natalia/T-9713-2017; Maria, Maksimova/T-9339-2017; Brazhnikov, Alexey I./U-9620-2017	Morozova, Lola/0000-0003-3033-1401; Stepanova, Ekaterina/0000-0002-5893-5517; Morozova, Lola/0000-0003-3033-1401; Morozov, Evgeny N./0000-0002-1324-9142; Turbabina, Natalia/0000-0002-7834-7560; Maria, Maksimova/0000-0002-9182-5184; Brazhnikov, Alexey I./0000-0002-5587-8860; Sergiev, Vladimir/0000-0002-1163-8419				Galvan-Ramirez MD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-294; Dolgikh T. I., 2008, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P19; Flegr J, 1996, PARASITOLOGY, V113, P49, DOI 10.1017/S0031182000066269; Flegr J, 2003, BIOL PSYCHOL, V63, P253, DOI 10.1016/S0301-0511(03)00075-9; Flegr J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-11; FLEGR J, 1994, FOLIA PARASIT, V41, P122; Flegr J, 2008, PARASITOLOGY, V135, P427, DOI 10.1017/S0031182007004064; Flegr J, 1999, FOLIA PARASIT, V46, P22; Flegr J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090203; Flegr J, 2013, J EXP BIOL, V216, P127, DOI 10.1242/jeb.073635; Flegr J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-72; Havlicek J, 2001, PARASITOLOGY, V122, P515, DOI 10.1017/S0031182001007624; Kocazeybek B, 2009, FORENSIC SCI INT, V187, P103, DOI 10.1016/j.forsciint.2009.03.007; Lafferty KD, 2006, P ROY SOC B-BIOL SCI, V273, P2749, DOI 10.1098/rspb.2006.3641; Novotna M, 2008, PARASITOLOGY, V135, P1253, DOI 10.1017/S003118200800485X; Rasouli MR, 2008, CHIN J TRAUMATOL, V11, P131, DOI 10.1016/S1008-1275(08)60028-0; Russian Federation Programme, INCR SAF ROADS; Sergiev V, 2010, MED PARASITOL, V3, P48; Sergiev V, 2008, PARASITIC DIS MAN PR; Sergiev V, 2010, J MICROB EPIDEM IMMU, V3, P108; Sergiev V, 2010, MAN HIS PARASITES CO; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Webster JP, 2010, FOLIA PARASIT, V57, P95, DOI 10.14411/fp.2010.012; WEBSTER JP, 1994, PARASITOLOGY, V109, P37, DOI 10.1017/S003118200007774X; WHO, 2013, WHO ROAD SAF EST ROA; Yereli K, 2006, FORENSIC SCI INT, V163, P34, DOI 10.1016/j.forsciint.2005.11.002	27	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184930	10.1371/journal.pone.0184930	http://dx.doi.org/10.1371/journal.pone.0184930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957427	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200022
J	Lee, SI; Lee, H; Jablonski, PG; Choe, JC; Husby, M				Lee, Sang-im; Lee, Hyunna; Jablonski, Piotr G.; Choe, Jae Chun; Husby, Magne			Microbial abundance on the eggs of a passerine bird and related fitness consequences between urban and rural habitats	PLOS ONE			English	Article							REAL-TIME PCR; BLACKBIRD TURDUS-MERULA; TRANS-SHELL INFECTION; MAGPIES PICA-PICA; ESCHERICHIA-COLI; WATER SAMPLES; BACTERIAL COMMUNITY; BACILLUS-SUBTILIS; CANDIDA-ALBICANS; WILD BIRDS	Urban environments present novel and challenging habitats to wildlife. In addition to wellknown difference in abiotic factors between rural and urban environments, the biotic environment, including microbial fauna, may also differ significantly. In this study, we aimed to compare the change in microbial abundance on eggshells during incubation between urban and rural populations of a passerine bird, the Eurasian Magpie ( Pica pica), and examine the consequences of any differences in microbial abundances in terms of hatching success and nestling survival. Using real-time PCR, we quantified the abundances of total bacteria, Escherichia coli/Shigella spp., surfactin-producing Bacillus spp. and Candida albicans on the eggshells of magpies. We found that urban magpie eggs harboured greater abundances of E. coli/Shigella spp. and C. albicans before incubation than rural magpie eggs. During incubation, there was an increase in the total bacterial load, but a decrease in C. albicans on urban eggs relative to rural eggs. Rural eggs showed a greater increase in E. coli/Shigella spp. relative to their urban counterpart. Hatching success of the brood was generally lower in urban than rural population. Nestling survival was differentially related with the eggshell microbial abundance between urban and rural populations, which was speculated to be the result of the difference in the strength of the interaction among the microbes. This is the first demonstration that avian clutches in urban and rural populations differ in eggshell microbial abundance, which can be further related to the difference in hatching success and nestling survival in these two types of environments. We suggest that future studies on the eggshell microbes should investigate the interaction among the microbes, because the incubation and/or environmental factors such as urbanization or climate condition can influence the dynamic interactions among the microbes on the eggshells which can further determine the breeding success of the parents.	[Lee, Sang-im] Daegu Gyeongbuk Inst Sci & Technol, Sch Undergrad Studies, Daegu, South Korea; [Lee, Hyunna; Choe, Jae Chun] Ewha Womans Univ, EcoCreat Program, Lab Behav & Ecol, Seoul, South Korea; [Jablonski, Piotr G.] Seoul Natl Univ, Sch Biol Sci, Lab Behav Ecol & Evolut, Seoul, South Korea; [Jablonski, Piotr G.] Polish Acad Sci, Museum & Inst Zool, Warsaw, Poland; [Husby, Magne] Nord Univ, Dept Sci, Levanger, Norway	Daegu Gyeongbuk Institute of Science & Technology (DGIST); Ewha Womans University; Seoul National University (SNU); Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; Nord University	Husby, M (corresponding author), Nord Univ, Dept Sci, Levanger, Norway.	Magne.Husby@nord.no	Jablonski, Piotr G/A-2753-2015	/0000-0002-8333-0106; Husby, Magne/0000-0002-7015-5011	National Research Foundation of Korea [NRF-2014048162, 2013005769]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea NRF-2014048162, 2013005769, http://www.nrf.re.kr/nrf_eng_cms/. NRF has no role in any part of the work.	Abbas M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00953; Ahmad S, 2002, J CLIN MICROBIOL, V40, P2483, DOI 10.1128/JCM.40.7.2483-2489.2002; AJELLO L, 1956, SCIENCE, V123, P876, DOI 10.1126/science.123.3203.876; [Anonymous], 2001, AVIAN ECOLOGY CONSER; [Anonymous], 1994, NONLINEAR WORLD; Antonov A, 2003, ORNIS FENNICA, V80, P21; Barrow P. A., 1994, MICROBIOLOGY AVIAN E, P117; Bauck LB, 1994, AVIAN MED PRINCIPLES, P998; Birkhead T. R., 1991, MAGPIES ECOLOGY BEHA; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Brandl HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114861; Brenner DJ, 1937, BERGEYS MANUAL SYSTE, V1, P410; BRITTINGHAM MC, 1988, J WILDLIFE DIS, V24, P299, DOI 10.7589/0090-3558-24.2.299; Brown CC, 2007, MYCOTIC DIS GASTROIN, V2, P229; Bruce J., 1994, P63; Burtt EH, 1999, AUK, V116, P364, DOI 10.2307/4089371; Chez JM, 2014, MICROB ECOL, V67, P480; Cook MI, 2005, ECOL LETT, V8, P532, DOI 10.1111/j.1461-0248.2005.00748.x; Cook MI, 2005, BEHAV ECOL, V16, P30, DOI 10.1093/beheco/arh131; Cook MI, 2003, P ROY SOC B-BIOL SCI, V270, P2233, DOI 10.1098/rspb.2003.2508; Cramp S.E., 1994, HDB BIRDS EUROPE MID; Crawley M. J., 1993, GLM FOR ECOLOGISTS; D'Alba L, 2010, NATURWISSENSCHAFTEN, V97, P1089, DOI 10.1007/s00114-010-0735-2; Deleu M, 2013, BBA-BIOMEMBRANES, V1828, P801, DOI 10.1016/j.bbamem.2012.11.007; Dho-Moulin M, 1999, VET RES, V30, P299; EDEN SF, 1985, J ZOOL, V205, P325; Einen J, 2008, FEMS MICROBIOL LETT, V282, P182, DOI 10.1111/j.1574-6968.2008.01119.x; Ellis JB, 2006, ENVIRON POLLUT, V144, P184, DOI 10.1016/j.envpol.2005.12.018; Evans KL, 2009, OIKOS, V118, P774, DOI 10.1111/j.1600-0706.2008.17226.x; Fontana A., 2007, WATER ACTIVITY FOODS, P405; Foster G, 1998, LETT APPL MICROBIOL, V26, P395; FUJITA SI, 1995, J CLIN MICROBIOL, V33, P962, DOI 10.1128/JCM.33.4.962-967.1995; Gantois I, 2009, FEMS MICROBIOL REV, V33, P718, DOI 10.1111/j.1574-6976.2008.00161.x; Gerlach Helga, 1994, P949; GIRAUDEAU M, 2014, J HELMINITHOL, V88, P97; Giraudeau M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086747; Grandchamp GM, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03293-16; Gregoire A, 2002, IBIS, V144, P640, DOI 10.1046/j.1474-919X.2002.00102.x; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hamer SA, 2012, ZOONOSES PUBLIC HLTH, V59, P355, DOI 10.1111/j.1863-2378.2012.01462.x; Hammami R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-22; Hansen CM, 2015, APPL ENVIRON MICROB, V81, P5583, DOI 10.1128/AEM.00706-15; Heijnen Leo, 2006, Journal of Water and Health, V4, P487, DOI 10.2166/wh.2006.0032; Higgins J, 1990, P C APPL STAT AGR, P185; Hsieh FC, 2004, CURR MICROBIOL, V49, P186, DOI 10.1007/s00284-004-4314-7; Huang Y.-L., 2015, NAT COMMUN, V6; Jacobsen ID, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019741; Javurkova V, 2014, IBIS, V156, P374, DOI 10.1111/ibi.12126; Jeong JH, 2010, BIODEGRADATION, V21, P1029, DOI 10.1007/s10532-010-9363-y; Jerzak Leszek, 2001, P403; Lee WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103959; Lee WY, 2013, J FIELD ORNITHOL, V84, P304, DOI 10.1111/jofo.12031; LEVISON ME, 1987, J INFECT DIS, V155, P841, DOI 10.1093/infdis/155.5.841; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.2307/3868314; MACKENZIE DW, 1971, APPL MICROBIOL, V22, P678, DOI 10.1128/AEM.22.4.678-682.1971; Madigan M.T., 2005, BROCK BIOL MICROORGA, V11; Maheux AF, 2009, WATER RES, V43, P3019, DOI 10.1016/j.watres.2009.04.017; Marti E, 2013, APPL ENVIRON MICROB, V79, P1743, DOI 10.1128/AEM.03409-12; Narushin VG, 1997, J AGR ENG RES, V68, P201, DOI 10.1006/jaer.1997.0188; Norsk E., 2006, RINGMERKINGSATLAS, V2; Oh JY, 2012, POULTRY SCI, V91, P370, DOI 10.3382/ps.2011-01807; Paradis S, 2005, INT J SYST EVOL MICR, V55, P2013, DOI 10.1099/ijs.0.63539-0; Peralta-Sanchez JM, 2010, FUNCT ECOL, V24, P426, DOI 10.1111/j.1365-2435.2009.01669.x; PINOWSKI J, 1994, J BIOSCIENCES, V19, P441, DOI 10.1007/BF02703180; Porob S, 2013, TURK J BIOL, V37, P212, DOI 10.3906/biy-1206-40; Reese AT, 2016, ISME J, V10, P751, DOI 10.1038/ismej.2015.152; Ruiz-De-Castaneda R, 2011, BEHAV PROCESS, V88, P142, DOI 10.1016/j.beproc.2011.08.012; SALTER KC, 1993, COMMUN STAT SIMULAT, V22, P137, DOI 10.1080/03610919308813085; Schuppler M, 2004, INFECT IMMUN, V72, P1983, DOI 10.1128/IAI.72.4.1983-1990.2004; Shawkey MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004522; Shen HH, 2010, LANGMUIR, V26, P7334, DOI 10.1021/la904212x; Soler JJ, 2011, BIOL J LINN SOC, V103, P836, DOI 10.1111/j.1095-8312.2011.01672.x; Soler Juan Jose, 2010, Open Ornithology Journal, V3, P93, DOI 10.2174/1874453201003010093; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Sun H, 2013, POULTRY SCI, V92, P392, DOI 10.3382/ps.2012-02533; van Dijl JM, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-3; Vaugoyeau M, 2016, ECOL EVOL, V6, P5907, DOI 10.1002/ece3.2335; Wang J, 2012, FOOD SCI BIOTECHNOL, V21, P859, DOI 10.1007/s10068-012-0111-4; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Wobbrock JO, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P143, DOI 10.1145/1978942.1978963; Xu HJ, 2014, FEMS MICROBIOL ECOL, V87, P182, DOI 10.1111/1574-6941.12215; Yan B, 2016, SCI REP-UK, V6, DOI 10.1038/srep38811; Zal B., 2014, Journal of Veterinary Science and Technology, V5, P170; Zhao C, 2016, J APPL MICROBIOL, V121, P254, DOI 10.1111/jam.13138	84	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185411	10.1371/journal.pone.0185411	http://dx.doi.org/10.1371/journal.pone.0185411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953940	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300063
J	Tjernberg, I; Hamsten, C; Apostolovic, D; van Hage, M				Tjernberg, Ivar; Hamsten, Carl; Apostolovic, Danijela; van Hage, Marianne			IgE reactivity to alpha-Gal in relation to Lyme borreliosis	PLOS ONE			English	Article							RED MEAT ALLERGY; TICK BITES; GALACTOSE-ALPHA-1,3-GALACTOSE; SWEDEN; ASSOCIATION; IDENTIFICATION; SENSITIZATION; ANTIBODIES; DIAGNOSIS; EUROPE	Background An association between tick bites, the development of immunoglobulin E (IgE) antibodies to galactose-alpha-1, 3-galactose (alpha-Gal) and red meat allergy has recently been reported. Here we wanted to elucidate the relation between tick exposure, IgE antibodies to alpha-Gal and Lyme borreliosis (LB). Methods In the highly LB endemic area of Kalmar County, Sweden, serum samples and health inquiries from 518 blood donors were included. All sera were investigated for multiple IgG antiBorrelia antibodies using a multiplex assay (recomBead, Mikrogen). In addition, three serially collected sera over a six month period from 148 patients with clinically defined erythema migrans (EM) were included. IgE antibodies against alpha-Gal were determined using ImmunoCAP (Thermo Fisher Scientific). Results In blood donors reporting previous LB (n = 124) IgE to alpha-Gal was found in 16%, while in donors denying previous LB but with multiple anti-Borrelia antibodies (n = 94; interpreted as asymptomatic LB) 10% were IgE alpha-Gal-positive. Finally, in donors without Borrelia antibodies denying previous LB (n = 300) 14% showed IgE to alpha-Gal. No significant difference in proportions among the groups were found. In EM patients, IgE to alpha-Gal was found in 32/148 (22%) at diagnosis, 31/148 (21%) after two-three months and 23/148 (16%) after six months. A significant reduction of proportion and level of IgE to alpha-Gal was found between the second and third sample (p< 0.01). A positive IgE anti alpha-Gal was more common among men compared with women both in blood donors and in EM patients (p <= 0.01). Conclusions IgE to alpha-Gal reactivity was common in a tick endemic area but showed no significant relation to previous LB. IgE anti-alpha-Gal reactivity in EM patients peaked within three months of diagnosis of EM, after which it waned indicating that recent tick exposure is of importance in alpha-Gal sensitization. Furthermore, IgE anti alpha-Gal was more common in men compared with women.	[Tjernberg, Ivar] Kalmar Cty Hosp, Dept Clin Chem & Transfus Med, Kalmar, Sweden; [Tjernberg, Ivar] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Hamsten, Carl; Apostolovic, Danijela; van Hage, Marianne] Karolinska Inst, Dept Med Solna, Immunol & Allergy Unit, Stockholm, Sweden; [Hamsten, Carl; Apostolovic, Danijela; van Hage, Marianne] Univ Hosp, Stockholm, Sweden	Linkoping University; Karolinska Institutet	Tjernberg, I (corresponding author), Kalmar Cty Hosp, Dept Clin Chem & Transfus Med, Kalmar, Sweden.; Tjernberg, I (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	ivar.tjernberg@ltkalmar.se	Apostolovic, Danijela/J-6089-2019; van Hage, Marianne/A-9678-2017; Apostolovic, Danijela/Q-9067-2016	Apostolovic, Danijela/0000-0001-8388-6916; van Hage, Marianne/0000-0003-3091-1596; Apostolovic, Danijela/0000-0001-8388-6916; Tjernberg, Ivar/0000-0001-8657-2496	Thermo Fisher Scientific, Uppsala, Sweden; Swedish Asthma and Allergy Foundation; Stockholm County Council (ALF Medicin); Swedish Research Council; Swedish Heart-Lung Foundation; Swedish Cancer and Allergy Foundation; King Gustaf V 80th Birthday Foundation; Hesselman Foundation; Konsul Th C Bergh Foundation; Magnus Bergvall Foundation; Medical Research Council in the South-east of Sweden	Thermo Fisher Scientific, Uppsala, Sweden; Swedish Asthma and Allergy Foundation; Stockholm County Council (ALF Medicin); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Cancer and Allergy Foundation; King Gustaf V 80th Birthday Foundation; Hesselman Foundation; Konsul Th C Bergh Foundation; Magnus Bergvall Foundation; Medical Research Council in the South-east of Sweden	This work was supported by Thermo Fisher Scientific, Uppsala, Sweden, and by research grants from the Swedish Asthma and Allergy Foundation, Stockholm County Council (ALF Medicin), Swedish Research Council, the Swedish Heart-Lung Foundation, the Swedish Cancer and Allergy Foundation, the King Gustaf V 80th Birthday Foundation, the Hesselman Foundation, The Konsul Th C Bergh Foundation, the Magnus Bergvall Foundation and the Medical Research Council in the South-east of Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo RN, 2016, INT J PARASITOL, V46, P213, DOI 10.1016/j.ijpara.2015.12.005; Armitage P., 2002, STAT METHODS MED RES; BERGLUND J, 1995, NEW ENGL J MED, V333, P1319, DOI 10.1056/NEJM199511163332004; Chinuki Y, 2016, ALLERGY, V71, P421, DOI 10.1111/all.12804; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Commins SP, 2011, J ALLERGY CLIN IMMUN, V127, P1286, DOI 10.1016/j.jaci.2011.02.019; Commins SP, 2009, J ALLERGY CLIN IMMUN, V123, P426, DOI 10.1016/j.jaci.2008.10.052; Fischer J, 2017, ALLERGY; Geblod. nu, 2017, FACTS BLOOD BLOOD GR; Gonzalez-Quintela A, 2014, CLIN EXP ALLERGY, V44, P1061, DOI 10.1111/cea.12326; Hamsten C, 2013, ALLERGY, V68, P549, DOI 10.1111/all.12128; Hamsten C, 2013, J ALLERGY CLIN IMMUN, V132, P1431, DOI 10.1016/j.jaci.2013.07.050; Johansson M, 2017, APMIS; Kilpatrick AM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0117; Morisset M, 2012, ALLERGY, V67, P609, DOI 10.1111/j.1398-9995.2012.02799.x; Mullins RJ, 2012, J ALLERGY CLIN IMMUN, V129, P1334, DOI 10.1016/j.jaci.2012.02.038; Piesman J, 2004, PARASITOLOGY, V129, pS191, DOI 10.1017/S0031182003004694; Rispens T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055566; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P69, DOI 10.1111/j.1469-0691.2010.03175.x; Strle Franc, 2009, V37, P51, DOI 10.1159/000213070; Tjernberg I, 2007, EUR J CLIN MICROBIOL, V26, P37, DOI 10.1007/s10096-006-0239-3; Tjernberg I, 2009, INT J MED MICROBIOL, V299, P439, DOI 10.1016/j.ijmm.2008.10.006; Van Nunen SA, 2009, MED J AUSTRALIA, V190, P510, DOI 10.5694/j.1326-5377.2009.tb02533.x; Wilhelmsson P, 2016, TICKS TICK-BORNE DIS, V7, P71, DOI 10.1016/j.ttbdis.2015.08.009; Wilhelmsson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081433	25	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185723	10.1371/journal.pone.0185723	http://dx.doi.org/10.1371/journal.pone.0185723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953957	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300080
J	Mukherjee, N; McBurney-Lin, S; Kuo, A; Bedlack, R; Tseng, H				Mukherjee, Nisha; McBurney-Lin, Shan; Kuo, Anthony; Bedlack, Richard; Tseng, Henry			Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic disease	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; OPEN-ANGLE GLAUCOMA; LENGTH POLYGLUTAMINE EXPANSIONS; FIBER LAYER THICKNESS; MULTIPLE-SCLEROSIS; OPTINEURIN; ALS; ASSOCIATION; INVOLVEMENT; MUTATIONS	Importance Amyotrophic lateral sclerosis (ALS) is a fatal, rapidly progressive neurodegenerative disease that primarily affects motor neurons. Recently, three causative genes have been implicated in both ALS and glaucoma. However, it is still uncertain whether patients with ALS have neurodegeneration in their retinas. If so, retinal thickness measurements might be a useful biomarker for ALS progression. Previous work in this area has been inconclusive, as it has not taken into account the effect of ophthalmic diseases on retinal thinning. Objective To determine whether there are differences in retinal neurons in ALS patients utilizing spectral-domain optical coherence tomography (SD-OCT). We tested the hypothesis that ALS patients exhibit retinal neurodegeneration that is not associated with ophthalmic diseases. Design, settings and participants Observational, comparative, cross-sectional study performed on patients recruited from the Duke University Medical Center ALS clinic. Patients underwent a comprehensive ophthalmologic examination to rule out ocular pathology. 21 patients met inclusion criteria. Two eyes with ocular pathology were excluded, leading to a total of 40 eyes of 21 patients included in the study. Retinal neurodegeneration was assessed by retinal nerve fiber layer (RNFL) thickness measurement using SD-OCT (Spectralis; Heidelberg Engineering). Main outcomes and measures ALS disease severity, determined through the ALS Functional Rating Scale (ALSFRS-R); mean and six sector RNFL thickness values compared to age-adjusted values in the normative database provided by Heidelberg Engineering; RNFL thickness correlation with ALSFRS-R, ALSFRS-R progression rate, forced vital capacity (FVC), and visual acuity. Results ALSFRS-R mean score was 30+/-10. Mean RNFL thickness in ALS patients was 88.95 +/10.8 microns, significantly thinner than values in the normative database (95.81 +/-0.8). These RNFL thickness values did not demonstrate correlation to ALSFRS-R score, ALSFRS-R progression rate, FVC, intraocular pressure, or visual acuity. Conclusions Using SD-OCT, our study shows that ALS patients without ocular pathology exhibit thinned retinal layers. Future studies are warranted to clarify the clinical relationship between retinal thinning and motor neuron loss in ALS.	[Mukherjee, Nisha; Kuo, Anthony; Tseng, Henry] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [McBurney-Lin, Shan] Duke Univ, Sch Med, Durham, NC USA; [Bedlack, Richard] Duke Univ, Med Ctr, Duke ALS Clin, Durham, NC USA	Duke University; Duke University; Duke University	Tseng, H (corresponding author), Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA.	Henry.Tseng@duke.edu		Bedlack, Richard/0000-0003-4666-7495; McBurney-Lin, Shan/0000-0001-9829-5748	Research to Prevent Blindness; Butler Pioneer Award	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Butler Pioneer Award	This work was supported by Research to Prevent Blindness (NM, HT) and Butler Pioneer Award (NM, HT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034891; Bailey JNC, 2016, NAT GENET, V48, P189, DOI 10.1038/ng.3482; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Connolly S, 2015, LANCET NEUROL, V14, P435, DOI 10.1016/S1474-4422(14)70221-2; Cordeiro MF, 2017, BRAIN, V140, P1757, DOI 10.1093/brain/awx088; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Fisher JB, 2006, OPHTHALMOLOGY, V113, P324, DOI 10.1016/j.ophtha.2005.10.040; Galetta KM, 2011, NEUROTHERAPEUTICS, V8, P117, DOI 10.1007/s13311-010-0005-1; Garcia-Martin E, 2012, OPHTHALMOLOGY, V119, P2161, DOI 10.1016/j.ophtha.2012.05.003; Hubers A, 2016, J NEURAL TRANSM, V123, P281, DOI 10.1007/s00702-015-1483-4; Jung W, 2011, IEEE T BIO-MED ENG, V58, P741, DOI 10.1109/TBME.2010.2096816; Kawase K, 2012, EXP EYE RES, V96, P178, DOI 10.1016/j.exer.2011.12.021; Kesler A, 2011, CLIN NEUROL NEUROSUR, V113, P523, DOI 10.1016/j.clineuro.2011.02.014; Kiernan DF, 2010, RETIN PHYS; Lee T, 2011, HUM MOL GENET, V20, P1697, DOI 10.1093/hmg/ddr045; Lu CD, 2014, BIOMED OPT EXPRESS, V5, P293, DOI 10.1364/BOE.5.000293; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Minegishi Y, 2013, HUM MOL GENET, V22, P3559, DOI 10.1093/hmg/ddt210; Murthy RK, 2015, EUR J OPHTHALMOL, V25, P546, DOI 10.5301/ejo.5000582; Oberwahrenbrock T, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/530305; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Ratchford JN, 2009, NEUROLOGY, V73, P302, DOI 10.1212/WNL.0b013e3181af78b8; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Ringelstein M, 2014, ANN CLIN TRANSL NEUR, V1, P290, DOI 10.1002/acn3.46; Roth NM, 2013, EUR J NEUROL, V20, P1170, DOI 10.1111/ene.12146; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Sayegh SI, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.4.3; Siger M, 2008, J NEUROL, V255, P1555, DOI 10.1007/s00415-008-0985-5; Simonett JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29187; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Tong AY, 2014, OPHTHALMOLOGY, V121, P1818, DOI 10.1016/j.ophtha.2014.03.020; Turner MR, 2015, J NEUROL NEUROSUR PS, V86, P667, DOI 10.1136/jnnp-2014-308946	33	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							0185242	10.1371/journal.pone.0185242	http://dx.doi.org/10.1371/journal.pone.0185242			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945811	Green Published, gold, Green Submitted			2022-12-27	WOS:000411645100035
J	Yun, SD; Shah, NJ				Yun, Seong Dae; Shah, N. Jon			Whole-brain high in-plane resolution fMRI using accelerated EPIK for enhanced characterisation of functional areas at 3T	PLOS ONE			English	Article							ECHO; SENSITIVITY; KEYHOLE; TESLA	The relatively high imaging speed of EPI has led to its widespread use in dynamic MRI studies such as functional MRI. An approach to improve the performance of EPI, EPI with Keyhole (EPIK), has been previously presented and its use in fMRI was verified at 1.5T as well as 3T. The method has been proven to achieve a higher temporal resolution and smaller image distortions when compared to single-shot EPI. Furthermore, the performance of EPIK in the detection of functional signals was shown to be comparable to that of EPI. For these reasons, we were motivated to employ EPIK here for high-resolution imaging. The method was optimised to offer the highest possible in-plane resolution and slice coverage under the given imaging constraints: fixed TR/TE, FOV and acceleration factors for parallel imaging and partial Fourier techniques. The performance of EPIK was evaluated in direct comparison to the optimised protocol obtained from EPI. The two imaging methods were applied to visual fMRI experiments involving sixteen subjects. The results showed that enhanced spatial resolution with a whole-brain coverage was achieved by EPIK (1.00 mm x 1.00 mm; 32 slices) when compared to EPI (1.25 mm x 1.25 mm; 28 slices). As a consequence, enhanced characterisation of functional areas has been demonstrated in EPIK particularly for relatively small brain regions such as the lateral geniculate nucleus (LGN) and superior colliculus (SC); overall, a significantly increased t-value and activation area were observed from EPIK data. Lastly, the use of EPIK for fMRI was validated with the simulation of different types of data reconstruction methods.	[Yun, Seong Dae; Shah, N. Jon] Forschungszentrum Julich, Inst Neurosci & Med, Med Imaging Phys INM 4, Julich, Germany; [Shah, N. Jon] Rhein Westfal TH Aachen, JARA, Fac Med, Dept Neurol, Aachen, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University	Shah, NJ (corresponding author), Forschungszentrum Julich, Inst Neurosci & Med, Med Imaging Phys INM 4, Julich, Germany.; Shah, NJ (corresponding author), Rhein Westfal TH Aachen, JARA, Fac Med, Dept Neurol, Aachen, Germany.	n.j.shah@fz-juelich.de	Shah, N. Jon/H-5849-2013	Shah, N. Jon/0000-0002-8151-6169; Yun, Seong Dae/0000-0001-7398-1899	Institute of Neuroscience and Medicine; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association [HA-314]	Institute of Neuroscience and Medicine; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association	For this work, Seong Dae Yun was funded fully by the internal organization (Institute of Neuroscience and Medicine). N. Jon Shah was funded in part internally and also in part externally by the Helmholtz Alliance ICEMED (HA-314) - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association (website: http://icemed.helmholtz.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Except the funding sources declared above, there was no additional external funding received for this study.; For this work, Seong Dae Yun was funded fully by the internal organization. N. Jon Shah was funded in part internally and also in part externally by the Helmholtz Alliance ICEMED (HA -314) - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association (website: http://icemed.helmholtz.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Except the funding sources declared above, there was no additional external funding received for this study. We would like to thank Tracy Warbrick and Claire Ryalls for proofreading the manuscript.	Budde J, 2014, MAGN RESON MED, V71, P209, DOI 10.1002/mrm.24656; De Martino F, 2011, NEUROIMAGE, V57, P1031, DOI 10.1016/j.neuroimage.2011.05.008; Du YPP, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/973972; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; FEINBERG DA, 1994, MAGNET RESON MED, V32, P535, DOI 10.1002/mrm.1910320418; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; HAACKE EM, 1991, J MAGN RESON, V92, P126, DOI 10.1016/0022-2364(91)90253-P; Heidemann RM, 2012, MAGN RESON MED, V68, P1506, DOI 10.1002/mrm.24156; Hennel F, 1997, CONCEPT MAGNETIC RES, V9, P43, DOI 10.1002/(SICI)1099-0534(1997)9:1<43::AID-CMR4>3.0.CO;2-N; Kraemer M, 2014, Z MED PHYS, V24, P164, DOI 10.1016/j.zemedi.2013.12.003; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Lutti A, 2013, MAGN RESON MED, V69, P1657, DOI 10.1002/mrm.24398; MCGIBNEY G, 1993, MAGNET RESON MED, V30, P51, DOI 10.1002/mrm.1910300109; Mintzopoulos D, 2009, OPEN MAGNETIC RESONA, V2, P57; Moeller S, 2006, J MAGN RESON IMAGING, V13, P313; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; RIEDERER SJ, 1988, MAGNET RESON MED, V8, P1, DOI 10.1002/mrm.1910080102; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Shah NJ., 2004, Imaging Process in the Spatial Frequency Space and Useful for Examining the Properties of Object. August, Patent No. [6781372, US6781372B2]; SHAH NJ, 2003, Patent No. 1996245; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Stocker T, 2005, HUM BRAIN MAPP, V25, P237, DOI 10.1002/hbm.20096; Todd N, 2016, NEUROIMAGE, V124, P32, DOI 10.1016/j.neuroimage.2015.08.056; VANVAALS JJ, 1993, JMRI-J MAGN RESON IM, V3, P671, DOI 10.1002/jmri.1880030419; Yacoub E, 2001, MAGN RESON MED, V45, P588, DOI 10.1002/mrm.1080; Yun S, 2014, P 22 INT SOC MAGN RE; Yun SD, 2013, NEUROIMAGE, V73, P135, DOI 10.1016/j.neuroimage.2013.01.070; Zaitsev M, 2005, PHYS MED BIOL, V50, P4491, DOI 10.1088/0031-9155/50/19/005; Zaitsev M, 2001, MAGN RESON MED, V45, P109, DOI 10.1002/1522-2594(200101)45:1<109::AID-MRM1015>3.0.CO;2-X	32	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0184759	10.1371/journal.pone.0184759	http://dx.doi.org/10.1371/journal.pone.0184759			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945780	Green Published, gold			2022-12-27	WOS:000411645100009
J	Li, HL; Crabbe, MJC; Xu, FL; Wang, WL; Ma, LH; Niu, RL; Gao, X; Li, XX; Zhang, P; Ma, X; Chen, HK				Li, Hailiang; Crabbe, M. James C.; Xu, Fuli; Wang, Weiling; Ma, Lihui; Niu, Ruilong; Gao, Xing; Li, Xingxing; Zhang, Pei; Ma, Xin; Chen, Haikui			Seasonal variations in carbon, nitrogen and phosphorus concentrations and C: N: P stoichiometry in different organs of a Larix principis- rupprechtii Mayr. plantation in the Qinling Mountains, China	PLOS ONE			English	Article							CO2 ENRICHMENT FACE; LEAF NITROGEN; NUTRIENT CONCENTRATION; DRY-MATTER; GROWTH; PLANTS; TERRESTRIAL; RESORPTION; TRAITS; RATIOS	Understanding how concentrations of elements and their stoichiometry change with plant growth and age is critical for predicting plant community responses to environmental change. We used long-term field experiments to explore how the leaf, stem and root carbon (C), nitrogen (N) and phosphorous (P) concentrations and their stoichiometry changed with growth and stand age in a L. principis-rupprechtii Mayr. plantation from 2012-2015 in the Qinling Mountains, China. Our results showed that the C, N and P concentrations and stoichiometric ratios in different tissues of larch stands were affected by stand age, organ type and sampling month and displayed multiple correlations with increased stand age in different growing seasons. Generally, leaf C and N concentrations were greatest in the fast-growing season, but leaf P concentrations were greatest in the early growing season. However, no clear seasonal tendencies in the stem and root C, N and P concentrations were observed with growth. In contrast to N and P, few differences were found in organ-specific C concentrations. Leaf N: P was greatest in the fast-growing season, while C: N and C: P were greatest in the late-growing season. No clear variations were observed in stem and root C: N, C: P and N: P throughout the entire growing season, but leaf N: P was less than 14, suggesting that the growth of larch stands was limited by N in our study region. Compared to global plant element concentrations and stoichiometry, the leaves of larch stands had higher C, P, C: N and C: P but lower N and N: P, and the roots had greater P and C: N but lower N, C: P and N: P. Our study provides baseline information for describing the changes in nutritional elements with plant growth, which will facilitates plantation forest management and restoration, and makes a valuable contribution to the global data pool on leaf nutrition and stoichiometry.	[Li, Hailiang; Xu, Fuli; Ma, Xin] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China; [Crabbe, M. James C.] Univ Oxford, Wolfson Coll, Oxford, England; [Wang, Weiling; Niu, Ruilong; Gao, Xing; Li, Xingxing; Zhang, Pei] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Ma, Lihui] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [Chen, Haikui] Beifang Univ Nationalities, Coll Biol Sci & Engn, Ningxia, Peoples R China; [Crabbe, M. James C.] Univ Bedfordshire, Inst Biomed & Environm Sci & Technol, Luton, Beds, England; [Xu, Fuli; Ma, Lihui] Chinese Acad Sci, Minist Water Resources, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; University of Oxford; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; North Minzu University; University of Bedfordshire; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources	Xu, FL (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China.; Xu, FL (corresponding author), Chinese Acad Sci, Minist Water Resources, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China.	xfl@nwsuaf.edu.cn			National Program on Key Basic Research Project of China (973 Program) [2012CB416902]	National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Program on Key Basic Research Project of China (973 Program) (No. 2012CB416902).	Abbas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058179; Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Agren GI, 2004, ECOL LETT, V7, P185, DOI 10.1111/j.1461-0248.2004.00567.x; Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Agren GI, 2012, NEW PHYTOL, V194, P953, DOI 10.1111/j.1469-8137.2012.04116.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bremmer J, 1982, AGRONOMY, P295; Dordas C, 2009, EUR J AGRON, V30, P129, DOI 10.1016/j.eja.2008.09.001; Du YX, 2011, ENVIRON EARTH SCI, V64, P299, DOI 10.1007/s12665-010-0847-1; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser Jim, 2002, Ecological Society of America Annual Meeting Abstracts, V87, P18; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Franklin O, 2002, FUNCT ECOL, V16, P727, DOI 10.1046/j.1365-2435.2002.00674.x; Gifford RM, 2000, PLANT SOIL, V224, P1, DOI 10.1023/A:1004790612630; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; He JS, 2008, OECOLOGIA, V155, P301, DOI 10.1007/s00442-007-0912-y; Hooker TD, 2003, ECOL APPL, V13, P299, DOI 10.1890/1051-0761(2003)013[0299:FECANA]2.0.CO;2; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Kim HY, 2011, PLANT SOIL, V342, P59, DOI 10.1007/s11104-010-0665-y; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Lannes LS, 2012, NEW PHYTOL, V196, P816, DOI 10.1111/j.1469-8137.2012.04363.x; Lei R.D., 1996, J NW FORESTRY COLL, V11, P43; Lelu-Walter MA, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008079; Li Yu-lin, 2010, Huanjing Kexue, V31, P1716; Liu Y, 2009, BOREAS, V38, P285, DOI 10.1111/j.1502-3885.2008.00065.x; Mahajan G, 2012, FIELD CROP RES, V134, P59, DOI 10.1016/j.fcr.2012.04.011; Markovic J., 2009, Biotechnology in Animal Husbandry, V25, P1225; Matzek V, 2009, ECOL LETT, V12, P765, DOI 10.1111/j.1461-0248.2009.01310.x; Niklas KJ, 2005, AM J BOT, V92, P1256, DOI 10.3732/ajb.92.8.1256; Ning P, 2013, FIELD CROP RES, V144, P19, DOI 10.1016/j.fcr.2013.01.020; Orgeas J, 2003, PLANT ECOL, V164, P201, DOI 10.1023/A:1021278421821; Pretzsch H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5967; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Sardans J, 2011, FOREST ECOL MANAG, V262, P2024, DOI 10.1016/j.foreco.2011.08.019; Sardans J, 2012, PLANT PHYSIOL, V160, P1741, DOI 10.1104/pp.112.208785; Schindler DW, 2003, NATURE, V423, P225, DOI 10.1038/423225b; [Tian Xingjun 田兴军], 2002, [植物生态学报, Acta Phytoecologica Sinica], V26, P257; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; Vrede T, 2004, ECOLOGY, V85, P1217, DOI 10.1890/02-0249; Wang Dong-zhi, 2015, Yingyong Shengtai Xuebao, V26, P3413; Wang LZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118553; Wang ZN, 2014, PLANT SOIL, V383, P301, DOI 10.1007/s11104-014-2166-x; Wright IJ, 2003, FUNCT ECOL, V17, P10, DOI 10.1046/j.1365-2435.2003.00694.x; Yang HM, 2011, BIOL FERT SOILS, V47, P377, DOI 10.1007/s00374-011-0543-7; Yang LX, 2007, FIELD CROP RES, V102, P141, DOI 10.1016/j.fcr.2007.03.004; Yang LX, 2007, FIELD CROP RES, V100, P189, DOI 10.1016/j.fcr.2006.07.003; Yang Y, 2011, GLOBAL ECOL BIOGEOGR, V20, P354, DOI 10.1111/j.1466-8238.2010.00602.x; Ye YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101776; YEOMANS JC, 1988, COMMUN SOIL SCI PLAN, V19, P1467, DOI 10.1080/00103628809368027; Yu Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032162, 10.1371/journal.pone.0050902]; Zhang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060360; Zhang LX, 2004, ACTA BOT SIN, V46, P259; Zheng SX, 2007, TREES-STRUCT FUNCT, V21, P357, DOI 10.1007/s00468-007-0129-z; Zhou Peng, 2010, Chinese Journal of Plant Ecology, V34, P7, DOI 10.3773/j.issn.1005-264x.2010.01.003; Ziadi N, 2007, AGRON J, V99, P833, DOI 10.2134/agronj2006.0199	60	20	25	12	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							0185163	10.1371/journal.pone.0185163	http://dx.doi.org/10.1371/journal.pone.0185163			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938020	Green Published, gold, Green Submitted			2022-12-27	WOS:000411524700020
J	Wang, JM; Ma, HY; Krishnamoorthy, RR; Yorio, T; He, SQ				Wang, Junming; Ma, Hai-Ying; Krishnamoorthy, Raghu R.; Yorio, Thomas; He, Shaoqing			A feed-forward regulation of endothelin receptors by c-Jun in human non-pigmented ciliary epithelial cells and retinal ganglion cells	PLOS ONE			English	Article							BINDING-PROTEIN-BETA; VASCULAR SMOOTH-MUSCLE; NF-KAPPA-B; TRANSCRIPTION FACTOR; SIGNALING PATHWAYS; AQUEOUS-HUMOR; COLLAGEN EXPRESSION; GENE-EXPRESSION; UP-REGULATION; ETB-RECEPTOR	c-Jun, c-Jun N-terminal kinase(JNK) and endothelin B (ETB) receptor have been shown to contribute to the pathogenesis of glaucoma. Previously, we reported that an increase of cJun and CCAAT/enhancer binding protein beta (C/EBP beta) immunohistostaining is associated with upregulation of the ETB receptor within the ganglion cell layer of rats with elevated intraocular pressure (IOP). In addition, both transcription factors regulate the expression of the ETB receptor in human non-pigmented ciliary epithelial cells (HNPE). The current study addressed the mechanisms by which ET-1 produced upregulation of ET receptors in primary rat retinal ganglion cells (RGCs) and HNPE cells. Treatment of ET-1 and ET-3 increased the immunocytochemical staining of c-Jun and C/EBP beta in primary rat RGCs and co-localization of both transcription factors was observed. A marked increase in DNA binding activity of AP-1 and C/EBP beta as well as elevated protein levels of c-Jun and c-Jun-N-terminal kinase (JNK) were detected following ET-1 treatment in HNPE cells. Overexpression of ETA or ETB receptor promoted the upregulation of c-Jun and also elevated its promoter activity. In addition, upregulation of C/EBP beta augmented DNA binding and mRNA expression of c-Jun, and furthermore, the interaction of c-Jun and C/EBP beta was confirmed using coimmunoprecipitation. Apoptosis of HNPE cells was identified following ET-1 treatment, and overexpression of the ETA or ETB receptor produced enhanced apoptosis. ET-1 mediated upregulation of c-Jun and C/EBP beta and their interaction may represent a novel mechanism contributing to the regulation of endothelin receptor expression. Reciprocally, c-Jun was also found to regulate the ET receptors and C/EBP beta appeared to play a regulatory role in promoting expression of c-Jun. Taken together, the data suggests that ET-1 triggers the upregulation of c-Jun through both ETA and ETB receptors, and conversely c-Jun also upregulates endothelin receptor expression, thereby generating a positive feed-forward loop of endothelin receptor activation and expression. This feed-forward regulation may contribute to RGC death and astrocyte proliferation following ET-1 treatment.	[Wang, Junming] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Ophthalmol, Wuhan, Hubei, Peoples R China; [Ma, Hai-Ying; Krishnamoorthy, Raghu R.; Yorio, Thomas; He, Shaoqing] Univ North Texas, Hlth Sci Ctr Ft Worth, North Texas Eye Res Inst, Ft Worth, TX 76107 USA	Huazhong University of Science & Technology; University of North Texas System; University of North Texas Denton	Yorio, T; He, SQ (corresponding author), Univ North Texas, Hlth Sci Ctr Ft Worth, North Texas Eye Res Inst, Ft Worth, TX 76107 USA.	Thomas.Yorio@unthsc.edu; Shaoqing.He@unthsc.edu	Wang, Junming/AAD-9636-2019		NIH [R01 EY019952-01, NIH/R01-EY019952-01]; Natural Science Foundation of China [81470632]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the NIH grant R01 EY019952-01 to RRK (http://grantome.com/grant/NIH/R01-EY019952-01) and the Natural Science Foundation of China to JW (No 81470632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2004, INVEST OPHTH VIS SCI, V45, P1247, DOI 10.1167/iovs.03-1123; Bagnato Anna, 2004, Cancer Treat Res, V119, P293; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Bein K, 2011, AM J RESP CELL MOL, V45, P436, DOI 10.1165/rcmb.2010-0260OC; Byun JY, 2006, MOL VIS, V12, P949; Cattaruzza M, 2001, J BIOL CHEM, V276, P36999, DOI 10.1074/jbc.M105158200; Chen SL, 2003, AM J PHYSIOL-CELL PH, V284, pC263, DOI 10.1152/ajpcell.00192.2002; Chintalgattu V, 2004, J PHARMACOL EXP THER, V311, P691, DOI 10.1124/jpet.104.070151; Cho YH, 2003, MOL PHARMACOL, V63, P512, DOI 10.1124/mol.63.3.512; Christian M, 2002, J BIOL CHEM, V277, P20825, DOI 10.1074/jbc.M201018200; Coss D, 2004, J BIOL CHEM, V279, P152, DOI 10.1074/jbc.M304697200; Dey S, 2012, J BIOL CHEM, V287, P21936, DOI 10.1074/jbc.M112.351783; Dogra C, 2008, MOL CELL BIOCHEM, V312, P17, DOI 10.1007/s11010-008-9716-6; Drey LL, 2013, BIOTECHNIQUES, V55, P28, DOI 10.2144/000114056; Felx M, 2006, CLIN SCI, V110, P645, DOI 10.1042/CS20050286; Fernandes KA, 2012, NEUROBIOL DIS, V46, P393, DOI 10.1016/j.nbd.2012.02.003; Gonsalves C, 2010, J IMMUNOL, V185, P6253, DOI 10.4049/jimmunol.1000660; Goraca Anna, 2002, Endocr Regul, V36, P161; Grant K, 2003, BRIT J CANCER, V88, P163, DOI 10.1038/sj.bjc.6700750; Grondin B, 2007, MOL CELL BIOL, V27, P2919, DOI 10.1128/MCB.00936-06; He S, 2007, INVEST OPHTH VIS SCI, V48, P3737, DOI 10.1167/iovs.06-1138; He SQ, 2007, EXP BIOL MED, V232, P370; He SQ, 2015, INVEST OPHTH VIS SCI, V56, P6144, DOI 10.1167/iovs.15-16569; He SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079183; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Howell GR, 2014, NEUROBIOL DIS, V71, P44, DOI 10.1016/j.nbd.2014.07.016; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; HSU W, 1994, MOL CELL BIOL, V14, P268, DOI 10.1128/MCB.14.1.268; Hua H, 2001, DIABETES, V50, P2376, DOI 10.2337/diabetes.50.10.2376; HUANG SM, 1993, AM HEART J, V125, P589, DOI 10.1016/0002-8703(93)90208-Q; Iwai-Kanai E, 2004, MOL CELL BIOCHEM, V259, P163, DOI 10.1023/B:MCBI.0000021368.80389.b9; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Kallberg ME, 2002, J GLAUCOMA, V11, P105; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851; Krishnamoorthy RR, 2008, CAN J PHYSIOL PHARM, V86, P380, DOI 10.1139/Y08-040; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Levkovitch-Verbin H, 2005, EXP EYE RES, V80, P663, DOI 10.1016/j.exer.2004.11.016; Liu SL, 2003, J BIOL CHEM, V278, P49929, DOI 10.1074/jbc.M306930200; MARTINVASALLO P, 1989, J CELL PHYSIOL, V141, P243, DOI 10.1002/jcp.1041410203; McGrady NR, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0346-3; Mietus-Snyder M, 1998, ARTERIOSCL THROM VAS, V18, P1440, DOI 10.1161/01.ATV.18.9.1440; Minton AZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043199; Nambi P, 2001, Heart Fail Rev, V6, P335, DOI 10.1023/A:1011464510857; Narayan S, 2003, INVEST OPHTH VIS SCI, V44, P4885, DOI 10.1167/iovs.03-0387; Nelson J, 2003, NAT REV CANCER, V3, P110, DOI 10.1038/nrc990; Nerlov C, 2008, CURR OPIN CELL BIOL, V20, P180, DOI 10.1016/j.ceb.2008.02.002; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Noske W, 1997, GRAEF ARCH CLIN EXP, V235, P551, DOI 10.1007/BF00947082; Peters CM, 2003, EXP NEUROL, V180, P1, DOI 10.1016/S0014-4886(02)00023-7; Prasanna G, 2005, PHARMACOL RES, V51, P41, DOI 10.1016/j.phrs.2004.04.006; Prasanna G, 2003, MOL CELL BIOCHEM, V253, P71, DOI 10.1023/A:1026005418874; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Raivich G, 2006, PROG NEUROBIOL, V78, P347, DOI 10.1016/j.pneurobio.2006.03.006; Rauh A, 2008, BRIT J PHARMACOL, V154, P13, DOI 10.1038/bjp.2008.92; Rosendorff C, 1997, CARDIOVASC DRUG THER, V10, P795, DOI 10.1007/BF00053038; Rozenberg JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078179; Schinelli S, 2001, J NEUROSCI, V21, P8842, DOI 10.1523/JNEUROSCI.21-22-08842.2001; Schorlemmer A, 2008, TRENDS CARDIOVAS MED, V18, P233, DOI 10.1016/j.tcm.2008.11.005; Seufert J, 1998, J CLIN INVEST, V101, P2528, DOI 10.1172/JCI2401; Shichiri M, 1998, MOL ENDOCRINOL, V12, P172, DOI 10.1210/me.12.2.172; Singh S, 2009, J BIOL CHEM, V284, P10409, DOI 10.1074/jbc.M809572200; Sokolovsky M, 1995, CELL MOL NEUROBIOL, V15, P561, DOI 10.1007/BF02071317; Sugden Peter H., 2005, Current Vascular Pharmacology, V3, P343, DOI 10.2174/157016105774329390; Sugden PH, 2003, J MOL CELL CARDIOL, V35, P871, DOI 10.1016/S0022-2828(03)00153-6; Sun H, 2011, MOL VIS, V17, P864; Tezel G, 1997, J GLAUCOMA, V6, P83; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Urtatiz O, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00059; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Wagner AH, 2000, MOL PHARMACOL, V58, P1333, DOI 10.1124/mol.58.6.1333; Wang X, 2009, EXP EYE RES, V88, P378, DOI 10.1016/j.exer.2008.09.009; Wang YJ, 2010, HEPATOLOGY, V52, P2118, DOI 10.1002/hep.23929; Yen JH, 2011, J BIOL CHEM, V286, P38913, DOI 10.1074/jbc.M111.252932; YIN J, 1992, MOL BRAIN RES, V14, P213, DOI 10.1016/0169-328X(92)90176-C; Yorio T, 2002, J GLAUCOMA, V11, P259, DOI 10.1097/00061198-200206000-00016; Zhang XY, 2003, INVEST OPHTH VIS SCI, V44, P5301, DOI 10.1167/iovs.03-0463; Zhang XY, 2003, EXP EYE RES, V76, P261, DOI 10.1016/S0014-4835(02)00323-8	81	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185390	10.1371/journal.pone.0185390	http://dx.doi.org/10.1371/journal.pone.0185390			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938016	gold, Green Submitted, Green Published			2022-12-27	WOS:000411524700030
J	Nosaka, T; Naito, T; Hiramatsu, K; Ohtani, M; Nemoto, T; Marusawa, H; Mai, N; Hiraku, Y; Kawanishi, S; Yamashita, T; Kaneko, S; Nakamoto, Y				Nosaka, Takuto; Naito, Tatsushi; Hiramatsu, Katsushi; Ohtani, Masahiro; Nemoto, Tomoyuki; Marusawa, Hiroyuki; Mai, Ning; Hiraku, Yusuke; Kawanishi, Shosuke; Yamashita, Taro; Kaneko, Shuichi; Nakamoto, Yasunari			Gene expression profiling of hepatocarcinogenesis in a mouse model of chronic hepatitis B	PLOS ONE			English	Article							VIRUS TRANSGENIC MICE; INDUCED HEPATOCELLULAR-CARCINOMA; LIVER-CANCER; T-CELLS; GROWTH-FACTOR; THERAPY; PATHOGENESIS; PROGNOSIS; MECHANISMS; INJURY	Background Hepatocellular carcinoma (HCC) is a common complication of chronic viral hepatitis. In support of this notion, we have reported that hepatitis B surface antigen (HBsAg)-specific CD8 + T lymphocytes critically contribute to inducing chronic liver cell injury that exerts high carcinogenic potential in a hepatitis B virus (HBV) transgenic mouse model. The dynamics of the molecular signatures responsible for hepatocellular carcinogenesis are not fully understood. The current study was designed to determine the serial changes in gene expression profiles in a model of chronic immune-mediated hepatitis. Methods Three-month-old HBV transgenic mice were immunologically reconstituted with bone marrow cells and splenocytes from syngeneic nontransgenic donors. Liver tissues were obtained every three months until 18 months at which time all mice developed multiple liver tumors. Nitrative DNA lesions and hepatocyte turnover were assessed immunohistochemically. Gene expression profiles were generated by extracting total RNA from the tissues and analyzing by microarray. Results The nitrative DNA lesions and the regenerative proliferation of hepatocytes were increased during the progression of chronic liver disease. In a gene expression profile analysis of liver samples, the chemokine-and T cell receptor (TCR)-mediated pathways were enhanced during chronic hepatitis, and the EGF-and VEGF-mediated pathways were induced in HCC. Among these molecules, the protein levels of STAT3 were greatly enhanced in all hepatocyte nuclei and further elevated in the cytoplasm in HCC tissue samples at 18 months, and the levels of phosphorylated TP53 (p-p53-Ser 6 and -Ser 15) were increased in liver tissues. Conclusions HBV-specific immune responses caused unique molecular signatures in the liver tissues of chronic hepatitis and triggered subsequent carcinogenic gene expression profiles in a mouse model. The results suggest a plausible molecular basis responsible for HBV-induced immune pathogenesis of HCC.	[Nosaka, Takuto; Naito, Tatsushi; Hiramatsu, Katsushi; Ohtani, Masahiro; Nemoto, Tomoyuki; Nakamoto, Yasunari] Univ Fukui, Fac Med Sci, Dept Internal Med 2, Fukui, Japan; [Marusawa, Hiroyuki] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto, Japan; [Mai, Ning] Suzuka Univ Med Sci, Fac Nursing Sci, Suzuka, Mie, Japan; [Hiraku, Yusuke] Mie Univ, Grad Sch Med, Dept Environm & Mol Med, Tsu, Mie, Japan; [Kawanishi, Shosuke] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie, Japan; [Yamashita, Taro; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med Sci, Dept Gastroenterol, Kanazawa, Ishikawa, Japan	University of Fukui; Kyoto University; Mie University; Kanazawa University	Nakamoto, Y (corresponding author), Univ Fukui, Fac Med Sci, Dept Internal Med 2, Fukui, Japan.	nakamoto_med2@med.u-fukui.ac.jp	Nosaka, Takuto/ABB-5695-2021	Ma, Ning/0000-0001-7315-8835; Marusawa, Hiroyuki/0000-0002-4286-2712; Naito, Tatsushi/0000-0001-5472-8193	JSPS KAKENHI [JP 25293171]; Research Programs on the Innovative Development; Application of New Drugs for Hepatitis B [16fk0310509h0005, 17fk0310116h0001]; Chubu Regional Consortium for Advanced Medicine; C-CAM from Japan Agency for Medical Research and development [17lm0203005j0001]; AMED; Grants-in-Aid for Scientific Research [26253046] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Programs on the Innovative Development; Application of New Drugs for Hepatitis B; Chubu Regional Consortium for Advanced Medicine; C-CAM from Japan Agency for Medical Research and development; AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partially supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (B) (JP 25293171) and the Research Programs on the Innovative Development and the Application of New Drugs for Hepatitis B (16fk0310509h0005 and 17fk0310116h0001) and on the Chubu Regional Consortium for Advanced Medicine, C-CAM (17lm0203005j0001) from Japan Agency for Medical Research and development, AMED, to Yasunari Nakamoto. Authors have no commercial or other associations that might pose a conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO K, 1993, J EXP MED, V178, P1541, DOI 10.1084/jem.178.5.1541; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; CHISARI FV, 1986, J VIROL, V60, P880, DOI 10.1128/JVI.60.3.880-887.1986; DiBisceglie AM, 1997, HEPATOLOGY, V26, pS34, DOI 10.1002/hep.510260706; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Ferrari C, 2015, LIVER INT, V35, P121, DOI 10.1111/liv.12749; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Franco A, 1997, J IMMUNOL, V159, P2001; Giordano S, 2013, HEPATOLOGY, V57, P840, DOI 10.1002/hep.26095; Guidotti LG, 2015, CURR OPIN IMMUNOL, V36, P61, DOI 10.1016/j.coi.2015.06.016; Guidotti LG, 2015, CELL, V161, P486, DOI 10.1016/j.cell.2015.03.005; Halama N, 2016, CANCER CELL, V29, P587, DOI 10.1016/j.ccell.2016.03.005; Hiraku Y, 2007, CANC SCI, V98; Inoue K, 2012, CLIN CANCER RES, V18, P3924, DOI 10.1158/1078-0432.CCR-11-2041; Kang HJ, 2017, ONCOTARGET, V8, P27263, DOI 10.18632/oncotarget.15930; Levrero M, 2016, J HEPATOL, V64, pS84, DOI 10.1016/j.jhep.2016.02.021; Llovet JM, 2012, CLIN CANCER RES, V18, P2290, DOI 10.1158/1078-0432.CCR-11-2175; Loughery J, 2014, NUCLEIC ACIDS RES, V42, P7664, DOI 10.1093/nar/gku501; Ma N, 2006, NITRIC OXIDE-BIOL CH, V14, P137, DOI 10.1016/j.niox.2005.09.012; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; MORIYAMA T, 1990, SCIENCE, V248, P361, DOI 10.1126/science.1691527; Nakamoto Y, 1998, J EXP MED, V188, P341, DOI 10.1084/jem.188.2.341; Nakamoto Y, 2004, CANCER RES, V64, P3326, DOI 10.1158/0008-5472.CAN-03-3817; Nakamoto Y, 2003, CURR MOL MED, V3, P537, DOI 10.2174/1566524033479591; Nakamoto Y, 2002, J EXP MED, V196, P1105, DOI 10.1084/jem.20020633; Nakamoto Y, 2017, HEPATOL RES, V47, P251, DOI 10.1111/hepr.12795; Ozturk M, 2009, CANCER LETT, V286, P103, DOI 10.1016/j.canlet.2008.10.048; Pencik J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8736; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Safa M, 2010, APOPTOSIS, V15, P196, DOI 10.1007/s10495-009-0417-8; Scheffel MJ, 2016, CANCER RES, V76, P6006, DOI 10.1158/0008-5472.CAN-16-0587; Sia D, 2017, GASTROENTEROLOGY, V152, P745, DOI 10.1053/j.gastro.2016.11.048; Sitia G, 2012, P NATL ACAD SCI USA, V109, pE2165, DOI 10.1073/pnas.1209182109; Tang S, 2016, CANCER LETT, V376, P137, DOI 10.1016/j.canlet.2016.03.034; Tsuruya K, 2003, DNA REPAIR, V2, P211, DOI 10.1016/S1568-7864(02)00214-8; Ueda S, 2006, CANCER RES, V66, P5346, DOI 10.1158/0008-5472.CAN-05-3684; White DL, 2017, GASTROENTEROLOGY, V152, P812, DOI 10.1053/j.gastro.2016.11.020; WIRTH S, 1995, J IMMUNOL, V154, P2504; Xu C, 2014, CANCER LETT, V345, P216, DOI 10.1016/j.canlet.2013.08.035; Yamaguchi R, 1998, HEPATOLOGY, V28, P68, DOI 10.1002/hep.510280111; Yamashita T, 2009, J HEPATOL, V50, P100, DOI 10.1016/j.jhep.2008.07.036; Yu HY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6218; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061	46	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185442	10.1371/journal.pone.0185442	http://dx.doi.org/10.1371/journal.pone.0185442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968425	Green Submitted, Green Published, gold			2022-12-27	WOS:000412029600021
J	Bremer, D; Inhestern, L; Knesebeck, OV				Bremer, Daniel; Inhestern, Laura; Knesebeck, Olaf von dem			Social relationships and physician utilization among older adults-A systematic review	PLOS ONE			English	Review							HEALTH-SERVICES UTILIZATION; PRIMARY-CARE; LIFE EVENTS; VISITS; SUPPORT; PEOPLE; ACCESS; DETERMINANTS; INEQUALITY; CHINESE	Background In older age health needs and demand for health services utilization increase. Individual's social relationships can play a decisive role regarding the utilization of outpatient health care services. This systematic review examines the associations of structural and functional dimensions of social relationships with outpatient health services use of older adults. Methods The databases PubMed, CINAHL, SocINDEX, PsycINFO, International Bibliography of the Social Sciences (IBSS), Sociological Abstracts, and Applied Social Sciences Index and Abstracts (ASSIA) were searched in February 2016. The methodological and reporting quality of the articles was assessed and the results were synthesized descriptively and systematically. Results Out of 1.392 hits, 36 articles (35 studies) were included in the systematic review. The methodological and reporting quality of the included articles was reasonable. Various structural and functional characteristics of social relationships were associated with the use (yes/no) and the frequency of using outpatient care among older adults. The majority of the associations between structural dimensions of social relationships and the use of physicians were positive and moderate in strength. The associations between functional dimensions of social relationships and the probability of using physician services were inconsistent and varied in strength. For the most part, social relationship variables assigned to the structural dimension were positively and weakly to moderately associated with the frequency of physician visits. Functional aspects of social relationships also tended to have positive associations with the frequency of physician utilization. The associations were weak to moderate in strength. Conclusions Measuring social relationships and their influence on health services use is a challenging methodological endeavor indicated by the inconclusive results. The results suggest that the outpatient care utilization behavior of older individuals being structurally and functionally integrated in social relationships is different to older adults being socially isolated or having no social support. All in all, the current status of quantitative data was insufficient. Future health services research should accentuate social ties in more detail, especially according to quality aspects of social relationships.	[Bremer, Daniel; Inhestern, Laura] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Bremer, Daniel] Univ Med Ctr Hamburg Eppendorf, Ctr Hlth Care Res, Hamburg, Germany; [Knesebeck, Olaf von dem] Univ Med Ctr Hamburg Eppendorf, Dept Med Sociol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Bremer, D (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.; Bremer, D (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Hlth Care Res, Hamburg, Germany.	da.bremer@uke.de		von dem Knesebeck, Olaf/0000-0001-6310-5879; Bremer, Daniel/0000-0002-5770-440X				Aida J, 2011, SOC SCI MED, V73, P1561, DOI 10.1016/j.socscimed.2011.09.005; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; ARLING G, 1985, MED CARE, V23, P361, DOI 10.1097/00005650-198504000-00008; Beaglehole R., 2003, WORLD HLTH REPORT 20; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; BLAZER DG, 1982, AM J EPIDEMIOL, V115, P684, DOI 10.1093/oxfordjournals.aje.a113351; Branch L, 1981, J Community Health, V7, P80, DOI 10.1007/BF01323227; CAFFERATA GL, 1987, J GERONTOL, V42, P613, DOI 10.1093/geronj/42.6.613; Cornwell EY, 2012, J HEALTH SOC BEHAV, V53, P215, DOI 10.1177/0022146512446832; COULTON C, 1982, J HEALTH SOC BEHAV, V23, P330, DOI 10.2307/2136491; COUNTE MA, 1991, MED CARE, V29, P348, DOI 10.1097/00005650-199104000-00004; Crespo-Cebada E, 2012, HEALTH POLICY, V104, P193, DOI 10.1016/j.healthpol.2011.10.007; Dahl E, 2010, SOCIOL HEALTH ILL, V32, P1102, DOI 10.1111/j.1467-9566.2010.01270.x; Dalsgaard EM, 2012, PRIM CARE DIABETES, V6, P313, DOI 10.1016/j.pcd.2012.06.002; EVE SB, 1988, J GERONTOL, V43, pM31, DOI 10.1093/geronj/43.2.M31; Ezeamama AE, 2016, QUAL LIFE RES, V25, P1007, DOI 10.1007/s11136-015-1144-y; Fone D, 2007, INT J EPIDEMIOL, V36, P338, DOI 10.1093/ije/dym004; Foreman SE, 1998, MED CARE, V36, P1265, DOI 10.1097/00005650-199808000-00014; Freid VM, 2010, HLTH CARE UTILIZATIO, P32; Fritel X, 2014, NEUROUROL URODYNAM, V33, P1116, DOI 10.1002/nau.22461; Gobbens RJJ, 2012, ARCH GERONTOL GERIAT, V55, P369, DOI 10.1016/j.archger.2012.04.008; GOLDSTEEN R, 1992, J AGING STUD, V6, P149, DOI 10.1016/0890-4065(92)90010-4; Hand C, 2014, CAN FAM PHYSICIAN, V60, pE322; Harris T, 2004, BRIT J GEN PRACT, V54, P928; HEDGES LV, 1980, PSYCHOL BULL, V88, P359, DOI 10.1037/0033-2909.88.2.359; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; Herzog R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-154; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Jordan K, 2006, BRIT J GEN PRACT, V56, P269; Ju E, 2003, SYSTEMATIC REV HLTH, P87; Korten AE, 1998, AUST NZ J PUBL HEAL, V22, P609, DOI 10.1111/j.1467-842X.1998.tb01447.x; KRAUSE N, 1988, J GERONTOL, V43, pS53, DOI 10.1093/geronj/43.2.S53; Laporte A, 2008, HEALTH ECON POLICY L, V3, P393, DOI 10.1017/S1744133108004568; LEVKOFF SE, 1987, MED CARE, V25, P1148, DOI 10.1097/00005650-198712000-00004; Li YW, 2011, J AGING HEALTH, V23, P933, DOI 10.1177/0898264311401390; Liao PA, 2012, J RURAL HEALTH, V28, P84, DOI 10.1111/j.1748-0361.2011.00363.x; Melchior M, 2003, SOC SCI MED, V56, P1817, DOI 10.1016/S0277-9536(02)00181-8; Miltiades HB, 2008, SOC SCI MED, V66, P704, DOI 10.1016/j.socscimed.2007.10.016; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Murad MH, 2017, EVID BASED MED; Park JM, 2012, ASIA-PAC J PUBLIC HE, V24, P953, DOI 10.1177/1010539511409392; PESCOSOLIDO BA, 1992, AM J SOCIOL, V97, P1096, DOI 10.1086/229863; Pourat N, 2000, J AGING HEALTH, V12, P112, DOI 10.1177/089826430001200106; Rennemark M, 2009, HLTH SOC CARE COMMUN, V17; ROOK KS, 1990, S AP PSYC S, P173; Ryvicker M, 2012, SOC SCI MED, V75, P914, DOI 10.1016/j.socscimed.2012.04.029; Sapsford, 2005, POLICY STUDIES, V26, P29, DOI [10.1080/01442870500041660, DOI 10.1080/01442870500041660]; Schafer MH, 2013, SOC SCI MED, V87, P176, DOI 10.1016/j.socscimed.2013.03.031; SCHMITZ MF, 1997, RES SOCIOL HEALTH CA, V14, P249; STOLLER EP, 1982, MED CARE, V20, P1080, DOI 10.1097/00005650-198211000-00003; STRAIN LA, 1990, CAN J SOCIOL, V15, P19, DOI 10.2307/3341171; Suominen-Taipale AL, 2004, EUR J PUBLIC HEALTH, V14, P375, DOI 10.1093/eurpub/14.4.375; von dem Knesebeck O, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-272; von dem Knesebeck O, 2009, PSYCHOTHER PSYCH MED, V59, P186, DOI 10.1055/s-2008-1067421; WAN TTH, 1983, RES AGING, V5, P411, DOI 10.1177/0164027583005003008; Wan TTH, 1983, AGEING SOC, V1, P95; Wells G.A., NEWCASTLE OTTAWA SCA; WOLINSKY FD, 1991, J GERONTOL, V46, pS345, DOI 10.1093/geronj/46.6.S345; WOLINSKY FD, 1984, J GERONTOL, V39, P334, DOI 10.1093/geronj/39.3.334; WOLINSKY FD, 1983, J HEALTH SOC BEHAV, V24, P325, DOI 10.2307/2136399; Zhang Amy Y, 2003, Oncol Nurs Forum, V30, P1022	62	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185672	10.1371/journal.pone.0185672	http://dx.doi.org/10.1371/journal.pone.0185672			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4YC	28957429	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200104
J	Rebnord, T; Ostbye, T; Mmbaga, BT; Mchome, B; Lie, RT; Daltveit, AK				Rebnord, Tormod; Ostbye, Truls; Mmbaga, Blandina Theophil; Mchome, Bariki; Lie, Roiv Terje; Daltveit, Anne Kjersti			Time trends in management of HIV-positive pregnant women in Northern Tanzania: A registry-based study	PLOS ONE			English	Article								Objective To examine time trends in antenatal factors and delivery characteristics in Northern Tanzania, and relate these to national guidelines for HIV in pregnancy. Design Registry-based study. Setting Northern Tanzania, 2000-2014. Population or sample Deliveries (n = 33 346). Methods HIV-positive women were compared with HIV-negative women during four periods spanning changing national guidelines. Main outcome measures Known maternal HIV status, HIV treatment for woman, number of antenatal care (ANC) visits, routine folate/iron in pregnancy, anemia, delivery complications/interventions. Results We observed an increase in deliveries with known maternal HIV status and women receiving HIV treatment, and a decline in deliveries with positive maternal HIV status (p-values for trend <0.001). The proportion of women with less than four ANC visits increased to above 30 percent irrespective of HIV status. Use of routine folate/iron increased, corresponding to a decrease in anemia which was strongest in HIV-negative women. Incidence of elective caesarean section (CS) and emergency CS remained unchanged for HIV-positive women (7.1% and 25.5%, respectively, in the last period). Use of invasive procedures declined in both groups of women. Mothers who were young, single, had low education, high parity or lived in the rural area more often had indicators of poor antenatal care. Conclusions Increasing adherence to national guidelines over time was found for most selected outcomes. Still, a high occurrence of insufficient ANC, anemia and emergency CS call for efforts to explore and identify barriers that hinder optimal care.	[Rebnord, Tormod; Ostbye, Truls; Lie, Roiv Terje; Daltveit, Anne Kjersti] Univ Bergen, Fac Med & Dent, Dept Global Publ Hlth & Primary Care IGS, Bergen, Norway; [Ostbye, Truls] Duke Univ, Durham, NC USA; [Mmbaga, Blandina Theophil; Mchome, Bariki] Kilimanjaro Christian Med Univ Coll, Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Mmbaga, Blandina Theophil] Kilimanjaro Clin Res Inst, Moshi, Tanzania; [Lie, Roiv Terje; Daltveit, Anne Kjersti] Norwegian Inst Publ Hlth, Bergen, Norway	University of Bergen; Duke University; Kilimanjaro Christian Medical Centre; Norwegian Institute of Public Health (NIPH)	Rebnord, T (corresponding author), Univ Bergen, Fac Med & Dent, Dept Global Publ Hlth & Primary Care IGS, Bergen, Norway.	tormod03@gmail.com	Mmbaga, Blandina Theophil/AAR-8707-2021	Mmbaga, Blandina Theophil/0000-0002-5550-1916	Research Council of Norway (RCN); University of Bergen (UiB) through Medical Student Research Programme	Research Council of Norway (RCN)(Research Council of Norway); University of Bergen (UiB) through Medical Student Research Programme	Funding was provided by the Research Council of Norway (RCN) and the University of Bergen (UiB) through the Medical Student Research Programme.; The authors thank the KCMC administration and all the staff at KCMC Reproductive Health Department for the work with interviews, registration of the data and maintenance of the Birth Registry through all these years. The authors also thank the Research Council of Norway (RCN) and the University of Bergen (UiB) for funding and for the opportunity to make this study possible through the Medical Student Research Programme.	Afnan-Holmes H, 2015, LANCET GLOB HEALTH, V3, pE396, DOI 10.1016/S2214-109X(15)00059-5; [Anonymous], 2014, GAP REPORT 2014; [Anonymous], 2012, TANZ NAT GUID MAN HI; [Anonymous], BACKGR INF; [Anonymous], 2013, 2012 TANZ POP HOUS C; [Anonymous], 2016, FACT SHEET JOINT UN; [Anonymous], 2012, NAT GUID COMPR CAR P; [Anonymous], 2007, PREV MOTH CHILD TRAN; Babbel B., 2012, EVALUATING EQUITY PR; Bergsjo Per, 2007, East Afr J Public Health, V4, P1; Cho G, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-173; Gamell A, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13775; Gupta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101893; Habib NA, 2008, BJOG-INT J OBSTET GY, V115, P616, DOI 10.1111/j.1471-0528.2008.01672.x; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Ministry of Health CD MoH/Zanzibar M of H- NBS/Tanzania NB of S- OCGS/Zanzibar O of CGS- ICF, 2016, TANZ DEM HLTH SURV M; Mwendo EM, 2014, TROP MED INT HEALTH, V19, P267, DOI 10.1111/tmi.12255; National Bureau of Statistics: Ministry of Finance & Office of Chief Government Statistician: President's Office Finance Economy and Development Planning, 2013, POP DISTR AG SEX; (NBS) NBoS, 2005, TANZ DEM HLTH SURV 2; (NBS) NBoS, 2011, TANZ DEM HLTH SURV 2; Nilsen C, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0087-1; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Read JS, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005479; Research NIfM, 2008, EV INF POL MAK UN RE; Sorbye IK, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-55; Tanzania Commission for AIDS (TACAIDS), 2012, NAT BEH CHANG COMM G; Tanzania Ministry of Health and Social Welfare, 2004, NAT GUID PREV MOTH C; Tanzania Ministry of Health and Social Welfare, 2013, NAT GUID COMPR CAR S; UNAIDS, 2014, GLOB AIDS RESP COUNT; UNICEF, 2012, EL NEW HIV INF CHILD; WHO, 2012, GUID DAIL IR FOL AC; Wilfert C, 2010, FDN SUPPORTED PMTCT; World Bank, PREV HIV TOT POP AG; World Bank, CONTR PREV AN METH W; World Bank, MAT MORT RAT MOD EST	35	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184362	10.1371/journal.pone.0184362	http://dx.doi.org/10.1371/journal.pone.0184362			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957345	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200012
J	Aregawi, HG; Gebrehiwot, TG; Abebe, YG; Meles, KG; Wuneh, AD				Aregawi, Hailay Gebretnsae; Gebrehiwot, Tesfay Gebregzabher; Abebe, Yamane Gebremariam; Meles, Kidanu Gebremariam; Wuneh, Alem Desta			Determinants of defaulting from completion of child immunization in Laelay Adiabo District, Tigray Region, Northern Ethiopia: A case-control study	PLOS ONE			English	Article							COVERAGE; STATE	Background Globally 2.5 million children under five years of age die every year due to vaccine preventable diseases. In Tigray Region in Northern Ethiopia, full vaccination coverage in children is low. However, the determinants of defaulting from completion of immunization have not been studied in depth. This study aimed to identify the determinants of defaulting from child immunization completion among children aged 9 - 23 months in the Laelay Adiabo District, North Ethiopia. Methods An unmatched community based case-control study design was conducted among children aged 9 - 23 months in the Laelay Adiabo District from February D March 2015. A survey was conducted to identify the existence of cases and controls. Two hundred and seventy children aged 9 - 23 months (90 cases and 180 controls) were recruited from 11 kebeles (the smallest administrative units) by a simple random sampling technique using computer based Open Epi software. Cases were children aged 9 - 23 months who missed at least one dose of the recommended vaccine. Controls were children aged 9 - 23 months who had received all recommended vaccines. Data were collected from mothers/care givers using structured pretested questionnaire. The data were entered into Epi Info version 3.5.1 and analyzed using Statistical Package for Social Sciences (SPSS) version 21. Bivariate and Multiple logistic regression analysis were used to identify the predictors of the outcome variable. The degree of association was assessed by using odds ratio with 95% Confidence Interval (CI). Result This study shows that mothers who take > 30 minutes to reach the vaccination site (Adjusted Odds Ratio (AOR) = 3.56,95% CI: 1.58 - 8.01); households not visited by health extension	[Aregawi, Hailay Gebretnsae] Tigray Hlth Res Inst, Tigray Reg Hlth Bur, Mekelle, Ethiopia; [Gebrehiwot, Tesfay Gebregzabher; Abebe, Yamane Gebremariam; Meles, Kidanu Gebremariam; Wuneh, Alem Desta] Mekelle Univ, Sch Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia	Mekelle University	Wuneh, AD (corresponding author), Mekelle Univ, Sch Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia.	alemdw@gmail.com		Gebretnsae, Hailay/0000-0001-5989-8810; Gebremariam, kidanu/0000-0002-7880-6907				[Anonymous], 2005, GLOB IMM VIS STRAT 2; [Anonymous], 2010, ETH NAT EXP PROGR IM; Awasthi A, 2014, CLIN EPIDEMIOLOGY GL; Bugvi AS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-232; Debie A., 2014, SCI J PUBLIC HLTH, V2, P342, DOI [10.11648/j.sjph.20140204.26, DOI 10.11648/J.SJPH.20140204.26]; Dube E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657; Etana B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-566; Ethiopia Federal Ministry of Health, 2014, IMM PRACT NAT GUID H; Ethiopia Federal Ministry of Health, 2013, VACC MAN TRAIN MAN E; Federal Democratic Republic of Ethiopia Ministry of health, 2011, POL GUID NAT EXP PRO; Federal Democratic Republic of Ethiopia Ministry of Health, 2014, Q HLTH B, V6; Federal Demographic Republic of Ethiopia Ministry of Health, 2013, ETH ROUT IMM IMPR PL; Ibnouf AH, 2007, S AFR FAM PRACT, V49, P14, DOI 10.1080/20786204.2007.10873611; Legesse E, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0345-4; Maina LC, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.3.2181; Mohammed H., 2013, SCI TECHNOLOGY ARTS, V2, P36, DOI [10.4314/star.v2i1.98842, DOI 10.4314/STAR.V2I1.98842]; Mohamud AN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-865; Mutua Martin Kavao, 2016, Trop Med Health, V44, P13, DOI 10.1186/s41182-016-0013-x; Odusanya OO, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-381; Russo G, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2000-2; Sanou A, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S10; Tadesse H, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-150; Tekile H, 2013, YE SCI ADMAS; Teklay Kidane, 2008, Ethiopian Journal of Health Development, V22, P148; Tesfaye F., 2014, INT J PUB HLTH SCI I, V3, P185; Usman HR, 2010, TROP MED INT HEALTH, V15, P140, DOI 10.1111/j.1365-3156.2009.02432.x; Vakili R, 2015, INT J PEDIATR-MASSHA, V3, P1; Wado Yohannes Dibaba, 2014, Pan Afr Med J, V17 Suppl 1, P9, DOI 10.11694/pamj.supp.2014.17.1.3135; Waisbord S.L., 2005, WHY INVEST COMMUNICA; World Health Organization, 2009, STAT WORLDS VACC IMM; Yenit MK, 2015, E GOJJAM ZONE CASE C, V2, P4	31	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185533	10.1371/journal.pone.0185533	http://dx.doi.org/10.1371/journal.pone.0185533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953970	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300074
J	Kim, Y; Kym, D; Hur, J; Yoon, J; Yim, H; Cho, YS; Chun, W				Kim, Youngmin; Kym, Dohern; Hur, Jun; Yoon, Jaechul; Yim, Haejun; Cho, Yong Suk; Chun, Wook			Does inhalation injury predict mortality in burns patients or require redefinition?	PLOS ONE			English	Article							MECHANICAL VENTILATION; MANAGEMENT; PROGNOSIS; DIAGNOSIS	Inhalation injury is known to be an important factor in predicting mortality in burns patients. However, the diagnosis is complicated by the heterogeneous presentation and inability to determine the severity of inhalation injury. The purpose of this study was to identify clinical features of inhalation injury that affect mortality and the values that could predict the outcome more precisely in burns patients with inhalation injury. This retrospective observational study included 676 burns patients who were over 18 years of age and hospitalized in the Burns Intensive Care Unit between January 2012 and December 2015. We analyzed variables that are already known to be prognostic factors (age, percentage of total body surface area (%TBSA) burned, and inhalation injury) and factors associated with inhalation injury (carboxyhemoglobin and PaO2/FiO(2) [PF] ratio) by univariate and multivariate logistic regression. Age group (odds ratio [OR] 1.069, p<0.001), (%TBSA) burned (OR 1.100, p<0.001), and mechanical ventilation (OR 3.774, p<0.001) were identified to be significant predictive factors. The findings for presence of inhalation injury, PF ratio, and carboxyhemoglobin were not statistically significant in multivariate logistic regression. Being in the upper inhalation group, the lower inhalation group, and having a PF ratio <100 were identified to be significant predictors only in univariate logistic regression analysis (OR 4.438, p<0.001; OR 2.379, p<0.001; and OR 2.765, p<0.001, respectively). History and physical findings are not appropriate for diagnosis of inhalation injury and do not predict mortality. Mechanical ventilation should be recognized as a risk factor for mortality in burns patients with inhalation injury.	[Kim, Youngmin; Kym, Dohern; Hur, Jun; Yoon, Jaechul; Yim, Haejun; Cho, Yong Suk; Chun, Wook] Hallym Univ, Med Ctr, Hangang Sacred Heart Hosp, Dept Surg & Crit Care,Burn Ctr, Seoul, South Korea	Hallym University	Hur, J (corresponding author), Hallym Univ, Med Ctr, Hangang Sacred Heart Hosp, Dept Surg & Crit Care,Burn Ctr, Seoul, South Korea.	hammerj@hallym.or.kr	Kym, Dohern/B-8966-2014	Kym, Dohern/0000-0001-9178-0599; Yoon, Jaechul/0000-0001-5206-3378; Hur, Jun/0000-0003-1402-2297; Yim, Haejun/0000-0002-1566-5000	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI15C1486]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI15C1486).	Ching JA, 2015, J BURN CARE RES, V36, P197, DOI 10.1097/BCR.0000000000000175; Colohan SM, 2010, J BURN CARE RES, V31, P529, DOI 10.1097/BCR.0b013e3181e4d680; Dries DJ, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-31; El-Helbawy R H, 2011, Ann Burns Fire Disasters, V24, P82; Endorf FW, 2007, J BURN CARE RES, V28, P80, DOI 10.1097/BCR.0B013E31802C889F; Foster KN, 2017, J BURN CARE RES, V38, P137, DOI 10.1097/BCR.0000000000000539; Hassan Z, 2010, BURNS, V36, P212, DOI 10.1016/j.burns.2009.06.205; Mackie DP, 2011, J TRAUMA, V70, P611, DOI 10.1097/TA.0b013e31821067aa; Mackie DP, 2009, J TRAUMA, V67, P1233, DOI 10.1097/TA.0b013e3181be9c67; Palmieri TL, 2007, J BURN CARE RES, V28, P549, DOI 10.1097/BCR.0B013E318093DEF0; Soni N, 2008, BRIT J ANAESTH, V101, P446, DOI 10.1093/bja/aen240; Sutton T, 2017, J BURN CARE RES; TOBIASEN J, 1982, ANN EMERG MED, V11, P260, DOI 10.1016/S0196-0644(82)80096-6; Wachtel TL, 2000, BURNS, V26, P156, DOI 10.1016/S0305-4179(99)00047-9; Walker PF, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1077-4; You K, 2014, BURNS, V40, P1470, DOI 10.1016/j.burns.2014.09.015	16	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185195	10.1371/journal.pone.0185195	http://dx.doi.org/10.1371/journal.pone.0185195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953914	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300041
J	Reilly, AC; Guikema, SD; Zhu, LY; Igusa, T				Reilly, Allison C.; Guikema, Seth D.; Zhu, Laiyin; Igusa, Takeru			Evolution of vulnerability of communities facing repeated hazards	PLOS ONE			English	Article							HURRICANE DAMAGE; CLIMATE-CHANGE; FLOOD DAMAGE; POWER-SYSTEM; MODELS; RISK; DECISIONS; FLORIDA; SIMULATION; MITIGATION	The decisions that individuals make when recovering from and adapting to repeated hazards affect a region's vulnerability in future hazards. As such, community vulnerability is not a static property but rather a dynamic property dependent on behavioral responses to repeated hazards and damage. This paper is the first of its kind to build a framework that addresses the complex interactions between repeated hazards, regional damage, mitigation decisions, and community vulnerability. The framework enables researchers and regional planners to visualize and quantify how a community could evolve over time in response to repeated hazards under various behavioral scenarios. An illustrative example using parcellevel data from Anne Arundel County, Maryland-a county that experiences fairly frequent hurricanes-is presented to illustrate the methodology and to demonstrate how the interplay between individual choices and regional vulnerability is affected by the region's hurricane experience.	[Reilly, Allison C.] Univ Maryland, Dept Civil & Environm Engn, College Pk, MD 20742 USA; [Guikema, Seth D.] Univ Michigan, Dept Ind & Operat Engn, Ann Arbor, MI 48109 USA; [Zhu, Laiyin] Western Michigan Univ, Dept Geog, Kalamazoo, MI 49008 USA; [Igusa, Takeru] Johns Hopkins Univ, Dept Civil Engn, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland College Park; University of Michigan System; University of Michigan; Western Michigan University; Johns Hopkins University	Reilly, AC (corresponding author), Univ Maryland, Dept Civil & Environm Engn, College Pk, MD 20742 USA.	areilly2@umd.edu	Igusa, Takeru/A-3218-2010; Reilly, Allison/HGA-8219-2022; Zhu, Laiyin/AFR-8302-2022	Igusa, Takeru/0000-0002-3632-2867; Reilly, Allison/0000-0001-7209-3566	National Science Foundation (US) [1149460, 1331399]; Divn Of Social and Economic Sciences [1631409] Funding Source: National Science Foundation; Div Of Civil, Mechanical, & Manufact Inn [1621116] Funding Source: National Science Foundation	National Science Foundation (US)(National Science Foundation (NSF)); Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work is funded by the National Science Foundation (US), grant numbers 1149460 and 1331399. The support of the sponsor is gratefully acknowledged. Any opinions, findings, conclusions or recommendations presented in this paper are those of the authors and do not necessarily reflect the view of the National Science Foundation, http://www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I., 1980, UNDERSTANDING ATTITU; An L, 2012, ECOL MODEL, V229, P25, DOI 10.1016/j.ecolmodel.2011.07.010; [Anonymous], 2010, 2010 TIGER LINE SHAP; [Anonymous], 2016, HIST HURR TRACKS; Barredo Jose I., 2010, Sustainability, V2, P1327, DOI 10.3390/su2051327; Berglund EZ, 2015, J WATER RES PLAN MAN, V141, DOI [10.1061/(ASCE)WR.1943-5452.0000544, 10.1061/(ASCE)WR.1943-5452.0000475]; Berrang-Ford L, 2011, GLOBAL ENVIRON CHANG, V21, P25, DOI 10.1016/j.gloenvcha.2010.09.012; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Brody SD, 2003, J PLAN EDUC RES, V23, P191, DOI 10.1177/0739456X03258635; Bubeck P, 2013, GLOBAL ENVIRON CHANG, V23, P1327, DOI 10.1016/j.gloenvcha.2013.05.009; Burby RJ, 2006, ANN AM ACAD POLIT SS, V604, P171, DOI 10.1177/0002716205284676; Carson JM, 2013, J RISK INSUR, V80, P309, DOI 10.1111/j.1539-6975.2012.01484.x; Chen X, 2008, J OPER RES SOC, V59, P25, DOI 10.1057/palgrave.jors.2602321; Chen XW, 2006, NAT HAZARDS, V38, P321, DOI 10.1007/s11069-005-0263-0; Dillon RL, 2011, RISK ANAL, V31, P440, DOI 10.1111/j.1539-6924.2010.01506.x; Emanuel K, 2008, B AM METEOROL SOC, V89, P347, DOI 10.1175/BAMS-89-3-347; Epstein J.M., 1996, GROWING ARTIFICIAL S; Evans TP, 2004, J ENVIRON MANAGE, V72, P57, DOI 10.1016/j.jenvman.2004.02.008; FEMA (Federal Emergency Management Agency), 2015, HAZUS 2 1 TECHN US M; Fujimi T, 2013, RISK ANAL, V33, P1858, DOI 10.1111/risa.12086; Gencturk BE, 2007, FRAGILITY RELATIONSH; Herault A., 2009, COMPUT GEOSCI, V35, P1050, DOI [10.1016/j.cageo.2007.10.008, DOI 10.1016/J.CAGE0.2007.10.008]; Holland GJ, 2010, MON WEATHER REV, V138, P4393, DOI 10.1175/2010MWR3317.1; Irwin EG, 2001, AGR ECOSYST ENVIRON, V85, P7, DOI 10.1016/S0167-8809(01)00200-6; Jacobs RA, 2011, WIRES COGN SCI, V2, P8, DOI 10.1002/wcs.80; Jain VK, 2007, RISK ANAL, V27, P45, DOI 10.1111/j.1539-6924.2006.00858.x; Jain VK, 2007, J INFRASTRUCT SYST, V13, P31, DOI 10.1061/(ASCE)1076-0342(2007)13:1(31); Jain VK, 2004, NAT HAZARDS REV, V6, P88, DOI [DOI 10.1061/(ASCE)1527-6988(2005)6:2(88), 10.1061/(ASCE)1527-6988(2005)6:2(88)]; Kesete Y, 2014, RISK ANAL, V34, P1040, DOI 10.1111/risa.12227; Kleindorfer PR, 1999, RISK ANAL, V19, P727, DOI 10.1111/j.1539-6924.1999.tb00442.x; Knutson TR, 2008, NAT GEOSCI, V1, P359, DOI 10.1038/ngeo202; Kunreuther H, 1996, J RISK UNCERTAINTY, V12, P171, DOI 10.1007/BF00055792; Kunreuther H, 2013, CLIMATIC CHANGE, V118, P339, DOI 10.1007/s10584-012-0625-z; Legg M, 2013, J INFRASTRUCT SYST, V19, P1, DOI 10.1061/(ASCE)IS.1943-555X.0000106; Lempert R, 2002, P NATL ACAD SCI USA, V99, P7195, DOI 10.1073/pnas.072079399; Logan TM, 2017, HARD DEFENSES FAIL I; Ludy J, 2012, NAT HAZARDS, V61, P829, DOI 10.1007/s11069-011-0072-6; Lux T., 2000, INT J THEOR APPL FIN, V3, P675, DOI DOI 10.1142/S0219024900000826; Magliocca NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086179; Malamud BD, 2000, COMPUT SCI ENG, V2, P42, DOI 10.1109/5992.841795; Matthews RB, 2007, LANDSCAPE ECOL, V22, P1447, DOI 10.1007/s10980-007-9135-1; Messner F, 2006, NATO SCI S SS IV EAR, V67, P149; Peacock WG, 2005, LANDSCAPE URBAN PLAN, V73, P120, DOI 10.1016/j.landurbplan.2004.11.004; Peng JZ, 2014, NAT HAZARDS, V74, P1043, DOI 10.1007/s11069-014-1231-3; Pinelli JP, 2004, J STRUCT ENG, V130, P1685, DOI 10.1061/(ASCE)0733-9445(2004)130:11(1685); Pita GL, 2013, J WIND ENG IND AEROD, V114, P96, DOI 10.1016/j.jweia.2012.12.004; Poussin JK, 2014, ENVIRON SCI POLICY, V40, P69, DOI 10.1016/j.envsci.2014.01.013; Rathfon D, 2013, DISASTERS, V37, P333, DOI 10.1111/j.1467-7717.2012.01305.x; Reilly A, 2017, P 27 EUR SAF REL C E, P2018; Reilly A, 2017, P 26 EUR SAF REL C E, P245; Reilly AC, 2017, P IEEE, V105, P1429, DOI 10.1109/JPROC.2017.2689720; Rubinstein A., 1998, MODELING BOUNDED RAT; Ryu H, 2008, P 14 WORLD C EARTHQ, p[12, 12]; Samanidou E, 2007, REP PROG PHYS, V70, P409, DOI 10.1088/0034-4885/70/3/R03; Sante I, 2010, LANDSCAPE URBAN PLAN, V96, P108, DOI 10.1016/j.landurbplan.2010.03.001; Saunders MA, 2008, NATURE, V451, P557, DOI 10.1038/nature06422; Scheitlin KN, 2011, THEOR APPL CLIMATOL, V105, P287, DOI 10.1007/s00704-010-0386-4; Simon A., 1972, DECISION ORG, P161, DOI DOI 10.1093/EREA/27.3.325; SIMON HA, 1990, ANNU REV PSYCHOL, V41, P1, DOI 10.1146/annurev.ps.41.020190.000245; Singhal A, 1996, J STRUCT ENG-ASCE, V122, P1459, DOI 10.1061/(ASCE)0733-9445(1996)122:12(1459); Smith B, 2000, CLIMATIC CHANGE, V45, P223, DOI 10.1023/A:1005661622966; Staid A, 2014, CLIMATIC CHANGE, V127, P535, DOI 10.1007/s10584-014-1272-3; Tonn G, 2017, AGENT BASED IN PRESS; Valbuena D, 2010, LANDSCAPE ECOL, V25, P185, DOI 10.1007/s10980-009-9380-6; van de Lindt JW, 2012, J PERFORM CONSTR FAC, V26, P739, DOI 10.1061/(ASCE)CF.1943-5509.0000270; Vickery P.J., 2006, NAT HAZARD REV, V7, P94, DOI 10.1061/(asce)1527-6988(2006)7:2(94); Vickery PJ, 2006, NAT HAZARD REV, V7, P82, DOI DOI 10.1061/(ASCE)1527-6988(2006)7:2(82); Weichselgartner J., 2001, DISASTER PREV MANAG, V10, P85, DOI [10.1108/09653560110388609, DOI 10.1108/09653560110388609]; Wilson GA, 2013, AREA, V45, P207, DOI 10.1111/area.12012; Yau SC, 2011, NAT HAZARDS REV, V12, P184, DOI 10.1061/(ASCE)NH.1527-6996.0000035; Zechman EM, 2011, RISK ANAL, V31, P758, DOI 10.1111/j.1539-6924.2010.01564.x	71	12	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0182719	10.1371/journal.pone.0182719	http://dx.doi.org/10.1371/journal.pone.0182719			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4WR	28953893	gold, Green Submitted, Green Published			2022-12-27	WOS:000411980300004
J	Zhang, YJ; Kong, XQ; Dai, JL; Luo, Z; Li, ZH; Lu, HQ; Xu, SZ; Tang, W; Zhang, DM; Li, WJ; Xin, CS; Dong, HZ				Zhang, Yanjun; Kong, Xiangqiang; Dai, Jianlong; Luo, Zhen; Li, Zhenhuai; Lu, Hequan; Xu, Shizhen; Tang, Wei; Zhang, Dongmei; Li, Weijiang; Xin, Chengsong; Dong, Hezhong			Global gene expression in cotton (Gossypium hirsutum L.) leaves to waterlogging stress	PLOS ONE			English	Article							END RULE PATHWAY; ETHYLENE RESPONSE FACTORS; LOW INTERNAL OXYGEN; DEEP-WATER RICE; TRANSCRIPTION FACTOR; NITRIC-OXIDE; ALCOHOLIC FERMENTATION; SUBMERGENCE TOLERANCE; ARABIDOPSIS-THALIANA; SHOOT ELONGATION	Cotton is sensitive to waterlogging stress, which usually results in stunted growth and yield loss. To date, the molecular mechanisms underlying the responses to waterlogging in cotton remain elusive. Cotton was grown in a rain-shelter and subjected to 0 (control)-, 10-, 15- and 20-d waterlogging at flowering stage. The fourth-leaves on the main-stem from the top were sampled and immediately frozen in liquid nitrogen for physiological measurement. Global gene transcription in the leaves of 15-d waterlogged plants was analyzed by RNA-Seq. Seven hundred and ninety four genes were up-regulated and 1018 genes were down-regulated in waterlogged cotton leaves compared with non-waterlogged control. The differentially expressed genes were mainly related to photosynthesis, nitrogen metabolism, starch and sucrose metabolism, glycolysis and plant hormone signal transduction. KEGG (Kyoto Encyclopedia of Genes and Genomes) analysis indicated that most genes related to flavonoid biosynthesis, oxidative phosphorylation, amino acid metabolism and biosynthesis as well as circadian rhythm pathways were differently expressed. Waterlogging increased the expression of anaerobic fermentation related genes, such as alcohol dehydrogenase (ADH), but decreased the leaf chlorophyll concentration and photosynthesis by down-regulating the expression of photosynthesis related genes. Many genes related to plant hormones and transcription factors were differently expressed under waterlogging stress. Most of the ethylene related genes and ethylene-responsive factor-type transcription factors were up-regulated under water-logging stress, suggesting that ethylene may play key roles in the survival of cotton under waterlogging stress.	[Zhang, Yanjun; Kong, Xiangqiang; Dai, Jianlong; Luo, Zhen; Li, Zhenhuai; Lu, Hequan; Xu, Shizhen; Tang, Wei; Zhang, Dongmei; Li, Weijiang; Xin, Chengsong; Dong, Hezhong] Shandong Acad Agr Sci, Cotton Res Ctr, Jinan, Shandong, Peoples R China; [Zhang, Yanjun; Dong, Hezhong] Shandong Univ, Sch Life Sci, Jinan, Shandong, Peoples R China; [Kong, Xiangqiang; Dong, Hezhong] Shandong Normal Univ, Coll Life Sci, Jinan, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shandong Academy of Agricultural Sciences; Shandong University; Shandong Normal University	Kong, XQ; Dong, HZ (corresponding author), Shandong Acad Agr Sci, Cotton Res Ctr, Jinan, Shandong, Peoples R China.; Dong, HZ (corresponding author), Shandong Univ, Sch Life Sci, Jinan, Shandong, Peoples R China.; Kong, XQ; Dong, HZ (corresponding author), Shandong Normal Univ, Coll Life Sci, Jinan, Shandong, Peoples R China.	kongqiang_1995@163.com; donghz@saas.ac.cn			National Natural Science Foundation of China [31771718]; Natural Science Foundation of Shandong Province [ZR2015QZ03, ZR2014YL018]; earmarked fund for China Agricultural Research System [CARS-18-21]; Seed Project of Shandong Province; special fund for Taishan Scholars [Tspd20150213]; Agricultural Scientific and Technological Innovation Project of Shandong Academy of Agricultural Sciences [CXGC2016C04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); earmarked fund for China Agricultural Research System; Seed Project of Shandong Province; special fund for Taishan Scholars; Agricultural Scientific and Technological Innovation Project of Shandong Academy of Agricultural Sciences	This work was supported by the National Natural Science Foundation of China (31771718), the Natural Science Foundation of Shandong Province (ZR2015QZ03; ZR2014YL018), the earmarked fund for China Agricultural Research System (CARS-18-21), the Seed Project of Shandong Province (2014-cotton), the special fund for Taishan Scholars (Tspd20150213), the Agricultural Scientific and Technological Innovation Project of Shandong Academy of Agricultural Sciences (CXGC2016C04).	Ahmed S, 2006, ENVIRON EXP BOT, V57, P278, DOI 10.1016/j.envexpbot.2005.06.006; Allegre A, 2004, J EXP BOT, V55, P2625, DOI 10.1093/jxb/erh258; [Anonymous], 2013, THESIS; Ashraf MA, 2011, CROP PASTURE SCI, V62, P25, DOI 10.1071/CP09225; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai TH, 2011, J PLANT GROWTH REGUL, V30, P119, DOI 10.1007/s00344-010-9173-9; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Bailey-Serres J, 2010, CURR OPIN PLANT BIOL, V13, P489, DOI 10.1016/j.pbi.2010.08.002; Bange MP, 2004, FIELD CROP RES, V88, P129, DOI 10.1016/j.fcr.2003.12.002; Bange MP, 2004, FIELD CROP RES, V87, P73, DOI 10.1016/j.fcr.2003.09.007; Barnawal D, 2012, PLANT PHYSIOL BIOCH, V58, P227, DOI 10.1016/j.plaphy.2012.07.008; Benschop JJ, 2006, PLANT PHYSIOL, V141, P1644, DOI 10.1104/pp.106.082636; Bieniawska Z., 2007, THESIS; Bologa KL, 2003, PLANT PHYSIOL, V132, P2058, DOI 10.1104/pp.103.022236; Branco-Price C, 2008, PLANT J, V56, P743, DOI 10.1111/j.1365-313X.2008.03642.x; Cao G, 2012, PROCEDIA ENGINEER, V28, P202, DOI 10.1016/j.proeng.2012.01.706; CASTONGUAY Y, 1993, PLANT CELL ENVIRON, V16, P695, DOI 10.1111/j.1365-3040.1993.tb00488.x; Chen T, 2016, FUNCTIONAL PLANT BIO, V43; Chen W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01044; Ding Fei, 2008, Agricultural Sciences in China, V7, P168, DOI 10.1016/S1671-2927(08)60036-X; Drew MC, 1997, ANNU REV PLANT PHYS, V48, P223, DOI 10.1146/annurev.arplant.48.1.223; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Nguyen D, 2016, PLANT MOL BIOL, V91, P727, DOI 10.1007/s11103-016-0481-8; Ellis MH, 2000, AUST J PLANT PHYSIOL, V27, P1041, DOI 10.1071/PP00052; Ellis MH, 1999, PLANT PHYSIOL, V119, P57, DOI 10.1104/pp.119.1.57; Fukao T, 2011, PLANT CELL, V23, P412, DOI 10.1105/tpc.110.080325; Gallego-Giraldo C, 2014, PLANT J, V79, P1020, DOI 10.1111/tpj.12603; Geigenberger P, 2000, BIOL CHEM, V381, P723, DOI 10.1515/BC.2000.093; Gibbs DJ, 2011, NATURE, V479, P415, DOI 10.1038/nature10534; Gibbs J, 2000, J EXP BOT, V51, P785, DOI 10.1093/jexbot/51.345.785; Gill SS, 2013, PLANT PHYSIOL BIOCH, V63, P254, DOI 10.1016/j.plaphy.2012.12.001; Gupta KJ, 2011, TRENDS PLANT SCI, V16, P160, DOI 10.1016/j.tplants.2010.11.007; Hamonts K, 2013, FEMS MICROBIOL ECOL, V83, P568, DOI 10.1111/1574-6941.12015; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; He CJ, 1996, PLANT PHYSIOL, V112, P463, DOI 10.1104/pp.112.2.463; Hess N, 2011, PHYSIOL PLANTARUM, V143, P41, DOI 10.1111/j.1399-3054.2011.01486.x; Hinz M, 2010, PLANT PHYSIOL, V153, P757, DOI 10.1104/pp.110.155077; HODGSON AS, 1982, AUST J AGR RES, V33, P1019, DOI 10.1071/AR9821019; HOFFMANNBENNING S, 1992, PLANT PHYSIOL, V99, P1156, DOI 10.1104/pp.99.3.1156; Horchani F, 2010, ACTA PHYSIOL PLANT, V32, P1113, DOI 10.1007/s11738-010-0503-0; Ismond KP, 2003, PLANT PHYSIOL, V132, P1292, DOI 10.1104/pp.103.022244; Jackson M.B., 1992, VEGETATION, V103, P167; Jain Veena, 2010, Physiology and Molecular Biology of Plants, V16, P241, DOI 10.1007/s12298-010-0025-7; Juntawong P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00658; Kato-Noguchi H, 2000, PHYSIOL PLANTARUM, V109, P28, DOI 10.1034/j.1399-3054.2000.100105.x; Kende H, 1998, PLANT PHYSIOL, V118, P1105, DOI 10.1104/pp.118.4.1105; Klok EJ, 2002, PLANT CELL, V14, P2481, DOI 10.1105/tpc.004747; Kozlowski T. T., 1984, Flooding and plant growth, P165; Kreuzwieser J, 2009, PLANT PHYSIOL, V149, P461, DOI 10.1104/pp.108.125989; Kuai J, 2015, EUR J AGRON, V67, P61, DOI 10.1016/j.eja.2015.03.005; Kumutha D, 2008, PLANT SCI, V175, P706, DOI 10.1016/j.plantsci.2008.07.013; Kursteiner O, 2003, PLANT PHYSIOL, V132, P968, DOI 10.1104/pp.102.016907; Lasanthi-Kudahettige R, 2007, PLANT PHYSIOL, V144, P218, DOI 10.1104/pp.106.093997; Lee SC, 2011, NEW PHYTOL, V190, P457, DOI 10.1111/j.1469-8137.2010.03590.x; Lee YH, 2014, PLANT CELL REP, V33, P289, DOI 10.1007/s00299-013-1529-8; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Licausi F, 2010, PLANT J, V62, P302, DOI 10.1111/j.1365-313X.2010.04149.x; Liu FL, 2005, PLANT PHYSIOL, V137, P1115, DOI 10.1104/pp.104.055475; Loreti E, 2005, PLANT PHYSIOL, V137, P1130, DOI 10.1104/pp.104.057299; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Luo Z, 2008, CROP PROT, V27, P1485, DOI 10.1016/j.cropro.2008.06.006; Milroy SP, 2013, FIELD CROP RES, V140, P51, DOI 10.1016/j.fcr.2012.10.016; Mithran M, 2014, PLANT BIOLOGY, V16, P28, DOI 10.1111/plb.12005; MORRIS DA, 1993, J EXP BOT, V44, P807, DOI 10.1093/jxb/44.4.807; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUENCH DG, 1993, PHYSIOL PLANTARUM, V89, P165, DOI 10.1111/j.1399-3054.1993.tb01800.x; MUSGRAVE A, 1972, NATURE-NEW BIOL, V238, P93, DOI 10.1038/newbio238093a0; Mustroph A, 2009, P NATL ACAD SCI USA, V106, P18843, DOI 10.1073/pnas.0906131106; Najeeb U, 2015, VALUATION CORPORATE, P55; Narsai R, 2009, PLANT PHYSIOL, V151, P306, DOI 10.1104/pp.109.142026; Oliveira HC, 2013, PLANT PHYSIOL BIOCH, V66, P141, DOI 10.1016/j.plaphy.2013.02.015; Oliveira HC, 2013, AMINO ACIDS, V44, P743, DOI 10.1007/s00726-012-1399-3; Perata P, 1997, ANN BOT-LONDON, V79, P49, DOI 10.1093/oxfordjournals.aob.a010306; Pierik R, 2005, ANN BOT-LONDON, V96, P533, DOI 10.1093/aob/mci208; Rivoal J, 1997, PLANT PHYSIOL, V114, P1021, DOI 10.1104/pp.114.3.1021; ROBERTS JKM, 1984, P NATL ACAD SCI-BIOL, V81, P3379, DOI 10.1073/pnas.81.11.3379; Sairam RK, 2009, J PLANT PHYSIOL, V166, P602, DOI 10.1016/j.jplph.2008.09.005; Sasidharan R, 2011, PLANT CELL, V23, P4173, DOI 10.1105/tpc.111.093880; SETTER TL, 1994, ANN BOT-LONDON, V74, P273, DOI 10.1006/anbo.1994.1118; Shi HT, 2012, PLANT CELL PHYSIOL, V53, P344, DOI 10.1093/pcp/pcr181; Stohr C, 2001, PLANTA, V212, P835, DOI 10.1007/s004250000447; Tang Q., 1997, DPS DATA PROCESSING, P188; Thirunavukkarasu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070433; Voesenek LACJ, 2004, ECOLOGY, V85, P16, DOI 10.1890/02-740; Voesenek LACJ, 2003, ANN BOT-LONDON, V91, P205, DOI 10.1093/aob/mcf116; Wang LH, 2012, ACTA PHYSIOL PLANT, V34, P2241, DOI 10.1007/s11738-012-1024-9; Wu T, 2010, J PLANT PHYSIOL, V167, P905, DOI 10.1016/j.jplph.2010.02.004; Wu WB, 2010, AGR SCI CHINA, V9, P101, DOI 10.1016/S1671-2927(09)60073-0; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Yang CY, 2011, PLANT PHYSIOL, V156, P202, DOI 10.1104/pp.111.172486; Yang SH, 2006, BIOCHEM BIOPH RES CO, V350, P685, DOI 10.1016/j.bbrc.2006.09.098; Zhang YJ, 2016, FIELD CROP RES, V194, P83, DOI 10.1016/j.fcr.2016.05.006; Zhang YJ, 2015, FIELD CROP RES, V179, P164, DOI 10.1016/j.fcr.2015.05.001; Zheng CF, 2009, PLANT SCI, V176, P575, DOI 10.1016/j.plantsci.2009.01.015	95	24	25	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185075	10.1371/journal.pone.0185075	http://dx.doi.org/10.1371/journal.pone.0185075			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953908	gold, Green Published, Green Submitted			2022-12-27	WOS:000411980300032
J	Linn, R; Tepper, Y; Bar-Oz, G				Linn, Ravit; Tepper, Yotam; Bar-Oz, Guy			Visible induced luminescence reveals invisible rays shining from Christ in the early Christian wall painting of the Transfiguration in Shivta	PLOS ONE			English	Article							EGYPTIAN BLUE; PIGMENTS; SINAI	The Transfiguration scene depicted in a Byzantine church at Shivta, Israel, is one of two figurative examples of the scene from the early Christian period. The use of Egyptian blue pigment in the wall painting was investigated with various analytical methods. Visible Induced Luminescence (VIL) imaging was used in-situ in order to map the distribution of the Egyptian blue pigment in the painting. The VIL imaging revealed surprising insights into the understanding of the iconography and the technology of this rare painting. Previously undetected elements of the painting include rays of light that were discovered emerging from the body of Christ and illuminating the other figures in the painting. Although this motif is an important part of the Transfiguration narrative and appears in most of its scenes depicted elsewhere, it had not been previously identified in this painting as it was undetectable by any other inspection technique. Another important result is the identification of Egyptian blue as a common blue pigment used at Shivta during the Byzantine period, when it is considered to be very rare.	[Linn, Ravit] Univ Haifa, Conservat Mat Culture Heritage Unit, Dept Archaeol, Haifa, Israel; [Tepper, Yotam; Bar-Oz, Guy] Univ Haifa, Zinman Inst Archaeol, Haifa, Israel	University of Haifa; University of Haifa	Linn, R (corresponding author), Univ Haifa, Conservat Mat Culture Heritage Unit, Dept Archaeol, Haifa, Israel.	linn@research.haifa.ac.il	BarOz, Guy/ABF-6518-2020	BarOz, Guy/0000-0002-1009-5619	European Research Council under the EU's Horizon research and innovation program [648427]; Israel Science Foundation [34014]	European Research Council under the EU's Horizon research and innovation program; Israel Science Foundation(Israel Science Foundation)	The project has received funding from the European Research Council under the EUs Horizon 2020 research and innovation program (648427) and the Israel Science Foundation (34014).	Accorsi G, 2009, CHEM COMMUN, P3392, DOI 10.1039/b902563d; Andreopoulo A., 2012, THIS IS MY BELOVED S; Andreopoulo A., 2005, METAMORPHOSIS TRANSF; Arnold A., 1986, CASE STUDIES CONSERV, P190; Avni Gideon, 2014, BYZANTINE ISLAMIC TR, P49; Biddle B., 1980, EXPEDITION, V22, P17; Brecoulaki H., 2014, TRANSFORMATIONS CLAS, P152; Caggiani MC, 2016, MICROCHEM J, V129, P123, DOI 10.1016/j.microc.2016.06.020; Comelli D, 2016, HERIT SCI, V4, DOI 10.1186/s40494-016-0090-5; Damiani D, 2003, ARCHAEOMETRY, V45, P341, DOI 10.1111/1475-4754.00112; DoErnyei Z., 2011, THESIS; Emmenegger O., 1986, CASE STUDIES CONSERV, P197; Figueras P., 2006, ARAM, V18, P127; Gaetani MC, 2004, STUD CONSERV, V49, P13, DOI 10.1179/sic.2004.49.1.13; Gage John, 1993, COLOR CULTURE PRACTI; Galey J., 1980, SINAI MONASTERY ST; Ganio M, 2015, APPL PHYS A-MATER, V121, P813, DOI 10.1007/s00339-015-9424-5; Granger F., 1962, ARCHITECTURA BOOKS 6, V2; Hay A. R., 2014, THESIS; Howard, 2003, PIGMENTS ENGLISH MED; Kakoulli I, 2009, GREEK PAINTING TECHN; Lazzarini L., 1982, STUD CONSERV, V27, P84, DOI [10.1179/sic.1982.27.2.84, DOI 10.1179/SIC.1982.27.2.84]; Leatherbury SV, 2016, GESTA, V55, P133, DOI 10.1086/687151; Lee D., 2004, ANZATS ANZSTS C MELB, P143; Lee D. A., 2004, TRANSFIGURATION; Leveto P. D., 1985, THESIS; LEVETO PD, 1990, ART BULL, V72, P393, DOI 10.2307/3045748; Linn R, 2017, J ARCHAEOL SCI-REP, V11, P774, DOI 10.1016/j.jasrep.2016.12.018; Linn R., TECHNICAL PERSPECTIV; Mairinger F., 1986, CASE STUDIES CONSERV, P195; MIZIOLEK J, 1990, J WARBURG COURTAULD, V53, P42, DOI 10.2307/751338; Negev A, 1974, REV BIBLIQUE, V81, P397; Negev A, 1985, EXCAVATIONS SURVEYS, V4, P102; Osborne J., 1984, THESIS; Pages-Camagna S, 2003, ARCHAEOMETRY, V45, P637, DOI 10.1046/j.1475-4754.2003.00134.x; Piovesan R, 2011, J ARCHAEOL SCI, V38, P2633, DOI 10.1016/j.jas.2011.05.021; Riederer J., 1997, ARTISTS PIGMENTS; SEGAL A, 1985, J SOC ARCHIT HIST, V44, P317, DOI 10.2307/990111; SEGAL A., 1983, BYZANTINE CITY SHIVT; Tepper Y., 2015, SEALED DOORS UNRAVEL, V348; Verri G, 2009, PROC SPIE, V7391, DOI 10.1117/12.827331; Verri G, 2009, ANAL BIOANAL CHEM, V394, P1011, DOI 10.1007/s00216-009-2693-0; Verri G, 2010, STUD CONSERV, V55, P220, DOI 10.1179/sic.2010.55.Supplement-2.220; Woolley C. L., 1914, WILDERNESS ZIN ARCHA, V3	44	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185149	10.1371/journal.pone.0185149	http://dx.doi.org/10.1371/journal.pone.0185149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI1DL	28949982	gold, Green Published, Green Submitted			2022-12-27	WOS:000411671000026
J	Sharif-Askari, FS; Sharif-Askari, NS; Javadi, M; Gholami, K				Sharif-Askari, Fatemeh Saheb; Sharif-Askari, Narjes Saheb; Javadi, Mohammadreza; Gholami, Kheirollah			Adverse drug reactions reported to the drug and poison information center of Tehran, Iran	PLOS ONE			English	Article							RISK-FACTORS; EVENTS; ERRORS	Background Burden of adverse drug reactions (ADRs), in home-environment and domestic settings, is unknown. Objective To discuss the epidemiology of reported ADRs to 13-Aban drug and poison information center (DPIC) and to discuss the burden of hospitalization caused by these ADRs from commonly implicated therapeutic groups. Methods A retrospective analysis of the yellow card schemes of suspected ADRs reported to the 13-Aban DPIC was conducted from 21 March 2013 to 21 November 2016 inclusive. Main outcome measures Characteristics of the ADRs, such as the sex and age of the patient, the therapeutic group involved, and the medical outcome of the exposure, were examined. ADR Hospitalization (ADRH) index was calculated for each drug group by dividing the number of ADR-related hospitalizations with total number of reported ADR cases (n = 748), and then multiplying by 100. Results ADRs were reported for 748 patients representing 5 cases per 1000 enquiries to the 13Aban DPIC over almost 4-years of the study period. Public were responsible for reporting every 4 out of 5 ADR cases (n = 651, 87%) and the remaining 1 out of 5 ADR cases was reported by the health care professionals (n = 97, 13%). Most of the ADRs had a medical outcome documented as having a minor effect or were minimally bothersome to the patients (n = 509, 68%), and less than 4.9% (n = 37) were documented as having a major effect or were life-threatening. Overall, 7.4% (n = 55) of ADRs were resulted in hospitalization. Antibacterials for systemic use represented the therapeutic group with the highest hospitalization index (1.7%). Conclusions The study concluded that ADRs to antibiotics are common and some of them resulted in hospitalization.	[Sharif-Askari, Fatemeh Saheb; Sharif-Askari, Narjes Saheb; Javadi, Mohammadreza; Gholami, Kheirollah] Univ Tehran Med Sci, Clin Pharm Dept, Fac Pharm, Tehran, Iran; [Javadi, Mohammadreza; Gholami, Kheirollah] Univ Tehran Med Sci, Res Ctr Rat Use Drugs, Karimkhan Zand Ave,Hafte Tir Sq, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences	Sharif-Askari, FS (corresponding author), Univ Tehran Med Sci, Clin Pharm Dept, Fac Pharm, Tehran, Iran.	dr.fatemeh.askari@gmail.com	Sharif-Askari, Narjes Saheb/I-1743-2019	Sharif-Askari, Narjes Saheb/0000-0003-0482-6777; Saheb Sharif-Askari, Fatemeh/0000-0001-8498-055X				Anderson C, 2011, BRIT J CLIN PHARMACO, V72, P806, DOI 10.1111/j.1365-2125.2011.03990.x; [Anonymous], 2016, IRAN CENSUS RESULTS; Bencheikh RS, 2009, BRIT J CLIN PHARMACO, V67, P687, DOI 10.1111/j.1365-2125.2009.03426.x; Bourgeois FT, 2010, PHARMACOEPIDEM DR S, V19, P901, DOI 10.1002/pds.1984; Cassidy N, 2011, CLIN TOXICOL, V49, P485, DOI 10.3109/15563650.2011.587193; Egberts TCG, 1996, BRIT MED J, V313, P530; Field TS, 2001, ARCH INTERN MED, V161, P1629, DOI 10.1001/archinte.161.13.1629; Grootheest K, 2003, NETHERLANDS, V26; HARTWIG SC, 1992, AM J HOSP PHARM, V49, P2229, DOI 10.1093/ajhp/49.9.2229; Hayes BD, 2009, J AM GERIATR SOC, V57, P653, DOI 10.1111/j.1532-5415.2008.02166.x; Hohl CM, 2001, ANN EMERG MED, V38, P666, DOI 10.1067/mem.2001.119456; Inacio P, 2016, BR J CLIN PHARM; Jarernsiripornkul N, 2002, BRIT J CLIN PHARMACO, V53, P318, DOI 10.1046/j.0306-5251.2001.01547.x; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Leendertse AJ, 2008, ARCH INTERN MED, V168, P1890, DOI 10.1001/archinternmed.2008.3; Mey C, 2002, INT J CLIN PHARM TH, V40, P102; Mowry JB, 2015, CLIN TOXICOL, V53, P962, DOI 10.3109/15563650.2015.1102927; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Organization WH, 1972, REP WHO M HELD GEN 2; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Royal Pharmaceutical Society of Great B, 2002, BMJ BOOKS; Sarkar U, 2011, HEALTH SERV RES, V46, P1517, DOI 10.1111/j.1475-6773.2011.01269.x; Shalviri G, 2009, IRAN J PUBLIC HEALTH, V38, P162; Smyth RMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024061; Vassilev ZP, 2009, AM J HLTH SYST PHARM, V66; Wester K, 2008, BRIT J CLIN PHARMACO, V65, P573, DOI 10.1111/j.1365-2125.2007.03064.x	28	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185450	10.1371/journal.pone.0185450	http://dx.doi.org/10.1371/journal.pone.0185450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950006	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000053
J	Wu, WH; Zhou, CF; Andres, B				Wu, Wen-Hao; Zhou, Chang-Fu; Andres, Brian			The toothless pterosaur Jidapterus edentus (Pterodactyloidea: Azhdarchoidea) from the Early Cretaceous Jehol Biota and its paleoecological implications	PLOS ONE			English	Article							JIUFOTANG FORMATION; HUAXIAPTERUS PTEROSAURIA; CHINA; TAPEJARIDAE; INFORMATION; DIVERSITY; TAXONOMY; GENUS	Background In the Early Cretaceous Jehol Biota, the toothless pterosaurs flourished with the chaoyangopterids and tapejarids playing a key role in understanding the early diversity and evolution of the Azhdarchoidea. Unlike the more diverse tapejarids, the rarer chaoyangopterids are characterized by a long and low rostrum, supporting a close relationship with the huge azhdarchids. Unfortunately, our knowledge is still limited in the osteology, paleoecology, and taxonomy of the Chaoyangopteridae. As one of the best preserved skeletons, the type and only specimen of Jidapterus edentus provides an opportunity to understand the morphology and paleoecology of the chaoyangopterids. Results Our study of the osteology of Jidapterus edentus reveals valuable information about the morphology of the Chaoyangopteridae such as a rostrum with a curved dorsal profile, high Rostral Index (RI), larger angle between the dorsal and postorbital processes of the jugal, sequentially shorter fourth to seventh cervical vertebrae, sternum with a plate wider than long, contact of the metacarpal I with the distal syncarpal, pneumatic foramen on first wing phalanx, hatchet-like postacetabular process with unconstricted neck and small dorsal process, distinctly concave anterior margin of pubis, subrectangular pubic plate with nearly parallel anterior and posterior margins, longer proximal phalanges of pedal digits III and IV, as well as reduced and less curved pedal unguals. These features further support the validity of Jidapterus edentus as a distinct species and the close relationship of the chaoyangopterids with the azhdarchids. Paleoecologically, the chaoyangopterids are probably like the azhdarchids, more terrestrial than the contemporaneous and putatively arboreal tapejarids, which may have been limited to the forest-dominated ecosystem of the Jehol Biota. Discussion The osteology of Jidapterus edentus further supports the close relationship of the Chaoyangopteridae with the Azhdarchidae in sharing a high RI value and reduced and mildly-curved pedal unguals, and it also implies a possible paleoecological similarity in their terrestrial capability. Combined with the putatively arboreal and herbivorous tapejarids, this distinct lifestyle of the chaoyangopterids provides new insights into the diversity of pterosaurs in the ecosystem of the Jehol Biota.	[Wu, Wen-Hao] Jilin Univ, Minist Educ, Key Lab Evolut Past Life & Environm Northeast Asi, Changchun, Jilin, Peoples R China; [Wu, Wen-Hao] Jilin Univ, Res Ctr Palaeontol & Stratig, Changchun, Jilin, Peoples R China; [Zhou, Chang-Fu] Shandong Univ Sci & Technol, Coll Earth Sci & Engn, Qingdao, Shandong, Peoples R China; [Zhou, Chang-Fu] Shenyang Normal Univ, Paleontol Inst, Shenyang, Liaoning, Peoples R China; [Andres, Brian] Univ Penn, Dept & Earth & Environm Sci, Philadelphia, PA 19104 USA	Jilin University; Jilin University; Shandong University of Science & Technology; Shenyang Normal University; University of Pennsylvania	Wu, WH (corresponding author), Jilin Univ, Minist Educ, Key Lab Evolut Past Life & Environm Northeast Asi, Changchun, Jilin, Peoples R China.; Wu, WH (corresponding author), Jilin Univ, Res Ctr Palaeontol & Stratig, Changchun, Jilin, Peoples R China.; Zhou, CF (corresponding author), Shandong Univ Sci & Technol, Coll Earth Sci & Engn, Qingdao, Shandong, Peoples R China.; Zhou, CF (corresponding author), Shenyang Normal Univ, Paleontol Inst, Shenyang, Liaoning, Peoples R China.	wenhao.wu@foxmail.com; zhoucf528@163.com	Wu, Wenhao/AAU-4325-2020	Andres, Brian/0000-0002-9958-0134; Wu, Wenhao/0000-0003-0970-9713; Zhou, Chang-Fu/0000-0002-3744-7573	Public Science and Technology Research Funds Projects of Land and Resources of China [201311120]; Liaoning Baiqianwan Talents Program [2014Q110]; National Natural Science Foundation of China [41202012]	Public Science and Technology Research Funds Projects of Land and Resources of China; Liaoning Baiqianwan Talents Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the Public Science and Technology Research Funds Projects of Land and Resources of China (No. 201311120) and Liaoning Baiqianwan Talents Program (No. 2014Q110) to CFZ, and National Natural Science Foundation of China (No. 41202012) to WHW. The funders had no role in study design, data collection and analysis, decision to pulish, or preparation of the manuscript.	Aires ASS, 2014, PALAEONTOLOGY, V57, P343, DOI 10.1111/pala.12069; Andres B, 2008, PALAEONTOLOGY, V51, P453, DOI 10.1111/j.1475-4983.2008.00761.x; Andres B, 2014, CURR BIOL, V24, P1011, DOI 10.1016/j.cub.2014.03.030; Andres B, 2012, EARTH ENV SCI T R SO, V103, P383, DOI 10.1017/S1755691013000303; Andres B, 2010, J VERTEBR PALEONTOL, V30, P163, DOI 10.1080/02724630903409220; [Anonymous], 1984, 33 C BRAS GEOL AN, V2, P578; Averianov A.O., 2010, P ZOOL I RAS, V314, P264; Bennett S. C., 2001, PALAEONTOGR ABT A, V260, P1; Bennett SC, 2007, J VERTEBR PALEONTOL, V27, P881, DOI 10.1671/0272-4634(2007)27[881:AAFOTP]2.0.CO;2; Bennett SC, 2007, PALAEONTOL Z, V81, P376, DOI 10.1007/BF02990250; Bennett SC, 2013, PALAEONTOL Z, V87, P269, DOI 10.1007/s12542-012-0159-8; Bennett SC, 2013, NEUES JAHRB GEOL P-A, V267, P23, DOI 10.1127/0077-7749/2012/0295; BENNETT SC, 1993, PALEOBIOLOGY, V19, P92, DOI 10.1017/S0094837300012331; BENNETT SC, 1995, J PALEONTOL, V69, P569, DOI 10.1017/S0022336000034946; Birn-Jeffery AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050555; Broom R, 1913, RECORDS ALBANY MUSEU, V2, P394; Buffetaut E, 1998, GEOL MAG, V135, P719, DOI 10.1017/S0016756898001575; Cai Zhengquan, 1994, Vertebrata Palasiatica, V32, P181; Chang SC, 2009, PALAEOGEOGR PALAEOCL, V280, P94, DOI 10.1016/j.palaeo.2009.06.021; Dong Z., 2003, GLOBAL GEOLOGY, V22, P1; Eck Kristina, 2011, Swiss Journal of Palaeontology, V130, P277, DOI 10.1007/s13358-011-0024-5; Elgin RA, 2012, HIST BIOL, V24, P586, DOI 10.1080/08912963.2011.613467; Elgin RA, 2011, SWISS J GEOSCI, V104, pS21, DOI 10.1007/s00015-011-0081-1; Frey Eberhard, 2003, Geological Society Special Publication, V217, P233, DOI 10.1144/GSL.SP.2003.217.01.14; Frey Eberhard, 2003, Geological Society Special Publication, V217, P55, DOI 10.1144/GSL.SP.2003.217.01.05; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hyder ES, 2014, ACTA PALAEONTOL POL, V59, P109, DOI 10.4202/app.2011.1109; Kaup SS, 1834, VERSUCH EINTHEILUNG, P311; Kellner A.W.A., 1989, Anais da Academia Brasileira de Ciencias, V61, P439; Kellner Alexander W.A., 2007, Boletim do Museu Nacional Nova Serie Geologia, V75, P1; Kellner Alexander Wilhelm Armin, 1994, Anais da Academia Brasileira de Ciencias, V66, P467; Kellner AWA, 2004, AMEGHINIANA, V41, P521; LEONARDI G, 1985, COLETANEA TRABALHOS, V27, P75; Liu DX, 2015, HIST BIOL, V27, P637, DOI 10.1080/08912963.2014.885962; Lu E J, 2006, PTEROSAURS CHINA BEI; Lu JC, 2005, ACTA GEOL SIN-ENGL, V79, P301; Lu JC, 2005, ACTA GEOL SIN-ENGL, V79, P453; Lu Jun-chang, 2006, Dizhi Tongbao, V25, P565; Lu JC, 2006, ACTA GEOL SIN-ENGL, V80, P783; Lu Junchang, 2005, Geological Review (Beijing), V51, P458; Lu JC, 2006, ACTA GEOL SIN-ENGL, V80, P315; Lu JC, 2008, NATURWISSENSCHAFTEN, V95, P891, DOI 10.1007/s00114-008-0397-5; Lu JC, 2007, ACTA GEOL SIN-ENGL, V81, P683; Manzig PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100005; Martill DM, 2006, PALAEONTOLOGY, V49, P925, DOI 10.1111/j.1475-4983.2006.00575.x; Martill DM, 2013, CRETACEOUS RES, V43, P26, DOI 10.1016/j.cretres.2013.02.007; Martin-Silverstone E, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160333; Naish D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058451; Nesov L.A., 1984, Paleontologicheskii Zhurnal, V1984, P47; Pinheiro FL, 2017, PEERJ, V5, DOI 10.7717/peerj.3285; Pinheiro FL, 2011, ACTA PALAEONTOL POL, V56, P567, DOI 10.4202/app.2010.0057; Plieninger F, 1901, PALAEONTOGRAPHICA, V48, P65; Quenstedt F.A., 1855, PTERODACTYLUS SUEVIC; Strong EE, 1999, CLADISTICS, V15, P363, DOI 10.1111/j.1096-0031.1999.tb00272.x; Unwin D., 2007, CRATO FOSSIL BEDS BR, P475, DOI 10.1017/CBO9780511535512.018; Unwin D. M, 2005, PTEROSAURS DEEP TIME; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Unwin David M., 2000, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V3, P181; Unwin David M., 1997, Historical Biology, V12, P199; Unwin David M., 1995, P69; Nova BCV, 2015, HIST BIOL, V27, P770, DOI 10.1080/08912963.2015.1007049; von Meyer CEH, 1854, MITTHEILUNGEN PROFES, P47; Vullo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038900; Wang Xiao-Lin, 2003, Vertebrata Palasiatica, V41, P34; Wang XL, 2008, P NATL ACAD SCI USA, V105, P1983, DOI 10.1073/pnas.0707728105; Wang XL, 2006, GEOL J, V41, P405, DOI 10.1002/gj.1046; Wang XL, 2012, NATURWISSENSCHAFTEN, V99, P249, DOI 10.1007/s00114-012-0889-1; Wang XL, 2003, CHINESE SCI BULL, V48, P16, DOI 10.1360/03tb9003; Wellnhofer P., 1991, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V31, P89; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Wheeler Q, 2000, SPECIES CONCEPTS PHY; Witton M.P., 2013, PTEROSAURS NATURAL H, DOI DOI 10.1515/9781400847655; Witton MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002271; Witton MP, 2008, PALAEONTOLOGY, V51, P1289, DOI 10.1111/j.1475-4983.2008.00811.x; Zhou CF, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160672; Zhou CF, 2011, NEUES JAHRB GEOL P-A, V260, P265, DOI 10.1127/0077-7749/2011/0131; Zhou CF, 2010, NEUES JAHRB GEOL P-A, V257, P341, DOI 10.1127/0077-7749/2010/0081; Zhou ZG, 2006, GEOL J, V41, P377, DOI 10.1002/gj.1045; Zhou ZH, 2010, SCI CHINA EARTH SCI, V53, P1894, DOI 10.1007/s11430-010-4094-9	81	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185486	10.1371/journal.pone.0185486	http://dx.doi.org/10.1371/journal.pone.0185486			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950013	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000058
J	Jackson, E; Zhang, CX; Kiani, Z; Lisovsky, I; Tallon, B; Del Corpo, A; Gilbert, L; Bruneau, J; Thomas, R; Cote, P; Trottier, B; LeBlanc, R; Rouleau, D; Tremblay, C; Tsoukas, CM; Routy, JP; Ni, XY; Mabanga, T; Bernard, NF				Jackson, Elise; Zhang, Cindy Xinyu; Kiani, Zahra; Lisovsky, Irene; Tallon, Benjamin; Del Corpo, Alexa; Gilbert, Louise; Bruneau, Julie; Thomas, Rejean; Cote, Pierre; Trottier, Benoit; LeBlanc, Roger; Rouleau, Danielle; Tremblay, Cecile; Tsoukas, Christos M.; Routy, Jean-Pierre; Ni, Xiaoyan; Mabanga, Tsoarello; Bernard, Nicole F.		Montreal Primary Infect Study Grp	HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness	PLOS ONE			English	Article							MHC CLASS-I; UNINFECTED INDIVIDUALS; HAPLOTYPES CONTAIN; KIR2DL5 ALLELES; DRUG-USERS; HLA-C; DIVERSITY; REPERTOIRES; RECOGNITION; KIR3DS1	Previously, we showed that Killer Immunoglobulin-like Receptor (KIR) 3DS1 homozygotes (hmz) are more frequent in HIV exposed seronegative (HESN) than in recently HIV infected (HIV+) individuals. KIR3DS1 encodes an activating Natural Killer (NK) cell receptor (NKR). The link between KIR genotype and HIV outcomes likely arises from the function that NK cells acquire through expression of particular NKRs. An initial screen of 97 HESN and 123 HIV+ subjects for the frequency of KIR region gene carriage observed between-group differences for several telomeric KIR region loci. In a larger set of up to 106 HESN and 439 HIV+ individuals, more HESN than HIV+ subjects were KIR3DS1 homozygotes, lacked a full length KIR2DS4 gene and carried the telomeric group B KIR haplotype motif, TB01. TB01 is characterized by the presence of KIR3DS1, KIR2DL5A, KIR2DS3/5 and KIR2DS1, in linkage disequilibrium with each other. We assessed which of the TB01 encoded KIR gene products contributed to NK cell responsiveness by stimulating NK cells from 8 HIV seronegative KIR3DS1 and TB01 motif homozygotes with 721.221 HLA null cells and evaluating the frequency of KIR3DS1 +/-KIR2DL5 +/-, KIR3DS1 +/-KIR2DS1 +/-, KIR3DS1 +/-KIR2DS5 +/-NK cells secreting IFN-. and/or expressing CD107a. A higher frequency of NK cells expressing, versus not, KIR3DS1 responded to 721.221 stimulation. KIR2DL5A +, KIR2DS1 + and KIR2DS5 + NK cells did not contribute to 721.221 responses or modulate those by KIR3DS1 + NK cells. Thus, of the TB01 KIR gene products, only KIR3DS1 conferred responsiveness to HLA-null stimulation, demonstrating its ligation can activate ex vivo NK cells	[Jackson, Elise; Zhang, Cindy Xinyu; Kiani, Zahra; Lisovsky, Irene; Tallon, Benjamin; Del Corpo, Alexa; Gilbert, Louise; Tsoukas, Christos M.; Routy, Jean-Pierre; Ni, Xiaoyan; Mabanga, Tsoarello; Bernard, Nicole F.] McGill Univ, Hlth Ctr RI MUHC, Res Inst, Montreal, PQ, Canada; [Jackson, Elise; Zhang, Cindy Xinyu] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Kiani, Zahra; Lisovsky, Irene; Tallon, Benjamin; Tsoukas, Christos M.; Routy, Jean-Pierre; Bernard, Nicole F.] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [Bruneau, Julie] CHU Montreal, CR CHUM, Ctr Rech, Montreal, PQ, Canada; [Bruneau, Julie] Univ Montreal, Dept Family Med, Montreal, PQ, Canada; [Thomas, Rejean] Clin Med Actuel, Montreal, PQ, Canada; [Thomas, Rejean] CHUM, Montreal, PQ, Canada; [Cote, Pierre; Trottier, Benoit] Clin Med Quartier Latin, Montreal, PQ, Canada; [LeBlanc, Roger] Clin OPUS, Montreal, PQ, Canada; [Rouleau, Danielle; Tremblay, Cecile] Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Tsoukas, Christos M.; Routy, Jean-Pierre; Bernard, Nicole F.] MUHC, Chron Viral Illness Serv, Montreal, PQ, Canada; [Tsoukas, Christos M.; Routy, Jean-Pierre; Bernard, Nicole F.] MUHC, Div Clin Immunol, Montreal, PQ, Canada; [Routy, Jean-Pierre] MUHC, Div Hematol, Montreal, PQ, Canada	McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal	Bernard, NF (corresponding author), McGill Univ, Hlth Ctr RI MUHC, Res Inst, Montreal, PQ, Canada.; Bernard, NF (corresponding author), McGill Univ, Div Expt Med, Montreal, PQ, Canada.; Bernard, NF (corresponding author), MUHC, Chron Viral Illness Serv, Montreal, PQ, Canada.; Bernard, NF (corresponding author), MUHC, Div Clin Immunol, Montreal, PQ, Canada.	nicole.bernard@mcgill.ca	Ni, xiaoyan/GWU-8114-2022	Jackson, Elise/0000-0002-1321-8979	Canadian Institutes for Health Research [MOP-142494, MOP-103230]; Canadian HIV Trials Network [CTN-257]; Fonds de Recherche du Quebec-Sante, AIDS and Infectious Diseases Network infrastructure grant; Fonds de Recherche du Quebec-Sante AIDS and Infectious Diseases Network Ph.D. scholarship grant; Canadian Institutes for Health Research Ph.D. scholarship; Fonds de Recherche du Quebec-Sante	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian HIV Trials Network; Fonds de Recherche du Quebec-Sante, AIDS and Infectious Diseases Network infrastructure grant; Fonds de Recherche du Quebec-Sante AIDS and Infectious Diseases Network Ph.D. scholarship grant; Canadian Institutes for Health Research Ph.D. scholarship; Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by Canadian Institutes for Health Research grants MOP-142494 and MOP-103230 to NFB; Canadian HIV Trials Network grant CTN-257 to J-PR; Fonds de Recherche du Quebec-Sante, AIDS and Infectious Diseases Network infrastructure grant to Dr. Nicole F. Bernard; Fonds de Recherche du Quebec-Sante AIDS and Infectious Diseases Network Ph.D. scholarship grant to IL; Canadian Institutes for Health Research Ph.D. scholarship to IL; Partial support from the Fonds de Recherche du Quebec-Sante to the Research Institute of the McGill University Health Center of which NFB and J-PR are members.	Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Beziat V, 2014, EUR J IMMUNOL, V44, P2192, DOI 10.1002/eji.201444464; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Boulet S, 2008, AIDS, V22, P595, DOI 10.1097/QAD.0b013e3282f56b23; Boulet S, 2010, J IMMUNOL, V184, P2057, DOI 10.4049/jimmunol.0902621; Bruneau J, 2011, AM J EPIDEMIOL, V173, P1049, DOI 10.1093/aje/kwq479; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Della Chiesa M, 2008, EUR J IMMUNOL, V38, P2284, DOI 10.1002/eji.200838434; Du Z, 2008, GENES IMMUN, V9, P470, DOI 10.1038/gene.2008.39; Estefania E, 2007, J IMMUNOL, V178, P4402, DOI 10.4049/jimmunol.178.7.4402; Fauriat C, 2010, BLOOD, V115, P1166, DOI 10.1182/blood-2009-09-245746; Garcia-Beltran WF, 2016, NAT IMMUNOL, V17, P1067, DOI 10.1038/ni.3513; Gillespie GMA, 2007, AIDS RES HUM RETROV, V23, P451, DOI 10.1089/aid.2006.0165; Gomez-Lozano N, 2002, IMMUNOGENETICS, V54, P314, DOI 10.1007/s00251-002-0476-2; Gomez-Lozano N, 2007, EUR J IMMUNOL, V37, P1954, DOI 10.1002/eji.200737277; Graef T, 2009, J EXP MED, V206, P2557, DOI 10.1084/jem.20091010; Guerini FR, 2011, J INFECT DIS, V203, P1235, DOI 10.1093/infdis/jir020; de Sorrentino AH, 2013, IMMUNOLOGY, V140, P273, DOI 10.1111/imm.12137; Hsu KC, 2002, IMMUNOL REV, V190, P40, DOI 10.1034/j.1600-065X.2002.19004.x; Jennes W, 2013, BLOOD, V121, P1157, DOI 10.1182/blood-2012-09-455352; Jiang W, 2012, GENOME RES, V22, P1845, DOI 10.1101/gr.137976.112; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Korner C, 2014, EUR J IMMUNOL, V44, P2938, DOI 10.1002/eji.201444751; Kulkarni S, 2010, METHODS MOL BIOL, V612, P365, DOI 10.1007/978-1-60761-362-6_25; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Llano M, 1998, EUR J IMMUNOL, V28, P2854, DOI 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W; Manser AR, 2015, IMMUNOL REV, V267, P178, DOI 10.1111/imr.12316; Marsh SGE, 2003, HUM IMMUNOL, V64, P648, DOI 10.1016/S0198-8859(03)00067-3; Martin AM, 2000, IMMUNOGENETICS, V51, P268, DOI 10.1007/s002510050620; Martin AM, 2004, GENE, V335, P121, DOI 10.1016/j.gene.2004.03.018; Maxwell LD, 2002, TISSUE ANTIGENS, V60, P254, DOI 10.1034/j.1399-0039.2002.600307.x; Merino A, 2011, J INFECT DIS, V203, P487, DOI 10.1093/infdis/jiq075; Merino AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099353; Middleton D, 2007, HUM IMMUNOL, V68, P128, DOI 10.1016/j.humimm.2006.12.007; O'Connor GM, 2007, J IMMUNOL, V178, P235, DOI 10.4049/jimmunol.178.1.235; O'Connor GM, 2015, J VIROL, V89, P5213, DOI 10.1128/JVI.03586-14; Oliva A, 1998, J CLIN INVEST, V102, P223, DOI 10.1172/JCI2323; Olvera A, 2015, AIDS, V29, P507, DOI 10.1097/QAD.0000000000000574; Ordonez D, 2008, GENES IMMUN, V9, P431, DOI 10.1038/gene.2008.34; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Ravet S, 2007, BLOOD, V109, P4296, DOI 10.1182/blood-2006-08-040238; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Scott-Algara D, 2003, J IMMUNOL, V171, P5663, DOI 10.4049/jimmunol.171.11.5663; Song RJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003867; Stewart CA, 2005, P NATL ACAD SCI US; Tallon BJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110480; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Trowsdale J, 2001, IMMUNOL REV, V181, P20, DOI 10.1034/j.1600-065X.2001.1810102.x; Trowsdale J, 2001, IMMUNITY, V15, P363, DOI 10.1016/S1074-7613(01)00197-2; Trowsdale J, 2015, IMMUNOL REV, V267, P117, DOI 10.1111/imr.12314; Uhrberg M, 2002, IMMUNOGENETICS, V54, P221, DOI 10.1007/s00251-002-0463-7; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; VandenBussche CJ, 2009, GENES IMMUN, V10, P162, DOI 10.1038/gene.2008.91; Vilches C, 2000, J IMMUNOL, V165, P6416, DOI 10.4049/jimmunol.165.11.6416; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Walzer T, 2005, BLOOD; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Yusa SI, 2004, J IMMUNOL, V172, P7385, DOI 10.4049/jimmunol.172.12.7385	63	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							0185160	10.1371/journal.pone.0185160	http://dx.doi.org/10.1371/journal.pone.0185160			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938026	gold, Green Submitted, Green Published			2022-12-27	WOS:000411524700019
J	Soundy, J; Day, D				Soundy, Jennifer; Day, Darren			Selection of DNA aptamers specific for live Pseudomonas aeruginosa	PLOS ONE			English	Article							IN-VITRO SELECTION; CELL-SELEX; RESISTANCE; BACTERIA; BIOFILMS	Pseudomonas aeruginosa is an opportunistic pathogen that causes significant morbidity and mortality in immunocompromised patients, particular cystic fibrosis sufferers, burns victims, diabetics and neonates. It thrives in moist places where it forms biofilms that are exceedingly difficult to eradicate on hospital surfaces, in water supplies and implanted biomaterials. Using a live cell SELEX approach we selected DNA aptamers to P. aeruginosa grown as biofilms in microfluidic cells. From a pool of aptamer candidates showing tight binding a stem-loop structure was identified as being important for binding. Enhanced binding and increased specificity was achieved by truncating structures and generating chimeric aptamers from the pool of top candidates. The top candidates have low nanomo larbinding constants and high discrimination for P. aeruginosa over other Gram-negative bacteria. The aptamers bind both planktonic grown and biofilm grown cells. They do not have intrinsic bacteriostatic or bactericidal activity, but are ideal candidates for modification for use as aptamer-drug conjugates and in biosensors.	[Soundy, Jennifer; Day, Darren] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	Victoria University Wellington	Day, D (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	darren.day@vuw.ac.nz		Soundy, Jennifer/0000-0002-5576-3529	Wellington Medical Research Foundation [2015/257]	Wellington Medical Research Foundation	This work was supported by the Wellington Medical Research Foundation (https://researchforlife.org,nz/), grant 2015/257 (DD). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababneh N, 2013, NUCLEIC ACID THER, V23, P401, DOI 10.1089/nat.2013.0423; Bruno JG, 2013, PHARMACEUTICALS, V6, P340, DOI 10.3390/ph6030340; Chen F, 2007, BIOCHEM BIOPH RES CO, V357, P743, DOI 10.1016/j.bbrc.2007.04.007; Creach V, 2003, J MICROBIOL METH, V52, P19, DOI 10.1016/S0167-7012(02)00128-8; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Heiat M, 2017, BIOTECHNOL APPL BIOC, V64, P541, DOI 10.1002/bab.1507; Kolovskaya OS, 2013, J MED CHEM, V56, P1564, DOI 10.1021/jm301856j; Mulcahy LR, 2014, MICROB ECOL, V68, P1, DOI 10.1007/s00248-013-0297-x; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Savory N, 2014, J MICROBIOL METH, V104, P94, DOI 10.1016/j.mimet.2014.06.016; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sun HG, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.32; Taylor PK, 2014, J BIOTECHNOL, V191, P121, DOI 10.1016/j.jbiotec.2014.09.003; Wang KY, 2011, EUR J CLIN MICROBIOL, V30, P273, DOI 10.1007/s10096-010-1074-0; Willyard C, 2017, NATURE, V543, P15, DOI 10.1038/nature.2017.21550; Ye M, 2012, INT J MOL SCI, V13, P3341, DOI 10.3390/ijms13033341; Zimbres FM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/731516; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	18	25	28	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185385	10.1371/journal.pone.0185385	http://dx.doi.org/10.1371/journal.pone.0185385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28937998	Green Published, gold, Green Submitted			2022-12-27	WOS:000411524700029
J	Pratt, H; Hassanin, K; Troughton, LD; Czanner, G; Zheng, YL; McCormick, AG; Hamill, KJ				Pratt, Harry; Hassanin, Kareem; Troughton, Lee D.; Czanner, Gabriela; Zheng, Yalin; McCormick, Austin G.; Hamill, Kevin J.			UV imaging reveals facial areas that are prone to skin cancer are disproportionately missed during sunscreen application	PLOS ONE			English	Article							BASAL-CELL-CARCINOMA; PITUITARY-ADRENAL AXIS; VITAMIN-D DEFICIENCY; SUN PROTECTION; ULTRAVIOLET-RADIATION; RISK-FACTORS; INTERVENTION; MELANOMA; EXPOSURE; COHORT	Application of sunscreen is a widely used mechanism for protecting skin from the harmful effects of UV light. However, protection can only be achieved through effective application, and areas that are routinely missed are likely at increased risk of UV damage. Here we sought to determine if specific areas of the face are missed during routine sunscreen application, and whether provision of public health information is sufficient to improve coverage. To investigate this, 57 participants were imaged with a UV sensitive camera before and after sunscreen application: first visit; minimal pre-instruction, second visit; provided with a public health information statement. Images were scored using a custom automated image analysis process designed to identify areas of high UV reflectance, i. e. missed during sunscreen application, and analysed for 5% significance. Analyses revealed eyelid and periorbital regions to be disproportionately missed during routine sunscreen application (median 14% missed in eyelid region vs 7% in rest of face, p<0.01). Provision of health information caused a significant improvement in coverage to eyelid areas in general however, the medial canthal area was still frequently missed. These data reveal that a public health announcement- type intervention could be effective at improving coverage of high risk areas of the face, however high risk areas are likely to remain unprotected therefore other mechanisms of sun protection should be widely promoted such as UV blocking sunglasses.	[Pratt, Harry; Hassanin, Kareem; Troughton, Lee D.; Czanner, Gabriela; Zheng, Yalin; Hamill, Kevin J.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Eye & Vis Sci, Liverpool, Merseyside, England; [Czanner, Gabriela] Univ Liverpool, Inst Translat Med, Dept Biostat, Liverpool, Merseyside, England; [McCormick, Austin G.] Aintree Univ, Teaching Hosp, Dept Opthalmol, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool	Hamill, KJ (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Dept Eye & Vis Sci, Liverpool, Merseyside, England.	khamill@liverpool.ac.uk	Czanner, Gabriela/ABC-7569-2021; Hamill, Kevin/ABF-9727-2020	Czanner, Gabriela/0000-0002-1157-2093; Hamill, Kevin/0000-0002-7852-1944	University of Liverpool Mastersin Research Course	University of Liverpool Mastersin Research Course	This work was supported by bench fees raised from a University of Liverpool Mastersin Research Course.	ABRAHAM JC, 1973, AM J SURG, V126, P492, DOI 10.1016/S0002-9610(73)80036-4; Arnold J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b541; Bauer A, 2011, BRIT J DERMATOL, V165, P612, DOI 10.1111/j.1365-2133.2011.10425.x; Buller DB, 2017, PREV MED, V99, P29, DOI 10.1016/j.ypmed.2017.01.014; Carter KD, 1999, OPHTHALMIC PLAST REC, V15, P83, DOI 10.1097/00002341-199903000-00004; Cherbuin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005265; Cook BE, 1999, OPHTHALMOLOGY, V106, P746, DOI 10.1016/S0161-6420(99)90161-6; Cook BE, 2001, OPHTHALMOLOGY, V108, P2088, DOI 10.1016/S0161-6420(01)00796-5; de Blacam C, 2017, SURG-J R COLL SURG E, V15, P12, DOI 10.1016/j.surge.2015.07.001; Gamble RG, 2012, J AM ACAD DERMATOL, V67, P587, DOI 10.1016/j.jaad.2011.11.922; Ganesan P, 2014, 2014 INTERNATIONAL CONFERENCE ON CONTROL, INSTRUMENTATION, COMMUNICATION AND COMPUTATIONAL TECHNOLOGIES (ICCICCT), P101, DOI 10.1109/ICCICCT.2014.6992938; Garland CF, 2006, AM J PUBLIC HEALTH, V96, P252, DOI 10.2105/AJPH.2004.045260; Gibbons FX, 2005, HEALTH PSYCHOL, V24, P358, DOI 10.1037/0278-6133.24.4.358; Glanz K, 2015, CANCER EPIDEM BIOMAR, V24, P415, DOI 10.1158/1055-9965.EPI-14-0926; Gorham ED, 2007, ANN EPIDEMIOL, V17, P956, DOI 10.1016/j.annepidem.2007.06.008; Grant WB, 2009, DERM-ENDOCRINOL, V1, P207, DOI 10.4161/derm.1.4.9841; Grencis P W, 1999, J Audiov Media Med, V22, P171; HADDAD RA, 1991, IEEE T SIGNAL PROCES, V39, P723, DOI 10.1109/78.80892; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Isedeh P, 2013, PHOTODERMATOL PHOTO, V29, P55, DOI 10.1111/phpp.12017; Iuliano A, 2012, AM J OPHTHALMOL, V153, P238, DOI 10.1016/j.ajo.2011.08.004; Jackson KM, 2006, HEALTH PSYCHOL, V25, P34, DOI 10.1037/0278-6133.25.1.34; Jeanmougin M, 2014, PHOTODERMATOL PHOTO, V30, P323, DOI 10.1111/phpp.12138; Kalra S, 2015, J PAK MED ASSOC, V65, P569; Kirchberger MC, 2016, PHOTODERMATOLOGY PHO; Kiviniemi MT, 2014, J BEHAV MED, V37, P1069, DOI 10.1007/s10865-013-9538-1; Koch S., 2016, J CANC ED; Lademann J, 2004, J Cosmet Dermatol, V3, P62, DOI 10.1111/j.1473-2130.2004.00107.x; Liou JC, 2015, MOL VIS, V21; LOESCH H, 1994, ARCH DERMATOL, V130, P665, DOI 10.1001/archderm.130.5.665; Mahler HIM, 2003, HEALTH PSYCHOL, V22, P199, DOI 10.1037/0278-6133.22.2.199; Manson JE, 2000, EPIDEMIOLOGY, V11, P728, DOI 10.1097/00001648-200011000-00021; MARGO CE, 1993, SURV OPHTHALMOL, V38, P169, DOI 10.1016/0039-6257(93)90100-L; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Petersen B, 2014, PHOTODERMATOL PHOTO, V30, P96, DOI 10.1111/phpp.12099; Ransohoff KJ, 2016, CANCER CAUSE CONTROL, V27, P817, DOI 10.1007/s10552-016-0730-9; Roberts JE, 2011, EYE CONTACT LENS, V37, P246, DOI 10.1097/ICL.0b013e31821cbcc9; Saleh GM, 2017, BRIT J OPHTHALMOL, V101, P209, DOI 10.1136/bjophthalmol-2015-308261; Samanek AJ, 2006, MED J AUSTRALIA, V184, P338, DOI 10.5694/j.1326-5377.2006.tb00267.x; Sattler U, 2014, BRIT J DERMATOL, V170, P1327, DOI 10.1111/bjd.12966; Schuz N, 2013, J BEHAV MED, V36, P508, DOI 10.1007/s10865-012-9445-x; Skobowiat C, 2017, PHOTOCHEM PHOTOBIOL, V93, P1008, DOI 10.1111/php.12642; Skobowiat C, 2016, EXP DERMATOL, V25, P120, DOI 10.1111/exd.12890; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Surdu Simona, 2014, Reviews on Environmental Health, V29, P255, DOI 10.1515/reveh-2014-0040; TRAHANIAS PE, 1992, 11TH IAPR INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION, PROCEEDINGS, VOL III, P545, DOI 10.1109/ICPR.1992.202045; Trakatelli M, 2016, J EUR ACAD DERMATOL, V30, P5, DOI 10.1111/jdv.13603; Walther U, 2004, BRIT J DERMATOL, V151, P170, DOI 10.1111/j.1365-2133.2004.06030.x; Wang SQ, 2016, PHOTODERMATOL PHOTO, V32, P55, DOI 10.1111/phpp.12211; Yan XS, 2008, CUTAN OCUL TOXICOL, V27, P231, DOI 10.1080/15569520802251072; Young AR, 2017, J AM ACAD DERMATOL, V76, pS100, DOI 10.1016/j.jaad.2016.09.038; Zgaga L, 2011, J NUTR, V141, P1535, DOI 10.3945/jn.111.140012	55	16	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185297	10.1371/journal.pone.0185297	http://dx.doi.org/10.1371/journal.pone.0185297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968413	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000412029600017
J	Chuchuen, O; Maher, JR; Henderson, MH; Desoto, M; Rohan, LC; Wax, A; Katz, DF				Chuchuen, Oranat; Maher, Jason R.; Henderson, Marcus H.; Desoto, Michael; Rohan, Lisa C.; Wax, Adam; Katz, David F.			Label-free analysis of tenofovir delivery to vaginal tissue using co-registered confocal Raman spectroscopy and optical coherence tomography	PLOS ONE			English	Article							BIOLOGICAL TISSUES; MICROBICIDE GEL; EX-VIVO; SKIN; PERMEATION; MICROSPECTROSCOPY; SCATTERING; MUCOSA; WOMEN; MODEL	Vaginally applied microbicide products offer a female-controlled strategy for preventing sexual transmission of HIV. Microbicide transport processes are central to their functioning, and there is a clear need for a better understanding of them. To contribute to that end, we developed an assay to analyze mass transport rates of microbicide molecules within the epithelial and stromal layers of polarized vaginal mucosal tissue during contact with a gel vehicle. The assay utilizes a new diffusion chamber mounted in a custom instrument that combines con-focal Raman spectroscopy and optical coherence tomography. This measures depth-resolved microbicide concentration distributions within epithelium and stroma. Data for a tenofovir gel were fitted with a compartmental diffusion model to obtain fundamental transport properties: the molecular diffusion and partition coefficients in different compartments. Diffusion coefficients in epithelium and stroma were computed to be 6.10 +/- 2.12 x 10(-8) and 4.52 +/- 1.86 x 10(-7) cm(2) /sec, respectively. The partition coefficients between epithelium and gel and between stroma and epithelium were found to be 0.53 +/- 0.15 and 1.17 +/- 0.16, respectively. These drug transport parameters are salient in governing the drug delivery performance of different drug and gel vehicle systems. They can be used to contrast drugs and vehicles during product design, development and screening. They are critical inputs to deterministic transport models that predict the gels' pharmacokinetic performance, which can guide improved design of products and optimization of their dosing regimens.	[Chuchuen, Oranat] Khon Kaen Univ, Fac Technol, Dept Biotechnol, Khon Kaen, Thailand; [Chuchuen, Oranat; Maher, Jason R.; Henderson, Marcus H.; Desoto, Michael; Wax, Adam; Katz, David F.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Rohan, Lisa C.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Rohan, Lisa C.] Magee Womens Res Inst, Pittsburgh, PA USA; [Katz, David F.] Duke Univ, Dept Obstet & Gynecol, Durham, NC 27708 USA	Khon Kaen University; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Duke University	Katz, DF (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.; Katz, DF (corresponding author), Duke Univ, Dept Obstet & Gynecol, Durham, NC 27708 USA.	dkatz@duke.edu	Chuchuen, Oranat/GQA-4250-2022	Chuchuen, Oranat/0000-0002-4152-683X	National Institute of Health [RO1 HD 072702, U19 Al 113127]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072702] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study is funded by National Institute of Health grants RO1 HD 072702 and U19 Al 113127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, 20 C RETR OPP INF AT, DOI DOI 10.1056/NEJM0A1402269; Baeten JM, 2016, NEW ENGLAND J MED; Belsey NA, 2014, J CONTROL RELEASE, V174, P37, DOI 10.1016/j.jconrel.2013.11.002; Berger AJ, 1997, APPL SPECTROSC, V51, P725, DOI 10.1366/0003702971940882; Camp CH, 2015, NAT PHOTONICS, V9, P295, DOI 10.1038/NPHOTON.2015.60; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Chuchuen O, 2017, J PHARM SCI-US, V106, P639, DOI 10.1016/j.xphs.2016.09.030; Chuchuen O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085124; Davis CC, 2014, TOXICOL APPL PHARM, V274, P240, DOI 10.1016/j.taap.2013.11.021; Dezzutti CS, 2012, J ANTIMICROB CHEMOTH, V67, P2139, DOI 10.1093/jac/dks173; Everall NJ, 2010, ANALYST, V135, P2512, DOI 10.1039/c0an00371a; Franz TJ, 1975, J INVEST DERMATOL, V64, P190; FUJIMOTO JG, 1995, NAT MED, V1, P970, DOI 10.1038/nm0995-970; Gao Y, 2015, PREGNANCY HYPERTENS, V5, P94, DOI DOI 10.1007/S13346-015-0227-1; Gao YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167696; Gao YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074404; HAALAND DM, 1988, ANAL CHEM, V60, P1193, DOI 10.1021/ac00162a020; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; IZATT JA, 1997, OPT PHOTONICS NEWS, V8, P41; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Katz DF, 2015, ADV DRUG DELIVER REV, V92, P2, DOI 10.1016/j.addr.2015.04.017; Lai BE, 2010, ANTIVIR RES, V88, P143, DOI 10.1016/j.antiviral.2010.08.006; Mahalingam A, 2011, ANTIMICROB AGENTS CH, V55, P1650, DOI 10.1128/AAC.01368-10; Maher JR, 2015, BIOMED OPT EXPRESS, V6, P2022, DOI 10.1364/BOE.6.002022; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Mcgowan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060147; Nel AM, 2010, AIDS RES HUM RETROV, V26, P1181, DOI 10.1089/aid.2009.0227; Neves JD, 2014, DRUG DELIVERY DEV AN; Nguyen TT, 2012, SPECTROSC-INT J, V27, P421, DOI 10.1155/2012/686183; Rees H, 2015, C RETR OPP INF SEATT, p26LB; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Roy K, 1995, INT SOC OPTICS PHOTO; Schmitt JM, 1999, IEEE J SEL TOP QUANT, V5, P1205, DOI 10.1109/2944.796348; Severcan F, 2012, ADV BIOMED SPECTROSC, V6, P1; Shrivastava A., 2011, CHRONICLES YOUNG SCI, V2, P21, DOI [DOI 10.4103/2229-5186.79345, 10.4103/2229-5186.79345]; Squier CA, 2008, J PHARM SCI-US, V97, P9, DOI 10.1002/jps.21077; Tfayli A, 2007, EUR BIOPHYS J BIOPHY, V36, P1049, DOI 10.1007/s00249-007-0191-x; Truskey G. A., 2004, TRANSPORT PHENOMENA; ur Rehman I., 2012, VIBRATIONAL SPECTROS; USAID, FACTS 001 TRIAL QUES; Van der Bijl P., 1998, EFFECT FREEZING PERM; Vargas G, 2009, J INFECT DIS, V199, P1546, DOI 10.1086/598221; Wood BR, 1996, BIOSPECTROSCOPY, V2, P143, DOI 10.1002/(SICI)1520-6343(1996)2:3<143::AID-BSPY1>3.0.CO;2-9; Xiao CH, 2005, J INVEST DERMATOL, V124, P622, DOI 10.1111/j.0022-202X.2004.23608.x; Zidan AS, 2014, J PHARM SCI-US, V103, P952, DOI 10.1002/jps.23867	46	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185633	10.1371/journal.pone.0185633	http://dx.doi.org/10.1371/journal.pone.0185633			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961280	Green Published, Green Submitted, gold			2022-12-27	WOS:000412027700028
J	Liu, YJ; Wei, JH; Yuen, SMWK; Sun, B; Tang, YJ; Wang, RW; Van Petegem, F; Chen, SRW				Liu, Yingjie; Wei, Jinhong; Yuen, Siobhan M. Wong King; Sun, Bo; Tang, Yijun; Wang, Ruiwu; Van Petegem, Filip; Chen, S. R. Wayne			CPVT-associated cardiac ryanodine receptor mutation G357S with reduced penetrance impairs Ca2+ release termination and diminishes protein expression	PLOS ONE			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; SUDDEN-DEATH; MOLECULAR CHARACTERIZATION; CHANNEL; REGION; ACTIVATION; AFTERDEPOLARIZATIONS; ARRHYTHMIAS; THRESHOLD; DIAGNOSIS	Catecholaminergic polymorphic ventricular tachycardia (CPVT) is one of the most lethal inherited cardiac arrhythmias mostly linked to cardiac ryanodine receptor (RyR2) mutations with high disease penetrance. Interestingly, a novel RyR2 mutation G357S discovered in a large family of more than 1400 individuals has reduced penetrance. The molecular basis for the incomplete disease penetrance in this family is unknown. To gain insights into the variable disease expression in this family, we determined the impact of the G357S mutation on RyR2 function and expression. We assessed spontaneous Ca2+ release in HEK293 cells expressing RyR2 wildtype and the G357S mutant during store Ca2+ overload, also known as store overload induced Ca2+ release (SOICR). We found that the G357S mutation reduced the percentage of RyR2-expressing cells that showed SOICR. However, in cells that displayed SOICR, G357S reduced the thresholds for the activation and termination of SOICR. Furthermore, G357S decreased the thermal stability of the N-terminal domain of RyR2, and markedly reduced the protein expression of the full-length RyR2. On the other hand, the G357S mutation did not alter the Ca2+ activation of [H-3] ryanodine binding or the Ca2+ induced release of Ca2+ from the intracellular stores in HEK293 cells. These data indicate that the CPVT-associated G357S mutation enhances the arrhythmogenic SOICR and reduces RyR2 protein expression, which may be attributable to the incomplete penetrance of CPVT in this family.	[Liu, Yingjie; Wei, Jinhong; Sun, Bo; Tang, Yijun; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Yuen, Siobhan M. Wong King; Van Petegem, Filip] Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC, Canada; [Tang, Yijun] Hubei Univ Med, Taihe Hosp, Affiliated Hosp, Wuhan, Hubei, Peoples R China	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of British Columbia; Hubei University of Medicine	Chen, SRW (corresponding author), Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Physiol & Pharmacol, Calgary, AB, Canada.	swchen@ucalgary.ca	Wei, Jinhong/GWV-0561-2022; Van petegem, Filip/M-6061-2016	Wei, Jinhong/0000-0002-5251-9192; Van petegem, Filip/0000-0003-2728-8537	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Canada Foundation for Innovation; Heart and Stroke Foundation Chair in Cardiovascular Research; Alberta Innovates-Health Solutions (AIHS) Studentship Award; Libin Cardiovascular Institute of Alberta and Cumming School of Medicine Postdoctoral Fellowship Award; Heart and Stroke Foundation of Canada Junior Fellowship Award; AIHS Fellowship Award; Alberta Innovates [201400104] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart and Stroke Foundation Chair in Cardiovascular Research; Alberta Innovates-Health Solutions (AIHS) Studentship Award; Libin Cardiovascular Institute of Alberta and Cumming School of Medicine Postdoctoral Fellowship Award; Heart and Stroke Foundation of Canada Junior Fellowship Award; AIHS Fellowship Award; Alberta Innovates	This work was supported by research grants from the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Canada, the Canada Foundation for Innovation, and the Heart and Stroke Foundation Chair in Cardiovascular Research (to S.R.W.C.). YL is a recipient of the Alberta Innovates-Health Solutions (AIHS) Studentship Award. JW is a recipient of the Libin Cardiovascular Institute of Alberta and Cumming School of Medicine Postdoctoral Fellowship Award. BS is a recipient of the Heart and Stroke Foundation of Canada Junior Fellowship Award and the AIHS Fellowship Award. SRWC is an AIHS Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Bai XC, 2016, CELL RES, V26, P995, DOI 10.1038/cr.2016.89; BASSANI JWM, 1995, AM J PHYSIOL-CELL PH, V268, pC1313, DOI 10.1152/ajpcell.1995.268.5.C1313; Bauce B, 2002, J AM COLL CARDIOL, V40, P341, DOI 10.1016/S0735-1097(02)01946-0; Diaz ME, 1997, J PHYSIOL-LONDON, V501, P3, DOI 10.1111/j.1469-7793.1997.003bo.x; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Haugaa KH, 2010, EUROPACE, V12, P417, DOI 10.1093/europace/eup448; Hayashi M, 2009, CIRCULATION, V119, P2426, DOI 10.1161/CIRCULATIONAHA.108.829267; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Kannankeril PJ, 2006, P NATL ACAD SCI USA, V103, P12179, DOI 10.1073/pnas.0600268103; Kimlicka L, 2013, STRUCTURE, V21, P1440, DOI 10.1016/j.str.2013.06.012; Kimlicka L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2501; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lahat H, 2001, AM J HUM GENET, V69, P1378, DOI 10.1086/324565; Laitinen PJ, 2001, CIRCULATION, V103, P485, DOI 10.1161/01.CIR.103.4.485; LAKATTA EG, 1992, CARDIOVASC RES, V26, P193, DOI 10.1093/cvr/26.3.193; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liu N, 2006, CIRC RES, V99, P292, DOI 10.1161/01.RES.0000235869.50747.e1; Liu YJ, 2015, J BIOL CHEM, V290, P7736, DOI 10.1074/jbc.M114.618827; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; MARBAN E, 1986, J CLIN INVEST, V78, P1185, DOI 10.1172/JCI112701; Medeiros-Domingo A, 2009, J AM COLL CARDIOL, V54, P2065, DOI 10.1016/j.jacc.2009.08.022; Napolitano C, 2007, HEART RHYTHM, V4, P675, DOI 10.1016/j.hrthm.2006.12.048; Nyegaard M, 2012, AM J HUM GENET, V91, P703, DOI 10.1016/j.ajhg.2012.08.015; ORCHARD CH, 1983, NATURE, V304, P735, DOI 10.1038/304735a0; Paavola J, 2007, EUR HEART J, V28, P1135, DOI 10.1093/eurheartj/ehl543; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; Postma AV, 2002, CIRC RES, V91, pE21, DOI 10.1161/01.RES.0000038886.18992.6B; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Priori SG, 2001, CIRCULATION, V103, P196; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Roston TM, 2015, CIRC-ARRHYTHMIA ELEC, V8, P633, DOI 10.1161/CIRCEP.114.002217; Roux-Buisson N, 2012, HUM MOL GENET, V21, P2759, DOI 10.1093/hmg/dds104; Sedej S., 2010, CARDIOVASCULAR RES; Shannon TR, 2003, CIRC RES, V93, P592, DOI 10.1161/01.RES.0000093399.11734.B3; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Tester DJ, 2004, MAYO CLIN PROC, V79, P1380, DOI 10.4065/79.11.1380; Tian XX, 2013, J BIOL CHEM, V288, P4066, DOI 10.1074/jbc.M112.427864; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; van der Werf C, 2012, CIRC-ARRHYTHMIA ELEC, V5, P748, DOI 10.1161/CIRCEP.112.970517; Wanguemert F, 2015, HEART RHYTHM, V12, P1636, DOI 10.1016/j.hrthm.2015.03.033; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971	48	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184177	10.1371/journal.pone.0184177	http://dx.doi.org/10.1371/journal.pone.0184177			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961276	Green Published, gold, Green Submitted			2022-12-27	WOS:000412027700004
J	Sammallahti, S; Kajantie, E; Matinolli, HM; Pyhala, R; Lahti, J; Heinonen, K; Lahti, M; Pesonen, AK; Eriksson, JG; Hovi, P; Jarvenpaa, AL; Andersson, S; Raikkonen, K				Sammallahti, Sara; Kajantie, Eero; Matinolli, Hanna-Maria; Pyhala, Riikka; Lahti, Jari; Heinonen, Kati; Lahti, Marius; Pesonen, Anu-Katriina; Eriksson, Johan G.; Hovi, Petteri; Jarvenpaa, Anna-Liisa; Andersson, Sture; Raikkonen, Katri			Nutrition after preterm birth and adult neurocognitive outcomes	PLOS ONE			English	Article							HUMAN-MILK PROTEIN; YOUNG-ADULTS; BREAST-MILK; DEVELOPMENTAL OUTCOMES; INFANT GROWTH; WEIGHT; SUPPLEMENTATION; ABILITIES; FORMULA; TRIAL	Background Preterm birth (<37 gestational weeks) poses a risk of poorer neurocognitive functioning. Faster growth after preterm birth predicts better cognitive abilities and can be promoted through adequate nutrition, but it remains unknown whether variations in nutrient intakes translate into long-term benefits for neurodevelopment. Methods In 86 participants of the Helsinki Study of Very Low Birth Weight Adults (birthweight < 1500g), we examined if higher intakes of energy, macronutrients, and human milk during the first nine weeks after preterm birth predict performance in tests of cognitive ability at 25.1 years of age (SD = 2.1). Results 10 kcal/kg/day higher total energy intake at 3 to 6 weeks of age was associated with 0.21 SD higher adult IQ (95% Confidence Interval [CI] 0.07-0.35). Higher carbohydrate and fat intake at 3-6 weeks, and higher energy intake from human milk at 3-6 and at 6-9 weeks were also associated with higher adult IQ: these effect sizes ranged from 0.09 SD (95% CI 0.01-0.18) to 0.34 SD (0.14-0.54) higher IQ, per one gram/kg/day more carbohydrate and fat, and per 10 kcal/kg/day more energy from human milk. Adjustment for neonatal complications attenuated the associations: intraventricular hemorrhage, in particular, was associated with both poorer nutrition and poorer IQ. Conclusion In preterm neonates with very low birth weight, higher energy and human milk intake predict better neurocognitive abilities in adulthood. To understand the determinants of these infants' neurocognitive outcome, it seems important to take into account the role of postnatal nutrition, not just as an isolated exposure, but as a potential mediator between neonatal illness and long-term neurodevelopment.	[Sammallahti, Sara; Pyhala, Riikka; Lahti, Jari; Heinonen, Kati; Lahti, Marius; Pesonen, Anu-Katriina; Raikkonen, Katri] Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland; [Sammallahti, Sara; Kajantie, Eero; Hovi, Petteri; Jarvenpaa, Anna-Liisa; Andersson, Sture] Helsinki Univ Hosp, Childrens Hosp, Helsinki, Finland; [Sammallahti, Sara; Kajantie, Eero; Hovi, Petteri; Jarvenpaa, Anna-Liisa; Andersson, Sture] Univ Helsinki, Helsinki, Finland; [Sammallahti, Sara; Kajantie, Eero; Matinolli, Hanna-Maria; Eriksson, Johan G.; Hovi, Petteri] Natl Inst Hlth & Welf, Helsinki, Finland; [Kajantie, Eero] Oulu Univ Hosp, PEDEGO Res Unit, MRC Oulu, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland; [Lahti, Jari] Helsinki Coll Adv Studies, Helsinki, Finland; [Lahti, Marius] Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Helsinki Univ Hosp, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Helsinki; University of Edinburgh; Folkhalsan Research Center; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Sammallahti, S (corresponding author), Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland.; Sammallahti, S (corresponding author), Helsinki Univ Hosp, Childrens Hosp, Helsinki, Finland.; Sammallahti, S (corresponding author), Univ Helsinki, Helsinki, Finland.; Sammallahti, S (corresponding author), Natl Inst Hlth & Welf, Helsinki, Finland.	sara.sammallahti@helsinki.fi	Lahti, Jari/P-2283-2019; Pyhälä, Riikka/AAG-1947-2021; Lahti, Jari/P-7987-2018; Matinolli, Hanna-Maria/P-9477-2019; Lahti-Pulkkinen, Marius/Q-2472-2017	Lahti, Jari/0000-0002-4310-5297; Lahti, Jari/0000-0002-4310-5297; Heinonen, Kati/0000-0002-1262-5599; Pesonen, Anu-Katriina/0000-0002-0662-6261; Lahti-Pulkkinen, Marius/0000-0002-5244-5525; Matinolli, Hanna-Maria/0000-0001-8281-6801; Sammallahti, Sara/0000-0001-8928-000X; Raikkonen, Katri/0000-0003-3124-3470	Academy of Finland; University of Helsinki Research Foundation; Finnish Medical Society Duodecim; Finska Lakaresallskapet; Foundation for Pediatric Research in Finland; Finnish Special Governmental Subsidy for Health Sciences; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Emil Aaltonen Foundation; Novo Nordisk Foundation; Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Orion-Pharma Foundation; Sigrid Juselius Foundation; Finnish National Graduate School of Clinical Investigation; Hope and Optimism Initiative; Wilhelm and Else Stockmann Foundation; Pediatric Graduate School, University of Helsinki; Novo Nordisk Fonden [NNF15OC0016362] Funding Source: researchfish	Academy of Finland(Academy of Finland); University of Helsinki Research Foundation; Finnish Medical Society Duodecim; Finska Lakaresallskapet; Foundation for Pediatric Research in Finland; Finnish Special Governmental Subsidy for Health Sciences; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Emil Aaltonen Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Orion-Pharma Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish National Graduate School of Clinical Investigation; Hope and Optimism Initiative; Wilhelm and Else Stockmann Foundation; Pediatric Graduate School, University of Helsinki; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was part of the Helsinki Study of Very Low Birth Weight Adults funded by the Academy of Finland (http://www.aka.fi/), University of Helsinki Research Foundation (https://www.helsinki.fi/en/university/university-of-helsink-research-foundation), the Finnish Medical Society Duodecim (http://www.duodecim.fi/english/), Finska Lakaresallskapet (htlp://www.fls.fi/), the Foundation for Pediatric Research in Finland (http://www.lastentautientutkimussaatio.fi/), the Finnish Special Governmental Subsidy for Health Sciences, the Jalmari and Rauha Ahokas Foundation (http://www.ahokkaansaatio.org/), the Juho Vainio Foundation (http://www.juhovainionsaatio.fi), the Emil Aaltonen Foundation (http://www.emilaaltonen.fi/), the Novo Nordisk Foundation (http://www.novonordisk.com/about-novo-nordisk/corporate-govemance/foundation.html), the Paivikki and Sakari Sohlberg Foundation (http://www.pss-saatio.fi/), the Signe and Ane Gyllenberg Foundation (http://gyllenbergs.fi/), the Yrjo Jahnsson Foundation (http://www.yis.fi/), the Orion-Pharma Foundation (http://www.orion.fi/tutkimus/orionin-tutkimussaatio/),the Sigrid Juselius Foundation (http://sigridjuselius.fi/), the Finnish National Graduate School of Clinical Investigation (http://www.vktk.fi/), Hope and Optimism Initiative (http://hopeoptimism.com/), the Wilhelm and Else Stockmann Foundation, and the Pediatric Graduate School, University of Helsinki (http://www.kll.helsinki.fi/tutkimus/Inktko.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0; ANDERSON DM, 1983, AM J CLIN NUTR, V37, P810, DOI 10.1093/ajcn/37.5.810; Belfort MB, 2016, J PEDIATR-US, V177, P133, DOI 10.1016/j.jpeds.2016.06.045; Bellagamba MP, 2016, J PEDIATR GASTR NUTR, V62, P879, DOI 10.1097/MPG.0000000000000989; Bohnen N, 1992, Clin Neuropsychol, V6, P178, DOI 10.1080/13854049208401854; Brandt I, 2003, J PEDIATR-US, V142, P463, DOI 10.1067/mpd.2003.149; Breeman LD, 2015, PEDIATRICS, V136, P415, DOI 10.1542/peds.2015-0608; Brown JVE, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000343.pub3; Collins CT, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007314; Conners C.K., 2004, CONNERS CONTINUOUS P; Ehrenkranz RA, 2011, PEDIATR RES, V69, P522, DOI 10.1203/PDR.0b013e318217f4f1; Fenton TR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003959.pub3; Furman L, 2004, J DEV BEHAV PEDIATR, V25, P247, DOI 10.1097/00004703-200408000-00004; Gibertoni D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116552; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Gutierrez E, 2015, ACTA PAEDIATR, V104, P974, DOI DOI 10.1111/APA.13128; Heinonen K, 2013, PEDIATRICS, V131, pE243, DOI 10.1542/peds.2012-0839; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Isaacs EB, 2008, PEDIATR RES, V63, P308, DOI 10.1203/PDR.0b013e318163a271; Isaacs EB, 2010, PEDIATR RES, V67, P357, DOI 10.1203/PDR.0b013e3181d026da; Isaacs EB, 2009, J PEDIATR-US, V155, P229, DOI 10.1016/j.jpeds.2009.02.030; Jarvenpaa A L, 1987, Duodecim, V103, P1238; Johnson S, 2011, DEV NEUROPSYCHOL, V36, P74, DOI 10.1080/87565641.2011.540541; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lohaugen GCC, 2010, DEV MED CHILD NEUROL, V52, P1133, DOI 10.1111/j.1469-8749.2010.03743.x; LUCAS A, 1994, ARCH DIS CHILD-FETAL, V70, pF141, DOI 10.1136/fn.70.2.F141; Lucas A, 1998, BRIT MED J, V317, P1481, DOI 10.1136/bmj.317.7171.1481; Matinolli HM, 2015, J NUTR, V145, P2084, DOI 10.3945/jn.115.212415; Moe-Byrne T, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001457.pub6; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; O'Connor DL, 2003, J PEDIATR GASTR NUTR, V37, P437, DOI 10.1097/00005176-200310000-00008; Patel RM, 2015, NEW ENGL J MED, V372, P331, DOI 10.1056/NEJMoa1403489; Pihkala J, 1989, Duodecim, V105, P1540; Pyhala R, 2011, NEUROLOGY, V77, P2052, DOI 10.1212/WNL.0b013e31823b473e; Pyhala R, 2014, PEDIATRICS, V134, P1075, DOI 10.1542/peds.2014-1097; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RONNHOLM KAR, 1984, PEDIATRICS, V74, P792; RONNHOLM KAR, 1982, J PEDIATR-US, V101, P243, DOI 10.1016/S0022-3476(82)80133-9; Roze JC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000834; Sammallahti S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137092; Sammallahti S, 2014, J PEDIATR-US, V165, P1109, DOI 10.1016/j.jpeds.2014.08.028; Schulzke SM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000375.pub4; Smith MM, 2003, AM J EPIDEMIOL, V158, P1075, DOI 10.1093/aje/kwg257; Stephens BE, 2009, PEDIATRICS, V123, P1337, DOI 10.1542/peds.2008-0211; Tan M, 2008, ARCH DIS CHILD-FETAL, V93, pF342, DOI 10.1136/adc.2007.124255; Trolli SED, 2012, EARLY HUM DEV, V88, pS25, DOI 10.1016/j.earlhumdev.2011.12.024; Vohr BR, 2007, PEDIATRICS, V120, pe953, DOI 10.1542/peds.2006-3227; Wechsler D., 2005, WECHSLER ADULT INTEL	51	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185632	10.1371/journal.pone.0185632	http://dx.doi.org/10.1371/journal.pone.0185632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957424	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200097
J	Liu, Y; Chen, YY; Gong, Q; Lai, JS; Du, J; Deng, XC				Liu, Ya; Chen, Yeyu; Gong, Quan; Lai, Jiansheng; Du, Jun; Deng, Xiaochuan			Paternity assignment in the polyploid Acipenser dabryanus based on a novel microsatellite marker system	PLOS ONE			English	Article							YANGTZE-RIVER; SIBSHIP INFERENCE; GENETIC-STRUCTURE; STURGEON; EVOLUTION; TRANSCRIPTOME; PARENTAGE; PROGRAM; IDENTIFICATION; RELATEDNESS	Acipenser dabryanus is listed as a Critical Endangered species in the IUCN Red List and the first class protected animals in China. Fortunately, A. dabryanus specimens are being successfully bred in captivity for conservation. However, for effective ex situ conservation, we should be aware of the genetic diversity and the degree of relatedness of the individuals selected for breeding. In this study, we aimed at the development of novel and reliable microsatellites used for the genetic study of A. dabryanus. A total of 14,321 simple sequence repeats (SSRs) were detected by transcriptome sequencing and screening. We selected 20 novel and polymorphic microsatellites (non-dinucleotide) with good repeatability from the 100 tested loci for a subsequent genetic and paternity study. A set of captive broodstock (F1 stock, n = 43) and their offspring (F2 stock, n = 96) were used to examine the efficiency of the 20 SSRs for assigning parentage to offspring, with an allocation success of 91.7%. We also found that only a few families predominantly contributed to the progeny produced by the 43 breeders. In addition, mitochondrial DNA data showed that the captive broodstock (F1 individuals) had an excellent probability of the same lineage, implying that a high level of inbreeding may have occurred in these individuals. Our research provides useful information on genetic diversity and reproductive pattern of A. dabryanus, and the 20 SSRs developed in this study can be applied to the future breeding program to avoid inbreeding for this stock or other related species of Acipenseriformes.	[Liu, Ya; Chen, Yeyu; Gong, Quan; Lai, Jiansheng; Du, Jun; Deng, Xiaochuan] Sichuan Acad Agr Sci, Fishery Inst, Chengdu, Sichuan, Peoples R China	Sichuan Academy of Agricultural Sciences (SAAS)	Du, J; Deng, XC (corresponding author), Sichuan Acad Agr Sci, Fishery Inst, Chengdu, Sichuan, Peoples R China.	dujun9100@126.com; dxcddd@163.com			Project of Development of Microsatellite Derived; Acipenser dabryanus and its Application in Paternity Test [2017QNJJ-012]; Project of Screening of Sex linked Markers and Sex Determination Gene for Acipenser dabryanus Based on Transcriptome Sequencing Technology [2017QNJJ-013]; Project of Provincial 13th Five Years' Animal Breeding of Sichuan Province [2016NYZ0047]	Project of Development of Microsatellite Derived; Acipenser dabryanus and its Application in Paternity Test; Project of Screening of Sex linked Markers and Sex Determination Gene for Acipenser dabryanus Based on Transcriptome Sequencing Technology; Project of Provincial 13th Five Years' Animal Breeding of Sichuan Province	This work was supported by grants from the Project of Development of Microsatellite Derived from Acipenser dabryanus and its Application in Paternity Test (NO. 2017QNJJ-012, recipient: YL), the Project of Screening of Sex linked Markers and Sex Determination Gene for Acipenser dabryanus Based on Transcriptome Sequencing Technology (NO. 2017QNJJ-013, recipient: YYC) and the Project of Provincial 13th Five Years' Animal Breeding of Sichuan Province (NO. #2016NYZ0047, recipient: JD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Honkola O, 2009, J EVOLUTION BIOL, V22, P1396, DOI 10.1111/j.1420-9101.2009.01765.x; [Anonymous], 2004, AQUACULTURE, V232, P165; BIRSTEIN VJ, 1993, CYTOMETRY, V14, P377, DOI 10.1002/cyto.990140406; BIRSTEIN VJ, 1987, GENETICA, V72, P3, DOI 10.1007/BF00126973; Birstein VJ, 1997, ENVIRON BIOL FISH, V48, P127, DOI 10.1023/A:1007366100353; Blonk RJW, 2009, AQUACULTURE, V289, P26, DOI 10.1016/j.aquaculture.2009.01.012; Buteler MI, 2002, J AM SOC HORTIC SCI, V127, P392, DOI 10.21273/JASHS.127.3.392; Chen YD, 2016, PHYSIOL GENOMICS, V48, P464, DOI 10.1152/physiolgenomics.00113.2015; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Congiu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018249; Du H, 2014, J APPL ICHTHYOL, V30, P1445, DOI 10.1111/jai.12591; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Erlich Y, 2008, NAT METHODS, V5, P679, DOI 10.1038/nmeth.1230; Fontana F, 2008, GENETICA, V132, P281, DOI 10.1007/s10709-007-9171-4; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hale MC, 2010, GENETICA, V138, P745, DOI 10.1007/s10709-010-9455-y; Hanson TR, 2008, MOL ECOL, V17, P2060, DOI 10.1111/j.1365-294X.2008.03726.x; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Leus K., 2013, ZOOL MIDDLE EAST, V54, P151; LI J, 2015, BOUND VALUE PRO 0110; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Meglecz E, 2014, MOL ECOL RESOUR, V14, P1302, DOI 10.1111/1755-0998.12271; Na-Nakorn U, 2010, AQUACULTURE, V306, P57, DOI 10.1016/j.aquaculture.2010.05.022; Porta J, 2006, AQUACULTURE, V251, P46, DOI 10.1016/j.aquaculture.2005.05.019; Postolache D, 2014, PLANT MOL BIOL REP, V32, P750, DOI 10.1007/s11105-013-0688-7; Que Y F, 2014, J GENET, V93, P1; Rajkov J, 2014, J HERED, V105, P521, DOI 10.1093/jhered/esu027; RASSMANN K, 1991, ELECTROPHORESIS, V12, P113, DOI 10.1002/elps.1150120205; Roques S, 2016, CONSERV GENET RESOUR, V8, P313, DOI 10.1007/s12686-016-0538-7; Rozen S., 1999, PRIMER3 WWW GEN USER; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tiffin P, 2002, J MOL EVOL, V54, P746, DOI 10.1007/s0023901-0074-1; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Trippel EA, 2009, AQUACULTURE, V296, P27, DOI 10.1016/j.aquaculture.2009.08.002; Vidotto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-407; Wang JL, 2014, MOL ECOL RESOUR, V14, P541, DOI 10.1111/1755-0998.12210; Wang S., 1998, CHINA RED DATA BOOK; Wu JM, 2014, J APPL ICHTHYOL, V30, P1423, DOI 10.1111/jai.12597; Yue HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127332; Zeng Q, 2013, J APPL ICHTHYOL, V29, P1219, DOI 10.1111/jai.12278; Zhang H, 2011, J APPL ICHTHYOL, V27, P181, DOI 10.1111/j.1439-0426.2011.01674.x; Zhang SH, 2013, CONSERV GENET RESOUR, V5, P409, DOI 10.1007/s12686-012-9815-2; Zhang Si-Ming, 1999, Acta Zoologica Sinica, V45, P200; Zhao N, 2015, J APPL ICHTHYOL, V31, P614, DOI 10.1111/jai.12698; Zhuang P, 1997, ENVIRON BIOL FISH, V48, P257, DOI 10.1023/A:1007399729080	46	5	9	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185280	10.1371/journal.pone.0185280	http://dx.doi.org/10.1371/journal.pone.0185280			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953941	gold, Green Published, Green Submitted			2022-12-27	WOS:000411980300051
J	Luo, T; Chen, H; Kassab, GS				Luo, Tong; Chen, Huan; Kassab, Ghassan S.			Resliced image space construction for coronary artery collagen fibers	PLOS ONE			English	Article							ELASTIN FIBERS; ARCHITECTURE	Collagen fibers play an important role in the biomechanics of the blood vessel wall. The objective of this study was to determine the 3D microstructure of collagen fibers in the media and adventitia of coronary arteries. We present a novel optimal angle consistence algorithm to reform image slices in the visualization and analysis of 3D collagen images. 3D geometry was reconstructed from resliced image space where the 3D skeleton was extracted as the primary feature for accurate reconstruction of geometrical parameters. Collagen fibers (range 80-200) were reconstructed from the porcine coronary artery wall for the measurement of various morphological parameters. Collagen waviness and diameters were 1.37 +/- 0.19 degrees and 2.61 +/- 0.89 mu m, respectively. The biaxial distributions of orientation had two different peaks at 110.7 +/- 25.2 degrees and 18.4 +/- 19.3 degrees. Results for width, waviness, and orientation were found to be in good agreement with manual measurements. In addition to accurately measuring 2D features more efficiently than the manual approach, the present method produced 3D features that could not be measured in the 2D manual approach. These additional parameters included the tilt angle (5.10 +/- 2.95 degrees) and cross-sectional area (CSA; 5.98 +/- 3.79 mu m(2)) of collagen fibers. These 3D collagen reconstructions provide accurate and reliable microstructure for biomechanical modeling of vessel wall mechanics.	[Luo, Tong; Chen, Huan; Kassab, Ghassan S.] Calif Med Innovat Inst, San Diego, CA 92121 USA		Kassab, GS (corresponding author), Calif Med Innovat Inst, San Diego, CA 92121 USA.	gkassab@calmi2.org			Micro-Mechanical Role of Hypertension in Intimal Hyperplasia [NIH/R01-HL117990-04]	Micro-Mechanical Role of Hypertension in Intimal Hyperplasia	This work was supported by Micro-Mechanical Role of Hypertension in Intimal Hyperplasia, http://grantome.com/grant/NIH/R01-HL117990-04, G.K.	ALDERMAN EL, 1993, J AM COLL CARDIOL, V22, P1141, DOI 10.1016/0735-1097(93)90429-5; Almutairi Y, 2016, P IEEE C COMP VIS PA; AZUMA T, 1971, JPN J PHYSIOL, V21, P27; B&AELIG;rentzen JA, 2001, IMPLEMENTATION FAST; Bayan C, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116626; Belongie S., 2017, RODRIGUES ROTATION F; Bredfeldt JS, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016007; BURTON AC, 1951, J APPL PHYSIOL, V4, P329, DOI 10.1152/jappl.1951.4.5.329; Chen H, 2013, J APPL PHYSIOL, V115, P1683, DOI 10.1152/japplphysiol.00601.2013; Chen H, 2011, BIOPHYS J, V101, P2555, DOI 10.1016/j.bpj.2011.10.043; Feng LQ, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0049-14.2014; Hassouna MS, 2007, IEEE T PATTERN ANAL, V29, P1563, DOI 10.1109/TPAMI.2007.1154; Hu WY, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.026007; Kanitsar A, 2002, P C VIS 02; Kerschnitzki M, 2013, J BONE MINER RES, V28, P1837, DOI 10.1002/jbmr.1927; Klok F., 1986, Computer-Aided Geometric Design, V3, P217, DOI 10.1016/0167-8396(86)90039-7; LANIR Y, 1983, J BIOMECH, V16, P1, DOI 10.1016/0021-9290(83)90041-6; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Luo T, 2017, J MICROSC-OXFORD, V265, P121, DOI 10.1111/jmi.12470; Luo T, 2016, J MICROSCOPY; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; ROACH MR, 1957, CAN J BIOCHEM PHYS, V35, P681, DOI 10.1139/o57-080; Schriefl AJ, 2013, QUANTIFICATION COLLA; Schriefl AJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0760; Spink DC Mark, 2015, NURBS; Van Uitert R, 2007, MED PHYS, V34, P627, DOI 10.1118/1.2409238; Xu T., 2015, SCI REPORTS, V5	28	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184972	10.1371/journal.pone.0184972	http://dx.doi.org/10.1371/journal.pone.0184972			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953913	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300029
J	Jiang, YY; Li, FD; Wu, JH; Shi, YY; Gong, QG				Jiang, Yiyang; Li, Fudong; Wu, Jihui; Shi, Yunyu; Gong, Qingguo			Structural insights into substrate selectivity of ribosomal RNA methyltransferase RlmCD	PLOS ONE			English	Article							PEPTIDYL-TRANSFERASE CENTER; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; M(5)U METHYLTRANSFERASES; STREPTOCOCCUS-PNEUMONIAE; MACROLIDE ANTIBIOTICS; EXIT TUNNEL; RLMA(II); RECOGNITION; PROTEINS	RlmCD has recently been identified as the S-adenosyl methionine (SAM)-dependent methyltransferase responsible for the formation of m U-5 at U747 and U1939 of 23S ribosomal RNA in Streptococcus pneumoniae. In this research, we determine the high-resolution crystal structures of apo-form RlmCD and its complex with SAH. Using an in-vitro methyltransferase assay, we reveal the crucial residues for its catalytic functions. Furthermore, structural comparison between RlmCD and its structural homologue RumA, which only catalyzes the m (5)U1939 in Escherichia coli, implicates that a unique long linker in the central domain of RlmCD is the key factor in determining its substrate selectivity. Its significance in the enzyme activity of RlmCD is further confirmed by in-vitro methyltransferase assay.	[Gong, Qingguo] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Gong, QG (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China.	qgg@ustc.edu.cn	Shi, Yunyu/B-3240-2009	Shi, Yunyu/0000-0002-1348-4759	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08010101, XDB08030302]; Chinese National Natural Science Foundation [31270782, 91540103, 31770805, 31330018]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08010101 and XDB08030302]; Chinese National Natural Science Foundation [31270782, 91540103, 31770805 and 31330018]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alian A, 2008, P NATL ACAD SCI USA, V105, P6876, DOI 10.1073/pnas.0802247105; Anantharaman V, 2003, CURR OPIN CHEM BIOL, V7, P12, DOI 10.1016/S1367-5931(02)00018-2; Auxilien S, 2011, RNA, V17, P45, DOI 10.1261/rna.2323411; Bulkley D, 2010, P NATL ACAD SCI USA, V107, P17158, DOI 10.1073/pnas.1008685107; Cantara William A, 2011, Nucleic Acids Res, V39, pD195, DOI 10.1093/nar/gkq1028; Christian T, 2007, J MOL BIOL, V373, P623, DOI 10.1016/j.jmb.2007.08.010; Das K, 2004, P NATL ACAD SCI USA, V101, P4041, DOI 10.1073/pnas.0400189101; Desmolaize B, 2011, NUCLEIC ACIDS RES, V39, P9368, DOI 10.1093/nar/gkr626; Englander MT, 2015, P NATL ACAD SCI USA, V112, P6038, DOI 10.1073/pnas.1424712112; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Grosjean H, 2007, METHOD ENZYMOL, V425, P57, DOI 10.1016/S0076-6879(07)25003-7; Gupta P, 2016, NAT CHEM BIOL, V12, P153, DOI [10.1038/NCHEMBIO.1998, 10.1038/nchembio.1998]; Gustafsson C, 1998, J BACTERIOL, V180, P359, DOI 10.1128/JB.180.2.359-365.1998; Hirata A, 2016, NUCLEIC ACIDS RES, V44, P6377, DOI 10.1093/nar/gkw561; Johansson M, 2014, CELL REP, V7, P1534, DOI 10.1016/j.celrep.2014.04.034; Kannan K, 2011, ANN NY ACAD SCI, V1241, P33, DOI 10.1111/j.1749-6632.2011.06315.x; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Lebars I, 2003, EMBO J, V22, P183, DOI 10.1093/emboj/cdg022; Lebars I, 2007, J MOL BIOL, V372, P525, DOI 10.1016/j.jmb.2007.06.068; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; Lee TT, 2004, STRUCTURE, V12, P397, DOI 10.1016/j.str.2004.02.009; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Sergiev PV, 2008, J MOL BIOL, V375, P291, DOI 10.1016/j.jmb.2007.10.051; Shao ZH, 2014, NUCLEIC ACIDS RES, V42, P509, DOI 10.1093/nar/gkt869; Shoji T, 2015, NUCLEIC ACIDS RES, V43, P8964, DOI 10.1093/nar/gkv609; Sothiselvam S, 2014, P NATL ACAD SCI USA, V111, P9804, DOI 10.1073/pnas.1403586111; Takaya A, 2013, ANTIMICROB AGENTS CH, V57, P3789, DOI 10.1128/AAC.00164-13; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Xiong LQ, 1999, MOL MICROBIOL, V31, P633, DOI 10.1046/j.1365-2958.1999.01203.x; Yamaguchi K, 2000, J BIOL CHEM, V275, P28466, DOI 10.1074/jbc.M005012200	33	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185226	10.1371/journal.pone.0185226	http://dx.doi.org/10.1371/journal.pone.0185226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28949991	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000030
J	Esteban, O; Birman, D; Schaer, M; Koyejo, OO; Poldrack, RA; Gorgolewski, KJ				Esteban, Oscar; Birman, Daniel; Schaer, Marie; Koyejo, Oluwasanmi O.; Poldrack, Russell A.; Gorgolewski, Krzysztof J.			MRIQC: Advancing the automatic prediction of image quality in MRI from unseen sites	PLOS ONE			English	Article							SIGNAL-TO-NOISE; HEAD MOTION; RATIOS	Quality control of MRI is essential for excluding problematic acquisitions and avoiding bias in subsequent image processing and analysis. Visual inspection is subjective and impractical for large scale datasets. Although automated quality assessments have been demonstrated on single-site datasets, it is unclear that solutions can generalize to unseen data acquired at new sites. Here, we introduce the MRI Quality Control tool (MRIQC), a tool for extracting quality measures and fitting a binary (accept/exclude) classifier. Our tool can be run both locally and as a free online service via the OpenNeuro. org portal. The classifier is trained on a publicly available, multi-site dataset (17 sites, N = 1102). We perform model selection evaluating different normalization and feature exclusion approaches aimed at maximizing across-site generalization and estimate an accuracy of 76%-13% on new sites, using leave-one-site-out cross-validation. We confirm that result on a held-out dataset (2 sites, N = 265) also obtaining a 76% accuracy. Even though the performance of the trained classifier is statistically above chance, we show that it is susceptible to site effects and unable to account for artifacts specific to new sites. MRIQC performs with high accuracy in intra-site prediction, but performance on unseen sites leaves space for improvement which might require more labeled data and new approaches to the between-site variability. Overcoming these limitations is crucial for a more objective quality assessment of neuroimaging data, and to enable the analysis of extremely large and multi-site samples.	[Esteban, Oscar; Birman, Daniel; Poldrack, Russell A.; Gorgolewski, Krzysztof J.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Schaer, Marie] Univ Geneva, Sch Med, Dept Psychiat, Geneva, Switzerland; [Koyejo, Oluwasanmi O.] Univ Illinois, Dept Comp Sci, Urbana, IL USA	Stanford University; University of Geneva; University of Illinois System; University of Illinois Urbana-Champaign	Esteban, O (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	phd@oscaresteban.es	Esteban, Oscar/A-4846-2015; Gorgolewski, Krzysztof Jacek/A-7883-2010	Esteban, Oscar/0000-0001-8435-6191; Gorgolewski, Krzysztof Jacek/0000-0003-3321-7583; Schaer, Marie/0000-0001-8479-6365; Koyejo, Oluwasanmi/0000-0002-4023-419X; Birman, Daniel/0000-0003-3748-6289; Poldrack, Russell/0000-0001-6755-0259	Laura and John Arnold Foundation; Swiss National Science Foundation (SNSF) [158831, 163859]	Laura and John Arnold Foundation; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work was supported by the Laura and John Arnold Foundation and Swiss National Science Foundation (SNSF), 158831,163859 (Dr. Marie Schaer).	Abraham A, 2017, NEUROIMAGE, V147, P736, DOI 10.1016/j.neuroimage.2016.10.045; Alexander-Bloch A, 2016, HUM BRAIN MAPP, V37, P2385, DOI 10.1002/hbm.23180; Alfaro-Almagro F, 2016, ORG HUMAN BRAIN MAPP, P1877; Atkinson D, 1997, IEEE T MED IMAGING, V16, P903, DOI 10.1109/42.650886; Avants BB, 2013, ANTS ADV NORMALIZATI; Backhausen LL, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00558; Bengio Y, 2006, DISCUSSION SEMISUPER; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Di Martino A, 2014, Mol Psychiatry, V19, P659, DOI 10.1038/mp.2013.78; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fonov V., 2009, NEUROIMAGE, V47, pS102, DOI [DOI 10.1016/S1053-8119(09)70884-5, 10.1016/s1053-8119(09)70884-5]; Fortin JP, 2017, BIORXIV; Friedman L, 2008, HUM BRAIN MAPP, V29, P958, DOI 10.1002/hbm.20440; Ganzetti M, 2016, FRONT NEUROINFORM, V10, DOI 10.3389/fninf.2016.00010; GARDNER EA, 1995, ACAD RADIOL, V2, P277, DOI 10.1016/S1076-6332(05)80184-9; Gedamu EL, 2008, J MAGN RESON IMAGING, V28, P308, DOI 10.1002/jmri.21434; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Gorgolewski K., 2017, OPENNEURO FREE ONLIN, P1677; Gorgolewski K.J., 2016, NIPYPE FLEXIBLE LIGH; Gorgolewski KJ, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005209; Gorgolewski KJ, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.44; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; KAUFMAN L, 1989, RADIOLOGY, V173, P265, DOI 10.1148/radiology.173.1.2781018; Kurtzer GM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177459; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Littlestone N., 1988, Machine Learning, V2, P285, DOI 10.1007/BF00116827; Magnotta VA, 2006, J DIGIT IMAGING, V19, P140, DOI 10.1007/s10278-006-0264-x; Miller KL, 2016, NAT NEUROSCI, V19, P1523, DOI 10.1038/nn.4393; Mortamet B, 2009, MAGN RESON MED, V62, P365, DOI 10.1002/mrm.21992; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pizarro RA, 2016, FRONT NEUROINFORM, V10, DOI 10.3389/fninf.2016.00052; Poldrack RA, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.110; Poldrack RA, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00012; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; PRICE RR, 1990, MED PHYS, V17, P287, DOI 10.1118/1.596566; Reuter M, 2015, NEUROIMAGE, V107, P107, DOI 10.1016/j.neuroimage.2014.12.006; Ripley B. D., 1996, PATTERN RECOGNITION; Shehzad Z, 2015, FRONT NEUR C NEUR CA; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Viera AJ, 2005, FAM MED, V37, P360; Woodard JP, 2006, NEUROINFORMATICS, V4, P243, DOI 10.1385/NI:4:3:243; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027	47	263	265	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0184661	10.1371/journal.pone.0184661	http://dx.doi.org/10.1371/journal.pone.0184661			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945803	Green Submitted, Green Published, gold			2022-12-27	WOS:000411645100007
J	Zhang, HL; Cao, YP; Shang, C; Lie, JK; Wang, JL; Wu, ZY; Ma, LC; Qi, TX; Fu, CX; Bai, ZT; Hu, BZ				Zhang, Hailing; Cao, Yingping; Shang, Chen; Lie, Jikai; Wang, Jianli; Wu, Zhenying; Ma, Lichao; Qi, Tianxiong; Fu, Chunxiang; Bai, Zetao; Hu, Baozhong			Genome-wide characterization of GRAS family genes in Medicago truncatula reveals their evolutionary dynamics and functional diversification	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; ARABIDOPSIS-THALIANA; GIBBERELLIN RESPONSES; EXPRESSION ANALYSIS; PHYLOGENETIC TREES; RNA-SEQ; RICE; PROTEINS; REGULATOR	The GRAS gene family is a large plant-specific family of transcription factors that are involved in diverse processes during plant development. Medicago truncatula is an ideal model plant for genetic research in legumes, and specifically for studying nodulation, which is crucial for nitrogen fixation. In this study, 59 MtGRAS genes were identified and classified into eight distinct subgroups based on phylogenetic relationships. Motifs located in the C-termini were conserved across the subgroups, while motifs in the N-termini were subfamily specific. Gene duplication was the main evolutionary force for MtGRAS expansion, especially proliferation of the LISCL subgroup. Seventeen duplicated genes showed strong effects of purifying selection and diverse expression patterns, highlighting their functional importance and diversification after duplication. Thirty MtGRAS genes, including NSP1 and NSP2, were preferentially expressed in nodules, indicating possible roles in the process of nodulation. A transcriptome study, combined with gene expression analysis under different stress conditions, suggested potential functions of MtGRAS genes in various biological pathways and stress responses. Taken together, these comprehensive analyses provide basic information for understanding the potential functions of GRAS genes, and will facilitate further discovery of MtGRAS gene functions.	[Zhang, Hailing; Hu, Baozhong] Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China; [Zhang, Hailing; Shang, Chen; Lie, Jikai; Wang, Jianli] Heilongjiang Acad Agr Sci, Pratacultural Sci Inst, Harbin, Heilongjiang, Peoples R China; [Zhang, Hailing; Cao, Yingping; Wu, Zhenying; Ma, Lichao; Qi, Tianxiong; Fu, Chunxiang; Bai, Zetao] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Energy Genet, Key Lab Biofuels, Qingdao, Peoples R China; [Cao, Yingping; Wu, Zhenying; Ma, Lichao; Qi, Tianxiong; Fu, Chunxiang; Bai, Zetao] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao Engn Res Ctr Biomass Resources & Environm, Qingdao, Peoples R China; [Hu, Baozhong] Harbin Univ, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China; Heilongjiang Academy of Agricultural Sciences; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Harbin University	Hu, BZ (corresponding author), Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China.; Bai, ZT (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Energy Genet, Key Lab Biofuels, Qingdao, Peoples R China.; Bai, ZT (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao Engn Res Ctr Biomass Resources & Environm, Qingdao, Peoples R China.; Hu, BZ (corresponding author), Harbin Univ, Harbin, Heilongjiang, Peoples R China.	baizt@qibebt.ac.cn; bzhu@neau.edu.cn	wang, jian/GVS-0711-2022; FF, switchgrass/AAI-2076-2020	Wu, Zhenying/0000-0003-1859-6431; Bai, Zetao/0000-0002-5524-6193	"100-Talent Program of the Chinese Academy of Sciences" foundation; National Science Foundation for Fostering Talents in Basic Research of China [J1210069]; Postdoc Youth Elite Project in Helongjiang province [LBH-TZ1209]; National Natural Science Foundation of Shandong province in China [ZR201702170122]	"100-Talent Program of the Chinese Academy of Sciences" foundation; National Science Foundation for Fostering Talents in Basic Research of China; Postdoc Youth Elite Project in Helongjiang province; National Natural Science Foundation of Shandong province in China	The work was supported by the "100-Talent Program of the Chinese Academy of Sciences" foundation, the National Science Foundation for Fostering Talents in Basic Research of China (J1210069), Postdoc Youth Elite Project in Helongjiang province (LBH-TZ1209) and the National Natural Science Foundation of Shandong province in China (ZR201702170122). The funders have participated in decision to publish and preparation of the manuscript.	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Aubourg S, 1999, NUCLEIC ACIDS RES, V27, P628, DOI 10.1093/nar/27.2.628; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baudin M, 2015, PLANT PHYSIOL, V169, P2761, DOI 10.1104/pp.15.01144; Bolle C, 2000, GENE DEV, V14, P1269; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; Curaba J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-6; Day RB, 2004, PLANT MOL BIOL, V54, P261, DOI 10.1023/B:PLAN.0000028792.72343.ee; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Engstrom EM, 2011, PLANT PHYSIOL, V155, P735, DOI 10.1104/pp.110.168757; Fan T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125833; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Fode B, 2008, PLANT CELL, V20, P3122, DOI 10.1105/tpc.108.058974; Fortes AM, 2015, MOLECULES, V20, P9326, DOI 10.3390/molecules20059326; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; Gao MJ, 2004, PLANT MOL BIOL, V55, P417, DOI 10.1007/s11103-004-0892-9; Greb T, 2003, GENE DEV, V17, P1175, DOI 10.1101/gad.260703; Grimplet J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00353; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; He ZL, 2016, NUCLEIC ACIDS RES, V44, pW236, DOI 10.1093/nar/gkw370; Heo JO, 2011, P NATL ACAD SCI USA, V108, P2166, DOI 10.1073/pnas.1012215108; Hirsch S, 2009, PLANT SIGNAL BEHAV, V4, P698, DOI 10.4161/psb.4.8.9176; Hirsch S, 2009, PLANT CELL, V21, P545, DOI 10.1105/tpc.108.064501; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Huang W, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0590-6; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Kalo P, 2005, SCIENCE, V308, P1786, DOI 10.1126/science.1110951; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Laloum T, 2014, PLANT J, V79, P757, DOI 10.1111/tpj.12587; Lee H, 2008, PLANT MOL BIOL, V67, P659, DOI 10.1007/s11103-008-9345-1; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Liu XY, 2014, PLANT MOL BIOL REP, V32, P1129, DOI 10.1007/s11105-014-0721-5; Lu JX, 2015, MOL GENET GENOMICS, V290, P303, DOI 10.1007/s00438-014-0918-1; Ma HS, 2010, J EXP BOT, V61, P4011, DOI 10.1093/jxb/erq217; Ma ZX, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004519; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Miwa H, 2006, MOL PLANT MICROBE IN, V19, P914, DOI 10.1094/MPMI-19-0914; Morohashi K, 2003, J BIOL CHEM, V278, P20865, DOI 10.1074/jbc.M301712200; Park HJ, 2013, INT J MOL SCI, V14, P11871, DOI 10.3390/ijms140611871; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schulze S, 2010, PLANT J, V64, P668, DOI 10.1111/j.1365-313X.2010.04359.x; Schumacher K, 1999, P NATL ACAD SCI USA, V96, P290, DOI 10.1073/pnas.96.1.290; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Song XM, 2014, GENOMICS, V103, P135, DOI 10.1016/j.ygeno.2013.12.004; Stuurman J, 2002, GENE DEV, V16, P2213, DOI 10.1101/gad.230702; Sui Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-11; Tian CG, 2004, PLANT MOL BIOL, V54, P519, DOI 10.1023/B:PLAN.0000038256.89809.57; Tong HN, 2009, PLANT J, V58, P803, DOI 10.1111/j.1365-313X.2009.03825.x; Torres-Galea P, 2006, MOL GENET GENOMICS, V276, P13, DOI 10.1007/s00438-006-0123-y; Torres-Galea P, 2013, PLANT PHYSIOL, V161, P291, DOI 10.1104/pp.112.206607; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vernie T, 2008, PLANT CELL, V20, P2696, DOI 10.1105/tpc.108.059857; Wang L, 2010, MOL PLANT, V3, P794, DOI 10.1093/mp/ssq042; Wang Y, 2016, PEERJ, V4, DOI 10.7717/peerj.2388; Wen CK, 2002, PLANT CELL, V14, P87, DOI 10.1105/tpc.010325; Wild M, 2012, PLANT CELL, V24, P3307, DOI 10.1105/tpc.112.101428; Wu G, 2013, J GENET GENOMICS, V40, P217, DOI 10.1016/j.jgg.2013.04.002; Xu K, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0532-3; Xu W, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071004; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhang DP, 2012, BIOINFORMATICS, V28, P2407, DOI 10.1093/bioinformatics/bts464; Zhang L, 2016, CHIN J NAT MEDICINES, V14, P161, DOI 10.1016/S1875-5364(16)30013-9; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	70	25	26	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0185439	10.1371/journal.pone.0185439	http://dx.doi.org/10.1371/journal.pone.0185439			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945786	Green Submitted, gold, Green Published			2022-12-27	WOS:000411645100061
J	Versteeg, B; Bruisten, SM; Heijman, T; Vermeulen, W; van Rooijen, MS; van Dam, AP; van der Loeff, MFS; de Vries, HJC; Scholing, M				Versteeg, Bart; Bruisten, Sylvia M.; Heijman, Titia; Vermeulen, Wilma; van Rooijen, Martijn S.; van Dam, Alje P.; van der Loeff, Maarten F. Schim; de Vries, Henry J. C.; Scholing, Maarten			Monitoring therapy success of urogenital Chlamydia trachomatis infections in women: A prospective observational cohort study	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; NEISSERIA-GONORRHOEAE; EPIDEMIOLOGY; AZITHROMYCIN; PERSISTENCE; DNA; DOXYCYCLINE; RESOLUTION; CULTURE; ASSAYS	Introduction The use of a nucleic acid amplification test (NAAT) as a test of cure after treatment is subject to discussion, as the presence of C. trachomatis nucleic acids after treatment may be prolonged and intermittent without presence of infectious bacteria. We used cell culture to assess if a positive RNA-or DNA-based NAAT after treatment indicates the presence of viable C. trachomatis. Methods We included women with asymptomatic urogenital C. trachomatis infection visiting the Amsterdam STI clinic from September 2015 through June 2016. Endocervical swabs were collected prior to treatment with azithromycin, and during three follow-up visits 7, 21 and 49 days after treatment. Collected swabs were subjected to C. trachomatis culture and a RNAand DNA-based NAAT. High-resolution multilocus sequence typing (hr-MLST) was used to further differentiate potential re-infections. Results We included 90 women with a positive RNA-test prior to receiving treatment of whom 81 (90%) were also DNA-positive, and 69 (76.7%) culture-positive. Prolonged and intermittent positive RNA and DNA results over time were observed. Three women had culture positive results at the second visit, but all were negative at the third visit. Five women had NAATpositive results at the fourth visit of whom three women were also culture-positive indicating a viable infection. All five women reported unprotected sexual contact since the first visit. From 2, hr-MLST sequence types were obtained. One had a different sequence type indicating a new infection the other was identical to the previously found indicating a potentially persisting infection. Conclusion Most RNA-or DNA-positive results after treatment of urogenital C. trachomatis may be caused by non-viable molecular remnants since they cannot be confirmed by culture. In a minority viable C. trachomatis was found in culture at the second visit, indicating that patients may remain infectious at least 7 days after treatment.	[Versteeg, Bart; Bruisten, Sylvia M.; Heijman, Titia; Vermeulen, Wilma; van Rooijen, Martijn S.; van Dam, Alje P.; van der Loeff, Maarten F. Schim; de Vries, Henry J. C.; Scholing, Maarten] Publ Hlth Serv Amsterdam, Dept Infect Dis, Amsterdam, Netherlands; [Bruisten, Sylvia M.; van der Loeff, Maarten F. Schim; de Vries, Henry J. C.] Univ Amsterdam, Amsterdam Infect & Immun Inst, Acad Med Ctr, Amsterdam, Netherlands; [van Dam, Alje P.; Scholing, Maarten] OLVG Gen Hosp, Dept Med Microbiol, Amsterdam, Netherlands; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, Amsterdam, Netherlands	Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Versteeg, B (corresponding author), Publ Hlth Serv Amsterdam, Dept Infect Dis, Amsterdam, Netherlands.	bversteeg@ggd.amsterdam.nl	de Vries, Henry/K-5963-2012	de Vries, Henry/0000-0001-9784-547X; Van Dam, Alje/0000-0003-3967-550X	Public Health Service Amsterdam [RD kp2163]	Public Health Service Amsterdam	This study was funded by a research and development grant (R&D kp2163) of the Public Health Service Amsterdam.	Bom RJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053869; Bom RJM, 2011, J CLIN MICROBIOL, V49, P2844, DOI 10.1128/JCM.00128-11; Boyadzhyan B, 2004, J CLIN MICROBIOL, V42, P3089, DOI 10.1128/JCM.42.7.3089-3093.2004; CLAAS HCJ, 1991, J CLIN MICROBIOL, V29, P42, DOI 10.1128/JCM.29.1.42-45.1991; Darwin LH, 2002, J CLIN MICROBIOL, V40, P641, DOI 10.1128/JCM.40.02.641-644.2002; Dukers-Muijrers NHTM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034108; Gaydos CA, 1998, J INFECT DIS, V177, P417, DOI 10.1086/514207; Geisler WM, 2008, SEX TRANSM DIS, V35, P119, DOI 10.1097/OLQ.0b013e318151497d; Geisler WM, 2016, NEW ENGL J MED, V374, P1787, DOI 10.1056/NEJMc1600830; Geisler WM, 2013, J INFECT DIS, V207, P1850, DOI 10.1093/infdis/jit094; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Handsfield HH, 2011, SEX TRANSM DIS, V38, P1028, DOI 10.1097/OLQ.0b013e318227a366; Heijne JC, 2016, SEX TRANSM INFECT; Isenberg H.D, CLIN MICROBIOLOGY PR, V2; Joyner JL, 2002, SEX TRANSM DIS, V29, P196, DOI 10.1097/00007435-200204000-00002; Kapil R, 2015, J CLIN MICROBIOL, V53, P546, DOI 10.1128/JCM.02483-14; Kong FYS, 2014, CLIN INFECT DIS, V59, P193, DOI 10.1093/cid/ciu220; Land JA, 2010, HUM REPROD UPDATE, V16, P189, DOI 10.1093/humupd/dmp035; Lanjouw E, 2016, INT J STD AIDS, V27, P333, DOI 10.1177/0956462415618837; Lanjouw E, 2015, INT J STD AIDS; Marangoni A, 2012, J CLIN LAB ANAL, V26, P70, DOI 10.1002/jcla.21485; Morre SA, 1998, J CLIN PATHOL-MOL PA, V51, P149; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Rekart ML, 2013, J INFECT DIS, V207, P30, DOI 10.1093/infdis/jis644; Rogers SM, 2007, SEX TRANSM INFECT, V84, P23, DOI 10.1136/sti.2007.027029; Sena AC, 2012, J INFECT DIS, V206, P357, DOI 10.1093/infdis/jis356; Shattock RM, 1998, SEX TRANSM INFECT, V74, P289, DOI 10.1136/sti.74.4.289; van Liere GAFS, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-274; Versteeg B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-464; Wind CM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1878-3; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; Wyrick PB, 2010, J INFECT DIS, V201, pS88, DOI 10.1086/652394	32	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185295	10.1371/journal.pone.0185295	http://dx.doi.org/10.1371/journal.pone.0185295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934342	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900142
J	Zainuddin, M; Farhum, A; Safruddin, S; Selamat, MB; Sudirman, S; Nurdin, N; Syamsuddin, M; Ridwan, M; Saitoh, S				Zainuddin, Mukti; Farhum, Aisjah; Safruddin, Safruddin; Selamat, Muhammad Banda; Sudirman, Sudirman; Nurdin, Nurjannah; Syamsuddin, Mega; Ridwan, Muhammad; Saitoh, Seiichi			Detection of pelagic habitat hotspots for skipjack tuna in the Gulf of Bone-Flores Sea, southwestern Coral Triangle tuna, Indonesia	PLOS ONE			English	Article							ALBACORE THUNNUS-ALALUNGA; WESTERN NORTH PACIFIC; KATSUWONUS-PELAMIS; SURFACE TEMPERATURE; HOT-SPOTS; OCEAN; FISHERIES; ECOSYSTEM; BEHAVIOR; FEATURES	Using remote sensing of sea surface temperature (SST), sea surface height anomaly (SSHA) and chlorophyll-a (Chl-a) together with catch data, we investigated the detection and persistence of important pelagic habitat hotspots for skipjack tuna in the Gulf of BoneFlores Sea, Indonesia. We analyzed the data for the period between the northwest and southeast monsoon 2007-2011. A pelagic hotspot index was constructed from a model of multi-spectrum satellite-based oceanographic data in relation to skipjack fishing performance. Results showed that skipjack catch per unit efforts (CPUEs) increased significantly in areas of highest pelagic hotspot indices. The distribution and dynamics of habitat hotspots were detected by the synoptic measurements of SST, SSHA and Chl-a ranging from 29.5 degrees to 31.5 degrees C, from 2.5 to 12.5 cm and from 0.15 to 0.35 mg m(-3), respectively. Total area of hotspots consistently peaked in May. Validation of skipjack CPUE predicted by our model against observed data from 2012 was highly significant. The key pelagic habitat corresponded with the Chl-a front, which could be related to the areas of relatively high prey abundance (enhanced feeding opportunity) for skipjack. We found that the area and persistence of the potential skipjack habitat hotspots for the 5 years were clearly identified by the 0.2 mg m(-3) Chl-a isopleth, suggesting that the Chl-a front provides a key oceanographic indicator for global understanding on skipjack tuna habitat hotspots in the western tropical Pacific Ocean, especially within Coral Triangle tuna.	[Zainuddin, Mukti; Farhum, Aisjah; Safruddin, Safruddin; Selamat, Muhammad Banda; Sudirman, Sudirman] Hasanuddin Univ, Fac Marine Sci & Fisheries, Makassar, Indonesia; [Nurdin, Nurjannah] Hasanuddin Univ, Ctr Reg Spatial Planning & Informat, Makassar, Indonesia; [Syamsuddin, Mega] Padjadjaran State Univ, Fac Fisheries & Marine Sci, Bandung, Indonesia; [Ridwan, Muhammad] Natl Agr Polytech, Fisheries Agribusiness Dept, Pangkep, Indonesia; [Saitoh, Seiichi] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido, Japan	Universitas Hasanuddin; Universitas Hasanuddin; Universitas Padjadjaran; Hokkaido University	Zainuddin, M (corresponding author), Hasanuddin Univ, Fac Marine Sci & Fisheries, Makassar, Indonesia.	mukti_fishocean@yahoo.co.id	Safruddin, Safruddin/ABA-4389-2021; Zainuddin, Mukti/O-9272-2019; Zainuddin, Mukti/U-2357-2017; Nurdin, Nurjannah/AAD-8307-2021	Safruddin, Safruddin/0000-0003-3877-6333; Zainuddin, Mukti/0000-0003-2018-7143; Zainuddin, Mukti/0000-0002-1600-4191; 	National Competitive Research Grant (Hibah Kompetensi) [019/SP2H/LT/DPRM/II/2016]; National Competitive Research Grant (PTUPT) Ministry of Research, Technology and Higher Education of the Republic of Indonesia [005/SP2H/LT/DPRM/IV/2017]; National Competitive Research Grant (PTUPT), Ministry of Research, Technology and Higher Education of the Republic of Indonesia; National Competitive Research Grant (Hibah Kompetensi)	National Competitive Research Grant (Hibah Kompetensi); National Competitive Research Grant (PTUPT) Ministry of Research, Technology and Higher Education of the Republic of Indonesia; National Competitive Research Grant (PTUPT), Ministry of Research, Technology and Higher Education of the Republic of Indonesia; National Competitive Research Grant (Hibah Kompetensi)	This work was partly supported by the National Competitive Research Grant (Hibah Kompetensi 2016 No. 019/SP2H/LT/DPRM/II/2016 and PTUPT 2017 No. 005/SP2H/LT/DPRM/IV/2017) Ministry of Research, Technology and Higher Education of the Republic of Indonesia, to MZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge to Prof. Susan Williams, Dr. Joanne Wilson and Dr. Laurence McCook for reading and improving English of this manuscript. We also appreciate the use of TERRA-MODIS SST and Chl-a datasets, downloaded from the ocean color portal (http://oceancolor.gsfc.nasa.gov) and SSHA (AVISO-altimetry). This work was partly supported to MZ by the National Competitive Research Grant (Hibah Kompetensi 2016 and PTUPT 2017), Ministry of Research, Technology and Higher Education of the Republic of Indonesia.	ADB, 2014, EC FISH AQ COR TRIAN, P1; Alabia ID, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142885; Andrade HA, 2003, FISH OCEANOGR, V12, P10, DOI 10.1046/j.1365-2419.2003.00220.x; Andrade HA, 1999, FISH OCEANOGR, V8, P245, DOI 10.1046/j.1365-2419.1999.00107.x; Arai T, 2005, J MAR BIOL ASSOC UK, V85, P1211, DOI 10.1017/S0025315405012336; Atmadipoera A S, 2015, JURNAL ILMU DAN TEKN, V6, P355; Azwir A, 2004, JURNAL NATURAL, V4, P20; Bailey M, 2012, OCEAN COAST MANAGE, V63, P30, DOI 10.1016/j.ocecoaman.2012.03.010; BARKLEY RA, 1978, FISH B-NOAA, V76, P653; Bergmann M, 2004, FISH RES, V66, P373, DOI 10.1016/j.fishres.2003.07.007; Bertignac M, 1998, FISH OCEANOGR, V7, P326, DOI 10.1046/j.1365-2419.1998.00065.x; Bertrand A, 2002, CAN J FISH AQUAT SCI, V59, P1002, DOI 10.1139/F02-073; Brill Richard W., 1994, Fisheries Oceanography, V3, P204, DOI 10.1111/j.1365-2419.1994.tb00098.x; Druon JN, 2016, IOTC P; Etnoyer Peter, 2004, Oceanography, V17, P90; Gordon A.L, 2005, OCEANOGRAPHY, V18, P15, DOI [10.5670/oceanog.2005.01, DOI 10.5670/OCEANOG.2005.01]; Harsono G., 2014, Asian Journal of Scientific Research, V7, P571, DOI 10.3923/ajsr.2014.571.580; Hendiarti Nani, 2005, Oceanography, V18, P112; IOTC. The Scientific Committee of The Indian Ocean Tuna Commission, 2015, IR HAR EK NUGR BUD W, P1; ISSF, 2015, 201503 ISSF; Kirby DS, 2000, FISH OCEANOGR, V9, P328, DOI 10.1046/j.1365-2419.2000.00144.x; Kitagawa T, 2007, FISHERIES SCI, V73, P98, DOI 10.1111/j.1444-2906.2007.01307.x; Lehodey P, 1998, FISH OCEANOGR, V7, P317, DOI 10.1046/j.1365-2419.1998.00063.x; Lehodey P, 2008, PROG OCEANOGR, V78, P304, DOI 10.1016/j.pocean.2008.06.004; Malakoff D, 2004, SCIENCE, V304, P1104, DOI 10.1126/science.304.5674.1104; Matsumoto T, 2016, FISH OCEANOGR, V25, P565, DOI 10.1111/fog.12173; Morato T, 2016, FISH FISH, V17, P1227, DOI 10.1111/faf.12126; Mugo R, 2010, FISH OCEANOGR, V19, P382, DOI 10.1111/j.1365-2419.2010.00552.x; Muhling BA, 2015, J MARINE SYST, V148, P1, DOI 10.1016/j.jmarsys.2015.01.010; Nuzula F, 2017, IOP C SER EARTH ENV, V54, DOI 10.1088/1755-1315/54/1/012079; Olson D., 1994, OCEANOGRAPHY, V7, P52, DOI DOI 10.5670/OCEANOG.1994.03; Palacios DM, 2006, DEEP-SEA RES PT II, V53, P250, DOI 10.1016/j.dsr2.2006.03.004; Pedraza M.J., 2006, ADV GEOSCI, V6, P155, DOI 10.5194/adgeo-6-155-2006; Polovina JJ, 2005, ICES J MAR SCI, V62, P319, DOI 10.1016/j.icesjms.2004.07.031; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Qu T., 2005, OCEANOGRAPHY, V18, P50, DOI [DOI 10.5670/OCEANOG.2005.05, 10.5670/oceanog.2005.05]; Ramos AG, 1996, INT J REMOTE SENS, V17, P749, DOI 10.1080/01431169608949042; REBERT JP, 1985, J GEOPHYS RES-OCEANS, V90, P1719, DOI 10.1029/JC090iC06p11719; Roger Claude, 1994, Fisheries Oceanography, V3, P133, DOI 10.1111/j.1365-2419.1994.tb00055.x; Royer F, 2004, MAR ECOL PROG SER, V269, P249, DOI 10.3354/meps269249; Setiawati MD, 2015, ADV SPACE RES, V55, P732, DOI 10.1016/j.asr.2014.10.007; Sprintall J., 2005, OCEANOGRAPHY, V18, P88, DOI [DOI 10.5670/0CEAN, 10.5670/oceanog.2005.09, DOI 10.5670/OCEANOG.2005.09]; STRETTA JM, 1991, INT J REMOTE SENS, V12, P771, DOI 10.1080/01431169108929693; Sund P.N., 1981, Oceanography and Marine Biology an Annual Review, V19, P443; Syamsuddin M, 2016, INT J REMOTE SENS, V37, P1, DOI DOI 10.1016/S1001-6058(06)60144-3; Sydeman WJ, 2006, DEEP-SEA RES PT II, V53, P247, DOI 10.1016/j.dsr2.2006.03.001; Uda M, 1973, J FAC MAR SCI TECHNO, V7, P245; Wilson C., 2008, REPORTS INT OCEAN CO; Wyrtki K., 1961, PHYS OCEANOGRAPHY SE, V2, P1; Yoder JA, 2010, OCEANOGRAPHY, V23, P104, DOI 10.5670/oceanog.2010.09; Zainuddin M., 2011, J ILMU TEKNOL KELAUT, V3, P82, DOI [10.29244/jitkt.v3i1.7837, DOI 10.29244/JITKT.V3I1.7837]; Zainuddin M, 2008, FISH OCEANOGR, V17, P61, DOI 10.1111/j.1365-2419.2008.00461.x; Zainuddin M, 2006, DEEP-SEA RES PT II, V53, P419, DOI 10.1016/j.dsr2.2006.01.007	53	22	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185601	10.1371/journal.pone.0185601	http://dx.doi.org/10.1371/journal.pone.0185601			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968405	Green Published, gold, Green Submitted			2022-12-27	WOS:000412029600028
J	Murray, KR; Dulli, LS; Ridgeway, K; Dal Santo, L; de Mora, DD; Olsen, P; Silverstein, H; McCarraher, DR				Murray, Kate R.; Dulli, Lisa S.; Ridgeway, Kathleen; Dal Santo, Leila; de Mora, Danielle Darrow; Olsen, Patrick; Silverstein, Hannah; McCarraher, Donna R.			Improving retention in HIV care among adolescents and adults in low- and middle-income countries: A systematic review of the literature	PLOS ONE			English	Review							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; TREATMENT OUTCOMES; INFECTED ADOLESCENTS; POSITIVE PATIENTS; FOLLOW-UP; ADHERENCE; PROGRAM; SUPPORT	Introduction A dolescents living with HIV are an underserved population, with poor retention in HIV health care services and high mortality, who are in need of targeted effective interventions. We conducted a literature review to identify strategies that could be adapted to meet the needs of adolescents living with HIV. Methods We searched PubMed, Web of Science, Popline, USAID's AIDSFree Resource Library, and the USAID Development Experience Clearinghouse for relevant studies published within a recent five-year period. Studies were included if they described interventions to improve the retention in care of HIV-positive patients who are initiating or already receiving antiretroviral therapy in low-and middle-income countries. To assess the quality of the studies, we used the NIH NHLBI Study Quality Assessment Tools. Results and discussion Of 13,429 potentially relevant citations, 23 were eligible for inclusion. Most studies took place in sub-Saharan Africa. Only one study evaluated a retention intervention for youth (15-24 years); it found no difference in loss to follow-up between a youth-friendly clinic and a family-oriented clinic. A study of community-based service delivery which was effective for adults found no effect for youths. We found no relevant studies conducted exclusively with adolescent participants (10-19 years). Most studies were conducted with adults only or with populations that included adults and adolescents but did not report separate results for adolescents. Interventions that involved community-based services showed the most robust evidence for improving retention in care. Several studies found statistically significant associations between decentralization, down-referral of stable patients, task-shifting of services, and differentiated care, and retention in care among adults; however, most evidence comes from retrospective, observational studies and none of these approaches were evaluated among adolescents or youth. Conclusions Interventions that target retention in care among adolescents living with HIV are rare in the published literature. We found only two studies conducted with youth and no studies with adolescents. Given the urgent need to increase the retention of adolescents in HIV care, interventions that are effective in increasing adult retention in care should be considered for adaptation and evaluation among adolescents and interventions specifically targeting the needs of adolescents must be developed and tested.	[Murray, Kate R.; Dulli, Lisa S.; Ridgeway, Kathleen; Olsen, Patrick; McCarraher, Donna R.] FHI 360, Global Hlth Populat & Nutr, Durham, NC 27701 USA; [Dal Santo, Leila; de Mora, Danielle Darrow] FHI 360, Global Hlth Populat & Nutr, Washington, DC USA; [Silverstein, Hannah] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Maternal & Child Hlth, Chapel Hill, NC USA	FHI 360; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Murray, KR (corresponding author), FHI 360, Global Hlth Populat & Nutr, Durham, NC 27701 USA.	kmurray@fhi360.org	Ridgeway, Kathleen/AAG-4126-2020	Ridgeway, Kathleen/0000-0003-0839-2830; Murray, Katherine/0000-0002-5990-0594; Dulli, Lisa/0000-0002-3987-8932	American People through the United States Agency for International Development (USAID) [AID-OM-TO-15-00003]; YouthPower Action under IDIQ [AID-OAA-I-15-00009]	American People through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); YouthPower Action under IDIQ	This publication was made possible by the support of the American People through the United States Agency for International Development (USAID) under task order contract number AID-OM-TO-15-00003, YouthPower Action under IDIQ contract number AID-OAA-I-15-00009, YouthPower: Implementation. The contents of this publication are the sole responsibility of FHI 360 and do not necessarily reflect the views of USAID or the United States Government.	Auld AF, 2014, MMWR-MORBID MORTAL W, V63, P1097; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bangsberg David R, 2007, Curr HIV/AIDS Rep, V4, P65, DOI 10.1007/s11904-007-0010-0; Bemelmans M, 2014, TROP MED INT HEALTH, V19, P968, DOI 10.1111/tmi.12332; Braitstein P, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-7; Brennan AT, 2011, AIDS, V25, P2027, DOI 10.1097/QAD.0b013e32834b6480; Brown LB, 2016, AIDS, V30, P2855, DOI 10.1097/QAD.0000000000001250; Bygrave H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052856; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Das S, 2014, JAIDS-J ACQ IMM DEF, V65, pE67, DOI 10.1097/QAI.0b013e3182a14f7e; Deeks SG, 2009, CLIN INFECT DIS, V49, P1582, DOI 10.1086/644768; Dick B, 2015, J ADOLESCENT HEALTH, V56, P3, DOI 10.1016/j.jadohealth.2014.10.260; Djarma O, 2014, T ROY SOC TROP MED H, V108, P735, DOI 10.1093/trstmh/tru130; Estopinal CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049564; Evans D, 2013, AIDS RES HUM RETROV, V29, P892, DOI [10.1089/aid.2012.0215, 10.1089/AID.2012.0215]; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Fatti G, 2012, JAIDS-J ACQ IMM DEF, V61, pE50, DOI 10.1097/QAI.0b013e31826a6aee; Ferrand RA, 2016, TROP MED INT HEALTH, V21, P325, DOI 10.1111/tmi.12656; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Franke MF, 2013, CLIN INFECT DIS, V56, P1319, DOI 10.1093/cid/cis1193; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Gorman SE, 2015, AIDS CARE, V27, P665, DOI 10.1080/09540121.2014.986053; Grimsrud A, 2015, J ACQUIR IMMUNE DEFI; Grimsrud A, 2014, TROP MED INT HEALTH, V19, P1029, DOI 10.1111/tmi.12346; Hickey MD, 2015, JAIDS-J ACQ IMM DEF, V69, pE127, DOI 10.1097/QAI.0000000000000664; Horstmann E, 2010, CLIN INFECT DIS, V50, P752, DOI 10.1086/649933; Idele P, 2014, JAIDS-J ACQ IMM DEF, V66, pS144, DOI 10.1097/QAI.0000000000000176; Igumbor JO, 2011, AIDS CARE, V23, P231, DOI 10.1080/09540121.2010.498909; Kim SH, 2014, AIDS, V28, P1945, DOI 10.1097/QAD.0000000000000316; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Labhardt ND, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18616; Lamb MR, 2014, AIDS, V28, P559, DOI 10.1097/QAD.0000000000000054; Luque-Fernandez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056088; MacPherson P, 2015, TROP MED INT HEALTH, V20, P1015, DOI 10.1111/tmi.12517; McGuire M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074090; McGuire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038044; Mekuria LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130649; Mosoko JJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-32; Mutasa-Apollo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086305; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Nakiwogga-Muwanga A, 2015, INT J STD AIDS, V26, P42, DOI 10.1177/0956462414529098; NIH National Heart Lung and Blood Institute, 2014, NHLBI STUD QUAL ASS; Ojwang' VO, 2016, AIDS CARE, V28, P500, DOI 10.1080/09540121.2015.1110234; PEPFAR, 2014, PEPFAR 3 0 CONTR EP; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; Stella-Talisuna A, 2014, JAIDS-J ACQ IMM DEF, V67, pE76, DOI 10.1097/QAI.0000000000000280; *UNAIDS, GLOB REP; UNAIDS, 2015, COREP SLID; UNAIDS Programme Coordinating Board, 2013, THERM SEGM HIV AD YO; UNICEF, 2016, EV CHILD AIDS 7 STAK; WHO, 2016, CONS HIV DIFF SERV D; WHO, 2013, HIV AD GUID HIV TEST; WHO [World Health Organization], 2017, AD HLTH RISKS SOL; World Bank, 2021, WORLD BANK COUNTR LE; World Health Organization, 2008, TASK SHIFT RAT RED T; World Health Organization, 2016, PREV HIV TEST TREAT; Zanoni BC, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000004; Zanoni BC, 2014, AIDS PATIENT CARE ST, V28, P128, DOI 10.1089/apc.2013.0345	58	71	72	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0184879	10.1371/journal.pone.0184879	http://dx.doi.org/10.1371/journal.pone.0184879			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MG	28961253	Green Published, Green Submitted, gold			2022-12-27	WOS:000412027700011
J	Sung, PL; Wen, KC; Chen, YJ; Chao, TC; Tsai, YF; Tseng, LM; Qiu, JTT; Chao, KC; Wu, HH; Chuang, CM; Wang, PH; Huang, CYF				Sung, Pi-Lin; Wen, Kuo-Chang; Chen, Yi-Jen; Chao, Ta-Chung; Tsai, Yi-Fang; Tseng, Ling-Ming; Qiu, Jian-Tai Timothy; Chao, Kuan-Chong; Wu, Hua-Hsi; Chuang, Chi-Mu; Wang, Peng-Hui; Huang, Chi-Ying F.			The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels	PLOS ONE			English	Article							FAMILIAL BREAST; RISK-ASSESSMENT; SUSCEPTIBILITY GENES; EARLY-ONSET; MAINTENANCE THERAPY; INHERITED MUTATIONS; GERMLINE MUTATIONS; GENOMIC CAPTURE; POLISH BREAST; MULTIPLE	An important role of genetic factors in the development of breast cancer (BC) or ovarian cancer (OC) in Taiwanese (ethnic Chinese) patients has been suggested. However, other than germline BRCA1 or BRCA2 mutations, which are related to hereditary breast-ovarian cancer (HBOC), cancer-predisposition genes have not been well studied in this population. The aim of the present study was to more accurately summarize the prevalence of genetic mutations in HBOC patients using various gene panels ranging in size from BRCA1/2 alone to multi-gene panels. Among 272 HBOC patients analyzed, the prevalence of BRCA1, BRCA2 and non-BRCA1/2 pathogenic mutations was 7.7% (21/272), 6.8% (16/236) and 8.2% (13/ 159), respectively. The total mutation rate was 18.4% (50/272). Although no founder mutations were identified in this study, two recurrent mutations, BRCA1 (c.3607C>T) and BRCA2 (c.5164_5165 delAG), were found. The main pathogenic/likely pathogenic mutations in nonBRCA1/2 genes included ATM, BRIP1, FANCI, MSH2, MUYTH, RAD50, RAD51C and TP53. The prevalence rate of gene mutations in HBOC patients did not differ with respect to whether BC or OC was the first diagnosis or they presented a family history of the disease or their age at diagnosis. HBOC patients with both BC and OC exhibited a higher prevalence rate of mutations (50.0%) than patients with OC (25.0%) or BC (8.6%) alone. In conclusion, evaluation of hereditary cancer risk in Taiwan HBOC patients, particularly individuals with double cancer, is strongly encouraged. Panel testing can yield additional genomic information, and widespread and well-designed panel testing will help in assessing more accurate mutational prevalence of risk genes.	[Sung, Pi-Lin; Wen, Kuo-Chang; Chen, Yi-Jen; Chuang, Chi-Mu; Wang, Peng-Hui; Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Sung, Pi-Lin; Wen, Kuo-Chang; Chen, Yi-Jen; Chao, Kuan-Chong; Wu, Hua-Hsi; Chuang, Chi-Mu; Wang, Peng-Hui] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Sung, Pi-Lin; Wen, Kuo-Chang; Chen, Yi-Jen; Chao, Kuan-Chong; Wu, Hua-Hsi; Chuang, Chi-Mu; Wang, Peng-Hui] Natl Yang Ming Univ, Dept Obstet & Gynecol, Taipei, Taiwan; [Chao, Ta-Chung] Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan; [Tsai, Yi-Fang; Tseng, Ling-Ming] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Qiu, Jian-Tai Timothy] Chang Gung Univ, Dept Biomed Sci, New Taipei, Taiwan; [Qiu, Jian-Tai Timothy] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taoyuan, Taiwan; [Wang, Peng-Hui] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University	Wang, PH; Huang, CYF (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.; Wang, PH (corresponding author), Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.; Wang, PH (corresponding author), Natl Yang Ming Univ, Dept Obstet & Gynecol, Taipei, Taiwan.; Wang, PH (corresponding author), China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.; Huang, CYF (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan.	phwang@vghtpe.gov.tw; cyhuang5@ym.edu.tw	Huang, Chi-Ying/AAG-7672-2022; Huang, Chi-Ying/AFL-7729-2022	Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937; Meir, Yaa-Jyuhn/0000-0001-6084-3446; Qiu, JT/0000-0001-7090-6906; Chen, CJ/0000-0003-3766-4612	YEN TJING LING MEDICAL FOUNDATION [CI-100-34]; Taipei Veterans General Hospital [V105B-006]; Ministry of Science and Technology, Taiwan, ROC [105-2314-B-075-039-]; Ministry of Science and Technology [104-2627-B-010-001-]	YEN TJING LING MEDICAL FOUNDATION; Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	Funded by YEN TJING LING MEDICAL FOUNDATION (CI-100-34), Taipei Veterans General Hospital (V105B-006), Ministry of Science and Technology, Taiwan, ROC (105-2314-B-075-039-) to PL Sung and by a grant from the Ministry of Science and Technology (104-2627-B-010-001-) to CY Huang.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ang P, 2007, CANCER EPIDEM BIOMAR, V16, P2276, DOI 10.1158/1055-9965.EPI-07-0403; [Anonymous], 2009, Obstet Gynecol, V113, P957, DOI 10.1097/AOG.0b013e3181a106d4; [Anonymous], 2009, GYNECOL ONCOL, V113, P6, DOI 10.1016/j.ygyno.2009.02.017; [Anonymous], 2015, LANCET ONCOLOGY, V16, pe158; Banerjee S, 2010, NAT REV CLIN ONCOL, V7, P508, DOI 10.1038/nrclinonc.2010.116; Berg AO, 2005, ANN INTERN MED, V143, P355, DOI 10.7326/0003-4819-143-5-200509060-00011; Beroud C, 2016, HUM MUTAT, V37, P1318, DOI 10.1002/humu.23113; Brozek I, 2012, FAM CANCER, V11, P351, DOI 10.1007/s10689-012-9519-5; Castera L, 2014, EUR J HUM GENET, V22, P1305, DOI 10.1038/ejhg.2014.16; Chao A, 2016, ONCOTARGET, V7, P85529, DOI 10.18632/oncotarget.13456; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Chen ST, 2003, BREAST CANCER RES TR, V77, P133, DOI 10.1023/A:1021386026051; Chiang CJ, 2016, J FORMOS MED ASSOC, V115, P1076, DOI 10.1016/j.jfma.2015.10.011; Desmond A, 2015, JAMA ONCOL, V1, P943, DOI 10.1001/jamaoncol.2015.2690; Gorski B, 2004, INT J CANCER, V110, P683, DOI 10.1002/ijc.20162; Guan YF, 2015, FAM CANCER, V14, P9, DOI 10.1007/s10689-014-9749-9; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; Harries M, 2002, LANCET ONCOL, V3, P529, DOI 10.1016/S1470-2045(02)00846-X; Hemminki K, 2003, BREAST CANCER RES TR, V82, P17, DOI 10.1023/B:BREA.0000003871.38587.8b; Kang E, 2015, BREAST CANCER RES TR, V151, P157, DOI 10.1007/s10549-015-3377-4; Kapoor NS, 2015, ANN SURG ONCOL, V22, P3282, DOI 10.1245/s10434-015-4754-2; Kim YC, 2016, ONCOTARGET, V7, P9601, DOI 10.18632/oncotarget.7144; Kraus C, 2017, INT J CANCER, V140, P95, DOI 10.1002/ijc.30428; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuo WH, 2012, J HUM GENET, V57, P130, DOI 10.1038/jhg.2011.142; Kurian AW, 2014, J CLIN ONCOL, V32, P2001, DOI 10.1200/JCO.2013.53.6607; Kwong A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043994; LaDuca H, 2014, GENET MED, V16, P830, DOI 10.1038/gim.2014.40; Ledermann J, 2014, LANCET ONCOL, V15, P852, DOI 10.1016/S1470-2045(14)70228-1; Li SSL, 1999, HUM GENET, V104, P201, DOI 10.1007/s004390050936; Lin PH, 2016, ONCOTARGET, V7, P8310, DOI 10.18632/oncotarget.7027; Liu C, 2007, GASTROENTEROLOGY, V132, P119, DOI 10.1053/j.gastro.2006.10.034; Llort G, 2015, CLIN TRANSL ONCOL, V17, P956, DOI 10.1007/s12094-015-1435-3; Minion LE, 2015, GYNECOL ONCOL, V137, P86, DOI 10.1016/j.ygyno.2015.01.537; Mirza MR, 2016, NEW ENGL J MED, V375, P2154, DOI 10.1056/NEJMoa1611310; Moyer VA, 2014, ANN INTERN MED, V160, P271, DOI 10.7326/M13-2747; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Ng PS, 2016, CLIN GENET, V90, P315, DOI 10.1111/cge.12735; Nilprabhassorn P, 1976, J Med Assoc Thai, V59, P162; Rahman B, 2017, BJOG-INT J OBSTET GY, V124, P855, DOI 10.1111/1471-0528.14603; Rajkumar Thangarajan, 2015, Asian Pac J Cancer Prev, V16, P5211; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ripperger T, 2009, EUR J HUM GENET, V17, P722, DOI 10.1038/ejhg.2008.212; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Schroeder C, 2010, BREAST CANCER RES TR, V122, P287, DOI 10.1007/s10549-009-0639-z; Serova OM, 1997, AM J HUM GENET, V60, P486; Shih HA, 2002, J CLIN ONCOL, V20, P994, DOI 10.1200/JCO.20.4.994; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Stadler ZK, 2012, CANCER-AM CANCER SOC, V118, P493, DOI 10.1002/cncr.26191; Szabo CI, 1997, AM J HUM GENET, V60, P1013; Tedaldi G, 2017, ONCOTARGET; Tung N, 2016, J CLIN ONCOL, V34, P1460, DOI 10.1200/JCO.2015.65.0747; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Wang PH, 2000, JPN J CLIN ONCOL, V30, P343, DOI 10.1093/jjco/hyd092; Weaver JMJ, 2011, GENOME MED, V3, DOI 10.1186/gm274; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Wong ESY, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2015.3; Wong ESY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134408	60	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185615	10.1371/journal.pone.0185615	http://dx.doi.org/10.1371/journal.pone.0185615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961279	gold, Green Published, Green Submitted			2022-12-27	WOS:000412027700026
J	Wang, YB; Ding, YJ; Guo, F; Wei, LY; Tang, JJ				Wang, Yubo; Ding, Yijie; Guo, Fei; Wei, Leyi; Tang, Jijun			Improved detection of DNA-binding proteins via compression technology on PSSM information	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; RIBOSOMAL-RNA-BINDING; WEB SERVER; PREDICTION; IDENTIFICATION; CLASSIFICATION; GENERATION; SELECTION; SITES	Since the importance of DNA-binding proteins in multiple biomolecular functions has been recognized, an increasing number of researchers are attempting to identify DNA-binding proteins. In recent years, the machine learning methods have become more and more compelling in the case of protein sequence data soaring, because of their favorable speed and accuracy. In this paper, we extract three features from the protein sequence, namely NMBAC (Normalized Moreau-Broto Autocorrelation), PSSM-DWT (Position-specific scoring matrix-D Discrete Wavelet Transform), and PSSM-DCT (Position-specific scoring matrix-D Discrete Cosine Transform). We also employ feature selection algorithm on these feature vectors. Then, these features are fed into the training SVM (support vector machine) model as classifier to predict DNA-binding proteins. Our method applys three datasets, namely PDB1075, PDB594 and PDB186, to evaluate the performance of our approach. The PDB1075 and PDB594 datasets are employed for Jackknife test and the PDB186 dataset is used for the independent test. Our method achieves the best accuracy in the Jacknife test, from 79.20% to 86.23% and 80.5% to 86.20% on PDB1075 and PDB594 datasets, respectively. In the independent test, the accuracy of our method comes to 76.3%. The performance of independent test also shows that our method has a certain ability to be effectively used for DNA-binding protein prediction.	[Wang, Yubo; Ding, Yijie; Guo, Fei; Wei, Leyi; Tang, Jijun] Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300350, Peoples R China; [Tang, Jijun] Univ South Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA; [Wang, Yubo; Ding, Yijie; Guo, Fei; Wei, Leyi; Tang, Jijun] Tianjin Univ, Inst Computat Biol, Tianjin 300350, Peoples R China	Tianjin University; University of South Carolina System; University of South Carolina Columbia; Tianjin University	Guo, F; Tang, JJ (corresponding author), Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300350, Peoples R China.; Tang, JJ (corresponding author), Univ South Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA.; Guo, F; Tang, JJ (corresponding author), Tianjin Univ, Inst Computat Biol, Tianjin 300350, Peoples R China.	fguo@tju.edu.cn; tangjijun@tju.edu.cn	Tang, Jijun/ABH-6528-2020; Wei, Leyi/Q-5699-2018	Wei, Leyi/0000-0003-1444-190X	National Science Foundation of China [NSFC 61772362, 61402326]; Peiyang Scholar Program of Tianjin University [2016XRG-0009]; Tianjin Research Program of Application Foundation and Advanced Technology [16JCQNJC00200]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peiyang Scholar Program of Tianjin University; Tianjin Research Program of Application Foundation and Advanced Technology	This work is supported by a grant from the National Science Foundation of China (NSFC 61772362 and 61402326 to FG), Peiyang Scholar Program of Tianjin University (no. 2016XRG-0009 to FG), and the Tianjin Research Program of Application Foundation and Advanced Technology (16JCQNJC00200 to FG).	Ahmad S, 2004, J MOL BIOL, V341, P65, DOI 10.1016/j.jmb.2004.05.058; AHMED N, 1974, IEEE T COMPUT, VC 23, P90, DOI 10.1109/T-C.1974.223784; Alhamdoosh M, BIORXIV2016061978; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bhardwaj N, 2005, NUCLEIC ACIDS RES, V33, P6486, DOI 10.1093/nar/gki949; Bhardwaj N, 2007, FEBS LETT, V581, P1058, DOI 10.1016/j.febslet.2007.01.086; Cai YD, 2003, BBA-PROTEINS PROTEOM, V1648, P127, DOI 10.1016/S1570-9639(03)00112-2; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dong QW, 2015, IEEE INT C BIOINFORM, P470, DOI 10.1109/BIBM.2015.7359730; Fang Y, 2008, AMINO ACIDS, V34, P103, DOI 10.1007/s00726-007-0568-2; Feng ZP, 2000, J PROTEIN CHEM, V19, P269, DOI 10.1023/A:1007091128394; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Gao M, 2008, NUCLEIC ACIDS RES, V36, P3978, DOI 10.1093/nar/gkn332; Gao M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000567; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hajisharifi Z, 2014, J THEOR BIOL, V341, P34, DOI 10.1016/j.jtbi.2013.08.037; Ho SY, 2007, BIOSYSTEMS, V90, P234, DOI 10.1016/j.biosystems.2006.08.007; Kumar KK, 2009, J BIOMOL STRUCT DYN, V26, P679, DOI 10.1080/07391102.2009.10507281; Kumar M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-463; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; LIU B, 2015, SCI REP UK, V5; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, MOL INFORM, V34, P8, DOI 10.1002/minf.201400025; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Lou WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086703; Ma X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167345; Martin S, 2005, BIOINFORMATICS, V21, P218, DOI 10.1093/bioinformatics/bth483; Motion GB, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv805; Mundra PA, 2010, IEEE T NANOBIOSCI, V9, P31, DOI 10.1109/TNB.2009.2035284; Nanni L, 2008, AMINO ACIDS, V34, P635, DOI 10.1007/s00726-007-0016-3; Nanni L, 2014, SCI WORLD J, DOI 10.1155/2014/236717; Nanni L, 2012, AMINO ACIDS, V43, P657, DOI 10.1007/s00726-011-1114-9; Nanni L, 2009, AMINO ACIDS, V36, P167, DOI 10.1007/s00726-008-0044-7; Nimrod G, 2010, BIOINFORMATICS, V26, P692, DOI 10.1093/bioinformatics/btq019; Pan G, 2017, SCI REP, V7; Patel A K, 2009, DIG J NANOMAT BIOSTR, V4; Roy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007813; Shao XJ, 2009, J THEOR BIOL, V258, P289, DOI 10.1016/j.jtbi.2009.01.024; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; Stawiski EW, 2003, J MOL BIOL, V326, P1065, DOI 10.1016/S0022-2836(03)00031-7; Szaboova A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S3; Szilagyi A, 2006, J MOL BIOL, V358, P922, DOI 10.1016/j.jmb.2006.02.053; Tolosi L, 2011, BIOINFORMATICS, V27, P1986, DOI 10.1093/bioinformatics/btr300; Wang D, BIORXIV2016058800; Waris M, 2016, NEUROCOMPUTING, V199, P154, DOI 10.1016/j.neucom.2016.03.025; Wei LY, 2017, INFORM SCIENCES, V384, P135, DOI 10.1016/j.ins.2016.06.026; Xu RF, 2015, J BIOMOL STRUCT DYN, V33, P1720, DOI 10.1080/07391102.2014.968624; Xu RF, 2015, BMC SYST BIOL, V9, DOI 10.1186/1752-0509-9-S1-S10; Xu RF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/294279; Yan K, 2015, SENSOR ACTUAT B-CHEM, V212, P353, DOI 10.1016/j.snb.2015.02.025; Yang L, 2010, PROTEIN PEPTIDE LETT, V17, P1085, DOI 10.2174/092986610791760306; Yu XJ, 2006, J THEOR BIOL, V240, P175, DOI 10.1016/j.jtbi.2005.09.018; Zhao HY, 2010, BIOINFORMATICS, V26, P1857, DOI 10.1093/bioinformatics/btq295; Zhou WQ, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S1; Zhou YZ, 2011, COMM COM INF SC, V202, P254; Zou CX, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-90	62	45	45	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185587	10.1371/journal.pone.0185587	http://dx.doi.org/10.1371/journal.pone.0185587			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961273	Green Submitted, Green Published, gold			2022-12-27	WOS:000412027700025
J	Zhang, M; Zhao, HT; Cai, J; Li, HH; Wu, Q; Qiao, T; Li, KY				Zhang, Meng; Zhao, Hongting; Cai, Jing; Li, Huihui; Wu, Qi; Qiao, Tong; Li, Kuanyu			Chronic administration of mitochondrion-targeted peptide SS-31 prevents atherosclerotic development in ApoE knockout mice fed Western diet	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; OXIDATIVE STRESS; APOLIPOPROTEIN-E; DEFICIENT MICE; RECEPTOR; CELLS; MACROPHAGES; INHIBITION; ATHEROGENESIS; INFLAMMATION	Background Oxidative stress and inflammatory factors are deeply involved in progression of atherosclerosis. Mitochondrion-targeted peptide SS-31, selectively targeting to mitochondrial inner membrane reacting with cardiolipin, has been reported to inhibit ROS generation and mitigate inflammation. The present study was designed to investigate whether SS-31 could suppress the development of atherosclerosis in vivo. Methods Male ApoE(-/-) mice (8 weeks old) fed with Western diet were treated with normal saline or SS-31 (1 mg/kg/d or 3 mg/kg/d) through subcutaneous injection for 12 weeks. Oil Red O staining was performed to evaluate area and sizes of the plaques. DHE staining and immunohistochemical staining of 8-OHDG was performed to assess the oxidative stress. The aorta ATP contents were assessed by the ATP bioluminescence assay kit. Immunohistochemical staining of CD68 and alpha-SMA and Masson's trichrome staining were performed to evaluate the composition of atherosclerotic plaque. Biochemical assays were performed to determine the protein level and activity of superoxide dismutase (SOD). The levels of CD36, LOX-1 and ABCA1 were immunohistochemically and biochemically determined to evaluate the cholesterol transport in aorta and peritoneal macrophages. Inflammatory factors, including ICAM-1, MCP-1, IL-6 and CRP in serum, were detected through ELISA. Results SS-31 administration reduced the area and sizes of western diet-induced atherosclerotic plaques and changed the composition of the plaques in ApoE(-/-) mice. Oxidative stress was suppressed, as evidenced by the reduced DHE stain, down-regulated 8-OHDG expression, and increased SOD activity after chronic SS-31 administration. Moreover, systemic inflammation was ameliorated as seen by decreasing serum ICAM-1, MCP-1, and IL-6 levels. Most importantly, SS-31 administration inhibited cholesterol influx by down-regulating expression of CD36 and LOX-1 to prevent lipid accumulation to further suppress the foam cell formation and atherosclerotic progression. Conclusion Administration of SS-31 prevents against atherosclerotic formation in ApoE(-/-) mice suggesting that SS-31 might be considered to be a potential drug to prevent atherosclerotic progression.	[Zhang, Meng; Qiao, Tong] Nanjing Med Univ, Dept Vasc Surg, Drum Tower Clin Med Coll, Nanjing, Jiangsu, Peoples R China; [Zhao, Hongting; Li, Huihui; Wu, Qi; Li, Kuanyu] Nanjing Univ, Jiangsu Key Lab Mol Med, Med Sch, Nanjing, Jiangsu, Peoples R China; [Cai, Jing; Qiao, Tong] Nanjing Univ, Dept Vasc Surg, Med Sch, Affiliated Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University; Nanjing University	Qiao, T (corresponding author), Nanjing Med Univ, Dept Vasc Surg, Drum Tower Clin Med Coll, Nanjing, Jiangsu, Peoples R China.; Li, KY (corresponding author), Nanjing Univ, Jiangsu Key Lab Mol Med, Med Sch, Nanjing, Jiangsu, Peoples R China.; Qiao, T (corresponding author), Nanjing Univ, Dept Vasc Surg, Med Sch, Affiliated Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China.	giaotongmail@aliyun.com; likuanyu@nju.edu.cn	Li, Kuanyu/AAL-2051-2020	Li, Kuanyu/0000-0001-9738-049X	National Natural Science Foundation of China [31571218, 81370387]; National Basic Research Program of China ("973" program) [2015C6856300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China ("973" program)(National Basic Research Program of China)	The financial assistance given by the National Natural Science Foundation of China (No. 31571218 and 81370387) and National Basic Research Program of China ("973" program, No. 2015C6856300) is gratefully acknowledged.; The financial assistance given by the National Basic Research Program of China ("973" program, No. 2015CB856300) and National Natural Science Foundation of China (No. 31571218 and 81370387) is gratefully acknowledged.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Barter PJ, 2016, PHARMACOL REV, V68, P458, DOI 10.1124/pr.115.012203; Birk AV, 2013, J AM SOC NEPHROL, V24, P1250, DOI 10.1681/ASN.2012121216; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Bourdillon MC, 2000, ARTERIOSCL THROM VAS, V20, P2630, DOI 10.1161/01.ATV.20.12.2630; Dai DF, 2011, J AM COLL CARDIOL, V58, P73, DOI 10.1016/j.jacc.2010.12.044; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; Fuhrman B, 2002, ATHEROSCLEROSIS, V161, P307, DOI 10.1016/S0021-9150(01)00646-3; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Goncalves JL, 2012, EUR J NUTR, V51, P927, DOI 10.1007/s00394-011-0270-8; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Hao SY, 2015, MOLECULES, V20, P21287, DOI 10.3390/molecules201219764; Higashi Y, 2016, CIRCULATION, V133, P2263, DOI 10.1161/CIRCULATIONAHA.116.021805; Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019; Joyce CW, 2006, J BIOL CHEM, V281, P33053, DOI 10.1074/jbc.M604526200; Koh KK, 2002, CARDIOVASC RES, V55, P714, DOI 10.1016/S0008-6363(02)00487-X; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Meurs I, 2012, ATHEROSCLEROSIS, V221, P41, DOI 10.1016/j.atherosclerosis.2011.11.024; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; Nickel AG, 2015, CELL METAB, V22, P472, DOI 10.1016/j.cmet.2015.07.008; Protogerou AD, 2011, ATHEROSCLEROSIS, V219, P734, DOI 10.1016/j.atherosclerosis.2011.09.015; Rios-Navarro C, 2015, EUR J PHARMACOL, V765, P355, DOI 10.1016/j.ejphar.2015.08.054; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461; Szeto HH, 2011, J AM SOC NEPHROL, V22, P1041, DOI 10.1681/ASN.2010080808; Terasaki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070933; Topper JN, 1996, P NATL ACAD SCI USA, V93, P10417, DOI 10.1073/pnas.93.19.10417; Tousoulis D, 2016, EUR HEART J, V37, P1723, DOI 10.1093/eurheartj/ehv759; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Yang LC, 2009, ANTIOXID REDOX SIGN, V11, P2095, DOI [10.1089/ars.2009.2445, 10.1089/ARS.2009.2445]; Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271; Yu EP, 2016, FREE RADICAL BIOL ME; Yu XH, 2013, CLIN CHIM ACTA, V424, P245, DOI 10.1016/j.cca.2013.06.006	37	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185688	10.1371/journal.pone.0185688	http://dx.doi.org/10.1371/journal.pone.0185688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961281	Green Published, Green Submitted, gold			2022-12-27	WOS:000412027700033
J	Boonkasidecha, S; Kannan, PS; Kallapur, SG; Jobe, AH; Kemp, MW				Boonkasidecha, Suppawat; Kannan, Paranthaman Senthamarai; Kallapur, Suhas G.; Jobe, Alan H.; Kemp, Matthew W.			Fetal skin as a pro-inflammatory organ: Evidence from a primate model of chorioamnionitis	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; PRETERM LAMBS; EPIDERMAL-KERATINOCYTES; INTRAAMNIOTIC ENDOTOXIN; OVINE SKIN; LIPOPOLYSACCHARIDE; IL-1-BETA; RESPONSES; EXPOSURE	Background Intrauterine infection is a primary cause of preterm birth and fetal injury. The pro-inflammatory role of the fetal skin in the setting of intrauterine infection remains poorly characterized. Whether or not inflammation of the fetal skin occurs in primates remains unstudied. Accordingly, we hypothesized that: i) the fetal primate skin would mount a pro-inflammatory response to preterm birth associated pro-inflammatory agents (lipopolysaccharides from Escherichia coli, live Ureaplasma parvum, interleukin-1 beta) and; ii) that inhibiting interleukin-1 signaling would decrease the skin inflammatory response. Methods Rhesus macaques with singleton pregnancies received intraamniotic injections of either sterile saline (control) or one of three pro-inflammatory agonists: E. coli lipopolysaccharides, interluekin-1 beta or live U. parvum under ultrasound guidance. A fourth group of animals received both E. coli lipopolysaccharide and interleukin-1 signaling inhibitor interleukin-1 receptor antagonist (Anakinra) prior to delivery. Animals were surgically delivered at approximately 130 days' gestational age. Results Intraamniotic lipopolysaccharide caused an inflammatory skin response characterized by increases in interluekin-1 beta,-6 and -8 mRNA at 16 hours. There was a modest inflammatory response to U. parvum, but interleukin-1 beta alone caused no inflammatory response in the fetal skin. Intraamniotic Anakinra treatment of lipopolysaccharide-exposed animals significantly reduced skin inflammation. Conclusions Intraamniotic lipopolysaccharide and U. parvum were associated with modest increases in the expression of inflammatory mediators in primate fetal skin. Although administration of Interleukin-1 beta alone did not elicit an inflammatory response, lipopolysaccharide-driven skin inflammation was decreased following intraamniotic Anakinra therapy. These findings provide support for the role of the fetal skin in the development of the fetal inflammatory response.	[Boonkasidecha, Suppawat; Kannan, Paranthaman Senthamarai; Kallapur, Suhas G.; Jobe, Alan H.] Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH USA; [Boonkasidecha, Suppawat] Rangsit Univ, Div Neonatol, Dept Pediat, Queen Sirikit Natl Inst Child Hlth,Coll Med, Bangkok, Thailand; [Kallapur, Suhas G.; Jobe, Alan H.; Kemp, Matthew W.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA, Australia; [Kemp, Matthew W.] Tohoku Univ Hosp, Ctr Perinatal & Neonatal Med, Sendai, Miyagi, Japan	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Rangsit University; University of Western Australia; Tohoku University	Kemp, MW (corresponding author), Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA, Australia.; Kemp, MW (corresponding author), Tohoku Univ Hosp, Ctr Perinatal & Neonatal Med, Sendai, Miyagi, Japan.	matthew.kemp@uwa.edu.au	Senthamaraikannan, Paranthaman/H-3992-2018	Senthamaraikannan, Paranthaman/0000-0002-3333-3720				Combs CA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.032; Dimes P, 2012, SAVE CHILDREN WHO BO; ENK AH, 1993, J IMMUNOL, V150, P3698; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; GROVES RW, 1994, AM J PATHOL, V145, P1048; Jobe AH, 2000, AM J OBSTET GYNECOL, V182, P401, DOI 10.1016/S0002-9378(00)70231-6; Kallapur SG, 2001, AM J PHYSIOL-LUNG C, V280, pL527, DOI 10.1152/ajplung.2001.280.3.L527; Kallapur SG, 2013, J IMMUNOL, V191, P1102, DOI 10.4049/jimmunol.1300270; Kallapur SG, 2009, AM J RESP CRIT CARE, V179, P955, DOI 10.1164/rccm.200811-1728OC; Kemp MW, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00574; Kemp MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063355; Kemp MW, 2011, REPROD SCI, V18, P1128, DOI 10.1177/1933719111408114; Kemp MW, 2011, REPROD SCI, V18, P88, DOI 10.1177/1933719110380470; Komine M, 2001, J INVEST DERMATOL, V116, P330, DOI 10.1046/j.1523-1747.2001.01249.x; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; KRISTENSEN M, 1992, BRIT J DERMATOL, V127, P305, DOI 10.1111/j.1365-2133.1992.tb00446.x; Miller Lloyd S, 2008, Adv Dermatol, V24, P71; MIZUTANI H, 1991, J CLIN INVEST, V87, P1066, DOI 10.1172/JCI115067; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Senthamaraikannan P, 2016, J INFECT DIS, V214, P1597, DOI 10.1093/infdis/jiw408; Sugita K, 2007, CLIN EXP IMMUNOL, V147, P176, DOI 10.1111/j.1365-2249.2006.03258.x; Terui T, 1998, EXP DERMATOL, V7, P327, DOI 10.1111/j.1600-0625.1998.tb00332.x; Thaxton J. E., 2010, INFECT DIS OBSTET GY, V2010; Visscher M, 2014, ADV WOUND CARE, V3, P291, DOI 10.1089/wound.2013.0467; Wolfs TGAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018355; Zhang L, 2012, REPROD SCI, V19, P1181, DOI 10.1177/1933719112446079	28	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184938	10.1371/journal.pone.0184938	http://dx.doi.org/10.1371/journal.pone.0184938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957335	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200024
J	Faburay, B; McGill, J; Jongejan, F				Faburay, Bonto; McGill, Jodi; Jongejan, Frans			A glycosylated recombinant subunit candidate vaccine consisting of Ehrlichia ruminantium major antigenic protein1 induces specific humoral and Th1 type cell responses in sheep	PLOS ONE			English	Article							INACTIVATED COWDRIA-RUMINANTIUM; IN-VITRO; MYCOBACTERIUM-TUBERCULOSIS; EXPERIMENTAL TRANSMISSION; ELEMENTARY BODIES; GENETIC DIVERSITY; CROSS-IMMUNITY; HEARTWATER; IMMUNIZATION; PROTECTION	Heartwater, or cowdriosis, is a tick-borne disease of domestic and wild ruminants that is endemic in the Caribbean and sub-Saharan Africa. The disease is caused by an intracellular pathogen, Ehrlichia ruminantium and may be fatal within days of the onset of clinical signs with mortality rates of up to 90% in susceptible hosts. Due to the presence of competent tick vectors in North America, there is substantial risk of introduction of heartwater with potentially devastating consequences to the domestic livestock industry. There is currently no reliable or safe vaccine for use globally. To develop a protective DIVA (differentiate infected from vaccinated animals) subunit vaccine for heartwater, we targeted the E. ruminantium immunodominant major antigenic protein1 (MAP1) with the hypothesis that MAP1 is a glycosylated protein and glycans contained in the antigenic protein are important epitope determinants. Using a eukaryotic recombinant baculovirus expression system, we expressed and characterized, for the first time, a glycoform profile of MAP1 of two Caribbean E. ruminantium isolates, Antigua and Gardel. We have shown that the 37-38 kDa protein corresponded to a glycosylated form of the MAP1 protein, whereas the 31-32 kDa molecular weight band represented the non-glycosylated form of the protein frequently reported in scientific literature. Three groups of sheep (n = 3-6) were vaccinated with increasing doses of a bivalent (Antigua and Gardel MAP1) rMAP1 vaccine cocktail formulation with montanide ISA25 as an adjuvant. The glycosylated recombinant subunit vaccine induced E. ruminantium-specific humoral and Th1 type T cell responses, which are critical for controlling intracellular pathogens, including E. ruminantium, in infected hosts. These results provide an important basis for development of a subunit vaccine as a novel strategy to protect susceptible livestock against heartwater in non-endemic and endemic areas.	[Faburay, Bonto; McGill, Jodi] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Jongejan, Frans] Univ Utrecht, Utrecht Ctr Tick Borne Dis, FAO Reference Ctr Ticks & Tick Borne Dis, Fac Vet Med, Yalelaan 1, Utrecht, Netherlands; [Jongejan, Frans] Univ Pretoria, Dept Vet Trop Dis, Fac Vet Sci, Private Bag X04, Onderstepoort, South Africa	Kansas State University; Utrecht University; University of Pretoria	Faburay, B (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	bfaburay@vet.k-state.edu			Science and Technology Directorate of the United States Department of Homeland Security (DHS) [D15PC0027]	Science and Technology Directorate of the United States Department of Homeland Security (DHS)(United States Department of Homeland Security (DHS))	This project is the result of funding provided by the Science and Technology Directorate of the United States Department of Homeland Security (DHS) under Award Instrument Number: D15PC0027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adakal H, 2010, VACCINE, V28, P4573, DOI 10.1016/j.vaccine.2010.04.087; Allsopp BA, 2009, ONDERSTEPOORT J VET, V76, P81; Allsopp MTEP, 2001, J CLIN MICROBIOL, V39, P4200, DOI 10.1128/JCM.39.11.4200-4203.2001; BIRNIE EF, 1985, VET REC, V116, P121, DOI 10.1136/vr.116.5.121; Brayton KA, 1998, ANN NY ACAD SCI, V849, P247, DOI 10.1111/j.1749-6632.1998.tb11055.x; BRETSCHER PA, 1994, IMMUNOBIOLOGY, V191, P548, DOI 10.1016/S0171-2985(11)80461-4; BRETSCHER PA, 1992, SCIENCE, V257, P539, DOI 10.1126/science.1636090; Burridge MJ, 1985, PARASITOL TODAY, V1, P1; Collins N. E., 2003, VVolume 114, P121; Doyle CK, 2006, INFECT IMMUN, V74, P711, DOI 10.1128/IAI.74.1.711-720.2006; Faburay B, 2007, THESIS; Faburay B, 2007, VACCINE, V25, P7939, DOI 10.1016/j.vaccine.2007.09.002; Faburay B, 2014, VECTOR-BORNE ZOONOT, V14, P746, DOI 10.1089/vbz.2014.1650; Faburay B, 2013, VECTOR-BORNE ZOONOT, V13, P619, DOI 10.1089/vbz.2012.1285; FLESCH I, 1987, J IMMUNOL, V138, P4408; Gerrard SR, 2007, VIROLOGY, V357, P124, DOI 10.1016/j.virol.2006.08.002; Gerrard SR, 2002, J VIROL, V76, P12200, DOI 10.1128/JVI.76.23.12200-12210.2002; JONGEJAN F, 1991, RES VET SCI, V51, P24, DOI 10.1016/0034-5288(91)90025-J; JONGEJAN F, 1991, INFECT IMMUN, V59, P729, DOI 10.1128/IAI.59.2.729-731.1991; JONGEJAN F, 1992, EXP APPL ACAROL, V15, P117, DOI 10.1007/BF01275522; JONGEJAN F, 1991, VET MICROBIOL, V28, P199, DOI 10.1016/0378-1135(91)90093-U; Louw E, 2002, ANN NY ACAD SCI, V969, P147, DOI 10.1111/j.1749-6632.2002.tb04367.x; MAHAN SM, 1995, RES VET SCI, V58, P46, DOI 10.1016/0034-5288(95)90087-X; Mahan SM, 1998, VACCINE, V16, P1203, DOI 10.1016/S0264-410X(98)80120-5; Mahan SM, 2001, VET PARASITOL, V97, P295, DOI 10.1016/S0304-4017(01)00437-X; MARTINEZ D, 1994, VET IMMUNOL IMMUNOP, V41, P153, DOI 10.1016/0165-2427(94)90064-7; Martinez D, 1996, VET PARASITOL, V67, P175, DOI 10.1016/S0304-4017(96)01043-6; McBride JW, 2000, INFECT IMMUN, V68, P13, DOI 10.1128/IAI.68.1.13-18.2000; McGill JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151083; McGill JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148229; Nyika A, 2002, VACCINE, V20, P1215, DOI 10.1016/S0264-410X(01)00430-3; Nyika A, 1998, PARASITE IMMUNOL, V20, P111, DOI 10.1046/j.1365-3024.1998.00120.x; ORME IM, 1993, J IMMUNOL, V151, P518; Postigo M, 2008, VET MICROBIOL, V128, P136, DOI 10.1016/j.vetmic.2007.09.023; Pretorius A, 2007, VACCINE, V25, P2316, DOI 10.1016/j.vaccine.2006.11.061; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; ROMAGNANI S, 1992, INT ARCH ALLERGY IMM, V98, P279, DOI 10.1159/000236199; Singu V, 2006, CELL MICROBIOL, V8, P1475, DOI 10.1111/j.1462-5822.2006.00727.x; Specht CA, 2007, J INFECT DIS, V196, P796, DOI 10.1086/520536; Totte P, 1997, INFECT IMMUN, V65, P236; Totte P, 1999, PARASITOL TODAY, V15, P286, DOI 10.1016/S0169-4758(99)01467-2; UILENBERG G, 1983, ADV VET SCI COMP MED, V27, P427; UILENBERG G, 1982, AM J VET RES, V43, P1279; UILENBERG G, 1983, RES VET SCI, V35, P200, DOI 10.1016/S0034-5288(18)32179-9; Vachiery N, 2008, ANN NY ACAD SCI, V1149, P191, DOI 10.1196/annals.1428.081; Vachiery N, 2006, VACCINE, V24, P4747, DOI 10.1016/j.vaccine.2006.03.031; Zweygarth E, 2005, VACCINE, V23, P1695, DOI 10.1016/j.vaccine.2004.09.030	48	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185495	10.1371/journal.pone.0185495	http://dx.doi.org/10.1371/journal.pone.0185495			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957443	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200069
J	Markussen, LK; Isidor, MS; Breining, P; Andersen, ES; Rasmussen, NE; Petersen, LI; Pedersen, SB; Richelsen, B; Hansen, JB				Markussen, Lasse K.; Isidor, Marie S.; Breining, Peter; Andersen, Elise S.; Rasmussen, Nanna E.; Petersen, Louise I.; Pedersen, Steen B.; Richelsen, Bjorn; Hansen, Jacob B.			Characterization of immortalized human brown and white pre-adipocyte cell models from a single donor	PLOS ONE			English	Article							ADIPOSE-TISSUE MITOCHONDRIA; GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; ENERGY-EXPENDITURE; MESSENGER-RNA; HIGH-CAPACITY; ACTIVATION; DISTINCT; MOUSE; POPULATION	Brown adipose tissue with its constituent brown adipocytes is a promising therapeutic target in metabolic disorders due to its ability to dissipate energy and improve systemic insulin sensitivity and glucose homeostasis. The molecular control of brown adipocyte differentiation and function has been extensively studied in mice, but relatively little is known about such regulatory mechanisms in humans, which in part is due to lack of human brown adipose tissue derived cell models. Here, we used retrovirus-mediated overexpression to stably integrate human telomerase reverse transcriptase (TERT) into stromal-vascular cell fractions from deep and superficial human neck adipose tissue biopsies from the same donor. The brown and white pre-adipocyte cell models (TERT-hBA and TERT-hWA, respectively) displayed a stable proliferation rate and differentiation until at least passage 20. Mature TERT-hBA adipocytes expressed higher levels of thermogenic marker genes and displayed a higher maximal respiratory capacity than mature TERT-hWA adipocytes. TERT-hBA adipocytes were UCP1-positive and responded to beta-adrenergic stimulation by activating the PKAMKK3/6-p38 MAPK signaling module and increasing thermogenic gene expression and oxygen consumption. Mature TERT-hWA adipocytes underwent efficient rosiglitazone-induced 'browning', as demonstrated by strongly increased expression of UCP1 and other brown adipocyte-enriched genes. In summary, the TERT-hBA and TERT-hWA cell models represent useful tools to obtain a better understanding of the molecular control of human brown and white adipocyte differentiation and function as well as of browning of human white adipocytes.	[Markussen, Lasse K.; Isidor, Marie S.; Andersen, Elise S.; Rasmussen, Nanna E.; Petersen, Louise I.; Hansen, Jacob B.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Breining, Peter; Pedersen, Steen B.; Richelsen, Bjorn] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Breining, Peter; Pedersen, Steen B.; Richelsen, Bjorn] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark	University of Copenhagen; Aarhus University; Aarhus University	Hansen, JB (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	jacob.hansen@bio.ku.dk	Hansen, Jacob B/F-3775-2010; Pedersen, Steen B./AAB-3331-2019	Hansen, Jacob B/0000-0001-5249-2586; Pedersen, Steen B./0000-0002-7838-8063; Isidor, Marie Sophie Lykke/0000-0003-3396-5389; Richelsen, Bjoern/0000-0001-8886-9736; Markussen, Lasse K./0000-0002-8655-3719	EU DIABAT [HEALTH-F2-2011-278373]; Novo Nordisk Foundation; Siemens Foundation; Novo Nordisk Fonden [NNF13OC0006651, NNF15OC0017634] Funding Source: researchfish	EU DIABAT; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Siemens Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants to JBH from the EU FP7 project DIABAT (HEALTH-F2-2011-278373) and The Novo Nordisk Foundation, and a grant to LKM from the Siemens Foundation.; We thank Reuven Agami (The Netherlands Cancer Institute, the Netherlands), Karsten Kristiansen (University of Copenhagen, Denmark), Christian Dani (University Nice Sophia Antipolis, France), Martin Wabitch (University of Ulm, Germany) for the kind gift of materials. This work was supported by grants to JBH from the EU FP7 project DIABAT (HEALTH-F2-2011-278373) and The Novo Nordisk Foundation, and a grant to LKM from the Siemens Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Breining P, 2016, MOL CELLULAR ENDOCRI; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; COUSIN B, 1992, J CELL SCI, V103, P931; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Darimont C, 2003, CELL DEATH DIFFER, V10, P1025, DOI 10.1038/sj.cdd.4401273; Digby JE, 1998, DIABETES, V47, P138, DOI 10.2337/diabetes.47.1.138; Elabd C, 2009, STEM CELLS, V27, P2753, DOI 10.1002/stem.200; Fjeldborg K, 2014, J MOL ENDOCRINOL, V53, P227, DOI 10.1530/JME-14-0089; Hansen JB, 1999, J BIOL CHEM, V274, P2386, DOI 10.1074/jbc.274.4.2386; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hugo ER, 2006, ENDOCRINOLOGY, V147, P306, DOI 10.1210/en.2005-0989; Isidor MS, 2016, ADIPOCYTE, V5, P175, DOI 10.1080/21623945.2015.1111972; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; KERN PA, 1988, J LIPID RES, V29, P909; Kiwaki K, 2003, J COMP PHYSIOL B, V173, P675, DOI 10.1007/s00360-003-0377-1; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Liu DX, 2016, J CLIN INVEST, V126, P1704, DOI 10.1172/JCI83532; Loft A, 2015, GENE DEV, V29, P7, DOI 10.1101/gad.250829.114; Murholm M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-41; Murholm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008458; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Pisani Didier F, 2011, Front Endocrinol (Lausanne), V2, P87, DOI 10.3389/fendo.2011.00087; Porter C, 2016, CELL METAB, V24, P246, DOI 10.1016/j.cmet.2016.07.004; Ramage LE, 2016, CELL METAB, V24, P130, DOI 10.1016/j.cmet.2016.06.011; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wabitsch M, 2000, INT J CANCER, V88, P889, DOI 10.1002/1097-0215(20001215)88:6<889::AID-IJC8>3.0.CO;2-N; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue RD, 2015, NAT MED, V21, P760, DOI 10.1038/nm.3881	41	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185624	10.1371/journal.pone.0185624	http://dx.doi.org/10.1371/journal.pone.0185624			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957413	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200096
J	Falardeau, J; Johnson, RP; Pagotto, F; Wang, SY				Falardeau, Justin; Johnson, Roger P.; Pagotto, Franco; Wang, Siyun			Occurrence, characterization, and potential predictors of verotoxigenic Escherichia coli, Listeria monocytogenes, and Salmonella in surface water used for produce irrigation in the Lower Mainland of British Columbia, Canada	PLOS ONE			English	Article							VIRULENCE FACTORS; FRUIT; PREVALENCE; PATHOGENS; SPP.; OUTBREAK; RIVER; PCR; TRANSMISSION; DIVERSITY	Produce has become a major source of foodborne illness, and may become contaminated through surface water irrigation. The objectives of this study were to (i) determine the frequency of verotoxigenic E. coli (VTEC), Listeria monocytogenes, and Salmonella in surface waters used for irrigation in the Lower Mainland of British Columbia, (ii) assess the suitability of fecal coliforms and generic E. coli as hygiene indicators, and (iii) investigate the correlations of environmental factors with pathogen occurrence. Water samples were collected semi-monthly for 18 months from seven irrigation ditches across the Serpentine and Sumas watersheds. VTEC colonies on water filters were detected using a verotoxin colony immunoblot, and the presence of virulence genes vt1 and vt2 was ascertained via multiplex PCR. Detection of L. monocytogenes and Salmonella was completed using standard, Health Canada Compendium of Analytical Methods. Fecal coliforms and generic E. coli were enumerated by 3M (TM) Petrifilm (TM) and filtration methods, and meteorological and geographic data were collected from government records. VTEC, L. monocytogenes, and Salmonella were detected in 4.93%, 10.3%, and 2.69% of 223 samples, respectively. L. monocytogenes occurrence was greatest in the Serpentine watershed (x(2); p < 0.05), and was most common during the winter and fall (Fisher exact test; p < 0.05). Site dependence of VTEC and Salmonella occurrence was observed within watersheds (Fisher's exact test; p < 0.10). Pathogen occurrence correlated with fecal coliform counts (r = 0.448), while VTEC occurrence also correlated with precipitation over the five days before sampling (r = 0.239). The density of upstream livestock correlated with VTEC (r(s) = 0.812), and L. monocytogenes (r(s) = 0.841) detection. These data show that foodborne pathogens are present in the waters used for irrigation in the Lower Mainland of British Columbia, but their frequency may depend on spatial and temporal factors.	[Falardeau, Justin; Wang, Siyun] Univ British Columbia, Dept Food Nutr & Hlth, Vancouver, BC, Canada; [Johnson, Roger P.] Publ Hlth Agcy Canada, Guelph, ON, Canada; [Pagotto, Franco] Hlth Canada, Bur Microbial Hazards, Listeriosis Reference Serv, Ottawa, ON, Canada	University of British Columbia; Public Health Agency of Canada; Health Canada	Wang, SY (corresponding author), Univ British Columbia, Dept Food Nutr & Hlth, Vancouver, BC, Canada.	siyun.wang@ubc.ca		Wang, Siyun/0000-0003-2468-2483				Angell K, 2021, EUR J POLIT THEORY, V20, P95, DOI 10.1177/1474885117741748; Angelo K. M., 2014, MMWR-MORBID MORTAL W, V64, P144; BC Centre for Disease Control, 2017, REP DIS DASHB; Benjamin L, 2013, INT J FOOD MICROBIOL, V165, P65, DOI 10.1016/j.ijfoodmicro.2013.04.003; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; Bidol S. A., 2007, Morbidity and Mortality Weekly Report, V56, P909; Bielaszewska M, 2006, CLIN INFECT DIS, V43, P1160, DOI 10.1086/508195; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Budzinska K, 2012, POL J ENVIRON STUD, V21, P31; CanAgPlus, 2015, CANADAGAP FOOD SAF M; CDC, 2016, MULTISTATE OUTBREAK; Centers for Disease Control and Prevention (CDC), 2016, MULT OUTBR SALM POON; Chapin TK, 2014, J FOOD PROTECT, V77, P1919, DOI 10.4315/0362-028X.JFP-14-132; Chen Y, 2017, J CLIN MICROBIOL, V55, P931, DOI 10.1128/JCM.02140-16; Constantiniu S, 2002, J PREV MED, V10, P57; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Cooley MB, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00030; Cooley MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065716; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; Doumith M, 2012, J CLIN MICROBIOL, V50, P3108, DOI 10.1128/JCM.01468-12; Edge TA, 2012, J ENVIRON QUAL, V41, P21, DOI 10.2134/jeq2010.0253; Ewing W.H., 1986, EDWARDS EWINGS IDENT; Feng PCH, 2013, APPL ENVIRON MICROB, V79, P6917, DOI 10.1128/AEM.02455-13; Fisher N, 2015, OUTBREAK ALERT 2015; Gannon VPJ, 2004, J TOXICOL ENV HEAL A, V67, P1643, DOI 10.1080/15287390490492421; Gazal S, 2014, INDIAN J MED MICROBI, V32, P57, DOI 10.4103/0255-0857.124308; Government of British Columbia. B. C, GOOD AGR PRACT GUID; Gu GY, 2013, CAN J MICROBIOL, V59, P339, DOI 10.1139/cjm-2013-0027; Haley BJ, 2009, APPL ENVIRON MICROB, V75, P1248, DOI 10.1128/AEM.01648-08; Honish L, 2001, Can Commun Dis Rep, V27, P151; Johnson JYM, 2003, CAN J MICROBIOL, V49, P326, DOI [10.1139/w03-046, 10.1139/W03-046]; Johnson RP, 2014, APPL ENVIRON MICROB, V80, P2166, DOI 10.1128/AEM.03391-13; Jokinen CC, 2012, J ENVIRON QUAL, V41, P242, DOI 10.2134/jeq2011.0203; Jokinen CC, 2010, J WATER HEALTH, V8, P374, DOI 10.2166/wh.2009.076; Jones LA, 2014, APPL ENVIRON MICROB, V80, P4814, DOI 10.1128/AEM.01012-14; Karama M, 2008, J CLIN MICROBIOL, V46, P3569, DOI 10.1128/JCM.01095-08; King LA, 2012, CLIN INFECT DIS, V54, P1588, DOI 10.1093/cid/cis255; Kozak GK, 2013, J FOOD PROTECT, V76, P173, DOI 10.4315/0362-028X.JFP-12-126; Lyautey E, 2007, CAN J MICROBIOL, V53, P1158, DOI 10.1139/W07-084; Lyautey E, 2007, APPL ENVIRON MICROB, V73, P5401, DOI 10.1128/AEM.00354-07; MARIANIKURKDJIAN P, 1993, J CLIN MICROBIOL, V31, P296, DOI 10.1128/JCM.31.2.296-301.1993; McCollum JT, 2013, NEW ENGL J MED, V369, P944, DOI 10.1056/NEJMoa1215837; McLauchlin J, 2004, INT J FOOD MICROBIOL, V92, P15, DOI 10.1016/S0168-1605(03)00326-X; Muraoka R, 2007, JPN J INFECT DIS, V60, P410; Myers DN, US GEOLOGICAL SURVEY; Nadya S, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00036; Nightingale KK, 2004, APPL ENVIRON MICROB, V70, P4458, DOI 10.1128/AEM.70.8.4458-4467.2004; Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002; OSHEA ML, 1992, CAN J MICROBIOL, V38, P267, DOI 10.1139/m92-045; Pachepsky Y, 2016, CRIT REV MICROBIOL, V42, P384, DOI 10.3109/1040841X.2014.954524; Pachepsky Y, 2011, ADV AGRON, V113, P73, DOI 10.1016/B978-0-12-386473-4.00007-5; Pagotto F, 2011, COMPENDIUM ANAL METH, V2; Paton AW, 1998, J CLIN MICROBIOL, V36, P598, DOI 10.1128/JCM.36.2.598-602.1998; Prager R, 2002, INFECT GENET EVOL, V1, P265, DOI 10.1016/S1567-1348(02)00032-1; Public Health Agency of Canada, 2016, PUBL HLTH NOT UPD OU; Public Health Agency of Canada, 2015, EX SUMM NAT ENT SURV; PulseNet International, 2013, STAND OP PROC PULSEN; Reid A., 2009, COMPENDIUM ANAL METH, V2; Sanchez S, 2014, EPIDEMIOL INFECT, V142, P1029, DOI 10.1017/S0950268813001842; SHIPP CR, 1980, J CLIN PATHOL, V33, P595, DOI 10.1136/jcp.33.6.595; Solomon EB, 2002, APPL ENVIRON MICROB, V68, P397, DOI 10.1128/AEM.68.1.397-400.2002; Steele M, 2004, J FOOD PROTECT, V67, P2839, DOI 10.4315/0362-028X-67.12.2839; Strawn LK, 2013, APPL ENVIRON MICROB, V79, P588, DOI 10.1128/AEM.02491-12; Thomas M Kate, 2006, Can J Infect Dis Med Microbiol, V17, P229; US Food and Drug Administration, 2017, FSMA FIN RUL PROD SA; Uyttendaele M, 2015, COMPR REV FOOD SCI F, V14, P336, DOI 10.1111/1541-4337.12133; Vivant AL, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00087; Wang X, 2013, CAN J INFECT DIS MED, V24, P102; World Health Organization, OUTBR E COL O104 H4; Ziebell KA, 2002, RES MICROBIOL, V153, P289, DOI 10.1016/S0923-2508(02)01322-0	70	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0185437	10.1371/journal.pone.0185437	http://dx.doi.org/10.1371/journal.pone.0185437			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953937	Green Published, gold, Green Submitted			2022-12-27	WOS:000411980300067
J	Kwiatkowski, SC; Guerrero, PA; Hirota, S; Chen, ZH; Morales, JE; Aghi, M; McCarty, JH				Kwiatkowski, Sam C.; Guerrero, Paola A.; Hirota, Shinya; Chen, Zhihua; Morales, John E.; Aghi, Manish; McCarty, Joseph H.			Neuropilin-1 modulates TGF beta signaling to drive glioblastoma growth and recurrence after anti-angiogenic therapy	PLOS ONE			English	Article							ALPHA-V-BETA-8 INTEGRIN; MESENCHYMAL TRANSITION; VASCULAR MORPHOGENESIS; ANTIANGIOGENIC THERAPY; CELL INVASION; VEGF THERAPY; BRAIN-TUMORS; HUMAN GLIOMA; RECEPTOR; CANCER	Glioblastoma (GBM) is a rapidly progressive brain cancer that exploits the neural microenvironment, and particularly blood vessels, for selective growth and survival. Anti-angiogenic agents such as the vascular endothelial growth factor-A (VEGF-A) blocking antibody bevacizumab yield short-term benefits to patients due to blood vessel regression and stabilization of vascular permeability. However, tumor recurrence is common, and this is associated with acquired resistance to bevacizumab. The mechanisms that drive acquired resistance and tumor recurrence in response to anti-angiogenic therapy remain largely unknown. Here, we report that Neuropilin-1 (Nrp1) regulates GBM growth and invasion by balancing tumor cell responses to VEGF-A and transforming growth factor beta s (TGF beta s). Nrp1 is expressed in GBM cells where it promotes TGF beta receptor internalization and signaling via Smad transcription factors. GBM that recur after bevacizumab treatment show down-regulation of Nrp1 expression, indicating that altering the balance between VEGF-A and TGF beta signaling is one mechanism that promotes resistance to anti-angiogenic agents. Collectively, these data reveal that Nrp1 plays a critical role in balancing responsiveness to VEGF-A versus TGF beta to regulate GBM growth, progression, and recurrence after anti-vascular therapy.	[Kwiatkowski, Sam C.; Guerrero, Paola A.; Hirota, Shinya; Chen, Zhihua; Morales, John E.; McCarty, Joseph H.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Aghi, Manish] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA	University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco	McCarty, JH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA.	jhmccarty@mdanderson.org			National Institute of Neurological Disease and Stroke [R01NS087635, R01NS078402, R01NS079697]; Cancer Prevention and Research Institute of Texas [RP140411]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079697] Funding Source: NIH RePORTER	National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disease and Stroke, R01NS087635. Joseph H. McCarty, https://www.ninds.nih.gov; National Institute of Neurological Disease and Stroke, R01NS078402. Joseph H. McCarty, https://www.ninds.nih.gov; The Cancer Prevention and Research Institute of Texas, RP140411. Joseph H. McCarty, http://www.cprit.state.tx.us; National Institute of Neurological Disease and Stroke, R01NS079697. Manish Aghi, https://www.ninds.nih.gov. For the above grants, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspalter IM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8264; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Cao Y, 2010, J BIOL CHEM, V285, P31840, DOI 10.1074/jbc.M110.151696; Carbonell WS, 2013, CANCER RES, V73, P3145, DOI 10.1158/0008-5472.CAN-13-0011; Chaudhary B, 2014, CANCER IMMUNOL IMMUN, V63, P81, DOI 10.1007/s00262-013-1500-0; Cheng SY, 1996, P NATL ACAD SCI USA, V93, P8502, DOI 10.1073/pnas.93.16.8502; Ellis LM, 2009, NATURE, V458, P290, DOI 10.1038/458290a; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Glinka Y, 2011, CARCINOGENESIS, V32, P613, DOI 10.1093/carcin/bgq281; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hillman RT, 2011, GENE DEV, V25, P2333, DOI 10.1101/gad.173054.111; Hirota S, 2015, DEVELOPMENT, V142, P4363, DOI 10.1242/dev.113746; Hu B, 2007, ONCOGENE, V26, P5577, DOI 10.1038/sj.onc.1210348; Jahangiri A, 2013, CLIN CANCER RES, V19, P1773, DOI 10.1158/1078-0432.CCR-12-1281; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kjellman C, 2000, INT J CANCER, V89, P251, DOI 10.1002/1097-0215(20000520)89:3<251::AID-IJC7>3.0.CO;2-5; Koch S, 2014, DEV CELL, V28, P633, DOI 10.1016/j.devcel.2014.02.010; Kofler N, 2016, CURR OPIN HEMATOL, V23, P260, DOI 10.1097/MOH.0000000000000233; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Matkar PN, 2016, ONCOTARGET, V7, P69489, DOI 10.18632/oncotarget.11060; McCarty JH, 2002, MOL CELL BIOL, V22, P7667, DOI 10.1128/MCB.22.21.7667-7677.2002; McCarty JH, 2004, DEVELOPMENT; McCarty JH, 2013, CLIN CANCER RES, V19, P1631, DOI 10.1158/1078-0432.CCR-13-0051; McCarty JH, 2009, CURR OPIN HEMATOL, V16, P209, DOI 10.1097/MOH.0b013e32832a07eb; Mu ZY, 2008, MECH DEVELOP, V125, P508, DOI 10.1016/j.mod.2008.01.003; Muhl L, 2017, J CELL SCI; Nguyen HL, 2011, LAB INVEST, V91, P1554, DOI 10.1038/labinvest.2011.124; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Patil V, 2015, ONCOTARGET, V6, P43452, DOI 10.18632/oncotarget.6171; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piao Y, 2013, CLIN CANCER RES, V19, P4392, DOI 10.1158/1078-0432.CCR-12-1557; Prahst C, 2008, J BIOL CHEM, V283, P25110, DOI 10.1074/jbc.C800137200; Proctor JM, 2005, J NEUROSCI, V25, P9940, DOI 10.1523/JNEUROSCI.3467-05.2005; Reyes SB, 2013, MOL BIOL CELL, V24, P474, DOI 10.1091/mbc.E12-07-0521; Rich JN, 2003, FRONT BIOSCI-LANDMRK, V8, pE245, DOI 10.2741/992; Rizzolio S, 2012, CANCER RES, V72, P5801, DOI 10.1158/0008-5472.CAN-12-0995; Sayegh ET, 2014, MOL NEUROBIOL, V49, P1212, DOI 10.1007/s12035-013-8593-5; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Tchaicha JH, 2010, ONCOGENE, V29, P4460, DOI 10.1038/onc.2010.199; Tchaicha JH, 2011, CANCER RES, V71, P6371, DOI 10.1158/0008-5472.CAN-11-0991; van Meeteren LA, 2011, CURR PHARM BIOTECHNO, V12, P2108; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wei J, 2010, CLIN CANCER RES, V16, P461, DOI 10.1158/1078-0432.CCR-09-1983; Wrana JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011197; Zhu JW, 2002, DEVELOPMENT, V129, P2891	52	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							0185065	10.1371/journal.pone.0185065	http://dx.doi.org/10.1371/journal.pone.0185065			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH9IR	28938007	Green Published, Green Submitted, gold			2022-12-27	WOS:000411524700016
J	Makarov, EM; Shtam, TA; Kovalev, RA; Pantina, RA; Varfolomeeva, EY; Filatov, MV				Makarov, Evgeny M.; Shtam, Tatyana A.; Kovalev, Roman A.; Pantina, Rimma A.; Varfolomeeva, Elena Yu; Filatov, Michael V.			The rare nonsense mutation in p53 triggers alternative splicing to produce a protein capable of inducing apoptosis	PLOS ONE			English	Article							BLADDER-CARCINOMA ONCOGENE; CANCER CELL-LINES; MUTANT P53; MEDIATED DECAY; RNA SURVEILLANCE; RESTORATION; GENE; REACTIVATION; EXPRESSION; DATABASE	P53 protein is more frequently mutated in human tumours compared with the other proteins. While the majority of the p53 mutations, especially within its DNA-binding domain, lead to the loss of the wild-type function, there are accumulating data demonstrating that the p53 mutants gain tumour promoting activities; the latter triggers a revitalised interest in functional analysis of the p53 mutants. A systematic screening for p53 mutations in surgical materials from patients with glioma revealed a 378C>G mutation that creates a stop codon at the position of amino acid residue 126. The mutation eliminates the recognition site for the restriction endonuclease Sca I that allowed us to carry out RFLP analysis of DNA extracted from the clinical samples and suggests that this mutation is more frequent than is documented in the p53 databases. Both the ECV-304 and EJ cell lines, that probably originate from the bladder carcinoma T24 cell line, were confirmed to contain the homozygous 378C>G mutation but were shown to produce the p53 protein of expected full-length size detected by Western blotting. We provide evidence that the 378C>G mutation generates an alternative 3' splice site (ss) which is more often used instead of the authentic upstream 3' ss, driving the production of mRNA encoding the protein with the single amino acid deletion (p53.Y126). Using endogenous expression, we demonstrated that the p53.Y126 protein is nearly as active as the wild type protein in inducing the p21/Waf1 expression and apoptosis.	[Makarov, Evgeny M.] Brunel Univ London, Coll Hlth & Life Sci, Div Biosci, Uxbridge, Middx, England; [Shtam, Tatyana A.; Kovalev, Roman A.; Pantina, Rimma A.; Varfolomeeva, Elena Yu; Filatov, Michael V.] Natl Res Ctr, Kurchatov Inst, BP Konstantinov Petersburg Nucl Phys Inst, Gatchina, Russia; [Shtam, Tatyana A.] Peter Great St Petersburg Polytech Univ, St Petersburg, Russia; [Shtam, Tatyana A.] Petrov Inst Oncol, St Petersburg, Russia	Brunel University; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; Peter the Great St. Petersburg Polytechnic University; N.N. Petrov Research Institute of Oncology	Filatov, MV (corresponding author), Natl Res Ctr, Kurchatov Inst, BP Konstantinov Petersburg Nucl Phys Inst, Gatchina, Russia.	fil53ster@gmail.com	Varfolomeeva, Elena Yu/G-1008-2015; Shtam, Tatyana A/B-1274-2014; Filatov, Michael/D-5004-2014	Varfolomeeva, Elena Yu/0000-0003-3287-4709; Shtam, Tatyana A/0000-0003-0651-4785; Makarov, Evgeny/0000-0003-2543-9637; Filatov, Michael/0000-0003-3908-3061				Akerman M, 2006, NUCLEIC ACIDS RES, V34, P23, DOI 10.1093/nar/gkj408; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BELLOC F, 1994, CYTOMETRY, V17, P59, DOI 10.1002/cyto.990170108; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Bridger JM, 2004, EXP GERONTOL, V39, P717, DOI 10.1016/j.exger.2004.02.002; BURNS JE, 1993, BRIT J CANCER, V67, P1274, DOI 10.1038/bjc.1993.238; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Bykov VJN, 2014, FEBS LETT, V588, P2622, DOI 10.1016/j.febslet.2014.04.017; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Dou YM, 2006, RNA, V12, P2047, DOI 10.1261/rna.151106; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; GRIMM MO, 1995, UROL RES, V23, P293, DOI 10.1007/BF00300017; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; Hiller M, 2004, NAT GENET, V36, P1255, DOI 10.1038/ng1469; Hinow P, 2006, BIOPHYS J, V91, P330, DOI 10.1529/biophysj.105.078303; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Joerger AC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000919; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Keeling KM, 2014, ANNU REV GENOM HUM G, V15, P81; Leroy B, 2014, HUM MUTAT, V35, P672, DOI 10.1002/humu.22552; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liu XR, 2013, NUCLEIC ACIDS RES, V41, P6034, DOI 10.1093/nar/gkt305; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Maxwell SA, 2000, P NATL ACAD SCI USA, V97, P13009, DOI 10.1073/pnas.230445997; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; PARADA LF, 1982, NATURE, V297, P474, DOI 10.1038/297474a0; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Pospelova TV, 2009, CELL CYCLE, V8, P4112, DOI 10.4161/cc.8.24.10215; RIEGER KM, 1995, BRIT J CANCER, V72, P683, DOI 10.1038/bjc.1995.394; SANTOS E, 1982, NATURE, V298, P343, DOI 10.1038/298343a0; SHARMA S, 1993, CELL GROWTH DIFFER, V4, P861; TAKAHASHI K, 1990, IN VITRO CELL DEV B, V26, P265; Tate WP, 1995, BIOCHEM CELL BIOL, V73, P1095, DOI 10.1139/o95-118; Ulus-Senguloglu G, 2012, BRIT J CANCER, V107, P1506, DOI 10.1038/bjc.2012.443; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wiman KG, 2010, ONCOGENE, V29, P4245, DOI 10.1038/onc.2010.188; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yu M, 2015, NATURE, V520, P307, DOI 10.1038/nature14397	46	4	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185126	10.1371/journal.pone.0185126	http://dx.doi.org/10.1371/journal.pone.0185126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MG	28961258	Green Submitted, gold, Green Published			2022-12-27	WOS:000412027700015
J	Gotta, V; Baumann, P; Ritz, N; Fuchs, A; Baer, G; Bonhoeffer, JM; Heininger, U; Szinnai, G; Bonhoeffer, J				Gotta, Verena; Baumann, Philipp; Ritz, Nicole; Fuchs, Aline; Baer, Gurli; Bonhoeffer, Jessica M.; Heininger, Ulrich; Szinnai, Gabor; Bonhoeffer, Jan		ProPAED Study Grp	Drivers of antibiotic prescribing in children and adolescents with febrile lower respiratory tract infections	PLOS ONE			English	Article							C-REACTIVE PROTEIN; WHITE BLOOD-CELL; ERYTHROCYTE SEDIMENTATION-RATE; COMMUNITY-ACQUIRED PNEUMONIA; CALCITONIN-I GENE; PNEUMOCOCCAL PNEUMONIA; CLINICAL-FEATURES; LEUKOCYTE COUNT; PROCALCITONIN; BACTERIAL	Background Knowledge of key drivers for antibiotic prescribing in pediatric lower respiratory tract infection (LRTI) could support rational antibiotic use. Thus, we aimed to determine the impact of clinical and laboratory factors on antibiotic prescribing in children and adolescents with febrile LRTI. Methods Pediatric patients from the standard care control group of a randomized controlled trial (ProPAED) investigating procalcitonin guided antibiotic treatment in febrile LRTI were included in a multivariate logistic regression analysis to evaluate the impact of laboratory and clinical factors on antibiotic prescribing. Results The standard care control group of the ProPAED study comprised 165 LRTI patients (median age: 2.7 years, range: 0.1-16), out of which 88 (55%) received antibiotic treatment. Factors significantly associated with antibiotic prescribing in patients with complete clinical and laboratory documentation (n = 158) were C-reactive protein (OR 5.8 for a 10-fold increase, 95% CI 2.2-14.9), white blood count beyond age-dependent reference range (OR 3.9, 95% CI 1.4-11.4), body temperature (OR 1.7 for an increase by 1 degrees C, 95% CI 1.02-2.68), and pleuritic pain (OR 2.8, 95% CI 1.1-7.6). Dyspnea (OR 0.3, 95% CI 0.1-0.7) and wheezing (OR 0.3, 95% CI 0.13-0.95) were inversely associated with antibiotic prescribing. Conclusion Laboratory markers were strong drivers of antibiotic prescribing in children with febrile lower respiratory tract infections, in spite of their known poor prediction of antibiotic need. Building on current guidelines for antibiotic treatment in children with febrile LRTI, a reliable decision algorithm for safe antibiotic withholding considering the laboratory and clinical factors evaluated in this study has the potential to further reduce antibiotic prescribing.	[Gotta, Verena; Ritz, Nicole; Fuchs, Aline] Univ Basel, Childrens Hosp, Dept Pediat Pharmacol & Pharmacometr, Basel, Switzerland; [Baumann, Philipp; Ritz, Nicole; Baer, Gurli; Heininger, Ulrich; Bonhoeffer, Jan] Univ Basel, Childrens Hosp, Dept Pediat Infect Dis & Vaccinol, Basel, Switzerland; [Bonhoeffer, Jessica M.] Univ Basel, Childrens Hosp, Basel, Switzerland; [Szinnai, Gabor] Univ Basel, Childrens Hosp, Dept Pediat Endocrinol & Diabetol, Basel, Switzerland; [Baumann, Philipp] Univ Childrens Hosp Zurich, Dept Intens Care Med & Neonatol, Zurich, Switzerland; [Bonhoeffer, Jessica M.] Univ Childrens Hosp Zurich, Child Dev Ctr, Zurich, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University Children's Hospital Zurich; University Children's Hospital Zurich	Baumann, P (corresponding author), Univ Basel, Childrens Hosp, Dept Pediat Infect Dis & Vaccinol, Basel, Switzerland.; Baumann, P (corresponding author), Univ Childrens Hosp Zurich, Dept Intens Care Med & Neonatol, Zurich, Switzerland.	philipp.baumann@kispi.uzh.ch	Ritz, Nicole/G-2924-2015; Ritz, Nicole/L-1452-2019	Ritz, Nicole/0000-0002-1498-1685; Ritz, Nicole/0000-0002-1498-1685; Gotta, Verena/0000-0001-6254-5207				Ahmed MN, 2010, CLIN PEDIATR, V49, P542, DOI 10.1177/0009922809357786; Baer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068419; Balfour-Lynn IM, 2005, THORAX, V60, P1, DOI 10.1136/thx.2004.030676; Behrman R., 2004, NELSON TXB PEDIAT, V17th ed., P1481; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Cevey-Macherel M, 2009, EUR J PEDIATR, V168, P1429, DOI 10.1007/s00431-009-0943-y; Chen SP, 2013, J CLIN VIROL, V56, P7, DOI 10.1016/j.jcv.2012.08.021; Christ-Crain M, 2007, EUR RESPIR J, V30, P556, DOI 10.1183/09031936.00166106; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Christ-Crain M, 2006, AM J RESP CRIT CARE, V174, P84, DOI 10.1164/rccm.200512-1922OC; Davies HD, 1996, PEDIATR INFECT DIS J, V15, P600, DOI 10.1097/00006454-199607000-00008; Domenech VS, 2001, J INVEST MED, V49, P514, DOI 10.2310/6650.2001.33628; Don M, 2009, PEDIATR INT, V51, P91, DOI 10.1111/j.1442-200X.2008.02678.x; Elemraid MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106051; Esposito S, 2011, RESP MED, V105, P1939, DOI 10.1016/j.rmed.2011.09.003; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Flood RG, 2008, PEDIATR INFECT DIS J, V27, P95, DOI 10.1097/INF.0b013e318157aced; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Horwood J, 2016, BRIT J GEN PRACT, V66, pE207, DOI 10.3399/bjgp16X683821; Jakobsen KA, 2010, SCAND J PRIM HEALTH, V28, P229, DOI 10.3109/02813432.2010.506995; Johnson J, 2010, EMERG RADIOL, V17, P285, DOI 10.1007/s10140-009-0854-2; Koller D, 2013, INFECTION, V41, P121, DOI 10.1007/s15010-012-0302-1; Korppi M, 2004, PEDIATR INT, V46, P545, DOI 10.1111/j.1442-200x.2004.01947.x; Korppi M, 1997, EUR RESPIR J, V10, P1125, DOI 10.1183/09031936.97.10051125; KORPPI M, 1993, SCAND J INFECT DIS, V25, P435, DOI 10.3109/00365549309008524; Korppi M, 2008, ACTA PAEDIATR, V97, P943, DOI 10.1111/j.1651-2227.2008.00789.x; Lemaitre C, 2013, PEDIATR INFECT DIS J, V32, P1146, DOI 10.1097/INF.0b013e31829be1bb; Lin Chao-Jen, 2006, Journal of Microbiology Immunology and Infection, V39, P489; Lucas PJ, 2015, SCAND J PRIM HEALTH, V33, P11, DOI 10.3109/02813432.2015.1001942; McDonagh M, 2016, AHRQ PUBLICATION, V163; Moro ML, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-69; Muller B, 2004, CLIN INFECT DIS, V39, P1867, DOI 10.1086/426148; Muller B, 2001, J CLIN ENDOCR METAB, V86, P396, DOI 10.1210/jc.86.1.396; NOHYNEK H, 1995, PEDIATR INFECT DIS J, V14, P484, DOI 10.1097/00006454-199506000-00004; Organization WH, 2001, STAND INT CHEST RAD; Peltola V, 2006, J PEDIATR-US, V149, P721, DOI 10.1016/j.jpeds.2006.08.051; Prat C, 2003, PEDIATR INFECT DIS J, V22, P963, DOI 10.1097/01.inf.0000095197.72976.4f; Schuetz P, 2012, CLIN INFECT DIS, V55, P651, DOI 10.1093/cid/cis464; SHUTTLEWORTH DB, 1971, AM J DIS CHILD, V122, P393, DOI 10.1001/archpedi.1971.02110050063005; Stocker M, 2010, NEONATOLOGY, V97, P165, DOI 10.1159/000241296; Tabain I, 2012, PEDIATR INFECT DIS J, V31, P680, DOI 10.1097/INF.0b013e318256605e; van Buuren S, 2011, J STAT SOFTW, V45, P1; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wexler ID, 2006, PEDIATR PULM, V41, P726, DOI 10.1002/ppul.20383; World Health Organization, 2013, GUIDELINES MANAGEMEN	46	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185197	10.1371/journal.pone.0185197	http://dx.doi.org/10.1371/journal.pone.0185197			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957358	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200032
J	Lanouette, G; Brodeur, J; Fournier, F; Martel, V; Vreysen, M; Caceres, C; Firlej, A				Lanouette, Genevieve; Brodeur, Jacques; Fournier, Francois; Martel, Veronique; Vreysen, Marc; Caceres, Carlos; Firlej, Annabelle			The sterile insect technique for the management of the spotted wing drosophila, Drosophila suzukii: Establishing the optimum irradiation dose	PLOS ONE			English	Article							MATSUMURA DIPTERA DROSOPHILIDAE; TEPHRITIDAE; INDUCTION; INVASION; VINEGAR; CHERRY; MODEL; PEST	The spotted wing drosophila Drosophila suzukii Matsumura (Diptera: Drosophilidae), a pest of berries stone fruits, invaded North America and Europe in 2008. Current control methods rely mainly on insecticides. The sterile insect technique (SIT) has potential as an additional control tactic for the integrated management of D. suzukii. As a step towards the development of the SIT, this study aimed at finding the optimum irradiation dose to sterilize D. suzukii under controlled laboratory conditions. Four-day-old D. suzukii pupae were irradiated 12 to 24 hours prior to adult emergence in a Co-60 Gamma Cell 220 and in a 137 Cs Gamma Cell 3000 with doses of 30, 50, 70, 80, 90, 100 or 120 Gy. Emergence rate (88.1%), percent of deformed flies (4.0%) and survival curves were not affected by the tested irradiation doses. However, some reproductive parameters of the flies were affected by irradiation. Females irradiated with a dose of 50 Gy or more had almost no fecundity. When non-irradiated females were mated with irradiated males, egg hatch decreased exponentially with irradiation dose from 82.6% for the untreated control males to 4.0% for males irradiated with 120 Gy. Mortality of F1 individuals from the irradiated treatment also occurred during larval and pupal stages, with an egg to adult survival of 0.2%. However, descendants produced by the irradiated generation were fertile. These results are an encouraging first experimental step towards the development of the SIT for the management of D. suzukii populations.	[Lanouette, Genevieve; Firlej, Annabelle] Inst Rech & Dev Agroenvironm, St Bruno De Montarville, PQ, Canada; [Brodeur, Jacques] Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ, Canada; [Fournier, Francois] Coll Montmorency, Laval, PQ, Canada; [Martel, Veronique] Ressources Nat Canada, Ctr Foresterie Laurentides, Quebec City, PQ, Canada; [Vreysen, Marc; Caceres, Carlos] Insect Pest Control Lab, Joint FAO IAEA Div Nucl Tech Food & Agr, Seibersdorf, Austria	Universite de Montreal; Natural Resources Canada; Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency	Lanouette, G (corresponding author), Inst Rech & Dev Agroenvironm, St Bruno De Montarville, PQ, Canada.	genevieve.lanouette@umontreal.ca	Martel, Véronique/Q-5127-2019	Martel, Véronique/0000-0001-8111-5931; Lanouette, Genevieve/0000-0003-4313-3447	Ministere de I'Education et de l'Enseignement superieur [IA113135]; Ministere de I'Agriculture, des Pecheries et de I'Alimentation du Quebec; Agriculture and Agri-food Canada	Ministere de I'Education et de l'Enseignement superieur; Ministere de I'Agriculture, des Pecheries et de I'Alimentation du Quebec; Agriculture and Agri-food Canada(Agriculture & Agri Food Canada)	This research, including M. Sc. scholarship, materials and part of travel costs to Austria have been realized with the financial support of the Programme Innov'Action agroalimentaire from the agreement Cultivons L'Avenir 2 concluded between the Ministere de I'Agriculture, des Pecheries et de I'Alimentation du Quebec (http://www.mapaq.gouvqu.ca) and Agriculture and Agri-food Canada (http://agr.gc.ca). Grant number is IA113135 received by AF. Travel costs have also been financed with the Scholarship for short-term university studies outside of Quebec from the Ministere de I'Education et de l'Enseignement superieur (http://www.education.gouv.qc.ca) received by GL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinghi A, 2007, FLA ENTOMOL, V90, P96, DOI 10.1653/0015-4040(2007)90[96:IOSIAF]2.0.CO;2; AMERESEKERE RV, 1971, J ECON ENTOMOL, V64, P1074, DOI 10.1093/jee/64.5.1074; AMOAKO-ATTA B, 1976, Journal of the Kansas Entomological Society, V49, P133; Bakri A, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P233, DOI 10.1007/1-4020-4051-2_9; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Bolda M.P., 2010, AGR RESOUR EC UPDATE, V13, P5, DOI DOI 10.1016/J.JFF.2015.04.027; BROWER JH, 1975, ANN ENTOMOL SOC AM, V68, P1086, DOI 10.1093/aesa/68.6.1086; Bruck DJ, 2011, PEST MANAG SCI, V67, P1375, DOI 10.1002/ps.2242; Carpenter JE, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P115, DOI 10.1007/1-4020-4051-2_5; Cha DH, 2012, J CHEM ECOL, V38, P1419, DOI 10.1007/s10886-012-0196-5; Chabert S, 2012, BIOL CONTROL, V63, P40, DOI 10.1016/j.biocontrol.2012.05.005; Cini A, 2012, B INSECTOL, V65, P149; COGBURN RR, 1973, J ECON ENTOMOL, V66, P745, DOI 10.1093/jee/66.3.745; Collins SR, 2008, J APPL ENTOMOL, V132, P398, DOI 10.1111/j.1439-0418.2008.01284.x; Cormier D., 2015, IOBC/WPRS Bulletin, V109, P181; Cossentine J, 2016, BIOL CONTROL, V103, P129, DOI 10.1016/j.biocontrol.2016.09.002; Cuthbertson Andrew G S, 2014, Insects, V5, P488, DOI 10.3390/insects5020488; Daane KM, 2016, J PEST SCI, V89, P823, DOI 10.1007/s10340-016-0740-0; Depra M, 2014, J PEST SCI, V87, P379, DOI 10.1007/s10340-014-0591-5; Farnsworth D, 2016, PEST MANAG SCI; Farnsworth DJ, 2014, THESIS; Follett PA, 2014, J ECON ENTOMOL, V107, P964, DOI 10.1603/EC14006; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Guerrieri E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147382; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Helinski MEH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-41; Helinski MEH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S6; Hopper G. H. S., 1975, Journal of the Australian Entomological Society, V14, P175, DOI 10.1111/j.1440-6055.1975.tb02021.x; Jang M, 2016, PEST MANAG SCI; Kaspi R, 2003, ANN APPL BIOL, V143, P25, DOI 10.1111/j.1744-7348.2003.tb00265.x; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P39, DOI 10.1007/1-4020-4051-2_2; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1; Knipling E.F., 1992, AGR HDB USDA; LACHANCE LE, 1970, CHROMOSOMA, V29, P20, DOI 10.1007/BF01183659; LACHANCE LE, 1984, MUTAT RES, V127, P49, DOI 10.1016/0027-5107(84)90139-8; Landolt PJ, 2012, J APPL ENTOMOL, V136, P148, DOI 10.1111/j.1439-0418.2011.01646.x; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; Mitchell S, 1965, USDA TECH B, p[1, 33]; Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414; Parker A, 2007, FLA ENTOMOL, V90, P88, DOI 10.1653/0015-4040(2007)90[88:SITAMF]2.0.CO;2; Pimentel David, 2009, P89, DOI 10.1007/978-1-4020-8992-3_4; R Development Core Team, 2016, R LANG ENV STAT COMP; Renkema JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21432; Robinson AS, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P95, DOI 10.1007/1-4020-4051-2_4; Rogers MA, 2016, J YOUTH ADOLESCENCE, P1; Smirle MJ, 2017, PEST MANAG SCI, V73, P130, DOI 10.1002/ps.4310; Statistical Analysis Software Institute Inc, 2016, SAS 9 4 DAT MAN OV; Tochen S, 2014, ENVIRON ENTOMOL, V43, P501, DOI 10.1603/EN13200; Toledo J, 2004, J ECON ENTOMOL, V97, P383, DOI 10.1603/0022-0493-97.2.383; Van Timmeren S, 2013, CROP PROT, V54, P126, DOI 10.1016/j.cropro.2013.08.003; Vreysen M. J. B., 2007, P723, DOI 10.1007/978-1-4020-6059-5_66; Walse SS, 2012, J ASIA-PAC ENTOMOL, V15, P451, DOI 10.1016/j.aspen.2012.05.003; Walsh DB, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10010; Wyss JH, 2000, ANN NY ACAD SCI, V916, P186, DOI 10.1111/j.1749-6632.2000.tb05289.x	54	38	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0180821	10.1371/journal.pone.0180821	http://dx.doi.org/10.1371/journal.pone.0180821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957331	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200001
J	Moreau, JM; Cen, S; Berger, A; Furlonger, C; Paige, CJ				Moreau, Joshua M.; Cen, Selena; Berger, Alexandra; Furlonger, Caren; Paige, Christopher J.			Bone marrow basophils provide survival signals to immature B cells in vitro but are dispensable in vivo	PLOS ONE			English	Article							NEGATIVE SELECTION; ANTIGEN; DIFFERENTIATION; LYMPHOCYTES; TOLERANCE; ROLES; BLOOD; MICE	Immature B cells are the first B cell progenitors to express a fully formed B cell receptor and are therefore subject to extensive selection processes that act to mitigate the emergence of autoreactive clones. While it is well appreciated that most B cell generation in the bone marrow is highly dependent on access to molecules present in the local milieu, the existence of extrinsically provided factors that modulate immature B cell biology is ambiguous. Nonetheless, a population of CD49b(+)CD90 lo cells has demonstrated in vitro potential to promote immature B cell survival. Using a mouse basophil reporter strain we confirmed the identity of these CD49b(+)CD90 lo supportive cells as basophils. However, analysis of bone marrow B cell populations following lineage specific basophil depletion demonstrates that basophils do not have a significant role in vivo in modulating immature B cell biology during steady-state conditions.	[Moreau, Joshua M.; Cen, Selena; Berger, Alexandra; Furlonger, Caren; Paige, Christopher J.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Paige, Christopher J.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Paige, Christopher J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto	Moreau, JM (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.	josh.moreau@mail.utoronto.ca		Moreau, Joshua/0000-0002-1227-1508	Princess Margaret Cancer Centre; Toronto General/Toronto Western Foundation	Princess Margaret Cancer Centre(University of Toronto); Toronto General/Toronto Western Foundation	This study was supported through Princess Margaret Cancer Centre and Toronto General/Toronto Western Foundation operating grants held by CJP.; This study was supported through Princess Margaret Cancer Centre and Toronto General/Toronto Western Foundation operating grants held by CJP. JMM conceived the study, designed and performed experiments, and wrote the paper; SC, AB, and CF performed experiments; CJP provided study oversight, funding, and wrote the paper.	Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; BATTEN SJ, 1984, J IMMUNOL METHODS, V72, P381, DOI 10.1016/0022-1759(84)90007-3; Cariappa A, 2005, IMMUNITY, V23, P397, DOI 10.1016/j.immuni.2005.09.004; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; CHERVENICK PA, 1968, AM J PHYSIOL, V215, P353, DOI 10.1152/ajplegacy.1968.215.2.353; Corfe SA, 2012, SEMIN IMMUNOL, V24, P198, DOI 10.1016/j.smim.2012.02.001; Donovan EE, 2010, EUR J IMMUNOL, V40, P688, DOI 10.1002/eji.200939858; Gomez MR, 2010, J IMMUNOL, V185, P7180, DOI 10.4049/jimmunol.1002319; Granato A, 2014, J IMMUNOL, V192, P5761, DOI 10.4049/jimmunol.1300749; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; Hideto N, 2011, J IMMUNOL, V186, P5766; Karasuyama H, 2009, NAT REV IMMUNOL, V9, P9, DOI 10.1038/nri2458; King LB, 2000, IMMUNOL REV, V176, P86; Lim VY, 2017, ADV IMMUNOL, V134, P47, DOI 10.1016/bs.ai.2017.02.001; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Merluzzi S, 2015, MOL IMMUNOL, V63, P94, DOI 10.1016/j.molimm.2014.02.016; Metcalf D, 2013, P NATL ACAD SCI USA, V110, P17029, DOI 10.1073/pnas.1317055110; Moreau JM, 2015, BLOOD, V126, P1184, DOI 10.1182/blood-2015-03-635805; Nemazee D, 2017, NAT REV IMMUNOL, V17, P281, DOI 10.1038/nri.2017.19; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Pelanda R, 2012, CENTRAL B CELL TOLER, V4; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Rowland SL, 2013, IMMUNOL RES, V55, P231, DOI 10.1007/s12026-012-8366-7; Rowland SL, 2010, J IMMUNOL, V185, P4570, DOI 10.4049/jimmunol.1001708; Sandel PC, 1999, IMMUNITY, V10, P289, DOI 10.1016/S1074-7613(00)80029-1; Sandel PC, 2001, J IMMUNOL, V166, P5935, DOI 10.4049/jimmunol.166.10.5935; Sapoznikov A, 2008, NAT IMMUNOL, V9, P388, DOI 10.1038/ni1571; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; URBINA C, 1981, INT ARCH ALLER A IMM, V66, P158, DOI 10.1159/000232814; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185509	10.1371/journal.pone.0185509	http://dx.doi.org/10.1371/journal.pone.0185509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957409	Green Published, Green Submitted, gold			2022-12-27	WOS:000411985200071
J	Mtui, DT; Lepczyk, CA; Chen, Q; Miura, T; Cox, LJ				Mtui, Devolent T.; Lepczyk, Christopher A.; Chen, Qi; Miura, Tomoaki; Cox, Linda J.			Assessing multi-decadal land-cover - land-use change in two wildlife protected areas in Tanzania using Landsat imagery	PLOS ONE			English	Article							NATIONAL-PARK; SAVANNA VEGETATION; WESTERN TANZANIA; AFRICAN SAVANNAS; MIOMBO WOODLAND; RUKWA ECOSYSTEM; SOUTH-AFRICA; MARA REGION; EAST-AFRICA; WOODY COVER	Landscape change in and around protected areas is of concern worldwide given the potential impacts of such change on biodiversity. Given such impacts, we sought to understand the extent of changes in different land-cover types at two protected areas, Tarangire and Katavi National Parks in Tanzania, over the past 27 years. Using Maximum Likelihood classification procedures we derived eight land-cover classes from Landsat TM and ETM+ images, including: woody savannah, savannah, grassland, open and closed shrubland, swamp and water, and bare land. We determined the extent and direction of changes for all land-cover classes using a post-classification comparison technique. The results show declines in woody savannah and increases in barren land and swamps inside and outside Tarangire National Park and increases in woody savannah and savannah, and declines of shrubland and grassland inside and outside Katavi National Park. The decrease of woody savannah was partially due to its conversion into grassland and barren land, possibly caused by human encroachment by cultivation and livestock. Based upon these changes, we recommend management actions to prevent detrimental effects on wildlife populations.	[Mtui, Devolent T.; Lepczyk, Christopher A.; Miura, Tomoaki; Cox, Linda J.] Univ Hawaii Manoa, Dept Nat Resources & Environm Management, Honolulu, HI 96822 USA; [Chen, Qi] Univ Hawaii Manoa, Dept Geog, Honolulu, HI 96822 USA; [Mtui, Devolent T.] Tanzania Wildlife Res Inst, Arusha, Tanzania; [Lepczyk, Christopher A.] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Auburn University System; Auburn University	Mtui, DT (corresponding author), Tanzania Wildlife Res Inst, Arusha, Tanzania.	deovolentem@gmail.com			International Ford Foundation Fellowship-Tanzania; East West Center-Honolulu; International Ford Foundation Fellowships Program	International Ford Foundation Fellowship-Tanzania; East West Center-Honolulu; International Ford Foundation Fellowships Program	Funded by International Ford Foundation Fellowship-Tanzania (2009-2012), East West Center-Honolulu (2013).; We wish to thank Tanzania National Parks Headquarters for granting a research permit, the Tarangire and Katavi National Parks management teams and ecology departments of these parks particularly James Wakibara, Abel Mtui, Houston Njamasi and Davis Mushi, for logistical support and information. Assistance by Joseph Mhina, Richard Ndaskoi, Yusuf, Luc Leblanc, and Travis Idol during the field study and data analysis is greatly appreciated. We would also like to thank two anonymous reviewers that provided feedback on the draft manuscript. The USGS Earth Resources Observation and Science Centre has provided the Landsat satellite images. Tanzania Wildlife Research Institute's Conservation and Monitoring Unit, particularly Simon Mduma, Honori Maliti, Machoke Mwita and Hadia Haji have kindly provided data on human activities. This study was financially supported by the International Ford Foundation Fellowships Program to Devolent Mtui.	Banda T, 2008, FOREST ECOL MANAG, V255, P3382, DOI 10.1016/j.foreco.2008.01.079; Banda T, 2006, FOREST ECOL MANAG, V230, P179, DOI 10.1016/j.foreco.2006.04.032; BARNES RFW, 1983, BIOL CONSERV, V26, P127, DOI 10.1016/0006-3207(83)90062-9; Bhola N, 2012, J ANIM ECOL, V81, P1268, DOI 10.1111/j.1365-2656.2012.02000.x; Birkett A, 2005, AFR J ECOL, V43, P123, DOI 10.1111/j.1365-2028.2005.00555.x; Brenneman RA, 2009, AFR J ECOL, V47, P711, DOI 10.1111/j.1365-2028.2008.01029.x; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Byamungu M, 2016, LIVEST RES RURAL DEV, V28; Caro TM, 1999, J APPL ECOL, V36, P205, DOI 10.1046/j.1365-2664.1999.00392.x; Coppin P, 2004, INT J REMOTE SENS, V25, P1565, DOI 10.1080/0143116031000101675; Cumming DHM, 1997, S AFR J SCI, V93, P231; Elisa Manase, 2010, Ecohydrology & Hydrobiology, V10, P153, DOI 10.2478/v10104-011-0001-z; Fisher B, 2007, ECOL ECON, V62, P93, DOI 10.1016/j.ecolecon.2006.05.020; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Govender N, 2006, J APPL ECOL, V43, P748, DOI 10.1111/j.1365-2664.2006.01184.x; Greenwald KR, 2009, BIOL CONSERV, V142, P2493, DOI 10.1016/j.biocon.2009.05.021; Guldemond R, 2008, J WILDLIFE MANAGE, V72, P892, DOI 10.2193/2007-072; Haberl H, 2009, ECOL ECON, V68, P1797, DOI 10.1016/j.ecolecon.2008.11.013; Higgins SI, 2000, J ECOL, V88, P213, DOI 10.1046/j.1365-2745.2000.00435.x; Holdo RM, 2006, J VEG SCI, V17, P509, DOI 10.1111/j.1654-1103.2006.tb02472.x; Holdo RM, 2009, ECOL APPL, V19, P95, DOI 10.1890/07-1954.1; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Ishengoma DRS, 2008, CONSERV GENET, V9, P247, DOI 10.1007/s10592-007-9332-0; Jensen JR, 2007, REMOTE SENSING ENV E; Jensen TE, 2005, INTRO DIGITAL IMAGE; Kiffner C, 2015, AFR J ECOL, V53, P156, DOI 10.1111/aje.12160; KIKULA IS, 1986, OIKOS, V46, P317, DOI 10.2307/3565829; Kioko J, 2013, S AFR J WILDL RES, V43, P44, DOI 10.3957/056.043.0109; LAWTON RM, 1978, J ECOL, V66, P175, DOI 10.2307/2259187; Loarie SR, 2009, BIOL CONSERV, V142, P3099, DOI 10.1016/j.biocon.2009.08.021; Lu D, 2004, INT J REMOTE SENS, V25, P2365, DOI 10.1080/0143116031000139863; Mapaure IN, 2002, AFR J ECOL, V40, P212, DOI 10.1046/j.1365-2028.2002.00355.x; Mfunda Iddi M., 2010, International Journal of Biodiversity and Conservation, V2, P263; MNRT (Ministry of Natural Resources and Tourism), 2007, WILDL POL TANZ; Msoffe FU, 2011, J LAND USE SCI, V6, P261, DOI 10.1080/1747423X.2010.511682; Mundia CN, 2009, REMOTE SENS-BASEL, V1, P952, DOI 10.3390/rs1040952; Munyati C, 2000, INT J REMOTE SENS, V21, P1787, DOI 10.1080/014311600209742; MWALYOSI RBB, 1992, ENVIRON CONSERV, V19, P145, DOI 10.1017/S0376892900030629; Ogutu JO, 2011, J ZOOL, V285, P99, DOI 10.1111/j.1469-7998.2011.00818.x; Ottichilo WK, 2001, BIOL CONSERV, V97, P271, DOI 10.1016/S0006-3207(00)00090-2; Owen-Smith N, 2006, S AFR J SCI, V102, P389; Owen-Smith N.R., 1988, MEGAHERBIVORES INFLU; Pelkey NW, 2003, INT J REMOTE SENS, V24, P2533, DOI 10.1080/01431160210155929; Peter Frost, 1996, MIOMBO TRANSITION WO; PRINS HHT, 1987, BIOL CONSERV, V40, P141, DOI 10.1016/0006-3207(87)90064-4; Reed DN, 2009, J BIOGEOGR, V36, P770, DOI 10.1111/j.1365-2699.2008.02017.x; Richards J. A., 2006, REMOTE SENSING DIGIT; Sanchez-Azofeifa GA, 2003, BIOL CONSERV, V109, P123, DOI 10.1016/S0006-3207(02)00145-3; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Sankaran M, 2008, GLOBAL ECOL BIOGEOGR, V17, P236, DOI 10.1111/j.1466-8238.2007.00360.x; SAS Institute, 2010, SAS SYST WIND VERS 9; Scanlon TM, 2002, REMOTE SENS ENVIRON, V82, P376, DOI 10.1016/S0034-4257(02)00054-8; Sinclair ARE, 2007, CONSERV BIOL, V21, P580, DOI 10.1111/j.1523-1739.2007.00699.x; SINGH A, 1989, INT J REMOTE SENS, V10, P989, DOI 10.1080/01431168908903939; Skarpe C, 2004, AMBIO, V33, P276, DOI 10.1639/0044-7447(2004)033[0276:TROTGE]2.0.CO;2; SKARPE C, 1991, AMBIO, V20, P351; Swain P. H, EMOTE SENSING QUANTI; Van de Vijver CADM, 1999, J TROP ECOL, V15, P545, DOI 10.1017/S0266467499001017; van Langevelde F, 2003, ECOLOGY, V84, P337, DOI 10.1890/0012-9658(2003)084[0337:EOFAHO]2.0.CO;2; Vanclay JK, 2001, SCIENCE, V293, P1007, DOI 10.1126/science.293.5532.1007a; Verbyla DL, 2000, INT J REMOTE SENS, V21, P3553, DOI 10.1080/014311600750037570; Wessels KJ, 2007, J ARID ENVIRON, V68, P271, DOI 10.1016/j.jaridenv.2006.05.015; Western D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006140	64	10	10	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185468	10.1371/journal.pone.0185468	http://dx.doi.org/10.1371/journal.pone.0185468			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957397	Green Published, gold, Green Submitted			2022-12-27	WOS:000411985200065
J	Wang, H; Zhang, WD; Gu, HL; Chen, WL; Zeng, M; Ji, CH; Song, RY; Zhang, GH				Wang, Heng; Zhang, Weidong; Gu, Honglang; Chen, Wanli; Zeng, Meng; Ji, Chihai; Song, Ruyue; Zhang, Guihong			Identification and characterization of two linear epitope motifs in hepatitis E virus ORF2 protein	PLOS ONE			English	Article							PEPTIDE-BASED IMMUNOASSAYS; CAPSID PROTEIN; MONOCLONAL-ANTIBODIES; HEV; NEUTRALIZATION; SWINE	Hepatitis E virus( HEV) is responsible for hepatitis E, which represents a global public health problem. HEV genotypes 3 and 4 are reported to be zoonotic, and animals are monitored for HEV infection in the interests of public hygiene and food safety. The development of novel diagnostic methods and vaccines for HEV in humans is thus important topics of research. Opening reading frame( ORF) 2 of HEV includes both linear and conformational epitopes and is regarded as the primary candidate for vaccines and diagnostic tests. We investigated the precise location of the HEV epitopes in the ORF2 protein. We prepared four monoclonal antibodies( mAbs) against genotype 4 ORF2 protein and identified two linear epitopes, G438IVIPHD444 and Y457DNQH461, corresponding to two of these mAbs using phage display biopanning technology. Both these epitopes were speculated to be universal to genotypes 1, 2, 3, 4, and avian HEVs. We also used two 12-mer fragments of ORF2 protein including these two epitopes to develop a peptide-based enzyme-linked immunosorbent assay( ELISA) to detect HEV in serum. This assay demonstrated good specificity but low sensitivity compared with the commercial method, indicating that these two epitopes could serve as potential candidate targets for diagnosis. Overall, these results further our understanding of the epitope distribution of HEV ORF2, and provide important information for the development of peptide-based immunodiagnostic tests to detect HEV in serum.	[Wang, Heng; Gu, Honglang; Chen, Wanli; Zeng, Meng; Ji, Chihai; Song, Ruyue; Zhang, Guihong] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Wang, Heng; Chen, Wanli; Zeng, Meng; Song, Ruyue] Guangdong Prov Key Lab Prevent & Control Severe C, Guangzhou, Guangdong, Peoples R China; [Zhang, Weidong] Hosp South China Agr Univ, Guangzhou, Guangdong, Peoples R China; [Gu, Honglang; Ji, Chihai; Zhang, Guihong] MOA Key Lab Anim Vaccine Dev, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Wang, H; Zhang, GH (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.; Wang, H (corresponding author), Guangdong Prov Key Lab Prevent & Control Severe C, Guangzhou, Guangdong, Peoples R China.; Zhang, GH (corresponding author), MOA Key Lab Anim Vaccine Dev, Guangzhou, Guangdong, Peoples R China.	wangheng2009@scau.edu.cn; guihongzh@scau.edu.cn			National Key Research and Development Program [2016YFD0500707]; Department of Education of Guangdong province [YQ201530]; Industry Technology System of Modern Agriculture Construction Fund [CARS-36]	National Key Research and Development Program; Department of Education of Guangdong province(National Natural Science Foundation of Guangdong Province); Industry Technology System of Modern Agriculture Construction Fund	This study was partially supported by the National Key Research and Development Program (2016YFD0500707) received by GZ and HW, http://service.most.gov.cn/, the Department of Education of Guangdong province (YQ201530) received by HW, http://gdjs.gdhed.edu.cn/main/main.php, and the Industry Technology System of Modern Agriculture Construction Fund (CARS-36) received by GZ, http://119.253.58.231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behloul N, 2015, INFECT GENET EVOL, V34, P211, DOI 10.1016/j.meegid.2015.06.026; Chandra V, 2008, J BIOSCIENCES, V33, P451, DOI 10.1007/s12038-008-0064-1; Dalton HR, 2016, TRANSFUS APHER SCI, V55, P271, DOI 10.1016/j.transci.2016.10.016; Gu H, 2015, CHINESE J VET MED, V51, P25; Gu Y, 2015, CELL RES, V25, P604, DOI 10.1038/cr.2015.34; Haqshenas G, 2002, J GEN VIROL, V83, P2201, DOI 10.1099/0022-1317-83-9-2201; Huang FF, 2004, J GEN VIROL, V85, P1609, DOI 10.1099/vir.0.79841-0; LI F, 1994, J CLIN MICROBIOL, V32, P2060, DOI 10.1128/JCM.32.9.2060-2066.1994; Liu BQ, 2009, J BIOTECHNOL, V141, P91, DOI 10.1016/j.jbiotec.2009.02.005; Ma HX, 2009, J MED VIROL, V81, P1052, DOI 10.1002/jmv.21484; Meng JH, 2001, VIROLOGY, V288, P203, DOI 10.1006/viro.2001.1093; Njouom R, 2010, J CLIN VIROL, V49, P61, DOI 10.1016/j.jcv.2010.06.005; Osterman A, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-28; Pavio N, 2015, CURR OPIN VIROL, V10, P34, DOI 10.1016/j.coviro.2014.12.006; Perez C, 2006, J MED VIROL, V78, P806, DOI 10.1002/jmv.20627; Riddell MA, 2000, J VIROL, V74, P8011, DOI 10.1128/JVI.74.17.8011-8017.2000; Rowley Merrill J, 2004, Biotechnol Annu Rev, V10, P151, DOI 10.1016/S1387-2656(04)10006-9; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanchez AB, 2010, CANCER CHEMOTH PHARM, V66, P919, DOI 10.1007/s00280-009-1240-1; Smith DB, 2016, J GEN VIROL, V97, P537, DOI 10.1099/jgv.0.000393; Smith DB, 2014, J GEN VIROL, V95, P2223, DOI 10.1099/vir.0.068429-0; Tang ZM, 2015, VACCINE, V33, P3504, DOI 10.1016/j.vaccine.2015.05.065; Wang H, 2015, J VIROL METHODS, V222, P231, DOI 10.1016/j.jviromet.2015.04.026; Wang HL, 2015, 2015 IEEE 5TH ASIA-PACIFIC CONFERENCE ON SYNTHETIC APERTURE RADAR (APSAR), P108, DOI 10.1109/APSAR.2015.7306166; Wang XJ, 2015, J VIROL, V89, P5491, DOI 10.1128/JVI.00107-15; Yamashita T, 2009, P NATL ACAD SCI USA, V106, P12986, DOI 10.1073/pnas.0903699106; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	27	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0184947	10.1371/journal.pone.0184947	http://dx.doi.org/10.1371/journal.pone.0184947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957334	Green Submitted, Green Published, gold			2022-12-27	WOS:000411985200025
J	Zheng, W; Wen, MJ; Zhao, ZY; Liu, J; Wang, ZH; Zhai, BN; Li, ZY				Zheng, Wei; Wen, Meijuan; Zhao, Zhiyuan; Liu, Jie; Wang, Zhaohui; Zhai, Bingnian; Li, Ziyan			Black plastic mulch combined with summer cover crop increases the yield and water use efficiency of apple tree on the rainfed Loess Plateau	PLOS ONE			English	Article							BELOW-GROUND INTERACTIONS; ORCHARD FLOOR MANAGEMENT; SOIL-MANAGEMENT; INTERCROPPING SYSTEM; ORGANIC MANURE; GRASS COVER; GROWTH; TEMPERATURE; COMPETITION; INFILTRATION	Water deficit significantly limits dryland rainfed fruit production, so increasing water conservation is crucial for improving fruit productivity in arid and semiarid areas. In this study, we tested two treatments in an apple orchard: 1) PC treatment comprising black plastic mulch (BPM) (in-row) with weed control (inter-row); 2) and PGC treatment comprising BPM (in-row) combined with a summer cover crop (inter-row) of rape (Brassica campestris L.), which was sown in mid-June and was living from July to September. Under PGC, the inter-row soil water storage increased by 17.9% and 11.5% compared with PC after the harvest in 2013 and 2014, respectively, but there was no significant increase in 2015. The evapotranspiration (ET) from the inter-row areas during the cover crop period was lower under PGC than PC in 2013 (19.6%), 2014 (11.3%), and 2015 (13.3%). However, the differences in the total ET from the inter-row areas between the two treatments were not obvious, and the total ET from in-row areas was higher under PGC than PC due to the increased water uptake by apple trees under PGC. The apple yield, water use efficiency during the cover crop period (WUEg) and total water use efficiency (WUE) fluctuated during the experimental years. Compared with PC, the apple yield increased by 14.1%, 18.8%, and 26.7% under PGC in 2013, 2014, and 2015, respectively. In addition, the WUEg was 26.4%, 24.7%, and 32.7% higher under PGC compared with PC in 2013, 2014, and 2015, respectively. Thus, the WUE under PGC was 13.8% and 11.7% higher than that under PC in 2013 and 2014, respectively, but the difference was not significant in 2015 (p = 0.0527). Thus, BPM combined with a summer cover crop is recommended for decreasing the summer ET and promoting apple production in rainfed dryland areas where the rainy season is usually the hot season.	[Zheng, Wei; Wen, Meijuan; Zhao, Zhiyuan; Liu, Jie; Wang, Zhaohui; Zhai, Bingnian; Li, Ziyan] Northwest A&F Univ, Coll Resources & Environm, Yangling, Peoples R China; [Zheng, Wei; Wen, Meijuan; Zhao, Zhiyuan; Liu, Jie; Wang, Zhaohui; Zhai, Bingnian; Li, Ziyan] Minist Agr, Key Lab Plant Nutr & Agrienvironm Northwest China, Yangling, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs	Zhai, BN; Li, ZY (corresponding author), Northwest A&F Univ, Coll Resources & Environm, Yangling, Peoples R China.; Zhai, BN; Li, ZY (corresponding author), Minist Agr, Key Lab Plant Nutr & Agrienvironm Northwest China, Yangling, Peoples R China.	bingnianzhaitg@126.com; liziyan0161@126.com		Zheng, Wei/0000-0002-5034-4712	Special Fund for Agro-scientific Research in the Public Interest of China [201303104, 201103005-9]; Agriculture Science Technology Achievement Transformation Fund of Shaanxi (NYKJ); Science and Technology Innovation Project of Shaanxi Province [2011KTZB02-02-05]; Project of Promoting Agricultural Science and Technology Demonstration of Yangling [2015-TS-18]; Scientific and Technological Achievements Promotion Project of Northwest AF University [TGZX2014-16]	Special Fund for Agro-scientific Research in the Public Interest of China; Agriculture Science Technology Achievement Transformation Fund of Shaanxi (NYKJ); Science and Technology Innovation Project of Shaanxi Province; Project of Promoting Agricultural Science and Technology Demonstration of Yangling; Scientific and Technological Achievements Promotion Project of Northwest AF University	Funded by Special Fund for Agro-scientific Research in the Public Interest of China (201303104, 201103005-9), Agriculture Science Technology Achievement Transformation Fund of Shaanxi (NYKJ-2015-17), the Science and Technology Innovation Project of Shaanxi Province (2011KTZB02-02-05), the Project of Promoting Agricultural Science and Technology Demonstration of Yangling (2015-TS-18), the Scientific and Technological Achievements Promotion Project of Northwest A&F University (TGZX2014-16) to Bingnian Zhai.	Bhardwaj R. L., 2013, Agricultural Reviews, V34, P188, DOI 10.5958/j.0976-0741.34.3.003; CARDINA J, 1986, WEED SCI, V34, P338, DOI 10.1017/S0043174500066959; Celette F, 2005, PLANT SOIL, V276, P205, DOI 10.1007/s11104-005-4415-5; Celette F, 2009, EUR J AGRON, V30, P41, DOI 10.1016/j.eja.2008.07.003; Celette F, 2008, EUR J AGRON, V29, P153, DOI 10.1016/j.eja.2008.04.007; Chen YX, 2014, SCI HORTIC-AMSTERDAM, V172, P248, DOI 10.1016/j.scienta.2014.04.010; Cook HF, 2006, SOIL TILL RES, V91, P227, DOI 10.1016/j.still.2005.12.007; Du SN, 2015, PLANT SOIL, V390, P431, DOI 10.1007/s11104-014-2363-7; DUNCAN RA, 1992, J NEMATOL, V24, P681; Fetene M, 2003, J ARID ENVIRON, V55, P441, DOI 10.1016/S0140-1963(03)00052-1; FOLORUNSO OA, 1992, SOIL TECHNOL, V5, P189, DOI 10.1016/0933-3630(92)90021-R; Giese G, 2014, SCI HORTIC-AMSTERDAM, V170, P256, DOI 10.1016/j.scienta.2014.03.011; GLENN DM, 1989, J AM SOC HORTIC SCI, V114, P10; GULICK SH, 1994, SOIL SCI SOC AM J, V58, P1539, DOI 10.2136/sssaj1994.03615995005800050038x; HAM JM, 1993, J AM SOC HORTIC SCI, V118, P188, DOI 10.21273/JASHS.118.2.188; Hammermeister AM, 2016, SCI HORTIC-AMSTERDAM, V208, P28, DOI 10.1016/j.scienta.2016.02.004; Hanninen K, 1999, PLANT SOIL, V216, P129, DOI 10.1023/A:1004731009386; HAYNES RJ, 1980, AGRO-ECOSYSTEMS, V6, P3, DOI 10.1016/0304-3746(80)90003-7; JARVIS BDW, 1983, CURR MICROBIOL, V8, P153, DOI 10.1007/BF01568849; King AP, 2005, AGR ECOSYST ENVIRON, V109, P262, DOI 10.1016/j.agee.2005.03.002; Klodd AE, 2016, PLANT SOIL, V400, P391, DOI 10.1007/s11104-015-2748-2; Lehmann J, 1998, FOREST ECOL MANAG, V111, P157, DOI 10.1016/S0378-1127(98)00322-3; LIAKATAS A, 1986, AGR FOREST METEOROL, V36, P227, DOI 10.1016/0168-1923(86)90037-7; Liu CA, 2013, AGR WATER MANAGE, V117, P123, DOI 10.1016/j.agwat.2012.11.002; Liu QF, 2016, SOIL TILL RES, V157, P1, DOI 10.1016/j.still.2015.11.003; Lopes CM, 2011, SCI HORTIC-AMSTERDAM, V129, P603, DOI 10.1016/j.scienta.2011.04.033; MERWIN IA, 1994, J AM SOC HORTIC SCI, V119, P209, DOI 10.21273/JASHS.119.2.209; NEILSEN GH, 1986, CAN J SOIL SCI, V66, P701, DOI 10.4141/cjss86-069; Parker ML, 1996, HORTSCIENCE, V31, P330, DOI 10.21273/HORTSCI.31.3.330; Poeplau C, 2015, AGR ECOSYST ENVIRON, V200, P33, DOI 10.1016/j.agee.2014.10.024; Pradel E., 2000, Australian Journal of Grape and Wine Research, V6, P59, DOI 10.1111/j.1755-0238.2000.tb00163.x; PRICHARD T L, 1989, California Agriculture, V43, P23; Qian X, 2015, EUR J SOIL BIOL, V70, P23, DOI 10.1016/j.ejsobi.2015.06.005; Qin SH, 2014, AGR WATER MANAGE, V131, P87, DOI 10.1016/j.agwat.2013.09.015; Ramos ME, 2011, SOIL TILL RES, V112, P85, DOI 10.1016/j.still.2010.11.007; ROBERSON EB, 1991, SOIL SCI SOC AM J, V55, P734, DOI 10.2136/sssaj1991.03615995005500030016x; de Oliveira FER, 2016, REV BRAS CIENC SOLO, V40, DOI 10.1590/18069657rbcs20150105; Sanchez EE, 2007, PLANT SOIL, V292, P193, DOI 10.1007/s11104-007-9215-7; Smith DM, 1999, PLANT SOIL, V211, P191, DOI 10.1023/A:1004635414462; Szilagyi J, 2014, J HYDROL, V519, P455, DOI 10.1016/j.jhydrol.2014.07.040; TerAvest D, 2011, HORTSCIENCE, V46, P1687, DOI 10.21273/HORTSCI.46.12.1687; Walsh BD, 1996, CAN J SOIL SCI, V76, P203, DOI 10.4141/cjss96-028; [王改兰 WANG Gailan], 2006, [水土保持学报, Journal of Soil and Water Conservation], V20, P82; Wang H, 2015, AGR WATER MANAGE, V154, P20, DOI 10.1016/j.agwat.2015.02.010; Wu JS, 2014, SOIL RES, V52, P575, DOI 10.1071/SR14021; Yang Y., 2013, FOOD NUTR CHINA, V19, P23; Yao S, 2005, PLANT SOIL, V271, P377, DOI 10.1007/s11104-004-3610-0; Zhao ZP, 2014, INT J AGR BIOL ENG, V7, P45, DOI 10.3965/j.ijabe.20140702.006; Zribi W, 2015, SOIL TILL RES, V148, P40, DOI 10.1016/j.still.2014.12.003	49	26	28	9	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2017	12	9							e0185705	10.1371/journal.pone.0185705	http://dx.doi.org/10.1371/journal.pone.0185705			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4YC	28957428	gold, Green Published, Green Submitted			2022-12-27	WOS:000411985200109
J	Fernandez-Crespo, T; Schulting, RJ				Fernandez-Crespo, Teresa; Schulting, Rick J.			Living different lives: Early social differentiation identified through linking mortuary and isotopic variability in Late Neolithic/Early Chalcolithic north-central Spain	PLOS ONE			English	Article							BONE-COLLAGEN; OSTEOLOGICAL PARADOX; MEGALITHIC GRAVES; CARBON; DIET; NITROGEN; RATIOS; PALAEODIETARY; TEMPERATE; C-13/C-12	Variation in burial location and treatment is often observed in the prehistoric archaeological record, but its interpretation is usually highly ambiguous. Biomolecular approaches provide the means of addressing this variability in a way not previously possible, linking the lives of individuals to their funerary treatment. Here, we undertake stable carbon and nitrogen isotope analyses on a substantial sample of 166 individuals from a series of broadly contemporary Late Neolithic/Early Chalcolithic (3500 to 2900 cal BC) mortuary monuments (El Sotillo, Alto de la Huesera, Chabola de la Hechicera and Longar) and caves (Las Yurdinas II, Los Husos I and Pena Larga) within a very spatially restricted area of north-central Spain, with sites separated by no more than 10 km on average. This spatial and temporal proximity allows us to focus on the question at the appropriate scale of analysis, avoiding confounding variables such as environmental change, diachronic trends in the subsistence economy, etc. The results demonstrate a statistically significant difference in human delta(13) C values between those interred in caves and those placed in monuments. The difference appears to be correlated with fine-grained environmental factors (elevation/temperature/precipitation), suggesting that use of the landscape was being divided at a very local scale. The reasons for this partitioning may involve differential social status (e.g. those interred in caves may be of lower standing with more restricted access to the valley's arable resources) or economic specialization (e.g. upland herding vs. valley farming) within the same community or, alternatively, different populations performing different funerary practices and following distinct subsistence economies in some respect. Our results contribute to a better understanding of the development of social differentiation and community specialisation on the scale of the immediate lived landscape.	[Fernandez-Crespo, Teresa] Univ Basque Country, UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Fernandez-Crespo, Teresa; Schulting, Rick J.] Univ Oxford, Res Lab Archaeol & Hist Art, Sch Archaeol, Oxford, England	University of Basque Country; University of Oxford	Fernandez-Crespo, T (corresponding author), Univ Basque Country, UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain.; Fernandez-Crespo, T (corresponding author), Univ Oxford, Res Lab Archaeol & Hist Art, Sch Archaeol, Oxford, England.	teresa.fernandezc@ehu.es	Fernández-Crespo, Teresa/ABH-2401-2020; Schulting, Rick/AAV-2339-2021	Fernández-Crespo, Teresa/0000-0001-5553-8578; Schulting, Rick/0000-0002-4444-766X	Basque Government [POS_2013_1_147, POS_2014_2_24, POS_2015_2_0001, IT542/10]; Spanish Ministry of Science and Research [HAR2011-26956]; University of the Basque Country (UPV/EHU) [UFI11/09]	Basque Government(Basque Government); Spanish Ministry of Science and Research(Spanish Government); University of the Basque Country (UPV/EHU)	The research was supported and financed by the Basque Government (POS_2013_1_147; POS_2014_2_24; POS_2015_2_0001; IT542/10), the Spanish Ministry of Science and Research (HAR2011-26956) and the University of the Basque Country (UPV/EHU) (UFI11/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt KW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146176; Altuna J., 1980, MUNIBE, V32, P1; Ambrose SH, 2003, J ANTHROPOL ARCHAEOL, V22, P217, DOI 10.1016/S0278-4165(03)00036-9; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Andres MT, 1998, COLECTIVISMO FUNERAR; Andres MT., 2009, ANEJOS DE VELEIA SER, V8, P11; [Anonymous], 2005, ACT 3 C NEOL PEN IB; Beaumont J, 2013, ARCHAEOMETRY, V55, P277, DOI 10.1111/j.1475-4754.2012.00682.x; Bentley RA, 2005, ARCHAEOMETRY, V47, P629, DOI 10.1111/j.1475-4754.2005.00223.x; Bevan B., 1997, RECONSTRUCTING IRON, P181; Beyneix A, 2012, ANTHROPOLOGIE, V116, P222, DOI 10.1016/j.anthro.2012.03.002; Bocherens H, 2005, J HUM EVOL, V49, P71, DOI 10.1016/j.jhevol.2005.03.003; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; Bogaard A, 2012, MANURE MATTERS: HISTORICAL, ARCHAEOLOGICAL AND ETHNOGRAPHIC PERSPECTIVES, P25; Bogaard A, 2013, P NATL ACAD SCI USA, V110, P12589, DOI 10.1073/pnas.1305918110; Bogaard A, 2011, ANTIQUITY, V85, P395, DOI 10.1017/S0003598X00067831; Bonafini M, 2013, J ARCHAEOL SCI, V40, P3926, DOI 10.1016/j.jas.2013.03.028; Bronk Ramsey C., 2013, OXCAL 4 2 2; Buikstra Jane., 1994, STANDARDS DATA COLLE, V44, P209, DOI DOI 10.1002/AJHB.1310070519; Buxo R, 2008, ARQUEOBOTANICA USOS; Castanos PM, 1997, MEMORIAS YACIMIENTOS, V4, P127; CerrilloCuenca E., 2014, RENDERING DEATH IDEO, V2648, P77; Chamberlain A.T., 2006, DEMOGRAPHY ARCHAEOLO; Chamberlain AT, 1996, ANTIQUITY, V70, P950, DOI 10.1017/S0003598X00084222; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen MN, 1993, SEX GENDER HIERARCHI, P273; de-la-Rua C, 2004, OSASUNAZ CUADERNOS C, V6, P239; Delibes G, 2012, SEPULTURES COLLECTIV, P305; Delibes G., 1995, ARQUEOLOXIA MORTE PE, P61; Delibes G., 2010, ACT C INT MEG OTR MA, P12; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; DeWitte SN, 2015, J ARCHAEOL RES, V23, P397, DOI 10.1007/s10814-015-9084-1; Diaz-Zorita M., 2013, THESIS; Dowd MA, 2008, ANTIQUITY, V82, P305, DOI 10.1017/S0003598X00096824; Drucker DG, 2008, PALAEOGEOGR PALAEOCL, V266, P69, DOI 10.1016/j.palaeo.2008.03.020; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fernandez Eraso J, 2007, VELEIA, V24-25, P669; Fernandez-Crespo T, 2016, INT J OSTEOARCHAEOL, V26, P1024, DOI 10.1002/oa.2513; Fernandez-Crespo T, 2017, INT J OSTEOARCHAEOL, V27, P76, DOI 10.1002/oa.2445; Fernandez-Crespo T., 2012, THESIS; Fernandez-Crespo T, 2016, AM J PHYS ANTHROPOL, V160, P284, DOI 10.1002/ajpa.22963; Fernandez-Crespo T, 2015, J ARCHAEOL SCI, V53, P604, DOI 10.1016/j.jas.2014.11.015; Fernandez-Eraso J., 2013, ZEPHYRUS, VLXXI, P89; Fernandez-Eraso J, 2015, ARPI, P257; Fontanals-Coll M, 2015, J ARCHAEOL SCI-REP, V3, P160, DOI 10.1016/j.jasrep.2015.06.013; Goncalves V., 2003, TRABALHOS ARQUEOLOGI, V25, P81; Halcrow S. E., 2011, SOCIAL BIOARCHAEOLOG, P333, DOI DOI 10.1002/9781444390537.CH12; Harbeck M, ARCHAEOL ANTHR SCI, V1, P43; Heaton THE, 1999, J ARCHAEOL SCI, V26, P637, DOI 10.1006/jasc.1998.0381; Hedges REM, 2013, 1 FARMERS CENTRAL EU, P341; Hedges REM, 2007, AM J PHYS ANTHROPOL, V133, P808, DOI 10.1002/ajpa.20598; Honch NV, 2006, J ARCHAEOL SCI, V33, P1493, DOI 10.1016/j.jas.2006.02.002; Iriarte MJ, 2009, QUATERN INT, V200, P66, DOI 10.1016/j.quaint.2008.10.008; Irigaray S, 2007, TIERRA SEA LEVE ARQU, P73; Irigaray S, 1994, INT J OSTEOARCHAEOL, V4, P215, DOI DOI 10.1002/OA.1390040306; Le Bras-Goude G, 2013, J ANTHROPOL ARCHAEOL, V32, P280, DOI 10.1016/j.jaa.2012.01.005; Lerner Gerda, 1986, CREATION PATRIARCHY; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; McClure SB, 2011, J ARCHAEOL SCI, V38, P420, DOI 10.1016/j.jas.2010.09.023; Mujika JA, 1998, VELEIA, V15, P121; Ninyerola M, 2005, ATLAS CLIMATICO DIGI; Olaria C., 2011, SERIE PREHISTORIA AR; Ontanon R, 2005, HOMENAJE JESU ALTUNA, V57, P257; Perez-Diaz S, 2015, QUATERN INT, V364, P65, DOI 10.1016/j.quaint.2014.10.019; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Richards MP, 1999, J ARCHAEOL SCI, V26, P717, DOI 10.1006/jasc.1998.0387; Richards MP, 1997, OXBOW MONOGRAPHS, V64, P363; Rofes J, 2013, QUATERNARY RES, V79, P158, DOI 10.1016/j.yqres.2012.11.002; Salazar-Garcia DC, 2011, SERIES TRABAJOS VARI, V113, P139; Schulting RJ, 2007, BERICHT ROMISCH GERM, V88, P581; Schurr MR, 1998, WORLD ARCHAEOL, V30, P327, DOI 10.1080/00438243.1998.9980413; SCHWARCZ HP, 1991, YEARB PHYS ANTHROPOL, V34, P283; Sealy J, 2014, J ARCHAEOL SCI, V47, P64, DOI 10.1016/j.jas.2014.04.011; Tome L, 2011, ORIGINS PREHISTORY I, P43; Tsutaya T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072327; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; van Klinken GJ, 2000, BIOGEOCHEMICAL APPRO, P39, DOI DOI 10.1007/0-306-47194-9_3; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; Vegas JI, 2012, STICKS STONES BROKEN, P265; Waterman AJ, 2016, ARCHAEOMETRY, V58, P131, DOI 10.1111/arcm.12159; Waterman AJ, 2012, THESIS; Waterman AJ, 2011, OXFORD J ARCHAEOL, V30, P165, DOI 10.1111/j.1468-0092.2011.00363.x; WOOD JW, 1992, CURR ANTHROPOL, V33, P343, DOI 10.1086/204084; Zapata L, 2000, COMPLUTUM, V11, P157	86	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0177881	10.1371/journal.pone.0177881	http://dx.doi.org/10.1371/journal.pone.0177881			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FI4WR	28953890	gold, Green Published			2022-12-27	WOS:000411980300001
J	Hossein, MS; Kunter, GM; El-Najjar, VF; Jaye, DL; Al-Kadhimi, Z; Taofeek, OK; Li, JM; Waller, EK				Hossein, Mohammad S.; Kunter, Ghada M.; El-Najjar, Vicky F.; Jaye, David L.; Al-Kadhimi, Zaid; Taofeek, Owonikoko K.; Li, Jian-Ming; Waller, Edmund K.			PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; ANTIVIRAL IMMUNITY; BLOCKADE; EXPRESSION; CD4(+); TOLERANCE; LETHALITY; INFECTION; RESPONSES	The expression of checkpoint blockade molecules PD-1, PD-L1, CTLA-4, and foxp3 +CD25+CD4+ T cells (Tregs) regulate donor T cell activation and graft-vs-host disease (GvHD) in allogeneic hematopoietic stem cell transplant (allo-HSCT). Detailed kinetics of PD-1-, CTLA-4-, and PD-L1 expression on donor and host cells in GvHD target organs have not been well studied. Using an established GvHD model of allo-HSCT (B6 -> CB6F1), we noted transient increases of PD-1- and CTLA-4-expressing donor CD4+ and CD8+ T cells on day 10 post transplant in spleens of allo-HSCT recipients compared with syngeneic HSCT (syn-HSCT) recipients. In contrast, expression of PD-1- and CTLA-4 on donor T cells was persistently increased in bone marrow (BM) of allo-HSCT recipients compared with syn-HSCT recipients. Similar differential patterns of donor T cell immune response were observed in a minor histocompatibility (miHA) mismatched transplant model of GvHD. Despite higher PD-1 and CTLA-4 expression in BM, numbers of foxp3+ T cells and Tregs were much lower in allo-HSCT recipients compared with syn-HSCT recipients. PD-L1-expressing host cells were markedly decreased concomitant with elimination of residual host hematopoietic elements in spleens of allo-HSCT recipients. Allo-HSCT recipients lacking PD-L1 rapidly developed increased serum inflammatory cytokines and lethal acute GvHD compared with wild-type (WT) B6 allo-HSCT recipients. These data suggest that increased expression of checkpoint blockade molecules PD-1 and CTLA-4 on donor T cells is not sufficient to prevent GvHD, and that cooperation between checkpoint blockade signaling by host cells and donor Tregs is necessary to limit GvHD in allo-HSCT recipients.	[Hossein, Mohammad S.; Al-Kadhimi, Zaid; Taofeek, Owonikoko K.; Li, Jian-Ming; Waller, Edmund K.] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol,Div Stem Cell & Bone Mar, Atlanta, GA 30322 USA; [Kunter, Ghada M.] Holzer Canc Ctr, Gallipolis, OH USA; [El-Najjar, Vicky F.; Jaye, David L.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA	Emory University; Emory University	Waller, EK (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol,Div Stem Cell & Bone Mar, Atlanta, GA 30322 USA.	ewaller@emory.edu	Waller, Edmund K/AAP-3055-2020	Waller, Edmund K./0000-0003-0816-6729; jaye, david/0000-0001-7977-6909	NIH grant [R01 CA188523]; NATIONAL CANCER INSTITUTE [R01CA188523] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NIH grant (R01 CA188523) to E.K.W.	Alderson KL, 2008, J IMMUNOL, V180, P2981, DOI 10.4049/jimmunol.180.5.2981; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Amarnath S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000302; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barrett AJ, 2010, EXPERT REV HEMATOL, V3, P429, DOI 10.1586/EHM.10.32; BEARMAN SI, 1988, J CLIN ONCOL, V6, P1562, DOI 10.1200/JCO.1988.6.10.1562; Beres AJ, 2012, J IMMUNOL, V189, P464, DOI 10.4049/jimmunol.1200886; Blazar BR, 2003, J IMMUNOL, V171, P1272, DOI 10.4049/jimmunol.171.3.1272; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cao TH, 2009, CELL IMMUNOL, V258, P65, DOI 10.1016/j.cellimm.2009.03.013; Dias SD, 2001, BLOOD, V97, P1134, DOI 10.1182/blood.V97.4.1134; DIIANNI M, 2011, BLOOD, V117, P3921, DOI [DOI 10.1182/blood-2010-10-311894, DOI 10.1182/BLOOD-2010-10-311894]; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Duffner UA, 2004, J IMMUNOL, V172, P7393, DOI 10.4049/jimmunol.172.12.7393; Duramad O, 2011, BIOL BLOOD MARROW TR, V17, P1154, DOI 10.1016/j.bbmt.2010.11.022; Fevery S, 2007, LEUKEMIA, V21, P1451, DOI 10.1038/sj.leu.2404720; Forghani P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064837; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gao WD, 2003, TRANSPLANTATION, V76, P994, DOI 10.1097/01.TP.0000085010.39567.FB; Hossain MS, 2008, J IMMUNOL, V180, P6892, DOI 10.4049/jimmunol.180.10.6892; Hossain MS, 2007, BLOOD, V109, P4548, DOI 10.1182/blood-2006-04-017442; Hossain MS, 2011, J IMMUNOL, V187, P5130, DOI 10.4049/jimmunol.1101334; Hossain MS, 2005, BIOL BLOOD MARROW TR, V11, P169, DOI 10.1016/j.bbmt.2004.12.332; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Li JM, 2013, BLOOD, V121, P2347, DOI 10.1182/blood-2012-06-437640; MARTIN PJ, 1985, BLOOD, V66, P664; Matte-Martone C, 2008, BLOOD, V111, P3884, DOI 10.1182/blood-2007-11-125294; Miura Y, 2004, BLOOD, V104, P2187, DOI 10.1182/blood-2004-03-1040; Mueller SN, 2010, J CLIN INVEST, V120, P2508, DOI 10.1172/JCI40040; Panoskaltsis-Mortari A, 2004, BLOOD, V103, P3590, DOI 10.1182/blood-2003-08-2827; PIRSCH JD, 1986, ANN INTERN MED, V104, P619, DOI 10.7326/0003-4819-104-5-619; Raimondi G, 2007, CRIT REV IMMUNOL, V27, P61, DOI 10.1615/CritRevImmunol.v27.i1.50; Reddy P, 2008, BIOL BLOOD MARROW TR, V14, P129, DOI 10.1016/j.bbmt.2007.10.021; Riesner K, 2016, BONE MARROW TRANSPL, V51, P410, DOI 10.1038/bmt.2015.279; Roback JD, 2003, J IMMUNOL, V171, P6023, DOI 10.4049/jimmunol.171.11.6023; Saha A, 2013, BLOOD, V122, P3062, DOI 10.1182/blood-2013-05-500801; Sandner SE, 2005, J IMMUNOL, V174, P3408, DOI 10.4049/jimmunol.174.6.3408; Sandner SE, 2005, AM J TRANSPLANT, V5, P31, DOI 10.1111/j.1600-6143.2004.00640.x; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trzonkowski P, 2009, CLIN IMMUNOL, V133, P22, DOI 10.1016/j.clim.2009.06.001; West EE, 2013, J CLIN INVEST, V123, P2604, DOI 10.1172/JCI67008; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zhang Y, 2002, J IMMUNOL, V169, P7111, DOI 10.4049/jimmunol.169.12.7111	48	8	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184254	10.1371/journal.pone.0184254	http://dx.doi.org/10.1371/journal.pone.0184254			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953925	Green Published, gold, Green Submitted			2022-12-27	WOS:000411980300012
J	Juarez, M; Egoavil, C; Rodriguez-Soler, M; Hernandez-Illan, E; Guarinos, C; Garcia-Martinez, A; Alenda, C; Giner-Calabuig, M; Murcia, O; Mangas, C; Paya, A; Aparicio, JR; Ruiz, FA; Martinez, J; Casellas, JA; Soto, JL; Zapater, P; Jover, R				Juarez, Miriam; Egoavil, Cecilia; Rodriguez-Soler, Maria; Hernandez-illan, Eva; Guarinos, Carla; Garcia-Martinez, Araceli; Alenda, Cristina; Giner-Calabuig, Mar; Murcia, Oscar; Mangas, Carolina; Paya, Artemio; Aparicio, Jose R.; Ruiz, Francisco A.; Martinez, Juan; Casellas, Juan A.; Soto, Jose L.; Zapater, Pedro; Jover, Rodrigo			KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia	PLOS ONE			English	Article							MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; COLORECTAL-CANCER; SERRATED POLYPS; COLONOSCOPY SURVEILLANCE; ADENOMAS; SUBTYPES; FEATURES; LESIONS; PATHOGENESIS; POLYPECTOMY	Background & aims High-risk features of colonic polyps are based on size, number, and pathologic characteristics. Surveillance colonoscopy is often recommended according to these findings. This study aimed to determine whether the molecular characteristics of polyps might provide information about the risk of metachronous advanced neoplasia. Methodology We retrospectively included 308 patients with colonic polyps. A total of 995 polyps were collected and tested for somatic BRAF and KRAS mutations. Patients were classified into 3 subgroups, based on the polyp mutational profile at baseline, as follows: non-mutated polyps (Wild-type), at least one BRAF-mutated polyp, or at least one KRAS-mutated polyp. At surveillance, advanced adenomas were defined as adenomas >= 10 mm and/or with high grade dysplasia or a villous component. In contrast, advanced serrated polyps were defined as serrated polyps >= 10 mm in any location, located proximal to the splenic flexure with any size or with dysplasia. Results At baseline, 289 patients could be classified as wild-type (62.3%), BRAF mutated (14.9%), or KRAS mutated (22.8%). In the univariate analysis, KRAS mutations were associated with the development of metachronous advanced polyps (OR: 2.36, 95% CI: 1.22-4.58; P= 0.011), and specifically, advanced adenomas (OR: 2.42, 95% CI: 1.13-5.21; P= 0.023). The multivariate analysis, adjusted for age and sex, also showed associations with the development of metachronous advanced polyps (OR: 2.27, 95% CI: 1.15-4.46) and advanced adenomas (OR: 2.23, 95% CI: 1.02-4.85). Conclusions Our results suggested that somatic KRAS mutations in polyps represent a potential molecular marker for the risk of developing advanced neoplasia.	[Juarez, Miriam; Hernandez-illan, Eva; Guarinos, Carla; Garcia-Martinez, Araceli; Giner-Calabuig, Mar] Alicante Univ, Gen Hosp, Res Lab, Alicante Inst Hlth & Biomed Res,ISABIAL FISABIO F, Alicante, Spain; [Juarez, Miriam; Alenda, Cristina; Paya, Artemio] Alicante Univ, Dept Pathol, Gen Hosp, Alicante Inst Hlth & Biomed Res,ISABIAL FISABIO F, Alicante, Spain; [Rodriguez-Soler, Maria; Murcia, Oscar; Mangas, Carolina; Aparicio, Jose R.; Ruiz, Francisco A.; Martinez, Juan; Casellas, Juan A.; Jover, Rodrigo] Alicante Univ, Serv Digest Med, Gen Hosp, Alicante Inst Hlth & Biomed Res,ISABIAL FISABIO F, Alicante, Spain; [Soto, Jose L.] Elche Univ, Gen Hosp, Mol Genet Lab, Alicante Inst Hlth & Biomed Res,ISABIAL FISABIO F, Elche, Spain; [Zapater, Pedro] Alicante Univ, Gen Hosp, Clin Pharmacol Dept, Alicante Inst Hlth & Biomed Re,ISABIAL FISABIO Fd, Alicante, Spain	General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); General University Hospital of Alicante; Universitat d'Alacant	Jover, R (corresponding author), Alicante Univ, Serv Digest Med, Gen Hosp, Alicante Inst Hlth & Biomed Res,ISABIAL FISABIO F, Alicante, Spain.	rodrigojover@gmail.com	Alenda, Cristina/AAR-3433-2020; Payá, Artemio/AFX-6518-2022; Egoavil, Cecilia/X-5134-2018; Soto, José Luis/AAC-6520-2020; Egoavil, Cecilia/ABG-8531-2020; Giner, Mar/GRM-8276-2022; Jover, Rodrigo/ABC-3258-2021; Zapater, Pedro/H-8450-2019	Egoavil, Cecilia/0000-0003-0166-4901; Egoavil, Cecilia/0000-0003-0166-4901; Giner, Mar/0000-0002-6267-3708; Jover, Rodrigo/0000-0003-3742-3413; Zapater, Pedro/0000-0001-7927-858X; Alenda, Cristina/0000-0002-0560-1759; Murcia, Oscar/0000-0003-3419-6067; Mangas-Sanjuan, Carolina/0000-0003-2611-1051; Aparicio Tormo, Jose Ramon/0000-0003-2245-4006; Garcia Martinez, Araceli/0000-0002-1052-1315; Soto, Jose Luis/0000-0003-0234-9188; Rodriguez Soler, Maria/0000-0001-5555-6418	Institute de Salud Carlos III [PI08/0726, INT-09/208, PI11/2630, INT-12-078, INT13-196, PI14/1386, FI12/00233]; FISABIO-ISABIAL foundation [UGP-13-221, UGP14-265]; Asociacion Espanola contra el Cancer [GCB13131592CAST]; AIGPA; Conselleria d'Educacio de la Generalitat Valenciana [VALi+d.EXP ACIF/2010/018, ACIF/2016/002]	Institute de Salud Carlos III(Instituto de Salud Carlos III); FISABIO-ISABIAL foundation; Asociacion Espanola contra el Cancer; AIGPA; Conselleria d'Educacio de la Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF))	This work was supported by the Institute de Salud Carlos III (PI08/0726, INT-09/208, PI11/ 2630, INT-12-078, INT13-196, PI14/1386), FISABIO-ISABIAL foundation (UGP-13-221, UGP14-265), the Asociacion Espanola contra el Cancer (Fundacion Cientifica GCB13131592CAST) and AIGPA, a private association that promotes research in gastrointestinal diseases in Alicante and also supported logistic aspects of the study, (this association declares no conflict of interest). Carla Guarinos and Mar Giner Calabuig received a predoctoral grant from Conselleria d'Educacio de la Generalitat Valenciana (VALi+d.EXP ACIF/2010/018, ACIF/2016/002) and Eva Hernandez-IIIan received a grant from Institute de Salud Carlos III (FI12/00233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2014, GUT LIVER, V8, P582, DOI 10.5009/gnl14248; Benlloch S, 2006, J MOL DIAGN, V8, P540, DOI 10.2353/jmoldx.2006.060070; Bond JH, 2003, ENDOSCOPY, V35, P27, DOI 10.1055/s-2003-36410; Bouwens MWE, 2013, J CLIN GASTROENTEROL, V47, P734, DOI 10.1097/MCG.0b013e318293a656; Burt RW, 2010, J NATL COMPR CANC NE, V8, P8, DOI 10.6004/jnccn.2010.0003; Carethers John M, 2015, J Dig Cancer Rep, V3, P5; Chen H, 2011, CANCER GENET-NY, V204, P245, DOI 10.1016/j.cancergen.2011.04.002; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Erichsen R, 2016, GASTROENTEROLOGY, V150, P895, DOI 10.1053/j.gastro.2015.11.046; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Guarinos C, 2013, CLIN GASTROENTEROL H, V11, P705, DOI 10.1016/j.cgh.2012.12.045; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hamilton SR, 2010, WHO CLASSIFICATION T, P134; Hassan C, 2013, ENDOSCOPY, V45, P842, DOI 10.1055/s-0033-1344548; Holme O, 2015, GUT, V64, P929, DOI 10.1136/gutjnl-2014-307793; Imperiale TF, 2010, GASTROENTEROLOGY, V138, P1642, DOI 10.1053/j.gastro.2010.03.027; Ishii T, 2011, AM J SURG PATHOL, V35, P212, DOI 10.1097/PAS.0b013e318205df20; Janjua HGR, 2015, APMIS, V123, P298, DOI 10.1111/apm.12355; Jass JR, 2006, HISTOPATHOLOGY, V49, P121, DOI 10.1111/j.1365-2559.2006.02466.x; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jass JR, 1999, J PATHOL, V187, P499, DOI 10.1002/(SICI)1096-9896(199904)187:5<499::AID-PATH309>3.0.CO;2-B; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kressner U, 1998, EUR J CANCER, V34, P518, DOI 10.1016/S0959-8049(97)10111-3; le Clercq CMC, 2015, GASTROINTEST ENDOSC, V82, P325, DOI 10.1016/j.gie.2014.12.052; le Clercq CMC, 2014, GUT, V63, P957, DOI 10.1136/gutjnl-2013-304880; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Lorentzen JA, 2016, CLIN MED INSIGHTS-PA, V9, P19, DOI [10.4137/CPath.s40143, 10.4137/CPath.S40143]; Maltzman T, 2001, GASTROENTEROLOGY, V121, P302, DOI 10.1053/gast.2001.26278; Martinez ME, 2012, ANN INTERN MED, V157, P856, DOI 10.7326/0003-4819-157-12-201212180-00005; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Nusko G, 1997, SCAND J GASTROENTERO, V32, P1035, DOI 10.3109/00365529709011221; Ogino S, 2016, EPIDEMIOLOGY, V27, P602, DOI 10.1097/EDE.0000000000000471; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Oono Y, 2009, DIGEST DIS SCI, V54, P906, DOI 10.1007/s10620-008-0407-7; Phipps AI, 2015, GASTROENTEROLOGY, V148, P77, DOI 10.1053/j.gastro.2014.09.038; Pohl H, 2013, GASTROENTEROLOGY, V144, P74, DOI 10.1053/j.gastro.2012.09.043; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Robertson DJ, 2014, GUT, V63, P949, DOI 10.1136/gutjnl-2012-303796; Rosty C, 2013, J GASTROENTEROL, V48, P287, DOI 10.1007/s00535-012-0720-y; Saini SD, 2006, GASTROINTEST ENDOSC, V64, P614, DOI 10.1016/j.gie.2006.06.057; Schreiner MA, 2010, GASTROENTEROLOGY, V139, P1497, DOI 10.1053/j.gastro.2010.06.074; Sinicrope FA, 2015, GASTROENTEROLOGY, V148, P88, DOI 10.1053/j.gastro.2014.09.041; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Snover DC, 2010, WHO CLASSIFICATION T, P160; Spring KJ, 2006, GASTROENTEROLOGY, V131, P1400, DOI 10.1053/j.gastro.2006.08.038; Yadamsuren EA, 2012, PATHOL ONCOL RES, V18, P1077, DOI 10.1007/s12253-012-9547-3; Yamane LS, 2014, ONCOL REP, V32, P1419, DOI 10.3892/or.2014.3338; Yang HM, 2015, ARCH PATHOL LAB MED, V139, P730, DOI 10.5858/arpa.2014-0424-RA; Yuen ST, 2002, CANCER RES, V62, P6451	50	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2017	12	9							e0184937	10.1371/journal.pone.0184937	http://dx.doi.org/10.1371/journal.pone.0184937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4WR	28953955	Green Published, Green Submitted, gold			2022-12-27	WOS:000411980300027
J	Mukherjee, N; Choudhuri, SP; Delay, RJ; Delay, ER				Mukherjee, Nabanita; Choudhuri, Shreoshi Pal; Delay, Rona J.; Delay, Eugene R.			Cellular mechanisms of cyclophosphamideinduced taste loss in mice	PLOS ONE			English	Article							QUALITY-OF-LIFE; PATIENTS RECEIVING CHEMOTHERAPY; BUD CELLS; CANCER-CHEMOTHERAPY; RECEPTOR-CELLS; DIFFERENTIAL EXPRESSION; STEM/PROGENITOR CELLS; FUNGIFORM PAPILLAE; ALPHA-GUSTDUCIN; BREAST-CANCER	Many commonly prescribed chemotherapy drugs such as cyclophosphamide (CYP) have adverse side effects including disruptions in taste which can result in loss of appetite, malnutrition, poorer recovery and reduced quality of life. Previous studies in mice found evidence that CYP has a two- phase disturbance in taste behavior: a disturbance immediately following drug administration and a second which emerges several days later. In this study, we examined the processes by which CYP disturbs the taste system by examining the effects of the drug on taste buds and cells responsible for taste cell renewal using immunohistochemical assays. Data reported here suggest CYP has direct cytotoxic effects on lingual epithelium immediately following administration, causing an early loss of taste sensory cells. Types II and III cells in fungiform taste buds appear to be more susceptible to this effect than circumvallate cells. In addition, CYP disrupts the population of rapidly dividing cells in the basal layer of taste epithelium responsible for taste cell renewal, manifesting a disturbance days later. The loss of these cells temporarily retards the system's capacity to replace Type II and Type III taste sensory cells that survived the cytotoxic effects of CYP and died at the end of their natural lifespan. The timing of an immediate, direct loss of taste cells and a delayed, indirect loss without replacement of taste sensory cells are broadly congruent with previously published behavioral data reporting two periods of elevated detection thresholds for umami and sucrose stimuli. These findings suggest that chemotherapeutic disturbances in the peripheral mechanisms of the taste system may cause dietary challenges at a time when the cancer patient has significant need for well balanced, high energy nutritional intake.	[Delay, Eugene R.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; Univ Vermont, Vermont Chemosensory Grp, Burlington, VT USA; [Delay, Rona J.] Univ Colorado, Dept Dermatol, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Choudhuri, Shreoshi Pal] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX USA	University of Vermont; University of Vermont; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Southwestern Medical Center Dallas	Delay, ER (corresponding author), Univ Vermont, Dept Biol, Burlington, VT 05405 USA.	edelay@uvm.edu	Choudhuri, Shreoshi Pal/I-4251-2019		National Institutes of Health [R01 DC012829 ERD]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by the National Institutes of Health R01 DC012829 ERD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahles TA, 2002, J CLIN ONCOL, V20, P485, DOI 10.1200/JCO.2002.20.2.485; Aihara E, 2015, SCI REP-UK, V5, DOI 10.1038/srep17185; Asano-Miyoshi M, 2008, J MOL HISTOL, V39, P193, DOI 10.1007/s10735-007-9151-0; Barlow LA, 2015, DEVELOPMENT, V142, P3620, DOI 10.1242/dev.120394; Barlow LA, 2015, CURR TOP DEV BIOL, V111, P401, DOI 10.1016/bs.ctdb.2014.11.012; Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; Bartoshuk L M, 1990, NCI Monogr, P179; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Bernhardson BM, 2008, SUPPORT CARE CANCER, V16, P275, DOI 10.1007/s00520-007-0319-7; Bernhardson BM, 2007, J PAIN SYMPTOM MANAG, V34, P403, DOI 10.1016/j.jpainsymman.2006.12.010; Bernhardt SJ, 1996, J PHYSL; BERNSTEIN IL, 1978, SCIENCE, V200, P1302, DOI 10.1126/science.663613; BERNSTEIN IL, 1980, PHYSIOL BEHAV, V25, P363, DOI 10.1016/0031-9384(80)90274-7; Boughter JD, 1997, J NEUROSCI, V17, P2852; Carozzi VA, 2010, EXP NEUROL, V226, P301, DOI 10.1016/j.expneurol.2010.09.004; Castillo D, 2014, DEVELOPMENT, V141, P2993, DOI 10.1242/dev.107631; Chambers MS, 2004, HEAD NECK-J SCI SPEC, V26, P796, DOI 10.1002/hed.20045; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Cho YK, 1998, CHEM SENSES, V23, P735, DOI 10.1093/chemse/23.6.735; Clapp TR, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-6; Clapp TR, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-7; Cohen J, 2016, CURR PHARM DESIGN, V22, P2253, DOI 10.2174/1381612822666160216150812; Cohn ZJ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-72; Comeau TB, 2001, SUPPORT CARE CANCER, V9, P575, DOI 10.1007/s005200100279; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; de Vries YC, 2017, SUPPORT CARE CANCER, V25, P2581, DOI 10.1007/s00520-017-3668-x; Dorr W, 2003, INT J RADIAT BIOL, V79, P531, DOI 10.1080/09553002310001600925; Dvoryanchikov G, 2007, J COMP NEUROL, V505, P302, DOI 10.1002/cne.21494; Dvoryanchikov G, 2009, J COMP NEUROL, V517, P1, DOI 10.1002/cne.22152; Epstein JB, 2002, BONE MARROW TRANSPL, V30, P785, DOI 10.1038/sj.bmt.1703716; FARBMAN AI, 1980, CELL TISSUE KINET, V13, P349, DOI 10.1111/j.1365-2184.1980.tb00474.x; Feng P, 2014, J NEUROSCI, V34, P2689, DOI 10.1523/JNEUROSCI.3074-13.2014; Feng P, 2014, CHEM SENSES, V39, P3, DOI 10.1093/chemse/bjt059; Finger TE, 2005, CHEM SENSES, V30, pI54, DOI 10.1093/chemse/bjh110; French CJ, 2009, FASEB J, V23, P1177, DOI 10.1096/fj.08-116509; Gaillard D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005208; Gaillard D, 2011, GENESIS, V49, P295, DOI 10.1002/dvg.20731; Girard BM, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00020; Halyard Michele Y, 2009, J Support Oncol, V7, P68; Hong Jae Hee, 2009, J Support Oncol, V7, P58; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Hung DT, 1996, CHEM BIOL, V3, P623, DOI 10.1016/S1074-5521(96)90129-5; Hutton JL, 2007, J PAIN SYMPTOM MANAG, V33, P156, DOI 10.1016/j.jpainsymman.2006.07.017; Jezernik K, 2003, CELL BIOL INT, V27, P863, DOI 10.1016/S1065-6995(03)00175-6; Kaley TJ, 2009, BRIT J HAEMATOL, V145, P3, DOI 10.1111/j.1365-2141.2008.07558.x; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Klanjsek P, 2016, EUR J ONCOL NURS, V23, P24, DOI 10.1016/j.ejon.2016.03.003; Kumari A, 2015, J NEUROPHYSIOL, V113, P1034, DOI 10.1152/jn.00822.2014; Lehrer MS, 1998, J CELL SCI, V111, P2867; Ma HZ, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-5; Matsuo R, 2000, CRIT REV ORAL BIOL M, V11, P216, DOI 10.1177/10454411000110020501; MATTES RD, 1987, CANCER, V60, P2576, DOI 10.1002/1097-0142(19871115)60:10<2576::AID-CNCR2820601038>3.0.CO;2-5; Miura H, 2004, CHEM SENSES, V29, P823, DOI 10.1093/chemse/bjh248; Miura H, 2006, ARCH HISTOL CYTOL, V69, P209, DOI 10.1679/aohc.69.209; Miura H, 2014, DEV DYNAM, V243, P1286, DOI [10.1002/DVDY.24121, 10.1002/dvdy.24121]; Mukherjee N, 2011, NEUROSCIENCE, V192, P732, DOI 10.1016/j.neuroscience.2011.07.006; Mukherjee N, 2013, PLOS ONE, V8, P1; Mukherjee N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061607, 10.1371/annotation/5487e265-8175-47cb-b9a4-d85862a4a96f]; NELSON GM, 1993, J COMP NEUROL, V336, P507, DOI 10.1002/cne.903360404; Nguyen HM, 2012, J NEUROSCI, V32, P3474, DOI 10.1523/JNEUROSCI.4167-11.2012; Oakley B, 2004, J NEUROCYTOL, V33, P631, DOI 10.1007/s11068-005-3332-0; Oike H, 2006, J COMP NEUROL, V494, P876, DOI 10.1002/cne.20848; Oka Y, 2013, NATURE, V494, P472, DOI 10.1038/nature11905; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Perea-Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053399; Ponticelli E, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12633; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Pumplin DW, 1999, J COMP NEUROL, V415, P230, DOI 10.1002/(SICI)1096-9861(19991213)415:2<230::AID-CNE7>3.0.CO;2-Y; Ren WW, 2014, P NATL ACAD SCI USA, V111, P16401, DOI 10.1073/pnas.1409064111; Renken RJ, 2016, CLIN NUTR; Rha SY, 2016, SUPPORT CARE CANC; Schneider FT, 2010, AM J PATHOL, V177, P404, DOI 10.2353/ajpath.2010.091079; Sollars SI, 2002, J NEUROBIOL, V51, P223, DOI 10.1002/neu.10055; Spotten LE, 2017, ANN ONCOL; Stone LM, 2002, J NEUROSCI, V22, P4522, DOI 10.1523/JNEUROSCI.22-11-04522.2002; Takeda N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066314; Turcott JG, 2016, NUTR CANCER, V68, P241, DOI 10.1080/01635581.2016.1144075; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; Wagland R, 2016, SUPPORT CARE CANCER, V24, P4901, DOI 10.1007/s00520-016-3346-4; Wang H, 2007, J NEUROSCI, V27, P10703, DOI 10.1523/JNEUROSCI.3102-07.2007; WITT M, 1992, HISTOCHEMISTRY, V98, P173, DOI 10.1007/BF00315876; Wolf S, 2008, EUR J CANCER, V44, P1507, DOI 10.1016/j.ejca.2008.04.018; Yang H, 2015, CANCER MED-US, V4, P245, DOI 10.1002/cam4.350; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Yee KK, 2013, STEM CELLS, V31, P992, DOI 10.1002/stem.1338; Zabernigg A, 2010, ONCOLOGIST, V15, P913, DOI 10.1634/theoncologist.2009-0333; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhu YH, 2013, CELL STEM CELL, V12, P298, DOI 10.1016/j.stem.2013.01.003	89	17	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185473	10.1371/journal.pone.0185473	http://dx.doi.org/10.1371/journal.pone.0185473			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	28950008	Green Published, Green Submitted, gold			2022-12-27	WOS:000411671000056
J	Huang, SL; Hsieh, CL; Wu, RM; Lu, WS				Huang, Sheau-Ling; Hsieh, Ching-Lin; Wu, Ruey-Meei; Lu, Wen-Shian			Test-retest reliability and minimal detectable change of the Beck Depression Inventory and the Taiwan Geriatric Depression Scale in patients with Parkinson's disease	PLOS ONE			English	Article							QUALITY-OF-LIFE; PSYCHOMETRIC PROPERTIES; STATISTICAL-METHODS; MEASUREMENT ERROR; DIFFERENCE; AGREEMENT; VALIDITY; GRIP	Background The Beck Depression Inventory II (BDI-II) and the Taiwan Geriatric Depression Scale (TGDS) are self-report scales used for assessing depression in patients with Parkinson's disease (PD) and geriatric people. The minimal detectable change (MDC) represents the least amount of change that indicates real difference (i.e., beyond random measurement error) for a single subject. Our aim was to investigate the test-retest reliability and MDC of the BDI-II and the TGDS in people with PD. Methods Seventy patients were recruited from special clinics for movement disorders at a medical center. The patients' mean age was 67.7 years, and 63.0% of the patients were male. All patients were assessed with the BDI-II and the TGDS twice, 2 weeks apart. We used the intraclass correlation coefficient (ICC) to determine the reliability between test and retest. We calculated the MDC based on standard error of measurement. The MDC% was calculated (i.e., by dividing the MDC by the possible maximal score of the measure). Results The test-retest reliabilities of the BDI-II/TGDS were high (ICC = 0.86/0.89). The MDCs (MDC% s) of the BDI-II and TGDS were 8.7 (13.8%) and 5.4 points (18.0%), respectively. Both measures had acceptable to nearly excellent random measurement errors. Conclusions The test-retest reliabilities of the BDI-II and the TGDS are high. The MDCs of both measures are acceptable to nearly excellent in people with PD. These findings imply that the BDI-II and the TGDS are suitable for use in a research context and in clinical settings to detect real change in a single subject.	[Huang, Sheau-Ling; Hsieh, Ching-Lin] Natl Taiwan Univ, Sch Occupat Therapy, Coll Med, Taipei, Taiwan; [Huang, Sheau-Ling; Hsieh, Ching-Lin] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Div Occupat Therapy, Taipei, Taiwan; [Wu, Ruey-Meei] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lu, Wen-Shian] Chung Shan Med Univ, Sch Occupat Therapy, Taichung, Taiwan; [Lu, Wen-Shian] Chung Shan Med Univ Hosp, Occupational Therapy Room, Taichung, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Lu, WS (corresponding author), Chung Shan Med Univ, Sch Occupat Therapy, Taichung, Taiwan.; Lu, WS (corresponding author), Chung Shan Med Univ Hosp, Occupational Therapy Room, Taichung, Taiwan.	weenshian.lu@gmail.com	Hsieh, Ching-Lin/G-6057-2011	Hsieh, Ching-Lin/0000-0001-9468-9969; Lu, Wen-Shian/0000-0002-5101-9778; Wu, Ruey-Meei/0000-0002-4947-5467; HUANG, SHEAU-LING/0000-0002-2675-2302				Aarsland D, 2002, ACTA PSYCHIAT SCAND, V106, P161, DOI 10.1034/j.1600-0447.2002.2e009.x; Aarsland D, 1999, INT J GERIATR PSYCH, V14, P866, DOI 10.1002/(SICI)1099-1166(199910)14:10<866::AID-GPS38>3.3.CO;2-Q; Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Beaton DE, 2002, CURR OPIN RHEUMATOL, V14, P109, DOI 10.1097/00002281-200203000-00006; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chang Y. S., 2006, TAIWAN GERIATRICS GE, V2, P21; Coles ME, 2001, DEPRESS ANXIETY, V14, P145, DOI 10.1002/da.1057; Duncan GW, 2014, MOVEMENT DISORD, V29, P195, DOI 10.1002/mds.25664; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Jette AM, 2007, J REHABIL MED, V39, P585, DOI 10.2340/16501977-0119; Karlsen KH, 2000, J NEUROL NEUROSUR PS, V69, P584, DOI 10.1136/jnnp.69.5.584; Leentjens AFG, 2004, J GERIATR PSYCH NEUR, V17, P120, DOI 10.1177/0891988704267456; LEVIN BE, 1988, J NEUROL NEUROSUR PS, V51, P1401, DOI 10.1136/jnnp.51.11.1401; Liao Y. C., 2004, TAIWANESE J PSYCHIAT, V18, P30; Liu WM, 2015, NEUROPSYCH DIS TREAT, V11, DOI 10.2147/NDT.S88968; Nocera Joe R, 2013, J Yoga Phys Ther, V3, DOI 10.4172/2157-7595.1000137; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Prince B, 1980, Physiother Can, V32, P201; Schreuders TAR, 2003, PHYS THER, V83, P806, DOI 10.1093/ptj/83.9.806; Schuck P, 2003, INT J REHABIL RES, V26, P85, DOI 10.1097/00004356-200306000-00002; Segal DL, 2008, BEHAV MODIF, V32, P3, DOI 10.1177/0145445507303833; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smidt N, 2002, ARCH PHYS MED REHAB, V83, P1145, DOI 10.1053/apmr.2002.33728; Storch EA, 2004, DEPRESS ANXIETY, V19, P187, DOI 10.1002/da.20002; Su TP, 2004, AUST NZ J PSYCHIAT, V38, P706, DOI 10.1111/j.1440-1614.2004.01444.x; Visser M, 2006, MOVEMENT DISORD, V21, P668, DOI 10.1002/mds.20792	29	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							e0184823	10.1371/journal.pone.0184823	http://dx.doi.org/10.1371/journal.pone.0184823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI0UK	28945776	gold, Green Published, Green Submitted			2022-12-27	WOS:000411645100011
J	Luan, XH; Cao, ZZ; Xing, Z; Liu, M; Gao, M; Meng, B; Fan, RM				Luan, Xinhong; Cao, Zhongzan; Xing, Zhe; Liu, Mei; Gao, Ming; Meng, Bo; Fan, Ruiming			Comparative proteomic analysis of pituitary glands from Huoyan geese between prelaying and laying periods using an iTRAQbased approach	PLOS ONE			English	Article							CHROMOGRANIN-A; ANTERIOR-PITUITARY; SECRETOGRANIN-II; PROTEIN EXPRESSION; VLDV-NEUROPHYSINS; MSEL-NEUROPHYSINS; GRANULOSA-CELLS; EGG-PRODUCTION; LH-RELEASE; CHICKEN	In this study, we performed a comprehensive evaluation of the proteomic profile of the pituitary gland of the Huoyan goose during the laying period compared to the pre-laying period using an iTRAQ-based approach. Protein samples were prepared from pituitary gland tissues of nine pre-laying period and nine laying period geese. Then the protein samples from three randomly selected geese within each period were pooled in equal amounts to generate one biological sample pool. We identified 684 differentially expressed proteins, including 418 up-regulated and 266 down-regulated proteins. GO annotation and KEGG pathway analyses of these proteins were conducted. Some of these proteins were found to be associated with hormone and neurotransmitter secretion and transport, neuropeptide signalling and GnRH signalling pathways, among others. Subsequently, the modification of the abundance of three proteins (prolactin, chromogranin-A and ITPR3) was verified using western blotting. Our results will provide a new source for mining genes and gene products related to the egg-laying performance of Huoyan geese, and may provide important information for the conservation and utilization of local goose breeds.	[Luan, Xinhong; Cao, Zhongzan; Xing, Zhe; Liu, Mei; Gao, Ming; Meng, Bo; Fan, Ruiming] Shenyang Agr Univ, Coll Anim Sci & Vet Med, Key Lab Zoonosis Liaoning Prov, Shenyang, Liaoning, Peoples R China	Shenyang Agricultural University	Luan, XH (corresponding author), Shenyang Agr Univ, Coll Anim Sci & Vet Med, Key Lab Zoonosis Liaoning Prov, Shenyang, Liaoning, Peoples R China.	xhluan@163.com	Xinhong, Luan/U-8480-2019		National Natural Science Foundation of China [31372395]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 31372395).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aste N, 2013, J NEUROENDOCRINOL, V25, P811, DOI 10.1111/jne.12076; Bu GX, 2013, MOL CELL ENDOCRINOL, V370, P149, DOI 10.1016/j.mce.2013.03.001; Chaiseha Y, 2005, J POULTRY SCI, V42; CHAUVET MT, 1986, BIOSCIENCE REP, V6, P381, DOI 10.1007/BF01116425; CLARKE IJ, 1982, ENDOCRINOLOGY, V111, P1737, DOI 10.1210/endo-111-5-1737; Crawford JL, 2002, REPRODUCTION, V124, P267, DOI 10.1530/reprod/124.2.267; Emsley A, 1997, POULTRY SCI, V76, P1127, DOI 10.1093/ps/76.8.1127; ETCHES RJ, 1984, J EXP ZOOL, V232, P501, DOI 10.1002/jez.1402320317; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; Gao GL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32961; Gao GL, 2015, ANIM SCI J, V86, P800, DOI 10.1111/asj.12356; GHARIB SD, 1990, ENDOCR REV, V11, P177, DOI 10.1210/edrv-11-1-177; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grant SGN, 2001, J NEUROSCI, V21, P8315, DOI 10.1523/JNEUROSCI.21-21-08315.2001; Gustavsson N, 2009, BIOSCIENCE REP, V29, P245, DOI 10.1042/BSR20090031; Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797; Habig C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046787; Hernandez AG, 2003, REPRODUCTION, V125, P683, DOI 10.1530/rep.0.1250683; Hrabia A, 2004, FOLIA BIOL-KRAKOW, V52, P197, DOI 10.3409/1734916044527494; Huang SY, 2006, PROTEOMICS, V6, P2217, DOI 10.1002/pmic.200500410; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Jin YM, 2006, PROSTAG OTH LIPID M, V81, P45, DOI 10.1016/j.prostaglandins.2006.07.002; Johnson AL, 2001, ENDOCRINOLOGY, V142, P3116, DOI 10.1210/en.142.7.3116; Jurkevich A, 2003, DOMEST ANIM ENDOCRIN, V25, P93, DOI 10.1016/S0739-7240(03)00048-1; Kameda Y, 1998, HISTOCHEM CELL BIOL, V109, P211, DOI 10.1007/s004180050220; Kameshita I, 1998, ANAL BIOCHEM, V262, P90, DOI 10.1006/abio.1998.2728; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kang B, 2009, POULTRY SCI, V88, P1975, DOI 10.3382/ps.2008-00519; Karp NA, 2009, PROTEOMICS, V9, P388, DOI 10.1002/pmic.200800485; Kim NS, 2007, J BIOCHEM MOL BIOL, V40, P212; Klein S, 2008, COMP BIOCHEM PHYS A, V149, P411, DOI 10.1016/j.cbpa.2008.01.039; KNIGHT DE, 1987, ANN NY ACAD SCI, V493, P504, DOI 10.1111/j.1749-6632.1987.tb27237.x; Kuo YM, 2005, THERIOGENOLOGY, V64, P1490, DOI 10.1016/j.theriogenology.2005.03.020; Lewis TS, 2000, MOL CELL, V6, P1343, DOI 10.1016/S1097-2765(00)00132-5; Lu LZ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0652-y; Luan XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113211; Luan XH, 2014, MOL BIOL REP, V41, P3401, DOI 10.1007/s11033-014-3202-x; Luan XH, 2013, ASIAN AUSTRAL J ANIM, V26, P921, DOI 10.5713/ajas.2013.13083; Luche S, 2003, PROTEOMICS, V3, P249, DOI 10.1002/pmic.200390037; MASON WT, 1988, J EXP BIOL, V139, P287; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nicol L, 2004, J MOL ENDOCRINOL, V32, P467, DOI 10.1677/jme.0.0320467; Nicol L, 2002, J ENDOCRINOL, V174, P473, DOI 10.1677/joe.0.1740473; Ozawa H, 1995, CELL STRUCT FUNCT, V20, P415, DOI 10.1247/csf.20.415; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Proudman JA, 2003, GEN COMP ENDOCR, V132, P293, DOI 10.1016/S0016-6480(03)00056-X; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; ROUILLE Y, 1989, NEUROPEPTIDES, V13, P187, DOI 10.1016/0143-4179(89)90090-5; Sandberg A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M112.016998; Sasaki T, 1998, COMP BIOCHEM PHYS A, V121, P149, DOI 10.1016/S1095-6433(98)10116-2; Sharp PJ, 2003, CAN J PHYSIOL PHARM, V81, P350, DOI 10.1139/Y03-025; Shin OH, 2009, P NATL ACAD SCI USA, V106, P16469, DOI 10.1073/pnas.0908798106; SHIN SH, 1995, J ENDOCRINOL, V144, P225, DOI 10.1677/joe.0.1440225; Shiue YL, 2006, THERIOGENOLOGY, V66, P1274, DOI 10.1016/j.theriogenology.2006.03.037; Srivastava R, 2007, COMP BIOCHEM PHYS A, V148, P451, DOI 10.1016/j.cbpa.2007.06.004; STOJILKOVIC SS, 1992, ENDOCR REV, V13, P256, DOI 10.1210/er.13.2.256; Takahashi T, 2008, POULTRY SCI, V87, P2107, DOI 10.3382/ps.2008-00076; Thakur SS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003699; Unwin RD, 2010, NAT PROTOC, V5, P1574, DOI 10.1038/nprot.2010.123; Watanabe T, 1998, ENDOCRINOLOGY, V139, P2765, DOI 10.1210/en.139.6.2765; WATANABE T, 1991, HISTOCHEMISTRY, V96, P285, DOI 10.1007/BF00271348; Willars GB, 2001, J BIOL CHEM, V276, P3123, DOI 10.1074/jbc.M008916200; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wojcikiewicz RJH, 2003, J BIOL CHEM, V278, P940, DOI 10.1074/jbc.M206607200; Yen CF, 2006, POULTRY SCI, V85, P2265, DOI 10.1093/ps/85.12.2265; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168	68	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2017	12	9							0185253	10.1371/journal.pone.0185253	http://dx.doi.org/10.1371/journal.pone.0185253			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI0UK	28945779	Green Submitted, gold, Green Published			2022-12-27	WOS:000411645100037
J	Harrison, RE; Pearson, L; Vere, M; Chonzi, P; Hove, BT; Mabaya, S; Chigwamba, M; Nhamburo, J; Gura, J; Vandeborne, A; Simons, S; Lagrou, D; De Plecker, E; Van den Bergh, R				Harrison, Rebecca E.; Pearson, Linda; Vere, Michael; Chonzi, Prosper; Hove, Brian Tafadzwa; Mabaya, Sharon; Chigwamba, Margaret; Nhamburo, Juliana; Gura, Juliet; Vandeborne, An; Simons, Sandra; Lagrou, Daphne; De Plecker, Eva; Van den Bergh, Rafael			Care requirements for clients who present after rape and clients who presented after consensual sex as a minor at a clinic in Harare, Zimbabwe, from 2011 to 2014	PLOS ONE			English	Article							ADOLESCENTS	Study goals To describe the differences between clients presenting after rape and clients who have consented to sex as a minor to an SGBV clinic in Harare, Zimbabwe, and how these differences affect their care requirements. Background Adolescents and adults presenting at the specialized Sexual and Gender Based Violence clinic in Harare are offered a standardised package of free medical and psychosocial care. Zimbabwe has an HIV prevalence of 14%, so prevention of HIV infection using PEP for those that present within 72 hours is a key part of the response. STI treatment, emergency contraceptive pills, referral for termination of pregnancy, psychological, social and legal support is also provided. Methods This is a retrospective descriptive study of routine programmatic data collected at the Edith Opperman polyclinic in Mbare SGBV clinic from 2011 to 2014. Chi-square tests and logistic regression were used to describe the different experiences and the differences in uptake of care between clients presenting for rape compared to those who consented to sex as a minor. Results During the study period a total of 3617 clients presented to the clinic. 2242 (62%) sought care after rape, 602 (17%) for having consented to sex as a minor and 395 (11%) for suspected sexual abuse. 1615 (45%) of people presenting were 12-15 year olds. Minors who consented to sex compared to survivors of rape were less likely to report within 72 hours-156 (26%) vs 894 (40%) p<0.001; less likely to report that they delayed due to fear-68 (17%) vs 472 (40%) p<0.001, less likely to have experienced accompanying violence-9 (1%) vs 176 (8%) p<0.001 or physical trauma-34 (6%) vs 427 (19%) p<0.001; and less likely to display psychological symptoms at presentation 51 (8%) vs 411 (18%) p<0.001. Minors who consented to sex compared to those who were raped were less likely to start PEP if eligible-123 (80%) vs 751 (93%) p<0.001, less likely to take emergency contraceptives if eligible-125 (81%) vs 598 (88%) p<0.001, more likely to be pregnant-132 (23%) vs 241 (15%) p<0.001; less likely to request a termination of pregnancy if pregnant-10 (8%) vs 74 (31%) p<0.001; and less likely to come for at least one follow up 281 (47%) vs 1304 (58%) p<0.001. Conclusion The experiences of those who consent to sex as a minor and those that have experienced forced sex were very different. The standardised SGBV medical response does not fully meet the needs to protect minors who have consented to sex from HIV or unwanted pregnancies. Clients who present for having consented to sex as a minor might benefit more from being offered long-term family planning or being assessed as a sero-discordant couple rather than simply PEP and ECP as is relevant for clients who have been raped. More provision of health care is needed for minors to ensure they have access to enough information and protection from HIV, other STIs and unwanted pregnancy, before they decide to engage in sexual intercourse, rather than as an emergency at an SGBV clinic.	[Harrison, Rebecca E.; Simons, Sandra] MSF OCB, Harare, Zimbabwe; [Pearson, Linda; Hove, Brian Tafadzwa; Mabaya, Sharon; Chigwamba, Margaret; Nhamburo, Juliana; Vandeborne, An] MSF OCB, Mbare Polyclin, Harare, Zimbabwe; [Vere, Michael; Chonzi, Prosper] City Hlth, Harare, Zimbabwe; [Gura, Juliet] MOHCC, Mbare Polyclin, Harare, Zimbabwe; [Lagrou, Daphne; De Plecker, Eva; Van den Bergh, Rafael] MSF OCB, Brussels, Belgium	Doctors Without Borders; Doctors Without Borders	Harrison, RE (corresponding author), MSF OCB, Harare, Zimbabwe.	rebecca8harrison@gmail.com		Van den Bergh, Rafael/0000-0001-6277-8713				Bearinger LH, 2007, LANCET, V369, P1220, DOI 10.1016/S0140-6736(07)60367-5; Cauffman E, 2000, BEHAV SCI LAW, V18, P741, DOI 10.1002/bsl.416; Cooka RJ, 2007, INT J GYNECOL OBSTET, V98, P182, DOI 10.1016/j.ijgo.2007.04.018; Flack WF, 2007, J INTERPERS VIOLENCE, V22, P139, DOI 10.1177/0886260506295354; Graupner H, 2005, J HOMOSEXUAL, V48, P107, DOI 10.1300/J082v48n03_07; Kim YM, 2001, INT FAM PLAN PERSPEC, V27, P11, DOI 10.2307/2673800; Levine JM.Judith, HARMFUL MINORS PERIL; ROEMER R, 1985, STUD FAMILY PLANN, V16, P241, DOI 10.2307/1966997; Savage-Oyekunle OA, 2015, COMP INT LAW J SOUTH, V48, P98; Shaw D, 2009, INT J GYNECOL OBSTET, V106, P132, DOI 10.1016/j.ijgo.2009.03.025; UNAIDS, 2013, THE GAP REP; Young L, 2003, PROF GEOGR, V55, P464, DOI 10.1111/0033-0124.5504005; Zebron S, 2013, IMPACT FACEBOOK PARE, V3	13	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184634	10.1371/journal.pone.0184634	http://dx.doi.org/10.1371/journal.pone.0184634			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934344	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900036
J	Ong, CT; Wong, YS; Sung, SF; Wu, CS; Hsu, YC; Su, YH; Hung, LC				Ong, Cheung-Ter; Wong, Yi-Sin; Sung, Sheng-Feng; Wu, Chi-Shun; Hsu, Yung-Chu; Su, Yu-Hsiang; Hung, Ling-Chien			Sex-related differences in the risk factors for in-hospital mortality and outcomes of ischemic stroke patients in rural areas of Taiwan	PLOS ONE			English	Article							CLINICAL PRESENTATION; GENDER-DIFFERENCES; ATRIAL-FIBRILLATION; CARE; MANAGEMENT; SEVERITY; EPIDEMIOLOGY; PREDICTORS; DEATH	Background and purpose Sex-related differences in the clinical presentation and outcomes of stroke patients are issues that have attracted increased interest from the scientific community. The present study aimed to investigate sex-related differences in the risk factors for in-hospital mortality and outcome in ischemic stroke patients. Methods A total of 4278 acute ischemic stroke patients admitted to a stroke unit between January 1, 2007 and December 31, 2014 were included in the study. We considered demographic characteristics, clinical characteristics, co-morbidities, and complications, among others, as factors that may affect clinical presentation and in-hospital mortality. Good and poor outcomes were defined as modified Ranking Score (mRS)<= 2 and mRS>2. Neurological deterioration (ND) was defined as an increase of National Institutes of Health Stroke Score (NIHSS) >= 4 points. Hemorrhagic transformation (HT) was defined as signs of hemorrhage in cranial CT or MRI scans. Transtentorial herniation was defined by brain edema, as seen in cranial CT or MRI scans, associated with the onset of acute unilateral or bilateral papillary dilation, loss of reactivity to light, and decline of >= 2 points in the Glasgow coma scale score. Results Of 4278 ischemic stroke patients (women 1757, 41.1%), 269 (6.3%) received thrombolytic therapy. The in hospital mortality rate was 3.35% (139/4278) [4.45% (80/1757) for women and 2.34% (59/2521) for men, p < 0.01]. At discharge, 41.2% (1761/4278) of the patients showed good outcomes [35.4% (622/1757) for women and 45.2% (1139/2521) for men]. Six months after stroke, 56.1% (1813/3231) showed good outcomes [47.4% (629/1328) for women and 62.2% (1184/1903) for men, p < 0.01]. Atrial fibrillation (AF), diabetes mellitus, stroke history, and old age were factors contributing to poor outcomes in men and women. Hypertension was associated with poor outcomes in women but not in men in comparison with patients without hypertension. Stroke severity and increased intracranial pressure were associated with increased in-hospital mortality in men and women. AF was associated with increased in-hospital mortality in women but not in men compared with patients without AF. Conclusion The in-hospital mortality rate was not significantly different between women and men. Functional outcomes at discharge and six months after stroke were poorer in women than in men. Hypertension is an independent factor causing poorer outcomes in women than in men. AF is an independent factor affecting sex differences in hospital mortality in women.	[Ong, Cheung-Ter; Sung, Sheng-Feng; Wu, Chi-Shun; Hsu, Yung-Chu; Su, Yu-Hsiang; Hung, Ling-Chien] Chia Yi Christian Hosp, Dept Neurol, Chiayi, Taiwan; [Ong, Cheung-Ter] Chung Jen Jr Coll Nursing Hlth Sci & Management, Dept Nursing, Chia- Yi, Taiwan; [Wong, Yi-Sin] Chia Yi Christian Hosp, Dept Family Med, Chia- Yi, Taiwan		Ong, CT (corresponding author), Chia Yi Christian Hosp, Dept Neurol, Chiayi, Taiwan.; Ong, CT (corresponding author), Chung Jen Jr Coll Nursing Hlth Sci & Management, Dept Nursing, Chia- Yi, Taiwan.	ctong98@yahoo.com.tw		Ong, Cheung-Ter/0000-0003-1814-4371				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Arboix A, 1998, CEREBROVASC DIS, V8, P8, DOI 10.1159/000015809; Boehme AK, 2014, J STROKE CEREBROVASC, V23, pE255, DOI 10.1016/j.jstrokecerebrovasdis.2013.11.003; Candelise L, 2007, LANCET, V369, P299, DOI 10.1016/S0140-6736(07)60152-4; Chang Yeu-Jhy, 2008, Acta Neurol Taiwan, V17, P275; Chen CJ, 2015, NEUROLOGY, V85, P1980, DOI 10.1212/WNL.0000000000002176; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gall SL, 2010, NEUROLOGY, V74, P975, DOI 10.1212/WNL.0b013e3181d5a48f; Gray LJ, 2007, STROKE, V38, P2960, DOI 10.1161/STROKEAHA.107.488304; Heuschmann PU, 2004, ARCH INTERN MED, V164, P1761, DOI 10.1001/archinte.164.16.1761; Heuschmann PU, 2004, JAMA-J AM MED ASSOC, V292, P1831, DOI 10.1001/jama.292.15.1831; Irie F, 2015, STROKE, V46, P471, DOI 10.1161/STROKEAHA.114.006739; Kapral MK, 2005, STROKE, V36, P809, DOI 10.1161/01.STR.0000157662.09551.e5; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Koton S, 2013, INT J CARDIOL, V168, P4081, DOI 10.1016/j.ijcard.2013.07.019; Lewsey JD, 2009, STROKE, V40, P1038, DOI 10.1161/STROKEAHA.108.542787; Li OL, 2016, STROKE, V47, P255, DOI 10.1161/STROKEAHA.115.010485; Martin RC, 2017, AM J CARDIOL, V119, P256, DOI 10.1016/j.amjcard.2016.09.049; Ong CT, 2016, THER CLIN RISK MANAG, V12, P1057, DOI 10.2147/TCRM.S105703; Ong CT, 2014, J CHIN MED ASSOC, V77, P179, DOI 10.1016/j.jcma.2014.02.002; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Santalucia P, 2013, EUR J INTERN MED, V24, P167, DOI 10.1016/j.ejim.2012.10.004; Smith EE, 2010, CIRCULATION, V122, P1496, DOI 10.1161/CIRCULATIONAHA.109.932822; Stuart-Shor EM, 2009, STROKE, V40, P1121, DOI 10.1161/STROKEAHA.108.543371; [王军 Wang Jun], 2012, [中国电力, Electric Power], V45, P31; Yoshida K, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.004999; Yu CS, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00174	29	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185361	10.1371/journal.pone.0185361	http://dx.doi.org/10.1371/journal.pone.0185361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934363	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900151
